PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lipson, D; Capelletti, M; Yelensky, R; Otto, G; Parker, A; Jarosz, M; Curran, JA; Balasubramanian, S; Bloom, T; Brennan, KW; Donahue, A; Downing, SR; Frampton, GM; Garcia, L; Juhn, F; Mitchell, KC; White, E; White, J; Zwirko, Z; Peretz, T; Nechushtan, H; Soussan-Gutman, L; Kim, J; Sasaki, H; Kim, HR; Park, SI; Ercan, D; Sheehan, CE; Ross, JS; Cronin, MT; Janne, PA; Stephens, PJ				Lipson, Doron; Capelletti, Marzia; Yelensky, Roman; Otto, Geoff; Parker, Alex; Jarosz, Mirna; Curran, John A.; Balasubramanian, Sohail; Bloom, Troy; Brennan, Kristina W.; Donahue, Amy; Downing, Sean R.; Frampton, Garrett M.; Garcia, Lazaro; Juhn, Frank; Mitchell, Kathy C.; White, Emily; White, Jared; Zwirko, Zac; Peretz, Tamar; Nechushtan, Hovav; Soussan-Gutman, Lior; Kim, Jhingook; Sasaki, Hidefumi; Kim, Hyeong Ryul; Park, Seung-il; Ercan, Dalia; Sheehan, Christine E.; Ross, Jeffrey S.; Cronin, Maureen T.; Jaenne, Pasi A.; Stephens, Philip J.			Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies	NATURE MEDICINE			English	Article							MUTATIONS; SENSITIVITY; CARCINOMAS; ACTIVATION; INHIBITOR; GEFITINIB; ERLOTINIB; CETUXIMAB; PATHWAYS; TUMORS	Applying a next-generation sequencing assay targeting 145 cancer-relevant genes in 40 colorectal cancer and 24 non-small cell lung cancer formalin-fixed paraffin-embedded tissue specimens identified at least one clinically relevant genomic alteration in 59% of the samples and revealed two gene fusions, C2orf44-ALK in a colorectal cancer sample and KIF5B-RET in a lung adenocarcinoma. Further screening of 561 lung adenocarcinomas identified 11 additional tumors with KIF5B-RET gene fusions (2.0%; 95% CI 0.8-3.1%). Cells expressing oncogenic KIF5B-RET are sensitive to multi-kinase inhibitors that inhibit RET.	[Lipson, Doron; Yelensky, Roman; Otto, Geoff; Parker, Alex; Jarosz, Mirna; Curran, John A.; Balasubramanian, Sohail; Bloom, Troy; Brennan, Kristina W.; Donahue, Amy; Downing, Sean R.; Frampton, Garrett M.; Garcia, Lazaro; Juhn, Frank; Mitchell, Kathy C.; White, Emily; White, Jared; Zwirko, Zac; Ross, Jeffrey S.; Cronin, Maureen T.; Stephens, Philip J.] Fdn Med, Cambridge, MA USA; [Capelletti, Marzia; Ercan, Dalia; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Peretz, Tamar; Nechushtan, Hovav] Hadassah Hebrew Univ Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Soussan-Gutman, Lior] Oncotest Teva Pharmaceut Ind, Petah Tiqwa, Israel; [Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Sasaki, Hidefumi] Nagoya City Univ, Dept Oncol Immunol & Surg 2, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kim, Hyeong Ryul; Park, Seung-il] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Sheehan, Christine E.; Ross, Jeffrey S.] Albany Med Ctr, Dept Pathol, Albany, NY USA	Foundation Medicine; Harvard University; Dana-Farber Cancer Institute; Hebrew University of Jerusalem; Teva Pharmaceutical Industries; Sungkyunkwan University (SKKU); Samsung Medical Center; Nagoya City University; University of Ulsan; Asan Medical Center; Albany Medical College	Stephens, PJ (corresponding author), Fdn Med, Cambridge, MA USA.	mcronin@foundationmedicine.com; pjanne@partners.org; pstephens@foundationmedicine.com	nechushtan, hovav/Z-3564-2019; Sheehan, Christine E./AAW-1429-2021; Capelletti, Marzia/L-6317-2016	Capelletti, Marzia/0000-0001-5095-7060; Frampton, Garrett/0000-0002-2361-2750	Dana Farber/Harvard Cancer Center Lung Cancer SPORE [P50 CA090578]; Cammarata Family Foundation; Dana-Farber Cancer Institute; Japan Society for the Promotion of Science (JSPS) [23659674, 21390394, 21591820]; NATIONAL CANCER INSTITUTE [R01CA136851, P50CA090578] Funding Source: NIH RePORTER	Dana Farber/Harvard Cancer Center Lung Cancer SPORE; Cammarata Family Foundation; Dana-Farber Cancer Institute; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. Hawryluk for his help in preparing this manuscript. This work is supported by the Dana Farber/Harvard Cancer Center Lung Cancer SPORE P50 CA090578 (P.A.J.), the Cammarata Family Foundation Research Fund (M. C. and P.A.J.), the Nirenberg Fellowship at the Dana-Farber Cancer Institute (M. C. and P.A.J.) and the Japan Society for the Promotion of Science (JSPS), grant references 23659674, 21390394 and 21591820 (H.S.).	Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Henderson YC, 2008, CLIN CANCER RES, V14, P4908, DOI 10.1158/1078-0432.CCR-07-1772; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Turner N, 2005, CURR OPIN PHARMACOL, V5, P388, DOI 10.1016/j.coph.2005.03.006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wong DWS, 2011, CANCER-AM CANCER SOC, V117, P2709, DOI 10.1002/cncr.25843	20	628	685	4	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					382	384		10.1038/nm.2673	http://dx.doi.org/10.1038/nm.2673			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22327622	Green Accepted			2022-12-27	WOS:000301264800038
J	Accili, D				Accili, Domenico			Domenico Accili	NATURE MEDICINE			English	Editorial Material									[Accili, Domenico] Columbia Univ Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA; [Accili, Domenico] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Accili, D (corresponding author), Columbia Univ Coll Phys & Surg, Berrie Diabet Ctr, 630 W 168th St, New York, NY 10032 USA.		de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; Sinclair, David/0000-0002-9936-436X; de Cabo, Rafael/0000-0002-3354-2442	NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG019719, R01AG028730] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG028730, R01 AG019719, R01 AG028730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1350	1351		10.1038/nm1111-1350	http://dx.doi.org/10.1038/nm1111-1350			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064411				2022-12-27	WOS:000296779300022
J	Benedetti, F; Amanzio, M; Rosato, R; Blanchard, C				Benedetti, Fabrizio; Amanzio, Martina; Rosato, Rosalba; Blanchard, Catherine			Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors	NATURE MEDICINE			English	Article							EXPECTATION; DISSECTION; RESPONSES; SYSTEMS; DISEASE; PAIN	Placebo analgesia is mediated by both opioid and nonopioid mechanisms, but so far nothing is known about the nonopioid component. Here we show that the specific CB1 cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-1-pyrazole-3-carboxamide (rimonabant or SR141716) blocks nonopioid placebo analgesic responses but has no effect on opioid placebo responses. These findings suggest that the endocannabinoid system has a pivotal role in placebo analgesia in some circumstances when the opioid system is not involved.	[Benedetti, Fabrizio] Univ Turin, Dept Neurosci, Sch Med, Turin, Italy; [Benedetti, Fabrizio] Natl Inst Neurosci, Turin, Italy; [Amanzio, Martina; Rosato, Rosalba] Univ Turin, Dept Psychol, Turin, Italy; [Rosato, Rosalba] San Giovanni Battista Hosp, Unit Canc Epidemiol, Prevent Oncol Ctr CPO Piemonte, Turin, Italy; [Blanchard, Catherine] Ctr Endocrine & Metab Disorders, Aoste, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Benedetti, F (corresponding author), Univ Turin, Dept Neurosci, Sch Med, Turin, Italy.	fabrizio.benedetti@unito.it	Amanzio, Martina/A-9085-2010	Amanzio, Martina/0000-0002-2504-032X; ROSATO, Rosalba/0000-0002-4921-374X	Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy); Volkswagen Foundation (Hannover, Germany)	Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy); Volkswagen Foundation (Hannover, Germany)(Volkswagen)	This work was supported by grants from Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy) and from the Volkswagen Foundation (Hannover, Germany).	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; BENEDETTI F, 1995, LANCET, V346, P1231, DOI 10.1016/S0140-6736(95)92938-X; Benedetti F, 2007, J NEUROSCI, V27, P11934, DOI 10.1523/JNEUROSCI.3330-07.2007; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fowler CJ, 2007, BRIT J PHARMACOL, V152, P594, DOI 10.1038/sj.bjp.0707379; Guo JY, 2010, J PSYCHOPHARMACOL, V24, P1561, DOI 10.1177/0269881109104848; Hamza May, 2009, Curr Mol Pharmacol, V2, P1; Horti AG, 2006, J NUCL MED, V47, P1689; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wong DF, 2010, NEUROIMAGE, V52, P1505, DOI 10.1016/j.neuroimage.2010.04.034; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	20	186	191	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1228	1230		10.1038/nm.2435	http://dx.doi.org/10.1038/nm.2435			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21963514	Green Submitted			2022-12-27	WOS:000296022100039
J	Korpal, M; Ell, BJ; Buffa, FM; Ibrahim, T; Blanco, MA; Celia-Terrassa, T; Mercatali, L; Khan, Z; Goodarzi, H; Hua, YL; Wei, Y; Hu, GH; Garcia, BA; Ragoussis, J; Amadori, D; Harris, AL; Kang, YB				Korpal, Manav; Ell, Brian J.; Buffa, Francesca M.; Ibrahim, Toni; Blanco, Mario A.; Celia-Terrassa, Toni; Mercatali, Laura; Khan, Zia; Goodarzi, Hani; Hua, Yuling; Wei, Yong; Hu, Guohong; Garcia, Benjamin A.; Ragoussis, Jiannis; Amadori, Dino; Harris, Adrian L.; Kang, Yibin			Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; E-CADHERIN; MICRORNA-21 TARGETS; REPRESSORS ZEB1; TUMOR INVASION; FEEDBACK LOOP; FAMILY; EMT; EXPRESSION	Although the role of miR-200s in regulating E-cadherin expression and epithelial-to-mesenchymal transition is well established, their influence on metastatic colonization remains controversial. Here we have used clinical and experimental models of breast cancer metastasis to discover a pro-metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial phenotype. Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone. Genomic and proteomic analyses revealed global shifts in gene expression upon miR-200 overexpression toward that of highly metastatic cells. miR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis-suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies. Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.	[Korpal, Manav; Ell, Brian J.; Blanco, Mario A.; Celia-Terrassa, Toni; Goodarzi, Hani; Hua, Yuling; Wei, Yong; Hu, Guohong; Garcia, Benjamin A.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Buffa, Francesca M.; Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Mol Oncol Labs, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Ibrahim, Toni; Mercatali, Laura; Amadori, Dino] Ist Sci Romagnolo Studio & Cura Tumori, Osteoncol Ctr, Meldola, Italy; [Celia-Terrassa, Toni] CSIC, Dept Cell Biol, Inst Biol Mol Barcelona, Barcelona, Spain; [Khan, Zia] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Khan, Zia; Goodarzi, Hani] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kang, Yibin] Canc Inst New Jersey, Genom Instabil & Tumor Progress Program, New Brunswick, NJ USA	Princeton University; University of Oxford; IRCCS Meldola (IRST); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Princeton University; Princeton University; University of Oxford; Wellcome Centre for Human Genetics; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu	Harris, Adrian L/ABA-3343-2020; Buffa, Francesca/D-2574-2013; Mercatali, Laura/J-9154-2016; Xie, Huangming/B-2260-2012; Ragoussis, Ioannis/AAD-9790-2022; Celia-Terrassa, Toni/M-4808-2014	Harris, Adrian L/0000-0003-1376-8409; Buffa, Francesca/0000-0003-0409-406X; Mercatali, Laura/0000-0003-2162-8238; Kang, Yibin/0000-0002-1626-6730; Ragoussis, Ioannis/0000-0002-8515-0934; Celia-Terrassa, Toni/0000-0002-0615-8744; Goodarzi, Hani/0000-0002-9648-8949; Ibrahim, Toni/0000-0003-0259-4167; Blanco, M. Andres/0000-0003-4404-2301; Khan, Zia/0000-0002-7859-3489; Hu, Guohong/0000-0002-2980-5166	Department of Defense; US National Institutes of Health [1R01-CA141062]; Brewster Foundation; Cancer Research UK; Oxford NHS Biomedical Research Centre; Friends of Kennington Cancer Fund; US Department of Defense; NATIONAL CANCER INSTITUTE [R01CA141062, P30CA072720, R01CA134519] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brewster Foundation; Cancer Research UK(Cancer Research UK); Oxford NHS Biomedical Research Centre; Friends of Kennington Cancer Fund; US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Kyne at the mass spectrometry core facility, D. Storton and J. Buckles at the microarray core facility, and E. Williams at the electron microscopy facility of Princeton University for expert technical advice and support, N. Sethi for insightful discussions and blinded verification of tumor counts, S.J. Parkinson for technical advice, and K. Socha for colony counting. We also thank E. Williams (Monash Institute of Medical Research) and F. Miller (Barbara Ann Karmanos Cancer Institute) for the TSU-PR1 and 4T1 cell line series, respectively. Y.K. is a Champalimaud Investigator and a Department of Defense Era of Hope Scholar Award recipient. This research was supported by grants from the US National Institutes of Health (1R01-CA141062) and the Brewster Foundation to Y.K. and from Cancer Research UK, Oxford NHS Biomedical Research Centre and Friends of Kennington Cancer Fund to A.L.H.M.K. and Y.H. are recipients of US Department of Defense predoctoral fellowships.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jeschke U, 2007, ANTICANCER RES, V27, P1969; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Park D, 2007, APMIS, V115, P52, DOI 10.1111/j.1600-0463.2007.apm_524.x; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	51	479	498	4	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1101	U108		10.1038/nm.2401	http://dx.doi.org/10.1038/nm.2401			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21822286	Green Accepted, Green Submitted			2022-12-27	WOS:000294605100030
J	Savidge, TC; Urvil, P; Oezguen, N; Ali, K; Choudhury, A; Acharya, V; Pinchuk, I; Torres, AG; English, RD; Wiktorowicz, JE; Loeffelholz, M; Kumar, R; Shi, LF; Nie, WJ; Braun, W; Herman, B; Hausladen, A; Feng, HP; Stamler, JS; Pothoulakis, C				Savidge, Tor C.; Urvil, Petri; Oezguen, Numan; Ali, Kausar; Choudhury, Aproteem; Acharya, Vinay; Pinchuk, Irina; Torres, Alfredo G.; English, Robert D.; Wiktorowicz, John E.; Loeffelholz, Michael; Kumar, Raj; Shi, Lianfa; Nie, Weijia; Braun, Werner; Herman, Bo; Hausladen, Alfred; Feng, Hanping; Stamler, Jonathan S.; Pothoulakis, Charalabos			Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins	NATURE MEDICINE			English	Article							CYSTEINE PROTEASE DOMAIN; DIFFICILE TOXIN; NITRIC-OXIDE; RTX TOXIN; CLEAVAGE; DENITROSYLATION; INFLAMMATION; ENTEROTOXIN; VIRULENCE; RELEASE	The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins(1-4). Virulence is dependent on the autoactivation of a toxin cysteine protease(5-9), which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP(6))(10-17). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins(18,19). Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP(6)- and inositol pyrophosphate (InsP(7))-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP(6) enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.	[Savidge, Tor C.; Urvil, Petri; Ali, Kausar; Choudhury, Aproteem; Acharya, Vinay; Pinchuk, Irina] Univ Texas Med Branch, Dept Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Oezguen, Numan; Wiktorowicz, John E.; Braun, Werner] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [English, Robert D.; Wiktorowicz, John E.] Univ Texas Med Branch, Natl Heart Lung & Blood Inst Prote Ctr, Galveston, TX USA; [Loeffelholz, Michael] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Shi, Lianfa; Nie, Weijia; Feng, Hanping] Tufts Univ Cummings Sch Vet Med, Div Infect Dis, Dept Biomed Sci, North Grafton, MA USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Inste Transformat Mol Med, Cleveland, OH 44106 USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Univ Hosp, Cleveland, OH USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Herman, Bo; Hausladen, Alfred; Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, Div Digest Dis, Los Angeles, CA USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Geisinger Commonwealth School of Medicine; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University of California System; University of California Los Angeles	Savidge, TC (corresponding author), Univ Texas Med Branch, Dept Gastroenterol & Hepatol, Galveston, TX 77555 USA.	tcsavidg@utmb.edu	Braun, Werner/A-6642-2012; Pinchuk, Irina V/A-7227-2008; Oezguen, Numan/C-9267-2009	Pinchuk, Irina V/0000-0003-1505-5779; Oezguen, Numan/0000-0002-3175-2382; Torres, Alfredo/0000-0001-6450-0643; Stamler, Jonathan/0000-0002-6866-1572	Eli & Edith Broad Foundation; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Howard Hughes Medical Institute; US National Institutes of Health National Institute of Allergy and Infectious Diseases [R01AI088748, N01AI30050]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK084509, K01DK076549, R21-DK078032-01]; National Heart, Lung, and Blood Institute [R01-HL059130, R01-HL091876, R01-HL095463, P01-HL075443-06A, NO1-HV-00245];  [1UL1RR029876-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095463, R01HL091876, P01HL075443, R01HL059130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050, R01AI088748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078032, R01DK084509, K01DK076549] Funding Source: NIH RePORTER	Eli & Edith Broad Foundation; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Eli & Edith Broad Foundation, the John S. Dunn Gulf Coast Consortium for Chemical Genomics Robert A. Welch Collaborative Grant Program, the Howard Hughes Medical Institute and grants from the US National Institutes of Health National Institute of Allergy and Infectious Diseases (R01AI088748, N01AI30050), National Institute of Diabetes and Digestive and Kidney Diseases (R01DK084509, K01DK076549; R21-DK078032-01), National Heart, Lung, and Blood Institute (R01-HL059130, R01-HL091876, R01-HL095463, P01-HL075443-06A, NO1-HV-00245) and 1UL1RR029876-01. We thank D. Powell, S. Weinman, C.S. Schein and G. Prestwich for their critiques.	Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Guttenberg G, 2011, J BIOL CHEM, V286, P14779, DOI 10.1074/jbc.M110.200691; Hausladen A, 2007, P NATL ACAD SCI USA, V104, P2157, DOI 10.1073/pnas.0611191104; He XY, 2009, J MICROBIOL METH, V78, P97, DOI 10.1016/j.mimet.2009.04.007; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kreimeyer I, 2011, N-S ARCH PHARMACOL, V383, P253, DOI 10.1007/s00210-010-0574-x; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; McMahon TJ, 2000, J BIOL CHEM, V275, P16738, DOI 10.1074/jbc.M000532200; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Pei JM, 2009, PROTEIN SCI, V18, P856, DOI 10.1002/pro.78; Popoff M.R., 2009, BIOCHIM BIOPHYS ACTA, V88, P797; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Puri AW, 2010, CHEM BIOL, V17, P1201, DOI 10.1016/j.chembiol.2010.09.011; Qiu BS, 1996, GASTROENTEROLOGY, V111, P409, DOI 10.1053/gast.1996.v111.pm8690206; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Saura M, 1999, IMMUNITY, V10, P21, DOI 10.1016/S1074-7613(00)80003-5; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Tang HY, 2004, ANAL BIOCHEM, V334, P48, DOI 10.1016/j.ab.2004.08.008; Wiktorowicz JE, 2011, BIOCHEMISTRY-US, V50, P5601, DOI 10.1021/bi200008b	40	71	72	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1136	U147		10.1038/nm.2405	http://dx.doi.org/10.1038/nm.2405			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857653	Green Accepted			2022-12-27	WOS:000294605100036
J	Sasaki, M; Kawahara, K; Nishio, M; Mimori, K; Kogo, R; Hamada, K; Itoh, B; Wang, J; Komatsu, Y; Yang, YR; Hikasa, H; Horie, Y; Yamashita, T; Kamijo, T; Zhang, YP; Zhu, Y; Prives, C; Nakano, T; Mak, TW; Sasaki, T; Maehama, T; Mori, M; Suzuki, A				Sasaki, Masato; Kawahara, Kohichi; Nishio, Miki; Mimori, Koshi; Kogo, Ryunosuke; Hamada, Koichi; Itoh, Bunsho; Wang, Jia; Komatsu, Yukako; Yang, Yong Ryoul; Hikasa, Hiroki; Horie, Yasuo; Yamashita, Takayuki; Kamijo, Takehiko; Zhang, Yanping; Zhu, Yan; Prives, Carol; Nakano, Toru; Mak, Tak Wah; Sasaki, Takehiko; Maehama, Tomohiko; Mori, Masaki; Suzuki, Akira			Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11	NATURE MEDICINE			English	Article							RIBOSOMAL-PROTEIN L11; SUPPRESSOR CANDIDATE; P53 STABILITY; GENE-PRODUCT; DNA-DAMAGE; INHIBITION; EXPRESSION; SURVIVAL; HDM2; DIFFERENTIATION	PICT1 (also known as GLTSCR2) is considered a tumor suppressor because it stabilizes phosphatase and tensin homolog (PTEN), but individuals with oligodendrogliomas lacking chromosome 19q13, where PICT1 is located, have better prognoses than other oligodendroglioma patients. To clarify the function of PICT1, we generated Pict1-deficient mice and embryonic stem (ES) cells. Pict1 is a nucleolar protein essential for embryogenesis and ES cell survival. Even without DNA damage, Pict1 loss led to p53-dependent arrest of cell cycle phase G(1) and apoptosis. Pict1-deficient cells accumulated p53, owing to impaired Mdm2 function. Pict1 binds Rpl11, and Rpl11 is released from nucleoli in the absence of Pict1. In Pict1-deficient cells, increased binding of Rpl11 to Mdm2 blocks Mdm2-mediated ubiquitination of p53. In human cancer, individuals whose tumors express less PICT1 have better prognoses. When PICT1 is depleted in tumor cells with intact P53 signaling, the cells grow more slowly and accumulate P53. Thus, PICT1 is a potent regulator of the MDM2-P53 pathway and promotes tumor progression by retaining RPL11 in the nucleolus.	[Sasaki, Masato; Sasaki, Takehiko; Suzuki, Akira] Akita Univ, Sch Med, Global Ctr Excellence Program, Akita 010, Japan; [Kawahara, Kohichi; Nishio, Miki; Hamada, Koichi; Itoh, Bunsho; Wang, Jia; Komatsu, Yukako; Yang, Yong Ryoul; Hikasa, Hiroki; Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 812, Japan; [Mimori, Koshi; Kogo, Ryunosuke; Mori, Masaki] Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Fukuoka 812, Japan; [Horie, Yasuo] Akita Univ, Grad Sch Med, Dept Gastroenterol, Akita 010, Japan; [Yamashita, Takayuki] Gunma Univ, Inst Mol & Cellular Regulat, Mol Genet Lab, Maebashi, Gunma 371, Japan; [Kamijo, Takehiko] Chiba Canc Ctr, Res Inst, Div Biochem & Mol Carcinogenesis, Chiba 2608717, Japan; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhu, Yan; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Nakano, Toru] Osaka Univ, Dept Pathol, Suita, Osaka, Japan; [Mak, Tak Wah] Univ Hlth Network, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 010, Japan; [Maehama, Tomohiko] Dept Biochem & Cell Biol, Tokyo, Japan; Natl Inst Infect Dis, Tokyo, Japan; [Mori, Masaki] Osaka Univ, Sch Med, Dept Surg Gastroenterol, Suita, Osaka 565, Japan; [Mori, Masaki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan	Akita University; Kyushu University; Kyushu University; Akita University; Gunma University; Chiba Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Osaka University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Akita University; National Institute of Infectious Diseases (NIID); Osaka University; Osaka University	Suzuki, A (corresponding author), Akita Univ, Sch Med, Global Ctr Excellence Program, Akita 010, Japan.	mmori@gesurg.med.osaka-u.ac.jp; suzuki@bioreg.kyushu-u.ac.jp	Kawahara, Kohichi/AAQ-5381-2021; Kogo, Ryunosuke/GOJ-9354-2022; Suzuki, Akira/GYD-6697-2022; Maehama, Tomohiko/HGB-4896-2022; Maehama, Tomohiko/AAX-8926-2020; 高, 雨莉/HGU-8187-2022	Kogo, Ryunosuke/0000-0002-7030-7302; Suzuki, Akira/0000-0002-5950-8808; Maehama, Tomohiko/0000-0002-9685-2317; Mimori, Koshi/0000-0003-3897-9974; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports and Technology of Japan (MEXT); Takeda Medical Foundation; Naito Foundation; Ono Medical Research Foundation; Yasuda Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Japanese Science and Technology Agency; NATIONAL CANCER INSTITUTE [K01CA087580, R01CA127770, R01CA100302] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23592132] Funding Source: KAKEN	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Medical Foundation; Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Yasuda Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Noda, S. Kuroda, H. Kishimoto, M. Natsui, H. Takahashi, H. Tashiro, N. Yasui, M. Suzuki, S. Suzuki, T. Shono and T. Sasaki for expert technical support and helpful discussions. We also thank H. Miyoshi (RIKEN BioResource Center, Tsukuba, Japan) for providing lentivirus vector plasmid DNA. This work was supported by grants from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT), Takeda Medical Foundation, Naito Foundation, Ono Medical Research Foundation, Yasuda Medical Foundation, and Astellas Foundation for Research on Metabolic Disorders. K. M. and M. M. are supported by the Core Research for Evolutionary Science and Technology program of the Japanese Science and Technology Agency. T.Y., T. S., M. M. and A. S. are supported by the Global Centers of Excellence Program of MEXT.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Egashira A, 2007, CANCER SCI, V98, P1152, DOI 10.1111/j.1349-7006.2007.00524.x; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kim JY, 2010, PATHOL RES PRACT, V206, P295, DOI 10.1016/j.prp.2009.12.012; Kim YJ, 2008, J PATHOL, V216, P218, DOI 10.1002/path.2401; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mariani L, 2006, J CLIN ONCOL, V24, P4758, DOI 10.1200/JCO.2006.05.9238; Merritt MA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-378; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Nakagawa Y, 2006, ONCOL REP, V15, P297; Okahara F, 2005, ANAL BIOCHEM, V336, P138, DOI 10.1016/j.ab.2004.09.018; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Solozobova V, 2010, EXP CELL RES, V316, P2434, DOI 10.1016/j.yexcr.2010.06.006; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; VONDEIMLING A, 1994, CANCER RES, V54, P1397; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yim JH, 2007, CELL DEATH DIFFER, V14, P1872, DOI 10.1038/sj.cdd.4402204; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	53	133	135	0	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					944	U153		10.1038/nm.2392	http://dx.doi.org/10.1038/nm.2392			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804542	Green Accepted, Green Submitted			2022-12-27	WOS:000293507400027
J	Huang, Q; Li, F; Liu, XJ; Li, WR; Shi, W; Liu, FF; O'Sullivan, B; He, ZM; Peng, YL; Tan, AC; Zhou, L; Shen, JP; Han, GW; Wang, XJ; Thorburn, J; Thorburn, A; Jimeno, A; Raben, D; Bedford, JS; Li, CY				Huang, Qian; Li, Fang; Liu, Xinjian; Li, Wenrong; Shi, Wei; Liu, Fei-Fei; O'Sullivan, Brian; He, Zhimin; Peng, Yuanlin; Tan, Aik-Choon; Zhou, Ling; Shen, Jingping; Han, Gangwen; Wang, Xiao-Jing; Thorburn, Jackie; Thorburn, Andrew; Jimeno, Antonio; Raben, David; Bedford, Joel S.; Li, Chuan-Yuan			Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy	NATURE MEDICINE			English	Article							APOPTOTIC CELLS; PHOSPHOLIPASE A(2); PROLIFERATION; DIFFERENTIATION; REGENERATION; ACTIVATION; MIGRATION; RELEASE	In cancer treatment, apoptosis is a well-recognized cell death mechanism through which cytotoxic agents kill tumor cells. Here we report that dying tumor cells use the apoptotic process to generate potent growth-stimulating signals to stimulate the repopulation of tumors undergoing radiotherapy. Furthermore, activated caspase 3, a key executioner in apoptosis, is involved in the growth stimulation. One downstream effector that caspase 3 regulates is prostaglandin E2 (PGE2), which can potently stimulate growth of surviving tumor cells. Deficiency of caspase 3 either in tumor cells or in tumor stroma caused substantial tumor sensitivity to radiotherapy in xenograft or mouse tumors. In human subjects with cancer, higher amounts of activated caspase 3 in tumor tissues are correlated with markedly increased rate of recurrence and death. We propose the existence of a cell death-induced tumor repopulation pathway in which caspase 3 has a major role.	[Huang, Qian; Li, Fang; Liu, Xinjian; Li, Wenrong; He, Zhimin; Shen, Jingping; Raben, David; Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA; [Huang, Qian] Shanghai Jiao Tong Univ, Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Huang, Qian] Shanghai Jiao Tong Univ, Inst Canc, Natl Lab Oncogenes & Related Genes Res, Shanghai 200030, Peoples R China; [Shi, Wei; Liu, Fei-Fei; O'Sullivan, Brian] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada; [Shi, Wei; Liu, Fei-Fei; O'Sullivan, Brian] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada; [Peng, Yuanlin; Bedford, Joel S.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Tan, Aik-Choon; Jimeno, Antonio] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Zhou, Ling] Shanghai First Peoples Branch Hosp, Dept Surg, Shanghai, Peoples R China; [Han, Gangwen; Wang, Xiao-Jing] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Wang, Xiao-Jing; Jimeno, Antonio; Raben, David] Univ Colorado, Ctr Canc, Head & Neck Canc Res Program, Aurora, CO USA; [Wang, Xiao-Jing; Jimeno, Antonio; Li, Chuan-Yuan] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Thorburn, Jackie; Thorburn, Andrew; Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, CY (corresponding author), Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA.	chuan.li@ucdenver.edu	Li, Chuan-Yuan/H-4148-2013; Tan, Aik Choon/A-3135-2011; Han, Gangwen/A-1773-2014	Tan, Aik Choon/0000-0003-2955-8369; Spence, Tara/0000-0001-7098-4103; O'Sullivan, Brian/0000-0001-8887-843X; Liu, Fei-Fei/0000-0003-4344-6486	US National Cancer Institute [CA131408, CA136748]; US National Aeronautics and Space Administration Ground [NNX09AH19G]; US Department of Energy [DEFG0207ER64350]; National Basic Research Project of China [2010CB529900]; China National Natural Science Foundation [30325043, 30428015]; NATIONAL CANCER INSTITUTE [R01CA136748, P30CA046934, R01CA131408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Aeronautics and Space Administration Ground; US Department of Energy(United States Department of Energy (DOE)); National Basic Research Project of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank R. Flavell of Yale University for providing us with MEF cells with caspase 3 or 7 deficiencies. We thank B. Liu of University of Colorado School of Medicine for providing us with the MCF-7 and MCF-7CASP3 cells. We also thank P. Kabos for insightful discussions. This study was supported in part by grants CA131408 and CA136748 from the US National Cancer Institute (to C.-Y.L.), and grant NNX09AH19G (to C.-Y.L.) from US National Aeronautics and Space Administration Ground-based Space Radiation Biology Research Program. It was also supported by a subcontract (to C.-Y.L.) of grant DEFG0207ER64350 (to J.S.B.) from the US Department of Energy Low Dose Radiation Research Program. Q.H. was supported by grant 2010CB529900 from the National Basic Research Project of China and Outstanding Young Scientist grants 30325043 & 30428015 from China National Natural Science Foundation.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Hall E J, 2006, RADIOBIOLOGY RADIOLO, P378; HERMENS AF, 1969, EUR J CANCER, V5, P173, DOI 10.1016/0014-2964(69)90065-6; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; STEEL GG, 2002, BASIC CLIN RADIOBIOL, P52; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; STEPHENS TC, 1978, BRIT J CANCER, V38, P573, DOI 10.1038/bjc.1978.252; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200; [No title captured]	29	573	609	3	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					860	U231		10.1038/nm.2385	http://dx.doi.org/10.1038/nm.2385			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21725296	Green Accepted			2022-12-27	WOS:000292500800041
J	Johnson, N; Li, YC; Walton, ZE; Cheng, KA; Li, DA; Rodig, SJ; Moreau, LA; Unitt, C; Bronson, RT; Thomas, HD; Newell, DR; D'Andrea, AD; Curtin, NJ; Wong, KK; Shapiro, GI				Johnson, Neil; Li, Yu-Chen; Walton, Zandra E.; Cheng, Katherine A.; Li, Danan; Rodig, Scott J.; Moreau, Lisa A.; Unitt, Christine; Bronson, Roderick T.; Thomas, Huw D.; Newell, David R.; D'Andrea, Alan D.; Curtin, Nicola J.; Wong, Kwok-Kin; Shapiro, Geoffrey I.			Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition	NATURE MEDICINE			English	Article							DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; LUNG-CANCER; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; REPAIR; PHOSPHORYLATION; TUMORS; CISPLATIN; LINES	Cells that are deficient in homologous recombination, such as those that lack functional breast cancer-associated 1 (BRCA1) or BRCA2, are hypersensitive to inhibition of poly(ADP-ribose) polymerase (PARP). However, BRCA-deficient tumors represent only a small fraction of adult cancers, which might restrict the therapeutic utility of PARP inhibitor monotherapy. Cyclindependent kinase 1 (Cdk1) phosphorylates BRCA1, and this is essential for efficient formation of BRCA1 foci. Here we show that depletion or inhibition of Cdk1 compromises the ability of cells to repair DNA by homologous recombination. Combined inhibition of Cdk1 and PARP in BRCA-wild-type cancer cells resulted in reduced colony formation, delayed growth of human tumor xenografts and tumor regression with prolonged survival in a mouse model of lung adenocarcinoma. Inhibition of Cdk1 did not sensitize nontransformed cells or tissues to inhibition of PARP. Because reduced Cdk1 activity impaired BRCA1 function and consequently, repair by homologous recombination, inhibition of Cdk1 represents a plausible strategy for expanding the utility of PARP inhibitors to BRCA-proficient cancers.	[Johnson, Neil; Li, Yu-Chen; Walton, Zandra E.; Cheng, Katherine A.; Li, Danan; Wong, Kwok-Kin; Shapiro, Geoffrey I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Rodig, Scott J.; Unitt, Christine; Bronson, Roderick T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Johnson, Neil; Wong, Kwok-Kin; Shapiro, Geoffrey I.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rodig, Scott J.; Unitt, Christine] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Moreau, Lisa A.; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Moreau, Lisa A.; D'Andrea, Alan D.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Thomas, Huw D.; Newell, David R.; Curtin, Nicola J.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Newcastle University - UK; Harvard University; Dana-Farber Cancer Institute	Shapiro, GI (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	geoffrey_shapiro@dfci.harvard.edu	Rodig, Scott/Y-3889-2019	Walton, Zandra/0000-0002-0465-0153; wong, kwok kin/0000-0001-6323-235X; Curtin, Nicola/0000-0003-1369-1843	US National Institutes of Health (NIH) [R01 CA090687, P50 CA089393]; Career Development Award; Susan G. Komen Post-Doctoral Fellowship [KG080773]; NIH [P50 CA090578, U01 CA141576, R01 AG2400401, R01 CA122794, R01 CA140594, 1RC2 CA147940-01]; Cancer Research U.K.; Uniting Against Lung Cancer grant; NATIONAL CANCER INSTITUTE [P50CA090578, UM1CA186709, R01CA090687, P50CA089393, RC2CA147940, U01CA141576, R01CA140594, R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG024004] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award; Susan G. Komen Post-Doctoral Fellowship(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research U.K.(Cancer Research UK); Uniting Against Lung Cancer grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Institutes of Health (NIH) Grants R01 CA090687 (G.I.S.), P50 CA089393 (Dana-Farber/Harvard Cancer Center (DF/HCC) Specialized Program of Research Excellence (SPORE) in Breast Cancer), including Developmental Project Funding (G.I.S.) and a Career Development Award (N.J.), as well as Susan G. Komen Post-Doctoral Fellowship Award KG080773 (N.J., G.I.S. and N.J. C.) and NIH Grant P50 CA090578 (DF/HCC SPORE in Lung Cancer) (G.I.S. and K.-K.W.). H.D.T., N.J.C. and D.R.N. were supported by a Programme Grant from Cancer Research U.K. K.-K. W. was also supported by a Uniting Against Lung Cancer grant and NIH grants U01 CA141576, R01 AG2400401, R01 CA122794, R01 CA140594 and 1RC2 CA147940-01. We thank M. Arora and J.D. Parvin for assistance with preliminary experiments; D. Skinner for technical assistance with tissue block and slide preparation; members of the Confocal and Light Microscopy Core Facility at the Dana-Farber Cancer Institute for technical assistance with acquisition of confocal microscopy images; M. Jasin (Memorial Sloan-Kettering Cancer Center) for U2OS pDR-GFP cells; and K. Hook, D. Madren and Z. Hostomsky of Pfizer for AG14361, AG014699 (PF-01367338) and AG024322 (PF-00176275).	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Brown AP, 2008, CANCER CHEMOTH PHARM, V62, P1091, DOI 10.1007/s00280-008-0771-1; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103	36	206	210	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					875	U257		10.1038/nm.2377	http://dx.doi.org/10.1038/nm.2377			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706030	Green Accepted			2022-12-27	WOS:000292500800043
J	Portugal, S; Carret, C; Recker, M; Armitage, AE; Goncalves, LA; Epiphanio, S; Sullivan, D; Roy, C; Newbold, CI; Drakesmith, H; Mota, MM				Portugal, Silvia; Carret, Celine; Recker, Mario; Armitage, Andrew E.; Goncalves, Ligia A.; Epiphanio, Sabrina; Sullivan, David; Roy, Cindy; Newbold, Chris I.; Drakesmith, Hal; Mota, Maria M.			Host-mediated regulation of superinfection in malaria	NATURE MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; LIVER STAGE; HEPATIC DEVELOPMENT; IRON; HEPCIDIN; TRANSMISSION; INFECTION; AREA; EPIDEMIOLOGY; FERROPORTIN	In regions of high rates of malaria transmission, mosquitoes repeatedly transmit liver-tropic Plasmodium sporozoites to individuals who already have blood-stage parasitemia(1). This manifests itself in semi-immune children (who have been exposed since birth to Plasmodium infection and as such show low levels of peripheral parasitemia but can still be infected) older than 5 years of age by concurrent carriage of different parasite genotypes at low asymptomatic parasitemias(2). Superinfection presents an increased risk of hyperparasitemia and death in less immune individuals but counterintuitively is not frequently observed in the young(3,4). Here we show in a mouse model that ongoing blood-stage infections, above a minimum threshold, impair the growth of subsequently inoculated sporozoites such that they become growth arrested in liver hepatocytes and fail to develop into blood-stage parasites. Inhibition of the liver-stage infection is mediated by the host iron regulatory hormone hepcidin(5), whose synthesis we found to be stimulated by blood-stage parasites in a density-dependent manner. We mathematically modeled this phenomenon and show how density-dependent protection against liver-stage malaria can shape the epidemiological patterns of age-related risk and the complexity of malaria infections seen in young children. The interaction between these two Plasmodium stages and host iron metabolism has relevance for the global efforts to reduce malaria transmission and for evaluation of iron supplementation programs in malaria-endemic regions.	[Portugal, Silvia; Carret, Celine; Epiphanio, Sabrina; Mota, Maria M.] Univ Lisbon, Fac Med, IMM, P-1699 Lisbon, Portugal; [Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Armitage, Andrew E.; Newbold, Chris I.; Drakesmith, Hal] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Goncalves, Ligia A.; Mota, Maria M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sullivan, David] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD USA; [Roy, Cindy] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD USA	Universidade de Lisboa; University of Oxford; University of Oxford; Instituto Gulbenkian de Ciencia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Mota, MM (corresponding author), Univ Lisbon, Fac Med, IMM, P-1699 Lisbon, Portugal.	mmota@fm.ul.pt	Mota, Maria/AAF-2048-2019; Epiphanio, Sabrina/C-7572-2012; Gonçalves, Lígia Antunes/F-6242-2014; Epiphanio, Sabrina/S-2564-2019	Epiphanio, Sabrina/0000-0001-6094-9750; Gonçalves, Lígia Antunes/0000-0001-9804-6899; Epiphanio, Sabrina/0000-0001-6094-9750; Armitage, Andrew/0000-0001-5977-6602; Drakesmith, Alexander/0000-0002-8503-6103; Mota, Maria Manuel/0000-0002-2858-1041; Recker, Mario/0000-0001-9489-1315; Portugal, Silvia/0000-0003-4567-9101; Newbold, Chris/0000-0002-9274-3789	European Community [242095]; Fundacao para a Ciencia e Tecnologia; European Science Foundation; Howard Hughes Medical Institute; Medical Research Council UK [92044]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/31523/2006, SFRH/BPD/40965/2007]; Royal Society; MRC [G0901149] Funding Source: UKRI; Medical Research Council [G0901149] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD061241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082722] Funding Source: NIH RePORTER	European Community(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank L. Renia (Agency for Science, Technology and Research, Singapore) for helpful comments and S-methylthiourea and N-acetylcysteine, as well as R. Appelberg (Instituto de Biologia Molecular e Celular (IBMC), Portugal), J. Di Santo (Institut Pasteur) and J. Rivera (US National Institutes of Arthritis and Musculoskeletal and Skin Diseases) for IFN-gamma-, RAG2 gamma<INF>c</INF>- and Mcpt4-deficient mice, respectively, S. Rivella (Weill Cornell Medical College) for GFP- and HAMP.GFP-expressing adenoviruses, and P. Arosio (Faculty of Medicine, University of Brescia) for antibodies against mouse heavy and light ferritin chains. P. berghei ANKA, P. berghei NK65, P. yoelii 17X NL and P. chabaudi chabaudi AS were obtained from C. Jansen (Leiden University), A. Rodriguez (New York University), D. Walliker (Edinburgh University) and W. Jarra (UK National Institute for Medical Research), respectively. This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095 (M.M.M.), Fundacao para a Ciencia e Tecnologia, European Science Foundation (European Young Investigator Award to M.M.M.), Howard Hughes Medical Institute (to M.M.M.) and the Medical Research Council UK (grant ID 92044). H.D. is a Beit Memorial Fellow for Medical Research and a Medical Research Council New Investigator. S.P. and C.C. were supported by Fundacao para a Ciencia e a Tecnologia fellowships (SFRH/BD/31523/2006 and SFRH/BPD/40965/2007, respectively). M.R. is supported by a Royal Society University Research Fellowship.	Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Armitage AE, 2009, BRIT J HAEMATOL, V147, P769, DOI 10.1111/j.1365-2141.2009.07880.x; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Drakesmith H, 2005, BLOOD, V106, P1092, DOI 10.1182/blood-2005-02-0561; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; GOMA J, 1995, PARASITE, V2, P351; Goma J, 1996, PARASITOLOGY, V112, P165, DOI 10.1017/S0031182000084729; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; HEPPNER DG, 1988, BLOOD, V72, P358; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Mmbando BP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-165; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; STAHEL E, 1988, AM J TROP MED HYG, V39, P236, DOI 10.4269/ajtmh.1988.39.236; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	36	176	179	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					732	U126		10.1038/nm.2368	http://dx.doi.org/10.1038/nm.2368			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21572427	Green Accepted			2022-12-27	WOS:000291308800035
J	Rolland, M; Tovanabutra, S; deCamp, AC; Frahm, N; Gilbert, PB; Sanders-Buell, E; Heath, L; Magaret, CA; Bose, M; Bradfield, A; O'Sullivan, A; Crossler, J; Jones, T; Nau, M; Wong, K; Zhao, H; Raugi, DN; Sorensen, S; Stoddard, JN; Maust, BS; Deng, WJ; Hural, J; Dubey, S; Michael, NL; Shiver, J; Corey, L; Li, FS; Self, SG; Kim, J; Buchbinder, S; Casimiro, DR; Robertson, MN; Duerr, A; McElrath, MJ; McCutchan, FE; Mullins, JI				Rolland, Morgane; Tovanabutra, Sodsai; deCamp, Allan C.; Frahm, Nicole; Gilbert, Peter B.; Sanders-Buell, Eric; Heath, Laura; Magaret, Craig A.; Bose, Meera; Bradfield, Andrea; O'Sullivan, Annemarie; Crossler, Jacqueline; Jones, Teresa; Nau, Marty; Wong, Kim; Zhao, Hong; Raugi, Dana N.; Sorensen, Stephanie; Stoddard, Julia N.; Maust, Brandon S.; Deng, Wenjie; Hural, John; Dubey, Sheri; Michael, Nelson L.; Shiver, John; Corey, Lawrence; Li, Fusheng; Self, Steve G.; Kim, Jerome; Buchbinder, Susan; Casimiro, Danilo R.; Robertson, Michael N.; Duerr, Ann; McElrath, M. Juliana; McCutchan, Francine E.; Mullins, James I.			Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial	NATURE MEDICINE			English	Article							T-LYMPHOCYTE RESPONSE; CELL RESPONSES; ESCAPE; PREDICTION; IMMUNITY; BINDING; GAG	We analyzed HIV-1 genome sequences from 68 newly infected volunteers in the STEP HIV-1 vaccine trial. To determine whether the vaccine exerted selective T cell pressure on breakthrough viruses, we identified potential T cell epitopes in the founder sequences and compared them to epitopes in the vaccine. We found greater distances to the vaccine sequence for sequences from vaccine recipients than from placebo recipients. The most significant signature site distinguishing vaccine from placebo recipients was Gag amino acid 84, a site encompassed by several epitopes contained in the vaccine and restricted by human leukocyte antigen (HLA) alleles common in the study cohort. Moreover, the extended divergence was confined to the vaccine components of the virus (HIV-1 Gag, Pol and Nef) and not found in other HIV-1 proteins. These results represent what is to our knowledge the first evidence of selective pressure from vaccine-induced T cell responses on HIV-1 infection in humans.	[Rolland, Morgane; Heath, Laura; Wong, Kim; Zhao, Hong; Raugi, Dana N.; Sorensen, Stephanie; Stoddard, Julia N.; Maust, Brandon S.; Deng, Wenjie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Tovanabutra, Sodsai; Sanders-Buell, Eric; Bose, Meera; Bradfield, Andrea; O'Sullivan, Annemarie; Crossler, Jacqueline; Jones, Teresa; Nau, Marty; Michael, Nelson L.; Kim, Jerome; McCutchan, Francine E.] US Mil HIV Res Program, Rockville, MD USA; [deCamp, Allan C.; Frahm, Nicole; Gilbert, Peter B.; Magaret, Craig A.; Hural, John; Corey, Lawrence; Li, Fusheng; Self, Steve G.; Duerr, Ann; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Dubey, Sheri; Shiver, John; Casimiro, Danilo R.; Robertson, Michael N.] Merck Res Labs, West Point, PA USA; [Buchbinder, Susan] San Francisco Dept Hlth, San Francisco, CA USA	University of Washington; University of Washington Seattle; Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; Merck & Company	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	US Public Health Service grant [AI41505]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068618, U01AI068618, R37AI054165, P30AI027757] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the study participants for their time and dedication; the HIV Vaccine Trials Network Laboratory Program, the Statistical Center for HIV/AIDS Research & Prevention and Core staff who contributed to the study implementation and analysis; the Merck functional teams: the Clinical Research Specialist Organization, Worldwide Clinical Data Management Operation, Clinical Research Operations, J.T. Herbeck and B.B. Larsen for comments on the manuscript, and the Clinical Assay and Sample Receiving Operations. This work was supported by US Public Health Service grant AI41505.	Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KORBER BTM, 2006, HIV MOL IMMUNOLOGY; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; LEITNER T, 2006, HIV SEQUENCE COMPEND, P648; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Reece JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012774; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; TARONE RE, 1990, BIOMETRICS, V46, P515, DOI 10.2307/2531456; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	19	172	174	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					366	U168		10.1038/nm.2316	http://dx.doi.org/10.1038/nm.2316			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21358627	Green Accepted			2022-12-27	WOS:000288070000048
J	Zhou, YJ; Lee, J; Reno, CM; Sun, C; Park, SW; Chung, J; Lee, J; Fisher, SJ; White, MF; Biddinger, SB; Ozcan, U				Zhou, Yingjiang; Lee, Justin; Reno, Candace M.; Sun, Cheng; Park, Sang Won; Chung, Jason; Lee, Jaemin; Fisher, Simon J.; White, Morris F.; Biddinger, Sudha B.; Ozcan, Umut			Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR FOXO1; INSULIN-RESISTANCE; ER STRESS; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; MICE LACKING; OBESITY; XBP-1; PHOSPHORYLATION	To date, the only known role of the spliced form of X-box-binding protein-1 (XBP-1s) in metabolic processes has been its ability to act as a transcription factor that regulates the expression of genes that increase the endoplasmic reticulum (ER) folding capacity, thereby improving insulin sensitivity. Here we show that XBP-1s interacts with the Forkhead box O1 (FoxO1) transcription factor and directs it toward proteasome-mediated degradation. Given this new insight, we tested modest hepatic overexpression of XBP-1s in vivo in mouse models of insulin deficiency or insulin resistance and found it improved serum glucose concentrations, even without improving insulin signaling or ER folding capacity. The notion that XBP-1s can act independently of its role in the ER stress response is further supported by our finding that in the severely insulin resistant ob/ob mouse strain a DNA-binding-defective mutant of XBP-1s, which does not have the ability to increase ER folding capacity, is still capable of reducing serum glucose concentrations and increasing glucose tolerance. Our results thus provide the first evidence to our knowledge that XBP-1s, through its interaction with FoxO1, can bypass hepatic insulin resistance independent of its effects on ER folding capacity, suggesting a new therapeutic approach for the treatment of type 2 diabetes.	[Zhou, Yingjiang; Lee, Justin; Sun, Cheng; Park, Sang Won; Chung, Jason; Lee, Jaemin; White, Morris F.; Biddinger, Sudha B.; Ozcan, Umut] Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02115 USA; [Reno, Candace M.; Fisher, Simon J.] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Washington University (WUSTL)	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	Children's Hospital Boston [R01DK081009]; US National Institutes of Health; Timothy Murphy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009] Funding Source: NIH RePORTER	Children's Hospital Boston; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Timothy Murphy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Ozcan laboratory for their help during the execution of the experiments. We thank L. Glimcher (Harvard School of Public Health) for providing us with the Xbp1<SUP>flox/flox</SUP> mouse strain. We are grateful to D. Accili (Columbia University) for providing us with various FoxO1 adenoviruses and to R. Kahn (Joslin Diabetes Center) for his permission to use LIRKO mice in our studies. We thank J. Majzoub (Harvard Medical School) for providing us with the mammalian two-hybrid system and R. King (Harvard Medical School) for providing us with a ubiquitin-expressing plasmid. We thank M. Birnbaum (University of Pennsylvania) for providing us with Akt1/2 double-knockout cells. This study was supported by junior faculty start-up funds provided to U.O. by Children's Hospital Boston, an RO1 grant (R01DK081009) provided to U.O. by the US National Institutes of Health, and the Timothy Murphy funds provided to the Division of Endocrinology, Children's Hospital Boston.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; de Luca C, 2006, NAT MED, V12, P41, DOI 10.1038/nm0106-41; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; FAN W, 2010, EMBO J; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsumoto M, 2006, NAT MED, V12, P33, DOI 10.1038/nm0106-33; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MORI K, 1993, CELL, V74, P743; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	46	205	224	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					356	U161		10.1038/nm.2293	http://dx.doi.org/10.1038/nm.2293			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21317886	Green Accepted			2022-12-27	WOS:000288070000047
J	Charles, N; Hardwick, D; Daugas, E; Illei, GG; Rivera, J				Charles, Nicolas; Hardwick, Donna; Daugas, Eric; Illei, Gabor G.; Rivera, Juan			Basophils and the T helper 2 environment can promote the development of lupus nephritis	NATURE MEDICINE			English	Article							LYN-DEFICIENT MICE; T-CELLS; REVISED CRITERIA; INTERFERON-GAMMA; IMMUNOGLOBULIN-E; DISEASE; CLASSIFICATION; ERYTHEMATOSUS; RESPONSES; AUTOREACTIVITY	In systemic lupus erythematosus (SLE), self-reactive antibodies can target the kidney (lupus nephritis), leading to functional failure and possible mortality. We report that activation of basophils by autoreactive IgE causes their homing to lymph nodes, promoting T helper type 2 (T(H)2) cell differentiation and enhancing the production of self-reactive antibodies that cause lupus-like nephritis in mice lacking the Src family protein tyrosine kinase Lyn (Lyn(-/-) mice). Individuals with SLE also have elevated serum IgE, self-reactive IgEs and activated basophils that express CD62 ligand (CD62L) and the major histocompatibility complex (MHC) class II molecule human leukocyte antigen-DR (HLA-DR), parameters that are associated with increased disease activity and active lupus nephritis. Basophils were also present in the lymph nodes and spleen of subjects with SLE. Thus, in Lyn(-/-) mice, basophils and IgE autoantibodies amplify autoantibody production that leads to lupus nephritis, and in individuals with SLE IgE autoantibodies and activated basophils are factors associated with disease activity and nephritis.	[Charles, Nicolas; Rivera, Juan] NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Hardwick, Donna] NIAMS, Off Clin Director, NIH, Bethesda, MD USA; [Daugas, Eric] Univ Paris Diderot, Inst Natl Sante & Rech Med U699, Dept Nephrol, Assistance Publ Hop Paris,Hop Bichat, Paris, France; [Illei, Gabor G.] Natl Inst Dent & Craniofacial Res, Sjogrens Syndrome Clin, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Rivera, J (corresponding author), NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA.	juan_rivera@nih.gov	CHARLES, Nicolas/P-5430-2014; CHARLES, Nicolas/S-2214-2019	CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; DAUGAS, Eric/0000-0001-7256-7979	Laboratory Animal Care and Use Section; Flow Cytometry Section of the Office of Science and Technology, NIAMS; National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180, ZIAAR041156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000704] Funding Source: NIH RePORTER	Laboratory Animal Care and Use Section; Flow Cytometry Section of the Office of Science and Technology, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Daruwalla and G. Souto-Adeva (Office of the Clinical Director, NIAMS) for human samples, data input and analysis and H. C. Oettgen (Harvard University) for providing the Igh-7<SUP>-/-</SUP> mice. We also thank M. Hourseau for human sample preparation and L. B. Schwartz (Virginia Commonwealth University) and A. F. Walls (University of Southampton) for the gift of human basophil-specific monoclonal antibodies. We acknowledge the support of the Laboratory Animal Care and Use Section and the Flow Cytometry Section of the Office of Science and Technology, NIAMS. This research was supported by the intramural programs of NIAMS and National Institute of Dental and Craniofacial Research, NIH.	Akahoshi M, 1999, ARTHRITIS RHEUM, V42, P1644, DOI 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Atta AM, 2004, BRAZ J MED BIOL RES, V37, P1497, DOI 10.1590/S0100-879X2004001000008; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Beavitt SJE, 2005, J IMMUNOL, V175, P1867, DOI 10.4049/jimmunol.175.3.1867; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; DECARLI M, 1994, AUTOIMMUNITY, V18, P301; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Getz EB, 2009, J CLIN PHARMACOL, V49, P1025, DOI 10.1177/0091270009341183; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Heine G, 2002, NEPHROL DIAL TRANSPL, V17, P1790, DOI 10.1093/ndt/17.10.1790; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOLMDAHL R, 1991, AUTOIMMUNITY, V8, P271, DOI 10.3109/08916939109007634; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KEPLEY CL, 1995, J IMMUNOL, V154, P6548; Kono DH, 2000, J IMMUNOL, V164, P38, DOI 10.4049/jimmunol.164.1.38; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kyttaris Vasileios C, 2005, Curr Rheumatol Rep, V7, P469, DOI 10.1007/s11926-005-0054-3; Lee HY, 2008, RHEUMATOLOGY, V47, P789, DOI 10.1093/rheumatology/ken108; Levesque MC, 2009, CLIN EXP IMMUNOL, V157, P198, DOI 10.1111/j.1365-2249.2009.03979.x; Liang MH, 2004, ARTHRITIS RHEUM-US, V50, P3418, DOI 10.1002/art.20628; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Liossis SNC, 2001, J INVEST MED, V49, P157, DOI 10.2310/6650.2001.34042; LIU FT, 1980, J IMMUNOL, V124, P2728; Lu R, 2009, GENES IMMUN, V10, P397, DOI 10.1038/gene.2009.19; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; McEuen AR, 1999, LAB INVEST, V79, P27; Miyajima H, 1996, INT ARCH ALLERGY IMM, V111, P152, DOI 10.1159/000237360; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Schroeder JT, 1997, J ALLERGY CLIN IMMUN, V99, P429, DOI 10.1016/S0091-6749(97)70065-4; Seshan SV, 2009, ARCH PATHOL LAB MED, V133, P233, DOI 10.1043/1543-2165-133.2.233; Shimizu S, 2005, J IMMUNOL, V175, P7185, DOI 10.4049/jimmunol.175.11.7185; Singh RR, 1995, J CLIN INVEST, V96, P2990, DOI 10.1172/JCI118371; Sinico RA, 2009, ANN NY ACAD SCI, V1173, P47, DOI 10.1111/j.1749-6632.2009.04746.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; TORAN EJ, 1995, J NATL MED ASSOC, V87, P693; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zeng DF, 2003, J CLIN INVEST, V112, P1211, DOI 10.1172/JCI200317165; Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI 10.1007/s11033-009-9533-3	57	245	256	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					701	U107		10.1038/nm.2159	http://dx.doi.org/10.1038/nm.2159			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20512127	Green Accepted			2022-12-27	WOS:000278394200037
J	Yang, S; Kim, J; Ryu, JH; Oh, H; Chun, CH; Kim, BJ; Min, BH; Chun, JS				Yang, Siyoung; Kim, Jonghwan; Ryu, Je-Hwang; Oh, Hwanhee; Chun, Churl-Hong; Kim, Byoung Ju; Min, Byoung Hyun; Chun, Jang-Soo			Hypoxia-inducible factor-2 alpha is a catabolic regulator of osteoarthritic cartilage destruction	NATURE MEDICINE			English	Article							ENDOTHELIAL PAS DOMAIN; II COLLAGEN EXPRESSION; RENAL-CELL CARCINOMA; GROWTH-FACTOR-I; ARTICULAR CHONDROCYTES; FACTOR (HIF)-1-ALPHA; GENE-EXPRESSION; MURINE MODEL; HIF-2-ALPHA; HIF-1-ALPHA	Osteoarthritic cartilage destruction is caused by an imbalance between anabolic and catabolic factors. Here, we show that hypoxia-inducible factor-2 alpha (HIF-2 alpha, encoded by EPAS1) is a catabolic transcription factor in the osteoarthritic process. HIF-2 alpha directly induces the expression in chondrocytes of genes encoding catabolic factors, including matrix metalloproteinases (MMP1, MMP3, MMP9, MMP12 and MMP13), aggrecanase-1 (ADAMTS4), nitric oxide synthase-2 (NOS2) and prostaglandin-endoperoxide synthase-2 (PTGS2). HIF-2 alpha expression was markedly increased in human and mouse osteoarthritic cartilage, and its ectopic expression triggered articular cartilage destruction in mice and rabbits. Moreover, mice transgenic for Epas1 only in chondrocytes showed spontaneous cartilage destruction, whereas heterozygous genetic deletion of Epas1 in mice suppressed cartilage destruction caused by destabilization of the medial meniscus (DMM) or collagenase injection, with concomitant modulation of catabolic factors. Our results collectively demonstrate that HIF-2 alpha causes cartilage destruction by regulating crucial catabolic genes.	[Yang, Siyoung; Kim, Jonghwan; Ryu, Je-Hwang; Oh, Hwanhee; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Sch Life Sci, Kwangju, South Korea; [Chun, Churl-Hong] Wonkwang Univ, Dept Orthoped Surg, Sch Med, Iksan, South Korea; [Kim, Byoung Ju; Min, Byoung Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Kim, Byoung Ju; Min, Byoung Hyun] Ajou Univ, Dept Orthoped Surg, Suwon 441749, South Korea	Gwangju Institute of Science & Technology (GIST); Wonkwang University; Ajou University; Ajou University	Chun, JS (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Sch Life Sci, Kwangju, South Korea.	jschun@gist.ac.kr		Yang, Siyoung/0000-0002-6374-0140	National Research Foundation of Korea [2009-00631480, 2009-0092210]; Korea Healthcare Technology [A084062]; Korea Research Foundation [KRF-2006-312-C00611]; Bioimaging Research Center (Gwangju Institute of Science and Technology)	National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology; Korea Research Foundation(National Research Foundation of Korea); Bioimaging Research Center (Gwangju Institute of Science and Technology)	This work was supported by grants from the National Research Foundation of Korea (Cell Dynamics Research Center 2009-00631480 and 2009-0092210), the Korea Healthcare Technology research and development project (A084062), the Korea Research Foundation (KRF-2006-312-C00611) and the Bioimaging Research Center (Gwangju Institute of Science and Technology).	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hofer T, 2001, FASEB J, V15, P2715, DOI 10.1096/fj.01-0546fje; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; KIVIRANTA I, 1984, HISTOCHEMISTRY, V80, P569; Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008; Kumar S, 2001, OSTEOARTHR CARTILAGE, V9, P641, DOI 10.1053/joca.2001.0421; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Martin G, 2004, ARTHRITIS RHEUM-US, V50, P3549, DOI 10.1002/art.20596; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Pan MR, 2002, J BIOL CHEM, V277, P32775, DOI 10.1074/jbc.M202334200; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Schipani E, 2001, GENE DEV, V15, P2865; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Sowter HM, 2003, CANCER RES, V63, P6130; Tanaka T, 2002, J MOL CELL CARDIOL, V34, P739, DOI 10.1006/jmcc.2002.2012; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; Yun SS, 2002, J BIOL CHEM, V277, P34808, DOI 10.1074/jbc.M205417200	47	365	382	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					687	U91		10.1038/nm.2153	http://dx.doi.org/10.1038/nm.2153			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495569				2022-12-27	WOS:000278394200035
J	Li, JL; Chen, JM; Ricupero, CL; Hart, RP; Schwartz, MS; Kusnecov, A; Herrup, K				Li, Jiali; Chen, Jianmin; Ricupero, Christopher L.; Hart, Ronald P.; Schwartz, Melanie S.; Kusnecov, Alexander; Herrup, Karl			Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE 4; INTRACELLULAR TRAFFICKING; GENE-EXPRESSION; MOUSE-BRAIN; DNA-DAMAGE; CELL-DEATH; MUSCLE; YEAST; TRICHOSTATIN; INHIBITION	Ataxia telangiectasia is a neurodegenerative disease caused by mutation of the Atm gene. Here we report that ataxia telangiectasia mutated (ATM) deficiency causes nuclear accumulation of histone deacetylase 4 (HDAC4) in neurons and promotes neurodegeneration. Nuclear HDAC4 binds to chromatin, as well as to myocyte enhancer factor 2A (MEF2A) and cAMP-responsive element binding protein (CREB), leading to histone deacetylation and altered neuronal gene expression. Blocking either HDAC4 activity or its nuclear accumulation blunts these neurodegenerative changes and rescues several behavioral abnormalities of ATM-deficient mice. Full rescue of the neurodegeneration, however, also requires the presence of HDAC4 in the cytoplasm, suggesting that the ataxia telangiectasia phenotype results both from a loss of cytoplasmic HDAC4 as well as its nuclear accumulation. To remain cytoplasmic, HDAC4 must be phosphorylated. The activity of the HDAC4 phosphatase, protein phosphatase 2A (PP2A), is downregulated by ATM-mediated phosphorylation. In ATM deficiency, enhanced PP2A activity leads to HDAC4 dephosphorylation and the nuclear accumulation of HDAC4. Our results define a crucial role of the cellular localization of HDAC4 in the events leading to ataxia telangiectasia neurodegeneration.	[Li, Jiali; Chen, Jianmin; Ricupero, Christopher L.; Hart, Ronald P.; Herrup, Karl] Rutgers State Univ, Nelson Biol Labs, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Schwartz, Melanie S.; Kusnecov, Alexander] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Herrup, K (corresponding author), Rutgers State Univ, Nelson Biol Labs, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	herrup@biology.rutgers.edu	Hart, Ronald P/G-6530-2019; li, Jiali/HGF-2395-2022; Hart, Ronald P/D-5219-2009; Herrup, Karl/C-5313-2014	Hart, Ronald P/0000-0003-4836-8712; li, Jiali/0000-0001-6202-7741; Hart, Ronald P/0000-0003-4836-8712; Li, Jiali/0000-0002-0039-3671; Herrup, Karl/0000-0001-7786-5844	National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders [N01-HD-4-3368, N01-HD-4-3383]; Ataxia Telangiectasia Children's Project; US National Institutes of Health [NS20591, NS71022, R21 MH085088, MH60706, NIEHS P30ES05022]; NATIONAL CANCER INSTITUTE [RC1CA147187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085088, R01MH060706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071022, R01NS020591] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders; Ataxia Telangiectasia Children's Project; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Xu (University of California San Diego) for providing homozygous mice carrying the Atm knockout mutation, tm1Bal. We thank R. Gatti (University of California Los Angeles) for sharing human ataxia telangiectasia paraffin-fixed samples. Human frozen tissue was obtained from the National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders (NICHD contracts N01-HD-4-3368 and N01-HD-4-3383). We thank M.B. Kastan (Duke University), T. Yao (Duke University) and S. Schreiber (Harvard University) for providing the wild-type and kinase-dead Flag-ATM, GFP-HDAC4 and Flag-HADC4 plasmids. M. Swerdel prepared the SOLiD ChIP-seq libraries. The long-term support of the Ataxia Telangiectasia Children's Project to K.H. is gratefully acknowledged. This work was also supported by grants from the US National Institutes of Health (NS20591 and NS71022) to K.H., R.P.H. (R21 MH085088) and A.K. (MH60706 and NIEHS P30ES05022). C.L.R. is a National Science Foundation Integrative Graduate Education and Research Traineeship fellow.	Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; BUNDEY S, 1994, INT J RADIAT BIOL, V66, pS23; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Cooper JF, 2007, NEUROSCIENCE, V148, P1048, DOI 10.1016/j.neuroscience.2007.07.034; Cortes ML, 2006, NEUROSCIENCE, V141, P1247, DOI 10.1016/j.neuroscience.2006.05.055; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Kaemmerer WF, 2000, MOL THER, V2, P446, DOI 10.1006/mthe.2000.0134; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YW, 2005, J CELL BIOL, V168, P887, DOI 10.1083/jcb.200408128; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Majdzadeh N, 2008, FRONT BIOSCI-LANDMRK, V13, P1072, DOI 10.2741/2745; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nervi C, 2001, CANCER RES, V61, P1247; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEDGWICK RP, 1960, NEUROLOGY, V10, P705, DOI 10.1212/WNL.10.7.705; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	40	149	157	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					783	U182		10.1038/nm.2709	http://dx.doi.org/10.1038/nm.2709			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22466704	Green Accepted			2022-12-27	WOS:000303763500046
J	Li, M; Du, X; Villaruz, AE; Diep, BA; Wang, DC; Song, Y; Tian, YR; Hu, JH; Yu, FY; Lu, Y; Otto, M				Li, Min; Du, Xin; Villaruz, Amer E.; Diep, Binh An; Wang, Decheng; Song, Yan; Tian, Yueru; Hu, Jinhui; Yu, Fangyou; Lu, Yuan; Otto, Michael			MRSA epidemic linked to a quickly spreading colonization and virulence determinant	NATURE MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NASAL COLONIZATION; GENOME SEQUENCE; 2 HOSPITALS; INFECTIONS; EVOLUTION; ADHERENCE; CARRIAGE; STRAINS; EVASION	The molecular processes underlying epidemic waves of methicillin-resistant Staphylococcus aureus (MRSA) infection are poorly understood(1). Although a major role has been attributed to the acquisition of virulence determinants by horizontal gene transfer(2), there are insufficient epidemiological and functional data supporting that concept. We here report the spread of clones containing a previously extremely rare(3,4) mobile genetic element-encoded gene, sasX. We demonstrate that sasX has a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease and abscess formation and promoting mechanisms of immune evasion. Moreover, we observed the recent spread of sasX from sequence type 239 (ST239) to invasive clones belonging to other sequence types. Our study identifies sasX as a quickly spreading crucial determinant of MRSA pathogenic success and a promising target for therapeutic interference. Our results provide proof of principle that horizontal gene transfer of key virulence determinants drives MRSA epidemic waves.	[Villaruz, Amer E.; Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Li, Min; Du, Xin; Song, Yan; Tian, Yueru; Hu, Jinhui; Lu, Yuan] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Diep, Binh An] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Wang, Decheng] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wang, Decheng] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Yu, Fangyou] Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University; University of California System; University of California San Francisco; Fudan University; Fudan University; Wenzhou Medical University	Otto, M (corresponding author), NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	yuanlu@hsh.stn.sh.cn; motto@niaid.nih.gov	Du, Xin/AAG-4635-2022; WANG, DECHENG/AGO-5098-2022; Ren, Guogang/P-4540-2017; Hu, Jinhui/AAG-9000-2021; Du, Xin/ABD-4327-2022	Du, Xin/0000-0002-6907-3609; WANG, DECHENG/0000-0002-1742-7460; Ren, Guogang/0000-0001-8865-1526; Du, Xin/0000-0002-6907-3609; Otto, Michael/0000-0002-2222-4115	China National Clinical Key Subject; National Natural Science Foundation of China [30900026, 81171623]; Shanghai Pujiang Program [09PJ1402300]; National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080, ZIAAI000904] Funding Source: NIH RePORTER	China National Clinical Key Subject; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the China National Clinical Key Subject to Y.L., the National Natural Science Foundation of China (grants 30900026 and 81171623) and the Shanghai Pujiang Program (grant 09PJ1402300) to M.L., and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (to M.O.).	Arakere G, 2005, J CLIN MICROBIOL, V43, P3198, DOI 10.1128/JCM.43.7.3198-3202.2005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Ip M, 2003, J CLIN MICROBIOL, V41, P4980, DOI 10.1128/JCM.41.11.4980-4985.2003; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Koh SS, 2009, MODERN PATHOL, V22, P538, DOI 10.1038/modpathol.2009.8; Li Y, 2011, J BACTERIOL, V193, P3411, DOI 10.1128/JB.05135-11; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2006, CURR TOP MICROBIOL, V306, P251; Soderquist B, 2009, J MED MICROBIOL, V58, P1395, DOI 10.1099/jmm.0.008771-0; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	30	184	215	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					816	U217		10.1038/nm.2692	http://dx.doi.org/10.1038/nm.2692			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22522561	Green Accepted			2022-12-27	WOS:000303763500050
J	Choi, C; Ganji, SK; DeBerardinis, RJ; Hatanpaa, KJ; Rakheja, D; Kovacs, Z; Yang, XL; Mashimo, T; Raisanen, JM; Marin-Valencia, I; Pascual, JM; Madden, CJ; Mickey, BE; Malloy, CR; Bachoo, RM; Maher, EA				Choi, Changho; Ganji, Sandeep K.; DeBerardinis, Ralph J.; Hatanpaa, Kimmo J.; Rakheja, Dinesh; Kovacs, Zoltan; Yang, Xiao-Li; Mashimo, Tomoyuki; Raisanen, Jack M.; Marin-Valencia, Isaac; Pascual, Juan M.; Madden, Christopher J.; Mickey, Bruce E.; Malloy, Craig R.; Bachoo, Robert M.; Maher, Elizabeth A.			2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas	NATURE MEDICINE			English	Article							METABOLITE QUANTIFICATION; BRAIN-METABOLITES; RELAXATION-TIMES; NMR-SPECTRA; PROTON; H-1; MUTATIONS; ACIDURIA; TUMORS; WATER	Mutations in isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) have been shown to be present in most World Health Organization grade 2 and grade 3 gliomas in adults. These mutations are associated with the accumulation of 2-hydroxyglutarate (2HG) in the tumor. Here we report the noninvasive detection of 2HG by proton magnetic resonance spectroscopy (MRS). We developed and optimized the pulse sequence with numerical and phantom analyses for 2HG detection, and we estimated the concentrations of 2HG using spectral fitting in the tumors of 30 subjects. Detection of 2HG correlated with mutations in IDH1 or IDH2 and with increased levels of D-2HG by mass spectrometry of the resected tumors. Noninvasive detection of 2HG may prove to be a valuable diagnostic and prognostic biomarker.	[Choi, Changho; Ganji, Sandeep K.; Kovacs, Zoltan; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Choi, Changho; Ganji, Sandeep K.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.; Marin-Valencia, Isaac; Pascual, Juan M.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.; Hatanpaa, Kimmo J.; Yang, Xiao-Li; Mashimo, Tomoyuki; Raisanen, Jack M.; Madden, Christopher J.; Mickey, Bruce E.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA; [Hatanpaa, Kimmo J.; Rakheja, Dinesh; Raisanen, Jack M.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Hatanpaa, Kimmo J.; Yang, Xiao-Li; Mashimo, Tomoyuki; Raisanen, Jack M.; Madden, Christopher J.; Mickey, Bruce E.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Annette Strauss Ctr Neurooncol, Dallas, TX 75390 USA; [Rakheja, Dinesh] Childrens Med Ctr, Dallas, TX 75235 USA; [Yang, Xiao-Li; Mashimo, Tomoyuki; Malloy, Craig R.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pascual, Juan M.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Pascual, Juan M.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Madden, Christopher J.; Mickey, Bruce E.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Malloy, Craig R.] Vet Affairs N Texas Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Choi, C (corresponding author), Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA.	changho.choi@utsouthwestern.edu; elizabeth.maher@utsouthwestern.edu	Ganji, Sandeep/G-4983-2013	Pascual, Juan/0000-0002-0843-8221; Malloy, Craig/0000-0001-5077-0642	US National Institutes of Health [RC1NS0760675, R21CA159128, RR02584]; Cancer Prevention Research Institute of Texas [RP101243-P04]; NATIONAL CANCER INSTITUTE [R01CA157996, R21CA159128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS070675] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants RC1NS0760675, R21CA159128, and RR02584 and by the Cancer Prevention Research Institute of Texas grant RP101243-P04. We thank C. Sheppard for expert management of the patient database and for coordinating research scans and tissue samples; S. McNeil for expert human subject care during scanning; C. Foong for expert assistance with pathological analysis of tumor; and R.L. Boriack for expert assistance with 2HG measurements by mass spectrometry.	Bal D, 2002, MAGN RESON CHEM, V40, P533, DOI 10.1002/mrc.1053; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; BOTTOMLEY PA, 1984, Patent No. 4480228; Choi C, 2011, MAGN RESON MED, V66, P609, DOI 10.1002/mrm.22857; Choi CH, 2010, NMR BIOMED, V23, P1044, DOI 10.1002/nbm.1529; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Ernst R.R., 1987, PRINCIPLES NUCLEAR M; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ganji SK, 2012, NMR BIOMED, V25, P523, DOI 10.1002/nbm.1767; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; Goffette SM, 2006, EUR J NEUROL, V13, P499, DOI 10.1111/j.1468-1331.2006.01282.x; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Keevil SF, 1998, MAGN RESON IMAGING, V16, P1093, DOI 10.1016/S0730-725X(98)00118-0; Krawczyk H, 2003, J PHARMACEUT BIOMED, V31, P455, DOI 10.1016/S0731-7085(02)00691-X; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; NORTON WT, 1966, J NEUROPATH EXP NEUR, V25, P582, DOI 10.1097/00005072-196610000-00006; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rakheja D, 2011, PEDIATR BLOOD CANCER, V56, P379, DOI 10.1002/pbc.22697; Rakheja D, 2011, TUMOR BIOL, V32, P325, DOI 10.1007/s13277-010-0125-6; Sener RN, 2003, J COMPUT ASSIST TOMO, V27, P38, DOI 10.1097/00004728-200301000-00008; Thompson RB, 1999, MAGNET RESON MED, V41, P1162, DOI 10.1002/(SICI)1522-2594(199906)41:6<1162::AID-MRM12>3.0.CO;2-N; Tong ZY, 2004, MAGN RESON IMAGING, V22, P1017, DOI 10.1016/j.mri.2004.02.007; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	31	530	545	9	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					624	629		10.1038/nm.2682	http://dx.doi.org/10.1038/nm.2682			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22281806	Green Accepted			2022-12-27	WOS:000302617800042
J	Jilek, BL; Zarr, M; Sampah, ME; Rabi, SA; Bullen, CK; Lai, J; Shen, L; Siliciano, RF				Jilek, Benjamin L.; Zarr, Melissa; Sampah, Maame E.; Rabi, S. Alireza; Bullen, Cynthia K.; Lai, Jun; Shen, Lin; Siliciano, Robert F.			A quantitative basis for antiretroviral therapy for HIV-1 infection	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; TREATMENT-NAIVE PATIENTS; RESPONSE CURVE SLOPE; DYNAMICS IN-VIVO; COMBINATION THERAPY; CONTROLLED-TRIAL; VIRAL DYNAMICS; ZIDOVUDINE; LAMIVUDINE; INHIBITOR	Highly active antiretroviral therapy (HAART)(1-3) has dramatically decreased mortality from HIV-1 infection(4) and is a major achievement of modern medicine. However, there is no fundamental theory of HAART. Elegant models describe the dynamics of viral replication(3,5-9), but a metric for the antiviral activity of drug combinations relative to a target value needed for control of replication is lacking. Treatment guidelines(10,11) are based on empirical results of clinical trials in which other factors such as regimen tolerability also affect outcome. Why only certain drug combinations control viral replication remains unclear. Here we quantify the intrinsic antiviral activity of antiretroviral drug combinations. We show that most single antiretroviral drugs show previously unappreciated complex nonlinear pharmacodynamics that determine their inhibitory potential at clinical concentrations. We demonstrate that neither of the major theories for drug combinations accurately predicts the combined effects of multiple antiretrovirals. However, the combined effects can be understood with a new approach that considers the degree of independence of drug effects. This analysis allows a direct comparison of the inhibitory potential of different drug combinations under clinical concentrations, reconciles the results of clinical trials, defines a target level of inhibition associated with treatment success and provides a rational basis for treatment simplification and optimization.	[Jilek, Benjamin L.; Sampah, Maame E.; Rabi, S. Alireza; Bullen, Cynthia K.; Lai, Jun; Shen, Lin; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Zarr, Melissa; Shen, Lin; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu			US National Institutes of Health [AI081600]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081600] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Blankson, A. Spivak, C. Durand, J. Gallant, J. Cofrancesco and W. Greco for helpful discussions. This work was supported by US National Institutes of Health grant AI081600 and by the Howard Hughes Medical Institute.	[Anonymous], 2009, GUID US ANT AG HIV 1; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Ferguson NM, 2001, TRENDS PHARMACOL SCI, V22, P97, DOI 10.1016/S0165-6147(00)01615-1; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gallant JE, 2005, J INFECT DIS, V192, P1921, DOI 10.1086/498069; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 2000, J INFECT DIS, V182, P321, DOI 10.1086/315683; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoggard PG, 1997, ANTIMICROB AGENTS CH, V41, P1231, DOI 10.1128/AAC.41.6.1231; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429, DOI 10.2165/00003088-198106060-00002; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perez-Valero I, 2011, CURR OPIN INFECT DIS, V24, P7, DOI 10.1097/QCO.0b013e3283422cdf; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002304; Siliciano JD, 2010, CURR OPIN HIV AIDS, V5, P491, DOI 10.1097/COH.0b013e32833f206f; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004	40	112	115	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					446	U211		10.1038/nm.2649	http://dx.doi.org/10.1038/nm.2649			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344296	Green Accepted, Green Published			2022-12-27	WOS:000301264800048
J	Kuchroo, VK; Ohashi, PS; Sartor, RB; Vinuesa, CG				Kuchroo, Vijay K.; Ohashi, Pamela S.; Sartor, R. Balfour; Vinuesa, Carola G.			Dysregulation of immune homeostasis in autoimmune diseases	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIGEN-PRESENTING CELLS; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; CROHNS-DISEASE; ULCERATIVE-COLITIS; UNIQUE POPULATION	Great strides have been made in our understanding of the pathogenesis of autoimmune diseases. Research has identified genetic associations, new functional subsets of effector and regulatory T cells and the gut microbiota as crucial environmental factors in regulating immune function. This commentary discusses recent advances in our understanding of genetic and environmental factors as well as the role of innate and adaptive immune responses in driving immune-mediated tissue injury.	[Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Ohashi, Pamela S.] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Ontario Canc Inst, Dept Immunol, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Sartor, R. Balfour] Univ N Carolina, Dept Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Australian National University; John Curtin School of Medical Research	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298; Ohashi, Pamela S./0000-0003-2915-9317				Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2011, SEMIN IMMUNOL, V23, P431, DOI 10.1016/j.smim.2011.06.002; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fantini MC, 2009, GASTROENTEROLOGY, V136, P1308, DOI 10.1053/j.gastro.2008.12.053; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Freeman HJ, 2000, CAN J GASTROENTEROL, V14, P21, DOI 10.1155/2000/349082; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hellwig K, 2011, J NEUROL, V258, P1920, DOI 10.1007/s00415-011-6116-8; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Montgomery SM, 1999, EUR J GASTROEN HEPAT, V11, P543, DOI 10.1097/00042737-199905000-00013; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2009, EUR J IMMUNOL, V39, P655, DOI 10.1002/eji.200839198; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Rajan TV, 2006, PERSPECT BIOL MED, V49, P171, DOI 10.1353/pbm.2006.0029; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Todd JA, 2010, CELL, V141, P1114, DOI 10.1016/j.cell.2010.06.015; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Trowsdale J, 2005, CURR OPIN IMMUNOL, V17, P498, DOI 10.1016/j.coi.2005.07.015; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wucherpfennig KW, 2011, SEMIN IMMUNOL, V23, P84, DOI 10.1016/j.smim.2011.01.007; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9	76	73	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					42	47		10.1038/nm.2621	http://dx.doi.org/10.1038/nm.2621			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227671				2022-12-27	WOS:000299018600026
J	Good, MF; Hill, AVS				Good, Michael F.; Hill, Adrian V. S.			Mixed results for a malaria vaccine	NATURE MEDICINE			English	Editorial Material							FOLLOW-UP; EFFICACY; CHILDREN; PROTEIN	Although malaria can be effectively controlled in high-risk endemic areas using measures such as bed nets, insecticides and antimalarial drugs, the complete eradication of the malaria-causing parasite is still a considerable challenge. An effective vaccine would offer hope for reaching this ambitious goal. A recent study describes the interim results from an ongoing phase 3 trial to assess the candidate malaria vaccine RTS, S/AS01 (ref. 1). This vaccine is composed of a hepatitis B surface antigen fused to a recombinant antigen from part of the malaria circumsporozoite protein (CSP) in the AS01 adjuvant. The vaccine was shown to offer some protection against both clinical and severe malaria. We asked three experts to comment on what the implications of this trial are for the future of the RTS, S vaccine, as well as for general strategies to eradicate malaria. [GRAPHICS] .	[Good, Michael F.] Griffith Univ, Inst Glyc, Gold Coast, Australia; [Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England	Griffith University; University of Oxford; Jenner Institute	Good, MF (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Australia.				Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Good MF, 2011, CELL MOL LIFE SCI, V68, P1105, DOI 10.1007/s00018-011-0634-5; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06	10	8	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1560	1561		10.1038/nm1211-1560	http://dx.doi.org/10.1038/nm1211-1560			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146460				2022-12-27	WOS:000297978000023
J	Yoo, H; Kim, JW; Shishkov, M; Namati, E; Morse, T; Shubochkin, R; McCarthy, JR; Ntziachristos, V; Bouma, BE; Jaffer, FA; Tearney, GJ				Yoo, Hongki; Kim, Jin Won; Shishkov, Milen; Namati, Eman; Morse, Theodore; Shubochkin, Roman; McCarthy, Jason R.; Ntziachristos, Vasilis; Bouma, Brett E.; Jaffer, Farouc A.; Tearney, Guillermo J.			Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo	NATURE MEDICINE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; DRUG-ELUTING STENTS; REPRODUCIBILITY; MICROSCOPY; ADVANTAGE; SYSTEM	Advancing understanding of human coronary artery disease requires new methods that can be used in patients for studying atherosclerotic plaque microstructure in relation to the molecular mechanisms that underlie its initiation, progression and clinical complications, including myocardial infarction and sudden cardiac death. Here we report a dual-modality intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo using a combination of optical frequency domain imaging (OFDI) and near-infrared fluorescence (NIRF) imaging. By providing simultaneous molecular information in the context of the surrounding tissue microstructure, this new catheter could provide new opportunities for investigating coronary atherosclerosis and stent healing and for identifying high-risk biological and structural coronary arterial plaques in vivo.	[Kim, Jin Won; Jaffer, Farouc A.] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Yoo, Hongki; Shishkov, Milen; Namati, Eman; Bouma, Brett E.] Harvard Univ, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Yoo, Hongki; Kim, Jin Won; Shishkov, Milen; Namati, Eman; McCarthy, Jason R.; Bouma, Brett E.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kim, Jin Won; Jaffer, Farouc A.] Harvard Univ, Sch Med, Div Cardiol, Boston, MA USA; [Kim, Jin Won] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea; [Morse, Theodore; Shubochkin, Roman] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [McCarthy, Jason R.] Harvard Univ, Sch Med, Ctr Syst Biol, Boston, MA USA; [Ntziachristos, Vasilis] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Munich, Germany; [Ntziachristos, Vasilis] Tech Univ Munich, Munich, Germany; [Bouma, Brett E.; Tearney, Guillermo J.] Harvard Massachusetts Inst Technol Hlth Sci & Tec, Cambridge, MA USA; [Tearney, Guillermo J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Korea University; Korea University Medicine (KU Medicine); Boston University; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard University; Harvard Medical School	Jaffer, FA (corresponding author), Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA.	fjaffer@mgh.harvard.edu; gtearney@partners.org	Jaffer, Farouc/AAK-8803-2020; Yoo, Hongki/B-6421-2013	Jaffer, Farouc/0000-0001-7980-384X; Yoo, Hongki/0000-0001-9819-3135	US National Institutes of Health [R01HL076398, R01HL093717, R01HL108229-01A1]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; American Heart Association [0830352N]; Howard Hughes Medical Institute; Cardio Vascular Research Foundation (CVRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076398, R01HL108229, R01HL093717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology; American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cardio Vascular Research Foundation (CVRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Gardecki for preparation of the cadaver coronary artery and CVPath for pathology of the stented artery. We also thank A. Rosenthal and G. Mallas for their technical support and A. Mauskapf for preparing and assisting in animal procedures. We thank Y. Iwamoto, Y. Yagi and E. Salomatina for assistance in histopathology. This research was supported in part by the US National Institutes of Health (R01HL076398 and R01HL093717 to G.J.T. and R01HL108229-01A1 to F.A.J.), the Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006 to G.J.T. and F.A.J.), an American Heart Association Scientist Development grant (#0830352N to F.A.J.), a Howard Hughes Medical Institute Early Career Award (F.A.J.) and the Cardio Vascular Research Foundation (CVRF, J.W.K.).	Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; de Boer OJ, 1999, CARDIOVASC RES, V41, P443, DOI 10.1016/S0008-6363(98)00255-7; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Gonzalo N, 2009, EUROINTERVENTION, V5, P224, DOI 10.4244/EIJV5I2A35; Guagliumi G, 2008, CATHETER CARDIO INTE, V72, P237, DOI 10.1002/ccd.21606; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Jaffer FA, 2009, ARTERIOSCL THROM VAS, V29, P1017, DOI 10.1161/ATVBAHA.108.165530; Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Ryu SY, 2008, OPT LETT, V33, P2347, DOI 10.1364/OL.33.002347; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Takano M, 2007, AM J CARDIOL, V99, P1033, DOI 10.1016/j.amjcard.2006.11.068; Takarada S, 2010, CATHETER CARDIO INTE, V75, P202, DOI 10.1002/ccd.22273; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Terashima M, 2009, J INVASIVE CARDIOL, V21, P602; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	26	223	230	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1680	U202		10.1038/nm.2555	http://dx.doi.org/10.1038/nm.2555			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057345	Green Accepted			2022-12-27	WOS:000297978000043
J	Hartl, FU				Hartl, F. Ulrich			Chaperone-assisted protein folding: the path to discovery from a personal perspective	NATURE MEDICINE			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; HEAT-SHOCK; CENTRAL CAVITY; YEAST MITOCHONDRIA; CRYSTAL-STRUCTURE; POLYPEPTIDE FLUX; ATPASE ACTIVITY; REACTION CYCLE		Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; COPPO A, 1973, J MOL BIOL, V76, P61, DOI 10.1016/0022-2836(73)90081-8; CREIGHTON TE, 1991, NATURE, V352, P17, DOI 10.1038/352017a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ELLIS RJ, 1994, CURR BIOL, V4, P633; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LORIMER GH, 1994, STRUCTURE, V2, P1125, DOI 10.1016/S0969-2126(94)00114-6; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MARTIN J, 1993, STRUCTURE, V1, P161, DOI 10.1016/0969-2126(93)90017-B; Mayhew M, 1996, SCIENCE, V271, P161, DOI 10.1126/science.271.5246.161; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; POLLOCK RA, 1988, EMBO J, V7, P3493, DOI 10.1002/j.1460-2075.1988.tb03225.x; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; STERNBERG N, 1973, J MOL BIOL, V76, P25, DOI 10.1016/0022-2836(73)90079-X; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	58	33	34	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1206	1210		10.1038/nm.2467	http://dx.doi.org/10.1038/nm.2467			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989011				2022-12-27	WOS:000296022100034
J	Lyons, TR; O'Brien, J; Borges, VF; Conklin, MW; Keely, PJ; Eliceiri, KW; Marusyk, A; Tan, AC; Schedin, P				Lyons, Traci R.; O'Brien, Jenean; Borges, Virginia F.; Conklin, Matthew W.; Keely, Patricia J.; Eliceiri, Kevin W.; Marusyk, Andriy; Tan, Aik-Choon; Schedin, Pepper			Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2	NATURE MEDICINE			English	Article							BREAST-CANCER METASTASIS; GENE-EXPRESSION SIGNATURE; CYCLOOXYGENASE-2 EXPRESSION; REPRODUCTIVE STATE; COLORECTAL-CANCER; CELL-MIGRATION; SURVIVAL; PREGNANCY; RISK; INFLAMMATION	The prognosis of breast cancer in young women is influenced by reproductive history. Women diagnosed within 5 years postpartum have worse prognosis than nulliparous women or women diagnosed during pregnancy. Here we describe a mouse model of postpartum breast cancer that identifies mammary gland involution as a driving force of tumor progression. In this model, human breast cancer cells exposed to the involuting mammary microenvironment form large tumors that are characterized by abundant fibrillar collagen, high cyclooxygenase-2 (COX-2) expression and an invasive phenotype. In culture, tumor cells are invasive in a fibrillar collagen and COX-2-dependent manner. In the involuting mammary gland, inhibition of COX-2 reduces the collagen fibrillogenesis associated with involution, as well as tumor growth and tumor cell infiltration to the lung. These data support further research to determine whether women at high risk for postpartum breast cancer would benefit from treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) during postpartum involution.	[Lyons, Traci R.; O'Brien, Jenean; Borges, Virginia F.; Tan, Aik-Choon; Schedin, Pepper] Univ Colorado, Dept Med, Div Med Oncol, Aurora, CO USA; [O'Brien, Jenean; Schedin, Pepper] Univ Colorado, Program Canc Biol, Aurora, CO USA; [Borges, Virginia F.; Tan, Aik-Choon; Schedin, Pepper] Univ Colorado, Ctr Canc, Aurora, CO USA; [Conklin, Matthew W.; Keely, Patricia J.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Conklin, Matthew W.; Keely, Patricia J.] Univ Wisconsin, UW Carbone Canc Ctr, Madison, WI USA; [Conklin, Matthew W.; Keely, Patricia J.; Eliceiri, Kevin W.] Univ Wisconsin, Lab Cell & Mol Biol, Lab Opt & Computat Instrumentat, Madison, WI USA; [Marusyk, Andriy] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA; [Schedin, Pepper] AMC Canc Res Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; AMC Cancer Research Center	Schedin, P (corresponding author), Univ Colorado, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO USA.	pepper.schedin@ucdenver.edu	Eliceiri, Kevin/ABD-4516-2020; Tan, Aik Choon/A-3135-2011; Schedin, Pepper/C-2532-2009	Eliceiri, Kevin/0000-0001-8678-670X; Tan, Aik Choon/0000-0003-2955-8369; Conklin, Matthew/0000-0001-7087-4561; Schedin, Pepper/0000-0003-4244-987X	Department of Defense [BC060531, BC074970, BC087579, BC073482]; Komen Foundation [KG090629]; Mary Kay Ash Foundation [078-08]; AMC; University of Colorado Cancer Center; American Cancer Society New England Division [PF-08-257-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA142833, R01CA136590, R01CA114462, P30CA046934] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Mary Kay Ash Foundation; AMC; University of Colorado Cancer Center; American Cancer Society New England Division(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to K. Polyak (Harvard Medical School) and M. Hu for providing MCF10DCIS parental cells and advice, C. Ambrosone, L. Hines, A. Thor and S. Edgerton for human tissue acquisition, M. Garcia and M. Skokan for FISH analysis, M. Lucia and R. Wilson for assistance with quantitative immunohistochemistry analysis, O. Maller, K. Bell, S. Jindal, K. Hedman, D. Powell, N. DeWaele and Y. Kwarteng for technical assistance, and S. Sillau for advanced statistical analyses. We thank K. Polyak, A. Thorburn, M. Moss and Nature Medicine reviewers for critical evaluation of the manuscript, and we gratefully acknowledge the subjects for their contribution to this research. This work was supported by Department of Defense Synergistic Idea Award BC060531, Komen Foundation grant KG090629, Mary Kay Ash Foundation grant 078-08, AMC cancer fund, and University of Colorado Cancer Center grants to P.S. and V.B., Department of Defense Award BC074970 to P.J.K., American Cancer Society New England Division Postdoctoral Fellowship Spin Odyssey PF-08-257-01-CSM to T.R.L., Department of Defense Postdoctoral grant BC087579 to A.M., and Department of Defense Predoctoral grant BC073482 to J.O.	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199; Bemis LT, 2000, CANCER RES, V60, P3414; Bladstrom Anna, 2003, Clin Breast Cancer, V4, P280, DOI 10.3816/CBC.2003.n.033; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Broom OJ, 2006, J CELL PHYSIOL, V209, P950, DOI 10.1002/jcp.20796; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daling JR, 2002, CANCER EPIDEM BIOMAR, V11, P235; Denkert C, 2003, CANCER-AM CANCER SOC, V97, P2978, DOI 10.1002/cncr.11437; Dodds L, 2008, OBSTET GYNECOL, V111, P1167, DOI 10.1097/AOG.0b013e31816fd778; Elder DJE, 1998, NAT MED, V4, P392, DOI 10.1038/nm0498-392; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Gupta PB, 2007, CANCER RES, V67, P2062, DOI 10.1158/0008-5472.CAN-06-3895; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2002, CANCER RES, V62, P5405; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Kwan ML, 2007, CANCER CAUSE CONTROL, V18, P613, DOI 10.1007/s10552-007-9003-y; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Lethaby AE, 1996, INT J CANCER, V67, P751, DOI 10.1002/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Lord SJ, 2008, CANCER EPIDEM BIOMAR, V17, P1723, DOI 10.1158/1055-9965.EPI-07-2824; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Mathews T. J., 2009, DELAYED CHILDBEARING, V21; McDaniel SM, 2006, AM J PATHOL, V168, P608, DOI 10.2353/ajpath.2006.050677; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; O'Brien J, 2010, AM J PATHOL, V176, P1241, DOI 10.2353/ajpath.2010.090735; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ristimaki A, 2002, CANCER RES, V62, P632; Rodriguez AO, 2008, OBSTET GYNECOL, V112, P71, DOI 10.1097/AOG.0b013e31817c4ebc; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Schedin P, 2004, MOL CARCINOGEN, V41, P207, DOI 10.1002/mc.20058; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spizzo G, 2003, BRIT J CANCER, V88, P574, DOI 10.1038/sj.bjc.6600741; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Visscher DW, 2008, J NATL CANCER I, V100, P421, DOI 10.1093/jnci/djn036; Wang WG, 2002, CANCER RES, V62, P6278; Whiteman MK, 2004, OBSTET GYNECOL, V104, P146, DOI 10.1097/01.AOG.0000128173.01611.ff; Wilgus TA, 2004, AM J PATHOL, V165, P753, DOI 10.1016/S0002-9440(10)63338-X	58	266	268	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1109	U116		10.1038/nm.2416	http://dx.doi.org/10.1038/nm.2416			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21822285	Green Accepted			2022-12-27	WOS:000294605100031
J	Brittain, JM; Duarte, DB; Wilson, SM; Zhu, WG; Ballard, C; Johnson, PL; Liu, NK; Xiong, WH; Ripsch, MS; Wang, YY; Fehrenbacher, JC; Fitz, SD; Khanna, M; Park, CK; Schmutzler, BS; Cheon, BM; Due, MR; Brustovetsky, T; Ashpole, NM; Hudmon, A; Meroueh, SO; Hingtgen, CM; Brustovetsky, N; Ji, RR; Hurley, JH; Jin, XM; Shekhar, A; Xu, XM; Oxford, GS; Vasko, MR; White, FA; Khanna, R				Brittain, Joel M.; Duarte, Djane B.; Wilson, Sarah M.; Zhu, Weiguo; Ballard, Carrie; Johnson, Philip L.; Liu, Naikui; Xiong, Wenhui; Ripsch, Matthew S.; Wang, Yuying; Fehrenbacher, Jill C.; Fitz, Stephanie D.; Khanna, May; Park, Chul-Kyu; Schmutzler, Brian S.; Cheon, Bo Myung; Due, Michael R.; Brustovetsky, Tatiana; Ashpole, Nicole M.; Hudmon, Andy; Meroueh, Samy O.; Hingtgen, Cynthia M.; Brustovetsky, Nickolay; Ji, Ru-Rong; Hurley, Joyce H.; Jin, Xiaoming; Shekhar, Anantha; Xu, Xiao-Ming; Oxford, Gerry S.; Vasko, Michael R.; White, Fletcher A.; Khanna, Rajesh			Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex	NATURE MEDICINE			English	Article							VIVO PROTEIN TRANSDUCTION; GATED CALCIUM-CHANNELS; N-TYPE; INTRATHECAL ZICONOTIDE; FORMALIN TEST; MODEL; AIDS; 2',3'-DIDEOXYCYTIDINE; LOCALIZATION; ANTAGONISTS	The use of N-type voltage-gated calcium channel (CaV2.2) blockers to treat pain is limited by many physiological side effects. Here we report that inflammatory and neuropathic hypersensitivity can be suppressed by inhibiting the binding of collapsin response mediator protein 2 (CRMP-2) to CaV2.2 and thereby reducing channel function. A peptide of CRMP-2 fused to the HIV transactivator of transcription (TAT) protein (TAT-CBD3) decreased neuropeptide release from sensory neurons and excitatory synaptic transmission in dorsal horn neurons, reduced meningeal blood flow, reduced nocifensive behavior induced by formalin injection or corneal capsaicin application and reversed neuropathic hypersensitivity produced by an antiretroviral drug. TAT-CBD3 was mildly anxiolytic without affecting memory retrieval, sensorimotor function or depression. At doses tenfold higher than that required to reduce hypersensitivity in vivo, TAT-CBD3 caused a transient episode of tail kinking and body contortion. By preventing CRMP-2-mediated enhancement of CaV2.2 function, TAT-CBD3 alleviated inflammatory and neuropathic hypersensitivity, an approach that may prove useful in managing chronic pain.	[Brittain, Joel M.; Duarte, Djane B.; Wilson, Sarah M.; Zhu, Weiguo; Ballard, Carrie; Liu, Naikui; Xiong, Wenhui; Ripsch, Matthew S.; Wang, Yuying; Fehrenbacher, Jill C.; Schmutzler, Brian S.; Cheon, Bo Myung; Due, Michael R.; Ashpole, Nicole M.; Hudmon, Andy; Meroueh, Samy O.; Hingtgen, Cynthia M.; Brustovetsky, Nickolay; Hurley, Joyce H.; Jin, Xiaoming; Xu, Xiao-Ming; Oxford, Gerry S.; Vasko, Michael R.; White, Fletcher A.; Khanna, Rajesh] Indiana Univ Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46204 USA; [Zhu, Weiguo; Wang, Yuying; Fehrenbacher, Jill C.; Schmutzler, Brian S.; Brustovetsky, Tatiana; Hudmon, Andy; Hingtgen, Cynthia M.; Brustovetsky, Nickolay; Oxford, Gerry S.; Vasko, Michael R.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN USA; [Ballard, Carrie; Khanna, May; Ashpole, Nicole M.; Hudmon, Andy; Meroueh, Samy O.; Hurley, Joyce H.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Johnson, Philip L.; Fitz, Stephanie D.; Shekhar, Anantha] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA; [Liu, Naikui] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN USA; [Xiong, Wenhui; Jin, Xiaoming; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Ripsch, Matthew S.; Fehrenbacher, Jill C.; Cheon, Bo Myung; Due, Michael R.; Vasko, Michael R.; White, Fletcher A.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN USA; [Park, Chul-Kyu; Ji, Ru-Rong] Brigham & Womens Hosp, Sensory Plast Lab, Pain Res Ctr, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Park, Chul-Kyu; Ji, Ru-Rong] Harvard Univ, Sch Med, Boston, MA USA; [Hingtgen, Cynthia M.; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA; [Shekhar, Anantha] Indiana Univ Sch Med, Dept Indiana Clin, Indianapolis, IN USA; [Shekhar, Anantha] Indiana Univ Sch Med, Translat Sci Inst, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), Indiana Univ Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46204 USA.	khanna5@iupui.edu	Johnson, Philip/K-8574-2019; White, Fletcher/F-3203-2015; Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; Ji, Ru-Rong/L-7070-2017; White, Fletcher A/F-2895-2012	Johnson, Philip/0000-0002-5398-8214; White, Fletcher/0000-0002-8408-9262; Jin, Xiaoming/0000-0002-8671-8640; Ji, Ru-Rong/0000-0002-9355-3688; Khanna, Rajesh/0000-0002-9066-2969; Xu, Xiao-ming/0000-0002-7229-0081; Khanna, May/0000-0002-9989-6374; Due, Michael/0000-0001-6771-7100	US National Institutes of Health: Dental and Craniofacial Research [DE14318-06, DE017794]; Drug Abuse [DA026040]; Neurological Disorders and Stroke [NS051668, NS050131]; Environmental Health Sciences [ES017430]; Indiana State Department of Health [A70-0-079212, A70-9-079138]; Indiana University Biomedical Committee [2286501]; American Heart Association [SDG5280023]; Elwert Award in Medicine; Larry Kays Medical Neuroscience fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794, T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049136, R01NS051668, R01NS050131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	US National Institutes of Health: Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Drug Abuse; Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Environmental Health Sciences; Indiana State Department of Health; Indiana University Biomedical Committee; American Heart Association(American Heart Association); Elwert Award in Medicine; Larry Kays Medical Neuroscience fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by grants from the US National Institutes of Health: Dental and Craniofacial Research (DE14318-06 to J.C.F. and DE017794 to R.-R.J.), Drug Abuse (DA026040 to F.A.W.), Neurological Disorders and Stroke (NS051668 to C.M.H. and NS050131 to N.B.) and Environmental Health Sciences (ES017430 to G.S.O. and J.H.H.); the Indiana State Department of Health-Spinal Cord and Brain Injury Fund (A70-0-079212 to N.B. and A70-9-079138 to R.K.) and the Indiana University Biomedical Committee-Research Support Funds (2286501 to R.K.); a National Scientist Development Grant from the American Heart Association (SDG5280023 to R.K.); and the Elwert Award in Medicine to R.K. J.M.B. is the recipient of a Larry Kays Medical Neuroscience fellowship. S.M.W. is a Stark Scholar. We thank A. Molosh and members of the Pain and Sensory Group for discussions, S.K. Ahuja for assistance with behavioral experiments and C. Kohn for comments on the manuscript.	Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Andrade A, 2010, NAT NEUROSCI, V13, P1249, DOI 10.1038/nn.2643; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bhangoo SK, 2007, BRAIN BEHAV IMMUN, V21, P581, DOI 10.1016/j.bbi.2006.12.003; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; Doak GJ, 1997, NEUROSCIENCE, V80, P939, DOI 10.1016/S0306-4522(97)00066-3; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUBINSKY RM, 1989, MUSCLE NERVE, V12, P856, DOI 10.1002/mus.880121012; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Farazifard R, 2005, BRAIN RES PROTOC, V16, P44, DOI 10.1016/j.brainresprot.2005.10.003; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GAGE FH, 1988, NEUROBIOL AGING, V9, P645, DOI 10.1016/S0197-4580(88)80129-5; Goadsby PJ, 2008, NEUROLOGY, V70, P1300, DOI 10.1212/01.wnl.0000309214.25038.fd; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Joseph EK, 2004, PAIN, V107, P147, DOI 10.1016/j.pain.2003.10.010; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Le Bars D, 2001, PHARMACOL REV, V53, P597; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; MALMBERG AB, 1994, J NEUROSCI, V14, P4882; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Nakanishi O, 1999, CELL MOL NEUROBIOL, V19, P191, DOI 10.1023/A:1006937209676; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Rauck RL, 2009, PAIN PRACT, V9, P327, DOI 10.1111/j.1533-2500.2009.00303.x; Rauck RL, 2006, J PAIN SYMPTOM MANAG, V31, P393, DOI 10.1016/j.jpainsymman.2005.10.003; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; SEWARD E, 1991, P ROY SOC B-BIOL SCI, V244, P129, DOI 10.1098/rspb.1991.0061; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Varty GB, 2003, BEHAV PHARMACOL, V14, P87, DOI 10.1097/00008877-200302000-00009; Wallace MS, 2008, ANESTH ANALG, V106, P628, DOI 10.1213/ane.0b013e3181606fad; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; Whiteside GT, 2005, J PHARMACOL EXP THER, V314, P1234, DOI 10.1124/jpet.105.088351; Winquist RJ, 2005, BIOCHEM PHARMACOL, V70, P489, DOI 10.1016/j.bcp.2005.04.035; Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377, DOI 10.2174/156802609788317838; YARCHOAN R, 1988, LANCET, V1, P76; Yoon JS, 2004, J MICROBIOL, V42, P328; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021	59	162	166	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					822	U260		10.1038/nm.2345	http://dx.doi.org/10.1038/nm.2345			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21642979	Green Accepted			2022-12-27	WOS:000292500800036
J	Dominguez-Villar, M; Baecher-Allan, CM; Hafler, DA				Dominguez-Villar, Margarita; Baecher-Allan, Clare M.; Hafler, David A.			Identification of T helper type 1-like, Foxp3(+) regulatory T cells in human autoimmune disease	NATURE MEDICINE			English	Article							MULTIPLE-SCLEROSIS; INTERLEUKIN-12; LYMPHOCYTES; VIVO	CD4(+) CD25(high)CD127(low)/-forkhead box p3 (Foxp3)(+) regulatory T cells (T-reg cells) possess functional plasticity. Here we describe a higher frequency of T helper type 1 (T(H)1)-like, interferon-gamma (IFN-gamma)-secreting Foxp3(+) T cells in untreated subjects with relapsing remitting multiple sclerosis (RRMS) as compared to healthy control individuals. In subjects treated with IFN-beta, the frequency of IFN-gamma(+) Foxp3(+) T cells is similar to that in healthy control subjects. In vitro, human T-reg cells from healthy subjects acquire a T(H)1-like phenotype when cultured in the presence of interleukin-12 (IL-12). T(H)1-like T-reg cells show reduced suppressive activity in vitro, which can partially be reversed by IFN-gamma-specific antibodies or by removal of IL-12.	[Dominguez-Villar, Margarita; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Dominguez-Villar, Margarita; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Dominguez-Villar, Margarita; Baecher-Allan, Clare M.; Hafler, David A.] Harvard Univ, Sch Med, Boston, MA USA	Yale University; Yale University; Harvard University; Harvard Medical School	Hafler, DA (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	david.hafler@yale.edu		Dominguez-Villar, Margarita/0000-0002-9719-0028; Baecher-Allan, Clare/0000-0003-2405-8525	US National Institutes of Health [U19AI070352, R01NS024247, P01AI03971, P01NS038037]; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, U19AI070352, R01AI091568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R01NS024247] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank K.C. O'Connor and members of the Hafler lab for valuable discussions and comments and D. Kozoriz for technical assistance. This work was supported by the US National Institutes of Health grants U19AI070352, R01NS024247, P01AI03971 and P01NS038037 (D.A.H.). D.A.H. is a Jacob Javits Scholar of the National Institute of Neurological Disorders and Stroke. C.M.B.-A. is supported by a Dana Scholars Grant from the Dana Foundation.	Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; HAFLER DA, 1985, NEW ENGL J MED, V312, P1405, DOI 10.1056/NEJM198505303122201; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kumar M, 2006, J NEUROIMMUNOL, V180, P178, DOI 10.1016/j.jneuroim.2006.08.003; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Rabinovitch A, 1996, J AUTOIMMUN, V9, P645, DOI 10.1006/jaut.1996.0084; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	15	325	333	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					673	675		10.1038/nm.2389	http://dx.doi.org/10.1038/nm.2389			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21540856	Green Accepted			2022-12-27	WOS:000291308800026
J	Papageorgiou, EA; Karagrigoriou, A; Tsaliki, E; Velissariou, V; Carter, NP; Patsalis, PC				Papageorgiou, Elisavet A.; Karagrigoriou, Alex; Tsaliki, Evdokia; Velissariou, Voula; Carter, Nigel P.; Patsalis, Philippos C.			Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21	NATURE MEDICINE			English	Article							MATERNAL PLASMA; QUANTITATIVE-ANALYSIS; DOWNS-SYNDROME; MARKERS; IDENTIFICATION; ANEUPLOIDY; SITES; WIDE	The trials performed worldwide toward noninvasive prenatal diagnosis (NIPD) of Down's syndrome (or trisomy 21) have shown the commercial and medical potential of NIPD compared to the currently used invasive prenatal diagnostic procedures. Extensive investigation of methylation differences between the mother and the fetus has led to the identification of differentially methylated regions (DMRs). In this study, we present a strategy using the methylated DNA immunoprecipitation (MeDiP) methodology in combination with real-time quantitative PCR (qPCR) to achieve fetal chromosome dosage assessment, which can be performed noninvasively through the analysis of fetal-specific DMRs. We achieved noninvasive prenatal detection of trisomy 21 by determining the methylation ratio of normal and trisomy 21 cases for each tested fetal-specific DMR present in maternal peripheral blood, followed by further statistical analysis. The application of this fetal-specific methylation ratio approach provided correct diagnosis of 14 trisomy 21 and 26 normal cases.	[Papageorgiou, Elisavet A.; Tsaliki, Evdokia; Patsalis, Philippos C.] Cyprus Inst Neurol & Genet, Cytogenet & Genom Dept, Nicosia, Cyprus; [Karagrigoriou, Alex] Univ Cyprus, Dept Math & Stat, Nicosia, Cyprus; [Tsaliki, Evdokia; Velissariou, Voula] Mitera Hosp, Dept Cytogenet & Mol Biol, Athens, Greece; [Tsaliki, Evdokia] Natl & Kapodistrian Univ Athens, Sch Sci, Fac Biol, Athens 11528, Greece; [Carter, Nigel P.] Wellcome Trust Sanger Inst, Mol Cytogenet Dept, Cambridge, Hinxton, England	University of Cyprus; National & Kapodistrian University of Athens; Wellcome Trust Sanger Institute	Patsalis, PC (corresponding author), Cyprus Inst Neurol & Genet, Cytogenet & Genom Dept, Nicosia, Cyprus.	patsalis@cing.ac.cy	Karagrigoriou, Alex/AAG-3040-2021	KARAGRIGORIOU, ALEX/0000-0002-4919-2133	Special Non-Invasive Advances in Fetal and Neonatal Evaluation Network of Excellence European Commission [LSHB-CT-2004-503243]; Cyprus Institute of Neurology and Genetics; University of Cyprus; State Scholarships Foundation of Greece; Mitera Hospital in Athens; Wellcome Trust	Special Non-Invasive Advances in Fetal and Neonatal Evaluation Network of Excellence European Commission; Cyprus Institute of Neurology and Genetics; University of Cyprus; State Scholarships Foundation of Greece; Mitera Hospital in Athens; Wellcome Trust(Wellcome TrustEuropean Commission)	E. A. P. and P. C. P. were supported by the Special Non-Invasive Advances in Fetal and Neonatal Evaluation Network of Excellence European Commission Funded 6th Framework Package Project Number: LSHB-CT-2004-503243 and the Cyprus Institute of Neurology and Genetics. A. K. was supported by the University of Cyprus. E. T. was supported by the State Scholarships Foundation of Greece. V. V. was supported by the Mitera Hospital in Athens. N.C. was supported by the Wellcome Trust. We thank C. Sismani, L. Kousoulidou and G. Koumbaris for extensive discussions, as well as M. Hulten for her encouragement to initiate this project.	Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Honda H, 2002, HUM GENET, V110, P75, DOI 10.1007/s00439-001-0649-3; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Poon LLM, 2002, CLIN CHEM, V48, P35; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Tsui Nancy B. Y., 2008, V444, P275, DOI 10.1007/978-1-59745-066-9_22; Tsui NBY, 2005, CLIN CHEM, V51, P2358, DOI 10.1373/clinchem.2005.056978; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weisz B, 2006, HUM REPROD UPDATE, V12, P513, DOI 10.1093/humupd/dml021	27	139	174	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					510	U152		10.1038/nm.2312	http://dx.doi.org/10.1038/nm.2312			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21378977	Green Accepted			2022-12-27	WOS:000289245100044
J	Murrough, JW; Charney, DS				Murrough, James W.; Charney, Dennis S.			Lifting the mood with ketamine	NATURE MEDICINE			English	Editorial Material							D-ASPARTATE ANTAGONIST; ANTIDEPRESSANT; DEPRESSION; RECEPTORS		[Murrough, James W.] Mt Sinai Sch Med, Mood & Anxiety Disorders Program, New York, NY USA; [Charney, Dennis S.] Mt Sinai Sch Med, Off Dean, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Murrough, JW (corresponding author), Mt Sinai Sch Med, Mood & Anxiety Disorders Program, New York, NY USA.	james.murrough@mssm.edu	Murrough, James/J-7129-2013	Murrough, James/0000-0001-6286-1242				Aan het Rot M, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Mathew SJ, 2010, INT J NEUROPSYCHOPH, V13, P71, DOI 10.1017/S1461145709000169; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Perry EB, 2007, PSYCHOPHARMACOLOGY, V192, P253, DOI 10.1007/s00213-007-0706-2; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; Skolnick P, 1996, PHARMACOPSYCHIATRY, V29, P23, DOI 10.1055/s-2007-979537; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	12	22	26	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1384	1385		10.1038/nm1210-1384	http://dx.doi.org/10.1038/nm1210-1384			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135850				2022-12-27	WOS:000285048900029
J	Anand, S; Majeti, BK; Acevedo, LM; Murphy, EA; Mukthavaram, R; Scheppke, L; Huang, M; Shields, DJ; Lindquist, JN; Lapinski, PE; King, PD; Weis, SM; Cheresh, DA				Anand, Sudarshan; Majeti, Bharat K.; Acevedo, Lisette M.; Murphy, Eric A.; Mukthavaram, Rajesh; Scheppke, Lea; Huang, Miller; Shields, David J.; Lindquist, Jeffrey N.; Lapinski, Philip E.; King, Philip D.; Weis, Sara M.; Cheresh, David A.			MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis	NATURE MEDICINE			English	Article							ARTERIOVENOUS-MALFORMATIONS; VASCULAR INTEGRITY; BINDING PROTEIN; RASA1 MUTATIONS; MICE; CAPILLARY; TISSUES; KINASE; METASTASIS; PHENOTYPE	Although it is well established that tumors initiate an angiogenic switch, the molecular basis of this process remains incompletely understood. Here we show that the miRNA miR-132 acts as an angiogenic switch by targeting p120RasGAP in the endothelium and thereby inducing neovascularization. We identified miR-132 as a highly upregulated miRNA in a human embryonic stem cell model of vasculogenesis and found that miR-132 was highly expressed in the endothelium of human tumors and hemangiomas but was undetectable in normal endothelium. Ectopic expression of miR-132 in endothelial cells in vitro increased their proliferation and tube-forming capacity, whereas intraocular injection of an antagomir targeting miR-132, anti-miR-132, reduced postnatal retinal vascular development in mice. Among the top-ranking predicted targets of miR-132 was p120RasGAP, which we found to be expressed in normal but not tumor endothelium. Endothelial expression of miR-132 suppressed p120RasGAP expression and increased Ras activity, whereas a miRNA-resistant version of p120RasGAP reversed the vascular response induced by miR-132. Notably, administration of anti-miR-132 inhibited angiogenesis in wild-type mice but not in mice with an inducible deletion of Rasa1 (encoding p120RasGAP). Finally, vessel-targeted nanoparticle delivery(1) of anti-miR-132 restored p120RasGAP expression in the tumor endothelium, suppressed angiogenesis and decreased tumor burden in an orthotopic xenograft mouse model of human breast carcinoma. We conclude that miR-132 acts as an angiogenic switch by suppressing endothelial p120RasGAP expression, leading to Ras activation and the induction of neovascularization, whereas the application of anti-miR-132 inhibits neovascularization by maintaining vessels in the resting state.	[Anand, Sudarshan; Majeti, Bharat K.; Acevedo, Lisette M.; Murphy, Eric A.; Mukthavaram, Rajesh; Scheppke, Lea; Huang, Miller; Shields, David J.; Lindquist, Jeffrey N.; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Anand, Sudarshan; Majeti, Bharat K.; Acevedo, Lisette M.; Murphy, Eric A.; Mukthavaram, Rajesh; Scheppke, Lea; Huang, Miller; Shields, David J.; Lindquist, Jeffrey N.; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Moores UCSD Canc Ctr, San Diego, CA 92103 USA; [Lapinski, Philip E.; King, Philip D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	dcheresh@ucsd.edu	King, Phil/C-7104-2013; ANAND, SUDARSHAN/I-5316-2019	ANAND, SUDARSHAN/0000-0002-4969-6884; Huang, Miller/0000-0002-3371-0100	US National Institutes of Health [HL078912, CA104898, CA050286, HL096498]; American Heart Association [09POST2040038]; NATIONAL CANCER INSTITUTE [R37CA050286, P01CA104898, R01CA050286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096498, R01HL078912] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank L. Barnes, E. Goka, B. Walsh and D. Wu for technical support. We thank S. Weng and J. Desgrosellier for discussions. We thank E. Brown (University of Pennsylvania) for the Ert2-ubiquitin-Cre mice. We thank R. Kerbel (University of Toronto) for the fast-growing variant of MDA-MB-231 breast carcinoma cells. We thank S. Kajiji (Scripps Research Institute) for FG human pancreatic adenocarcinoma cells. This work was supported by US National Institutes of Health grants HL078912, CA104898 and CA050286 to D.A.C. and HL096498 to P.D.K.S.A. is supported in part by an American Heart Association postdoctoral fellowship 09POST2040038.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Eng KT, 2006, CLIN INTERV AGING, V1, P451, DOI 10.2147/ciia.2006.1.4.451; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Hershkovitz D, 2008, BRIT J DERMATOL, V158, P1035, DOI 10.1111/j.1365-2133.2008.08493.x; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; HOSHINO M, 1988, MOL CELL BIOL, V8, P4169, DOI 10.1128/MCB.8.10.4169; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Lapinski PE, 2007, GENESIS, V45, P762, DOI 10.1002/dvg.20354; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LINDQUIST JN, 2010, CURR PROTOC STEM CEL, V12; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; Meadows KN, 2004, ONCOGENE, V23, P192, DOI 10.1038/sj.onc.1206921; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005	40	406	434	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					909	U109		10.1038/nm.2186	http://dx.doi.org/10.1038/nm.2186			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20676106	Green Accepted			2022-12-27	WOS:000280649200031
J	Lamprecht, B; Walter, K; Kreher, S; Kumar, R; Hummel, M; Lenze, D; Kochert, K; Bouhlel, MA; Richter, J; Soler, E; Stadhouders, R; Johrens, K; Wurster, KD; Callen, DF; Harte, MF; Giefing, M; Barlow, R; Stein, H; Anagnostopoulos, I; Janz, M; Cockerill, PN; Siebert, R; Dorken, B; Bonifer, C; Mathas, S				Lamprecht, Bjoern; Walter, Korden; Kreher, Stephan; Kumar, Raman; Hummel, Michael; Lenze, Dido; Koechert, Karl; Bouhlel, Mohamed Amine; Richter, Julia; Soler, Eric; Stadhouders, Ralph; Joehrens, Korinna; Wurster, Kathrin D.; Callen, David F.; Harte, Michael F.; Giefing, Maciej; Barlow, Rachael; Stein, Harald; Anagnostopoulos, Ioannis; Janz, Martin; Cockerill, Peter N.; Siebert, Reiner; Doerken, Bernd; Bonifer, Constanze; Mathas, Stephan			Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma	NATURE MEDICINE			English	Article							REED-STERNBERG CELLS; STIMULATING FACTOR-I; HODGKIN LYMPHOMA; DIFFERENTIAL TRANSCRIPTION; DNA HYPOMETHYLATION; BREAST-CANCER; B-CELLS; KAPPA-B; GENE; RECEPTOR	Mammalian genomes contain many repetitive elements, including long terminal repeats (LTRs), which have long been suspected to have a role in tumorigenesis. Here we present evidence that aberrant LTR activation contributes to lineage-inappropriate gene expression in transformed human cells and that such gene expression is central for tumor cell survival. We show that B cell-derived Hodgkin's lymphoma cells depend on the activity of the non-B, myeloid-specific proto-oncogene colony-stimulating factor 1 receptor (CSF1R). In these cells, CSF1R transcription initiates at an aberrantly activated endogenous LTR of the MaLR family (THE1B). Derepression of the THE1 subfamily of MaLR LTRs is widespread in the genome of Hodgkin's lymphoma cells and is associated with impaired epigenetic control due to loss of expression of the corepressor CBFA2T3. Furthermore, we detect LTR-driven CSF1R transcripts in anaplastic large cell lymphoma, in which CSF1R is known to be expressed aberrantly. We conclude that LTR derepression is involved in the pathogenesis of human lymphomas, a finding that might have diagnostic, prognostic and therapeutic implications.	[Lamprecht, Bjoern; Kreher, Stephan; Koechert, Karl; Wurster, Kathrin D.; Janz, Martin; Doerken, Bernd; Mathas, Stephan] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lamprecht, Bjoern; Kreher, Stephan; Koechert, Karl; Wurster, Kathrin D.; Janz, Martin; Doerken, Bernd; Mathas, Stephan] Charite, CVK, D-13353 Berlin, Germany; [Walter, Korden; Bouhlel, Mohamed Amine; Barlow, Rachael; Cockerill, Peter N.; Bonifer, Constanze] Univ Leeds, St Jamess Univ Hosp, Sect Expt Haematol, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Kumar, Raman; Callen, David F.] Univ Adelaide, Breast Canc Genet Grp, Discipline Med, Adelaide, SA 5005, Australia; [Hummel, Michael; Lenze, Dido; Joehrens, Korinna; Stein, Harald; Anagnostopoulos, Ioannis] Charite, Inst Pathol, CBF, D-13353 Berlin, Germany; [Richter, Julia; Giefing, Maciej; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Richter, Julia; Giefing, Maciej; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Soler, Eric; Stadhouders, Ralph] Erasmus MC, Univ Med Ctr, Dept Cell Biol, Rotterdam, Netherlands; [Harte, Michael F.] Cytopia Res Pty Ltd, Richmond, Vic, Australia; [Giefing, Maciej] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saint James's University Hospital; University of Leeds; University of Adelaide; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Erasmus University Rotterdam; Erasmus MC; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Mathas, S (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	c.bonifer@leeds.ac.uk; stephan.mathas@charite.de	Soler, Eric/ABE-9723-2021; Kumar, Raman/AHE-0538-2022; Mathas, Stephan/I-5589-2015; Stadhouders, Ralph/J-8663-2015	Soler, Eric/0000-0003-0521-7463; Kumar, Raman/0000-0001-7976-8386; Bonifer, Constanze/0000-0002-4267-0825; Callen, David/0000-0002-6189-9991; Stadhouders, Ralph/0000-0002-1060-5607; Kochert, Karl/0000-0002-5548-2022; Cockerill, Peter/0000-0002-4410-8174; Janz, Martin/0000-0002-1127-0044; Hummel, Michael/0000-0001-6717-605X; Giefing, Maciej/0000-0002-4760-8246	Federation of European Biochemical Societies; Deutsche Forschungsgemeinschaft [SFB/TRR54]; Wilhelm Sander-Stiftung; Deutsche Krebshilfe; KinderKrebsInitiative Buchholz/Holm-Seppensen; Susan G. Komen for the Cure; Leukaemia and Lymphoma Research; Cancer Research UK; Yorkshire Cancer Research	Federation of European Biochemical Societies; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); KinderKrebsInitiative Buchholz/Holm-Seppensen; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research	We thank F. Hummel, S. Kressmann, S. Meier, C. Cieluch, B. Wollert-Wulf and R. Zuhlke-Jenisch for outstanding technical assistance, H. Tagoh for help with experiments, P. Rahn for cell sorting and K. Rajewsky for helpful discussion and critical reading of the manuscript. M. G. is funded by the Federation of European Biochemical Societies. This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB/TRR54), the Wilhelm Sander-Stiftung, the Deutsche Krebshilfe, the KinderKrebsInitiative Buchholz/Holm-Seppensen, Susan G. Komen for the Cure, Leukaemia and Lymphoma Research, Cancer Research UK and Yorkshire Cancer Research. We also thank V. Diehl (University Cologne) for cell lines L1236 and L591, A. Engert (University Cologne) for L540Cy cells, P. Krammer (German Cancer Research Center Heidelberg) for BJAB cells, L. Staudt (US National Cancer Institute) for OCI-Ly3 and OCI-Ly10 cells, M. Falk (Helmholtz Zentrum Munchen) for BL-60 cells and S. Rosen (Northwestern University) for MM1.S cells.	Bonifer C, 2008, FRONT BIOSCI-LANDMRK, V13, P549, DOI 10.2741/2700; Borowitz MJ., 2008, WHO CLASSIFICATION T, P149; Burns CJ, 2009, BIOORG MED CHEM LETT, V19, P1206, DOI 10.1016/j.bmcl.2008.12.073; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Chyla BJ, 2008, MOL CELL BIOL, V28, P6234, DOI 10.1128/MCB.00404-08; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehlers A, 2008, LEUKEMIA, V22, P835, DOI 10.1038/leu.2008.12; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fan T, 2008, EPIGENETICS-US, V3, P134, DOI 10.4161/epi.3.3.6252; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Gamou T, 1998, BLOOD, V91, P4028, DOI 10.1182/blood.V91.11.4028.411a45_4028_4037; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Irvine KM, 2006, FASEB J, V20, P1921, DOI 10.1096/fj.06-5848fje; Janz M, 2006, CELL CYCLE, V5, P1057, DOI 10.4161/cc.5.10.2737; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; KACINSKI BM, 1995, ANN MED, V27, P79, DOI 10.3109/07853899509031941; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kumar R, 2008, J BIOL CHEM, V283, P19026, DOI 10.1074/jbc.M709136200; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; MOREAU A, 1992, LEUKEMIA, V6, P126; Ohshima K, 2001, INT J CANCER, V92, P678, DOI 10.1002/1097-0215(20010601)92:5<678::AID-IJC1259>3.0.CO;2-R; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; VISVADER J, 1989, MOL CELL BIOL, V9, P1336, DOI 10.1128/MCB.9.3.1336; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786	39	232	237	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					571	579		10.1038/nm.2129	http://dx.doi.org/10.1038/nm.2129			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20436485				2022-12-27	WOS:000277394700036
J	Kriegeskorte, A; Peters, G				Kriegeskorte, Andre; Peters, Georg			Horizontal gene transfer boosts MRSA spreading	NATURE MEDICINE			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL CARRIAGE; SEQUENCE	Mechanisms triggering methicillin-resistant Staphylococcus aureus (MRSA) epidemics are poorly understood. A recent study provides new evidence that horizontal gene transfer may be the culprit for the emergence of new resistant and virulent MRSA clones.	[Kriegeskorte, Andre; Peters, Georg] Univ Munster, Inst Med Microbiol, Munster, Germany	University of Munster	Kriegeskorte, A (corresponding author), Univ Munster, Inst Med Microbiol, Munster, Germany.	georg.peters@uni-muenster.de						Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Espedido BA, 2012, ANTIMICROB AGENTS CH, V56, P3380, DOI 10.1128/AAC.00013-12; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	14	14	17	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					662	663		10.1038/nm.2765	http://dx.doi.org/10.1038/nm.2765			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561821				2022-12-27	WOS:000303763500029
J	Leshan, RL; Greenwald-Yarnell, M; Patterson, CM; Gonzalez, IE; Myers, MG				Leshan, Rebecca L.; Greenwald-Yarnell, Megan; Patterson, Christa M.; Gonzalez, Ian E.; Myers, Martin G., Jr.			Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance	NATURE MEDICINE			English	Article							VENTRAL PREMAMMILLARY NUCLEUS; MESOLIMBIC DOPAMINE SYSTEM; DIRECT INNERVATION; RECEPTOR NEURONS; BODY-WEIGHT; FOOD-INTAKE; SYNTHASE; MODULATION; EXPRESSION; HINDBRAIN	Few effective measures exist to combat the worldwide obesity epidemic(1), and the identification of potential therapeutic targets requires a deeper understanding of the mechanisms that control energy balance. Leptin, an adipocyte-derived hormone that signals the long-term status of bodily energy stores, acts through multiple types of leptin receptor long isoform (LepRb)-expressing neurons (called here LepRb neurons) in the brain to control feeding, energy expenditure and endocrine function(2-4). The modest contributions to energy balance that are attributable to leptin action in many LepRb populations(5-9) suggest that other previously unidentified hypothalamic LepRb neurons have key roles in energy balance. Here we examine the role of LepRb in neuronal nitric oxide synthase (NOS1)-expressing LebRb (LepRb(NOS1)) neurons that comprise approximately 20% of the total hypothalamic LepRb neurons. Nos1(cre)-mediated genetic ablation of LepRb (Lepr(Nos1KO)) in mice produces hyperphagic obesity, decreased energy expenditure and hyperglycemia approaching that seen in whole-body LepRb-null mice. In contrast, the endocrine functions in Lepr(Nos1KO) mice are only modestly affected by the genetic ablation of LepRb in these neurons. Thus, hypothalamic LepRb(NOS1) neurons are a key site of action of the leptin-mediated control of systemic energy balance.	[Leshan, Rebecca L.; Greenwald-Yarnell, Megan; Patterson, Christa M.; Gonzalez, Ian E.; Myers, Martin G., Jr.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Leshan, Rebecca L.; Myers, Martin G., Jr.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Greenwald-Yarnell, Megan; Myers, Martin G., Jr.] Univ Michigan, Dept Neurosci, Grad Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Greenwald-Yarnell, M (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu		Gonzalez, Ian/0000-0002-4571-909X	Marilyn H. Vincent Foundation; American Diabetes Association; US National Institutes of Health (NIH) [DK057768]; NIH [T32GM008322, T32HL007853]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057768, P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER	Marilyn H. Vincent Foundation; American Diabetes Association(American Diabetes Association); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Amylin Pharmaceuticals for the generous gift of leptin; S. Chua (Albert Einstein College of Medicine), B. Lowell (Beth Israel-Deaconess Medical Center) and G. Barsh (Stanford University) for the gift of Lepr<SUP>flox/flox</SUP>, Agrp<SUP>cre</SUP> and Pomc<SUP>cre</SUP> mice, respectively; and members of the Myers lab for helpful discussions and technical support. Core support (animal phenotyping, Cell and Molecular Biology (CMB); clinical, Microscopy and Image Analysis Core (MIAC)) was provided by the Michigan Diabetes Research and Training Center and Nutrition and Obesity Research Center. This work was supported by the Marilyn H. Vincent Foundation and grants from the American Diabetes Association (M. G. M.), the American Heart Association (M. G. M. and R. L. L.) and the US National Institutes of Health (NIH) (DK057768 to M. G. M.). M. G.-Y. is supported by NIH grant T32GM008322; C. M. P. was supported by NIH grant T32HL007853.	Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bray GA, 2011, PSYCHIAT CLIN N AM, V34, P871, DOI 10.1016/j.psc.2011.08.013; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Donato J, 2010, ENDOCRINOLOGY, V151, P5415, DOI 10.1210/en.2010-0651; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Feil Robert, 2008, V184, P529; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Leshan RL, 2009, J NEUROSCI, V29, P3138, DOI 10.1523/JNEUROSCI.0155-09.2009; Liu J, 2011, MOL PSYCHIATR, V16, P1024, DOI 10.1038/mp.2011.36; Louis GW, 2010, J NEUROSCI, V30, P11278, DOI 10.1523/JNEUROSCI.1340-10.2010; McMinn JE, 2004, MAMM GENOME, V15, P677, DOI 10.1007/s00335-004-2340-1; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Patterson CM, 2011, BRAIN RES, V1378, P18, DOI 10.1016/j.brainres.2011.01.010; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Soliman GA, 2007, TRANSGENIC RES, V16, P665, DOI 10.1007/s11248-007-9110-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Williams KW, 2011, J NEUROSCI, V31, P13147, DOI 10.1523/JNEUROSCI.2602-11.2011; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yokosuka M, 1997, DEV BRAIN RES, V99, P226, DOI 10.1016/S0165-3806(96)00217-9	38	102	105	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					820	U236		10.1038/nm.2724	http://dx.doi.org/10.1038/nm.2724			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22522563	Green Accepted			2022-12-27	WOS:000303763500051
J	Morales, M; Bonci, A				Morales, Marisela; Bonci, Antonello			Hooking CB2 receptor into drug abuse?	NATURE MEDICINE			English	Editorial Material							CANNABINOID RECEPTOR; BRAIN; EXPRESSION; MICROGLIA; SYSTEM		[Morales, Marisela; Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Morales, M (corresponding author), NIDA, Intramural Res Program, Baltimore, MD USA.	antonello.bonci@nih.gov			Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Gamaleddin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029900; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874	14	21	23	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					504	505		10.1038/nm.2722	http://dx.doi.org/10.1038/nm.2722			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22481411				2022-12-27	WOS:000302617800026
J	Thu, MS; Bryant, LH; Coppola, T; Jordan, EK; Budde, MD; Lewis, BK; Chaudhry, A; Ren, JQ; Varma, NRS; Arbab, AS; Frank, JA				Thu, Mya S.; Bryant, L. Henry; Coppola, Tiziana; Jordan, E. Kay; Budde, Matthew D.; Lewis, Bobbi K.; Chaudhry, Aneeka; Ren, Jiaqiang; Varma, Nadimpalli Ravi S.; Arbab, Ali S.; Frank, Joseph A.			Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging	NATURE MEDICINE			English	Article							STEM-CELLS; DELIVERY-SYSTEM; LABELED CELLS; IRON; NANOPARTICLES; MRI; OPTIMIZATION; FERUMOXIDES; EXPRESSION; DRUGS	We report on a new straightforward magnetic cell-labeling approach that combines three US Food and Drug Administration (FDA)-approved drugs-ferumoxytol, heparin and protamine-in serum-free medium to form self-assembling nanocomplexes that effectively label cells for in vivo magnetic resonance imaging (MRI). We observed that the ferumoxytol-heparin-protamine (HPF) nanocomplexes were stable in serum-free cell culture medium. HPF nanocomplexes show a threefold increase in T2 relaxivity compared to ferumoxytol. Electron microscopy showed internalized HPF in endosomes, which we confirmed by Prussian blue staining of labeled cells. There was no long-term effect or toxicity on cellular physiology or function of HPF-labeled hematopoietic stem cells, bone marrow stromal cells, neural stem cells or T cells when compared to controls. In vivo MRI detected 1,000 HPF-labeled cells implanted in rat brains. This HPF labeling method should facilitate the monitoring by MRI of infused or implanted cells in clinical trials.	[Thu, Mya S.; Bryant, L. Henry; Coppola, Tiziana; Jordan, E. Kay; Budde, Matthew D.; Lewis, Bobbi K.; Chaudhry, Aneeka; Frank, Joseph A.] NIH, Frank Lab, Bethesda, MD 20892 USA; [Thu, Mya S.; Bryant, L. Henry; Coppola, Tiziana; Jordan, E. Kay; Budde, Matthew D.; Lewis, Bobbi K.; Chaudhry, Aneeka; Frank, Joseph A.] NIH, Lab Diagnost Radiol Res, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Ren, Jiaqiang] NIH, Cell Proc Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Varma, Nadimpalli Ravi S.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Frank, Joseph A.] NIH, Natl Inst Biomed Imaging & Bioengn, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Frank, JA (corresponding author), NIH, Frank Lab, Bldg 10, Bethesda, MD 20892 USA.	jafrank@helix.nih.gov	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019		Clinical Center of the US National Institutes of Health (NIH); NIH [R01CA122031]; NATIONAL CANCER INSTITUTE [R01CA122031] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER	Clinical Center of the US National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported by and performed in part in the intramural research program at the Clinical Center of the US National Institutes of Health (NIH). BMSCs were provided from the Center for Bone Marrow Stromal Cell Transplantation at the NIH. NSCs were provided as part of a material transfer agreement with K. Aboody (City of Hope Medical Center). The authors would like to acknowledge the Clinical Image Processing Section at the NIH. This work was also supported by NIH grant R01CA122031.	ABORG CH, 1968, ACTA PHYSIOL SCAND, V74, P552, DOI 10.1111/j.1748-1716.1968.tb04267.x; [Anonymous], 2010, MED LETT DRUGS THER, V52, P23; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Auerbach M, 2008, AM J KIDNEY DIS, V52, P826, DOI 10.1053/j.ajkd.2008.09.006; Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462; Boutry S, 2008, CONTRAST MEDIA MOL I, V3, P223, DOI 10.1002/cmmi.256; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Castaneda R.T., 2011, J VIS EXP, V4, pe3482; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Daley GQ, 2002, CURR OPIN GENET DEV, V12, P607, DOI 10.1016/S0959-437X(02)00346-5; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Golovko DM, 2010, EUR RADIOL, V20, P640, DOI 10.1007/s00330-009-1585-1; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kemp MM, 2010, WIRES NANOMED NANOBI, V2, P77, DOI 10.1002/wnan.68; Khurshid H, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068018; Liang JF, 2002, J CONTROL RELEASE, V78, P67, DOI 10.1016/S0168-3659(01)00484-9; Liang JF, 2000, J PHARM SCI-US, V89, P664, DOI 10.1002/(SICI)1520-6017(200005)89:5<664::AID-JPS12>3.3.CO;2-0; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Modo M, 2008, CURR OPIN ORGAN TRAN, V13, P654, DOI 10.1097/MOT.0b013e328317a43c; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Motaln H, 2010, CANCER-AM CANCER SOC, V116, P2519, DOI 10.1002/cncr.25056; Neuwelt EA, 2007, NEUROSURGERY, V60, P601, DOI 10.1227/01.NEU.0000255350.71700.37; Neuwelt EA, 2009, KIDNEY INT, V75, P465, DOI 10.1038/ki.2008.496; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Provenzano R, 2009, CLIN J AM SOC NEPHRO, V4, P386, DOI 10.2215/CJN.02840608; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; ROSSMANN P, 1982, VIRCHOWS ARCH B, V40, P81, DOI 10.1007/BF02932853; Santoro L, 2009, J MAGN RESON IMAGING, V30, P1012, DOI 10.1002/jmri.21937; Schwenk MH, 2010, PHARMACOTHERAPY, V30, P70, DOI 10.1592/phco.30.1.70; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Walczak P, 2005, MAGN RESON MED, V54, P769, DOI 10.1002/mrm.20701; Xie DH, 2010, NMR BIOMED, V23, P480, DOI 10.1002/nbm.1485; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459	38	154	162	8	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					463	U165		10.1038/nm.2666	http://dx.doi.org/10.1038/nm.2666			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366951	Green Accepted			2022-12-27	WOS:000301264800051
J	Zloza, A; Kohlhapp, FJ; Lyons, GE; Schenkel, JM; Moore, TV; Lacek, AT; O'Sullivan, JA; Varanasi, V; Williams, JW; Jagoda, MC; Bellavance, EC; Marzo, AL; Thomas, PG; Zafirova, B; Polic, B; Al-Harthi, L; Sperling, AI; Guevara-Patino, JA				Zloza, Andrew; Kohlhapp, Frederick J.; Lyons, Gretchen E.; Schenkel, Jason M.; Moore, Tamson V.; Lacek, Andrew T.; O'Sullivan, Jeremy A.; Varanasi, Vineeth; Williams, Jesse W.; Jagoda, Michael C.; Bellavance, Emily C.; Marzo, Amanda L.; Thomas, Paul G.; Zafirova, Biljana; Polic, Bojan; Al-Harthi, Lena; Sperling, Anne I.; Guevara-Patino, Jose A.			NKG2D signaling on CD8(+) T cells represses T-bet and rescues CD4-unhelped CD8(+) T cell memory recall but not effector responses	NATURE MEDICINE			English	Article							NK CELLS; CUTTING EDGE; CD8-T-CELL MEMORY; IMMUNE-RESPONSE; CD4-T-CELL HELP; ACUTE INFECTION; CELIAC-DISEASE; TUMOR-IMMUNITY; HIV-INFECTION; KILLER-CELLS	CD4-unhelped CD8(+) T cells are functionally defective T cells primed in the absence of CD4(+) T cell help. Given the co-stimulatory role of natural-killer group 2, member D protein (NKG2D) on CD8(+) T cells, we investigated its ability to rescue these immunologically impotent cells. We demonstrate that augmented co-stimulation through NKG2D during priming paradoxically rescues memory, but not effector, CD8(+) T cell responses. NKG2D-mediated rescue is characterized by reversal of elevated transcription factor T-box expressed in T cells (T-bet) expression and recovery of interleukin-2 and interferon-g production and cytolytic responses. Rescue is abrogated in CD8(+) T cells lacking NKG2D. Augmented co-stimulation through NKG2D confers a high rate of survival to mice lacking CD4(+) T cells in a CD4-dependent influenza model and rescues HIV-specific CD8(+) T cell responses from CD4-deficient HIV-positive donors. These findings demonstrate that augmented co-stimulation through NKG2D is effective in rescuing CD4-unhelped CD8(+) T cells from their pathophysiological fate and may provide therapeutic benefits.	[Zloza, Andrew; Kohlhapp, Frederick J.; Lyons, Gretchen E.; Moore, Tamson V.; Lacek, Andrew T.; O'Sullivan, Jeremy A.; Jagoda, Michael C.; Bellavance, Emily C.; Guevara-Patino, Jose A.] Univ Chicago, Dept Surg, Comm Immunol, Chicago, IL 60637 USA; [Zloza, Andrew; Moore, Tamson V.; O'Sullivan, Jeremy A.; Guevara-Patino, Jose A.] Loyola Univ Chicago, Dept Surg, Inst Oncol, Cardinal Bernardin Canc Ctr, Maywood, IL USA; [Schenkel, Jason M.] Univ Minnesota, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; [Varanasi, Vineeth] Univ Chicago, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; [Williams, Jesse W.; Sperling, Anne I.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Comm Immunol, Chicago, IL 60637 USA; [Marzo, Amanda L.; Al-Harthi, Lena] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Marzo, Amanda L.; Al-Harthi, Lena] Rush Univ, Med Ctr, Dev Ctr AIDS Res, Chicago, IL 60612 USA; [Marzo, Amanda L.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA; [Thomas, Paul G.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Zafirova, Biljana; Polic, Bojan] Univ Rijeka, Sch Med, Dept Histol & Embryol, Rijeka, Croatia	University of Chicago; Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; University of Chicago; Rush University; Rush University; Rush University; St Jude Children's Research Hospital; University of Rijeka	Guevara-Patino, JA (corresponding author), Univ Chicago, Dept Surg, Comm Immunol, Chicago, IL 60637 USA.	jaguevara@lumc.edu	Polic, Bojan/B-8622-2014; Guevara, Jose/AAD-6707-2020; Thomas, Paul G./H-1063-2018; Sperling, Anne/ACZ-2351-2022; Schenkel, Jason/AAV-8184-2020	Polic, Bojan/0000-0003-3930-9630; Thomas, Paul G./0000-0001-7955-0256; Schenkel, Jason/0000-0003-4641-6872; Williams, Jesse/0000-0003-3815-0891; Varanasi, Vineeth/0000-0002-6542-5777; Marzo, amanda/0000-0002-5839-0430; Sperling, Anne I./0000-0002-4265-9212; O'Sullivan, Jeremy/0000-0002-3862-202X; Zloza, Andrew/0000-0001-8844-6493	US National Cancer Institute Cancer Center [5P30CA014599-35]; American Cancer Society [ACSLIB112496-RSG]; American Cancer Society-Illinois Division [07-20]; Croatian Ministry of Science, Education and Sports [062-0621261-1271]; Croatian-Israeli Grant; US National Institutes of Health [R21CA127037, PO1AI082971, K22AI077714]; Immunology Training Grant [T32]; University of Chicago [5T32AI007090]; Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R21CA127037, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077714, T32AI007090, P01AI082971] Funding Source: NIH RePORTER	US National Cancer Institute Cancer Center; American Cancer Society(American Cancer Society); American Cancer Society-Illinois Division(American Cancer Society); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Croatian-Israeli Grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunology Training Grant; University of Chicago(University of Chicago); Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	For their kind gifts, we thank: A. Houghton (pCRAN vector and OVA DNA; Memorial Sloan-Kettering Cancer Center); V. Kumar and L. Chlewicki (non-Rae-1 epsilon-expressing EL-4 cells; The University of Chicago); L. Lanier (genes encoding Rae-1 epsilon, Rae-1 epsilon-GFP, and H60; University of California, San Francisco); A. Tenorio (HIV-positive donor identification; Rush University Medical Center); W. Yokoyama (NKG2D-deficient mouse spleens; Washington University School of Medicine in St. Louis), and D. Raulet (NKG2D-decifient mice, University of California, Berkeley). We thank B. Jabri, A. Bendelac, M. I. Nishimura and M.J. Turk for constructive discussions and manuscript edits. We are grateful to the flow cytometry facilities at The University of Chicago and at Loyola University Chicago for their invaluable support and to the Frank W. Fitch Monoclonal Antibody Facility of The University of Chicago Cancer Center (funded by US National Cancer Institute Cancer Center Support Grant 5P30CA014599-35) for CD4 depletion antibody production. HMG2D-specific antibody was used with permission from H. Yagita (Juntendo University School of Medicine). This work was supported in part by the American Cancer Society (ACSLIB112496-RSG) to J.A.G.-P.; American Cancer Society-Illinois Division (Young Investigator Award Grant 07-20) to J.A.G.-P.; Croatian Ministry of Science, Education and Sports (062-0621261-1271), as well as the Croatian-Israeli Grant to B. P.; the US National Institutes of Health R21CA127037 to J.A.G.-P., PO1AI082971 to L. A.-H., K22AI077714 to P. G. T.; T32 Immunology Training Grant, The University of Chicago, 5T32AI007090 to A.Z., F.J.K. and J.A.O.; and the Cancer Research Foundation (Young Investigator Award) to J.A.G.-P.	Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bellavance EC, 2011, J IMMUNOL, V186, P3309, DOI 10.4049/jimmunol.1002549; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Flecknell P, 2000, PAIN MANAGEMENT ANIM; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kuerten S, 2008, AIDS RES HUM RETROV, V24, P1175, DOI 10.1089/aid.2008.0062; Kuerten S, 2008, AIDS RES HUM RETROV, V24, P62, DOI 10.1089/aid.2007.0125; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Matthews K, 2007, SCAND J IMMUNOL, V65, P298, DOI 10.1111/j.1365-3083.2007.01902.x; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mueller KL, 2007, J IMMUNOL, V179, P3559, DOI 10.4049/jimmunol.179.6.3559; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schmidt CS, 2007, EXPERT REV VACCINES, V6, P391, DOI 10.1586/14760584.6.3.391; Schnizlein-Bick CT, 2000, CLIN DIAGN LAB IMMUN, V7, P336, DOI 10.1128/CDLI.7.3.336-343.2000; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Tao J, 2007, EUR J IMMUNOL, V37, P818, DOI 10.1002/eji.200636726; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Van Belle TL, 2009, MOL IMMUNOL, V47, P8, DOI 10.1016/j.molimm.2009.02.023; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677; Zloza A, 2011, AUTOIMMUNITY, V44, P599, DOI 10.3109/08916934.2011.593599; Zloza A, 2011, CANCER IMMUNOL IMMUN, V60, P291, DOI 10.1007/s00262-010-0962-6; Zloza A, 2009, BLOOD, V114, P3841, DOI 10.1182/blood-2009-02-202481	57	44	45	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					422	U184		10.1038/nm.2683	http://dx.doi.org/10.1038/nm.2683			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366950	Green Accepted			2022-12-27	WOS:000301264800044
J	Sainz, B; Barretto, N; Martin, DN; Hiraga, N; Imamura, M; Hussain, S; Marsh, KA; Yu, XM; Chayama, K; Alrefai, WA; Uprichard, SL				Sainz, Bruno, Jr.; Barretto, Naina; Martin, Danyelle N.; Hiraga, Nobuhiko; Imamura, Michio; Hussain, Snawar; Marsh, Katherine A.; Yu, Xuemei; Chayama, Kazuaki; Alrefai, Waddah A.; Uprichard, Susan L.			Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor	NATURE MEDICINE			English	Article							B TYPE-I; VIRION-ASSOCIATED CHOLESTEROL; NPC1L1; INFECTION; EZETIMIBE; PROTEIN; CD81; HEPATOCYTES; SECRETION; DENSITY	Hepatitis C virus (HCV) is a leading cause of liver disease worldwide. With similar to 170 million individuals infected and current interferon-based treatment having toxic side effects and marginal efficacy, more effective antivirals are crucially needed(1). Although HCV protease inhibitors were just approved by the US Food and Drug Administration (FDA), optimal HCV therapy, analogous to HIV therapy, will probably require a combination of antivirals targeting multiple aspects of the viral lifecycle. Viral entry represents a potential multifaceted target for antiviral intervention; however, to date, FDA-approved inhibitors of HCV cell entry are unavailable. Here we show that the cellular Niemann-Pick C1-like 1 (NPC1L1) cholesterol uptake receptor is an HCV entry factor amendable to therapeutic intervention. Specifically, NPC1L1 expression is necessary for HCV infection, as silencing or antibody-mediated blocking of NPC1L1 impairs cell culture-derived HCV (HCVcc) infection initiation. In addition, the clinically available FDA-approved NPC1L1 antagonist ezetimibe(2,3) potently blocks HCV uptake in vitro via a virion cholesterol-dependent step before virion-cell membrane fusion. Moreover, ezetimibe inhibits infection by all major HCV genotypes in vitro and in vivo delays the establishment of HCV genotype 1b infection in mice with human liver grafts. Thus, we have not only identified NPC1L1 as an HCV cell entry factor but also discovered a new antiviral target and potential therapeutic agent.	[Sainz, Bruno, Jr.; Barretto, Naina; Hussain, Snawar; Yu, Xuemei; Alrefai, Waddah A.; Uprichard, Susan L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Martin, Danyelle N.; Marsh, Katherine A.; Uprichard, Susan L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Hiraga, Nobuhiko; Imamura, Michio; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Grad Sch Biomed Sci, Hiroshima, Japan; [Alrefai, Waddah A.] Jesse Brown Virginia Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hiroshima University	Sainz, B (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.	bsainz@uic.edu; sluprich@uic.edu	Anding, Bruno Sainz/ABH-5365-2020; HUSSAIN, SNAWAR/M-4373-2016	Anding, Bruno Sainz/0000-0003-4829-7651; HUSSAIN, SNAWAR/0000-0002-9765-0565; Marsh, Katherine/0000-0002-7051-3819; Chayama, Kazuaki/0000-0002-5530-5341	US National Institutes of Health Public Health Service [R01-AI070827, R03-AI085226]; American Cancer Society [RSG-09-076-01]; UIC Center for Clinical and Translational Science NIH [UL1RR029879]; UIC Council; Ministry of Education, Culture, Sports, Science and Technology-Japan, Ministry of Health, Labour and Welfare-Japan; Grants-in-Aid for Scientific Research [24659368, 22659147] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070827, R03AI085226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071596] Funding Source: NIH RePORTER	US National Institutes of Health Public Health Service; American Cancer Society(American Cancer Society); UIC Center for Clinical and Translational Science NIH; UIC Council; Ministry of Education, Culture, Sports, Science and Technology-Japan, Ministry of Health, Labour and Welfare-Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Wakita (National Institute of Infectious Diseases, Japan) for JFH1-based plasmids, F. Chisari (The Scripps Research Institute) for Huh7 cells, J. Buhk (Copenhagen University Hospital Hepatitis C Program) for JFH-1-based intergenotypic HCV clones, Y. loannou (Mount Sinai School of Medicine) for the antibody (Bsn4052) against NPC1L1, D. Burton and M. Law (The Scripps Research Institute) for the antibody (C1) against the HCV glycoprotein E2 and C. Rice (The Rockefeller Institute) for the antibody (E910) against the HCV nonstructural protein NS5A. We would also like to thank P. Corcoran for outstanding technical assistance, H. Dahari for assistance with statistical analyses and T. Layden and S. Cotler for editing the manuscript. We also thank J. Graves of the University of Illinois at Chicago (UIC) Research Resources Center Flow Cytometry laboratory and K. Ma of the UIC Research Resources Center Confocal Microscopy laboratory for technical assistance. This work was supported by the US National Institutes of Health Public Health Service grants R01-AI070827 and R03-AI085226 (S.L.U.), the American Cancer Society Research Scholar Grant RSG-09-076-01 (S.L.U.), the UIC Center for Clinical and Translational Science NIH grant UL1RR029879, the UIC Council to Support Gastrointestinal and Liver Disease and a grant from the Ministry of Education, Culture, Sports, Science and Technology-Japan, Ministry of Health, Labour and Welfare-Japan (K.C.).	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P447, DOI 10.1586/14779072.6.4.447; Betters JL, 2010, CLIN PHARMACOL THER, V87, P117, DOI 10.1038/clpt.2009.209; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIRAL HEPATITIS, V15, P849, DOI 10.1111/j.1365-2893.2008.01051.x; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Gupta Eric K, 2002, Heart Dis, V4, P399, DOI 10.1097/00132580-200211000-00011; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kneteman Norman M., 2009, V510, P383, DOI 10.1007/978-1-59745-394-3_29; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Matsumura T, 2009, GASTROENTEROLOGY, V137, P673, DOI 10.1053/j.gastro.2009.04.048; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Sweeney ME, 2007, EXPERT OPIN DRUG MET, V3, P441, DOI 10.1517/17425255.3.3.441; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Uprichard Susan L., 2010, Virologica Sinica, V25, P227, DOI 10.1007/s12250-010-3134-0; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Yu LQ, 2008, CURR OPIN LIPIDOL, V19, P263, DOI 10.1097/MOL.0b013e3282f9b563; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	35	342	353	0	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					281	285		10.1038/nm.2581	http://dx.doi.org/10.1038/nm.2581			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22231557	Green Accepted			2022-12-27	WOS:000300140300043
J	Otto, SL				Otto, Shawn Lawrence			One way to help science: become Republican	NATURE MEDICINE			English	Editorial Material																		Brownstein R., 2011, NATL J          0521; CNN, 2008, CNN             0413; Cornwall Alliance for the Stewardship of Creation, EV DECL GLOB WARM; Giberson K. W., 2011, NY TIMES        1017; Jefferson Thomas, 1789, COMMUNICATION   0108; STEIN R, 2005, WASHINGTON POST 1031; The Pew Research Center For The People & The Press, 2009, PUBL PRAIS SCI SCI F	7	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					17	17		10.1038/nm0112-17	http://dx.doi.org/10.1038/nm0112-17			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227657				2022-12-27	WOS:000299018600013
J	Roep, B; Buckner, J; Sawcer, S; Toes, R; Zipp, F				Roep, Bart; Buckner, Jane; Sawcer, Stephen; Toes, Rene; Zipp, Frauke			The problems and promises of research into human immunology and autoimmune disease	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; CITRULLINATED PROTEIN ANTIBODY; TYPE-1 DIABETES-MELLITUS; PLACEBO-CONTROLLED TRIAL; MULTIPLE-SCLEROSIS; T-CELLS; RHEUMATOID-ARTHRITIS; NEUROMYELITIS-OPTICA; INTERFERON-BETA; LIGAND TRAIL	Translational research in autoimmunity is hampered by a number of hurdles, including a lack of knowledge regarding initiating and pathologically relevant autoantigens, the low frequency of autoreactive pathogenic B and T cells, difficulty in accessing the affected tissue, differences between self-reactive and pathogen-specific lymphocytes, a lack of etiologically relevant preclinical animal models and the heterogeneity of disease presentation. Given the need for biomarkers and new therapeutics, it is imperative that these hurdles be surmounted.	[Roep, Bart] Leiden Univ, Med Ctr, Natl Diabet Expert Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Buckner, Jane] Benaroya Res Inst, Translat Res Program, Seattle, WA USA; [Sawcer, Stephen] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Toes, Rene] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Univ Med Mainz, Klin & Poliklin Neurol, Mainz, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Benaroya Research Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johannes Gutenberg University of Mainz	Roep, B (corresponding author), Leiden Univ, Med Ctr, Natl Diabet Expert Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands.	boroep@lumc.nl	Zipp, Frauke/C-9968-2015; Roep, Bart/AAD-7609-2021	Zipp, Frauke/0000-0002-1231-1928; Toes, Rene/0000-0002-9618-6414				Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Bos WH, 2010, ANN RHEUM DIS, V69, P571, DOI 10.1136/ard.2008.105767; Castaldo P, 2011, CURR DRUG METAB, V12, P278, DOI 10.2174/138920011795101840; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; COPPIETERS KT, J EXP MED IN PRESS; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; De Grijse J, 2010, DIABETOLOGIA, V53, P517, DOI 10.1007/s00125-009-1618-y; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Farina C, 2001, BRAIN, V124, P705, DOI 10.1093/brain/124.4.705; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gillard P, 2009, DIABETES CARE, V32, P1817, DOI 10.2337/dc08-2339; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Halteren AGS, 2005, DIABETOLOGIA, V48, P75, DOI 10.1007/s00125-004-1613-2; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kaas A, 2010, CLIN EXP IMMUNOL, V161, P444, DOI 10.1111/j.1365-2249.2010.04193.x; Kemppinen A, 2011, BRIEF FUNCT GENOMICS, V10, P61, DOI 10.1093/bfgp/elr004; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Klareskog L, 2006, CURR OPIN IMMUNOL, V18, P650, DOI 10.1016/j.coi.2006.06.004; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Li N, 2003, J EXP MED, V197, P1501, DOI 10.1084/jem.20022031; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Naik RG, 2004, J AUTOIMMUN, V23, P55, DOI 10.1016/j.jaut.2004.04.002; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Petersen LD, 1999, DIABETOLOGIA, V42, P443; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Qin OY, 2006, DIABETES, V55, P3068, DOI 10.2337/db06-0065; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roep BO, 2011, LANCET, V378, P376, DOI 10.1016/S0140-6736(11)60977-X; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Roep BO, 1996, EUR J IMMUNOL, V26, P1285, DOI 10.1002/eji.1830260616; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Tree TIM, 2010, DIABETES, V59, P1451, DOI 10.2337/db09-0503; Unger WW, 2011, J AUTOIMMUN, V37, P151, DOI 10.1016/j.jaut.2011.05.012; Valle A, 2009, DIABETES, V58, P875, DOI 10.2337/db08-1432; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; Velthuis JH, 2009, DIABETOLOGIA, V52, P494, DOI 10.1007/s00125-008-1237-z; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	90	43	54	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					48	53		10.1038/nm.2626	http://dx.doi.org/10.1038/nm.2626			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227672				2022-12-27	WOS:000299018600027
J	Wekerle, H; Flugel, A; Fugger, L; Schett, G; Serreze, D				Wekerle, Hartmut; Fluegel, Alexander; Fugger, Lars; Schett, Georg; Serreze, David			Autoimmunity's next top models	NATURE MEDICINE			English	Article							MYELIN BASIC-PROTEIN; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MULTIPLE-SCLEROSIS; T-CELLS; RHEUMATOID-ARTHRITIS; ANIMAL-MODELS; NOD MICE; HEALTHY-INDIVIDUALS; CROSS-REACTIVITY; HUMAN IMMUNOLOGY	Animal models are indispensable for studying disease pathogenesis and discovering new treatments for human organ-specific autoimmune diseases. However, there is a need of more refined paradigms for these models. Ideally, a small-animal model should represent the clinical features of human disease in their entirety. Disease in the animals should develop spontaneously, should be followed over an extended period of time and should involve the genetic, molecular and cellular elements that contribute to human pathogenesis.	[Wekerle, Hartmut] Max Planck Inst Neurobiol, Dept Neuroimmunol, Munich, Germany; [Fluegel, Alexander] Inst Multiple Sclerosis Res, Dept Neuroimmunol, Gottingen, Germany; [Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Schett, Georg] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med 3, Erlangen, Germany; [Serreze, David] Jackson Lab, Dept Immunol Inflammat & Hematol, Bar Harbor, ME 04609 USA	Max Planck Society; University of Oxford; University of Oxford; University of Erlangen Nuremberg; Jackson Laboratory	Wekerle, H (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, Munich, Germany.	hwekerle@neuro.mpg.de			Medical Research Council [G1000800i] Funding Source: researchfish; Medical Research Council [G1000800I] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bach JF, 2001, ANNU REV IMMUNOL, V19, P131, DOI 10.1146/annurev.immunol.19.1.131; Bajramovic J., 2008, DRUG DISCOV TODAY, V5, P97, DOI [DOI 10.1016/J.DDMOD.2008.06.001, 10.1016/j.ddmod.2008.06.001]; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; BRENNAN FM, 1989, LANCET, V2, P244; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fabriek BO, 2005, J NEUROIMMUNOL, V161, P190, DOI 10.1016/j.jneuroim.2004.12.018; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; GENAIN CP, 1994, J CLIN INVEST, V94, P1339, DOI 10.1172/JCI117454; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Jarchum I, 2007, DIABETES, V56, P2551, DOI 10.2337/db07-0332; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LAMPETER EF, 1993, LANCET, V341, P1243, DOI 10.1016/0140-6736(93)91148-F; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LININGTON C, 1988, AM J PATHOL, V130, P443; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MARTIN R, 1990, J IMMUNOL, V145, P540; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meinl E, 1997, AM J PATHOL, V150, P445; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nossal GJV, 2001, NATURE, V412, P685, DOI 10.1038/35089152; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128; Serreze DV, 2005, TRENDS IMMUNOL, V26, P603, DOI 10.1016/j.it.2005.08.012; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Takaki T, 2006, J IMMUNOL, V176, P3257, DOI 10.4049/jimmunol.176.5.3257; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wiendl H, 2009, NEUROLOGY, V72, P1008, DOI 10.1212/01.wnl.0000344417.42972.54; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	50	36	45	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					66	70		10.1038/nm.2635	http://dx.doi.org/10.1038/nm.2635			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227675				2022-12-27	WOS:000299018600030
J	Erez, A; Nagamani, SCS; Shchelochkov, OA; Premkumar, MH; Campeau, PM; Chen, YQ; Garg, HK; Li, L; Mian, A; Bertin, TK; Black, JO; Zeng, H; Tang, YP; Reddy, AK; Summar, M; O'Brien, WE; Harrison, DG; Mitch, WE; Marini, JC; Aschner, JL; Bryan, NS; Lee, B				Erez, Ayelet; Nagamani, Sandesh C. S.; Shchelochkov, Oleg A.; Premkumar, Muralidhar H.; Campeau, Philippe M.; Chen, Yuqing; Garg, Harsha K.; Li, Li; Mian, Asad; Bertin, Terry K.; Black, Jennifer O.; Zeng, Heng; Tang, Yaoping; Reddy, Anilkumar K.; Summar, Marshall; O'Brien, William E.; Harrison, David G.; Mitch, William E.; Marini, Juan C.; Aschner, Judy L.; Bryan, Nathan S.; Lee, Brendan			Requirement of argininosuccinate lyase for systemic nitric oxide production	NATURE MEDICINE			English	Article							L-ARGININE; LIVER FIBROSIS; SYNTHASE; RELAXATION; DEFICIENCY; CRYSTALLIN; ENZYMES; MUSCLE	Nitric oxide (NO) is crucial in diverse physiological and pathological processes. We show that a hypomorphic mouse model of argininosuccinate lyase (encoded by Asl) deficiency has a distinct phenotype of multiorgan dysfunction and NO deficiency. Loss of Asl in both humans and mice leads to reduced NO synthesis, owing to both decreased endogenous arginine synthesis and an impaired ability to use extracellular arginine for NO production. Administration of nitrite, which can be converted into NO in vivo, rescued the manifestations of NO deficiency in hypomorphic Asl mice, and a nitric oxide synthase (NOS)-independent NO donor restored NO-dependent vascular reactivity in humans with ASL deficiency. Mechanistic studies showed that ASL has a structural function in addition to its catalytic activity, by which it contributes to the formation of a multiprotein complex required for NO production. Our data demonstrate a previously unappreciated role for ASL in NOS function and NO homeostasis. Hence, ASL may serve as a target for manipulating NO production in experimental models, as well as for the treatment of NO-related diseases.	[Erez, Ayelet; Nagamani, Sandesh C. S.; Shchelochkov, Oleg A.; Premkumar, Muralidhar H.; Campeau, Philippe M.; Chen, Yuqing; Mian, Asad; Bertin, Terry K.; O'Brien, William E.; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Chen, Yuqing; Bertin, Terry K.; Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA; [Garg, Harsha K.; Tang, Yaoping; Bryan, Nathan S.] Univ Texas Houston Hlth Sci Ctr, Brown Fdn Inst Mol Med, Houston, TX USA; [Li, Li; Harrison, David G.] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Black, Jennifer O.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Zeng, Heng; Summar, Marshall; Aschner, Judy L.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Zeng, Heng; Summar, Marshall; Aschner, Judy L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Reddy, Anilkumar K.; Mitch, William E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA; [Mitch, William E.] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Marini, Juan C.] USDA ARS, Dept Pediat Nutr, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX USA	Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Health Science Center Houston; Emory University; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.tmc.edu	Premkumar, Muralidhar/AAX-6868-2020; Reddy, Anilkumar/GLS-1391-2022; Black, Jennifer/A-3612-2012; Campeau, Philippe/J-8614-2015	Campeau, Philippe/0000-0001-9713-7107; Nagamani, Sandesh/0000-0001-6818-7367; Summar, Marshall/0000-0001-8920-0110	US National Institutes of Health [DK54450, RR19453, RR00188, GM90310, GM07526, DK081735, HL75511, RR024173, DK37175]; National Urea Cycle Disorder Foundation; Urea Cycle Disorders Rare Disease Clinical Research Network; American Heart Association [National 0735042N]; Canadian Institute of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR024173, U54RR019453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075511, R01HL022512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081735, R01DK054450, R01DK037175, R37DK037175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090310, T32GM007526] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Urea Cycle Disorder Foundation; Urea Cycle Disorders Rare Disease Clinical Research Network; American Heart Association(American Heart Association); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (DK54450, RR19453, RR00188, GM90310 to B.L., GM07526 and DK081735 to A.E., HL75511 to J.L.A., RR024173 to J.C.M. and DK37175 to W.E.M.). We acknowledge and thank the clinical efforts of M. Mullins, S. Carter, A. Tran, J. Stuff, W. Martinek and the Texas Children's Hospital General Clinical Research Center nursing staff. The mutated human ASL-encoding plasmids were kindly provided by L. Salviati from the Department of Pediatrics, University of Padova, Padova, Italy. We thank the families of the subjects for their kind participation. We greatly appreciate the technical contributions of M. Jiang, E. Munivez, B. Dawson, G. Sule and J. Zhang. We thank L. Castillo for helpful discussions. Figures were produced using Servier Medical Art. A.E., S.C.S.N. and O.A.S. are awardees of the National Urea Cycle Disorder Foundation Research Fellowship. O.A.S. is an awardee of the O'Malley Fellowship of the Urea Cycle Disorders Rare Disease Clinical Research Network. N.S.B. is supported by the American Heart Association-National 0735042N. P.M.C. is an awardee of the Canadian Institute of Health Research clinician-scientist training award.	Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Brunetti-Pierri N, 2009, MOL GENET METAB, V98, P195, DOI 10.1016/j.ymgme.2009.06.006; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dal Pra I, 2005, J CELL BIOCHEM, V96, P428, DOI 10.1002/jcb.20511; de Jonge WJ, 2002, AM J CLIN NUTR, V76, P128, DOI 10.1093/ajcn/76.1.128; Erez A, 2011, AM J MED GENET C, V157C, P45, DOI 10.1002/ajmg.c.30289; FAKLER CR, 1995, ACTA PAEDIATR, V84, P460, DOI 10.1111/j.1651-2227.1995.tb13673.x; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; GOLD ME, 1990, AM J PHYSIOL, V259, pH1813, DOI 10.1152/ajpheart.1990.259.6.H1813; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; Krivitzky L, 2009, PEDIATR RES, V66, P96, DOI 10.1203/PDR.0b013e3181a27a16; Kurotobi S, 2004, PEDIATR NEPHROL, V19, P138, DOI 10.1007/s00467-003-1335-6; LEE HJ, 1992, BIOCHEM J, V283, P597, DOI 10.1042/bj2830597; Li CY, 2005, BIOCHEM J, V386, P567, DOI 10.1042/BJ20041005; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Marley R, 2000, FREE RADICAL RES, V32, P1, DOI 10.1080/10715760000300011; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Mori T, 2002, PEDIATR DEVEL PATHOL, V5, P597, DOI 10.1007/s10024-002-0109-7; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Nagasaka H, 2009, METABOLISM, V58, P278, DOI 10.1016/j.metabol.2008.09.025; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Oyadomari S, 2001, NITRIC OXIDE-BIOL CH, V5, P252, DOI 10.1006/niox.2001.0344; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Scaglia F, 2004, J NUTR, V134, p2775S, DOI 10.1093/jn/134.10.2775S; Shimizu Yoshinori, 1997, Journal of Dermatology (Tokyo), V24, P80; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Sutton VR, 2003, MOL GENET METAB, V78, P11, DOI 10.1016/S1096-7192(02)00206-8; THOMAS G, 1989, BIOCHEM BIOPH RES CO, V158, P177, DOI 10.1016/S0006-291X(89)80194-9; Tojo A, 2006, MED MOL MORPHOL, V39, P2, DOI 10.1007/s00795-006-0310-2; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; Trevisson E, 2009, J BIOL CHEM, V284, P28926, DOI 10.1074/jbc.M109.050195; Vallee F, 1999, BIOCHEMISTRY-US, V38, P2425, DOI 10.1021/bi982149h; Wang RJ, 1996, J INVEST DERMATOL, V106, P419, DOI 10.1111/1523-1747.ep12343428; Wang XD, 2006, J BIOL CHEM, V281, P26994, DOI 10.1074/jbc.M603953200; ZIMMERMANN A, 1986, ARCH PATHOL LAB MED, V110, P136; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	43	146	152	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1619	U134		10.1038/nm.2544	http://dx.doi.org/10.1038/nm.2544			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081021	Green Submitted, Green Accepted			2022-12-27	WOS:000297978000033
J	Tiscornia, G; Vivas, EL; Belmonte, JCI				Tiscornia, Gustavo; Lorenzo Vivas, Erica; Izpisua Belmonte, Juan Carlos			Diseases in a dish: modeling human genetic disorders using induced pluripotent cells	NATURE MEDICINE			English	Review							EMBRYONIC STEM-CELLS; PATIENT-SPECIFIC IPSCS; EPIGENETIC MEMORY; ANIMAL-MODELS; DIFFERENTIATION; MOUSE; GENERATION; DERIVATION; BIOLOGY; LINES	The derivation of induced pluripotent cells (iPSCs) from individuals suffering from genetic syndromes offers new opportunities for basic research into these diseases and the development of therapeutic compounds. iPSCs can self renew and can be differentiated to many cell types, offering a potentially unlimited source of material for study. In this review we discuss the conceptual and practical issues to consider when attempting to model genetic diseases using iPSCs.	[Tiscornia, Gustavo; Lorenzo Vivas, Erica; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Barcelona, Spain.	belmonte@salk.edu	Tiscornia, Gustavo/F-4423-2012	Tiscornia, Gustavo/0000-0002-1841-5330; Lorenzo Vivas, Erika/0000-0002-8150-5902	Ramon y Cajal; Helmsley Charitable Trust; Sanofi-Aventis; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Cellex; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Ramon y Cajal(Spanish Government); Helmsley Charitable Trust; Sanofi-Aventis(Sanofi-Aventis); G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Cellex(Foundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank R. Vassena and M. Barragan Monasterio for their critical reading of the manuscript. Work in the laboratory of J.C.I.B. was funded by Ramon y Cajal, The Helmsley Charitable Trust, Sanofi-Aventis, The G. Harold and Leila Y. Mathers Charitable Foundation and Fundacion Cellex.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Irion S, 2008, COLD SH Q B, V73, P101, DOI 10.1101/sqb.2008.73.065; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Sermon KD, 2009, HUM REPROD, V24, P1556, DOI 10.1093/humrep/dep062; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Wilson JM, 1996, J CLIN INVEST, V97, P1138, DOI 10.1172/JCI118527; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	38	154	165	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1570	1576		10.1038/nm.2504	http://dx.doi.org/10.1038/nm.2504			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146428				2022-12-27	WOS:000297978000027
J	Inoshima, I; Inoshima, N; Wilke, GA; Powers, ME; Frank, KM; Wang, Y; Wardenburg, JB				Inoshima, Ichiro; Inoshima, Naoko; Wilke, Georgia A.; Powers, Michael E.; Frank, Karen M.; Wang, Yang; Wardenburg, Juliane Bubeck			A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice	NATURE MEDICINE			English	Article							ALPHA-HEMOLYSIN; E-CADHERIN; DISINTEGRIN; PATHOGENESIS; METALLOPROTEINASES; CYTOLYSINS; EXPRESSION; PROTECTION; PROTEINS; NOTCH	Staphylococcus aureus is a major cause of human disease, responsible for half a million infections and approximately 20,000 deaths per year in the United States alone(1,2). This pathogen secretes a-hemolysin, a pore-forming cytotoxin that contributes to the pathogenesis of pneumonia(3-5). alpha-hemolysin injures epithelial cells in vitro by interacting with its receptor, the zinc-dependent metalloprotease ADAM10 ( ref. 6). We show here that mice harboring a conditional disruption of the Adam10 gene in lung epithelium are resistant to lethal pneumonia. Investigation of the molecular mechanism of toxin-receptor function revealed that alpha-hemolysin upregulates ADAM10 metalloprotease activity in alveolar epithelial cells, resulting in cleavage of the adherens junction protein E-cadherin. Cleavage is associated with disruption of epithelial barrier function, contributing to the pathogenesis of lethal acute lung injury. A metalloprotease inhibitor of ADAM10 prevents E-cadherin cleavage in response to Hla; similarly, toxin-dependent E-cadherin proteolysis and barrier disruption is attenuated in ADAM10-knockout mice. Together, these data attest to the function of ADAM10 as the cellular receptor for alpha-hemolysin. The observation that alpha-hemolysin can usurp the metalloprotease activity of its receptor reveals a previously unknown mechanism of pore-forming cytotoxin action in which pathologic insults are not solely the result of irreversible membrane injury and defines ADAM10 inhibition as a strategy to attenuate alpha-hemolysin-induced disease.	[Inoshima, Ichiro; Inoshima, Naoko; Wilke, Georgia A.; Wang, Yang; Wardenburg, Juliane Bubeck] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Powers, Michael E.; Wardenburg, Juliane Bubeck] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Frank, Karen M.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Wardenburg, JB (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	jbubeckw@peds.bsd.uchicago.edu			Departments of Pediatrics and Microbiology at the University of Chicago; US National Institutes of Health [T32 GM007183]; Region V 'Great Lakes' Regional Center for Excellence (US National Institutes of Health [2-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	Departments of Pediatrics and Microbiology at the University of Chicago(University of Chicago); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region V 'Great Lakes' Regional Center for Excellence (US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Golovkina for assistance with mouse breeding strategies, A. Crofts for pilot studies of E-cadherin cleavage in vitro, D. Gruenert (University of California San Francisco) for 16HBE14o-cells, R. Tweten (The University of Oklahoma Health Sciences Center) for the provision of recombinant PLY, J. Whitsett (Cincinnati Children's Medical Center) for SP-C-rtTA-(tetO)<INF>7</INF>CMV-Cre mice, O. Schneewind for discussions and comments on the manuscript, C. Labno for microscopy support, T. Li for immunohistochemistry support, and the Integrated Microscopy and Immunohistochemistry Facilities at the University of Chicago. This work was supported by the Departments of Pediatrics and Microbiology at the University of Chicago. M. E. P. was partially supported by US National Institutes of Health grant T32 GM007183. The authors acknowledge membership in and support from the Region V 'Great Lakes' Regional Center for Excellence (US National Institutes of Health award 2-U54-AI-057153).	Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hoettecke N, 2010, NEURODEGENER DIS, V7, P232, DOI 10.1159/000267865; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Martin FJ, 2011, INFECT IMMUN, V79, P1898, DOI 10.1128/IAI.01299-10; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Tomita T, 1997, BIOSCI BIOTECH BIOCH, V61, P565, DOI 10.1271/bbb.61.565; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	32	288	297	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1310	U196		10.1038/nm.2451	http://dx.doi.org/10.1038/nm.2451			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21926978	Green Accepted			2022-12-27	WOS:000296022100051
J	Vassar, R				Vassar, Robert			Alzheimer's therapy: a BACE in the hand?	NATURE MEDICINE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; CLEAVAGE; DISEASE		Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.							Alzheimer Research Forum, 2011, UPPS IS TAU IMMU TAK; Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Kim SH, 2010, J NEUROSCI, V30, P3870, DOI 10.1523/JNEUROSCI.4717-09.2010; Lilly E., 2010, LILLY HALTS DEV SEMA; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yamakawa H, 2010, J BIOL CHEM, V285, P1634, DOI 10.1074/jbc.M109.066753; Yoshimizu T, 2004, BIOCHEM BIOPH RES CO, V315, P493, DOI 10.1016/j.bbrc.2004.01.073; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	11	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					932	933		10.1038/nm0811-932	http://dx.doi.org/10.1038/nm0811-932			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21818090				2022-12-27	WOS:000293507400023
J	Fugier, C; Klein, AF; Hammer, C; Vassilopoulos, S; Ivarsson, Y; Toussaint, A; Tosch, V; Vignaud, A; Ferry, A; Messaddeq, N; Kokunai, Y; Tsuburaya, R; de la Grange, P; Dembele, D; Francois, V; Precigout, G; Boulade-Ladame, C; Hummel, MC; de Munain, AL; Sergeant, N; Laquerriere, A; Thibault, C; Deryckere, F; Auboeuf, D; Garcia, L; Zimmermann, P; Udd, B; Schoser, B; Takahashi, MP; Nishino, I; Bassez, G; Laporte, J; Furling, D; Charlet-Berguerand, N				Fugier, Charlotte; Klein, Arnaud F.; Hammer, Caroline; Vassilopoulos, Stephane; Ivarsson, Ylva; Toussaint, Anne; Tosch, Valerie; Vignaud, Alban; Ferry, Arnaud; Messaddeq, Nadia; Kokunai, Yosuke; Tsuburaya, Rie; de la Grange, Pierre; Dembele, Doulaye; Francois, Virginie; Precigout, Guillaume; Boulade-Ladame, Charlotte; Hummel, Marie-Christine; Lopez de Munain, Adolfo; Sergeant, Nicolas; Laquerriere, Annie; Thibault, Christelle; Deryckere, Francois; Auboeuf, Didier; Garcia, Luis; Zimmermann, Pascale; Udd, Bjarne; Schoser, Benedikt; Takahashi, Masanori P.; Nishino, Ichizo; Bassez, Guillaume; Laporte, Jocelyn; Furling, Denis; Charlet-Berguerand, Nicolas			Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; CHLORIDE CHANNEL; AMPHIPHYSIN-2 BIN1; PROTEIN-KINASE; MESSENGER-RNA; CTG REPEAT; MUTATIONS; RECEPTOR; GENE; DISORGANIZATION	Myotonic dystrophy is the most common muscular dystrophy in adults and the first recognized example of an RNA-mediated disease. Congenital myotonic dystrophy (CDM1) and myotonic dystrophy of type 1 (DM1) or of type 2 (DM2) are caused by the expression of mutant RNAs containing expanded CUG or CCUG repeats, respectively. These mutant RNAs sequester the splicing regulator Muscleblind-like-1 (MBNL1), resulting in specific misregulation of the alternative splicing of other pre-mRNAs. We found that alternative splicing of the bridging integrator-1 (BIN1) pre-mRNA is altered in skeletal muscle samples of people with CDM1, DM1 and DM2. BIN1 is involved in tubular invaginations of membranes and is required for the biogenesis of muscle T tubules, which are specialized skeletal muscle membrane structures essential for excitation-contraction coupling. Mutations in the BIN1 gene cause centronuclear myopathy, which shares some histopathological features with myotonic dystrophy. We found that MBNL1 binds the BIN1 pre-mRNA and regulates its alternative splicing. BIN1 missplicing results in expression of an inactive form of BIN1 lacking phosphatidylinositol 5-phosphate-binding and membrane-tubulating activities. Consistent with a defect of BIN1, muscle T tubules are altered in people with myotonic dystrophy, and membrane structures are restored upon expression of the normal splicing form of BIN1 in muscle cells of such individuals. Finally, reproducing BIN1 splicing alteration in mice is sufficient to promote T tubule alterations and muscle weakness, a predominant feature of myotonic dystrophy.	[Fugier, Charlotte; Hammer, Caroline; Toussaint, Anne; Tosch, Valerie; Messaddeq, Nadia; Dembele, Doulaye; Hummel, Marie-Christine; Thibault, Christelle; Laporte, Jocelyn; Charlet-Berguerand, Nicolas] Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR7104, Illkirch Graffenstaden, France; [Klein, Arnaud F.; Vassilopoulos, Stephane; Vignaud, Alban; Ferry, Arnaud; Francois, Virginie; Precigout, Guillaume; Garcia, Luis; Furling, Denis] Univ Paris 06, INSERM, Inst Myol, UM76,U974, Paris, France; [Klein, Arnaud F.; Vassilopoulos, Stephane; Vignaud, Alban; Ferry, Arnaud; Francois, Virginie; Precigout, Guillaume; Garcia, Luis; Furling, Denis] CNRS, UMR7215, Paris, France; [Ivarsson, Ylva; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Kokunai, Yosuke] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Tsuburaya, Rie; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [de la Grange, Pierre] Hop St Louis, Paris, France; [Boulade-Ladame, Charlotte] Univ Strasbourg 1, Ecole Super Biotechnol Strasbourg, CNRS, UMR7175, Illkirch Graffenstaden, France; [Lopez de Munain, Adolfo] Hosp Donostia, Biodonostia Inst, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Carlos III, San Sebastian, Spain; [Sergeant, Nicolas] Jean Pierre Aubert Res Ctr, INSERM, U837 1, Lille, France; [Laquerriere, Annie] Univ Hosp Rouen, Pathol Lab, Rouen, France; [Auboeuf, Didier] Ctr Leon Berard, INSERM, U590, F-69373 Lyon, France; [Udd, Bjarne] Tampere Univ, Neuromuscular Res Ctr, FIN-33101 Tampere, Finland; [Udd, Bjarne] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, Helsinki, Finland; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa, Finland; [Schoser, Benedikt] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Bassez, Guillaume] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); KU Leuven; Osaka University; National Center for Neurology & Psychiatry - Japan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CIBERNED; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Tampere University; University of Helsinki; Vaasa Central Hospital; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Charlet-Berguerand, N (corresponding author), Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR7104, Illkirch Graffenstaden, France.	ncharlet@igbmc.fr	Bassez, Guillaume/AAD-3033-2022; Sergeant, Nicolas/O-5467-2017; laporte, jocelyn/O-4888-2019; Nishino, Ichizo/G-2676-2010; Charlet-Berguerand, Nicolas/I-6727-2016; Furling, Denis/M-2346-2017; Ivarsson, Ylva/HGE-0283-2022; Schoser, Benedikt/AAH-6286-2020; ferry, arnaud/D-2816-2019; Charlet-Berguerand, Nicolas/GZM-6636-2022; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; KLEIN, Arnaud/AAD-3333-2022; Laporte, Jocelyn/H-6801-2016; Zimmermann, Pascale/P-4190-2017; laporte, jocelyn/J-7008-2012; Auboeuf, Didier/M-4610-2014; Dembélé, Doulaye/O-6513-2017; Takahashi, Masanori/O-8946-2019; vassilopoulos, stephane/AAF-3865-2021; vassilopoulos, stéphane/F-6041-2014	Sergeant, Nicolas/0000-0003-1448-124X; Nishino, Ichizo/0000-0001-9452-112X; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Furling, Denis/0000-0001-7912-4409; Ivarsson, Ylva/0000-0002-7081-3846; ferry, arnaud/0000-0002-6050-4556; Charlet-Berguerand, Nicolas/0000-0002-4423-4920; KLEIN, Arnaud/0000-0002-3860-7049; Dembélé, Doulaye/0000-0003-3879-6940; Takahashi, Masanori/0000-0002-5513-5012; vassilopoulos, stephane/0000-0003-0172-330X; Auboeuf, Didier/0000-0002-3757-0002; Bassez, Guillaume/0000-0002-2044-1052; /0000-0002-9509-4032; Schoser, Benedikt/0000-0002-2757-8131; Thibault-Carpentier, Christelle/0000-0003-1562-1451	INSERM AVENIR; Agence nationale de la recherche [07-942, 08-005, 07-065]; Association Francaise contre les Myopathies [MNM1 12982, 12570, 14269, 12576, 14058]; Fondation pour la Recherche Medicale [20071210538]; Japan Society for the Promotion of Science [20590998]; European Molecular Biology Organization	INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence nationale de la recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank T. Cooper (Baylor College of Medicine) for the gift of the beta-globin 4.11.12, DMPKS, DT960 and tgCUGBP1 plasmids, L. Ranum (University of Minnesota) for the gift of the CCTG300 expression plasmid, C. Branlant (CNRS) for the gift of the pGEX-MBNL1 Delta 101 vector, M. Swanson (University of Florida) for the gift of the pGEX-6P-MBNL1-His vector, P. Hawkins (Babraham Research Campus) for the gift of the GFP-PH domain of PLCg and GFP-PX domain of P40 constructs, O. Gozani (Stanford University) for the gift of the GFP-PHD domain of ING2 vector, Z. Xue (Universite Paris 7) for the gift of the synemin-specific antibody, I. Marty (INSERM) for the gift of the RYR1-specific antibody, M. Swanson (University of Florida), G. Gourdon (INSERM) and C. Thornton (University of Rochester) for the gift of RNA from skeletal muscles of MBNL1<SUP>Delta E3</SUP>, DM300 and HSA<SUP>LR</SUP> mice, respectively, the IGBMC facilities for assistance, J. Laine, G. Butler-Browne and all members of the French DM Network for fruitful discussion. This work was supported by INSERM AVENIR (N.C.-B.), Agence nationale de la recherche GENOPAT 07-942 (N.C.-B.), 08-005 (J.L.) and BLANC 07-065 (J.L.), Association Francaise contre les Myopathies MNM1 12982 (N.C.-B.), 12570 and 14269 (D.F.), 12576 and 14058 (J.L.), Fondation pour la Recherche Medicale 20071210538 (J.L.), Japan Society for the Promotion of Science KAKENHI 20590998 (M.P.T.) and a European Molecular Biology Organization long-term fellowship (Y.I.).	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mouisel E, 2006, NEUROSCI RES, V55, P389, DOI 10.1016/j.neures.2006.05.002; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Ueda H, 1999, J NEUROL SCI, V162, P38, DOI 10.1016/S0022-510X(98)00290-1; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; YUAN S, 1990, J CELL BIOL, V110, P1187, DOI 10.1083/jcb.110.4.1187; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	40	220	224	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					720	U112		10.1038/nm.2374	http://dx.doi.org/10.1038/nm.2374			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21623381				2022-12-27	WOS:000291308800033
J	Khosla, S				Khosla, Sundeep			A shift in calcium	NATURE MEDICINE			English	Editorial Material							VASCULAR CALCIFICATION; OSTEOPOROSIS; ASSOCIATION; DISEASE; CELLS; BONE		Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372				Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gossl M, 2008, J AM COLL CARDIOL, V52, P1314, DOI 10.1016/j.jacc.2008.07.019; Hyder JA, 2009, AM J EPIDEMIOL, V169, P186, DOI 10.1093/aje/kwn303; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosla S, 2007, NEW ENGL J MED, V356, P2293, DOI 10.1056/NEJMcp070341; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Modder UI, 2011, OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS, P269, DOI 10.1016/B978-0-12-375670-1.10009-3; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711	12	26	31	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					430	431		10.1038/nm0411-430	http://dx.doi.org/10.1038/nm0411-430			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475237				2022-12-27	WOS:000289245100031
J	Quarles, LD				Quarles, L. Darryl			'Dem bones' are made for more than walking	NATURE MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; VITAMIN-D; FGF23 LEVELS; FIBROBLAST-GROWTH-FACTOR-23; EXPRESSION; RATS; PTH		Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896	NIAMS NIH HHS [R01 AR045955] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Katsnelson A, 2010, NATURE, V466, P914, DOI 10.1038/466914a; Komaba H, 2010, KIDNEY INT, V77, P292, DOI 10.1038/ki.2009.466; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Tsuji K, 2010, J BONE MINER RES, V25, P1711, DOI 10.1002/jbmr.65; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227; Wetmore JB, 2010, CLIN J AM SOC NEPHRO, V5, P110, DOI 10.2215/CJN.03630509	16	28	29	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					428	430		10.1038/nm0411-428	http://dx.doi.org/10.1038/nm0411-428			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475236	Green Accepted			2022-12-27	WOS:000289245100030
J	Clement, LC; Avila-Casado, C; Mace, C; Soria, E; Bakker, WW; Kersten, S; Chugh, SS				Clement, Lionel C.; Avila-Casado, Carmen; Mace, Camille; Soria, Elizabeth; Bakker, Winston W.; Kersten, Sander; Chugh, Sumant S.			Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome	NATURE MEDICINE			English	Article							GENE-EXPRESSION; OLIGOMERIZATION	The main manifestations of nephrotic syndrome include proteinuria, hypoalbuminemia, edema, hyperlipidemia and lipiduria. Common causes of nephrotic syndrome are diabetic nephropathy, minimal change disease (MCD), focal and segmental glomerulosclerosis (FSGS) and membranous nephropathy. Among the primary glomerular diseases, MCD is usually sensitive to glucocorticoid treatment, whereas the other diseases show variable responses(1). Despite the identification of key structural proteins in the glomerular capillary loop which may contribute to defects in ultrafiltration, many of the disease mechanisms of nephrotic syndrome remain unresolved. In this study, we show that the glomerular expression of angiopoietin-like-4 (Angptl4), a secreted glycoprotein, is glucocorticoid sensitive and is highly upregulated in the serum and in podocytes in experimental models of MCD and in the human disease. Podocyte-specific transgenic overexpression of Angptl4 (NPHS2-Angptl4) in rats induced nephrotic-range, and selective, proteinuria (over 500-fold increase in albuminuria), loss of glomerular basement membrane (GBM) charge and foot process effacement, whereas transgenic expression specifically in the adipose tissue (aP2-Angptl4) resulted in increased circulating Angptl4, but no proteinuria. Angptl4-/-mice that were injected with lipopolysaccharide (LPS) or nephritogenic antisera developed markedly less proteinuria than did control mice. Angptl4 secreted from podocytes in some forms of nephrotic syndrome lacks normal sialylation. When we fed the sialic acid precursor N-acetyl-D-mannosamine (ManNAc) to NPHS2-Angptl4 transgenic rats it increased the sialylation of Angptl4 and decreased albuminuria by more than 40%. These results suggest that podocyte-secreted Angptl4 has a key role in nephrotic syndrome.	[Clement, Lionel C.; Mace, Camille; Chugh, Sumant S.] Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA; [Clement, Lionel C.; Mace, Camille; Chugh, Sumant S.] Univ Alabama Birmingham, Nephrol Res & Training Ctr, Birmingham, AL USA; [Avila-Casado, Carmen; Soria, Elizabeth] Inst Nacl Cardiol, Dept Pathol, Mexico City, DF, Mexico; [Bakker, Winston W.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Kersten, Sander] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institute of Cardiology - Mexico; University of Groningen; Wageningen University & Research	Chugh, SS (corresponding author), Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA.	chugh@uab.edu	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; SORIA-CASTRO, ELIZABETH/0000-0001-8050-1961	US National Institutes of Health [R56DK077073, R01DK077073]; Norman S. Coplon Satellite Research Grant; CONACYT [111]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077073, R56DK077073] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman S. Coplon Satellite Research Grant; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Spiegelman (Dana-Farber Cancer Institute) for the mouse aP2 promoter construct; L. Holzman (University of Michigan) for the human NPHS2 promoter construct; P. Mundel (University of Miami) for mouse GECs; T. van Kuppevelt (Radboud University Nijmegen Medical Center) for the heparan sulfate proteoglycan-specific antibody p1113; D. Salant (Boston University) for gamma 2-NTS; and A. Koster (Eli Lilly) for Angptl4<SUP>-/-</SUP> mice. We also thank G. Bai for the generation of probe for in situ hybridization; S. Shastry for some ELISA assays for rat and mouse albumin; S. Rahmanuddin for selected immunogold studies and polyethyleneimine studies; F. Mattijssen for mouse LPS study; J. Novak for advice on choice of lectins; and Y.S. Kanwar and M. Venkatachalam for useful discussions on heparan sulfate proteoglycans. Supported by the US National Institutes of Health (R56DK077073, R01DK077073 to S.S.C.), Norman S. Coplon Satellite Research Grant to S.S.C. and CONACYT 111 grant to C.A.-C. We thank the University of Alabama at Birmingham-University of California-San Diego George O'Brien Center Core C for measuring mouse urine creatinine by mass spectrometry. The use of sialic acid precursors, including ManNAc, to treat proteinuria and nephrotic syndrome is covered by US Provisional Application 61/351,865 filed by S.S.C.	Avila-Casado MD, 2004, KIDNEY INT, V66, P133, DOI 10.1111/j.1523-1755.2004.00715.x; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Clement LC, 2007, KIDNEY INT, V72, P337, DOI 10.1038/sj.ki.5002302; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Nachman PH., 2008, BRENNER RECTORS KIDN, V8th, P987; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	23	214	235	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					117	U294		10.1038/nm.2261	http://dx.doi.org/10.1038/nm.2261			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151138	Green Accepted			2022-12-27	WOS:000285994000044
J	Wilhelm, K; Ganesan, J; Muller, T; Durr, C; Grimm, M; Beilhack, A; Krempl, CD; Sorichter, S; Gerlach, UV; Juttner, E; Zerweck, A; Gartner, F; Pellegatti, P; Di Virgilio, F; Ferrari, D; Kambham, N; Fisch, P; Finke, J; Idzko, M; Zeiser, R				Wilhelm, Konrad; Ganesan, Jayanthi; Mueller, Tobias; Duerr, Christoph; Grimm, Melanie; Beilhack, Andreas; Krempl, Christine D.; Sorichter, Stephan; Gerlach, Ulrike V.; Juettner, Eva; Zerweck, Alf; Gaertner, Frank; Pellegatti, Patrizia; Di Virgilio, Francesco; Ferrari, Davide; Kambham, Neeraja; Fisch, Paul; Finke, Juergen; Idzko, Marco; Zeiser, Robert			Graft-versus-host disease is enhanced by extracellular ATP activating P2X(7)R	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; NICOTINAMIDE ADENINE-DINUCLEOTIDE; BONE-MARROW-TRANSPLANTATION; RAPAMYCIN INHIBITION; MAMMALIAN TARGET; HIGH-SENSITIVITY; DENDRITIC CELLS; RECEPTOR; RESPONSES; GAMMA	Danger signals released upon cell damage can cause excessive immune-mediated tissue destruction such as that found in acute graft-versus-host disease (GVHD), allograft rejection and systemic inflammatory response syndrome. Given that ATP is found in small concentrations in the extracellular space under physiological conditions(1), and its receptor P2X(7)R is expressed on several immune cell types, ATP could function as a danger signal when released from dying cells. We observed increased ATP concentrations in the peritoneal fluid after total body irradiation, and during the development of GVHD in mice and in humans. Stimulation of antigen-presenting cells (APCs) with ATP led to increased expression of CD80 and CD86 in vitro and in vivo and actuated a cascade of proinflammatory events, including signal transducer and activator of transcription-1 (STAT1) phosphorylation, interferon-gamma (IFN-gamma) production and donor T cell expansion, whereas regulatory T cell numbers were reduced. P2X(7)R expression increased when GVHD evolved, rendering APCs more responsive to the detrimental effects of ATP, thereby providing positive feedback signals. ATP neutralization, early P2X(7)R blockade or genetic deficiency of P2X(7)R during GVHD development improved survival without immune paralysis. These data have major implications for transplantation medicine, as pharmacological interference with danger signals that act via P2X(7)R could lead to the development of tolerance without the need for intensive immunosuppression.	[Wilhelm, Konrad; Ganesan, Jayanthi; Duerr, Christoph; Zerweck, Alf; Gaertner, Frank; Finke, Juergen; Zeiser, Robert] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-7800 Freiburg, Germany; [Ganesan, Jayanthi; Mueller, Tobias; Grimm, Melanie; Sorichter, Stephan; Idzko, Marco] Univ Freiburg, Med Ctr, Dept Pneumol, D-7800 Freiburg, Germany; [Ganesan, Jayanthi; Duerr, Christoph] Univ Freiburg, Dept Biol, D-7800 Freiburg, Germany; [Beilhack, Andreas] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Beilhack, Andreas] Univ Hosp Wurzburg, Interdisciplinary Ctr Clin Res, Wurzburg, Germany; [Krempl, Christine D.] Univ Wurzburg, Inst Virol & Immunbiol, D-8700 Wurzburg, Germany; [Gerlach, Ulrike V.; Juettner, Eva; Fisch, Paul] Univ Freiburg, Med Ctr, Dept Pathol, D-7800 Freiburg, Germany; [Pellegatti, Patrizia; Di Virgilio, Francesco; Ferrari, Davide] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Kambham, Neeraja] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	University of Freiburg; University of Freiburg; University of Freiburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Freiburg; University of Ferrara; Stanford University	Zeiser, R (corresponding author), Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-7800 Freiburg, Germany.	marco.idzko@uniklinik-freiburg.de; robert.zeiser@uniklinik-freiburg.de	Di Virgilio, Francesco/J-3754-2018; Ferrari, Davide/F-5644-2015; Müller, Tobias/ABH-7263-2020; Pellegatti, Patrizia/A-1891-2011; DI VIRGILIO, Francesco/O-4634-2019; Krempl, Christine D/O-2081-2015	Di Virgilio, Francesco/0000-0003-3566-1362; Ferrari, Davide/0000-0002-5727-9204; Müller, Tobias/0000-0002-9801-3496; DI VIRGILIO, Francesco/0000-0003-3566-1362; Zeiser, Robert/0000-0001-6565-3393; Kambham, Neeraja/0000-0003-1136-3686; Anand, Jayanthi/0000-0002-8883-7299	Forschungskommission der Universitat Freiburg (FoKo) [ZEI616/08]; Wilhelm Sander Stiftung [2008.046.1]; Deutsche Forschungsgemeinschaft [ID 7/4-1, ZE 872/1-1]	Forschungskommission der Universitat Freiburg (FoKo); Wilhelm Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to S. Kruger, C. Faller, C. Kiesel, C. A. Bauerlein, M. Ritz and V. Schmidt. This study was supported by the Forschungskommission der Universitat Freiburg (FoKo ZEI616/08 to R.Z.), the Wilhelm Sander Stiftung (2008.046.1 to R.Z., M. I. and J.F.) and the Deutsche Forschungsgemeinschaft (ID 7/4-1 to M. I. and ZE 872/1-1 to R.Z.).	Anderson BE, 2008, BLOOD, V111, P5242, DOI 10.1182/blood-2007-09-107953; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Hauri-Hohl MM, 2007, BLOOD, V109, P4080, DOI 10.1182/blood-2006-07-034157; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hill GR, 1999, J CLIN INVEST, V104, P459, DOI 10.1172/JCI6896; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Kawamura H, 2005, J IMMUNOL, V174, P1971, DOI 10.4049/jimmunol.174.4.1971; Krempl CD, 2007, J VIROL, V81, P9490, DOI 10.1128/JVI.00364-07; Lee KH, 2007, HAEMATOL-HEMATOL J, V92, P651, DOI 10.3324/haematol.10810; Metaxas Y, 2005, LEUKEMIA, V19, P1287, DOI 10.1038/sj.leu.2403789; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Rao V, 2008, SCAND J IMMUNOL, V68, P645, DOI 10.1111/j.1365-3083.2008.02179.x; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Wang H, 2009, BLOOD, V113, P3612, DOI 10.1182/blood-2008-07-168419; Zeiser R, 2007, BLOOD, V110, P4588, DOI 10.1182/blood-2007-08-106005; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeiser R, 2007, BIOL BLOOD MARROW TR, V13, P1427, DOI 10.1016/j.bbmt.2007.08.041; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	30	308	317	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1434	U117		10.1038/nm.2242	http://dx.doi.org/10.1038/nm.2242			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102458				2022-12-27	WOS:000285048900038
J	Marcos, V; Zhou, Z; Yildirim, AO; Bohla, A; Hector, A; Vitkov, L; Wiedenbauer, EM; Krautgartner, WD; Stoiber, W; Belohradsky, BH; Rieber, N; Kormann, M; Koller, B; Roscher, A; Roos, D; Griese, M; Eickelberg, O; Doring, G; Mall, MA; Hartl, D				Marcos, Veronica; Zhou, Zhe; Yildirim, Ali Oender; Bohla, Alexander; Hector, Andreas; Vitkov, Ljubomir; Wiedenbauer, Eva-Maria; Krautgartner, Wolf Dietrich; Stoiber, Walter; Belohradsky, Bernd H.; Rieber, Nikolaus; Kormann, Michael; Koller, Barbara; Roscher, Adelbert; Roos, Dirk; Griese, Matthias; Eickelberg, Oliver; Doering, Gerd; Mall, Marcus A.; Hartl, Dominik			RETRACTED: CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation (Retracted article. See vol. 17, pg. 899, 2011)	NATURE MEDICINE			English	Article; Retracted Publication							MITOCHONDRIAL-DNA; INTERLEUKIN-8; RECEPTORS; IMMUNITY; RELEASE; CHEMOKINES; INDUCTION; BACTERIA; LIGANDS; DEFENSE	Upon activation, neutrophils release DNA fibers decorated with antimicrobial proteins, forming neutrophil extracellular traps (NETs)(1-3). Although NETs are bactericidal and contribute to innate host defense, excessive NET formation has been linked to the pathogenesis of autoinflammatory diseases(4,5). However, the mechanisms regulating NET formation, particularly during chronic inflammation, are poorly understood. Here we show that the G protein-coupled receptor (GPCR) CXCR2 mediates NET formation. Downstream analyses showed that CXCR2-mediated NET formation was independent of NADPH oxidase and involved Src family kinases. We show the pathophysiological relevance of this mechanism in cystic fibrosis lung disease, characterized by chronic neutrophilic inflammation(6,7). We found abundant NETs in airway fluids of individuals with cystic fibrosis and mouse cystic fibrosis lung disease, and NET amounts correlated with impaired obstructive lung function. Pulmonary blockade of CXCR2 by intra-airway delivery of small-molecule antagonists inhibited NET formation and improved lung function in vivo without affecting neutrophil recruitment, proteolytic activity or antibacterial host defense. These studies establish CXCR2 as a receptor mediating NADPH oxidase-independent NET formation and provide evidence that this GPCR pathway is operative and druggable in cystic fibrosis lung disease.	[Marcos, Veronica; Hector, Andreas; Wiedenbauer, Eva-Maria; Belohradsky, Bernd H.; Rieber, Nikolaus; Kormann, Michael; Roscher, Adelbert; Griese, Matthias; Hartl, Dominik] Univ Munich, Childrens Hosp, Res Ctr, D-8000 Munich, Germany; [Zhou, Zhe; Mall, Marcus A.] Heidelberg Univ, Dept Pediat 3, Div Pediat Pulmonol, Heidelberg, Germany; [Zhou, Zhe; Mall, Marcus A.] Heidelberg Univ, Dept Pediat 3, Cyst Fibrosis Ctr, Heidelberg, Germany; [Yildirim, Ali Oender; Bohla, Alexander; Eickelberg, Oliver] Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-8000 Munich, Germany; [Hector, Andreas; Kormann, Michael; Hartl, Dominik] Univ Tubingen, Childrens Hosp, Tubingen, Germany; [Hector, Andreas; Kormann, Michael; Hartl, Dominik] Univ Tubingen, Interdisciplinary Ctr Infect Dis, Tubingen, Germany; [Vitkov, Ljubomir] Univ Saarland, Dept Operat Dent & Periodontol, D-6650 Homburg, Germany; [Vitkov, Ljubomir; Krautgartner, Wolf Dietrich; Stoiber, Walter] Salzburg Univ, Dept Organism Biol, Div Light & Electron Microscopy, A-5020 Salzburg, Austria; [Koller, Barbara] Univ Munich, Dept Dermatol & Allergy, D-8000 Munich, Germany; [Roos, Dirk] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Doering, Gerd] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany	University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munich; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Saarland University; Salzburg University; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hartl, D (corresponding author), Univ Munich, Childrens Hosp, Res Ctr, D-8000 Munich, Germany.	dominik.hartl@med.uni-tuebingen.de	Vitkov, Ljubomir/H-5873-2019; Eickelberg, Oliver/A-5461-2013; Mall, Marcus A./AAA-1498-2022; Bohla, Alexander/J-1537-2012	Vitkov, Ljubomir/0000-0002-1249-0161; Eickelberg, Oliver/0000-0001-7170-0360; Mall, Marcus A./0000-0002-4057-2199; Bohla, Alexander/0000-0001-9610-5138; Yildirim, Ali Onder/0000-0003-1969-480X; Hector, Andreas/0000-0002-5745-4746	German Research Foundation; Alexander von Humboldt Foundation; German Society of Pediatric Pneumology; PINAe.V.; Novartis Foundation; Ernest-Solvay-Foundation;  [HA 5274/3-1];  [2081/3-3];  [MA 2081/4-1]	German Research Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Society of Pediatric Pneumology; PINAe.V.; Novartis Foundation(Novartis); Ernest-Solvay-Foundation; ; ; 	We thank B. Lange-Sperandio and F. Beitinger for lung sample preparations. We thank O. Gires and L. Mays for manuscript discussions. We thank M. Klappacher, A. Obermayer, T. Stoger, B. Ritter, S. Stritzke and M. Franz for assistance in experimental workup and S. Hirtz for breeding and genotyping of experimental mice. Supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, Emmy Noether Programme HA 5274/3-1 to D. H., MA 2081/3-3 and MA 2081/4-1 to M. A. M.), the Alexander von Humboldt Foundation (B. K.), the German Society of Pediatric Pneumology (D. H.), PINAe.V. (D. H.), the Novartis Foundation (D. H.) and the Ernest-Solvay-Foundation (D. H.).	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Barnes PJ, 2008, CURR OPIN PHARMACOL, V8, P300, DOI 10.1016/j.coph.2008.03.001; Belperio JA, 2005, J CLIN INVEST, V115, P1150, DOI 10.1172/JCI200524233; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; Frizzell RA, 2004, NAT MED, V10, P452, DOI 10.1038/nm0504-452; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Herbold W, 2010, INFECT IMMUN, V78, P2620, DOI 10.1128/IAI.01169-09; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; Mehrad B, 1999, J IMMUNOL, V163, P6086; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Ness TL, 2003, J IMMUNOL, V171, P3775, DOI 10.4049/jimmunol.171.7.3775; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pease James E, 2002, Am J Respir Med, V1, P19; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; Sue RD, 2004, J IMMUNOL, V172, P3860, DOI 10.4049/jimmunol.172.6.3860; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban C, 2007, NAT MED, V13, P403, DOI 10.1038/nm0407-403; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zarbock A, 2008, BRIT J PHARMACOL, V155, P357, DOI 10.1038/bjp.2008.270	39	153	163	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1018	U114		10.1038/nm.2209	http://dx.doi.org/10.1038/nm.2209			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20818377				2022-12-27	WOS:000281622900031
J	Nadig, SN; Wieckiewicz, J; Wu, DC; Warnecke, G; Zhang, W; Luo, SQ; Schiopu, A; Taggart, DP; Wood, KJ				Nadig, Satish N.; Wieckiewicz, Joanna; Wu, Douglas C.; Warnecke, Gregor; Zhang, Wei; Luo, Shiqiao; Schiopu, Alexandru; Taggart, David P.; Wood, Kathryn J.			In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells	NATURE MEDICINE			English	Article							CHRONIC REJECTION; GAMMA; EXPANSION; TOLERANCE; EXPRESSION; RECIPIENTS; MODEL	Transplant arteriosclerosis is the hallmark of chronic allograft dysfunction (CAD) affecting transplanted organs in the long term(1,2). These fibroproliferative lesions lead to neointimal thickening of arteries in all transplanted allografts(2). Luminal narrowing then leads to graft ischemia and organ demise. To date, there are no known tolerance induction strategies that prevent transplant arteriosclerosis(3,4). Therefore, we designed this study to test the hypothesis that human regulatory T cells (T-reg cells) expanded ex vivo can prevent transplant arteriosclerosis. Here we show the comparative capacity of T-reg cells, sorted via two separate strategies, to prevent transplant arteriosclerosis in a clinically relevant chimeric humanized mouse system. We found that the in vivo development of transplant arteriosclerosis in human arteries was prevented by treatment of ex vivo-expanded human T-reg cells. Additionally, we show that T-reg cells sorted on the basis of low expression of CD127 provide a more potent therapy to conventional T-reg cells. Our results demonstrate that human T-reg cells can inhibit transplant arteriosclerosis by impairing effector function and graft infiltration. We anticipate our findings to serve as a foundation for the clinical development of therapeutics targeting transplant arteriosclerosis in both allograft transplantation and other immune-mediated causes of vasculopathy(5).	[Nadig, Satish N.; Wieckiewicz, Joanna; Wu, Douglas C.; Warnecke, Gregor; Zhang, Wei; Luo, Shiqiao; Schiopu, Alexandru; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England; [Taggart, David P.] John Radcliffe Hosp, Nuffield Dept Surg, Div Cardiothorac Surg, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Wood, KJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England.	kathryn.wood@nds.ox.ac.uk	Wu, Douglas/AAP-8324-2020; Schiopu, Alexandru/AAY-7229-2021	Schiopu, Alexandru/0000-0002-7587-5050; Hester, Joanna/0000-0002-7466-3849	Wellcome Trust; European Union; RISET; Medical Research Council UK; Garfield Weston Trust; Becton Dickinson; Swedish Heart and Lung Foundation; Swedish Research Council; Medical Research Council [G0800842] Funding Source: researchfish; MRC [G0800842] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); RISET; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Garfield Weston Trust; Becton Dickinson; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of the Biomedical Services Unit at the John Radcliffe Hospital for expert animal care, M. Barnardo and the staff at the Clinical Transplant Immunology Laboratory, The Oxford Transplant Centre for molecular human leukocyte antigen typing, M. Carvalho-Gaspar for advice on real-time PCR, F. Issa and R. Goto for assistance with some experiments, A. Bushell and N. Jones for valuable discussions and the cardiac surgical registrars and operating theater staff for assistance with the procurement of vessels. This work was supported by grants from The Wellcome Trust, the European Union Integrated Project, RISET, Medical Research Council UK and Garfield Weston Trust. S. N. N. is an International Society for Heart and Lung Transplantation Research Fellow; J.W. is a RISET investigator, G. W. is a Deutsche Forschungsgemeinschaft Fellow; W.Z. was supported by an unrestricted grant from Becton Dickinson; A. S. was supported by the Swedish Heart and Lung Foundation and the Swedish Research Council.	Cuffy MC, 2007, J IMMUNOL, V179, P5246, DOI 10.4049/jimmunol.179.8.5246; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; HILLEBRANDS JL, 2003, EXPERT REV MOL MED, V33, P1; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; JUTILA MA, 1992, J EXP MED, V175, P1565, DOI 10.1084/jem.175.6.1565; Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035; Koenen HJPM, 2005, J IMMUNOL, V174, P7573, DOI 10.4049/jimmunol.174.12.7573; KOULACK J, 1995, MICROSURG, V16, P110, DOI 10.1002/micr.1920160213; Lin CY, 2002, NAT IMMUNOL, V3, P1208, DOI 10.1038/ni853; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mitchell RN, 2004, J CLIN INVEST, V114, P762, DOI 10.1172/JCI200422927; Mussa S, 2005, J THORAC CARDIOV SUR, V129, P250, DOI 10.1016/j.jtcvs.2004.07.040; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; PUCCI AM, 1990, J HEART TRANSPLANT, V9, P339; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Taylor DO, 2006, J HEART LUNG TRANSPL, V25, P869, DOI 10.1016/j.healun.2006.05.002; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Tellides G, 2007, CIRC RES, V100, P622, DOI 10.1161/01.RES.0000258861.72279.29; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Tullius SG, 1998, KIDNEY INT, V53, P465, DOI 10.1046/j.1523-1755.1998.00757.x; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Warnecke G, 2007, TRANSPLANTATION, V83, P1459, DOI 10.1097/01.tp.0000265446.61754.d2; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027	27	229	238	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					809	U112		10.1038/nm.2154	http://dx.doi.org/10.1038/nm.2154			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20473306	Green Accepted			2022-12-27	WOS:000279631900032
J	Palanisamy, N; Ateeq, B; Kalyana-Sundaram, S; Pflueger, D; Ramnarayanan, K; Shankar, S; Han, B; Cao, Q; Cao, XH; Suleman, K; Kumar-Sinha, C; Dhanasekaran, SM; Chen, YB; Esgueva, R; Banerjee, S; LaFargue, CJ; Siddiqui, J; Demichelis, F; Moeller, P; Bismar, TA; Kuefer, R; Fullen, DR; Johnson, TM; Greenson, JK; Giordano, TJ; Tan, P; Tomlins, SA; Varambally, S; Rubin, MA; Maher, CA; Chinnaiyan, AM				Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker; Pflueger, Dorothee; Ramnarayanan, Kalpana; Shankar, Sunita; Han, Bo; Cao, Qi; Cao, Xuhong; Suleman, Khalid; Kumar-Sinha, Chandan; Dhanasekaran, Saravana M.; Chen, Ying-bei; Esgueva, Raquel; Banerjee, Samprit; LaFargue, Christopher J.; Siddiqui, Javed; Demichelis, Francesca; Moeller, Peter; Bismar, Tarek A.; Kuefer, Rainer; Fullen, Douglas R.; Johnson, Timothy M.; Greenson, Joel K.; Giordano, Thomas J.; Tan, Patrick; Tomlins, Scott A.; Varambally, Sooryanarayana; Rubin, Mark A.; Maher, Christopher A.; Chinnaiyan, Arul M.			Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma	NATURE MEDICINE			English	Article							ETS TRANSCRIPTION FACTOR; EML4-ALK FUSION GENE; BRAF ACTIVATION; THYROID-CANCER; BREAST-CANCER; LUNG-CANCER; TRANSFORMATION; MUTATIONS; ADENOCARCINOMA; IDENTIFICATION	Although recurrent gene fusions involving erythroblastosis virus E26 transformation-specific (ETS) family transcription factors are common in prostate cancer, their products are considered 'undruggable' by conventional approaches. Recently, rare targetable gene fusions involving the anaplastic lymphoma receptor tyrosine kinase (ALK) gene, have been identified in 1-5% of lung cancers(1), suggesting that similar rare gene fusions may occur in other common epithelial cancers, including prostate cancer. Here we used paired-end transcriptome sequencing to screen ETS rearrangement-negative prostate cancers for targetable gene fusions and identified the SLC45A3-BRAF (solute carrier family 45, member 3-v-raf murine sarcoma viral oncogene homolog B1) and ESRP1-RAF1 (epithelial splicing regulatory protein-1-v-raf-1 murine leukemia viral oncogene homolog-1) gene fusions. Expression of SLC45A3-BRAF or ESRP1-RAF1 in prostate cells induced a neoplastic phenotype that was sensitive to RAF and mitogen-activated protein kinase kinase (MAP2K1) inhibitors. Screening a large cohort of patients, we found that, although rare, recurrent rearrangements in the RAF pathway tend to occur in advanced prostate cancers, gastric cancers and melanoma. Taken together, our results emphasize the key role of RAF family gene rearrangements in cancer, suggest that RAF and MEK inhibitors may be useful in a subset of gene fusion-harboring solid tumors and demonstrate that sequencing of tumor transcriptomes and genomes may lead to the identification of rare targetable fusions across cancer types.	[Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker; Ramnarayanan, Kalpana; Shankar, Sunita; Han, Bo; Cao, Qi; Cao, Xuhong; Suleman, Khalid; Kumar-Sinha, Chandan; Dhanasekaran, Saravana M.; Siddiqui, Javed; Tomlins, Scott A.; Varambally, Sooryanarayana; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker; Ramnarayanan, Kalpana; Shankar, Sunita; Han, Bo; Cao, Qi; Suleman, Khalid; Kumar-Sinha, Chandan; Dhanasekaran, Saravana M.; Siddiqui, Javed; Fullen, Douglas R.; Greenson, Joel K.; Giordano, Thomas J.; Tomlins, Scott A.; Varambally, Sooryanarayana; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Palanisamy, Nallasivam; Kalyana-Sundaram, Shanker; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Pflueger, Dorothee; Chen, Ying-bei; Esgueva, Raquel; LaFargue, Christopher J.; Demichelis, Francesca; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Pflueger, Dorothee; Kuefer, Rainer] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Cao, Xuhong; Chinnaiyan, Arul M.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Banerjee, Samprit] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Siddiqui, Javed; Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Moeller, Peter] Univ Hosp Ulm, Dept Pathol, Ulm, Germany; [Bismar, Tarek A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Bismar, Tarek A.] Calgary Lab Serv, Calgary, AB, Canada; [Fullen, Douglas R.; Johnson, Timothy M.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Maher, Christopher A.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Tan, Patrick] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; Ulm University; Howard Hughes Medical Institute; Cornell University; Cornell University; University of Michigan System; University of Michigan; Ulm University; University of Calgary; University of Calgary; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National University of Singapore	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020; chen, ying/HHS-8254-2022; Demichelis, Francesca/J-9829-2016; Cao, Qi/A-5517-2010; Bismar, Tarek/ABH-6129-2020; Kalyana-Sundaram, Shanker/F-6860-2012	Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Demichelis, Francesca/0000-0002-8266-8631; Cao, Qi/0000-0002-5140-3681; Rubin, Mark/0000-0002-8321-9950; Tomlins, Scott/0000-0001-8661-9821; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Varambally, Sooryanarayana/0000-0002-2277-1127; Kumar, Chandan/0000-0002-8696-3400; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Giordano, Thomas/0000-0003-0641-8873; LaFargue, Christopher/0000-0001-6473-8061	US National Institutes of Health [R01CA132874]; Early Detection Research Network [UO1 CA111275]; Prostate SPORE [P50CA69568]; National Center for Integrative Bioinformatics [U54 DA21519-01A1]; Department of Defense [R01 CA125612-01]; Prostate Cancer Foundation; Doris Duke Charitable Foundation; Burroughs Welcome Foundation; Melanoma Research Alliance; American Association of Cancer Research Amgen; Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection; Genentech Foundation; Expedition Inspiration; Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE [R01CA125612, P50CA069568, R01CA132874, U01CA111275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; Prostate SPORE; National Center for Integrative Bioinformatics; Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Welcome Foundation(Burroughs Wellcome Fund); Melanoma Research Alliance; American Association of Cancer Research Amgen; Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection; Genentech Foundation(Roche HoldingGenentech); Expedition Inspiration; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. B. Jenkins (Mayo Clinic) for providing prostate cancer tissues with BRAF overexpression for FISH evaluation, R. Morey for assistance in paired-end sequencing and Illumina for technical support. We thank T. Barrette, R. Lonigro, M. Quist, C. Quist and S. Begley for hardware support, sample database maintenance, data curation and maintenance of paired-end sequence data and useful discussions; D. Sanders and M. Vinco for their assistance in procuring gastric cancer samples; and D. Kim, R. Mehra and R. Varambally for providing prostate and melanoma tissue microarray and clinical information from the University of Michigan cohort. We thank D. F. Fries, X. Jiang, L. Wang, R. Jagirdar, N. Kitabayashi and X. Jing for technical assistance, K. Giles for critical reading of the manuscript and A. K. Tewari, Biobank, Weill Cornell Medical College, for providing prostate cancer samples for mutation analysis. This work was supported in part by the US National Institutes of Health (R01CA132874), Early Detection Research Network grant UO1 CA111275, Prostate SPORE grant P50CA69568, the National Center for Integrative Bioinformatics (U54 DA21519-01A1), the National Center for Functional Genomics supported by the Department of Defense (A. M. C.) and R01 CA125612-01 (M. A. R. and F. D.). S. A. T. is supported by a Young Investigator Award from the Prostate Cancer Foundation. A. M. C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award, a Burroughs Welcome Foundation Award in Clinical Translational Research and the Prostate Cancer Foundation. A. M. C. is an American Cancer Society Research Professor. N. P. is supported by the development award from the Melanoma Research Alliance. C. A. M. currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship, and a Prostate Cancer Foundation Young Investigator Award. B. A. is supported by a Genentech Foundation Postdoctoral Fellowship and Young Investigator Award from Expedition Inspiration. T. A. B. is supported by funding from the Prostate Cancer Foundation, a Young Investigator Award and the Canadian Institute of Health Research.	Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dessars B, 2007, J INVEST DERMATOL, V127, P1468, DOI 10.1038/sj.jid.5700725; Esgueva R, 2010, MODERN PATHOL, V23, P539, DOI 10.1038/modpathol.2009.193; GARTE SJ, 1987, CANCER RES, V47, P3159; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang L, 2003, CANCER RES, V63, P5209; Wang XS, 2009, NAT BIOTECHNOL, V27, P1005, DOI 10.1038/nbt.1584; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978	32	363	392	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					793	U94		10.1038/nm.2166	http://dx.doi.org/10.1038/nm.2166			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20526349	Green Accepted			2022-12-27	WOS:000279631900029
J	Eckle, T; Hartmann, K; Bonney, S; Reithel, S; Mittelbronn, M; Walker, LA; Lowes, BD; Han, J; Borchers, CH; Buttrick, PM; Kominsky, DJ; Colgan, SP; Eltzschig, HK				Eckle, Tobias; Hartmann, Katherine; Bonney, Stephanie; Reithel, Susan; Mittelbronn, Michel; Walker, Lori A.; Lowes, Brian D.; Han, Jun; Borchers, Christoph H.; Buttrick, Peter M.; Kominsky, Douglas J.; Colgan, Sean P.; Eltzschig, Holger K.			Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia	NATURE MEDICINE			English	Article							CIRCADIAN CLOCK; GLUCOSE-METABOLISM; TISSUE-DAMAGE; INFARCT SIZE; MOUSE MODEL; ADENOSINE; HYPOXIA; REPERFUSION; MECHANISMS; EXPRESSION	Adenosine signaling has been implicated in cardiac adaptation to limited oxygen availability. In a wide search for adenosine receptor A2b (Adora2b)-elicited cardioadaptive responses, we identified the circadian rhythm protein period 2 (Per2) as an Adora2b target. Adora2b signaling led to Per2 stabilization during myocardial ischemia, and in this setting, Per2(-/-) mice had larger infarct sizes compared to wild-type mice and loss of the cardioprotection conferred by ischemic preconditioning. Metabolic studies uncovered a limited ability of ischemic hearts in Per2(-/-) mice to use carbohydrates for oxygen-efficient glycolysis. This impairment was caused by a failure to stabilize hypoxia-inducible factor-1 alpha (Hif-1 alpha). Moreover, stabilization of Per2 in the heart by exposing mice to intense light resulted in the transcriptional induction of glycolytic enzymes and Per2-dependent cardioprotection from ischemia. Together, these studies identify adenosine-elicited stabilization of Per2 in the control of HIF-dependent cardiac metabolism and ischemia tolerance and implicate Per2 stabilization as a potential new strategy for treating myocardial ischemia.	[Eckle, Tobias; Hartmann, Katherine; Bonney, Stephanie; Reithel, Susan; Kominsky, Douglas J.; Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO USA; [Mittelbronn, Michel] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, Frankfurt, Germany; [Walker, Lori A.; Lowes, Brian D.; Buttrick, Peter M.] Univ Colorado Denver, Div Cardiol, Dept Med, Aurora, CO USA; [Han, Jun; Borchers, Christoph H.] Univ Victoria, Dept Biochem & Microbiol, Genome BC Prote Ctr, Victoria, BC, Canada; [Colgan, Sean P.] Univ Colorado Denver, Dept Med, Mucosal Inflammat Program, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Goethe University Frankfurt; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Victoria; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Eckle, T (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO USA.	tobias.eckle@ucdenver.edu	Eckle, Tobias/AAE-6705-2020; Walker, Lori/J-7098-2013; BORCHERS, Christoph/U-5964-2019; Lowes, Brian/M-9020-2017	Eckle, Tobias/0000-0002-6065-4669; Walker, Lori/0000-0003-2556-8076; Hartmann, Katherine/0000-0002-3048-2210; Mittelbronn, Michel/0000-0002-2998-052X; Lowes, Brian/0000-0002-5919-2540; , Susan/0000-0003-4136-8488	National Heart, Lung and Blood Institute [R01-HL092188, R01-DK083385, R01-HL098294, R01-HL060569, 1K08HL102267]; Foundation for Anesthesia Education and Research; American Heart Association; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060569, R01HL092188, R01HL098294, K08HL102267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095491, R01DK083385, R37DK050189] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Anesthesia Education and Research; American Heart Association(American Heart Association); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge S.A. Eltzschig (Mucosal Inflammation Program, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, USA) for artwork during manuscript preparation, A. Medway (Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, Colorado, USA), K. Hoffmann, J. Macas and C. Zachskorn (Institute of Neurology (Edinger Institute), University of Frankfurt, Frankfurt, Germany) and M. Bonney (Mucosal Inflammation Program, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, USA) for technical assistance and C.-C. Lee (Department of Biochemistry and Molecular Biology, University of Texas Health Science Center, Houston, Texas, USA) for providing the Per1<SUP>-/-</SUP> mice. The present research work is supported by National Heart, Lung and Blood Institute grants R01-HL092188, R01-DK083385 and R01-HL098294 to H.K.E., R01-HL060569 to S.P.C. and 1K08HL102267 to T.E., Foundation for Anesthesia Education and Research grants to T.E. and H.K.E., an American Heart Association grant to T.E. and a Crohn's and Colitis Foundation of America grant to H.K.E.	Albrecht U, 2002, J APPL PHYSIOL, V92, P1348, DOI 10.1152/japplphysiol.00759.2001; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Bendova Z, 2006, PHYSIOL RES, V55, P623, DOI 10.33549/physiolres.930849; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; FINEGAN BA, 1993, CIRCULATION, V87, P900, DOI 10.1161/01.CIR.87.3.900; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.225; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Lopaschuk GD, 1997, CIRCULATION, V95, P313; Mikus P, 2005, SEMIN CELL DEV BIOL, V16, P462, DOI 10.1016/j.semcdb.2005.03.002; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Peliciari-Garcia RA, 2011, CHRONOBIOL INT, V28, P21, DOI 10.3109/07420528.2010.525675; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Reiter R, 2012, CIRC RES, V110, P105, DOI 10.1161/CIRCRESAHA.111.254284; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Ryan HE, 2000, CANCER RES, V60, P4010; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schulte G, 2003, EXP CELL RES, V290, P168, DOI 10.1016/S0014-4827(03)00324-0; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Suarez-Barrientos A, 2011, HEART, V97, P970, DOI 10.1136/hrt.2010.212621; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tian R, 2001, CIRCULATION, V103, P2961, DOI 10.1161/01.CIR.103.24.2961; Virag JAI, 2010, AM J PHYSIOL-HEART C, V298, pH1088, DOI 10.1152/ajpheart.01280.2008; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Walker LA, 2010, J MOL CELL CARDIOL, V48, P1180, DOI 10.1016/j.yjmcc.2009.09.010; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wolff Andrew A, 2002, Heart Fail Rev, V7, P187, DOI 10.1023/A:1015384710373; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	60	225	229	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					774	U173		10.1038/nm.2728	http://dx.doi.org/10.1038/nm.2728			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22504483	Green Accepted			2022-12-27	WOS:000303763500045
J	Kircher, MF; de la Zerda, A; Jokerst, JV; Zavaleta, CL; Kempen, PJ; Mittra, E; Pitter, K; Huang, RM; Campos, C; Habte, F; Sinclair, R; Brennan, CW; Mellinghoff, IK; Holland, EC; Gambhir, SS				Kircher, Moritz F.; de la Zerda, Adam; Jokerst, Jesse V.; Zavaleta, Cristina L.; Kempen, Paul J.; Mittra, Erik; Pitter, Ken; Huang, Ruimin; Campos, Carl; Habte, Frezghi; Sinclair, Robert; Brennan, Cameron W.; Mellinghoff, Ingo K.; Holland, Eric C.; Gambhir, Sanjiv S.			A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle	NATURE MEDICINE			English	Article							LIVING MICE; 5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; CARBON NANOTUBES; SPECTROSCOPY; RESECTION; FLUORESCENCE; AGENTS; SENSITIVITY; MICROSCOPY	The difficulty in delineating brain tumor margins is a major obstacle in the path toward better outcomes for patients with brain tumors. Current imaging methods are often limited by inadequate sensitivity, specificity and spatial resolution. Here we show that a unique triple-modality magnetic resonance imaging-photoacoustic imaging-Raman imaging nanoparticle (termed here MPR nanoparticle) can accurately help delineate the margins of brain tumors in living mice both preoperatively and intraoperatively. The MPRs were detected by all three modalities with at least a picomolar sensitivity both in vitro and in living mice. Intravenous injection of MPRs into glioblastoma-bearing mice led to MPR accumulation and retention by the tumors, with no MPR accumulation in the surrounding healthy tissue, allowing for a noninvasive tumor delineation using all three modalities through the intact skull. Raman imaging allowed for guidance of intraoperative tumor resection, and a histological correlation validated that Raman imaging was accurately delineating the brain tumor margins. This new triple-modality-nanoparticle approach has promise for enabling more accurate brain tumor imaging and resection.	[Kircher, Moritz F.; de la Zerda, Adam; Jokerst, Jesse V.; Zavaleta, Cristina L.; Mittra, Erik; Habte, Frezghi; Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Kircher, Moritz F.; Huang, Ruimin] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Kircher, Moritz F.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Kircher, Moritz F.; Pitter, Ken; Huang, Ruimin; Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [de la Zerda, Adam] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Kempen, Paul J.; Sinclair, Robert; Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Pitter, Ken; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Huang, Ruimin; Mellinghoff, Ingo K.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Campos, Carl; Brennan, Cameron W.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA; [Mellinghoff, Ingo K.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Bio X Program, Stanford, CA 94305 USA	Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Stanford University; Stanford University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Zavaleta, Cristina/AAC-2306-2020; Kempen, Paul/J-6098-2014; Brennan, Cameron/R-7082-2019	Zavaleta, Cristina/0000-0001-7314-2446; Kempen, Paul/0000-0003-2179-2257; Brennan, Cameron/0000-0003-4064-8891; Campos, Carl/0000-0002-7616-8518; Pitter, Kenneth/0000-0002-9450-313X	National Cancer Institute [CCNE U54 CA119367, CCNE U54 U54CA151459, ICMIC P50 CA114747, 5R25CA118681]; Ben and Catherine Ivy Foundation; Canary Foundation; Sir Peter Michael Foundation; Bio-X Graduate Student Fellowship; Department of Defense [BC083014]; NATIONAL CANCER INSTITUTE [U54CA119367, U54CA151459, P50CA114747, U01CA141502, R25CA118681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ben and Catherine Ivy Foundation; Canary Foundation; Sir Peter Michael Foundation; Bio-X Graduate Student Fellowship; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Gozin for help with ICP-AES, L. Pisani for assistance with quantifying and acquiring magnetic resonance data, S. M. Korn and S. Bodapati for assistance in conducting the photoacoustic experiments, J. Rosenberg for assistance with the statistical analysis and the Memorial Sloan-Kettering Cancer Center Animal Imaging Core Facility (J. Koutcher and C. C. Le) for technical assistance. M. F. K. would like to thank R. Herfkens and the Stanford Department of Radiology for providing academic time to perform the study. We would like to acknowledge the following funding sources: National Cancer Institute grants CCNE U54 CA119367 (S. S. G.), CCNE U54 U54CA151459 (S. S. G.) and ICMIC P50 CA114747 (S. S. G.); The Ben and Catherine Ivy Foundation (S. S. G.); the Canary Foundation (S. S. G.); the Sir Peter Michael Foundation (S. S. G.); the Bio-X Graduate Student Fellowship (A.d.l.Z.); the Department of Defense Breast Cancer Research Program-Pre-doctoral Traineeship Award BC083014 (A.d.l.Z.) and the National Cancer Institute SMIS R25T Fellowship 5R25CA118681 (J. V. J.). The authors would also like to thank T. F. Massoud, D. Akin, H. E. Daldrup-Link, S. Bohndiek, S. Harmsen and J. Samii for critical review of the manuscript and B. T. Khuri-Yakub, S. Vaithilingam, O. Oralkan, E. E. Graves and H. Fan-Minogue for helpful discussions.	Adiseshaiah PP, 2010, WIRES NANOMED NANOBI, V2, P99, DOI 10.1002/wnan.66; American National Standards Institute, 2000, Z13612000 ANSI INC; Beljebbar A, 2010, ANAL BIOANAL CHEM, V398, P477, DOI 10.1007/s00216-010-3910-6; Bucci MK, 2004, CANCER-AM CANCER SOC, V101, P817, DOI 10.1002/cncr.20422; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; de la Zerda A, 2011, CONTRAST MEDIA MOL I, V6, P346, DOI 10.1002/cmmi.455; de la Zerda A, 2010, MOL IMAGING BIOL, V12, P500, DOI 10.1007/s11307-009-0290-4; de la Zerda A, 2010, NANO LETT, V10, P2168, DOI 10.1021/nl100890d; de la Zerda A, 2010, OPT LETT, V35, P270, DOI 10.1364/OL.35.000270; Ermilov SA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3086616; Graves EE, 2007, TECHNOL CANCER RES T, V6, P111, DOI 10.1177/153303460700600207; Kantelhardt SR, 2008, LASER SURG MED, V40, P273, DOI 10.1002/lsm.20623; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Knauth M, 2001, NEURORADIOLOGY, V43, P254, DOI 10.1007/PL00006047; Knauth M, 1999, AM J NEURORADIOL, V20, P1547; Koljenovic S, 2007, ANAL CHEM, V79, P557, DOI 10.1021/ac0616512; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Ludemann L, 2000, MAGN RESON IMAGING, V18, P1201, DOI 10.1016/S0730-725X(00)00223-X; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Manohar S, 2007, OPT EXPRESS, V15, P12277, DOI 10.1364/OE.15.012277; Orringer DA, 2010, NEUROSURGERY, V66, P736, DOI 10.1227/01.NEU.0000367631.02903.50; Ozawa T, 2005, NEUROSURGERY, V57, P1041, DOI 10.1227/01.NEU.0000180036.42193.f6; Reinges MHT, 2004, ACTA NEUROCHIR, V146, P369, DOI 10.1007/s00701-003-0204-1; Shinoda J, 2003, J NEUROSURG, V99, P597, DOI 10.3171/jns.2003.99.3.0597; Short MA, 2008, OPT LETT, V33, P711, DOI 10.1364/OL.33.000711; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Thakor AS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001963; Thakor AS, 2011, SMALL, V7, P126, DOI 10.1002/smll.201001466; Toms SA, 2005, NEUROSURGERY, V57, P382, DOI 10.1227/01.NEU.000176855.39826.2D; Trehin R, 2006, NEOPLASIA, V8, P302, DOI 10.1593/neo.05751; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Zavaleta C, 2008, NANO LETT, V8, P2800, DOI 10.1021/nl801362a; Zavaleta CL, 2011, J NUCL MED, V52, P1839, DOI 10.2967/jnumed.111.087775; Zavaleta CL, 2011, SMALL, V7, P2232, DOI 10.1002/smll.201002317; Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106; Zuin S, 2011, NANOTOXICOLOGY, V5, P445, DOI 10.3109/17435390.2010.512986	39	785	818	31	639	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					829	U235		10.1038/nm.2721	http://dx.doi.org/10.1038/nm.2721			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22504484	Green Accepted			2022-12-27	WOS:000303763500053
J	Siewert, K; Malotka, J; Kawakami, N; Wekerle, H; Hohlfeld, R; Dornmair, K				Siewert, Katherina; Malotka, Joachim; Kawakami, Naoto; Wekerle, Hartmut; Hohlfeld, Reinhard; Dornmair, Klaus			Unbiased identification of target antigens of CD8(+) T cells with combinatorial libraries coding for short peptides	NATURE MEDICINE			English	Article							RECEPTOR; RECOGNITION; LYMPHOCYTES; AUTOANTIGEN; RESPONSES; CHAIN; CDNA	Cytotoxic CD8(+) T cells recognize the antigenic peptides presented by class I major histocompatibility complex (MHC) molecules. These T cells have key roles in infectious diseases, autoimmunity and tumor immunology, but there is currently no unbiased method for the reliable identification of their target antigens. This is because of the low affinities of antigen-specific T cell receptors (TCR) to their target MHC-peptide complexes, the polyspecificity of these TCRs and the requirement that these TCRs recognize protein antigens that have been processed by antigen-presenting cells (APCs). Here we describe a technology for the unbiased identification of the antigenic peptides presented by MHC class I molecules. The technology uses plasmid-encoded combinatorial peptide libraries and a single-cell detection system. We validated this approach using a well-characterized influenza-virus-specific TCR, MHC and peptide combination. Single APCs carrying antigenic peptides can be detected among several million APCs that carry irrelevant peptides. The identified peptide sequences showed a converging pattern of mimotopes that revealed the parent influenza antigen. This technique should be generally applicable to the identification of disease-relevant T cell antigens.	[Siewert, Katherina; Hohlfeld, Reinhard; Dornmair, Klaus] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Siewert, Katherina; Malotka, Joachim; Kawakami, Naoto; Wekerle, Hartmut; Hohlfeld, Reinhard; Dornmair, Klaus] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany	University of Munich; Max Planck Society	Dornmair, K (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Munich, Germany.	klaus.dornmair@med.uni-muenchen.de		Siewert, Katherina/0000-0003-0380-1594; Kawakami, Naoto/0000-0001-7693-3489	Deutsche Forschungsgemeinschaft [SFB 571 A1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Meinl and W. E. F. Klinkert for comments on the manuscript, D. Hackl and M. Ackmann for help with synthesizing the plasmid pcDNA-NFAT-sGFP, I. Bartholomaus and M. Mues for advice regarding fluorescence microscopy, I. Eiglmeier for expert technical assistance and K. Ogston for editing the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (grant SFB 571 A1).	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Bettinotti MP, 2003, J IMMUNOL METHODS, V279, P143, DOI 10.1016/S0022-1759(03)00233-3; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hemmer B, 1999, NAT MED, V5, P1375; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Nino-Vasquez JJ, 2004, MOL IMMUNOL, V40, P1063, DOI 10.1016/j.molimm.2003.11.005; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Seitz S, 2006, P NATL ACAD SCI USA, V103, P12057, DOI 10.1073/pnas.0604247103; Smith ES, 2001, NAT MED, V7, P967, DOI 10.1038/91017; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130	36	39	44	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					824	U228		10.1038/nm.2720	http://dx.doi.org/10.1038/nm.2720			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22484809				2022-12-27	WOS:000303763500052
J	Bird-Lieberman, EL; Neves, AA; Lao-Sirieix, P; O'Donovan, M; Novelli, M; Lovat, LB; Eng, WS; Mahal, LK; Brindle, KM; Fitzgerald, RC				Bird-Lieberman, Elizabeth L.; Neves, Andre A.; Lao-Sirieix, Pierre; O'Donovan, Maria; Novelli, Marco; Lovat, Laurence B.; Eng, William S.; Mahal, Lara K.; Brindle, Kevin M.; Fitzgerald, Rebecca C.			Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus	NATURE MEDICINE			English	Article							WHEAT-GERM-AGGLUTININ; HIGH-GRADE DYSPLASIA; CANCER; ADENOCARCINOMA; BIOPSY; SPECTROSCOPY; MICROARRAY; NEOPLASIA; SURVIVAL; JUNCTION	Barrett's esophagus is an example of a pre-invasive state, for which current endoscopic surveillance methods to detect dysplasia are time consuming and inadequate. The prognosis of cancer arising in Barrett's esophagus is improved by early detection at the stage of mucosal carcinoma or high-grade dysplasia. Molecular imaging methods could revolutionize the detection of dysplasia, provided they permit a wide field of view and highlight abnormalities in real time. We show here that cell-surface glycans are altered in the progression from Barrett's esophagus to adenocarcinoma and lead to specific changes in lectin binding patterns. We chose wheat germ agglutinin as a candidate lectin with clinical potential. The binding of wheat germ agglutinin to human tissue was determined to be specific, and we validated this specific binding by successful endoscopic visualization of high-grade dysplastic lesions, which were not detectable by conventional endoscopy, with a high signal-to-background ratio of over 5.	[Bird-Lieberman, Elizabeth L.; Lao-Sirieix, Pierre; Fitzgerald, Rebecca C.] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge, England; [Neves, Andre A.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England; [Neves, Andre A.; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [O'Donovan, Maria] Addenbrookes Hosp, Dept Pathol, Cambridge, England; [Novelli, Marco] UCL, Dept Pathol, London, England; [Lovat, Laurence B.] UCL, Dept Gastroenterol, London, England; [Eng, William S.; Mahal, Lara K.] NYU, Dept Chem, New York, NY 10003 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of London; University College London; New York University	Fitzgerald, RC (corresponding author), Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge, England.	rcf29@hutchison-mrc.cam.ac.uk	Mahal, Lara/GRY-7287-2022; Lovat, Laurence/C-1986-2009; Neves, Andre/B-8397-2011	Lovat, Laurence/0000-0003-4542-3915; Neves, Andre/0000-0003-2740-5166; Mahal, Lara/0000-0003-4791-8524; Bird-Lieberman, Elizabeth/0000-0002-5273-7536; Fitzgerald, Rebecca/0000-0002-3434-3568	GlaxoSmithKline; Medical Research Centre; Cambridge Experimental Medicine Centre; National Institute for Health Research Cambridge Biomedical Research Centre; Cancer Research UK; New York University; US National Institutes of Health; Department of Health's NIHR Biomedical Research Centre; MRC [MC_U105365007] Funding Source: UKRI; Medical Research Council [MC_U105365007] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Medical Research Centre; Cambridge Experimental Medicine Centre; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); New York University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a research fellowship from GlaxoSmithKline awarded to E.L.B.-L. The authors thank J. Ong, C. Peters, S. Hilborne, E. Moore, N. Shannon, B. Spencer, R. Cayado-Lopez, B. Haynes, J. Gray, W. Howat, J. Harris and S. Reichelt for their advice and support and the Moritex Corporation for lending the evanescent lectin array equipment (Glycostation). This work was supported by a Medical Research Centre core grant (R.C.F.), the Cambridge Experimental Medicine Centre (R.C.F.), the National Institute for Health Research Cambridge Biomedical Research Centre (R.C.F.), a Cancer Research UK core grant (K.M.B.) and a Clinical Research Fellowship from GlaxoSmithKline (E.L.B.-L.). The work undertaken in the Department of Chemistry, University of New York was supported by a New York University startup fund and by the US National Institutes of Health (W.S.E. and L.K.M.). The work undertaken at UCLH/UCL was supported in part by funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme and also by a grant from Cancer Research UK to the Experimental Cancer Research Centre, UCL. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health.	Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Curvers WL, 2011, GASTROINTEST ENDOSC, V73, P195, DOI 10.1016/j.gie.2010.10.014; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Kendall C, 2003, J PATHOL, V200, P602, DOI 10.1002/path.1376; Kobayashi H, 2004, CLIN CANCER RES, V10, P7712, DOI 10.1158/1078-0432.CCR-04-1175; KRONIS KA, 1982, BIOCHEMISTRY-US, V21, P3050, DOI 10.1021/bi00256a003; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Li M, 2010, GASTROENTEROLOGY, V139, P1472, DOI 10.1053/j.gastro.2010.07.007; Lovat LB, 2006, GUT, V55, P1078, DOI 10.1136/gut.2005.081467; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; NAGATA Y, 1972, J BIOL CHEM, V247, P2248; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Pohl H, 2008, GUT, V57, P1648, DOI 10.1136/gut.2008.157461; Pyhtila JW, 2007, GASTROINTEST ENDOSC, V65, P487, DOI 10.1016/j.gie.2006.10.016; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1988, GASTROENTEROLOGY, V94, P81, DOI 10.1016/0016-5085(88)90613-0; Reid BJ, 2000, AM J GASTROENTEROL, V95, P3089, DOI 10.1111/j.1572-0241.2000.03182.x; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shen YQ, 2004, BIOL CHEM, V385, P145, DOI 10.1515/BC.2004.033; Soukos NS, 2001, CANCER RES, V61, P4490; Spechler SJ, 2010, GASTROENTEROLOGY, V138, P854, DOI 10.1053/j.gastro.2010.01.002; Themelis G., 2010, BIOMEDICAL OPTICS; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237	33	175	177	0	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					315	321		10.1038/nm.2616	http://dx.doi.org/10.1038/nm.2616			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245781				2022-12-27	WOS:000300140300049
J	Badeanlou, L; Furlan-Freguia, C; Yang, G; Ruf, W; Samad, F				Badeanlou, Leylla; Furlan-Freguia, Christian; Yang, Guang; Ruf, Wolfram; Samad, Fahumiya			Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation	NATURE MEDICINE			English	Article							INDUCED INSULIN-RESISTANCE; FACTOR GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; FACTOR CYTOPLASMIC DOMAIN; METABOLIC SYNDROME; IN-VIVO; DIABETES-MELLITUS; SKELETAL-MUSCLE; KUPFFER CELLS; BODY-WEIGHT	Tissue factor, the initiator of the coagulation cascade, mediates coagulation factor VIIa-dependent activation of protease-activated receptor 2 (PAR2). Here we delineate a role for this signaling pathway in obesity and its complications. Mice lacking PAR2 (F2rl1) or the cytoplasmic domain of tissue factor were protected from weight gain and insulin resistance induced by a high-fat diet. In hematopoietic cells, genetic ablation of tissue factor-PAR2 signaling reduced adipose tissue macrophage inflammation, and specific pharmacological inhibition of macrophage tissue factor signaling rapidly ameliorated insulin resistance. In contrast, nonhematopoietic cell tissue factor-VIIa-PAR2 signaling specifically promoted obesity. Mechanistically, adipocyte tissue factor cytoplasmic domain-dependent VIIa signaling suppressed Akt phosphorylation with concordant adverse transcriptional changes of key regulators of obesity and metabolism. Pharmacological blockade of adipocyte tissue factor in vivo reversed these effects of tissue factor-VIIa signaling and rapidly increased energy expenditure. Thus, inhibition of tissue factor signaling is a potential therapeutic avenue for improving impaired metabolism and insulin resistance in obesity.	[Furlan-Freguia, Christian; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Badeanlou, Leylla; Yang, Guang; Samad, Fahumiya] Torrey Pines Inst Mol Studies, Dept Cell Biol, San Diego, CA USA	Scripps Research Institute; Torrey Pines Institute for Molecular Studies, California	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ruf@scripps.edu; fsamad@tpims.org			US National Institutes of Health [HL71146, HL104232, HL77753]; Diabetes National Research Group; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071146, R01HL077753, R01HL104232] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes National Research Group; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by US National Institutes of Health grants HL71146, HL104232 (F. S.) and HL77753 (W. R.), a grant from the Diabetes National Research Group (F. S.) and a postdoctoral fellowship from the American Heart Association (C.F.-F.). We thank M. Anderson (Johnson & Johnson Pharmaceutical Research and Development, Radnor, Pennsylvania, USA) for TFKI mice, C. Biazak, J. Royce, N. Vu and R. Zubairi for technical assistance, A. J. Roberts for assistance with metabolic studies and C. Johnson for preparation of figures.	Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Bradshaw G, 2005, P NATL ACAD SCI USA, V102, P11029, DOI 10.1073/pnas.0502677102; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Diamant M, 2002, CIRCULATION, V106, P2442, DOI 10.1161/01.CIR.0000036596.59665.C6; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gerrits AJ, 2011, J THROMB HAEMOST, V9, P873, DOI 10.1111/j.1538-7836.2011.04201.x; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Kopp CW, 2003, OBES RES, V11, P950, DOI 10.1038/oby.2003.131; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MACKMAN N, 1993, AM J PATHOL, V143, P76; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Melis E, 2001, BIOCHEM BIOPH RES CO, V286, P580, DOI 10.1006/bbrc.2001.5425; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Randolph GJ, 1998, BLOOD, V92, P4167, DOI 10.1182/blood.V92.11.4167.423k35_4167_4177; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Samad F, 2001, BLOOD, V98, P3353, DOI 10.1182/blood.V98.12.3353; Schaffner F, 2010, BLOOD, V116, P6106, DOI 10.1182/blood-2010-06-289314; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Snyder LA, 2008, J THROMB HAEMOST, V6, P306, DOI 10.1111/j.1538-7836.2007.02833.x; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Venugopal J, 2004, P NATL ACAD SCI USA, V101, P17120, DOI 10.1073/pnas.0405278101; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang P, 2007, BIOCHEM J, V408, P221, DOI 10.1042/BJ20070483; Wang P, 2006, BIOCHEMISTRY-US, V45, P9374, DOI 10.1021/bi0602617; Wang P, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-36; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	60	121	127	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1490	U200		10.1038/nm.2461	http://dx.doi.org/10.1038/nm.2461			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019885	Green Accepted			2022-12-27	WOS:000296779300041
J	Wei, CL; El Hindi, S; Li, J; Fornoni, A; Goes, N; Sageshima, J; Maiguel, D; Karumanchi, SA; Yap, HK; Saleem, M; Zhang, QY; Nikolic, B; Chaudhuri, A; Daftarian, P; Salido, E; Torres, A; Salifu, M; Sarwal, MM; Schaefer, F; Morath, C; Schwenger, V; Zeier, M; Gupta, V; Roth, D; Rastaldi, MP; Burke, G; Ruiz, P; Reiser, J				Wei, Changli; El Hindi, Shafic; Li, Jing; Fornoni, Alessia; Goes, Nelson; Sageshima, Junichiro; Maiguel, Dony; Karumanchi, S. Ananth; Yap, Hui-Kim; Saleem, Moin; Zhang, Qingyin; Nikolic, Boris; Chaudhuri, Abanti; Daftarian, Pirouz; Salido, Eduardo; Torres, Armando; Salifu, Moro; Sarwal, Minnie M.; Schaefer, Franz; Morath, Christian; Schwenger, Vedat; Zeier, Martin; Gupta, Vineet; Roth, David; Rastaldi, Maria Pia; Burke, George; Ruiz, Phillip; Reiser, Jochen			Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis	NATURE MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; IDIOPATHIC NEPHROTIC SYNDROME; GLOMERULAR-PERMEABILITY; RENAL-TRANSPLANTATION; PL(A2) POLYMORPHISM; RECURRENCE; PROTEINURIA; SERUM; FSGS; PLASMAPHERESIS	Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease, compromising both native and transplanted kidneys. Treatment is limited because of a complex pathogenesis, including unknown serum factors. Here we report that serum soluble urokinase receptor (suPAR) is elevated in two-thirds of subjects with primary FSGS, but not in people with other glomerular diseases. We further find that a higher concentration of suPAR before transplantation underlies an increased risk for recurrence of FSGS after transplantation. Using three mouse models, we explore the effects of suPAR on kidney function and morphology. We show that circulating suPAR activates podocyte beta(3) integrin in both native and grafted kidneys, causing foot process effacement, proteinuria and FSGS-like glomerulopathy. Our findings suggest that the renal disease only develops when suPAR sufficiently activates podocyte beta(3) integrin. Thus, the disease can be abrogated by lowering serum suPAR concentrations through plasmapheresis, or by interfering with the suPAR-beta(3) integrin interaction through antibodies and small molecules targeting either uPAR or beta(3) integrin. Our study identifies serum suPAR as a circulating factor that may cause FSGS.	[Wei, Changli; El Hindi, Shafic; Li, Jing; Fornoni, Alessia; Maiguel, Dony; Gupta, Vineet; Roth, David; Reiser, Jochen] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Goes, Nelson] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Goes, Nelson; Karumanchi, S. Ananth; Nikolic, Boris] Harvard Univ, Sch Med, Boston, MA USA; [Sageshima, Junichiro; Burke, George; Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Yap, Hui-Kim] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Saleem, Moin] Univ Bristol, Childrens Renal Unit, Bristol Royal Hosp Children, Bristol, Avon, England; [Zhang, Qingyin] Columbia Univ, Dept Surg, New York, NY USA; [Chaudhuri, Abanti; Sarwal, Minnie M.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Daftarian, Pirouz] Univ Miami, Miller Sch Med, Wallace H Coulter Ctr Translat Res, Miami, FL 33136 USA; [Daftarian, Pirouz] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Salido, Eduardo; Torres, Armando] Hosp Univ Canarias, Serv Nefrol, Canary Isl, Spain; [Salido, Eduardo; Torres, Armando] Hosp Univ Canarias, Ctr Biomed Res Rare Dis CIBERER, Canary Isl, Spain; [Salifu, Moro] Suny Downstate Med Ctr, Div Nephrol, Brooklyn, NY 11203 USA; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Morath, Christian; Schwenger, Vedat; Zeier, Martin] Heidelberg Univ, Dept Nephrol & Endocrinol, Heidelberg, Germany; [Rastaldi, Maria Pia] Fdn IRCCS Osped Maggiore Policlin, Renal Res Lab, Milan, Italy; [Rastaldi, Maria Pia] Fdn Amico Ric Malattie Renali, Milan, Italy; [Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Miami; University of Miami; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Miami; Harvard University; Beth Israel Deaconess Medical Center; National University of Singapore; Bristol Royal Hospital For Children; University of Bristol; Columbia University; Stanford University; University of Miami; University of Miami; Universidad de la Laguna; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Miami	Reiser, J (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	jreiser@med.miami.edu	Morath, Christian/ABC-5091-2021; Salido, Eduardo C/I-2232-2015; Karumanchi, Subbian Ananth/AAI-1694-2021; Fornoni, Alessia/F-8350-2013; Yap, Hui Kim/S-2934-2016; Schaefer, Franz/G-4365-2010	Salido, Eduardo C/0000-0001-9599-9854; fornoni, Alessia/0000-0002-1313-7773; Yap, Hui Kim/0000-0001-6008-382X; Torres, Armando/0000-0003-1121-5173; Gupta, Vineet/0000-0001-6987-2550; Saleem, Moin/0000-0002-9808-4518	US National Institutes of Health [DK073495, DK089394, DK-82636, DK070011]; Halpin Foundation-American Society of Nephrology; American Diabetes Association [7-09-JF-23]; Diabetes Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101350, R01DK073495, R01DK089394, Z01DK070011, R01DK070011, K08DK082636] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Halpin Foundation-American Society of Nephrology; American Diabetes Association(American Diabetes Association); Diabetes Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Sidenius (Foundation FIRC Institute of Molecular Oncology, Italy) for help with the suPAR assay in mouse samples. We are grateful to L. H. Beck, Jr. and D. Salant (Boston University Medical Center) for providing the membranous nephropathy patient cohort. We thank S. Hsiesh for help with sample collection. We thank G. Hoyer-Hansen (the Finsen Laboratory, Denmark) for additional suPAR assays and discussions. The authors are grateful to P.J. Goldschmidt for helpful scientific discussions regarding the manuscript and to M.J. Tracy for critical reading of the manuscript. This work was supported in part by the US National Institutes of Health (grants DK073495 and DK089394 to J.R., DK-82636 to A. F., DK070011 to G. B.), the Halpin Foundation-American Society of Nephrology Research Grant (to C. W.), a grant from the American Diabetes Association (7-09-JF-23 to A. F.), and a grant from the Diabetes Research Institute Foundation (to A. F.). The authors also wish to acknowledge the generous support of the Katz Family Fund.	ARTERO ML, 1994, AM J KIDNEY DIS, V23, P574, DOI 10.1016/S0272-6386(12)80381-7; Baum MA, 2004, PEDIATR TRANSPLANT, V8, P329, DOI 10.1111/j.1399-3046.2004.00181.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bruneau S, 2009, AM J KIDNEY DIS, V54, P522, DOI 10.1053/j.ajkd.2009.03.021; Chiras T, 2009, IN VIVO, V23, P177; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Dekkers PEP, 2000, INFECT IMMUN, V68, P2156, DOI 10.1128/IAI.68.4.2156-2160.2000; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Ghiggeri GM, 2004, NEPHROL DIAL TRANSPL, V19, P1036, DOI 10.1093/ndt/gfh173; Glassock RJ, 2003, J AM SOC NEPHROL, V14, P541, DOI 10.1097/01.ASN.0000051640.04273.75; Gohh RY, 2005, AM J TRANSPLANT, V5, P2907, DOI 10.1111/j.1600-6143.2005.01112.x; Haas M, 1998, NEPHROL DIAL TRANSPL, V13, P2013, DOI 10.1093/ndt/13.8.2013; Hada Y, 2007, BIOCHEM BIOPH RES CO, V356, P487, DOI 10.1016/j.bbrc.2007.03.004; Hickson LJ, 2009, TRANSPLANTATION, V87, P1232, DOI 10.1097/TP.0b013e31819f12be; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Hoyer JR, 2001, J AM SOC NEPHROL, V12, P1994; HOYER JR, 1972, LANCET, V2, P343; Kemper MJ, 2001, NEW ENGL J MED, V344, P386, DOI 10.1056/NEJM200102013440517; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; KRISTENSEN P, 1991, J CELL BIOL, V115, P1763, DOI 10.1083/jcb.115.6.1763; Marszal J, 2006, NEPHRON EXP NEPHROL, V104, pE1, DOI 10.1159/000093259; Mathieson PW, 2008, NEW ENGL J MED, V359, P2492, DOI 10.1056/NEJMcibr0806881; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Ponticelli C, 2010, CLIN J AM SOC NEPHRO, V5, P2363, DOI 10.2215/CJN.06720810; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Salido E, 1999, J AM SOC NEPHROL, V10, P2599; Savin VJ, 2008, TRANSL RES, V151, P288, DOI 10.1016/j.trsl.2008.04.001; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Selleri C, 2006, CANCER RES, V66, P10885, DOI 10.1158/0008-5472.CAN-06-1311; SENGGUTUVAN P, 1990, PEDIATR NEPHROL, V4, P21, DOI 10.1007/BF00858431; Sharma M, 1999, J AM SOC NEPHROL, V10, P552; Sidenius N, 2000, BLOOD, V96, P4091; Sier CFM, 1998, CANCER RES, V58, P1843; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678	47	590	626	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					952	U70		10.1038/nm.2411	http://dx.doi.org/10.1038/nm.2411			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804539	Green Accepted			2022-12-27	WOS:000293507400028
J	Purkayastha, S; Zhang, G; Cai, DS				Purkayastha, Sudarshana; Zhang, Guo; Cai, Dongsheng			Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappa B	NATURE MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; BLOOD-PRESSURE; INSULIN-RESISTANCE; LEPTIN RESISTANCE; IMMUNE-SYSTEM; INFLAMMATION; MICE; DYSFUNCTION; MODULATION; BRAIN	Obesity-related hypertension has become an epidemic health problem and a major risk factor for the development of cardiovascular disease (CVD). Recent research on the pathophysiology of obesity has implicated a role for the hypothalamus in the pathogenesis of this condition(1-3). However, it remains unknown whether the often-seen coupling of hypertension with obesity can also be explained by hypothalamic dysfunction, despite the emerging appreciation that many forms of hypertension are neurogenic in origin4-13. Our studies here revealed that acute activation of the proinflammatory protein nuclear factor kB (NF-kappa B) and its upstream activator I kappa B kinase-beta (IKK-beta, encoded by Ikbkb) in the mediobasal hypothalamus rapidly elevated blood pressure in mice independently of obesity. This form of hypothalamic inflammation-induced hypertension involved the sympathetic upregulation of hemodynamics and was reversed by sympathetic suppression. Loss-of-function studies further showed that NF-kappa B inhibition in the mediobasal hypothalamus counteracted obesity-related hypertension in a manner that was dissociable from changes in body weight. In addition, we found that pro-opiomelanocortin (POMC) neurons were crucial for the hypertensive effects of the activation of hypothalamic IKK-beta and NF-kappa B, which underlie obesity-related hypertension. In conclusion, obesity-associated activation of IKK-beta and NF-kappa B in the mediobasal hypothalamus-particularly in the hypothalamic POMC neurons-is a primary pathogenic link between obesity and hypertension. Breaking this pathogenic link may represent an avenue for controlling obesity-related hypertension and CVD without requiring obesity control.	[Purkayastha, Sudarshana; Zhang, Guo; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY USA; [Purkayastha, Sudarshana; Zhang, Guo; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, New York, NY USA	Yeshiva University; Yeshiva University	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY USA.	dongsheng.cai@einstein.yu.edu	Zhang, Guo/Q-8513-2016	Zhang, Guo/0000-0003-0841-4710; Zhang, Guo/0000-0002-3880-6996	US National Institutes of Health [RO1 DK078750, RO1 AG 031774]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Barsh and A. Xu for Pomc-Cre and Agrp-Cre mice. This study was supported by US National Institutes of Health grants (RO1 DK078750 and RO1 AG 031774) (D.C.) and by an American Diabetes Association Junior Faculty Award (1-07-JF-09) (D.C.).	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cai DS, 2009, CELL CYCLE, V8, P2542, DOI 10.4161/cc.8.16.9386; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Farah VMA, 2004, PHYSIOL BEHAV, V83, P135, DOI 10.1016/j.physbeh.2004.08.004; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Goncalves ACD, 2009, HYPERTENSION, V53, P387, DOI 10.1161/HYPERTENSIONAHA.108.124776; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Harrison David G, 2008, Curr Cardiol Rep, V10, P464; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Haynes WG, 2005, EXP PHYSIOL, V90, P683, DOI 10.1113/expphysiol.2005.031237; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Veerasingham SJ, 2004, PROG BIOPHYS MOL BIO, V84, P107, DOI 10.1016/j.pbiomolbio.2003.11.007; Veerasingham SJ, 2003, BRIT J PHARMACOL, V139, P191, DOI 10.1038/sj.bjp.0705262; Wofford MR, 2004, CURR PHARM DESIGN, V10, P3621, DOI 10.2174/1381612043382855; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	39	180	184	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					883	U255		10.1038/nm.2372	http://dx.doi.org/10.1038/nm.2372			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21642978	Green Accepted			2022-12-27	WOS:000292500800044
J	Muramatsu, R; Kubo, T; Mori, M; Nakamura, Y; Fujita, Y; Akutsu, T; Okuno, T; Taniguchi, J; Kumanogoh, A; Yoshida, M; Mochizuki, H; Kuwabara, S; Yamashita, T				Muramatsu, Rieko; Kubo, Takekazu; Mori, Masahiro; Nakamura, Yuka; Fujita, Yuki; Akutsu, Tsugio; Okuno, Tatsusada; Taniguchi, Junko; Kumanogoh, Atsushi; Yoshida, Mari; Mochizuki, Hideki; Kuwabara, Satoshi; Yamashita, Toshihide			RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis	NATURE MEDICINE			English	Article							MULTIPLE-SCLEROSIS; GUIDANCE MOLECULE; RAP1; ACTIVATION; DISABILITY; PATHOLOGY; ADHESION; DISTINCT; INJURY; SYSTEM	In multiple sclerosis, activated CD4(+) T cells initiate an immune response in the brain and spinal cord, resulting in demyelination, degeneration and progressive paralysis. Repulsive guidance molecule-a (RGMa) is an axon guidance molecule that has a role in the visual system and in neural tube closure. Our study shows that RGMa is expressed in bone marrow-derived dendritic cells (BMDCs) and that CD4(+) T cells express neogenin, a receptor for RGMa. Binding of RGMa to CD4(+) T cells led to activation of the small GTPase Rap1 and increased adhesion of T cells to intracellular adhesion molecule-1 (ICAM-1). Neutralizing antibodies to RGMa attenuated clinical symptoms of mouse myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) and reduced invasion of inflammatory cells into the CNS. Silencing of RGMa in MOG-pulsed BMDCs reduced their capacity to induce EAE following adoptive transfer to naive C57BL/6 mice. CD4(+) T cells isolated from mice treated with an RGMa-specific antibody showed diminished proliferative responses and reduced interferon-gamma (IFN-gamma), interleukin-2 (IL-2), IL-4 and IL-17 secretion. Incubation of PBMCs from patients with multiple sclerosis with an RGMa-specific antibody reduced proliferative responses and pro-inflammatory cytokine expression. These results demonstrate that an RGMa-specific antibody suppresses T cell responses, and suggest that RGMa could be a promising molecular target for the treatment of multiple sclerosis.	[Muramatsu, Rieko; Nakamura, Yuka; Fujita, Yuki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Muramatsu, Rieko; Nakamura, Yuka; Fujita, Yuki; Mochizuki, Hideki; Yamashita, Toshihide] Japan Sci & Technol Agcy, Tokyo, Japan; [Kubo, Takekazu; Yamashita, Toshihide] Chiba Univ, Grad Sch Med, Dept Neurobiol, Chiba, Japan; [Mori, Masahiro; Taniguchi, Junko; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Akutsu, Tsugio; Mochizuki, Hideki] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa, Japan; [Okuno, Tatsusada; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Osaka, Japan; [Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Aichi, Japan	Osaka University; Japan Science & Technology Agency (JST); Chiba University; Chiba University; Kitasato University; Osaka University; Aichi Medical University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Muramatsu, Rieko/F-4109-2014	Muramatsu, Rieko/0000-0001-5342-7823; Kuwabara, Satoshi/0000-0002-4716-8578; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Sciences [19679007]; Ministry of Health, Labour and Welfare	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Sciences (19679007) to T. Y., and a Grant-in-Aid from Ministry of Health, Labour and Welfare to T. Y. We thank H. Hayakawa and members of the Yamashita laboratory for fruitful discussion and help.	Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Nohra R, 2010, GENES IMMUN, V11, P279, DOI 10.1038/gene.2009.111; Onuki I, 2001, MICROSC RES TECHNIQ, V52, P731; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001	19	85	92	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					488	U129		10.1038/nm.2321	http://dx.doi.org/10.1038/nm.2321			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21423182				2022-12-27	WOS:000289245100040
J	Weber, K; Thomaschewski, M; Warlich, M; Volz, T; Cornils, K; Niebuhr, B; Tager, M; Lutgehetmann, M; Pollok, JM; Stocking, C; Dandri, M; Benten, D; Fehse, B				Weber, Kristoffer; Thomaschewski, Michael; Warlich, Michael; Volz, Tassilo; Cornils, Kerstin; Niebuhr, Birte; Taeger, Maike; Luetgehetmann, Marc; Pollok, Joerg-Matthias; Stocking, Carol; Dandri, Maura; Benten, Daniel; Fehse, Boris			RGB marking facilitates multicolor clonal cell tracking	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; ONTOLOGY LEGO VECTORS; HEPATITIS-B-VIRUS; FLUORESCENT PROTEINS; IN-VIVO; RETROVIRAL VECTORS; LENTIVIRAL VECTOR; TUMOR CLONALITY; SITE ANALYSIS; GENE-THERAPY	We simultaneously transduced cells with three lentiviral gene ontology (LeGO) vectors encoding red, green or blue fluorescent proteins. Individual cells were thereby marked by different combinations of inserted vectors, resulting in the generation of numerous mixed colors, a principle we named red-green-blue (RGB) marking. We show that lentiviral vector-mediated RGB marking remained stable after cell division, thus facilitating the analysis of clonal cell fates in vitro and in vivo. Particularly, we provide evidence that RGB marking allows assessment of clonality after regeneration of injured livers by transplanted primary hepatocytes. We also used RGB vectors to mark hematopoietic stem/progenitor cells that generated colored spleen colonies. Finally, based on limiting-dilution and serial transplantation assays with tumor cells, we found that clonal tumor cells retained their specific color-code over extensive periods of time. We conclude that RGB marking represents a useful tool for cell clonality studies in tissue regeneration and pathology.	[Weber, Kristoffer; Thomaschewski, Michael; Warlich, Michael; Cornils, Kerstin; Fehse, Boris] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Niebuhr, Birte; Taeger, Maike; Stocking, Carol] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Pollok, Joerg-Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fehse, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany.	fehse@uke.de	Fehse, Boris/A-8721-2012; Riecken, Kristoffer/AAD-2371-2020; Volz, Tassilo/U-1942-2019; Dandri, Maura/ABG-4773-2021	Fehse, Boris/0000-0001-9780-7211; Riecken, Kristoffer/0000-0001-9050-6766; Dandri, Maura/0000-0002-0073-6689; Warlich, Michael/0000-0001-8915-4134; Volz, Tassilo/0000-0003-3120-8958	Deutsche Forschungsgemeinschaft [SFB841, FE568/11-1]; integrated graduate school "Inflammation and Regeneration" of the University Medical Center Hamburg-Eppendorf	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); integrated graduate school "Inflammation and Regeneration" of the University Medical Center Hamburg-Eppendorf	We wish to thank to V. Matzat and U. Bergholz for expert technical assistance, R. Reusch for excellent mouse care and J. Petersen for continuous support with the uPA model and critical reading of the manuscript. Confocal imaging was performed with the kind help from O. Bruns in collaboration with the Nikon Application Center Northern Germany (Nikon). We are indebted to many colleagues for their kind support with various cells and constructs: H. Wege (University Medical Center Hamburg-Eppendorf) for FH-hTERT, D. Hosch (University Marburg) for BON cells, W. Beyer (Heinrich-Pette-Institute) for vesicular stomatitis virus G protein cDNA R. Y. Tsien (Howard Hughes Medical Institute) for mCherry cDNA, A. Miyawaki (RIKEN) and T. Schroeder (Institute for Stem Cell Research) for Venus cDNA and D. W. Piston (Vanderbilt-Ingram Cancer Center) for Cerulean cDNA. This work was supported by the Deutsche Forschungsgemeinschaft (SFB841 to B. F., D. B. and M. D. and FE568/11-1 to B. F.). M. Thomaschewski was supported by the integrated graduate school "Inflammation and Regeneration" of the University Medical Center Hamburg-Eppendorf.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Appelt JU, 2009, GENE THER, V16, P885, DOI 10.1038/gt.2009.37; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Cornils K, 2009, MOL THER, V17, P131, DOI 10.1038/mt.2008.238; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Fehse B, 2004, GENE THER, V11, P879, DOI 10.1038/sj.gt.3302270; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hock H, 2010, J EXP MED, V207, P1127, DOI 10.1084/jem.20100950; Kim YJ, 2009, BLOOD, V113, P5434, DOI 10.1182/blood-2008-10-185199; Kustikova Olga S., 2009, V506, P373, DOI 10.1007/978-1-59745-409-4_25; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Leedham SJ, 2008, J PATHOL, V215, P351, DOI 10.1002/path.2379; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lutgehetmann M, 2010, HEPATOLOGY, V52, P16, DOI 10.1002/hep.23611; Metcalf D, 2008, P NATL ACAD SCI USA, V105, P18501, DOI 10.1073/pnas.0810072105; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Novelli M, 2003, P NATL ACAD SCI USA, V100, P3311, DOI 10.1073/pnas.0437825100; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; Schwieger M, 2009, BLOOD, V114, P2476, DOI 10.1182/blood-2008-05-158196; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; TOWNSEND CM, 1993, ACTA ONCOL, V32, P125, DOI 10.3109/02841869309083900; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Vafaizadeh V, 2010, STEM CELLS, V28, P928, DOI 10.1002/stem.407; Weber K, 2010, GENE THER, V17, P511, DOI 10.1038/gt.2009.149; WEBER K, 2009, CELL THER TRANSPLANT, V1; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	40	105	105	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					504	U147		10.1038/nm.2338	http://dx.doi.org/10.1038/nm.2338			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21441917				2022-12-27	WOS:000289245100043
J	Bissell, MJ; Hines, WC				Bissell, Mina J.; Hines, William C.			Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression	NATURE MEDICINE			English	Review							ROUS-SARCOMA-VIRUS; HUMAN BREAST CELLS; TUMOR-GROWTH; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; 3-DIMENSIONAL CULTURE; STROMAL FIBROBLASTS; TISSUE ARCHITECTURE; STIMULATING FACTOR; OCCULT CARCINOMA	Tumors are like new organs and are made of multiple cell types and components. The tumor competes with the normal microenvironment to overcome antitumorigenic pressures. Before that battle is won, the tumor may exist within the organ unnoticed by the host, referred to as 'occult cancer'. We review how normal tissue homeostasis and architecture inhibit progression of cancer and how changes in the microenvironment can shift the balance of these signals to the procancerous state. We also include a discussion of how this information is being tailored for clinical use.	[Bissell, Mina J.; Hines, William C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	mjbissell@lbl.gov		Hines, William/0000-0002-0707-3160	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH1123]; US National Cancer Institute [R37CA064786, U54CA126552, R01CA057621, U54CA112970, U01CA143233, U54CA143836]; US Department of Defense [W81XWH0810736]; NATIONAL CANCER INSTITUTE [R37CA064786, U01CA143233, U54CA143836, R01CA064786, U54CA112970, R01CA057621, U54CA126552] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Ghajar for considerable help for the background materials and him, J. Mott and I. Kuhn for critical reading of the manuscript. We also thank K. Andersen, D. Lyden, S. Rafii, M. de Sousa and M. H. Barcellos-Hoff for referring us to clinically related articles qualifying as 'microenvironmental therapy'. We thank M. Bisoffi for providing the full-text versions of articles on the occult tumors in the prostate and E. Collisson for directing us to references on occult tumors of the pancreas. The work from M. J. B.'s laboratory is supported by grants from the US Department of Energy, Office of Biological and Environmental Research and Low Dose Radiation Program (contract no. DE-AC02-05CH1123), by the US National Cancer Institute (awards R37CA064786, U54CA126552, R01CA057621, U54CA112970, U01CA143233 and U54CA143836-Bay Area Physical Sciences-Oncology Center, University of California-Berkeley) and by the US Department of Defense (W81XWH0810736).	Anders M, 2003, P NATL ACAD SCI USA, V100, P1943, DOI 10.1073/pnas.0337599100; Ashkenas J, 1996, DEV BIOL, V180, P433, DOI 10.1006/dbio.1996.0317; Balis FM, 2002, J NATL CANCER I, V94, P78, DOI 10.1093/jnci/94.2.78; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Beliveau A, 2010, GENE DEV, V24, P2800, DOI 10.1101/gad.1990410; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; BERENBLUM I, 1949, BRIT J CANCER, V3, P109, DOI 10.1038/bjc.1949.13; Berenblum I, 1941, CANCER RES, V1, P44; BERENBLUM I, 1954, CANCER RES, V14, P471; BERENBLUM I, 1974, CARCINOGENESIS BIOLO; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Biernaux C, 1996, BONE MARROW TRANSPL, V17, pS45; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; BISSELL MJ, 1979, P NATL ACAD SCI USA, V76, P348, DOI 10.1073/pnas.76.1.348; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen A, 2009, CANCER RES, V69, P6721, DOI 10.1158/0008-5472.CAN-08-4069; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Colozza M, 2007, ONCOLOGIST, V12, P253, DOI 10.1634/theoncologist.12-3-253; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deelman H T, 1927, Proc R Soc Med, V20, P1157; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0; DOLBERG DS, 1985, SCIENCE, V230, P676, DOI 10.1126/science.2996144; DURAN-REYNALS F., 1940, YALE JOUR BIOL AND MED, V13, P77; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Friedewald WF, 1944, J EXP MED, V80, P101, DOI 10.1084/jem.80.2.101; FUJII H, 1982, J UROLOGY, V128, P858, DOI 10.1016/S0022-5347(17)53221-8; Gudjonsson T, 2002, J CELL SCI, V115, P39; HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; HAYASHI N, 1990, CANCER RES, V50, P4747; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; HOWLETT AR, 1994, J NATL CANCER I, V86, P1838, DOI 10.1093/jnci/86.24.1838; HRUBAN R, 2008, PANCREATIC CANC; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kupsch Petra, 2005, Clin Colorectal Cancer, V5, P188, DOI 10.3816/CCC.2005.n.030; Polo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010786; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Maher J J, 1993, Semin Cell Biol, V4, P189, DOI 10.1006/scel.1993.1023; Manser RL, 2005, RESP MED, V99, P501, DOI 10.1016/j.rmed.2004.08.017; MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olumi AF, 1999, CANCER RES, V59, P5002; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PATEL J, 1981, CANCER, V47, P2923, DOI 10.1002/1097-0142(19810615)47:12<2923::AID-CNCR2820471231>3.0.CO;2-N; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pierce G B, 1967, Curr Top Dev Biol, V2, P223; PIERCE GB, 1988, CANCER RES, V48, P1996; PIERCE GB, 1967, J NATL CANCER I, V39, P755; PIERCE GB, 1977, J TOXICOL ENV HEALTH, V2, P1335, DOI 10.1080/15287397709529534; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Postovit LM, 2006, STEM CELLS, V24, P501, DOI 10.1634/stemcells.2005-0459; POTT P, 1775, POLYPUS NOSE CANC SC; Potter JD, 2007, NAT REV CANCER, V7, P464, DOI 10.1038/nrc2146; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Rich AR, 1935, J UROLOGY, V33, P215, DOI 10.1016/S0022-5347(17)72260-4; Rich AR, 2007, INT J EPIDEMIOL, V36, P274, DOI 10.1093/ije/dym050; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; SCHOR SL, 1985, J CELL SCI, V73, P235; Schor SL, 2003, CANCER RES, V63, P8827; SCHOR SL, 1985, J CELL SCI, V73, P221; SCHOR SL, 1988, J CELL SCI, V90, P401; Sickles EA, 2007, AM J ROENTGENOL, V188, P301, DOI 10.2214/AJR.06.0635; SIEWEKE MH, 1990, SCIENCE, V248, P1656, DOI 10.1126/science.2163544; SIEWEKE MH, 1994, CRIT REV ONCOGENESIS, V5, P297, DOI 10.1615/CritRevOncog.v5.i2-3.90; SLAGA TJ, 1983, ENVIRON HEALTH PERSP, V50, P3, DOI 10.2307/3429529; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Stevens L C, 1967, Adv Morphog, V6, P1; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; STOKER AW, 1990, J CELL BIOL, V111, P217, DOI 10.1083/jcb.111.1.217; SYMPSON CJ, 1995, SEMIN CANCER BIOL, V6, P159, DOI 10.1006/scbi.1995.0022; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Thomasset N, 1998, AM J PATHOL, V153, P457, DOI 10.1016/S0002-9440(10)65589-7; Thompson CB, 2010, MOL CANCER THER, V9, P3052, DOI 10.1158/1535-7163.MCT-10-0470; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Veltman JD, 2010, BRIT J CANCER, V103, P629, DOI 10.1038/sj.bjc.6605814; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; WESSELS NK, 1977, TISSUE INTERACTION D; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Wolf AM, 2006, HAEMATOLOGICA, V91, P1165; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021	140	1020	1038	3	232	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					320	329		10.1038/nm.2328	http://dx.doi.org/10.1038/nm.2328			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383745	Green Accepted			2022-12-27	WOS:000288070000043
J	Aftergood, S				Aftergood, Steven			Review of classification rules represents an opportunity, even for medicine	NATURE MEDICINE			English	News Item								The US system of classifying national security information is bloated and dysfunctional, shielding the government from the scrutiny it needs to avoid error and abusive practices. In the medical field, this secrecy has, in rare cases, enabled unethical, state-sponsored research to proceed without public knowledge. The Fundamental Classification Guidance Review that is now underway could make a difference-if it's done right.											0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2011	17	2					153	153		10.1038/nm0211-153	http://dx.doi.org/10.1038/nm0211-153			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297603	hybrid			2022-12-27	WOS:000286969900015
J	Bhang, HEC; Gabrielson, KL; Laterra, J; Fisher, PB; Pomper, MG				Bhang, Hyo-eun C.; Gabrielson, Kathleen L.; Laterra, John; Fisher, Paul B.; Pomper, Martin G.			Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression	NATURE MEDICINE			English	Article							2-STEP TRANSCRIPTIONAL AMPLIFICATION; LYMPH-NODE METASTASIS; TK GENE; PHASE-I; THERAPY; DNA; ADENOVIRUS; DELIVERY; BIODISTRIBUTION; INTEGRATION	Molecular-genetic imaging is advancing from a valuable preclinical tool to a guide for patient management. The strategy involves pairing an imaging reporter gene with a complementary imaging agent in a system that can be used to measure gene expression or protein interaction or track gene-tagged cells in vivo. Tissue-specific promoters can be used to delineate gene expression in certain tissues, particularly when coupled with an appropriate amplification mechanism. Here we show that the progression elevated gene-3 (PEG-3) promoter, derived from a rodent gene mediating tumor progression and metastatic phenotypes, can be used to drive imaging reporters selectively to enable detection of micrometastatic disease in mouse models of human melanoma and breast cancer using bioluminescence and radionuclide-based molecular imaging techniques. Because of its strong promoter activity, tumor specificity and capacity for clinical translation, PEG-3 promoter-driven gene expression may represent a practical, new system for facilitating cancer imaging and therapy.	[Bhang, Hyo-eun C.; Pomper, Martin G.] Johns Hopkins Med Inst, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Gabrielson, Kathleen L.] Johns Hopkins Med Inst, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Laterra, John] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; [Laterra, John] Kennedy Krieger Inst, Baltimore, MD USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Massey Canc Ctr, Inst Mol Med, Dept Human & Mol Genet,Sch Med, Richmond, VA USA; [Pomper, Martin G.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Medicine	Pomper, MG (corresponding author), Johns Hopkins Med Inst, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mpomper@jhmi.edu			US National Institutes of Health [U24 CA92871, P01 CA104177]; Society of Nuclear Medicine; Korea Science and Engineering Foundation; US National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA127641, P01CA104177, U24CA092871, R01CA097318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093195] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Nuclear Medicine; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); US National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We appreciate the technical support provided by S. Dhara, S. Nimmagadda, M. Goggins and M. Griffith. We are grateful to J. Fox and G. Green for providing [<SUP>125</SUP>I]FIAU and assisting in the SPECT-CT and PET-CT imaging studies. We also thank C. Endres, B. Tsui, J. Yu and J. Fox for help with SPECT and PET data processing. The MDA-MB-231 cell line and pCMV-Tri construct were generous gifts from Z. Bhujwalla (Johns Hopkins University) and S. Gambhir (Stanford University), respectively. Funding was provided by US National Institutes of Health grant U24 CA92871 (to M.G.P.), by the Predoctoral Molecular Imaging Scholar Program from the Society of Nuclear Medicine and the Korea Science and Engineering Foundation Fellowship Program (to H.C.B.) and by the US National Institutes of Health grant P01 CA104177 and the US National Foundation for Cancer Research (to P.B.F.). P.B.F. holds the Thelma Newmeyer Corman Chair in Cancer Research at the Virginia Commonwealth University Massey Cancer Center.	Blasberg RG, 2003, J CLIN INVEST, V111, P1620, DOI 10.1172/JCI200318855; Bonnet ME, 2008, PHARM RES-DORDR, V25, P2972, DOI 10.1007/s11095-008-9693-1; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Coelho-Castelo A A M, 2006, Genet Vaccines Ther, V4, P1, DOI 10.1186/1479-0556-4-1; Dwyer RM, 2005, CLIN CANCER RES, V11, P1483, DOI 10.1158/1078-0432.CCR-04-1636; Evans Kevin D, 2007, Radiol Technol, V78, P361; Freytag SO, 2007, MOL THER, V15, P1016, DOI 10.1038/mt.sj.6300120; Huyn ST, 2009, CLIN CANCER RES, V15, P3126, DOI 10.1158/1078-0432.CCR-08-2666; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098; Iyer M, 2004, MOL THER, V10, P545, DOI 10.1016/j.ymthe.2004.06.118; Jacobs A, 2001, LANCET, V358, P727, DOI 10.1016/S0140-6736(01)05904-9; Kang KK, 2003, INTERVIROLOGY, V46, P270, DOI 10.1159/000073206; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Klatzmann D, 1998, HUM GENE THER, V9, P2595, DOI 10.1089/hum.1998.9.17-2595; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Manam S, 2000, INTERVIROLOGY, V43, P273, DOI 10.1159/000053994; Padmanabhan P, 2006, J NUCL MED, V47, P270; Peng KW, 2001, GENE THER, V8, P1456, DOI 10.1038/sj.gt.3301552; Qiao J, 2002, GENE THER, V9, P168, DOI 10.1038/sj.gt.3301618; Ramirez K, 2008, HUM GENE THER, V19, P522, DOI 10.1089/hum.2007.172; Ray S, 2008, MOL THER, V16, P1848, DOI 10.1038/mt.2008.180; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sarkar D, 2008, CANCER GENE THER, V15, P293, DOI 10.1038/cgt.2008.14; Sarkar D, 2005, P NATL ACAD SCI USA, V102, P14034, DOI 10.1073/pnas.0506837102; Sarkar D, 2005, CANCER RES, V65, P9056, DOI 10.1158/0008-5472.CAN-05-1261; Sarkar D, 2007, CANCER RES, V67, P5434, DOI 10.1158/0008-5472.CAN-07-0195; Shreve PD, 1999, RADIOGRAPHICS, V19, P61, DOI 10.1148/radiographics.19.1.g99ja0761; Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125; Su ZZ, 2000, ONCOGENE, V19, P3411, DOI 10.1038/sj.onc.1203666; Su ZZ, 2005, ONCOGENE, V24, P2247, DOI 10.1038/sj.onc.1208420; Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102; Trask TW, 2000, MOL THER, V1, P195, DOI 10.1006/mthe.2000.0030; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Wood M, 1999, CANCER GENE THER, V6, P367, DOI 10.1038/sj.cgt.7700090; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	38	71	80	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					123	U302		10.1038/nm.2269	http://dx.doi.org/10.1038/nm.2269			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151140	Green Accepted			2022-12-27	WOS:000285994000045
J	Grumati, P; Coletto, L; Sabatelli, P; Cescon, M; Angelin, A; Bertaggia, E; Blaauw, B; Urciuolo, A; Tiepolo, T; Merlini, L; Maraldi, NM; Bernardi, P; Sandri, M; Bonaldo, P				Grumati, Paolo; Coletto, Luisa; Sabatelli, Patrizia; Cescon, Matilde; Angelin, Alessia; Bertaggia, Enrico; Blaauw, Bert; Urciuolo, Anna; Tiepolo, Tania; Merlini, Luciano; Maraldi, Nadir M.; Bernardi, Paolo; Sandri, Marco; Bonaldo, Paolo			Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration	NATURE MEDICINE			English	Article							MITOCHONDRIAL DYSFUNCTION; MUSCLE APOPTOSIS; DISEASE; PATHOGENESIS; DEGRADATION; PREVENTS; MYOPATHY; CELLS; MICE	Autophagy is crucial in the turnover of cell components, and clearance of damaged organelles by the autophagic-lysosomal pathway is essential for tissue homeostasis. Defects of this degradative system have a role in various diseases, but little is known about autophagy in muscular dystrophies. We have previously found that muscular dystrophies linked to collagen VI deficiency show dysfunctional mitochondria and spontaneous apoptosis, leading to myofiber degeneration. Here we demonstrate that this persistence of abnormal organelles and apoptosis are caused by defective autophagy. Skeletal muscles of collagen VI-knockout (Col6a1(-/-)) mice had impaired autophagic flux, which matched the lower induction of beclin-1 and BCL-2/adenovirus E1B-interacting protein-3 (Bnip3) and the lack of autophagosomes after starvation. Forced activation of autophagy by genetic, dietary and pharmacological approaches restored myofiber survival and ameliorated the dystrophic phenotype of Col6a1(-/-) mice. Furthermore, muscle biopsies from subjects with Bethlem myopathy or Ullrich congenital muscular dystrophy had reduced protein amounts of beclin-1 and Bnip3. These findings indicate that defective activation of the autophagic machinery is pathogenic in some congenital muscular dystrophies.	[Grumati, Paolo; Cescon, Matilde; Urciuolo, Anna; Tiepolo, Tania; Bonaldo, Paolo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Coletto, Luisa; Bertaggia, Enrico; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sabatelli, Patrizia; Maraldi, Nadir M.] CNR, Inst Med Genet, Bologna, Italy; [Angelin, Alessia; Bernardi, Paolo; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Blaauw, Bert] Univ Padua, Dept Human Anat & Physiol, Padua, Italy; [Merlini, Luciano] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Maraldi, Nadir M.] Univ Bologna, Dept Anat Sci, Bologna, Italy	University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Ferrara; University of Bologna	Bonaldo, P (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy.	marco.sandri@unipd.it; bonaldo@bio.unipd.it	Bernardi, Paolo/C-3656-2008; Cescon, Matilde/Y-3116-2019; Sabatelli, Patrizia/C-7479-2019; blaauw, bert/A-7614-2014; Merlini, Luciano/N-6478-2019; Grumati, Paolo/AAA-5787-2019	Bernardi, Paolo/0000-0001-9187-3736; Cescon, Matilde/0000-0001-7138-1857; Sabatelli, Patrizia/0000-0003-2345-5094; blaauw, bert/0000-0002-3893-1463; Merlini, Luciano/0000-0002-1108-1198; Grumati, Paolo/0000-0002-9942-9389; BLAAUW, BERT/0000-0002-4167-5106; Bonaldo, Paolo/0000-0002-9571-8140; Urciuolo, Anna/0000-0001-7571-9747	Telethon Foundation [GGP08107, TCP04009]; Italian Ministry of University and Research, Association Francaise contre les Myopathies; EU	Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research, Association Francaise contre les Myopathies; EU(European Commission)	We thank N. Bergamin for her involvement in the initial study, P. Braghetta for help with mouse manipulations, E. Rizzo and S. Castagnaro for histology, S. Cogliati for assistance with mitochondria isolation and F. Gualandi for muscle biopsies. We are grateful to N. Heintz (Rockefeller University) for supplying the beclin-1-EGFP expression construct and E. Kominami (Juntendo University School of Medicine) for the YFP-LC3 construct. This work was supported by the Telethon Foundation (GGP08107 and TCP04009), the Italian Ministry of University and Research, Association Francaise contre les Myopathies and the EU (BIO-NMD and MYOAGE).	Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; DEGRASSI A, 1994, AIDS RES HUM RETROV, V10, P675, DOI 10.1089/aid.1994.10.675; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pepe G, 2002, NEUROMUSCULAR DISORD, V12, P720; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHMALBRUCH H, 1980, J NEUROPATH EXP NEUR, V39, P65, DOI 10.1097/00005072-198001000-00006; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sugawara T, 2009, AMINO ACIDS, V37, P609, DOI 10.1007/s00726-008-0180-0; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yoo YM, 2010, J PINEAL RES, V48, P204, DOI 10.1111/j.1600-079X.2010.00744.x; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	43	380	394	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1313	U169		10.1038/nm.2247	http://dx.doi.org/10.1038/nm.2247			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21037586	Green Published			2022-12-27	WOS:000283860100044
J	Mionnet, C; Buatois, V; Kanda, A; Milcent, V; Fleury, S; Lair, D; Langelot, M; Lacoeuille, Y; Hessel, E; Coffman, R; Magnan, A; Dombrowicz, D; Glaichenhaus, N; Julia, V				Mionnet, Cyrille; Buatois, Vanessa; Kanda, Akira; Milcent, Valerie; Fleury, Sebastien; Lair, David; Langelot, Marie; Lacoeuille, Yannick; Hessel, Edith; Coffman, Robert; Magnan, Antoine; Dombrowicz, David; Glaichenhaus, Nicolas; Julia, Valerie			CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung	NATURE MEDICINE			English	Article							FRACTALKINE-RECEPTOR CX(3)CR1; INTERFERON-GAMMA; CHEMOKINE; EXPRESSION; ACTIVATION; ASTHMA; RECRUITMENT; INTERLEUKIN-4; EOSINOPHILS; INVOLVEMENT	Allergic asthma is a T helper type 2 (T(H)2)-dominated disease of the lung. In people with asthma, a fraction of CD4(+) T cells express the CX3CL1 receptor, CX3CR1, and CX3CL1 expression is increased in airway smooth muscle, lung endothelium and epithelium upon allergen challenge. Here we found that untreated CX3CR1-deficient mice or wild-type (WT) mice treated with CX3CR1-blocking reagents show reduced lung disease upon allergen sensitization and challenge. Transfer of WT CD4+ T cells into CX3CR1-deficient mice restored the cardinal features of asthma, and CX3CR1-blocking reagents prevented airway inflammation in CX3CR1-deficient recipients injected with WT T(H)2 cells. We found that CX3CR1 signaling promoted T(H)2 survival in the inflamed lungs, and injection of B cell leukemia/lymphoma-2 protein (BCl-2)-transduced CX3CR1-deficient T(H)2 cells into CX3CR1-deficient mice restored asthma. CX3CR1-induced survival was also observed for T(H)1 cells upon airway inflammation but not under homeostatic conditions or upon peripheral inflammation. Therefore, CX3CR1 and CX3CL1 may represent attractive therapeutic targets in asthma.	[Mionnet, Cyrille; Buatois, Vanessa; Milcent, Valerie; Glaichenhaus, Nicolas; Julia, Valerie] Univ Nice Sophia Antipolis, U924, Valbonne, France; [Mionnet, Cyrille; Buatois, Vanessa; Kanda, Akira; Milcent, Valerie; Fleury, Sebastien; Lair, David; Langelot, Marie; Lacoeuille, Yannick; Magnan, Antoine; Dombrowicz, David; Glaichenhaus, Nicolas; Julia, Valerie] Inst Natl Sante & Rech Med, Paris, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Univ Lille 2, U1011, Lille, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Inst Pasteur, F-59019 Lille, France; [Lair, David; Langelot, Marie; Lacoeuille, Yannick; Magnan, Antoine] Univ Nantes, Inst Thorax, UMR915, Nantes, France; [Hessel, Edith; Coffman, Robert] Dynavax Technol, Berkeley, CA USA	UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Nantes Universite; CHU de Nantes	Julia, V (corresponding author), Univ Nice Sophia Antipolis, U924, Valbonne, France.	vjulia@unice.fr	MAGNAN, ANTOINE/GVT-4308-2022; mionnet, cyrille/P-9168-2016; Magnan, Antoine/D-4100-2015; Hessel, Edith M/AAB-6002-2021; Dombrowicz, David/F-7044-2013	mionnet, cyrille/0000-0001-8431-3837; Hessel, Edith M/0000-0002-2339-4482; Dombrowicz, David/0000-0002-0485-8923; Fleury, Sebastien/0000-0002-0679-3086	Fondation pour la Recherche Medical; Agence Nationale de la Recherche; French Society of Allergology; French Pneumologie Society; Genavie foundation; Pays de la Loire and Provence Alpes Cote d'Azur regional councils	Fondation pour la Recherche Medical(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Society of Allergology; French Pneumologie Society; Genavie foundation; Pays de la Loire and Provence Alpes Cote d'Azur regional councils	We thank N. Guy, V. Thieffin and A. Barbot for animal care, J. Cazareth and F. Larbret for cell sorting and S. Kirschnek (Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich) for providing the MIG-mBcl-2 and MIGR1 vectors. IFN-gamma-specific antibody R4-6A2 and IL-4 specific antibody 11B11 were kind gifts from DNAX Research Institute. Cx3cr1<SUP>GFP/GFP</SUP> mice were a gift from S. Jung (Weizmann Institute of Science, Immunology Department). This research was supported by the Fondation pour la Recherche Medical, the Agence Nationale de la Recherche, the French Society of Allergology, the French Pneumologie Society, the Genavie foundation and the Pays de la Loire and Provence Alpes Cote d'Azur regional councils.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Benamar K, 2008, EUR J PHARMACOL, V592, P93, DOI 10.1016/j.ejphar.2008.07.009; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Chen SZ, 2002, J NEUROIMMUNOL, V133, P46, DOI 10.1016/S0165-5728(02)00354-5; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Chung CD, 2003, J IMMUNOL, V170, P581, DOI 10.4049/jimmunol.170.1.581; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Conroy DM, 2003, J LEUKOCYTE BIOL, V74, P558, DOI 10.1189/jlb.0103030; Depner M, 2007, INT ARCH ALLERGY IMM, V144, P91, DOI 10.1159/000102620; Echigo T, 2004, J ALLERGY CLIN IMMUN, V113, P940, DOI 10.1016/S0091-6749(04)01061-9; El Biaze M, 2003, ALLERGY, V58, P844, DOI 10.1034/j.1398-9995.2003.00282.x; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Foussat A, 2000, EUR J IMMUNOL, V30, P87, DOI 10.1002/1521-4141(200001)30:1<87::AID-IMMU87>3.3.CO;2-Z; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Garin A, 2002, BIOCHEM J, V368, P753, DOI 10.1042/BJ20020951; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Goya I, 2003, J IMMUNOL, V170, P2138, DOI 10.4049/jimmunol.170.4.2138; Hamelmann E, 2008, CLIN EXP ALLERGY, V38, P233, DOI 10.1111/j.1365-2222.2007.02901.x; Hippe A, 2010, RECENT RESULTS CANC, V180, P35, DOI 10.1007/978-3-540-78281-0_4; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Inoue A, 2005, ARTHRITIS RHEUM-US, V52, P1522, DOI 10.1002/art.21007; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Linge HM, 2008, J INTERF CYTOK RES, V28, P190, DOI 10.1089/jir.2007.0100; Liu XD, 2007, AM J RESP CELL MOL, V37, P121, DOI 10.1165/rcmb.2005-0253OC; Lopez Vina A, 2006, ARCH BRONCONEUMOL, V42, P20; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mikhak Z, 2009, J ALLERGY CLIN IMMUN, V123, P67, DOI 10.1016/j.jaci.2008.09.049; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2008.04.011; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nanki T, 2004, J IMMUNOL, V173, P7010, DOI 10.4049/jimmunol.173.11.7010; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; O'Byrne PM, 2007, AM J RESP CRIT CARE, V176, P1059, DOI 10.1164/rccm.200708-1264ED; Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T; Ramos MV, 2010, IMMUNOLOGY, V129, P600, DOI 10.1111/j.1365-2567.2009.03181.x; Rimaniol AC, 2003, J ALLERGY CLIN IMMUN, V112, P1139, DOI 10.1016/j.jaci.2003.09.041; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Suzuki F, 2005, J IMMUNOL, V175, P6987, DOI 10.4049/jimmunol.175.10.6987; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Wang Q, 2001, J IMMUNOL, V167, P4311, DOI 10.4049/jimmunol.167.8.4311; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yajima N, 2005, ARTHRITIS RHEUM-US, V52, P1670, DOI 10.1002/art.21042; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	59	89	92	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1305	U160		10.1038/nm.2253	http://dx.doi.org/10.1038/nm.2253			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21037587				2022-12-27	WOS:000283860100043
J	Lafreniere, RG; Cader, MZ; Poulin, JF; Andres-Enguix, I; Simoneau, M; Gupta, N; Boisvert, K; Lafreniere, F; McLaughlan, S; Dube, MP; Marcinkiewicz, MM; Ramagopalan, S; Ansorge, O; Brais, B; Sequeiros, J; Pereira-Monteiro, JM; Griffiths, LR; Tucker, SJ; Ebers, G; Rouleau, GA				Lafreniere, Ronald G.; Cader, M. Zameel; Poulin, Jean-Francois; Andres-Enguix, Isabelle; Simoneau, Maryse; Gupta, Namrata; Boisvert, Karine; Lafreniere, Francois; McLaughlan, Shannon; Dube, Marie-Pierre; Marcinkiewicz, Martin M.; Ramagopalan, Sreeram; Ansorge, Olaf; Brais, Bernard; Sequeiros, Jorge; Pereira-Monteiro, Jose Maria; Griffiths, Lyn R.; Tucker, Stephen J.; Ebers, George; Rouleau, Guy A.			A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura	NATURE MEDICINE			English	Article							DOMAIN K+ CHANNEL; SPREADING DEPRESSION; HEMIPLEGIC MIGRAINE; ACTIVATION; CALCINEURIN; CURRENTS; LONG	Migraine with aura is a common, debilitating, recurrent headache disorder associated with transient and reversible focal neurological symptoms(1). A role has been suggested for the two-pore domain (K2P) potassium channel, TWIK-related spinal cord potassium channel (TRESK, encoded by KCNK18), in pain pathways and general anaesthesia(2). We therefore examined whether TRESK is involved in migraine by screening the KCNK18 gene in subjects diagnosed with migraine. Here we report a frameshift mutation, F139WfsX24, which segregates perfectly with typical migraine with aura in a large pedigree. We also identified prominent TRESK expression in migraine-salient areas such as the trigeminal ganglion. Functional characterization of this mutation demonstrates that it causes a complete loss of TRESK function and that the mutant subunit suppresses wild-type channel function through a dominant-negative effect, thus explaining the dominant penetrance of this allele. These results therefore support a role for TRESK in the pathogenesis of typical migraine with aura and further support the role of this channel as a potential therapeutic target.	[Lafreniere, Ronald G.; Brais, Bernard; Rouleau, Guy A.] Univ Montreal, Res Ctr, Ctr Excellence Neur, Ctr Hosp Univ Montreal,Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada; [Lafreniere, Ronald G.; Brais, Bernard; Rouleau, Guy A.] Univ Montreal, Res Ctr, Dept Med, Ctr Hosp Univ Montreal,Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada; [Lafreniere, Ronald G.; Poulin, Jean-Francois; Simoneau, Maryse; Gupta, Namrata; Boisvert, Karine; Lafreniere, Francois; McLaughlan, Shannon; Rouleau, Guy A.] Emerillon Therapeut, Montreal, PQ, Canada; [Cader, M. Zameel] Univ Oxford, Med Res Council Funct Genom Unit, Dept Physiol Anat & Genet, Oxford, England; [Cader, M. Zameel] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Andres-Enguix, Isabelle] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Dube, Marie-Pierre] Univ Montreal, Montreal Heart Inst, Fac Med, Montreal, PQ H3C 3J7, Canada; [Marcinkiewicz, Martin M.] Cytochem, Montreal, PQ, Canada; [Ramagopalan, Sreeram; Ebers, George] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ansorge, Olaf] Univ Oxford, Dept Neuropathol, Oxford, England; [Sequeiros, Jorge] Univ Porto, Inst Mol & Cell Biol, UnlGENe, P-4100 Oporto, Portugal; [Pereira-Monteiro, Jose Maria] Hosp Santo Antonio, Oporto, Portugal; [Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Gen Res Ctr, Gold Coast, Qld, Australia	Universite de Montreal; Universite de Montreal; University of Oxford; University of Oxford; University of Oxford; Universite de Montreal; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Universidade do Porto; Griffith University; Menzies Health Institute Queensland	Rouleau, GA (corresponding author), Univ Montreal, Res Ctr, Ctr Excellence Neur, Ctr Hosp Univ Montreal,Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada.	zameel.cader@dpag.ox.ac.uk; guy.rouleau@umontreal.ca	Tucker, Stephen J./ABE-7468-2020; Pereira-Monteiro, José/K-6036-2013; Tucker, Stephen J./ABE-6741-2020; Dubé, Marie-Pierre/B-9364-2008; Brais, Bernard/Y-3910-2019	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Dubé, Marie-Pierre/0000-0001-8442-4393; Ebers, George/0000-0003-4771-4177; Pereira-Monteiro, Jose/0000-0001-8846-0754; Griffiths, Lyn/0000-0002-6774-5475; Sequeiros, Jorge/0000-0002-9846-1037; Cader, Zameel/0000-0002-6952-406X	Genome Canada; Genome Quebec; Emerillon Therapeutics; Wellcome Trust; Pfizer; Medical Research Council (UK); Natural Sciences and Engineering Research Council of Canada; Medical Research Council [G0601887] Funding Source: researchfish; MRC [G0601887] Funding Source: UKRI	Genome Canada(Genome Canada); Genome Quebec; Emerillon Therapeutics; Wellcome Trust(Wellcome TrustEuropean Commission); Pfizer(Pfizer); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the subjects and their families for participating in the study and M. K. Charles, M. Albanese, M. Imbeau, A. Anton, S. Meilleur and F. Fernandez for technical assistance. Funding was kindly provided by Genome Canada, Genome Quebec, Emerillon Therapeutics, the Wellcome Trust and Pfizer. M.Z.C. was supported by the Medical Research Council (UK). J.-F.P. was supported by an industrial postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Cader ZM, 2003, HUM MOL GENET, V12, P2511, DOI 10.1093/hmg/ddg252; Colson NJ, 2005, NEUROGENETICS, V6, P17, DOI 10.1007/s10048-004-0205-0; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ferrari Uta, 2005, Headache, V45, P211, DOI 10.1111/j.1526-4610.2005.05046.x; Huang Dong-Yue, 2008, Neurosci Bull, V24, P166, DOI 10.1007/s12264-008-0225-0; Iadecola C, 2002, NAT MED, V8, P110, DOI 10.1038/nm0202-110; Lemos C, 2009, HEADACHE, V49, P404, DOI 10.1111/j.1526-4610.2008.01177.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Piper RD, 1996, CEPHALALGIA, V16, P87, DOI 10.1046/j.1468-2982.1996.1602087.x; Ramagopalan SV, 2007, J NEUROL, V254, P1629, DOI 10.1007/s00415-007-0641-5; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith HS, 2009, PAIN PHYSICIAN, V12, pE309; Wuttke TV, 2007, NEUROLOGY, V69, P2045, DOI 10.1212/01.wnl.0000275523.95103.36; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zerr P, 1998, J NEUROSCI, V18, P2842; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	30	231	243	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1157	U1501		10.1038/nm.2216	http://dx.doi.org/10.1038/nm.2216			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871611				2022-12-27	WOS:000282644800048
J	Van Dyke, T				Van Dyke, Terry			Approximating a human cancer	NATURE MEDICINE			English	Editorial Material							PANCREATIC-CANCER; CHEMOTHERAPY		[Van Dyke, Terry] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Van Dyke, Terry] NCI, Ctr Adv Preclin Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Van Dyke, T (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA.	vandyket@mail.nih.gov			Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZICBC011137, ZIABC011240] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Xiong HQ, 2006, DRUGS, V66, P1059, DOI 10.2165/00003495-200666080-00003; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	8	13	13	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					976	977		10.1038/nm0910-976	http://dx.doi.org/10.1038/nm0910-976			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823881	Green Accepted			2022-12-27	WOS:000281622900024
J	[Anonymous]				[Anonymous]			Cancer vaccine approval could open floodgates	NATURE MEDICINE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					615	615						1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526296	Bronze			2022-12-27	WOS:000278394200008
J	White, YAR; Woods, DC; Takai, Y; Ishihara, O; Seki, H; Tilly, JL				White, Yvonne A. R.; Woods, Dori C.; Takai, Yasushi; Ishihara, Osamu; Seki, Hiroyuki; Tilly, Jonathan L.			Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women	NATURE MEDICINE			English	Article							EMBRYONIC STEM-CELLS; ADULT MAMMALIAN OVARIES; FEMALE INFERTILITY; GENE-EXPRESSION; BONE-MARROW; TRANSPLANTATION; MOUSE; MICE; OOGENESIS; PROTEIN	Germline stem cells that produce oocytes in vitro and fertilization-competent eggs in vivo have been identified in and isolated from adult mouse ovaries. Here we describe and validate a fluorescence-activated cell sorting-based protocol that can be used with adult mouse ovaries and human ovarian cortical tissue to purify rare mitotically active cells that have a gene expression profile that is consistent with primitive germ cells. Once established in vitro, these cells can be expanded for months and can spontaneously generate 35- to 50-mu m oocytes, as determined by morphology, gene expression and haploid (1n) status. Injection of the human germline cells, engineered to stably express GFP, into human ovarian cortical biopsies leads to formation of follicles containing GFP-positive oocytes 1-2 weeks after xenotransplantation into immunodeficient female mice. Thus, ovaries of reproductive-age women, similar to adult mice, possess rare mitotically active germ cells that can be propagated in vitro as well as generate oocytes in vitro and in vivo.	[White, Yvonne A. R.; Woods, Dori C.; Tilly, Jonathan L.] Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA; [White, Yvonne A. R.; Woods, Dori C.; Tilly, Jonathan L.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Takai, Yasushi; Ishihara, Osamu; Seki, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, Saitama, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Saitama Medical University	Tilly, JL (corresponding author), Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA.	jtilly@partners.org			US National Institute on Aging [NIH R37-AG012279]; Henry and Vivian Rosenberg Philanthropic Fund; Sea Breeze Foundation; Vincent Memorial Hospital; NIH [F32-AG034809]; Grants-in-Aid for Scientific Research [22591833] Funding Source: KAKEN; NATIONAL INSTITUTE ON AGING [F32AG034809, R37AG012279] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Henry and Vivian Rosenberg Philanthropic Fund; Sea Breeze Foundation; Vincent Memorial Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank L. Prickett-Rice and K. Folz-Donahue of the Harvard Stem Cell Institute Flow Cytometry Core Facility and J. Groeneweg for expert technical assistance. We also thank J. R. Mann and K. J. MacLaughlin for the provision of TgOG2 transgenic mice. This work was supported by a Method to Extend Research in Time (MERIT) Award from the US National Institute on Aging (NIH R37-AG012279), the Henry and Vivian Rosenberg Philanthropic Fund, the Sea Breeze Foundation and Vincent Memorial Hospital Research Funds. This work was conducted while D. C. W. was supported in part by a Ruth L. Kirschstein National Research Service Award (NIH F32-AG034809).	Abban G, 2009, HUM REPROD, V24, P2974, DOI 10.1093/humrep/dep281; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Dolci S, 2002, J CELL SCI, V115, P1643; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gong SP, 2010, FERTIL STERIL, V93, P2594, DOI 10.1016/j.fertnstert.2009.12.053; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Ko K, 2006, SEMIN REPROD MED, V24, P322, DOI 10.1055/s-2006-952157; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Massasa E, 2010, AGING-US, V2, P1; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Nicholas CR, 2009, ENDOCR REV, V30, P264, DOI 10.1210/er.2008-0034; Niikura Y, 2010, AGING-US, V2, P999, DOI 10.18632/aging.100255; Niikura Y, 2009, AGING-US, V1, P971, DOI 10.18632/aging.100105; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Normile D, 2009, SCIENCE, V324, P320, DOI 10.1126/science.324.5925.320; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Pacchiarotti J, 2010, DIFFERENTIATION, V79, P159, DOI 10.1016/j.diff.2010.01.001; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Sonmezer M, 2010, BEST PRACT RES CL OB, V24, P113, DOI 10.1016/j.bpobgyn.2009.09.002; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tilly JL, 2009, MOL HUM REPROD, V15, P393, DOI 10.1093/molehr/gap036; Tilly JL, 2009, BIOL REPROD, V80, P2, DOI 10.1095/biolreprod.108.069088; Wang N, 2010, CELL CYCLE, V9, P339, DOI 10.4161/cc.9.2.10447; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; West FD, 2011, STEM CELLS DEV, V20, P1079, DOI 10.1089/scd.2010.0255; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; Zou K, 2011, STEM CELLS DEV, V20, P2197, DOI 10.1089/scd.2011.0091; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	50	462	492	3	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					413	U176		10.1038/nm.2669	http://dx.doi.org/10.1038/nm.2669			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366948	Green Accepted			2022-12-27	WOS:000301264800043
J	Bouman, HJ; Schomig, E; van Werkum, JW; Velder, J; Hackeng, CM; Hirschhauser, C; Waldmann, C; Schmalz, HG; ten Berg, JM; Taubert, D				Bouman, Heleen J.; Schoemig, Edgar; van Werkum, Jochem W.; Velder, Janna; Hackeng, Christian M.; Hirschhaeuser, Christoph; Waldmann, Christopher; Schmalz, Hans-Guenther; ten Berg, Jurrien M.; Taubert, Dirk			Paraoxonase-1 is a major determinant of clopidogrel efficacy	NATURE MEDICINE			English	Article							CARDIOVASCULAR RISK; GENE POLYMORPHISMS; ACTIVE METABOLITE; RESPONSIVENESS; METAANALYSIS; ASSOCIATION; VARIABILITY; CYP2C19; DISEASE; EVENTS	Clinical efficacy of the antiplatelet drug clopidogrel is hampered by its variable biotransformation into the active metabolite1,2. The variability in the clinical response to clopidogrel treatment has been attributed to genetic factors, but the specific genes and mechanisms underlying clopidogrel bioactivation remain unclear. Using in vitro metabolomic profiling techniques, we identified paraoxonase-1 (PON1) as the crucial enzyme for clopidogrel bioactivation, with its common Q192R polymorphism determining the rate of active metabolite formation. We tested the clinical relevance of the PON1 Q192R genotype in a population of individuals with coronary artery disease who underwent stent implantation and received clopidogrel therapy. PON1 QQ192 homozygous individuals showed a considerably higher risk than RR192 homozygous individuals of stent thrombosis, lower PON1 plasma activity, lower plasma concentrations of active metabolite and lower platelet inhibition. Thus, we identified PON1 as a key factor for the bioactivation and clinical activity of clopidogrel. These findings have therapeutic implications and may be exploited to prospectively assess the clinical efficacy of clopidogrel.	[Schoemig, Edgar; Taubert, Dirk] Univ Hosp Cologne, Dept Pharmacol, Cologne, Germany; [Bouman, Heleen J.; van Werkum, Jochem W.; Hackeng, Christian M.; ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Bouman, Heleen J.; van Werkum, Jochem W.; ten Berg, Jurrien M.] St Antonius Hosp, St Antonius Ctr Platelet Funct Res, Nieuwegein, Netherlands; [Bouman, Heleen J.] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Velder, Janna; Hirschhaeuser, Christoph; Schmalz, Hans-Guenther] Univ Cologne, Dept Chem, Cologne, Germany; [Hackeng, Christian M.] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands; [Waldmann, Christopher] Univ Munster, Klin & Poliklin Nukl Med, Munster, Germany	University of Cologne; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Maastricht University; University of Cologne; St. Antonius Hospital Utrecht; University of Munster	Taubert, D (corresponding author), Univ Hosp Cologne, Dept Pharmacol, Cologne, Germany.	dirk.taubert@medizin.uni-koeln.de	Schmalz, Hans-Guenther/S-4940-2016; Waldmann, Christoph/F-3386-2017; Hirschhäuser, Christoph/AHB-8450-2022	Schmalz, Hans-Guenther/0000-0003-0489-1827; Waldmann, Christoph/0000-0003-3388-7579; Hirschhäuser, Christoph/0000-0002-9409-1550				ADKINS S, 1993, AM J HUM GENET, V52, P598; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Angiolillo DJ, 2010, REV ESP CARDIOL, V63, P60, DOI 10.1016/S0300-8932(10)70010-5; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bertrand-Thiebault C, 2008, ANN HUM GENET, V72, P178, DOI 10.1111/j.1469-1809.2007.00417.x; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Bouman HJ, 2010, J THROMB HAEMOST, V8, P482, DOI 10.1111/j.1538-7836.2009.03733.x; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Correia M. A., 2005, CYTOCHROME P450 STRU, P253; Dansette PM, 2009, CHEM RES TOXICOL, V22, P369, DOI 10.1021/tx8004828; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Gurbel PA, 2009, EXPERT OPIN DRUG MET, V5, P989, DOI 10.1517/17425250903107772; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kosaka T, 2005, CLIN CHIM ACTA, V359, P156, DOI 10.1016/j.cccn.2005.03.046; Pereillo JM, 2002, DRUG METAB DISPOS, V30, P1288, DOI 10.1124/dmd.30.11.1288; Perla-Kajan J, 2010, FASEB J, V24, P931, DOI 10.1096/fj.09-144410; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Rainwater DL, 2009, HEREDITY, V102, P147, DOI 10.1038/hdy.2008.110; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Taubert D, 2004, THROMB HAEMOSTASIS, V92, P311, DOI 10.1160/TH04-02-0105; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	380	420	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					110	U287		10.1038/nm.2281	http://dx.doi.org/10.1038/nm.2281			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21170047				2022-12-27	WOS:000285994000043
J	Gold, MS; Gebhart, GF				Gold, Michael S.; Gebhart, Gerald F.			Nociceptor sensitization in pain pathogenesis	NATURE MEDICINE			English	Review							PERIPHERAL-NERVE INJURY; IRRITABLE-BOWEL-SYNDROME; DORSAL-ROOT-GANGLIA; SENSORY NEURONS; K+ CHANNELS; 1D RECEPTORS; RAT; TRPA1; ACTIVATION; COLD	The incidence of chronic pain is estimated to be 20-25% worldwide. Few patients with chronic pain obtain complete relief from the drugs that are currently available, and more than half report inadequate relief. Underlying the challenge of developing better drugs to manage chronic pain is incomplete understanding of the heterogeneity of mechanisms that contribute to the transition from acute tissue insult to chronic pain and to pain conditions for which the underlying pathology is not apparent. An intact central nervous system (CNS) is required for the conscious perception of pain, and changes in the CNS are clearly evident in chronic pain states. However, the blockage of nociceptive input into the CNS can effectively relieve or markedly attenuate discomfort and pain, revealing the importance of ongoing peripheral input to the maintenance of chronic pain. Accordingly, we focus here on nociceptors: their excitability, their heterogeneity and their role in initiating and maintaining pain.	[Gold, Michael S.; Gebhart, Gerald F.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Ctr Pain Res, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gebhart, GF (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Ctr Pain Res, Pittsburgh, PA 15261 USA.	gebhartgf@upmc.edu		Gold, Michael/0000-0002-2083-6206	National Institutes of Health [NS019912, NS035790, DE018252, NS063010]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035790, R01NS019912, R01NS063010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are supported by National Institutes of Health awards NS019912 (G.F.G.), NS035790 (G.F.G.), DE018252 (M.S.G.) and NS063010 (M.S.G.).	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Alves DP, 2004, EUR J PHARMACOL, V489, P59, DOI 10.1016/j.ejphar.2004.02.022; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Bharucha AE, 2010, NEUROGASTROENT MOTIL, V22, P227, DOI 10.1111/j.1365-2982.2009.01465.x; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111/j.1469-7793.1999.533ac.x; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Camilleri M, 2009, ALIMENT PHARM THER, V31, P35, DOI 10.1111/j.1365-2036.2009.04153.x; Carlton SM, 1999, BRAIN RES, V820, P63, DOI 10.1016/S0006-8993(98)01328-6; Carlton SM, 2007, J COMP NEUROL, V501, P780, DOI 10.1002/cne.21285; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; DAO TTT, 1995, PAIN, V62, P241, DOI 10.1016/0304-3959(95)00025-N; DELCAMINO D, 2001, J NEUROSCI IN PRESS; Dubreuil AS, 2004, J NEUROSCI, V24, P8480, DOI 10.1523/JNEUROSCI.1598-04.2004; Edvinsson L, 2010, NEUROTHERAPEUTICS, V7, P164, DOI 10.1016/j.nurt.2010.02.004; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Fehrenbacher JC, 2009, BRAIN RES REV, V60, P114, DOI 10.1016/j.brainresrev.2008.12.019; GEBHART GF, 2008, SENSES COMPREHENSIVE, P543; GOLD MS, 2008, SENSES COMPREHENSIVE, V5, P43; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Guler AD, 2002, J NEUROSCI, V22, P6408; Harriott AM, 2008, CEPHALALGIA, V28, P933, DOI 10.1111/j.1468-2982.2008.01635.x; Harriott AM, 2009, CURR PAIN HEADACHE R, V13, P197, DOI 10.1007/s11916-009-0034-9; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Hokfelt T, 1997, PROG PAIN RES MANAG, V9, P115; Honore P, 2005, J PHARMACOL EXP THER, V314, P410, DOI 10.1124/jpet.105.083915; HOWE JF, 1977, PAIN, V3, P25, DOI 10.1016/0304-3959(77)90033-1; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Janig W, 2009, EXP BRAIN RES, V196, P101, DOI 10.1007/s00221-008-1673-5; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; KIRCHHOFF C, 1992, J NEUROPHYSIOL, V67, P125, DOI 10.1152/jn.1992.67.1.125; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Koltzenburg M., 2005, NEUROBIOLOGY PAIN, P1; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kruger L, 1988, Prog Brain Res, V74, P253; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Lewis T, 1936, CLIN SCI, V2, P373; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; LYNN B, 1982, BRAIN RES, V238, P29, DOI 10.1016/0006-8993(82)90768-5; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MCLACHLAN EM, 1993, NATURE, V363, P543, DOI 10.1038/363543a0; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; MEYER RA, 1991, BRAIN RES, V561, P252, DOI 10.1016/0006-8993(91)91601-V; Michaelis M, 1999, NEUROSCIENCE, V94, P7, DOI 10.1016/S0306-4522(99)00325-5; Mousa SA, 2003, ADV EXP MED BIOL, V521, P77; Murdaca G, 2009, INT J IMMUNOPATH PH, V22, P557, DOI 10.1177/039463200902200301; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel L, 2003, EXPERT OPIN PHARMACO, V4, P2279; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Potrebic S, 2003, J NEUROSCI, V23, P10988; Price DD, 2006, J PAIN, V7, P529, DOI 10.1016/j.jpain.2005.12.011; Price DD, 2009, NEUROIMAGE, V47, P995, DOI 10.1016/j.neuroimage.2009.04.028; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rau KK, 2005, J NEUROPHYSIOL, V93, P1358, DOI 10.1152/jn.00591.2004; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; RITTER AM, 1992, J NEUROPHYSIOL, V68, P2033, DOI 10.1152/jn.1992.68.6.2033; Robinson DR, 2008, MOL INTERV, V8, P242, DOI 10.1124/mi.8.5.9; Rukwied R, 2010, PAIN, V148, P407, DOI 10.1016/j.pain.2009.11.022; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; SCHAIBLE HG, 1983, J NEUROPHYSIOL, V49, P1118, DOI 10.1152/jn.1983.49.5.1118; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; SENGUPTA JN, 1995, PROG PAIN RES MANAG, V5, P75; SHAKHANBEH J, 1993, BRAIN RES, V607, P314, DOI 10.1016/0006-8993(93)91522-T; Shinoda M, 2009, GASTROENTEROLOGY, V137, P2096, DOI 10.1053/j.gastro.2009.06.048; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Staud R, 2009, PAIN, V145, P96, DOI 10.1016/j.pain.2009.05.020; Steranka L R, 1988, Adv Exp Med Biol, V236, P111; Tfelt-Hansen P, 2000, DRUGS, V60, P1259, DOI 10.2165/00003495-200060060-00003; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Tsuzuki K, 2001, PAIN, V91, P351, DOI 10.1016/S0304-3959(00)00456-5; Vaughn AH, 2010, J NEUROSCI, V30, P7878, DOI 10.1523/JNEUROSCI.6053-09.2010; Verne GN, 2003, PAIN, V105, P223, DOI 10.1016/S0304-3959(03)00210-0; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	101	471	485	2	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1248	1257		10.1038/nm.2235	http://dx.doi.org/10.1038/nm.2235			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948530	Green Accepted			2022-12-27	WOS:000283860100036
J	MacDonald, TT				MacDonald, Thomas T.			Inside the microbial and immune labyrinth: Totally gutted	NATURE MEDICINE			English	Editorial Material							SEVERE CROHNS-DISEASE; ANTIINTERFERON-GAMMA ANTIBODY; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; DOUBLE-BLIND; MODERATE; FONTOLIZUMAB; INFLAMMATION; SAFETY	In Crohn's disease, immune damage to the gut wall is both induced and modified by the gut microflora, challenging researchers to solve the maze of interactions exploitable for therapeutic benefit. Whether these microbial 'guests' are worsening or helping in this scenario is still open to debate. In 'Bench to Bedside', Warren Strober highlights mice studies showing that certain microbes in the gut have a protective role promoting a shift towards an increased regulatory response that protects from recurrence of the disease. In 'Bedside to Bench', Thomas MacDonald examines how human studies using strategies to block soluble proinflammatory cytokines-despite solid supporting data from animal models-have shown disappointing results compared with therapies that neutralize soluble cytokines but also deplete proinflammatory cells, calling into question whether targeting a single soluble cytokine will ever be useful to treat people with Crohn's disease.	Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London, England	University of London; Queen Mary University London	MacDonald, TT (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London, England.	t.t.macdonald@qmul.ac.uk						Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; MacDonald T. T., 2010, INFLAMM BOWEL DIS, P82; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Reinisch W, 2010, INFLAMM BOWEL DIS, V16, P233, DOI 10.1002/ibd.21038; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014	12	18	18	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1194	1195		10.1038/nm1110-1194	http://dx.doi.org/10.1038/nm1110-1194			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052069				2022-12-27	WOS:000283860100022
J	Tracey, I				Tracey, Irene			Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans	NATURE MEDICINE			English	Review							CHOLECYSTOKININ ANTAGONIST PROGLUMIDE; OPIOID RECEPTOR AVAILABILITY; MEDIAL PREFRONTAL CORTEX; BOWEL-SYNDROME PATIENTS; NEUROPATHIC PAIN; BRAIN ACTIVITY; CENTRAL SENSITIZATION; ANALGESIC RESPONSE; EMOTION REGULATION; NEURAL MECHANISMS	The perception of pain is subject to powerful influences. Understanding how these are mediated at a neuroanatomical and neurobiological level provides us with valuable information that has a direct impact on our ability to harness positive and minimize negative effects therapeutically, as well as optimize clinical trial designs when developing new analgesics. This is particularly relevant for placebo and nocebo effects. New research findings have directly contributed to an increased understanding of how placebo and nocebo effects are produced and what biological and psychological factors influence variances in the magnitude of the effect. The findings have relevance for chronic pain states and other disorders, where abnormal functioning of crucial brain regions might affect analgesic outcome even in the normal therapeutic setting.	[Tracey, Irene] Univ Oxford, Nuffield Dept Anaesthet, Oxford, England; [Tracey, Irene] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Dept Clin Neurol, Oxford, England	University of Oxford; University of Oxford	Tracey, I (corresponding author), Univ Oxford, Nuffield Dept Anaesthet, Oxford, England.	irene@fmrib.ox.ac.uk		Tracey, Irene/0000-0003-4134-6115	Medical Research Council [G0700399] Funding Source: Medline; MRC [G0700399] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADER R, 1995, LANCET, V345, P99, DOI 10.1016/S0140-6736(95)90066-7; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Apkarian AV, 2001, NEUROSCI LETT, V311, P193, DOI 10.1016/S0304-3940(01)02122-X; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3; Benedetti F, 1997, PAIN, V71, P135, DOI 10.1016/S0304-3959(97)03346-0; Benedetti F, 1999, J NEUROSCI, V19, P3639; Benedetti F, 1996, PAIN, V64, P535, DOI 10.1016/0304-3959(95)00179-4; BENEDETTI F, 1995, LANCET, V346, P1231, DOI 10.1016/S0140-6736(95)92938-X; Benedetti F, 2006, J NEUROSCI, V26, P12014, DOI 10.1523/JNEUROSCI.2947-06.2006; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Borsook D, 2010, NEUROSCIENTIST, V16, P171, DOI 10.1177/1073858409349902; Colloca L, 2008, EUR J APPL PHYSIOL, V102, P371, DOI 10.1007/s00421-007-0593-6; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fields H.L., 2005, TXB PAIN, P125; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011; GELFAND DM, 1965, PSYCHOL REP, V17, P555, DOI 10.2466/pr0.1965.17.2.555; Goebel MU, 2002, FASEB J, V16, P1869, DOI 10.1096/fj.02-0389com; GRACELY RH, 1983, NATURE, V306, P264, DOI 10.1038/306264a0; Gundel H, 2008, PAIN, V137, P413, DOI 10.1016/j.pain.2007.10.003; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Haygarth John, 1801, IMAGINATION CAUSE CU; Jones AKP, 2004, EUR J PAIN, V8, P479, DOI 10.1016/j.ejpain.2003.11.017; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, J COGNITIVE NEUROSCI, V18, P1266, DOI 10.1162/jocn.2006.18.8.1266; Kalivas PW, 1999, ANN NY ACAD SCI, V877, P64, DOI 10.1111/j.1749-6632.1999.tb09261.x; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Lee MC, 2008, J NEUROSCI, V28, P11642, DOI 10.1523/JNEUROSCI.2638-08.2008; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; LIPMAN JJ, 1990, PSYCHOPHARMACOLOGY, V102, P112, DOI 10.1007/BF02245754; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lorenz R, 2005, BRAIN BEHAV IMMUN, V19, P283, DOI 10.1016/j.bbi.2005.03.010; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Morton DL, 2009, PAIN, V146, P194, DOI 10.1016/j.pain.2009.07.026; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Pollo A, 2009, PROG BRAIN RES, V175, P283, DOI 10.1016/S0079-6123(09)17520-9; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vase L, 2003, PAIN, V105, P17, DOI 10.1016/S0304-3959(03)00073-3; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wasan AD, 2006, PAIN MED, V7, P217, DOI 10.1111/j.1526-4637.2006.00154.x; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Zubieta JK, 2006, BRAIN BEHAV IMMUN, V20, P15, DOI 10.1016/j.bbi.2005.08.006; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	102	329	336	1	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1277	1283		10.1038/nm.2229	http://dx.doi.org/10.1038/nm.2229			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948533				2022-12-27	WOS:000283860100039
J	Galli, SJ; Tsai, M				Galli, Stephen J.; Tsai, Mindy			IgE and mast cells in allergic disease	NATURE MEDICINE			English	Review							FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; AIRWAY SMOOTH-MUSCLE; HUMAN INTESTINAL EPITHELIUM; HUMAN NEUTROPHILS EXPRESS; STRUCTURE-BASED DESIGN; LUNG DENDRITIC CELLS; IMMUNOGLOBULIN-E; TYROSINE KINASE; IN-VIVO	Immunoglobulin E (IgE) antibodies and mast cells have been so convincingly linked to the pathophysiology of anaphylaxis and other acute allergic reactions that it can be difficult to think of them in other contexts. However, a large body of evidence now suggests that both IgE and mast cells are also key drivers of the long-term pathophysiological changes and tissue remodeling associated with chronic allergic inflammation in asthma and other settings. Such potential roles include IgE-dependent regulation of mast-cell functions, actions of IgE that are largely independent of mast cells and roles of mast cells that do not directly involve IgE. In this review, we discuss findings supporting the conclusion that IgE and mast cells can have both interdependent and independent roles in the complex immune responses that manifest clinically as asthma and other allergic disorders.	[Galli, Stephen J.; Tsai, Mindy] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	US Public Health Service [AI23990, AI070813, CA72074]; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Galli lab and our collaborators and colleagues for their contributions to some of the work reviewed herein, apologize to the many contributors to this field whose work was not cited because of space limitations and acknowledge the support of US Public Health Service grants AI23990, AI070813 and CA72074 (to S.J.G.).	Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; Akin C, 2003, EXP HEMATOL, V31, P686, DOI 10.1016/S0301-472X(03)00112-7; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Beer F, 2007, IMMUNOL REV, V217, P96, DOI 10.1111/j.1600-065X.2007.00521.x; Bergmann RL, 1997, CLIN EXP ALLERGY, V27, P752, DOI 10.1046/j.1365-2222.1997.310899.x; Berin MC, 2006, ANN NY ACAD SCI, V1072, P253, DOI 10.1196/annals.1326.002; Bonnelykke K, 2010, J ALLERGY CLIN IMMUN, V126, P657, DOI 10.1016/j.jaci.2010.06.027; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Boyce JA, 2006, J ALLERGY CLIN IMMUN, V117, P1415, DOI 10.1016/j.jaci.2006.04.003; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Buku A, 2003, J MED CHEM, V46, P3008, DOI 10.1021/jm0204892; Buku A, 2008, CHEM BIOL DRUG DES, V72, P133, DOI 10.1111/j.1747-0285.2008.00684.x; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Campbell AM, 1998, AM J RESP CELL MOL, V19, P92, DOI 10.1165/ajrcmb.19.1.2648; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; Carroll NG, 2002, EUR RESPIR J, V19, P879, DOI 10.1183/09031936.02.00275802; Chang TW, 2006, J ALLERGY CLIN IMMUN, V117, P1203, DOI 10.1016/j.jaci.2006.04.005; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Cheung DS, 2010, J IMMUNOL, V185, P4983, DOI 10.4049/jimmunol.1002456; Coeffier M, 2005, ALLERGY, V60, P822, DOI 10.1111/j.1398-9995.2005.00782.x; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; CRAIG SS, 1995, ANAT RECORD, V242, P211, DOI 10.1002/ar.1092420210; Dahlin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020261; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; FURUICHI K, 1985, P NATL ACAD SCI USA, V82, P1522, DOI 10.1073/pnas.82.5.1522; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Ganguly S, 2007, J BIOL CHEM, V282, P32758, DOI 10.1074/jbc.M705950200; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gilfillan AM, 2011, ADV EXP MED BIOL, V716, P2, DOI 10.1007/978-1-4419-9533-9_1; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gonem S, 2011, CURR OPIN ALLERGY CL, V11, P381, DOI 10.1097/ACI.0b013e328348a8f9; Gotlib J, 2005, BLOOD, V106, P2865, DOI 10.1182/blood-2005-04-1568; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Groot Kormelink T, 2009, CLIN EXP ALLERGY, V39, P33, DOI 10.1111/j.1365-2222.2008.03135.x; HAINES KA, 1983, P NATL ACAD SCI-BIOL, V80, P3448, DOI 10.1073/pnas.80.11.3448; Hasegawa S, 1999, BLOOD, V93, P2543, DOI 10.1182/blood.V93.8.2543.408k14_2543_2551; Haselden BM, 1999, J EXP MED, V189, P1885, DOI 10.1084/jem.189.12.1885; Hirano M, 2007, NAT IMMUNOL, V8, P762, DOI 10.1038/ni1477; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; HO MK, 1982, J IMMUNOL, V128, P1221; Hofmann AM, 2010, DISCOV MED, V9, P79; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hsu C, 1996, IMMUNOL LETT, V52, P129, DOI 10.1016/0165-2478(96)02599-0; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Hua XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024947; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; ISHIZAKA K, 1966, J IMMUNOL, V97, P75; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Johansson S.G.O., 1967, NOBEL S, P193; Joseph M, 1997, EUR J IMMUNOL, V27, P2212, DOI 10.1002/eji.1830270914; Juurikivi A, 2005, ANN RHEUM DIS, V64, P1126, DOI 10.1136/ard.2004.029835; Kaplan AP, 2008, J ALLERGY CLIN IMMUN, V122, P569, DOI 10.1016/j.jaci.2008.07.006; Karagiannis SN, 2007, J IMMUNOL, V179, P2832, DOI 10.4049/jimmunol.179.5.2832; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kashiwakura JI, 2011, ADV EXP MED BIOL, V716, P29, DOI 10.1007/978-1-4419-9533-9_3; Kato A, 2009, J IMMUNOL, V182, P7233, DOI 10.4049/jimmunol.0801375; Kaur D, 2012, CHEST, V142, P76, DOI 10.1378/chest.11-1782; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim BE, 2012, ALLERGY ASTHMA IMMUN, V4, P12, DOI 10.4168/aair.2012.4.1.12; KleinJan A, 2000, EUR RESPIR J, V15, P491, DOI 10.1034/j.1399-3003.2000.15.11.x; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lantz CS, 1997, J IMMUNOL, V158, P2517; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Li HX, 2006, GASTROENTEROLOGY, V131, P47, DOI 10.1053/j.gastro.2006.03.044; Lima JO, 2000, J ALLERGY CLIN IMMUN, V106, P911, DOI 10.1067/mai.2000.110228; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; LIU FT, 1995, AM J PATHOL, V147, P1016; MacGlashan D, 2009, J ALLERGY CLIN IMMUN, V123, P114, DOI 10.1016/j.jaci.2008.10.053; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; MAEDA K, 1992, J IMMUNOL, V148, P2340; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Marone G, 2005, TRENDS IMMUNOL, V26, P25, DOI 10.1016/j.it.2004.10.010; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; Matsuda K, 2005, J ALLERGY CLIN IMMUN, V116, P1357, DOI 10.1016/j.jaci.2005.08.042; Maurer M, 2011, J ALLERGY CLIN IMMUN, V128, P202, DOI 10.1016/j.jaci.2011.04.038; Mayr SI, 2002, J IMMUNOL, V169, P2061, DOI 10.4049/jimmunol.169.4.2061; McDonnell JM, 1996, NAT STRUCT BIOL, V3, P419, DOI 10.1038/nsb0596-419; McDonnell JM, 1997, BIOCHEM SOC T, V25, P387, DOI 10.1042/bst0250387; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Moiseeva EP, 2011, ADV EXP MED BIOL, V716, P235, DOI 10.1007/978-1-4419-9533-9_13; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Nagai H, 2000, J ALLERGY CLIN IMMUN, V106, pS91, DOI 10.1067/mai.2000.106778; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Nakamura GR, 2002, P NATL ACAD SCI USA, V99, P1303, DOI 10.1073/pnas.022635599; Nakamura GR, 2001, BIOCHEMISTRY-US, V40, P9828, DOI 10.1021/bi0109360; Novak R, 2012, BBA-GEN SUBJECTS, V1820, P1383, DOI 10.1016/j.bbagen.2011.11.014; Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697; Olivera A, 2011, ADV EXP MED BIOL, V716, P123, DOI 10.1007/978-1-4419-9533-9_8; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Palaniyandi S, 2011, J IMMUNOL, V186, P3484, DOI 10.4049/jimmunol.1002146; Pelaia G, 2011, J ASTHMA ALLERGY, V4, P49, DOI 10.2147/JAA.S14520; Peng Z, 2007, CLIN EXP ALLERGY, V37, P1040, DOI 10.1111/j.1365-2222.2007.02741.x; PLATERZYBERK C, 1995, NAT MED, V1, P781, DOI 10.1038/nm0895-781; Platzer B, 2011, IMMUNOL LETT, V141, P36, DOI 10.1016/j.imlet.2011.08.004; Porcherie A, 2011, J EXP MED, V208, P2225, DOI 10.1084/jem.20110845; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Rafi A, 2010, ALLERGY ASTHMA PROC, V31, P76, DOI 10.2500/aap.2010.31.3304; Redhu NS, 2011, J ALLERGY CLIN IMMUN, V128, P892, DOI 10.1016/j.jaci.2011.06.045; Ring J, 2010, CHEM IMMUNOL ALLERGY, V95, P201, DOI 10.1159/000315953; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Rossi M, 2008, MOL IMMUNOL, V45, P226, DOI 10.1016/j.molimm.2007.04.020; Ryan JJ, 2007, CRIT REV IMMUNOL, V27, P15, DOI 10.1615/CritRevImmunol.v27.i1.20; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Saegusa J, 2009, AM J PATHOL, V174, P922, DOI 10.2353/ajpath.2009.080500; Sandomenico A, 2011, J PEPT SCI, V17, P604, DOI 10.1002/psc.1368; Sandomenico A, 2009, MOL IMMUNOL, V46, P3300, DOI 10.1016/j.molimm.2009.07.025; SATO S, 1994, EUR J IMMUNOL, V24, P216, DOI 10.1002/eji.1830240134; Sheinkopf LE, 2008, ALLERGY ASTHMA PROC, V29, P530, DOI 10.2500/aap.2008.29.3160; Sibilano R, 2011, J LEUKOCYTE BIOL, V90, P831, DOI 10.1189/jlb.1210651; Smetana K, 1999, J LEUKOCYTE BIOL, V66, P644, DOI 10.1002/jlb.66.4.644; Stamos J, 2004, STRUCTURE, V12, P1289, DOI 10.1016/j.str.2004.04.015; STANWORTH DR, 1993, ALLERGY, V48, P67, DOI 10.1111/j.1398-9995.1993.tb00687.x; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, P60, DOI 10.1016/j.jaci.2011.11.011; Szefler SJ, 2011, CURR OPIN IMMUNOL, V23, P801, DOI 10.1016/j.coi.2011.07.014; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; Tebib J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2740; Thornton CA, 2003, CLIN EXP ALLERGY, V33, P306, DOI 10.1046/j.1365-2222.2003.01614.x; TRUONG MJ, 1993, J EXP MED, V177, P243, DOI 10.1084/jem.177.1.243; TRUONG MJ, 1993, EUR J IMMUNOL, V23, P3230, DOI 10.1002/eji.1830231228; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; Tu YH, 2006, AM J PHYSIOL-GASTR L, V291, pG532, DOI 10.1152/ajpgi.00524.2005; van der Kleij H, 2010, J ALLERGY CLIN IMMUN, V125, P757, DOI 10.1016/j.jaci.2009.10.054; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Vouldoukis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018289; Vray B, 2004, GLYCOBIOLOGY, V14, P647, DOI 10.1093/glycob/cwh068; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Wang CY, 2003, VACCINE, V21, P1580, DOI 10.1016/S0264-410X(02)00732-6; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; WERSHIL BK, 1995, J IMMUNOL, V154, P1391; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Ying S, 2006, J ALLERGY CLIN IMMUN, V118, P1386, DOI 10.1016/j.jaci.2006.08.030; Yu LCH, 2003, AM J PHYSIOL-GASTR L, V285, pG223, DOI 10.1152/ajpgi.00445.2002; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	168	1091	1116	17	214	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					693	704		10.1038/nm.2755	http://dx.doi.org/10.1038/nm.2755			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561833	Green Accepted			2022-12-27	WOS:000303763500037
J	Osborn, O; Olefsky, JM				Osborn, Olivia; Olefsky, Jerrold M.			The cellular and signaling networks linking the immune system and metabolism in disease	NATURE MEDICINE			English	Review							INDUCED INSULIN-RESISTANCE; DIET-INDUCED OBESITY; TUMOR-NECROSIS-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE INFLAMMATION; TYPE-2 DIABETES-MELLITUS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; PPAR-GAMMA ACTIVATION; KAPPA-B; SKELETAL-MUSCLE	It is now recognized that obesity is driving the type 2 diabetes epidemic in Western countries. Obesity-associated chronic tissue inflammation is a key contributing factor to type 2 diabetes and cardiovascular disease, and a number of studies have clearly demonstrated that the immune system and metabolism are highly integrated. Recent advances in deciphering the various cellular and signaling networks that participate in linking the immune and metabolic systems together have contributed to understanding of the pathogenesis of metabolic diseases and may also inform new therapeutic strategies based on immunomodulation. Here we discuss how these various networks underlie the etiology of the inflammatory component of insulin resistance, with a particular focus on the central roles of macrophages in adipose tissue and liver.	[Osborn, Olivia; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	osborn, olivia/R-1460-2018	osborn, olivia/0000-0003-0516-7937				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Centers for Disease Control and Prevention, 2011, US NAT DIAB FACT SHE; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; FEINGOLD KR, 1989, J CLIN INVEST, V83, P1116, DOI 10.1172/JCI113991; Feng DR, 2011, DIABETES, V60, P2134, DOI 10.2337/db10-1411; Feral CC, 2008, DIABETES, V57, P1842, DOI 10.2337/db07-1751; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Frisdal E, 2011, J BIOL CHEM, V286, P30926, DOI 10.1074/jbc.M111.264325; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; GRUNFELD C, 1991, BIOTHERAPY, V3, P143, DOI 10.1007/BF02172087; Hanefeld M., 2011, 71 AM DIAB ASS SCI S; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HELLMAN B, 1963, ACTA PHYSIOL SCAND, V58, P255, DOI 10.1111/j.1748-1716.1963.tb02647.x; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirasaka K, 2007, DIABETES, V56, P2511, DOI 10.2337/db06-1768; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Hupfeld C.J., 2010, ENDOCRINOLOGY, V1; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Miller GD, 2011, SURG OBES RELAT DIS, V7, P618, DOI 10.1016/j.soard.2011.03.006; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pascual G., 2007, NOVART FDN SYMP, V286; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Sachithanandan N, 2011, DIABETES, V60, P2023, DOI 10.2337/db11-0259; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Shah R, 2009, DIABETES, V58, P2211, DOI 10.2337/db09-0256; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; SMITH MJH, 1980, J PHARM PHARMACOL, V32, P517, DOI 10.1111/j.2042-7158.1980.tb12985.x; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Surmi BK, 2010, AM J PHYSIOL-ENDOC M, V299, pE437, DOI 10.1152/ajpendo.00050.2010; TILG H, 1994, BLOOD, V83, P113; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zeyda M, 2010, INT J OBESITY, V34, P1684, DOI 10.1038/ijo.2010.103; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	168	1057	1098	13	233	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					363	374		10.1038/nm.2627	http://dx.doi.org/10.1038/nm.2627			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22395709				2022-12-27	WOS:000301264800035
J	Chen, F; Liu, ZG; Wu, WH; Rozo, C; Bowdridge, S; Millman, A; Van Rooijen, N; Urban, JF; Wynn, TA; Gause, WC				Chen, Fei; Liu, Zhugong; Wu, Wenhui; Rozo, Cristina; Bowdridge, Scott; Millman, Ariel; Van Rooijen, Nico; Urban, Joseph F., Jr.; Wynn, Thomas A.; Gause, William C.			An essential role for T(H)2-type responses in limiting acute tissue damage during experimental helminth infection	NATURE MEDICINE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; INDUCED LUNG INJURY; T-CELLS; INFLAMMATORY CELLS; IMMUNE-RESPONSES; GENE-EXPRESSION; TYPE-2 IMMUNITY; WOUND REPAIR; IN-VIVO; IL-4	Helminths induce potent T helper 2 (T(H)2)-type immune responses that can mediate worm expulsion, but the role of this response in controlling the acute tissue damage caused by migrating multicellular parasites through vital tissues remains uncertain. We used a helminth infection model in which parasitic nematode larvae migrate transiently through the lung, resulting in hemorrhage and inflammation. We found that IL-17 initially contributed to inflammation and lung damage, whereas subsequent IL-4 receptor (IL-4R) signaling reduced elevations in IL-17 mRNA levels, enhanced the expression of insulin-like growth factor 1 (IGF-1) and IL-10 and stimulated the development of M2 macrophages, all of which contributed to the rapid resolution of tissue damage. These studies indicate an essential role for T(H)2-type immune responses in mediating acute wound healing during helminth infection.	[Chen, Fei; Liu, Zhugong; Wu, Wenhui; Rozo, Cristina; Bowdridge, Scott; Millman, Ariel; Gause, William C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Chen, Fei; Liu, Zhugong; Wu, Wenhui; Rozo, Cristina; Bowdridge, Scott; Millman, Ariel; Gause, William C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Wynn, Thomas A.] NIAID, Parasit Dis Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Vrije Universiteit Amsterdam; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gause, WC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.	gausewc@umdnj.edu	Wynn, Thomas A/C-2797-2011; Wynn, Thomas A/AAO-3523-2021; Van Rooijen, Nico/Z-1578-2019	Wynn, Thomas A/0000-0002-7244-8731; Urban, Joseph/0000-0002-1590-8869	US National Institutes of Health [AI031678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066188, ZIAAI000829, R01AI031678] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants AI031678.	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Apewokin S, 2010, CYTOPATHOLOGY, V21, P345, DOI 10.1111/j.1365-2303.2010.00765.x; Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Bliss SK, 2003, J IMMUNOL, V171, P3142, DOI 10.4049/jimmunol.171.6.3142; Brunet LR, 1997, J IMMUNOL, V159, P777; Brunet LR, 1998, PARASITOL TODAY, V14, P422, DOI 10.1016/S0169-4758(98)01317-9; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cooper AM, 2009, EUR J IMMUNOL, V39, P649, DOI 10.1002/eji.200839090; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Enobe CS, 2006, PARASITE IMMUNOL, V28, P453, DOI 10.1111/j.1365-3024.2006.00892.x; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; GILLERY P, 1992, J CELL PHYSIOL, V152, P389, DOI 10.1002/jcp.1041520221; Girod N, 2003, INT J PARASITOL, V33, P71, DOI 10.1016/S0020-7519(02)00248-5; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; HERBERT DR, 2009, J EXP MED, V206, P2947, DOI DOI 10.1084/jem.20091268; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Kolosionek E, 2010, EXPERT REV ANTI-INFE, V8, P1467, DOI [10.1586/eri.10.124, 10.1586/ERI.10.124]; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Krzyzaniak M, 2011, SHOCK, V36, P24, DOI 10.1097/SHK.0b013e318212276b; Laan M, 1999, J IMMUNOL, V162, P2347; Lee JJ, 2005, CLIN EXP ALLERGY, V35, P986, DOI 10.1111/j.1365-2222.2005.02302.x; Li B, 2011, J CELL PHYSIOL, V226, P2398, DOI 10.1002/jcp.22577; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Marsland BJ, 2008, EUR J IMMUNOL, V38, P479, DOI 10.1002/eji.200737827; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McNeil KS, 2002, PARASITE IMMUNOL, V24, P15, DOI 10.1046/j.0141-9838.2001.00428.x; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; ROM WN, 1988, J CLIN INVEST, V82, P1685, DOI 10.1172/JCI113781; Sakamoto T, 2005, PATHOL INT, V55, P497, DOI 10.1111/j.1440-1827.2005.01859.x; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wynes MW, 2004, J LEUKOCYTE BIOL, V76, P1019, DOI 10.1189/jlb.0504288; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	56	313	318	1	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					260	266		10.1038/nm.2628	http://dx.doi.org/10.1038/nm.2628			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245779	Green Accepted			2022-12-27	WOS:000300140300040
J	Ntziachristos, P; Tsirigos, A; Van Vlierberghe, P; Nedjic, J; Trimarchi, T; Flaherty, MS; Ferres-Marco, D; da Ros, V; Tang, ZJ; Siegle, J; Asp, P; Hadler, M; Rigo, I; De Keersmaecker, K; Patel, J; Huynh, T; Utro, F; Poglio, S; Samon, JB; Paietta, E; Racevskis, J; Rowe, JM; Rabadan, R; Levine, RL; Brown, S; Pflumio, F; Dominguez, M; Ferrando, A; Aifantis, I				Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Van Vlierberghe, Pieter; Nedjic, Jelena; Trimarchi, Thomas; Flaherty, Maria Sol; Ferres-Marco, Dolors; da Ros, Vanina; Tang, Zuojian; Siegle, Jasmin; Asp, Patrik; Hadler, Michael; Rigo, Isaura; De Keersmaecker, Kim; Patel, Jay; Tien Huynh; Utro, Filippo; Poglio, Sandrine; Samon, Jeremy B.; Paietta, Elisabeth; Racevskis, Janis; Rowe, Jacob M.; Rabadan, Raul; Levine, Ross L.; Brown, Stuart; Pflumio, Francoise; Dominguez, Maria; Ferrando, Adolfo; Aifantis, Iannis			Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; NOTCH1; PRC2; EZH2; CONTEXT	T cell acute lymphoblastic leukemia (T-ALL) is an immature hematopoietic malignancy driven mainly by oncogenic activation of NOTCH1 signaling(1). In this study we report the presence of loss-of-function mutations and deletions of the EZH2 and SUZ12 genes, which encode crucial components of the Polycomb repressive complex 2 (PRC2)(2,3), in 25% of T-ALLs. To further study the role of PRC2 in T-ALL, we used NOTCH1-dependent mouse models of the disease, as well as human T-ALL samples, and combined locus-specific and global analysis of NOTCH1-driven epigenetic changes. These studies demonstrated that activation of NOTCH1 specifically induces loss of the repressive mark Lys27 trimethylation of histone 3 (H3K27me3)(4) by antagonizing the activity of PRC2. These studies suggest a tumor suppressor role for PRC2 in human leukemia and suggest a hitherto unrecognized dynamic interplay between oncogenic NOTCH1 and PRC2 function for the regulation of gene expression and cell transformation.	[Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10003 USA; [Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Asp, Patrik; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY USA; [Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Asp, Patrik; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY USA; [Tsirigos, Aristotelis; Tien Huynh; Utro, Filippo] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Van Vlierberghe, Pieter; Flaherty, Maria Sol; Hadler, Michael; Rigo, Isaura; Samon, Jeremy B.; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY USA; [Van Vlierberghe, Pieter; Samon, Jeremy B.; Ferrando, Adolfo] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Van Vlierberghe, Pieter; Samon, Jeremy B.; Ferrando, Adolfo] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Ferres-Marco, Dolors; da Ros, Vanina; Dominguez, Maria] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante, Spain; [Tang, Zuojian; Brown, Stuart] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Tang, Zuojian; Brown, Stuart] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [De Keersmaecker, Kim] Flanders Inst Biotechnol, Dept Mol & Dev Genet, Louvain, Belgium; [De Keersmaecker, Kim] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Patel, Jay; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Patel, Jay; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Poglio, Sandrine; Pflumio, Francoise] Inst Radiobiol Cellulaire & Mol, CEA, Unite Mixte Rech 967, Fontenay Aux Roses, France; [Poglio, Sandrine; Pflumio, Francoise] INSERM, U967, Fontenay Aux Roses, France; [Poglio, Sandrine; Pflumio, Francoise] Univ Paris Diderot, UMR 967, Fontenay Aux Roses, France; [Poglio, Sandrine; Pflumio, Francoise] Univ Paris Sud, UMR 967, Fontenay Aux Roses, France; [Paietta, Elisabeth; Racevskis, Janis] Montefiore Med Ctr N, Bronx, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel; [Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; International Business Machines (IBM); Columbia University; Columbia University; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); New York University; New York University; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Montefiore Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Columbia University	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10003 USA.	atsirigo@us.ibm.com; af2196@columbia.edu; iannis.aifantis@nyumc.org	Dominguez, Maria/G-2171-2014; De Keersmaecker, Kim/W-9702-2018; Pflumio, Francoise/E-2074-2017; Van Vlierberghe, Pieter/G-8894-2013; levine, ross/AAE-7658-2019; Patel, Jay/HDM-6251-2022; Rabadan, Raul/AAZ-7367-2020	Dominguez, Maria/0000-0002-3329-7862; De Keersmaecker, Kim/0000-0002-7420-9531; Van Vlierberghe, Pieter/0000-0001-9063-7205; Poglio, Sandrine/0000-0001-8783-0709; Rabadan, Raul/0000-0001-7946-9255; Utro, Filippo/0000-0003-3226-7642; Da Ros, Vanina Gabriela/0000-0003-2367-0042; Pflumio, Francoise/0000-0001-8995-596X; Tsirigos, Aristotelis/0000-0002-7512-8477	US National Institutes of Health National Cancer Institute [P30 CA016087-30, 5 P30CA16087-31]; Damon Runyon Cancer Research Foundation; US National Institutes of Health [RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655, RO1GM088847, R01CA120196, R01CA155743]; The Leukemia & Lymphoma Society; The V Foundation; American Cancer Society [RSG0806801]; Dana Foundation; Feinberg Lymphoma Pilot grant; Fund for Scientific Research of Flanders; US National Library of Medicine [1R01LM010140-01]; Eastern Cooperative Oncology Group tumor bank; Northeast Biodefense Center [U54-AI057158]; Stand Up To Cancer Innovative Research Award; Chemotherapy Foundation; Rally Across America Foundation; Swim Across America Foundation; Spanish Ministerio de Ciencia e Innovacion [BFU2009-09074, MEC-CONSOLIDER CSD2007-00023]; Generalitat Valenciana [PROMETEO2006/134]; EU [UE-HEALH-F2-2008-201666]; Institut du Cancer; Association Laurette Fugain; Ligue National Contre le Cancer; INSERM; CEA; StemPole; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA141399, U24CA114737, R01CA120196, R01CA155743, R01CA133379, R01CA105129, R01CA149655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); The V Foundation; American Cancer Society(American Cancer Society); Dana Foundation; Feinberg Lymphoma Pilot grant; Fund for Scientific Research of Flanders(FWO); US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Eastern Cooperative Oncology Group tumor bank; Northeast Biodefense Center; Stand Up To Cancer Innovative Research Award; Chemotherapy Foundation; Rally Across America Foundation; Swim Across America Foundation; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EU(European Commission); Institut du Cancer(Institut National du Cancer (INCA) France); Association Laurette Fugain; Ligue National Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); StemPole; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank R. Bonasio and D. Reinberg (Howard Hughes Medical Institute and NYU School of Medicine) for critical reading of the manuscript and Ezh2-specific antibody; C. Siebel (Genentech) for technical advice; and P. Ballerini, C. Deswartes, T. Leblanc and A. Baruchel (Services d'Hematologie Pediatrique, Hopital Trousseau and Hopital Robert Debre Saint-Louis, respectively) for providing primary human T-ALL samples. We thank M. Gialitakis, L. Parida and G. Stolovitzky for comments on the manuscript and J. Zavadil, B. Berrin and the NYU Genome Technology Center (supported in part by US National Institutes of Health National Cancer Institute P30 CA016087-30 grant) for expert genomic assistance. The NYU Flow Cytometry facility (supported in part by US National Institutes of Health National Cancer Institute grant 5 P30CA16087-31) for expert cell sorting. We also thank the NYU Histology Core (5P30CA16087-31) and the Transgenic Mouse Core (NYU Cancer Institute Center Grant (5P30CA16087-31). J.N. was supported by the Damon Runyon Cancer Research Foundation. I.A. was supported by the US National Institutes of Health (RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655 and RO1GM088847), The Leukemia & Lymphoma Society, The V Foundation, the American Cancer Society (RSG0806801) and the Dana Foundation. The Aifantis laboratory is also supported by a Feinberg Lymphoma Pilot grant. This study was also supported by the Fund for Scientific Research of Flanders (P.V.V. and K.D.K.); the US National Library of Medicine (1R01LM010140-01 to R.R.); the Eastern Cooperative Oncology Group tumor bank; a Northeast Biodefense Center American Recovery and Reinvestment Act award (U54-AI057158 to R.R.); the US National Institutes of Health (R01CA120196 and R01CA155743 to A.F.); the Stand Up To Cancer Innovative Research Award (A.F.), the Chemotherapy Foundation (I.A. and A.F.); the Rally Across America Foundation (A.F.) and the Swim Across America Foundation (A.F.). P.V.V. is an American Society of Hematology Scholar, and I.A. and A.F. are Leukemia & Lymphoma Society Scholars. M.D. is supported by grants from Spanish Ministerio de Ciencia e Innovacion (BFU2009-09074 and MEC-CONSOLIDER CSD2007-00023), Generalitat Valenciana (PROMETEO2006/134) and an EU Research Grant (UE-HEALH-F2-2008-201666). F.P. is supported by the Institut du Cancer, the Association Laurette Fugain, the Ligue National Contre le Cancer and also by INSERM, CEA and StemPole. S.P. is supported by a fellowship by the Institut du Cancer. I.A. is a Howard Hughes Medical Institute Early Career Scientist.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Natoli G, 2009, CURR OPIN DRUG DISC, V12, P607; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Paganin M, 2011, BLOOD REV, V25, P83, DOI 10.1016/j.blre.2010.09.004; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	32	370	380	0	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					298	303		10.1038/nm.2651	http://dx.doi.org/10.1038/nm.2651			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22237151	Green Accepted			2022-12-27	WOS:000300140300046
J	Sullivan, NJ; Hensley, L; Asiedu, C; Geisbert, TW; Stanley, D; Johnson, J; Honko, A; Olinger, G; Bailey, M; Geisbert, JB; Reimann, KA; Bao, S; Rao, S; Roederer, M; Jahrling, PB; Koup, RA; Nabel, GJ				Sullivan, Nancy J.; Hensley, Lisa; Asiedu, Clement; Geisbert, Thomas W.; Stanley, Daphne; Johnson, Joshua; Honko, Anna; Olinger, Gene; Bailey, Michael; Geisbert, Joan B.; Reimann, Keith A.; Bao, Saran; Rao, Srinivas; Roederer, Mario; Jahrling, Peter B.; Koup, Richard A.; Nabel, Gary J.			CD8(+) cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates	NATURE MEDICINE			English	Article							HEMORRHAGIC-FEVER; MARBURG VIRUS; INDUCTION; ANTIBODY	Vaccine-induced immunity to Ebola virus infection in nonhuman primates (NHPs) is marked by potent antigen-specific cellular and humoral immune responses(1,2); however, the immune mechanism of protection remains unknown. Here we define the immune basis of protection conferred by a highly protective recombinant adenovirus virus serotype 5 (rAd5) encoding Ebola virus glycoprotein (GP)(1,3) in NHPs. Passive transfer of high-titer polyclonal antibodies from vaccinated Ebola virus-immune cynomolgus macaques to naive macaques failed to confer protection against disease, suggesting a limited role of humoral immunity. In contrast, depletion of CD3(+) T cells in vivo after vaccination and immediately before challenge eliminated immunity in two vaccinated macaques, indicating a crucial requirement for T cells in this setting. The protective effect was mediated largely by CD8(+) cells, as depletion of CD8(+) cells in vivo using the cM-T807 monoclonal antibody (mAb), which does not affect CD4(+) T cell or humoral immune responses, abrogated protection in four out of five subjects. These findings indicate that CD8(+) cells have a major role in rAd5-GP-induced immune protection against Ebola virus infection in NHPs. Understanding the immunologic mechanism of Ebola virus protection will facilitate the development of vaccines for Ebola and related hemorrhagic fever viruses in humans.	[Sullivan, Nancy J.; Asiedu, Clement; Stanley, Daphne; Bailey, Michael; Bao, Saran; Rao, Srinivas; Roederer, Mario; Koup, Richard A.; Nabel, Gary J.] US Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD USA; [Hensley, Lisa; Geisbert, Thomas W.; Johnson, Joshua; Honko, Anna; Olinger, Gene; Geisbert, Joan B.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Reimann, Keith A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Jahrling, Peter B.] US Natl Inst Allergy & Infect Dis, Integrated Res Facil, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sullivan, NJ (corresponding author), US Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD USA.	nsullivan@nih.gov	Honko, Anna/H-9539-2019; Roederer, Mario/G-1887-2011	Honko, Anna/0000-0001-9165-148X; Johnson, Joshua/0000-0002-5677-3841; Hensley, Lisa/0000-0003-1188-4342; Olinger, Gene/0000-0001-7338-0292	National Center for Research Resource, US National Institutes of Health [R24RR016001]; US National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005001, ZIAAI005019, ZIAAI005079, ZIAAI005082, ZIAAI001025] Funding Source: NIH RePORTER	National Center for Research Resource, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Jeffers, T. Suhana, A. Tislerics and B. Hartman for help with manuscript preparation; M. Cichanowski for graphics; D. Braun, K. Daddario and C. Rice for technical and animal care assistance; S. Norris and M. Nason for assistance with statistical considerations; and K. Kenyon for editorial support. We thank D. Neville (US National Institute of Mental Health) for the generous gift of FN18-CRM9 immunotoxin. Reagent support was provided by the Nonhuman Primate Reagent Resource (grant number R24RR016001 from the National Center for Research Resource, US National Institutes of Health). Support for this work was provided by the Intramural Research Program of the US National Institutes of Health. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the US Army or the Department of Defense.	Chattopadhyay Pratip K, 2007, Methods Mol Biol, V374, P175; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Gupta M, 2004, J VIROL, V78, P958, DOI 10.1128/JVI.78.2.958-967.2004; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Jahrling PB, 1996, ARCH VIROL, P135; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Neville DM, 1996, J IMMUNOTHER, V19, P85, DOI 10.1097/00002371-199603000-00001; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037	20	162	167	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1128	U135		10.1038/nm.2447	http://dx.doi.org/10.1038/nm.2447			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857654				2022-12-27	WOS:000294605100034
J	Zhou, Q; Xiao, JM; Jiang, DW; Wang, RW; Vembaiyan, K; Wang, AX; Smith, CD; Xie, CH; Chen, WQ; Zhang, JQ; Tian, XX; Jones, PP; Zhong, XW; Guo, A; Chen, HY; Zhang, L; Zhu, WZ; Yang, DM; Li, XD; Chen, J; Gillis, AM; Duff, HJ; Cheng, HP; Feldman, AM; Song, LS; Fill, M; Back, TG; Chen, SRW				Zhou, Qiang; Xiao, Jianmin; Jiang, Dawei; Wang, Ruiwu; Vembaiyan, Kannan; Wang, Aixia; Smith, Chris D.; Xie, Cuihong; Chen, Wenqian; Zhang, Jingqun; Tian, Xixi; Jones, Peter P.; Zhong, Xiaowei; Guo, Ang; Chen, Haiyan; Zhang, Lin; Zhu, Weizhong; Yang, Dongmei; Li, Xiaodong; Chen, Ju; Gillis, Anne M.; Duff, Henry J.; Cheng, Heping; Feldman, Arthur M.; Song, Long-Sheng; Fill, Michael; Back, Thomas G.; Chen, S. R. Wayne			Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release	NATURE MEDICINE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; CARDIAC RYANODINE RECEPTOR; CONGESTIVE-HEART-FAILURE; BETA-BLOCKER THERAPY; IN MOUSE MODEL; MYOCARDIAL-INFARCTION; INTRACELLULAR CALCIUM; PURKINJE-FIBERS; SUDDEN-DEATH; MUSCLE	Carvedilol is one of the most effective beta blockers for preventing ventricular tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic benefits remain unclear. Spontaneous Ca2+ waves, also called store overload-induced Ca2+ release (SOICR), evoke ventricular tachyarrhythmias in individuals with heart failure. Here we show that carvedilol is the only beta blocker tested that effectively suppresses SOICR by directly reducing the open duration of the cardiac ryanodine receptor (RyR2). This unique anti-SOICR activity of carvedilol, combined with its beta-blocking activity, probably contributes to its favorable antiarrhythmic effect. To enable optimal titration of carvedilol's actions as a beta blocker and as a suppressor of SOICR separately, we developed a new SOICR-inhibiting, minimally beta-blocking carvedilol analog, VK-II-86. VK-II-86 prevented stress-induced ventricular tachyarrhythmias in RyR2-mutant mice and did so more effectively when combined with either of the selective beta blockers metoprolol or bisoprolol. Combining SOICR inhibition with optimal beta blockade has the potential to provide antiarrhythmic therapy that can be tailored to individual patients.	[Zhou, Qiang; Xiao, Jianmin; Jiang, Dawei; Wang, Ruiwu; Xie, Cuihong; Chen, Wenqian; Tian, Xixi; Jones, Peter P.; Zhong, Xiaowei; Zhang, Lin; Gillis, Anne M.; Duff, Henry J.; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Zhou, Qiang; Xie, Cuihong; Zhang, Jingqun; Chen, Haiyan; Fill, Michael; Chen, S. R. Wayne] Rush Univ, Med Ctr, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA; [Vembaiyan, Kannan; Wang, Aixia; Smith, Chris D.; Back, Thomas G.] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; [Guo, Ang; Song, Long-Sheng] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Zhu, Weizhong; Feldman, Arthur M.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA; [Yang, Dongmei; Cheng, Heping] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Li, Xiaodong; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Rush University; University of Calgary; University of Iowa; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	swchen@ucalgary.ca	cheng, heping/A-7299-2011; Chen, Ju/E-5579-2011; Guo, Ang/M-3549-2013; Chen, Haiyan/HGB-6216-2022; Jones, Peter P/G-2618-2013; Heping, Cheng/AAE-2680-2019; Song, Long-Sheng/D-5899-2012	Guo, Ang/0000-0002-5551-2279; Heping, Cheng/0000-0002-9604-6702; Jones, Pete/0000-0001-7977-1737; Song, Long-Sheng/0000-0002-6035-8106; Duff, Henry/0000-0001-9292-5411	Canadian Institutes of Health Research; US National Institutes of Health (NIH); Heart and Stroke Foundation of Alberta; US National Institute on Aging; Alberta Innovates-Health Solutions (AIHS); Heart and Stroke Foundation; King family; Libin Cardiovascular Institute of Alberta; Alberta Innovates [201001238] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210, R01HL090905, R01HL057832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111397] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Alberta; US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alberta Innovates-Health Solutions (AIHS); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); King family; Libin Cardiovascular Institute of Alberta; Alberta Innovates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Canadian Institutes of Health Research (S. R. W. C.), the US National Institutes of Health (NIH; S. R. W. C., L.-S.S., M. F. and A. M. F.), the Heart and Stroke Foundation of Alberta (A. M. G. and H.J.D.) and the Intramural Research Program of the US National Institute on Aging (D.Y. and H. Cheng). D.J., W. C. and X. T. were supported by Alberta Innovates-Health Solutions (AIHS) studentship awards, C. D. S. by an AIHS fellowship award, P.P.J. by an AIHS and Heart and Stroke Foundation fellowship award and H.J.D. and S. R. W. C. by AIHS scientist awards. We thank the King family and the Libin Cardiovascular Institute of Alberta for their donations and S. Pogwizd and S. Priori for critical reading of the manuscript.	Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Caron G, 1999, HELV CHIM ACTA, V82, P1211, DOI 10.1002/(SICI)1522-2675(19990804)82:8<1211::AID-HLCA1211>3.0.CO;2-K; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Cerrone M, 2007, CIRC RES, V101, P1039, DOI 10.1161/CIRCRESAHA.107.148064; Chen BY, 2009, J MOL CELL CARDIOL, V47, P706, DOI 10.1016/j.yjmcc.2009.07.007; Doze P, 2002, NEUROCHEM INT, V40, P145, DOI 10.1016/S0197-0186(01)00081-X; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; FUJIMAKI M, 1992, CHIRALITY, V4, P148, DOI 10.1002/chir.530040304; Greenberg Barry, 2004, Rev Cardiovasc Med, V5 Suppl 1, pS10; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Hjalmarson A, 2000, BASIC RES CARDIOL, V95, P41; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Hwang HS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P128, DOI 10.1161/CIRCEP.110.959916; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kamath GS, 2008, PROG CARDIOVASC DIS, V50, P439, DOI 10.1016/j.pcad.2007.12.001; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; KASS RS, 1982, BIOPHYS J, V38, P259, DOI 10.1016/S0006-3495(82)84557-8; Ko DT, 2004, ARCH INTERN MED, V164, P1389, DOI 10.1001/archinte.164.13.1389; Kukin ML, 1996, AM J CARDIOL, V77, P486, DOI 10.1016/S0002-9149(97)89342-3; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; McMurray J, 2005, J AM COLL CARDIOL, V45, P525, DOI 10.1016/j.jacc.2004.09.076; Miller Leslie W, 2003, Rev Cardiovasc Med, V4 Suppl 2, pS21; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; NEUGEBAUER G, 1987, J CARDIOVASC PHA S11, V10, P85; OHLSTEIN EH, 1993, P NATL ACAD SCI USA, V90, P6189, DOI 10.1073/pnas.90.13.6189; Okafor Chukwuka C, 2003, BMC Physiol, V3, P6, DOI 10.1186/1472-6793-3-6; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Remme WJ, 2010, CARDIOVASC DRUG THER, V24, P351, DOI 10.1007/s10557-010-6247-7; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; STAHL E, 1993, ARCH PHARM, V326, P529, DOI 10.1002/ardp.19933260907; STERN MD, 1983, J GEN PHYSIOL, V82, P119, DOI 10.1085/jgp.82.1.119; Stroe Alice F, 2004, Rev Cardiovasc Med, V5 Suppl 1, pS18; Tenero D, 2000, J CLIN PHARMACOL, V40, P844, DOI 10.1177/00912700022009576; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; VERMEULEN JT, 1994, CARDIOVASC RES, V28, P1547, DOI 10.1093/cvr/28.10.1547; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; WIER WG, 1983, P NATL ACAD SCI-BIOL, V80, P7367, DOI 10.1073/pnas.80.23.7367; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; YAO A, 2003, NATURE, V67, P83; YUE TL, 1992, J PHARMACOL EXP THER, V263, P92	53	163	169	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					1003	U126		10.1038/nm.2406	http://dx.doi.org/10.1038/nm.2406			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21743453	Green Accepted			2022-12-27	WOS:000293507400035
J	Lecoq, J; Parpaleix, A; Roussakis, E; Ducros, M; Houssen, YG; Vinogradov, SA; Charpak, S				Lecoq, Jerome; Parpaleix, Alexandre; Roussakis, Emmanuel; Ducros, Mathieu; Houssen, Yannick Goulam; Vinogradov, Sergei A.; Charpak, Serge			Simultaneous two-photon imaging of oxygen and blood flow in deep cerebral vessels	NATURE MEDICINE			English	Article							ERYTHROCYTE-ASSOCIATED TRANSIENTS; BRAIN-TISSUE; CAPILLARIES; MICROSCOPY; PO-2; PHOSPHORESCENCE; CONSUMPTION; ARTERIOLES; MODEL; PO2	Uncovering principles that regulate energy metabolism in the brain requires mapping of partial pressure of oxygen (PO2) and blood flow with high spatial and temporal resolution. Using two-photon phosphorescence lifetime microscopy (2PLM) and the oxygen probe PtP-C343, we show that PO2 can be accurately measured in the brain at depths up to 300 mm with micron-scale resolution. In addition, 2PLM allowed simultaneous measurements of blood flow and of PO2 in capillaries with less than one-second temporal resolution. Using this approach, we detected erythrocyte-associated transients (EATs) in oxygen in the rat olfactory bulb and showed the existence of diffusion-based arterio-venous shunts. Sensory stimulation evoked functional hyperemia, accompanied by an increase in PO2 in capillaries and by a biphasic PO2 response in the neuropil, consisting of an 'initial dip' and a rebound. 2PLM of PO2 opens new avenues for studies of brain metabolism and blood flow regulation.	[Lecoq, Jerome; Parpaleix, Alexandre; Ducros, Mathieu; Houssen, Yannick Goulam; Charpak, Serge] INSERM, U603, Paris, France; [Lecoq, Jerome; Parpaleix, Alexandre; Ducros, Mathieu; Houssen, Yannick Goulam; Charpak, Serge] CNRS, UMR 8154, Paris, France; [Lecoq, Jerome; Parpaleix, Alexandre; Ducros, Mathieu; Houssen, Yannick Goulam; Charpak, Serge] Univ Paris 05, Lab Neurophysiol & New Microscopies, Paris, France; [Roussakis, Emmanuel; Vinogradov, Sergei A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Charpak, S (corresponding author), INSERM, U603, Paris, France.	vinograd@mail.med.upenn.edu; serge.charpak@parisdescartes.fr	Ducros, Mathieu/Q-6663-2017; Charpak, Serge/M-9412-2017	Ducros, Mathieu/0000-0002-7625-036X; , Emmanouil/0000-0002-2824-2840; PARPALEIX, Alexandre/0000-0001-9007-3155	INSERM; CNRS; Region Ile de France (Sesame program); Fondation Bettancourt Schueller the Leducq Foundation; Human Frontier Science Program Organization; European Commission [LSHM-CT-2007-037765]; Fondation pour la Recherche Medicale; US National Institutes of Health [EB007279]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007279] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile de France (Sesame program)(Region Ile-de-France); Fondation Bettancourt Schueller the Leducq Foundation; Human Frontier Science Program Organization(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank V. De Sars and N. Chaari for technical assistance in the design of electronic circuits, G. Bouchery for her help in rat surgery, C. Pouzat for help with statistical analysis and L.E. Sinks for discussion of the phosphorescence microscopy data. Support was provided by INSERM, CNRS, the Region Ile de France (Sesame program), the Fondation Bettancourt Schueller the Leducq Foundation, the Human Frontier Science Program Organization, the European Commission FP6 (LSHM-CT-2007-037765), the Fondation pour la Recherche Medicale and the US National Institutes of Health (grant EB007279). Photophysical characterization of the probe was performed in the Ultrafast Optical Processes Laboratory at the University of Pennsylvania (US National Institutes of Health grant P41-RR001348).	Barker MC, 2007, AM J PHYSIOL-HEART C, V292, pH2540, DOI 10.1152/ajpheart.00915.2006; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; ELLSWORTH ML, 1990, AM J PHYSIOL, V258, pH1240, DOI 10.1152/ajpheart.1990.258.4.H1240; Estrada AD, 2008, OPT LETT, V33, P1038, DOI 10.1364/OL.33.001038; Finikova OS, 2008, CHEMPHYSCHEM, V9, P1673, DOI 10.1002/cphc.200800296; Finikova OS, 2007, J PHYS CHEM A, V111, P6977, DOI 10.1021/jp071586f; Golub AS, 2008, AM J PHYSIOL-HEART C, V294, pH2905, DOI 10.1152/ajpheart.01347.2007; Golub AS, 2005, AM J PHYSIOL-HEART C, V288, pH2735, DOI 10.1152/ajpheart.00711.2004; HELLUMS JD, 1977, MICROVASC RES, V13, P131, DOI 10.1016/0026-2862(77)90122-4; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lebedev AY, 2009, ACS APPL MATER INTER, V1, P1292, DOI 10.1021/am9001698; Lecoq J, 2009, J NEUROSCI, V29, P3067, DOI 10.1523/JNEUROSCI.6187-08.2009; Lecoq J, 2009, J NEUROSCI, V29, P1424, DOI 10.1523/JNEUROSCI.4817-08.2009; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Ndubuizu O, 2007, ANTIOXID REDOX SIGN, V9, P1207, DOI 10.1089/ars.2007.1634; Nwaigwe CI, 2003, ADV EXP MED BIOL, V530, P101; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Shepherd GM, 2008, NEURON, V58, P827, DOI 10.1016/j.neuron.2008.06.005; Sinks LE, 2010, J PHYS CHEM B, V114, P14373, DOI 10.1021/jp100353v; STEIN JC, 1993, AM J PHYSIOL, V265, pH537, DOI 10.1152/ajpheart.1993.265.2.H537; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tsai AG, 2005, AM J PHYSIOL-HEART C, V289, pH1777, DOI 10.1152/ajpheart.00503.2005; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Tsoukias NM, 2007, J THEOR BIOL, V248, P657, DOI 10.1016/j.jtbi.2007.06.012; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825	29	174	178	5	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					893	U262		10.1038/nm.2394	http://dx.doi.org/10.1038/nm.2394			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21642977	Green Accepted			2022-12-27	WOS:000292500800046
J	Kempf, T; Zarbock, A; Widera, C; Butz, S; Stadtmann, A; Rossaint, J; Bolomini-Vittori, M; Korf-Klingebiel, M; Napp, LC; Hansen, B; Kanwischer, A; Bavendiek, U; Beutel, G; Hapke, M; Sauer, MG; Laudanna, C; Hogg, N; Vestweber, D; Wollert, KC				Kempf, Tibor; Zarbock, Alexander; Widera, Christian; Butz, Stefan; Stadtmann, Anika; Rossaint, Jan; Bolomini-Vittori, Matteo; Korf-Klingebiel, Mortimer; Napp, L. Christian; Hansen, Birte; Kanwischer, Anna; Bavendiek, Udo; Beutel, Gernot; Hapke, Martin; Sauer, Martin G.; Laudanna, Carlo; Hogg, Nancy; Vestweber, Dietmar; Wollert, Kai C.			GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice	NATURE MEDICINE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; ACUTE CORONARY SYNDROME; INTERCELLULAR-ADHESION MOLECULE-1; ISCHEMIA-REPERFUSION INJURY; PREVENTS CARDIAC RUPTURE; TGF-BETA SUPERFAMILY; TARGETED DELETION; NEUTROPHIL ARREST; P-SELECTIN; LFA-1	Inflammatory cell recruitment after myocardial infarction needs to be tightly controlled to permit infarct healing while avoiding fatal complications such as cardiac rupture. Growth differentiation factor-15 (GDF-15), a transforming growth factor-beta (TGF-beta)-related cytokine, is induced in the infarcted heart of mice and humans. We show that coronary artery ligation in Gdf15-deficient mice led to enhanced recruitment of polymorphonuclear leukocytes (PMNs) into the infarcted myocardium and an increased incidence of cardiac rupture. Conversely, infusion of recombinant GDF-15 repressed PMN recruitment after myocardial infarction. In vitro, GDF-15 inhibited PMN adhesion, arrest under flow and transendothelial migration. Mechanistically, GDF-15 counteracted chemokine-triggered conformational activation and clustering of beta(2) integrins on PMNs by activating the small GTPase Cdc42 and inhibiting activation of the small GTPase Rap1. Intravital microscopy in vivo in Gdf15-deficient mice showed that Gdf-15 is required to prevent excessive chemokine-activated leukocyte arrest on the endothelium. Genetic ablation of beta(2) integrins in myeloid cells rescued the mortality of Gdf15-deficient mice after myocardial infarction. To our knowledge, GDF-15 is the first cytokine identified as an inhibitor of PMN recruitment by direct interference with chemokine signaling and integrin activation. Loss of this anti-inflammatory mechanism leads to fatal cardiac rupture after myocardial infarction.	[Kempf, Tibor; Widera, Christian; Korf-Klingebiel, Mortimer; Napp, L. Christian; Kanwischer, Anna; Wollert, Kai C.] Hannover Med Sch, Hans Borst Ctr Heart & Stem Cell Res, D-3000 Hannover, Germany; [Kempf, Tibor; Widera, Christian; Korf-Klingebiel, Mortimer; Napp, L. Christian; Hansen, Birte; Kanwischer, Anna; Bavendiek, Udo; Wollert, Kai C.] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Zarbock, Alexander; Butz, Stefan; Stadtmann, Anika; Rossaint, Jan; Vestweber, Dietmar] Univ Munster, Max Planck Inst Mol Biomed, Munster, Germany; [Zarbock, Alexander; Stadtmann, Anika; Rossaint, Jan] Univ Munster, Dept Anesthesiol & Crit Care Med, Munster, Germany; [Bolomini-Vittori, Matteo] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Beutel, Gernot] Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany; [Hapke, Martin; Sauer, Martin G.] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-3000 Hannover, Germany; [Hogg, Nancy] London Res Inst, London, England	Hannover Medical School; Hannover Medical School; Max Planck Society; University of Munster; University of Munster; University of Verona; Hannover Medical School; Hannover Medical School	Wollert, KC (corresponding author), Hannover Med Sch, Hans Borst Ctr Heart & Stem Cell Res, D-3000 Hannover, Germany.	wollert.kai@mh-hannover.de	Bolomini-Vittori, Matteo/Q-5659-2016; Napp, L. Christian/AAD-2498-2020; Kempf, Tibor/ABA-3167-2021	Bolomini-Vittori, Matteo/0000-0002-5762-0791; Kempf, Tibor/0000-0001-6901-8442; Vestweber, Dietmar/0000-0002-3517-732X; Napp, L. Christian/0000-0001-9945-0842	German Research Foundation [SFB 566, AZ 428/3-1, SFB 738]; Else Kroner Fresenius Foundation [2010_EKES.01]; Max Planck Society	German Research Foundation(German Research Foundation (DFG)); Else Kroner Fresenius Foundation; Max Planck Society(Max Planck Society)	K.C.W. was supported by the German Research Foundation (SFB 566), A.Z. by the German Research Foundation (AZ 428/3-1) and the Else Kroner Fresenius Foundation (2010_EKES.01), M. G. S. by the German Research Foundation (SFB 738) and D. V. by the Max Planck Society. We acknowledge A. Quint for expert technical assistance. We thank S.J. Lee (Johns Hopkins University) for providing the Gdf15-knockout mouse.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Baran KW, 2001, CIRCULATION, V104, P2778, DOI 10.1161/hc4801.100236; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bonaca MP, 2011, ARTERIOSCL THROM VAS, V31, P203, DOI 10.1161/ATVBAHA.110.213512; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Dirksen MT, 2007, CARDIOVASC RES, V74, P343, DOI 10.1016/j.cardiores.2007.01.014; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Giugliano RP, 2003, CIRCULATION, V108, P2828, DOI 10.1161/01.CIR.0000106684.71725.98; HAVERSTICK DM, 1991, J IMMUNOL, V146, P3306; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Ichihara S, 2002, CIRCULATION, V106, P2244, DOI 10.1161/01.CIR.0000033826.52681.37; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lum AFH, 2002, J BIOL CHEM, V277, P20660, DOI 10.1074/jbc.M202223200; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Palazzo AJ, 1998, AM J PHYSIOL-HEART C, V275, pH1865, DOI 10.1152/ajpheart.1998.275.5.H1865; Palazzo AJ, 1998, AM J PHYSIOL-HEART C, V275, pH2300, DOI 10.1152/ajpheart.1998.275.6.H2300; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; van den Bome SWM, 2009, CARDIOVASC PATHOL, V18, P37, DOI 10.1016/j.carpath.2007.12.012; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wehrens XHT, 2004, INT J CARDIOL, V95, P285, DOI 10.1016/j.ijcard.2003.06.006; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	52	335	353	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					581	U101		10.1038/nm.2354	http://dx.doi.org/10.1038/nm.2354			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21516086				2022-12-27	WOS:000290250400034
J	Good, MF; Engwerda, C				Good, Michael F.; Engwerda, Christian			Arming T cells to halt malaria	NATURE MEDICINE			English	Editorial Material							PLASMODIUM-YOELII; MEDIATED-IMMUNITY; PROTECTION; SPOROZOITES; ANTIBODIES; INFECTION; MICE		[Good, Michael F.] Griffith Univ, Gold Coast, Qld, Australia; [Engwerda, Christian] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Griffith University; QIMR Berghofer Medical Research Institute	Good, MF (corresponding author), Griffith Univ, Gold Coast, Qld, Australia.	Michael.Good@griffith.edu.au; Christian.Engwerda@qimr.edu.au	Engwerda, Christian/I-3072-2015	Engwerda, Christian/0000-0003-2813-4804				BRAKE DA, 1988, J IMMUNOL, V140, P1989; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Elliott SR, 2005, INFECT IMMUN, V73, P2478, DOI 10.1128/IAI.73.4.2478-2485.2005; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; JAYAWARDENA AN, 1982, J IMMUNOL, V129, P377; MOGIL RJ, 1987, J IMMUNOL, V138, P1933; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; van der Heyde HC, 2006, INFECT IMMUN, V74, P2717, DOI 10.1128/IAI.74.5.2717-2725.2006; VINETZ JM, 1990, J IMMUNOL, V144, P1069; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	14	20	20	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					49	51		10.1038/nm0111-49	http://dx.doi.org/10.1038/nm0111-49			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21217684	Bronze			2022-12-27	WOS:000285994000035
J	Medici, D; Shore, EM; Lounev, VY; Kaplan, FS; Kalluri, R; Olsen, BR				Medici, Damian; Shore, Eileen M.; Lounev, Vitali Y.; Kaplan, Frederick S.; Kalluri, Raghu; Olsen, Bjorn R.			Conversion of vascular endothelial cells into multipotent stem-like cells	NATURE MEDICINE			English	Article							TO-MESENCHYMAL TRANSITION; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; GROWTH-FACTOR-BETA; ATRIOVENTRICULAR CUSHION TRANSFORMATION; CARDIAC FIBROSIS; PROGENITOR CELLS; EMBRYONIC HEART; BMP RECEPTOR; SKELETOGENESIS; MOUSE	Mesenchymal stem cells can give rise to several cell types, but varying results depending on isolation methods and tissue source have led to controversies about their usefulness in clinical medicine. Here we show that vascular endothelial cells can transform into multipotent stem-like cells by an activin-like kinase-2 (ALK2) receptor-dependent mechanism. In lesions from individuals with fibrodysplasia ossificans progressiva (FOP), a disease in which heterotopic ossification occurs as a result of activating ALK2 mutations, or from transgenic mice expressing constitutively active ALK2, chondrocytes and osteoblasts expressed endothelial markers. Lineage tracing of heterotopic ossification in mice using a Tie2-Cre construct also suggested an endothelial origin of these cell types. Expression of constitutively active ALK2 in endothelial cells caused endothelial-to-mesenchymal transition and acquisition of a stem cell-like phenotype. Similar results were obtained by treatment of untransfected endothelial cells with the ligands transforming growth factor-beta 2 (TGF-beta 2) or bone morphogenetic protein-4 (BMP4) in an ALK2-dependent manner. These stem-like cells could be triggered to differentiate into osteoblasts, chondrocytes or adipocytes. We suggest that conversion of endothelial cells to stem-like cells may provide a new approach to tissue engineering. (C) 2010 Nature America, Inc. All rights reserved.	[Medici, Damian; Kalluri, Raghu] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Matrix Biol, Sch Med,Dept Med, Boston, MA 02215 USA; [Shore, Eileen M.; Lounev, Vitali Y.; Kaplan, Frederick S.] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Shore, Eileen M.; Lounev, Vitali Y.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Shore, Eileen M.; Lounev, Vitali Y.; Kaplan, Frederick S.] Univ Penn, Sch Med, Ctr Res Fibrodysplasia Ossificans Progressiva & R, Philadelphia, PA 19104 USA; [Kaplan, Frederick S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Olsen, Bjorn R.] Harvard Univ, Sch Dent, Dept Dev Biol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Harvard University	Medici, D (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Matrix Biol, Sch Med,Dept Med, Boston, MA 02215 USA.	dmedici@bidmc.harvard.edu; bjorn_olsen@hms.harvard.edu	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	US National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Xu for technical assistance, J. Bischoff (Children's Hospital Boston) for providing primary cultures of human endothelial cells, A. Maidment for X-rays and Y. Mishina (University of Michigan) for providing caALK2-transgenic mice. We also thank E. Hay (Harvard Medical School) for human corneal fibroblasts. This work was supported by grants from the US National Institutes of Health to B.R.O., R. K., F. S. K. and E. M. S. and to the University of Pennsylvania Vector Core. Additional support was from the International Fibrodysplasia Ossificans Progressiva Association, the Ian Cali and the Weldon Family Endowments, the Penn Center for Musculoskeletal Disorders, the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine and the Rita Allen Foundation.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; ILIZAROV GA, 1988, B HOSP JOINT DIS ORT, V48, P1; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaplan FS, 2008, J BONE MINER METAB, V26, P521, DOI 10.1007/s00774-008-0879-8; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Karhausen J, 2005, CELL CYCLE, V4, P256; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Lai YT, 2000, DEV BIOL, V222, P1, DOI 10.1006/dbio.2000.9698; Lee JG, 2006, EXP EYE RES, V83, P1309, DOI 10.1016/j.exer.2006.04.007; Lewinson D, 2001, HISTOCHEM CELL BIOL, V116, P381, DOI 10.1007/s004180100331; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315; Mironov V., 1995, ANN BIOMED ENG, V23; Okagawa H, 2007, DEV BIOL, V306, P179, DOI 10.1016/j.ydbio.2007.03.015; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	38	538	563	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1400	U80		10.1038/nm.2252	http://dx.doi.org/10.1038/nm.2252			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102460	Green Accepted			2022-12-27	WOS:000285048900033
J	Ren, K; Dubner, R				Ren, Ke; Dubner, Ronald			Interactions between the immune and nervous systems in pain	NATURE MEDICINE			English	Review							DORSAL-ROOT GANGLIA; SATELLITE GLIAL-CELLS; PROINFLAMMATORY CYTOKINE EXPRESSION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIPHERAL TISSUE INFLAMMATION; MICROGLIAL CATHEPSIN-S; SPINAL-CORD; NEUROPATHIC PAIN; SCIATIC-NERVE; MECHANICAL ALLODYNIA	Immune cells and glia interact with neurons to alter pain sensitivity and to mediate the transition from acute to chronic pain. In response to injury, resident immune cells are activated and blood-borne immune cells are recruited to the site of injury. Immune cells not only contribute to immune protection but also initiate the sensitization of peripheral nociceptors. Through the synthesis and release of inflammatory mediators and interactions with neurotransmitters and their receptors, the immune cells, glia and neurons form an integrated network that coordinates immune responses and modulates the excitability of pain pathways. The immune system also reduces sensitization by producing immune-derived analgesic and anti-inflammatory or proresolution agents. A greater understanding of the role of the immune system in pain processing and modulation reveals potential targets for analgesic drug development and new therapeutic opportunities for managing chronic pain.	[Ren, Ke] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ren, K (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA.	kren@umaryland.edu			US National Institutes of Health [R01-DE11964, R01-NS060735, R01-NS059028]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059028, R01NS060735] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors' work is supported by US National Institutes of Health grants R01-DE11964, R01-NS060735 and R01-NS059028.	Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; BRENNAN PC, 1994, J MANIP PHYSIOL THER, V17, P219; Bruck W, 1996, J NEUROSCI RES, V46, P477; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chacur M, 2009, EUR J PAIN, V13, P915, DOI 10.1016/j.ejpain.2008.11.008; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; Chiang CY, 2007, J NEUROSCI, V27, P9068, DOI 10.1523/JNEUROSCI.2260-07.2007; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Clark JD, 2006, ANESTHESIOLOGY, V104, P1274, DOI 10.1097/00000542-200606000-00024; Constantinescu CS, 2001, CYTOKINE, V13, P244, DOI 10.1006/cyto.2000.0818; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cui JG, 2000, PAIN, V88, P239, DOI 10.1016/S0304-3959(00)00331-6; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Deruddre S, 2010, BRAIN BEHAV IMMUN, V24, P652, DOI 10.1016/j.bbi.2010.01.013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Dublin P, 2007, BRAIN BEHAV IMMUN, V21, P592, DOI 10.1016/j.bbi.2006.11.011; Durham PL., 2010, OPEN PAIN J, V3, P3, DOI 10.2174/1876386301003010003; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; Feng QX, 2010, NEUROSCIENCE, V167, P501, DOI 10.1016/j.neuroscience.2010.02.005; Folgueras AR, 2009, P NATL ACAD SCI USA, V106, P16451, DOI 10.1073/pnas.0908507106; Fu ES, 2010, PAIN, V148, P509, DOI 10.1016/j.pain.2010.01.001; Fu KY, 2000, NEUROSCIENCE, V101, P1127, DOI 10.1016/S0306-4522(00)00376-6; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; GARRISON CJ, 1994, EXP NEUROL, V129, P237, DOI 10.1006/exnr.1994.1165; GILMANSACHS A, 1989, HEADACHE, V29, P290, DOI 10.1111/j.1526-4610.1989.hed2905290.x; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Guerrero ATG, 2008, J LEUKOCYTE BIOL, V83, P122, DOI 10.1189/jlb.0207123; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; Hemley SJ, 2009, J NEUROSURG-SPINE, V11, P696, DOI 10.3171/2009.6.SPINE08564; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Hua S, 2010, TRENDS PHARMACOL SCI, V31, P427, DOI 10.1016/j.tips.2010.05.008; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Hutchinson MR, 2009, BRAIN BEHAV IMMUN, V23, P240, DOI 10.1016/j.bbi.2008.09.012; Ikeda H, 2007, EUR J NEUROSCI, V25, P1297, DOI 10.1111/j.1460-9568.2007.05386.x; Jang JH, 2010, PAIN, V148, P343, DOI 10.1016/j.pain.2009.11.021; Jessop DS, 2010, ANN NY ACAD SCI, V1193, P117, DOI 10.1111/j.1749-6632.2009.05294.x; Johnston IN, 2004, J NEUROSCI, V24, P7353, DOI 10.1523/JNEUROSCI.1850-04.2004; Jung H, 2008, J NEUROCHEM, V104, P254, DOI 10.1111/j.1471-4159.2007.04969.x; Kaufmann A, 2005, J BIOL CHEM, V280, P32459, DOI 10.1074/jbc.M505301200; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kramer HH, 2009, NEUROBIOL DIS, V35, P177, DOI 10.1016/j.nbd.2008.11.002; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Ledda M, 2009, NEUROSCIENCE, V164, P1538, DOI 10.1016/j.neuroscience.2009.09.038; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Levin ME, 2008, PAIN, V137, P182, DOI 10.1016/j.pain.2007.11.005; LEVINE JD, 1985, J NEUROSCI, V5, P3025; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Li M, 2007, EUR J NEUROSCI, V26, P3486, DOI 10.1111/j.1460-9568.2007.05971.x; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Lu PM, 2009, LIFE SCI, V85, P450, DOI 10.1016/j.lfs.2009.07.009; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mitchell K, 2009, NEUROSCIENCE, V158, P885, DOI 10.1016/j.neuroscience.2008.10.047; Mitchell K, 2008, PAIN, V134, P216, DOI 10.1016/j.pain.2007.10.024; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Molander C, 1997, BRAIN RES, V747, P122, DOI 10.1016/S0006-8993(96)01230-9; Nie H, 2009, J NEUROPHYSIOL, V101, P2041, DOI 10.1152/jn.91138.2008; Oka Y, 2007, NEUROSCIENCE, V145, P530, DOI 10.1016/j.neuroscience.2006.10.055; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; Orhan CE, 2010, NEUROSCI LETT, V481, P17, DOI 10.1016/j.neulet.2010.06.039; Ottosson A, 1997, CEPHALALGIA, V17, P166, DOI 10.1046/j.1468-2982.1997.1703166.x; PERRETTI M, 1993, IMMUNOLOGY, V80, P73; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Ren K, 2008, CURR OPIN ANESTHESIO, V21, P570, DOI 10.1097/ACO.0b013e32830edbdf; Ren K, 2010, JPN DENT SCI REV, V46, P86, DOI 10.1016/j.jdsr.2009.10.005; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Roberts J, 2009, EUR J NEUROSCI, V30, P229, DOI 10.1111/j.1460-9568.2009.06813.x; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Rutkowski MD, 2000, PHYSIOL BEHAV, V71, P225, DOI 10.1016/S0031-9384(00)00333-4; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Soderquist RG, 2010, PHARM RES-DORDR, V27, P841, DOI 10.1007/s11095-010-0077-y; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Sung BK, 2003, J NEUROSCI, V23, P2899; Suzuki A, 2004, BIOL PHARM BULL, V27, P1891, DOI 10.1248/bpb.27.1891; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; Tchivileva IE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-13; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Ting E, 2008, BRIT J PHARMACOL, V153, P1043, DOI 10.1038/sj.bjp.0707640; Torres R, 2009, ANN RHEUM DIS, V68, P1602, DOI 10.1136/ard.2009.109355; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Twining CM, 2005, J PAIN, V6, P174, DOI 10.1016/j.jpain.2004.11.011; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Verri WA, 2006, P NATL ACAD SCI USA, V103, P9721, DOI 10.1073/pnas.0603286103; Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008; Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7; Weyerbacher Amanda R, 2010, Pain, V148, P237, DOI 10.1016/j.pain.2009.11.003; Willemen HLDM, 2010, PAIN, V150, P550, DOI 10.1016/j.pain.2010.06.015; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Xie W, 2009, NEUROSCIENCE, V160, P847, DOI 10.1016/j.neuroscience.2009.03.016; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	148	542	569	2	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1267	1276		10.1038/nm.2234	http://dx.doi.org/10.1038/nm.2234			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948535	Green Accepted			2022-12-27	WOS:000283860100038
J	Strober, W				Strober, Warren			Gut microbes: friends or fiends?	NATURE MEDICINE			English	Editorial Material							INFLAMMATORY BOWEL DISEASES; IMMUNE-SYSTEM; T-CELLS; MICROFLORA		US Natl Inst Allergy & Infect Dis, Mucosal Immun Sect, Host Def Lab, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), US Natl Inst Allergy & Infect Dis, Mucosal Immun Sect, Host Def Lab, Bethesda, MD USA.	wstrober@niaid.nih.gov			Intramural NIH HHS [Z01 AI000354-25] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000432, ZIAAI000354] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725	14	17	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1195	1197		10.1038/nm1110-1195	http://dx.doi.org/10.1038/nm1110-1195			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052070	Green Accepted			2022-12-27	WOS:000283860100023
J	Murray, KC; Nakae, A; Stephens, MJ; Rank, M; D'Amico, J; Harvey, PJ; Li, XL; Harris, RLW; Ballou, EW; Anelli, R; Heckman, CJ; Mashimo, T; Vavrek, R; Sanelli, L; Gorassini, MA; Bennett, DJ; Fouad, K				Murray, Katherine C.; Nakae, Aya; Stephens, Marilee J.; Rank, Michelle; D'Amico, Jessica; Harvey, Philip J.; Li, Xiaole; Harris, R. Luke W.; Ballou, Edward W.; Anelli, Roberta; Heckman, Charles J.; Mashimo, Takashi; Vavrek, Romana; Sanelli, Leo; Gorassini, Monica A.; Bennett, David J.; Fouad, Karim			Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors	NATURE MEDICINE			English	Article							PERSISTENT INWARD CURRENTS; PLATEAU POTENTIALS; POSTSYNAPTIC POTENTIALS; SIGNAL-TRANSDUCTION; CALCIUM CURRENTS; MUSCLE SPASMS; RATS; 5-HYDROXYTRYPTAMINE; SPASTICITY; TURTLE	Muscle paralysis after spinal cord injury is partly caused by a loss of brainstem-derived serotonin (5-HT), which normally maintains motoneuron excitability by regulating crucial persistent calcium currents. Here we examine how over time motoneurons compensate for lost 5-HT to regain excitability. We find that, months after a spinal transection in rats, changes in post-transcriptional editing of 5-HT2C receptor mRNA lead to increased expression of 5-HT2C receptor isoforms that are spontaneously active (constitutively active) without 5-HT. Such constitutive receptor activity restores large persistent calcium currents in motoneurons in the absence of 5-HT. We show that this helps motoneurons recover their ability to produce sustained muscle contractions and ultimately enables recovery of motor functions such as locomotion. However, without regulation from the brain, these sustained contractions can also cause debilitating muscle spasms. Accordingly, blocking constitutively active 5-HT2C receptors with SB206553 or cyproheptadine, in both rats and humans, largely eliminates these calcium currents and muscle spasms, providing a new rationale for antispastic drug therapy.	[Murray, Katherine C.; Stephens, Marilee J.; Rank, Michelle; Harvey, Philip J.; Li, Xiaole; Harris, R. Luke W.; Vavrek, Romana; Sanelli, Leo; Bennett, David J.; Fouad, Karim] Univ Alberta, Ctr Neurosci, Fac Rehabil Med, Edmonton, AB, Canada; [Nakae, Aya; Mashimo, Takashi] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Osaka, Japan; [D'Amico, Jessica; Anelli, Roberta; Gorassini, Monica A.] Univ Alberta, Fac Med, Ctr Neurosci, Edmonton, AB, Canada; [Heckman, Charles J.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA	University of Alberta; Osaka University; University of Alberta; Northwestern University	Bennett, DJ (corresponding author), Univ Alberta, Ctr Neurosci, Fac Rehabil Med, Edmonton, AB, Canada.	bennettd@ualberta.ca	Rank, Michelle/AAQ-2281-2020; RANK, MICHELLE/G-8293-2013	Rank, Michelle/0000-0002-8547-0321; D'Amico, Jessica/0000-0002-3487-0712; Bennett, David/0000-0001-7838-7573; Heckman, CJ/0000-0002-1324-7278; Fouad, Karim/0000-0003-3654-7852	Alberta Heritage Foundation; Canadian Institutes of Health Research; US National Institutes of Health [NS47567, NS48170]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048170, R01NS047567] Funding Source: NIH RePORTER	Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to F. Geddes, T. Tanaka, K. Miyake, G. Van Patten, J. Nevett-Duchcherer, G. Funk, M. Finlay and L. Hahn for assistance. This research was supported by the Alberta Heritage Foundation, Canadian Institutes of Health Research and the US National Institutes of Health (NS47567 and NS48170).	Ashby P, 1987, HDB SPINAL CORD, P119; BAKER LL, 1987, BRAIN RES, V420, P340, DOI 10.1016/0006-8993(87)91255-8; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; BARBEAU H, 1982, J NEUROL NEUROSUR PS, V45, P923, DOI 10.1136/jnnp.45.10.923; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Berg KA, 2008, J PHARMACOL EXP THER, V324, P1084, DOI 10.1124/jpet.107.131524; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; BROWNSTONE RM, 1994, EXP BRAIN RES, V102, P34; Button DC, 2008, J PHYSIOL-LONDON, V586, P529, DOI 10.1113/jphysiol.2007.141499; Carlin KP, 2000, EUR J NEUROSCI, V12, P1624, DOI 10.1046/j.1460-9568.2000.00050.x; CARLSSON A, 1963, EXPERIENTIA, V19, P359, DOI 10.1007/BF02152316; Chanrion B, 2008, MOL PHARMACOL, V73, P748, DOI 10.1124/mol.107.041574; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; DAVIDOFF RA, 1985, ANN NEUROL, V17, P107, DOI 10.1002/ana.410170202; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Gorassini MA, 2009, J NEUROPHYSIOL, V101, P969, DOI 10.1152/jn.91131.2008; Gurevich I, 2002, J NEUROSCI, V22, P10529; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1141, DOI 10.1152/jn.00335.2005; Hayashi Y, 2010, EXP NEUROL, V221, P68, DOI 10.1016/j.expneurol.2009.10.003; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Holohean AM, 2004, BRIT J PHARMACOL, V143, P351, DOI 10.1038/sj.bjp.0705935; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hultborn H, 2003, J PHYSIOL-LONDON, V552, P945, DOI 10.1113/jphysiol.2003.050971; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P609, DOI 10.1016/S0028-3908(97)00038-5; Kennett GA, 1996, BRIT J PHARMACOL, V117, P427, DOI 10.1111/j.1476-5381.1996.tb15208.x; Knight AR, 2004, N-S ARCH PHARMACOL, V370, P114, DOI 10.1007/s00210-004-0951-4; KUHN RA, 1948, B J HOPKINS HOSP, V84, P43; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; McGrew L, 2004, MOL PHARMACOL, V65, P252, DOI 10.1124/mol.65.1.252; Mejia-Gervacio S, 2004, NEUROSCIENCE, V123, P123, DOI 10.1016/j.neuroscience.2003.08.049; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Nakae A, 2008, NEUROSCI RES, V60, P228, DOI 10.1016/j.neures.2007.10.004; NEWTON BW, 1988, BRAIN RES BULL, V20, P349, DOI 10.1016/0361-9230(88)90064-0; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Norton JA, 2008, BRAIN, V131, P1478, DOI 10.1093/brain/awn050; Perrier JF, 2000, J PHYSIOL-LONDON, V528, P107, DOI 10.1111/j.1469-7793.2000.t01-1-00107.x; Perrier JF, 2005, J NEUROSCI, V25, P7993, DOI 10.1523/JNEUROSCI.1957-05.2005; Perrier JF, 2003, J NEUROPHYSIOL, V89, P954, DOI 10.1152/jn.00753.2002; Rank MM, 2007, J NEUROPHYSIOL, V97, P3166, DOI 10.1152/jn.01168.2006; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V53, P1345, DOI 10.1152/jn.1985.53.6.1345; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Ung RV, 2008, EUR J NEUROSCI, V28, P2231, DOI 10.1111/j.1460-9568.2008.06508.x; WAINBERG M, 1990, J NEUROL NEUROSUR PS, V53, P754, DOI 10.1136/jnnp.53.9.754; WALLIS DI, 1993, NEUROPHARMACOLOGY, V32, P73, DOI 10.1016/0028-3908(93)90132-M; WESTPHAL RS, 1994, MOL PHARMACOL, V46, P937	60	264	273	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					694	U99		10.1038/nm.2160	http://dx.doi.org/10.1038/nm.2160			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20512126	Green Accepted			2022-12-27	WOS:000278394200036
J	Aikawa, Y; Katsumoto, T; Zhang, P; Shima, H; Shino, M; Terui, K; Ito, E; Ohno, H; Stanley, ER; Singh, H; Tenen, DG; Kitabayashi, I				Aikawa, Yukiko; Katsumoto, Takuo; Zhang, Pu; Shima, Haruko; Shino, Mika; Terui, Kiminori; Ito, Etsuro; Ohno, Hiroaki; Stanley, E. Richard; Singh, Harinder; Tenen, Daniel G.; Kitabayashi, Issay			PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; ACUTE MYELOBLASTIC-LEUKEMIA; ZINC-FINGER PROTEIN; BONE-MARROW-CELLS; C-FMS; FACTOR-RECEPTOR; BINDING-PROTEIN; EXPRESSION; GENE	Leukemias and other cancers possess self-renewing stem cells that help to maintain the cancer(1,2). Cancer stem cell eradication is thought to be crucial for successful anticancer therapy. Using an acute myeloid leukemia (AML) model induced by the leukemia-associated monocytic leukemia zinc finger (MOZ)-TIF2 fusion protein, we show here that AML can be cured by the ablation of leukemia stem cells. The MOZ fusion proteins MOZ-TIF2 and MOZ-CBP interacted with the transcription factor PU.1 to stimulate the expression of macrophage colony-stimulating factor receptor (CSF1R, also known as M-CSFR, c-FMS or CD115). Studies using PU.1-deficient mice showed that PU.1 is essential for the ability of MOZ-TIF2 to establish and maintain AML stem cells. Cells expressing high amounts of CSF1R (CSF1R(high) cells), but not those expressing low amounts of CSF1R (CSF1R(low) cells), showed potent leukemia-initiating activity. Using transgenic mice expressing a drug-inducible suicide gene controlled by the CSF1R promoter, we cured AML by ablation of CSF1R(high) cells. Moreover, induction of AML was suppressed in CSF1R-deficient mice and CSF1R inhibitors slowed the progression of MOZ-TIF2-induced leukemia. Thus, in this subtype of AML, leukemia stem cells are contained within the CSF1R(high) cell population, and we suggest that targeting of PU.1-mediated upregulation of CSF1R expression might be a useful therapeutic approach.	[Aikawa, Yukiko; Katsumoto, Takuo; Shima, Haruko; Shino, Mika; Kitabayashi, Issay] Natl Canc Ctr, Div Mol Oncol, Res Inst, Chuo Ku, Tokyo, Japan; [Zhang, Pu; Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA USA; [Terui, Kiminori; Ito, Etsuro] Hirosaki Univ, Sch Med, Dept Pediat, Hirosaki, Aomori 036, Japan; [Ohno, Hiroaki] Kyowa Hakko Kirin, Pharmacol Res Labs, Div Res, Gunma, Japan; [Stanley, E. Richard] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	National Cancer Center - Japan; Harvard University; Hirosaki University; Kyowa Kirin Ltd; Yeshiva University; Albert Einstein College of Medicine; University of Chicago; National University of Singapore	Kitabayashi, I (corresponding author), Natl Canc Ctr, Div Mol Oncol, Res Inst, Chuo Ku, Tokyo, Japan.	ikitabay@ncc.go.jp	Stanley, Evan R/J-9154-2013; Kitabayashi, Issay/G-2204-2017	Stanley, Evan R/0000-0002-2910-2065; Tenen, Daniel/0000-0002-6423-3888; Ito, Etsuro/0000-0002-0168-2475; Kitabayashi, Issay/0000-0002-8409-0407	Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation of Japan; US National Institutes of Health [R01-CA41456, CA32551, 5P30-CA13330]; NATIONAL CANCER INSTITUTE [R01CA041456, R01CA032551, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719] Funding Source: NIH RePORTER	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank D. E. Zhang for the CSF1R promoter mutant lacking PU.1-binding sites, Y. Kamei and A. Iwama for MOZ-TIF2 cDNA, H. Ichikawa for N-MYC cDNA, T. Taya for SaOS2 cells (National Cancer Center Research Institute) and A. Kuchiba for help with statistical analyses. This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor and Welfare and from the Japanese Ministry of Education, Culture, Sports, Science and Technology (I. K.), by the Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan (I. K.), and by US National Institutes of Health grants R01-CA41456 (D. G. T.), CA32551 and 5P30-CA13330 (E. R. S.).	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Dewar AL, 2005, CELL CYCLE, V4, P851, DOI 10.4161/cc.4.7.1788; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; PREISLER HD, 1987, CANCER RES, V47, P874; RAMBALDI A, 1988, J CLIN INVEST, V81, P1030, DOI 10.1172/JCI113413; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Taylor JR, 2006, ONCOGENE, V25, P147, DOI 10.1038/sj.onc.1209007; Terui K, 2008, HAEMATOL-HEMATOL J, V93, P1591, DOI 10.3324/haematol.13020; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; WANG C, 1988, J CELL PHYSIOL, V135, P133, DOI 10.1002/jcp.1041350119; Yoshida H, 2007, MOL CELL BIOL, V27, P5819, DOI 10.1128/MCB.02422-06; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	33	69	83	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					580	U115		10.1038/nm.2122	http://dx.doi.org/10.1038/nm.2122			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20418886	Green Accepted			2022-12-27	WOS:000277394700037
J	Shmelkov, SV; Hormigo, A; Jing, DQ; Proenca, CC; Bath, KG; Milde, T; Shmelkov, E; Kushner, JS; Baljevic, M; Dincheva, I; Murphy, AJ; Valenzuela, DM; Gale, NW; Yancopoulos, GD; Ninan, I; Lee, FS; Rafii, S				Shmelkov, Sergey V.; Hormigo, Adilia; Jing, Deqiang; Proenca, Catia C.; Bath, Kevin G.; Milde, Till; Shmelkov, Evgeny; Kushner, Jared S.; Baljevic, Muhamed; Dincheva, Iva; Murphy, Andrew J.; Valenzuela, David M.; Gale, Nicholas W.; Yancopoulos, George D.; Ninan, Ipe; Lee, Francis S.; Rafii, Shahin			Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice	NATURE MEDICINE			English	Article							CAUDATE-NUCLEUS; SHORT-TERM; LONG-TERM; DISORDER; FAMILY; MODELS; BRAIN; EPIDEMIOLOGY; PLASTICITY; VARIANTS	Obsessive-compulsive disorder (OCD) is a common psychiatric disorder defined by the presence of obsessive thoughts and repetitive compulsive actions, and it often encompasses anxiety and depressive symptoms(1,2). Recently, the corticostriatal circuitry has been implicated in the pathogenesis of OCD3,4. However, the etiology, pathophysiology and molecular basis of OCD remain unknown. Several studies indicate that the pathogenesis of OCD has a genetic component(5-8). Here we demonstrate that loss of a neuron-specific transmembrane protein, SLIT and NTRK-like protein-5 (Slitrk5), leads to OCD-like behaviors in mice, which manifests as excessive self-grooming and increased anxiety-like behaviors, and is alleviated by the selective serotonin reuptake inhibitor fluoxetine. Slitrk5(-/-) mice show selective overactivation of the orbitofrontal cortex, abnormalities in striatal anatomy and cell morphology and alterations in glutamate receptor composition, which contribute to deficient corticostriatal neurotransmission. Thus, our studies identify Slitrk5 as an essential molecule at corticostriatal synapses and provide a new mouse model of OCD-like behaviors.	[Jing, Deqiang; Proenca, Catia C.; Bath, Kevin G.; Dincheva, Iva; Lee, Francis S.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Shmelkov, Sergey V.; Hormigo, Adilia; Milde, Till; Shmelkov, Evgeny; Kushner, Jared S.; Baljevic, Muhamed; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, New York, NY USA; [Shmelkov, Sergey V.; Hormigo, Adilia; Milde, Till; Shmelkov, Evgeny; Kushner, Jared S.; Baljevic, Muhamed; Rafii, Shahin] Weill Cornell Med Coll, Dept Geriatr Med, New York, NY USA; [Hormigo, Adilia] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Hormigo, Adilia] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Proenca, Catia C.] Inst Gulbenkian Ciencias, Gulbenkian PhD Programe Biomed, Oeiras, Portugal; [Dincheva, Iva; Lee, Francis S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Murphy, Andrew J.; Valenzuela, David M.; Gale, Nicholas W.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Ninan, Ipe] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Instituto Gulbenkian de Ciencia; Cornell University; Regeneron; New York University; NYU Langone Medical Center	Lee, FS (corresponding author), Weill Cornell Med Coll, Dept Psychiat, New York, NY USA.	fslee@med.cornell.edu; srafii@med.cornell.edu	Milde, Till/AAR-4528-2021; Baljevic, Muhamed/GOE-3611-2022; Milde, Till/L-7755-2015	Milde, Till/0000-0002-7267-1052; Murphy, Andrew/0000-0003-4152-4081; Ninan, Ipe/0000-0001-9774-6455; Kushner, Jared S./0000-0003-4821-0990	US National Institutes of Health [MH079513, NS052819, HL66592, HL097797, AI080309]; Burroughs Wellcome Foundation; International Mental Health Research Organization; Sackler Institute; New York Community Trust; Pritzker Consortium; National Alliance for Research on Schizophrenia and Depression; Mildred-Scheel-Stiftung, Deutsche Krebshilfe; Gulbenkian PhD Programe in Biomedicine; Fundacao para Ciencia e Tecnologia; Howard Hughes Medical Institute; Ansary Stem Cell Institute; Anbinder and Newmans Own Foundations; Qatar National Priorities Research Program; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797, U01HL066952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079513, RC1MH088814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052819] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); International Mental Health Research Organization; Sackler Institute; New York Community Trust; Pritzker Consortium; National Alliance for Research on Schizophrenia and Depression(NARSAD); Mildred-Scheel-Stiftung, Deutsche Krebshilfe(Deutsche Krebshilfe); Gulbenkian PhD Programe in Biomedicine; Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Anbinder and Newmans Own Foundations; Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); Empire State Stem Cell Board; New York State Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Flint Beal for providing expertise on behavioral experiments. We thank G. Thurston for critical comments and suggestions. PSD95-cherry was a kind gift from R. H. Edwards (University of California-San Francisco). We acknowledge support from US National Institutes of Health grants MH079513 (F. S. L.) and NS052819 (F. S. L.), HL66592 (S. R.), HL097797 (S. R.) and AI080309 (S. R.), Burroughs Wellcome Foundation (F. S. L.), International Mental Health Research Organization (F. S. L.), the Sackler Institute (K. G. B., F. S. L.), DeWitt-Wallace Fund of the New York Community Trust (F. S. L.), Pritzker Consortium (F. S. L.), National Alliance for Research on Schizophrenia and Depression (S. V. S.), Mildred-Scheel-Stiftung, Deutsche Krebshilfe (T. M.), Gulbenkian PhD Programe in Biomedicine (C. C. P.), Fundacao para Ciencia e Tecnologia (C. C. P.), Howard Hughes Medical Institute (S. R.), Ansary Stem Cell Institute (S. R.), Anbinder and Newmans Own Foundations (S. R.), Qatar National Priorities Research Program (S. R.), Empire State Stem Cell Board (S. R.) and the New York State Department of Health grant NYS C024180 (S. R.).	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Aylward EH, 1996, ARCH GEN PSYCHIAT, V53, P577; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CLIFFORD CA, 1984, PSYCHOL MED, V14, P791, DOI 10.1017/S0033291700019760; Deng H, 2006, ACTA NEUROL SCAND, V114, P400, DOI 10.1111/j.1600-0404.2006.00706.x; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Hollander E, 2007, CNS SPECTRUMS, V12, P5, DOI 10.1017/S1092852900002467; Joel D, 2006, PROG NEURO-PSYCHOPH, V30, P374, DOI 10.1016/j.pnpbp.2005.11.006; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617; Milde T, 2007, LEUKEMIA, V21, P824, DOI 10.1038/sj.leu.2404525; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; RASMUSSEN SA, 1984, J CLIN PSYCHIAT, V45, P450; Rauch SL, 2007, BIOL PSYCHIAT, V61, P330, DOI 10.1016/j.biopsych.2005.12.012; Rauch SL, 2003, NEUROSURG CLIN N AM, V14, P213, DOI 10.1016/S1042-3680(02)00114-6; ROBINSON D, 1995, ARCH GEN PSYCHIAT, V52, P393; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Shmelkov SV, 2001, ANAL BIOCHEM, V290, P26, DOI 10.1006/abio.2001.4969; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Szeszko PR, 2004, AM J PSYCHIAT, V161, P1049, DOI 10.1176/appi.ajp.161.6.1049; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang L, 2009, BEHAV PHARMACOL, V20, P119, DOI 10.1097/FBP.0b013e32832a80ad; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001	38	217	220	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					598	U135		10.1038/nm.2125	http://dx.doi.org/10.1038/nm.2125			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20418887	Green Accepted			2022-12-27	WOS:000277394700040
J	Wang, SX; Zhang, C; Zhang, M; Liang, B; Zhu, HP; Lee, J; Viollet, B; Xia, LJ; Zhang, Y; Zou, MH				Wang, Shuangxi; Zhang, Cheng; Zhang, Miao; Liang, Bin; Zhu, Huaiping; Lee, Jiyeon; Viollet, Benoit; Xia, Lijun; Zhang, Yun; Zou, Ming-Hui			Activation of AMP-activated protein kinase alpha 2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; TGF-BETA; TRANSCRIPTION; PHOSPHORYLATION; DELETION; STRESS; IDENTIFICATION; PROTEOLYSIS	Smoking is the only modifiable risk factor that is associated with the development, expansion and rupture of abdominal aortic aneurysm (AAA). However, the causative link between cigarette smoke and AAA is unknown. Here we report a causative link between smoking and AAA in vivo. Acute infusion of angiotensin II (AngII) or nicotine, a major component of cigarette smoke, markedly increased the incidence of AAA in apolipoprotein E (apoE) knockout (Apoe(-/-)) mice and in mice deficient in both apoE and the AMP-activated kinase alpha 1 subunit (AMPK-alpha 1) (Apoe(-/-); Prkaa1(-/-) mice). In contrast, genetic deletion of AMPK-alpha 2 (Apoe(-/-); Prkaa2(-/-) mice) ablated nicotine-or AngII-triggered AAA in vivo. Mechanistically, we found that both nicotine and AngII activated AMPK-alpha 2 in cultured vascular smooth muscle cells (VSMCs), resulting in the phosphorylation of activator protein 2 alpha (AP-2 alpha) and consequent matrix metallopeptidase 2 (MMP2) gene expression. We conclude that smoking (through nicotine) instigates AAA through AMPK-alpha 2-mediated AP-2 alpha-dependent MMP2 expression in VSMCs.	[Wang, Shuangxi; Zhang, Cheng; Zhang, Miao; Liang, Bin; Zhu, Huaiping; Lee, Jiyeon; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Mol Med, Oklahoma City, OK 73104 USA; [Wang, Shuangxi; Zhang, Cheng; Zhang, Yun; Zou, Ming-Hui] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Wang, Shuangxi; Zhang, Cheng; Zhang, Yun; Zou, Ming-Hui] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Shandong University; Shandong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Oklahoma Medical Research Foundation	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Mol Med, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	US National Institutes of Health (NIH) [HL079584, HL074399, HL080499, HL089920, HL096032, HL105157, HL110488]; NIH [HL085607, RR018758]; National High-tech Research and Development Program of China [2012AA02A510]; National 973 Basic Research Program of China [2011CB503906]; National Natural Science Foundation of China for Innovative Research Group [81021001]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080499, R01HL105157, R01HL079584, R43HL110448, R01HL110488, R01HL096032, R01HL074399, P01HL085607, R01HL089920] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for helpful discussions with J. Du, X.L. Wang and C. Yan. We also thank D. Wang and M. McDaniel for technical support. This work was supported by US National Institutes of Health (NIH) grants (HL079584, HL074399, HL080499, HL089920, HL096032, HL105157 and HL110488 to M.-H.Z.). L.X.'s lab is supported by NIH grants (HL085607 and RR018758). This work was also supported by the National High-tech Research and Development Program of China (No. 2012AA02A510) awarded to C.Z. and the National 973 Basic Research Program of China (number 2011CB503906) and the State Program of National Natural Science Foundation of China for Innovative Research Group (number 81021001) awarded to Y.Z. M.-H.Z. is a recipient of the National Established Investigator Award of the American Heart Association.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Aziz F, 2007, ANN VASC SURG, V21, P392, DOI 10.1016/j.avsg.2006.11.001; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Dua MM, 2010, SURGERY, V148, P429, DOI 10.1016/j.surg.2010.05.014; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Garcia MA, 1999, FEBS LETT, V444, P27, DOI 10.1016/S0014-5793(99)00021-6; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Golledge J, 2008, EUR HEART J, V29, P665, DOI 10.1093/eurheartj/ehm557; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; Miyama N, 2010, J VASC SURG, V52, P975, DOI 10.1016/j.jvs.2010.05.086; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Pearce WH, 2006, ANN NY ACAD SCI, V1085, P117, DOI 10.1196/annals.1383.025; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shah PK, 1997, CIRCULATION, V96, P2115; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Sparks AR, 2002, AM FAM PHYSICIAN, V65, P1565; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Thompson RW, 2002, CURR PROB SURG, V39, P98; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tundulawessa Yongyuth, 2010, Journal of the Medical Association of Thailand, V93, P574; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Wang SX, 2008, CARDIOVASC RES, V80, P255, DOI 10.1093/cvr/cvn179; Wang SX, 2008, HYPERTENSION, V52, P484, DOI 10.1161/HYPERTENSIONAHA.108.112094; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253	58	184	192	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					902	+		10.1038/nm.2711	http://dx.doi.org/10.1038/nm.2711			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561688	Green Accepted			2022-12-27	WOS:000305116600027
J	Bornstein, SR; Licinio, J				Bornstein, Stefan R.; Licinio, Julio			Improving the efficacy of translational medicine by optimally integrating health care, academia and industry	NATURE MEDICINE			English	Article							FLEXNER REPORT; CENTERS		[Bornstein, Stefan R.] Tech Univ Dresden, Univ Clin Carl Gustav Carus, D-01062 Dresden, Germany; [Licinio, Julio] Australian Natl Univ, John Curtin Sch Med Res, Dept Translat Med, Canberra, ACT 2601, Australia	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Australian National University; John Curtin School of Medical Research	Bornstein, SR (corresponding author), Tech Univ Dresden, Univ Clin Carl Gustav Carus, D-01062 Dresden, Germany.	stefan.bornstein@uniklinikum-dresden.de; julio.licinio@anu.edu.au	Licinio, Julio/L-4244-2013	Licinio, Julio/0000-0001-6905-5884				Adli M, 2010, LANCET, V376, P1197, DOI 10.1016/S0140-6736(10)61549-8; Albani S, 2009, NAT MED, V15, P1006, DOI 10.1038/nm0909-1006; [Anonymous], 2010, NAT MED, V16, P1200; Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873; Coller BS, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000265; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Finkbeiner S, 2010, NAT MED, V16, P1227, DOI 10.1038/nm.2222; Fisk NM, 2011, MED J AUSTRALIA, V194, P59, DOI 10.5694/j.1326-5377.2011.tb04165.x; Hallak JEC, 2010, REV BRAS PSIQUIATR, V32, P83, DOI 10.1590/S1516-44462010000100016; Licinio J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.3; Licinio J, 2011, MOL PSYCHIATR, V16, P882, DOI 10.1038/mp.2011.103; Licinio J, 2010, MOL PSYCHIATR, V15, P878, DOI 10.1038/mp.2010.91; Ludmerer KM, 2010, ACAD MED, V85, P193, DOI 10.1097/ACM.0b013e3181c8f1e7; Ludwig B, 2010, HORM METAB RES, V42, P918, DOI 10.1055/s-0030-1267916	15	33	34	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1567	1569		10.1038/nm.2583	http://dx.doi.org/10.1038/nm.2583			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146467				2022-12-27	WOS:000297978000026
J	Neul, JL				Neul, Jeffrey L.			BEDSIDE TO BENCH The mystery of developing connections	NATURE MEDICINE			English	Editorial Material							FUNCTIONAL CONNECTIVITY; DEFAULT NETWORK; BRAIN; CIRCUIT; FMRI		[Neul, Jeffrey L.] Texas Childrens Hosp, Duncan Neurol Res Inst, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Pediat, Program Dev Biol, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Neurosci, Program Dev Biol, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Mol & Human Genet, Program Dev Biol, Houston, TX 77030 USA; [Neul, Jeffrey L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Neul, JL (corresponding author), Texas Childrens Hosp, Duncan Neurol Res Inst, Houston, TX 77030 USA.	jneul@bcm.edu	Neul, Jeffrey/AAF-5324-2020	Neul, Jeffrey/0000-0002-5628-5872	NICHD NIH HHS [R01 HD062553] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062553] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	15	9	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1353	1355		10.1038/nm.2552	http://dx.doi.org/10.1038/nm.2552			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064413	Green Accepted			2022-12-27	WOS:000296779300026
J	Eppert, K; Takenaka, K; Lechman, ER; Waldron, L; Nilsson, B; van Galen, P; Metzeler, KH; Poeppl, A; Ling, V; Beyene, J; Canty, AJ; Danska, JS; Bohlander, SK; Buske, C; Minden, MD; Golub, TR; Jurisica, I; Ebert, BL; Dick, JE				Eppert, Kolja; Takenaka, Katsuto; Lechman, Eric R.; Waldron, Levi; Nilsson, Bjoern; van Galen, Peter; Metzeler, Klaus H.; Poeppl, Armando; Ling, Vicki; Beyene, Joseph; Canty, Angelo J.; Danska, Jayne S.; Bohlander, Stefan K.; Buske, Christian; Minden, Mark D.; Golub, Todd R.; Jurisica, Igor; Ebert, Benjamin L.; Dick, John E.			Stem cell gene expression programs influence clinical outcome in human leukemia	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; INTRAFEMORAL TRANSPLANTATION; FAVORABLE PROGNOSIS; CANCER; AML; MUTATIONS; SIGNATURE; RARE; HETEROGENEITY	Xenograft studies indicate that some solid tumors and leukemias are organized as cellular hierarchies sustained by cancer stem cells (CSCs). Despite the promise of the CSC model, its relevance in humans remains uncertain. Here we show that acute myeloid leukemia (AML) follows a CSC model on the basis of sorting multiple populations from each of 16 primary human AML samples and identifying which contain leukemia stem cells (LSCs) using a sensitive xenograft assay. Analysis of gene expression from all functionally validated populations yielded an LSC-specific signature. Similarly, a hematopoietic stem cell (HSC) gene signature was established. Bioinformatic analysis identified a core transcriptional program shared by LSCs and HSCs, revealing the molecular machinery underlying 'stemness' properties. Both stem cell programs were highly significant independent predictors of patient survival and were found in existing prognostic signatures. Thus, determinants of stemness influence the clinical outcome of AML, establishing that LSCs are clinically relevant and not artifacts of xenotransplantation.	[Eppert, Kolja; Lechman, Eric R.; van Galen, Peter; Poeppl, Armando; Dick, John E.] Univ Toronto, Ontario Canc Inst, Div Stem Cell & Dev Biol, Campbell Family Inst Canc Res,Univ Hlth Network, Toronto, ON, Canada; [Eppert, Kolja; Lechman, Eric R.; van Galen, Peter; Poeppl, Armando; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Takenaka, Katsuto] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Waldron, Levi; Danska, Jayne S.; Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Nilsson, Bjoern; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Metzeler, Klaus H.; Bohlander, Stefan K.] Univ Munich, Dept Internal Med 2, Munich, Germany; [Ling, Vicki; Beyene, Joseph] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Canty, Angelo J.] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Danska, Jayne S.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Danska, Jayne S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Buske, Christian] Univ Hosp Ulm, Inst Expt Canc Res, Ctr Comprehens Canc, Ulm, Germany; [Minden, Mark D.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Golub, Todd R.] Broad Inst, Cambridge, MA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Kyushu University; University of Toronto; Harvard University; Brigham & Women's Hospital; University of Munich; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Ulm University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Dick, JE (corresponding author), Univ Toronto, Ontario Canc Inst, Div Stem Cell & Dev Biol, Campbell Family Inst Canc Res,Univ Hlth Network, Toronto, ON, Canada.	jdick@uhnresearch.ca	Metzeler, Klaus H./C-2118-2009; Waldron, Levi/H-2967-2019	Metzeler, Klaus H./0000-0003-3920-7490; Waldron, Levi/0000-0003-2725-0694; Bohlander, Stefan/0000-0002-2202-9088; Dick, John/0000-0002-9527-8317; Eppert, Kolja/0000-0001-9061-8856; van Galen, Peter/0000-0002-0735-1570; Lechman, Eric/0000-0001-8874-2874	German Ministry of Education and Research (BMBF) [01GS0448, 01GS0876]; Deutsche Forschungsgemeinschaft [BU-1177/3-1]; Ontario Research Fund [GL2-01-030]; Leukemia and Lymphoma Society; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society Research Institute; Ministry of Education, Culture, Sports, Science and Technology in Japan [20591134]; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research; Canada Research Chair; Canada Foundation for Innovation [12301, 203383]; Ontario Ministry of Health and Long-Term Care (OMOHLTC)	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ontario Research Fund; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Health and Long-Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was in part supported by grants from the German Ministry of Education and Research (BMBF; C.B. and S.K.B., 01GS0448 and 01GS0876); the Deutsche Forschungsgemeinschaft (C.B., BU-1177/3-1); Ontario Research Fund (I.J., GL2-01-030); a fellowship (K.E.) and grants (J.E.D.) from the Leukemia and Lymphoma Society; the Stem Cell Network of Canadian National Centres of Excellence (J.E.D.); the Canadian Cancer Society Research Institute (J.E.D.); Ministry of Education, Culture, Sports, Science and Technology in Japan (20591134, K.T.); the Terry Fox Foundation (J.E.D.); Genome Canada through the Ontario Genomics Institute (J.E.D.); Ontario Institute for Cancer Research with funds from the province of Ontario (J.E.D.); the Canadian Institutes for Health Research (J.E.D.); and a Canada Research Chair (J.E.D. and I.J.). Computational resources were supported in part by Canada Foundation for Innovation (12301 and 203383) and IBM (I.J.). This research was funded in part by the Ontario Ministry of Health and Long-Term Care (OMOHLTC). The views expressed do not necessarily reflect those of OMOHLTC.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2001, BLOOD, V97, P2177, DOI 10.1182/blood.V97.7.2177; Hassan KA, 2009, CLIN CANCER RES, V15, P6386, DOI 10.1158/1078-0432.CCR-09-1105; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oh IH, 2002, ONCOGENE, V21, P4778, DOI 10.1038/sj.onc.1205592; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Terpstra W, 1996, BLOOD, V88, P1944, DOI 10.1182/blood.V88.6.1944.bloodjournal8861944; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Wang JCY, 2010, TRENDS MOL MED, V16, P145, DOI 10.1016/j.molmed.2010.01.001; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	63	687	709	0	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1086	U91		10.1038/nm.2415	http://dx.doi.org/10.1038/nm.2415			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21873988				2022-12-27	WOS:000294605100028
J	Ohtsubo, K; Chen, MZ; Olefsky, JM; Marth, JD				Ohtsubo, Kazuaki; Chen, Mark Z.; Olefsky, Jerrold M.; Marth, Jamey D.			Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport	NATURE MEDICINE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION; C57BL/6J MICE; IN-VIVO; SECRETION; DYSFUNCTION; MECHANISMS; OBESITY	A connection between diet, obesity and diabetes exists in multiple species and is the basis of an escalating human health problem. The factors responsible provoke both insulin resistance and pancreatic beta cell dysfunction but remain to be fully identified. We report a combination of molecular events in human and mouse pancreatic beta cells, induced by elevated levels of free fatty acids or by administration of a high-fat diet with associated obesity, that comprise a pathogenic pathway to diabetes. Elevated concentrations of free fatty acids caused nuclear exclusion and reduced expression of the transcription factors FOXA2 and HNF1A in beta cells. This resulted in a deficit of GnT-4a glycosyltransferase expression in beta cells that produced signs of metabolic disease, including hyperglycemia, impaired glucose tolerance, hyperinsulinemia, hepatic steatosis and diminished insulin action in muscle and adipose tissues. Protection from disease was conferred by enforced beta cell-specific GnT-4a protein glycosylation and involved the maintenance of glucose transporter expression and the preservation of glucose transport. We observed that this pathogenic process was active in human islet cells obtained from donors with type 2 diabetes; thus, illuminating a pathway to disease implicated in the diet-and obesity-associated component of type 2 diabetes mellitus.	[Ohtsubo, Kazuaki; Marth, Jamey D.] Univ Calif Santa Barbara, Ctr Nanomed, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA; [Ohtsubo, Kazuaki; Marth, Jamey D.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ohtsubo, Kazuaki] RIKEN Adv Sci Inst, Dis Glyc Team, Saitama, Japan; [Chen, Mark Z.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; RIKEN; University of California System; University of California San Diego	Marth, JD (corresponding author), Univ Calif Santa Barbara, Ctr Nanomed, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA.	jmarth@sanfordburnham.org			US National Institutes of Health (NIH) [DK48247]; Eunice Kennedy Shriver National Institute of Child Health and Human Development-NIH [U54 HD 012303-25]; Japan Diabetes Foundation; Suntory Institute for Bioorganic Research;  [GM62116];  [CA71932];  [DK033651];  [DK074868];  [T32 DK007494];  [DK063491]; Grants-in-Aid for Scientific Research [23790363] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247, P30DK063491, P01DK074868, R01DK033651, T32DK007494, R37DK033651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100192, U54GM062116] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Japan Diabetes Foundation; Suntory Institute for Bioorganic Research(Suntory Foundation for Life Sciences); ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded primarily by US National Institutes of Health (NIH) grant DK48247 with additional support from GM62116 and CA71932 (J.D.M.). Further funding was obtained from DK033651, DK074868, T32 DK007494, DK063491 and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-NIH through cooperative agreement of U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research (J.M.O.) and the Japan Diabetes Foundation and Suntory Institute for Bioorganic Research (SUNBOR grant; K.O.).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Chen YW, 2006, DIABETES, V55, P1614, DOI 10.2337/db06-0029; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Gremlich S, 1997, J BIOL CHEM, V272, P3216, DOI 10.1074/jbc.272.6.3216; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Korner J, 2009, AM J MED, V122, pS12, DOI 10.1016/j.amjmed.2009.01.003; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; LeRoith D, 2008, NAT CLIN PRACT ENDOC, V4, P164, DOI 10.1038/ncpendmet0729; Minowa MT, 1998, J BIOL CHEM, V273, P11556, DOI 10.1074/jbc.273.19.11556; Mitchell SMS, 2002, MOL GENET METAB, V77, P35, DOI 10.1016/S1096-7192(02)00150-6; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Olefsky JM, 2005, ENDOCRINOLOGY, P1093; ORCI L, 1990, J CLIN INVEST, V86, P1615, DOI 10.1172/JCI114883; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; Parillo M, 2004, BRIT J NUTR, V92, P7, DOI 10.1079/BJN20041117; Pillay TS, 1996, J CLIN INVEST, V97, P613, DOI 10.1172/JCI118457; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rapoport EM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P393, DOI 10.1134/S0006297908040032; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; REVERS RR, 1984, J CLIN ENDOCR METAB, V58, P353, DOI 10.1210/jcem-58-2-353; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SCARLETT JA, 1982, DIABETES CARE, V5, P353, DOI 10.2337/diacare.5.4.353; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; VALERA A, 1994, J BIOL CHEM, V269, P28543; Weir GC, 1994, JOSLINS DIABETES MEL, P240; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047	52	157	165	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1067	U162		10.1038/nm.2414	http://dx.doi.org/10.1038/nm.2414			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21841783	Green Accepted			2022-12-27	WOS:000294605100026
J	Tayyari, F; Marchant, D; Moraes, TJ; Duan, WM; Mastrangelo, P; Hegele, RG				Tayyari, Farnoosh; Marchant, David; Moraes, Theo J.; Duan, Wenming; Mastrangelo, Peter; Hegele, Richard G.			Identification of nucleolin as a cellular receptor for human respiratory syncytial virus	NATURE MEDICINE			English	Article							SURFACE-EXPRESSED NUCLEOLIN; EPITHELIAL-CELLS; FUSION GLYCOPROTEIN; INFECTION; BINDING; ATTACHMENT; GLYCOSAMINOGLYCANS; NEUTRALIZATION; PALIVIZUMAB; PROTEIN	Human respiratory syncytial virus (RSV) causes a large burden of disease worldwide(1). There is no effective vaccine or therapy, and the use of passive immunoprophylaxis with RSV-specific antibodies is limited to high-risk patients(2-5). The cellular receptor (or receptors) required for viral entry and replication has yet to be described; its identification will improve understanding of the pathogenesis of infection and provide a target for the development of novel antiviral interventions. Here we show that RSV interacts with host-cell nucleolin via the viral fusion envelope glycoprotein and binds specifically to nucleolin at the apical cell surface in vitro. We observed decreased RSV infection in vitro in neutralization experiments using nucleolin-specific antibodies before viral inoculation, in competition experiments in which virus was incubated with soluble nucleolin before inoculation of cells, and upon RNA interference (RNAi) to silence cellular nucleolin expression. Transfection of nonpermissive Spodoptera frugiperda Sf9 insect cells with human nucleolin conferred susceptibility to RSV infection. RNAi-mediated knockdown of lung nucleolin was associated with a significant reduction in RSV infection in mice (P = 0.0004), confirming that nucleolin is a functional RSV receptor in vivo.	[Moraes, Theo J.; Mastrangelo, Peter; Hegele, Richard G.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Tayyari, Farnoosh; Marchant, David] Univ British Columbia, James Hogg Res Ctr, Providence Heart & Lung Inst, St Pauls Hosp,Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Moraes, Theo J.; Duan, Wenming] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Hegele, Richard G.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada	University of Toronto; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hegele, RG (corresponding author), Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada.	richard.hegele@utoronto.ca	Moraes, Theo/CAJ-3254-2022	Moraes, Theo/0000-0001-9968-6601; Hegele, Richard/0000-0003-1073-8044	Canadian Institutes of Health Research (CIHR) Institute of Genetics; CIHR IMPACT and Heart and Stroke Foundation of British Columbia	Canadian Institutes of Health Research (CIHR) Institute of Genetics(Canadian Institutes of Health Research (CIHR)); CIHR IMPACT and Heart and Stroke Foundation of British Columbia(Canadian Institutes of Health Research (CIHR))	The authors thank R.A. Weiss, B. McManus and F. Jean for helpful comments, and L. Morikawa and Q. Xu for help with immunohistochemical staining of mouse lung. F.T. is the recipient of a Canadian Institutes of Health Research (CIHR) Institute of Genetics Grant for Short-term Visits, and D.M. is the recipient of CIHR IMPACT and Heart and Stroke Foundation of British Columbia Post-doctoral Fellowship awards.	Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; Behera AK, 2001, BIOCHEM BIOPH RES CO, V280, P188, DOI 10.1006/bbrc.2000.4093; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; COLLINS PL, 1991, J GEN VIROL, V72, P3095, DOI 10.1099/0022-1317-72-12-3095; Crim RL, 2007, J VIROL, V81, P261, DOI 10.1128/JVI.01226-06; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Dimmock NJ., 2007, INTRO MODERN VIROLOG, V6th ed.; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Hallak Louay K, 2007, Methods Mol Biol, V379, P15; HIBBS AR, 2006, HDB BIOL CONFOCAL MI; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; LOWRY F, 2010, MEDSCAPE NEWS   0603; Magro M, 2010, J VIROL, V84, P7970, DOI 10.1128/JVI.00447-10; Malhotra R, 2003, MICROBES INFECT, V5, P123, DOI 10.1016/S1286-4579(02)00079-5; Martinez I, 2000, J GEN VIROL, V81, P2715, DOI 10.1099/0022-1317-81-11-2715; Mikhaylova LM, 2006, P NATL ACAD SCI USA, V103, P11975, DOI 10.1073/pnas.0605087103; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Olszewska W, 2011, EUR RESPIR J, V38, P401, DOI 10.1183/09031936.00005610; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; OSIOWY C, 1995, J VIROL, V69, P1271, DOI 10.1128/JVI.69.2.1271-1274.1995; Perlman SL, 1999, VIROLOGY, V265, P57, DOI 10.1006/viro.1999.0024; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; TAYLOR G, 1984, INFECT IMMUN, V43, P649, DOI 10.1128/IAI.43.2.649-655.1984; Techaarpornkul S, 2002, VIROLOGY, V294, P296, DOI 10.1006/viro.2001.1340; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tufaro F, 1997, TRENDS MICROBIOL, V5, P257, DOI 10.1016/S0966-842X(97)01057-3; Welliver RC, 2010, CURR OPIN PHARMACOL, V10, P289, DOI 10.1016/j.coph.2010.04.013; Wu H, 2008, CURR TOP MICROBIOL, V317, P103; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	38	258	268	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1132	U140		10.1038/nm.2444	http://dx.doi.org/10.1038/nm.2444			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21841784				2022-12-27	WOS:000294605100035
J	Chung, Y; Tanaka, S; Chu, FL; Nurieva, RI; Martinez, GJ; Rawal, S; Wang, YH; Lim, H; Reynolds, JM; Zhou, XH; Fan, HM; Liu, ZM; Neelapu, SS; Dong, C				Chung, Yeonseok; Tanaka, Shinya; Chu, Fuliang; Nurieva, Roza I.; Martinez, Gustavo J.; Rawal, Seema; Wang, Yi-Hong; Lim, Hoyong; Reynolds, Joseph M.; Zhou, Xiao-hui; Fan, Hui-min; Liu, Zhong-ming; Neelapu, Sattva S.; Dong, Chen			Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions	NATURE MEDICINE			English	Article							CXC CHEMOKINE RECEPTOR-5; TRANSCRIPTION FACTOR; HELPER-CELLS; GENERATION; DIFFERENTIATION; INTERLEUKIN-21; FOLLICLES; BLIMP-1; IRF4; ACTS	Foxp3(+) regulatory T (T-reg) cells suppress different types of immune responses to help maintain homeostasis in the body. How T-reg cells regulate humoral immunity, including germinal center reactions, is unclear. Here we identify a subset of Treg cells expressing CXCR5 and Bcl-6 that localize to the germinal centers in mice and humans. The expression of CXCR5 on T-reg cells depends on Bcl-6. These CXCR5(+) Bcl-6(+) T-reg cells are absent in the thymus but can be generated de novo from CXCR5-Foxp3(+) natural T-reg precursors. A lack of CXCR5+ T-reg cells leads to greater germinal center reactions including germinal center B cells, affinity maturation of antibodies and the differentiation of plasma cells. These results unveil a Bcl-6-CXCR5 axis in T-reg cells that drives the development of follicular regulatory T (T-FR) cells that function to inhibit the germinal center reactions.	[Chung, Yeonseok; Tanaka, Shinya; Nurieva, Roza I.; Martinez, Gustavo J.; Wang, Yi-Hong; Reynolds, Joseph M.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Chung, Yeonseok; Lim, Hoyong] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Ctr Immunol & Autoimmune Dis, Houston, TX USA; [Chu, Fuliang; Rawal, Seema; Neelapu, Sattva S.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Zhou, Xiao-hui; Fan, Hui-min; Liu, Zhong-ming] Shanghai Dong Fang Hosp, Shanghai, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Ctr Canc Immunol Res, Houston, TX 77030 USA.	yeonseok.chung@uth.tmc.edu; cdong@mdanderson.org	Tanaka, Shinya/AAO-8771-2021; dong, chen/B-3181-2009; Chu, Fuliang/F-6925-2011	Tanaka, Shinya/0000-0001-6470-3301; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841; Reynolds, Joseph/0000-0003-3490-0544; Martinez, Gustavo/0000-0003-0178-3329	US National Institutes of Health; Leukemia and Lymphoma Society; MD Anderson Cancer Center; American Heart Association; Doris Duke Charitable Foundation; China Ministry of Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR059010, R01AR050772] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MD Anderson Cancer Center; American Heart Association(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); China Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Dalla-Favera (Columbia University) for the Bcl-6-deficient mice, A. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3<SUP>GFP</SUP> reporter mice, D. Tran (University of Texas at Houston) for the antibody to Helios, Z. He, K. Ramirez and K. Dwyer for help with cell sorting and the entire Dong lab for their help. This work was supported by research grants from the US National Institutes of Health (C. D., to R.I.N. and to S.S.N.), the Leukemia and Lymphoma Society (C. D.), the MD Anderson Cancer Center (C. D.), the American Heart Association (Y.C.), Doris Duke Charitable Foundation Clinical Scientist Development Award (S.S.N.) and China Ministry of Science and Technology Protein Science Key Research Project (X. Z., H. F. and C. D.).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	36	750	783	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					983	U102		10.1038/nm.2426	http://dx.doi.org/10.1038/nm.2426			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785430	Green Accepted			2022-12-27	WOS:000293507400032
J	Andrabi, SA; Kang, HC; Haince, JF; Lee, YI; Zhang, J; Chi, ZK; West, AB; Koehler, RC; Poirier, GG; Dawson, TM; Dawson, VL				Andrabi, Shaida A.; Kang, Ho Chul; Haince, Jean-Francois; Lee, Yun-Il; Zhang, Jian; Chi, Zhikai; West, Andrew B.; Koehler, Raymond C.; Poirier, Guy G.; Dawson, Ted M.; Dawson, Valina L.			Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death	NATURE MEDICINE			English	Article							ELEMENT-BINDING PROTEIN; IN-VITRO; PAR POLYMER; IDENTIFICATION; ACTIVATION; VIVO; PARTHANATOS; PLASTICITY; CHROMATIN; NUCLEAR	Glutamate acting on N-methyl-D-aspartate (NMDA) receptors induces neuronal injury following stroke, through activation of poly(ADPribose) polymerase-1 (PARP-1) and generation of the death molecule poly(ADP-ribose) (PAR) polymer. Here we identify Iduna, a previously undescribed NMDA receptor-induced survival protein that is neuroprotective against glutamate NMDA receptor-mediated excitotoxicity both in vitro and in vivo and against stroke through interfering with PAR polymer-induced cell death (parthanatos). Iduna's protective effects are independent and downstream of PARP-1 activity. Iduna is a PAR polymer-binding protein, and mutation at the PAR polymer binding site abolishes the PAR binding activity of Iduna and attenuates its protective actions. Iduna is protective in vivo against NMDA-induced excitotoxicity and middle cerebral artery occlusion-induced stroke in mice. To our knowledge, these results define Iduna as the first known endogenous inhibitor of parthanatos. Interfering with PAR polymer signaling could be a new therapeutic strategy for the treatment of neurologic disorders.	[Andrabi, Shaida A.; Kang, Ho Chul; Lee, Yun-Il; Chi, Zhikai; West, Andrew B.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA; [Andrabi, Shaida A.; Kang, Ho Chul; Lee, Yun-Il; Chi, Zhikai; West, Andrew B.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Haince, Jean-Francois; Poirier, Guy G.] Univ Laval, Med Res Ctr, Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada; [Zhang, Jian; Koehler, Raymond C.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Laval University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Andrabi, Shaida/I-6167-2012	Andrabi, Shaida/0000-0002-3305-2638; Dawson, Valina/0000-0002-2915-3970; West, Andrew/0000-0002-3034-4061; Poirier, Guy/0000-0002-4869-1424	US National Institutes of Health National Institute of Neurological Disorders and Stroke [NS039148, NS067525, NS051764]; National Institute on Drug Abuse [DA000266]; McKnight Endowment for the Neurosciences; Canadian Institutes Health Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067525, R01NS051764, R37NS067525, P01NS039148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); McKnight Endowment for the Neurosciences; Canadian Institutes Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	pROSA26PA was provided by P. Soriano (University of Washington). This work was supported by grants from the US National Institutes of Health National Institute of Neurological Disorders and Stroke (NS039148, NS067525 and NS051764) and National Institute on Drug Abuse (DA000266) and the McKnight Endowment for the Neurosciences. S.A.A. is an American Heart Research Postdoctoral Fellow. G.G.P. was supported from a Canadian Institutes Health Research grant and holds a Research Chair in Proteomics. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Affar EB, 1999, BBA-GEN SUBJECTS, V1428, P137, DOI 10.1016/S0304-4165(99)00054-9; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; BROCHU G, 1994, ANAL BIOCHEM, V218, P265, DOI 10.1006/abio.1994.1177; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Faraco G, 2010, STROKE, V41, P181, DOI 10.1161/STROKEAHA.109.567826; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hara T, 2003, J NEUROCHEM, V86, P805, DOI 10.1046/j.1471-4159.2003.01847.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; KIEHLBAUCH CC, 1993, ANAL BIOCHEM, V208, P26, DOI 10.1006/abio.1993.1004; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lee HT, 2004, ANN NEUROL, V56, P611, DOI 10.1002/ana.20259; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	44	155	169	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					692	U82		10.1038/nm.2387	http://dx.doi.org/10.1038/nm.2387			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602803	Green Accepted			2022-12-27	WOS:000291308800029
J	Nilsson, EC; Storm, RJ; Bauer, J; Johansson, SMC; Lookene, A; Angstrom, J; Hedenstrom, M; Eriksson, TL; Frangsmyr, L; Rinaldi, S; Willison, HJ; Domellof, FP; Stehle, T; Arnberg, N				Nilsson, Emma C.; Storm, Rickard J.; Bauer, Johannes; Johansson, Susanne M. C.; Lookene, Aivar; Angstrom, Jonas; Hedenstrom, Mattias; Eriksson, Therese L.; Frangsmyr, Lars; Rinaldi, Simon; Willison, Hugh J.; Domellof, Fatima Pedrosa; Stehle, Thilo; Arnberg, Niklas			The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis	NATURE MEDICINE			English	Article							USES SIALIC-ACID; STRUCTURAL-ANALYSIS; BINDING; TYPE-37; TROPISM; VIRUS; SITE	Adenovirus type 37 (Ad37) is a leading cause of epidemic keratoconjunctivitis (EKC)(1,2), a severe and highly contagious ocular disease. Whereas most other adenoviruses infect cells by engaging CD46 or the coxsackie and adenovirus receptor (CAR), Ad37 binds previously unknown sialic acid-containing cell surface molecules(3,4). By glycan array screening, we show here that the receptor-recognizing knob domain of the Ad37 fiber protein specifically binds a branched hexasaccharide that is present in the GD1a ganglioside and that features two terminal sialic acids. Soluble GD1a glycan and GD1a-binding antibodies efficiently prevented Ad37 virions from binding and infecting corneal cells. Unexpectedly, the receptor is constituted by one or more glycoproteins containing the GD1a glycan motif rather than the ganglioside itself, as shown by binding, infection and flow cytometry experiments. Molecular modeling, nuclear magnetic resonance and X-ray crystallography reveal that the two terminal sialic acids dock into two of three previously established sialic acid-binding sites in the trimeric Ad37 knob. Surface plasmon resonance analysis shows that the knob-GD1a glycan interaction has high affinity. Our findings therefore form a basis for the design and development of sialic acid-containing antiviral drugs for topical treatment of EKC.	[Nilsson, Emma C.; Storm, Rickard J.; Johansson, Susanne M. C.; Eriksson, Therese L.; Frangsmyr, Lars; Arnberg, Niklas] Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden; [Bauer, Johannes; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Lookene, Aivar] Tallinn Univ Technol, Dept Chem, Tallinn, Estonia; [Angstrom, Jonas] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Hedenstrom, Mattias] Umea Univ, Dept Chem, Umea, Sweden; [Rinaldi, Simon; Willison, Hugh J.] Univ Glasgow, Glasgow Biomed Res Ctr, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Domellof, Fatima Pedrosa] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Arnberg, Niklas] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Domellof, Fatima Pedrosa] Umea Univ, Dept Clin Sci, Umea, Sweden	Umea University; Eberhard Karls University of Tubingen; Tallinn University of Technology; University of Gothenburg; Umea University; University of Glasgow; Umea University; Vanderbilt University; Umea University; Umea University	Arnberg, N (corresponding author), Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden.	niklas.arnberg@climi.umu.se	willison, hugh/HCI-7819-2022; Nilsson, Emma/HGB-0605-2022; Arnberg, Niklas/G-2663-2012; Arnberg, Niklas/K-5878-2019	Arnberg, Niklas/0000-0002-7069-6678; Rinaldi, Simon/0000-0003-2039-3457; Nilsson, Emma/0000-0001-8123-3292	National Institute of General Medical Sciences [GM62116]; Swedish Research Council [2007-3402, 2009-3859, 11612]; Swedish Foundation for Strategic Research [F06-0011]; Swedish Society of Medicine [97031]; Estonian Science Foundation [8300]; Collaborative Research Center [SFB-685]; University of Tubingen; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Society of Medicine; Estonian Science Foundation; Collaborative Research Center; University of Tubingen; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We highly appreciate the support from F. Lindh and S. Spjut regarding the purification of GD1a glycan; F. Lindh (Isosep) provided GD1a gangliosides. We also thank A. Carlsson (Medigelium) for providing GD1a-containing liposomes; D. Guilligay (EMBL) for providing the Ad37 knob gene cloned into pPROEX Htb plasmid (Life Technologies)<SUP>16</SUP>; R.L. Schnaar (The Johns Hopkins University School of Medicine) for providing P4 compounds; and K. Lindman, M. Hagg and F. Jamshidi for technical support. HCE cells were provided by K. Araki-Sasaki (Kinki Central Hospital). GM3 and GD2 glycans were provided by the Consortium for Functional Glycomics. We also highly appreciate the resources provided by the Consortium for Functional Glycomics (funded by National Institute of General Medical Sciences grant no. GM62116) Core D and H, as well as related technical support from O. Blixt and N. Reza. We are grateful to the Berlin Electron Storage Ring Society for Synchrotron Radiation (BESSY) for beamtime and beamline support. This project was supported by the Swedish Research Council (grants no. 2007-3402 (N.A.); 2009-3859 (N.A.) and 11612 (J.A. via M.E. Breimer)), the Swedish Foundation for Strategic Research (grant no. F06-0011 to N.A.), the Swedish Society of Medicine (grant no. 97031 to N.A.), the Estonian Science Foundation (grant 8300 to A.L.), the Collaborative Research Center SFB-685 (T.S.), a student fellowship from the University of Tubingen (J.B.) and The Wellcome Trust (S.R. and H.J.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arnberg N, 1997, VIROLOGY, V227, P239, DOI 10.1006/viro.1996.8269; Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2002, VIROLOGY, V302, P33, DOI 10.1006/viro.2002.1503; Arnberg N, 2002, J VIROL, V76, P8834, DOI 10.1128/JVI.76.17.8834-8841.2002; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Boffey J, 2005, J NEUROIMMUNOL, V165, P92, DOI 10.1016/j.jneuroim.2005.04.011; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Cashman SM, 2004, VIROLOGY, V324, P129, DOI 10.1016/j.virol.2004.04.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORD E, 1987, EPIDEMIOL REV, V9, P244, DOI 10.1093/oxfordjournals.epirev.a036304; Gordon Y., 1996, OCULAR INFECT IMMUNI, P877; Johansson SMC, 2007, ANTIVIR RES, V73, P92, DOI 10.1016/j.antiviral.2006.08.004; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kinchington PR, 2005, J ANTIMICROB CHEMOTH, V55, P424, DOI 10.1093/jac/dki057; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Lecollinet S, 2006, J VIROL, V80, P2747, DOI 10.1128/JVI.80.6.2747-2759.2006; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Thirion C, 2006, HUM GENE THER, V17, P193, DOI 10.1089/hum.2006.17.193; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wold W.S.M., 2007, FIELDS VIROLOGY, V7th, P2395; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004	34	148	153	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					105	U279		10.1038/nm.2267	http://dx.doi.org/10.1038/nm.2267			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151139				2022-12-27	WOS:000285994000042
J	[Anonymous]				[Anonymous]			Microglial pilgrimage to the brain	NATURE MEDICINE			English	Editorial Material							CELLS; DERIVE; MICE											Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615	7	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1380	1380		10.1038/nm1210-1380	http://dx.doi.org/10.1038/nm1210-1380			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135848				2022-12-27	WOS:000285048900024
J	Massoud, TF; Paulmurugan, R; Gambhir, SS				Massoud, Tarik F.; Paulmurugan, Ramasamy; Gambhir, Sanjiv S.			A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography	NATURE MEDICINE			English	Article							TYPE-1 THYMIDINE KINASE; FRAGMENT COMPLEMENTATION ASSAYS; GENE-EXPRESSION; IN-VIVO; LIVING SUBJECTS; STRATEGIES; CELLS	Improved techniques to noninvasively image protein-protein interactions (PPIs) are essential. We molecularly engineered a positron emission tomography (PET)-based split reporter (herpes simplex virus type 1 thymidine kinase), cleaved between Thr265 and Ala266, and used this in a protein-fragment complementation assay (PCA) to quantify PPIs in mammalian cells and to microPET image them in living mice. An introduced point mutation (V119C) markedly enhanced thymidine kinase complementation in PCAs, on the basis of rapamycin modulation of FKBP12-rapamycin-binding domain (FRB) and FKBP12 (FK506 binding protein), the interaction of hypoxia-inducible factor-1 alpha with the von Hippel-Lindau tumor suppressor, and in an estrogen receptor intramolecular protein folding assay. Applications of this unique split thymidine kinase are potentially far reaching, including, for example, considerably more accurate monitoring of immune and stem cell therapies, allowing for fully quantitative and tomographic PET localization of PPIs in preclinical small- and large-animal models of disease.	[Massoud, Tarik F.; Paulmurugan, Ramasamy; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Bio X Program, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Massoud, Tarik F.] Univ Cambridge, Sch Clin Med, Dept Radiol, Cambridge, England; [Massoud, Tarik F.] Univ Cambridge, Sch Clin Med, Dept Oncol, Cambridge, England; [Massoud, Tarik F.; Paulmurugan, Ramasamy; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; University of Cambridge; University of Cambridge; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Sch Med, Bio X Program, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	sgambhir@stanford.edu		Paulmurugan, Ramasamy/0000-0001-7155-4738	US National Cancer Institute In Vivo Cellular and Molecular Imaging Center [P50 CA86306]; The Health Foundation, UK; General Electric Medical Systems, UK; Palgrave Brown Foundation, UK; Cancer Prevention Research Trust, UK; Royal College of Radiologists X-Appeal, UK; Steel Charitable Trust, UK; Sir Samuel Scott of Yews Trust, UK; National Institute of Health Research Cambridge Biomedical Research Centre, UK; NATIONAL CANCER INSTITUTE [P50CA114747, R01CA082214, P50CA086306] Funding Source: NIH RePORTER	US National Cancer Institute In Vivo Cellular and Molecular Imaging Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Health Foundation, UK; General Electric Medical Systems, UK; Palgrave Brown Foundation, UK; Cancer Prevention Research Trust, UK; Royal College of Radiologists X-Appeal, UK; Steel Charitable Trust, UK; Sir Samuel Scott of Yews Trust, UK; National Institute of Health Research Cambridge Biomedical Research Centre, UK(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Gobalakrishnan, J. Willmann and O. Gheysens for their assistance with the microPET imaging. T. Massoud was supported in part by US National Cancer Institute In Vivo Cellular and Molecular Imaging Center grant P50 CA86306 and by a Mid-Career Award for Established Practitioners from The Health Foundation, General Electric Medical Systems, the Palgrave Brown Foundation, the Cancer Prevention Research Trust, a Royal College of Radiologists X-Appeal pump priming grant, the Steel Charitable Trust, the Sir Samuel Scott of Yews Trust and the National Institute of Health Research Cambridge Biomedical Research Centre, all in the UK. This work was funded by US National Cancer Institute grant In Vivo Cellular and Molecular Imaging Center P50 CA114747 (S.S.G.) and US National Cancer Institute RO1 CA082214 (S.S.G.).	Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chen RD, 2001, TRENDS BIOTECHNOL, V19, P13, DOI 10.1016/S0167-7799(00)01522-5; Gambhir SS, 2000, P NATL ACAD SCI USA, V97, P2785, DOI 10.1073/pnas.97.6.2785; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Iyer M, 2001, J NUCL MED, V42, P96; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kang KW, 2005, MOL IMAGING BIOL, V7, P296, DOI 10.1007/s11307-005-0010-7; Massoud TF, 2007, TRENDS MOL MED, V13, P183, DOI 10.1016/j.molmed.2007.03.003; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; MASSOUD TF, 2007, THESIS U CAMBRIDGE; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Michnick SW, 2001, CURR OPIN STRUC BIOL, V11, P472, DOI 10.1016/S0959-440X(00)00235-9; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Park K, 2007, PROTEIN J, V26, P107, DOI 10.1007/s10930-006-9051-2; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Paulmurugan R, 2006, P NATL ACAD SCI USA, V103, P15883, DOI 10.1073/pnas.0607385103; Penuelas I, 2005, GASTROENTEROLOGY, V128, P1787, DOI 10.1053/j.gastro.2005.03.024; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Spotts JM, 2002, P NATL ACAD SCI USA, V99, P15142, DOI 10.1073/pnas.232565699; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Valdar WSJ, 2001, PROTEINS, V42, P108; Wurth C, 2001, J MOL BIOL, V313, P657, DOI 10.1006/jmbi.2001.5060; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	27	47	50	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					921	U123		10.1038/nm.2185	http://dx.doi.org/10.1038/nm.2185			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20639890	Green Accepted			2022-12-27	WOS:000280649200033
J	Pasca, SP; Portmann, T; Voineagu, I; Yazawa, M; Shcheglovitov, A; Pasca, AM; Cord, B; Palmer, TD; Chikahisa, S; Nishino, S; Bernstein, JA; Hallmayer, J; Geschwind, DH; Dolmetsch, RE				Pasca, Sergiu P.; Portmann, Thomas; Voineagu, Irina; Yazawa, Masayuki; Shcheglovitov, Aleksandr; Pasca, Anca M.; Cord, Branden; Palmer, Theo D.; Chikahisa, Sachiko; Nishino, Seiji; Bernstein, Jonathan A.; Hallmayer, Joachim; Geschwind, Daniel H.; Dolmetsch, Ricardo E.			Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome	NATURE MEDICINE			English	Article							GATING MECHANISMS; SYNDROME MUTATION; GENE-EXPRESSION; CALCIUM-CHANNEL; DIFFERENTIATION; IDENTITY; ANTERIOR; REVEAL; SATB2; CELLS	Monogenic neurodevelopmental disorders provide key insights into the pathogenesis of disease and help us understand how specific genes control the development of the human brain. Timothy syndrome is caused by a missense mutation in the L-type calcium channel Ca(v)1.2 that is associated with developmental delay and autism(1). We generated cortical neuronal precursor cells and neurons from induced pluripotent stem cells derived from individuals with Timothy syndrome. Cells from these individuals have defects in calcium (Ca2+) signaling and activity-dependent gene expression. They also show abnormalities in differentiation, including decreased expression of genes that are expressed in lower cortical layers and in callosal projection neurons. In addition, neurons derived from individuals with Timothy syndrome show abnormal expression of tyrosine hydroxylase and increased production of norepinephrine and dopamine. This phenotype can be reversed by treatment with roscovitine, a cyclin-dependent kinase inhibitor and atypical L-type-channel blocker(2-4). These findings provide strong evidence that Ca(v)1.2 regulates the differentiation of cortical neurons in humans and offer new insights into the causes of autism in individuals with Timothy syndrome.	[Pasca, Sergiu P.; Portmann, Thomas; Yazawa, Masayuki; Shcheglovitov, Aleksandr; Pasca, Anca M.; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Voineagu, Irina; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Voineagu, Irina; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Los Angeles, CA 90095 USA; [Cord, Branden; Palmer, Theo D.] Stanford Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Cord, Branden; Palmer, Theo D.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA; [Chikahisa, Sachiko; Nishino, Seiji; Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Chikahisa, Sachiko] Univ Tokushima, Grad Sch, Dept Integrat Physiol, Inst Hlth Biosci, Tokushima 770, Japan; [Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Stanford University; Stanford University; Tokushima University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Pasca, Sergiu/AAY-3949-2021; Palmer, Theo/GSI-6635-2022	Pasca, Sergiu/0000-0002-3216-3248; Voineagu, Irina/0000-0003-4162-3872; Palmer, Theo/0000-0002-6266-1862; Cord, Branden/0000-0002-9120-5989	US National Institutes of Health; US National Institute of Mental Health; California Institute for Regenerative Medicine; Simons Foundation for Autism Research; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science; American Heart Association; Swiss National Science Foundation; Flora foundation; International Brain Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087898, R01MH094714, R21MH087898, DP1MH099904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Simons Foundation for Autism Research; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Flora foundation; International Brain Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the individuals with Timothy syndrome who participated in this study; E. Nigh for editing of the manuscript; U. Francke for karyotyping; A. Cherry and D. Bangs for help with fibroblast cultures; G. Panagiotakos and C. Young-Park for insightful discussions, and A. Krawisz, R. Schwemberger, D. Fu and R. Shu for help with data analysis. Antibodies to FORSE-1 were developed by P.H. Patterson and were obtained from the Developmental Studies Hybridoma Bank (University of Iowa). Financial support was provided by a US National Institutes of Health Director's Pioneer Award, and by grants to R.E.D. from the US National Institute of Mental Health, the California Institute for Regenerative Medicine and the Simons Foundation for Autism Research. S.P.P. was supported by awards from the International Brain Research Organization Outstanding Research Fellowship and the Tashia and John Morgridge Endowed Fellowship, M.Y. by a Japan Society of the Promotion for Science Postdoctoral Fellowship for Research Abroad and an American Heart Association Western States postdoctoral fellowship, T. P. by a Swiss National Science Foundation Postdoctoral Fellowship and A.S. by a California Institute for Regenerative Medicine Postdoctoral Fellowship. We are also grateful for funding from B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang and the Flora foundation.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Casanova MF, 2009, J AUTISM DEV DISORD, V39, P751, DOI 10.1007/s10803-008-0681-4; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Garbelli R, 2009, NEUROLOGY, V73, P746, DOI 10.1212/WNL.0b013e3181af3397; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Ip BK, 2011, CEREB CORTEX, V21, P1395, DOI 10.1093/cercor/bhq219; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Raghanti MA, 2009, NEUROSCIENCE, V158, P1551, DOI 10.1016/j.neuroscience.2008.10.058; Romano G, 2005, J CELL PHYSIOL, V204, P666, DOI 10.1002/jcp.20319; Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TOLE S, 1995, J NEUROSCI, V15, P970; TORU M, 1982, J NEURAL TRANSM, V54, P181, DOI 10.1007/BF01254928; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Yarotskyy V, 2007, BRIT J PHARMACOL, V152, P386, DOI 10.1038/sj.bjp.0707414; Yarotskyy V, 2010, J BIOL CHEM, V285, P43, DOI 10.1074/jbc.M109.076448; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	37	405	425	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1657	U176		10.1038/nm.2576	http://dx.doi.org/10.1038/nm.2576			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22120178	Green Submitted, Green Accepted			2022-12-27	WOS:000297978000039
J	Negishi-Koga, T; Shinohara, M; Komatsu, N; Bito, H; Kodama, T; Friedel, RH; Takayanagi, H				Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Bito, Haruhiko; Kodama, Tatsuhiko; Friedel, Roland H.; Takayanagi, Hiroshi			Suppression of bone formation by osteoclastic expression of semaphorin 4D	NATURE MEDICINE			English	Article							NERVOUS-SYSTEM; OSTEOBLAST DIFFERENTIATION; BIOLOGICAL-ACTIVITY; SOLUBLE CD100; GROWTH CONE; PDZ-RHOGEF; B-CELL; RECEPTORS; MECHANISMS; PLEXIN-B1	Most of the currently available drugs for osteoporosis inhibit osteoclastic bone resorption; only a few drugs promote osteoblastic bone formation. It is thus becoming increasingly necessary to identify the factors that regulate bone formation. We found that osteoclasts express semaphorin 4D (Sema4D), previously shown to be an axon guidance molecule, which potently inhibits bone formation. The binding of Sema4D to its receptor Plexin-B1 on osteoblasts resulted in the activation of the small GTPase RhoA, which inhibits bone formation by suppressing insulin-like growth factor-1 (IGF-1) signaling and by modulating osteoblast motility. Sema4d(-/-) mice, Plxnb1(-/-) mice and mice expressing a dominant-negative RhoA specifically in osteoblasts showed an osteosclerotic phenotype due to augmented bone formation. Notably, Sema4D-specific antibody treatment markedly prevented bone loss in a model of postmenopausal osteoporosis. Thus, Sema4D has emerged as a new therapeutic target for the discovery and development of bone-increasing drugs.	[Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan; [Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, Takayanagi Osteonetwork Project, Tokyo, Japan; [Negishi-Koga, Takako; Shinohara, Masahiro; Komatsu, Noriko; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan; [Bito, Haruhiko] Univ Tokyo, Dept Neurochem, Grad Sch Med, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Tokyo, Japan; [Friedel, Roland H.] Mt Sinai Sch Med, Dept Neurosurg, New York, NY USA; [Takayanagi, Hiroshi] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Perth, WA 6009, Australia	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Icahn School of Medicine at Mount Sinai; University of Western Australia	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan.	taka.csi@tmd.ac.jp	Bito, Haruhiko/A-8635-2008	Shinohara, Masahiro/0000-0002-5532-1042; Friedel, Roland/0000-0002-7513-3604; Bito, Haruhiko/0000-0001-6315-9594	Japan Science and Technology Agency; JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ichiro Kanehara Foundation; Uehara Memorial Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [20670002, 23659149] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ichiro Kanehara Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to G. Karsenty (Columbia University), K. Kobayashi (Fukushima Medical University School of Medicine), A. Kumanogoh (Osaka University) and T. Kitamura (The University of Tokyo) for kindly providing alpha(1)I-Cre mice, CAT-RhoA DN mice, recombinant Fc-sema4D protein, and the retrovirus vectors and Plat-E cells, respectively. We also thank E. Sumiya, A. Suematsu, Y. Kunisawa, T. Ando, K. Okamoto, T. Nakashima, M. Oh-hora, M. Hayashi, A. Terashima, Y. Nagai and H. Negishi for discussion and assistance. This work was supported in part by a grant for the Exploratory Research for Advanced Technology, Takayanagi Osteonetwork Project from the Japan Science and Technology Agency, Grant-in-Aid for Young Scientist A, Grant-in-Aid for Challenging Exploratory Research and Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science, a grant for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Ichiro Kanehara Foundation, the Uehara Memorial Foundation and the Naito Foundation.	Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Delorme G, 2005, BIOL CELL, V97, P589; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; HAYDEN JM, 1995, BONE, V17, P93; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koh JM, 2006, J HUM GENET, V51, P112, DOI 10.1007/s10038-005-0331-z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Regev A, 2005, FERTIL STERIL, V84, P1210, DOI 10.1016/j.fertnstert.2005.05.011; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; TAKAHASHI H, 1964, Surg Forum, V15, P437; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	55	314	354	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1473	U181		10.1038/nm.2489	http://dx.doi.org/10.1038/nm.2489			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019888				2022-12-27	WOS:000296779300039
J	Elahi, S; Dinges, WL; Lejarcegui, N; Laing, KJ; Collier, AC; Koelle, DM; McElrath, MJ; Horton, H				Elahi, Shokrollah; Dinges, Warren L.; Lejarcegui, Nicholas; Laing, Kerry J.; Collier, Ann C.; Koelle, David M.; McElrath, M. Juliana; Horton, Helen			Protective HIV-specific CD8(+) T cells evade T-reg cell suppression	NATURE MEDICINE			English	Article							DISEASE PROGRESSION; INFECTED PATIENTS; IMMUNE CONTROL; CUTTING EDGE; EXPRESSION; TIM-3; PROLIFERATION; AUTOIMMUNITY; TOLERANCE; RESPONSES	Specific human leukocyte antigens (HLAs), notably HLA-B* 27 and HLA-B* 57 allele groups, have long been associated with control of HIV-1. Although the majority of HIV-specific CD8(+) T cells lose proliferative capacity during chronic infection, T cells restricted by HLA-B* 27 or HLA-B* 57 allele groups do not. Here we show that CD8(+) T cells restricted by 'protective' HLA allele groups are not suppressed by T-reg cells, whereas, within the same individual, T cells restricted by 'nonprotective' alleles are highly suppressed ex vivo. This differential sensitivity of HIV-specific CD8(+) T cells to T-reg cell-mediated suppression correlates with their expression of the inhibitory receptor T cell immunoglobulin domain and mucin domain 3 (Tim-3) after stimulation with their cognate epitopes. Furthermore, we show that HLA-B* 27- and HLA-B* 57-restricted effectors also evade T-reg cell-mediated suppression by directly killing T-reg cells they encounter in a granzyme B (GzmB)-dependent manner. This study uncovers a previously unknown explanation for why HLA-B* 27 and HLA-B* 57 allele groups are associated with delayed HIV-1 disease progression.	[Elahi, Shokrollah; Dinges, Warren L.; Lejarcegui, Nicholas; Horton, Helen] Seattle Biomed Res Inst Seattle Biomed, Viral Vaccine Program, Seattle, WA USA; [Dinges, Warren L.] Polyclin Infect Dis, Seattle, WA USA; [Laing, Kerry J.; Koelle, David M.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Collier, Ann C.; Koelle, David M.; McElrath, M. Juliana; Horton, Helen] Univ Washington, Dept Med, Seattle, WA USA; [Koelle, David M.; McElrath, M. Juliana; Horton, Helen] Univ Washington, Dept Global Hlth Med, Seattle, WA 98195 USA; [Koelle, David M.; McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Koelle, David M.] Benaroya Res Inst, Seattle, WA USA	Center for Infectious Disease Research; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute	Horton, H (corresponding author), Seattle Biomed Res Inst Seattle Biomed, Viral Vaccine Program, Seattle, WA USA.	helen.horton@seattlebiomed.org	Koelle, David/Q-6529-2016; Laing, Kerry J./C-2211-2008	Koelle, David/0000-0003-1255-9023; Laing, Kerry J./0000-0001-9245-5325; Elahi, Shokrollah/0000-0002-7215-2009	US National Institutes of Health (NIH) [R01 AI65328, R21 AI089373, U01 AI4674, U01 AI 46725, P01 AI57005, P30 AI27757]; University of Washington/Fred Hutchinson Cancer Research Center Center for AIDS Research (CFAR) (the University of Washington General Clinical Research Center) [AI30731, AI 081060, R37 AI042528, M01-RR-00037]; University of Washington Center for AIDS Research (CFAR); NIH [P30 AI027757]; James. B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042528, R01AI065328, P30AI027757, P01AI057005, U01AI046725, R21AI089373, R21AI081060, R01AI042528, U01AI046747, P01AI030731] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington/Fred Hutchinson Cancer Research Center Center for AIDS Research (CFAR) (the University of Washington General Clinical Research Center)(University of Washington); University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James. B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our study volunteers for providing samples and supporting this work, as well as the clinical staff for their dedication to this research. This work was supported by US National Institutes of Health (NIH) grants R01 AI65328, R21 AI089373, U01 AI4674, U01 AI 46725, P01 AI57005, P30 AI27757, a New Investigator Award (for S. E.) from the University of Washington/Fred Hutchinson Cancer Research Center Center for AIDS Research (CFAR), AI30731, AI 081060, R37 AI042528 and M01-RR-00037 (the University of Washington General Clinical Research Center). This research was supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the NIH National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute and National Center for Complementary and Alternative Medicine). We also acknowledge the support of the James. B. Pendleton Charitable Trust.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Antoniou AN, 2004, J BIOL CHEM, V279, P8895, DOI 10.1074/jbc.M311757200; Ashley CW, 2009, J IMMUNOL, V183, P4843, DOI 10.4049/jimmunol.0900845; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Galgani M, 2009, CURR MED CHEM, V16, P4626, DOI 10.2174/092986709789878201; Henseler T, 1998, ARCH DERMATOL RES, V290, P463, DOI 10.1007/s004030050338; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Horton H, 2006, J VIROL, V80, P9779, DOI 10.1128/JVI.00794-06; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Migueles SA, 2001, IMMUNOL LETT, V79, P141, DOI 10.1016/S0165-2478(01)00276-0; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sabbagh L, 2004, J IMMUNOL, V173, P5425, DOI 10.4049/jimmunol.173.9.5425; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Vila J, 2009, CURR OPIN HEMATOL, V16, P274, DOI 10.1097/MOH.0b013e32832a9a01; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wehler TC, 2008, J IMMUNOL METHODS, V339, P23, DOI 10.1016/j.jim.2008.07.017; Weiss L, 2010, P NATL ACAD SCI USA, V107, P10632, DOI 10.1073/pnas.1000027107; Xing SJ, 2010, JAIDS-J ACQ IMM DEF, V54, P455, DOI 10.1097/QAI.0b013e3181e453b9; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	41	160	164	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					989	U110		10.1038/nm.2422	http://dx.doi.org/10.1038/nm.2422			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21765403	Green Accepted			2022-12-27	WOS:000293507400033
J	Lee, JH; Giannikopoulos, P; Duncan, SA; Wang, J; Johansen, CT; Brown, JD; Plutzky, J; Hegele, RA; Glimcher, LH; Lee, AH				Lee, Jung Hoon; Giannikopoulos, Petros; Duncan, Stephen A.; Wang, Jian; Johansen, Christopher T.; Brown, Jonathan D.; Plutzky, Jorge; Hegele, Robert A.; Glimcher, Laurie H.; Lee, Ann-Hwee			The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism	NATURE MEDICINE			English	Article							LIPOPROTEIN-LIPASE; RARE VARIANTS; PPAR-ALPHA; CREB-H; LIVER; ASSOCIATION; EXPRESSION; GENETICS; DISEASES	Here we report that the transcription factor cyclic AMP-responsive element-binding protein H (CREB-H, encoded by CREB3L3) is required for the maintenance of normal plasma triglyceride concentrations. CREB-H-deficient mice showed hypertriglyceridemia secondary to inefficient triglyceride clearance catalyzed by lipoprotein lipase (Lpl), partly due to defective expression of the Lpl coactivators Apoc2, Apoa4 and Apoa5 (encoding apolipoproteins C2, A4 and A5, respectively) and concurrent augmentation of the Lpl inhibitor Apoc3. We identified multiple nonsynonymous mutations in CREB3L3 that produced hypomorphic or nonfunctional CREB-H protein in humans with extreme hypertriglyceridemia, implying a crucial role for CREB-H in human triglyceride metabolism.	[Lee, Jung Hoon; Giannikopoulos, Petros; Glimcher, Laurie H.; Lee, Ann-Hwee] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Wang, Jian; Johansen, Christopher T.; Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Wang, Jian; Johansen, Christopher T.; Hegele, Robert A.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Brown, Jonathan D.; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Glimcher, Laurie H.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Medical College of Wisconsin; Western University (University of Western Ontario); Western University (University of Western Ontario); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu; ahlee@hsph.harvard.edu	Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011; Plutzky, Jorge/V-3410-2019	Hegele, Robert/0000-0003-2861-5325; Duncan, Stephen/0000-0002-2507-7827	Harvard University; Howard Hughes Medical Institute (HHMI); Harvard Digestive Disease Center; US National Institutes of Health [P30 DK34845, DK082448]; American Heart Association; Canadian Institutes for Health Research and Genome Canada through the Ontario Genomics Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK082448] Funding Source: NIH RePORTER	Harvard University; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Harvard Digestive Disease Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Canadian Institutes for Health Research and Genome Canada through the Ontario Genomics Institute(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank. B. Zhai and S. Gygi for mass spectrometry analysis, K. Sigrist for assistance with the development of transgenic mice, R. Hassell for assistance with genomic DNA sequencing, B. Monia (Isis Innovation) for Apoc3-specific antibody and D. Cohen for invaluable suggestions and comments on the manuscript. The research was supported by the Harvard University Accelerator Fund (L.H.G.), a Howard Hughes Medical Institute (HHMI) fellowship (P.G.), the Harvard Digestive Disease Center, US National Institutes of Health grant P30 DK34845 (A.-H.L.), US National Institutes of Health grant DK082448 (L.H.G.) and grants from the American Heart Association (A.-H.L. and J.H.L.), Canadian Institutes for Health Research and Genome Canada through the Ontario Genomics Institute.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bailey D, 2007, TRAFFIC, V8, P1796, DOI 10.1111/j.1600-0854.2007.00654.x; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	20	145	149	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					812	815		10.1038/nm.2347	http://dx.doi.org/10.1038/nm.2347			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21666694	Green Accepted			2022-12-27	WOS:000292500800034
J	Russell, RC; Sufan, RI; Zhou, B; Heir, P; Bunda, S; Sybingco, SS; Greer, SN; Roche, O; Heathcote, SA; Chow, VWK; Boba, LM; Richmond, TD; Hickey, MM; Barber, DL; Cheresh, DA; Simon, MC; Irwin, MS; Kim, WY; Ohh, M				Russell, Ryan C.; Sufan, Roxana I.; Zhou, Bing; Heir, Pardeep; Bunda, Severa; Sybingco, Stephanie S.; Greer, Samantha N.; Roche, Olga; Heathcote, Samuel A.; Chow, Vinca W. K.; Boba, Lukasz M.; Richmond, Terri D.; Hickey, Michele M.; Barber, Dwayne L.; Cheresh, David A.; Simon, M. Celeste; Irwin, Meredith S.; Kim, William Y.; Ohh, Michael			Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia	NATURE MEDICINE			English	Article							VON-HIPPEL-LINDAU; TUMOR-SUPPRESSOR PROTEIN; TYROSINE KINASE JAK2; OF-FUNCTION MUTATION; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; CONGENITAL POLYCYTHEMIA; DEPENDENT PROTEOLYSIS; HEMATOPOIETIC-CELLS; OXYGEN HOMEOSTASIS	Chuvash polycythemia is a rare congenital form of polycythemia caused by homozygous R200W and H191D mutations in the VHL (von Hippel-Lindau) gene, whose gene product is the principal negative regulator of hypoxia-inducible factor. However, the molecular mechanisms underlying some of the hallmark abnormalities of Chuvash polycythemia, such as hypersensitivity to erythropoietin, are unclear. Here we show that VHL directly binds suppressor of cytokine signaling 1 (SOCS1) to form a heterodimeric E3 ligase that targets phosphorylated JAK2 (pJAK2) for ubiquitin-mediated destruction. In contrast, Chuvash polycythemia-associated VHL mutants have altered affinity for SOCS1 and do not engage with and degrade pJAK2. Systemic administration of a highly selective JAK2 inhibitor, TG101209, reversed the disease phenotype in Vhl(R200W/R200W) knock-in mice, an experimental model that recapitulates human Chuvash polycythemia. These results show that VHL is a SOCS1-cooperative negative regulator of JAK2 and provide biochemical and preclinical support for JAK2-targeted therapy in individuals with Chuvash polycythemia.	[Russell, Ryan C.; Sufan, Roxana I.; Heir, Pardeep; Bunda, Severa; Sybingco, Stephanie S.; Greer, Samantha N.; Roche, Olga; Chow, Vinca W. K.; Boba, Lukasz M.; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhou, Bing; Heathcote, Samuel A.; Kim, William Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Hematol Oncol, Chapel Hill, NC 27599 USA; [Richmond, Terri D.; Barber, Dwayne L.] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON, Canada; [Hickey, Michele M.; Simon, M. Celeste] Univ Penn, Sch Med, Dept Cell & Dev Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Simon, M. Celeste] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Irwin, Meredith S.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ohh, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	michael.ohh@utoronto.ca	Simon, Celeste/AAG-3941-2021; Roche, Olga/K-9342-2014; zhou, bing/C-2150-2011; Roche, UCLM/F-5697-2019	Roche, UCLM/0000-0003-1884-8256; Barber, Dwayne/0000-0001-5528-8150; Russell, Ryan/0000-0003-3364-8869	Canadian Cancer Society [020110, 018054]; US National Institutes of Health [R01 CA142794, U54 CA151652]; US Department of Defense [PC094631, W81XWH-08-1-0064]; NATIONAL CANCER INSTITUTE [U54CA151652, R01CA142794] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the Canadian Cancer Society (020110 to M.O. and 018054 to M.S.I.), US National Institutes of Health R01 CA142794 (W.Y.K.), U54 CA151652 (W.Y.K.) and US Department of Defense grants PC094631 and W81XWH-08-1-0064 (W.Y.K). Plasmid encoding HA-SOCS1 was provided by R. Rottapel (Ontario Cancer Institute). Lentiviral reagents pMDG1. vsvg and psPAX2 were provided by L. Penn (Ontario Cancer Institute). JAK2 inhibitor TG101209 was provided by TargeGen. We thank the University North Carolina Animal Studies Core Facility and Mouse Phase 1 Unit for their assistance in the animal study. W.Y.K. is a Damon Runyon Merck clinical investigator. M.O. is a Canada Research Chair in molecular oncology.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellucci S, 2006, SEMIN THROMB HEMOST, V32, P381, DOI 10.1055/s-2006-942759; Bento JC, 2005, HAEMATOLOGICA, V90, P128; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Cario H, 2005, HAEMATOLOGICA, V90, P19; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Constantinescu SN, 2008, TRENDS BIOCHEM SCI, V33, P122, DOI 10.1016/j.tibs.2007.12.002; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Le Y, 2009, AM J HEMATOL, V84, P273, DOI 10.1002/ajh.21381; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Messinezy M, 1999, CLIN LAB HAEMATOL, V21, P309, DOI 10.1046/j.1365-2257.1999.00246.x; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pastore Y, 2003, AM J HUM GENET, V73, P412, DOI 10.1086/377108; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Perrotta S, 2006, BLOOD, V107, P514, DOI 10.1182/blood-2005-06-2422; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Roberts AM, 2008, CURR OPIN ONCOL, V20, P83, DOI 10.1097/CCO.0b013e3282f310de; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Shibata J, 2003, BLOOD, V101, P4416, DOI 10.1182/blood-2002-09-2814; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	59	56	56	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					845	U261		10.1038/nm.2370	http://dx.doi.org/10.1038/nm.2370			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21685897	Green Accepted			2022-12-27	WOS:000292500800039
J	Collisson, EA; Sadanandam, A; Olson, P; Gibb, WJ; Truitt, M; Gu, SD; Cooc, J; Weinkle, J; Kim, GE; Jakkula, L; Feiler, HS; Ko, AH; Olshen, AB; Danenberg, KL; Tempero, MA; Spellman, PT; Hanahan, D; Gray, JW				Collisson, Eric A.; Sadanandam, Anguraj; Olson, Peter; Gibb, William J.; Truitt, Morgan; Gu, Shenda; Cooc, Janine; Weinkle, Jennifer; Kim, Grace E.; Jakkula, Lakshmi; Feiler, Heidi S.; Ko, Andrew H.; Olshen, Adam B.; Danenberg, Kathleen L.; Tempero, Margaret A.; Spellman, Paul T.; Hanahan, Douglas; Gray, Joe W.			Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy	NATURE MEDICINE			English	Article							GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; K-RAS; IDENTIFICATION; CHEMOTHERAPY; DIFFERENTIATION; MICROARRAYS; SENSITIVITY; MUTATIONS	Pancreatic ductal adenocarcinoma (PDA) is a lethal disease. Overall survival is typically 6 months from diagnosis(1). Numerous phase 3 trials of agents effective in other malignancies have failed to benefit unselected PDA populations, although patients do occasionally respond. Studies in other solid tumors have shown that heterogeneity in response is determined, in part, by molecular differences between tumors. Furthermore, treatment outcomes are improved by targeting drugs to tumor subtypes in which they are selectively effective, with breast(2) and lung(3) cancers providing recent examples. Identification of PDA molecular subtypes has been frustrated by a paucity of tumor specimens available for study. We have overcome this problem by combined analysis of transcriptional profiles of primary PDA samples from several studies, along with human and mouse PDA cell lines. We define three PDA subtypes: classical, quasimesenchymal and exocrine-like, and we present evidence for clinical outcome and therapeutic response differences between them. We further define gene signatures for these subtypes that may have utility in stratifying patients for treatment and present preclinical model systems that may be used to identify new subtype specific therapies.	[Collisson, Eric A.; Sadanandam, Anguraj; Gibb, William J.; Gu, Shenda; Weinkle, Jennifer; Jakkula, Lakshmi; Feiler, Heidi S.; Spellman, Paul T.; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Collisson, Eric A.; Ko, Andrew H.; Tempero, Margaret A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Sadanandam, Anguraj; Hanahan, Douglas] Swiss Fed Inst Technol, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [Olson, Peter; Truitt, Morgan; Hanahan, Douglas] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Olson, Peter; Truitt, Morgan; Hanahan, Douglas] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Cooc, Janine; Danenberg, Kathleen L.] Response Genet, Los Angeles, CA USA; [Kim, Grace E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Oregon Health & Science University	Gray, JW (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	grayjo@ohsu.edu	Gray, Joe/AAX-9549-2020	Gu, Shenda/0000-0003-2271-0524; Kim, Grace/0000-0003-4603-9448; Sadanandam, Anguraj/0000-0001-8485-5150	American Society of Clinical Oncology; US National Cancer Institute (NCI) [K08 CA137153]; US Department of Defense [BC087768]; NCI [PO1 CA 117969, P50 CA 58207, P50 CA 83639, U54 CA 112970]; American Cancer Society; Office of Science, Office of Biological & Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA117969, P50CA083639, U54CA112970, P50CA058207, K08CA137153] Funding Source: NIH RePORTER	American Society of Clinical Oncology; US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Office of Science, Office of Biological & Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to M. Lenburg and the Gray, Hanahan and Speed labs for discussion. We thank L. Chin (Dana-Farber Cancer Institute) for 3.27, TU8988S, TU8988T, Tu8902, DanG and HupT3, S. Batra (University of Nebraska Medical Center) for Suit2, M. McMahon (UCSF) for HPAC, Capan2, HPAF II, 6.03, CFPac1, MPanc96, 2.13, Panc1, MiaPaca2, 10.05 and Colo357, and A. Singh (Massachusetts General Hospital) for Sw1990. B. Stockwell (New York University) kindly provided pLKOshKRAS 5. R. Adam (Children's Hospital Boston) kindly provided pLKOshGATA6 5. E. A. C. was supported by a Young Investigator Award from the American Society of Clinical Oncology and US National Cancer Institute (NCI) K08 CA137153. A. S. was supported by a US Department of Defense Postdoctoral Fellowship (BC087768). The research in the laboratory of D. H. was supported by an NCI Program Project Grant PO1 CA 117969; D. H. is an American Cancer Society Research Professor. This work was supported by the Director, Office of Science, Office of Biological & Environmental Research, of the United States Department of Energy under contract no. DE-AC02-05CH11231, and by NCI grants P50 CA 58207, P50 CA 83639 and U54 CA 112970 to J. W. G.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Balagurunathan Y, 2008, MOL CANCER THER, V7, P3071, DOI 10.1158/1535-7163.MCT-08-0402; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Collisson EA, 2003, CANCER RES, V63, P5669; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kanematsu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1093, DOI 10.1152/ajpcell.00225.2007; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; KUEHN H, 2008, CURR PROTOC BIOINFOR, V22; Kwei KA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000081; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Raut Chandrajit P, 2004, Surg Oncol Clin N Am, V13, P639, DOI 10.1016/j.soc.2004.06.007; SADANANDAM A, 2011, NATURE PROTOCOLS, DOI DOI 10.1038/PROTEX.2011.231; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	36	999	1032	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					500	U140		10.1038/nm.2344	http://dx.doi.org/10.1038/nm.2344			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21460848	Green Accepted, Green Submitted			2022-12-27	WOS:000289245100042
J	Rodriguez-Paredes, M; Esteller, M				Rodriguez-Paredes, Manuel; Esteller, Manel			Cancer epigenetics reaches mainstream oncology	NATURE MEDICINE			English	Review							HISTONE DEACETYLASE INHIBITOR; CPG ISLAND HYPERMETHYLATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; SMALL-MOLECULE INHIBITORS; TUMOR-SUPPRESSOR GENES; EMBRYONIC STEM-CELLS; IN-VIVO ACTIVITY; NF-KAPPA-B; DNA METHYLATION; PROSTATE-CANCER	Epigenetics is one of the most promising and expanding fields in the current biomedical research landscape. Since the inception of epigenetics in the 1940s, the discoveries regarding its implications in normal and disease biology have not stopped, compiling a vast amount of knowledge in the past decade. The field has moved from just one recognized marker, DNA methylation, to a variety of others, including a wide spectrum of histone modifications. From the methodological standpoint, the successful initial single gene candidate approaches have been complemented by the current comprehensive epigenomic approaches that allow the interrogation of genomes to search for translational applications in an unbiased manner. Most important, the discovery of mutations in the epigenetic machinery and the approval of the first epigenetic drugs for the treatment of subtypes of leukemias and lymphomas has been an eye-opener for many biomedical scientists and clinicians. Herein, we will summarize the progress in the field of cancer epigenetics research that has reached mainstream oncology in the development of new biomarkers of the disease and new pharmacological strategies.	[Rodriguez-Paredes, Manuel; Esteller, Manel] Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona, Spain; [Esteller, Manel] Univ Barcelona, Dept Physiol Sci 2, Sch Med, Barcelona, Catalonia, Spain; [Esteller, Manel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Esteller, M (corresponding author), Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona, Spain.	mesteller@idibell.cat	Rodríguez Paredes, Manuel/B-1480-2019; Rodríguez, Manuel/N-2708-2019; Esteller, Manel/L-5956-2014	Rodríguez Paredes, Manuel/0000-0001-5471-4277; Esteller, Manel/0000-0003-4490-6093	ICREA Funding Source: Custom	ICREA(ICREA)		Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384047, 10.1517/14728222.12.11.1457 , 10.1517/14728220802384013]; Bailey VJ, 2009, GENOME RES, V19, P1455, DOI 10.1101/gr.088831.108; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bastian PJ, 2008, J UROLOGY, V179, P529, DOI 10.1016/j.juro.2007.09.038; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Beumer JH, 2008, CANCER CHEMOTH PHARM, V62, P363, DOI 10.1007/s00280-007-0603-8; Billam M, 2009, CANCER BIOL THER, V8, P485, DOI 10.4161/cbt.8.6.7582; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Brooks JD, 1998, CANCER EPIDEM BIOMAR, V7, P531; Brueckner B, 2010, MOL CANCER THER, V9, P1256, DOI 10.1158/1535-7163.MCT-09-1202; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Cairns P, 2001, CLIN CANCER RES, V7, P2727; Chakravarti A, 2006, CLIN CANCER RES, V12, P4738, DOI 10.1158/1078-0432.CCR-06-0596; Chan EM, 2007, EXP HEMATOL, V35, P1782, DOI 10.1016/j.exphem.2007.07.015; Chen SA, 2010, P NATL ACAD SCI USA, V107, P11032, DOI 10.1073/pnas.1000917107; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Esteller M, 1999, CANCER RES, V59, P67; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 1998, CANCER RES, V58, P4515; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2002, J NATL CANCER I, V94, P26; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fang MZ, 2003, CANCER RES, V63, P7563; Feinberg AP, 2005, CANCER CELL, V8, P267, DOI 10.1016/j.ccr.2005.09.014; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferreri AJM, 2004, BRIT J HAEMATOL, V126, P657, DOI 10.1111/j.1365-2141.2004.05109.x; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garcia JS, 2010, ONCOTARGETS THER, V3, P1; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Gilbert J, 2001, CLIN CANCER RES, V7, P2292; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Itoh Y, 2008, CURR PHARM DESIGN, V14, P529; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kantarjian HM, 2010, BLOOD, V116, P3163, DOI 10.1182/blood-2010-03-274753; Kanzaki M, 2007, ONCOL REP, V17, P761; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koga Y, 2006, J GASTROENTEROL, V41, P133, DOI 10.1007/s00535-005-1732-7; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Li Y, 2010, PROCEEDINGS OF 2010 ASIA-PACIFIC YOUTH CONFERENCE ON COMMUNICATION, VOLS 1 AND 2, P10, DOI 10.1371/journal.pbio.1000533; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lucas DM, 2004, LEUKEMIA, V18, P1207, DOI 10.1038/sj.leu.2403388; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Mai A, 2008, J MED CHEM, V51, P2279, DOI 10.1021/jm701595q; Marchion DC, 2005, MOL CANCER THER, V4, P1993, DOI 10.1158/1535-7163.MCT-05-0194; Martinez R, 2007, J NEURO-ONCOL, V83, P91, DOI 10.1007/s11060-006-9292-0; McCormack AI, 2009, CLIN ENDOCRINOL, V71, P226, DOI 10.1111/j.1365-2265.2008.03487.x; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Plumb JA, 2000, CANCER RES, V60, P6039; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Qian XZ, 2008, INT J CANCER, V122, P1400, DOI 10.1002/ijc.23243; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Ropero S, 2006, NAT GENET, V38, P566, DOI 10.1038/ng1773; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Steeghs N, 2009, J CLIN ONCOL, V27, P5094, DOI 10.1200/JCO.2008.21.6655; Steele NL, 2008, CLIN CANCER RES, V14, P804, DOI 10.1158/1078-0432.CCR-07-1786; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Terao Y, 2001, INT J CANCER, V94, P257, DOI 10.1002/ijc.1448; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Veeck J, 2010, J CLIN ONCOL, V28, pE563, DOI 10.1200/JCO.2010.30.1010; Villar-Garea A, 2003, CANCER RES, V63, P4984; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Watson AJ, 2010, CLIN CANCER RES, V16, P743, DOI 10.1158/1078-0432.CCR-09-1389; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011	174	873	917	2	257	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					330	339		10.1038/nm.2305	http://dx.doi.org/10.1038/nm.2305			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21386836				2022-12-27	WOS:000288070000044
J	Wang, HJ; Li, ZY; Liu, Y; Persson, J; Beyer, I; Moller, T; Koyuncu, D; Drescher, MR; Strauss, R; Zhang, XB; Wahl, JK; Urban, N; Drescher, C; Hemminki, A; Fender, P; Lieber, A				Wang, Hongjie; Li, Zong-Yi; Liu, Ying; Persson, Jonas; Beyer, Ines; Moeller, Thomas; Koyuncu, Dilara; Drescher, Max R.; Strauss, Robert; Zhang, Xiao-Bing; Wahl, James K., III; Urban, Nicole; Drescher, Charles; Hemminki, Akseli; Fender, Pascal; Lieber, Andre			Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14	NATURE MEDICINE			English	Article							CELLULAR ATTACHMENT RECEPTORS; GENE-TRANSFER; FIBER KNOB; DESMOSOMAL CADHERINS; B ADENOVIRUSES; BINDING-SITES; CELLS; CD46; CANCER; EXPRESSION	We have identified desmoglein-2 (DSG-2) as the primary high-affinity receptor used by adenoviruses Ad3, Ad7, Ad11 and Ad14. These serotypes represent key human pathogens causing respiratory and urinary tract infections. In epithelial cells, adenovirus binding of DSG-2 triggers events reminiscent of epithelial-to-mesenchymal transition, leading to transient opening of intercellular junctions. This opening improves access to receptors, for example, CD46 and Her2/neu, that are trapped in intercellular junctions. In addition to complete virions, dodecahedral particles (PtDds), formed by excess amounts of viral capsid proteins, penton base and fiber during viral replication, can trigger DSG-2-mediated opening of intercellular junctions as shown by studies with recombinant Ad3 PtDds. Our findings shed light on adenovirus biology and pathogenesis and may have implications for cancer therapy.	[Wang, Hongjie; Li, Zong-Yi; Liu, Ying; Persson, Jonas; Beyer, Ines; Drescher, Max R.; Strauss, Robert; Lieber, Andre] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Wang, Hongjie; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Helsinki, Finland; [Wang, Hongjie; Hemminki, Akseli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Koyuncu, Dilara] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA; [Wahl, James K., III] Univ Nebraska Med Ctr, Omaha, NE USA; [Urban, Nicole; Drescher, Charles] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Fender, Pascal] Unit Virus Host Cell Interact, Grenoble, France	University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Washington; University of Washington Seattle; Bogazici University; Loma Linda University; University of Nebraska System; University of Nebraska Medical Center; Fred Hutchinson Cancer Center; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lieber, A (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	lieber00@u.washington.edu	Beyer, Ines/Q-3236-2017	Beyer, Ines/0000-0001-7468-4466; Zhang, Xiao-Bing/0000-0003-4319-6181; Lieber, Andre/0000-0001-6742-6266; Fender, Pascal/0000-0002-6698-3367	US National Institutes of Health [R01 CA080192, R01 HLA078836]; Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer [P50 CA83636]; NATIONAL CANCER INSTITUTE [R01CA144057, R01CA136487, R01CA080192, P50CA083636] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072774] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants R01 CA080192 and R01 HLA078836 and Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer Grant P50 CA83636. We thank R. van Rensburg for critical comments and the Functional Genomics Core at the Center for Ecogenetics and Environmental Health, School of Public Health University of Washington for array analysis.	Abbod MF, 2009, EXPERT REV ANTICANC, V9, P867, DOI [10.1586/era.09.47, 10.1586/ERA.09.47]; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; COWIN P, 1994, P NATL ACAD SCI USA, V91, P10759, DOI 10.1073/pnas.91.23.10759; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; DIGUILMI AM, 1995, VIRUS RES, V38, P71, DOI 10.1016/0168-1702(95)00043-P; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2005, VIROLOGY, V340, P167, DOI 10.1016/j.virol.2005.06.030; Fleischli C, 2007, J GEN VIROL, V88, P2925, DOI 10.1099/vir.0.83142-0; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gaggar Anuj, 2007, Methods Mol Med, V131, P141; Gao WT, 2003, CANCER GENE THER, V10, pS21; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Green SK, 2002, CANCER RES, V62, P6891; Gustafsson DJ, 2006, J VIROL, V80, P1897, DOI 10.1128/JVI.80.4.1897-1905.2006; Harada H, 1996, ACTA DERM-VENEREOL, V76, P417; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Khatri P, 2006, NUCLEIC ACIDS RES, V34, pW626, DOI 10.1093/nar/gkl213; KOWALCZYK AP, 1994, BIOPHYS CHEM, V50, P97, DOI 10.1016/0301-4622(94)85023-2; Leopold PL, 2007, ADV DRUG DELIVER REV, V59, P810, DOI 10.1016/j.addr.2007.06.007; Li Z, 2009, BLOOD, V113, P5423, DOI 10.1182/blood-2008-10-187237; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Mahoney MG, 2002, EXP DERMATOL, V11, P115, DOI 10.1034/j.1600-0625.2002.110203.x; Marttila M, 2005, J VIROL, V79, P14429, DOI 10.1128/JVI.79.22.14429-14436.2005; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; NORRBY E., 1967, J VIROL, V1, P1101; Persson BD, 2009, J VIROL, V83, P673, DOI 10.1128/JVI.01967-08; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Segerman A, 2003, J VIROL, V77, P1157, DOI 10.1128/JVI.77.2.1157-1162.2003; Seppen J, 2001, BLOOD, V98, P594, DOI 10.1182/blood.V98.3.594; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Short JJ, 2004, VIROLOGY, V322, P349, DOI 10.1016/j.virol.2004.02.016; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Trojan L, 2005, ANTICANCER RES, V25, P183; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2008, J VIROL, V82, P10567, DOI 10.1128/JVI.01308-08; Wang HJ, 2007, J VIROL, V81, P12785, DOI 10.1128/JVI.01732-07; Wang HJ, 2010, BLOOD, V115, P592, DOI 10.1182/blood-2009-05-222463; Wang HJ, 2009, VIROLOGY, V387, P436, DOI 10.1016/j.virol.2009.02.034; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266	54	274	288	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					96	U273		10.1038/nm.2270	http://dx.doi.org/10.1038/nm.2270			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151137	Green Accepted			2022-12-27	WOS:000285994000041
J	Friedman, JM				Friedman, Jeffrey M.			A tale of two hormones	NATURE MEDICINE			English	Article							LEPTIN RECEPTOR; FOOD-INTAKE; OBESE GENE; PANCREAS; PROTEIN; CLONING		Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu						ALLEN F, 1955, COMMUNICATION   0324; Allen FM, 1913, STUDIES GLYCOSURIA D; ALLEN FM, 1913, STUDIES CONCERNING G, P815; [Anonymous], 1941, TIME            0317; Avraham KB, 2000, METH MOL B, V158, P369; Banting FG, 1922, J LAB CLIN MED, V7, P251; Banting FG, 1922, CAN MED ASSOC J, V7, P141; Barthold SW, 2004, ILAR J, V45, P227, DOI 10.1093/ilar.45.3.227; Benedict SR, 1911, J BIOL CHEM, V9, P57; Bernard C., 1855, LECONS PHYSL EXPT AP, DOI [10.5962/bhl.title.1818, DOI 10.5962/BHL.TITLE.1818]; Bliss M., 1982, DISCOVERY INSULIN; BLISS M, 1982, DISCOVERY INSULIN, P111; BLISS M, 1982, DISCOVERY INSULIN, P29; BLISS M, 1982, DISCOVERY INSULIN, P238; BLISS M, 1982, DISCOVERY INSULIN, P118; BLISS M, 1982, DISCOVERY INSULIN, P39; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHITTENDEN R, 1936, BIOGRAPHICAL MEMOIRS, V18, P123; COLE R, 1914, Q REPORT; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; CORNER G, 1964, HIST ROCKEFELLER I 1, P152; CORNER G, 1964, HIST ROCKEFELLER I 1, P28; Dickie M. M., 1957, MOUSE NEWS LETT, V17, P52; ELLIOT J, 1955, COMMUNICATION   0324; FRIEDMAN J, OBESITY IN PRESS; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; GLADWELL M, 2008, NEW YORKER      0312; GLADWELL M, 2005, NEW YORKER      1010; GOLDNER MG, 1972, ISRAEL J MED SCI, V8, P492; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HERVEY GR, 1959, J PHYSIOL-LONDON, V145, P336, DOI 10.1113/jphysiol.1959.sp006145; Hetherington AW, 1942, AM J PHYSIOL, V136, P609, DOI 10.1152/ajplegacy.1942.136.4.609; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; KLEINER I, 1919, COMMUNICATION   0804; KLEINER I, 1919, COMMUNICATION   0628; KLEINER I, 2010, COMMUNICATION   0327; KLEINER I, 1913, P AM PHYS SOC PHIL, V17; KLEINER I, 2009, STUDIES INTERMEDIARY; Kleiner IS, 1919, J BIOL CHEM, V40, P153; Kleiner IS, 1930, ENDOCRINOLOGY, V14, P226, DOI 10.1210/endo-14-4-226; Kleiner IS, 1915, P NATL ACAD SCI USA, V1, P338, DOI 10.1073/pnas.1.6.338; KLEINER IS, 1959, CLIN CHEM, V5, P79; KLEINER IS, 1914, P SOC EXP BIOL MED, V12, P58; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; MAYER J, 1951, J NUTR, V45, P3, DOI 10.1093/jn/45.1.1; MELTZER S, 1914, COMMUNICATION   0112; MELTZER S, 1919, MELTZERS Q REPORT S; Meltzer SJ, 1913, J AMER MED ASSOC, V60, P1407, DOI 10.1001/jama.1913.04340190001001; MERTON RK, 1961, P AM PHILOS SOC, V105, P470; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MURLIN J R, 1956, J Hist Med Allied Sci, V11, P288; MURRAY I, 1971, Journal of the History of Medicine and Allied Sciences, V26, P150; Murray I, 1969, Scott Med J, V14, P286; Myers VC, 1916, J BIOL CHEM, V24, P147; OPIE EL, 1900, J EXP MED, V5, P419; OREN D, 2001, JOINING CLUB HSIT JE, P121; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pratt JH, 1910, J AMER MED ASSOC, V55, P2112, DOI 10.1001/jama.1910.04330250008004; SAMUEL M, 1918, COMMUNICATION   0404; Scott EL., 1913, P SOC EXP BIOL MED, V10, P101; STILLMAN E, 1919, TOTAL DIETARY REGULA; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; VANSLYKE D, 1955, COMMUNICATION   0324; von Mering J., 1890, ARCH EXP PATHOL PH, V26, P371, DOI DOI 10.1007/BF01831214; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zulzer G, 1908, J EXP PATHOL, V5, P307; 1916, NY TIMES        0213; 1923, TIME            1022; 1915, NY TIMES        0812	72	44	46	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1100	1106		10.1038/nm1010-1100	http://dx.doi.org/10.1038/nm1010-1100			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930753				2022-12-27	WOS:000282644800038
J	Berkley, S; Bertram, K; Delfraissy, JF; Draghia-Akli, R; Fauci, A; Hallenbeck, C; Kagame, MJ; Kim, P; Mafubelu, D; Makgoba, MW; Piot, P; Walport, M; Warren, M; Yamada, T; Esparza, J; Hankins, C; Johnston, MI; Levy, Y; Romaris, M; Ahmed, R; Bernstein, A				Berkley, Seth; Bertram, Kenneth; Delfraissy, Jean-Francois; Draghia-Akli, Ruxandra; Fauci, Anthony; Hallenbeck, Cynthia; Kagame, Madame Jeannette; Kim, Peter; Mafubelu, Daisy; Makgoba, Malegapuru W.; Piot, Peter; Walport, Mark; Warren, Mitchell; Yamada, Tadataka; Esparza, Jose; Hankins, Catherine; Johnston, Margaret I.; Levy, Yves; Romaris, Manuel; Ahmed, Rafi; Bernstein, Alan		Council Global HIV Vaccine Enterpr	The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise	NATURE MEDICINE			English	Article							YELLOW-FEVER VACCINE; MONOCLONAL-ANTIBODIES; CELL RESPONSES; IMMUNOLOGY; CHALLENGES; PROTECTION; INFECTION; EFFICACY		[Berkley, Seth] IAVI, New York, NY USA; [Bertram, Kenneth] MHRP, Rockville, MD USA; [Delfraissy, Jean-Francois; Levy, Yves] ANRS, Paris, France; [Draghia-Akli, Ruxandra; Romaris, Manuel] European Commiss, Brussels, Belgium; [Fauci, Anthony; Johnston, Margaret I.] NIAID, NIH, Bethesda, MD 20892 USA; [Hallenbeck, Cynthia] Enterprise Secretary Treasurer, New York, NY USA; [Kagame, Madame Jeannette] First Lady Rwanda, Kigali, Rwanda; [Kim, Peter] Merck Res Labs, Rahway, NJ USA; [Mafubelu, Daisy; Hankins, Catherine] WHO UNAIDS, Geneva, Switzerland; [Makgoba, Malegapuru W.] Univ KwaZulu Natal, Durban, South Africa; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Walport, Mark] Wellcome Trust Res Labs, London, England; [Warren, Mitchell] AVAC Global Advocacy HIV Prevent, New York, NY USA; [Yamada, Tadataka; Esparza, Jose] Bill & Melinda Gates Fdn, Seattle, WA USA; [Bernstein, Alan] Global HIV Vaccine Enterprise, New York, NY USA; [Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Merck & Company; UNAIDS; World Health Organization; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation; Emory University; Emory University	Berkley, S (corresponding author), IAVI, New York, NY USA.	abernstein@vaccineenterprise.org		Walport, Mark/0000-0001-7220-5273; Draghia-Akli, Ruxandra/0000-0001-6372-4039; Hankins, Catherine/0000-0002-1642-8592				BAROUCH DH, 2010, PREPRINT; Bhan MK, 2005, PLOS MED, V2, P111, DOI 10.1371/journal.pmed.0020025; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; CENTRES R, 2007, LANCET, V370, P1665; [Committee on Science Engineering and Public Policy (US) Committee on Ensuring the Utility and Integrity of Research Data in a Digital Age], 2009, ENS INT ACC STEW RES; COREY L, 2010, PREPRINT; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; *HIV VACC MICR RES, 2010, ADV SCI TIM FISC CON; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; MASCOLA J, 2010, PREPRINT; McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004; MCMICHAEL A, 2010, PREPRINT; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Noorani S, 2007, GOOD PART PRACT GUID; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; PULENDRAN B, 2010, PREPRINT; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBINSON ET, 2010, COMMUNICATIONS HDB C; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; UNAIDS, 2009, AIDS EP UPD NOV 2009; UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Woodman Z, 2009, CURR OPIN HIV AIDS, V4, P247, DOI 10.1097/COH.0b013e32832c0672; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	46	31	33	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					981	989		10.1038/nm0910-981	http://dx.doi.org/10.1038/nm0910-981			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823883	Bronze			2022-12-27	WOS:000281622900025
J	Warren, TK; Warfield, KL; Wells, J; Swenson, DL; Donner, KS; Van Tongeren, SA; Garza, NL; Dong, LA; Mourich, DV; Crumley, S; Nichols, DK; Iversen, PL; Bavari, S				Warren, Travis K.; Warfield, Kelly L.; Wells, Jay; Swenson, Dana L.; Donner, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Dong, Lian; Mourich, Dan V.; Crumley, Stacy; Nichols, Donald K.; Iversen, Patrick L.; Bavari, Sina			Advanced antisense therapies for postexposure protection against lethal filovirus infections	NATURE MEDICINE			English	Article							EBOLA HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; VIRUS INFECTION; MARBURG VIRUSES; MOUSE MODEL; GUINEA-PIGS; PATHOGENESIS; EFFICACY; MONKEYS	Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects >60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.	[Warren, Travis K.; Warfield, Kelly L.; Wells, Jay; Swenson, Dana L.; Donner, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Dong, Lian; Nichols, Donald K.; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Mourich, Dan V.; Crumley, Stacy; Iversen, Patrick L.] AVI Biopharma, Corvallis, OR USA		Bavari, S (corresponding author), USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	piversen@avibio.com; sina.bavari@amedd.army.mil	Iversen, Patrick L./L-5454-2019; Bavari, Sina/L-3642-2019; Iversen, Patrick L/D-8854-2019	Iversen, Patrick L./0000-0003-0106-9790; Bavari, Sina/0000-0001-8424-5635; Iversen, Patrick L/0000-0003-0106-9790	US Defense Threat Reduction Agency [HDTRA1-07-C-010, 4.10022-08-RD-B, TMTI0048-09-RD-T]	US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	We thank C. Rice, D. Reed, N. Posten and J. Stockman for technical assistance and M. Ait Ichou and J. Hardick for their help in the initial viral quantification studies. S. Norris and D. Fisher provided statistical assistance and conducted animal randomization procedures. L. Welch, S. Bradfute, R. Panchal and J. Kuhn provided support and discussions and critically reviewed the manuscript. These studies were supported by the US Defense Threat Reduction Agency awarded to AVI BioPharma (HDTRA1-07-C-010) and S. B. (4.10022-08-RD-B and TMTI0048-09-RD-T).	Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; BOWEN ETW, 1978, T ROY SOC TROP MED H, V72, P188, DOI 10.1016/0035-9203(78)90058-5; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; FISHERHOCH SP, 1985, J INFECT DIS, V152, P887, DOI 10.1093/infdis/152.5.887; FISHERHOCH SP, 1983, LANCET, V2, P1055; Geisbert TW, 2008, J VIROL, V82, P5664, DOI 10.1128/JVI.00456-08; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; Geisbert TW, 2010, EMERG INFECT DIS, V16, P1119, DOI 10.3201/eid1607.100159; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Iversen P, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P375; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Swenson DL, 2009, ANTIMICROB AGENTS CH, V53, P2089, DOI 10.1128/AAC.00936-08; Warfield K.L., 2006, BIODEFENSE RES METHO, P227; Warfield Kelly L., 2006, PLoS Pathogens, V2, P5; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09	20	149	167	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					991	994		10.1038/nm.2202	http://dx.doi.org/10.1038/nm.2202			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20729866				2022-12-27	WOS:000281622900026
J	Westly, E				Westly, Erica			When powerhouses fail	NATURE MEDICINE			English	News Item							MITOCHONDRIAL-DNA; DISEASE											Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schiff M, 2009, J INHERIT METAB DIS, V32, P684, DOI 10.1007/s10545-009-1263-0; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368	6	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					625	627		10.1038/nm0610-625	http://dx.doi.org/10.1038/nm0610-625			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526309				2022-12-27	WOS:000278394200020
J	Liddy, N; Bossi, G; Adams, KJ; Lissina, A; Mahon, TM; Hassan, NJ; Gavarret, J; Bianchi, FC; Pumphrey, NJ; Ladell, K; Gostick, E; Sewell, AK; Lissin, NM; Harwood, NE; Molloy, PE; Li, Y; Cameron, BJ; Sami, M; Baston, EE; Todorov, PT; Paston, SJ; Dennis, RE; Harper, JV; Dunn, SM; Ashfield, R; Johnson, A; McGrath, Y; Plesa, G; June, CH; Kalos, M; Price, DA; Vuidepot, A; Williams, DD; Sutton, DH; Jakobsen, BK				Liddy, Nathaniel; Bossi, Giovanna; Adams, Katherine J.; Lissina, Anna; Mahon, Tara M.; Hassan, Namir J.; Gavarret, Jessie; Bianchi, Frayne C.; Pumphrey, Nicholas J.; Ladell, Kristin; Gostick, Emma; Sewell, Andrew K.; Lissin, Nikolai M.; Harwood, Naomi E.; Molloy, Peter E.; Li, Yi; Cameron, Brian J.; Sami, Malkit; Baston, Emma E.; Todorov, Penio T.; Paston, Samantha J.; Dennis, Rebecca E.; Harper, Jane V.; Dunn, Steve M.; Ashfield, Rebecca; Johnson, Andy; McGrath, Yvonne; Plesa, Gabriela; June, Carl H.; Kalos, Michael; Price, David A.; Vuidepot, Annelise; Williams, Daniel D.; Sutton, Deborah H.; Jakobsen, Bent K.			Monoclonal TCR-redirected tumor cell killing	NATURE MEDICINE			English	Article							CYTOTOXIC T-LYMPHOCYTES; ANTIBODY THERAPY; HIGH-AFFINITY; DIRECTED EVOLUTION; PEPTIDE EPITOPES; PHAGE DISPLAY; CANCER; ANTIGEN; RECEPTOR; MELANOMA	T cell immunity can potentially eradicate malignant cells and lead to clinical remission in a minority of patients with cancer. In the majority of these individuals, however, there is a failure of the specific T cell receptor (TCR)-mediated immune recognition and activation process. Here we describe the engineering and characterization of new reagents termed immune-mobilizing monoclonal TCRs against cancer (ImmTACs). Four such ImmTACs, each comprising a distinct tumor-associated epitope-specific monoclonal TCR with picomolar affinity fused to a humanized cluster of differentiation 3 (CD3)-specific single-chain antibody fragment (scFv), effectively redirected T cells to kill cancer cells expressing extremely low surface epitope densities. Furthermore, these reagents potently suppressed tumor growth in vivo. Thus, ImmTACs overcome immune tolerance to cancer and represent a new approach to tumor immunotherapy.	[Liddy, Nathaniel; Bossi, Giovanna; Adams, Katherine J.; Mahon, Tara M.; Hassan, Namir J.; Gavarret, Jessie; Bianchi, Frayne C.; Pumphrey, Nicholas J.; Lissin, Nikolai M.; Harwood, Naomi E.; Molloy, Peter E.; Li, Yi; Cameron, Brian J.; Sami, Malkit; Baston, Emma E.; Todorov, Penio T.; Paston, Samantha J.; Dennis, Rebecca E.; Harper, Jane V.; Dunn, Steve M.; Ashfield, Rebecca; Johnson, Andy; McGrath, Yvonne; Vuidepot, Annelise; Williams, Daniel D.; Sutton, Deborah H.; Jakobsen, Bent K.] Immunocore Ltd, Abingdon, Oxon, England; [Lissina, Anna; Ladell, Kristin; Gostick, Emma; Sewell, Andrew K.; Price, David A.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Plesa, Gabriela; June, Carl H.; Kalos, Michael] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Cardiff University; University of Pennsylvania	Jakobsen, BK (corresponding author), Immunocore Ltd, Abingdon, Oxon, England.	bent.jakobsen@immunocore.com	Ladell, Kristin/C-8301-2013; Price, David A/C-7876-2013; Ladell, Kristin/K-2475-2013; Sewell, Andrew/GPT-4220-2022	Ladell, Kristin/0000-0002-9856-2938; Price, David A/0000-0001-9416-2737; Sewell, Andrew/0000-0003-3194-3135; Molloy, Peter/0000-0002-0238-4744	Sanofi Pasteur; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish	Sanofi Pasteur; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank Sanofi Pasteur for funding affinity maturation of the gp100 and MAGE-A3 mTCRs; C. Yee (Fred Hutchinson Cancer Research Centre, Seattle, Washington, USA), P. Coulie (University of Louvain, Brussels, Belgium) and V. Cerundolo (Weatherall Institute of Molecular Medicine, University of Oxford, UK) for providing T cell clones; Southern Research and Cellvax for conducting mouse xenograft experiments; Southern Research for immunohistochemistry staining; R. Liu for assistance with mouse imaging and tumor measurements; K. Haines (Translational and Correlative Studies Laboratory, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA) for technical support; and A. Secreto, C. Keefer and G. Danet-Desnoyers (Stem Cell and Xenograft Core, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA) for assistance with the established tumor xenograft studies.	ADEMA GJ, 1993, AM J PATHOL, V143, P1579; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Benowitz S, 2008, J NATL CANCER I, V100, P237, DOI 10.1093/jnci/djn030; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; CELIS E, 1994, P NATL ACAD SCI USA, V91, P2105, DOI 10.1073/pnas.91.6.2105; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; ISAACS JD, 1992, LANCET, V340, P748, DOI 10.1016/0140-6736(92)92294-P; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kiewe P, 2006, CLIN CANCER RES, V12, P3085, DOI 10.1158/1078-0432.CCR-05-2436; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; Moysey R, 2004, ANAL BIOCHEM, V326, P284, DOI 10.1016/j.ab.2003.12.011; Price DA, 1999, IMMUNOL TODAY, V20, P212, DOI 10.1016/S0167-5699(99)01447-4; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Schietinger A, 2010, J EXP MED, V207, P2469, DOI 10.1084/jem.20092450; Sebastian M, 2009, J IMMUNOTHER, V32, P195, DOI 10.1097/CJI.0b013e318195b5bb; von Mehren M, 2003, ANNU REV MED, V54, P343, DOI 10.1146/annurev.med.54.101601.152442; Withoff S, 2001, CURR OPIN MOL THER, V3, P53	40	195	237	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					980	+		10.1038/nm.2764	http://dx.doi.org/10.1038/nm.2764			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561687				2022-12-27	WOS:000305116600038
J	Provasi, E; Genovese, P; Lombardo, A; Magnani, Z; Liu, PQ; Reik, A; Chu, V; Paschon, DE; Zhang, L; Kuball, J; Camisa, B; Bondanza, A; Casorati, G; Ponzoni, M; Ciceri, F; Bordignon, C; Greenberg, PD; Holmes, MC; Gregory, PD; Naldini, L; Bonini, C				Provasi, Elena; Genovese, Pietro; Lombardo, Angelo; Magnani, Zulma; Liu, Pei-Qi; Reik, Andreas; Chu, Victoria; Paschon, David E.; Zhang, Lei; Kuball, Jurgen; Camisa, Barbara; Bondanza, Attilio; Casorati, Giulia; Ponzoni, Maurilio; Ciceri, Fabio; Bordignon, Claudio; Greenberg, Philip D.; Holmes, Michael C.; Gregory, Philip D.; Naldini, Luigi; Bonini, Chiara			Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer	NATURE MEDICINE			English	Article							VERSUS-HOST-DISEASE; ENHANCED ANTITUMOR-ACTIVITY; METASTATIC MELANOMA; RECEPTOR EXPRESSION; CANCER REGRESSION; TCR CHAINS; THERAPY; MEMORY; LYMPHOCYTES; DIFFERENTIATION	The transfer of high-avidity T cell receptor (TCR) genes isolated from rare tumor-specific lymphocytes into polyclonal T cells is an attractive cancer immunotherapy strategy. However, TCR gene transfer results in competition for surface expression and inappropriate pairing between the exogenous and endogenous TCR chains, resulting in suboptimal activity and potentially harmful unpredicted antigen specificities of the resultant TCRs. We designed zinc-finger nucleases (ZFNs) that promoted the disruption of endogenous TCR beta- and alpha-chain genes. Lymphocytes treated with ZFNs lacked surface expression of CD3-TCR and expanded with the addition of interleukin-7 (IL-7) and IL-15. After lentiviral transfer of a TCR specific for the Wilms tumor 1 (WT1) antigen, these TCR-edited cells expressed the new TCR at high levels, were easily expanded to near purity and were superior at specific antigen recognition compared to donor-matched, unedited TCR-transferred cells. In contrast to unedited TCR-transferred cells, the TCR-edited lymphocytes did not mediate off-target reactivity while maintaining their anti-tumor activity in vivo, thus showing that complete editing of T cell specificity generates tumor-specific lymphocytes with improved biosafety profiles.	[Provasi, Elena; Magnani, Zulma; Camisa, Barbara; Bondanza, Attilio; Ciceri, Fabio; Bonini, Chiara] Ist Sci San Raffaele, Leukemia Unit, Program Immunol Gene Therapy & Bioimmunotherapy C, Expt Hematol Unit,Div Regenerat Med Gene Therapy, I-20132 Milan, Italy; [Provasi, Elena; Genovese, Pietro; Bordignon, Claudio; Naldini, Luigi; Bonini, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Genovese, Pietro; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Genovese, Pietro; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, Div Regenerat Med Gene Therapy & Stem Cells, I-20132 Milan, Italy; [Liu, Pei-Qi; Reik, Andreas; Chu, Victoria; Paschon, David E.; Zhang, Lei; Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA USA; [Kuball, Jurgen; Greenberg, Philip D.] Univ Washington, Seattle, WA 98195 USA; [Kuball, Jurgen; Greenberg, Philip D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Casorati, Giulia] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, Program Immunol Gene Therapy & Bioimmunotherapy C, I-20132 Milan, Italy; [Ponzoni, Maurilio] Ist Sci San Raffaele, Leukemia Unit, Dept Pathol, I-20132 Milan, Italy; [Ciceri, Fabio; Bonini, Chiara] Ist Sci San Raffaele, Hematol Clin Unit, Div Regenerat Med Gene Therapy & Stem Cells, I-20132 Milan, Italy; [Bordignon, Claudio] MolMed SpA, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sangamo Therapeutics, Inc.; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bonini, C (corresponding author), Ist Sci San Raffaele, Leukemia Unit, Program Immunol Gene Therapy & Bioimmunotherapy C, Expt Hematol Unit,Div Regenerat Med Gene Therapy, I-20132 Milan, Italy.	naldini.luigi@hsr.it; bonini.chiara@hsr.it	Magnani, Zulma Irene/AAN-7588-2020; Naldini, Luigi/E-9083-2012; bonini, chiara/I-9202-2012; lombardo, angelo/J-6241-2016; camisa, barbara/AAN-1897-2020; Genovese, Pietro/H-3710-2018; Casorati, Giulia/J-7141-2018	Magnani, Zulma Irene/0000-0001-7612-6097; lombardo, angelo/0000-0001-8262-042X; camisa, barbara/0000-0002-3867-2457; Genovese, Pietro/0000-0001-9507-9003; BONINI, Maria Chiara/0000-0002-0772-1674; Gregory, Philip/0000-0001-9249-2468; Casorati, Giulia/0000-0002-5102-4112; NALDINI, Luigi/0000-0002-7835-527X	Italian Ministry of Health [GR07-5 BO, RO10/07-B-1]; Italian Ministry of Research and University (FIRB-IDEAS); Fondazione Cariplo; Italian Association for Cancer Research (AIRC); EU (ERC) [GA 222878, 249845]; AIRC; Italian Telethon [TELE11/12-D2]; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research and University (FIRB-IDEAS); Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); EU (ERC)(European Research Council (ERC)European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. Rebar, J. Miller, D. Guschin, E. Leung, X. Meng, S. Hinkley, S. Lam, A. Hassenberg, Z. Zhang, C. Flinders and A. Tam for help in the generation of the TCR-specific ZFNs and the off-target analysis using SELEX, L. Sergi for technical assistance in vector production, M. Bernardi, M.T. Lupo-Stanghellini, A. Forcina, C. Traversari and all of the individuals at the Naldini and Bonini laboratories for fruitful discussion, and C. Tresoldi and the San Raffaele Scientific Institute Leukemia Biobanking for assistance. E. P. and P. G. conducted this study as partial fulfillment of their PhD in molecular medicine at the Program in Immunology, San Raffaele University, Milan, Italy. This work was supported by the Italian Ministry of Health (GR07-5 BO and RO10/07-B-1), the Italian Ministry of Research and University (FIRB-IDEAS, linked to European Research Council (ERC) starting grants), Fondazione Cariplo and the Italian Association for Cancer Research (AIRC) to C. Bonini and by the EU (FP7: GA 222878, PERSIST and ERC advanced grant 249845 TARGETINGGENETHERAPY), AIRC, Italian Ministry of Health (Challenge in Oncology) and Italian Telethon (TELE11/12-D2) to L.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Cooke KR, 2001, J CLIN INVEST, V107, P1581, DOI 10.1172/JCI12156; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Heslop HE, 2010, BLOOD, V115, P925, DOI 10.1182/blood-2009-08-239186; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Sacre K, 2005, J EXP MED, V201, P1999, DOI 10.1084/jem.20042408; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Loenen MM, 2010, P NATL ACAD SCI USA, V107, P10972, DOI 10.1073/pnas.1005802107	37	325	369	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					807	U212		10.1038/nm.2700	http://dx.doi.org/10.1038/nm.2700			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22466705	Green Accepted			2022-12-27	WOS:000303763500049
J	Russell, AJ; Hartman, JJ; Hinken, AC; Muci, AR; Kawas, R; Driscoll, L; Godinez, G; Lee, KH; Marquez, D; Browne, WF; Chen, MM; Clarke, D; Collibee, SE; Garard, M; Hansen, R; Jia, ZH; Lu, PP; Rodriguez, H; Saikali, KG; Schaletzky, J; Vijayakumar, V; Albertus, DL; Claflin, DR; Morgans, DJ; Morgan, BP; Malik, FI				Russell, Alan J.; Hartman, James J.; Hinken, Aaron C.; Muci, Alexander R.; Kawas, Raja; Driscoll, Lena; Godinez, Guillermo; Lee, Kenneth H.; Marquez, David; Browne, William F.; Chen, Michael M.; Clarke, David; Collibee, Scott E.; Garard, Marc; Hansen, Richard; Jia, Zhiheng; Lu, Pu-Ping; Rodriguez, Hector; Saikali, Khalil G.; Schaletzky, Julia; Vijayakumar, Vipin; Albertus, Daniel L.; Claflin, Dennis R.; Morgans, David J.; Morgan, Bradley P.; Malik, Fady I.			Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MYASTHENIA-GRAVIS; MOTOR-UNIT; MYOSIN; FIBERS; PURIFICATION; CONTRACTION; TROPOMYOSIN; MYOFIBRILS; FATIGUE	Limited neural input results in muscle weakness in neuromuscular disease because of a reduction in the density of muscle innervation, the rate of neuromuscular junction activation or the efficiency of synaptic transmission(1). We developed a small-molecule fast-skeletal-troponin activator, CK-2017357, as a means to increase muscle strength by amplifying the response of muscle when neural input is otherwise diminished secondary to neuromuscular disease. Binding selectively to the fast-skeletal-troponin complex, CK-2017357 slows the rate of calcium release from troponin C and sensitizes muscle to calcium. As a consequence, the force-calcium relationship of muscle fibers shifts leftwards, as does the force-frequency relationship of a nerve-muscle pair, so that CK-2017357 increases the production of muscle force in situ at sub-maximal nerve stimulation rates. Notably, we show that sensitization of the fast-skeletal-troponin complex to calcium improves muscle force and grip strength immediately after administration of single doses of CK-2017357 in a model of the neuromuscular disease myasthenia gravis. Troponin activation may provide a new therapeutic approach to improve physical activity in diseases where neuromuscular function is compromised.	[Russell, Alan J.; Hartman, James J.; Hinken, Aaron C.; Muci, Alexander R.; Kawas, Raja; Driscoll, Lena; Godinez, Guillermo; Lee, Kenneth H.; Marquez, David; Browne, William F.; Clarke, David; Collibee, Scott E.; Garard, Marc; Hansen, Richard; Jia, Zhiheng; Lu, Pu-Ping; Rodriguez, Hector; Schaletzky, Julia; Vijayakumar, Vipin; Morgans, David J.; Morgan, Bradley P.; Malik, Fady I.] Preclin Res & Dev, San Francisco, CA USA; [Chen, Michael M.; Saikali, Khalil G.] Cytokinet Inc, Biometr, San Francisco, CA USA; [Albertus, Daniel L.; Claflin, Dennis R.] Univ Michigan, Dept Surg, Sect Plast Surg, Ann Arbor, MI 48109 USA; [Albertus, Daniel L.; Claflin, Dennis R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Malik, FI (corresponding author), Preclin Res & Dev, San Francisco, CA USA.	fmalik@cytokinetics.com		Claflin, Dennis/0000-0001-8044-0142; Russell, Alan/0000-0001-7545-5008	Cytokinetics, Inc.; National Institute of Neurological Disorders and Stroke [1RC3NS070670-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC3NS070670] Funding Source: NIH RePORTER	Cytokinetics, Inc.; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Cytokinetics, Inc. and by award number 1RC3NS070670-01 (F. I. M.) from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the US National Institutes of Health.	Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Claflin DR, 2011, J APPL PHYSIOL, V111, P1021, DOI 10.1152/japplphysiol.01119.2010; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; EBASHI S, 1967, J BIOCHEM-TOKYO, V62, P137, DOI 10.1093/oxfordjournals.jbchem.a128628; Erim Z, 1999, J NEUROPHYSIOL, V82, P2081, DOI 10.1152/jn.1999.82.5.2081; FREUND HJ, 1983, PHYSIOL REV, V63, P387, DOI 10.1152/physrev.1983.63.2.387; HERRMANN C, 1993, BIOCHEMISTRY-US, V32, P7255, DOI 10.1021/bi00079a023; JASMIN BJ, 1987, J APPL PHYSIOL, V63, P713, DOI 10.1152/jappl.1987.63.2.713; Jimenez-Moreno R, 2008, BIOPHYS J, V94, P3178, DOI 10.1529/biophysj.107.118786; Kent-Braun JA, 2000, MUSCLE NERVE, V23, P909, DOI 10.1002/(SICI)1097-4598(200006)23:6<909::AID-MUS10>3.0.CO;2-V; LINDSTROM JM, 1976, J EXP MED, V144, P739, DOI 10.1084/jem.144.3.739; Ling SM, 2009, ARCH PHYS MED REHAB, V90, P1237, DOI 10.1016/j.apmr.2008.09.565; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Pollard T. D., 2008, CELL BIOL; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Research Group in Neuromuscular Diseases, 1968, LANCET, V291, P1020; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; ROSENFELD SS, 1985, J BIOL CHEM, V260, P242; Sharma KR, 1996, MUSCLE NERVE, V19, P1391, DOI 10.1002/(SICI)1097-4598(199611)19:11<1391::AID-MUS3>3.3.CO;2-A; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; YOUNG OA, 1981, BIOCHEM J, V195, P317, DOI 10.1042/bj1950317	32	95	100	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					452	U216		10.1038/nm.2618	http://dx.doi.org/10.1038/nm.2618			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344294	Green Accepted			2022-12-27	WOS:000301264800049
J	Ting, JT; Feng, GP				Ting, Jonathan T.; Feng, Guoping			Found in translation	NATURE MEDICINE			English	Editorial Material							X MENTAL-RETARDATION; MESSENGER-RNAS; MOUSE MODEL; PROTEIN; FMRP; ASSOCIATION		[Ting, Jonathan T.; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Stanley Ctr Psychiat Res,Broad Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ting, JT (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Stanley Ctr Psychiat Res,Broad Inst, E25-618, Cambridge, MA 02139 USA.	fengg@mit.edu	Feng, Guoping/Y-2827-2019	Ting, Jonathan/0000-0001-8266-0392				Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Feng Y, 1997, J NEUROSCI, V17, P1539; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Sherman S. L., 2002, FRAGILE X SYNDROME D, P136; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758	15	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1352	1353		10.1038/nm.2553	http://dx.doi.org/10.1038/nm.2553			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064412				2022-12-27	WOS:000296779300025
J	Buckingham, SC; Campbell, SL; Haas, BR; Montana, V; Robel, S; Ogunrinu, T; Sontheimer, H				Buckingham, Susan C.; Campbell, Susan L.; Haas, Brian R.; Montana, Vedrana; Robel, Stefanie; Ogunrinu, Toyin; Sontheimer, Harald			Glutamate release by primary brain tumors induces epileptic activity	NATURE MEDICINE			English	Article							MALIGNANT GLIOMAS; EXTRACELLULAR MAGNESIUM; EPILEPTOGENESIS; TRANSPORTER; INVASION; SEIZURE; GROWTH; CELLS; MICRODIALYSIS; SULFASALAZINE	Epileptic seizures are a common and poorly understood comorbidity for individuals with primary brain tumors. To investigate peritumoral seizure etiology, we implanted human-derived glioma cells into severe combined immunodeficient mice. Within 14-18 d, glioma-bearing mice developed spontaneous and recurring abnormal electroencephalogram events consistent with progressive epileptic activity. Acute brain slices from these mice showed marked glutamate release from the tumor mediated by the system x(c)(-) cystine-glutamate transporter (encoded by Slc7a11). Biophysical and optical recordings showed glutamatergic epileptiform hyperexcitability that spread into adjacent brain tissue. We inhibited glutamate release from the tumor and the ensuing hyperexcitability by sulfasalazine (SAS), a US Food and Drug Administration-approved drug that blocks system x(c)(-). We found that acute administration of SAS at concentrations equivalent to those used to treat Crohn's disease in humans reduced epileptic event frequency in tumor-bearing mice compared with untreated controls. SAS should be considered as an adjuvant treatment to ameliorate peritumoral seizures associated with glioma in humans.	[Buckingham, Susan C.; Campbell, Susan L.; Haas, Brian R.; Montana, Vedrana; Robel, Stefanie; Ogunrinu, Toyin; Sontheimer, Harald] Univ Alabama, Dept Neurobiol, Ctr Glial Biol Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), Univ Alabama, Dept Neurobiol, Ctr Glial Biol Med, Birmingham, AL 35294 USA.	sontheimer@uab.edu	Robel, Stefanie/G-2924-2011; Robel, Stefanie/AAA-7166-2019	Robel, Stefanie/0000-0001-6716-3670; Sontheimer, Harald/0000-0002-5843-9871	National Center for Research Resources [S10 RR19231]; US National Institutes of Health [U54 CA 100949, P50 AT00477, P30 DK079337, P30 AR50948, 2R01-NS052634, 5R01-NS036692, 5T32NS048039-03]; Neuroscience Blueprint Core Grant [NS57098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA097247, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039, P30NS057098, R01NS052634, R01NS036692] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint Core Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank J. Hablitz and A. Albertson for technical assistance with diode array recordings; A. Margolies for help with histology; C. Langford for orthotopic xenografts; V. Cuddapah for editorial advice; M. McFerrin for technical support, and E. Dudek and K. Wilson at the University of Utah for training in EEG acquisition. We conducted glutamate measurements at the University of Alabama at Birmingham Targeted Metabolomics and Proteomics Facility (funded by the National Center for Research Resources grant S10 RR19231 and US National Institutes of Health grants U54 CA 100949, P50 AT00477, P30 DK079337 and P30 AR50948). We obtained bioluminescence imaging and some field electrode recordings in the Neuroscience Blueprint Core facility (Neuroscience Blueprint Core Grant NS57098). We obtained U251-MG cells from Y. Gillespie (University of Alabama at Birmingham) and U251-MGffluc cells from M. Jensen (City of Hope National Medical Center); GBM12 and GBM22 tumors were obtained from J. Sarkaria (Mayo Clinic) and provided by the University of Alabama at Birmingham Brain Tumor Animal Models Core (UAB SPORE P50-CA097247). This work was supported by US National Institutes of Health grants 2R01-NS052634, 5R01-NS036692 and 5T32NS048039-03.	Behrens PF, 2000, J NEURO-ONCOL, V47, P11, DOI 10.1023/A:1006426917654; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Vries NA, 2009, CANCER TREAT REV, V35, P714, DOI 10.1016/j.ctrv.2009.08.011; DeFazio RA, 2005, DEV BRAIN RES, V157, P83, DOI 10.1016/j.devbrainres.2005.03.008; DURING MJ, 1993, LANCET, V341, P1607; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; JONES RSG, 1989, EXP NEUROL, V104, P155, DOI 10.1016/S0014-4886(89)80009-3; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Kohling R, 2006, NEUROBIOL DIS, V22, P64, DOI 10.1016/j.nbd.2005.10.001; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; MELDRUM BS, 1994, NEUROLOGY, V44, P14; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; MOOTS PL, 1995, ARCH NEUROL-CHICAGO, V52, P717, DOI 10.1001/archneur.1995.00540310091021; Patt S, 2000, NEUROBIOL DIS, V7, P260, DOI 10.1006/nbdi.2000.0288; Robe PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-372; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Senner V, 2004, ACTA NEUROPATHOL, V107, P1, DOI 10.1007/s00401-003-0771-5; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; van Breemen MSM, 2009, J NEUROL, V256, P1519, DOI 10.1007/s00415-009-5156-9; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; ZHENG W, 1993, DRUG METAB DISPOS, V21, P1091	34	303	310	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1269	U299		10.1038/nm.2453	http://dx.doi.org/10.1038/nm.2453			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21909104	Green Accepted			2022-12-27	WOS:000296022100045
J	Yang, XD; Ai, W; Asfaha, S; Bhagat, G; Friedman, RA; Jin, GC; Park, H; Shykind, B; Diacovo, TG; Falus, A; Wang, TC				Yang, Xiang Dong; Ai, Walden; Asfaha, Samuel; Bhagat, Govind; Friedman, Richard A.; Jin, Guangchun; Park, Heuijoon; Shykind, Benjamin; Diacovo, Thomas G.; Falus, Andras; Wang, Timothy C.			Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b(+)Ly6G(+) immature myeloid cells	NATURE MEDICINE			English	Article							L-HISTIDINE DECARBOXYLASE; TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; T-CELL; TRANSCRIPTIONAL REGULATION; COLORECTAL-CANCER; CPG METHYLATION; RISK; POLARIZATION; EXPRESSION	Histidine decarboxylase (HDC), the unique enzyme responsible for histamine generation, is highly expressed in myeloid cells, but its function in these cells is poorly understood. Here we show that Hdc-knockout mice show a high rate of colon and skin carcinogenesis. Using Hdc-EGFP bacterial artificial chromosome (BAC) transgenic mice in which EGFP expression is controlled by the Hdc promoter, we show that Hdc is expressed primarily in CD11b(+)Ly6G(+) immature myeloid cells (IMCs) that are recruited early on in chemical carcinogenesis. Transplant of Hdc-deficient bone marrow to wild-type recipients results in increased CD11b(+)Ly6G(+) cell mobilization and reproduces the cancer susceptibility phenotype of Hdc-knockout mice. In addition, Hdc-deficient IMCs promote the growth of tumor allografts, whereas mouse CT26 colon cancer cells downregulate Hdc expression through promoter hypermethylation and inhibit myeloid cell maturation. Exogenous histamine induces the differentiation of IMCs and suppresses their ability to support the growth of tumor allografts. These data indicate key roles for Hdc and histamine in myeloid cell differentiation and CD11b(+)Ly6G(+) IMCs in early cancer development.	[Yang, Xiang Dong; Ai, Walden; Asfaha, Samuel; Jin, Guangchun; Park, Heuijoon; Wang, Timothy C.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY 10027 USA; [Yang, Xiang Dong; Ai, Walden; Asfaha, Samuel; Jin, Guangchun; Park, Heuijoon; Wang, Timothy C.] Columbia Univ, Irving Canc Ctr, New York, NY USA; [Ai, Walden] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Bhagat, Govind] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Friedman, Richard A.] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Shykind, Benjamin] Columbia Univ, Dept Neurosci, New York, NY USA; [Diacovo, Thomas G.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Falus, Andras] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary	Columbia University; Columbia University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Columbia University; Columbia University; Columbia University; Columbia University; Semmelweis University	Wang, TC (corresponding author), Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY 10027 USA.	tcw21@columbia.edu	Bhagat, Govind/AAE-9493-2021; Asfaha, Samuel/I-8245-2015	Bhagat, Govind/0000-0001-6250-048X; Asfaha, Samuel/0000-0001-6972-0338; Falus, Andras/0000-0002-6843-6789; Wang, Timothy/0000-0001-5730-3019	US National Institutes of Health [RO1 DK048077, RO1 DK52778, U54 CA126513]; Canadian Institutes for Health Research; Alberta Heritage Foundation; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048077, R01DK052778] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S.P. Tu, S.W. Wang, S. Takaishi and H. Tomita for their helpful contributions. We thank K.S. Betz for her help with animal procedures. We are grateful to A. Leiter (University of Massachusetts) for the PKD4-NICD-EGFP plasmid. RAGE-knockout mice were kindly provided by A.M. Schmidt (Columbia University). This work was funded by the US National Institutes of Health grants RO1 DK048077, RO1 DK52778 and U54 CA126513. S.A. was supported by a Canadian Institutes for Health Research Clinician Scientist Award and Alberta Heritage Foundation for Medical Research Clinical Fellowship.	Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bolton E, 2000, SEMIN CANCER BIOL, V10, P3, DOI 10.1006/scbi.2000.0301; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gandini S, 2005, CANCER EPIDEM BIOMAR, V14, P1908, DOI 10.1158/1055-9965.EPI-05-0119; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Haile LA, 2010, J IMMUNOL, V185, P203, DOI 10.4049/jimmunol.0903573; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; Hirasawa N, 1997, IMMUNOPHARMACOLOGY, V36, P87, DOI 10.1016/S0162-3109(96)00164-6; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Karlstedt K, 2001, DEV DYNAM, V221, P81, DOI 10.1002/dvdy.1127; Kitamura Y, 1983, Princess Takamatsu Symp, V14, P327; Kuramasu A, 1998, J BIOL CHEM, V273, P31607, DOI 10.1074/jbc.273.47.31607; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; NISSINEN MJ, 1995, J HISTOCHEM CYTOCHEM, V43, P1241, DOI 10.1177/43.12.8537641; NISSINEN MJ, 1995, J HISTOCHEM CYTOCHEM, V43, P211, DOI 10.1177/43.2.7822777; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Ohtsu H, 2003, BIOCHEM BIOPH RES CO, V305, P443, DOI 10.1016/S0006-291X(03)00696-X; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Prizment AE, 2007, CANCER EPIDEM BIOMAR, V16, P2357, DOI 10.1158/1055-9965.EPI-07-0468; Rad FH, 2007, P NATL ACAD SCI USA, V104, P2837, DOI 10.1073/pnas.0611022104; Radeke HH, 2005, EXP DERMATOL, V14, P641, DOI 10.1111/j.0906-6705.2005.00350.x; Reynolds JL, 1997, EUR J SURG ONCOL, V23, P224, DOI 10.1016/S0748-7983(97)92388-X; Robertson DJ, 2005, ALIMENT PHARM THER, V22, P123, DOI 10.1111/j.1365-2036.2005.02529.x; Sasaguri Y, 2005, CIRC RES, V96, P974, DOI 10.1161/01.RES.0000166325.00383.ed; Schmielau J, 2001, CANCER RES, V61, P4756; Shen L, 2007, CLIN EXP IMMUNOL, V149, P155, DOI 10.1111/j.1365-2249.2007.03376.x; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Suzuki-Ishigaki S, 2000, NUCLEIC ACIDS RES, V28, P2627, DOI 10.1093/nar/28.14.2627; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vajdic CM, 2009, CANCER RES, V69, P6482, DOI 10.1158/0008-5472.CAN-08-4372; van der Pouw Kraan TCTM, 1998, J CLIN INVEST, V102, P1866, DOI 10.1172/JCI3692; Velicer CM, 2006, ANN EPIDEMIOL, V16, P895, DOI 10.1016/j.annepidem.2006.03.003; Wang H, 2005, ALLERGY, V60, P1098, DOI 10.1111/j.1398-9995.2005.00813.x; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Wiener Z, 2002, INT IMMUNOL, V14, P381, DOI 10.1093/intimm/14.4.381; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zwadlo-Klarwasser G, 1998, INFLAMM RES, V47, P434, DOI 10.1007/s000110050357	49	157	163	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					87	U263		10.1038/nm.2278	http://dx.doi.org/10.1038/nm.2278			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21170045	Green Submitted, Green Accepted			2022-12-27	WOS:000285994000040
J	Pei, L; Li, SP; Wang, M; Diwan, M; Anisman, H; Fletcher, PJ; Nobrega, JN; Liu, F				Pei, Lin; Li, Shupeng; Wang, Min; Diwan, Mustansir; Anisman, Hymie; Fletcher, Paul J.; Nobrega, Jose N.; Liu, Fang			Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects	NATURE MEDICINE			English	Article							REUPTAKE INHIBITORS; SWIMMING TEST; DEPRESSION; SCHIZOPHRENIA; IMMOBILITY; ACTIVATION; PROTEIN; SYSTEM; DRUGS	We report that coupling between dopamine D1 and D2 receptors was markedly increased in postmortem brain of subjects suffering from major depression. Biochemical analyses revealed that D1 and D2 receptors form heterodimers via a direct protein-protein interaction. Administration of an interfering peptide that disrupts the D1-D2 receptor complex substantially reduced immobility in the forced swim test (FST) without affecting locomotor activity, and decreased escape failures in learned helplessness tests in rats. (C) 2010 Nature America, Inc. All rights reserved.	[Pei, Lin; Li, Shupeng; Wang, Min; Diwan, Mustansir; Fletcher, Paul J.; Nobrega, Jose N.; Liu, Fang] Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON, Canada; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada; [Fletcher, Paul J.; Nobrega, Jose N.; Liu, Fang] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Fletcher, Paul J.; Nobrega, Jose N.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Carleton University; University of Toronto; University of Toronto	Liu, F (corresponding author), Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON, Canada.	f.liu.a@utoronto.ca	soler, martha maricel m gomez/L-6025-2014; Yan, Shuo/B-8381-2009	soler, martha maricel m gomez/0000-0002-4412-8108; Fletcher, Paul/0000-0001-8906-2280	Centre for Addictions and Mental Health; Ontario Mental Health Foundation; Heart and Stroke Foundation of Canada	Centre for Addictions and Mental Health; Ontario Mental Health Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	We thank the Stanley Foundation Neuropathology Consortium for the brain samples. This work was supported by the Centre for Addictions and Mental Health (F. L.) and the Ontario Mental Health Foundation (J.N.N.). S. L. is a recipient of postdoctoral fellowship from the Heart and Stroke Foundation of Canada.	Agid O, 2008, EXPERT OPIN EMERG DR, V13, P479, DOI [10.1517/14728214.13.3.479, 10.1517/14728214.13.3.479 ]; Basso AM, 2005, NEUROPSYCHOPHARMACOL, V30, P1257, DOI 10.1038/sj.npp.1300677; CERVO L, 1988, J PHARM PHARMACOL, V40, P155, DOI 10.1111/j.2042-7158.1988.tb05208.x; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Fuxe K, 2008, BRAIN RES REV, V58, P415, DOI 10.1016/j.brainresrev.2007.11.007; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; KAPUR S, 1992, BIOL PSYCHIAT, V32, P1, DOI 10.1016/0006-3223(92)90137-O; Lee FJS, 2009, SYNAPSE, V63, P710, DOI 10.1002/syn.20648; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MUSCAT R, 1992, BIOL PSYCHIAT, V31, P937, DOI 10.1016/0006-3223(92)90119-K; Nutt DJ, 2006, J CLIN PSYCHIAT, V67, P3; Pigott HE, 2010, PSYCHOTHER PSYCHOSOM, V79, P267, DOI 10.1159/000318293; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Yadid G, 2008, PROG BRAIN RES, V172, P265, DOI 10.1016/S0079-6123(08)00913-8; Yamada J, 2004, EUR J PHARMACOL, V504, P207, DOI 10.1016/j.ejphar.2004.09.057; Zisook S, 2006, BIOL PSYCHIAT, V59, P203, DOI 10.1016/j.biopsych.2005.06.027	20	129	130	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1393	1395		10.1038/nm.2263	http://dx.doi.org/10.1038/nm.2263			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21113156				2022-12-27	WOS:000285048900031
J	Yao, LN; Fan, PD; Arolfo, M; Jiang, Z; Olive, MF; Zablocki, J; Sun, HL; Chu, N; Lee, J; Kim, HY; Leung, K; Shryock, J; Blackburn, B; Diamond, I				Yao, Lina; Fan, Peidong; Arolfo, Maria; Jiang, Zhang; Olive, M. Foster; Zablocki, Jeff; Sun, Hai-Ling; Chu, Nancy; Lee, Jeongrim; Kim, Hee-Yong; Leung, Kwan; Shryock, John; Blackburn, Brent; Diamond, Ivan			Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis	NATURE MEDICINE			English	Article							VENTRAL TEGMENTAL AREA; PROTEIN-KINASE-A; NUCLEUS-ACCUMBENS; TYROSINE-HYDROXYLASE; DRUG-ADDICTION; NEUROBIOLOGY; BRAIN; METABOLISM; CIRCUITRY; ASSAY	There is no effective treatment for cocaine addiction despite extensive knowledge of the neurobiology of drug addiction(1-4). Here we show that a selective aldehyde dehydrogenase-2 (ALDH-2) inhibitor, ALDH2i, suppresses cocaine self-administration in rats and prevents cocaine-or cue-induced reinstatement in a rat model of cocaine relapse-like behavior. We also identify a molecular mechanism by which ALDH-2 inhibition reduces cocaine-seeking behavior: increases in tetrahydropapaveroline (THP) formation due to inhibition of ALDH-2 decrease cocaine-stimulated dopamine production and release in vitro and in vivo. Cocaine increases extracellular dopamine concentration, which activates dopamine D2 autoreceptors to stimulate cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC) in primary ventral tegmental area (VTA) neurons. PKA and PKC phosphorylate and activate tyrosine hydroxylase, further increasing dopamine synthesis in a positive-feedback loop. Monoamine oxidase converts dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL), a substrate for ALDH-2. Inhibition of ALDH-2 enables DOPAL to condense with dopamine to form THP in VTA neurons. THP selectively inhibits phosphorylated (activated) tyrosine hydroxylase to reduce dopamine production via negative-feedback signaling. Reducing cocaine-and craving-associated increases in dopamine release seems to account for the effectiveness of ALDH2i in suppressing cocaine-seeking behavior. Selective inhibition of ALDH-2 may have therapeutic potential for treating human cocaine addiction and preventing relapse.	[Yao, Lina; Fan, Peidong; Arolfo, Maria; Jiang, Zhang; Zablocki, Jeff; Sun, Hai-Ling; Chu, Nancy; Leung, Kwan; Shryock, John; Blackburn, Brent; Diamond, Ivan] Gilead Sci Inc, Palo Alto, CA USA; [Olive, M. Foster] Med Univ S Carolina, Dept Psychiat, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA; [Olive, M. Foster] Med Univ S Carolina, Dept Neurosci, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA; [Lee, Jeongrim; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA	Gilead Sciences; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Yao, LN (corresponding author), Gilead Sci Inc, Palo Alto, CA USA.	lina.yao@gilead.com	Jiang, Zhang/Q-3827-2019	Jiang, Zhang/0000-0003-3503-8909; Olive, Foster/0000-0002-2517-0351	Intramural NIH HHS [Z01 AA000500-05] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000500] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Arolfo MP, 2009, ALCOHOL CLIN EXP RES, V33, P1935, DOI 10.1111/j.1530-0277.2009.01031.x; Balter M, 1996, SCIENCE, V271, P909, DOI 10.1126/science.271.5251.909; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bossert JM, 2005, EUR J PHARMACOL, V526, P36, DOI 10.1016/j.ejphar.2005.09.030; BRODIE MS, 1990, N-S ARCH PHARMACOL, V342, P660, DOI 10.1007/BF00175709; Chen SY, 1996, BRAIN RES, V729, P294, DOI 10.1016/0006-8993(96)00671-3; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Gaval-Cruz M, 2009, MOL INTERV, V9, P175, DOI 10.1124/mi.9.4.6; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Inoue Y, 2007, J PHARMACOL EXP THER, V322, P23, DOI 10.1124/jpet.107.120675; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KEUNG WM, 1995, P NATL ACAD SCI USA, V92, P8990, DOI 10.1073/pnas.92.19.8990; Kim YM, 2005, NEUROSCI LETT, V386, P1, DOI 10.1016/j.neulet.2005.04.105; Koob GF, 2009, NAT REV DRUG DISCOV, V8, P500, DOI 10.1038/nrd2828; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; Lamensdorf I, 2000, BRAIN RES, V868, P191, DOI 10.1016/S0006-8993(00)02309-X; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; MYERS RD, 1990, ALCOHOL, V7, P449, DOI 10.1016/0741-8329(90)90031-7; NAGATSU T, 1972, CLIN CHEM, V18, P980; Negus SS, 1996, J PHARMACOL EXP THER, V278, P879; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nestler Eric J, 2005, Sci Pract Perspect, V3, P4; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; ROBERTS DCS, 1982, PHARMACOL BIOCHEM BE, V17, P901, DOI 10.1016/0091-3057(82)90469-5; Saeedi H, 2006, SCHIZOPHR RES, V85, P222, DOI 10.1016/j.schres.2006.03.033; SHERALD AF, 1973, ANAL BIOCHEM, V56, P300, DOI 10.1016/0003-2697(73)90194-2; Sofuoglu Mehmet, 2006, Expert Opin Emerg Drugs, V11, P91, DOI 10.1517/14728214.11.1.91; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Tinsley RB, 2009, ANN NEUROL, V66, P472, DOI 10.1002/ana.21716; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; YAMAUCHI T, 1978, ANAL BIOCHEM, V89, P143, DOI 10.1016/0003-2697(78)90735-2; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580	41	76	79	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1024	U120		10.1038/nm.2200	http://dx.doi.org/10.1038/nm.2200			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20729865	Green Accepted			2022-12-27	WOS:000281622900032
J	Sorge, RE; Trang, T; Dorfman, R; Smith, SB; Beggs, S; Ritchie, J; Austin, JS; Zaykin, DV; Vander Meulen, H; Costigan, M; Herbert, TA; Yarkoni-Abitbul, M; Tichauer, D; Livneh, J; Gershon, E; Zheng, M; Tan, K; John, SL; Slade, GD; Jordan, J; Woolf, CJ; Peltz, G; Maixner, W; Diatchenko, L; Seltzer, Z; Salter, MW; Mogil, JS				Sorge, Robert E.; Trang, Tuan; Dorfman, Ruslan; Smith, Shad B.; Beggs, Simon; Ritchie, Jennifer; Austin, Jean-Sebastien; Zaykin, Dmitri V.; Vander Meulen, Heather; Costigan, Michael; Herbert, Teri A.; Yarkoni-Abitbul, Merav; Tichauer, David; Livneh, Jessica; Gershon, Edith; Zheng, Ming; Tan, Keith; John, Sally L.; Slade, Gary D.; Jordan, Joanne; Woolf, Clifford J.; Peltz, Gary; Maixner, William; Diatchenko, Luda; Seltzer, Ze'ev; Salter, Michael W.; Mogil, Jeffrey S.			Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity	NATURE MEDICINE			English	Article							SPARED NERVE INJURY; NEUROPATHIC PAIN; SPINAL-CORD; P2X(7); MOUSE; NOCICEPTION; ANTAGONIST; COMPLEX; RAT; INTERLEUKIN-1-BETA	Chronic pain is highly variable between individuals, as is the response to analgesics. Although much of the variability in chronic pain and analgesic response is heritable, an understanding of the genetic determinants underlying this variability is rudimentary(1). Here we show that variation within the coding sequence of the gene encoding the P2X7 receptor (P2X7R) affects chronic pain sensitivity in both mice and humans. P2X7Rs, which are members of the family of ionotropic ATP-gated receptors, have two distinct modes of function: they can function through their intrinsic cationic channel or by forming nonselective pores that are permeable to molecules with a mass of up to 900 Da(2,3). Using genome-wide linkage analyses, we discovered an association between nerve-injury-induced pain behavior (mechanical allodynia) and the P451L mutation of the mouse P2rx7 gene, such that mice in which P2X7Rs have impaired pore formation as a result of this mutation showed less allodynia than mice with the pore-forming P2rx7 allele. Administration of a peptide corresponding to the P2X7R C-terminal domain, which blocked pore formation but not cation channel activity, selectively reduced nerve injury and inflammatory allodynia only in mice with the pore-forming P2rx7 allele. Moreover, in two independent human chronic pain cohorts, a cohort with pain after mastectomy and a cohort with osteoarthritis, we observed a genetic association between lower pain intensity and the hypofunctional His270 (rs7958311) allele of P2RX7. Our findings suggest that selectively targeting P2X7R pore formation may be a new strategy for individualizing the treatment of chronic pain.	[Sorge, Robert E.; Ritchie, Jennifer; Austin, Jean-Sebastien; Mogil, Jeffrey S.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Sorge, Robert E.; Ritchie, Jennifer; Austin, Jean-Sebastien; Mogil, Jeffrey S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Trang, Tuan; Dorfman, Ruslan; Beggs, Simon; Vander Meulen, Heather; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Smith, Shad B.; Maixner, William; Diatchenko, Luda] Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC USA; [Smith, Shad B.; Slade, Gary D.; Maixner, William; Diatchenko, Luda; Mogil, Jeffrey S.] Algynomics Inc, Chapel Hill, NC USA; [Zaykin, Dmitri V.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Costigan, Michael; Herbert, Teri A.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Yarkoni-Abitbul, Merav; Tichauer, David; Seltzer, Ze'ev; Salter, Michael W.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Yarkoni-Abitbul, Merav; Tichauer, David; Seltzer, Ze'ev; Salter, Michael W.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Livneh, Jessica] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel; [Gershon, Edith] Ein Hod, Hof Hacarmel, Israel; [Zheng, Ming; Peltz, Gary] Stanford Univ Sch Med, Dept Anesthesia, Stanford, CA USA; [Tan, Keith; John, Sally L.] Pfizer Global Res & Dev, Sandwich, Kent, England; [Slade, Gary D.] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA; [Jordan, Joanne] Univ N Carolina, Thurston Arthrit Ctr, Chapel Hill, NC USA	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; University of Toronto; University of Toronto; Chaim Sheba Medical Center; Stanford University; Pfizer; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mogil, JS (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	mike.salter@utoronto.ca; jeffrey.mogil@mcgill.ca	Mogil, Jeffrey/AAA-9611-2019; Zaykin, Dmitri/C-3752-2019; Beggs, Simon/AAI-4438-2021; Smith, Shad/AAO-8760-2020; Woolf, Clifford/A-9784-2010	Mogil, Jeffrey/0000-0003-1359-5720; Zaykin, Dmitri/0000-0002-9444-2859; Beggs, Simon/0000-0002-1582-8391; Dorfman, Ruslan/0000-0002-3421-5582; Vandermeulen, Heather/0000-0003-1885-2298; Ritchie, Jennifer/0000-0003-2092-1387	US National Institutes of Health (NIH); Louise and Alan Edwards Foundation; Canada Research Chairs program; Howard Hughes Medical Institute; Canadian Institutes of Health Research; Krembil Foundation; Ontario Research Foundation; Algynomics/Pfizer; AstraZeneca-Alan Edwards Centre for Research on Pain; NIH; NIH (National Institute of Environmental Health Sciences); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R01NS058870] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louise and Alan Edwards Foundation; Canada Research Chairs program(Canada Research Chairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Ontario Research Foundation; Algynomics/Pfizer; AstraZeneca-Alan Edwards Centre for Research on Pain(AstraZeneca); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the US National Institutes of Health (NIH) (C.J.W., W.M., L.D., Z.S. and J.S.M.), the Louise and Alan Edwards Foundation (J.S.M.), the Canada Research Chairs program (M.W.S., J.S.M. and Z.S.), the Howard Hughes Medical Institute (M.W.S.), the Canadian Institutes of Health Research (M.W.S. and J.S.M.), the Krembil Foundation (M.W.S. and J.S.M.), the Ontario Research Foundation (M.W.S.) and Algynomics/Pfizer research funds (W.M., L.D.). R.E.S. was supported by an AstraZeneca-Alan Edwards Centre for Research on Pain postdoctoral fellowship. T.T. was supported by a Canadian Institutes of Health Research Fellowship. S.B.S. was supported by a National Research Service Award Fellowship from the NIH. D.V.Z. was supported by the Intramural Research Program of the NIH (National Institute of Environmental Health Sciences).	Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Bradley HJ, 2011, J BIOL CHEM, V286, P8176, DOI 10.1074/jbc.M110.211284; Broom DC, 2008, J PHARMACOL EXP THER, V327, P620, DOI 10.1124/jpet.108.141853; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dell'Antonio G, 2002, NEUROSCI LETT, V327, P87, DOI 10.1016/S0304-3940(02)00385-3; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Mogil JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-34; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; SALTER MW, 1995, J NEUROSCI, V15, P2961; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Wang JM, 2005, TRENDS GENET, V21, P526, DOI 10.1016/j.tig.2005.06.010; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x	30	263	281	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					595	599		10.1038/nm.2710	http://dx.doi.org/10.1038/nm.2710			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22447075	Green Accepted, Green Submitted			2022-12-27	WOS:000302617800037
J	Di Niro, R; Mesin, L; Zheng, NY; Stamnaes, J; Morrissey, M; Lee, JH; Huang, M; Iversen, R; du Pre, MF; Qiao, SW; Lundin, KEA; Wilson, PC; Sollid, LM				Di Niro, Roberto; Mesin, Luka; Zheng, Nai-Ying; Stamnaes, Jorunn; Morrissey, Michael; Lee, Jane-Hwei; Huang, Min; Iversen, Rasmus; du Pre, M. Fleur; Qiao, Shuo-Wang; Lundin, Knut E. A.; Wilson, Patrick C.; Sollid, Ludvig M.			High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions	NATURE MEDICINE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; TISSUE TRANSGLUTAMINASE; IMMUNE-RESPONSES; GERMINAL-CENTER; RAPID GENERATION; AFFINITY; ANTIGEN; ASSOCIATION; PEPTIDES	Celiac disease is an immune-mediated disorder in which mucosal autoantibodies to the enzyme transglutaminase 2 (TG2)(1) are generated in response to the exogenous antigen gluten(2) in individuals who express human leukocyte antigen HLA-DQ2 or HLA-DQ8 (ref. 3). We assessed in a comprehensive and nonbiased manner the IgA anti-TG2 response by expression cloning of the antibody repertoire of ex vivo-isolated intestinal antibody-secreting cells (ASCs). We found that TG2-specific plasma cells are markedly expanded within the duodenal mucosa in individuals with active celiac disease. TG2-specific antibodies were of high affinity yet showed little adaptation by somatic mutations. Unlike infection-induced peripheral blood plasmablasts4, the TG2-specific ASCs had not recently proliferated and were not short-lived ex vivo. Altogether, these observations demonstrate that there is a germline repertoire with high affinity for TG2 that may favor massive generation of autoreactive B cells. TG2-specific antibodies did not block enzymatic activity and served as substrates for TG2-mediated crosslinking when expressed as IgD or IgM but not as IgA1 or IgG1. This could result in preferential recruitment of plasma cells from naive IgD- and IgM-expressing B cells, thus possibly explaining why the antibody response to TG2 bears signs of a primary immune response despite the disease chronicity.	[Di Niro, Roberto; Mesin, Luka; Stamnaes, Jorunn; Iversen, Rasmus; du Pre, M. Fleur; Qiao, Shuo-Wang; Lundin, Knut E. A.; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Di Niro, Roberto; Mesin, Luka; Stamnaes, Jorunn; Iversen, Rasmus; du Pre, M. Fleur; Qiao, Shuo-Wang; Lundin, Knut E. A.; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, Oslo, Norway; [Lundin, Knut E. A.] Univ Oslo, Rikshosp, Oslo Univ Hospital, Dept Med, N-0027 Oslo, Norway; [Zheng, Nai-Ying; Morrissey, Michael; Lee, Jane-Hwei; Huang, Min; Wilson, Patrick C.] Univ Chicago, Gwenn Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Chicago; University of Chicago; University of Chicago	Sollid, LM (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	wilsonp@uchicago.edu; l.m.sollid@medisin.uio.no	Lundin, Knut E. A./AAW-9519-2021; Wilson, Patrick/HGC-3157-2022; Sollid, Ludvig/N-9691-2015; Qiao, Shuo-Wang/ABE-8148-2020	Lundin, Knut E. A./0000-0003-1713-5545; Sollid, Ludvig/0000-0001-8860-704X; Qiao, Shuo-Wang/0000-0002-0935-8397; Iversen, Rasmus/0000-0002-3292-1766; Stamnaes, Jorunn/0000-0002-0257-2112; du Pre, M. Fleur/0000-0001-9231-643X	Marie Curie Research and Training Network (European Commission) [MRTN-CT-2006-036032]; European Research Council; Research Council of Norway; US National Institutes of Health National Institute of Allergy and Infectious Disease [U19 AI082724-01, R01 AI76585-03, HHSN266200500026C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082724, R01AI076585, N01AI050026, U19AI057266] Funding Source: NIH RePORTER	Marie Curie Research and Training Network (European Commission)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); US National Institutes of Health National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Mummert (Phadia) for providing recombinant human TG2 produced in Sf9 insect cells, C. Khosla (Stanford University) and L. Fesus (University of Debrecen) for providing plasmids encoding His-tagged recombinant TG2 for expression in Escherichia coli, M. Raki for help in sample collection and immunofluorescence analysis, J. Jahnsen for providing biopsy samples from two subjects, and the staffs at the LIIPAT laboratory and the flow cytometry core facility (both at Oslo University Hospital-Rikshospitalet) for technical assistance. This work was supported by the Marie Curie Research and Training Network (European Commission) contract MRTN-CT-2006-036032, the European Research Council and grants from the Research Council of Norway to L. M. S., and US National Institutes of Health National Institute of Allergy and Infectious Disease grants U19 AI082724-01, R01 AI76585-03 and HHSN266200500026C to P. C. W. We thank M. Shlomchik and B. Jabri for discussion and critical reading of the manuscript.	Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Bjorck S, 2010, J PEDIATR GASTR NUTR, V50, P49, DOI 10.1097/MPG.0b013e3181b477a6; Borrelli M, 2010, CLIN EXP IMMUNOL, V160, P199, DOI 10.1111/j.1365-2249.2009.04077.x; Boursier L, 1999, IMMUNOLOGY, V97, P558; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; HALSTENSEN TS, 1992, GASTROENTEROLOGY, V102, P751, DOI 10.1016/0016-5085(92)90155-R; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; KROESE FGM, 1989, IMMUNOL INVEST, V18, P47, DOI 10.3109/08820138909112226; Kurppa K, 2010, J PEDIATR-US, V157, P373, DOI 10.1016/j.jpeds.2010.02.070; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Mesin L, 2011, J IMMUNOL, V187, P2867, DOI 10.4049/jimmunol.1003181; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stamnaes J, 2008, BBA-PROTEINS PROTEOM, V1784, P1804, DOI 10.1016/j.bbapap.2008.08.011; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	40	139	140	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					441	U204		10.1038/nm.2656	http://dx.doi.org/10.1038/nm.2656			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366952	Green Accepted			2022-12-27	WOS:000301264800047
J	Tost, H; Meyer-Lindenberg, A				Tost, Heike; Meyer-Lindenberg, Andreas			Schizophrenia, social environment and the brain	NATURE MEDICINE			English	Editorial Material							URBANICITY		[Tost, Heike; Meyer-Lindenberg, Andreas] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Tost, H (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Tost, med. Dr. phil. Heike/AAX-8305-2020; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123				Borgwardt SJ, 2008, NEUROIMAGE, V39, P553, DOI 10.1016/j.neuroimage.2007.08.047; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Brunelin J., 2010, J PSYCHIATR RES, V181, P130; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	15	38	38	3	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					211	213		10.1038/nm.2671	http://dx.doi.org/10.1038/nm.2671			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310688				2022-12-27	WOS:000300140300032
J	Erturk, A; Mauch, CP; Hellal, F; Forstner, F; Keck, T; Becker, K; Jahrling, N; Steffens, H; Richter, M; Hubener, M; Kramer, E; Kirchhoff, F; Dodt, HU; Bradke, F				Ertuerk, Ali; Mauch, Christoph P.; Hellal, Farida; Foerstner, Friedrich; Keck, Tara; Becker, Klaus; Jaehrling, Nina; Steffens, Heinz; Richter, Melanie; Huebener, Mark; Kramer, Edgar; Kirchhoff, Frank; Dodt, Hans Ulrich; Bradke, Frank			Three-dimensional imaging of the unsectioned adult spinal cord to assess axon regeneration and glial responses after injury	NATURE MEDICINE			English	Article							NOGO-A; FUNCTIONAL RECOVERY; TRANSGENIC MICE; ANTIBODY IN-1; ASTROCYTES; PROTEIN; LESION; BRAIN; DEGENERATION; FIBERS	Studying regeneration in the central nervous system (CNS) is hampered by current histological and imaging techniques because they provide only partial information about axonal and glial reactions. Here we developed a tetrahydrofuranbased clearing procedure that renders fixed and unsectioned adult CNS tissue transparent and fully penetrable for optical imaging. In large spinal cord segments, we imaged fluorescently labeled cells by `ultramicroscopy' and two-photon microscopy without the need for histological sectioning. We found that more than a year after injury growth-competent axons regenerated abundantly through the injury site. A few growth-incompetent axons could also regenerate when they bypassed the lesion. Moreover, we accurately determined quantitative changes of glial cells after spinal cord injury. Thus, clearing CNS tissue enables an unambiguous evaluation of axon regeneration and glial reactions. Our clearing procedure also renders other organs transparent, which makes this approach useful for a large number of preclinical paradigms.	[Ertuerk, Ali; Hellal, Farida; Bradke, Frank] Max Planck Inst Neurobiol Axonal Growth & Regener, Martinsried, Germany; [Ertuerk, Ali] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Mauch, Christoph P.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Hellal, Farida; Bradke, Frank] Deutsch Zentrum Neurodegenerat Erkrankungen Axona, Bonn, Germany; [Foerstner, Friedrich] Max Planck Inst Neurobiol Syst & Computat Neurobi, Martinsried, Germany; [Keck, Tara; Huebener, Mark] Max Planck Inst Neurobiol Cellular & Syst Neurobi, Martinsried, Germany; [Keck, Tara] Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England; [Becker, Klaus; Jaehrling, Nina; Dodt, Hans Ulrich] Vienna Univ Technol, Inst Solid State Elect, Dept Bioelect, A-1060 Vienna, Austria; [Becker, Klaus; Jaehrling, Nina; Dodt, Hans Ulrich] Med Univ Vienna, Sect Bioelect, Ctr Brain Res, Vienna, Austria; [Jaehrling, Nina] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany; [Steffens, Heinz; Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, Glial Physiol & Imaging, D-3400 Gottingen, Germany; [Richter, Melanie; Kramer, Edgar] Univ Hamburg, Ctr Mol Neurobiol, D-2000 Hamburg, Germany; [Kirchhoff, Frank] Univ Saarland, Inst Physiol, D-6650 Homburg, Germany	Max Planck Society; Roche Holding; Genentech; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Max Planck Society; University of London; King's College London; Technische Universitat Wien; Medical University of Vienna; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Hamburg; Saarland University	Bradke, F (corresponding author), Max Planck Inst Neurobiol Axonal Growth & Regener, Martinsried, Germany.	frank.bradke@dzne.de	Kramer, Edgar/A-9288-2012; Hellal, Farida/E-8533-2013; Hellal, Farida/AHC-2588-2022; Hellal, Farida/D-1834-2015; Kirchhoff, Frank/B-9335-2008	Kramer, Edgar/0000-0002-4882-4143; Hellal, Farida/0000-0002-9344-1846; Hellal, Farida/0000-0002-9344-1846; Kirchhoff, Frank/0000-0002-2324-2761; Bradke, Frank/0000-0002-0345-3772; Keck, Tara/0000-0001-6623-1037; Becker, Klaus/0000-0002-2406-0476; Richter, Melanie/0000-0003-0575-9625	Marie Curie Association (European Union) [WEN MRTN-CT-2, WEN MRTN-CT-003-504, WEN MRTN-CT-636]; Hertie Stiftung; Theodor Korner Fonds; Human Frontier Science Program; Max Planck Society; Deutsche Forschungsgemeinschaft; Austrian Science Fund (FWF) [P 23102] Funding Source: researchfish; Medical Research Council [G0900499] Funding Source: researchfish; MRC [G0900499] Funding Source: UKRI	Marie Curie Association (European Union)(European Commission); Hertie Stiftung(Austrian Science Fund (FWF)); Theodor Korner Fonds; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Dornmair, J. Enes, C. Hojer, A. Kania, D. Neukirchen, K. Olsen, M. Stiess and S. Tahirovic for critically reading the manuscript, V. Duc Ha for technical assistance and R. Brand for his help with Amira. We are indebted to A. Borst and M. Sheng for their support and to J. Sanes (Harvard University) for the GFP-M mice. A.E. was supported by the Marie Curie Association (European Union; WEN MRTN-CT-2,003-504,636). C.P.M. was supported by the Hertie Stiftung. N.J. was supported by the Theodor Korner Fonds. F.B. is a recipient of a Career Development Award from the Human Frontier Science Program. This work was supported by the Max Planck Society, the International Foundation for Research in Paraplegia and additional grants from the Deutsche Forschungsgemeinschaft and the Hertie Stiftung.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DIAZ RS, 1992, J NEUROSCI RES, V31, P136, DOI 10.1002/jnr.490310119; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Enes J, 2010, CURR BIOL, V20, P1154, DOI 10.1016/j.cub.2010.05.055; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Labombarda F, 2000, J STEROID BIOCHEM, V73, P159, DOI 10.1016/S0960-0760(00)00064-9; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nolte C, 2001, GLIA, V33, P72; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; STARR RMH, 1943, ORG SYNTH, V2, P566; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; STUART DA, 1995, J NEUROSCI METH, V61, P5, DOI 10.1016/0165-0270(95)00017-O; Wang L, 2009, NEUROPATHOLOGY, V29, P230, DOI 10.1111/j.1440-1789.2008.00969.x; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	28	247	266	5	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					166	171		10.1038/nm.2600	http://dx.doi.org/10.1038/nm.2600			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22198277				2022-12-27	WOS:000299018600044
J	Phillipson, M; Kubes, P				Phillipson, Mia; Kubes, Paul			The neutrophil in vascular inflammation	NATURE MEDICINE			English	Review							EXTRACELLULAR TRAP FORMATION; TRANSENDOTHELIAL MIGRATION; HEPARAN-SULFATE; CHEMOKINE RECEPTORS; LEUKOCYTE ADHESION; SIGNALING PATHWAYS; MITOCHONDRIAL-DNA; SEPSIS; RECRUITMENT; EXPRESSION	Here we focus on how neutrophils have a key regulatory role in vascular inflammation. Recent studies using advanced imaging techniques have yielded new insights into the mechanisms by which neutrophils contribute to defense against bacterial infections and also against sterile injury. In these settings, neutrophils are recruited by various mechanisms depending on the situation. We also describe how these processes may be disrupted in systemic infections, with a particular emphasis on mouse models of sepsis. Neutrophils are often immobilized in the lungs and liver during systemic infections, and this immobilization may be a mechanism through which bacteria can evade the innate immune response or allow neutrophils to form neutrophil extracellular traps that trap and kill bacteria in blood. The platelet is also an important player in sepsis, and we describe how it collaborates with neutrophils in the formation of neutrophil extracellular traps.	[Kubes, Paul] Univ Calgary, Immunol Res Grp, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada; [Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, Uppsala, Sweden	University of Calgary; Uppsala University	Kubes, P (corresponding author), Univ Calgary, Immunol Res Grp, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada.	pkubes@ucalgary.ca	Sawant, Kirti V/H-3778-2013	Phillipson, Mia/0000-0002-2387-0266	Canadian Foundation for Innovation; Swedish Medical Research Council [57X-20675]; Swedish Diabetes Foundation [DIA2010-063]; Alberta Heritage Foundation for Medical Research Scientist; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Heart and Stroke Foundation	Canadian Foundation for Innovation(Canada Foundation for Innovation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Foundation; Alberta Heritage Foundation for Medical Research Scientist(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	We wish to express their thanks to the Canadian Foundation for Innovation for the funding of the University of Calgary Live Cell Imaging Facility that enabled this work and to C. Jenne, S. Massena and B. McDonald for helping with the figures. M. P. is supported by the Swedish Medical Research Council (57X-20675) and the Swedish Diabetes Foundation (DIA2010-063), and P.K., an Alberta Heritage Foundation for Medical Research Scientist, Canada Research Chair and the Snyder Chair in Critical Care Medicine, is supported by the Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research and the Heart and Stroke Foundation.	Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barreiro O, 2004, FRONT BIOSCI-LANDMRK, V9, P1849, DOI 10.2741/1285; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burns AR, 1997, J IMMUNOL, V159, P2893; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Christoffersson G, 2010, DIABETES, V59, P2569, DOI 10.2337/db10-0205; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cummings CJ, 1999, J IMMUNOL, V162, P2341; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Gambero A, 2004, TOXICON, V44, P473, DOI 10.1016/j.toxicon.2004.06.004; Gaudry M, 1997, BLOOD, V90, P4153, DOI 10.1182/blood.V90.10.4153; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Gotsch U, 1997, J CELL SCI, V110, P583; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauser B, 2005, ANESTH ANALG, V101, P488, DOI 10.1213/01.ANE.0000177117.80058.4D; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Herrmann JM, 2007, INFECT IMMUN, V75, P3989, DOI 10.1128/IAI.00388-07; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; LEWIS RE, 1989, MICROVASC RES, V37, P53, DOI 10.1016/0026-2862(89)90072-1; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LINDAHL U, 1991, THROMB HAEMOSTASIS, V66, P44; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Lokuta MA, 2005, J LEUKOCYTE BIOL, V78, P210, DOI 10.1189/jlb.0205067; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McDonald B, 2010, IMMUNITY, V33, P148, DOI 10.1016/j.immuni.2010.08.006; Menezes GB, 2009, J IMMUNOL, V183, P7557, DOI 10.4049/jimmunol.0901786; Mizgerd JP, 1996, J EXP MED, V184, P639, DOI 10.1084/jem.184.2.639; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Penack O, 2011, ANN ONCOL, V22, P1019, DOI 10.1093/annonc/mdq442; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Petri B, 2011, BLOOD, V117, P942, DOI 10.1182/blood-2010-02-270561; Phillipson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001649; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; VanUffelen BE, 1996, J LEUKOCYTE BIOL, V60, P94, DOI 10.1002/jlb.60.1.94; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Vincent J. L., 2009, SEPSIS NONINFECTIOUS; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zimmerman GA, 1997, J CLIN INVEST, V100, pS3	98	478	494	2	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1381	1390		10.1038/nm.2514	http://dx.doi.org/10.1038/nm.2514			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064428	Green Published			2022-12-27	WOS:000296779300029
J	Weber, C; Noels, H				Weber, Christian; Noels, Heidi			Atherosclerosis: current pathogenesis and therapeutic options	NATURE MEDICINE			English	Review							LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; ENDOPLASMIC-RETICULUM STRESS; DENDRITIC CELLS; REDUCES ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; PROMOTES ATHEROSCLEROSIS; MONOCYTE RECRUITMENT; CHEMOKINE RECEPTORS; PLAQUE-FORMATION	Coronary artery disease (CAD) arising from atherosclerosis is a leading cause of death and morbidity worldwide. The underlying pathogenesis involves an imbalanced lipid metabolism and a maladaptive immune response entailing a chronic inflammation of the arterial wall. The disturbed equilibrium of lipid accumulation, immune responses and their clearance is shaped by leukocyte trafficking and homeostasis governed by chemokines and their receptors. New pro- and anti-inflammatory pathways linking lipid and inflammation biology have been discovered, and genetic profiling studies have unveiled variations involved in human CAD. The growing understanding of the inflammatory processes and mediators has uncovered an intriguing diversity of targetable mechanisms that can be exploited to complement lipid-lowering therapies. Here we aim to systematically survey recently identified molecular mechanisms, translational developments and clinical strategies for targeting lipid-related inflammation in atherosclerosis and CAD.	[Weber, Christian] Univ Munich, Inst Cardiovas Prevent, Munich, Germany; [Weber, Christian] Munich Heart Alliance, Munich, Germany; [Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Noels, Heidi] Rhein Westfal Tech Hsch Aachen Univ, Inst Mol Cardiovasc Res, Aachen, Germany	University of Munich; Munich Heart Alliance; Maastricht University; RWTH Aachen University	Weber, C (corresponding author), Univ Munich, Inst Cardiovas Prevent, Munich, Germany.	christian.weber@med.uni-muenchen.de	Weber, Christian/AAW-2153-2020; Noels, Heidi/AAQ-2622-2020	Weber, Christian/0000-0003-4610-8714; 	Deutsche Forschungsgemeinschaft [FOR809]; European Research Council; Fondation Leducq	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Fondation Leducq(Leducq Foundation)	This work was supported by Deutsche Forschungsgemeinschaft (FOR809), the European Research Council and Fondation Leducq. We sincerely apologize to all scientists whose important contributions to the field could not be cited due to space limitations.	Ait-Oufella H, 2007, CIRCULATION, V116, P1707, DOI 10.1161/CIRCULATIONAHA.107.699470; Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Damas JK, 2002, CIRCULATION, V106, P36, DOI 10.1161/01.CIR.0000020001.09990.90; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Epps KC, 2011, J INTERN MED, V269, P94, DOI 10.1111/j.1365-2796.2010.02297.x; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Gilbert J, 2011, AM J CARDIOL, V107, P906, DOI 10.1016/j.amjcard.2010.11.005; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Habets KLL, 2010, CARDIOVASC RES, V85, P622, DOI 10.1093/cvr/cvp338; Han JW, 2008, CIRC RES, V102, P546, DOI 10.1161/CIRCRESAHA.107.161653; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Hermansson A, 2010, J EXP MED, V207, P1081, DOI 10.1084/jem.20092243; Hjerpe C, 2010, ATHEROSCLEROSIS, V209, P436, DOI 10.1016/j.atherosclerosis.2009.10.003; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Jandeleit-Dahm KAM, 2009, CURR OPIN LIPIDOL, V20, P24, DOI 10.1097/MOL.0b013e32831f1b18; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kiechl S, 2010, ARTERIOSCL THROM VAS, V30, P2678, DOI 10.1161/ATVBAHA.110.213785; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Koenen RR, 2010, NAT REV DRUG DISCOV, V9, P141, DOI 10.1038/nrd3048; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Kwon GP, 2008, CIRCULATION, V117, P2919, DOI 10.1161/CIRCULATIONAHA.107.754614; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Liehn EA, 2010, J AM COLL CARDIOL, V56, P1847, DOI 10.1016/j.jacc.2010.04.066; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Liu JB, 2011, CIRC RES, V108, P469, DOI 10.1161/CIRCRESAHA.110.228742; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; Ludewig B, 2000, P NATL ACAD SCI USA, V97, P12752, DOI 10.1073/pnas.220427097; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Mehta NN, 2011, EUR HEART J, V32, P963, DOI 10.1093/eurheartj/ehr091; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Millonig G, 2001, ARTERIOSCL THROM VAS, V21, P503, DOI 10.1161/01.ATV.21.4.503; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Navab M, 2010, ARTERIOSCL THROM VAS, V30, P164, DOI 10.1161/ATVBAHA.109.187518; Nicholls SJ, 2008, CIRCULATION, V118, P2506, DOI 10.1161/CIRCULATIONAHA.108.790733; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P18, DOI 10.1161/01.ATV.0000149142.42590.a2; Nissen SE, 2005, AM J CARDIOL, V96, p61F, DOI 10.1016/j.amjcard.2005.07.013; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Schiopu A, 2007, J AM COLL CARDIOL, V50, P2313, DOI 10.1016/j.jacc.2007.07.081; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shaposhnik Z, 2007, ARTERIOSCL THROM VAS, V27, P621, DOI 10.1161/01.ATV.0000254673.55431.e6; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Sipahi I, 2007, ANN INTERN MED, V147, P10, DOI 10.7326/0003-4819-147-1-200707030-00003; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Van Wanrooij EJA, 2008, ARTERIOSCL THROM VAS, V28, P251, DOI 10.1161/ATVBAHA.107.147827; Veillard NR, 2005, CIRCULATION, V112, P870, DOI 10.1161/CIRCULATIONAHA.104.520718; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yla-Herttuala S, 2011, THROMB HAEMOSTASIS, V106, P1, DOI 10.1160/TH10-12-0784; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866	135	1477	1560	16	487	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1410	1422		10.1038/nm.2538	http://dx.doi.org/10.1038/nm.2538			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064431				2022-12-27	WOS:000296779300032
J	Zhang, Z; Cai, YQ; Zou, F; Bie, BH; Pan, ZZZ				Zhang, Zhi; Cai, You-Qing; Zou, Fang; Bie, Bihua; Pan, Zhizhong Z.			Epigenetic suppression of GAD65 expression mediates persistent pain	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE INHIBITORS; ROSTRAL VENTROMEDIAL MEDULLA; PATHOLOGICAL PAIN; NERVOUS-SYSTEM; MODULATION; TRANSMISSION; MECHANISMS; RECEPTORS; NUCLEUS; NEURONS	Chronic pain is a common neurological disease involving lasting, multifaceted maladaptations ranging from gene modulation to synaptic dysfunction and emotional disorders. Sustained pathological stimuli in many diseases alter the output activities of certain genes through epigenetic modifications, but it is unclear how epigenetic mechanisms operate in the development of chronic pain. We show here that in the rat brainstem nucleus raphe magnus, which is important for central mechanisms of chronic pain, persistent inflammatory and neuropathic pain epigenetically suppresses Gad2 (encoding glutamic acid decarboxylase 65 (GAD65)) transcription through histone deacetylase (HDAC)-mediated histone hypoacetylation, resulting in impaired gamma-aminobutyric acid (GABA) synaptic inhibition. Gad2 knockout mice showed sensitized pain behavior and impaired GABA synaptic function in their brainstem neurons. In wild-type but not Gad2 knockout mice, HDAC inhibitors strongly increased GAD65 activity, restored GABA synaptic function and relieved sensitized pain behavior. These findings suggest GAD65 and HDACs as potential therapeutic targets in an epigenetic approach to the treatment of chronic pain.	[Zhang, Zhi; Cai, You-Qing; Zou, Fang; Bie, Bihua; Pan, Zhizhong Z.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Pain Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, ZZZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Pain Med, Houston, TX 77030 USA.	zzpan@mdanderson.org	Zou, Fang/F-3270-2013; CAI, YOU-QING/A-4315-2013	CAI, YOU-QING/0000-0002-1440-6779	US National Institutes of Health National Institute on Drug Abuse [DA023069, DA027541]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027541, R01DA023069] Funding Source: NIH RePORTER	US National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health National Institute on Drug Abuse grants DA023069 and DA027541. We thank L. Gao of Baylor College of Medicine for his generous gifts of GAD67 primers.	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; Blackburn-Munro G, 2001, J NEUROENDOCRINOL, V13, P1009, DOI 10.1046/j.0007-1331.2001.00727.x; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Doehring A, 2011, EUR J PAIN, V15, P11, DOI 10.1016/j.ejpain.2010.06.004; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gilbert AK, 2001, PAIN, V90, P25, DOI 10.1016/S0304-3959(00)00383-3; Grayson DR, 2010, MOL PHARMACOL, V77, P126, DOI 10.1124/mol.109.061333; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; HEINRICHER MM, 1991, PAIN, V47, P105, DOI 10.1016/0304-3959(91)90017-R; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; Ma JY, 2006, PAIN, V122, P163, DOI 10.1016/j.pain.2006.01.031; Ma JY, 2006, MOL PHARMACOL, V69, P1137, DOI 10.1124/mol.105.019109; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Munro G, 2009, TRENDS PHARMACOL SCI, V30, P453, DOI 10.1016/j.tips.2009.06.004; Pan ZZ, 1998, TRENDS PHARMACOL SCI, V19, P94, DOI 10.1016/S0165-6147(98)01169-9; Pan ZZ, 1997, NATURE, V389, P382, DOI 10.1038/38730; PAN ZZ, 1990, J PHYSIOL-LONDON, V427, P519, DOI 10.1113/jphysiol.1990.sp018185; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Ren WJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-93; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Scascighini L, 2008, NAT CLIN PRACT RHEUM, V4, P74, DOI 10.1038/ncprheum0680; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vit JP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-42; Watkins LR, 2000, ANNU REV PSYCHOL, V51, P29, DOI 10.1146/annurev.psych.51.1.29; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Woolf Clifford J, 2004, Curr Opin Investig Drugs, V5, P61; Zhang L, 2010, PAIN, V149, P107, DOI 10.1016/j.pain.2010.01.017; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	198	214	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1448	U152		10.1038/nm.2442	http://dx.doi.org/10.1038/nm.2442			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	21983856	Green Accepted			2022-12-27	WOS:000296779300036
J	Linterman, MA; Pierson, W; Lee, SK; Kallies, A; Kawamoto, S; Rayner, TF; Srivastava, M; Divekar, DP; Beaton, L; Hogan, JJ; Fagarasan, S; Liston, A; Smith, KGC; Vinuesa, CG				Linterman, Michelle A.; Pierson, Wim; Lee, Sau K.; Kallies, Axel; Kawamoto, Shimpei; Rayner, Tim F.; Srivastava, Monika; Divekar, Devina P.; Beaton, Laura; Hogan, Jennifer J.; Fagarasan, Sidonia; Liston, Adrian; Smith, Kenneth G. C.; Vinuesa, Carola G.			Foxp3(+) follicular regulatory T cells control the germinal center response	NATURE MEDICINE			English	Article							HELPER-CELLS; PERIPHERAL HOMEOSTASIS; CUTTING EDGE; DIFFERENTIATION; BLIMP-1; BCL6; DYSREGULATION; INFLAMMATION; SUPPRESSION; ENTEROPATHY	Follicular helper (T-FH) cells provide crucial signals to germinal center B cells undergoing somatic hypermutation and selection that results in affinity maturation. Tight control of T-FH numbers maintains self tolerance. We describe a population of Foxp3(+) Blimp-1(+) CD4(+) T cells constituting 10-25% of the CXCR5(high)PD-1(high)CD4(+) T cells found in the germinal center after immunization with protein antigens. These follicular regulatory T (T-FR) cells share phenotypic characteristics with T-FH and conventional Foxp3(+) regulatory T (T-reg) cells yet are distinct from both. Similar to T-FH cells, T-FR cell development depends on Bcl-6, SLAM-associated protein (SAP), CD28 and B cells; however, T-FR cells originate from thymic-derived Foxp3(+) precursors, not naive or T-FH cells. T-FR cells are suppressive in vitro and limit T-FH cell and germinal center B cell numbers in vivo. In the absence of T-FR cells, an outgrowth of non-antigen-specific B cells in germinal centers leads to fewer antigen-specific cells. Thus, the T-FH differentiation pathway is co-opted by T-reg cells to control the germinal center response.	[Linterman, Michelle A.; Lee, Sau K.; Srivastava, Monika; Beaton, Laura; Hogan, Jennifer J.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Linterman, Michelle A.; Rayner, Tim F.; Divekar, Devina P.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Linterman, Michelle A.; Rayner, Tim F.; Divekar, Devina P.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Pierson, Wim; Liston, Adrian] Catholic Univ Louvain VIB, B-3000 Louvain, Belgium; [Pierson, Wim; Liston, Adrian] Catholic Univ Louvain, Dept Expt Med, B-3000 Louvain, Belgium; [Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Dept Immunol, Parkville, Vic 3050, Australia; [Kawamoto, Shimpei; Fagarasan, Sidonia] RIKEN Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama, Kanagawa, Japan	Australian National University; John Curtin School of Medical Research; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Royal Melbourne Hospital; Walter & Eliza Hall Institute; RIKEN	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	adrian.liston@vib.be; kgcs2@cam.ac.uk; carola.vinuesa@anu.edu.au	Liston, Adrian/G-8606-2013; Vinuesa, Carola G/B-1108-2010; Linterman, Michelle/AAN-4210-2021; Fagarasan, Sidonia/A-5258-2016	Liston, Adrian/0000-0002-6272-4085; Vinuesa, Carola G/0000-0001-9799-0298; Linterman, Michelle/0000-0001-6047-1996; Fagarasan, Sidonia/0000-0003-2086-6402; Pierson, Wim/0000-0003-1369-4606; Rayner, Tim/0000-0002-6992-5592; Beaton, Laura/0000-0002-5885-6915; Kallies, Axel/0000-0002-6312-6968; Smith, Kenneth/0000-0003-3829-4326	National Health and Medical Research Council; Vlaams Instituut voor Biotechnologie; Wellcome Trust [083650/Z/07/Z]; EMBO [ALTF 1041-2009]; Churchill College, Cambridge; Viertel Senior Medical Research Fellowship; Lister Prize Fellowship; National Institute of Health Research, Cambridge Biomedical Research Centre; Juvenile Diabetes Research Foundation; Marie Curie Reintegration Grant Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Vlaams Instituut voor Biotechnologie; Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Churchill College, Cambridge; Viertel Senior Medical Research Fellowship; Lister Prize Fellowship; National Institute of Health Research, Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Marie Curie Reintegration Grant Fellowship(European Commission)	We thank X. Hu and J. Fitch for technical assistance, D. Zotos for help with experiments not included in this manuscript, A. Rudensky for kind provision of Foxp3<SUP>gfp</SUP> mice and M. Espeli for helpful discussions. This work was funded by National Health and Medical Research Council program and project grants to C. G. V., a Vlaams Instituut voor Biotechnologie principal investigator grant to A. L. and a Wellcome Trust Programme grant (083650/Z/07/Z) to K. G. C. S. M. A. L. is supported by an EMBO post-doctoral long-term fellowship (ALTF 1041-2009) and a Raymond and Beverly Sackler Junior Research Fellowship, Churchill College, Cambridge; C. G. V. is supported by a Viertel Senior Medical Research Fellowship; K. G. C. S. is supported by a Lister Prize Fellowship; T. F. R. is supported by the National Institute of Health Research, Cambridge Biomedical Research Centre; and A. L. is supported by a Juvenile Diabetes Research Foundation Career Development Fellowship and a Marie Curie Reintegration Grant Fellowship.	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Fields ML, 2005, J IMMUNOL, V175, P4255, DOI 10.4049/jimmunol.175.7.4255; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Guo WZ, 2010, J EXP MED, V207, P2225, DOI 10.1084/jem.20092712; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wehner JR, 2010, TRANSPLANTATION, V89, P1141, DOI 10.1097/TP.0b013e3181d3f271; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yoshida K, 2006, EUR J IMMUNOL, V36, P3146, DOI 10.1002/eji.200636165; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	50	869	899	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					975	U95		10.1038/nm.2425	http://dx.doi.org/10.1038/nm.2425			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785433	Green Submitted, Green Accepted			2022-12-27	WOS:000293507400031
J	Hansson, GK; Klareskog, L				Hansson, Goran K.; Klareskog, Lars			Pulling the plug on atherosclerosis Cooling down the inflammasome	NATURE MEDICINE			English	Editorial Material							INTERLEUKIN-1-RECEPTOR ANTAGONIST; DEFICIENT MICE; IMMUNE-SYSTEM; CRYSTALS; ACTIVATION; PROTEIN; DANGER; GOUT; BETA	Atherosclerotic lesions can result in fatal cardiovascular disease, but what triggers the formation of the atheroma plaques and their progression still begs further investigation. In 'Bench to Bedside', Goran K Hansson and Lars Klareskog peruse how the NLRP3 inflammasome can be activated by cholesterol crystals and worsen atherosclerosis by triggering inflammation through the release of IL-1 beta from macrophages. But these cells can also die at the lesion site, forming a necrotic core in the atheroma by building up apoptotic cells and debris. In 'Bedside to Bench', Ira Tabas discusses a human study showing that lesional necrosis along with thinning of the fibrotic cap are predictive of culprit lesions involved in fatal disease. Understanding the molecular underpinnings of these two morphological features may lead to new therapies to prevent or decrease the risk for major cardiovascular disease.	[Hansson, Goran K.; Klareskog, Lars] Karolinska Inst, Dept Med, Stockholm, Sweden; [Hansson, Goran K.; Klareskog, Lars] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hansson, GK (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	goran.hansson@ki.se; lars.klareskog@ki.se	Hansson, Goran K/B-7423-2012	Klareskog, Lars/0000-0001-9601-6186; Hansson, Goran/0000-0003-4148-5190				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	17	20	22	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					790	791		10.1038/nm0711-790	http://dx.doi.org/10.1038/nm0711-790			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738158				2022-12-27	WOS:000292500800030
J	Saul, ME; Thomas, PA; Dosen, PJ; Isbister, GK; O'Leary, MA; Whyte, IM; McFadden, SA; van Helden, DF				Saul, Megan E.; Thomas, Paul A.; Dosen, Peter J.; Isbister, Geoffrey K.; O'Leary, Margaret A.; Whyte, Ian M.; McFadden, Sally A.; van Helden, Dirk F.			A pharmacological approach to first aid treatment for snakebite	NATURE MEDICINE			English	Article							LYMPH-FLOW; ABSORPTION; VENOM	Snake venom toxins first transit the lymphatic system before entering the bloodstream. Ointment containing a nitric oxide donor, which impedes the intrinsic lymphatic pump, prolonged lymph transit time in rats and humans and also increased rat survival time after injection of venom. This pharmacological approach should give snakebite victims more time to obtain medical care and antivenom treatment.	[Dosen, Peter J.; van Helden, Dirk F.] Univ Newcastle, Sch Pharm & Biomed Sci, Callaghan, NSW 2308, Australia; [Saul, Megan E.] John Hunter Hosp, Dept Nucl Med, New Lambton, NSW, Australia; [Thomas, Paul A.] Royal Brisbane & Womens Hosp, Dept Nucl Med, Herston, Qld, Australia; [Isbister, Geoffrey K.; Whyte, Ian M.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Isbister, Geoffrey K.; O'Leary, Margaret A.; Whyte, Ian M.] Calvary Mater Newcastle, Dept Clin Toxicol & Pharmacol, Waratah, NSW, Australia; [McFadden, Sally A.] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia	University of Newcastle; John Hunter Hospital; Royal Brisbane & Women's Hospital; University of Newcastle; Calvary Mater Newcastle Hospital; University of Newcastle	van Helden, DF (corresponding author), Univ Newcastle, Sch Pharm & Biomed Sci, Callaghan, NSW 2308, Australia.	dirk.vanhelden@newcastle.edu.au	Thomas, Paul A/K-7463-2012; Isbister, Geoffrey K/G-8052-2015; MCFADDEN, SALLY/G-7164-2013; Whyte, Ian/A-1621-2010	Thomas, Paul A/0000-0002-2420-0950; Isbister, Geoffrey K/0000-0003-1519-7419; Whyte, Ian/0000-0001-7693-3948; McFadden, Sally/0000-0001-6761-1592; O'Leary, Margaret/0000-0003-2579-2334	National Health and Medical Research Council of Australia; Hunter Medical Research Institute	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute	We sincerely thank L. Milward and D. Laver for critical evaluation of the manuscript, the National Health and Medical Research Council of Australia and Hunter Medical Research Institute for funding support and J. Weigel from The Australian Reptile Park for the donation of snake venom.	ANKER RL, 1982, MED J AUSTRALIA, V1, P103, DOI 10.5694/j.1326-5377.1982.tb132180.x; Aukland K, 2005, ACTA PHYSIOL SCAND, V185, P171, DOI 10.1111/j.1365-201X.2005.01470.x; Barnes JM, 1941, LANCET, V1, P623; Canale E, 2009, EMERG MED AUSTRALAS, V21, P184, DOI 10.1111/j.1742-6723.2009.01180.x; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Gilchrist J., 2008, WORLD REPORT CHILD I; Hack JB, 2010, J MED TOXICOL, V6, P207, DOI 10.1007/s13181-010-0050-5; HOWARTH DM, 1994, MED J AUSTRALIA, V161, P695, DOI 10.5694/j.1326-5377.1994.tb126923.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Krifi MN, 2005, TOXICON, V45, P187, DOI 10.1016/j.toxicon.2004.10.007; MARCO AJ, 1992, LAB ANIM, V26, P200, DOI 10.1258/002367792780740549; Meggs WJ, 2010, CLIN TOXICOL, V48, P61, DOI 10.3109/15563650903376071; OLSZEWSKI WL, 1980, AM J PHYSIOL, V239, pH775, DOI 10.1152/ajpheart.1980.239.6.H775; Riviere G, 1998, J PHARMACOL EXP THER, V285, P490; SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987, DOI 10.1152/physrev.1990.70.4.987; Sutherland SK, 2005, WILD ENVIRON MED, V16, P164, DOI 10.1580/1080-6032(2005)16[164:ROFMFE]2.0.CO;2; YOKOYAMA S, 1993, AM J PHYSIOL, V264, pH1460, DOI 10.1152/ajpheart.1993.264.5.H1460	17	33	33	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					809	811		10.1038/nm.2382	http://dx.doi.org/10.1038/nm.2382			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706027	Green Published			2022-12-27	WOS:000292500800033
J	Zhang, SY; Huang, WC; Li, P; Guo, H; Poh, SB; Brady, SW; Xiong, Y; Tseng, LM; Li, SH; Ding, ZX; Sahin, AA; Esteva, FJ; Hortobagyi, GN; Yu, DH				Zhang, Siyuan; Huang, Wen-Chien; Li, Ping; Guo, Hua; Poh, Say-Bee; Brady, Samuel W.; Xiong, Yan; Tseng, Ling-Ming; Li, Shau-Hsuan; Ding, Zhaoxi; Sahin, Aysegul A.; Esteva, Francisco J.; Hortobagyi, Gabriel N.; Yu, Dihua			Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; METASTATIC BREAST-CANCER; C-SRC; TYROSINE KINASES; FAMILY KINASES; CELLS; CONTRIBUTES; APOPTOSIS; ERBB2	Trastuzumab is a successful rationally designed ERBB2-targeted therapy. However, about half of individuals with ERBB2-overexpressing breast cancer do not respond to trastuzumab-based therapies, owing to various resistance mechanisms. Clinically applicable regimens for overcoming trastuzumab resistance of different mechanisms are not yet available. We show that the nonreceptor tyrosine kinase c-SRC (SRC) is a key modulator of trastuzumab response and a common node downstream of multiple trastuzumab resistance pathways. We find that SRC is activated in both acquired and de novo trastuzumab-resistant cells and uncover a novel mechanism of SRC regulation involving dephosphorylation by PTEN. Increased SRC activation conferred considerable trastuzumab resistance in breast cancer cells and correlated with trastuzumab resistance in patients. Targeting SRC in combination with trastuzumab sensitized multiple lines of trastuzumab-resistant cells to trastuzumab and eliminated trastuzumab-resistant tumors in vivo, suggesting the potential clinical application of this strategy to overcome trastuzumab resistance.	[Zhang, Siyuan; Huang, Wen-Chien; Li, Ping; Guo, Hua; Poh, Say-Bee; Brady, Samuel W.; Xiong, Yan; Tseng, Ling-Ming; Li, Shau-Hsuan; Ding, Zhaoxi; Esteva, Francisco J.; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Brady, Samuel W.; Esteva, Francisco J.; Yu, Dihua] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA; [Sahin, Aysegul A.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Esteva, Francisco J.; Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yu, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	dyu@mdanderson.org	Zhang, Siyuan/A-1276-2014; Zhang, Siyuan/AAH-1157-2021	Zhang, Siyuan/0000-0003-0910-3666; Zhang, Siyuan/0000-0003-0910-3666; Esteva, Francisco J./0000-0003-2437-3920; Yu, Dihua/0000-0001-6231-9381	US National Institutes of Health [P30-CA 16672, RO1-CA112567, PO1-CA099031]; MD Anderson Cancer Center Breast SPORE [P50 CA116199]; US Department of Defense Center of Excellence [W81XWH-06-2-0033]; Susan G. Komen Breast Cancer Foundation [KG091020]; Cancer Prevention Research Institute of Texas [RP100726]; MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA112567, P50CA116199, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Breast SPORE; US Department of Defense Center of Excellence(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Cancer Prevention Research Institute of Texas; MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank AstraZeneca for providing us with saracatinib and W. Zhang in the Department of Pathology, MD Anderson Cancer Center for providing us with the IGF-1R expression vector. We also thank C. Neal, J. Lu, S. Rehman and F. J. Lowery for insightful comments on this manuscript. This work was supported by US National Institutes of Health grants P30-CA 16672 (MD Anderson Cancer Center), RO1-CA112567 (D. Y.), PO1-CA099031 project 4 (D. Y.), MD Anderson Cancer Center Breast SPORE P50 CA116199 (G. N. H.) project 4 (D. Y.), US Department of Defense Center of Excellence subproject W81XWH-06-2-0033 (D. Y.), Susan G. Komen Breast Cancer Foundation promise grant KG091020 (D. Y.), Cancer Prevention Research Institute of Texas grant RP100726 (D. Y.), the MD Anderson Cancer Center Breast SPORE Career Development Award (S.Z.) and the Susan G. Komen Breast Cancer Foundation postdoctoral fellowship (S.Z.). D. Y. is the Hubert L. and Olive Stringer Distinguished Chair in Basic Science at MD Anderson Cancer Center.	Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chang FM, 2003, INT J ONCOL, V22, P469; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Johnson D, 2000, CELL DEATH DIFFER, V7, P685, DOI 10.1038/sj.cdd.4400700; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lu CH, 2007, CLIN CANCER RES, V13, P5883, DOI 10.1158/1078-0432.CCR-06-2837; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Moulder SL, 2001, CANCER RES, V61, P8887; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Nautiyal J, 2010, MOL CANCER THER, V9, P1503, DOI 10.1158/1535-7163.MCT-10-0019; Olayioye MA, 2001, EXP CELL RES, V267, P81, DOI 10.1006/excr.2001.5242; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Piccart M, 2008, CLIN BREAST CANCER, V8, pS100, DOI 10.3816/CBC.2008.s.006; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; TABERNERO J, 2007, ASCO ANN M P 1, V25, P3520; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	53	384	398	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					461	U101		10.1038/nm.2309	http://dx.doi.org/10.1038/nm.2309			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21399647	Green Accepted			2022-12-27	WOS:000289245100037
J	Callendret, B; Walker, C				Callendret, Benoit; Walker, Christopher			A siege of hepatitis Immune boost for viral hepatitis	NATURE MEDICINE			English	Editorial Material							T-CELLS; C VIRUS; INFECTION; BLOCKADE; LIVER	Finding mechanisms of viral resistance and new ways to tackle chronic hepatitis will help find a cure for this disease. In 'Bench to Bedside', Christopher Walker and Benoit Callendret highlight studies showing that overcoming immune exhaustion during chronic infection by blocking several inhibitory pathways of T cells may restore an adequate immune response. In 'Bedside to Bench', Lawrence Corey, Joshua Schiffer and John Scott discuss recent advances in antiviral therapy with protease inhibitors and the findings of a mathematical model that predicts possible single and double mutations prior to antiviral therapy.	[Callendret, Benoit; Walker, Christopher] Ohio State Univ, Ctr Vaccines & Immun, Nationwide Childrens Hosp, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Callendret, B (corresponding author), Ohio State Univ, Ctr Vaccines & Immun, Nationwide Childrens Hosp, Columbus, OH 43210 USA.	christopher.walker@nationwidechildrens.org	callendret, benoit/U-4193-2019		NIAID NIH HHS [R37 AI047367] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047367] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Brillanti S, 2011, DIGEST LIVER DIS, V43, P425, DOI 10.1016/j.dld.2010.10.007; Di Giacomo AM, 2010, SEMIN ONCOL, V37, P499, DOI 10.1053/j.seminoncol.2010.09.007; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7	15	19	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					252	253		10.1038/nm0311-252	http://dx.doi.org/10.1038/nm0311-252			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383718	Green Accepted			2022-12-27	WOS:000288070000018
J	Pardoll, D				Pardoll, Drew			Timeline: a decade of advances in immunotherapy	NATURE MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University	Pardoll, D (corresponding author), Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA.	dpardol1@jhmi.edu			NATIONAL CANCER INSTITUTE [P30CA006973, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973, P30 CA021765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	3	3	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					296	296		10.1038/nm0311-296	http://dx.doi.org/10.1038/nm0311-296			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383743	Bronze, Green Accepted			2022-12-27	WOS:000288070000039
J	Wang, JX; Jiao, JQ; Li, QA; Long, B; Wang, K; Liu, JP; Li, YR; Li, PF				Wang, Jian-Xun; Jiao, Jian-Qin; Li, Qian; Long, Bo; Wang, Kun; Liu, Jin-Ping; Li, Yan-Rui; Li, Pei-Feng			miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1	NATURE MEDICINE			English	Article							ISCHEMIA-REPERFUSION INJURY; CASPASE RECRUITMENT DOMAIN; MUSCLE-SPECIFIC MICRORNA; MYOCARDIAL-INFARCTION; APOPTOSIS REPRESSOR; HUMAN HEART; FISSION; GENES; DEPHOSPHORYLATION; PATHWAY	Myocardial infarction is a leading cause of mortality worldwide. Here we report that modulation of microRNA-499 (miR-499) levels affects apoptosis and the severity of myocardial infarction and cardiac dysfunction induced by ischemia-reperfusion. We found that both the alpha-and beta-isoforms of the calcineurin catalytic subunit are direct targets of miR-499 and that miR-499 inhibits cardiomyocyte apoptosis through its suppression of calcineurin-mediated dephosphorylation of dynamin-related protein-1 (Drp1), thereby decreasing Drp1 accumulation in mitochondria and Drp1-mediated activation of the mitochondrial fission program. We also found that p53 transcriptionally downregulates miR-499 expression. Our data reveal a role for miR-499 in regulating the mitochondrial fission machinery and we suggest that modulation of miR-499 levels may provide a therapeutic approach for treating myocardial infarction.	[Wang, Jian-Xun; Jiao, Jian-Qin; Li, Qian; Long, Bo; Wang, Kun; Liu, Jin-Ping; Li, Yan-Rui; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Inst Zool, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China.	peifli@ioz.ac.cn	Long, Bo/AGX-8013-2022; Long, Bo/GQH-5131-2022; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; LI, YANRUI/0000-0002-0930-0590; Wang, Jianxun/0000-0002-3731-6514	National Natural Science Foundation of China [30730045, 31010103911]; National Basic Research Program of China (973 Program) [2007CB512000, 2011CB965300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (30730045, 31010103911) and the National Basic Research Program of China (973 Program, 2007CB512000, 2011CB965300). p alpha MHC-clone26 was kindly provided by Z. Yang (Nanjing University). CnA alpha and CnA beta cDNAs were kindly provided by T. Kuno (Kobe University). The antibody to phospho-Drp1 (Ser656) was kindly provided by S. Strack (University of Iowa).	Basson M, 2007, NAT MED, V13, P541, DOI 10.1038/nm0507-541; Cai Q, 1998, CARDIOVASC DRUG THER, V12, P499, DOI 10.1023/A:1007745814463; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chao W, 2002, J BIOL CHEM, V277, P31639, DOI 10.1074/jbc.M204104200; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Chien KR, 2007, NATURE, V447, P389, DOI 10.1038/447389a; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lim HW, 1999, NAT MED, V5, P246, DOI 10.1038/6430; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Mann DL, 2007, NEW ENGL J MED, V356, P2644, DOI 10.1056/NEJMcibr072068; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Nakamura T, 2000, CIRCULATION, V102, P572; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shizukuda Y, 1998, AM J PHYSIOL-HEART C, V275, pH961, DOI 10.1152/ajpheart.1998.275.3.H961; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Weinbrenner C, 1998, CARDIOVASC RES, V38, P676, DOI 10.1016/S0008-6363(98)00064-9; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	59	454	502	5	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					71	U243		10.1038/nm.2282	http://dx.doi.org/10.1038/nm.2282			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21186368				2022-12-27	WOS:000285994000038
J	Zink, CF; Weinberger, DR				Zink, Caroline F.; Weinberger, Daniel R.			Cracking the moody brain The rewards of self starvation	NATURE MEDICINE			English	Editorial Material							ANOREXIA-NERVOSA; DOPAMINE		[Zink, Caroline F.; Weinberger, Daniel R.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zink, CF (corresponding author), NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, US Natl Inst Hlth, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov						American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Attia E, 2010, ANNU REV MED, V61, P425, DOI 10.1146/annurev.med.050208.200745; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Kaye WH, 2005, INT J EAT DISORDER, V37, pS15, DOI 10.1002/eat.20109; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006	12	44	44	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1382	1383		10.1038/nm1210-1382	http://dx.doi.org/10.1038/nm1210-1382			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135849				2022-12-27	WOS:000285048900028
J	De Keersmaecker, K; Real, PJ; Della Gatta, G; Palomero, T; Sulis, ML; Tosello, V; Van Vlierberghe, P; Barnes, K; Castillo, M; Sole, X; Hadler, M; Lenz, J; Aplan, PD; Kelliher, M; Kee, BL; Pandolfi, PP; Kappes, D; Gounari, F; Petrie, H; Van der Meulen, J; Speleman, F; Paietta, E; Racevskis, J; Wiernik, PH; Rowe, JM; Soulier, J; Avran, D; Cave, H; Dastugue, N; Raimondi, S; Meijerink, JPP; Cordon-Cardo, C; Califano, A; Ferrando, AA				De Keersmaecker, Kim; Real, Pedro J.; Della Gatta, Giusy; Palomero, Teresa; Luisa Sulis, Maria; Tosello, Valeria; Van Vlierberghe, Pieter; Barnes, Kelly; Castillo, Mireia; Sole, Xavier; Hadler, Michael; Lenz, Jack; Aplan, Peter D.; Kelliher, Michelle; Kee, Barbara L.; Pandolfi, Pier Paolo; Kappes, Dietmar; Gounari, Fotini; Petrie, Howard; Van der Meulen, Joni; Speleman, Frank; Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.; Rowe, Jacob M.; Soulier, Jean; Avran, David; Cave, Helene; Dastugue, Nicole; Raimondi, Susana; Meijerink, Jules P. P.; Cordon-Cardo, Carlos; Califano, Andrea; Ferrando, Adolfo A.			The TLX1 oncogene drives aneuploidy in T cell transformation	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; MUTATIONS; HOX11; BCL11B; NOTCH1; LYMPHOMAGENESIS; SELECTION; RECURRENT; PATHWAYS	The TLX1 oncogene (encoding the transcription factor T cell leukemia homeobox protein-1) has a major role in the pathogenesis of T cell acute lymphoblastic leukemia (T-ALL). However, the specific mechanisms of T cell transformation downstream of TLX1 remain to be elucidated. Here we show that transgenic expression of human TLX1 in mice induces T-ALL with frequent deletions and mutations in Bcl11b (encoding B cell leukemia/lymphoma-11B) and identify the presence of recurrent mutations and deletions in BCL11B in 16% of human T-ALLs. Most notably, mouse TLX1 tumors were typically aneuploid and showed a marked defect in the activation of the mitotic checkpoint. Mechanistically, TLX1 directly downregulates the expression of CHEK1 (encoding CHK1 checkpoint homolog) and additional mitotic control genes and induces loss of the mitotic checkpoint in nontransformed preleukemic thymocytes. These results identify a previously unrecognized mechanism contributing to chromosomal missegregation and aneuploidy active at the earliest stages of tumor development in the pathogenesis of cancer.	[De Keersmaecker, Kim; Real, Pedro J.; Della Gatta, Giusy; Palomero, Teresa; Luisa Sulis, Maria; Tosello, Valeria; Van Vlierberghe, Pieter; Barnes, Kelly; Hadler, Michael; Califano, Andrea; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [De Keersmaecker, Kim] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [De Keersmaecker, Kim] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Palomero, Teresa; Castillo, Mireia; Cordon-Cardo, Carlos; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Luisa Sulis, Maria; Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Sole, Xavier] Inst Invest Biomed Bellvitge, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Barcelona, Spain; [Sole, Xavier] IDIBELL, Biomed Res Ctr Network Epidemiol & Publ Hlth, Catalan Inst Oncol, Barcelona, Spain; [Lenz, Jack] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; [Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kelliher, Michelle] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Kappes, Dietmar] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Gounari, Fotini] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Petrie, Howard] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Van der Meulen, Joni; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] Montefiore Med Ctr, North Div, New York, NY USA; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] New York Med Coll, New York, NY USA; [Rowe, Jacob M.] Technion Israel Inst Technol, Haifa, Israel; [Soulier, Jean; Avran, David] Hop St Louis, AP HP, Hematol Lab, Paris, France; [Soulier, Jean; Avran, David] Hop St Louis, INSERM, U944, Paris, France; [Soulier, Jean; Avran, David] Univ Paris 07, Hop St Louis, Inst Univ Hematol, Paris, France; [Cave, Helene] Univ Paris 07, Hop Robert Debre, AP HP, Dept Genet, Paris, France; [Dastugue, Nicole] Hop Purpan, Hematol Lab, Toulouse, France; [Raimondi, Susana] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Meijerink, Jules P. P.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel	Columbia University; Flanders Institute for Biotechnology (VIB); KU Leuven; Columbia University; Columbia University; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fox Chase Cancer Center; University of Chicago; Scripps Research Institute; Ghent University; Ghent University Hospital; Montefiore Medical Center; New York Medical College; Technion Israel Institute of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; St Jude Children's Research Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Columbia University; Rambam Health Care Campus; Technion Israel Institute of Technology	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	af2196@columbia.edu	De Keersmaecker, Kim/W-9702-2018; Solé, Xavier/AAF-3015-2019; Raimondi, Susana C/N-8166-2018; Real, Pedro J./K-2994-2014; Aplan, Peter D/K-9064-2016; Van Vlierberghe, Pieter/G-8894-2013; speleman, frank/AAR-5184-2020; Real, Pedro J./ABH-3493-2021; Meijerink, Jules P/D-4393-2017; Ferrando, Adolfo A/Q-7026-2016; Castillo-Martin, Mireia/H-6152-2013; Van der Meulen, Joni/AFS-1616-2022; Tosello, Valeria/N-1010-2016	De Keersmaecker, Kim/0000-0002-7420-9531; Solé, Xavier/0000-0002-2197-3325; Real, Pedro J./0000-0001-7968-5353; Van Vlierberghe, Pieter/0000-0001-9063-7205; speleman, frank/0000-0002-6628-8559; Meijerink, Jules P/0000-0002-6860-798X; Van der Meulen, Joni/0000-0002-1916-2769; Cave, Helene/0000-0003-2840-1511; Pandolfi, Pier Paolo/0000-0002-5352-5295; van der Meulen, Jan/0000-0002-9451-2335; Califano, Andrea/0000-0003-4742-3679; Tosello, Valeria/0000-0001-9560-340X	New York Community Trust; US National Institutes of Health [R01CA120196, R01CA129382, CA21765, U24 CA114737]; Eastern Cooperative Oncology Group tumor bank; European Organization for Research and Treatment of Cancer Children Leukemia Group; Leukemia AMP; Lymphoma Society Scholar Award; US National Institutes of Health; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Belgian American Educational Foundation; France National Cancer Institute; NATIONAL CANCER INSTITUTE [U24CA114737, R01CA120196, ZIASC010378, R01CA129382, P30CA021765] Funding Source: NIH RePORTER	New York Community Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eastern Cooperative Oncology Group tumor bank; European Organization for Research and Treatment of Cancer Children Leukemia Group; Leukemia AMP; Lymphoma Society Scholar Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Belgian American Educational Foundation; France National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Blood Disease Research Project research grant from The New York Community Trust (A.A.F.); the US National Institutes of Health (grants R01CA120196 and R01CA129382 to A.A.F.; CA21765 to S.R. and U24 CA114737 to E.P.), the Spanish Ministry of Science and Innovation (fellowship EX-2006-0739 to P.J.R.), a Canceropole Ile-de-France Research research grant (J.S.), the Eastern Cooperative Oncology Group tumor bank and the European Organization for Research and Treatment of Cancer Children Leukemia Group, the Leukemia & Lymphoma Society Scholar Award (A.A.F.) and the Intramural Program of the US National Institutes of Health (P.D.A.). K.D.K. is a postdoctoral researcher funded by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen and a recipient of a Belgian American Educational Foundation fellowship. D.A. is recipient of a predoctoral fellowship from the France National Cancer Institute. We are also grateful to T. Ludwig for helpful discussions, to J.C. Zuniga-Pflucker (University of Toronto) for the OP9-DL1 cells, to F. Gounari (University of Chicago) for the pUC1017 vector and S. Cory (Walter and Eliza Hall Institute of Medical Research) and H.G. Wendel (Memorial Sloan Kettering Cancer Center) for the Vav-Bcl2 mouse line.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Berger R, 2003, LEUKEMIA, V17, P1851, DOI 10.1038/sj.leu.2403061; Bergeron J, 2007, BLOOD, V110, P2324, DOI 10.1182/blood-2007-04-079988; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Chandhok NS, 2009, CURR OPIN GENET DEV, V19, P74, DOI 10.1016/j.gde.2008.12.004; Chen E, 2006, ONCOGENE, V25, P2575, DOI 10.1038/sj.onc.1209285; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Hough MR, 1998, P NATL ACAD SCI USA, V95, P13853, DOI 10.1073/pnas.95.23.13853; Kamimura K, 2007, BIOCHEM BIOPH RES CO, V355, P538, DOI 10.1016/j.bbrc.2007.02.003; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Kees UR, 2003, LEUKEMIA, V17, P887, DOI 10.1038/sj.leu.2402892; Kohn EA, 2003, CANCER RES, V63, P31; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383	35	104	107	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1321	+		10.1038/nm.2246	http://dx.doi.org/10.1038/nm.2246			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20972433	Green Accepted			2022-12-27	WOS:000283860100045
J	Llewellyn, ME; Thompson, KR; Deisseroth, K; Delp, SL				Llewellyn, Michael E.; Thompson, Kimberly R.; Deisseroth, Karl; Delp, Scott L.			Orderly recruitment of motor units under optical control in vivo	NATURE MEDICINE			English	Article							LEBERS CONGENITAL AMAUROSIS; ELECTRICAL-STIMULATION; SKELETAL-MUSCLE; MEDIAL GASTROCNEMIUS; CAT GASTROCNEMIUS; SIZE PRINCIPLE; GENE-THERAPY; MOUSE; MOTONEURONS; FORCE	A drawback of electrical stimulation for muscle control is that large, fatigable motor units are preferentially recruited before smaller motor units by the lowest-intensity electrical cuff stimulation. This phenomenon limits therapeutic applications because it is precisely the opposite of the normal physiological (orderly) recruitment pattern; therefore, a mechanism to achieve orderly recruitment has been a long-sought goal in physiology, medicine and engineering. Here we demonstrate a technology for reliable orderly recruitment in vivo. We find that under optical control with microbial opsins, recruitment of motor units proceeds in the physiological recruitment sequence, as indicated by multiple independent measures of motor unit recruitment including conduction latency, contraction and relaxation times, stimulation threshold and fatigue. As a result, we observed enhanced performance and reduced fatigue in vivo. These findings point to an unanticipated new modality of neural control with broad implications for nervous system and neuromuscular physiology, disease research and therapeutic innovation.	[Llewellyn, Michael E.; Thompson, Kimberly R.; Deisseroth, Karl; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Delp, SL (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu; delp@stanford.edu		Delp, Scott/0000-0002-9643-7551	Stanford Bio-X Interdisciplinary Initiatives; National Alliance for Research on Schizophrenia and Depression; Stanford-US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065690] Funding Source: NIH RePORTER	Stanford Bio-X Interdisciplinary Initiatives; National Alliance for Research on Schizophrenia and Depression(NARSAD); Stanford-US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Barretto and D. Wetmore for technical assistance and K. McGill, Z. Lateva, R. Lieber, D. Lin and F. Zajac for fruitful discussions. This work was supported by a Stanford Bio-X Interdisciplinary Initiatives award (S. L. D. and K. D.), the National Alliance for Research on Schizophrenia and Depression (K. R. T.), and the Stanford-US National Institutes of Health Medical Scientist Training Program (M. E. L.).	ALAMOOD WS, 1991, J PHYSIOL-LONDON, V441, P243, DOI 10.1113/jphysiol.1991.sp018749; ALLEN DG, 1995, J PHYSIOL-LONDON, V487, P331, DOI 10.1113/jphysiol.1995.sp020883; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BAKELS R, 1993, J PHYSIOL-LONDON, V463, P307, DOI 10.1113/jphysiol.1993.sp019596; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; COPE TC, 1991, J NEUROPHYSIOL, V66, P1127, DOI 10.1152/jn.1991.66.4.1127; FANG ZP, 1991, IEEE T BIO-MED ENG, V38, P175, DOI 10.1109/10.76384; FANG ZP, 1991, IEEE T BIO-MED ENG, V38, P168, DOI 10.1109/10.76383; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Gordon T, 2004, CAN J PHYSIOL PHARM, V82, P645, DOI 10.1139/Y04-081; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hamada T, 2004, J ELECTROMYOGR KINES, V14, P531, DOI 10.1016/j.jelekin.2004.03.008; Hayashi A, 2007, J RECONSTR MICROSURG, V23, P381, DOI 10.1055/s-2007-992344; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; IRINTCHEV A, 1990, NEUROSCIENCE, V39, P231, DOI 10.1016/0306-4522(90)90236-W; Kan HE, 2005, AM J PHYSIOL-CELL PH, V289, pC113, DOI 10.1152/ajpcell.00040.2005; Lertmanorat Z, 2004, J NEURAL ENG, V1, P202, DOI 10.1088/1741-2560/1/4/003; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McClelland S, 2007, AM J PHYS MED REHAB, V86, P412, DOI 10.1097/PHM.0b013e31804a83cf; MCHANWELL S, 1981, PROC R SOC SER B-BIO, V213, P201, DOI 10.1098/rspb.1981.0062; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P359, DOI 10.1113/jphysiol.1973.sp010192; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Singh K, 2000, IEEE T REHABIL ENG, V8, P276; Sokoloff AJ, 1999, J NEUROPHYSIOL, V81, P2485, DOI 10.1152/jn.1999.81.5.2485; Thrasher A, 2005, ARTIF ORGANS, V29, P453, DOI 10.1111/j.1525-1594.2005.29076.x; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85; ZAJAC FE, 1985, J NEUROPHYSIOL, V53, P1303, DOI 10.1152/jn.1985.53.5.1303; Zhan WZ, 1999, J APPL PHYSIOL, V87, P2326, DOI 10.1152/jappl.1999.87.6.2326; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; ZHOU BH, 1987, IEEE T BIO-MED ENG, V34, P128, DOI 10.1109/TBME.1987.326037	38	137	185	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1161	U144		10.1038/nm.2228	http://dx.doi.org/10.1038/nm.2228			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871612	Green Accepted			2022-12-27	WOS:000282644800049
J	Swarbrick, A; Woods, SL; Shaw, A; Balakrishnan, A; Phua, Y; Nguyen, A; Chanthery, Y; Lim, L; Ashton, LJ; Judson, RL; Huskey, N; Blelloch, R; Haber, M; Norris, MD; Lengyel, P; Hackett, CS; Preiss, T; Chetcuti, A; Sullivan, CS; Marcusson, EG; Weiss, W; L'Etoile, N; Goga, A				Swarbrick, Alexander; Woods, Susan L.; Shaw, Alexander; Balakrishnan, Asha; Phua, Yuwei; Nguyen, Akira; Chanthery, Yvan; Lim, Lionel; Ashton, Lesley J.; Judson, Robert L.; Huskey, Noelle; Blelloch, Robert; Haber, Michelle; Norris, Murray D.; Lengyel, Peter; Hackett, Christopher S.; Preiss, Thomas; Chetcuti, Albert; Sullivan, Christopher S.; Marcusson, Eric G.; Weiss, William; L'Etoile, Noelle; Goga, Andrei			miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma	NATURE MEDICINE			English	Article							INDUCED APOPTOSIS; IN-VIVO; MICRORNA; EXPRESSION; PATHWAY; RESTORATION; INHIBITION; SENESCENCE; PROTEIN; TARGET	Inactivation of the p53 tumor suppressor pathway allows cell survival in times of stress and occurs in many human cancers; however, normal embryonic stem cells and some cancers such as neuroblastoma maintain wild-type human TP53 and mouse Trp53 (referred to collectively as p53 herein). Here we describe a miRNA, miR-380-5p, that represses p53 expression via a conserved sequence in the p53 3' untranslated region (UTR). miR-380-5p is highly expressed in mouse embryonic stem cells and neuroblastomas, and high expression correlates with poor outcome in neuroblastomas with neuroblastoma derived v-myc myelocytomatosis viral-related oncogene (MYCN) amplification. miR-380 overexpression cooperates with activated HRAS oncoprotein to transform primary cells, block oncogene-induced senescence and form tumors in mice. Conversely, inhibition of endogenous miR-380-5p in embryonic stem or neuroblastoma cells results in induction of p53, and extensive apoptotic cell death. In vivo delivery of a miR-380-5p antagonist decreases tumor size in an orthotopic mouse model of neuroblastoma. We demonstrate a new mechanism of p53 regulation in cancer and stem cells and uncover a potential therapeutic target for neuroblastoma.	[Balakrishnan, Asha; Lengyel, Peter; Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Swarbrick, Alexander; Shaw, Alexander; Phua, Yuwei; Nguyen, Akira] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Swarbrick, Alexander; Phua, Yuwei; Preiss, Thomas] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Woods, Susan L.] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [Woods, Susan L.] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld, Australia; [Shaw, Alexander; Preiss, Thomas] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Shaw, Alexander; Preiss, Thomas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Balakrishnan, Asha; Lengyel, Peter; Goga, Andrei] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chanthery, Yvan; Lim, Lionel; Judson, Robert L.; Huskey, Noelle; Hackett, Christopher S.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Ashton, Lesley J.; Haber, Michelle; Norris, Murray D.] Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Judson, Robert L.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Chetcuti, Albert] Childrens Hosp, Childrens Canc Res Inst, Westmead, NSW, Australia; [Hackett, Christopher S.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Marcusson, Eric G.] Regulus Therapeut, San Diego, CA USA; [Weiss, William] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [L'Etoile, Noelle] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Goga, Andrei] Univ Calif San Francisco, Helen Diller Canc Ctr, San Francisco, CA USA; [Goga, Andrei] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Garvan Institute of Medical Research; University of New South Wales Sydney; University of California System; University of California San Francisco; QIMR Berghofer Medical Research Institute; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Cancer Institute; University of Sydney; University of Texas System; University of Texas Austin; Isis Pharmaceuticals Inc; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Goga, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	a.swarbrick@garvan.org.au; andrei.goga@ucsf.edu	Swarbrick, Alexander/E-6107-2010; Xie, Huangming/B-2260-2012; Shaw, Alex/C-9826-2011; Preiss, Thomas/F-7355-2010	Swarbrick, Alexander/0000-0002-3051-5676; Preiss, Thomas/0000-0001-6273-784X; Weiss, William/0000-0003-2230-9132; Norris, Murray/0000-0002-0632-4589; Haber, Michelle/0000-0003-2036-8817; Woods, Susan/0000-0002-8955-2017; Marcusson, Eric/0000-0002-0504-8674	US National Institutes of Health [P50-CA58207, K08-CA104032, 1R01CA136717, 5R01DC005991, R01CA102321, R01NS055750, P01CA081403]; NATIONAL CANCER INSTITUTE [R01CA136717, K08CA104032, P50CA058207, P01CA081403, R01CA102321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS055750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We gratefully thank J.M. Bishop, N.K. Hayward and R. L. Sutherland for their support of this project, the Children's Oncology Group and M. Grimmer (University of California-San Francisco) for providing tumor samples, D. Lynch and J. Brugge (Harvard Medical School) for MCF10A cells expressing the ecotropic receptor, R. Jaenisch (Whitehead Institute) for Trp53<SUP>-/-</SUP> ES cells and S. Lowe (Cold Spring Harbor) for the p53 shRNA retrovirus. TH-MYCN transgenic mice were from W. Weiss (University of California-San Francisco). This work was supported by grants from the US National Institutes of Health: P50-CA58207, K08-CA104032 and 1R01CA136717 (to A. G.), 5R01DC005991 (to N.L.), R01CA102321, R01NS055750 and P01CA081403 (to W. W.) and K08NS48118 (to R. B.); the Susan G. Komen Foundation; the University of California-San Francisco Program for Breakthrough Biomedical Research (to A. G.); the G. W. Hooper Foundation; the Australian National Health and Medical Research Council (to T. P., M. H., M.D.N. and A. Swarbrick) and the Cancer Institute New South Wales (M. H. and M.D.N.). A. Swarbrick is a recipient of a Cancer Institute New South Wales early career development fellowship, and R. L. J. received a US National Science Foundation fellowship. A. G. is a V-Foundation Scholar, A. Shaw is a Cancer Institute New South Wales Research Scholar and Y.P. is supported by an Australian Postgraduate Award from the Australian National Health and Medical Research Council.	Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; CLARKE AR, 1994, ONCOGENE, V9, P1767; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fu LN, 1999, ONCOGENE, V18, P6419, DOI 10.1038/sj.onc.1203064; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Halaby MJ, 2007, GENE, V395, P1, DOI 10.1016/j.gene.2007.01.029; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; MEDINA PP, 2010, NATURE          0808, DOI DOI 10.1038/NATURE09284; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Tweddle DA, 2001, CANCER RES, V61, P8; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yoon H, 2002, P NATL ACAD SCI USA, V99, P15632, DOI 10.1073/pnas.242597299; Zhao RB, 2000, GENE DEV, V14, P981; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	148	155	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1134	U113		10.1038/nm.2227	http://dx.doi.org/10.1038/nm.2227			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871609	Green Accepted			2022-12-27	WOS:000282644800044
J	Stephan, MT; Moon, JJ; Um, SH; Bershteyn, A; Irvine, DJ				Stephan, Matthias T.; Moon, James J.; Um, Soong Ho; Bershteyn, Anna; Irvine, Darrell J.			Therapeutic cell engineering with surface-conjugated synthetic nanoparticles	NATURE MEDICINE			English	Article							T-LYMPHOCYTES; STEM-CELLS; TRANSPLANTATION; ANTIGEN; IMPACT; CANCER; EXPANSION; TARGET; IL-15; TRIAL	A major limitation of cell therapies is the rapid decline in viability and function of the transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation of adjuvant drug-loaded nanoparticles to the surfaces of therapeutic cells. With this method of providing sustained pseudoautocrine stimulation to donor cells, we elicited marked enhancements in tumor elimination in a model of adoptive T cell therapy for cancer. We also increased the in vivo repopulation rate of hematopoietic stem cell grafts with very low doses of adjuvant drugs that were ineffective when given systemically. This approach is a simple and generalizable strategy to augment cytoreagents while minimizing the systemic side effects of adjuvant drugs. In addition, these results suggest therapeutic cells are promising vectors for actively targeted drug delivery.	[Stephan, Matthias T.; Moon, James J.; Um, Soong Ho; Bershteyn, Anna; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Stephan, Matthias T.; Moon, James J.; Um, Soong Ho; Bershteyn, Anna; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Um, Soong Ho; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Irvine, Darrell J.] Harvard Univ, Boston, MA 02115 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute	Irvine, DJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	djirvine@mit.edu	Moon, James J/ABE-4429-2021	Moon, James J/0000-0003-2238-2372; Stephan, Matthias/0000-0001-8310-0100	US National Institutes of Health [CA140476]; US National Science Foundation [DMR-02-13282]; US National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA140476] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the US National Institutes of Health (CA140476), the US National Science Foundation (Materials Research Science and Engineering Center award DMR-02-13282), Cancer Center Support (core) grant P30-CA14051 from the US National Cancer Institute and a gift to the Koch Institute by Curtis and Cathy Marble. D.J.I. is an investigator of the Howard Hughes Medical Institute. We thank M. Sadelain (Memorial Sloan-Kettering Cancer Center) for extG-luc and M. van den Brink (Memorial Sloan-Kettering Cancer Center) for F-luc-transgenic mice.	Alison MR, 2009, CURR OPIN MOL THER, V11, P364; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; BERNSTEIN I, 2008, BIOL BLOOD MARROW TR, V14, P94; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dinauer N, 2005, BIOMATERIALS, V26, P5898, DOI 10.1016/j.biomaterials.2005.02.038; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jain RK, 2009, NEW ENGL J MED, V360, P2669, DOI 10.1056/NEJMcibr0902054; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Lu J, 2002, CLIN CANCER RES, V8, P3877; Mackinnon S, 2008, BLOOD CELL MOL DIS, V40, P63, DOI 10.1016/j.bcmd.2007.07.003; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; THOMPSON JA, 1987, CANCER RES, V47, P4202; Tong R, 2009, MRS BULL, V34, P422, DOI 10.1557/mrs2009.118; TREISMAN J, 1995, BLOOD, V85, P139, DOI 10.1182/blood.V85.1.139.bloodjournal851139; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wallace A, 2008, CLIN CANCER RES, V14, P3966, DOI 10.1158/1078-0432.CCR-08-0356; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	32	491	508	15	323	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					1035	U135		10.1038/nm.2198	http://dx.doi.org/10.1038/nm.2198			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20711198	Green Accepted			2022-12-27	WOS:000281622900034
J	White, J				White, Jeb			Masterminds behind pharmaceutical fraud deserve prison time	NATURE MEDICINE			English	Editorial Material									[White, Jeb] Nolan & Auerbach PA, Philadelphia, PA USA; [White, Jeb] Taxpayers Fraud, Washington, DC USA		White, J (corresponding author), Nolan & Auerbach PA, Philadelphia, PA USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					956	956		10.1038/nm0910-956	http://dx.doi.org/10.1038/nm0910-956			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823868	Bronze			2022-12-27	WOS:000281622900012
J	Qualls, JE; Murray, PJ				Qualls, Joseph E.; Murray, Peter J.			A double agent in cancer: Stopping macrophages wounds tumors	NATURE MEDICINE			English	Editorial Material							PROGRESSION; METASTASIS		[Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Qualls, JE (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802				Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; FANTIN A, 2010, BLOOD           0419, DOI DOI 10.1182/BLOOD-2009-12-257832; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445	9	10	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					863	864		10.1038/nm0810-863	http://dx.doi.org/10.1038/nm0810-863			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20689551				2022-12-27	WOS:000280649200024
J	Chibon, F; Lagarde, P; Salas, S; Perot, G; Brouste, V; Tirode, F; Lucchesi, C; de Reynies, A; Kauffmann, A; Bui, B; Terrier, P; Bonvalot, S; Le Cesne, A; Vince-Ranchere, D; Blay, JY; Collin, F; Guillou, L; Leroux, A; Coindre, JM; Aurias, A				Chibon, Frederic; Lagarde, Pauline; Salas, Sebastien; Perot, Gaelle; Brouste, Veronique; Tirode, Franck; Lucchesi, Carlo; de Reynies, Aurelien; Kauffmann, Audrey; Bui, Binh; Terrier, Philippe; Bonvalot, Sylvie; Le Cesne, Axel; Vince-Ranchere, Dominique; Blay, Jean-Yves; Collin, Francoise; Guillou, Louis; Leroux, Agnes; Coindre, Jean-Michel; Aurias, Alain			Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity	NATURE MEDICINE			English	Article							SOFT-TISSUE SARCOMAS; MALIGNANT FIBROUS HISTIOCYTOMAS; ADJUVANT CHEMOTHERAPY; FRENCH-FEDERATION; CENTERS-SARCOMA; CLASSIFICATION; METASTASIS; LEIOMYOSARCOMAS; LIPOSARCOMA; SUBGROUP	Sarcomas are heterogeneous and aggressive mesenchymal tumors. Histological grading has so far been the best predictor for metastasis-free survival, but it has several limitations, such as moderate reproducibility and poor prognostic value for some histological types. To improve patient grading, we performed genomic and expression profiling in a training set of 183 sarcomas and established a prognostic gene expression signature, complexity index in sarcomas (CINSARC), composed of 67 genes related to mitosis and chromosome management. In a multivariate analysis, CINSARC predicts metastasis outcome in the training set and in an independent 127 sarcomas validation set. It is superior to the Federation Francaise des Centres de Lutte Contre le Cancer grading system in determining metastatic outcome for sarcoma patients. Furthermore, it also predicts outcome for gastrointestinal stromal tumors (GISTs), breast carcinomas and lymphomas. Application of the signature will permit more selective use of adjuvant therapies for people with sarcomas, leading to decreased iatrogenic morbidity and improved outcomes for such individuals.	[Chibon, Frederic; Lagarde, Pauline; Salas, Sebastien; Bui, Binh; Coindre, Jean-Michel] Inst Bergonie, Dept Pathol, Bordeaux, France; [Chibon, Frederic; Lagarde, Pauline; Kauffmann, Audrey; Bui, Binh; Coindre, Jean-Michel] Inst Bergonie, INSERM, U916, Bordeaux, France; [Perot, Gaelle; Tirode, Franck; Lucchesi, Carlo; Aurias, Alain] Inst Curie, INSERM, U830, Paris, France; [Brouste, Veronique] Inst Bergonie, Dept Biostat, Bordeaux, France; [de Reynies, Aurelien] Ligue Natl Canc, Carte Identite Tumeurs, Paris, France; [Terrier, Philippe; Bonvalot, Sylvie; Le Cesne, Axel] Inst Gustave Roussy, Villejuif, France; [Vince-Ranchere, Dominique; Blay, Jean-Yves] Ctr Leon Berard, F-69373 Lyon, France; [Collin, Francoise] Ctr GF Leclerc, Dijon, France; [Guillou, Louis] Inst Univ Pathol, Lausanne, Switzerland; [Leroux, Agnes] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France; [Coindre, Jean-Michel] Univ Bordeaux 2, F-33076 Bordeaux, France	UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; UNICANCER; Centre Georges-Francois Leclerc; UNICANCER; Institut de cancerologie de Lorraine (ICL); UDICE-French Research Universities; Universite de Bordeaux	Chibon, F (corresponding author), Inst Bergonie, Dept Pathol, Bordeaux, France.	chibon@bergonie.org	Teh, Muy-Teck/B-9284-2016; TIRODE, Franck/HHS-7070-2022; chibon, frederic/A-2651-2013; Pérot, Gaëlle/J-3912-2014; de Reyniès, Aurélien/Q-8640-2017; Pérot, Gaëlle/W-8038-2019; Blay, Jean-Yves/N-3966-2016; Tirode, Franck/B-4586-2009	Teh, Muy-Teck/0000-0002-7725-8355; de Reyniès, Aurélien/0000-0002-1328-5290; Blay, Jean-Yves/0000-0001-7190-120X; Lucchesi, Carlo/0000-0001-6657-2341; chibon, Frederic/0000-0002-6548-2181; Tirode, Franck/0000-0003-4731-7817	French Institut National du Cancer; French Projets Hospitaliers de Recherche Clinique program; European Connective Tissue Cancer Network; Curie Institute; Bergonie Cancer Institute; l'INSERM; French Ligue Nationale Contre le Cancer	French Institut National du Cancer(Institut National du Cancer (INCA) France); French Projets Hospitaliers de Recherche Clinique program; European Connective Tissue Cancer Network; Curie Institute; Bergonie Cancer Institute; l'INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the French Institut National du Cancer, the French Projets Hospitaliers de Recherche Clinique program, the European Connective Tissue Cancer Network, the Curie Institute, the Bergonie Cancer Institute and l'INSERM. The construction of the human BAC array was supported by grants from the Carte d'Identite des Tumeurs program of the French Ligue Nationale Contre le Cancer. We are grateful to members of the French Sarcoma Group for providing tumor samples : Y.-M. Robin, X. Leroy, X. Saster-Garau, B. Marques, M-C. Chateau, J-P. Ghnassia and F. Mishelany, J-B. Courrege, V. Dapremont and C. Ferreira. We would like to thank R. Maki and R. Iggo for critical reading of the manuscript. We thank R. Cook for English editing.	[Anonymous], 2010, R LANG ENV STAT COMP; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Broders AC, 1939, SURG GYNECOL OBSTET, V69, P267; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chibon F, 2003, CANCER GENET CYTOGEN, V141, P75, DOI 10.1016/S0165-4608(02)00664-7; Chibon F, 2002, CANCER GENET CYTOGEN, V139, P24, DOI 10.1016/S0165-4608(02)00614-3; Coindre JM, 2003, MODERN PATHOL, V16, P256, DOI 10.1097/01.MP.0000056983.78547.77; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; COSTA J, 1984, CANCER, V53, P530, DOI 10.1002/1097-0142(19840201)53:3<530::AID-CNCR2820530327>3.0.CO;2-D; Derre J, 2001, LAB INVEST, V81, P211, DOI 10.1038/labinvest.3780229; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fletcher CDM, 2002, WHO CLASSIFICATION T; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Fritz B, 2002, CANCER RES, V62, P2993; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Idbaih A, 2005, LAB INVEST, V85, P176, DOI 10.1038/labinvest.3700202; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Lee YF, 2004, CANCER RES, V64, P7201, DOI 10.1158/0008-5472.CAN-04-1673; Lee YF, 2003, BRIT J CANCER, V88, P510, DOI 10.1038/sj.bjc.6600766; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; MARKHEDE G, 1982, CANCER, V48, P1721, DOI 10.1002/1097-0142(19820415)49:8<1721::AID-CNCR2820490832>3.0.CO;2-X; Matushansky I, 2008, AM J PATHOL, V172, P1069, DOI 10.2353/ajpath.2008.070284; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Pervaiz N, 2008, CANCER-AM CANCER SOC, V113, P573, DOI 10.1002/cncr.23592; RUSSELL WO, 1977, CANCER, V40, P1562, DOI 10.1002/1097-0142(197710)40:4<1562::AID-CNCR2820400428>3.0.CO;2-6; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; Singer S, 2007, CANCER RES, V67, P6626, DOI 10.1158/0008-5472.CAN-07-0584; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Tierney JF, 1997, LANCET, V350, P1647; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Zagars GK, 2003, CANCER, V97, P2530, DOI 10.1002/cncr.11365	42	290	294	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					781	U81		10.1038/nm.2174	http://dx.doi.org/10.1038/nm.2174			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20581836				2022-12-27	WOS:000279631900027
J	Natoli, TA; Smith, LA; Rogers, KA; Wang, B; Komarnitsky, S; Budman, Y; Belenky, A; Bukanov, NO; Dackowski, WR; Husson, H; Russo, RJ; Shayman, JA; Ledbetter, SR; Leonard, JP; Ibraghimov-Beskrovnaya, O				Natoli, Thomas A.; Smith, Laurie A.; Rogers, Kelly A.; Wang, Bing; Komarnitsky, Svetlana; Budman, Yeva; Belenky, Alexei; Bukanov, Nikolay O.; Dackowski, William R.; Husson, Herve; Russo, Ryan J.; Shayman, James A.; Ledbetter, Steven R.; Leonard, John P.; Ibraghimov-Beskrovnaya, Oxana			Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models	NATURE MEDICINE			English	Article							HAN-SPRD RATS; GANGLIOSIDE GM3; INSULIN SENSITIVITY; CELL-CYCLE; SYNTHASE; NEPHRONOPHTHISIS; PROGRESSION; GROWTH; ABNORMALITIES; PATHOGENESIS	Polycystic kidney disease (PKD) represents a family of genetic disorders characterized by renal cystic growth and progression to kidney failure(1). No treatment is currently available for people with PKD, although possible therapeutic interventions are emerging(2-8). Despite genetic and clinical heterogeneity, PKDs have in common defects of cystic epithelia, including increased proliferation, apoptosis and activation of growth regulatory pathways(1). Sphingolipids and glycosphingolipids are emerging as major regulators of these cellular processes(9). We sought to evaluate the therapeutic potential for glycosphingolipid modulation as a new approach to treat PKD. Here we demonstrate that kidney glucosylceramide (GlcCer) and ganglioside GM3 levels are higher in human and mouse PKD tissue as compared to normal tissue, regardless of the causative mutation. Blockade of GlcCer accumulation with the GlcCer synthase inhibitor Genz-123346 effectively inhibits cystogenesis in mouse models orthologous to human autosomal dominant PKD (Pkd1 conditional knockout mice) and nephronophthisis (jck and pcy mice). Molecular analysis in vitro and in vivo indicates that Genz-123346 acts through inhibition of the two key pathways dysregulated in PKD: Akt protein kinase-mammalian target of rapamycin signaling and cell cycle machinery. Taken together, our data suggest that inhibition of GlcCer synthesis represents a new and effective treatment option for PKD.	[Natoli, Thomas A.; Smith, Laurie A.; Rogers, Kelly A.; Bukanov, Nikolay O.; Dackowski, William R.; Husson, Herve; Russo, Ryan J.; Ledbetter, Steven R.; Ibraghimov-Beskrovnaya, Oxana] Genzyme Corp, Dept Cell Biol, Framingham, MA 01701 USA; [Wang, Bing; Komarnitsky, Svetlana; Budman, Yeva; Belenky, Alexei] Genzyme Corp, Dept Analyt Res & Dev, Waltham, MA USA; [Shayman, James A.] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Leonard, John P.] Genzyme Corp, Dept Pharmacol, Waltham, MA USA	Sanofi-Aventis; Genzyme Corporation; Sanofi-Aventis; Genzyme Corporation; University of Michigan System; University of Michigan; Sanofi-Aventis; Genzyme Corporation	Ibraghimov-Beskrovnaya, O (corresponding author), Genzyme Corp, Dept Cell Biol, Framingham, MA 01701 USA.	oxana.beskrovnaya@genzyme.com	Leonard, John/M-4379-2014	Leonard, John/0000-0002-5083-1115	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK055823] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Chatterjee S, 1996, J LIPID RES, V37, P1334; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DESHMUKH GD, 1994, J LIPID RES, V35, P1611; FOLCH J, 1957, J BIOL CHEM, V226, P497; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hong S, 2004, CELL DEATH DIFFER, V11, P714, DOI 10.1038/sj.cdd.4401405; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jankowski K, 2001, MICROCHEM J, V70, P41, DOI 10.1016/S0026-265X(01)00097-2; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Leuenroth SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2187, DOI 10.1093/ndt/gfp777; LUKINA E, 2010, BLOOD           0503, DOI DOI 10.1182/BL00D-2010-03-273151; Masoumi A, 2007, DRUGS, V67, P2495, DOI 10.2165/00003495-200767170-00004; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Natoli TA, 2008, AM J PHYSIOL-RENAL, V294, pF73, DOI 10.1152/ajprenal.00362.2007; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Rebbaa A, 1996, GLYCOBIOLOGY, V6, P399, DOI 10.1093/glycob/6.4.399; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TAKAHASHI H, 1991, J AM SOC NEPHROL, V1, P980; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Wahl PR, 2007, NEPHROLOGY, V12, P357, DOI 10.1111/j.1440-1797.2007.00811.x; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	40	118	129	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					788	U87		10.1038/nm.2171	http://dx.doi.org/10.1038/nm.2171			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20562878	Green Accepted			2022-12-27	WOS:000279631900028
J	Fan, ZG; Spencer, JA; Lu, Y; Pitsillides, CM; Singh, G; Kim, P; Yun, SH; Toxavidis, V; Strom, TB; Lin, CP; Koulmanda, M				Fan, Zhigang; Spencer, Joel A.; Lu, Yan; Pitsillides, Costas M.; Singh, Gurbakhshish; Kim, Pilhan; Yun, Seok H.; Toxavidis, Vasilis; Strom, Terry B.; Lin, Charles P.; Koulmanda, Maria			In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response	NATURE MEDICINE			English	Article							TRANSPLANTATION TOLERANCE; INDUCTION; REJECTION; GENERATION; AUTOIMMUNE; APOPTOSIS; BALANCE; FOXP3	Here we present methods to longitudinally track islet allograft-infiltrating T cells in live mice by endoscopic confocal microscopy and to analyze circulating T cells by in vivo flow cytometry. We developed a new reporter mouse whose T cell subsets express distinct, 'color-coded' proteins enabling in vivo detection and identification of effector T cells (T(eff) cells) and discrimination between natural and induced regulatory T cells (nT(reg) and iT(reg) cells). Using these tools, we observed marked differences in the T cell response in recipients receiving tolerance-inducing therapy (CD154-specific monoclonal antibody plus rapamycin) compared to untreated controls. These results establish real-time cell tracking as a powerful means to probe the dynamic cellular interplay mediating immunologic rejection or transplant tolerance.	[Fan, Zhigang; Lu, Yan; Singh, Gurbakhshish; Toxavidis, Vasilis; Strom, Terry B.; Koulmanda, Maria] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med, Boston, MA 02215 USA; [Spencer, Joel A.; Pitsillides, Costas M.; Lin, Charles P.] Harvard Univ, Sch Med, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02215 USA; [Spencer, Joel A.] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA; [Pitsillides, Costas M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Kim, Pilhan; Yun, Seok H.] Harvard Univ, Sch Med,Adv Microscopy Program, Massachusetts Gen Hosp, Wellman Ctr Photomed,Dept Dermatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Strom, TB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med, Boston, MA 02215 USA.	tstrom@bidmc.harvard.edu; lin@helix.mgh.harvard.edu	Spencer, Joel/A-4590-2013; Strom, Terry B./E-9268-2010; Kim, Pilhan/C-1836-2011; Spencer, Joel/GLT-9687-2022	Strom, Terry B./0000-0002-7570-0736; Kim, Pilhan/0000-0001-8388-1840; Spencer, Joel/0000-0002-4013-8763	US National Institutes of Health [R21 AI081010, R01 EY14106, P01-AI041521, P01-AI041521-S1]; Juvenile Diabetes Research Foundation (JDRF) [7-2005-1329]; NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, R21AI081010] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the US National Institutes of Health (R21 AI081010 to S.H.Y. and R01 EY14106 to C.P.L. and P01-AI041521 and P01-AI041521-S1 to T.B.S.) and the Juvenile Diabetes Research Foundation (JDRF 7-2005-1329 to T.B.S. and M.K.).	Betti M, 2006, ANN ONCOL, V17, P235; Edinger M, 2003, METHODS, V31, P172, DOI 10.1016/S1046-2023(03)00127-0; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Medarova Z, 2008, MAGN RESON MED, V59, P712, DOI 10.1002/mrm.21494; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Strom TB, 2004, J CLIN INVEST, V113, P1681, DOI 10.1172/JCI200422153; Strom TB, 1996, CURR OPIN IMMUNOL, V8, P688, DOI 10.1016/S0952-7915(96)80087-2; Toso C, 2006, TRANSPL P, V38, P3033, DOI 10.1016/j.transproceed.2006.08.135; Tran HM, 1997, J IMMUNOL, V159, P2232; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Zheng XX, 2003, IMMUNOL REV, V196, P75, DOI 10.1046/j.1600-065X.2003.00089.x; Zhong XM, 2007, EUR J IMMUNOL, V37, P2400, DOI 10.1002/eji.200737296	29	119	124	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					718	U125		10.1038/nm.2155	http://dx.doi.org/10.1038/nm.2155			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495571	Green Accepted			2022-12-27	WOS:000278394200040
J	Jaumann, M; Dettling, J; Gubelt, M; Zimmermann, U; Gerling, A; Paquet-Durand, F; Feil, S; Wolpert, S; Franz, C; Varakina, K; Xiong, H; Brandt, N; Kuhn, S; Geisler, HS; Rohbock, K; Ruth, P; Schlossmann, J; Hutter, J; Sandner, P; Feil, R; Engel, J; Knipper, M; Ruttiger, L				Jaumann, Mirko; Dettling, Juliane; Gubelt, Martin; Zimmermann, Ulrike; Gerling, Andrea; Paquet-Durand, Francois; Feil, Susanne; Wolpert, Stephan; Franz, Christoph; Varakina, Ksenya; Xiong, Hao; Brandt, Niels; Kuhn, Stephanie; Geisler, Hyun-Soon; Rohbock, Karin; Ruth, Peter; Schlossmann, Jens; Huetter, Joachim; Sandner, Peter; Feil, Robert; Engel, Jutta; Knipper, Marlies; Ruettiger, Lukas			cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function	NATURE MEDICINE			English	Article							GUINEA-PIG COCHLEA; DEPENDENT PROTEIN-KINASE; P2X(2) RECEPTOR SUBUNIT; NITRIC-OXIDE SYNTHASE; CYCLIC-GMP; STEREOCILIA DAMAGE; POTASSIUM CURRENT; INNER-EAR; CGMP; PHOSPHODIESTERASE	Noise-induced hearing loss (NIHL) is a global health hazard with considerable pathophysiological and social consequences that has no effective treatment. In the heart, lung and other organs, cyclic guanosine monophosphate (cGMP) facilitates protective processes in response to traumatic events. We therefore analyzed NIHL in mice with a genetic deletion of the gene encoding cGMP-dependent protein kinase type 1 (Prkg1) and found a greater vulnerability to and markedly less recovery from NIHL in these mice as compared to mice without the deletion. Prkg1 was expressed in the sensory cells and neurons of the inner ear of wild-type mice, and its expression partly overlapped with the expression profile of cGMP-hydrolyzing phosphodiesterase 5 (Pde5). Treatment of rats and wild-type mice with the Pde5 inhibitor vardenafil almost completely prevented NIHL and caused a Prkg1-dependent upregulation of poly (ADP-ribose) in hair cells and the spiral ganglion, suggesting an endogenous protective cGMP-Prkg1 signaling pathway that culminates in the activation of poly (ADP-ribose) polymerase. These data suggest vardenafil or related drugs as possible candidates for the treatment of NIHL.	[Jaumann, Mirko; Dettling, Juliane; Gubelt, Martin; Zimmermann, Ulrike; Wolpert, Stephan; Franz, Christoph; Varakina, Ksenya; Xiong, Hao; Geisler, Hyun-Soon; Rohbock, Karin; Knipper, Marlies; Ruettiger, Lukas] Univ Tubingen, Dept Otolaryngol, THRC, Tubingen, Germany; [Gerling, Andrea; Feil, Susanne; Feil, Robert] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Div Expt Ophthalmol, Tubingen, Germany; [Brandt, Niels; Kuhn, Stephanie; Engel, Jutta] Univ Tubingen, Inst Physiol 2, D-7400 Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Saarland, Dept Biophys, Fac Med, D-6650 Homburg, Germany; [Ruth, Peter] Univ Tubingen, Inst Pharm, Dept Pharmacol & Toxicol, Tubingen, Germany; [Schlossmann, Jens] Univ Regensburg, Dept Pharmacol & Toxicol, Regensburg, Germany; [Huetter, Joachim; Sandner, Peter] Bayer Hlth Care Pharmaceut, Global Drug Discovery Common Mech Res, Pharma Res Ctr Wuppertal, Wuppertal, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Saarland University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Bayer AG	Ruttiger, L (corresponding author), Univ Tubingen, Dept Otolaryngol, THRC, Tubingen, Germany.	lukas.ruettiger@uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015; Feil, Susanne/AAF-7032-2019; Feil, Robert/B-8918-2014; Schlossmann, Jens/I-7743-2016	Paquet-Durand, Francois/0000-0001-7355-5742; Feil, Robert/0000-0002-7335-4841; Schlossmann, Jens/0000-0002-2550-6839; , Stephanie/0000-0001-6633-9478	Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; Royal National Institute for Deaf People (RNID) [G54_Ruttiger]; Hahn Stiftung (Index AG); University of Tubingen; Landesgraduiertenforderung Baden-Wurttemberg, Germany; Kerstan Stiftung; Deutsche Forschungsgemeinschaft (DFG) [PA1751/1-1, DFG Fe 438/2]	Marie Curie Research Training Network CavNET(European Commission); Royal National Institute for Deaf People (RNID); Hahn Stiftung (Index AG); University of Tubingen; Landesgraduiertenforderung Baden-Wurttemberg, Germany; Kerstan Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank S. Kasperek for excellent technical assistance and R. Panford-Walsh for proofreading the manuscript. This work was supported by the Marie Curie Research Training Network CavNET MRTN-CT-2006-035367, the Royal National Institute for Deaf People (RNID) G54_Ruttiger, the Hahn Stiftung (Index AG), the Graduate Program of the University of Tubingen, the Landesgraduiertenforderung Baden-Wurttemberg, Germany, the Kerstan Stiftung and Deutsche Forschungsgemeinschaft (DFG) PA1751/1-1 and DFG Fe 438/2.	Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; Chen YS, 2003, ORL-J OTO-RHIN-LARYN, V65, P266, DOI 10.1159/000075224; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Feil R, 2006, EMBO REP, V7, P149, DOI 10.1038/sj.embor.7400627; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Giuliano F, 2010, INT J CLIN PRACT, V64, P240, DOI 10.1111/j.1742-1241.2009.02254.x; Hibino H, 1999, AM J PHYSIOL-CELL PH, V277, pC638, DOI 10.1152/ajpcell.1999.277.4.C638; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hong BN, 2008, BIOL PHARM BULL, V31, P1981, DOI 10.1248/bpb.31.1981; Housley GD, 1999, J NEUROSCI, V19, P8377; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1984, HEARING RES, V16, P43, DOI 10.1016/0378-5955(84)90024-8; LIBERMAN MC, 1990, HEARING RES, V49, P209, DOI 10.1016/0378-5955(90)90105-X; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Meltser I, 2009, J NEUROTRAUM, V26, P1835, DOI 10.1089/neu.2008.0874; Murai N, 2008, J NEUROTRAUM, V25, P72, DOI 10.1089/neu.2007.0346; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Porst H, 2011, EUR UROL, V60, P1105, DOI 10.1016/j.eururo.2011.08.005; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shen J, 2006, BRAIN RES, V1081, P101, DOI 10.1016/j.brainres.2005.12.129; Shen J, 2005, EUR J NEUROSCI, V21, P2912, DOI 10.1111/j.1460-9568.2005.04135.x; Shen J, 2003, NEUROSCI LETT, V337, P135, DOI 10.1016/S0304-3940(02)01320-4; Sugasawa M, 1996, J PHYSIOL-LONDON, V491, P707, DOI 10.1113/jphysiol.1996.sp021251; Szabo C, 2006, NITRIC OXIDE-BIOL CH, V14, P169, DOI 10.1016/j.niox.2005.06.008; Takeda-Nakazawa H, 2007, HEARING RES, V227, P59, DOI 10.1016/j.heares.2006.09.007; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; Tian F, 1999, HEARING RES, V131, P63, DOI 10.1016/S0378-5955(99)00015-5; Uemaetomari I, 2009, TOHOKU J EXP MED, V218, P41, DOI 10.1620/tjem.218.41; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Wang HL, 2009, J MOL CELL CARDIOL, V47, P304, DOI 10.1016/j.yjmcc.2009.03.021; Wang JCC, 2003, NEUROREPORT, V14, P817, DOI 10.1097/00001756-200305060-00008; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200	50	63	69	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					252	259		10.1038/nm.2634	http://dx.doi.org/10.1038/nm.2634			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270721				2022-12-27	WOS:000300140300039
J	Blumberg, RS; Dittel, B; Hailer, D; von Herrath, M; Nestle, FO				Blumberg, Richard S.; Dittel, Bonnie; Hailer, David; von Herrath, Matthias; Nestle, Frank O.			Unraveling the autoimmune translational research process layer by layer	NATURE MEDICINE			English	Article							CLINICAL-RESEARCH; NIH BUDGET; RECEPTOR; HEALTH; ANTIBODIES; INNOVATION; DISCOVERY; MEDICINE; THERAPY; TRENDS	Autoimmune diseases have a complex etiology and despite great progress having been made in our comprehension of these disorders, there has been limited success in the development of approved medications based on these insights. Development of drugs and strategies for application in translational research and medicine are hampered by an inadequate molecular definition of the human autoimmune phenotype and the organizational models that are necessary to clarify this definition.	[Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol & Hepatol,Dept Med, Boston, MA 02115 USA; [Hailer, David] Yale Univ, Dept Neurol & Immunobiol, New Haven, CT USA; [von Herrath, Matthias] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Nestle, Frank O.] Guys & St Thomas Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London SE1 9RT, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; La Jolla Institute for Immunology; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol & Hepatol,Dept Med, Boston, MA 02115 USA.	rblumberg@partners.org			US National Institutes of Health [DK44319, DK53056, DK51362, DK88199]; Harvard Digestive Diseases Center [DK34854]; National Institutes of Health Research; Wellcome Trust [GR078173MA]; Medical Research Council UK [G0601387]; UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; MRC [G0601387] Funding Source: UKRI; Medical Research Council [MR/J006742/1, G0601387] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK044319, P30DK034854, R01DK053056, R01DK051362, R01DK088199] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank T Rath, C. Pola and L. Paradiso for assistance in assembling data related to recent approvals of therapeutic agents in autoimmunity and assembling the manuscript. R.S.B. was supported by US National Institutes of Health grants DK44319, DK53056, DK51362, DK88199 and the Harvard Digestive Diseases Center (grant DK34854). F.O.N. is supported by a Senior Investigator award of the National Institutes of Health Research, Wellcome Trust Programme grant GR078173MA, Medical Research Council UK Programme grant G0601387 and the UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London.	[Anonymous], NHE FACT SHEET; [Anonymous], 2006, C US C BUDG OFF OCT; [Anonymous], 2011, NAT I HLTH RES PORTF; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Azarova AM, 2011, SEMIN CANCER BIOL, V21, P267, DOI 10.1016/j.semcancer.2011.09.005; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Califf RM, 2010, ACAD MED, V85, P457, DOI 10.1097/ACM.0b013e3181ccb74d; Cech TR, 2005, JAMA-J AM MED ASSOC, V294, P1390, DOI 10.1001/jama.294.11.1390; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Couzin-Frankel J, 2011, SCIENCE, V333, P819, DOI 10.1126/science.333.6044.819; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Disis ML, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000421; Finkbeiner S, 2010, NAT MED, V16, P1227, DOI 10.1038/nm.2222; Goldman M, 2011, NAT REV DRUG DISCOV, V10, P321, DOI 10.1038/nrd3434; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Honey K, 2011, J CLIN INVEST, V121, P3778, DOI 10.1172/JCI60890; Horig H, 2005, NAT MED, V11, P705, DOI 10.1038/nm0705-705; Hughes B, 2008, NAT REV DRUG DISCOV, V7; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P89, DOI 10.1038/nrd3101; Hughes B, 2009, NAT REV DRUG DISCOV, V8, P93, DOI 10.1038/nrd2813; Ioannidis JP, 2004, J TRANSL MED, V2, P5, DOI DOI 10.1186/1479-5876-2-5; Ji Z., 2011, TRENDS MOL MED, DOI [10.1016/j.mol-med.2011.08.001, DOI 10.1016/J.MOL-MED.2011.08.001]; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GUT, V60, P430, DOI 10.1136/gut.2010.229138; Kelly RJ, 2010, J CLIN ONCOL, V28, pE507, DOI 10.1200/JCO.2010.29.3126; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Littman BH, 2007, CLIN SCI, V112, P217, DOI 10.1042/CS20060108; LoRusso PM, 2009, J CLIN ONCOL, V27, P2586, DOI 10.1200/JCO.2008.21.5798; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Mankoff Stacey P, 2004, J Transl Med, V2, P14, DOI 10.1186/1479-5876-2-14; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MINTZBERG H, 1981, HARVARD BUS REV, V59, P103; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P82, DOI 10.1038/nrd3370; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Nussenblatt RB, 2010, ANN NY ACAD SCI, V1200, pE1, DOI 10.1111/j.1749-6632.2010.05682.x; Owens J, 2007, NAT REV DRUG DISCOV, V6, P99, DOI 10.1038/nrd2247; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Philipson L, 2005, JAMA-J AM MED ASSOC, V294, P1394, DOI 10.1001/jama.294.11.1394; Porter M, 1996, HARVARD BUSINESS NOV, P61; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Ratner M, 2011, NAT BIOTECHNOL, V29, P3, DOI 10.1038/nbt0111-3; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Snape K, 2008, QJM-INT J MED, V101, P901, DOI 10.1093/qjmed/hcn100; Soderquest K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001129; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Tigue CC, 2007, TARGET ONCOL, V2, P113, DOI 10.1007/s11523-007-0043-8; von Herrath M, 2009, J CLIN INVEST, V119, P1061, DOI 10.1172/JCI37593; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224; Webb Craig P, 2004, J Transl Med, V2, P35, DOI 10.1186/1479-5876-2-35; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819; Woolley M, 2005, JAMA-J AM MED ASSOC, V294, P1380, DOI 10.1001/jama.294.11.1380; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	75	35	39	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					35	41		10.1038/nm.2632	http://dx.doi.org/10.1038/nm.2632			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227670	Green Accepted			2022-12-27	WOS:000299018600025
J	Wong, VW; Rustad, KC; Akaishi, S; Sorkin, M; Glotzbach, JP; Januszyk, M; Nelson, ER; Levi, K; Paterno, J; Vial, IN; Kuang, AA; Longaker, MT; Gurtner, GC				Wong, Victor W.; Rustad, Kristine C.; Akaishi, Satoshi; Sorkin, Michael; Glotzbach, Jason P.; Januszyk, Michael; Nelson, Emily R.; Levi, Kemal; Paterno, Josemaria; Vial, Ivan N.; Kuang, Anna A.; Longaker, Michael T.; Gurtner, Geoffrey C.			Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling	NATURE MEDICINE			English	Article							HYPERTROPHIC SCAR FORMATION; MEDIATED MECHANOTRANSDUCTION; WOUND REPAIR; FIBROBLASTS; FAK; CELLS; REGENERATION; DEFICIENCY; EXPRESSION; DELETION	Exuberant fibroproliferation is a common complication after injury for reasons that are not well understoodl. One key component of wound repair that is often overlooked is mechanical force, which regulates cell-matrix interactions through intracellular focal adhesion components, including focal adhesion kinase (FAK)(1,2). Here we report that FAK is activated after cutaneous injury and that this process is potentiated by mechanical loading. Fibroblast-specific FAK knockout mice have substantially less inflammation and fibrosis than control mice in a model of hypertrophic scar formation. We show that FAK acts through extracellular-related kinase (ERK) to mechanically trigger the secretion of monocyte chemoattractant protein-1 (MCP-1, also known as CCL2), a potent chemokine that is linked to human fibrotic disorders3-5. Similarly, MCP-1 knockout mice form minimal scars, indicating that inflammatory chemokine pathways are a major mechanism by which FAK mechanotransduction induces fibrosis. Smallmolecule inhibition of FAK blocks these effects in human cells and reduces scar formation in vivo through attenuated MCP-1 signaling and inflammatory cell recruitment. These findings collectively indicate that physical force regulates fibrosis through inflammatory FAK-ER K-MCP-1 pathways and that molecular strategies targeting FAK can effectively uncouple mechanical force from pathologic scar formation.	[Wong, Victor W.; Rustad, Kristine C.; Akaishi, Satoshi; Sorkin, Michael; Glotzbach, Jason P.; Januszyk, Michael; Nelson, Emily R.; Levi, Kemal; Paterno, Josemaria; Vial, Ivan N.; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Kuang, Anna A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Stanford University; Oregon Health & Science University	Gurtner, GC (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	ggurtner@stanford.edu	Glotzbach, Jason P./O-4394-2019	Glotzbach, Jason P./0000-0002-8002-9422; Levi, Kemal/0000-0001-9760-166X	Oak Foundation; Hagey Family Endowed Fund in Stem Cell Research and Regenerative Medicine; United States Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0033]; NATIONAL INSTITUTE ON AGING [R01AG025016] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Oak Foundation; Hagey Family Endowed Fund in Stem Cell Research and Regenerative Medicine; United States Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank B. de Crombrugghe (The University of Texas MD Anderson Cancer Center, Houston, Texas) for providing the procollagen-alpha 2(I)-Cre transgenic mice, J. Rajadas for experimental insight, F. You for harvesting human fibroblasts and Y. Park for histologic processing. This work was supported by the Oak Foundation, the Hagey Family Endowed Fund in Stem Cell Research and Regenerative Medicine and a United States Armed Forces Institute of Regenerative Medicine grant (DOD #W81XWH-08-2-0033).	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; CHANTARASAK ND, 1989, BRIT J PLAST SURG, V42, P687, DOI 10.1016/0007-1226(89)90082-9; Dun ZN, 2010, WORLD J GASTROENTERO, V16, P4100, DOI 10.3748/wjg.v16.i32.4100; Durkaya S, 2005, TEX HEART I J, V32, P544; Ehrlich HP, 2003, METH MOLEC MED, V78, P277; ELLIOT D, 1989, BRIT J PLAST SURG, V42, P74, DOI 10.1016/S0007-1226(89)90117-3; Essayem S, 2006, ONCOGENE, V25, P1081, DOI 10.1038/sj.onc.1209130; Ferreira AM, 2006, J INVEST DERMATOL, V126, P1900, DOI 10.1038/sj.jid.5700302; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; LANGER K, 1978, BRIT J PLAST SURG, V31, P3, DOI 10.1016/0007-1226(78)90003-6; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Shibusawa Y, 2008, RHEUMATOLOGY, V47, P454, DOI 10.1093/rheumatology/ken058; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454; Wang Z, 2006, J CELL PHYSIOL, V206, P510, DOI 10.1002/jcp.20486; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamamoto T, 2008, FRONT BIOSCI-LANDMRK, V13, P2686, DOI 10.2741/2875; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	29	311	337	8	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					148	152		10.1038/nm.2574	http://dx.doi.org/10.1038/nm.2574			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157678	Green Accepted			2022-12-27	WOS:000299018600041
J	Dissanayake, D; Hall, H; Berg-Brown, N; Elford, AR; Hamilton, SR; Murakami, K; Deluca, LS; Gommerman, JL; Ohashi, PS				Dissanayake, Dilan; Hall, Hakan; Berg-Brown, Nancy; Elford, Alisha R.; Hamilton, Sara R.; Murakami, Kiichi; Deluca, Leslie Summers; Gommerman, Jennifer L.; Ohashi, Pamela S.			Nuclear factor-kappa B1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells	NATURE MEDICINE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ANTIGEN-PRESENTING CELLS; P50 SUBUNIT; TOLERANCE; MICE; ASSOCIATION; INDUCTION; ROLES; RISK	Mature dendritic cells (DCs) are crucial for the induction of adaptive immune responses and perturbed DC homeostasis can result in autoimmune disease. Either uncontrolled expansion(1) or enhanced survival(2,3) of DCs can result in a variety of autoimmune diseases in mouse models. In addition, increased maturation signals, through overexpression of surface Toll-like receptors (TLRs)(4) or stimulation by type I interferon (IFN)(5), has been associated with systemic autoimmunity. Whereas recent studies have focused on identifying factors required for initiating the maturation process, the possibility that resting DCs also express molecules that 'hold' them in an immature state has generally not been considered. Here we show that nuclear factor-kappa B1 (NF-kappa B1) is crucial for maintaining the resting state of DCs. Self-antigen-pulsed unstimulated DCs that do not express NF-kappa B1 were able to activate CD8(+) T lymphocytes and induce autoimmunity. We further show that NF-kappa B1 negatively regulates the spontaneous production of tumor necrosis factor-alpha (TNF-alpha), which is associated with increased granzyme B expression in cytotoxic T lymphocytes (CTLs). These findings provide a new perspective on functional DC maturation and a potential mechanism that may account for pathologic T cell activation.	[Dissanayake, Dilan; Hall, Hakan; Berg-Brown, Nancy; Elford, Alisha R.; Hamilton, Sara R.; Murakami, Kiichi; Ohashi, Pamela S.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Dissanayake, Dilan; Deluca, Leslie Summers; Gommerman, Jennifer L.; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Ohashi, PS (corresponding author), Ontario Canc Inst, Campbell Family Inst Breast Canc Res, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	pohashi@uhnresearch.ca		Dissanayake, Dilan/0000-0003-4270-7015; Hamilton, Sara/0000-0001-6062-2037; Ohashi, Pamela S./0000-0003-2915-9317; Gommerman, Jennifer/0000-0003-4576-6168	Canadian Institutes for Health Research (CIHR); Ontario Ministry of Health and Long Term Care (OMHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario)	We would like to thank S. Mariathasan (Genentech) for kindly providing Pycard-deficient mice. We would also like to thank L.T. Nguyen for critical evaluation of the manuscript. This work was supported by a Canadian Institutes for Health Research (CIHR) grant to P.S.O. and CIHR studentship to D.D. P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMHLTC). The views expressed do not necessarily reflect those of the OMHLTC.	Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; CAVALLO MG, 1991, CLIN EXP IMMUNOL, V86, P256; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Corvol JC, 2008, P NATL ACAD SCI USA, V105, P11839, DOI 10.1073/pnas.0805065105; Date Y, 1999, ARTHRITIS RHEUM, V42, P2577, DOI 10.1002/1529-0131(199912)42:12<2577::AID-ANR10>3.0.CO;2-O; De Cesaris P, 1998, J BIOL CHEM, V273, P7566, DOI 10.1074/jbc.273.13.7566; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Hilliard B, 1999, J IMMUNOL, V163, P2937; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Li N, 2008, CLIN BIOCHEM, V41, P881, DOI 10.1016/j.clinbiochem.2008.04.014; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Ruan QG, 2010, DIABETES, V59, P2549, DOI 10.2337/db10-0480; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Stayoussef M, 2010, EUR CYTOKINE NETW, V21, P285, DOI 10.1684/ecn.2010.0215; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Weaver DJ, 2001, J IMMUNOL, V167, P1461, DOI 10.4049/jimmunol.167.3.1461; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Wheat W, 2004, EUR J IMMUNOL, V34, P1395, DOI 10.1002/eji.200324490; Zhao JL, 1996, J EXP MED, V183, P777, DOI 10.1084/jem.183.3.777; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	40	62	68	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1663	U182		10.1038/nm.2556	http://dx.doi.org/10.1038/nm.2556			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081022				2022-12-27	WOS:000297978000040
J	Moran, JH				Moran, Jeffery H.			Smart resource allocation needed to study 'legal highs'	NATURE MEDICINE			English	Editorial Material								Ground-breaking science in the area of cannabinoid signaling holds great promise for new drug development, but an unintended consequence of this research has led to the emergence of an onslaught of deadly 'legal highs'. Providing public health scientists with access to laboratory resources designed to investigate emerging chemicals of concern is crucial for timely, sound evaluation of products that pose major threats to public health.	[Moran, Jeffery H.] Arkansas Dept Hlth, Publ Hlth Lab, Little Rock, AR 72205 USA; [Moran, Jeffery H.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Moran, JH (corresponding author), Arkansas Dept Hlth, Publ Hlth Lab, Little Rock, AR 72205 USA.							Dresen S, 2010, J MASS SPECTROM, V45, P1186, DOI 10.1002/jms.1811; Fattore L, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00060; Hudson S, 2010, J ANAL TOXICOL, V34, P252, DOI 10.1093/jat/34.5.252; Wang LD, 2010, CHEM ENG NEWS, V88, P43, DOI 10.1021/cen-v088n026.p043	4	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1339	1339		10.1038/nm1111-1339	http://dx.doi.org/10.1038/nm1111-1339			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064403	Bronze			2022-12-27	WOS:000296779300014
J	Park, KS; Martelotto, LG; Peifer, M; Sos, ML; Karnezis, AN; Mahjoub, MR; Bernard, K; Conklin, JF; Szczepny, A; Yuan, J; Guo, RB; Ospina, B; Falzon, J; Bennett, S; Brown, TJ; Markovic, A; Devereux, WL; Ocasio, CA; Chen, JK; Stearns, T; Thomas, RK; Dorsch, M; Buonamici, S; Watkins, DN; Peacock, CD; Sage, J				Park, Kwon-Sik; Martelotto, Luciano G.; Peifer, Martin; Sos, Martin L.; Karnezis, Anthony N.; Mahjoub, Moe R.; Bernard, Katie; Conklin, Jamie F.; Szczepny, Anette; Yuan, Jing; Guo, Ribo; Ospina, Beatrice; Falzon, Jeanette; Bennett, Samara; Brown, Tracey J.; Markovic, Ana; Devereux, Wendy L.; Ocasio, Cory A.; Chen, James K.; Stearns, Tim; Thomas, Roman K.; Dorsch, Marion; Buonamici, Silvia; Watkins, D. Neil; Peacock, Craig D.; Sage, Julien			A crucial requirement for Hedgehog signaling in small cell lung cancer	NATURE MEDICINE			English	Article							STEM-CELL; MOUSE MODEL; PATHWAY; INHIBITION; GROWTH; MEDULLOBLASTOMA; ACTIVATION; INACTIVATION; EXPRESSION; REVEALS	Small-cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer for which there is no effective treatment(1,2). Using a mouse model in which deletion of Rb1 and Trp53 in the lung epithelium of adult mice induces SCLC3,4, we found that the Hedgehog signaling pathway is activated in SCLC cells independently of the lung microenvironment. Constitutive activation of the Hedgehog signaling molecule Smoothened (Smo) promoted the clonogenicity of human SCLC in vitro and the initiation and progression of mouse SCLC in vivo. Reciprocally, deletion of Smo in Rb1 and Trp53-mutant lung epithelial cells strongly suppressed SCLC initiation and progression in mice. Furthermore, pharmacological blockade of Hedgehog signaling inhibited the growth of mouse and human SCLC, most notably following chemotherapy. These findings show a crucial cell-intrinsic role for Hedgehog signaling in the development and maintenance of SCLC and identify Hedgehog pathway inhibition as a therapeutic strategy to slow the progression of disease and delay cancer recurrence in individuals with SCLC.	[Markovic, Ana; Devereux, Wendy L.; Peacock, Craig D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA; [Park, Kwon-Sik; Bernard, Katie; Conklin, Jamie F.; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Park, Kwon-Sik; Mahjoub, Moe R.; Bernard, Katie; Conklin, Jamie F.; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martelotto, Luciano G.; Szczepny, Anette; Watkins, D. Neil] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Peifer, Martin; Sos, Martin L.; Thomas, Roman K.] Univ Cologne, Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, Cologne, Germany; [Peifer, Martin; Sos, Martin L.; Thomas, Roman K.] Univ Cologne, Fac Med, Cologne, Germany; [Sos, Martin L.; Thomas, Roman K.] Univ Cologne, Dept Internal Med, Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Lab Translat Canc Genom, Cologne, Germany; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Mahjoub, Moe R.; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Yuan, Jing; Guo, Ribo; Ospina, Beatrice; Dorsch, Marion; Buonamici, Silvia] Novartis Inst Biomed Res, Cambridge, MA USA; [Falzon, Jeanette; Bennett, Samara; Brown, Tracey J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Ocasio, Cory A.; Chen, James K.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Johns Hopkins University; Stanford University; Stanford University; Monash University; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of California System; University of California San Francisco; Stanford University; Novartis; Monash University; Stanford University	Peacock, CD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA.	cpeacoc3@jhmi.edu; julsage@stanford.edu	Watkins, David N/I-6113-2013; Martelotto, Luciano/D-1946-2015; Martelotto, Luciano/A-6017-2012; Chen, James/G-9972-2011; Sos, Martin L/I-1852-2014	Martelotto, Luciano/0000-0002-9625-1183; Chen, James/0000-0002-9220-8436; Park, Kwon-Sik/0000-0003-3346-9086; Stearns, Tim/0000-0002-0671-6582; Ocasio, Cory Antonio/0000-0002-4957-4131; Mahjoub, Moe/0000-0001-8129-7464; Peifer, Martin/0000-0002-5243-5503	Lucile Packard Foundation for Children's Health; Damon Runyon Cancer Research Foundation; American Lung Association; Francis Family Foundation; American Cancer Society; Tobacco-Related Disease Research Program of California; US National Institutes of Health (NIH) National Cancer Institute [R01 CA136574]; Flight Attendant Medical Research Institute [YCSA 072033]; NIH [5T32 CA009302-33]; National Health and Medical Research Council of Australia [546024, 546098]; Victorian Cancer Agency; Deutsche Krebshilfe [107954]; German Ministry of Science and Education as part of the Nationales Genomforschungsnetz [01GS08100]; Max Planck Society [MIFA NEUR8061]; Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereiche [TP6]; Ministry for Innovation, Science, Research and Technology of the State of Nordrhein-Westfalen (MIWT) [4000-12 09]; NATIONAL CANCER INSTITUTE [R01CA136574, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Damon Runyon Cancer Research Foundation; American Lung Association; Francis Family Foundation; American Cancer Society(American Cancer Society); Tobacco-Related Disease Research Program of California(University of California System); US National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; Deutsche Krebshilfe(Deutsche Krebshilfe); German Ministry of Science and Education as part of the Nationales Genomforschungsnetz; Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereiche(German Research Foundation (DFG)); Ministry for Innovation, Science, Research and Technology of the State of Nordrhein-Westfalen (MIWT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Berns (The Netherlands Cancer Institute) and M. Scott (Stanford University) for the Trp53<SUP>lox</SUP> and Ptch1<SUP>lacZ/+</SUP> mice, respectively, J. Whitsett (Cincinnati Children's Hospital) for the antibodies to surfactant protein C, C. Janke (Orsay Curie Institute) for antibodies to polyglutamylated tubulin and C.-M. Fan (Carnegie Institution of Washington) for the adenovirally expressed SmoM2 virus, as well as T. Oro, James Kim, Jynho Kim and P. Beachy for helpful discussions throughout the course of this study. We thank R. Toftgard (Karolinska Institute) and K. McGovern at Infinity Pharmaceuticals for their generous gift of the GANT-61 and cyclopamine, respectively, R. Rohatgi for help with the immunoblot analysis and B. Schaffer for help with the cell culture. This work was supported by the Lucile Packard Foundation for Children's Health (J. S.), the Damon Runyon Cancer Research Foundation (J. S.), the American Lung Association (J. S. and K.-S.P.), the Francis Family Foundation (K.-S.P.), the American Cancer Society (J. S.), the Tobacco-Related Disease Research Program of California (J.F.C.), US National Institutes of Health (NIH) National Cancer Institute R01 CA136574 (J.K.C.), the Flight Attendant Medical Research Institute (YCSA 072033) (C. D. P.), NIH 5T32 CA009302-33 (C.O.), the National Health and Medical Research Council of Australia project grants 546024 and 546098 and the Victorian Cancer Agency (D.N.W., L. G. M. and A. S.), the Deutsche Krebshilfe (107954) (R. K. T.), the German Ministry of Science and Education as part of the Nationales Genomforschungsnetz (NGFN-plus) program (01GS08100) (R. K. T.), the Max Planck Society (MIFA NEUR8061) (R. K. T.), the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereiche (TP6) (R. K. T.), the Ministry for Innovation, Science, Research and Technology of the State of Nordrhein-Westfalen (MIWT, 4000-12 09) (R. K. T.) and by an anonymous foundation to R.K.T.	Arimura S, 2009, GASTROENTEROLOGY, V137, P629, DOI 10.1053/j.gastro.2009.04.059; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Rudin Charles M, 2008, J Natl Compr Canc Netw, V6, P315; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Singh S, 2011, CANCER RES, V71, P4454, DOI 10.1158/0008-5472.CAN-10-2313; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Voortman J, 2010, P NATL ACAD SCI USA, V107, P13040, DOI 10.1073/pnas.1008132107; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860	40	183	196	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1504	U1506		10.1038/nm.2473	http://dx.doi.org/10.1038/nm.2473			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	21983857	Green Accepted			2022-12-27	WOS:000296779300043
J	Paiardini, M; Cervasi, B; Reyes-Aviles, E; Micci, L; Ortiz, AM; Chahroudi, A; Vinton, C; Gordon, SN; Bosinger, SE; Francella, N; Hallberg, PL; Cramer, E; Schlub, T; Chan, ML; Riddick, NE; Collman, RG; Apetrei, C; Pandrea, I; Else, J; Munch, J; Kirchhoff, F; Davenport, MP; Brenchley, JM; Silvestri, G				Paiardini, Mirko; Cervasi, Barbara; Reyes-Aviles, Elane; Micci, Luca; Ortiz, Alexandra M.; Chahroudi, Ann; Vinton, Carol; Gordon, Shari N.; Bosinger, Steven E.; Francella, Nicholas; Hallberg, Paul L.; Cramer, Elizabeth; Schlub, Timothy; Chan, Ming Liang; Riddick, Nadeene E.; Collman, Ronald G.; Apetrei, Cristian; Pandrea, Ivona; Else, James; Munch, Jan; Kirchhoff, Frank; Davenport, Miles P.; Brenchley, Jason M.; Silvestri, Guido			Low levels of SIV infection in sooty mangabey central memory CD4(+) T cells are associated with limited CCR5 expression	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; AFRICAN-GREEN MONKEYS; IMMUNE ACTIVATION; DOWN-REGULATION; NATURAL HOSTS; DEPLETION; REPLICATION; HOMEOSTASIS; RESPONSES; LESSONS	Naturally simian immunodeficiency virus (SIV)-infected sooty mangabeys do not progress to AIDS despite high-level virus replication. We previously showed that the fraction of CD4(+)CCR5(+) T cells is lower in sooty mangabeys compared to humans and macaques. Here we found that, after in vitro stimulation, sooty mangabey CD4(+) T cells fail to upregulate CCR5 and that this phenomenon is more pronounced in CD4(+) central memory T cells (T-CM cells). CD4(+) T cell activation was similarly uncoupled from CCR5 expression in sooty mangabeys in vivo during acute SIV infection and the homeostatic proliferation that follows antibody-mediated CD4(+) T cell depletion. Sooty mangabey CD4(+) TCM cells that express low amounts of CCR5 showed reduced susceptibility to SIV infection both in vivo and in vitro when compared to CD4(+) TCM cells of rhesus macaques. These data suggest that low CCR5 expression on sooty mangabey CD4(+) T cells favors the preservation of CD4(+) T cell homeostasis and promotes an AIDS-free status by protecting CD4(+) TCM cells from direct virus infection.	[Paiardini, Mirko; Cervasi, Barbara; Micci, Luca; Ortiz, Alexandra M.; Chahroudi, Ann; Gordon, Shari N.; Bosinger, Steven E.; Else, James; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Paiardini, Mirko; Cervasi, Barbara; Micci, Luca; Ortiz, Alexandra M.; Chahroudi, Ann; Gordon, Shari N.; Bosinger, Steven E.; Else, James; Silvestri, Guido] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Paiardini, Mirko; Cervasi, Barbara; Reyes-Aviles, Elane; Ortiz, Alexandra M.; Gordon, Shari N.; Francella, Nicholas; Hallberg, Paul L.; Cramer, Elizabeth; Silvestri, Guido] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Micci, Luca] Univ Urbino, I-61029 Urbino, Italy; [Vinton, Carol; Brenchley, Jason M.] US Natl Inst Hlth, Mol Microbiol Lab, Bethesda, MD USA; [Schlub, Timothy; Chan, Ming Liang; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Kensington, NSW 2033, Australia; [Riddick, Nadeene E.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Apetrei, Cristian; Pandrea, Ivona] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Munch, Jan; Kirchhoff, Frank] Univ Hosp Ulm, Inst Mol Virol, Ulm, Germany	Emory University; Emory University; University of Pennsylvania; University of Urbino; National Institutes of Health (NIH) - USA; University of New South Wales Sydney; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ulm University	Silvestri, G (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mirko.paiardini@emory.edu; gsilves@emory.edu	Brenchley, Jason/AAC-5085-2019; Kirchhoff, Frank/O-8367-2018; Apetrei, Cristian/AAG-9032-2021	Kirchhoff, Frank/0000-0002-7052-2360; Apetrei, Cristian/0000-0002-0322-7185; Davenport, Miles/0000-0002-4751-1831; Schlub, Timothy/0000-0001-7746-9649; Jan, Munch/0000-0001-7316-7141; Brenchley, Jason/0000-0001-8357-2984; Collman, Ronald/0000-0002-0508-3701	 [R01-AI66998];  [P01-AI76074];  [R56-AI087186];  [P51-RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084836, R01AI066998, P01AI076174, ZIAAI001029, R56AI087186, R37AI066998, T32AI007632] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank L. Picker, D. Sodora and Z. Grossman for helpful discussions; F. Villinger, B. Lawson, F. Shaheen and J. Tilton for their technical support; and S. Ehnert and T. Meeker for their assistance with primate studies. We are grateful to the Emory Center for AIDS Research Virology Core and the Penn Center for AIDS Research Virology Core for their assistance. This work was supported by grant R01-AI66998 and P01-AI76074 (to G.S.), R56-AI087186 (to M.P.) and P51-RR-00165 (to Yerkes National Primate Research Center).	Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Engram JC, 2010, BLOOD, V116, P748, DOI 10.1182/blood-2010-01-263814; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Gautam R, 2007, VIROLOGY, V362, P257, DOI 10.1016/j.virol.2006.12.037; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; Mummidi S, 2007, J IMMUNOL, V178, P5668, DOI 10.4049/jimmunol.178.9.5668; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Onlamoon N, 2006, J MED PRIMATOL, V35, P178, DOI 10.1111/j.1600-0684.2006.00182.x; Paiardini M, 2009, BLOOD, V113, P612, DOI 10.1182/blood-2008-06-159442; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Palacios E, 1998, CURR BIOL, V8, P943, DOI 10.1016/S0960-9822(07)00378-8; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rey-Cuille MA, 1998, J VIROL, V72, P3872; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	34	150	150	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					830	U197		10.1038/nm.2395	http://dx.doi.org/10.1038/nm.2395			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706028	Green Accepted			2022-12-27	WOS:000292500800037
J	Delahaye, NF; Rusakiewicz, S; Martins, I; Menard, C; Roux, S; Lyonnet, L; Paul, P; Sarabi, M; Chaput, N; Semeraro, M; Minard-Colin, V; Poirier-Colame, V; Chaba, K; Flament, C; Baud, V; Authier, H; Kerdine-Romer, S; Pallardy, M; Cremer, I; Peaudecerf, L; Rocha, B; Valteau-Couanet, D; Gutierrez, JC; Nunes, JA; Commo, F; Bonvalot, S; Ibrahim, N; Terrier, P; Opolon, P; Bottino, C; Moretta, A; Tavernier, J; Rihet, P; Coindre, JM; Blay, JY; Isambert, N; Emile, JF; Vivier, E; Lecesne, A; Kroemer, G; Zitvogel, L				Delahaye, Nicolas F.; Rusakiewicz, Sylvie; Martins, Isabelle; Menard, Cedric; Roux, Stephan; Lyonnet, Luc; Paul, Pascale; Sarabi, Matthieu; Chaput, Nathalie; Semeraro, Michaela; Minard-Colin, Veronique; Poirier-Colame, Vichnou; Chaba, Kariman; Flament, Caroline; Baud, Veronique; Authier, Helene; Kerdine-Roemer, Saadia; Pallardy, Marc; Cremer, Isabelle; Peaudecerf, Laetitia; Rocha, Benedita; Valteau-Couanet, Dominique; Gutierrez, Javier Celis; Nunes, Jacques A.; Commo, Frederic; Bonvalot, Sylvie; Ibrahim, Nicolas; Terrier, Philippe; Opolon, Paule; Bottino, Cristina; Moretta, Alessandro; Tavernier, Jan; Rihet, Pascal; Coindre, Jean-Michel; Blay, Jean-Yves; Isambert, Nicolas; Emile, Jean-Francois; Vivier, Eric; Lecesne, Axel; Kroemer, Guido; Zitvogel, Laurence			Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors	NATURE MEDICINE			English	Article							NATURAL-KILLER-CELLS; HUMAN DENDRITIC CELLS; NK CELLS; HUMAN MHC; CYTOTOXICITY RECEPTORS; TRIGGERING RECEPTOR; IL-10 PRODUCTION; CLASS-III; C-KIT; EXPRESSION	The natural killer (NK) cell receptor NKp30 is involved in the recognition of tumor and dendritic cells (DCs). Here we describe the influence of three NKp30 splice variants on the prognosis of gastrointestinal sarcoma (GIST), a malignancy that expresses NKp30 ligands and that is treated with NK-stimulatory KIT tyrosine kinase inhibitors. Healthy individuals and those with GIST show distinct patterns of transcription of functionally different NKp30 isoforms. In a retrospective analysis of 80 individuals with GIST, predominant expression of the immunosuppressive NKp30c isoform (over the immunostimulatory NKp30a and NKp30b isoforms) was associated with reduced survival of subjects, decreased NKp30-dependent tumor necrosis factor-alpha (TNF-alpha) and CD107a release, and defective interferon-gamma (IFN-gamma) and interleukin-12 (IL-12) secretion in the NK-DC cross-talk that could be restored by blocking of IL-10. Preferential NKp30c expression resulted partly from a single-nucleotide polymorphism at position 3790 in the 3' untranslated region of the gene encoding NKp30. The genetically determined NKp30 status predicts the clinical outcomes of individuals with GIST independently from KIT mutation.	[Delahaye, Nicolas F.; Rusakiewicz, Sylvie; Menard, Cedric; Roux, Stephan; Sarabi, Matthieu; Chaput, Nathalie; Semeraro, Michaela; Minard-Colin, Veronique; Chaba, Kariman; Flament, Caroline; Valteau-Couanet, Dominique; Zitvogel, Laurence] IGR, INSERM, U1015, Villejuif, France; [Delahaye, Nicolas F.; Rusakiewicz, Sylvie; Menard, Cedric; Roux, Stephan; Sarabi, Matthieu; Chaput, Nathalie; Poirier-Colame, Vichnou; Flament, Caroline; Lecesne, Axel; Zitvogel, Laurence] IGR, Ctr Clin Invest CBT507, Villejuif, France; [Martins, Isabelle; Baud, Veronique; Authier, Helene; Kroemer, Guido] Univ Paris 05, Paris, France; [Martins, Isabelle; Kroemer, Guido] IGR, INSERM, U848, Villejuif, France; [Lyonnet, Luc; Paul, Pascale] Hop Conception, Hematol Unit, Marseille, France; [Semeraro, Michaela; Minard-Colin, Veronique; Valteau-Couanet, Dominique] IGR, Dept Pediat Oncol, Villejuif, France; [Baud, Veronique; Authier, Helene] Inst Cochin, INSERM, U1016, Paris, France; [Baud, Veronique; Authier, Helene] CNRS, UMR8104, Paris, France; [Kerdine-Roemer, Saadia; Pallardy, Marc] Universud, INSERM, Fac Pharm, UMR 996, Chatenay Malabry, France; [Cremer, Isabelle] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Cremer, Isabelle] Univ Paris 06, UMRS 872, Paris, France; [Peaudecerf, Laetitia; Rocha, Benedita] INSERM, U1020, Paris, France; [Peaudecerf, Laetitia; Rocha, Benedita] Fac Med Rene Descartes, Paris, France; [Gutierrez, Javier Celis; Nunes, Jacques A.] Ctr Rech Cancerol Marseille, INSERM, U891, Marseille, France; [Gutierrez, Javier Celis; Nunes, Jacques A.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Commo, Frederic] IGR, INSERM, U981, Villejuif, France; [Bonvalot, Sylvie; Terrier, Philippe; Lecesne, Axel] IGR, Dept Med, Sarcoma Comm, Villejuif, France; [Ibrahim, Nicolas; Terrier, Philippe] IGR, Dept Pathol, Villejuif, France; [Opolon, Paule] IGR, Expt Pathol Unit, Villejuif, France; [Opolon, Paule] Univ Paris 11, Fac Med Paris Sud, Le Kremlin Bicetre, France; [Bottino, Cristina; Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; [Bottino, Cristina] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Tavernier, Jan] Univ Ghent, Fac Med & Hlth, Dept Med Prot Res, B-9000 Ghent, Belgium; [Tavernier, Jan] Univ Ghent VIB, Ghent, Belgium; [Rihet, Pascal] Aix Marseille Univ, INSERM, TAGC, U928, Marseille, France; [Coindre, Jean-Michel] Inst Bergonie, Dept Pathol, Bordeaux, France; [Blay, Jean-Yves] Ctr Leon Berard, Dept Med, F-69373 Lyon, France; [Isambert, Nicolas] Ctr Georges Francois Leclerc, Dept Oncol, Dijon, France; [Isambert, Nicolas] INSERM, CIC P 803, Dijon, France; [Emile, Jean-Francois] Hop Ambroise Pare, Dept Pathol, EA4340, Boulogne, France; [Vivier, Eric] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, Marseille, France; [Vivier, Eric] INSERM, U631, F-13258 Marseille, France; [Vivier, Eric] CNRS, UniteMixte Rech 6102, Marseille, France; [Vivier, Eric] Hop Conception, AP HM, Marseille, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Bergonie; UNICANCER; Centre Leon Berard; UNICANCER; Centre Georges-Francois Leclerc; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), IGR, INSERM, U1015, Villejuif, France.	kroemer@orange.fr; zitvogel@igr.fr	Ménard, Cédric/AAB-3180-2020; Kerdine-Römer, Saadia/AAT-9855-2020; Cremer, Isabelle/D-4278-2017; PAUL, Pascale/R-1484-2016; GUTIERREZ, Javier CELIS/AAB-2605-2020; Blay, Jean-Yves/N-3966-2016; Rihet, Pascal/L-2173-2016; Rihet, Pascal/AAD-2018-2022; Rihet, Pascal/GQP-1381-2022; Baud, Veronique/F-7699-2013; PAUL, Pascale/AAI-1772-2020; Kerdine-Römer, Saadia/A-9789-2014; KROEMER, Guido/B-4263-2013; Baud, Veronique/AAL-3950-2020; Tavernier, Jan/AAG-3636-2019; NUNES, Jacques A/F-4952-2013; Vivier, Eric/F-8939-2010; Kroemer, Guido/AAY-9859-2020; Bottino, Cristina/J-9977-2016	Ménard, Cédric/0000-0002-2207-361X; Cremer, Isabelle/0000-0002-0963-1031; PAUL, Pascale/0000-0002-6734-4479; Blay, Jean-Yves/0000-0001-7190-120X; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Baud, Veronique/0000-0002-4090-718X; PAUL, Pascale/0000-0002-6734-4479; KROEMER, Guido/0000-0002-9334-4405; Baud, Veronique/0000-0002-4090-718X; NUNES, Jacques A/0000-0003-4865-0400; Vivier, Eric/0000-0001-7022-8287; Sarabi, Matthieu/0000-0003-4588-0585; Kerdine-Romer, Saadia/0000-0003-3313-952X; authier, helene/0000-0002-5556-4570; Bottino, Cristina/0000-0001-6695-1739; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale; European Union; INCa; Agence Nationale de la Recherche; Fondation de France; Institut National du Cancer; Fondation Gustave Roussy; Ligue contre le Cancer; Association pour la Recherche contre le Cancer; Belgian Interuniversity Attraction Pole; Canceropole Ile-de-France; Universite Paris Descartes; Fundayacucho-CNOUS joint program	Ligue contre le Cancer (equipes labellisees); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union(European Commission); INCa(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Gustave Roussy; Ligue contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Belgian Interuniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Universite Paris Descartes; Fundayacucho-CNOUS joint program	We thank P. Anderson for providing the CD3 zeta-specific antibody (2H2 clone), M. Baratin for helpful discussions and the affected subjects as well as the healthy volunteers for their kind participation. U848 and U1015 are supported by Ligue contre le Cancer (equipes labellisees), Fondation pour la Recherche Medicale, European Union (Apo-Sys, ArtForce, ChemoRes, INFLACARE), INCa ('NKp30' in 2006; 'NCR3 isoforms' in 2008), Agence Nationale de la Recherche and Fondation de France (2009-2011). N.F.D. was supported by Institut National du Cancer and Fondation Gustave Roussy. S. Rusakiewicz was supported by a studentship from the Fondation pour la Recherche Medicale. V.B. was supported by the Ligue contre le Cancer, Agence Nationale de la Recherche, Association pour la Recherche contre le Cancer, Belgian Interuniversity Attraction Pole, Canceropole Ile-de-France and Universite Paris Descartes. J.C.G. was supported by the Fundayacucho-CNOUS joint program. Some materials and data used in this study were provided by the conticagist (https://www.conticagist.org/).	Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Delahaye NF, 2007, MICROBES INFECT, V9, P160, DOI 10.1016/j.micinf.2006.11.002; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emile JF, 2002, DIAGN MOL PATHOL, V11, P107, DOI 10.1097/00019606-200206000-00007; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fuller CL, 2007, CELL MICROBIOL, V9, P962, DOI 10.1111/j.1462-5822.2006.00844.x; Grant LR, 2008, GENES IMMUN, V9, P316, DOI 10.1038/gene.2008.20; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hermann E, 2006, PEDIATR RES, V60, P38, DOI 10.1203/01.pdr.0000220335.05588.ea; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hollyoake M, 2005, MOL BIOL EVOL, V22, P1661, DOI 10.1093/molbev/msi162; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Miettinen M, 2002, EUR J CANCER, V38, pS39, DOI 10.1016/S0959-8049(02)80602-5; Nalabolu SR, 1996, GENOMICS, V31, P215, DOI 10.1006/geno.1996.0034; Neville MJ, 1999, J IMMUNOL, V162, P4745; Pandey R, 2007, J IMMUNOL, V179, P7385, DOI 10.4049/jimmunol.179.11.7385; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Poggi A, 2007, ANN NY ACAD SCI, V1109, P47, DOI 10.1196/annals.1398.007; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rutjens E, 2007, J IMMUNOL, V178, P1702, DOI 10.4049/jimmunol.178.3.1702; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Sivakamasundari R, 2000, IMMUNOGENETICS, V51, P723, DOI 10.1007/s002510000192; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Van Glabbeke M, 2010, J CLIN ONCOL, V28, P1247, DOI 10.1200/JCO.2009.24.2099; Vankayalapati R, 2005, J IMMUNOL, V175, P4611, DOI 10.4049/jimmunol.175.7.4611; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; VITALE M, 1995, P NATL ACAD SCI USA, V92, P3536, DOI 10.1073/pnas.92.8.3536; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vivier E, 2009, CELL HOST MICROBE, V6, P493, DOI 10.1016/j.chom.2009.12.001; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Xie T, 2003, GENOME RES, V13, P2621, DOI 10.1101/gr.1736803; Yutkin V, 2007, J UROLOGY, V178, P2660, DOI 10.1016/j.juro.2007.07.118	43	241	252	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					700	+		10.1038/nm.2366	http://dx.doi.org/10.1038/nm.2366			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21552268				2022-12-27	WOS:000291308800030
J	Lupberger, J; Zeisel, MB; Xiao, F; Thumann, C; Fofana, I; Zona, L; Davis, C; Mee, CJ; Turek, M; Gorke, S; Royer, C; Fischer, B; Zahid, MN; Lavillette, D; Fresquet, J; Cosset, FL; Rothenberg, SM; Pietschmann, T; Patel, AH; Pessaux, P; Doffoel, M; Raffelsberger, W; Poch, O; McKeating, JA; Brino, L; Baumert, TF				Lupberger, Joachim; Zeisel, Mirjam B.; Xiao, Fei; Thumann, Christine; Fofana, Isabel; Zona, Laetitia; Davis, Christopher; Mee, Christopher J.; Turek, Marine; Gorke, Sebastian; Royer, Cathy; Fischer, Benoit; Zahid, Muhammad N.; Lavillette, Dimitri; Fresquet, Judith; Cosset, Francois-Loic; Rothenberg, S. Michael; Pietschmann, Thomas; Patel, Arvind H.; Pessaux, Patrick; Doffoel, Michel; Raffelsberger, Wolfgang; Poch, Olivier; McKeating, Jane A.; Brino, Laurent; Baumert, Thomas F.			EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy	NATURE MEDICINE			English	Article							EPIDERMAL-GROWTH-FACTOR; B TYPE-I; FACTOR RECEPTOR; NEUTRALIZING ANTIBODIES; CELL TRANSMISSION; HUMAN LIVER; INFECTION; ACTIVATION; ERLOTINIB; MOUSE	Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited and there are no prevention strategies. Viral entry is the first step of infection and requires the cooperative interaction of several host cell factors. Using a functional RNAi kinase screen, we identified epidermal growth factor receptor and ephrin receptor A2 as host cofactors for HCV entry. Blocking receptor kinase activity by approved inhibitors broadly impaired infection by all major HCV genotypes and viral escape variants in cell culture and in a human liver chimeric mouse model in vivo. The identified receptor tyrosine kinases (RTKs) mediate HCV entry by regulating CD81-claudin-1 co-receptor associations and viral glycoprotein-dependent membrane fusion. These results identify RTKs as previously unknown HCV entry cofactors and show that tyrosine kinase inhibitors have substantial antiviral activity. Inhibition of RTK function may constitute a new approach for prevention and treatment of HCV infection.	[Lupberger, Joachim; Zeisel, Mirjam B.; Xiao, Fei; Thumann, Christine; Fofana, Isabel; Zona, Laetitia; Turek, Marine; Royer, Cathy; Zahid, Muhammad N.; Baumert, Thomas F.] INSERM, U748, Strasbourg, France; [Lupberger, Joachim; Zeisel, Mirjam B.; Xiao, Fei; Thumann, Christine; Fofana, Isabel; Zona, Laetitia; Turek, Marine; Royer, Cathy; Zahid, Muhammad N.; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Davis, Christopher; Mee, Christopher J.; McKeating, Jane A.] Univ Birmingham, Div Immun & Infect, Hepatitis C Res Grp, Birmingham, W Midlands, England; [Gorke, Sebastian] Univ Freiburg, Dept Med 2, Freiburg, Germany; [Fischer, Benoit; Raffelsberger, Wolfgang; Poch, Olivier; Brino, Laurent; Baumert, Thomas F.] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire,U964,UMR1704, Illkirch Graffenstaden, France; [Lavillette, Dimitri; Fresquet, Judith; Cosset, Francois-Loic] Univ Lyon 1, INSERM, Ecole Normale Super, Inst Fed Rech 128,U758, F-69365 Lyon, France; [Rothenberg, S. Michael] Massachusetts Gen Hosp, Ctr Canc, Howard Hughes Med Inst, Charlestown, MA USA; [Rothenberg, S. Michael] Harvard Univ, Sch Med, Charlestown, MA USA; [Pietschmann, Thomas] Ctr Expt & Clin Infect Res, TWINCORE, Div Expt Virol, Hannover, Germany; [Patel, Arvind H.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Pessaux, Patrick; Doffoel, Michel; Baumert, Thomas F.] Hop Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Birmingham; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Glasgow; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Baumert, TF (corresponding author), INSERM, U748, Strasbourg, France.	thomas.baumert@unistra.fr	Pietschmann, Thomas/E-9241-2015; Lupberger, Joachim/AAL-7721-2020; Xiao, Fei/E-7133-2013; Cosset, François-Loïc/M-5862-2019; zahid, Muhammad Nauman/F-8793-2013; Zeisel, Mirjam B/E-9205-2016; Baumert, Thomas/ABF-4718-2020	Pietschmann, Thomas/0000-0001-5138-6239; Lupberger, Joachim/0000-0003-3996-3907; Xiao, Fei/0000-0001-7353-2700; Cosset, François-Loïc/0000-0001-8842-3726; Zeisel, Mirjam B/0000-0003-1606-0131; Baumert, Thomas/0000-0002-8864-2168; Mee, Christopher/0000-0002-6359-2694; Brino, laurent/0000-0002-9036-1461; davis, chris/0000-0002-7317-3266; Fischer, Benoit/0000-0002-9911-1397; McKeating, Jane/0000-0002-7229-5886; Lavillette, Dimitri/0000-0002-4706-1519	European Research Council [ERC-2008-AdG-233130-HEPCENT]; INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net; Agence Nationale de la Recherche [ANR-05-CEXC-008]; Agence Nationale de Recherche sur le Sida [2008/354]; Region Alsace; Institut National du Cancer; Institut de Genetique et de Biologie Moleculaire et Cellulaire; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite de Strasbourg; US National Insititutes of Health [1K08DE020139-01A1]; UK Medical Research Council; Wellcome Trust; Medical Research Council [MC_U130184144, G0400802, G0801976] Funding Source: researchfish; MRC [G0400802, MC_U130184144, G0801976] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE020139] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net; Agence Nationale de la Recherche(French National Research Agency (ANR)); Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Region Alsace(Region Grand-Est); Institut National du Cancer(Institut National du Cancer (INCA) France); Institut de Genetique et de Biologie Moleculaire et Cellulaire; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; US National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the European Research Council (ERC-2008-AdG-233130-HEPCENT), INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009, Agence Nationale de la Recherche (ANR-05-CEXC-008), Agence Nationale de Recherche sur le Sida 2008/354, Region Alsace, Institut National du Cancer, the Institut de Genetique et de Biologie Moleculaire et Cellulaire, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite de Strasbourg, the US National Insititutes of Health (1K08DE020139-01A1), the UK Medical Research Council and the Wellcome Trust. We acknowledge A.-L. Morand, L. Froidevaux, A. Weiss, L. Poidevin, S. Durand and E. Soulier for excellent technical work. We thank R. Bartenschlager (University of Heidelberg) for providing Jc1 and Luc-Jc1 expression vectors, J. Ball (University of Nottingham) for UKN2A.2.4, UKN3A1.28 and UKN4.21.16 expression vectors, T. Wakita (National Institute of Infectious Diseases, Japan) for JFH1 constructs, C. M. Rice (The Rockefeller University) for Huh7.5 cells, F. V. Chisari (The Scripps Research Institute) for Huh7.5.1 cells, E. Harlow (Harvard University) for CDC2 expression plasmids and M. Tanaka (Hamamatsu University) for EphA2 expression plasmids.	Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Chahbouni A, 2009, THER DRUG MONIT, V31, P683, DOI 10.1097/FTD.0b013e3181c05a14; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hidalgo M, 2003, SEMIN ONCOL, V30, P25, DOI 10.1016/S0093-7754(03)00186-6; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Hiraga N, 2009, J HEPATOL, V51, P1046, DOI 10.1016/j.jhep.2009.09.002; Kamiya N, 2010, J GEN VIROL, V91, P1668, DOI 10.1099/vir.0.019315-0; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reiter JL, 1996, NUCLEIC ACIDS RES, V24, P4050, DOI 10.1093/nar/24.20.4050; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Tai AW, 2009, J HEPATOL, V50, P412, DOI 10.1016/j.jhep.2008.11.010; Thoresen GH, 1998, J CELL PHYSIOL, V175, P10, DOI 10.1002/(SICI)1097-4652(199804)175:1<10::AID-JCP2>3.3.CO;2-6; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wang YJ, 2002, BIOCHEM BIOPH RES CO, V296, P214, DOI 10.1016/S0006-291X(02)00806-9; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Zeisel MB, 2008, HEPATOLOGY, V48, P299, DOI 10.1002/hep.22307; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994	53	510	541	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					589	U109		10.1038/nm.2341	http://dx.doi.org/10.1038/nm.2341			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21516087	Green Submitted, Green Accepted			2022-12-27	WOS:000290250400035
J	Johnston, SC; Hauser, SL; Desmond-Hellmann, S				Johnston, S. Claiborne; Hauser, Stephen L.; Desmond-Hellmann, Susan			Enhancing ties between academia and industry to improve health	NATURE MEDICINE			English	Article							SCIENCE	Concerns about conflicts of interest have driven a wedge between academia and the pharmaceutical and devices industries. Although elevated concern for bias is justified, particularly when academics may affect drug sales, partnerships between industry and academia are essential to achieve the full promise of health improvement from the public investment in biomedical research. New models for such partnerships are developing and should be encouraged.	[Johnston, S. Claiborne; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Johnston, S. Claiborne] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94143 USA; [Desmond-Hellmann, Susan] Univ Calif San Francisco, Off Chancellor, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnston, SC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	clay.johnston@ucsfmedctr.org						ADAMS CP, 2008, HEALTH ECON, V19, P130; Bruneel J, 2010, RES POLICY, V39, P858, DOI 10.1016/j.respol.2010.03.006; Cosgrove L, 2009, NEW ENGL J MED, V360, P2035, DOI 10.1056/NEJMc0810237; HARRIS G, 2008, NY TIMES        0608; Hauser SL, 2008, ANN NEUROL, V64, pA13, DOI 10.1002/ana.21588; Lenzer J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a930; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; VOGEL G, 1997, SCIENCE, V276, P523; Zinner DE, 2009, JAMA-J AM MED ASSOC, V302, P969, DOI 10.1001/jama.2009.1265	10	15	16	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					434	436		10.1038/nm0411-434	http://dx.doi.org/10.1038/nm0411-434			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475239				2022-12-27	WOS:000289245100032
J	Engel, DR; Koscielny, A; Wehner, S; Maurer, J; Schiwon, M; Franken, L; Schumak, B; Limmer, A; Sparwasser, T; Hirner, A; Knolle, PA; Kalff, JC; Kurts, C				Engel, Daniel R.; Koscielny, Arne; Wehner, Sven; Maurer, Juliane; Schiwon, Marzena; Franken, Lars; Schumak, Beatrix; Limmer, Andreas; Sparwasser, Tim; Hirner, Andreas; Knolle, Percy A.; Kalff, Joerg C.; Kurts, Christian			T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SMOOTH-MUSCLE DYSFUNCTION; NITRIC-OXIDE SYNTHASE; DENDRITIC CELLS; LAMINA-PROPRIA; RETINOIC-ACID; AUTOIMMUNE INFLAMMATION; RESIDENT MACROPHAGES; ABDOMINAL-SURGERY; ECONOMIC BURDEN	Localized abdominal surgery can lead to disruption of motility in the entire gastrointestinal tract (postoperative ileus). Intestinal macrophages produce mediators that paralyze myocytes, but it is unclear how the macrophages are activated, especially those in unmanipulated intestinal areas. Here we show that intestinal surgery activates intestinal CD103(+) CD11b(+) dendritic cells (DCs) to produce interleukin-12 (IL-12). This promotes interferon-gamma(IFN-gamma) secretion by CCR9(+) memory T helper type 1 (T(H)1) cells which activates the macrophages. IL-12 also caused some T(H)1 cells to migrate from surgically manipulated sites through the bloodstream to unmanipulated intestinal areas where they induced ileus. Preventing T cell migration with the drug FTY720 or inhibition of IL-12, T-bet (T(H)1-specific T box transcription factor) or IFN-gamma prevented postoperative ileus. CCR9(+) T(H)1 memory cells were detected in the venous blood of subjects 1 h after abdominal surgery. These findings indicate that postoperative ileus is a T(H)1 immune-mediated disease and identify potential targets for disease monitoring and therapy. (C) 2010 Nature America, Inc. All rights reserved.	[Koscielny, Arne; Wehner, Sven; Hirner, Andreas; Kalff, Joerg C.] Univ Bonn, Sch Med, Dept Surg, D-5300 Bonn, Germany; [Engel, Daniel R.; Maurer, Juliane; Schiwon, Marzena; Franken, Lars; Schumak, Beatrix; Limmer, Andreas; Knolle, Percy A.; Kurts, Christian] Univ Clin Bonn, Inst Mol Med, Bonn, Germany; [Engel, Daniel R.; Maurer, Juliane; Schiwon, Marzena; Franken, Lars; Schumak, Beatrix; Limmer, Andreas; Knolle, Percy A.; Kurts, Christian] Univ Clin Bonn, Inst Expt Immunol, Bonn, Germany; [Sparwasser, Tim] Twincore Res Ctr, Inst Infect Immunol, Hannover, Germany	University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research	Kalff, JC (corresponding author), Univ Bonn, Sch Med, Dept Surg, D-5300 Bonn, Germany.	kalff@uni-bonn.de; ckurts@web.de	Engel, Daniel Robert/C-5945-2013; Wehner, Sven/X-6326-2019; Sparwasser, Tim/AAF-7085-2019; Kalff, Joerg C/U-8580-2017; Sparwasser, Tim D/AAA-4306-2022; Koscielny, Arne/M-6185-2016	Engel, Daniel Robert/0000-0001-7301-353X; Sparwasser, Tim/0000-0001-5645-902X; Wehner, Sven/0000-0002-8632-7631; Knolle, Percy A./0000-0003-2983-0414	Institutes for Molecular Medicine and Experimental Immunology; Cooperative Clinical Research Center of Deutsche Forschungsgemeinschaft [Ka1270/9-1/2, Ku1063/4-1, KFO115]	Institutes for Molecular Medicine and Experimental Immunology; Cooperative Clinical Research Center of Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Lysson for technical assistance, S. Hegenbarth for producing monoclonal antibodies and M. Forst for animal maintenance, and we acknowledge the support of the Central Animal Facilities and the Flow Cytometry Core Facility at the Institutes for Molecular Medicine and Experimental Immunology. D. R. E., S. W., J.C.K., A. K. and C. K. were supported by the Cooperative Clinical Research Center KFO115 of the Deutsche Forschungsgemeinschaft (Grants Ka1270/9-1/2 and Ku1063/4-1).	Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Barada KA, 2006, LIFE SCI, V79, P2032, DOI 10.1016/j.lfs.2006.06.047; Barquist E, 1996, AM J PHYSIOL-REG I, V270, pR888, DOI 10.1152/ajpregu.1996.270.4.R888; Bauer AJ, 2008, NEUROGASTROENT MOTIL, V20, P81, DOI 10.1111/j.1365-2982.2008.01105.x; Bauer Anthony J, 2002, Curr Opin Crit Care, V8, P152, DOI 10.1097/00075198-200204000-00011; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Goldstein JL, 2007, P & T, V32, P82; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Iyer S, 2009, J MANAGE CARE PHARM, V15, P485, DOI 10.18553/jmcp.2009.15.6.485; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schaefer N, 2007, AM J TRANSPLANT, V7, P1062, DOI 10.1111/j.1600-6143.2007.01747.x; Schafer N, 2008, TRANSPL INT, V21, P778, DOI 10.1111/j.1432-2277.2008.00676.x; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tomita T, 2008, INFLAMM BOWEL DIS, V14, P1630, DOI 10.1002/ibd.20636; Turler A, 2006, ANN SURG, V244, P220, DOI 10.1097/01.sla.0000229963.37544.59; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; WEHNER S, 2010, NAT PROTOC      1128, DOI DOI 10.1038/PROTEX.2010.1158; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wehner S, 2009, GASTROENTEROLOGY, V136, P619, DOI 10.1053/j.gastro.2008.10.017; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	60	78	85	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1407	U88		10.1038/nm.2255	http://dx.doi.org/10.1038/nm.2255			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21113155				2022-12-27	WOS:000285048900034
J	Palczewska, G; Maeda, T; Imanishi, Y; Sun, WY; Chen, Y; Williams, DR; Piston, DW; Maeda, A; Palczewski, K				Palczewska, Grazyna; Maeda, Tadao; Imanishi, Yoshikazu; Sun, Wenyu; Chen, Yu; Williams, David R.; Piston, David W.; Maeda, Akiko; Palczewski, Krzysztof			Noninvasive multiphoton fluorescence microscopy resolves retinol and retinal condensation products in mouse eyes	NATURE MEDICINE			English	Article							COMPLEMENT ACTIVATION; VISUAL FUNCTIONS; 2-PHOTON; EXCITATION; PIGMENT; CELLS; LIGHT; MODEL; FLUOROPHORES; ACCUMULATION	Multiphoton excitation fluorescence microscopy (MPM) can image certain molecular processes in vivo. In the eye, fluorescent retinyl esters in subcellular structures called retinosomes mediate regeneration of the visual chromophore, 11-cis-retinal, by the visual cycle. But harmful fluorescent condensation products of retinoids also occur in the retina. We report that in wild-type mice, excitation with a wavelength of similar to 730 nm identified retinosomes in the retinal pigment epithelium, and excitation with a wavelength of similar to 910 nm revealed at least one additional retinal fluorophore. The latter fluorescence was absent in eyes of genetically modified mice lacking a functional visual cycle, but accentuated in eyes of older wild-type mice and mice with defective clearance of all-trans-retinal, an intermediate in the visual cycle. MPM, a noninvasive imaging modality that facilitates concurrent monitoring of retinosomes along with potentially harmful products in aging eyes, has the potential to detect early molecular changes due to age-related macular degeneration and other defects in retinoid metabolism.	[Palczewska, Grazyna; Sun, Wenyu; Palczewski, Krzysztof] Polgenix, Cleveland, OH USA; [Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Maeda, Tadao; Imanishi, Yoshikazu; Chen, Yu; Maeda, Akiko; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Williams, David R.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Williams, David R.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Case Western Reserve University; Case Western Reserve University; University of Rochester; Vanderbilt University	Palczewski, K (corresponding author), Polgenix, Cleveland, OH USA.	gpalczewska@polgenixinc.com; kxp65@case.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836	US National Institutes of Health [EY008061, EY009339, EY019880, EY019031, EY020715, P30 EY11373]; State of Ohio Department of Development and Third Frontier Commission [TECH 09-004]; European Life Scientist Organization; Klaus Tschira Foundation; NATIONAL EYE INSTITUTE [R01EY008061, K08EY019031, P30EY011373, K08EY019880, R29EY008061, R01EY009339, R43EY020715] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio Department of Development and Third Frontier Commission; European Life Scientist Organization; Klaus Tschira Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank M. Golczak for help during the course of this study and Z. Dong for expert handling of mice. We also thank L. T. Webster and members of Palczewski laboratory for critical comments on the manuscript. Rpe65<SUP>-/-</SUP> mice were a kind gift from M. Redmond ( US National Eye Institute). This research was supported in part by grants EY008061, EY009339, EY019880, EY019031, EY020715 and P30 EY11373 from the US National Institutes of Health, TECH 09-004 from the State of Ohio Department of Development and Third Frontier Commission, the European Life Scientist Organization and the Klaus Tschira Foundation.	Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; DaCosta RS, 2005, CURR OPIN GASTROEN, V21, P70; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DRABENT R, 1997, J FLUORESC, V7, P347, DOI DOI 10.1023/A:1022594329601; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Imanishi Y, 2007, BIOCHEMISTRY-US, V46, P9674, DOI 10.1021/bi701055g; Imanishi Y, 2010, METHODS MOL BIOL, V652, P247, DOI 10.1007/978-1-60327-325-1_14; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim JS, 2008, SCIENCE, V321, P1472, DOI 10.1126/science.1161517; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P322, DOI 10.1167/iovs.08-2301; Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530; Piston DW, 1999, TRENDS CELL BIOL, V9, P66, DOI 10.1016/S0962-8924(98)01432-9; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JM, 1999, INVEST OPHTH VIS SCI, V40, pS195; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zhang EZ, 2009, PHYS MED BIOL, V54, P1035, DOI 10.1088/0031-9155/54/4/014; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	40	59	60	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1444	U130		10.1038/nm.2260	http://dx.doi.org/10.1038/nm.2260			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21076393	Green Accepted			2022-12-27	WOS:000285048900040
J	Lo, EH				Lo, Eng H.			Degeneration and repair in central nervous system disease	NATURE MEDICINE			English	Article							CEREBRAL ENDOTHELIAL-CELLS; AMYLOID-BETA PEPTIDES; ALZHEIMERS-DISEASE; DOPAMINERGIC-NEURONS; NEUROVASCULAR NICHE; PHYSIOLOGICAL ROLES; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; MUTANT HUNTINGTIN; BLOOD-VESSELS	Divergent disease triggers in neurodegeneration may induce convergent endogenous pathways in neuronal, glial and vascular elements as the central nervous system (CNS) attempts to compensate, remodel and recover. Dissecting these multicellular mechanisms and the integrative responses in cerebral blood flow and metabolism may allow us to understand the balance between injury and repair, validate new targets and define therapeutic time windows for neurodegeneration.	[Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lo, Eng H.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Boston, MA 02114 USA.	lo@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS055104] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Agosta F, 2010, HUM BRAIN MAPP, V31, P515, DOI 10.1002/hbm.20883; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Barcia C, 2004, FRONT BIOSCI-LANDMRK, V9, P277, DOI 10.2741/1145; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Betarbet R, 1997, J NEUROSCI, V17, P6761; BLANCHARD V, 1995, J NEUROCHEM, V64, P1669; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Cantara S, 2004, FASEB J, V18, P1943, DOI 10.1096/fj.04-2114fje; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Desai BS, 2009, J NEURAL TRANSM, V116, P587, DOI 10.1007/s00702-009-0226-9; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Fisher M, 2009, STROKE, V40, pE288, DOI 10.1161/STROKEAHA.109.551820; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; HYMAN BT, 1987, ANN NEUROL, V21, P259, DOI 10.1002/ana.410210307; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2003, CELL MOL NEUROBIOL, V23, P681, DOI 10.1023/A:1025092617651; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jin HK, 2009, CELL PROLIFERAT, V42, P571, DOI 10.1111/j.1365-2184.2009.00625.x; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Marlatt MW, 2010, CURR ALZHEIMER RES, V7, P113, DOI 10.2174/156720510790691362; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Wang Y, 2010, NEURODEGENER DIS, V7, P103, DOI 10.1159/000285516; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	65	86	92	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1205	1209		10.1038/nm.2226	http://dx.doi.org/10.1038/nm.2226			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052074	Green Accepted			2022-12-27	WOS:000283860100026
J	Weatherall, D				Weatherall, David			Thalassemia: the long road from the bedside through the laboratory to the community	NATURE MEDICINE			English	Article							HEMOGLOBIN; DISEASE; MALARIA		Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford	Weatherall, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	liz.rose@imm.ox.ac.uk						Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Haldane J. B. S., 1949, P 8 INT C GEN, P267; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; O'Donnell A, 2009, P NATL ACAD SCI USA, V106, P18716, DOI 10.1073/pnas.0910142106; WEATHERA.DJ, 1965, NATURE, V208, P1061, DOI 10.1038/2081061a0; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WEATHERALL DJ, 1975, PHILOS T R SOC B, V271, P411, DOI 10.1098/rstb.1975.0061; WHO, 2002, GEN WORLD HLTH	11	7	7	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1112	1115		10.1038/nm1010-1112	http://dx.doi.org/10.1038/nm1010-1112			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930755				2022-12-27	WOS:000282644800040
J	[Anonymous]				[Anonymous]			The persistence of memory	NATURE MEDICINE			English	Editorial Material							PLURIPOTENT STEM-CELLS											Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Loh KM, 2010, CELL STEM CELL, V7, P137, DOI 10.1016/j.stem.2010.07.005; McLean CA, 2010, ANIM REPROD SCI, V118, P388, DOI 10.1016/j.anireprosci.2009.06.017; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017	6	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1082	1083		10.1038/nm1010-1082	http://dx.doi.org/10.1038/nm1010-1082			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930747				2022-12-27	WOS:000282644800032
J	Lee, BD; Shin, JH; VanKampen, J; Petrucelli, L; West, AB; Ko, HS; Lee, YI; Maguire-Zeiss, KA; Bowers, WJ; Federoff, HJ; Dawson, VL; Dawson, TM				Lee, Byoung Dae; Shin, Joo-Ho; VanKampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.			Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease	NATURE MEDICINE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NEURONAL TOXICITY; LRRK2; PHOSPHORYLATION	Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.	[Lee, Byoung Dae; Shin, Joo-Ho; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA; [Lee, Byoung Dae; Shin, Joo-Ho; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Lee, Byoung Dae; Shin, Joo-Ho; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [VanKampen, Jackalina; Petrucelli, Leonard] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Maguire-Zeiss, Kathleen A.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Bowers, William J.] Univ Rochester, Med Ctr, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Off Execut Vice President & Execut Dean, Washington, DC 20007 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Georgetown University; University of Rochester; Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA.	vdawson@jhmi.edu; tdawson@jhmi.edu	Shin, Joo-Ho/P-1417-2018; Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970; West, Andrew/0000-0002-3034-4061	US National Institutes of Health [P50NS38377, R01ES014470, R01-AG023593, R00-NS058111, NS36420]; Army Medical Research and Materiel Command [DAMD17-02-1-0695]; Mayo Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069450, R01NS036420, R00NS058111, R01NS064934, P50NS038377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023593] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Mayo Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Burris and L. Lotta for packaging helper virus-free amplicons. C. Cook, K. Kehoe, J. Dunmore and C. Eckman provided technical support for some of the in vivo HSV studies. We also thank G. and K. Caldwell and S. Hamamichi for helpful discussions. This work was supported by grants from the US National Institutes of Health, P50NS38377, R01ES014470 (K.A.M.-Z.), R01-AG023593 (W. J. B.), R00-NS058111 (A. B. W.), NS36420 (H. J. F.) and Army Medical Research and Materiel Command, DAMD17-02-1-0695 (H. J. F.), the Mayo Foundation and the Michael J. Fox Foundation.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; GASSER T, 2009, MOL MED, V11, pE22; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Reichling LJ, 2009, BIOCHEM BIOPH RES CO, V384, P255, DOI 10.1016/j.bbrc.2009.04.098; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Whaley NR, 2006, J NEURAL TRANSM-SUPP, P221	15	285	297	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					998	1000		10.1038/nm.2199	http://dx.doi.org/10.1038/nm.2199			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20729864	Green Accepted, Green Submitted			2022-12-27	WOS:000281622900028
J	McMahon, M				McMahon, Martin			RAF translocations expand cancer targets	NATURE MEDICINE			English	Editorial Material							PROSTATE-CANCER; BRAF MUTATION; MAPK PATHWAY; FUSION; GENE; INHIBITION; ACTIVATION; MELANOMA; THERAPY	Chromosomal translocations can promote cancers by eliciting the expression of fusion genes with oncogenic activity. The identification of translocations affecting RAF genes in prostate and gastric cancers and melanoma provides compelling evidence for the key role of RAF signaling in a subset of these cancers and suggests possible new avenues for personalized cancer therapy (pages 793-798).	Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	McMahon, M (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	mcmahon@cc.ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA131261] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chapman P, 2009, EJC SUPPL, V7, P5, DOI 10.1016/S1359-6349(09)72036-1; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FLAHERTY K, 2009, J CLIN ONCOL, V27, pS15; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498	17	5	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					749	750		10.1038/nm0710-749	http://dx.doi.org/10.1038/nm0710-749			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613748	Green Accepted			2022-12-27	WOS:000279631900018
J	Rosenwaks, Z; Simon, C; Wallace, DC				Rosenwaks, Zev; Simon, Carlos; Wallace, Douglas C.			A mother's gift, minus mitochondria	NATURE MEDICINE			English	Editorial Material							HUMAN EMBRYOS		[Rosenwaks, Zev] New York Presbyterian Hosp, Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Simon, Carlos] Univ Valencia, Dept Obstet & Gynecology, Valencia, Spain; [Simon, Carlos] Inst Valenciano Infertilidad, Valencia, Spain; [Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genetics, Irvine, CA USA	Cornell University; NewYork-Presbyterian Hospital; University of Valencia; University of Valencia; University of California System; University of California Irvine	Rosenwaks, Z (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA.		Simon, Carlos/G-2186-2014	Simon, Carlos/0000-0003-0902-9531				Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Escriba MJ, 2006, FERTIL STERIL, V86, P1601, DOI 10.1016/j.fertnstert.2006.04.047; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368	3	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					645	645		10.1038/nm0610-645	http://dx.doi.org/10.1038/nm0610-645			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526317	Bronze			2022-12-27	WOS:000278394200041
J	Lu, MJ; Wan, M; Leavens, KF; Chu, QW; Monks, BR; Fernandez, S; Ahima, RS; Ueki, K; Kahn, CR; Birnbaum, MJ				Lu, Mingjian; Wan, Min; Leavens, Karla F.; Chu, Qingwei; Monks, Bobby R.; Fernandez, Sully; Ahima, Rexford S.; Ueki, Kohjiro; Kahn, C. Ronald; Birnbaum, Morris J.			Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION; GLUCOSE-HOMEOSTASIS; MICE LACKING; PHOSPHORYLATION; GROWTH; LIPOGENESIS; RESISTANCE; INHIBITION	Considerable data support the idea that forkhead box O1 (Foxo1) drives the liver transcriptional program during fasting and is then inhibited by thymoma viral proto-oncogene 1 (Akt) after feeding. Here we show that mice with hepatic deletion of Akt1 and Akt2 were glucose intolerant, insulin resistant and defective in their transcriptional response to feeding in the liver. These defects were normalized with concomitant liver-specific deletion of Foxo1. Notably, in the absence of both Akt and Foxo1, mice adapted appropriately to both the fasted and fed state, and insulin suppressed hepatic glucose production normally. A gene expression analysis revealed that deletion of Akt in liver led to the constitutive activation of Foxo1-dependent gene expression, but again, concomitant ablation of Foxo1 restored postprandial regulation, preventing the inhibition of the metabolic response to nutrient intake caused by deletion of Akt. These results are inconsistent with the canonical model of hepatic metabolism in which Akt is an obligate intermediate for proper insulin signaling. Rather, they show that a major role of hepatic Akt is to restrain the activity of Foxo1 and that in the absence of Foxo1, Akt is largely dispensable for insulin-and nutrient-mediated hepatic metabolic regulation in vivo.	[Lu, Mingjian; Wan, Min; Leavens, Karla F.; Chu, Qingwei; Monks, Bobby R.; Fernandez, Sully; Ahima, Rexford S.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ueki, Kohjiro] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan; [Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; University of Tokyo; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Birnbaum, MJ (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu	Kahn, Ronald/AAY-2435-2021; Fernandez, Sully/E-9812-2013; Ahima, Rexford/W-1394-2019; Lu, Mingjian/AAO-6179-2021; Lu, Mingjian/AGK-0751-2022	Kahn, Ronald/0000-0002-7583-9228; Lu, Mingjian/0000-0001-9328-4935; Birnbaum, Morris/0000-0001-9972-8680	NIH [P30 DK19525]; US National Institutes of Health [RO1 DK56886]; diabetes training grant [T32 DK007314]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK056886, T32DK007314, R01DK033201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); diabetes training grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank M. Magnuson (Vanderbilt University) for providing the antibody to Gck and D. Accili (Columbia University) for sharing the Foxo1<SUP>loxP/loxP</SUP> mice. We are grateful to J. Schug, who helped with the microarray data analysis and generated the heat map and the density plot. The Functional Genomics Core and the Transgenic, Knockout, Mouse Phenotyping and Biomarker Cores of the University of Pennsylvania Diabetes and Endocrinology Research Center (NIH grant P30 DK19525) were instrumental in this work. This work was supported by the US National Institutes of Health grant RO1 DK56886 (M. J. B.) and the diabetes training grant T32 DK007314 (M.L.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wan M, 2012, MOL CELL BIOL, V32, P96, DOI 10.1128/MCB.05806-11; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	59	259	271	0	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					388	U254		10.1038/nm.2686	http://dx.doi.org/10.1038/nm.2686			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344295	Green Submitted, Green Accepted			2022-12-27	WOS:000301264800040
J	Maeda, K; Kobayashi, Y; Udagawa, N; Uehara, S; Ishihara, A; Mizoguchi, T; Kikuchi, Y; Takada, I; Kato, S; Kani, S; Nishita, M; Marumo, K; Martin, TJ; Minami, Y; Takahashi, N				Maeda, Kazuhiro; Kobayashi, Yasuhiro; Udagawa, Nobuyuki; Uehara, Shunsuke; Ishihara, Akihiro; Mizoguchi, Toshihide; Kikuchi, Yuichiro; Takada, Ichiro; Kato, Shigeaki; Kani, Shuichi; Nishita, Michiru; Marumo, Keishi; Martin, T. John; Minami, Yasuhiro; Takahashi, Naoyuki			Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis	NATURE MEDICINE			English	Article							RECEPTOR TYROSINE KINASE; BONE-FORMATION; WNT; DIFFERENTIATION; ROR2; PATHWAY; OSTEOPROTEGERIN; EXPRESSION; LIGAND; PROTEIN	The signaling molecule Wnt regulates bone homeostasis through beta-catenin-dependent canonical and beta-catenin-independent noncanonical pathways. Impairment of canonical Wnt signaling causes bone loss in arthritis and osteoporosis; however, it is unclear how noncanonical Wnt signaling regulates bone resorption. Wnt5a activates noncanonical Wnt signaling through receptor tyrosine kinase-like orphan receptor (Ror) proteins. We showed that Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhanced osteoclastogenesis. Osteoblast-lineage cells expressed Wnt5a, whereas osteoclast precursors expressed Ror2. Mice deficient in either Wnt5a or Ror2, and those with either osteoclast precursor-specific Ror2 deficiency or osteoblast-lineage cell-specific Wnt5a deficiency showed impaired osteoclastogenesis. Wnt5a-Ror2 signals enhanced receptor activator of nuclear factor-kappa B (RANK) expression in osteoclast precursors by activating JNK and recruiting c-Jun on the promoter of the gene encoding RANK, thereby enhancing RANK ligand (RANKL)-induced osteoclastogenesis. A soluble form of Ror2 acted as a decoy receptor of Wnt5a and abrogated bone destruction in mouse arthritis models. Our results suggest that the Wnt5a-Ror2 pathway is crucial for osteoclastogenesis in physiological and pathological environments and represents a therapeutic target for bone diseases, including arthritis.	[Maeda, Kazuhiro; Kobayashi, Yasuhiro; Mizoguchi, Toshihide; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan; [Maeda, Kazuhiro; Marumo, Keishi] Jikei Univ, Dept Orthoped Surg, Sch Med, Tokyo, Japan; [Udagawa, Nobuyuki; Uehara, Shunsuke] Matsumoto Dent Univ, Dept Biochem, Nagano, Japan; [Ishihara, Akihiro] Matsumoto Dent Univ, Dept Periodontol, Nagano, Japan; [Kikuchi, Yuichiro] Matsumoto Dent Univ, Dept Microbiol, Nagano, Japan; [Takada, Ichiro] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Kato, Shigeaki] Univ Tokyo, Lab Nucl Signaling, Inst Mol & Cellular Biosci, Tokyo, Japan; [Kani, Shuichi; Nishita, Michiru; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan; [Martin, T. John] St Vincent Inst Med Res, Melbourne, Vic, Australia	Matsumoto Dental University; Jikei University; Matsumoto Dental University; Matsumoto Dental University; Matsumoto Dental University; Keio University; University of Tokyo; Kobe University; St. Vincent's Institute of Medical Research	Takahashi, N (corresponding author), Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan.	ykoba@po.mdu.ac.jp; takahashinao@po.mdu.ac.jp	KOBAYASHI, YASUHIRO/AAU-4931-2021; Maeda, Kazuhiro/ABD-5762-2020	KIKUCHI, YUICHIRO/0000-0001-7232-837X; Kobayashi, Yasuhiro/0000-0002-0903-3226	Ministry of Education, Culture, Sports, Science and Technology of Japan [18390495, 22390351, 18390557, 21390551, 19390476, 21390498]; Naito Foundation; Grants-in-Aid for Scientific Research [23791668, 22790291, 21390080, 22021039, 23593054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura (Tokyo University) for pMX-IRES-GFP vectors and Plat-E cells; M. Sakoda, S. Kinugawa, Y. Nakamichi and T. Yamashita for technical assistance; A. Yamaguchi, H. Takayanagi and T. Nakashima for thoughtful discussion; and T. Nishizawa, Y. Ueno and M. Saito for discussions about mice models. This work was supported by a Grant-in-Aid for Scientific Research (18390495, 22390351 (N.T.); 18390557, 21390551 (Y. Kobayashi); 19390476, 21390498 (N.U.)) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Naito Foundation (Y. Kobayashi).	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kubota A, 2004, J RHEUMATOL, V31, P426; Kwon OH, 2005, BIOCHEM BIOPH RES CO, V335, P437, DOI 10.1016/j.bbrc.2005.07.092; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schett G, 2008, NAT CLIN PRACT RHEUM, V4, P473, DOI 10.1038/ncprheum0881; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Spellman PT, 2002, GENOME BIOL, V3; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamane T, 2001, J IMMUNOL, V167, P765, DOI 10.4049/jimmunol.167.2.765; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	60	328	354	3	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					405	U166		10.1038/nm.2653	http://dx.doi.org/10.1038/nm.2653			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344299				2022-12-27	WOS:000301264800042
J	Takeuchi, K; Soda, M; Togashi, Y; Suzuki, R; Sakata, S; Hatano, S; Asaka, R; Hamanaka, W; Ninomiya, H; Uehara, H; Choi, YL; Satoh, Y; Okumura, S; Nakagawa, K; Mano, H; Ishikawa, Y				Takeuchi, Kengo; Soda, Manabu; Togashi, Yuki; Suzuki, Ritsuro; Sakata, Seiji; Hatano, Satoko; Asaka, Reimi; Hamanaka, Wakako; Ninomiya, Hironori; Uehara, Hirofumi; Choi, Young Lim; Satoh, Yukitoshi; Okumura, Sakae; Nakagawa, Ken; Mano, Hiroyuki; Ishikawa, Yuichi			RET, ROS1 and ALK fusions in lung cancer	NATURE MEDICINE			English	Article							EML4-ALK FUSION; TRANSFORMING GENE; IDENTIFICATION; IMMUNOHISTOCHEMISTRY; REARRANGEMENTS; RADIATION; ONCOGENE	Through an integrated molecular-and histopathology-based screening system, we performed a screening for fusions of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1, receptor tyrosine kinase (ROS1) in 1,529 lung cancers and identified 44 ALK-fusion-positive and 13 ROS1-fusion-positive adenocarcinomas, including for unidentified fusion partners for ROS1. In addition, we discovered previously unidentified kinase fusions that may be promising for molecular-targeted therapy, kinesin family member 5B (KIF5B)-ret proto-oncogene (RET) and coiled-coil domain containing 6 (CCDC6)-RET, in 14 adenocarcinomas. A multivariate analysis of 1,116 adenocarcinomas containing these 71 kinase-fusion-positive adenocarcinomas identified four independent factors that are indicators of poor prognosis: age >= 50 years, male sex, high pathological stage and negative kinase-fusion status.	[Takeuchi, Kengo; Togashi, Yuki; Sakata, Seiji; Hatano, Satoko; Asaka, Reimi] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Takeuchi, Kengo; Togashi, Yuki; Asaka, Reimi; Hamanaka, Wakako; Ninomiya, Hironori; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 4648601, Japan; [Uehara, Hirofumi; Satoh, Yukitoshi; Okumura, Sakae; Nakagawa, Ken] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Thorac Ctr, Tokyo 170, Japan; [Choi, Young Lim; Mano, Hiroyuki] Univ Tokyo, Dept Med Genom, Grad Sch Med, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Nagoya University; Japanese Foundation for Cancer Research; University of Tokyo	Takeuchi, K (corresponding author), Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan.	kentakeuchi-tky@umin.net	Gotoh, Osamu/B-4704-2012; Takeuchi, Kengo/C-3614-2008	Suzuki, Ritsuro/0000-0002-5974-7614; Takeuchi, Kengo/0000-0002-1599-5800	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22300326] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Iwakoshi, K. Shiozawa, T. Kakita, H. Nagano and K. Nomura for their technical assistance and S. Sengoku for providing administrative assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as by grants from the Japan Society for the Promotion of Science; the Ministry of Health, Labor and Welfare of Japan; the Vehicle Racing Commemorative Foundation of Japan; the Princess Takamatsu Cancer Research Fund; and the Uehara Memorial Foundation.	Bounacer A, 1997, ONCOGENE, V15, P1263, DOI 10.1038/sj.onc.1200206; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Flanigan J, 2010, BIOL-TARGETS THER, V4, P237, DOI 10.2147/BTT.S7223; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; ITO T, 1994, LANCET, V344, P259; Jokoji R, 2010, J CLIN PATHOL, V63, P1066, DOI 10.1136/jcp.2010.081166; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sugawara E, 2012, CANCER-AM CANCER SOC, V118, P4427, DOI 10.1002/cncr.27391; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Takeuchi K., 2010, PATHOL CLIN MED, V28, P139; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2011, CLIN CANCER RES, V17, P3341, DOI 10.1158/1078-0432.CCR-11-0063; Takeuchi K, 2011, HAEMATOL-HEMATOL J, V96, P464, DOI 10.3324/haematol.2010.033514; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0	20	925	1024	10	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					378	381		10.1038/nm.2658	http://dx.doi.org/10.1038/nm.2658			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22327623				2022-12-27	WOS:000301264800037
J	Schneider, A; Thiel, C; Rindermann, J; DeRossi, C; Popovici, D; Hoffmann, GF; Grone, HJ; Korner, C				Schneider, Anette; Thiel, Christian; Rindermann, Jan; DeRossi, Charles; Popovici, Diana; Hoffmann, Georg F.; Groene, Hermann-Josef; Koerner, Christian			Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice	NATURE MEDICINE			English	Article							SYNDROME TYPE 1A; SUPPLEMENTATION; DISEASE; PMM2; GENE	Congenital disorder of glycosylation-Ia (CDG-Ia, also known as PMM2-CDG) is caused by mutations in the gene that encodes phosphomannomutase 2 (PMM2, EC 5.4.2.8) leading to a multisystemic disease with severe psychomotor and mental retardation. In a hypomorphic Pmm2 mouse model, we were able to overcome embryonic lethality by feeding mannose to pregnant dams. The results underline the essential role of glycosylation in embryonic development and may open new treatment options for this disease.	[Schneider, Anette; Thiel, Christian; DeRossi, Charles; Popovici, Diana; Hoffmann, Georg F.; Koerner, Christian] Ctr Child & Adolescent Med, Heidelberg, Germany; [Schneider, Anette; Thiel, Christian; DeRossi, Charles; Popovici, Diana; Hoffmann, Georg F.; Koerner, Christian] Ctr Metab Dis Heidelberg, Dept Kinderheilkunde 1, Heidelberg, Germany; [Rindermann, Jan] Inst Biochem II, Gottingen, Germany; [Groene, Hermann-Josef] German Canc Res Ctr Heidelberg, Div Cellular & Mol Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Korner, C (corresponding author), Ctr Child & Adolescent Med, Heidelberg, Germany.	christian.koerner@med.uni-heidelberg.de		Thiel, Christian/0000-0001-6419-8747	Deutsche Forschungsgemeinschaft [KO 2152/3-2, TH1461/2-1]; Fritz Thyssen Stiftung; US National Institutes of Health [R21 HD062914]; Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062914] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Stiftung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work of C.K. and C.T. was supported by grants of the Deutsche Forschungsgemeinschaft (KO 2152/3-2 and TH1461/2-1) and the Fritz Thyssen Stiftung. The work of C.D. was supported by a US National Institutes of Health grant (R21 HD062914) and The Rocket Fund.	Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Grunewald S, 2009, BBA-MOL BASIS DIS, V1792, P827, DOI 10.1016/j.bbadis.2009.01.003; Kjaergaard S, 1998, ACTA PAEDIATR, V87, P884, DOI 10.1080/080352598750013680; Kjaergaard S, 1999, EUR J HUM GENET, V7, P884, DOI 10.1038/sj.ejhg.5200398; Korner C, 1998, GLYCOCONJUGATE J, V15, P499, DOI 10.1023/A:1006939104442; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Mayatepek E, 1998, EUR J PEDIATR, V157, P605, DOI 10.1007/s004310050889; Mayatepek E, 1997, ACTA PAEDIATR, V86, P1138, DOI 10.1111/j.1651-2227.1997.tb14825.x; Panneerselvam K, 1996, J CLIN INVEST, V97, P1478, DOI 10.1172/JCI118570; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05	12	56	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					71	73		10.1038/nm.2548	http://dx.doi.org/10.1038/nm.2548			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157680				2022-12-27	WOS:000299018600031
J	Alitalo, K				Alitalo, Kari			The lymphatic vasculature in disease	NATURE MEDICINE			English	Review							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; DENDRITIC CELLS; FACTOR-C; IN-VIVO; VEGF-C; THERAPEUTIC LYMPHANGIOGENESIS; MOLECULAR-MECHANISMS; PRECLINICAL MODELS; PRIMARY LYMPHEDEMA	Blood vessels form a closed circulatory system, whereas lymphatic vessels form a one-way conduit for tissue fluid and leukocytes. In most vertebrates, the main function of lymphatic vessels is to collect excess protein-rich fluid that has extravasated from blood vessels and transport it back into the blood circulation. Lymphatic vessels have an important immune surveillance function, as they import various antigens and activated antigen-presenting cells into the lymph nodes and export immune effector cells and humoral response factors into the blood circulation. Defects in lymphatic function can lead to lymph accumulation in tissues, dampened immune responses, connective tissue and fat accumulation, and tissue swelling known as lymphedema. This review highlights the most recent developments in lymphatic biology and how the lymphatic system contributes to the pathogenesis of various diseases involving immune and inflammatory responses and its role in disseminating tumor cells.	[Alitalo, Kari] Univ Helsinki, Mol Canc Biol Program, Fac Med, Inst Mol Med Finland,Biomedicum Helsinki, Helsinki, Finland; Univ Helsinki, Cent Hosp, Biomedicum Helsinki, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Alitalo, K (corresponding author), Univ Helsinki, Mol Canc Biol Program, Fac Med, Inst Mol Med Finland,Biomedicum Helsinki, Helsinki, Finland.	kari.alitalo@helsinki.fi	Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902	Academy of Finland; Finnish Cancer Organisations; Association for International Cancer Research; Sigrid Juselius Foundation; European Union; Finnish Foundation for Cardiovascular Research and Biocentrum Finland	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Association for International Cancer Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Union(European Commission); Finnish Foundation for Cardiovascular Research and Biocentrum Finland	I am grateful to M. Bry, L. Eklund, S. Jalkanen, D. Kerjaschki, G.Y. Koh, V.-M. Leppanen, T. Makinen, A. Nykanen, M. Ohman, P. Ojala, P. Saharinen, M. Swartz and T. Tammela for useful discussions of the topics of this review. The lymph node images in Figure 5a were kindly provided by D. Kerjaschki and by G.Y. Koh, and draft figures were produced by H. Schmidt. The studies in my laboratory are currently supported by the Academy of Finland, the Finnish Cancer Organisations, the Association for International Cancer Research, the Sigrid Juselius Foundation, Seventh Framework Program of the European Union (ERC Advanced Grant), Finnish Foundation for Cardiovascular Research and Biocentrum Finland. I apologize to the many authors whose important work could not be cited because of space restrictions and the focus on the recent developments; older references appear in the many excellent reviews that have been cited.	Albrecht I, 2011, INT J DEV BIOL, V55, P483, DOI 10.1387/ijdb.103226ia; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng F., 2001, CELL HOST M IN PRESS; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Contassot E, 2009, TRENDS IMMUNOL, V30, P569, DOI 10.1016/j.it.2009.08.001; Cormier JN, 2012, ANN SURG ONCOL, V19, P642, DOI 10.1245/s10434-011-2017-4; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dixon JB, 2010, TRENDS ENDOCRIN MET, V21, P480, DOI 10.1016/j.tem.2010.04.003; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V306, P385, DOI 10.1001/jama.2011.1034; Goyal S, 2012, ARCH OPHTHALMOL-CHIC, V130, P84, DOI 10.1001/archophthalmol.2011.266; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Harari S, 2011, EUR RESPIR REV, V20, P34, DOI 10.1183/09059180.00011010; Harvey NL, 2008, ANN NY ACAD SCI, V1131, P82, DOI 10.1196/annals.1413.007; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kanady JD, 2011, DEV BIOL, V354, P253, DOI 10.1016/j.ydbio.2011.04.004; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Karikoski M, 2009, EUR J IMMUNOL, V39, P3477, DOI 10.1002/eji.200939896; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kendrew J, 2011, MOL CANCER THER, V10, P770, DOI 10.1158/1535-7163.MCT-10-0876; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kerjaschki D, 2011, J CLIN INVEST, V121, P2000, DOI 10.1172/JCI44751; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Kisko K, 2011, FASEB J, V25, P2980, DOI 10.1096/fj.11-185397; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lahteenvuo M, 2011, CIRCULATION, V123, P613, DOI 10.1161/CIRCULATIONAHA.110.965384; Leijte JAP, 2009, J NUCL MED, V50, P364, DOI 10.2967/jnumed.108.059733; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lim HY, 2009, AM J PATHOL, V175, P1328, DOI 10.2353/ajpath.2009.080963; Liu R, 2010, BLOOD, V115, P887, DOI 10.1182/blood-2009-08-236745; Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Mumprecht V, 2010, CANCER RES, V70, P8842, DOI 10.1158/0008-5472.CAN-10-0896; Muniz LR, 2011, J IMMUNOL, V187, P828, DOI 10.4049/jimmunol.1004233; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; Saaristo A.M., ANN SURG IN PRESS; Saharinen P, 2010, GENE DEV, V24, P875, DOI 10.1101/gad.565010; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Seyama Kuniaki, 2006, Lymphatic Research and Biology, V4, P143, DOI 10.1089/lrb.2006.4.143; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Sleeman JP, 2011, INT J CANCER, V128, P2511, DOI 10.1002/ijc.26027; Song LA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3333545; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Stanton Anthony W. B., 2009, Lymphatic Research and Biology, V7, P29, DOI 10.1089/lrb.2008.1026; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Tammela T, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001699; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; von der Weid PY, 2011, CURR OPIN GASTROEN, V27, P335, DOI 10.1097/MOG.0b013e3283476e8f; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MF, 2009, DEVELOPMENT, V136, P29, DOI 10.1242/dev.028456; Wang HM, 2004, J ADV MATER-COVINA, V36, P36; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Yin N, 2011, TRANSPLANTATION, V92, P25, DOI 10.1097/TP.0b013e31821d2661; Zbytek Blazej, 2008, Expert Rev Dermatol, V3, P569, DOI 10.1586/17469872.3.5.569; Zhang XF, 2005, J BIOL CHEM, V280, P26216, DOI 10.1074/jbc.M411392200; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800	126	638	654	7	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1371	1380		10.1038/nm.2545	http://dx.doi.org/10.1038/nm.2545			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064427				2022-12-27	WOS:000296779300028
J	Eltzschig, HK; Eckle, T				Eltzschig, Holger K.; Eckle, Tobias			Ischemia and reperfusion-from mechanism to translation	NATURE MEDICINE			English	Review							SICKLE-CELL-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; REGULATORY T-CELLS; PERCUTANEOUS CORONARY INTERVENTION; HANGING-WEIGHT SYSTEM; INDUCED VASCULAR LEAK; FIND-ME SIGNAL; ISCHEMIA/REPERFUSION INJURY; IN-VIVO	Ischemia and reperfusion-elicited tissue injury contributes to morbidity and mortality in a wide range of pathologies, including myocardial infarction, ischemic stroke, acute kidney injury, trauma, circulatory arrest, sickle cell disease and sleep apnea. Ischemia-reperfusion injury is also a major challenge during organ transplantation and cardiothoracic, vascular and general surgery. An imbalance in metabolic supply and demand within the ischemic organ results in profound tissue hypoxia and microvascular dysfunction. Subsequent reperfusion further enhances the activation of innate and adaptive immune responses and cell death programs. Recent advances in understanding the molecular and immunological consequences of ischemia and reperfusion may lead to innovative therapeutic strategies for treating patients with ischemia and reperfusion-associated tissue inflammation and organ dysfunction.	[Eltzschig, Holger K.; Eckle, Tobias] Univ Colorado, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Eltzschig, HK (corresponding author), Univ Colorado, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO 80045 USA.	holger.eltzschig@ucdenver.edu	Eckle, Tobias/AAE-6705-2020	Eckle, Tobias/0000-0002-6065-4669	US National Institutes of Health [R01-HL0921, R01-DK083385, R01-HL098294]; Crohn's and Colitis Foundation;  [K08HL102267-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098294, K08HL102267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. A. Eltzschig for providing artwork during the manuscript preparation. This work is supported by US National Institutes of Health Grants R01-HL0921, R01-DK083385 and R01-HL098294 and a grant from the Crohn's and Colitis Foundation (H. K. E.) and grant number K08HL102267-01 (T.E.).	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Azoulay D, 2005, ANN SURG, V242, P133, DOI 10.1097/01.sla.0000167848.96692.ad; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Carroll MC, 2005, ADV IMMUNOL, V86, P137, DOI 10.1016/S0065-2776(04)86004-8; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Colgan S. P., 2011, ANN REV PHYSL   0919, DOI [10.1146/annurev-physiol-020911-153230, DOI 10.1146/ANNUREV-PHYSIOL-020911-153230]; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Day YJ, 2006, J IMMUNOL, V176, P3108, DOI 10.4049/jimmunol.176.5.3108; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Esmon CT, 2005, BIOCHEM SOC T, V33, P401, DOI 10.1042/BST0330401; Fantacci M, 2006, P NATL ACAD SCI USA, V103, P17531, DOI 10.1073/pnas.0608814103; Fenhammar J, 2011, ANESTHESIOLOGY, V114, P1130, DOI 10.1097/ALN.0b013e31820b8b44; Field JJ, 2011, CLIN IMMUNOL, V140, P177, DOI 10.1016/j.clim.2011.03.002; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gao ZH, 2001, J PHARMACOL EXP THER, V298, P209; Gladwin MT, 2011, JAMA-J AM MED ASSOC, V305, P893, DOI 10.1001/jama.2011.235; Gladwin MT, 2011, NAT MED, V17, P38, DOI 10.1038/nm0111-38; Gladwin MT, 2001, SEMIN HEMATOL, V38, P333, DOI 10.1053/shem.2001.27574; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, AM J PHYSIOL-RENAL, V292, pF475, DOI 10.1152/ajprenal.00275.2006; Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2008, AM J PHYSIOL-GASTR L, V294, pG1431, DOI 10.1152/ajpgi.00083.2008; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Hausenloy DJ, 2008, NEW ENGL J MED, V359, P518, DOI 10.1056/NEJMe0803746; He SQ, 2009, J CLIN INVEST, V119, P2304, DOI 10.1172/JCI38289; Hendel RC, 2005, J AM COLL CARDIOL, V46, P2069, DOI 10.1016/j.jacc.2005.05.097; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; KLAUSNER JM, 1989, JAMA-J AM MED ASSOC, V261, P1030, DOI 10.1001/jama.261.7.1030; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; OGAWA S, 1992, AM J PHYSIOL, V262, pC546, DOI 10.1152/ajpcell.1992.262.3.C546; OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Park SW, 2011, HEPATOLOGY, V53, P1662, DOI 10.1002/hep.24253; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; Satpute SR, 2009, J IMMUNOL, V183, P984, DOI 10.4049/jimmunol.0801928; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thakar CV, 2005, J CLIN INVEST, V115, P3451, DOI 10.1172/JCI25461; Thibault H, 2008, CIRCULATION, V117, P1037, DOI 10.1161/CIRCULATIONAHA.107.729780; Thompson CA, 2008, AM J HEALTH-SYST PH, V65, P890, DOI 10.2146/news080038; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319; Volpato GP, 2008, ANESTHESIOLOGY, V108, P659, DOI 10.1097/ALN.0b013e318167af0d; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Wood KC, 2007, NAT MED, V13, P673, DOI 10.1038/nm0607-673; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	142	2030	2157	34	703	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1391	1401		10.1038/nm.2507	http://dx.doi.org/10.1038/nm.2507			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064429	Green Accepted			2022-12-27	WOS:000296779300030
J	Selkoe, DJ				Selkoe, Dennis J.			Resolving controversies on the path to Alzheimer's therapeutics	NATURE MEDICINE			English	Article							APOLIPOPROTEIN-E GENOTYPE; TAU-HYPERPHOSPHORYLATION; SYNAPTIC PLASTICITY; AMYLOID HYPOTHESIS; DISEASE; IMMUNIZATION; DEPOSITION; MISSENSE; GENE; DEGENERATION	Alzheimer's disease constitutes a personal and societal tragedy of immense proportions. Since 1960, research in laboratories and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents. However, some of these agents have already failed. Gnawing controversies and important gaps in our knowledge seem to cast additional doubt on the ability of the field to move forward effectively. Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future. Rigorous preclinical validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their associated biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.							Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; REBECK GW, 1993, NEURON, V11, P575; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	38	398	414	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1060	1065		10.1038/nm.2460	http://dx.doi.org/10.1038/nm.2460			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900936				2022-12-27	WOS:000294605100025
J	Ambrose, PG				Ambrose, Paul G.			Antibiotic bill doesn't GAIN enough ground	NATURE MEDICINE			English	Editorial Material								With an eye to tackling the growing problem of antimicrobial drug resistance, US lawmakers last month proposed new incentives to jump-start the ailing antibiotic industry. but the legislation as written is not likely to have the intended consequences, as it fails to adequately shield companies from competition with generic drugs. To truly entice investment and research from the drug industry, the bill needs to simplify the path to regulatory approval, provide greater protection from generic competition and aid drug companies with intellectual property extensions, tax relief and guaranteed market commitments.	[Ambrose, Paul G.] Inst Clin Pharmacodynam, Latham, NY USA; [Ambrose, Paul G.] Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Ambrose, PG (corresponding author), Inst Clin Pharmacodynam, Latham, NY USA.								0	10	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					772	772		10.1038/nm0711-772	http://dx.doi.org/10.1038/nm0711-772			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738147				2022-12-27	WOS:000292500800018
J	Kashyap, DR; Wang, MH; Liu, LH; Boons, GJ; Gupta, D; Dziarski, R				Kashyap, Des Raj; Wang, Minhui; Liu, Li-Hui; Boons, Geert-Jan; Gupta, Dipika; Dziarski, Roman			Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems	NATURE MEDICINE			English	Article							L-ALANINE AMIDASE; BACILLUS-SUBTILIS; SECRETION STRESS; STAPHYLOCOCCUS-AUREUS; REGULATORY SYSTEM; ESCHERICHIA-COLI; CELL-SEPARATION; PEPTIDES; GROWTH; DEATH	Mammalian peptidoglycan recognition proteins (PGRPs), similar to antimicrobial lectins, bind the bacterial cell wall and kill bacteria through an unknown mechanism. We show that PGRPs enter the Gram-positive cell wall at the site of daughter cell separation during cell division. In Bacillus subtilis, PGRPs activate the CssR-CssS two-component system that detects and disposes of misfolded proteins that are usually exported out of bacterial cells. This activation results in membrane depolarization, cessation of intracellular peptidoglycan, protein, RNA and DNA synthesis, and production of hydroxyl radicals, which are responsible for bacterial death. PGRPs also bind the outer membrane of Escherichia coli and activate the functionally homologous CpxA-CpxR two-component system, which kills the bacteria. We exclude other potential bactericidal mechanisms, including inhibition of extracellular peptidoglycan synthesis, hydrolysis of peptidoglycan and membrane permeabilization. Thus, we reveal a previously unknown mechanism by which innate immunity proteins that bind the cell wall or outer membrane exploit the bacterial stress defense response to kill bacteria.	[Kashyap, Des Raj; Wang, Minhui; Liu, Li-Hui; Gupta, Dipika; Dziarski, Roman] Indiana Univ Sch Med NW, Gary, IN USA; [Boons, Geert-Jan] Univ Georgia, Athens, GA 30602 USA	Indiana University System; Indiana University Northwest; University System of Georgia; University of Georgia	Dziarski, R (corresponding author), Indiana Univ Sch Med NW, Gary, IN USA.	rdziar@iun.edu	Boons, Geert-Jan P H/J-3211-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Kashyap, Des/0000-0002-7151-2404	US Public Health Service from the US National Institutes of Health [AI073290, AI028797, GM061761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073290, R01AI028797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	US Public Health Service from the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J.M. van Dijl, O.P. Kuipers and V.P. Kontinen and their associates J. Zweers and S. Holsappel (University of Groningen and National Institute of Health and Welfare Finland), J. Sekiguchi (Shinshu University) and S.J. Foster (University of Sheffield) for providing B. subtilis mutants; to J.J. Collins and M.A. Kohanski (Boston University) for providing E. coli mutants; to J.M. van Dijl and his associates T. Kouwen and M. Sibbald (University of Groningen) for the pGDL48 plasmid and its sequence; to M. Wang for analyzing samples by mass spectrometry; and to Huvepharma for providing moenomycin. This work was supported by the US Public Health Service grants from the US National Institutes of Health AI073290 and AI028797 to R.D. and D.G. and GM061761 to G.-J.B.	Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Darmon E, 2002, J BACTERIOL, V184, P5661, DOI 10.1128/JB.184.20.5661-5671.2002; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; MEIJER WJJ, 1995, MOL MICROBIOL, V17, P621, DOI 10.1111/j.1365-2958.1995.mmi_17040621.x; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Westers H, 2006, FEBS J, V273, P3816, DOI 10.1111/j.1742-4658.2006.05389.x; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yamamoto H, 2003, J BACTERIOL, V185, P6666, DOI 10.1128/JB.185.22.6666-6677.2003	36	116	127	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					676	U64		10.1038/nm.2357	http://dx.doi.org/10.1038/nm.2357			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602801	Green Accepted			2022-12-27	WOS:000291308800027
J	[Anonymous]				[Anonymous]			Tracing the roots of squamous cell carcinomas	NATURE MEDICINE			English	Editorial Material							TUMORS; ORIGIN; SKIN											Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Epstein EH, 2011, J CLIN INVEST, V121, P1681, DOI 10.1172/JCI57700; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	9	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					668	668		10.1038/nm0611-668	http://dx.doi.org/10.1038/nm0611-668			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21647146				2022-12-27	WOS:000291308800022
J	Won, H; Mah, W; Kim, E; Kim, JW; Hahm, EK; Kim, MH; Cho, S; Kim, J; Jang, H; Cho, SC; Kim, BN; Shin, MS; Seo, J; Jeong, J; Choi, SY; Kim, D; Kang, C; Kim, E				Won, Hyejung; Mah, Won; Kim, Eunjin; Kim, Jae-Won; Hahm, Eun-Kyoung; Kim, Myoung-Hwan; Cho, Sukhee; Kim, Jeongjin; Jang, Hyeran; Cho, Soo-Churl; Kim, Boong-Nyun; Shin, Min-Sup; Seo, Jinsoo; Jeong, Jaeseung; Choi, Se-Young; Kim, Daesoo; Kang, Changwon; Kim, Eunjoon			GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice	NATURE MEDICINE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SPINE MORPHOGENESIS; MOUSE MODEL; SYNAPSE FORMATION; GENOMEWIDE SCAN; LINKAGE; INHIBITION; CHILDREN; FAMILY	Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder that affects similar to 5% of school-aged children; however, the mechanisms underlying ADHD remain largely unclear. Here we report a previously unidentified association between G protein-coupled receptor kinase-interacting protein-1 (GIT1) and ADHD in humans. An intronic single-nucleotide polymorphism in GIT1, the minor allele of which causes reduced GIT1 expression, shows a strong association with ADHD susceptibility in humans. Git1-deficient mice show ADHD-like phenotypes, with traits including hyperactivity, enhanced electroencephalogram theta rhythms and impaired learning and memory. Hyperactivity in Git1(-/-) mice is reversed by amphetamine and methylphenidate, psychostimulants commonly used to treat ADHD. In addition, amphetamine normalizes enhanced theta rhythms and impaired memory. GIT1 deficiency in mice leads to decreases in ras-related C3 botulinum toxin substrate-1 (RAC1) signaling and inhibitory presynaptic input; furthermore, it shifts the neuronal excitation-inhibition balance in postsynaptic neurons toward excitation. Our study identifies a previously unknown involvement of GIT1 in human ADHD and shows that GIT1 deficiency in mice causes psychostimulant-responsive ADHD-like phenotypes.	[Won, Hyejung; Mah, Won; Kim, Eunjin; Hahm, Eun-Kyoung; Kim, Myoung-Hwan; Kim, Jeongjin; Kim, Daesoo; Kang, Changwon; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Won, Hyejung; Mah, Won; Hahm, Eun-Kyoung; Kim, Myoung-Hwan; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; [Kim, Jae-Won; Cho, Soo-Churl; Kim, Boong-Nyun; Shin, Min-Sup] Seoul Natl Univ Hosp, Coll Med, Dept Child & Adolescent Psychiat, Seoul 110744, South Korea; [Cho, Sukhee; Seo, Jinsoo; Choi, Se-Young] Seoul Natl Univ, Sch Dent, Dept Physiol, Seoul, South Korea; [Jang, Hyeran; Jeong, Jaeseung] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, World Class Univ, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	ckang@kaist.ac.kr; kime@kaist.ac.kr	Kim, Boong Nyun/J-5397-2012; Cho, Soo Churl/J-5667-2012; Seo, Jinsoo/AAD-4950-2019; Kim, Daesoo/C-1625-2011; Kim, Jae Won/J-5430-2012; Jeong, Jaeseung/C-1620-2011; Kim, Myoung-Hwan/J-2444-2012; Kang, Changwon/C-1938-2011; Shin, Min Sup/J-5521-2012; Kim, Eunjoon/C-1566-2011	Seo, Jinsoo/0000-0001-6432-6964; Kim, Daesoo/0000-0001-9915-1463; Kang, Changwon/0000-0002-0867-6385; Kim, Eunjin/0000-0002-2309-4420; Choi, Se-Young/0000-0001-7534-5167	Ministry of Education, Science, and Technology [R31-2008-000-10071-0]; National Research Foundation of Korea [2010-0014162, 313-2007-2-C00630, 2010-0002283, 20100000032]; Seoul National University Hospital [09-2008-001-0]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Hospital	We thank the Vector Integration Site Analysis service at the University of California-Davis Mouse Biology Program for providing the data on the single-copy status of the Git1 gene trap. This work was supported by the Korean National Creative Research Initiative program and WCU (World Class University) program (R31-2008-000-10071-0) funded by the Ministry of Education, Science, and Technology (to Eunjoon K.), the National Research Foundation of Korea 2010-0014162 to C. K. and 313-2007-2-C00630 to S.-Y.C.), the Basic Science Program through the National Research Foundation of Korea (2010-0002283 to J.K.), the Mid-career Researcher Program through the National Research Foundation of Korea (20100000032 to D. K.), the Seoul National University Hospital Research Fund (09-2008-001-0 to J.K.) and by a T.J. Park Doctoral Fellowship (to H. W.).	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; BARKLEY RA, 1977, J CHILD PSYCHOL PSYC, V18, P137, DOI 10.1111/j.1469-7610.1977.tb00425.x; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, HDB DIAGNOSIS TREATM; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Boda B, 2006, MOL NEUROBIOL, V34, P67, DOI 10.1385/MN:34:1:67; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Clarke AR, 2002, PSYCHOPHARMACOLOGY, V164, P277, DOI 10.1007/s00213-002-1205-0; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Deutsch SI, 2001, CLIN NEUROPHARMACOL, V24, P43, DOI 10.1097/00002826-200101000-00008; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gilden DL, 2007, PSYCHOL SCI, V18, P796, DOI 10.1111/j.1467-9280.2007.01982.x; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Kim YS, 2004, YONSEI MED J, V45, P81, DOI 10.3349/ymj.2004.45.1.81; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Ko J, 2003, J NEUROSCI, V23, P1667; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Moll GH, 2000, NEUROSCI LETT, V284, P121, DOI 10.1016/S0304-3940(00)00980-0; Moll GH, 2003, ACTA PSYCHIAT SCAND, V107, P69, DOI 10.1034/j.1600-0447.2003.02114.x; Ogdie MN, 2004, AM J HUM GENET, V75, P661, DOI 10.1086/424387; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Pouget P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005208; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Richter MM, 2007, NEUROSCI LETT, V419, P137, DOI 10.1016/j.neulet.2007.04.024; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Rosa-Neto P, 2005, NEUROIMAGE, V25, P868, DOI 10.1016/j.neuroimage.2004.11.031; Russell VA, 2007, J NEUROSCI METH, V166, pI, DOI 10.1016/j.jneumeth.2006.12.020; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shilyansky C, 2010, P NATL ACAD SCI USA, V107, P13141, DOI 10.1073/pnas.1004829107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	60	93	96	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					566	+		10.1038/nm.2330	http://dx.doi.org/10.1038/nm.2330			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499268				2022-12-27	WOS:000290250400032
J	Harari, A; Rozot, V; Enders, FB; Perreau, M; Stalder, JM; Nicod, LP; Cavassini, M; Calandra, T; Blanchet, CL; Jaton, K; Faouzi, M; Day, CL; Hanekom, WA; Bart, PA; Pantaleo, G				Harari, Alexandre; Rozot, Virginie; Enders, Felicitas Bellutti; Perreau, Matthieu; Stalder, Jesica Mazza; Nicod, Laurent P.; Cavassini, Matthias; Calandra, Thierry; Blanchet, Catherine Lazor; Jaton, Katia; Faouzi, Mohamed; Day, Cheryl L.; Hanekom, Willem A.; Bart, Pierre-Alexandre; Pantaleo, Giuseppe			Dominant TNF-alpha(+) Mycobacterium tuberculosis-specific CD4(+) T cell responses discriminate between latent infection and active disease	NATURE MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; FUNCTIONAL SIGNATURES; RHEUMATOID-ARTHRITIS; IMMUNOLOGY; DIAGNOSIS; IMMUNITY; ASSAY	Rapid diagnosis of active Mycobacterium tuberculosis (Mtb) infection remains a clinical and laboratory challenge. We have analyzed the cytokine profile (interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2)) of Mtb-specific T cells by polychromatic flow cytometry. We studied Mtb-specific CD4(+) T cell responses in subjects with latent Mtb infection and active tuberculosis disease. The results showed substantial increase in the proportion of single-positive TNF-alpha Mtb-specific CD4(+) T cells in subjects with active disease, and this parameter was the strongest predictor of diagnosis of active disease versus latent infection. We validated the use of this parameter in a cohort of 101 subjects with tuberculosis diagnosis unknown to the investigator. The sensitivity and specificity of the flow cytometry-based assay were 67% and 92%, respectively, the positive predictive value was 80% and the negative predictive value was 92.4%. Therefore, the proportion of single-positive TNF-alpha Mtb-specific CD4(+) T cells is a new tool for the rapid diagnosis of active tuberculosis disease.	[Harari, Alexandre; Rozot, Virginie; Enders, Felicitas Bellutti; Perreau, Matthieu; Bart, Pierre-Alexandre; Pantaleo, Giuseppe] Univ Lausanne, Div Immunol & Allergy, CHU Vaudois, Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] Swiss Vaccine Res Inst, Lausanne, Switzerland; [Stalder, Jesica Mazza; Nicod, Laurent P.] Univ Lausanne, Div Pneumol, CHU Vaudois, Lausanne, Switzerland; [Cavassini, Matthias; Calandra, Thierry] Univ Lausanne, Div Infect Dis, CHU Vaudois, Lausanne, Switzerland; [Blanchet, Catherine Lazor] Univ Lausanne, Div Occupat Med, CHU Vaudois, Lausanne, Switzerland; [Jaton, Katia] Univ Lausanne, Inst Microbiol, CHU Vaudois, Lausanne, Switzerland; [Faouzi, Mohamed] Univ Lausanne, Ctr Clin Epidemiol, CHU Vaudois, Lausanne, Switzerland; [Day, Cheryl L.; Hanekom, Willem A.] Univ Cape Town, S African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Cape Town	Pantaleo, G (corresponding author), Univ Lausanne, Div Immunol & Allergy, CHU Vaudois, Lausanne, Switzerland.	giuseppe.pantaleo@chuv.ch	Rozot, Virginie/AAR-7789-2020; Nicod, Laurent/ABD-3360-2020; Calandra, Thierry/D-9017-2015; Pantaleo, Giuseppe/K-6163-2016; Jaton, Katia/A-2828-2016; Day, Cheryl L/J-9844-2012; Perreau, Matthieu/D-6309-2017; Day, Cheryl/GQQ-9720-2022; Enders, Felicitas Bellutti/AAB-8916-2020; cavassini, matthias/F-8987-2017	Rozot, Virginie/0000-0001-9757-1501; Calandra, Thierry/0000-0003-3051-1285; Day, Cheryl L/0000-0002-6497-4846; Hanekom, Willem/0000-0003-3070-6154; MAZZA-STALDER, JESICA/0000-0002-5693-7156; cavassini, matthias/0000-0003-0933-7833; Jaton, Katia/0000-0001-8944-7295; Nicod, Laurent P/0000-0002-0905-916X; Harari, Alexandre/0000-0002-1055-2090	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was partially conducted as part of the Vaccine Immune Monitoring Consortium under the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation. Furthermore, we thank N. Rettby, D. Bonnet and K. Ellefsen Lavoie for logistic coordination. We also thank many additional members of the South African Tuberculosis Vaccine Initiative team who helped with enrollment and evaluation of participants and, finally, the participants themselves.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Griner P F, 1981, Ann Intern Med, V94, P557; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; ZWEIG MH, 1993, CLIN CHEM, V39, P561	22	295	314	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					372	U174		10.1038/nm.2299	http://dx.doi.org/10.1038/nm.2299			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21336285	Green Accepted			2022-12-27	WOS:000288070000049
J	Song, WJ; Chen, J; Petrilli, A; Liot, G; Klinglmayr, E; Zhou, Y; Poquiz, P; Tjong, J; Pouladi, MA; Hayden, MR; Masliah, E; Ellisman, M; Rouiller, I; Schwarzenbacher, R; Bossy, B; Perkins, G; Bossy-Wetzel, E				Song, Wenjun; Chen, Jin; Petrilli, Alejandra; Liot, Geraldine; Klinglmayr, Eva; Zhou, Yue; Poquiz, Patrick; Tjong, Jonathan; Pouladi, Mahmoud A.; Hayden, Michael R.; Masliah, Eliezer; Ellisman, Mark; Rouiller, Isabelle; Schwarzenbacher, Robert; Bossy, Blaise; Perkins, Guy; Bossy-Wetzel, Ella			Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity	NATURE MEDICINE			English	Article							S-NITROSYLATION; NITRIC-OXIDE; MOUSE MODEL; CELL-DEATH; SUSCEPTIBILITY; FRAGMENTATION; DISEASE; FUSION; DRP1; DYSFUNCTION	Huntington's disease is an inherited and incurable neurodegenerative disorder caused by an abnormal polyglutamine (polyQ) expansion in huntingtin (encoded by HTT). PolyQ length determines disease onset and severity, with a longer expansion causing earlier onset. The mechanisms of mutant huntingtin-mediated neurotoxicity remain unclear; however, mitochondrial dysfunction is a key event in Huntington's disease pathogenesis(1,2). Here we tested whether mutant huntingtin impairs the mitochondrial fission-fusion balance and thereby causes neuronal injury. We show that mutant huntingtin triggers mitochondrial fragmentation in rat neurons and fibroblasts of individuals with Huntington's disease in vitro and in a mouse model of Huntington's disease in vivo before the presence of neurological deficits and huntingtin aggregates. Mutant huntingtin abnormally interacts with the mitochondrial fission GTPase dynamin-related protein-1 (DRP1) in mice and humans with Huntington's disease, which, in turn, stimulates its enzymatic activity. Mutant huntingtin-mediated mitochondrial fragmentation, defects in anterograde and retrograde mitochondrial transport and neuronal cell death are all rescued by reducing DRP1 GTPase activity with the dominant-negative DRP1 K38A mutant. Thus, DRP1 might represent a new therapeutic target to combat neurodegeneration in Huntington's disease.	[Song, Wenjun; Chen, Jin; Petrilli, Alejandra; Liot, Geraldine; Zhou, Yue; Bossy, Blaise; Bossy-Wetzel, Ella] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Klinglmayr, Eva; Schwarzenbacher, Robert] Salzburg Univ, Struct Biol Grp, Dept Mol Biol, A-5020 Salzburg, Austria; [Poquiz, Patrick; Tjong, Jonathan; Ellisman, Mark; Perkins, Guy] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA; [Pouladi, Mahmoud A.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Masliah, Eliezer] Univ Calif San Diego, La Jolla, CA 92093 USA; [Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	State University System of Florida; University of Central Florida; Salzburg University; University of California System; University of California San Diego; University of British Columbia; University of California System; University of California San Diego; McGill University	Bossy-Wetzel, E (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	ebossywe@mail.ucf.edu	Klinglmayr, Eva/L-2967-2015; Hayden, Michael R/D-8581-2011; Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012; Chen, Jin/M-1837-2019; Pouladi, Mahmoud A/B-8743-2016; Song, Wenjun/HGB-4891-2022	Hayden, Michael R/0000-0001-5159-1419; rouiller, isabelle/0000-0002-1288-8575; Chen, Jin/0000-0001-7617-1664; Pouladi, Mahmoud A/0000-0002-9030-0976; Liot, Geraldine/0000-0002-4784-7693; Song, Wenjun/0000-0002-6355-2983; Perkins, Guy/0000-0002-1834-6646	NIH [R01EY016164, R01NS055193, P41RR004050]; Hereditary Disease Foundation; Canadian Institutes of Health Research; CHDI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055193, R01NS047456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CHDI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Finkbeiner (University of California-San Francisco) for the pGW1 plasmids encoding huntingtin<SUP>ex1</SUP>-Q<INF>17</INF>-GFP, huntingtine<SUP>x1-</SUP>Q<INF>46</INF>-GFP, huntingtin<SUP>ex1</SUP>-Q<INF>97-</INF>GFP; L. Thompson (University of California-Irvine) for the huntingtin plasmids pcDNA3.1-Q25-GFP and pcDNA3.1-Q97-GFP; U. Hartl (Max Planck Institute of Biochemistry) for the GST-huntingtin<SUP>ex1</SUP>-Q<INF>20</INF> and -Q<INF>53</INF> constructs; A. van der Bliek (University of California-Los Angeles) for the DRP1 K38A cDNA in baculovirus expression vector (US National Center for Biotechnology Information accession number NM_005690.3); R. Youle (US National Institutes of Health (NIH)) for the YFP-DRP1 plasmid; R. Slack (University of Ottawa) for the MFN2 RasG12V (p82-FzoRV12pECFP-C1) expression plasmid; S. Strack (University of Iowa) for his pcDNA3.1 beta-DRP1shRNA vector; S. Lubitz, J. Johnson, V. DeAssis, C. Eldon and B. Kincaid for technical assistance; and A. Knott for manuscript development and editing. This work is supported by NIH grants to E.B.-W. (R01EY016164 and R01NS055193), a fellowship from the Hereditary Disease Foundation (to G. L.), grants to I. R., M. A. P. and M. R. H. from the Canadian Institutes of Health Research, and support from CHDI to M. R. H. The electron microscope tomography work was carried out in facilities of the US National Center for Microscopy and Imaging Research, supported by NIH grant P41RR004050 awarded to M. E.	Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Graham RK, 2009, J NEUROSCI, V29, P2193, DOI 10.1523/JNEUROSCI.5473-08.2009; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perkins GA, 2001, EUR J CELL BIOL, V80, P139, DOI 10.1078/0171-9335-00149; Perkins GA, 2008, J STRUCT BIOL, V161, P469, DOI 10.1016/j.jsb.2007.10.005; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046	33	373	379	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					377	U181		10.1038/nm.2313	http://dx.doi.org/10.1038/nm.2313			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21336284	Green Accepted, Green Submitted			2022-12-27	WOS:000288070000050
J	Greten, FR; Karin, M				Greten, Florian R.; Karin, Michael			JAKi rips STAT3 in cancer	NATURE MEDICINE			English	Editorial Material							NF-KAPPA-B; INFLAMMATION; IMMUNITY; TUMORIGENESIS; PROGRESSION		[Greten, Florian R.] Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, Munich, Germany; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Technical University of Munich; University of California System; University of California San Diego	Greten, FR (corresponding author), Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, Munich, Germany.	florian.greten@lrz.tum.de; karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080				Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; O'Shea JJ, 2005, CURR OPIN RHEUMATOL, V17, P305, DOI 10.1097/01.bor.0000160781.07174.db; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	13	11	11	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1085	1087		10.1038/nm1010-1085	http://dx.doi.org/10.1038/nm1010-1085			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930749				2022-12-27	WOS:000282644800035
J	Weber, C				Weber, Christian			Far from the Heart: Receptor cross-talk in remote conditioning	NATURE MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; INJURY; TRIAL; KAPPA; DELTA; CCR5; MU		[Weber, Christian] Univ Aachen, Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, D-5100 Aachen, Germany; [Weber, Christian] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	RWTH Aachen University; Maastricht University	Weber, C (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, D-5100 Aachen, Germany.	cweber@ukaachen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714				Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Liehn EA, 2008, J CELL MOL MED, V12, P496, DOI 10.1111/j.1582-4934.2007.00194.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Peart JN, 2004, BASIC RES CARDIOL, V99, P29, DOI 10.1007/s00395-003-0430-y; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Rentoukas I, 2010, JACC-CARDIOVASC INTE, V3, P49, DOI 10.1016/j.jcin.2009.10.015; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Suzuki S, 2002, EXP CELL RES, V280, P192, DOI 10.1006/excr.2002.5638; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Weinbrenner C, 2004, CARDIOVASC RES, V61, P591, DOI 10.1016/j.cardiores.2003.10.008	16	30	32	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					760	762		10.1038/nm0710-760	http://dx.doi.org/10.1038/nm0710-760			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613755				2022-12-27	WOS:000279631900024
J	Hill, DA; Siracusa, MC; Abt, MC; Kim, BS; Kobuley, D; Kubo, M; Kambayashi, T; LaRosa, DF; Renner, ED; Orange, JS; Bushman, FD; Artis, D				Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Kubo, Masato; Kambayashi, Taku; LaRosa, David F.; Renner, Ellen D.; Orange, Jordan S.; Bushman, Frederic D.; Artis, David			Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation	NATURE MEDICINE			English	Article							FUNGAL MICROBIOTA; IGE PRODUCTION; MAST-CELLS; IN-VIVO; ASTHMA; IL-4; SUSCEPTIBILITY; ACTIVATION; ANTIGEN; ANTIBIOTICS	Commensal bacteria that colonize mammalian barrier surfaces are reported to influence T helper type 2 (T(H)2) cytokine-dependent inflammation and susceptibility to allergic disease, although the mechanisms that underlie these observations are poorly understood. In this report, we find that deliberate alteration of commensal bacterial populations via oral antibiotic treatment resulted in elevated serum IgE concentrations, increased steady-state circulating basophil populations and exaggerated basophil-mediated T(H)2 cell responses and allergic inflammation. Elevated serum IgE levels correlated with increased circulating basophil populations in mice and subjects with hyperimmunoglobulinemia E syndrome. Furthermore, B cell-intrinsic expression of myeloid differentiation factor 88 (MyD88) was required to limit serum IgE concentrations and circulating basophil populations in mice. Commensal-derived signals were found to influence basophil development by limiting proliferation of bone marrow-resident precursor populations. Collectively, these results identify a previously unrecognized pathway through which commensal-derived signals influence basophil hematopoiesis and susceptibility to T(H)2 cytokine-dependent inflammation and allergic disease.	[Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Bushman, Frederic D.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba, Japan; [Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [LaRosa, David F.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Renner, Ellen D.] Univ Munich, Dr von Haunersches Kinderspital, Univ Childrens Hosp, D-80337 Munich, Germany; [Orange, Jordan S.] Childrens Hosp Philadelphia, Dept Pediat, Div Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; RIKEN; Tokyo University of Science; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Artis, D (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Kim, Brian/GZK-6649-2022; Renner, Ellen/R-7168-2016; Kubo, Masato/A-5918-2016	Kim, Brian/0000-0002-8100-7161; Renner, Ellen/0000-0001-9816-8538; Artis, David/0000-0002-1753-4100; Bushman, Frederic/0000-0003-4740-4056; Abt, Michael/0000-0002-7351-2061; Hill, David/0000-0001-9286-4268; orange, jordan/0000-0001-7117-7725	National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core [DK50306]; Abramson Cancer Center Flow Cytometry; Cell Sorting Resource Laboratory; US National Cancer Institute Comprehensive Cancer Center Support [2-P30 CA016520]; US National Institutes of Health [AI061570, AI087990, AI074878, AI095608, AI083480, AI095466, T32-AI060516, F32-AI085828, T32-AI05528]; Burroughs Wellcome Fund; Penn Genome Frontiers Institute; University of Pennsylvania Veterinary Center of Infectious Diseases;  [HL107589];  [HL111501];  [AI067946];  [UH2DK083981]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107589, R01HL111501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R21AI083480, T32AI060516, R56AI067946, F32AI085828, R01AI095466, U01AI095608, R01AI067946, R01AI074878, R21AI087990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981, P30DK050306] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22021041] Funding Source: KAKEN	National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core; Abramson Cancer Center Flow Cytometry; Cell Sorting Resource Laboratory; US National Cancer Institute Comprehensive Cancer Center Support; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Penn Genome Frontiers Institute; University of Pennsylvania Veterinary Center of Infectious Diseases; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Artis lab for helpful discussions; M. R. Comeau (Tslp<SUP>-/-</SUP> mice, Amgen), H. Oettgen (Igh-7<SUP>-/-</SUP> mice, Harvard University) and J. Weiser (Nod1<SUP>-/-</SUP> mice, University of Pennsylvania) for providing access to mice; L. Shawver, R. Sinha and R. Custers-Allen for assistance with data; J. Sawalle-Belohradsky and B. Hagl for performing DOCK8 sequencing; A. Jansson, G. Notheis, B.H. Belohradsky, M. Albert and the referring physicians for patient care; the Matthew J. Ryan Veterinary Hospital Pathology Lab; the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core (DK50306); the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory (supported by US National Cancer Institute Comprehensive Cancer Center Support grant (2-P30 CA016520) for technical advice and support; and the University of Pennsylvania Gnotobiotic Mouse Facility for germ-free mice. Research in the Artis lab is supported by the US National Institutes of Health (AI061570, AI087990, AI074878, AI095608, AI083480 and AI095466 to D.A.; T32-AI060516 to D.A.H.; F32-AI085828 to M.C.S.; T32-AI05528 to M.C.A.) the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D.A.), the Penn Genome Frontiers Institute (D.A. and F.D.B.), and pilot grants from the University of Pennsylvania Veterinary Center of Infectious Diseases (D.A.). Additional National Institutes of Health support provided by HL107589 and HL111501 to T.K., AI067946 to J.S.O. and UH2DK083981 to F.D.B.	Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Fink LN, 2012, AM J PHYSIOL-GASTR L, V302, pG55, DOI 10.1152/ajpgi.00428.2010; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gilliland FD, 2009, PEDIATRICS, V123, pS168, DOI 10.1542/peds.2008-2233G; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Holgate S, 2009, RESP MED, V103, P1098, DOI 10.1016/j.rmed.2009.03.008; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; Layland LE, 2005, EUR J IMMUNOL, V35, P3248, DOI 10.1002/eji.200526273; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Pace E, 2011, J ASTHMA, V48, P387, DOI 10.3109/02770903.2011.561512; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Redhu NS, 2011, J ALLERGY CLIN IMMUN, V128, P892, DOI 10.1016/j.jaci.2011.06.045; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Siracusa MC, 2010, IMMUNOL CELL BIOL, V88, P275, DOI 10.1038/icb.2010.1; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sudo N, 1997, J IMMUNOL, V159, P1739; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xiang Z, 2006, ALLERGY, V61, P1040, DOI 10.1111/j.1398-9995.2006.01024.x; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zeiger RS, 2003, PEDIATRICS, V111, P1662; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	56	312	327	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					538	546		10.1038/nm.2657	http://dx.doi.org/10.1038/nm.2657			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22447074	Green Accepted			2022-12-27	WOS:000302617800030
J	Sugimoto, H; LeBleu, VS; Bosukonda, D; Keck, P; Taduri, G; Bechtel, W; Okada, H; William, C; Bey, P; Rusckowski, M; Tampe, B; Tampe, D; Kanasaki, K; Zeisberg, M; Kalluri, R				Sugimoto, Hikaru; LeBleu, Valerie S.; Bosukonda, Dattatreyamurty; Keck, Peter; Taduri, Gangadhar; Bechtel, Wibke; Okada, Hirokazu; Carlson, William, Jr.; Bey, Philippe; Rusckowski, Mary; Tampe, Bjoern; Tampe, Desiree; Kanasaki, Keizo; Zeisberg, Michael; Kalluri, Raghu			Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis	NATURE MEDICINE			English	Article							BONE MORPHOGENETIC PROTEIN-7; TO-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; CRYSTAL-STRUCTURE; RENAL FIBROSIS; EXPRESSION; PROGRESSION; BMP-7; FIBROBLASTS; RECEPTORS	Molecules associated with the transforming growth factor beta (TGF-beta) superfamily, such as bone morphogenic proteins (BMPs) and TGF-beta, are key regulators of inflammation, apoptosis and cellular transitions. Here we show that the BMP receptor activin-like kinase 3 (Alk3) is elevated early in diseased kidneys after injury. We also found that its deletion in the tubular epithelium leads to enhanced TGF-beta 1-Smad family member 3 (Smad3) signaling, epithelial damage and fibrosis, suggesting a protective role for Alk3-mediated signaling in the kidney. A structure-function analysis of the BMP-Alk3-BMP receptor, type 2 (BMPR2) ligand-receptor complex, along with synthetic organic chemistry, led us to construct a library of small peptide agonists of BMP signaling that function through the Alk3 receptor. One such peptide agonist, THR-123, suppressed inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reversed established fibrosis in five mouse models of acute and chronic renal injury. THR-123 acts specifically through Alk3 signaling, as mice with a targeted deletion for Alk3 in their tubular epithelium did not respond to therapy with THR-123. Combining THR-123 and the angiotensin-converting enzyme inhibitor captopril had an additive therapeutic benefit in controlling renal fibrosis. Our studies show that BMP signaling agonists constitute a new line of therapeutic agents with potential utility in the clinic to induce regeneration, repair and reverse established fibrosis.	[Sugimoto, Hikaru; LeBleu, Valerie S.; Taduri, Gangadhar; Bechtel, Wibke; Okada, Hirokazu; Kanasaki, Keizo; Zeisberg, Michael; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Bosukonda, Dattatreyamurty; Keck, Peter; Carlson, William, Jr.] Thrasos Innovat Inc, Montreal, PQ, Canada; [Carlson, William, Jr.; Bey, Philippe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA; [Rusckowski, Mary] Univ Massachusetts, Div Nucl Med, Dept Radiol, Coll Med, Worcester, MA 01605 USA; [Tampe, Bjoern; Tampe, Desiree; Zeisberg, Michael; Kalluri, Raghu] Univ Gottingen, Goettingen Univ Med Ctr, Dept Nephrol & Rheumatol, D-3400 Gottingen, Germany; [Kalluri, Raghu] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Gottingen; Harvard University; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Tampe, Björn/ABA-6091-2021; LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Tampe, Björn/0000-0002-4357-9863; Tampe, Desiree/0000-0002-8724-4803; Bechtel-Walz, Wibke/0000-0001-6032-3627; Kalluri, Raghu/0000-0002-2190-547X	US National Institutes of Health [DK55001, DK061688, DK081576, DK074558, CA155370 CA163191, CA125550, CA151925]; Else Kroner-Memorial-Stipend [P58/05//EKMS 05/59]; Research Training Grant in Gastroenterology [2T32DK007760-11]; Research Training Grant in Cardiovascular Biology [5T32HL007374-30]; NATIONAL CANCER INSTITUTE [U01CA151925, R01CA155370, U54CA163191, R01CA125550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061688, R01DK081576, K08DK074558, T32DK007760] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Else Kroner-Memorial-Stipend; Research Training Grant in Gastroenterology; Research Training Grant in Cardiovascular Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by US National Institutes of Health grants DK55001, DK061688, DK081576, DK074558, CA155370 CA163191, CA125550, CA151925 and the Else Kroner-Memorial-Stipend P58/05//EKMS 05/59 (M.Z.). V. S. L. is funded from the Research Training Grant in Gastroenterology (2T32DK007760-11). H. S. is funded by the Research Training Grant in Cardiovascular Biology (5T32HL007374-30). Mice with the Alk3<SUP>flox/flox</SUP> allele (Alk3<SUP>f/f</SUP>) were kindly provided by Y. Mishina, US National Institutes of Health under a material transfer agreement. gamma GT-Cre mice, NP-1 cells and the polyclonal antibody to FSP1 were provided by E. Neilson, Vanderbilt University Medical Center. We thank S. McGoohan for his technical assistance.	Archdeacon P, 2008, ADV CHRONIC KIDNEY D, V15, P314, DOI 10.1053/j.ackd.2008.04.011; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bosukonda D, 2000, KIDNEY INT, V58, P1902, DOI 10.1046/j.1523-1755.2000.00362.x; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Haaijman A, 2000, GROWTH FACTORS, V17, P177, DOI 10.3109/08977190009001067; Hojo H, 2010, J BONE MINER METAB, V28, P489, DOI 10.1007/s00774-010-0199-7; Ide H, 1997, CANCER RES, V57, P5022; ISHIDOU Y, 1995, J BONE MINER RES, V10, P1651; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kashtan CE, 1999, MEDICINE, V78, P338, DOI 10.1097/00005792-199909000-00005; Keck P.C., 2002, United States Patent Office, Patent No. [WO/2002/037313, 2002037313]; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; MACKENSENHAEN S, 1981, CLIN NEPHROL, V15, P167; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; PARVING HH, 1989, BMJ-BRIT MED J, V299, P533, DOI 10.1136/bmj.299.6698.533; RISDON RA, 1968, LANCET, V2, P363; Rodriguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Simic P, 2007, EMBO REP, V8, P327, DOI 10.1038/sj.embor.7400943; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Striker G E, 1970, Hum Pathol, V1, P615, DOI 10.1016/S0046-8177(70)80060-0; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Tuglular S, 2004, TRANSPL P, V36, P131, DOI 10.1016/j.transproceed.2003.11.018; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Wang SN, 2001, J AM SOC NEPHROL, V12, P2392, DOI 10.1681/ASN.V12112392; Wetzel P, 2006, KIDNEY INT, V70, P717, DOI 10.1038/sj.ki.5001653; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	40	168	180	0	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					396	U264		10.1038/nm.2629	http://dx.doi.org/10.1038/nm.2629			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22306733	Green Submitted, Green Accepted			2022-12-27	WOS:000301264800041
J	Ebrahimkhani, MR; Oakley, F; Murphy, LB; Mann, J; Moles, A; Perugorria, MJ; Ellis, E; Lakey, AF; Burt, AD; Douglass, A; Wright, MC; White, SA; Jaffre, F; Maroteaux, L; Mann, DA				Ebrahimkhani, Mohammad R.; Oakley, Fiona; Murphy, Lindsay B.; Mann, Jelena; Moles, Anna; Perugorria, Maria J.; Ellis, Elizabeth; Lakey, Anne F.; Burt, Alastair D.; Douglass, Angela; Wright, Matthew C.; White, Steven A.; Jaffre, Fabrice; Maroteaux, Luc; Mann, Derek A.			Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease	NATURE MEDICINE			English	Article							HEPATIC STELLATE CELLS; BILE-DUCT LIGATION; FIBROSIS; RAT; GROWTH; INJURY; JUND; PROLIFERATION; TRANSCRIPTION; ANTAGONIST	Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood(1). Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT2B) on HSCs by serotonin, which activates expression of transforming growth factor beta 1 (TGF-beta 1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT2B is clinically safe in humans and may be therapeutic in chronic liver disease.	[Ebrahimkhani, Mohammad R.; Oakley, Fiona; Murphy, Lindsay B.; Mann, Jelena; Moles, Anna; Perugorria, Maria J.; Ellis, Elizabeth; Lakey, Anne F.; Burt, Alastair D.; Douglass, Angela; Wright, Matthew C.; White, Steven A.; Mann, Derek A.] Newcastle Univ, Fibrosis Lab, Liver Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ebrahimkhani, Mohammad R.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Dept Biol, Cambridge, MA 02139 USA; [Jaffre, Fabrice; Maroteaux, Luc] INSERM, Unite Mixte Rech S 839, Paris, France; [Jaffre, Fabrice; Maroteaux, Luc] Univ Paris 06, Paris, France; [Jaffre, Fabrice; Maroteaux, Luc] Inst Fer Moulin, Paris, France	Newcastle University - UK; Massachusetts Institute of Technology (MIT); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Mann, DA (corresponding author), Newcastle Univ, Fibrosis Lab, Liver Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	derek.mann@ncl.ac.uk	Burt, Alastair D/D-3634-2013; Maroteaux, Luc/H-4585-2019; Moles, Ana/A-5889-2017; Mann, Derek/E-4765-2011	Burt, Alastair D/0000-0002-3011-7774; Maroteaux, Luc/0000-0002-9499-8603; Moles, Ana/0000-0002-3915-0060; Ebrahimkhani, Mo R./0000-0001-5753-6779; Oakley, Fiona/0000-0001-8692-1836; Mann, Derek/0000-0003-0950-243X; Jaffre, Fabrice/0000-0002-4858-1954; Wright, Matthew/0000-0003-3167-6743	UK Medical Research Council [G0700890, G0900535]; Wellcome Trust [WT084961MA, WT086755MA]; European Commission (EC) [223151]; European Association for Study of the Liver (EASL); Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; French ministry of research (Agence Nationale pour la Recherche); European Commission (DEVANX); MRC [G0700890, G0900535] Funding Source: UKRI; Medical Research Council [G0700890, G0900535] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); European Association for Study of the Liver (EASL); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French ministry of research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Commission (DEVANX)(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the UK Medical Research Council (grant G0700890 to D.A.M., M.C.W. and F.O. and G0900535 to F.O.), the Wellcome Trust (grant WT084961MA to F.O., D. A. M. and M.C.W. and WT086755MA to M.C.W., A.D.B. and D.A.M.). Work in D.A.M.'s lab is also funded by a European Commission FP7 program grant 'INFLA-CARE' (EC Contract No. 223151; http://inflacare.imbb.forth.gr/). M.R.E. was supported by a European Association for Study of the Liver (EASL) Sheila Sherlock fellowship. L.M.'s work was supported by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, the French ministry of research (Agence Nationale pour la Recherche) and the European Commission (DEVANX).	ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Douglass A, 2008, J HEPATOL, V49, P88, DOI 10.1016/j.jhep.2008.01.032; Elrick LJ, 2005, J HEPATOL, V42, P888, DOI 10.1016/j.jhep.2005.01.028; FAUSTO N, 1991, DIGEST DIS SCI, V36, P653, DOI 10.1007/BF01297034; FORBES IT, 1995, J MED CHEM, V38, P855, DOI 10.1021/jm00006a001; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gieling RG, 2010, HEPATOLOGY, V51, P922, DOI 10.1002/hep.23385; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Higgins GM, 1931, ARCH PATHOL, V12, P186; Kalinichenko VV, 2003, HEPATOLOGY, V37, P107, DOI 10.1053/jhep.2003.50005; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Malik R, 2002, SEMIN CELL DEV BIOL, V13, P425, DOI 10.1016/S1084952102001301; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2011, AM J PHYSIOL-GASTR L, V300, pG303, DOI 10.1152/ajpgi.00368.2010; Palmer MJ, 2009, EXPERT OPIN THER PAT, V19, P575, DOI 10.1517/13543770902877725; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Pillebout E, 2003, J CLIN INVEST, V112, P843, DOI 10.1172/JCI200317647; POLIMENO L, 1995, HEPATOLOGY, V21, P1070, DOI 10.1016/0270-9139(95)90257-0; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; SCOBIE BA, 1965, AM J DIG DIS, V10, P135, DOI 10.1007/BF02236664; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; Varty GB, 1995, EUR J PHARMACOL, V287, P201, DOI 10.1016/0014-2999(95)00660-5; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	31	139	155	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1668	U189		10.1038/nm.2490	http://dx.doi.org/10.1038/nm.2490			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22120177	Green Submitted, Green Accepted			2022-12-27	WOS:000297978000041
J	Ellingsgaard, H; Hauselmann, I; Schuler, B; Habib, AM; Baggio, LL; Meier, DT; Eppler, E; Bouzakri, K; Wueest, S; Muller, YD; Hansen, AMK; Reinecke, M; Konrad, D; Gassmann, M; Reimann, F; Halban, PA; Gromada, J; Drucker, DJ; Gribble, FM; Ehses, JA; Donath, MY				Ellingsgaard, Helga; Hauselmann, Irina; Schuler, Beat; Habib, Abdella M.; Baggio, Laurie L.; Meier, Daniel T.; Eppler, Elisabeth; Bouzakri, Karim; Wueest, Stephan; Muller, Yannick D.; Hansen, Ann Maria Kruse; Reinecke, Manfred; Konrad, Daniel; Gassmann, Max; Reimann, Frank; Halban, Philippe A.; Gromada, Jesper; Drucker, Daniel J.; Gribble, Fiona M.; Ehses, Jan A.; Donath, Marc Y.			Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells	NATURE MEDICINE			English	Article							BETA-CELL; SKELETAL-MUSCLE; IN-VITRO; GLUCOSE-HOMEOSTASIS; BENEFICIAL ROLE; EXPRESSION; HORMONE; GLP-1; PROGLUCAGON; EXERCISE	Exercise, obesity and type 2 diabetes are associated with elevated plasma concentrations of interleukin-6 (IL-6). Glucagon-like peptide-1 (GLP-1) is a hormone that induces insulin secretion. Here we show that administration of IL-6 or elevated IL-6 concentrations in response to exercise stimulate GLP-1 secretion from intestinal L cells and pancreatic alpha cells, improving insulin secretion and glycemia. IL-6 increased GLP-1 production from alpha cells through increased proglucagon (which is encoded by GCG) and prohormone convertase 1/3 expression. In models of type 2 diabetes, the beneficial effects of IL-6 were maintained, and IL-6 neutralization resulted in further elevation of glycemia and reduced pancreatic GLP-1. Hence, IL-6 mediates crosstalk between insulin-sensitive tissues, intestinal L cells and pancreatic islets to adapt to changes in insulin demand. This previously unidentified endocrine loop implicates IL-6 in the regulation of insulin secretion and suggests that drugs modulating this loop may be useful in type 2 diabetes.	[Ellingsgaard, Helga; Hauselmann, Irina; Meier, Daniel T.; Donath, Marc Y.] Univ Basel Hosp, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland; [Ellingsgaard, Helga; Hauselmann, Irina; Meier, Daniel T.; Donath, Marc Y.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Schuler, Beat; Gassmann, Max] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Schuler, Beat; Wueest, Stephan; Konrad, Daniel; Gassmann, Max] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Habib, Abdella M.; Reimann, Frank; Gribble, Fiona M.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Habib, Abdella M.; Reimann, Frank; Gribble, Fiona M.] Addenbrookes Hosp, Dept Clin Biochem, Cambridge, England; [Baggio, Laurie L.; Drucker, Daniel J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Eppler, Elisabeth; Reinecke, Manfred] Univ Zurich, Inst Anat, Res Grp Neuroendocrine Immune Interact, Zurich, Switzerland; [Bouzakri, Karim; Halban, Philippe A.] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, Geneva, Switzerland; [Wueest, Stephan; Konrad, Daniel] Univ Zurich, Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, Zurich, Switzerland; [Muller, Yannick D.] Univ Geneva, Univ Med Ctr, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Hansen, Ann Maria Kruse] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Gromada, Jesper] Novartis Inst Biomed Res, Cardiovasc & Metab Dis Area, Cambridge, MA USA; [Ehses, Jan A.] Univ British Columbia, Dept Surg, Fac Med, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	University of Basel; University of Basel; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Zurich; University of Geneva; University Children's Hospital Zurich; University of Zurich; University of Geneva; Novo Nordisk; Novartis; Child & Family Research Institute; University of British Columbia	Ellingsgaard, H (corresponding author), Univ Basel Hosp, Clin Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland.	helga.ellingsgaard@unibas.ch	Ehses, Jan/AAK-1635-2020; Drucker, Daniel J/A-4092-2010; Wueest, Stephan/H-9864-2012; Wüest, Stephan/AAG-9706-2020; Ellingsgaard, Helga/AAD-5705-2022	Wüest, Stephan/0000-0002-0176-8906; Ellingsgaard, Helga/0000-0002-9105-5247; Gassmann, Max/0000-0003-2750-8878; Gribble, Fiona/0000-0002-4232-2898; Habib, Abdella Mohammed/0000-0001-7453-3932; Reimann, Frank/0000-0001-9399-6377; Ehses, Jan/0000-0001-9066-7607; Zeman-Meier, Daniel/0000-0003-3348-4657; Muller, Yannick/0000-0003-0513-7156; Konrad, Daniel/0000-0001-9067-4356	Swiss National Science Foundation; Merck; Hartman Muller organization; Child and Family Research Institute; University of British Columbia; Canadian Diabetes Association; Juvenile Diabetes Research Foundation [31-2008-416]; Canada Research Chair in Regulatory Peptides; Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology; Canadian Institutes of Health Research [93749]; Wellcome Trust [WT088357, WT084210]; EU [266408]; Medical Research Council [G0600717B] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Merck(Merck & Company); Hartman Muller organization; Child and Family Research Institute; University of British Columbia; Canadian Diabetes Association; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canada Research Chair in Regulatory Peptides(Canada Research Chairs); Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge O. Madsen and D. Steiner for their suggestion to investigate the role of IL-6 on GLP-1 and PC1/3. We thank R. Prazak and M. Borsigova for technical assistance and M. Niessen for discussions. This work was supported by grants from the Swiss National Science Foundation and by the Merck Investigator Studies Program. J.A.E. was supported by grants from the Hartman Muller organization, the Child and Family Research Institute and the University of British Columbia and has salary support from the Canadian Diabetes Association. We obtained human islets thanks to grant 31-2008-416 from the Juvenile Diabetes Research Foundation. D.J.D. is supported by the Canada Research Chair in Regulatory Peptides, the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology and Canadian Institutes of Health Research operating grant 93749. F. M. G., F. R. and A. M. H. are supported by grants from the Wellcome Trust (WT088357 to F. M. G. and WT084210 to F. R.) and EU FP7 grant 266408.	Adam TCM, 2004, PHYSIOL BEHAV, V83, P459, DOI 10.1016/j.physbeh.2004.08.035; Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252; BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chanoine JP, 2008, OBESITY, V16, P202, DOI 10.1038/oby.2007.39; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Delmeire D, 2004, BIOCHEM PHARMACOL, V68, P33, DOI 10.1016/j.bcp.2004.02.035; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Febbraio MA, 2003, J PHYSIOL-LONDON, V549, P607, DOI 10.1113/jphysiol.2003.042374; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Holmes AG, 2008, J ENDOCRINOL, V198, P367, DOI 10.1677/JOE-08-0113; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Jansson JO, 2007, J APPL PHYSIOL, V102, P821, DOI 10.1152/japplphysiol.01353.2006; Jevdjovic T, 2005, HISTOCHEM CELL BIOL, V123, P179, DOI 10.1007/s00418-005-0760-y; Jevdjovic T, 2004, EUR J ENDOCRINOL, V151, P223, DOI 10.1530/eje.0.1510223; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Li M, 2010, J AUTOIMMUN, V35, P414, DOI 10.1016/j.jaut.2010.09.001; LUND PK, 1982, P NATL ACAD SCI-BIOL, V79, P345, DOI 10.1073/pnas.79.2.345; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mooney RA, 2007, J APPL PHYSIOL, V102, P816, DOI 10.1152/japplphysiol.01208a.2006; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; Ostrowski K, 1998, J PHYSIOL-LONDON, V508, P949, DOI 10.1111/j.1469-7793.1998.949bp.x; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rouille Y, 1997, J BIOL CHEM, V272, P32810, DOI 10.1074/jbc.272.52.32810; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sadagurski M, 2010, DIABETOLOGIA, V53, P525, DOI 10.1007/s00125-009-1580-8; Schuler B, 2010, P NATL ACAD SCI USA, V107, P419, DOI 10.1073/pnas.0912924107; Sporeno E, 1996, BLOOD, V87, P4510, DOI 10.1182/blood.V87.11.4510.bloodjournal87114510; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Ueda S, 2009, J ENDOCRINOL, V201, P151, DOI 10.1677/JOE-08-0500; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200; Weigert C, 2007, J APPL PHYSIOL, V102, P820, DOI 10.1152/japplphysiol.01353.2006; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yamaguchi K, 2011, LAB INVEST, V91, P609, DOI 10.1038/labinvest.2011.2; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	57	567	588	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1481	U1500		10.1038/nm.2513	http://dx.doi.org/10.1038/nm.2513			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22037645	Green Accepted			2022-12-27	WOS:000296779300040
J	Panizzi, P; Nahrendorf, M; Figueiredo, JL; Panizzi, J; Marinelli, B; Iwamoto, Y; Keliher, E; Maddur, AA; Waterman, P; Kroh, HK; Leuschner, F; Aikawa, E; Swirski, FK; Pittet, MJ; Hackeng, TM; Fuentes-Prior, P; Schneewind, O; Bock, PE; Weissleder, R				Panizzi, Peter; Nahrendorf, Matthias; Figueiredo, Jose-Luiz; Panizzi, Jennifer; Marinelli, Brett; Iwamoto, Yoshiko; Keliher, Edmund; Maddur, Ashoka A.; Waterman, Peter; Kroh, Heather K.; Leuschner, Florian; Aikawa, Elena; Swirski, Filip K.; Pittet, Mikael J.; Hackeng, Tilman M.; Fuentes-Prior, Pablo; Schneewind, Olaf; Bock, Paul E.; Weissleder, Ralph			In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation	NATURE MEDICINE			English	Article							COAGULASE-DEFICIENT MUTANTS; INFECTIVE ENDOCARDITIS; STAPHYLOCOAGULASE; DIAGNOSIS; VIRULENCE; PROBES	Coagulase-positive Staphylococcus aureus (S. aureus) is the major causal pathogen of acute endocarditis, a rapidly progressing, destructive infection of the heart valves. Bacterial colonization occurs at sites of endothelial damage, where, together with fibrin and platelets, the bacteria initiate the formation of abnormal growths known as vegetations. Here we report that an engineered analog of prothrombin could be used to detect S. aureus in endocarditic vegetations via noninvasive fluorescence or positron emission tomography (PET) imaging. These prothrombin derivatives bound staphylocoagulase and intercalated into growing bacterial vegetations. We also present evidence for bacterial quorum sensing in the regulation of staphylocoagulase expression by S. aureus. Staphylocoagulase expression was limited to the growing edge of mature vegetations, where it was exposed to the host and co-localized with the imaging probe. When endocarditis was induced with an S. aureus strain with genetic deletion of coagulases, survival of mice improved, highlighting the role of staphylocoagulase as a virulence factor.	[Panizzi, Peter; Nahrendorf, Matthias; Figueiredo, Jose-Luiz; Marinelli, Brett; Iwamoto, Yoshiko; Keliher, Edmund; Waterman, Peter; Leuschner, Florian; Aikawa, Elena; Swirski, Filip K.; Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Panizzi, Peter] Auburn Univ, Dept Pharmacal Sci, Harrison Sch Pharm, Auburn, AL 36849 USA; [Panizzi, Jennifer] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Maddur, Ashoka A.; Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Hackeng, Tilman M.] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Fuentes-Prior, Pablo] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain; [Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Auburn University System; Auburn University; Harvard University; Massachusetts General Hospital; Vanderbilt University; Maastricht University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; University of Chicago	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	mnahrendorf@mgh.harvard.edu; rweissleder@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019; Panizzi, Peter/A-6072-2019; Aikawa, Elena/L-6173-2019; Pittet, Mikael/ABD-6300-2021	Panizzi, Peter/0000-0003-0141-8807; /0000-0003-0828-4143; Hackeng, Tilman/0000-0003-0142-0843; Fuentes-Prior, Pablo/0000-0002-6618-3204; Swirski, Filip/0000-0002-3163-9152; Aikawa, Elena/0000-0001-7835-2135	US National Institutes of Health [F32-HL094010, K99-HL094533, F32DK083868, R01-HL096576, R01-HL095629, R01-EB006432, T32-CA79443, R24-CA92782, P50-CA86355, R37-HL071544, R01-HL038779]; Deutsche Herzstiftung; NATIONAL CANCER INSTITUTE [T32CA079443, P50CA086355, R24CA092782] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095629, R01HL038779, K99HL094533, F32HL094010, R01HL096576, R37HL071544, R00HL094533, R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK083868] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Y. Fisher-Jeffes for review of the manuscript and C. Vinegoni, Z. Mueller and J. Sullivan for help with imaging and data analysis. We would also like to thank T. Foster for materials and helpful suggestions. This work was funded in part by grants from the US National Institutes of Health F32-HL094010, K99-HL094533 (P.P.); F32DK083868 (J.P.); R01-HL096576, R01-HL095629 (M.N.); R01-EB006432, T32-CA79443, R24-CA92782, P50-CA86355 (R.W.) and R37-HL071544, R01-HL038779 (P.E.B.) and a Deutsche Herzstiftung grant (F.L.).	BADDOUR LM, 1994, J MED MICROBIOL, V41, P259, DOI 10.1099/00222615-41-4-259; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; Berny MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010415; Bleeker-Rovers CP, 2007, J NUCL MED, V48, P337; BOCK PE, 1992, J BIOL CHEM, V267, P14963; Cabell CH, 2004, HEART, V90, P975, DOI 10.1136/hrt.2003.031328; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Chevalier C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000809; Dumarey N, 2006, J NUCL MED, V47, P625; DURACK DT, 1990, HEART ARTERIES VEINS, V63, P1230; Friedrich R, 2006, J BIOL CHEM, V281, P1188, DOI 10.1074/jbc.M507957200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Loeb L, 1904, J MED RES, V10, P407; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Panizzi P, 2006, J BIOL CHEM, V281, P1179, DOI 10.1074/jbc.M507956200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; PHONIMDAENG P, 1990, MOL MICROBIOL, V4, P393, DOI 10.1111/j.1365-2958.1990.tb00606.x; Rennen HJJM, 2007, NUCL MED BIOL, V34, P691, DOI 10.1016/j.nucmedbio.2007.04.012; Rouzet F, 2008, CIRCULATION, V117, P781, DOI 10.1161/CIRCULATIONAHA.107.718114; SALAMAH AA, 1992, MICROBIOLOGICA, V15, P75; Sawai T, 1997, INFECT IMMUN, V65, P466, DOI 10.1128/IAI.65.2.466-471.1997	24	119	126	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1142	U153		10.1038/nm.2423	http://dx.doi.org/10.1038/nm.2423			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857652	Green Accepted			2022-12-27	WOS:000294605100037
J	Wright, C; Quake, SR; Bianchi, D; Wald, NJ				Wright, Caroline; Quake, Stephen R.; Bianchi, Diana; Wald, Nicholas J.			COMMUNITY CORNER Opening the Pandora's box of prenatal genetic testing	NATURE MEDICINE			English	Editorial Material							DOWNS-SYNDROME; FETAL DNA; 1ST-TRIMESTER; DIAGNOSIS	Trisomy 21, or Down's syndrome, is the most common autosomal aneuploidy, occurring in 1 in 600 live births in the absence of prenatal testing and selective abortion. However, current prenatal diagnosis of trisomy 21 requires invasive procedures, which are associated with a risk of miscarriage. Rossa Chiu et al.(1) now report the first large-scale noninvasive prenatal assessment of trisomy 21 using multiplex sequencing to analyze fetal DNA from maternal plasma. These results raise the possibility that sequencing approaches might be integrated into current screening and diagnosis programs for Down's syndrome and perhaps even be applied to the diagnosis of other genetic diseases. We asked four experts to comment on the implications of this study for prenatal genetic screening and diagnostics.	[Wright, Caroline] PHG Fdn, Cambridge, England; [Wright, Caroline] Wellcome Trust Sanger Inst, Hinxton, England; [Quake, Stephen R.] Stanford Univ, Stanford, CA 94305 USA; [Quake, Stephen R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bianchi, Diana] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA; [Bianchi, Diana] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Wald, Nicholas J.] Queen Mary Univ, Royal Soc, London, England; [Wald, Nicholas J.] Queen Mary Univ, Wolfson Inst Prevent Med, London, England	Wellcome Trust Sanger Institute; Stanford University; Howard Hughes Medical Institute; Tufts Medical Center; Tufts University; University of London; Queen Mary University London; University of London; Queen Mary University London	Wright, C (corresponding author), PHG Fdn, Cambridge, England.		Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021					Bestwick JP, 2010, J MED SCREEN, V17, P8, DOI 10.1258/jms.2010.009107; Borrell A, 2009, J MED SCREEN, V16, P112, DOI 10.1258/jms.2009.009043; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Driscoll DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.027; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Hall A, 2010, PUBLIC HEALTH GENOM, V13, P246, DOI 10.1159/000279626; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133	11	9	9	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					250	251		10.1038/nm0311-250	http://dx.doi.org/10.1038/nm0311-250			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383717				2022-12-27	WOS:000288070000017
J	[Anonymous]				[Anonymous]			Blame your genes, but not your copy numbers	NATURE MEDICINE			English	Editorial Material																		Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979	1	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					526	526		10.1038/nm0510-526	http://dx.doi.org/10.1038/nm0510-526			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20448576				2022-12-27	WOS:000277394700028
J	Linke, WA; Bucker, S				Linke, Wolfgang A.; Buecker, Sandra			King of hearts: a splicing factor rules cardiac proteins	NATURE MEDICINE			English	Editorial Material							DILATED CARDIOMYOPATHY; GENETIC-VARIATION; TITIN; STIFFNESS	Alternative splicing ensures the expression of functionally diverse proteins from individual genes; however, aberrant mRNA splicing is associated with various conditions, including heart disease. A recent study provides new mechanistic insights into heart failure by showing that a human cardiomyopathy-linked mutation in a cardiac splice factor affects post-transcriptional regulation, causing the expression of anomalous isoforms of a whole network of cardiac proteins (pages 766-773).	[Linke, Wolfgang A.; Buecker, Sandra] Ruhr Univ Bochum, Dept Cardiovasc Physiol, Bochum, Germany	Ruhr University Bochum	Linke, WA (corresponding author), Ruhr Univ Bochum, Dept Cardiovasc Physiol, Univ Str 150, Bochum, Germany.	wolfgang.linke@rub.de	Linke, Wolfgang A/E-8662-2012	Linke, Wolfgang/0000-0003-0801-3773; Swist, Sandra/0000-0002-1269-2177				Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; MacRae CA, 2009, J AM COLL CARDIOL, V54, P942, DOI 10.1016/j.jacc.2009.06.009; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1; Refaat MM, 2012, HEART RHYTHM, V9, P390, DOI 10.1016/j.hrthm.2011.10.016; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036	13	14	14	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					660	661		10.1038/nm.2762	http://dx.doi.org/10.1038/nm.2762			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561820				2022-12-27	WOS:000303763500028
J	Prockop, DJ				Prockop, Darwin J.			Mitochondria to the rescue	NATURE MEDICINE			English	Editorial Material							CELLS; MICROPARTICLES; MECHANISM; CANCER	A new study using a mouse model of lung diseases is the first demonstration in vivo that bone marrow-derived stromal cells can repair tissue injury through the transfer of mitochondria (pages 759-765). This suggests that rescue of injured cells through mitochondrial transfer may be an important process in many diseases.	Scott & White Mem Hosp & Clin, Inst Regenerat Med, Coll Med, Texas A&M Hlth Sci Ctr, Temple, TX USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Prockop, DJ (corresponding author), Scott & White Mem Hosp & Clin, Inst Regenerat Med, Coll Med, Texas A&M Hlth Sci Ctr, Temple, TX USA.	prockop@medicine.tamhsc.edu						Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Cho YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032778; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Prockop DJ, 2012, J CELL BIOCHEM, V113, P1460, DOI 10.1002/jcb.24046; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Rebbeck CA, 2011, SCIENCE, V331, P303, DOI 10.1126/science.1197696; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x	13	20	22	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					653	654		10.1038/nm.2769	http://dx.doi.org/10.1038/nm.2769			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561816				2022-12-27	WOS:000303763500024
J	Aceto, N; Sausgruber, N; Brinkhaus, H; Gaidatzis, D; Martiny-Baron, G; Mazzarol, G; Confalonieri, S; Quarto, M; Hu, G; Balwierz, PJ; Pachkov, M; Elledge, SJ; van Nimwegen, E; Stadler, MB; Bentires-Alj, M				Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Martiny-Baron, Georg; Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela; Hu, Guang; Balwierz, Piotr J.; Pachkov, Mikhail; Elledge, Stephen J.; van Nimwegen, Erik; Stadler, Michael B.; Bentires-Alj, Mohamed			Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop	NATURE MEDICINE			English	Article							IN-VITRO PROPAGATION; STEM-CELL; MYELOID-LEUKEMIA; DUCTAL CARCINOMA; NOONAN-SYNDROME; PROTEIN; GENE; DIFFERENTIATION; METASTASIS; MUTATIONS	New cancer therapies are likely to arise from an in-depth understanding of the signaling networks influencing tumor initiation, progression and metastasis. We show a fundamental role for Src-homology 2 domain-containing phosphatase 2 (SHP2) in these processes in human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancers. Knockdown of SHP2 eradicated breast tumor-initiating cells in xenograft models, and SHP2 depletion also prevented invasion in three-dimensional cultures and in a transductal invasion assay in vivo. Notably, SHP2 knockdown in established breast tumors blocked their growth and reduced metastasis. Mechanistically, SHP2 activated stemness-associated transcription factors, including v-myc myelocytomatosis viral oncogene homolog (c-Myc) and zinc finger E-box binding homeobox 1 (ZEB1), which resulted in the repression of let-7 microRNA and the expression of a set of 'SHP2 signature' genes. We found these genes to be simultaneously activated in a large subset of human primary breast tumors that are associated with invasive behavior and poor prognosis. These results provide new insights into the signaling cascades influencing tumor-initiating cells as well as a rationale for targeting SHP2 in breast cancer.	[Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Stadler, Michael B.; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland; [Martiny-Baron, Georg] Novartis Inst Biomed Res, Basel, Switzerland; [Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy; [Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela] IEO, Milan, Italy; [Hu, Guang; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet,Med Sch, Boston, MA 02115 USA; [Hu, Guang; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Dept Genet, Div Genet,Med Sch, Boston, MA 02115 USA; [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland; [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS European Institute of Oncology (IEO); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Basel; Swiss Institute of Bioinformatics	Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland.	bentires@fmi.ch	Hu, Guang/E-7474-2016; Mohamed, Bentires-Alj/F-4484-2015; Balwierz, Piotr J/AAG-4187-2020; van Nimwegen, Erik/ABF-1085-2021; Confalonieri, Stefano/AAQ-6786-2020; Hu, Guang/B-2909-2012; Aceto, Nicola/O-2484-2014	Hu, Guang/0000-0003-0437-4723; Mohamed, Bentires-Alj/0000-0001-6344-1127; Balwierz, Piotr J/0000-0002-1548-4605; van Nimwegen, Erik/0000-0001-6338-1312; Confalonieri, Stefano/0000-0001-6886-9851; Hu, Guang/0000-0002-8754-1541; Aceto, Nicola/0000-0001-9579-6918	Novartis Research Foundation; European Research Council (ERC) [243211-PTPsBDC]; Swiss Cancer League; Krebsliga Beider Basel; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER	Novartis Research Foundation; European Research Council (ERC)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank N. Hynes (FMI) and G. Christofori (University of Basel) for helpful comments on the manuscript, S. Gasser, W. Filipowicz, H. Grosshans, J. Krol (FMI) and R.B. Clarke (Manchester University) for helpful discussions, W. Xian (in the lab of J. Brugge, Harvard Medical School) and D. Medina (Baylor College of Medicine) for help with the intraductal protocol, T. Westbrook (Baylor College of Medicine) for providing the dox-inducible lentiviral vector, C. Kuperwasser (Tufts University) for providing the SUM159 and SUM1315 cells, V. Reddy (GNF) for providing the primary breast tumor, and A. Terrier (Novartis Institutes for Biomedical Research) for excellent technical assistance, as well as additional members of the Bentires-Alj lab for advice and discussions and various colleagues for reagents. We also thank the International Genomics Consortium and expO (http://www.intgen.org/expo/) for offering free access to clinically annotated tumor data. Research in the lab of M.B.-A. is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant 243211-PTPsBDC), the Swiss Cancer League and the Krebsliga Beider Basel.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhan Y, 2009, EXP CELL RES, V315, P2343, DOI 10.1016/j.yexcr.2009.05.001; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x	51	196	217	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					529	537		10.1038/nm.2645	http://dx.doi.org/10.1038/nm.2645			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388088				2022-12-27	WOS:000302617800029
J	Schenk, T; Chen, WC; Gollner, S; Howell, L; Jin, LQ; Hebestreit, K; Klein, HU; Popescu, AC; Burnett, A; Mills, K; Casero, RA; Marton, L; Woster, P; Minden, MD; Dugas, M; Wang, JCY; Dick, JE; Muller-Tidow, C; Petrie, K; Zelent, A				Schenk, Tino; Chen, Weihsu Claire; Goellner, Stefanie; Howell, Louise; Jin, Liqing; Hebestreit, Katja; Klein, Hans-Ulrich; Popescu, Andreea C.; Burnett, Alan; Mills, Ken; Casero, Robert A., Jr.; Marton, Laurence; Woster, Patrick; Minden, Mark D.; Dugas, Martin; Wang, Jean C. Y.; Dick, John E.; Mueller-Tidow, Carsten; Petrie, Kevin; Zelent, Arthur			Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia	NATURE MEDICINE			English	Article							STEM-CELLS; EXPRESSION; ANALOGS; TARGET; REEXPRESSION; INDUCTION; HIERARCHY; DEATH; RARA; MAP	Acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML), characterized by the t(15; 17)-associated PML-RARA fusion, has been successfully treated with therapy utilizing all-trans-retinoic acid (ATRA) to differentiate leukemic blasts. However, among patients with non-APL AML, ATRA-based treatment has not been effective. Here we show that, through epigenetic reprogramming, inhibitors of lysine-specific demethylase 1 (LSD1, also called KDM1A), including tranylcypromine (TCP), unlocked the ATRA-driven therapeutic response in non-APL AML. LSD1 inhibition did not lead to a large-scale increase in histone 3 Lys4 dimethylation (H3K4(me2)) across the genome, but it did increase H3K4(me2) and expression of myeloid-differentiation-associated genes. Notably, treatment with ATRA plus TCP markedly diminished the engraftment of primary human AML cells in vivo in nonobese diabetic (NOD)-severe combined immunodeficient (SCID) mice, suggesting that ATRA in combination with TCP may target leukemia-initiating cells. Furthermore, initiation of ATRA plus TCP treatment 15 d after engraftment of human AML cells in NOD-SCID gamma (with interleukin-2 (IL-2) receptor gamma chain deficiency) mice also revealed the ATRA plus TCP drug combination to have a potent anti-leukemic effect that was superior to treatment with either drug alone. These data identify LSD1 as a therapeutic target and strongly suggest that it may contribute to AML pathogenesis by inhibiting the normal pro-differentiative function of ATRA, paving the way for new combinatorial therapies for AML.	[Schenk, Tino; Howell, Louise; Petrie, Kevin; Zelent, Arthur] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Chen, Weihsu Claire; Jin, Liqing; Popescu, Andreea C.; Wang, Jean C. Y.; Dick, John E.] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada; [Chen, Weihsu Claire; Jin, Liqing; Popescu, Andreea C.; Wang, Jean C. Y.; Dick, John E.] Ontario Canc Inst, Campbell Family Canc Res Inst, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Goellner, Stefanie; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol & Oncol, Munster, Germany; [Goellner, Stefanie; Mueller-Tidow, Carsten] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Hebestreit, Katja; Klein, Hans-Ulrich; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany; [Burnett, Alan] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Mills, Ken] Queens Univ, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Casero, Robert A., Jr.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Marton, Laurence] Progen Pharmaceut Inc, Palo Alto, CA USA; [Woster, Patrick] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Minden, Mark D.; Wang, Jean C. Y.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of London; Institute of Cancer Research - UK; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Munster; University of Munster; University of Munster; Cardiff University; Queens University Belfast; Johns Hopkins University; Medical University of South Carolina; University of Toronto; University of Toronto	Zelent, A (corresponding author), Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England.	arthur.zelent@icr.ac.uk	Klein, Hans-Ulrich/O-5118-2019; Müller-Tidow, Carsten CMT/B-5257-2014; Hebestreit, Katja/A-7906-2013; Petrie, Kevin/I-7115-2015; Dugas, Martin/F-5454-2011; Klein, Hans-Ulrich/A-7801-2013; Zelent, Arthur/B-3532-2009; Göllner, Stefanie/AAX-3901-2020; Woster, Patrick M/A-5604-2010; Müller-Tidow, Carsten/O-7207-2018; Schenk, Tino/P-4381-2019; Mills, Ken/A-8556-2012	Klein, Hans-Ulrich/0000-0002-6382-9428; Petrie, Kevin/0000-0002-9805-9152; Klein, Hans-Ulrich/0000-0002-6382-9428; Woster, Patrick M/0000-0002-9471-1916; Müller-Tidow, Carsten/0000-0002-7166-5232; Schenk, Tino/0000-0003-3430-5876; Zelent, Arthur/0000-0002-7968-9888; Casero, Robert/0000-0001-5653-3306; Dick, John/0000-0002-9527-8317; Mills, Ken/0000-0002-6362-4481; Wang, Jean/0000-0001-7543-3917	Leukaemia and Lymphoma Research; Samuel Waxman Cancer Research Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft [1328/6-1, 8-1, 9-1]; Cancer Stem Cell Consortium; Government of Canada; Ontario Genomics Institute through the Canadian Institute of Health Research [OGI-047, CSC-105367]; Canadian Institutes for Health Research (CIHR); Canadian Cancer Society Research Institute; Terry Fox Foundation; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC); National Cancer Institute [CA51085]; NATIONAL CANCER INSTITUTE [R01CA149095, R01CA051085] Funding Source: NIH RePORTER	Leukaemia and Lymphoma Research; Samuel Waxman Cancer Research Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Stem Cell Consortium; Government of Canada(CGIAR); Ontario Genomics Institute through the Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.S., L.H., K.P. and A.Z. were supported by a Specialist Programme Grant from Leukaemia and Lymphoma Research. T. S., L. H., K. P. and A.Z. were also supported in part by the Samuel Waxman Cancer Research Foundation. S.G. and C.M.-T. were supported by the Interdisziplinares Zentrum fur Klinische Forschung (IZKF) and the Deutsche Forschungsgemeinschaft (1328/6-1, 8-1 and 9-1). W.C.C., L.J., J.C.Y.W. and J.E.D. were supported by the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047) and through the Canadian Institute of Health Research (CSC-105367), as well as with funding from Canadian Institutes for Health Research (CIHR), the Canadian Cancer Society Research Institute, the Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research with funds from the province of Ontario; and a Canada Research Chair. W.C.C., L.J., J.C.Y.W. and J.E.D. were also funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed here do not necessarily reflect those of the OMOHLTC. R.A.C. Jr. was supported by a National Cancer Institute Grant (CA51085). The authors would like to thank D. Leongamornlert, L. Jasnos and S. Bashir for valuable discussions on the interpretation of the ChIP-Seq data and the statistical analyses. The authors would also like to thank M. Greaves for support and critical reading of the manuscript.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Culhane JC, 2010, J AM CHEM SOC, V132, P3164, DOI 10.1021/ja909996p; DALTON WT, 1988, BLOOD, V71, P242; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Florean C, 2011, EPIGENOMICS-UK, V3, P581, DOI [10.2217/EPI.11.73, 10.2217/epi.11.73]; Glasow A, 2005, BLOOD, V105, P341, DOI 10.1182/blood-2004-03-1074; Glasow A, 2008, BLOOD, V111, P2374, DOI 10.1182/blood-2007-05-088344; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; HOWELL AL, 1990, BLOOD, V75, P721; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; McDermott SP, 2012, BLOOD, V119, P1200, DOI 10.1182/blood-2011-01-330019; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Milojkovic D, 2004, J IMMUNOL, V173, P6745, DOI 10.4049/jimmunol.173.11.6745; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Pollyea DA, 2011, BRIT J HAEMATOL, V152, P524, DOI 10.1111/j.1365-2141.2010.08470.x; Sharma SK, 2010, J MED CHEM, V53, P5197, DOI 10.1021/jm100217a; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Wang H, 2000, BLOOD, V96, P3529; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Whyte I.M, 2003, MED TOXICOL, P823; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Yin B, 2009, BLOOD, V113, P1075, DOI 10.1182/blood-2008-03-144436; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	36	486	531	5	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					605	611		10.1038/nm.2661	http://dx.doi.org/10.1038/nm.2661			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22406747	Green Accepted			2022-12-27	WOS:000302617800039
J	Montagut, C; Dalmases, A; Bellosillo, B; Crespo, M; Pairet, S; Iglesias, M; Salido, M; Gallen, M; Marsters, S; Tsai, SP; Minoche, A; Somasekar, S; Serrano, S; Himmelbauer, H; Bellmunt, J; Rovira, A; Settleman, J; Bosch, F; Albanell, J				Montagut, Clara; Dalmases, Alba; Bellosillo, Beatriz; Crespo, Marta; Pairet, Silvia; Iglesias, Mar; Salido, Marta; Gallen, Manuel; Marsters, Scot; Tsai, Siao Ping; Minoche, Andre; Somasekar, Seshagiri; Serrano, Sergi; Himmelbauer, Heinz; Bellmunt, Joaquim; Rovira, Ana; Settleman, Jeff; Bosch, Francesc; Albanell, Joan			Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer	NATURE MEDICINE			English	Article							1ST-LINE TREATMENT; PHASE-III; PANITUMUMAB; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; EFFICACY	Antibodies against epidermal growth factor receptor (EGFR)-cetuximab and panitumumab-are widely used to treat colorectal cancer. Unfortunately, patients eventually develop resistance to these agents. We describe an acquired EGFR ectodomain mutation (S492R) that prevents cetuximab binding and confers resistance to cetuximab. Cells with this mutation, however, retain binding to and are growth inhibited by panitumumab. Two of ten subjects studied here with disease progression after cetuximab treatment acquired this mutation. A subject with cetuximab resistance harboring the S492R mutation responded to treatment with panitumumab.	[Montagut, Clara; Dalmases, Alba; Gallen, Manuel; Bellmunt, Joaquim; Rovira, Ana; Albanell, Joan] Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Montagut, Clara; Dalmases, Alba; Bellosillo, Beatriz; Pairet, Silvia; Gallen, Manuel; Serrano, Sergi; Bellmunt, Joaquim; Rovira, Ana; Albanell, Joan] Hosp del Mar, Canc Res Program, IMIM, Res Inst, Barcelona, Spain; [Bellosillo, Beatriz; Pairet, Silvia; Iglesias, Mar; Salido, Marta; Serrano, Sergi] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Crespo, Marta; Bosch, Francesc] Vall dHebron Univ Hosp, Dept Hematol, Barcelona, Spain; [Iglesias, Mar; Serrano, Sergi; Albanell, Joan] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain; [Marsters, Scot; Tsai, Siao Ping; Somasekar, Seshagiri; Settleman, Jeff] Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA; [Minoche, Andre; Himmelbauer, Heinz] Ctr Genom Regulat, Barcelona, Spain; [Bellmunt, Joaquim] UPF, Sch Med, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Roche Holding; Genentech; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Montagut, C (corresponding author), Hosp del Mar, Dept Med Oncol, Barcelona, Spain.	cmontagut@hospitaldelmar.cat; jalbanell@hospitaldelmar.cat	Bellmunt, Joaquim/B-8151-2019; Albanell, Joan/R-9470-2019; Bosch, Francesc/AAE-7052-2019; Rovira, Ana/ABH-5661-2020	Bellmunt, Joaquim/0000-0003-2328-3421; Bosch, Francesc/0000-0001-9241-2886; Crespo, Marta/0000-0002-7732-7808; Rovira, Ana/0000-0003-1301-2599; Himmelbauer, Heinz/0000-0001-8897-2928	Institut de Salud Carlos III (ISCIII) -Subdireccion General de Evaluacion y Fomento de la Investigacion [PS09/01491, PI08/0211, PI09/1285]; Plan Nacional (PN) de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio, programa Consolider; ISCIII/FEDER [RD06/0020/0109]; PN de I+D+I [2008-20011]; DIUE Generalitat de Catalunya [2009 SGR 321]; FEDER [RD09/0076/00036]; Xarxa de Bancs de Tumors de Catalunya; PDO (XBTC)	Institut de Salud Carlos III (ISCIII) -Subdireccion General de Evaluacion y Fomento de la Investigacion; Plan Nacional (PN) de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio, programa Consolider; ISCIII/FEDER; PN de I+D+I; DIUE Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); Xarxa de Bancs de Tumors de Catalunya; PDO (XBTC)	This work was supported by Institut de Salud Carlos III (ISCIII) -Subdireccion General de Evaluacion y Fomento de la Investigacion (PS09/01491, PI08/0211 and PI09/1285) and Plan Nacional (PN) de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, programa Consolider and ISCIII/FEDER (RD06/0020/0109); PN de I+D+I 2008-20011 and DIUE Generalitat de Catalunya (2009 SGR 321) grants. We thank the Fundacio Privada Cellex (Barcelona) for a generous donation to the Medical Oncology Service, Hospital del Mar. We thank the Tumor Bank of Pathology of Hospital del Mar (MARBiobanc), which is supported by FEDER (RD09/0076/00036), and Xarxa de Bancs de Tumors de Catalunya, which is sponsored by PDO (XBTC). We thank L. Roth and R. Cook for assistance with the EGFR binding studies, J. Guillory and J. Stinson for DNA sequencing, and J. Yelamos for key discussions.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Saif MW, 2010, CLIN COLORECTAL CANC, V9, P315, DOI 10.3816/CCC.2010.n.046; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	7	356	375	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					221	223		10.1038/nm.2609	http://dx.doi.org/10.1038/nm.2609			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270724				2022-12-27	WOS:000300140300034
J	Wang, WS; Lv, N; Zhang, SS; Shui, GH; Qian, H; Zhang, JF; Chen, YY; Ye, J; Xie, YS; Shen, YM; Wenk, MR; Li, P				Wang, Wenshan; Lv, Na; Zhang, Shasha; Shui, Guanghou; Qian, Hui; Zhang, Jingfeng; Chen, Yuanying; Ye, Jing; Xie, Yuansheng; Shen, Yuemao; Wenk, Markus R.; Li, Peng			Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids	NATURE MEDICINE			English	Article							BINDING-PROTEIN-BETA; XANTHINE-OXIDOREDUCTASE; DEFICIENT MICE; DUCTAL MORPHOGENESIS; INSULIN SENSITIVITY; SOCS-3 GENE; C/EBP-BETA; EXPRESSION; OBESITY; DROPLETS	Adequate lipid secretion by mammary glands during lactation is essential for the survival of mammalian offspring. However, the mechanism governing this process is poorly understood. Here we show that Cidea is expressed at high levels in lactating mammary glands and its deficiency leads to premature pup death as a result of severely reduced milk lipids. Furthermore, the expression of xanthine oxidoreductase (XOR), an essential factor for milk lipid secretion, is markedly lower in Cidea-deficient mammary glands. Conversely, ectopic Cidea expression induces the expression of XOR and enhances lipid secretion in vivo. Unexpectedly, as Cidea has heretofore been thought of as a cytoplasmic protein, we detected it in the nucleus and found it to physically interact with transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta) in mammary epithelial cells. We also observed that Cidea induces XOR expression by promoting the association of C/EBP beta onto, and the dissociation of HDAC1 from, the promoter of the Xdh gene encoding XOR. Finally, we found that Fsp27, another CIDE family protein, is detected in the nucleus and interacts with C/EBP beta to regulate expression of a subset of C/EBP beta downstream genes in adipocytes. Thus, Cidea acts as a previously unknown transcriptional coactivator of C/EBP beta in mammary glands to control lipid secretion and pup survival.	[Wang, Wenshan; Lv, Na; Zhang, Shasha; Qian, Hui; Zhang, Jingfeng; Chen, Yuanying; Li, Peng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ye, Jing] Fourth Mil Med Univ, Dept Pathol, Xian 710032, Shaanxi, Peoples R China; [Xie, Yuansheng] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Inst Nephrol, Beijing, Peoples R China; [Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China	Tsinghua University; National University of Singapore; National University of Singapore; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Shandong University	Li, P (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn	Wenk, Markus Rene/D-1441-2014	Shui, Guanghou/0000-0002-1621-9643	Ministry of Science and Technology of China [2007CB914404, 2011CB910800]; National Natural Science Foundation of China [30925017, 31030038, 90913024]; National University of Singapore; Singapore National Research Foundation under CRP [2007-04]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National University of Singapore(National University of Singapore); Singapore National Research Foundation under CRP(National Research Foundation, Singapore)	We thank L. Yu, L. Huang, Y. Hong and Y. Zhou for helpful discussions, and B. Groner (Georg-Speyer-Haus Institute for Biomedical Research) for providing HC11 cells. This work was supported by grants from the National Basic Research Program (2007CB914404, 2011CB910800) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30925017 and 31030038 to PL., 90913024 to Y.S.), and from the National University of Singapore and the Singapore National Research Foundation under CRP award no. 2007-04 to M.R.W.	Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Borland G, 2009, J BIOL CHEM, V284, P17391, DOI 10.1074/jbc.M109.015370; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Jeong J, 2009, J BIOL CHEM, V284, P22444, DOI 10.1074/jbc.M109.020446; Karaya K, 2005, NUCLEIC ACIDS RES, V33, P1924, DOI 10.1093/nar/gki339; Kleinberg DL, 2000, J MAMMARY GLAND BIOL, V5, P7, DOI 10.1023/A:1009507030633; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kulyte A, 2011, FEBS LETT, V585, P744, DOI 10.1016/j.febslet.2011.02.004; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; LINZELL JL, 1971, PHYSIOL REV, V51, P564, DOI 10.1152/physrev.1971.51.3.564; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McCarthy TL, 2007, MOL ENDOCRINOL, V21, P2713, DOI 10.1210/me.2007-0210; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; Mori S, 2000, EMBO J, V19, P5772, DOI 10.1093/emboj/19.21.5772; Neifert MR, 2001, PEDIATR CLIN N AM, V48, P273, DOI 10.1016/S0031-3955(08)70026-9; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Paz-Priel I, 2011, BLOOD, V117, P4085, DOI 10.1182/blood-2010-07-294470; Pettersson AT, 2008, INT J OBESITY, V32, P1380, DOI 10.1038/ijo.2008.101; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Seymour KJ, 2006, J BIOL CHEM, V281, P8545, DOI 10.1074/jbc.M507349200; Shekar PC, 2006, P NATL ACAD SCI USA, V103, P8000, DOI 10.1073/pnas.0601611103; Smith S, 1975, Adv Lipid Res, V13, P195; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	47	72	79	0	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					235	243		10.1038/nm.2614	http://dx.doi.org/10.1038/nm.2614			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245780				2022-12-27	WOS:000300140300037
J	Mitsunaga, M; Ogawa, M; Kosaka, N; Rosenblum, LT; Choyke, PL; Kobayashi, H				Mitsunaga, Makoto; Ogawa, Mikako; Kosaka, Nobuyuki; Rosenblum, Lauren T.; Choyke, Peter L.; Kobayashi, Hisataka			Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODY; PHOTODYNAMIC THERAPY; SINGLET OXYGEN; OVARIAN-CANCER; TUMOR; PHOTOSENSITIZERS; HEMATOPORPHYRIN	Three major modes of cancer therapy (surgery, radiation and chemotherapy) are the mainstay of modern oncologic therapy. To minimize the side effects of these therapies, molecular-targeted cancer therapies, including armed antibody therapy, have been developed with limited success. In this study, we have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was induced immediately after irradiating mAbIR-700-bound target cells with NIR light. We observed in vivo tumor shrinkage after irradiation with NIR light in target cells expressing the epidermal growth factor receptor. The mAb-IR700 conjugates were most effective when bound to the cell membrane and produced no phototoxicity when not bound, suggesting a different mechanism for PIT as compared to conventional photodynamic therapies. Target-selective PIT enables treatment of cancer based on mAb binding to the cell membrane.	[Mitsunaga, Makoto; Ogawa, Mikako; Kosaka, Nobuyuki; Rosenblum, Lauren T.; Choyke, Peter L.; Kobayashi, Hisataka] NCI, Mol Imaging Program, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kobayashi, H (corresponding author), NCI, Mol Imaging Program, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA.	kobayash@mail.nih.gov			US National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010656] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research. We would like to thank C. Regino, T. Hirano and C. Paik for their technical support.	Carcenac M, 2001, BRIT J CANCER, V85, P1787, DOI 10.1054/bjoc.2001.2170; Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Hamblin MR, 1996, CANCER RES, V56, P5205; Kosaka N, 2010, PROC SPIE, V7576, DOI 10.1117/12.842090; Kosaka N, 2010, CANCER SCI, V101, P820, DOI 10.1111/j.1349-7006.2009.01423.x; Mandler R, 2004, CANCER RES, V64, P1460, DOI 10.1158/0008-5472.CAN-03-2485; MEW D, 1985, CANCER RES, V45, P4380; MEW D, 1983, J IMMUNOL, V130, P1473; Nanus DM, 2003, J UROLOGY, V170, pS84, DOI 10.1097/01.ju.0000095151.97404.7c; Ogawa M, 2009, BIOCONJUGATE CHEM, V20, P2177, DOI 10.1021/bc900362k; Ogawa M, 2009, MOL CANCER THER, V8, P232, DOI 10.1158/1535-7163.MCT-08-0862; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; PATTERSON MS, 1990, J PHOTOCH PHOTOBIO B, V5, P69, DOI 10.1016/1011-1344(90)85006-I; POOLER JP, 1979, PHOTOCHEM PHOTOBIOL, V30, P581, DOI 10.1111/j.1751-1097.1979.tb07183.x; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sobolev AS, 2000, PROG BIOPHYS MOL BIO, V73, P51, DOI 10.1016/S0079-6107(00)00002-X; THORPE WP, 1995, BIOPHYS J, V68, P2198, DOI 10.1016/S0006-3495(95)80402-9; van Dongen GAMS, 2004, ADV DRUG DELIVER REV, V56, P31, DOI 10.1016/j.addr.2003.09.003; Vrouenraets MB, 1999, CANCER RES, V59, P1505; Vrouenraets MB, 2001, CANCER RES, V61, P1970; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Wilson BC, 1990, PHOTODYNAMIC THERAPY, V1, P129; Yang XD, 1999, CANCER RES, V59, P1236; Zhong W, 2009, BRIT J CANCER, V101, P2015, DOI 10.1038/sj.bjc.6605436	28	675	705	15	334	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1685	U210		10.1038/nm.2554	http://dx.doi.org/10.1038/nm.2554			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057348	Green Accepted			2022-12-27	WOS:000297978000044
J	Xu, M; Pavone, ME; Woodruff, T				Xu, Min; Pavone, Mary Ellen; Woodruff, Teresa			Fruitful progress to fertility Preserving oocytes from chemodestruction	NATURE MEDICINE			English	Editorial Material							FOLLICLE-STIMULATING-HORMONE; BREAST-CANCER; CHEMOTHERAPY; PRESERVATION; MENOPAUSE; OVARY; WOMEN	Chemotherapy can save the lives of many individuals with cancer. Unfortunately, it usually causes infertility after treatment, posing a concern for these people who will face a lifetime condition that considerably limits the quality of their lives. Advances in the field of oncofertility have brought hope to cancer survivors who long to plan a family; however, standard approaches only rely on cryopreservation of sperms and eggs before treatment and do not prevent infertility. In 'Bedside to Bench', Min Xu, Mary Ellen Pavone and Teresa Woodruff examine a study where individuals treated with gonadotropin-releasing hormone (GnRH) agonists before cancer therapy showed a decreased risk of infertility. How these agonists work to suppress and protect ovarian function and increase fertility in women after treatment is still unclear and begs further investigation at the bench. In 'Bench to Bedside', Amander Clark, Bart Phillips and Kyle Orwig discuss potential experimental options to preserve and restore male fertility after chemotherapy. These approaches will shed light into mechanisms of male fertility and spermatogenesis and may be the alternative to sperm freezing, which is not suitable for prepubertal boys and men unable to make sperm.	[Xu, Min; Pavone, Mary Ellen; Woodruff, Teresa] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Xu, M (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA.	tkw@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399; Pavone, Mary Ellen/0000-0001-9682-6381				Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; BAUERDANTOIN AC, 1995, ENDOCRINOLOGY, V136, P4432, DOI 10.1210/en.136.10.4432; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Danforth DR, 2005, FERTIL STERIL, V83, P1333, DOI 10.1016/j.fertnstert.2004.12.030; Del Mastro L, 2011, JAMA-J AM MED ASSOC, V306, P269, DOI 10.1001/jama.2011.991; Del Mastro L, 2011, EXPERT OPIN PHARMACO, V12, P387, DOI 10.1517/14656566.2011.522568; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Gerber B, 2011, J CLIN ONCOL, V29, P2334, DOI 10.1200/JCO.2010.32.5704; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kang SK, 2003, ENDOCR-RELAT CANCER, V10, P169, DOI 10.1677/erc.0.0100169; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; MAIANI E, 2011, PHARMACOLOGY, V82, P1269; Meirow D, 2004, HUM REPROD, V19, P1294, DOI 10.1093/humrep/deh257; Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159; Sverrisdottir A, 2009, BREAST CANCER RES TR, V117, P561, DOI 10.1007/s10549-009-0313-5	16	12	13	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1562	1563		10.1038/nm.2595	http://dx.doi.org/10.1038/nm.2595			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146461				2022-12-27	WOS:000297978000024
J	Walker, BD; Ahmed, R; Plotkin, S				Walker, Bruce D.; Ahmed, Rafi; Plotkin, Stanley			Moving ahead an HIV vaccine Use both arms to beat HIV	NATURE MEDICINE			English	Editorial Material							NEUTRALIZING ANTIBODIES; INFECTION; TRIAL; CHALLENGE; IMMUNITY; BROAD; SIV		[Walker, Bruce D.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Massachusetts Gen Hosp, Boston, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Plotkin, Stanley] Univ Penn & Vaxconsult, Doylestown, PA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Emory University	Walker, BD (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Massachusetts Gen Hosp, Boston, MA USA.	bwalker@partners.org						[Anonymous], GLOB REP; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Johnston MI, 2011, NEW ENGL J MED, V365, P873, DOI 10.1056/NEJMp1107621; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; PLOTKIN SA, 1994, TRANSPLANTATION, V58, P1176, DOI 10.1097/00007890-199412270-00006; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; SCHEID JF, 2011, SCIENCE         0714, DOI DOI 10.1126/SCIENCE.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WALKER LM, 2011, NATURE          0817, DOI DOI 10.1038/NATURE10373	17	37	37	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1194	1195		10.1038/nm.2529	http://dx.doi.org/10.1038/nm.2529			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21988996	Bronze			2022-12-27	WOS:000296022100031
J	Farrell, A				Farrell, Alison			A close look at cancer INTRODUCTION	NATURE MEDICINE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; GENOMIC ANALYSIS; IDENTIFICATION; MUTATIONS; RESISTANCE; PATHWAYS; MELANOMA; ORIGIN; BREAST	Advances in cancer research are enabling fast-paced discovery and translation of results into potential clinical tools. Here we consider some of the most influential findings of the past two years, selected by experts in the cancer field.										Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	29	10	11	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					262	265		10.1038/nm0311-262	http://dx.doi.org/10.1038/nm0311-262			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383721				2022-12-27	WOS:000288070000020
J	[Anonymous]				[Anonymous]			Cancer's top papers	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					278	279		10.1038/nm0311-278	http://dx.doi.org/10.1038/nm0311-278			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383734				2022-12-27	WOS:000288070000031
J	Barretto, RPJ; Ko, TH; Jung, JC; Wang, TJ; Capps, G; Waters, AC; Ziv, Y; Attardo, A; Recht, L; Schnitzer, MJ				Barretto, Robert P. J.; Ko, Tony H.; Jung, Juergen C.; Wang, Tammy J.; Capps, George; Waters, Allison C.; Ziv, Yaniv; Attardo, Alessio; Recht, Lawrence; Schnitzer, Mark J.			Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy	NATURE MEDICINE			English	Article							IN-VIVO; MULTIPHOTON MICROSCOPY; CRANIAL WINDOWS; ADULT CORTEX; SPINAL-CORD; HIGH-SPEED; MICE; GLIOMAS; CELLS; ANGIOGENESIS	The combination of intravital microscopy and animal models of disease has propelled studies of disease mechanisms and treatments. However, many disorders afflict tissues inaccessible to light microscopy in live subjects. Here we introduce cellular-level time-lapse imaging deep within the live mammalian brain by one-and two-photon fluorescence microendoscopy over multiple weeks. Bilateral imaging sites allowed longitudinal comparisons within individual subjects, including of normal and diseased tissues. Using this approach, we tracked CA1 hippocampal pyramidal neuron dendrites in adult mice, revealing these dendrites' extreme stability and rare examples of their structural alterations. To illustrate disease studies, we tracked deep lying gliomas by observing tumor growth, visualizing three-dimensional vasculature structure and determining microcirculatory speeds. Average erythrocyte speeds in gliomas declined markedly as the disease advanced, notwithstanding significant increases in capillary diameters. Time-lapse microendoscopy will be applicable to studies of numerous disorders, including neurovascular, neurological, cancerous and trauma-induced conditions.	[Barretto, Robert P. J.; Ko, Tony H.; Jung, Juergen C.; Wang, Tammy J.; Capps, George; Waters, Allison C.; Ziv, Yaniv; Attardo, Alessio; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Recht, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Recht, Lawrence] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.	mschnitz@stanford.edu	Attardo, Alessio/ABE-5208-2021	Attardo, Alessio/0000-0003-0665-6011	National Institute of Neurological Disorders and Stroke [R01NS050533]; National Institute of Neurological Disorders and Stroke, National Cancer Institute [P50CA114747]; Mauna Kea Technologies; Stanford-US National Institutes of Health; Machiah postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA017895] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders and Stroke, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Mauna Kea Technologies; Stanford-US National Institutes of Health; Machiah postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was initiated under National Institute on Drug Abuse CEBRA DA017895 and further supported by National Institute of Neurological Disorders and Stroke R01NS050533, National Cancer Institute P50CA114747 and a research contract with Mauna Kea Technologies. We gratefully acknowledge support from the Stanford-US National Institutes of Health Biophysics Program (R.P.J.B.) and a Machiah postdoctoral fellowship (Y.Z.). We thank M. Lim and J. Weimann for help with GL261 cells, S. Kim, T. Jang, A. Lui, J. Li and M. Ramkumar for technical assistance with histology and image processing, E. Mukamel for helpful conversations and B. Colyear and B. Wilt for help with graphic illustration.	Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jang T, 2008, J NEUROSURG, V108, P782, DOI 10.3171/JNS/2008/108/4/0782; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; McLellan ME, 2003, J NEUROSCI, V23, P2212; MELDER RJ, 1995, MICROVASC RES, V50, P35, DOI 10.1006/mvre.1995.1036; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Pyapali GK, 1998, J COMP NEUROL, V391, P335, DOI 10.1002/(SICI)1096-9861(19980216)391:3<335::AID-CNE4>3.0.CO;2-2; Ramnarayan R, 2007, J NEUROL SCI, V260, P49, DOI 10.1016/j.jns.2007.04.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; YUAN F, 1994, CANCER RES, V54, P4564	40	172	184	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					223	U120		10.1038/nm.2292	http://dx.doi.org/10.1038/nm.2292			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21240263	Green Accepted			2022-12-27	WOS:000286969900032
J	Vandanmagsar, B; Youm, YH; Ravussin, A; Galgani, JE; Stadler, K; Mynatt, RL; Ravussin, E; Stephens, JM; Dixit, VD				Vandanmagsar, Bolormaa; Youm, Yun-Hee; Ravussin, Anthony; Galgani, Jose E.; Stadler, Krisztian; Mynatt, Randall L.; Ravussin, Eric; Stephens, Jacqueline M.; Dixit, Vishwa Deep			The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; URIC-ACID; T-CELLS; NALP3 INFLAMMASOME; ACTIVATION; MECHANISMS; LINKS; MICE; DIET; FAT	The emergence of chronic inflammation during obesity in the absence of overt infection or well-defined autoimmune processes is a puzzling phenomenon. The Nod-like receptor (NLR) family of innate immune cell sensors, such as the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (Nlrp3, but also known as Nalp3 or cryopyrin) inflammasome are implicated in recognizing certain nonmicrobial originated 'danger signals' leading to caspase-1 activation and subsequent interleukin-1 beta (IL-1 beta) and IL-18 secretion. We show that calorie restriction and exercise-mediated weight loss in obese individuals with type 2 diabetes is associated with a reduction in adipose tissue expression of Nlrp3 as well as with decreased inflammation and improved insulin sensitivity. We further found that the Nlrp3 inflammasome senses lipotoxicity-associated increases in intracellular ceramide to induce caspase-1 cleavage in macrophages and adipose tissue. Ablation of Nlrp3 in mice prevents obesity-induced inflammasome activation in fat depots and liver as well as enhances insulin signaling. Furthermore, elimination of Nlrp3 in obese mice reduces IL-18 and adipose tissue interferon-gamma (IFN-gamma) expression, increases naive T cell numbers and reduces effector T cell numbers in adipose tissue. Collectively, these data establish that the Nlrp3 inflammasome senses obesity-associated danger signals and contributes to obesity-induced inflammation and insulin resistance.	[Vandanmagsar, Bolormaa; Youm, Yun-Hee; Ravussin, Anthony; Dixit, Vishwa Deep] Louisiana State Univ, Lab Neuroendocrine Immunol, Baton Rouge, LA 70803 USA; [Vandanmagsar, Bolormaa; Youm, Yun-Hee; Ravussin, Anthony; Galgani, Jose E.; Stadler, Krisztian; Mynatt, Randall L.; Ravussin, Eric; Dixit, Vishwa Deep] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Galgani, Jose E.; Ravussin, Eric] Louisiana State Univ, Human Physiol Lab, Baton Rouge, LA 70803 USA; [Stadler, Krisztian] Louisiana State Univ, Oxidat Stress & Dis Lab, Baton Rouge, LA 70803 USA; [Stephens, Jacqueline M.] Louisiana State Univ Syst, Dept Biol Sci, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Dixit, VD (corresponding author), Louisiana State Univ, Lab Neuroendocrine Immunol, Baton Rouge, LA 70803 USA.	vishwa.dixit@pbrc.edu	Stadler, Krisztian/N-1992-2017; Mynatt, Randall L/N-1980-2017; Stephens, Jacqueline M/R-5217-2018; Ravussin, Eric/N-1985-2017; Vandanmagsar, Bolormaa/R-4565-2018	Mynatt, Randall L/0000-0003-4399-0019; Ravussin, Eric/0000-0003-2129-547X; Youm, Yun-Hee/0000-0002-8098-8527; Ravussin, Anthony/0000-0003-4237-3190	Nutrition and Obesity Research Center (US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072476]; NIH [R01AG31797, DK083615, 1 P20 RR02/1945]; Coypu Foundation; Pennington Biomedical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556, R00DK083615, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031797] Funding Source: NIH RePORTER	Nutrition and Obesity Research Center (US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coypu Foundation; Pennington Biomedical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Vishva M. Dixit at Genentech for providing caspase-1-specific antibody and Nlrp3<SUP>-/-</SUP> mice and J. Suttles from the University of Louisville for L929 media. We also thank S. Bond for expert technical assistance and D. H. Ryan, C. Bouchard and J. M. Salbaum for helpful discussions. This work was supported in part by pilot grants to B. V. and V. D. D. from the Nutrition and Obesity Research Center (US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases grant P30 DK072476). The research in the Dixit laboratory is supported in part by the NIH (R01AG31797), the Coypu Foundation and the Pennington Biomedical Research Foundation. K. S. was partially supported by the NIH (DK083615). This work used the facilities of the Genomics and Cell Biology & Bioimaging Core supported by NIH grant 1 P20 RR02/1945.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Galgani JE, 2008, DIABETES, V57, P841, DOI 10.2337/db08-0043; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Luchsinger JA, 2009, J ALZHEIMERS DIS, V16, P693, DOI 10.3233/JAD-2009-1022; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	60	1726	1791	9	304	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					179	U214		10.1038/nm.2279	http://dx.doi.org/10.1038/nm.2279			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21217695	Green Accepted, Green Submitted			2022-12-27	WOS:000286969900025
J	Lang, AE				Lang, Anthony E.			Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future	NATURE MEDICINE			English	Article							NEUROIMAGING INITIATIVE PROGRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DELAYED-START; DOUBLE-BLIND; ANIMAL-MODELS; NEUROPROTECTION; ONSET; TRANSPLANTATION; RASAGILINE	Neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease represent a crucial and exponentially increasing challenge to health care systems throughout the world. There is an urgent need for effective treatments that will both delay their onset and slow their inexorable progression. Many obstacles stand in the way of realizing these goals. It is expected that future advances will have a major impact on how and when the diagnosis will be made. It is hoped that these will eventually make it possible to initiate effective disease-modifying therapies long before the neurodegenerative process becomes established and symptomatic.	Univ Toronto, Dept Med Neurol, Toronto, ON, Canada	University of Toronto	Lang, AE (corresponding author), Univ Toronto, Dept Med Neurol, Toronto, ON, Canada.	lang@uhnresearch.ca	Lang, Anthony/ABF-8114-2021	Lang, Anthony/0000-0003-1229-3667				Aarsland D, 2007, J NEUROL, V254, P38, DOI 10.1007/s00415-006-0234-8; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Blennow K, 2010, NAT MED, V16, P1218, DOI 10.1038/nm.2221; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brooks DJ, 1998, ANN NEUROL, V44, pS10, DOI 10.1002/ana.410440704; Broussolle E, 2000, NEUROLOGY, V55, P877, DOI 10.1212/WNL.55.6.877; Clarke CE, 2008, MOVEMENT DISORD, V23, P784, DOI 10.1002/mds.21918; D'Agostino RB, 2009, NEW ENGL J MED, V361, P1304, DOI 10.1056/NEJMsm0904209; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Eckert T, 2007, LANCET NEUROL, V6, P926, DOI 10.1016/S1474-4422(07)70245-4; Epis R, 2010, EUR J PHARMACOL, V626, P57, DOI 10.1016/j.ejphar.2009.10.020; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Francis PT, 2005, TRENDS PHARMACOL SCI, V26, P104, DOI 10.1016/j.tips.2004.12.010; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Huang P, 2009, MOVEMENT DISORD, V24, P1732, DOI 10.1002/mds.22645; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kieburtz K, 2006, NEUROLOGY, V66, pS50, DOI 10.1212/WNL.66.10_suppl_4.S50; Kieburtz K, 2007, NEUROLOGY, V68, P20; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Lang AE, 2006, LANCET NEUROL, V5, P990, DOI 10.1016/S1474-4422(06)70605-6; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Levy G, 2005, ARCH NEUROL-CHICAGO, V62, P467, DOI 10.1001/archneur.62.3.467; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; *LEW GROUP, 2004, SAV LIV SAV MON DIV; Lim SY, 2009, ARCH NEUROL-CHICAGO, V66, P167, DOI 10.1001/archneurol.2008.561; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Olanow CW, 2008, ANN NEUROL, V64, pS3; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Olanow CW, 2008, MOVEMENT DISORD, V23, P2194, DOI 10.1002/mds.22218; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Philipson O, 2010, FEBS J, V277, P1389, DOI 10.1111/j.1742-4658.2010.07564.x; Ploeger BA, 2009, PHARM STAT, V8, P225, DOI 10.1002/pst.355; Ponsen MM, 2009, MOVEMENT DISORD, V24, P1060, DOI 10.1002/mds.22534; Ravina B, 2009, MOVEMENT DISORD, V24, P2081, DOI 10.1002/mds.22690; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Scherzer CR, 2009, NEUROBIOL DIS, V35, P148, DOI 10.1016/j.nbd.2009.02.016; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Siderowf A, 2008, ANN NEUROL, V64, pS139, DOI 10.1002/ana.21462; Tang CC, 2010, J NEUROSCI, V30, P1049, DOI 10.1523/JNEUROSCI.4188-09.2010; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609	52	59	60	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1223	1226		10.1038/nm.2220	http://dx.doi.org/10.1038/nm.2220			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052078				2022-12-27	WOS:000283860100030
J	Li, LP; Lampert, JC; Chen, XJ; Leitao, C; Popovic, J; Muller, W; Blankenstein, T				Li, Liang-Ping; Lampert, J. Christoph; Chen, Xiaojing; Leitao, Catarina; Popovic, Jelena; Mueller, Werner; Blankenstein, Thomas			Transgenic mice with a diverse human T cell antigen receptor repertoire	NATURE MEDICINE			English	Article							ALPHA-BETA; GAMMA-DELTA; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; POSITIVE SELECTION; AMINO-ACIDS; RECOGNITION; GENE; LYMPHOCYTES; THYMUS	Because of tolerance mechanisms, it has been hard to identify the T cell receptors (TCRs) of high-avidity T cells against self (for example, tumor) antigens. TCRs that are specific for foreign human antigens from the nontolerant T cell repertoire can be identified in mice. Moreover, if mice are constructed to express the human TCR repertoire, they can be used to analyze the unskewed repertoire against human self antigens. Here we generated transgenic mice with the entire human TCR alpha beta gene loci (1.1 and 0.7 Mb), whose T cells express a diverse human TCR repertoire that compensates for mouse TCR deficiency. A human major histocompatibility class I transgene increases the generation of CD8(+) T cells with human compared to mouse TCRs. Functional CD8(+) T cells against several human tumor antigens were induced, and those against the Melan-A melanoma antigen used similar TCRs to those that have been detected in T cell clones from individuals with autoimmune vitiligo or melanoma. These mice will allow researchers to identify pathogenic and therapeutic human TCRs.	[Li, Liang-Ping; Lampert, J. Christoph; Chen, Xiaojing; Leitao, Catarina; Popovic, Jelena; Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany; [Li, Liang-Ping; Lampert, J. Christoph; Chen, Xiaojing; Leitao, Catarina; Popovic, Jelena; Blankenstein, Thomas] Charite Campus Benjamin Franklin, Inst Immunol, Berlin, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Bill Ford Chair Cellular Immunol, Manchester, Lancs, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Manchester	Blankenstein, T (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	tblanke@mdc-berlin.de	Muller, Werner/B-9044-2008	Muller, Werner/0000-0002-1297-9725; Leitao, Catarina/0000-0001-9884-2983	Deutsche Forschungsgemeinschaft; Helmholtz-Gemeinschaft Deutscher Forschungszentren [HA-202]; European Commission [CT-2005-005203]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Gemeinschaft Deutscher Forschungszentren(Helmholtz Association); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank M. Textor, M. Rosch, A. Gartner and C. Westen for technical assistance; A. Garratt, E. Rohde and A. Samuels for help with ES cell culture; M. Hafner and M. Ebel for ES cell injection; H.-P. Rahn for FACS sorting; M. Gong for help with spectratyping and statistical analysis; F. Lemonier (Institut Pasteur) for HHDII mice; E. Mcintyre (Hopital Necker) and E. Green (US National Institutes of Health) for YACs; and D. Schendel and D. Busch for critically reading the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich TR36) and the Helmholtz-Gemeinschaft Deutscher Forschungszentren (HA-202). W. M. was supported by the European Commission program MUGEN LSHG-CT-2005-005203 at the Helmholtz Centre for Infection Research, Braunschweig, Germany.	Alexander J, 1997, J IMMUNOL, V159, P4753; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Burtrum DB, 1996, J IMMUNOL, V157, P4293; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; Dietrich PY, 2001, CANCER RES, V61, P2047; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Joachims ML, 2006, J IMMUNOL, V176, P1543, DOI 10.4049/jimmunol.176.3.1543; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2010, CURR OPIN IMMUNOL, V22, P185, DOI 10.1016/j.coi.2009.12.006; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Mantovani S, 2003, J INVEST DERMATOL, V121, P308, DOI 10.1046/j.1523-1747.2003.12368.x; Mantovani S, 2002, J IMMUNOL, V169, P6253, DOI 10.4049/jimmunol.169.11.6253; MARKIE D, 1995, METH MOL BIOL, V54; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SENSI M, 1995, P NATL ACAD SCI USA, V92, P5674, DOI 10.1073/pnas.92.12.5674; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; Sherman LA, 1998, CRIT REV IMMUNOL, V18, P47, DOI 10.1615/CritRevImmunol.v18.i1-2.60; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	35	84	113	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					1029	U127		10.1038/nm.2197	http://dx.doi.org/10.1038/nm.2197			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20693993				2022-12-27	WOS:000281622900033
J	Kharas, MG; Lengner, CJ; Al-Shahrour, F; Bullinger, L; Ball, B; Zaidi, S; Morgan, K; Tam, W; Paktinat, M; Okabe, R; Gozo, M; Einhorn, W; Lane, SW; Scholl, C; Frohling, S; Fleming, M; Ebert, BL; Gilliland, DG; Jaenisch, R; Daley, GQ				Kharas, Michael G.; Lengner, Christopher J.; Al-Shahrour, Fatima; Bullinger, Lars; Ball, Brian; Zaidi, Samir; Morgan, Kelly; Tam, Winnie; Paktinat, Mahnaz; Okabe, Rachel; Gozo, Maricel; Einhorn, William; Lane, Steven W.; Scholl, Claudia; Froehling, Stefan; Fleming, Mark; Ebert, Benjamin L.; Gilliland, D. Gary; Jaenisch, Rudolf; Daley, George Q.			Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia	NATURE MEDICINE			English	Article							RNA-BINDING PROTEIN; ONCOGENIC PATHWAY SIGNATURES; GENE-EXPRESSION; STEM-CELLS; THERAPEUTIC-EFFICACY; HUMAN CANCER; PROGENITOR; TRANSFORMATION; DIFFERENTIATION; PROGRESSION	RNA-binding proteins of the Musashi (Msi) family are expressed in stem cell compartments and in aggressive tumors, but they have not yet been widely explored in the blood. Here we demonstrate that Msi2 is the predominant form expressed in hematopoietic stem cells (HSCs), and its knockdown leads to reduced engraftment and depletion of HSCs in vivo. Overexpression of human MSI2 in a mouse model increases HSC cell cycle progression and cooperates with the chronic myeloid leukemia-associated BCR-ABL1 oncoprotein to induce an aggressive leukemia. MSI2 is overexpressed in human myeloid leukemia cell lines, and its depletion leads to decreased proliferation and increased apoptosis. Expression levels in human myeloid leukemia directly correlate with decreased survival in patients with the disease, thereby defining MSI2 expression as a new prognostic marker and as a new target for therapy in acute myeloid leukemia (AML).	[Kharas, Michael G.; Al-Shahrour, Fatima; Ball, Brian; Morgan, Kelly; Tam, Winnie; Paktinat, Mahnaz; Okabe, Rachel; Gozo, Maricel; Einhorn, William; Ebert, Benjamin L.; Gilliland, D. Gary; Daley, George Q.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lengner, Christopher J.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Al-Shahrour, Fatima] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Bullinger, Lars; Scholl, Claudia; Froehling, Stefan] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Zaidi, Samir; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA; [Einhorn, William; Lane, Steven W.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Fleming, Mark] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gilliland, D. Gary] Merck Res Labs, N Wales, PA USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Daley, George Q.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ulm University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Merck & Company; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital	Kharas, MG (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	mkharas@partners.org; george.daley@childrens.harvard.edu	Lane, Steven/C-3215-2012; Bullinger, Lars/AAL-7965-2020	Lane, Steven/0000-0002-8050-6209; Bullinger, Lars/0000-0002-5890-5510; Lengner, Christopher/0000-0002-0574-5189; Ball, Brian/0000-0001-8625-7023; Fleming, Mark/0000-0003-0948-4024	US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases; NIH; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084261] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S. Armstrong (Children's Hospital Boston) for valuable reagents. We would like to acknowledge T. Zhang, D. Kalaitzidis, K. Gritsman, P. Stern and S. Sykes for their critical suggestions and J.-A. Kwon for assistance with microarray processing. We would like to thank M. Wernig for his assistance with the project. M.G.K. was supported by the US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award. This work was supported by grants from the NIH (D.G.G., R.J. and G.Q.D.), the Leukemia and Lymphoma Society (D.G.G. and G.Q.D.) and the Howard Hughes Medical Institute (D.G.G. and G.Q.D.). C.J.L. was supported by a Ruth L. Kirschstein Fellowship from the NIH.	Barbouti A, 2003, CANCER RES, V63, P1202; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Creighton CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001816; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kanai R, 2006, J GENE MED, V8, P1329, DOI 10.1002/jgm.965; Kanal R, 2007, HUM GENE THER, V18, P63, DOI 10.1089/hum.2006.107; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	33	250	270	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					903	U101		10.1038/nm.2187	http://dx.doi.org/10.1038/nm.2187			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20616797	Green Published, Green Accepted			2022-12-27	WOS:000280649200030
J	Massberg, S; Grahl, L; von Bruehl, ML; Manukyan, D; Pfeiler, S; Goosmann, C; Brinkmann, V; Lorenz, M; Bidzhekov, K; Khandagale, AB; Konrad, I; Kennerknecht, E; Reges, K; Holdenrieder, S; Braun, S; Reinhardt, C; Spannagl, M; Preissner, KT; Engelmann, B				Massberg, Steffen; Grahl, Lenka; von Bruehl, Marie-Luise; Manukyan, Davit; Pfeiler, Susanne; Goosmann, Christian; Brinkmann, Volker; Lorenz, Michael; Bidzhekov, Kiril; Khandagale, Avinash B.; Konrad, Ildiko; Kennerknecht, Elisabeth; Reges, Katja; Holdenrieder, Stefan; Braun, Siegmund; Reinhardt, Christoph; Spannagl, Michael; Preissner, Klaus T.; Engelmann, Bernd			Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases	NATURE MEDICINE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR; EXTRACELLULAR TRAPS; PLATELETS SECRETE; IN-VIVO; ELASTASE; THROMBOSIS; FIBRIN; MICE; MACROPHAGES	Blood neutrophils provide the first line of defense against pathogens but have also been implicated in thrombotic processes. This dual function of neutrophils could reflect an evolutionarily conserved association between blood coagulation and antimicrobial defense, although the molecular determinants and in vivo significance of this association remain unclear. Here we show that major microbicidal effectors of neutrophils, the serine proteases neutrophil elastase and cathepsin G, together with externalized nucleosomes, promote coagulation and intravascular thrombus growth in vivo. The serine proteases and extracellular nucleosomes enhance tissue factor- and factor XII-dependent coagulation in a process involving local proteolysis of the coagulation suppressor tissue factor pathway inhibitor. During systemic infection, activation of coagulation fosters compartmentalization of bacteria in liver microvessels and reduces bacterial invasion into tissue. In the absence of a pathogen challenge, neutrophil-derived serine proteases and nucleosomes can contribute to large-vessel thrombosis, the main trigger of myocardial infarction and stroke. The ability of coagulation to suppress pathogen dissemination indicates that microvessel thrombosis represents a physiological tool of host defense.	[Grahl, Lenka; Manukyan, Davit; Pfeiler, Susanne; Bidzhekov, Kiril; Khandagale, Avinash B.; Reges, Katja; Holdenrieder, Stefan; Reinhardt, Christoph; Engelmann, Bernd] Univ Munich, Inst Klin Chem, Munich, Germany; [Massberg, Steffen; von Bruehl, Marie-Luise; Lorenz, Michael; Konrad, Ildiko; Kennerknecht, Elisabeth; Braun, Siegmund] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany; [Goosmann, Christian; Brinkmann, Volker] Max Planck Inst Infekt Biol, Berlin, Germany; [Preissner, Klaus T.] Univ Giessen, Inst Biochem, Giessen, Germany	University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Max Planck Society; Justus Liebig University Giessen	Engelmann, B (corresponding author), Univ Munich, Inst Klin Chem, Munich, Germany.	bernd.engelmann@med.uni-muenchen.de	Brinkmann, Volker/A-6015-2009; Massberg, Steffen/AAN-6054-2021	Pfeiler, Susanne/0000-0002-8591-6186	Deutsche Forschungsgemeinschaft-Forschergruppe [440]; Rudolf-Marx-Stipendium from Gesellschaft fur Thrombose-und Hamostaseforschung	Deutsche Forschungsgemeinschaft-Forschergruppe(German Research Foundation (DFG)); Rudolf-Marx-Stipendium from Gesellschaft fur Thrombose-und Hamostaseforschung	We acknowledge support of Deutsche Forschungsgemeinschaft and Wilhelm Sander-Stiftung to B.E. and S.M. We are grateful to W. Bode, J. Roes, Peter Lohse, Pia Lohse and A. Moseman for helpful suggestions and comments. We thank G. Langst (University of Regensburg) and K. Rippe (University of Heidelberg) for preparation of isolated nucleosomes, M. Monestier (Temple University), H. Wardemann and R. Hurwitz (Max-Planck-Institut fur Infektionsbiologie) for providing H2A-H2B-DNA-specific antibody, DNA-specific antibody and human neutrophil elastase-specific antibody, K. Schledzewski (University of Heidelberg) for supplying the stabilin-2-positive antibody, L. Petersen (NovoNordisk) for donating rVIIa and D. Kirchhofer (Genentech) for providing mouse tissue factor-specific antibody. L.G. was supported by Deutsche Forschungsgemeinschaft-Forschergruppe 440 and by Rudolf-Marx-Stipendium from Gesellschaft fur Thrombose-und Hamostaseforschung. K.B. and C.R. were participants of Deutsche Forschungsgemeinschaft-Graduiertenkolleg 438.	Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWER MS, 1982, J BIOL CHEM, V257, P9849; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Day SM, 2005, BLOOD, V105, P192, DOI 10.1182/blood-2004-06-2225; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; Falanga A, 2005, SEMIN HEMATOL, V42, P239, DOI 10.1053/j.seminhematol.2005.05.023; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; HIGUCHI DA, 1992, BLOOD, V79, P1712; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; JOCHUM M, 1981, H-S Z PHYSIOL CHEM, V362, P103, DOI 10.1515/bchm2.1981.362.1.103; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; KIRSCHNER MW, 2005, PLAUSIBILITY LIFE RE, P133; KLEIN A, 1994, J LEUKOCYTE BIOL, V55, P248, DOI 10.1002/jlb.55.2.248; Komorowicz E, 1998, CIRC RES, V82, P1102, DOI 10.1161/01.RES.82.10.1102; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Machovich R, 1990, Blood Coagul Fibrinolysis, V1, P79, DOI 10.1097/00001721-199003000-00011; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Maroney SA, 2008, J THROMB HAEMOST, V6, P1344, DOI 10.1111/j.1538-7836.2008.03033.x; Maroney SA, 2009, J THROMB HAEMOST, V7, P1106, DOI 10.1111/j.1538-7836.2009.03454.x; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Maugeri N, 2006, J THROMB HAEMOST, V4, P1323, DOI 10.1111/j.1538-7836.2006.01968.x; MEIER HL, 1989, INFLAMMATION, V13, P295, DOI 10.1007/BF00914396; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; NOVOTNY WF, 1988, BLOOD, V72, P2020; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; Pawlinski R, 2004, THROMB HAEMOSTASIS, V92, P444, DOI 10.1160/TH04-05-0309; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; PLOW EF, 1980, BIOCHIM BIOPHYS ACTA, V630, P47, DOI 10.1016/0304-4165(80)90136-1; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; PRATT CW, 1990, J BIOL CHEM, V265, P6092; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Si-Tahar M, 1997, J BIOL CHEM, V272, P11636; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; WELBOURN CRB, 1992, BRIT J SURG, V79, P998, DOI 10.1002/bjs.1800791006; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zillmann A, 2001, BIOCHEM BIOPH RES CO, V281, P603, DOI 10.1006/bbrc.2001.4399	58	751	780	2	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					887	U87		10.1038/nm.2184	http://dx.doi.org/10.1038/nm.2184			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20676107				2022-12-27	WOS:000280649200028
J	Ott, HC; Clippinger, B; Conrad, C; Schuetz, C; Pomerantseva, I; Ikonomou, L; Kotton, D; Vacanti, JP				Ott, Harald C.; Clippinger, Ben; Conrad, Claudius; Schuetz, Christian; Pomerantseva, Irina; Ikonomou, Laertis; Kotton, Darrell; Vacanti, Joseph P.			Regeneration and orthotopic transplantation of a bioartificial lung	NATURE MEDICINE			English	Article							TISSUE-ENGINEERED LUNG; MARROW-DERIVED CELLS; EMBRYONIC STEM-CELLS; IN-VITRO; MECHANICAL FORCES; MATRIX; EPITHELIUM; COLLAGEN; BONE; VIVO	About 2,000 patients now await a donor lung in the United States. Worldwide, 50 million individuals are living with end-stage lung disease. Creation of a bioartificial lung requires engineering of viable lung architecture enabling ventilation, perfusion and gas exchange. We decellularized lungs by detergent perfusion and yielded scaffolds with acellular vasculature, airways and alveoli. To regenerate gas exchange tissue, we seeded scaffolds with epithelial and endothelial cells. To establish function, we perfused and ventilated cell-seeded constructs in a bioreactor simulating the physiologic environment of developing lung. By day 5, constructs could be perfused with blood and ventilated using physiologic pressures, and they generated gas exchange comparable to that of isolated native lungs. To show in vivo function, we transplanted regenerated lungs into orthotopic position. After transplantation, constructs were perfused by the recipient's circulation and ventilated by means of the recipient's airway and respiratory muscles, and they provided gas exchange in vivo for up to 6 h after extubation.	[Ott, Harald C.; Clippinger, Ben; Conrad, Claudius; Schuetz, Christian; Pomerantseva, Irina; Vacanti, Joseph P.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Ikonomou, Laertis; Kotton, Darrell] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ikonomou, Laertis; Kotton, Darrell] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Boston University	Ott, HC (corresponding author), Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA.	hott@partners.org	Schuetz, Christian/K-5234-2013; Ikonomou, Laertis/D-4579-2009	Schuetz, Christian/0000-0002-6828-4543; Ikonomou, Laertis/0000-0003-0993-6713; Kotton, Darrell/0000-0002-9604-8476	Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Department of Surgery, Massachusetts General Hospital; Center for Integration of Medicine and Innovative Technology (CIMIT); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER	Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center; Department of Surgery, Massachusetts General Hospital; Center for Integration of Medicine and Innovative Technology (CIMIT); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Harvard Apparatus Inc. for providing bioreactor components and, in particular, J. Consiglio, R. Zink and T. Beha for technical support. We thank J. Titus for assistance with animal surgeries and video recording. We further thank E. Bassett and D. Hoganson for their help with bioreactor parts and materials, A. Pardo for her technical support with western blots and K. Kulig for assistance with confocal microscopy. Electron microscopy was performed in the Microscopy Core of the Center for Systems Biology/Program in Membrane Biology, which is partially supported by Inflammatory Bowel Disease Grant DK43351 and Boston Area Diabetes and Endocrinology Research Center Award DK57521. This study was supported by a Faculty Development Grant provided by the Department of Surgery, Massachusetts General Hospital and by a Young Clinician Researcher Award granted by the Center for Integration of Medicine and Innovative Technology (CIMIT).	Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006; Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213; Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; COWAN GSM, 1976, J APPL PHYSIOL, V40, P962, DOI 10.1152/jappl.1976.40.6.962; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kitterman JA, 1996, CLIN PERINATOL, V23, P727, DOI 10.1016/S0095-5108(18)30205-7; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Loi R, 2006, AM J RESP CRIT CARE, V173, P171, DOI 10.1164/rccm.200502-309OC; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mondrinos MJ, 2007, AM J PHYSIOL-LUNG C, V293, pL639, DOI 10.1152/ajplung.00403.2006; Mondrinos MJ, 2008, TISSUE ENG PT A, V14, P361, DOI 10.1089/tea.2007.0041; Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717; Ng CY, 2009, FRONT BIOSCI-LANDMRK, V14, P1627, DOI 10.2741/3330; Nichols JE, 2009, ORGANOGENESIS, V5, P57, DOI 10.4161/org.5.2.8564; Nichols Joan E, 2008, Proc Am Thorac Soc, V5, P723, DOI 10.1513/pats.200802-022AW; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Olsen CE, 2005, EXP LUNG RES, V31, P461, DOI 10.1080/01902140590918830; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Soccal PM, 2000, TRANSPLANTATION, V70, P998, DOI 10.1097/00007890-200010150-00002; SUGIHARA H, 1993, AM J PATHOL, V142, P783; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; WEIBEL ER, 1964, J CELL BIOL, V21, P367, DOI 10.1083/jcb.21.3.367; Xu J, 1998, AM J PHYSIOL-LUNG C, V275, pL545, DOI 10.1152/ajplung.1998.275.3.L545; 2004, DEATHS FINAL DATA 20; 2004, NATL HLTH INTERVIEW	34	781	822	6	235	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					927	U131		10.1038/nm.2193	http://dx.doi.org/10.1038/nm.2193			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20628374				2022-12-27	WOS:000280649200034
J	Larder, R; O'Rahilly, S				Larder, Rachel; O'Rahilly, Stephen			Guts over glory-why diets fail	NATURE MEDICINE			English	Editorial Material							LONG-TERM PERSISTENCE; WEIGHT-LOSS		[Larder, Rachel; O'Rahilly, Stephen] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Larder, R (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England.	so104@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Larder, Rachel/0000-0003-1697-9455	Medical Research Council [G0900554] Funding Source: Medline; MRC [G0900554] Funding Source: UKRI; Medical Research Council [G0600717B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Meguid MM, 2008, NUTRITION, V24, P832, DOI 10.1016/j.nut.2008.06.027; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Powell AG, 2011, CLIN PHARMACOL THER, V90, P40, DOI 10.1038/clpt.2011.82; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816	14	15	16	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					666	667		10.1038/nm.2747	http://dx.doi.org/10.1038/nm.2747			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561823				2022-12-27	WOS:000303763500033
J	D'Arcy, P; Brnjic, S; Olofsson, MH; Fryknas, M; Lindsten, K; De Cesare, M; Perego, P; Sadeghi, B; Hassan, M; Larsson, R; Linder, S				D'Arcy, Padraig; Brnjic, Slavica; Olofsson, Maria Hagg; Fryknas, Marten; Lindsten, Kristina; De Cesare, Michelandrea; Perego, Paola; Sadeghi, Behnam; Hassan, Moustapha; Larsson, Rolf; Linder, Stig			Inhibition of proteasome deubiquitinating activity as a new cancer therapy	NATURE MEDICINE			English	Article							26S PROTEASOME; CELL-DEATH; DEGRADATION; APOPTOSIS; ROLES; P53; PHOSPHORYLATION; UBIQUITINATION; EXPRESSION; BORTEZOMIB	Ubiquitin-tagged substrates are degraded by the 26S proteasome, which is a multisubunit complex comprising a proteolytic 20S core particle capped by 19S regulatory particles(1,2). The approval of bortezomib for the treatment of multiple myeloma validated the 20S core particle as an anticancer drug target(3). Here we describe the small molecule b-AP15 as a previously unidentified class of proteasome inhibitor that abrogates the deubiquitinating activity of the 19S regulatory particle. b-AP15 inhibited the activity of two 19S regulatory-particle-associated deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and ubiquitin-specific peptidase 14 (USP14), resulting in accumulation of polyubiquitin. b-AP15 induced tumor cell apoptosis that was insensitive to TP53 status and overexpression of the apoptosis inhibitor BCL2. We show that treatment with b-AP15 inhibited tumor progression in four different in vivo solid tumor models and inhibited organ infiltration in an acute myeloid leukemia model. Our results show that the deubiquitinating activity of the 19S regulatory particle is a new anticancer drug target.	[D'Arcy, Padraig; Brnjic, Slavica; Olofsson, Maria Hagg; Linder, Stig] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Fryknas, Marten; Larsson, Rolf] Uppsala Univ, Div Clin Pharmacol, Dept Med Sci, Uppsala, Sweden; [Lindsten, Kristina] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [De Cesare, Michelandrea; Perego, Paola] Ist Nazl Studio & Cura Tumori, Fdn Ist Ricovero & Cura Carattere Sci, I-20133 Milan, Italy; [Sadeghi, Behnam] Karolinska Inst, Inst Lab Med, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clin Res Ctr Novum, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Fondazione IRCCS Istituto Nazionale Tumori Milan; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Linder, S (corresponding author), Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.	stig.linder@ki.se	D'Arcy, Pádraig/AAB-5045-2019; 高, 雨莉/HGU-8187-2022; Sadeghi, Behnam/AAH-1221-2019; Hassan, Moustapha/H-9260-2015; De Cesare, Michelandrea/M-6667-2017; Perego, Paola/J-7647-2016; D'Arcy, Pádraig/F-7633-2018	D'Arcy, Pádraig/0000-0001-6671-7600; Sadeghi, Behnam/0000-0002-8721-0400; Hassan, Moustapha/0000-0003-1927-5859; De Cesare, Michelandrea/0000-0001-9687-0753; Perego, Paola/0000-0003-2806-7269; D'Arcy, Pádraig/0000-0001-6671-7600	Cancerfonden; Radiumhemmets forskningsfonder; Vetenskapsradet; Strategiska forskningsstiftelsen; Vinnova; European Union CHEMORES [LSHC-CT-2007-037665]; Lions Cancerforskningsfond; Swedish Children Cancer Society	Cancerfonden(Swedish Cancer Society); Radiumhemmets forskningsfonder; Vetenskapsradet(Swedish Research Council); Strategiska forskningsstiftelsen; Vinnova(Vinnova); European Union CHEMORES; Lions Cancerforskningsfond; Swedish Children Cancer Society(Swedish Cancer Society)	We thank M. Glickman (Department of Biology, Technion-Israel Institute of Technology) for providing the Ub-GFP constructs, N. Dantuma (Department of Cell and Molecular Biology, Karolinska Institutet) for providing the MelJuSo Ub-YFP reporter cell line, B. Vogelstein (Sidney Kimmel Comprehensive Cancer Center, John Hopkins University) for providing the HCT-116 cell lines with targeted disruptions, L. Perup Segerstrom for technical advice, Uppsala Array Platform and L. Gatti for drug formulation. We thank Cancerfonden, Radiumhemmets forskningsfonder, Vetenskapsradet, Strategiska forskningsstiftelsen, Vinnova, European Union CHEMORES, Frame Program 6 (LSHC-CT-2007-037665), Lions Cancerforskningsfond and Swedish Children Cancer Society for support.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Berndtsson M, 2009, INT J CANCER, V124, P1463, DOI 10.1002/ijc.24004; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Dimmock JR, 2001, J MED CHEM, V44, P586, DOI 10.1021/jm0002580; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; MA CP, 1994, J BIOL CHEM, V269, P3539; Maki CG, 1996, CANCER RES, V56, P2649; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mullally JE, 2002, MOL PHARMACOL, V62, P351, DOI 10.1124/mol.62.2.351; Olofsson MH, 2009, CANCER BIOMARK, V5, P117, DOI 10.3233/CBM-2009-0597; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	32	369	378	7	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1636	U150		10.1038/nm.2536	http://dx.doi.org/10.1038/nm.2536			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057347	Green Accepted			2022-12-27	WOS:000297978000035
J	Jung, P; Sato, T; Merlos-Suarez, A; Barriga, FM; Iglesias, M; Rossell, D; Auer, H; Gallardo, M; Blasco, MA; Sancho, E; Clevers, H; Batlle, E				Jung, Peter; Sato, Toshiro; Merlos-Suarez, Anna; Barriga, Francisco M.; Iglesias, Mar; Rossell, David; Auer, Herbert; Gallardo, Mercedes; Blasco, Maria A.; Sancho, Elena; Clevers, Hans; Batlle, Eduard			Isolation and in vitro expansion of human colonic stem cells	NATURE MEDICINE			English	Article							COLORECTAL-CANCER; INTESTINAL EPITHELIUM; SELF-RENEWAL	Here we describe the isolation of stem cells of the human colonic epithelium. Differential cell surface abundance of ephrin type-B receptor 2 (EPHB2) allows the purification of different cell types from human colon mucosa biopsies. The highest EPHB2 surface levels correspond to epithelial colonic cells with the longest telomeres and elevated expression of intestinal stem cell (ISC) marker genes. Moreover, using culturing conditions that recreate the ISC niche, a substantial proportion of EPHB2-high cells can be expanded in vitro as an undifferentiated and multipotent population.	[Jung, Peter; Merlos-Suarez, Anna; Barriga, Francisco M.; Sancho, Elena; Batlle, Eduard] Inst Biomed Res, Oncol Program, Barcelona, Spain; [Sato, Toshiro; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Sato, Toshiro; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Shinjuku Ku, Tokyo, Japan; [Iglesias, Mar] Univ Autonoma Barcelona, Dept Pathol, Hosp Univ Mar, E-08193 Barcelona, Spain; [Rossell, David] Inst Biomed Res, Biostat & Bioinformat Unit, Barcelona, Spain; [Auer, Herbert] Inst Biomed Res, Funct Genom Core Facil, Barcelona, Spain; [Gallardo, Mercedes; Blasco, Maria A.] Spanish Natl Canc Res Ctr, Telomeres & Telomerase Grp, Mol Oncol Program, Madrid, Spain; [Batlle, Eduard] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Keio University; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); ICREA	Batlle, E (corresponding author), Inst Biomed Res, Oncol Program, Barcelona, Spain.	eduard.batlle@irbbarcelona.org	Blasco, Maria A./M-1694-2014; Batlle, Eduard/K-8080-2014; Rossell, David/AAM-4292-2021; Sato, Toshiro/J-3522-2014; Auer, Herbert/AAV-2332-2020; Sancho, Elena/ABH-4867-2020	Blasco, Maria A./0000-0002-4211-233X; Batlle, Eduard/0000-0003-2422-0326; Rossell, David/0000-0002-7104-5789; Sato, Toshiro/0000-0001-8353-8137; Sancho, Elena/0000-0002-8182-513X; Barriga, Francisco/0000-0002-0996-7707	Spanish Ministry of Science and Innovation (MICINN); European Research Council (ERC); Instituto de Salud Carlos III [RD09/0076/00036]; Pla Director d'Oncologia de Catalunya (XBTC); EU; Botin Foundation; Lilly Foundation; Korber European Science Award; Marie Curie Fellowship (FP7); ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Pla Director d'Oncologia de Catalunya (XBTC); EU(European Commission); Botin Foundation; Lilly Foundation; Korber European Science Award; Marie Curie Fellowship (FP7)(European Commission); ICREA(ICREA)	We thank Genentech for the EphB2-specific antibody Mab 2H9 and the Institute for Research in Biomedicine transcriptomic facility, electronic microscopy service (Universitat de Barcelona) and Cell separation unit (UB) for expert assistance. We thank L. Lopez Vilaro and E. Calderon Gomez for help with mucosas. This work is supported by grants to E.B. from the CONSOLIDER and Plan Nacional I+D+i Programs from Spanish Ministry of Science and Innovation (MICINN) and the European Research Council (ERC-FP7). Work was furthermore supported by grants from Instituto de Salud Carlos III FEDER (RD09/0076/00036). The 'Xarxa de Bancs de tumors' is sponsored by Pla Director d'Oncologia de Catalunya (XBTC). The M.A.B. laboratory is founded by the MICINN, the EU, the Botin and Lilly Foundations, and the Korber European Science Award to M.A.B. P.J. holds a Marie Curie Fellowship (FP7).	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Joseph RR, 2005, APOPTOSIS, V10, P1221, DOI 10.1007/s10495-005-2049-y; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211	10	463	494	6	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1225	1227		10.1038/nm.2470	http://dx.doi.org/10.1038/nm.2470			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21892181				2022-12-27	WOS:000296022100038
J	Liu, PX; Cheng, HL; Santiago, S; Raeder, M; Zhang, F; Isabella, A; Yang, J; Semaan, DJ; Chen, CZ; Fox, EA; Gray, NS; Monahan, J; Schlegel, R; Beroukhim, R; Mills, GB; Zhao, JJ				Liu, Pixu; Cheng, Hailing; Santiago, Stephanie; Raeder, Maria; Zhang, Fan; Isabella, Adam; Yang, Janet; Semaan, Derek J.; Chen, Changzhong; Fox, Edward A.; Gray, Nathanael S.; Monahan, John; Schlegel, Robert; Beroukhim, Rameen; Mills, Gordon B.; Zhao, Jean J.			Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms	NATURE MEDICINE			English	Article							BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; MET AMPLIFICATION; EPITHELIAL-CELLS; COPY NUMBER; MUTATIONS; PIK3CA; INHIBITORS; GDC-0941; PTEN	PIK3CA gain-of-function mutations are a common oncogenic event in human malignancy(1-4), making phosphatidylinositol 3-kinase (PI3K) a target for cancer therapy. Despite the promise of targeted therapy, resistance often develops, leading to treatment failure. To elucidate mechanisms of resistance to PI3K-targeted therapy, we constructed a mouse model of breast cancer conditionally expressing human PIK3CA(H1047R). Notably, most PIK3CA(H1047R)-driven mammary tumors recurred after PIK3CA(H1047R) inactivation. Genomic analyses of recurrent tumors revealed multiple lesions, including focal amplification of Met or Myc (also known as c-Met and c-Myc, respectively). Whereas Met amplification led to tumor survival dependent on activation of endogenous PI3K, tumors with Myc amplification became independent of the PI3K pathway. Functional analyses showed that Myc contributed to oncogene independence and resistance to PI3K inhibition. Notably, PIK3CA mutations and c-MYC elevation co-occur in a substantial fraction of human breast tumors. Together, these data suggest that c-MYC elevation represents a potential mechanism by which tumors develop resistance to current PI3K-targeted therapies.	[Liu, Pixu; Cheng, Hailing; Santiago, Stephanie; Raeder, Maria; Isabella, Adam; Yang, Janet; Semaan, Derek J.; Gray, Nathanael S.; Beroukhim, Rameen; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Pixu; Cheng, Hailing; Santiago, Stephanie; Gray, Nathanael S.; Zhao, Jean J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cheng, Hailing; Zhao, Jean J.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Raeder, Maria] Univ Bergen, Dept Clin Med, Bergen, Norway; [Raeder, Maria] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Zhang, Fan; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Fox, Edward A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fox, Edward A.; Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Monahan, John; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA USA; [Beroukhim, Rameen] Broad Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Novartis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean_zhao@dfci.harvard.edu		Monahan, John/0000-0002-3125-8704	US National Institutes of Health [CA134502, CA148164-01, K08CA122833]; Stand Up To Cancer; Dana Farber Harvard Cancer Center breast cancer SPORE [P50 CA089393-08S1]; US Department of Defense [BC051565]; V Foundation; Claudia Barr Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [RC2CA148164, P50CA098258, R01CA134502, P50CA089393, K08CA122833, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer; Dana Farber Harvard Cancer Center breast cancer SPORE; US Department of Defense(United States Department of Defense); V Foundation; Claudia Barr Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Roberts, L. Cantley and W. Sellers for scientific discussions and suggestions. We thank L. Clayton and D. Silver for critical review of this manuscript. We thank R. Bronson for pathological analyses of tumor samples. We thank C. Li and E. Allgood for technical assistance. We thank L. Chodosh (University of Pennsylvania School of Medicine) for providing MMTV-rtTA mice. This work was supported by US National Institutes of Health grants CA134502 (J.J.Z.), CA148164-01 (J.J.Z. and N.S.G.) and K08CA122833 (R.B.), Stand Up To Cancer (J.J.Z. and G.B.M.), Dana Farber Harvard Cancer Center breast cancer SPORE grant P50 CA089393-08S1 (J.J.Z.), the US Department of Defense (BC051565 to J.J.Z.), the V Foundation (J.J.Z. and R.B.) and the Claudia Barr Program (J.J.Z.). In compliance with Harvard Medical School guidelines, we disclose that J.J.Z. and R.B. are consultants for Novartis Pharmaceuticals.	Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	28	200	203	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1116	U122		10.1038/nm.2402	http://dx.doi.org/10.1038/nm.2402			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21822287	Green Accepted			2022-12-27	WOS:000294605100032
J	d'Ydewalle, C; Krishnan, J; Chiheb, DM; Van Damme, P; Irobi, J; Kozikowski, AP; Vanden Berghe, P; Timmerman, V; Robberecht, W; Van Den Bosch, L				d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Irobi, Joy; Kozikowski, Alan P.; Vanden Berghe, Pieter; Timmerman, Vincent; Robberecht, Wim; Van Den Bosch, Ludo			HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease	NATURE MEDICINE			English	Article							HEAT-SHOCK PROTEINS; HEREDITARY MOTOR NEUROPATHY; NERVOUS-SYSTEM; MITOCHONDRIAL TRANSPORT; NEUROFILAMENT NETWORK; TUBULIN ACETYLATION; CELLULAR FUNCTIONS; TRANSGENIC MICE; GAIT ANALYSIS; MITOFUSIN 2	Charcot-Marie-Tooth disease (CMT) is the most common inherited disorder of the peripheral nervous system. Mutations in the 27-kDa small heat-shock protein gene (HSPB1) cause axonal CMT or distal hereditary motor neuropathy (distal HMN). We developed and characterized transgenic mice expressing two different HSPB1 mutations (S135F and P182L) in neurons only. These mice showed all features of CMT or distal HMN dependent on the mutation. Expression of mutant HSPB1 decreased acetylated a-tubulin abundance and induced severe axonal transport deficits. An increase of a-tubulin acetylation induced by pharmacological inhibition of histone deacetylase 6 (HDAC6) corrected the axonal transport defects caused by HSPB1 mutations and rescued the CMT phenotype of symptomatic mutant HSPB1 mice. Our findings demonstrate the pathogenic role of a-tubulin deacetylation in mutant HSPB1-induced neuropathies and offer perspectives for using HDAC6 inhibitors as a therapeutic strategy for hereditary axonopathies.	[d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo] VIB, Vesalius Res Ctr, Louvain, Belgium; [d'Ydewalle, Constantin; Krishnan, Jyothsna; Chiheb, Driss M.; Van Damme, Philip; Robberecht, Wim; Van Den Bosch, Ludo] Katholieke Univ Leuven, Neurobiol Lab, Louvain, Belgium; [Van Damme, Philip; Robberecht, Wim] Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Irobi, Joy; Timmerman, Vincent] VIB, Dept Mol Genet, Peripheral Neuropathy Grp, Antwerp, Belgium; [Irobi, Joy; Timmerman, Vincent] Univ Antwerp, B-2020 Antwerp, Belgium; [Irobi, Joy; Timmerman, Vincent] Inst Born Bunge, Neurogenet Lab, Antwerp, Belgium; [Kozikowski, Alan P.] Univ Illinois, Dept Med Chem & Pharmacognosy, Drug Discovery Program, Chicago, IL USA; [Vanden Berghe, Pieter] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Lab Enter Neurosci, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; KU Leuven	Van Den Bosch, L (corresponding author), VIB, Vesalius Res Ctr, Campus Gasthuisberg, Louvain, Belgium.	ludo.vandenbosch@vib-kuleuven.be	Timmerman, Vincent/O-7283-2019; Van Den Bosch, Ludo/B-7258-2012; Van Damme, Philip/A-6464-2009	Timmerman, Vincent/0000-0002-2162-0933; Van Damme, Philip/0000-0002-4010-2357; Van Den Bosch, Ludo/0000-0003-0104-4067; Vanden Berghe, Pieter/0000-0002-0009-2094	American Chemical Society; International Rett Syndrome Foundation; Fund for Scientific Research Flanders (FWO-Vlaanderen); University of Leuven [GOA/12/014, OT/10/046]; Belgian government (Belgian Federal Science Policy Office) [P6/43]; Association Belge contre les Maladies neuro-Musculaires; Association Francaise contre les Myopathies [13169, 14471]; Frick Foundation for Amyotrophic Lateral Sclerosis Research; Muscular Dystrophy Association; European Community [259867]; Agency for Innovation by Science and Technology in Flanders	American Chemical Society(American Chemical Society); International Rett Syndrome Foundation; Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); University of Leuven(KU Leuven); Belgian government (Belgian Federal Science Policy Office)(Belgian Federal Science Policy Office); Association Belge contre les Maladies neuro-Musculaires; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Frick Foundation for Amyotrophic Lateral Sclerosis Research; Muscular Dystrophy Association(Muscular Dystrophy Association); European Community(European Commission); Agency for Innovation by Science and Technology in Flanders	We thank L. Almeida-Souza and S. Janssens for their constructive comments and the Molecular Small Animal Imaging Centre (MoSAIC, K. U. Leuven) for the use of the Catwalk system. We are grateful to B. Weynants and N. Hersmus for the technical assistance. We thank R. Mazitschek and J. Bradner (Dana-Farber Cancer Institute, Harvard Medical School) for kindly giving us tubacin. The research to create tubastatin A was supported by an American Chemical Society Fellowship and by the International Rett Syndrome Foundation. We thank J. H. Kalin for helping us with the creation of the HDAC6 homology model. This work was supported by grants from the Fund for Scientific Research Flanders (FWO-Vlaanderen), the University of Leuven (K. U. Leuven, GOA/12/014 and OT/10/046), the Belgian government (Interuniversity Attraction Poles, programme P6/43 of the Belgian Federal Science Policy Office), the Association Belge contre les Maladies neuro-Musculaires, the Association Francaise contre les Myopathies (projects 13169 and 14471), the Frick Foundation for Amyotrophic Lateral Sclerosis Research, the Muscular Dystrophy Association and the European Community's Health Seventh Framework Programme (FP7/2007-2013 under grant agreement 259867). C.d.Y. is supported by the Agency for Innovation by Science and Technology in Flanders. P. V. D. is a clinical researcher, and J. I. is a postdoctoral fellow of the FWO-Vlaanderen. W. R. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dequen F, 2010, HUM MOL GENET, V19, P2616, DOI 10.1093/hmg/ddq149; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Dietz KC, 2010, PHARMACOL RES, V62, P11, DOI 10.1016/j.phrs.2010.01.011; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ikeda Y, 2009, J NEUROL SCI, V277, P9, DOI 10.1016/j.jns.2008.09.031; Ismailov SM, 2001, EUR J HUM GENET, V9, P646, DOI 10.1038/sj.ejhg.5200686; James PA, 2008, J NEUROL NEUROSUR PS, V79, P461, DOI 10.1136/jnnp.2007.125179; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kijima K, 2005, J HUM GENET, V50, P473, DOI 10.1007/s10038-005-0280-6; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Vanden Berghe P, 2004, AM J PHYSIOL-GASTR L, V286, pG671, DOI 10.1152/ajpgi.00283.2003; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Xanthoudakis S, 2000, NAT CELL BIOL, V2, pE163, DOI 10.1038/35023643; Zhai JB, 2007, HUM MOL GENET, V16, P3103, DOI 10.1093/hmg/ddm272; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	47	319	348	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					968	U86		10.1038/nm.2396	http://dx.doi.org/10.1038/nm.2396			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785432				2022-12-27	WOS:000293507400030
J	Majewski, IJ; Bernards, R				Majewski, Ian J.; Bernards, Rene			Taming the dragon: genomic biomarkers to individualize the treatment of cancer	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; GENE-EXPRESSION SIGNATURE; CHRONIC MYELOGENOUS LEUKEMIA; ANAPLASTIC LYMPHOMA KINASE; METASTATIC BREAST-CANCER; EML4-ALK FUSION GENE; DNA-REPAIR DEFECT; COLORECTAL-CANCER; ACTIVATING MUTATIONS; TYROSINE KINASE	The gradual shift from cytotoxic drugs to highly selective, targeted therapeutic agents for cancer requires a parallel effort to characterize cancers at the molecular level to guide the choice of therapy for the individual patient. Here we review the genomic technologies that can be used to develop these drug response indicators, or biomarkers. We also discuss hurdles in their development and the implementation of biomarkers in clinical practice.	[Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands; Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423; Majewski, Ian/0000-0002-6087-635X	Dutch Cancer Society; The Netherlands Organisation for Scientific Research; European Research Council; National Health and Medical Research Council of Australia	Dutch Cancer Society(KWF Kankerbestrijding); The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Our work was supported by grants from the Dutch Cancer Society, The Netherlands Organisation for Scientific Research and the European Research Council. I.M. was supported by a fellowship from the National Health and Medical Research Council of Australia.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Borst P, 2010, CELL CYCLE, V9, P4836, DOI 10.4161/cc.9.24.14326; Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Clark G M, 1983, Prog Clin Biol Res, V132E, P183; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Dagher R, 2002, CLIN CANCER RES, V8, P3034; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hazarika M, 2008, CLIN CANCER RES, V14, P5325, DOI 10.1158/1078-0432.CCR-08-0308; Hede K, 2008, J NATL CANCER I, V100, P836, DOI 10.1093/jnci/djn200; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lee Adam, 2004, Clin Adv Hematol Oncol, V2, P527; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lo YMD, 2009, CLIN CHEM, V55, P607, DOI 10.1373/clinchem.2009.123661; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Monzon FA, 2010, ARCH PATHOL LAB MED, V134, P216, DOI 10.1043/1543-2165-134.2.216; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Moroni M, 2005, ANN ONCOL, V16, P1848, DOI 10.1093/annonc/mdi356; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Nkoy FL, 2010, ARCH PATHOL LAB MED, V134, P606, DOI 10.1043/1543-2165-134.4.606; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Singer JB, 2007, LEUKEMIA, V21, P2311, DOI 10.1038/sj.leu.2404827; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sparano JA, 2006, CLIN BREAST CANCER, V7, P347, DOI 10.3816/CBC.2006.n.051; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turner N, 2005, CURR OPIN PHARMACOL, V5, P388, DOI 10.1016/j.coph.2005.03.006; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Kuilenburg ABP, 2002, INT J CANCER, V101, P253, DOI 10.1002/ijc.10599; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	124	62	65	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					304	312		10.1038/nm.2311	http://dx.doi.org/10.1038/nm.2311			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21386834				2022-12-27	WOS:000288070000041
J	Makowski, MR; Wiethoff, AJ; Blume, U; Cuello, F; Warley, A; Jansen, CHP; Nagel, E; Razavi, R; Onthank, DC; Cesati, RR; Marber, MS; Schaeffter, T; Smith, A; Robinson, SP; Botnar, RM				Makowski, Marcus R.; Wiethoff, Andrea J.; Blume, Ulrike; Cuello, Friederike; Warley, Alice; Jansen, Christian H. P.; Nagel, Eike; Razavi, Reza; Onthank, David C.; Cesati, Richard R.; Marber, Michael S.; Schaeffter, Tobias; Smith, Alberto; Robinson, Simon P.; Botnar, Rene M.			Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent	NATURE MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; VESSEL WALL; PROGNOSTIC VALUE; CAROTID-ARTERY; ANGIOGRAPHY; COLLAGEN; ACQUISITION; TOMOGRAPHY; EXPRESSION	Atherosclerosis and its consequences remain the main cause of mortality in industrialized and developing nations. Plaque burden and progression have been shown to be independent predictors for future cardiac events by intravascular ultrasound. Routine prospective imaging is hampered by the invasive nature of intravascular ultrasound. A noninvasive technique would therefore be more suitable for screening of atherosclerosis in large populations. Here we introduce an elastin-specific magnetic resonance contrast agent (ESMA) for noninvasive quantification of plaque burden in a mouse model of atherosclerosis. The strong signal provided by ESMA allows for imaging with high spatial resolution, resulting in accurate assessment of plaque burden. Additionally, plaque characterization by quantifying intraplaque elastin content using signal intensity measurements is possible. Changes in elastin content and the high abundance of elastin during plaque development, in combination with the imaging properties of ESMA, provide potential for noninvasive assessment of plaque burden by molecular magnetic resonance imaging (MRI).	[Makowski, Marcus R.; Wiethoff, Andrea J.; Blume, Ulrike; Jansen, Christian H. P.; Nagel, Eike; Razavi, Reza; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Makowski, Marcus R.; Cuello, Friederike; Nagel, Eike; Razavi, Reza; Marber, Michael S.; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, British Heart Fdn BHF Ctr Excellence, London WC2R 2LS, England; [Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany; [Wiethoff, Andrea J.] Philips Healthcare, Guildford, Surrey, England; [Cuello, Friederike; Marber, Michael S.; Smith, Alberto] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Warley, Alice] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Nagel, Eike; Razavi, Reza; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, Wellcome Trust, London WC2R 2LS, England; [Nagel, Eike; Razavi, Reza; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, Engn & Phys Sci Res Council, Med Engn Ctr, London WC2R 2LS, England; [Nagel, Eike; Razavi, Reza; Marber, Michael S.; Schaeffter, Tobias; Smith, Alberto; Botnar, Rene M.] Kings Coll London, Natl Inst Hlth Res, Biomed Res Ctr, London WC2R 2LS, England; [Smith, Alberto] Kings Coll London, Acad Surg, London WC2R 2LS, England; [Onthank, David C.; Cesati, Richard R.; Robinson, Simon P.] Lantheus Med Imaging, N Billerica, MA USA	University of London; King's College London; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philips; Philips Healthcare; University of London; King's College London; University of London; King's College London; University of London; King's College London; University College London; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; King's College London; University of London; King's College London; University of London; King's College London	Makowski, MR (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England.	marcus.makowski@kcl.ac.uk	Schaeffter, Tobias/AAI-6826-2020; Nagel, Eike/C-6903-2008; Makowski, Marcus R/Q-7957-2018; marber, michael/AAW-7916-2021; Botnar, Rene Michael/AAZ-2112-2020; Cuello, Friederike/A-9642-2016; Botnar, Rene M/E-6875-2012	Schaeffter, Tobias/0000-0003-1310-2631; Nagel, Eike/0000-0002-6044-950X; Botnar, Rene M/0000-0003-2811-2509; Razavi, Reza/0000-0003-1065-3008; Marber, Michael/0000-0002-3463-7128; Botnar, Rene/0000-0002-9447-4367	BHF [PG/09/061]; Medical Research Council [G0600698B] Funding Source: researchfish	BHF(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a BHF project grant (PG/09/061) awarded to R. M. B. M. R. M. was partly funded by a BHF studentship awarded to R. M. B. ESMA (BMS753951) was provided by Lantheus Medical Imaging. Supporting data for the in vitro rabbit competition and in vivo mouse distribution studies were provided by P. Yalamanchili, M. Kavosi and P. Silva from Lantheus Medical Imaging.	Botnar RM, 2000, CIRCULATION, V102, P2582; Botnar RM, 2004, CIRCULATION, V110, P1463, DOI 10.1161/01.CIR.0000134960.31304.87; Botnar RM, 2001, MAGNET RESON MED, V46, P848, DOI 10.1002/mrm.1268; Brasselet C, 2005, AM J PHYSIOL-HEART C, V289, pH2228, DOI 10.1152/ajpheart.00410.2005; Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Fayad ZA, 2000, CIRCULATION, V102, P506; Finn AV, 2010, CIRCULATION, V121, P1165, DOI 10.1161/CIR.0b013e3181d83b4f; Firbank MJ, 2000, BRIT J RADIOL, V73, P376, DOI 10.1259/bjr.73.868.10844863; Hadamitzky M, 2010, DIABETES CARE, V33, P1358, DOI 10.2337/dc09-2104; Helm PA, 2008, RADIOLOGY, V247, P788, DOI 10.1148/radiol.2473070975; Ibrahim T, 2009, JACC-CARDIOVASC IMAG, V2, P580, DOI 10.1016/j.jcmg.2008.12.029; ISIK FF, 1994, TRANSPLANTATION, V58, P1246, DOI 10.1097/00007890-199412270-00019; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Katsuda Shogo, 2003, J Atheroscler Thromb, V10, P267; KAUFMAN L, 1989, RADIOLOGY, V173, P265, DOI 10.1148/radiology.173.1.2781018; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Masuda H, 1999, ARTERIOSCL THROM VAS, V19, P2298, DOI 10.1161/01.ATV.19.10.2298; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; MOCK MB, 1982, CIRCULATION, V66, P562, DOI 10.1161/01.CIR.66.3.562; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; Nili NF, 2002, CARDIOVASC PATHOL, V11, P272, DOI 10.1016/S1054-8807(02)00119-9; Onthank D, 2007, CIRCULATION, V116, P411; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926; Wasserman BA, 2002, RADIOLOGY, V223, P566, DOI 10.1148/radiol.2232010659; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052	36	130	131	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					383	U188		10.1038/nm.2310	http://dx.doi.org/10.1038/nm.2310			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21336283				2022-12-27	WOS:000288070000051
J	Parra, A; Madrid, R; Echevarria, D; del Olmo, S; Morenilla-Palao, C; Acosta, MC; Gallar, J; Dhaka, A; Viana, F; Belmonte, C				Parra, Andres; Madrid, Rodolfo; Echevarria, Diego; del Olmo, Susana; Morenilla-Palao, Cruz; Carmen Acosta, M.; Gallar, Juana; Dhaka, Ajay; Viana, Felix; Belmonte, Carlos			Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea	NATURE MEDICINE			English	Article							TEAR SECRETION; DRY EYE; TRPM8; STIMULATION; CHANNELS; NEURONS; TRPA1	Basal tearing is crucial to maintaining ocular surface wetness. Corneal cold thermoreceptors sense small oscillations in ambient temperature and change their discharge accordingly. Deletion of the cold-transducing ion channel Transient receptor potential cation channel subfamily M member 8 (TRPM8) in mice abrogates cold responsiveness and reduces basal tearing without affecting nociceptor-mediated irritative tearing. Warming of the cornea in humans also decreases tearing rate. These findings indicate that TRPM8-dependent impulse activity in corneal cold receptors contributes to regulating basal tear flow. (C) 2010 Nature America, Inc. All rights reserved.	[Parra, Andres; Madrid, Rodolfo; Echevarria, Diego; Morenilla-Palao, Cruz; Carmen Acosta, M.; Gallar, Juana; Viana, Felix; Belmonte, Carlos] Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alacant, Spain; [Madrid, Rodolfo] Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Santiago, Chile; [del Olmo, Susana; Belmonte, Carlos] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo, Spain; [Dhaka, Ajay] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de Santiago de Chile; University of Washington; University of Washington Seattle	Belmonte, C (corresponding author), Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alacant, Spain.	carlos.belmonte@umh.es	Acosta, M.Carmen/K-1313-2014; Gallar, Juana/B-4563-2011; del Olmo Aguado, Susana/AAY-3497-2021; Echevarria, Diego/P-7391-2019; Viana, Felix/U-8533-2017; Echevarria, Diego/E-6386-2016	Gallar, Juana/0000-0002-3559-3649; del Olmo Aguado, Susana/0000-0002-2867-7254; Echevarria, Diego/0000-0002-0938-7470; Viana, Felix/0000-0003-1439-949X; Echevarria, Diego/0000-0002-0938-7470; parra martin, andres/0000-0003-3389-5288; Madrid, Rodolfo/0000-0002-8623-5761; Acosta, M. Carmen/0000-0002-1759-068X; Morenilla-Palao, Cruz/0000-0002-8159-1206	Spanish MICINN [BFU2008-04425, BFU2007-61855, SAF2008-00529, SAF2008-01004, CSD2007-00023]; Fundacion de Investigacion Oftalmologica, Instituto de Oftalmologia Fernandez-Vega; FONDECYT [1100983]; Fundacion M. C.-Masadeu-Peterson	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion de Investigacion Oftalmologica, Instituto de Oftalmologia Fernandez-Vega; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacion M. C.-Masadeu-Peterson	We thank E. Quintero, A. Miralles, M. Bayonas, A. Estirado, S. Ingham and A. Perez-Vegara for skillful technical assistance and P. Orio for help with the spike frequency analysis. The Trpa1<SUP>-/-</SUP> mice were a generous gift from D. Corey (Harvard Medical School). This work was supported by the Spanish MICINN: projects BFU2008-04425 to C. B., BFU2007-61855 to F. V., SAF2008-00529 to J.G., SAF2008-01004 to D. E. and CONSOLIDER-INGENIO 2010 CSD2007-00023, and by the Fundacion de Investigacion Oftalmologica, Instituto de Oftalmologia Fernandez-Vega and Fundacion M. C.-Masadeu-Peterson. R. M. thanks the support of FONDECYT-1100983.	Acosta MC, 2004, INVEST OPHTH VIS SCI, V45, P2333, DOI 10.1167/iovs.03-1366; Acosta MC, 2001, J PHYSIOL-LONDON, V534, P511, DOI 10.1111/j.1469-7793.2001.t01-1-00511.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Belmonte C, 2007, J REFRACT SURG, V23, P598, DOI 10.3928/1081-597X-20070601-11; Belmonte C, 2009, EXP BRAIN RES, V196, P13, DOI 10.1007/s00221-009-1797-2; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LEHRER S, 1994, AM J OBSTET GYNECOL, V170, P835, DOI 10.1016/S0002-9378(94)70294-2; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moss SE, 2008, OPTOMETRY VISION SCI, V85, P668, DOI 10.1097/OPX.0b013e318181a947; Niederer RL, 2007, BRIT J OPHTHALMOL, V91, P1165, DOI 10.1136/bjo.2006.112656; Purslow C, 2007, OPTOMETRY VISION SCI, V84, P197, DOI 10.1097/OPX.0b013e3180339f6e; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030	20	213	220	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1396	1399		10.1038/nm.2264	http://dx.doi.org/10.1038/nm.2264			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21076394				2022-12-27	WOS:000285048900032
J	Ryan, MA; Nattamai, KJ; Xing, E; Schleimer, D; Daria, D; Sengupta, A; Kohler, A; Liu, W; Gunzer, M; Jansen, M; Ratner, N; Le Cras, TD; Waterstrat, A; Van Zant, G; Cancelas, JA; Zheng, Y; Geiger, H				Ryan, Marnie A.; Nattamai, Kalpana J.; Xing, Ellen; Schleimer, David; Daria, Deidre; Sengupta, Amitava; Koehler, Anja; Liu, Wei; Gunzer, Matthias; Jansen, Michael; Ratner, Nancy; Le Cras, Timothy D.; Waterstrat, Amanda; Van Zant, Gary; Cancelas, Jose A.; Zheng, Yi; Geiger, Hartmut			Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; CDC42; RECEPTOR; ADHESION; GTPASES; ACTIVATION; EXPRESSION; MIGRATION; MURINE	Mobilization of hematopoietic stem and progenitor cells (HSPCs) from bone marrow into peripheral blood by the cytokine granulocyte colony-stimulating factor (G-CSF) has become the preferred source of HSPCs for stem cell transplants(1-9). However, G-CSF fails to mobilize sufficient numbers of stem cells in up to 10% of donors, precluding autologous transplantation in those donors or substantially delaying transplant recovery time(2). Consequently, new regimens are needed to increase the number of stem cells in peripheral blood upon mobilization. Using a forward genetic approach in mice, we mapped the gene encoding the epidermal growth factor receptor (Egfr) to a genetic region modifying G-CSF-mediated HSPC mobilization. Amounts of EGFR in HSPCs inversely correlated with the cells' ability to be mobilized by G-CSF, implying a negative role for EGFR signaling in mobilization. In combination with G-CSF treatment, genetic reduction of EGFR activity in HSPCs (in waved-2 mutant mice) or treatment with the EGFR inhibitor erlotinib increased mobilization. Increased mobilization due to suppression of EGFR activity correlated with reduced activity of cell division control protein-42 (Cdc42), and genetic Cdc42 deficiency in vivo also enhanced G-CSF-induced mobilization. Our findings reveal a previously unknown signaling pathway regulating stem cell mobilization and provide a new pharmacological approach for improving HSPC mobilization and thereby transplantation outcomes.	[Ryan, Marnie A.; Nattamai, Kalpana J.; Xing, Ellen; Schleimer, David; Daria, Deidre; Sengupta, Amitava; Liu, Wei; Jansen, Michael; Ratner, Nancy; Cancelas, Jose A.; Zheng, Yi; Geiger, Hartmut] CCHMC, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Daria, Deidre; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Koehler, Anja; Gunzer, Matthias] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39016 Magdeburg, Germany; [Le Cras, Timothy D.] CCHMC, Div Pulm Biol, Cincinnati, OH USA; [Waterstrat, Amanda] Eastern Kentucky Univ, Dept Biol Sci, Richmond, KY 40475 USA; [Van Zant, Gary] Univ Kentucky, Dept Internal Med, Markey Canc Ctr, Div Hematol Oncol, Lexington, KY USA; [Cancelas, Jose A.] Univ Cincinnati, Coll Med, Hoxworth Blood Ctr, Cincinnati, OH USA	Ulm University; Otto von Guericke University; University of Kentucky; University System of Ohio; University of Cincinnati	Geiger, H (corresponding author), CCHMC, Div Expt Hematol & Canc Biol, Cincinnati, OH USA.	hartmut.geiger@cchmc.org	Gunzer, Matthias/AAW-7026-2021; Zheng, Yi/J-7235-2015; Cancelas, Jose/AAR-9324-2020	Gunzer, Matthias/0000-0002-5534-6055; Zheng, Yi/0000-0001-7089-6074; RATNER, NANCY/0000-0001-5030-9354; Le Cras, Timothy/0000-0001-8538-2703	US National Institutes of Health [HL076604, DK077762, AG024950, HD060915]; American Heart Association [0740069N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024950] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Cincinnati Children's Hospital Medical Center Translational Research Initiative Award to H. G. and M. A. R., grants from the US National Institutes of Health, HL076604 and DK077762 to H. G., AG024950 and HD060915 to G.V.Z. and an American Heart Association established investigator award to T. D. L. C. (0740069N). H. G. is a New Investigator in Aging, and G.V.Z. is a Senior Scholar in Aging of The Ellison Medical Foundation. A. S. is a recipient of the Lady Tata Memorial Trust Fellowship Award. We would like to thank T. Weaver and M.-D. Filippi for discussions and critical comments on the manuscript. We would like to thank B. Hardie for advice on the erlotinib experiments and the Comprehensive Mouse and Cancer Core as well as the Flow Cytometry Core at CCHMC for help with the experiments and OSI Pharmaceuticals for providing erlotinib.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Breems DA, 1996, BLOOD, V87, P5370, DOI 10.1182/blood.V87.12.5370.bloodjournal87125370; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Buerger H, 2000, CANCER RES, V60, P854; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Carlo-Stella C, 2004, BLOOD, V103, P3287, DOI 10.1182/blood-2003-07-2428; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Flomenberg N, 2005, BLOOD, V106, P1867, DOI 10.1182/blood-2005-02-0468; Geiger H, 2004, EXP HEMATOL, V32, P60, DOI 10.1016/j.exphem.2003.09.015; Giet O, 2002, BLOOD, V99, P2023, DOI 10.1182/blood.V99.6.2023; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; GRIGG AP, 1995, BLOOD, V86, P4437, DOI 10.1182/blood.V86.12.4437.bloodjournal86124437; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hasegawa M, 2000, BLOOD, V95, P1872, DOI 10.1182/blood.V95.5.1872.005k26_1872_1874; Huygen S, 2002, BLOOD, V100, P2744, DOI 10.1182/blood.V100.8.2744; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Liu FL, 2000, BLOOD, V95, P3025, DOI 10.1182/blood.V95.10.3025.010k32_3025_3031; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Roberts AW, 1997, BLOOD, V89, P2736, DOI 10.1182/blood.V89.8.2736; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yamaguchi M, 1998, BLOOD, V92, P842; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yuan R, 2005, EXP HEMATOL, V33, P243, DOI 10.1016/j.exphem.2004.10.014	40	47	49	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1141	U121		10.1038/nm.2217	http://dx.doi.org/10.1038/nm.2217			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871610	Green Accepted			2022-12-27	WOS:000282644800045
J	Yoshida, T; Mett, I; Bhunia, AK; Bowman, J; Perez, M; Zhang, L; Gandjeva, A; Zhen, LJ; Chukwueke, U; Mao, TZ; Richter, A; Brown, E; Ashush, H; Notkin, N; Gelfand, A; Thimmulappa, RK; Rangasamy, T; Sussan, T; Cosgrove, G; Mouded, M; Shapiro, SD; Petrache, I; Biswal, S; Feinstein, E; Tuder, RM				Yoshida, Toshinori; Mett, Igor; Bhunia, Anil K.; Bowman, Joel; Perez, Mario; Zhang, Li; Gandjeva, Aneta; Zhen, Lijie; Chukwueke, Ugonma; Mao, Tianzhi; Richter, Amy; Brown, Emile; Ashush, Hagit; Notkin, Natalie; Gelfand, Anna; Thimmulappa, Rajesh K.; Rangasamy, Tirumalai; Sussan, Thomas; Cosgrove, Gregory; Mouded, Majd; Shapiro, Steven D.; Petrache, Irina; Biswal, Shyam; Feinstein, Elena; Tuder, Rubin M.			Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema	NATURE MEDICINE			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELL APOPTOSIS; MAMMALIAN TARGET; OXIDATIVE STRESS; AIRWAY INFLAMMATION; LUNG INFLAMMATION; GENE-EXPRESSION; TRANSGENIC MICE; DISEASE; HYPOXIA	Rtp801 (also known as Redd1, and encoded by Ddit4), a stress-related protein triggered by adverse environmental conditions, inhibits mammalian target of rapamycin (mTOR) by stabilizing the TSC1-TSC2 inhibitory complex and enhances oxidative stress-dependent cell death. We postulated that Rtp801 acts as a potential amplifying switch in the development of cigarette smoke-induced lung injury, leading to emphysema. Rtp801 mRNA and protein were overexpressed in human emphysematous lungs and in lungs of mice exposed to cigarette smoke. The regulation of Rtp801 expression by cigarette smoke may rely on oxidative stress-dependent activation of the CCAAT response element in its promoter. We also found that Rtp801 was necessary and sufficient for nuclear factor-kappa B (NF-kappa B) activation in cultured cells and, when forcefully expressed in mouse lungs, it promoted NF-kappa B activation, alveolar inflammation, oxidative stress and apoptosis of alveolar septal cells. In contrast, Rtp801 knockout mice were markedly protected against acute cigarette smoke-induced lung injury, partly via increased mTOR signaling, and, when exposed chronically to cigarette smoke, against emphysema. Our data support the notion that Rtp801 may represent a major molecular sensor and mediator of cigarette smoke-induced lung injury.	[Mett, Igor; Ashush, Hagit; Notkin, Natalie; Gelfand, Anna; Feinstein, Elena] Quark Pharmaceut Inc, Fremont, CA 94555 USA; [Yoshida, Toshinori; Bhunia, Anil K.; Zhen, Lijie; Chukwueke, Ugonma; Mao, Tianzhi; Richter, Amy; Brown, Emile; Petrache, Irina; Tuder, Rubin M.] Johns Hopkins Univ, Dept Pathol, Div Cardiopulm Pathol, Baltimore, MD USA; [Bowman, Joel; Perez, Mario; Zhang, Li; Gandjeva, Aneta; Tuder, Rubin M.] Univ Colorado, Program Translat Lung Res,Dept Med, Denver Sch Med, Div Pulm Sci & Crit Care Med, Denver, CO USA; [Thimmulappa, Rajesh K.; Rangasamy, Tirumalai; Sussan, Thomas; Biswal, Shyam] Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Cosgrove, Gregory] Natl Jewish Hlth, Denver, CO USA; [Mouded, Majd; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm & Crit Care Med, Pittsburgh, PA USA; [Petrache, Irina] Indiana Univ, Sch Med, Dept Med, Div Pulm Allergy Crit Care & Occupat Med, Indianapolis, IN USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Jewish Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University-Purdue University Indianapolis	Feinstein, E (corresponding author), Quark Pharmaceut Inc, Fremont, CA 94555 USA.	efeinstein@quarkpharma.com; rubin.tuder@ucdenver.edu	Petrache, Irina/AAZ-9648-2020; Thimmulappa, Rajesh/AAW-5013-2021; Yoshida, Toshinori/B-7255-2015	Thimmulappa, Rajesh/0000-0001-6050-1323; Sussan, Thomas/0000-0002-5240-4299	US National Heart, Lung, and Blood Institute (NHLBI) [RO1 66554, 077328]; Alpha 1 Foundation; Flight Attendant Medical Research Institute; Quark Pharmaceuticals; COPD SCCOR [P01-NHLBI 085609]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL082541, R01HL066554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alpha 1 Foundation; Flight Attendant Medical Research Institute; Quark Pharmaceuticals; COPD SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank T. Stevens (University of South Alabama) for providing the primary rat lung microvascular endothelial cells, J. Whitsett (University of Cincinnati) for allowing us to use the MLE-15 cells, T. Flotte and P. Cruz (Universities of Florida and Massachusetts, respectively) for preparing the AAV5 vectors, Y. Chen (University of Indiana) for the DDIT4 promoter constructs, I. Rahman (University of Rochester) for sharing cigarette smoke-sensitive and cigarette smoke-resistant mouse lung specimens, D. Brenner (University of California, San Diego) for the adenovirus I kappa B superrepressor, L. Ellison (Dana-Farber Cancer Center) for providing the DDIT4-RPAA construct and S. Reynolds (National Jewish Health) for the mouse-specific clara cell antigen 10 antibody. This work was supported by the grants R01 US National Heart, Lung, and Blood Institute (NHLBI) RO1 66554, Alpha 1 Foundation, Flight Attendant Medical Research Institute and Quark Pharmaceuticals (to R. M. T.); R01 NHLBI 077328 (to I. P.), COPD SCCOR P01-NHLBI 085609, Project 1 (to R. M. T. and I. P.) and Project 4 (to S. B.), RO1 NHLBI RO1 081205 to (S. B.) and NHLBI R01 HL082541-01 to (S. D. S.).	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; FLOTTE TR, 1995, GENE THER, V2, P357; Fujitani Y, 2003, AM J RESP CRIT CARE, V167, P193, DOI 10.1164/rccm.200205-455OC; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; McGrath-Morrow SA, 2005, AM J RESP CELL MOL, V32, P420, DOI 10.1165/rcmb.2004-0287OC; Morelon E, 2000, NEW ENGL J MED, V343, P225, DOI 10.1056/NEJM200007203430317; Neuhaus P, 2001, LIVER TRANSPLANT, V7, P473, DOI 10.1053/jlts.2001.24645; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ryter SW, 2009, AUTOPHAGY, V5, P235, DOI 10.4161/auto.5.2.7495; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shi MM, 1999, IMMUNOLOGY, V97, P309; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200	56	170	175	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					767	U65		10.1038/nm.2157	http://dx.doi.org/10.1038/nm.2157			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20473305	Green Accepted			2022-12-27	WOS:000279631900025
J	Yang, L; Besschetnova, TY; Brooks, CR; Shah, JV; Bonventre, JV				Yang, Li; Besschetnova, Tatiana Y.; Brooks, Craig R.; Shah, Jagesh V.; Bonventre, Joseph V.			Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury	NATURE MEDICINE			English	Article							TISSUE-GROWTH-FACTOR; MESENCHYMAL TRANSITION; HISTONE H3; P53; REPAIR; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; MOLECULE-1; MECHANISM	Fibrosis is responsible for chronic progressive kidney failure, which is present in a large number of adults in the developed world. It is increasingly appreciated that acute kidney injury (AKI), resulting in aberrant incomplete repair, is a major contributor to chronic fibrotic kidney disease. The mechanism that triggers the fibrogenic response after injury is not well understood. In ischemic, toxic and obstructive models of AKI, we demonstrate a causal association between epithelial cell cycle G2/M arrest and a fibrotic outcome. G2/M-arrested proximal tubular cells activate c-jun NH2-terminal kinase (JNK) signaling, which acts to upregulate profibrotic cytokine production. Treatment with a JNK inhibitor, or bypassing the G2/M arrest by administration of a p53 inhibitor or the removal of the contralateral kidney, rescues fibrosis in the unilateral ischemic injured kidney. Hence, epithelial cell cycle arrest at G2/M and its subsequent downstream signaling are hitherto unrecognized therapeutic targets for the prevention of fibrosis and interruption of the accelerated progression of kidney disease.	[Yang, Li; Besschetnova, Tatiana Y.; Brooks, Craig R.; Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Univ, Brigham & Womens Hosp, Div Renal, Sch Med,Dept Med, Boston, MA 02115 USA; [Yang, Li] Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing 100871, Peoples R China; [Besschetnova, Tatiana Y.; Shah, Jagesh V.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Peking University; Harvard University; Harvard Medical School; Harvard University	Bonventre, JV (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Renal, Sch Med,Dept Med, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu			US National Institutes of Health (NIH) [DK39773, DK72381, DK074030]; International Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, R37DK039773, P50DK074030, F32DK088418, R01DK072381] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grants DK39773 and DK72381 to J.V.B. and DK074030 to J.V.S. L.Y. was supported by a fellowship from the International Society of Nephrology.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Chkhotua AB, 2006, TRANSPL INT, V19, P72, DOI 10.1111/j.1432-2277.2005.00227.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Forbes JM, 2000, KIDNEY INT, V57, P2375, DOI 10.1046/j.1523-1755.2000.00097.x; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HICKSON I, 1999, SCIENCE, V285, P1733; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ikawa Y, 2008, J CELL PHYSIOL, V216, P680, DOI 10.1002/jcp.21449; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lameire N, 2005, KIDNEY INT, V68, P30, DOI 10.1111/j.1523-1755.2005.09907.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li KL, 2007, BIOCELL, V31, P213; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Megyesi J, 1999, P NATL ACAD SCI USA, V96, P10830, DOI 10.1073/pnas.96.19.10830; Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Okada H, 2005, J AM SOC NEPHROL, V16, P133, DOI 10.1681/ASN.2004040339; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Price PM, 2004, KIDNEY INT, V66, P509, DOI 10.1111/j.1523-1755.2004.761_8.x; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SILVA FG, 1993, ARCH PATHOL LAB MED, V117, P1233; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Tanaka Hiroyuki, 2005, Nephron Physiology, V101, pP27, DOI 10.1159/000086642; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YU CCW, 1992, HISTOCHEM J, V24, P121, DOI 10.1007/BF01047461; Zahedi K, 2006, AM J PHYSIOL-RENAL, V290, pF1559, DOI 10.1152/ajprenal.00424.2005; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	51	854	890	6	90	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					535	U27		10.1038/nm.2144	http://dx.doi.org/10.1038/nm.2144			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20436483	Green Accepted			2022-12-27	WOS:000277394700031
J	Holgate, ST				Holgate, Stephen T.			Innate and adaptive immune responses in asthma	NATURE MEDICINE			English	Review							KILLER T-CELLS; THYMIC STROMAL LYMPHOPOIETIN; BRONCHIAL EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; DENDRITIC CELLS; MONOCLONAL-ANTIBODY; BARRIER FUNCTION; DOUBLE-BLIND; AIRWAY HYPERRESPONSIVENESS	The recognition that asthma is primarily an inflammatory disorder of the airways associated with T helper type 2 (T(H)2) cell-dependent promotion of IgE production and recruitment of mast cells and eosinophils has provided the rationale for disease control using inhaled corticosteroids and other anti-inflammatory drugs. As more has been discovered about the cytokine, chemokine and inflammatory pathways that are associated with T(H)2-driven adaptive immunity, attempts have been made to selectively inhibit these in the hope of discovering new therapeutics as predicted from animal models of allergic inflammation. The limited success of this approach, together with the recognition that asthma is more than allergic inflammation, has drawn attention to the innate immune response in this disease. Recent advances in our understanding of the sentinel role played by innate immunity provides new targets for disease prevention and treatment. These include pathways of innate stimulation by environmental or endogenous pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) to influence the activation and trafficking of DCs, innate sources of cytokines, and the identification of new T cell subsets and lymphoid cells.	Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton SO9 4XY, Hants, England	University of Southampton	Holgate, ST (corresponding author), Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton SO9 4XY, Hants, England.	sth@soton.ac.uk			MRC [G0900453] Funding Source: UKRI; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Medical Research Council [G0900453] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abonia JP, 2011, EXPERT REV CLIN IMMU, V7, P411, DOI [10.1586/ECI.11.27, 10.1586/eci.11.27]; Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Altin J, 2010, BLOOD REV, V24, P163, DOI 10.1016/j.blre.2010.06.002; Alvarez-Quiroga C, 2011, J CLIN IMMUNOL, V31, P588, DOI 10.1007/s10875-011-9527-5; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Arima M, 2008, CURR MOL MED, V8, P365, DOI 10.2174/156652408785160970; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Baines KJ, 2010, EUR RESPIR J, V35, P522, DOI 10.1183/09031936.00027409; Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1447, DOI 10.1111/j.1365-2222.2011.03806.x; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barnes N, 2012, CLIN EXP ALLERGY, V42, P38, DOI 10.1111/j.1365-2222.2011.03813.x; Barnes PJ, 2009, CLIN EXP ALLERGY, V39, P1145, DOI 10.1111/j.1365-2222.2009.03298.x; Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Bel Elisabeth, 2005, Treat Respir Med, V4, P365, DOI 10.2165/00151829-200504060-00002; Berry MA, 2004, J ALLERGY CLIN IMMUN, V114, P1106, DOI 10.1016/j.jaci.2004.08.032; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Blank F, 2011, IMMUNOBIOLOGY, V216, P86, DOI 10.1016/j.imbio.2010.02.006; Bosco A, 2010, MUCOSAL IMMUNOL, V3, P399, DOI 10.1038/mi.2010.13; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Bowen H, 2008, CLIN EXP ALLERGY, V38, P1422, DOI 10.1111/j.1365-2222.2008.03067.x; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Bryce PJ, 2011, AM J RESP CRIT CARE, V183, P834, DOI 10.1164/rccm.201009-1464ED; Busse WW, 2008, AM J RESP CRIT CARE, V178, P1002, DOI 10.1164/rccm.200708-1200OC; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Cady CT, 2010, IMMUNOL LETT, V130, P57, DOI 10.1016/j.imlet.2009.12.001; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Capone M, 2003, J IMMUNOL, V170, P2390, DOI 10.4049/jimmunol.170.5.2390; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chaudhuri R, 2006, AM J RESP CRIT CARE, V174, P127, DOI 10.1164/rccm.200510-1589OC; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Dua B, 2010, J ALLERGY CLIN IMMUN, V126, P133, DOI 10.1016/j.jaci.2010.04.006; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2008, J ALLERGY CLIN IMMUN, V122, P407, DOI 10.1016/j.jaci.2008.06.011; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Faulkner H, 1998, INFECT IMMUN, V66, P3832, DOI 10.1128/IAI.66.8.3832-3840.1998; Gern JE, 2011, NEW ENGL J MED, V364, P769, DOI 10.1056/NEJMe1013713; Gervais FG, 2011, MOL PHARMACOL, V79, P69, DOI 10.1124/mol.110.068585; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Haahtela T, 2009, ALLERGY, V64, P1799, DOI 10.1111/j.1398-9995.2009.02246.x; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hidi R, 2000, J IMMUNOL, V164, P412, DOI 10.4049/jimmunol.164.1.412; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; Hughes JL, 2006, ALLERGY, V61, P1268, DOI 10.1111/j.1398-9995.2006.01207.x; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Jaffar ZH, 1999, J IMMUNOL, V163, P6283; Jartti T, 2010, PEDIAT ALLERG IMM-UK, V21, P1008, DOI 10.1111/j.1399-3038.2010.01059.x; Jartti T, 2011, PEDIAT ALLERG IMM-UK, V22, P350, DOI 10.1111/j.1399-3038.2011.01170.x; Karman J, 2012, J BIOL CHEM, V287, P11098, DOI 10.1074/jbc.M111.283705; Kassianos AJ, 2010, METHODS MOL BIOL, V595, P45, DOI 10.1007/978-1-60761-421-0_3; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Kon OM, 1998, LANCET, V352, P1109, DOI 10.1016/S0140-6736(97)12261-9; Kon OM, 2001, EUR RESPIR J, V18, P45, DOI 10.1183/09031936.01.00064101; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lam D, 2008, J IMMUNOL, V181, P2925, DOI 10.4049/jimmunol.181.4.2925; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lordan JL, 2001, J ALLERGY CLIN IMMUN, V108, P976, DOI 10.1067/mai.2001.119740; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McLean W H Irwin, 2011, F1000 Med Rep, V3, P2, DOI 10.3410/M3-2; MCWILLIAM AS, 1994, J EXP MED, V179, P1331, DOI 10.1084/jem.179.4.1331; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NELSON DJ, 1994, J EXP MED, V179, P203, DOI 10.1084/jem.179.1.203; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Platts-Mills JA, 2005, J ALLERGY CLIN IMMUN, V116, P384, DOI 10.1016/j.jaci.2005.05.012; Rabinovitch N, 2005, J ALLERGY CLIN IMMUN, V116, P1053, DOI 10.1016/j.jaci.2005.08.045; Reyes CL, 2009, IDRUGS, V12, P692; Rodriguez B, 2011, FEMS MICROBIOL ECOL, V76, P133, DOI 10.1111/j.1574-6941.2010.01035.x; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Sallmann E, 2011, J IMMUNOL, V187, P164, DOI 10.4049/jimmunol.1003392; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Shalev I, 2011, SEMIN IMMUNOL, V23, P282, DOI 10.1016/j.smim.2011.04.003; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V129, P456, DOI 10.1016/j.jaci.2011.11.044; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Tieu DD, 2010, J ALLERGY CLIN IMMUN, V125, P667, DOI 10.1016/j.jaci.2009.11.045; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Uddin M, 2008, EUR RESPIR J, V31, P714, DOI 10.1183/09031936.00144307; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veres TZ, 2011, AM J PATHOL, V179, P603, DOI 10.1016/j.ajpath.2011.04.039; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wang XF, 2010, TRANSPL P, V42, P4567, DOI 10.1016/j.transproceed.2010.09.169; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x; Wills-Karp Marsha, 2007, Proc Am Thorac Soc, V4, P247, DOI 10.1513/pats.200704-046AW; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yano H, 2007, CLIN CANCER RES, V13, P6494, DOI 10.1158/1078-0432.CCR-07-1324; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Ying S, 2001, J ALLERGY CLIN IMMUN, V107, P686, DOI 10.1067/mai.2001.114339	149	568	618	5	147	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					673	683		10.1038/nm.2731	http://dx.doi.org/10.1038/nm.2731			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561831				2022-12-27	WOS:000303763500035
J	Liao, GY; An, JJ; Gharami, K; Waterhouse, EG; Vanevski, F; Jones, KR; Xu, BJ				Liao, Guey-Ying; An, Juan Ji; Gharami, Kusumika; Waterhouse, Emily G.; Vanevski, Filip; Jones, Kevin R.; Xu, Baoji			Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin	NATURE MEDICINE			English	Article							LOCAL PROTEIN-SYNTHESIS; NEUROTROPHIC FACTOR; FOOD-INTAKE; BODY-WEIGHT; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; SEVERE OBESITY; BRAIN; MICE; EXPRESSION	Mutations in the Bdnf gene, which produces transcripts with either short or long 3' untranslated regions (3' UTRs), cause human obesity; however, the precise role of brain-derived neurotrophic factor (BDNF) in the regulation of energy balance is unknown. Here we show the relationship between Bdnf mRNA with a long 3' UTR (long 3' UTR Bdnf mRNA), leptin, neuronal activation and body weight. We found that long 3' UTR Bdnf mRNA was enriched in the dendrites of hypothalamic neurons and that insulin and leptin could stimulate its translation in dendrites. Furthermore, mice harboring a truncated long Bdnf 3' UTR developed severe hyperphagic obesity, which was completely reversed by viral expression of long 3' UTR Bdnf mRNA in the hypothalamus. In these mice, the ability of leptin to activate hypothalamic neurons and inhibit food intake was compromised despite normal activation of leptin receptors. These results reveal a novel mechanism linking leptin action to BDNF expression during hypothalamic-mediated regulation of body weight, while also implicating dendritic protein synthesis in this process.	[Liao, Guey-Ying; An, Juan Ji; Gharami, Kusumika; Waterhouse, Emily G.; Vanevski, Filip; Xu, Baoji] Georgetown Univ Med Ctr, Dept Physiol & Pharmacol, Washington, DC USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Georgetown University; University of Colorado System; University of Colorado Boulder	Xu, BJ (corresponding author), Georgetown Univ Med Ctr, Dept Physiol & Pharmacol, Washington, DC USA.	bx3@georgetown.edu		JONES, KEVIN/0000-0002-3802-7562	US National Institutes of Health [R01 DK089237, R21 DK081008, R01 NS050596, F30 DK084717, F31 NS060453]; American Diabetes Association [7-07-RA-183]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081008, F30DK084717, R01DK089237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS050596, R01NS050596, F31NS060453] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the grants from the US National Institutes of Health to B.X. (R01 DK089237, R21 DK081008 and R01 NS050596), E.G.W. (F30 DK084717) and F.V. (F31 NS060453) and from the American Diabetes Association to B.X. (7-07-RA-183).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Coppola V, 2004, NEUROREPORT, V15, P2665, DOI 10.1097/00001756-200412030-00022; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Gorski JA, 2003, J NEUROSCI, V23, P6856; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Joseph-Bravo P, 2002, BRAIN RES PROTOC, V9, P93, DOI 10.1016/S1385-299X(01)00140-4; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	51	126	130	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					564	571		10.1038/nm.2687	http://dx.doi.org/10.1038/nm.2687			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426422	Green Accepted			2022-12-27	WOS:000302617800033
J	Prysyazhna, O; Rudyk, O; Eaton, P				Prysyazhna, Oleksandra; Rudyk, Olena; Eaton, Philip			Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE HYPERPOLARIZATION; HYDROGEN-PEROXIDE; IN-VIVO; MICE; RELAXATION; DISEASE; ARTERY	Blood pressure regulation is crucial for the maintenance of health, and hypertension is a risk factor for myocardial infarction, heart failure, stroke and renal disease. Nitric oxide (NO) and prostacyclin trigger well-defined vasodilator pathways; however, substantial vasorelaxation in response to agents such as acetylcholine persists when the synthesis of these molecules is prevented. This remaining vasorelaxation activity, termed endothelium-derived hyperpolarizing factor (EDHF), is more prevalent in resistance than in conduit blood vessels and is considered a major mechanism for blood pressure control(1-4). Hydrogen peroxide (H2O2) has been shown to be a major component of EDHF in several vascular beds in multiple species, including in humans(5-10). H2O2 causes the formation of a disulfide bond between the two a subunits of protein kinase G I-alpha (PKGI-alpha), which activates the kinase independently of the NO-cyclic guanosine monophosphate (cGMP) pathway and is coupled to vasodilation(11). To test the importance of PKGI-alpha oxidation in the EDHF mechanism and blood pressure control in vivo, we generated a knock-in mouse expressing only a C42S 'redox-dead' version of PKGI-alpha. This amino acid substitution, a single-atom change (an oxygen atom replacing a sulfur atom), blocked the vasodilatory action of H2O2 on resistance vessels and resulted in hypertension in vivo.	[Prysyazhna, Oleksandra; Rudyk, Olena; Eaton, Philip] Kings Coll London, Cardiovasc Div, British Heart Fdn Ctr Excellence, Rayne Inst,St Thomas Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Eaton, P (corresponding author), Kings Coll London, Cardiovasc Div, British Heart Fdn Ctr Excellence, Rayne Inst,St Thomas Hosp, London WC2R 2LS, England.	philip.eaton@kcl.ac.uk	Rudyk, Olena/AAY-3789-2020; Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Rudyk, Olena/0000-0001-9422-9233; Prysyazhna, Oleksandra/0000-0002-0394-7000	Medical Research Council; British Heart Foundation; Leducq Foundation; UK Department of Health through the National Institute for Health Research comprehensive Biomedical Research Centre; British Heart Foundation [PG/10/98/28655] Funding Source: researchfish; Medical Research Council [G1000458, G0700320, G0600785] Funding Source: researchfish; MRC [G1000458, G0600785, G0700320] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Leducq Foundation(Leducq Foundation); UK Department of Health through the National Institute for Health Research comprehensive Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge support from the Medical Research Council, the British Heart Foundation, the Leducq Foundation and the UK Department of Health through the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust.	Burgoyne J.R., 2008, THESIS KINGS COLL LO; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Dalsgaard T, 2010, EXPERT OPIN THER TAR, V14, P825, DOI 10.1517/14728222.2010.500616; Dora KA, 2001, AM J PHYSIOL-HEART C, V280, pH2424, DOI 10.1152/ajpheart.2001.280.6.H2424; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; Griffith TM, 2004, BRIT J PHARMACOL, V141, P881, DOI 10.1038/sj.bjp.0705698; Leung HS, 2006, VASC PHARMACOL, V44, P299, DOI 10.1016/j.vph.2006.01.010; Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; Shimokawa H, 2005, J MOL CELL CARDIOL, V39, P725, DOI 10.1016/j.yjmcc.2005.07.007; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Suvorava T, 2005, CIRCULATION, V112, P2487, DOI 10.1161/CIRCULATIONAHA.105.543157; Takaki A, 2008, J CARDIOVASC PHARM, V52, P510, DOI 10.1097/FJC.0b013e318190358b; Tataki A., 2008, J EXP MED, V205, P2053; Yada T, 2006, AM J PHYSIOL-HEART C, V291, pH1138, DOI 10.1152/ajpheart.00187.2006; Yang H, 2003, AM J HYPERTENS, V16, P1, DOI 10.1016/S0895-7061(02)03086-8; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483	22	127	128	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					286	290		10.1038/nm.2603	http://dx.doi.org/10.1038/nm.2603			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245782	Green Accepted			2022-12-27	WOS:000300140300044
J	Zhang, G; Guo, BS; Wu, H; Tang, T; Zhang, BT; Zheng, LZ; He, YX; Yang, ZJ; Pan, XH; Chow, H; To, K; Li, YP; Li, DH; Wang, XL; Wang, YX; Lee, K; Hou, ZB; Dong, N; Li, G; Leung, K; Hung, L; He, FC; Zhang, LQ; Qin, L				Zhang, Ge; Guo, Baosheng; Wu, Heng; Tang, Tao; Zhang, Bao-Ting; Zheng, Lizhen; He, Yixin; Yang, Zhijun; Pan, Xiaohua; Chow, Heelum; To, Kinwah; Li, Yaping; Li, Dahu; Wang, Xinluan; Wang, Yixiang; Lee, Kwongman; Hou, Zhibo; Dong, Nan; Li, Gang; Leung, Kwoksui; Hung, Leungkim; He, Fuchu; Zhang, Lingqiang; Qin, Ling			A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy	NATURE MEDICINE			English	Article							PARATHYROID-HORMONE; POSTMENOPAUSAL WOMEN; COMBINATION; ALENDRONATE; DEPOSITION; FRACTURES; DOMAINS	Metabolic skeletal disorders associated with impaired bone formation are a major clinical challenge. One approach to treat these defects is to silence bone-formation-inhibitory genes by small interference RNAs (siRNAs) in osteogenic-lineage cells that occupy the niche surrounding the bone-formation surfaces. We developed a targeting system involving dioleoyl trimethylammonium propane (DOTAP)-based cationic liposomes attached to six repetitive sequences of aspartate, serine, serine ((AspSerSer)(6)) for delivering siRNAs specifically to bone-formation surfaces. Using this system, we encapsulated an osteogenic siRNA that targets casein kinase-2 interacting protein-1 (encoded by Plekho1, also known as Plekho1). In vivo systemic delivery of Plekho1 siRNA in rats using our system resulted in the selective enrichment of the siRNAs in osteogenic cells and the subsequent depletion of Plekho1. A bioimaging analysis further showed that this approach markedly promoted bone formation, enhanced the bone micro-architecture and increased the bone mass in both healthy and osteoporotic rats. These results indicate (AspSerSer)(6)-liposome as a promising targeted delivery system for RNA interference- based bone anabolic therapy.	[Zhang, Ge; Guo, Baosheng; Wu, Heng; Tang, Tao; Zhang, Bao-Ting; Zheng, Lizhen; He, Yixin; Wang, Xinluan; Li, Gang; Leung, Kwoksui; Hung, Leungkim; Qin, Ling] Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Bao-Ting] Chinese Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Yang, Zhijun] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Pan, Xiaohua] Ji Nan Univ, Dept Orthoped, Hosp Med Coll 2, Shenzhen Peoples Hosp, Shenzhen, Peoples R China; [Chow, Heelum; To, Kinwah] Chinese Univ Hong Kong, Sch Pharm, Hong Kong, Hong Kong, Peoples R China; [Li, Yaping] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Delivery Syst, Shanghai 200031, Peoples R China; [Li, Dahu; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Wang, Yixiang] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Lee, Kwongman] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China; [Hou, Zhibo] Jinan Univ, Biomed Res & Dev Ctr, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Dong, Nan] Nankai Univ, Inst Mol Biol, Tianjin, Peoples R China; [Qin, Ling] Shenzhen Inst Adv Technol, Translat Med Res & Dev Ctr, Inst Biomed & Hlth Engn, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University; Jinan University; Chinese University of Hong Kong; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Academy of Military Medical Sciences - China; Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University; Nankai University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Qin, L (corresponding author), Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	zhangge@ort.cuhk.edu.hk; zhanglq@nic.bmi.ac.cn; lingqin@cuhk.edu.hk	Li, Gang/J-7830-2018; To, Kenneth K W/M-4500-2013; Zhang, Baoting/B-6273-2015; Zhang, Ge/N-4150-2013; Zhang, Ge/K-9118-2019; Guo, Baosheng/ABD-4800-2021; Qin, Ling/J-9047-2018; Zheng, Lizhen/C-6550-2014; GUO, Baosheng/M-6023-2013; Wang, Yi Xiang/I-5952-2016	Li, Gang/0000-0002-3981-2239; To, Kenneth K W/0000-0003-2755-0283; Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695; Guo, Baosheng/0000-0002-4510-5418; Qin, Ling/0000-0001-6173-6167; Wang, Yi Xiang/0000-0001-5697-0717; Zhang, Lingqiang/0000-0002-9795-2141; Zhang, Bao-Ting/0000-0003-1421-0212; Yang, Zhijun/0000-0002-6094-0438	Chinese National Basic Research Programs [2011CB910602]; Hong Kong Competitive Earmarked Research Grant [CUHK479111, 473011]; Faculty of Medicine of the Chinese University of Hong Kong [2041478, 2041525]; Hong Kong Baptist University [31-08-089]; Chinese National Natural Science Foundation [30830029]; National Key Technologies Research and Development Program for New Drugs [2009ZX09503-002]	Chinese National Basic Research Programs(National Basic Research Program of China); Hong Kong Competitive Earmarked Research Grant; Faculty of Medicine of the Chinese University of Hong Kong; Hong Kong Baptist University; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program for New Drugs	We thank X.-H. Yang for technical support with the confocal imaging, H. Yang for technical support with the flow cytometry and F.C. Chun-Wan for assistance with the bone histomorphometry. This study was supported by the Chinese National Basic Research Programs (2011CB910602), the Hong Kong Competitive Earmarked Research Grant (CUHK479111 and 473011), the Direct Grant of Faculty of Medicine of the Chinese University of Hong Kong (2041478 and 2041525), the Faculty Research Grant of Hong Kong Baptist University (31-08-089), the Chinese National Natural Science Foundation Project (30830029) and the National Key Technologies Research and Development Program for New Drugs (2009ZX09503-002).	Aubin J., 2002, PEDIAT BONE, P43; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; CULLIS P R, 1989, Advanced Drug Delivery Reviews, V3, P267, DOI 10.1016/0169-409X(89)90024-0; Federman N, 2010, PEDIATR RES, V67, P514, DOI 10.1203/PDR.0b013e3181d601c5; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Ishikawa S, 2004, INT IMMUNOL, V16, P1019, DOI 10.1093/intimm/dxh103; Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8; Lopez-Fraga M, 2009, BIODRUGS, V23, P305, DOI 10.2165/11318190-000000000-00000; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; STUART AJ, 1992, AVIAN DIS, V36, P447, DOI 10.2307/1591527; Takahashi-Nishioka Tatsuo, 2008, Curr Drug Discov Technol, V5, P39; Vegni FE, 2004, NEW ENGL J MED, V350, P189; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j; Wang D, 2007, BIOCONJUGATE CHEM, V18, P1375, DOI 10.1021/bc7002132; Wang GL, 2010, J DRUG TARGET, V18, P611, DOI 10.3109/10611861003622560; Yarbrough DK, 2010, CALCIFIED TISSUE INT, V86, P58, DOI 10.1007/s00223-009-9312-0; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002	28	285	301	5	198	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					307	314		10.1038/nm.2617	http://dx.doi.org/10.1038/nm.2617			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286306				2022-12-27	WOS:000300140300048
J	Shkreli, M; Sarin, KY; Pech, MF; Papeta, N; Chang, W; Brockman, SA; Cheung, P; Lee, E; Kuhnert, F; Olson, JL; Kuo, CJ; Gharavi, AG; D'Agati, VD; Artandi, SE				Shkreli, Marina; Sarin, Kavita Y.; Pech, Matthew F.; Papeta, Natalia; Chang, Woody; Brockman, Stephanie A.; Cheung, Peggie; Lee, Eunice; Kuhnert, Frank; Olson, Jean L.; Kuo, Calvin J.; Gharavi, Ali G.; D'Agati, Vivette D.; Artandi, Steven E.			Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling	NATURE MEDICINE			English	Article							UP-REGULATION; PROLIFERATION; DIFFERENTIATION; PROTEINS; DICKKOPF-1; INDUCTION; BIOLOGY; REPAIR; MOUSE; LEADS	Mechanisms of epithelial cell renewal remain poorly understood in the mammalian kidney, particularly in the glomerulus, a site of cellular damage in chronic kidney disease. Within the glomerulus, podocytes-differentiated epithelial cells crucial for filtration are thought to lack substantial capacity for regeneration. Here we show that podocytes rapidly lose differentiation markers and enter the cell cycle in adult mice in which the telomerase protein component TERT is conditionally expressed. Transgenic TERT expression in mice induces marked upregulation of Wnt signaling and disrupts glomerular structure, resulting in a collapsing glomerulopathy resembling those in human disease, including HIV-associated nephropathy (HIVAN). Human and mouse HIVAN kidneys show increased expression of TERT and activation of Wnt signaling, indicating that these are general features of collapsing glomerulopathies. Silencing transgenic TERT expression or inhibiting Wnt signaling through systemic expression of the Wnt inhibitor Dkk1 in either TERT transgenic mice or in a mouse model of HIVAN results in marked normalization of podocytes, including rapid cell-cycle exit, re-expression of differentiation markers and improved filtration barrier function. These data reveal an unexpected capacity of podocytes to reversibly enter the cell cycle, suggest that podocyte renewal may contribute to glomerular homeostasis and implicate the telomerase and Wnt-beta-catenin pathways in podocyte proliferation and disease.	[Pech, Matthew F.; Kuo, Calvin J.; Artandi, Steven E.] Stanford Sch Med, Program Canc Biol, Stanford, CA USA; [Papeta, Natalia; Gharavi, Ali G.] Columbia Univ, Dept Med, New York, NY USA; [Olson, Jean L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [D'Agati, Vivette D.] Columbia Univ, Dept Pathol, New York, NY USA; [Artandi, Steven E.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Shkreli, Marina; Sarin, Kavita Y.; Pech, Matthew F.; Chang, Woody; Brockman, Stephanie A.; Cheung, Peggie; Lee, Eunice; Kuhnert, Frank; Kuo, Calvin J.; Artandi, Steven E.] Stanford Sch Med, Dept Med, Stanford, CA USA	Stanford University; Columbia University; University of California System; University of California San Francisco; Columbia University; Stanford University; Stanford University	Artandi, SE (corresponding author), Univ Nice, Lab Biol & Pathol Genomes, Nice, France.	sartandi@stanford.edu		Shkreli, Marina/0000-0002-8615-1891; Kuo, Calvin/0000-0002-7427-5985; Sarin, Kavita/0000-0001-5363-3053	Stanford School of Medicine; Stanford Center on Longevity; US National Institutes of Health [DK085527, DK085720, DK087626, CA111691, CA125453, AG033747, AG036695]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA125453, R01CA111691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087626, U01DK085527, R01DK085720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R56AG033747, R01AG033747] Funding Source: NIH RePORTER	Stanford School of Medicine; Stanford Center on Longevity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Chu in the Stanford Comparative Medicine Histology Research Core Laboratory, S. Busque for guidance with nephrectomy, and R. Nusse, Stanford University, for Axin2<SUP>LacZ/+</SUP> mice. M.S. was supported by the Stanford School of Medicine Dean's postdoctoral fellowship and the Stanford Center on Longevity postdoctoral fellowship. This work was supported by US National Institutes of Health grants DK085527 and DK085720 to C.J.K., DK087626 to A.G.G. and CA111691, CA125453, AG033747 and AG036695 to S.E.A.	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P137, DOI 10.1046/j.1523-1755.2000.00149.x; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Heikkila E, 2007, MOL CELL BIOCHEM, V305, P9, DOI 10.1007/s11010-007-9522-6; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Husain M, 2005, AIDS, V19, P1975, DOI 10.1097/01.aids.0000191918.42110.27; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Imai E, 1999, EXP NEPHROL, V7, P63; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Korgaonkar SN, 2008, J AM SOC NEPHROL, V19, P877, DOI 10.1681/ASN.2007050629; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Marshall CB, 2007, NEPHRON EXP NEPHROL, V106, pE51, DOI 10.1159/000101793; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; NADASDY T, 1994, J AM SOC NEPHROL, V4, P2032; Nagata M, 1998, AM J PATHOL, V153, P1511, DOI 10.1016/S0002-9440(10)65739-2; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Rosenstiel P, 2009, J AM SOC NEPHROL, V20, P2296, DOI 10.1681/ASN.2008121230; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shankland SJ, 2000, AM J PHYSIOL-RENAL, V278, pF515, DOI 10.1152/ajprenal.2000.278.4.F515; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zuo YQ, 2006, J AM SOC NEPHROL, V17, P2832, DOI 10.1681/ASN.2005080878	50	79	83	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					111	119		10.1038/nm.2550	http://dx.doi.org/10.1038/nm.2550			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138751	Green Accepted			2022-12-27	WOS:000299018600036
J	He, BJ; Joiner, MLA; Singh, MV; Luczak, ED; Swaminathan, PD; Koval, OM; Kutschke, W; Allamargot, C; Yang, JY; Guan, XQ; Zimmerman, K; Grumbach, IM; Weiss, RM; Spitz, DR; Sigmund, CD; Blankesteijn, WM; Heymans, S; Mohler, PJ; Anderson, ME				He, B. Julie; Joiner, Mei-ling A.; Singh, Madhu V.; Luczak, Elizabeth D.; Swaminathan, Paari Dominic; Koval, Olha M.; Kutschke, William; Allamargot, Chantal; Yang, Jinying; Guan, Xiaoqun; Zimmerman, Kathy; Grumbach, Isabella M.; Weiss, Robert M.; Spitz, Douglas R.; Sigmund, Curt D.; Blankesteijn, W. Matthijs; Heymans, Stephane; Mohler, Peter J.; Anderson, Mark E.			Oxidation of CaMKII determines the cardiotoxic effects of aldosterone	NATURE MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; CALMODULIN KINASE-II; PREVENTS CARDIAC RUPTURE; CONGESTIVE-HEART-FAILURE; MATRIX METALLOPROTEINASES; ANGIOTENSIN-II; NADPH OXIDASE; ACTIVATION; INHIBITION	Excessive activation of the beta-adrenergic, angiotensin II (Ang II) and aldosterone signaling pathways promotes mortality after myocardial infarction, and antagonists targeting these pathways are core therapies for treating this condition. Catecholamines and Ang II activate the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII), the inhibition of which prevents isoproterenol-mediated and Ang II-mediated cardiomyopathy. Here we show that aldosterone exerts direct toxic actions on myocardium by oxidative activation of CaMKII, causing cardiac rupture and increased mortality in mice after myocardial infarction. Aldosterone induces CaMKII oxidation by recruiting NADPH oxidase, and this oxidized and activated CaMKII promotes matrix metalloproteinase 9 (MMP9) expression in cardiomyocytes. Myocardial CaMKII inhibition, overexpression of methionine sulfoxide reductase A (an enzyme that reduces oxidized CaMKII) or NADPH oxidase deficiency prevented aldosterone-enhanced cardiac rupture after myocardial infarction. These findings show that oxidized myocardial CaMKII mediates the cardiotoxic effects of aldosterone on the cardiac matrix and establish CaMKII as a nodal signal for the neurohumoral pathways associated with poor outcomes after myocardial infarction.	[He, B. Julie; Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [He, B. Julie; Joiner, Mei-ling A.; Singh, Madhu V.; Luczak, Elizabeth D.; Swaminathan, Paari Dominic; Koval, Olha M.; Kutschke, William; Yang, Jinying; Guan, Xiaoqun; Grumbach, Isabella M.; Weiss, Robert M.; Anderson, Mark E.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA USA; [Zimmerman, Kathy; Weiss, Robert M.] Univ Iowa, Dept Vet Affairs Med Ctr, Carver Coll Med, Iowa City, IA USA; [Spitz, Douglas R.] Univ Iowa, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Carver Coll Med, Iowa City, IA USA; [Sigmund, Curt D.] Univ Iowa, Dept Pharmacol, Caver Coll Med, Iowa City, IA 52242 USA; [Blankesteijn, W. Matthijs] Maastricht Univ, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Heymans, Stephane] Maastricht Univ, Ctr Heart Failure Res, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Heymans, Stephane] ICIN Netherlands Heart Inst, Utrecht, Netherlands; [Heymans, Stephane] Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium; [Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; Maastricht University; Maastricht University; KU Leuven; University System of Ohio; Ohio State University	Anderson, ME (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA.	mark-e-anderson@uiowa.edu	Singh, Madhu V./AAJ-8507-2020; Swaminathan, Paari Dominic/AAN-5265-2021; Sigmund, Curt D./W-1611-2019	Singh, Madhu V./0000-0003-3048-4432; Swaminathan, Paari Dominic/0000-0002-7843-375X; Sigmund, Curt D./0000-0002-1453-0921; Heymans, Stephane/0000-0001-9477-7803; Spitz, Douglas/0000-0002-1254-8765; Weiss, Robert/0000-0003-1307-2647; Koval, Olha/0000-0003-1644-0046; Grumbach, Isabella/0000-0002-2285-3157; Joiner, Mei-ling/0000-0002-7775-7349	US National Institutes of Health [1F30HL-095325, RR-017369, P30 CA086862, R01CA133114, R01HL083422, R01HL70250, R01HL079031, R01HL096652]; Fondation Leducq [08CVD01]; Netherlands Organization for Scientific Research [91796338]; Netherlands Heart Foundation (NHS) [2007B036, 2008B011]; Research Foundation-Flanders (FWO) [1183211N, 1167610N, G074009N]; European Union; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA133114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061446, T32HL007121, R01HL079031, R01HL083422, F30HL095325, R01HL070250, R01HL096652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337, T32GM067795] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation (NHS)(Netherlands Heart Foundation); Research Foundation-Flanders (FWO)(FWO); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for discussions with K. Campbell, W. Nauseef and F. Abboud (University of Iowa). We acknowledge the technical contributions of D. Farley and M. Scheel (University of Iowa). We thank N. Sinclair, P. Yarolem and J. Schwarting (University of Iowa) for their technical expertise in generating transgenic mice. J. Robbins (University of Cincinnati) provided the alpha MHC complementary DNA (cDNA) for creating the transgenic mice. E. Olson (University of Texas Southwestern) provided mice harboring the MEF2-lacZ reporter gene. MsrA<SUP>-/-</SUP> mice were provided by the late E. Stadtman of the US National Institutes of Health. Transgenic mice were engineered at the University of Iowa Transgenic Animal Facility, and viral constructs were generated at the University of Iowa Gene Vector Transfer Core, which are both funded by the US National Institutes of Health. We acknowledge support by the US National Institutes of Health (1F30HL-095325 to B.J.H., RR-017369 to R.M.W., P30 CA086862 and R01CA133114 to D.R.S., R01HL083422 to P.J.M., and R01HL70250, R01HL079031 and R01HL096652 to M.E.A.) and by a grant (08CVD01) from the Fondation Leducq as part of the 'Alliance for CaMKII Signaling in Heart'. S.H. received a Vidi grant from the Netherlands Organization for Scientific Research (91796338) and research grants from the Netherlands Heart Foundation (NHS 2007B036 and 2008B011), Research Foundation-Flanders (FWO 1183211N, 1167610N, G074009N), European Union, FP7-HEALTH-2010, MEDIA, Large scale integrating project.	AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Beygui F, 2010, AM HEART J, V160, P642, DOI 10.1016/j.ahj.2010.06.049; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Christensen MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000583; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fonarow GC, 2007, AM HEART J, V154, P637, DOI 10.1016/j.ahj.2007.06.002; GUTIERREZMARCOS FM, 1991, EUR HEART J, V12, P503, DOI 10.1093/oxfordjournals.eurheartj.a059930; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Iwashima F, 2008, ENDOCRINOLOGY, V149, P1009, DOI 10.1210/en.2007-0864; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kinugawa S, 2000, CIRC RES, V87, P392; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; KUSCH M, 1978, AM J PHYSIOL, V235, pC82, DOI 10.1152/ajpcell.1978.235.3.C82; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Munaut C, 1999, J BIOL CHEM, V274, P5588, DOI 10.1074/jbc.274.9.5588; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Nakamura S, 2004, CIRCULATION, V110, P1787, DOI 10.1161/01.CIR.0000143072.36782.51; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Owusu-Ansah E., 2008, RES SQ; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pouleur AC, 2010, CIRCULATION, V122, P597, DOI 10.1161/CIRCULATIONAHA.110.940619; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Rousseau MF, 2002, J AM COLL CARDIOL, V40, P1596, DOI 10.1016/S0735-1097(02)02382-3; Rude MK, 2005, HYPERTENSION, V46, P555, DOI 10.1161/01.HYP.0000176236.55322.18; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Tomaselli GF, 2010, NAT MED, V16, P648, DOI 10.1038/nm0610-648; van den Bome SWM, 2009, CARDIOVASC PATHOL, V18, P37, DOI 10.1016/j.carpath.2007.12.012; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Wehrens XHT, 2004, INT J CARDIOL, V95, P285, DOI 10.1016/j.ijcard.2003.06.006; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9	60	173	183	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1610	U125		10.1038/nm.2506	http://dx.doi.org/10.1038/nm.2506			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081025	Green Accepted, Green Published			2022-12-27	WOS:000297978000032
J	Liu, Y; Wang, L; Kikuiri, T; Akiyama, K; Chen, CD; Xu, XT; Yang, RL; Chen, WJ; Wang, SL; Shi, ST				Liu, Yi; Wang, Lei; Kikuiri, Takashi; Akiyama, Kentaro; Chen, Chider; Xu, Xingtian; Yang, Ruili; Chen, WanJun; Wang, Songlin; Shi, Songtao			Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha	NATURE MEDICINE			English	Article							NF-KAPPA-B; STROMAL CELLS; BONE-FORMATION; OSTEOGENESIS; INDUCTION; APOPTOSIS; INHIBIT; ASPIRIN; MOUSE	Stem cell-based regenerative medicine is a promising approach in tissue reconstruction. Here we show that proinflammatory T cells inhibit the ability of exogenously added bone marrow mesenchymal stem cells (BMMSCs) to mediate bone repair. This inhibition is due to interferon gamma (IFN-gamma)-induced downregulation of the runt-related transcription factor 2 (Runx-2) pathway and enhancement of tumor necrosis factor alpha (TNF-alpha) signaling in the stem cells. We also found that, through inhibition of nuclear factor kappa B (NF-kappa B), TNF-alpha converts the signaling of the IFN-gamma-activated, nonapoptotic form of TNF receptor superfamily member 6 (Fas) in BMMSCs to a caspase 3- and caspase 8-associated proapoptotic cascade, resulting in the apoptosis of these cells. Conversely, reduction of IFN-gamma and TNF-alpha concentrations by systemic infusion of Foxp3(+) regulatory T cells, or by local administration of aspirin, markedly improved BMMSC-based bone regeneration and calvarial defect repair in C57BL/6 mice. These data collectively show a previously unrecognized role of recipient T cells in BMMSC-based tissue engineering.	[Liu, Yi; Wang, Lei; Kikuiri, Takashi; Akiyama, Kentaro; Chen, Chider; Xu, Xingtian; Yang, Ruili; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Liu, Yi; Wang, Songlin] Capital Med Univ, Mol Lab Gene Therapy & Tooth Regenerat, Sch Stomatol, Beijing, Peoples R China; [Wang, Lei] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China; [Xu, Xingtian] Tongji Univ, Key Lab Translat Res, Sch Stomatol, Shanghai 200092, Peoples R China; [Chen, WanJun] Natl Inst Dent & Craniofacial Res, US Natl Inst Hlth, Bethesda, MD USA	University of Southern California; Capital Medical University; Air Force Military Medical University; Tongji University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Shi, ST (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	songtaos@usc.edu	XU, XINGTIAN/E-4518-2014; Chen, Chider/L-9880-2016	Chen, Chider/0000-0003-2899-1208	US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services [R01DE017449, R01DE019932, R01DE019413]; California Institute for Regenerative Medicine [RN1-00572]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449, ZIADE000101, R01DE019932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019413] Funding Source: NIH RePORTER	US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank X. Duan and T. Zhou of the Fourth Military Medical University for generating microCT images. This work was supported by grants from the US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services (R01DE017449, R01DE019932 and R01DE019413 to S.S.), a grant from California Institute for Regenerative Medicine (RN1-00572 to S.S.) and the Intramural Program of the US National Institute of Dental and Craniofacial Research, US National Institutes of Health, Department of Health and Human Services.	Ahuja SS, 2003, ENDOCRINOLOGY, V144, P1761, DOI 10.1210/en.2002-221136; Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Buckland M, 2006, AM J TRANSPLANT, V6, P2046, DOI 10.1111/j.1600-6143.2006.01450.x; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fredericks DC, 2004, ORTHOPEDICS, V27, pS167; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Kogianni G, 2004, LIFE SCI, V75, P2879, DOI 10.1016/j.lfs.2004.04.048; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Kwon MS, 2005, PHARMACOLOGY, V74, P152, DOI 10.1159/000084548; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Li ZX, 2011, INT IMMUNOPHARMACOL, V11, P496, DOI 10.1016/j.intimp.2011.01.001; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; OWEN M, 1988, CIBA F SYMP, V136, P42; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qin JZ, 1999, J BIOL CHEM, V274, P37957, DOI 10.1074/jbc.274.53.37957; Schrum LW, 2003, INFECT IMMUN, V71, P1209, DOI 10.1128/IAI.71.3.1209-1216.2003; Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Tasso R, 2010, BIOMATERIALS, V31, P2121, DOI 10.1016/j.biomaterials.2009.11.064; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5; Ura K, 2000, ENDOCR J, V47, P293, DOI 10.1507/endocrj.47.293; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhou XH, 2011, AUTOIMMUNITY, V44, P43, DOI 10.3109/08916931003782163	40	474	499	5	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1594	U106		10.1038/nm.2542	http://dx.doi.org/10.1038/nm.2542			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101767	Green Accepted			2022-12-27	WOS:000297978000030
J	Wang, Q; Rozelle, AL; Lepus, CM; Scanzello, CR; Song, JJ; Larsen, DM; Crish, JF; Bebek, G; Ritter, SY; Lindstrom, TM; Hwang, IY; Wong, HDH; Punzi, L; Encarnacion, A; Shamloo, M; Goodman, SB; Wyss-Coray, T; Goldring, SR; Banda, NK; Thurman, JM; Gobezie, R; Crow, MK; Holers, VM; Lee, DM; Robinson, WH				Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Scanzello, Carla R.; Song, Jason J.; Larsen, D. Meegan; Crish, James F.; Bebek, Gurkan; Ritter, Susan Y.; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Punzi, Leonardo; Encarnacion, Angelo; Shamloo, Mehrdad; Goodman, Stuart B.; Wyss-Coray, Tony; Goldring, Steven R.; Banda, Nirmal K.; Thurman, Joshua M.; Gobezie, Reuben; Crow, Mary K.; Holers, V. Michael; Lee, David M.; Robinson, William H.			Identification of a central role for complement in osteoarthritis	NATURE MEDICINE			English	Article							OLIGOMERIC MATRIX PROTEIN; RHEUMATOID-ARTHRITIS; CARTILAGE DEGRADATION; KNEE OSTEOARTHRITIS; SYNOVIAL-FLUID; IN-VIVO; ACTIVATION; EXPRESSION; GENERATION; INDUCTION	Osteoarthritis, characterized by the breakdown of articular cartilage in synovial joints, has long been viewed as the result of 'wear and tear'(1). Although low-grade inflammation is detected in osteoarthritis, its role is unclear(2-4). Here we identify a central role for the inflammatory complement system in the pathogenesis of osteoarthritis. Through proteomic and transcriptomic analyses of synovial fluids and membranes from individuals with osteoarthritis, we find that expression and activation of complement is abnormally high in human osteoarthritic joints. Using mice genetically deficient in complement component 5 (C5), C6 or the complement regulatory protein CD59a, we show that complement, specifically, the membrane attack complex (MAC)-mediated arm of complement, is crucial to the development of arthritis in three different mouse models of osteoarthritis. Pharmacological modulation of complement in wild-type mice confirmed the results obtained with genetically deficient mice. Expression of inflammatory and degradative molecules was lower in chondrocytes from destabilized joints from C5-deficient mice than C5-sufficient mice, and MAC induced production of these molecules in cultured chondrocytes. Further, MAC colocalized with matrix metalloprotease 13 (MMP13) and with activated extracellular signal-regulated kinase (ERK) around chondrocytes in human osteoarthritic cartilage. Our findings indicate that dysregulation of complement in synovial joints has a key role in the pathogenesis of osteoarthritis.	[Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Song, Jason J.; Larsen, D. Meegan; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Wyss-Coray, Tony; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ Ctr, Palo Alto, CA USA; [Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Song, Jason J.; Larsen, D. Meegan; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Wyss-Coray, Tony; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Clin, Palo Alto, CA USA; [Wang, Qian; Rozelle, Andrew L.; Lepus, Christin M.; Song, Jason J.; Larsen, D. Meegan; Lindstrom, Tamsin M.; Hwang, Inyong; Wong, Heidi H.; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Scanzello, Carla R.] Rush Univ, Med Ctr, Rheumatol Sect, Chicago, IL 60612 USA; [Crish, James F.; Bebek, Gurkan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH USA; [Bebek, Gurkan] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Ritter, Susan Y.; Lee, David M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Ritter, Susan Y.; Lee, David M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Punzi, Leonardo] Univ Padua, Rheumatol Unit, Dept Clin & Expt Med, Padua, Italy; [Encarnacion, Angelo; Shamloo, Mehrdad] Stanford Univ, Behav & Funct Neurosci Lab, Sch Med, Stanford, CA 94305 USA; [Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Goldring, Steven R.; Crow, Mary K.] Hosp Special Surg, Dept Rheumatol, New York, NY 10021 USA; [Banda, Nirmal K.; Thurman, Joshua M.; Holers, V. Michael] Univ Colorado, Dept Immunol, Hlth Sci Ctr, Aurora, CO USA; [Banda, Nirmal K.; Thurman, Joshua M.; Holers, V. Michael] Univ Colorado, Dept Med, Hlth Sci Ctr, Aurora, CO USA; [Gobezie, Reuben] Case Western Reserve Univ, Dept Orthopaed Surg, Sch Med, Cleveland, OH 44106 USA; [Lee, David M.] Novartis Pharma AG, Novartis Inst Biomed Res, Basel, Switzerland	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Rush University; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Padua; Stanford University; Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Case Western Reserve University; Novartis	Robinson, WH (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ Ctr, Palo Alto, CA USA.	wrobins@stanford.edu	Scanzello, Carla R/AAE-4348-2019; Wyss-Coray, Tony/AAF-3380-2019; Crow, Mary/R-8480-2019; Goodman, Stuart/AAZ-7499-2020	Scanzello, Carla R/0000-0002-9290-188X; Wyss-Coray, Tony/0000-0001-5893-0831; PUNZI, LEONARDO/0000-0002-8853-516X; Goodman, Stuart/0000-0002-1919-3717; Robinson, William/0000-0003-4385-704X; Thurman, Joshua Michael/0000-0002-3476-9956	Department of Veterans Affairs; US National Heart, Lung, and Blood Institute Proteomics Center [N01 HV 28183]; Northern California Chapter Arthritis Foundation; New York Chapter Arthritis Foundation/Merck; Atlantic Philanthropies; American College of Rheumatology Research; Association of Specialty Professors; US National Institute of Arthritis, Musculoskeletal and Skin Diseases [K08 AR057859]; US National Institute of Neurological Disorders and Stroke [NS069375]; US National Institutes of Health [T32 AR007530]; National Institutes of Health [R01 AR051749]; Frankenthaler Foundation; Kohlberg Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051749, T32AR007530, K08AR057859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); US National Heart, Lung, and Blood Institute Proteomics Center; Northern California Chapter Arthritis Foundation; New York Chapter Arthritis Foundation/Merck(Merck & Company); Atlantic Philanthropies; American College of Rheumatology Research; Association of Specialty Professors; US National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frankenthaler Foundation; Kohlberg Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by a Rehabilitation Research and Development Merit Award from the Department of Veterans Affairs and the US National Heart, Lung, and Blood Institute Proteomics Center contract N01 HV 28183 (W.H.R.); a Northern California Chapter Arthritis Foundation Postdoctoral Fellowship Award (A.L.R.); a New York Chapter Arthritis Foundation/Merck Osteoarthritis Research Fellowship Award, the Atlantic Philanthropies, the American College of Rheumatology Research and the Education Fund, the Association of Specialty Professors and the US National Institute of Arthritis, Musculoskeletal and Skin Diseases Mentored Clinical Scientist Research Career Development Award K08 AR057859 (C.R.S.); US National Institute of Neurological Disorders and Stroke P30 Center Core grant NS069375 (M.S.); US National Institutes of Health training grant T32 AR007530 (S.Y.R.); National Institutes of Health R01 AR051749 (V.M.H.); and the Frankenthaler and Kohlberg Foundations (M.K.C.).	Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Badea TD, 2003, J NEUROIMMUNOL, V142, P58, DOI 10.1016/S0165-5728(03)00261-3; Banda NK, 2009, J IMMUNOL, V183, P5928, DOI 10.4049/jimmunol.0901826; Banda NK, 2002, ARTHRITIS RHEUM-US, V46, P3065, DOI 10.1002/art.10591; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; COOKE TDV, 1987, J RHEUMATOL, V14, P77; COOKE TDV, 1980, INT ORTHOP, V4, P211, DOI 10.1007/BF00268158; CORVETTA A, 1992, CLIN EXP RHEUMATOL, V10, P433; Daiger SP, 2005, SCIENCE, V308, P362, DOI 10.1126/science.1111655; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; FREI Y, 1987, MOL CELL PROBE, V1, P141, DOI 10.1016/0890-8508(87)90022-3; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Glasson SS, 2007, CURR DRUG TARGETS, V8, P367, DOI 10.2174/138945007779940061; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gobezie R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2172; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Hill CL, 2007, ANN RHEUM DIS, V66, P1599, DOI 10.1136/ard.2006.067470; Holt DS, 2001, BLOOD, V98, P442, DOI 10.1182/blood.V98.2.442; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kraus S, 2001, CLIN EXP IMMUNOL, V123, P366, DOI 10.1046/j.1365-2249.2001.01477.x; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; OOI YM, 1979, NATURE, V282, P207, DOI 10.1038/282207a0; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rus HG, 1996, J IMMUNOL, V156, P4892; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Scanzello CR, 2011, ARTHRITIS RHEUM-US, V63, P391, DOI 10.1002/art.30137; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sofat N, 2009, INT J EXP PATHOL, V90, P463, DOI 10.1111/j.1365-2613.2009.00676.x; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	40	378	399	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1674	U196		10.1038/nm.2543	http://dx.doi.org/10.1038/nm.2543			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22057346	Green Accepted			2022-12-27	WOS:000297978000042
J	Bollee, G; Flamant, M; Schordan, S; Fligny, C; Rumpel, E; Milon, M; Schordan, E; Sabaa, N; Vandermeersch, S; Galaup, A; Rodenas, A; Casal, I; Sunnarborg, SW; Salant, DJ; Kopp, JB; Threadgill, DW; Quaggin, SE; Dussaule, JC; Germain, S; Mesnard, L; Endlich, K; Boucheix, C; Belenfant, X; Callard, P; Endlich, N; Tharaux, PL				Bollee, Guillaume; Flamant, Martin; Schordan, Sandra; Fligny, Cecile; Rumpel, Elisabeth; Milon, Marine; Schordan, Eric; Sabaa, Nathalie; Vandermeersch, Sophie; Galaup, Ariane; Rodenas, Anita; Casal, Ibrahim; Sunnarborg, Susan W.; Salant, David J.; Kopp, Jeffrey B.; Threadgill, David W.; Quaggin, Susan E.; Dussaule, Jean-Claude; Germain, Stephane; Mesnard, Laurent; Endlich, Karlhans; Boucheix, Claude; Belenfant, Xavier; Callard, Patrice; Endlich, Nicole; Tharaux, Pierre-Louis			Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis	NATURE MEDICINE			English	Article							PARIETAL EPITHELIAL-CELLS; GENE-EXPRESSION; CELLULAR CRESCENTS; ENDOTHELIAL-CELLS; NEPHROTOXIC SERUM; MEDIATED-IMMUNITY; BOWMANS CAPSULE; TRANSGENIC MICE; MESANGIAL CELLS; T-LYMPHOCYTES	Rapidly progressive glomerulonephritis (RPGN) is a life-threatening clinical syndrome and a morphological manifestation of severe glomerular injury that is marked by a proliferative histological pattern ('crescents') with accumulation of T cells and macrophages and proliferation of intrinsic glomerular cells. We show de novo induction of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in intrinsic glomerular epithelial cells (podocytes) from both mice and humans with RPGN. HB-EGF induction increases phosphorylation of the epidermal growth factor receptor (EGFR, also known as ErbB1) in mice with RPGN. In HB-EGF-deficient mice, EGFR activation in glomeruli is absent and the course of RPGN is improved. Autocrine HB-EGF induces a phenotypic switch in podocytes in vitro. Conditional deletion of the Egfr gene from podocytes of mice alleviates the severity of RPGN. Likewise, pharmacological blockade of EGFR also improves the course of RPGN, even when started 4 d after the induction of experimental RPGN. This suggests that targeting the HB-EGF-EGFR pathway could also be beneficial in treatment of human RPGN.	[Bollee, Guillaume; Fligny, Cecile; Milon, Marine; Tharaux, Pierre-Louis] INSERM, Unite Mixte Rech UMR 970, Paris Cardiovasc Res Ctr, Paris, France; [Bollee, Guillaume; Fligny, Cecile; Milon, Marine; Tharaux, Pierre-Louis] Univ Paris 05, Paris, France; [Flamant, Martin; Sabaa, Nathalie] Univ Paris Diderot, Paris, France; [Flamant, Martin; Sabaa, Nathalie] Hop Bichat Claude Bernard, AP HP, Serv Physiol Explorat Fonct, F-75877 Paris, France; [Schordan, Sandra; Rumpel, Elisabeth; Schordan, Eric; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Zellbiol, Greifswald, Germany; [Vandermeersch, Sophie; Dussaule, Jean-Claude; Mesnard, Laurent] Hop Tenon, INSERM, UMR702, F-75970 Paris, France; [Vandermeersch, Sophie; Dussaule, Jean-Claude; Mesnard, Laurent; Callard, Patrice] Sorbonne Univ, Univ Paris 06, Paris, France; [Galaup, Ariane; Germain, Stephane] INSERM, Ctr Interdisciplinary Res Biol, Ctr Natl Rech Sci, UMR 7241,U1050, Paris, France; [Galaup, Ariane; Germain, Stephane] Coll France, Chaire Med Expt, F-75231 Paris, France; [Rodenas, Anita; Callard, Patrice] Hop Tenon, AP HP, Serv Anat & Cytol Pathol, F-75970 Paris, France; [Casal, Ibrahim; Boucheix, Claude] Hop Paul Brousse, INSERM, UMR 1004, Inst Andre Lwoff, Villejuif, France; [Casal, Ibrahim; Boucheix, Claude] Univ Paris 11, Villejuif, France; [Sunnarborg, Susan W.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Salant, David J.] Boston Univ, Med Ctr, Renal Sect, Boston, MA USA; [Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, Bethesda, MD USA; [Threadgill, David W.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Quaggin, Susan E.] Univ Toronto, Mt Sinai Hosp, St Michaels Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Dussaule, Jean-Claude] Hop St Antoine, AP HP, Serv Physiol Explorat Fonct, F-75571 Paris, France; [Belenfant, Xavier] Ctr Hosp Intercommunal Andre Gregoire, Serv Nephrol & Dialyse, Montreuil, France; [Tharaux, Pierre-Louis] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Nephrol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Greifswald Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; North Carolina State University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Tharaux, PL (corresponding author), INSERM, Unite Mixte Rech UMR 970, Paris Cardiovasc Res Ctr, Paris, France.	pierre-louis.tharaux@inserm.fr	Germain, Stephane/E-2301-2016; Tharaux, Pierre-Louis/A-9155-2009; Kopp, Jeffrey B/O-2681-2015; Endlich, Karlhans/G-5485-2013; Threadgill, David W/N-4425-2013	Germain, Stephane/0000-0001-5992-1275; Tharaux, Pierre-Louis/0000-0002-6062-5905; Kopp, Jeffrey B/0000-0001-9052-186X; Threadgill, David W/0000-0003-3538-1635; Endlich, Karlhans/0000-0001-6052-6061; VANDERMEERSCH, sophie/0000-0001-6021-1334; Salant, David/0000-0002-3866-3120; Boucheix, Claude/0000-0003-4184-7008	INSERM; l'Agence Nationale de la Recherche of France [ANR-08-EBIO-003]; German Federal Ministry of Education and Research (BMBF) [01GN0805, 03IP612]; US National Institutes of Health [CA43793, DK30932]; la Fondation pour la Recherche Medicale; la Fondation Lefoulon-Delalande; NATIONAL CANCER INSTITUTE [R01CA043793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030932, R56DK030932] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Agence Nationale de la Recherche of France(French National Research Agency (ANR)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); la Fondation Lefoulon-Delalande; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by INSERM, grant ANR-08-EBIO-003 (P.-L. T.) from l'Agence Nationale de la Recherche of France, grant 01GN0805 (K.E.) from the German Federal Ministry of Education and Research (BMBF) and grants CA43793 (S.W.S.) and DK30932 (D.S.) from the US National Institutes of Health. We are grateful to la Fondation pour la Recherche Medicale and la Fondation Lefoulon-Delalande for supporting G.B. and C.F., respectively. We thank L.B. Holzman (Perelman School of Medicine, University of Pennsylvania) for the use of podocin-Cre mice crossed with Z/EGFP mice. We also thank X. Biolchini, C. Kitou, C. Martin, E. Huc and the ERI970 team for assistance in animal care and handling, H. Wegner, R. Maciejewski and T. Felix for technical assistance and J. Peters for help with fluorescence-activated cell sorting (FACS; supported by InnoProfile grant 03IP612 of the BMBF). We acknowledge administrative support from M.-C. Poeuf, V. Oberweiss, A. De Rueda, M. Autran and P. Coudol.	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Bariety J, 2006, KIDNEY INT, V69, P194, DOI 10.1038/sj.ki.5000069; Besse-Eschmann V, 2004, HISTOCHEM CELL BIOL, V122, P139, DOI 10.1007/s00418-004-0683-z; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; BOUCHER A, 1987, LAB INVEST, V56, P526; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Feng LL, 2000, J CLIN INVEST, V105, P341, DOI 10.1172/JCI2869; GUETTIER C, 1986, VIRCHOWS ARCH A, V409, P739, DOI 10.1007/BF00713438; HANCOCK WW, 1984, AM J NEPHROL, V4, P177, DOI 10.1159/000166800; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jennette JC, 2001, NEPHROL DIAL TRANSPL, V16, P80, DOI 10.1093/ndt/16.suppl_6.80; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; Khong TF, 2000, KIDNEY INT, V58, P1098, DOI 10.1046/j.1523-1755.2000.00267.x; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; KUME N, 1994, J CLIN INVEST, V93, P907, DOI 10.1172/JCI117047; Le Hir M, 2001, J AM SOC NEPHROL, V12, P2060, DOI 10.1681/ASN.V12102060; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee D, 2004, MOL CELL BIOL, V24, P8907, DOI 10.1128/MCB.24.20.8907-8916.2004; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; LEE YJ, 1995, BIOCHEM BIOPH RES CO, V207, P216, DOI 10.1006/bbrc.1995.1175; Levy J, 2003, OXFORD TXB MED; Levy JB, 2001, ANN INTERN MED, V134, P1033, DOI 10.7326/0003-4819-134-11-200106050-00009; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Mishra R, 2002, AM J PHYSIOL-RENAL, V283, pF1151, DOI 10.1152/ajprenal.00103.2002; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; NEALE TJ, 1988, LANCET, V2, P421; Ng YY, 1999, NEPHROL DIAL TRANSPL, V14, P2860, DOI 10.1093/ndt/14.12.2860; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Paizis K, 1999, KIDNEY INT, V55, P2310, DOI 10.1046/j.1523-1755.1999.00469.x; Paizis K, 1998, KIDNEY INT, V53, P1162, DOI 10.1046/j.1523-1755.1998.00846.x; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; Polihronis M, 1996, EXP NEPHROL, V4, P271; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Segerer S, 2000, J AM SOC NEPHROL, V11, P2231, DOI 10.1681/ASN.V11122231; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Takemura T, 1999, J PATHOL, V189, P431; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tipping PG, 2003, SPRINGER SEMIN IMMUN, V24, P377, DOI 10.1007/s00281-003-0121-7; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Wassef L, 2004, KIDNEY INT, V66, P1805, DOI 10.1111/j.1523-1755.2004.00955.x; YOSHIZUMI M, 1992, J BIOL CHEM, V267, P9467	56	170	177	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1242	U272		10.1038/nm.2491	http://dx.doi.org/10.1038/nm.2491			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946538	Green Accepted			2022-12-27	WOS:000296022100042
J	Goldstein, JL				Goldstein, Joseph L.			The card players of Caravaggio, Cezanne and Mark Twain: tips for getting lucky in high-stakes research	NATURE MEDICINE			English	Article												joe.goldstein@utsouthwestern.edu							0	0	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1201	1205		10.1038/nm.2465	http://dx.doi.org/10.1038/nm.2465			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989010				2022-12-27	WOS:000296022100033
J	Guo, WX; Allan, AM; Zong, RT; Zhang, L; Johnson, EB; Schaller, EG; Murthy, AC; Goggin, SL; Eisch, AJ; Oostra, BA; Nelson, DL; Jin, P; Zhao, XY				Guo, Weixiang; Allan, Andrea M.; Zong, Ruiting; Zhang, Li; Johnson, Eric B.; Schaller, Eric G.; Murthy, Adeline C.; Goggin, Samantha L.; Eisch, Amelia J.; Oostra, Ben A.; Nelson, David L.; Jin, Peng; Zhao, Xinyu			Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning	NATURE MEDICINE			English	Article							FRAGILE-X-SYNDROME; ENHANCED SYNAPTIC PLASTICITY; DENTATE GYRUS; KNOCKOUT MICE; DORSAL HIPPOCAMPUS; GENE-EXPRESSION; GRANULE CELLS; MOUSE MODEL; NEUROGENESIS; MEMORY	Deficiency in fragile X mental retardation protein (FMRP) results in fragile X syndrome (FXS), an inherited form of intellectual disability. Despite extensive research, it is unclear how FMRP deficiency contributes to the cognitive deficits in FXS. Fmrp-null mice show reduced adult hippocampal neurogenesis. As Fmrp is also enriched in mature neurons, we investigated the function of Fmrp expression in neural stem and progenitor cells (aNSCs) and its role in adult neurogenesis. Here we show that ablation of Fmrp in aNSCs by inducible gene recombination leads to reduced hippocampal neurogenesis in vitro and in vivo, as well as markedly impairing hippocampus-dependent learning in mice. Conversely, restoration of Fmrp expression specifically in aNSCs rescues these learning deficits in Fmrp-deficient mice. These data suggest that defective adult neurogenesis may contribute to the learning impairment seen in FXS, and these learning deficits can be rectified by delayed restoration of Fmrp specifically in aNSCs.	[Guo, Weixiang; Allan, Andrea M.; Zhang, Li; Johnson, Eric B.; Schaller, Eric G.; Murthy, Adeline C.; Goggin, Samantha L.; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Zong, Ruiting; Nelson, David L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Oostra, Ben A.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	University of New Mexico; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Erasmus University Rotterdam; Erasmus MC; Emory University	Zhao, XY (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	xzhao@waisman.wisc.edu		Eisch, Amelia/0000-0001-6476-5385; Allan, Andrea/0000-0002-6745-4352	NIH [MH080434, MH078972, HD38038, HD024064]; NIH National Institute of Mental Health [MH19101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T34MH019101, R01MH080434, R01MH078972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. T. Strauss for editing the manuscript; H. van Praag, D. Schaffer and T. Xie for critical reading of the manuscript; members of the Zhao lab for discussions; S.J. von Hoyningen-Huene for technical assistance; D. C. Lagace and R. D. Smrt for technical help; and H. van Praag (US National Institutes of Health (NIH)/National Institute of Aging) and F. Gage (Salk Institute) for the Cre-GFP construct. This work was supported by grants from the NIH to X.Z. (MH080434 and MH078972) and D.L.N. (HD38038 and HD024064). E. G. S. is supported by an NIH National Institute of Mental Health Career Opportunity for Research training grant (MH19101). Images in this paper were generated in the University of New Mexico Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed here: http://hsc.unm.edu/crtc/microscopy/acknowledgement.shtml/.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bhattacharyya A, 2008, STEM CELLS DEV, V17, P107, DOI 10.1089/scd.2007.0073; Brennan FX, 2006, GENES BRAIN BEHAV, V5, P467, DOI 10.1111/j.1601-183X.2005.00183.x; Castren M, 2005, P NATL ACAD SCI USA, V102, P17834, DOI 10.1073/pnas.0508995102; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Cunningham CL, 2011, HUM MOL GENET, V20, P64, DOI 10.1093/hmg/ddq432; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eadie BD, 2009, NEUROBIOL DIS, V36, P361, DOI 10.1016/j.nbd.2009.08.001; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Harrell AV, 2003, LEARN MEMORY, V10, P410, DOI 10.1101/lm.56103; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lightbody AA, 2009, DEV DISABIL RES REV, V15, P343, DOI 10.1002/ddrr.77; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Mercaldo V, 2009, MOL CELLS, V28, P501, DOI 10.1007/s10059-009-0193-x; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moore MD, 2010, NEUROBIOL LEARN MEM, V93, P383, DOI 10.1016/j.nlm.2009.12.004; Paz R, 2007, NEUROPSYCHOPHARMACOL, V32, P693, DOI 10.1038/sj.npp.1301066; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pepper ASR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007618; Quinn JJ, 2002, HIPPOCAMPUS, V12, P495, DOI 10.1002/hipo.10029; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	58	170	172	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					559	U75		10.1038/nm.2336	http://dx.doi.org/10.1038/nm.2336			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21516088	Green Accepted			2022-12-27	WOS:000290250400031
J	Pier, G; Prince, A; Cantin, A				Pier, Gerald; Prince, Alice; Cantin, Andre			Cystic fibrosis: an-ion transport issue?	NATURE MEDICINE			English	Editorial Material								Cystic fibrosis can manifest in many organs, but infection and inflammation of the airways cause the most severe morbidity and mortality. Early studies suggested that increased epithelial Na+ reabsorption may be a key initiating event in cystic fibrosis lung disease. However, the importance of Na+ hyperabsorption and the consequent depletion of pericellular airway liquid in cystic fibrosis lung disease has been called into question by a recent study by Jeng-Haur Chen et al.(1). Newborn pigs lacking cystic fibrosis transmembrane conductance regulator (CFTR-/- pigs) developed lung pathology reminiscent of human cystic fibrosis. Although epithelia from these pigs had reduced Cl- and HCO3- transport, there were no alterations in Na+ or liquid absorption, suggesting that defective anion transport is responsible for cystic fibrosis lung disease. Here three experts comment on how these findings might affect our understanding of cystic fibrosis lung pathogenesis and strategies for cystic fibrosis therapy. [GRAPHICS] .	[Pier, Gerald] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pier, Gerald] Brigham & Womens Hosp, Boston, MA 02115 USA; [Prince, Alice] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Cantin, Andre] CHU Sherbrooke, Clin Res Ctr Etienne Le Bel, Sherbrooke, PQ J1H 5N4, Canada	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Columbia University; University of Sherbrooke	Pier, G (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331	NHLBI NIH HHS [R01 HL073989] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073989] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928	7	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					166	167		10.1038/nm0211-166	http://dx.doi.org/10.1038/nm0211-166			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297610	Green Accepted			2022-12-27	WOS:000286969900021
J	Herker, E; Harris, C; Hernandez, C; Carpentier, A; Kaehlcke, K; Rosenberg, AR; Farese, RV; Ott, M				Herker, Eva; Harris, Charles; Hernandez, Celine; Carpentier, Arnaud; Kaehlcke, Katrin; Rosenberg, Arielle R.; Farese, Robert V., Jr.; Ott, Melanie			Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1	NATURE MEDICINE			English	Article							LIPID DROPLETS; CORE PROTEIN; CELL-CULTURE; VIRAL GENOME; REPLICATION; LOCALIZATION; SECRETION; DGAT; MICE	Hepatitis C virus (HCV) infection is closely tied to the lipid metabolism of liver cells. Here we identify the triglyceride-synthesizing enzyme diacylglycerol acyltransferase-1 (DGAT1) as a key host factor for HCV infection. DGAT1 interacts with the viral nucleocapsid core and is required for the trafficking of core to lipid droplets. Inhibition of DGAT1 activity or RNAi-mediated knockdown of DGAT1 severely impairs infectious virion production, implicating DGAT1 as a new target for antiviral therapy.	[Herker, Eva; Kaehlcke, Katrin; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Herker, Eva; Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Herker, Eva; Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Harris, Charles; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Hernandez, Celine; Carpentier, Arnaud; Rosenberg, Arielle R.] Univ Paris 05, EA Virol Hepatite C 4474, Paris, France; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484; Carpentier, Arnaud/0000-0002-6994-4689; Rosenberg, Arielle/0000-0003-2085-8146; Ott, Melanie/0000-0002-5697-1274	Gladstone Institutes; Hellman Family Foundation; US National Institutes of Health [R03 AI069090, R01 DK056084, P30 DK026743]; Human Frontiers Science Program; Agence nationale de recherches sur le sida et les hepatites virales; US National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK056084] Funding Source: NIH RePORTER	Gladstone Institutes(University of California System); Hellman Family Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Yen (University of North Carolina-Chapel Hill) for Sf9 cell lysates, R. Bartenschlager (University of Heidelberg) for Luc-Jc1, Luc-JFH1, Jc1 constructs and Huh7 Lunet cells, C. M. Rice (Rockefeller University) for Huh7.5 cells, F.V. Chisari (Scripps Research Institute) for Huh7.5.1 cells, J. McLauchlan (Medical Research Council Virology Unit) for JFH1, JFH1 GND and JFH1 Delta E1E2, T. Wakita (National Institute of Infectious Diseases, Japan) for the JFH1 construct and M. Spindler (Gladstone Institute of Cardiovascular Disease) for the pSicoRMS. We thank the members of the Ott and Farese laboratories for support. This work was supported by funds from the Gladstone Institutes, the Hellman Family Foundation (M.O.) and the US National Institutes of Health (R03 AI069090 (M.O.); R01 DK056084 (R.V.F. Jr.); P30 DK026743 (University of California-San Francisco Liver Center)). We gratefully acknowledge support through fellowships from the Human Frontiers Science Program (E.H.), the Agence nationale de recherches sur le sida et les hepatites virales (C. Hernandez and A.C.), and a training grant from the US National Institute of Diabetes and Digestive and Kidney Diseases (C. Harris).	Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	20	237	248	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1295	1298		10.1038/nm.2238	http://dx.doi.org/10.1038/nm.2238			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20935628	Green Accepted, Green Submitted			2022-12-27	WOS:000283860100041
J	Kotz, KT; Xiao, W; Miller-Graziano, C; Qian, WJ; Russom, A; Warner, EA; Moldawer, LL; De, A; Bankey, PE; Petritis, BO; Camp, DG; Rosenbach, AE; Goverman, J; Fagan, SP; Brownstein, BH; Irimia, D; Xu, WH; Wilhelmy, J; Mindrinos, MN; Smith, RD; Davis, RW; Tompkins, RG; Toner, M				Kotz, Kenneth T.; Xiao, Wenzong; Miller-Graziano, Carol; Qian, Wei-Jun; Russom, Aman; Warner, Elizabeth A.; Moldawer, Lyle L.; De, Asit; Bankey, Paul E.; Petritis, Brianne O.; Camp, David G., II; Rosenbach, Alan E.; Goverman, Jeremy; Fagan, Shawn P.; Brownstein, Bernard H.; Irimia, Daniel; Xu, Weihong; Wilhelmy, Julie; Mindrinos, Michael N.; Smith, Richard D.; Davis, Ronald W.; Tompkins, Ronald G.; Toner, Mehmet		Inflammation Host Response Injury	Clinical microfluidics for neutrophil genomics and proteomics	NATURE MEDICINE			English	Article							T-CELL; EXPRESSION; LIPOPOLYSACCHARIDE; MASS; ACTIVATION; BLOOD; CHALLENGES; APOPTOSIS; SUBSETS; PATHWAY	Neutrophils have key roles in modulating the immune response. We present a robust methodology for rapidly isolating neutrophils directly from whole blood with 'on-chip' processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and by comparison with standard bulk isolation methodologies. Last, we implement this tool as part of a near-patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury. The preliminary results from a small cohort of subjects in our study and healthy controls show a unique time-dependent gene expression pattern clearly demonstrating the ability of this tool to discriminate temporal transcriptional events of neutrophils within a clinical setting.	[Kotz, Kenneth T.; Xiao, Wenzong; Russom, Aman; Rosenbach, Alan E.; Goverman, Jeremy; Fagan, Shawn P.; Irimia, Daniel; Tompkins, Ronald G.; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Surg, Boston, MA 02115 USA; [Xiao, Wenzong; Xu, Weihong; Wilhelmy, Julie; Mindrinos, Michael N.; Davis, Ronald W.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Miller-Graziano, Carol; De, Asit; Bankey, Paul E.] Univ Rochester, Sch Med, Dept Surg, Rochester, NY USA; [Qian, Wei-Jun; Petritis, Brianne O.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Qian, Wei-Jun; Petritis, Brianne O.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Warner, Elizabeth A.; Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA; [Brownstein, Bernard H.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; University of Rochester; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; University of Florida; Washington University (WUSTL)	Kotz, KT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Surg, Boston, MA 02115 USA.	kkotz@partners.org; mtoner@hms.harvard.edu	Xu, Weihong/C-4175-2012; Qian, Wei-Jun/C-6167-2011; Russom, Aman/B-1675-2012; Smith, Richard D/J-3664-2012; Irimia, Daniel/A-4095-2008; Goverman, Jeremy/AAZ-6769-2020; QIAN, Wei-Jun/AAC-1907-2021; Irimia, Daniel/S-5404-2019	Xu, Weihong/0000-0002-3988-3571; Smith, Richard D/0000-0002-2381-2349; Irimia, Daniel/0000-0001-7347-2082; QIAN, Wei-Jun/0000-0002-5393-2827; Irimia, Daniel/0000-0001-7347-2082; Russom, Aman/0000-0002-0242-358X; Moldawer, Lyle/0000-0002-9041-9838; West, Michaela A/0000-0002-6598-4114; xiao, wenzhong/0000-0003-4944-6380	US National Institutes of Health (NIH) [T32 GM-007035-32]; US NIH Inflammation; NATIONAL CANCER INSTITUTE [R33CA094304] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036214, U54GM062119, R01GM040586, T32GM007035] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH Inflammation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Hurtado, K. Eken, K. Richter and A. Gupta for microfabrication support. We thank C. Vanderburg for help with nucleic acid analysis and the use of the Harvard NeuroDiscovery Center Agilent Bioanalyzer 2100. We thank the University of Florida technical staff (A. Abouhamze, C. Tannahill and R. Ungaro) for managing clinical implementation of the microfluidic devices. K. T. K. was supported by a US National Institutes of Health (NIH) training grant T32 GM-007035-32. These studies were supported by the US NIH Inflammation and the Host Response to Injury Large Scale Collaborative Project, U54 GM-062119, BioMEMS Resource Center P41 EB-002503 and Proteomics Research Resource for Integrative Biology RR018522. The ex vivo stimulation studies and genomics protocol development were partially supported by US National Institutes of Health grants R01-GM-36214 and P01 HG000205, respectively. The proteomics work was performed in the Environmental Molecular Sciences Laboratory, a US Department of Energy Office of Biological and Environmental Research national scientific user facility on the Pacific Northwest National Laboratory (PNNL) campus. PNNL is multiprogram national laboratory operated by Battelle for the Department of Energy under contract number DE-AC05-76RLO 1830.	Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cassatella MA, 1997, ANN NY ACAD SCI, V832, P233, DOI 10.1111/j.1749-6632.1997.tb46251.x; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; De AK, 2005, J IMMUNOL, V175, P6155, DOI 10.4049/jimmunol.175.9.6155; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; DEFORGE LE, 1992, J IMMUNOL, V148, P2133; Elghetany MT, 2005, CYTOM PART B-CLIN CY, V65B, P1, DOI 10.1002/cyto.b.20051; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kobayashi SD, 2003, J IMMUNOL, V170, P3357, DOI 10.4049/jimmunol.170.6.3357; Kotz Kenneth, 2007, J Vis Exp, P319, DOI 10.3791/319; Kotz Kenneth, 2007, J Vis Exp, P320, DOI 10.3791/320; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Singh R, 2005, AM J PHYSIOL-CELL PH, V288, pC1179, DOI 10.1152/ajpcell.00258.2004; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang XL, 2006, ELECTROPHORESIS, V27, P1659, DOI 10.1002/elps.200500736; Zhang XQ, 2004, J LEUKOCYTE BIOL, V75, P358, DOI 10.1189/jlb.0903412; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	39	127	134	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1042	U142		10.1038/nm.2205	http://dx.doi.org/10.1038/nm.2205			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20802500	Green Accepted			2022-12-27	WOS:000281622900035
J	Schwab, M; Tuszynski, MH				Schwab, Martin; Tuszynski, Mark H.			Mutant mice challenged as models of injury in the central nervous system	NATURE MEDICINE			English	Editorial Material									[Schwab, Martin] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Schwab, Martin] Swiss Fed Inst Technol, Zurich, Switzerland; [Tuszynski, Mark H.] Univ Calif San Diego, Ctr Neural Repair, San Diego, CA 92103 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Diego	Schwab, M (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.								0	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					860	860		10.1038/nm0810-860	http://dx.doi.org/10.1038/nm0810-860			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20689549	Bronze			2022-12-27	WOS:000280649200022
J	Sheng, Z; Li, L; Zhu, LHJ; Smith, TW; Demers, A; Ross, AH; Moser, RP; Green, MR				Sheng, Zhi; Li, Li; Zhu, Lihua J.; Smith, Thomas W.; Demers, Andrea; Ross, Alonzo H.; Moser, Richard P.; Green, Michael R.			A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications	NATURE MEDICINE			English	Article							REFRACTORY SOLID TUMORS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR ATF5; FACTOR RECEPTOR INHIBITOR; ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; ATF/CREB FAMILY; DOWN-REGULATION; RAF KINASE; CELL-DEATH	Activating transcription factor-5 (ATF5) is highly expressed in malignant glioma and has a key role in promoting cell survival. Here we perform a genome-wide RNAi screen to identify transcriptional regulators of ATF5. Our results reveal an essential survival pathway in malignant glioma, whereby activation of a RAS-mitogen-activated protein kinase or phosphoinositide-3-kinase signaling cascade leads to induction of the transcription factor cAMP response element-binding protein-3-like-2 (CREB3L2), which directly activates ATF5 expression. ATF5, in turn, promotes survival by stimulating transcription of myeloid cell leukemia sequence-1 (MCL1), an antiapoptotic B cell leukemia-2 family member. Analysis of human malignant glioma samples indicates that ATF5 expression inversely correlates with disease prognosis. The RAF kinase inhibitor sorafenib suppresses ATF5 expression in glioma stem cells and inhibits malignant glioma growth in cell culture and mouse models. Our results demonstrate that ATF5 is essential in malignant glioma genesis and reveal that the ATF5-mediated survival pathway described here provides potential therapeutic targets for treatment of malignant glioma.	[Sheng, Zhi; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; [Sheng, Zhi; Green, Michael R.] Univ Massachusetts, Sch Med, Program & Mol Med, Worcester, MA USA; [Li, Li; Ross, Alonzo H.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Smith, Thomas W.] Univ Massachusetts, Sch Med, Dept Pathol & Neurol, Worcester, MA USA; [Demers, Andrea; Moser, Richard P.] Univ Massachusetts, Sch Med, Dept Surg,Div Neurosurg, Massachusetts Ctr Translat Res Neurosurg Oncol, Worcester, MA USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Sheng, Zhi/F-8433-2010	Zhu, Lihua/0000-0001-7416-0590	US National Institutes of Health [RO1CA115817]; NATIONAL CANCER INSTITUTE [R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021716] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Gillespie (University of Alabama at Birmingham) for GL261 cells, D. Bigner (Duke University) for D456MG cells and R. Lang (University of Cincinnati) for mCD11C-DTR-EFGP; the University of Massachusetts Medical School (UMMS) RNAi Core Facility for providing shRNAs; the UMMS Department of Pathology for providing human tissue sections and the UMMS Diabetes and Endocrinology Research Center core for performing the immunohistochemistry; K. Rock for suggesting the diphtheria toxin strategy; Y. Sun for critical advice on MRI; C. Gilbert for maintaining GS9-6 cells; S. Griggs for technical support; and S. Evans for editorial assistance. This work is supported by US National Institutes of Health grant RO1CA115817 to M.R.G. M.R.G. is an investigator of the Howard Hughes Medical Institute.	Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Aoki H, 2007, CLIN CANCER RES, V13, P6603, DOI 10.1158/1078-0432.CCR-07-0145; Awada A, 2005, BRIT J CANCER, V92, P1855, DOI 10.1038/sj.bjc.6602584; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; da Fonseca CO, 2006, SURG NEUROL S1, V65; Discafani CM, 1999, BIOCHEM PHARMACOL, V57, P917, DOI 10.1016/S0006-2952(98)00356-6; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; Hu SY, 2009, CLIN CANCER RES, V15, P6062, DOI 10.1158/1078-0432.CCR-09-0048; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McCubrey JA, 2009, EXPERT OPIN EMERG DR, V14, P633, DOI 10.1517/14728210903232633; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pelloski CE, 2006, CLIN CANCER RES, V12, P3935, DOI 10.1158/1078-0432.CCR-05-2202; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Richly H, 2006, ANN ONCOL, V17, P866, DOI 10.1093/annonc/mdl017; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sato T, 2009, EXPERT OPIN THER TAR, V13, P689, DOI 10.1517/14728220902942330; Sen A, 2004, TISSUE ENG, V10, P904, DOI 10.1089/1076327041348554; Sheng Z, 2009, EMBO J, V28, P866, DOI 10.1038/emboj.2009.35; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sparidans RW, 2009, J CHROMATOGR B, V877, P269, DOI 10.1016/j.jchromb.2008.12.026; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841	51	120	124	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					671	U73		10.1038/nm.2158	http://dx.doi.org/10.1038/nm.2158			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495567	Green Submitted, Green Accepted			2022-12-27	WOS:000278394200033
J	Torres, C				Torres, Christian			Up against the wall	NATURE MEDICINE			English	News Item							INFECTIOUS-DISEASES SOCIETY; AMERICA		[Torres, Christian] Nat Med, San Diego, CA USA									Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Kallen AJ, 2010, INFECT CONT HOSP EP, V31, P528, DOI 10.1086/652152; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754	5	8	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					628	631		10.1038/nm0610-628	http://dx.doi.org/10.1038/nm0610-628			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526310				2022-12-27	WOS:000278394200021
J	Jeong, H; Cohen, DE; Cui, LB; Supinski, A; Savas, JN; Mazzulli, JR; Yates, JR; Bordone, L; Guarente, L; Krainc, D				Jeong, Hyunkyung; Cohen, Dena E.; Cui, Libin; Supinski, Andrea; Savas, Jeffrey N.; Mazzulli, Joseph R.; Yates, John R., III; Bordone, Laura; Guarente, Leonard; Krainc, Dimitri			Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway	NATURE MEDICINE			English	Article							GENE-TRANSCRIPTION; PGC-1-ALPHA; EXPRESSION; REPEAT	Sirt1, a NAD-dependent protein deacetylase, has emerged as a key regulator of mammalian transcription in response to cellular metabolic status and stressl. Here we show that Sirt1 has a neuroprotective role in models of Huntington's disease, an inherited neurodegenerative disorder caused by a glutamine repeat expansion in huntingtin protein (HIT)2. Brain-specific knockout of Sirt1 results in exacerbation of brain pathology in a mouse model of Huntington's disease, whereas overexpression of Sirt1 improves survival, neuropathology and the expression of brain-derived neurotrophic factor (BDNF) in Huntington's disease mice. We show that Sirt1 deacetylase activity directly targets neurons to mediate neuroprotection from mutant HTT. The neuroprotective effect of Sirt1 requires the presence of CREB-regulated transcription coactivator 1 (TORC1), a brain-specific modulator of CREB activity3. We show that under normal conditions, Sirt1 deacetylates and activates TORC1 by promoting its dephosphorylation and its interaction with CREB. We identified BDNF as a key target of Sirt1 and TORC1 transcriptional activity in both normal and Huntington's disease neurons. Mutant HTT interferes with the TORC1-CREB interaction to repress BDNF transcription, and Sirt1 rescues this defect in vitro and in vivo. These studies suggest a key role for Sirt1 in transcriptional networks in both the normal and Huntington's disease brain and offer an opportunity for therapeutic development.	[Jeong, Hyunkyung; Cui, Libin; Mazzulli, Joseph R.; Krainc, Dimitri] Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Cohen, Dena E.; Supinski, Andrea; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bordone, Laura] Novartis Inst BioMed Res, Cardiovasc & Metab Dis Area, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Novartis	Krainc, D (corresponding author), Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA.	leng@mit.edu; krainc@helix.mgh.harvard.edu	Mazzulli, joseph/AAS-4480-2020		US National Institutes of Health [R01NS051303, R01MH067880-08, P41RR011823-15]; Cure Huntington's Disease Initiative (CHDI); Hereditary Disease Foundation (FIDE); Glenn Foundation for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Huntington's Disease Initiative (CHDI); Hereditary Disease Foundation (FIDE); Glenn Foundation for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Montminy (Peptide Biology Laboratories (PBL), Salk Institute) for the Flag-CREB, Flag-TORC1 and Flag-TORC1 S151A plasmids and for antibody to TORC1 (#6937, PBL, Salk Institute) and helpful discussions; M.E. Greenberg (Harvard Medical School) for the pIII(170)Luc plasmid 15; T. Kouzarides (University of Cambridge) for Sirt1 and Sift1 HY plasmids; Z. Wu (Novartis Institutes for Biomedical Research) for the TORC1 plasmid; M. Difiglia (Massachusetts General Hospital) for antibody to HTT (Ab1); E. Regulier (Novartis Institutes for Biomedical Research) for lentiviral vectors expressing HTTEx1-25Q, HTTEx1-72Q and Sirt1; and J.M. Park (Massachusetts General Hospital) for the lentiviral vector used for CREB knockdown. We also acknowledge C. Whitaker (Massachusetts Institute of Technology) for analysis of the microarray data. This work was supported by grant R01NS051303 from the US National Institutes of Health (D.K.); the Cure Huntington's Disease Initiative (CHDI), Hereditary Disease Foundation (FIDE) (D.E.C.); US National Institutes of Health, Glenn Foundation for Medical Research (L.G.) and grants R01MH067880-08 and P41RR011823-15 from the US National Institutes of Health (J.R.Y.).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wang J, 2010, BBA-PROTEINS PROTEOM, V1804, P1690, DOI 10.1016/j.bbapap.2009.11.015; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	31	261	268	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					159	165		10.1038/nm.2559	http://dx.doi.org/10.1038/nm.2559			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179316	Green Submitted, Green Accepted			2022-12-27	WOS:000299018600043
J	Xue, Y; Lim, S; Yang, YL; Wang, ZW; Jensen, LDE; Hedlund, EM; Andersson, P; Sasahara, M; Larsson, O; Galter, D; Gao, RH; Hosaka, K; Cao, YH				Xue, Yuan; Lim, Sharon; Yang, Yunlong; Wang, Zongwei; Jensen, Lasse Dahl Ejby; Hedlund, Eva-Maria; Andersson, Patrik; Sasahara, Masakiyo; Larsson, Ola; Galter, Dagmar; Gao, Renhai; Hosaka, Kayoko; Cao, Yihai			PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells	NATURE MEDICINE			English	Article							GROWTH FACTOR-A; VASCULAR STABILITY; BETA-RECEPTOR; CANCER; MICE; THERAPY; STRESS; COMBINATION; PROGENITORS; FIBROBLASTS	The platelet-derived growth factor (PDGF) signaling system contributes to tumor angiogenesis and vascular remodeling. Here we show in mouse tumor models that PDGF-BB induces erythropoietin (EPO) mRNA and protein expression by targeting stromal and perivascular cells that express PDGF receptor-beta (PDGFR-beta). Tumor-derived PDGF-BB promoted tumor growth, angiogenesis and extramedullary hematopoiesis at least in part through modulation of EPO expression. Moreover, adenoviral delivery of PDGF-BB to tumor-free mice increased both EPO production and erythropoiesis, as well as protecting from irradiation-induced anemia. At the molecular level, we show that the PDGF-BB PDGFR-beta signaling system activates the EPO promoter, acting in part through transcriptional regulation by the transcription factor Atf3, possibly through its association with two additional transcription factors, c-Jun and Sp1. Our findings suggest that PDGF-BB-induced EPO promotes tumor growth through two mechanisms: first, paracrine stimulation of tumor angiogenesis by direct induction of endothelial cell proliferation, migration, sprouting and tube formation, and second, endocrine stimulation of extramedullary hematopoiesis leading to increased oxygen perfusion and protection against tumor-associated anemia.	[Xue, Yuan; Lim, Sharon; Yang, Yunlong; Wang, Zongwei; Jensen, Lasse Dahl Ejby; Hedlund, Eva-Maria; Andersson, Patrik; Gao, Renhai; Hosaka, Kayoko; Cao, Yihai] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 930, Japan; [Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Galter, Dagmar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Cao, Yihai] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Karolinska Institutet; University of Toyama; Karolinska Institutet; Karolinska Institutet; Linkoping University	Cao, YH (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	yihai.cao@ki.se	Andersson, Patrik/AAJ-6994-2020; Larsson, Ola/F-8151-2013; Xue, Yuan/D-3030-2012; Galter, Dagmar/C-4826-2011	Andersson, Patrik/0000-0002-8454-3963; Galter, Dagmar/0000-0001-6485-6244; Jensen, Lasse/0000-0003-2338-357X; Yang, Yunlong/0000-0003-1551-9828; Larsson, Ola/0000-0003-1412-1308; Hedlund, Eva-Maria/0000-0002-5452-2547	Swedish Research Council; Swedish Cancer Foundation; Karolinska Institute Foundation; Karolinska Institute; ImClone; European Union of Metoxia [222741]; European Research Council [250021]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Karolinska Institute Foundation(Karolinska Institutet); Karolinska Institute(Karolinska Institutet); ImClone; European Union of Metoxia; European Research Council(European Research Council (ERC)European Commission)	We thank J. Nissen and Z. Peng for their technical support. We thank Z. Zhu at ImClone for providing us the antibodies specific to mouse PDGFR-a and PDGFR-beta. The MS-5 and S17 cell lines were provided by A. Berardi (Ospedale Bambin Gesu, Italy) and K. Dorshkind (University of California, Los Angeles, California, USA), and the adenoviruses were provided by S. Yla-Herttuala (University of Kuopio, Kuopio, Finland). This work was supported by the laboratory of Y.C. through research grants from the Swedish Research Council, the Swedish Cancer Foundation, the Karolinska Institute Foundation, the Karolinska Institute distinguished professor award Torsten och Ragnar Soderbergs Stiftelser, a grant from ImClone, the European Union Integrated Project of Metoxia (project number 222741) and the European Research Council advanced grant ANGIOFAT (project number 250021).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Ameri K, 2007, ONCOGENE, V26, P284, DOI 10.1038/sj.onc.1209781; BACCARANI M, 1978, B I SIEROTER MILAN, V57, P257; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kirschner KM, 2003, MOL CANCER RES, V1, P970; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Korpisalo P, 2008, CIRC RES, V103, P1092, DOI 10.1161/CIRCRESAHA.108.182287; Kuhnert F, 2008, P NATL ACAD SCI USA, V105, P10185, DOI 10.1073/pnas.0803194105; Kurimoto M, 1995, ACTA NEUROCHIR, V137, P182, DOI 10.1007/BF02187191; KUSHNER JP, 1971, MEDICINE, V50, P139, DOI 10.1097/00005792-197105000-00001; LEITZEL K, 1991, CANCER RES, V51, P4149; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Nakayama T, 2007, J NATL CANCER I, V99, P223, DOI 10.1093/jnci/djk031; Nisancioglu MH, 2010, CANCER RES, V70, P5109, DOI 10.1158/0008-5472.CAN-09-4245; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; Saintigny P, 2007, CLIN CANCER RES, V13, P4825, DOI 10.1158/1078-0432.CCR-06-3061; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SOUTTER AD, 1993, CANCER RES, V53, P5297; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; WESTERMARK B, 1985, NEUROL CLIN, V3, P785, DOI 10.1016/S0733-8619(18)31009-0; WESTERMARK B, 1987, ACTA MED SCAND, P19; Xue Y, 2008, P NATL ACAD SCI USA, V105, P18513, DOI 10.1073/pnas.0807967105; Yamaguchi T, 1996, PEDIATR RADIOL, V26, P312, DOI 10.1007/BF01395704; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860	51	148	152	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					100	110		10.1038/nm.2575	http://dx.doi.org/10.1038/nm.2575			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138754				2022-12-27	WOS:000299018600035
J	Cudkowicz, M; Bozik, ME; Ingersoll, EW; Miller, R; Mitsumoto, H; Shefner, J; Moore, DH; Schoenfeld, D; Mather, JL; Archibald, D; Sullivan, M; Amburgey, C; Moritz, J; Gribkoff, VK				Cudkowicz, Merit; Bozik, Michael E.; Ingersoll, Evan W.; Miller, Robert; Mitsumoto, Hiroshi; Shefner, Jeremy; Moore, Dan H.; Schoenfeld, David; Mather, James L.; Archibald, Donald; Sullivan, Mary; Amburgey, Craig; Moritz, Juliet; Gribkoff, Valentin K.			The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis	NATURE MEDICINE			English	Article							PREDICTS SURVIVAL-TIME; ALS CLINICAL-TRIALS; QUALITY-OF-LIFE; MITOCHONDRIAL DYSFUNCTION; RANDOMIZED-TRIAL; EARLY PHASE; PROGRESSION; DESIGN	Amyotrophic lateral sclerosis (ALS) is characterized by upper and lower motor neuron dysfunction and loss, rapidly progressive muscle weakness, wasting and death(1-3). Many factors, including mitochondrial dysfunction, may contribute to ALS pathogenesis(4-9). Riluzole, which has shown only modest benefits in a measure of survival time without demonstrated effects on muscle strength or function, is the only approved treatment for ALS(10,11). We tested the putative mitochondrial modulator dexpramipexole (KNS-760704; (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine)(12-14) in subjects with ALS in a two-part, double-blind safety and tolerability study, with a preliminary assessment of its effects on functional decline and mortality. In part 1, the effects of dexpramipexole (50, 150 or 300 mg d(-1)) versus placebo were assessed over 12 weeks. In part 2, after a 4-week, single-blind placebo washout, continuing subjects were re-randomized to dexpramipexole at 50 mg d(-1) or 300 mg d(-1) as double-blind active treatment for 24 weeks. Dexpramipexole was safe and well tolerated. Trends showing a dose-dependent attenuation of the slope of decline of the ALS Functional Rating Scale-Revised (ALSFRS-R) in part 1 and a statistically significant (P = 0.046) difference between groups in a joint rank test of change from baseline in ALSFRS-R and mortality in part 2 strongly support further testing of dexpramipexole in ALS.	[Bozik, Michael E.; Ingersoll, Evan W.; Mather, James L.; Archibald, Donald; Sullivan, Mary; Amburgey, Craig; Moritz, Juliet; Gribkoff, Valentin K.] Knopp Biosci, Pittsburgh, PA USA; [Cudkowicz, Merit] Massachusetts Gen Hosp, Neurol Clin Trial Unit, Boston, MA 02114 USA; [Miller, Robert; Moore, Dan H.] Calif Pacific Med Ctr, San Francisco, CA USA; [Mitsumoto, Hiroshi] Columbia Univ, Med Ctr, New York, NY USA; [Shefner, Jeremy] SUNY Upstate Med Univ, Syracuse, NY USA	Harvard University; Massachusetts General Hospital; California Pacific Medical Center; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Gribkoff, VK (corresponding author), Knopp Biosci, Pittsburgh, PA USA.	gribkoffv@aol.com	Shefner, Jeremy/ABF-2901-2020; CUDKOWICZ, MERIT/GWM-6585-2022	CUDKOWICZ, MERIT/0000-0002-7075-1681; Oskarsson, Bjorn/0000-0002-1725-9866				Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; Baron M, 2007, BIOCHEM SOC T, V35, P1228, DOI 10.1042/BST0351228; Bedlack RS, 2008, AMYOTROPH LATERAL SC, V9, P257, DOI 10.1080/17482960802195913; Bozik ME, 2011, J CLIN PHARMACOL, V51, P1177, DOI 10.1177/0091270010379412; Castrillo-Viguera C, 2010, AMYOTROPH LATERAL SC, V11, P178, DOI 10.3109/17482960903093710; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cheung YK, 2006, NEUROLOGY, V67, P1748, DOI 10.1212/01.wnl.0000244464.73221.13; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Corti S, 2009, J NEUROL SCI, V276, P170, DOI 10.1016/j.jns.2008.09.030; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Cudkowicz ME, 2010, AMYOTROPH LATERAL SC, V11, P259, DOI 10.3109/17482960903358865; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Gordon PH, 2007, AMYOTROPH LATERAL SC, V8, P270, DOI 10.1080/17482960701547958; Gordon PH, 2006, NEUROLOGY, V67, P1314, DOI 10.1212/01.wnl.0000243812.25517.87; Gordon PH, 2004, AMYOTROPH LATERAL SC, V5, P90, DOI 10.1080/17434470410019906; Gribkoff VK, 2008, CNS NEUROSCI THER, V14, P215, DOI 10.1111/j.1755-5949.2008.00048.x; Groeneveld GJ, 2007, AMYOTROPH LATERAL SC, V8, P266, DOI 10.1080/17482960701419497; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; Kaufmann P, 2005, NEUROLOGY, V64, P38, DOI 10.1212/01.WNL.0000148648.38313.64; Kaufmann P, 2007, AMYOTROPH LATERAL SC, V8, P42, DOI 10.1080/17482960600888156; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Liu Xiao-xuan, 2009, Zhonghua Yi Xue Za Zhi, V89, P2472; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Messori A, 1999, PHARMACOECONOMICS, V16, P153, DOI 10.2165/00019053-199916020-00004; Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Schoenfeld DA, 2008, AMYOTROPH LATERAL SC, V9, P16, DOI 10.1080/17482960701875896; Shefner JM, 2008, PHYS MED REH CLIN N, V19, P495, DOI 10.1016/j.pmr.2008.02.002; Shi P, 2010, J ALZHEIMERS DIS, V20, pS311, DOI 10.3233/JAD-2010-100366; Simmons Z, 2000, NEUROLOGY, V55, P388, DOI 10.1212/WNL.55.3.388; Stewart A, 2001, Health Technol Assess, V5, P1; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Wang H, 2008, AMYOTROPH LATERAL SC, V9, P50, DOI 10.1080/17482960701791234; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3	37	132	142	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1652	U169		10.1038/nm.2579	http://dx.doi.org/10.1038/nm.2579			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101764				2022-12-27	WOS:000297978000038
J	Salker, MS; Christian, M; Steel, JH; Nautiyal, J; Lavery, S; Trew, G; Webster, Z; Al-Sabbagh, M; Puchchakayala, G; Foller, M; Landles, C; Sharkey, AM; Quenby, S; Aplin, JD; Regan, L; Lang, F; Brosens, JJ				Salker, Madhuri S.; Christian, Mark; Steel, Jennifer H.; Nautiyal, Jaya; Lavery, Stuart; Trew, Geoffrey; Webster, Zoe; Al-Sabbagh, Marwa; Puchchakayala, Goverdhan; Foeller, Michael; Landles, Christian; Sharkey, Andrew M.; Quenby, Siobhan; Aplin, John D.; Regan, Lesley; Lang, Florian; Brosens, Jan J.			Deregulation of the serum- and glucocorticoid-inducible kinase SGK1 in the endometrium causes reproductive failure	NATURE MEDICINE			English	Article							STROMAL CELLS; PROGESTERONE-RECEPTOR; OXIDATIVE STRESS; EMBRYO IMPLANTATION; DEPENDENT MANNER; MOUSE UTERUS; IN-VITRO; PREGNANCY; EXPRESSION; MICE	Infertility and recurrent pregnancy loss (RPL) are prevalent but distinct causes of reproductive failure that often remain unexplained despite extensive investigations(1,2). Analysis of midsecretory endometrial samples revealed that SGK1, a kinase involved in epithelial ion transport and cell survival(3-6), is upregulated in unexplained infertility, most prominently in the luminal epithelium, but downregulated in the endometrium of women suffering from RPL. To determine the functional importance of these observations, we first expressed a constitutively active SGK1 mutant in the luminal epithelium of the mouse uterus. This prevented expression of certain endometrial receptivity genes, perturbed uterine fluid handling and abolished embryo implantation. By contrast, implantation was unhindered in Sgk1(-/-) mice, but pregnancy was often complicated by bleeding at the decidual-placental interface and fetal growth retardation and subsequent demise. Compared to wild-type mice, Sgk1(-/-) mice had gross impairment of pregnancy-dependent induction of genes involved in oxidative stress defenses. Relative SGK1 deficiency was also a hallmark of decidualizing stromal cells from human subjects with RPL and sensitized these cells to oxidative cell death. Thus, depending on the cellular compartment, deregulated SGK1 activity in cycling endometrium interferes with embryo implantation, leading to infertility, or predisposes to pregnancy complications by rendering the feto-maternal interface vulnerable to oxidative damage.	[Salker, Madhuri S.; Christian, Mark; Steel, Jennifer H.; Nautiyal, Jaya; Lavery, Stuart; Trew, Geoffrey; Al-Sabbagh, Marwa; Landles, Christian; Regan, Lesley; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Webster, Zoe] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Embryon Stem Cell Facil, London, England; [Puchchakayala, Goverdhan; Foeller, Michael; Lang, Florian] Univ Tubingen, Inst Physiol, Tubingen, Germany; [Sharkey, Andrew M.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Quenby, Siobhan; Brosens, Jan J.] Univ Hosp, Clin Sci Res Labs, Div Reprod Hlth, Warwick Med Sch, Coventry, W Midlands, England; [Aplin, John D.] Univ Manchester, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester M13 0JH, Lancs, England	Imperial College London; Imperial College London; Eberhard Karls University of Tubingen; University of Cambridge; University of Warwick; University of Manchester	Brosens, JJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Hammersmith Campus, London, England.	j.j.brosens@warwick.ac.uk	Sharkey, Andrew M/H-7015-2013; Steel, Jennifer/B-4737-2013; Aplin, John/AET-4363-2022	Sharkey, Andrew M/0000-0002-5072-7748; Steel, Jennifer/0000-0003-4439-0090; Aplin, John/0000-0001-8777-9261; Landles, Christian/0000-0001-9715-6447; Brosens, Jan/0000-0003-0116-9329; Quenby, Siobhan/0000-0003-3221-5471; Christian, Mark/0000-0002-1616-4179; Salker, Madhuri Sonal/0000-0002-7939-289X	Contraceptive Research and Development Program Consortium for Industrial Collaboration in Contraceptive Research [CIG-08-122]; UK National Institute for Health Research Biomedical Research Centre; Genesis Research Trust	Contraceptive Research and Development Program Consortium for Industrial Collaboration in Contraceptive Research; UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Genesis Research Trust	We are grateful to all the women who participated in this study. This work was further supported by funds to J.J.B. and M. C. from the Contraceptive Research and Development Program Consortium for Industrial Collaboration in Contraceptive Research (CIG-08-122), the UK National Institute for Health Research Biomedical Research Centre funding scheme and from the Genesis Research Trust (M. S. S.) We are grateful to M. Parker for his insightful suggestions.	Aghajanova L, 2010, ENDOCRINOLOGY, V151, P1341, DOI 10.1210/en.2009-0923; Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Alam SMK, 2007, DEVELOPMENT, V134, P407, DOI 10.1242/dev.02743; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Campbell EA, 2006, HUM REPROD, V21, P2495, DOI 10.1093/humrep/del195; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Crossey PA, 2002, J CLIN INVEST, V110, P411, DOI 10.1172/JCI200210077; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Feroze-Zaidi F, 2007, ENDOCRINOLOGY, V148, P5020, DOI 10.1210/en.2007-0659; Fluhr Herbert, 2008, Reproductive Medicine and Biology, V7, P169, DOI 10.1111/j.1447-0578.2008.00213.x; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; HIGUCHI T, 1995, ENDOCRINOLOGY, V136, P4973, DOI 10.1210/en.136.11.4973; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Joswig Anike, 2003, Reprod Biol Endocrinol, V1, P44; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tabibzadeh S, 2000, J CLIN ENDOCR METAB, V85, P2526, DOI 10.1210/jc.85.7.2526; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Tang MY, 2005, HUM REPROD, V20, P1772, DOI 10.1093/humrep/deh849; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Yang JZ, 2011, FERTIL STERIL, V95, P2100, DOI 10.1016/j.fertnstert.2011.02.036; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605	40	128	134	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1509	U1505		10.1038/nm.2498	http://dx.doi.org/10.1038/nm.2498			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22001908	Green Submitted			2022-12-27	WOS:000296779300044
J	Celli, S; Albert, ML; Bousso, P				Celli, Susanna; Albert, Matthew L.; Bousso, Philippe			Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy	NATURE MEDICINE			English	Article							CD8(+) T-CELLS; DERMAL DENDRITIC CELLS; LANGERHANS CELLS; IN-VIVO; GRAFT-REJECTION; LYMPHOID ORGANS; SITE; LEISHMANIASIS; ELIMINATION; ACTIVATION	Transplant rejection involves a coordinated attack of the innate and the adaptive immune systems of the host. To investigate this dynamic process and the contributions of both donor and host cells, we developed an ear skin graft model suitable for intravital imaging. We found that donor dermal dendritic cells (DCs) migrated rapidly from the graft and were replaced by host CD11b(+) mononuclear cells. The infiltrating host cells captured donor antigen, reached the draining lymph node and cross-primed graft-reactive CD8(+) T cells. Furthermore, we defined the mechanisms by which host T cells target graft cells. We found that primed T cells entered the graft from the surrounding tissue and localized selectively at the dermis-epidermis junction. Later, CD8(+) T cells disseminated throughout the graft and many became arrested. These results provide insights into the antigen presentation pathway and the stepwise progression of CD8(+) T cell activity, thereby offering a framework for evaluating how immunotherapy might abrogate the key steps in allograft rejection.	[Celli, Susanna; Bousso, Philippe] Inst Pasteur, Dept Immunol, Unite Dynam Reponses Immunes, F-75724 Paris, France; [Celli, Susanna; Bousso, Philippe] INSERM, U668, Paris, France; [Albert, Matthew L.] Inst Pasteur, Unite Immunobiol Cellules Dendrit, F-75724 Paris, France; [Albert, Matthew L.] INSERM, U818, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bousso, P (corresponding author), Inst Pasteur, Dept Immunol, Unite Dynam Reponses Immunes, F-75724 Paris, France.	philippe.bousso@pasteur.fr	Celli, Susanna/M-7138-2014; Albert, Matthew L/C-9782-2009; BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X	INSERM; Institut Pasteur; Marie Curie Excellence grant	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Marie Curie Excellence grant(European Commission)	We wish to thank H. Saklani and C. Auriau (Institut Pasteur) for providing B2m<SUP>-/-</SUP> mOVA mice and E. Robey and the members of the Bousso laboratory for comments on the manuscript. This work was supported by INSERM, Institut Pasteur and a Marie Curie Excellence grant.	Auchincloss H, 1996, CURR OPIN IMMUNOL, V8, P681, DOI 10.1016/S0952-7915(96)80086-0; BARKER CF, 1968, J EXP MED, V128, P197, DOI 10.1084/jem.128.1.197; BEIL WJ, 1992, J LEUKOCYTE BIOL, V52, P135, DOI 10.1002/jlb.52.2.135; Benichou G, 1999, J IMMUNOL, V162, P352; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Garrod KR, 2010, J IMMUNOL, V184, P2329, DOI 10.4049/jimmunol.0902748; Gelman AE, 2009, J IMMUNOL, V182, P3969, DOI 10.4049/jimmunol.0803514; Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Konjufca V, 2009, CELL MICROBIOL, V11, P551, DOI 10.1111/j.1462-5822.2009.01289.x; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; LARSEN CP, 1990, ANN SURG, V212, P308, DOI 10.1097/00000658-199009000-00009; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Matsuo Shinji, 2007, J Med Invest, V54, P267, DOI 10.2152/jmi.54.267; Ng LG, 2008, IMMUNOL REV, V221, P147, DOI 10.1111/j.1600-065X.2008.00596.x; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Obhrai JS, 2008, J INVEST DERMATOL, V128, P1950, DOI 10.1038/jid.2008.52; Ochando JC, 2006, AM J TRANSPLANT, V6, P2488, DOI 10.1111/j.1600-6143.2006.01494.x; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Richards DM, 2004, J IMMUNOL, V172, P3469, DOI 10.4049/jimmunol.172.6.3469; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x; ROSENBERG AS, 1988, P NATL ACAD SCI USA, V85, P7739, DOI 10.1073/pnas.85.20.7739; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; Valujskikh A, 2001, TRANSPLANTATION, V71, P418, DOI 10.1097/00007890-200102150-00014; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Wang J, 2006, AM J TRANSPLANT, V6, P2563, DOI 10.1111/j.1600-6143.2006.01516.x; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Zhou P, 2003, AM J TRANSPLANT, V3, P259, DOI 10.1034/j.1600-6143.2003.00067.x	40	108	110	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					744	U140		10.1038/nm.2376	http://dx.doi.org/10.1038/nm.2376			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21572426				2022-12-27	WOS:000291308800037
J	Pan, X; Zhou, T; Tai, YH; Wang, CG; Zhao, J; Cao, Y; Chen, Y; Zhang, PJ; Yu, M; Zhen, C; Mu, R; Bai, ZF; Li, HY; Li, AL; Liang, B; Jian, Z; Zhang, WN; Man, JH; Gao, YF; Gong, WL; Wei, LX; Zhang, XM				Pan, Xin; Zhou, Tao; Tai, Yan-Hong; Wang, Chenguang; Zhao, Jie; Cao, Yuan; Chen, Yuan; Zhang, Pei-Jing; Yu, Ming; Zhen, Cheng; Mu, Rui; Bai, Zhao-Fang; Li, Hui-Yan; Li, Ai-Ling; Liang, Bing; Jian, Zhao; Zhang, Wei-Na; Man, Jiang-Hong; Gao, Yan-Fei; Gong, Wei-Li; Wei, Li-Xin; Zhang, Xue-Min			Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer	NATURE MEDICINE			English	Article							ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; AROMATASE INHIBITORS; TAMOXIFEN; THERAPY; MECHANISMS; DOMAIN; IMMUNOHISTOCHEMISTRY; OVEREXPRESSION; DEGRADATION	Endocrine resistance is a major obstacle to hormonal therapy for breast cancers. Although reduced expression of estrogen receptor-alpha (ER-alpha) is a known contributing factor to endocrine resistance, the mechanism of ER-alpha downregulation in endocrine resistance is still not fully understood. Here we report that CUE domain-containing protein-2 (CUEDC2), a ubiquitin-binding motif-containing protein, is a key factor in endocrine resistance in breast cancer. We show that CUEDC2 modulates ER-alpha protein stability through the ubiquitin-proteasome pathway. Through the study of specimens from a large cohort of subjects with breast cancer, we found a strong inverse correlation between CUEDC2 and ER-alpha protein expression. Notably, subjects with tumors that highly expressed CUEDC2 had poor responsiveness to tamoxifen treatment and high potential for relapse. We further show that ectopic CUEDC2 expression impaired the responsiveness of breast cancer cells to tamoxifen. Therefore, our findings suggest that CUEDC2 is a crucial determinant of resistance to endocrine therapies in breast cancer.	[Pan, Xin; Zhou, Tao; Zhao, Jie; Chen, Yuan; Zhang, Pei-Jing; Yu, Ming; Zhen, Cheng; Mu, Rui; Bai, Zhao-Fang; Li, Hui-Yan; Li, Ai-Ling; Liang, Bing; Jian, Zhao; Zhang, Wei-Na; Man, Jiang-Hong; Gao, Yan-Fei; Gong, Wei-Li; Zhang, Xue-Min] China Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing, Peoples R China; [Tai, Yan-Hong; Wei, Li-Xin] Gen Hosp Chinese Peoples Liberat Army, Dept Pathol, Beijing, Peoples R China; [Tai, Yan-Hong; Cao, Yuan] 90th Hosp Jinan, Jinan, Peoples R China; [Wang, Chenguang] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	Zhang, XM (corresponding author), China Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing, Peoples R China.	weilx301@263.net; xmzhang@nic.bmi.ac.cn	tai, yh/GRR-4574-2022	Man, Jianghong/0000-0001-6020-3537; /0000-0002-2681-8711; Zhang, Peijing/0000-0003-1586-8710; Pan, Xin/0000-0002-1982-2261	China National Natural Science Foundation [91029733, 30830097, 30900754]; China National High Technology Research and Development Program [2009AA02Z103]; China National Basic Research Program [2010CB911900, 2010CB529404]; Key State Science and Technology Projects [2009ZX09503-001, 2009ZX09501-031, 2009ZX09301-002, 2008ZX10002-016]; Pennsylvania Department of Health	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National High Technology Research and Development Program(National High Technology Research and Development Program of China); China National Basic Research Program(National Basic Research Program of China); Key State Science and Technology Projects; Pennsylvania Department of Health	We thank Z. Liu for critical reading of the manuscript, L. Hu for assistance with statistical analysis and Q. Ye at Beijing Institute of Biotechnology for DBD-ER-alpha plasmids. This work was supported by grants from the China National Natural Science Foundation (No. 91029733, No. 30830097 and No. 30900754), the China National High Technology Research and Development Program (Grant 2009AA02Z103), the China National Basic Research Program (Grant 2010CB911900, 2010CB529404), the Key State Science and Technology Projects (2009ZX09503-001, 2009ZX09501-031, 2009ZX09301-002 and 2008ZX10002-016). Work conducted at Thomas Jefferson University is funded in part by a Pennsylvania Department of Health grant (to C.W.).	Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Baum M, 2002, LANCET, V359, P2131; Bernoux A, 1998, BREAST CANCER RES TR, V49, P219, DOI 10.1023/A:1006011328655; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Ingle JN, 2008, CANCER, V112, P695, DOI 10.1002/cncr.23192; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Jensen EV, 2003, CLIN CANCER RES, V9, P1980; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; LIPPMAN ME, 1980, CANCER, V46, P2829, DOI 10.1002/1097-0142(19801215)46:12+<2829::AID-CNCR2820461419>3.0.CO;2-M; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Osborne CK, 2001, CLIN CANCER RES, V7, p4338S; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Rochefort H, 2003, ENDOCR-RELAT CANCER, V10, P261, DOI 10.1677/erc.0.0100261; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602	44	108	128	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2011	17	6					708	U99		10.1038/nm.2369	http://dx.doi.org/10.1038/nm.2369			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21572428				2022-12-27	WOS:000291308800031
J	Eddy, AA				Eddy, Allison A.			UMODulating renal fibrosis	NATURE MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; TAMM-HORSFALL PROTEIN; JUVENILE HYPERURICAEMIC NEPHROPATHY; UROMODULIN; IDENTIFICATION; MUTATIONS; RISK		[Eddy, Allison A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Eddy, Allison A.] Seattle Childrens Res Inst, Tissue & Cells Sci Res Ctr, Div Nephrol, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Eddy, AA (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	allison.eddy@seattlechildrens.org		Eddy, Allison/0000-0002-3560-7510				Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; HOYER JR, 1980, KIDNEY INT, V17, P284, DOI 10.1038/ki.1980.34; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Lhotta K, 2010, KIDNEY BLOOD PRESS R, V33, P393, DOI 10.1159/000320681; Mohandas R, 2008, J AM SOC NEPHROL, V19, P2251, DOI 10.1681/ASN.2008091012; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; Pfistershammer K, 2008, J LEUKOCYTE BIOL, V83, P131, DOI 10.1189/jlb.0407231; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Vyletal P, 2010, KIDNEY BLOOD PRESS R, V33, P456, DOI 10.1159/000321013; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235	16	16	16	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					553	555		10.1038/nm0511-553	http://dx.doi.org/10.1038/nm0511-553			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21546974				2022-12-27	WOS:000290250400030
J	Tanaka, H; Kono, E; Tran, CP; Miyazaki, H; Yamashiro, J; Shimomura, T; Fazli, L; Wada, R; Huang, JT; Vessella, RL; An, JB; Horvath, S; Gleave, M; Rettig, MB; Wainberg, ZA; Reiter, RE				Tanaka, Hiroshi; Kono, Evelyn; Tran, Chau P.; Miyazaki, Hideyo; Yamashiro, Joyce; Shimomura, Tatsuya; Fazli, Ladan; Wada, Robert; Huang, Jiaoti; Vessella, Robert L.; An, Jaibin; Horvath, Steven; Gleave, Martin; Rettig, Matthew B.; Wainberg, Zev A.; Reiter, Robert E.			Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance	NATURE MEDICINE			English	Article							MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; ANTITUMOR-ACTIVITY; STEM-CELLS; PROGRESSION; THERAPY; INDEPENDENCE; INCREASES; PATHWAY; BIOLOGY	The transition from androgen-dependent to castration-resistant prostate cancer (CRPC) is a lethal event of uncertain molecular etiology. Comparing gene expression in isogenic androgen-dependent and CRPC xenografts, we found a reproducible increase in N-cadherin expression, which was also elevated in primary and metastatic tumors of individuals with CRPC. Ectopic expression of N-cadherin in nonmetastatic, androgen-dependent prostate cancer models caused castration resistance, invasion and metastasis. Monoclonal antibodies against the ectodomain of N-cadherin reduced proliferation, adhesion and invasion of prostate cancer cells in vitro. In vivo, these antibodies slowed the growth of multiple established CRPC xenografts, blocked local invasion and metastasis and, at higher doses, led to complete regression. N-cadherin-specific antibodies markedly delayed the time to emergence of castration resistance, markedly affected tumor histology and angiogenesis, and reduced both AKT serine-threonine kinase activity and serum interleukin-8 (IL-8) secretion. These data indicate that N-cadherin is a major cause of both prostate cancer metastasis and castration resistance. Therapeutic targeting of this factor with monoclonal antibodies may have considerable clinical benefit. (C) 2010 Nature America, Inc. All rights reserved.	[Tanaka, Hiroshi; Kono, Evelyn; Tran, Chau P.; Yamashiro, Joyce; Shimomura, Tatsuya; Wada, Robert; An, Jaibin; Rettig, Matthew B.; Reiter, Robert E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Tanaka, Hiroshi; Kono, Evelyn; Tran, Chau P.; Yamashiro, Joyce; Shimomura, Tatsuya; Huang, Jiaoti; Rettig, Matthew B.; Wainberg, Zev A.; Reiter, Robert E.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Miyazaki, Hideyo] Univ Tokyo, Dept Urol, Tokyo, Japan; [Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Vessella, Robert L.] Univ Washington, Med Ctr, Dept Urol, Puget Sound Vet Hlth Care Adm, Seattle, WA 98195 USA; [An, Jaibin; Rettig, Matthew B.] Vet Affairs Greater Los Angeles Healthcare Syst W, Dept Med, Los Angeles, CA USA; [Horvath, Steven] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steven] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Wainberg, Zev A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Reiter, Robert E.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reiter, RE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.	rreiter@mednet.ucla.edu	Tran, Chau/GRX-4633-2022	Huang, Jiaoti/0000-0003-1195-1998	US National Cancer Institute Prostate Cancer SPORE at the University of California-Los Angeles [P50CA092131-09]; US Department of Defense [W81XWH-06-1-0324, W81XWH-09-1-0630, PC061456]; Takeda Pharmaceuticals; Jean Perkins Foundation; American Cancer Society [RSG-07-092-01-TBE]; NATIONAL CANCER INSTITUTE [P50CA092131] Funding Source: NIH RePORTER	US National Cancer Institute Prostate Cancer SPORE at the University of California-Los Angeles(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Jean Perkins Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in parts by the US National Cancer Institute Prostate Cancer SPORE at the University of California-Los Angeles (P50CA092131-09 to R. E. R.), US Department of Defense Prostate Cancer Research grants (W81XWH-06-1-0324 to Z.A.W., W81XWH-09-1-0630 to R. E. R. and M. B. R., PC061456 to J.H.), Takeda Pharmaceuticals, the Jean Perkins Foundation and the American Cancer Society (RSG-07-092-01-TBE to J.H.). We also thank S. and L. Resnick, the Prostate Cancer Foundation and the Luskin Foundation for generous support and J. Said and N. Doan for immunohistochemical assessments. LNCaP-CL1 cells were provided by C. L. Tso (University of California-Los Angeles). Plasmid p Delta VPR was provided by I. Chen (University of California-Los Angeles).	Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Gleave M, 2005, CANCER CHEMOTH PHARM, V56, pS47, DOI 10.1007/s00280-005-0098-0; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; Hara T, 2008, CANCER RES, V68, P1128, DOI 10.1158/0008-5472.CAN-07-1929; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Jaggi M, 2006, PROSTATE, V66, P193, DOI 10.1002/pros.20334; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Lassi K, 2009, CURR OPIN ONCOL, V21, P260, DOI 10.1097/CCO.0b013e32832a1868; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Rizzi F, 2008, J PHYSIOL PHARMACOL, V59, P265; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sharifi N, 2006, CANCER BIOL THER, V5, P901, DOI 10.4161/cbt.5.8.2949; Suzuki H, 2003, ENDOCR-RELAT CANCER, V10, P209, DOI 10.1677/erc.0.0100209; Tomita K, 2000, CANCER RES, V60, P3650; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Tso CL, 2000, CANCER J, V6, P220	28	240	259	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1414	U96		10.1038/nm.2236	http://dx.doi.org/10.1038/nm.2236			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21057494	Green Accepted			2022-12-27	WOS:000285048900035
J	Van Broeckhoven, C				Van Broeckhoven, Christine			The future of genetic research on neurodegeneration	NATURE MEDICINE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; TARDBP MUTATIONS; LOCUS; PROGRANULIN; DEMENTIA	Why, with all the progress in the field of neurodegeneration, do we still lack disease-modifying drugs that tackle the primary defect of severe cell loss? How much progress has been made toward this goal? Have we spent our time and resources wisely? And, most important, is there room for improvement? This commentary highlights several problems faced by researchers in studying the genetic etiology of neurodegenerative diseases and seeks to provide direction in overcoming some of these obstacles.	[Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Van Broeckhoven, Christine] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp	Van Broeckhoven, C (corresponding author), VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium.	christine.vanbroeckhoven@molgen.vib-ua.be	Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665	Flemish and Federal governments of Belgium; VIB; Institute Born-Bunge; University of Antwerp	Flemish and Federal governments of Belgium; VIB; Institute Born-Bunge; University of Antwerp	A number of the issues identified in this commentary were discussed in a session on genetics at the Herrenhausen Symposium on Neurodegeneration with P. St. George-Hyslop, P. Heutink and B. De Strooper, with added discussion points and commentary provided by the attendees at the conference. The research in my group has been funded by the Flemish and Federal governments of Belgium, the VIB, the Institute Born-Bunge and the University of Antwerp, as well as by many national and international governmental research funding agencies and charity organizations. The main contributors, however, are the many people with neurodegenerative disease and their families that generously participate in research and the efforts of researchers to pave the way toward new therapeutics.	Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BEECHAM GW, 2010, ALZHEIMERS DEMENT, V6, pS113; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Clarimon J, 2009, NEUROBIOL AGING, V30, P1986, DOI 10.1016/j.neurobiolaging.2008.02.008; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Jones L., 2012, ALZHEIMERS DEMENT, V6, pS113, DOI [10.1016/j.jalz.2010.05.350, DOI 10.1016/J.JALZ.2010.05.350]; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269; Rademakers R, 2005, AM J HUM GENET, V77, P643, DOI 10.1086/491749; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rovelet-Lecrux A, 2010, J ALZHEIMERS DIS, V21, P897, DOI 10.3233/JAD-2010-100441; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Sleegers K, 2009, NATURE, V458, P415, DOI 10.1038/458415a; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; ZUCHNER S, 2010, ALZHEIMERS DEMENT, V6, pS74	50	16	16	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1215	1217		10.1038/nm.2225	http://dx.doi.org/10.1038/nm.2225			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052076				2022-12-27	WOS:000283860100028
J	Quigley, M; Pereyra, F; Nilsson, B; Porichis, F; Fonseca, C; Eichbaum, Q; Julg, B; Jesneck, JL; Brosnahan, K; Imam, S; Russell, K; Toth, I; Piechocka-Trocha, A; Dolfi, D; Angelosanto, J; Crawford, A; Shin, H; Kwon, DS; Zupkosky, J; Francisco, L; Freeman, GJ; Wherry, EJ; Kaufmann, DE; Walker, BD; Ebert, B; Haining, WN				Quigley, Michael; Pereyra, Florencia; Nilsson, Bjoern; Porichis, Filippos; Fonseca, Catia; Eichbaum, Quentin; Julg, Boris; Jesneck, Jonathan L.; Brosnahan, Kathleen; Imam, Sabrina; Russell, Kate; Toth, Ildiko; Piechocka-Trocha, Alicja; Dolfi, Douglas; Angelosanto, Jill; Crawford, Alison; Shin, Haina; Kwon, Douglas S.; Zupkosky, Jennifer; Francisco, Loise; Freeman, Gordon J.; Wherry, E. John; Kaufmann, Daniel E.; Walker, Bruce D.; Ebert, Benjamin; Haining, W. Nicholas			Transcriptional analysis of HIV-specific CD8(+) T cells shows that PD-1 inhibits T cell function by upregulating BATF	NATURE MEDICINE			English	Article							CHRONIC VIRAL-INFECTION; MEMORY DIFFERENTIATION; NEGATIVE REGULATOR; GENE-EXPRESSION; ACTIVATION; EXHAUSTION; AP-1; NONPROGRESSORS; PERSISTENCE; RECEPTORS	CD8(+) T cells in chronic viral infections such as HIV develop functional defects including loss of interleukin-2 (IL-2) secretion and decreased proliferative potential that are collectively termed 'exhaustion' 1. Exhausted T cells express increased amounts of multiple inhibitory receptors, such as programmed death-1 (PD-1)(2,3), that contribute to impaired virus-specific T cell function. Although reversing PD-1 inhibition is therefore an attractive therapeutic strategy, the cellular mechanisms by which PD-1 ligation results in T cell inhibition are not fully understood. PD-1 is thought to limit T cell activation by attenuating T cell receptor (TCR) signaling(4,5). It is not known whether PD-1 also acts by upregulating genes in exhausted T cells that impair their function. Here we analyzed gene expression profiles from HIV-specific CD8(+) T cells in individuals with HIV and show that PD-1 coordinately upregulates a program of genes in exhausted CD8(+) T cells from humans and mice. This program includes upregulation of basic leucine transcription factor, ATF-like (BATF), a transcription factor in the AP-1 family. Enforced expression of BATF was sufficient to impair T cell proliferation and cytokine secretion, whereas BATF knockdown reduced PD-1 inhibition. Silencing BATF in T cells from individuals with chronic viremia rescued HIV-specific T cell function. Thus, inhibitory receptors can cause T cell exhaustion by upregulating genes-such as BATF-that inhibit T cell function. Such genes may provide new therapeutic opportunities to improve T cell immunity to HIV.	[Pereyra, Florencia; Porichis, Filippos; Eichbaum, Quentin; Julg, Boris; Toth, Ildiko; Piechocka-Trocha, Alicja; Kwon, Douglas S.; Zupkosky, Jennifer; Kaufmann, Daniel E.; Walker, Bruce D.] Massachusetts Gen Hosp, Ragon Inst, MIT, Charlestown, MA USA; [Pereyra, Florencia; Porichis, Filippos; Eichbaum, Quentin; Julg, Boris; Toth, Ildiko; Piechocka-Trocha, Alicja; Kwon, Douglas S.; Zupkosky, Jennifer; Kaufmann, Daniel E.; Walker, Bruce D.] Harvard Univ, Charlestown, MA USA; [Quigley, Michael; Fonseca, Catia; Jesneck, Jonathan L.; Brosnahan, Kathleen; Imam, Sabrina; Russell, Kate; Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Jesneck, Jonathan L.; Ebert, Benjamin] Broad Inst, Canc Program, Cambridge, MA USA; [Dolfi, Douglas; Angelosanto, Jill; Crawford, Alison; Shin, Haina; Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Dolfi, Douglas; Angelosanto, Jill; Crawford, Alison; Shin, Haina; Wherry, E. John] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Francisco, Loise] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA; [Kaufmann, Daniel E.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Ebert, Benjamin] Harvard Univ, Sch Med, Div Hematol, Brigham & Womens Hosp, Boston, MA USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Walker, BD (corresponding author), Massachusetts Gen Hosp, Ragon Inst, MIT, Charlestown, MA USA.	bwalker@partners.org; nicholas_haining@dfci.harvard.edu	crawford, alison/AAS-3155-2020; Wherry, John/ABI-1280-2020; Freeman, Gordon/AAC-5380-2019; Juelg, Boris/ABA-1955-2020; Crawford, Alison/N-3234-2014	Freeman, Gordon/0000-0002-7210-5616; Juelg, Boris/0000-0002-4687-9626; Crawford, Alison/0000-0002-4591-6341; Shin, Haina/0000-0002-1014-1451; Woodworth, Kate/0000-0001-9343-3355	US National Institutes of Health [AI082630, AI56299, HHSN26620050030C, HL092565]; International HIV Controllers Study; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NATIONAL CANCER INSTITUTE [R21CA129670] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, U19AI090023, P01AI056299, P01AI080192, U19AI082630, U19AI057266] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International HIV Controllers Study; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the subjects for taking part in the study; E. Cutrell, B. Baker, K. Moss, A. Rathod and C. Brume for coordinating sample management; and A. Sharpe, T. Golub, G. Lauer, M. Altfeld and H. Joffe for valuable discussions. This work was supported by US National Institutes of Health grants AI082630, AI56299, HHSN26620050030C and HL092565, the International HIV Controllers Study and the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chemnitz JM, 2007, BLOOD, V110, P3226, DOI 10.1182/blood-2006-12-064360; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Nilsson B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r74; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	334	354	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1147	U127		10.1038/nm.2232	http://dx.doi.org/10.1038/nm.2232			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20890291	Green Accepted			2022-12-27	WOS:000282644800046
J	Alves, JC; Sonego, F; Souto, FO; Freitas, A; Verri, WA; Auxiliadora-Martins, M; Basile, A; McKenzie, AN; Xu, DM; Cunha, FQ; Liew, FY				Alves-Filho, Jose C.; Sonego, Fabiane; Souto, Fabricio O.; Freitas, Andressa; Verri, Waldiceu A., Jr.; Auxiliadora-Martins, Maria; Basile-Filho, Anibal; McKenzie, Andrew N.; Xu, Damo; Cunha, Fernando Q.; Liew, Foo Y.			Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection	NATURE MEDICINE			English	Article							RECEPTOR ACCESSORY PROTEIN; IL-33; CYTOKINE; EXPRESSION; ST2; MIGRATION; INHIBITION; ACTIVATION; ARRESTINS; ANTIGEN	Sepsis is a systemic inflammatory condition following bacterial infection with a high mortality rate and limited therapeutic options(1,2). Here we show that interleukin-33 (IL-33) reduces mortality in mice with experimental sepsis from cecal ligation and puncture (CLP). IL-33-treated mice developed increased neutrophil influx into the peritoneal cavity and more efficient bacterial clearance than untreated mice. IL-33 reduced the systemic but not the local proinflammatory response, and it did not induce a T helper type 1 (T(H)1) to T(H)2 shift. The chemokine receptor CXCR2 is crucial for recruitment of neutrophils from the circulation to the site of infection(3). Activation of Toll-like receptors (TLRs) in neutrophils downregulates CXCR2 expression and impairs neutrophil migration(4). We show here that IL-33 prevents the downregulation of CXCR2 and inhibition of chemotaxis induced by the activation of TLR4 in mouse and human neutrophils. Furthermore, we show that IL-33 reverses the TLR4-induced reduction of CXCR2 expression in neutrophils via the inhibition of expression of G protein coupled receptor kinase-2 (GRK2), a serine-threonine protein kinase that induces internalization of chemokine receptors(5,6). Finally, we find that individuals who did not recover from sepsis had significantly more soluble ST2 (sST2, the decoy receptor of IL-33) than those who did recover. Together, our results indicate a previously undescribed mechanism of action of IL-33 and suggest a therapeutic potential of IL-33 in sepsis.	[Alves-Filho, Jose C.; Sonego, Fabiane; Souto, Fabricio O.; Freitas, Andressa; Verri, Waldiceu A., Jr.; Cunha, Fernando Q.] Univ Sao Paulo, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil; [Alves-Filho, Jose C.; Xu, Damo; Liew, Foo Y.] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [Auxiliadora-Martins, Maria; Basile-Filho, Anibal] Univ Sao Paulo, Div Intens Care, Dept Surg & Anat, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [McKenzie, Andrew N.] MRC, Mol Med Lab, Cambridge, England	Universidade de Sao Paulo; University of Glasgow; Universidade de Sao Paulo	Cunha, FQ (corresponding author), Univ Sao Paulo, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil.	fdqcunha@fmrp.usp.br; f.y.liew@clinmed.gla.ac.uk	Souto, Fabricio/AAS-7671-2020; Basile-Filho, Anibal/J-8354-2016; de Freitas, Andressa/B-7264-2012; Xu, Damo/A-8212-2011; Souto, Fabricio/I-3071-2013; Cunha, Fernando Q/M-3090-2014; Alves-Filho, Jose Carlos/B-5814-2008; Souto, Fabricio/AAX-8668-2021; Inofar, Inct/J-8605-2013; WA, Verri/I-1330-2013; Auxiliadora-Martins, Maria/L-2412-2014	Basile-Filho, Anibal/0000-0002-6547-0615; de Freitas, Andressa/0000-0001-8453-7742; Souto, Fabricio/0000-0002-2392-8499; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Souto, Fabricio/0000-0002-2392-8499; WA, Verri/0000-0003-2756-9283; Auxiliadora-Martins, Maria/0000-0003-3923-4464; Cunha, Fernando Queiroz/0000-0003-4755-1670	Wellcome Trust; UK Medical Research Council, the UK; EU; State of Sao Paulo Research Foundation; National Research Council, Brazil; MRC [G0801198, MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805, G0801198] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council, the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, the UK Medical Research Council, the UK and the EU (to F.Y.L.) and the State of Sao Paulo Research Foundation and National Research Council, Brazil (to F.Q.C.). Tlr4<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice were from S. Akira (University of Osaka).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Cummings CJ, 1999, J IMMUNOL, V162, P2341; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Manley MO, 2005, SHOCK, V23, P521, DOI 10.1097/01.shk.0000161386.23817.7f; Moritz DR, 1998, J IMMUNOL, V161, P4866; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	39	358	379	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					708	U113		10.1038/nm.2156	http://dx.doi.org/10.1038/nm.2156			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473304				2022-12-27	WOS:000278394200038
J	Islam, MN; Das, SR; Emin, MT; Wei, M; Sun, L; Westphalen, K; Rowlands, DJ; Quadri, SK; Bhattacharya, S; Bhattacharya, J				Islam, Mohammad Naimul; Das, Shonit R.; Emin, Memet T.; Wei, Michelle; Sun, Li; Westphalen, Kristin; Rowlands, David J.; Quadri, Sadiqa K.; Bhattacharya, Sunita; Bhattacharya, Jahar			Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; DYSFUNCTION; ENGRAFTMENT; EXOCYTOSIS; SURFACTANT; SEVERITY; CONNEXIN; THERAPY; SEPSIS; ROS	Bone marrow-derived stromal cells (BMSCs) protect against acute lung injury (ALI). To determine the role of BMSC mitochondria in this protection, we airway-instilled mice first with lipopolysaccharide (LPS) and then with either mouse BMSCs (mBMSCs) or human BMSCs (hBMSCs). Live optical studies revealed that the mBMSCs formed connexin 43 (Cx43)-containing gap junctional channels (GJCs) with the alveolar epithelia in these mice, releasing mitochondria-containing microvesicles that the epithelia engulfed. The presence of BMSC-derived mitochondria in the epithelia was evident optically, as well as by the presence of human mitochondrial DNA in mouse lungs instilled with hBMSCs. The mitochondrial transfer resulted in increased alveolar ATP concentrations. LPS-induced ALI, as indicated by alveolar leukocytosis and protein leak, inhibition of surfactant secretion and high mortality, was markedly abrogated by the instillation of wild-type mBMSCs but not of mutant, GJC-incompetent mBMSCs or mBMSCs with dysfunctional mitochondria. This is the first evidence, to our knowledge, that BMSCs protect against ALI by restituting alveolar bioenergetics through Cx43-dependent alveolar attachment and mitochondrial transfer.	[Islam, Mohammad Naimul; Das, Shonit R.; Emin, Memet T.; Wei, Michelle; Sun, Li; Westphalen, Kristin; Rowlands, David J.; Quadri, Sadiqa K.; Bhattacharya, Sunita; Bhattacharya, Jahar] Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, Lung Biol Lab, New York, NY 10032 USA	Columbia University	Bhattacharya, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, Lung Biol Lab, New York, NY 10032 USA.	jb39@columbia.edu		Islam, Mohammad Naimul/0000-0001-7929-9444	US National Institutes of Health [HL64896, HL36024, HL57556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057556, R01HL036024, R01HL064896, R37HL036024] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by US National Institutes of Health grants HL64896, HL36024 and HL57556 to J.B. The authors thank G. Yellen (Harvard University) for the Perceval plasmid.	Ashino Y, 2000, AM J PHYSIOL-LUNG C, V279, pL5, DOI 10.1152/ajplung.2000.279.1.L5; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Chang JC, 2005, AM J RESP CELL MOL, V33, P335, DOI 10.1165/rcmb.2005-0129OC; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; Das Sarma J, 2001, J CELL SCI, V114, P4013; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Harrois A, 2009, CURR OPIN ANESTHESIO, V22, P143, DOI 10.1097/ACO.0b013e328328d1cc; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Heller AR, 2007, EUR J ANAESTH, V24, P258, DOI 10.1017/S026502150600144X; Kao SJ, 2007, J CARDIOVASC PHARM, V50, P333, DOI 10.1097/FJC.0b013e3180cbd18a; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matthay MA, 2010, CRIT CARE MED, V38, pS569, DOI 10.1097/CCM.0b013e3181f1ff1d; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Wang PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1327, DOI 10.1152/ajplung.2001.281.6.L1327; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302	40	879	913	19	211	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					759	U153		10.1038/nm.2736	http://dx.doi.org/10.1038/nm.2736			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22504485	Green Accepted			2022-12-27	WOS:000303763500043
J	Petersen, BC; Budelsky, AL; Baptist, AP; Schaller, MA; Lukacs, NW				Petersen, Bryan C.; Budelsky, Alison L.; Baptist, Alan P.; Schaller, Matthew A.; Lukacs, Nicholas W.			Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB(+) myeloid population that exacerbates asthmatic pathology	NATURE MEDICINE			English	Article							INDUCED AIRWAY HYPERREACTIVITY; RESPIRATORY VIRAL-INFECTION; ALLERGIC INFLAMMATION; IMMUNE-RESPONSES; CELL-POPULATION; IL-25 RECEPTOR; EXPRESSION; PROMOTES; EOSINOPHILS; IL-17RB	Interleukin-25 (IL-25) is a cytokine associated with allergy and asthma that functions to promote type 2 immune responses at mucosal epithelial surfaces and serves to protect against helminth parasitic infections in the intestinal tract. This study identifies the IL-25 receptor, IL-17RB, as a key mediator of both innate and adaptive pulmonary type 2 immune responses. Allergen exposure upregulated IL-25 and induced type 2 cytokine production in a previously undescribed granulocytic population, termed type 2 myeloid (T2M) cells. Il17rb(-/-) mice showed reduced lung pathology after chronic allergen exposure and decreased type 2 cytokine production in T2M cells and CD4(+) T lymphocytes. Airway instillation of IL-25 induced IL-4 and IL-13 production in T2M cells, demonstrating their importance in eliciting T cell-independent inflammation. The adoptive transfer of T2M cells reconstituted IL-25-mediated responses in Il17rb(-/-) mice. High-dose dexamethasone treatment did not reduce the IL-25-induced T2M pulmonary response. Finally, a similar IL-4- and IL-13-producing granulocytic population was identified in peripheral blood of human subjects with asthma. These data establish IL-25 and its receptor IL-17RB as targets for innate and adaptive immune responses in chronic allergic airway disease and identify T2M cells as a new steroid-resistant cell population.	[Petersen, Bryan C.; Schaller, Matthew A.; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Budelsky, Alison L.] Amgen Inc, Dept Inflammat, Seattle, WA USA; [Baptist, Alan P.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Amgen; University of Michigan System; University of Michigan	Lukacs, NW (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	nlukacs@umich.edu	Lukacs, Nicholas W/ABH-5583-2020; Schaller, Matthew/AAL-7640-2020		US National Institutes of Health [R01 HL05178, R01 HL036302]; National Institute of General Medical Studies [3T32GM007863-31S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Connett for comments on the manuscript, K. Augusztiny for valuable insight and perspective, members of the Lukacs, Kunkel and Hogaboam labs for many helpful discussions, and the University of Michigan Flow Cytometry and DNA Sequencing Cores for technical assistance. This work was supported by US National Institutes of Health grants R01 HL05178 and R01 HL036302 (to N.W.L.) and National Institute of General Medical Studies grant 3T32GM007863-31S1 (to the University of Michigan Medical Scientist Training Program and B.C.P.). Il17rb<SUP>-/-</SUP> mice were provided by A.L. Budelsky (Amgen).	Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bandeira-Melo C, 2002, J IMMUNOL, V168, P4756, DOI 10.4049/jimmunol.168.9.4756; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Campbell E, 1999, AM J PATHOL, V154, P1259, DOI 10.1016/S0002-9440(10)65377-1; Campbell EM, 1998, J IMMUNOL, V161, P7047; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Drews AC, 2009, ALLERGY, V64, P1597, DOI 10.1111/j.1398-9995.2009.02057.x; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fukakusa M, 2005, J ALLERGY CLIN IMMUN, V115, P280, DOI 10.1016/j.jaci.2004.10.036; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garley A, 2009, NEOPLASMA, V56, P96, DOI 10.4149/neo_2009_02_96; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Holtzman MJ, 2009, ADV IMMUNOL, V102, P245, DOI 10.1016/S0065-2776(09)01205-X; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jung JS, 2009, CHEST, V135, P1173, DOI 10.1378/chest.08-1595; Kaiko GE, 2010, J IMMUNOL, V185, P4681, DOI 10.4049/jimmunol.1001758; Kallal LE, 2010, J IMMUNOL, V185, P4137, DOI 10.4049/jimmunol.1000677; Kikuchi S, 2005, INT ARCH ALLERGY IMM, V137, P7, DOI 10.1159/000085425; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ogawa Y, 2010, CURR OPIN PULM MED, V16, P48, DOI 10.1097/MCP.0b013e3283357d15; PAUL WE, 1991, SKIN PHARMACOL, V4, P8; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; SEDER RA, 1991, INT ARCH ALLER A IMM, V94, P137, DOI 10.1159/000235345; Sharkhuu T, 2006, CLIN EXP ALLERGY, V36, P1575, DOI 10.1111/j.1365-2222.2006.02595.x; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Terrier B, 2010, BLOOD, V116, P4523, DOI 10.1182/blood-2010-02-267542; Torrero MN, 2010, J IMMUNOL, V185, P7426, DOI 10.4049/jimmunol.0903864; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wang HB, 2007, J IMMUNOL, V179, P7585, DOI 10.4049/jimmunol.179.11.7585; Wang W, 2010, CURR DRUG TARGETS, V11, P957, DOI 10.2174/138945010791591412; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wong CK, 2007, IMMUNOL LETT, V112, P82, DOI 10.1016/j.imlet.2007.07.002; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	57	75	77	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					751	U145		10.1038/nm.2735	http://dx.doi.org/10.1038/nm.2735			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22543263	Green Accepted			2022-12-27	WOS:000303763500042
J	Hoetzenecker, W; Echtenacher, B; Guenova, E; Hoetzenecker, K; Woelbing, F; Bruck, J; Teske, A; Valtcheva, N; Fuchs, K; Kneilling, M; Park, JH; Kim, KH; Kim, KW; Hoffmann, P; Krenn, C; Hai, T; Ghoreschi, K; Biederman, T; Rocken, M				Hoetzenecker, Wolfram; Echtenacher, Bernd; Guenova, Emmanuella; Hoetzenecker, Konrad; Woelbing, Florian; Brueck, Juergen; Teske, Anna; Valtcheva, Nadejda; Fuchs, Kerstin; Kneilling, Manfred; Park, Ji-Hyeon; Kim, Kyu-Han; Kim, Kyu-Won; Hoffmann, Petra; Krenn, Claus; Hai, Tsonwin; Ghoreschi, Kamran; Biederman, Tilo; Roecken, Martin			ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression	NATURE MEDICINE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; OXIDATIVE STRESS; MONOCLONAL-ANTIBODY; NEGATIVE REGULATOR; GENETIC-CONTROL; PROTECTS MICE; SEPTIC SHOCK; DOUBLE-BLIND; GLUTATHIONE; INFLAMMATION	Sepsis, sepsis-induced hyperinflammation and subsequent sepsis-associated immunosuppression (SAIS) are important causes of death. Here we show in humans that the loss of the major reactive oxygen species (ROS) scavenger, glutathione (GSH), during SAIS directly correlates with an increase in the expression of activating transcription factor 3 (ATF3). In endotoxin-stimulated monocytes, ROS stress strongly superinduced NF-E2-related factor 2 (NRF2)-dependent ATF3. In vivo, this ROS-mediated superinduction of ATF3 protected against endotoxic shock by inhibiting innate cytokines, as Atf3(-/-) mice remained susceptible to endotoxic shock even under conditions of ROS stress. Although it protected against endotoxic shock, this ROS-mediated superinduction of ATF3 caused high susceptibility to bacterial and fungal infections through the suppression of interleukin 6 (IL-6). As a result, Atf3(-/-) mice were protected against bacterial and fungal infections, even under conditions of ROS stress, whereas Atf3(-/-)ll6(-/-) mice were highly susceptible to these infections. Moreover, in a model of SAIS, secondary infections caused considerably less mortality in Atf3(-/-) mice than in wild-type mice, indicating that ROS-induced ATF3 crucially determines susceptibility to secondary infections during SAIS.	[Hoetzenecker, Wolfram; Guenova, Emmanuella; Woelbing, Florian; Brueck, Juergen; Teske, Anna; Fuchs, Kerstin; Kneilling, Manfred; Ghoreschi, Kamran; Biederman, Tilo; Roecken, Martin] Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany; [Echtenacher, Bernd] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Hoetzenecker, Konrad] Med Univ Vienna, Dept Surg, Vienna, Austria; [Valtcheva, Nadejda] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Fuchs, Kerstin; Kneilling, Manfred] Univ Tubingen, Univ Med Ctr, Dept Preclin Imaging & Radiopharm, Lab Preclin Imaging & Imaging Technol,Werner Siem, Tubingen, Germany; [Park, Ji-Hyeon; Kim, Kyu-Han; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Park, Ji-Hyeon; Kim, Kyu-Han; Kim, Kyu-Won] Seoul Natl Univ, NeuroVasc Coordinat Res Ctr, Coll Pharm, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Hoffmann, Petra] Univ Hosp Regensburg, Dept Haematol & Oncol, Regensburg, Germany; [Krenn, Claus] Med Univ Vienna, Dept Anaesthesia & Gen Intens Care, Vienna, Austria; [Hai, Tsonwin] Ohio State Univ, Neurobiotechnol Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Medical University of Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Regensburg; Medical University of Vienna; University System of Ohio; Ohio State University	Rocken, M (corresponding author), Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany.	tilo.biedermann@med.uni-tuebingen.de; mrocken@med.uni-tuebingen.de	Hai, Tsonwin/E-3185-2011; Textoris, Julien/H-3317-2019; Kim, Kyu Won/AAJ-7213-2020; Friggeri, Arnaud/AAE-7644-2020; Guenova, Emmanuella/G-7441-2017	Hai, Tsonwin/0000-0003-4510-0315; Textoris, Julien/0000-0002-3821-9337; Friggeri, Arnaud/0000-0003-4687-2173; Guenova, Emmanuella/0000-0001-5478-8735; Hoetzenecker, Konrad/0000-0001-6775-7460; Ghoreschi, Kamran/0000-0002-5526-7517; Rocken, Martin/0000-0003-3795-7001; Biedermann, Tilo/0000-0002-5352-5105	Sander Stiftung [2005.043.2, 2005.043.3]; Deutsche Krebshilfe [109037]; Deutsche Forschungsgemeinschaft [SFB 685 A6, SFB 685 C1, Bi 696/3-3, Bi 696/5-1]; German Federal Ministry of Education and Research [BMBF FKZ 0315079, DLR 01GN0970]; University of Tuebingen [f-33654-87, f-1803-0-0]; European Union [FP7-HEALTH-2007-2.4.4-1 200515]; German Dermatologic Society/Arbeitsgemeinschaft Dermatologische Forschung; National Research Foundation of Korea; Ministry of Education, Science and Technology through the Creative Research Initiative [R16-2004-001010010]; World Class University [R31-2008-000-10103-0]; NATIONAL CANCER INSTITUTE [R01CA118306] Funding Source: NIH RePORTER	Sander Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Tuebingen; European Union(European Commission); German Dermatologic Society/Arbeitsgemeinschaft Dermatologische Forschung; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology through the Creative Research Initiative; World Class University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Pichler, N. Suttorp, T. Welte, S. Werner and P. Dotto for helpful discussions, and for reviewing the manuscript, and M. Haberbosch and S. Hemberger for technical assistance. S. Werner (Eidgenossische Technische Hochschule Zurich) provided the Nrf2<SUP>-/-</SUP> (Nfe2l2<SUP>tm1Ywk</SUP>) mice<SUP>25</SUP> with the permission of J.A. Johnson (University of California, San Francisco). This work has been supported by grants from the Sander Stiftung (2005.043.2 and 2005.043.3), Deutsche Krebshilfe (no. 109037), Deutsche Forschungsgemeinschaft (SFB 685 A6 and C1, Bi 696/3-3, Bi 696/5-1), German Federal Ministry of Education and Research (BMBF FKZ 0315079 to KG., DLR 01GN0970 to M.R.), University of Tuebingen (W.H., f-33654-87; E.G., f-1803-0-0; K.G. and M.R., IZKF-Tuebingen, collaborative research program), European Union FP7-HEALTH-2007-2.4.4-1 200515 (M.R.), The German Dermatologic Society/Arbeitsgemeinschaft Dermatologische Forschung (W.H.), a National Research Foundation of Korea grant that was funded by the Ministry of Education, Science and Technology through the Creative Research Initiative Program (grant R16-2004-001010010,2010) and a World Class University grant (no. R31-2008-000-10103-0).	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; [Anonymous], 2009, CHEST; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Biolo G, 2007, CRIT CARE MED, V35, pS591, DOI 10.1097/01.CCM.0000278913.19123.13; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Flaring UB, 2009, CLIN SCI, V117, P313, DOI 10.1042/CS20080462; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hai T, 1999, GENE EXPRESSION, V7, P321; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hoogerwerf JJ, 2011, AM J RESP CRIT CARE, V183, P932, DOI 10.1164/rccm.201006-0934OC; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Kneilling M, 2007, ARTHRITIS RHEUM, V56, P1806, DOI 10.1002/art.22602; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Ortolani O, 2000, AM J RESP CRIT CARE, V161, P1907, DOI 10.1164/ajrccm.161.6.9903043; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Steinhauser ME, 1999, J IMMUNOL, V162, P392; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Villa P, 2002, J INFECT DIS, V185, P1115, DOI 10.1086/340042; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	51	135	136	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					128	134		10.1038/nm.2557	http://dx.doi.org/10.1038/nm.2557			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179317	Green Accepted			2022-12-27	WOS:000299018600038
J	Bautch, VL				Bautch, Victoria L.			Stem cells and the vasculature	NATURE MEDICINE			English	Review							ENDOTHELIAL PROGENITOR CELLS; TO-MESENCHYMAL TRANSITION; SMOOTH-MUSCLE-CELLS; APOE-DEFICIENT MICE; BONE-MARROW; INFANTILE HEMANGIOMA; BLOOD-VESSELS; HAEMOGENIC ENDOTHELIUM; AORTIC ENDOTHELIUM; SKELETAL-MUSCLE	Unraveling the contribution of stem and progenitor cells to blood vessel formation and, reciprocally, the importance of blood vessels to the production and function of stem and progenitor cells, has been a major focus of vascular research over the last decade, but has spawned many controversies. Here I review how vascular stem and progenitor cells contribute both vascular and nonvascular cells during development and in disease, and how nonvascular stem and progenitor cells might contribute to vascular lineages. I also discuss the role of the vasculature in forming stem and progenitor cell niches. Finally, I highlight the potential relevance of these relationships to disease etiology and treatment.	[Bautch, Victoria L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Bautch, Victoria L.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Bautch, Victoria L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bautch, VL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	bautch@med.unc.edu	Tsai, Shih-Hung/G-1394-2014		US National Institutes of Health [HL43174, HL86465]; University of North Carolina Lineberger Comprehensive Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043174, R01HL086465] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Lineberger Comprehensive Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	I apologize to the many colleagues whose work could not be cited due to space constraints. I thank lab members and colleagues for fruitful discussions. I especially thank J. Bischoff, S.-W. Jin, M. Majesky and C. Patterson for thoughtful suggestions and critical comments on an early draft of the manuscript. This work was supported by grants from the US National Institutes of Health (HL43174 and HL86465) and an Innovation Award from the University of North Carolina Lineberger Comprehensive Cancer Center.	Ambler CA, 2001, DEV BIOL, V234, P352, DOI 10.1006/dbio.2001.0267; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2009, CURR OPIN HEMATOL, V16, P243, DOI 10.1097/MOH.0b013e32832c05e4; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Boscolo E, 2011, ARTERIOSCL THROM VAS, V31, P2181, DOI 10.1161/ATVBAHA.111.232934; Boscolo E, 2009, ANGIOGENESIS, V12, P197, DOI 10.1007/s10456-009-9148-2; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chiller KG, 2002, ARCH DERMATOL, V138, P1567, DOI 10.1001/archderm.138.12.1567; Choi K, 1998, DEVELOPMENT, V125, P725; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daniel JM, 2010, ARTERIOSCL THROM VAS, V30, P1890, DOI 10.1161/ATVBAHA.110.209692; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Dudley AC, 2010, BLOOD, V116, P3367, DOI 10.1182/blood-2010-02-271122; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Goldberg JS, 2009, REGEN MED, V4, P879, DOI [10.2217/rme.09.61, 10.2217/RME.09.61]; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Hagensen MK, 2010, CIRCULATION, V121, P898, DOI 10.1161/CIRCULATIONAHA.109.885459; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hogan KA, 2004, CURR TOP DEV BIOL, V62, P55; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Iacovino M, 2011, NAT CELL BIOL, V13, P72, DOI 10.1038/ncb2137; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; James JM, 2009, DEVELOPMENT, V136, P833, DOI 10.1242/dev.028845; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Jinnin M, 2010, J DERMATOL, V37, P283, DOI 10.1111/j.1346-8138.2010.00813.x; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kerbel Robert S, 2008, Proc Natl Acad Sci U S A, V105, pE55, DOI 10.1073/pnas.0804876105; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kurz H, 1996, DEV BIOL, V173, P133, DOI 10.1006/dbio.1996.0012; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Limaye N, 2009, HUM MOL GENET, V18, pR65, DOI 10.1093/hmg/ddp002; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Park C, 2005, EXP HEMATOL, V33, P965, DOI 10.1016/j.exphem.2005.06.003; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Psaltis PJ, 2011, J CARDIOVASC TRANSL, V4, P161, DOI 10.1007/s12265-010-9248-9; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tilki D, 2009, TRENDS MOL MED, V15, P501, DOI 10.1016/j.molmed.2009.09.004; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Xu QB, 2003, CIRC RES, V93, pE76, DOI 10.1161/01.RES.0000097864.24725.60; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	99	108	112	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1437	1443		10.1038/nm.2539	http://dx.doi.org/10.1038/nm.2539			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064433				2022-12-27	WOS:000296779300034
J	Coulon, S; Dussiot, M; Grapton, D; Maciel, TT; Wang, PHM; Callens, C; Tiwari, MK; Agarwal, S; Fricot, A; Vandekerckhove, J; Tamouza, H; Zermati, Y; Ribeil, JA; Djedaini, K; Oruc, Z; Pascal, V; Courtois, G; Arnulf, B; Alyanakian, MA; Mayeux, P; Leanderson, T; Benhamou, M; Cogne, M; Monteiro, RC; Hermine, O; Moura, IC				Coulon, Severine; Dussiot, Michael; Grapton, Damien; Maciel, Thiago Trovati; Wang, Pamella Huey Mei; Callens, Celine; Tiwari, Meetu Kaushik; Agarwal, Saurabh; Fricot, Aurelie; Vandekerckhove, Julie; Tamouza, Houda; Zermati, Yael; Ribeil, Jean-Antoine; Djedaini, Kamel; Oruc, Zeliha; Pascal, Virginie; Courtois, Genevieve; Arnulf, Bertrand; Alyanakian, Marie-Alexandra; Mayeux, Patrick; Leanderson, Tomas; Benhamou, Marc; Cogne, Michel; Monteiro, Renato C.; Hermine, Olivier; Moura, Ivan C.			Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia	NATURE MEDICINE			English	Article							STEM-CELL FACTOR; TRANSFERRIN-RECEPTOR; STRESS ERYTHROPOIESIS; IMMUNOGLOBULIN (IG)A1; PROGENITOR CELLS; IN-VIVO; IRON; EXPANSION; DISEASE; IDENTIFICATION	Anemia because of insufficient production of and/or response to erythropoietin (Epo) is a major complication of chronic kidney disease and cancer. The mechanisms modulating the sensitivity of erythroblasts to Epo remain poorly understood. We show that, when cultured with Epo at suboptimal concentrations, the growth and clonogenic potential of erythroblasts was rescued by transferrin receptor 1 (TfR1)-bound polymeric IgA1 (pIgA1). Under homeostatic conditions, erythroblast numbers were increased in mice expressing human IgA1 compared to control mice. Hypoxic stress of these mice led to increased amounts of pIgA1 and erythroblast expansion. Expression of human IgA1 or treatment of wild-type mice with the TfR1 ligands pIgA1 or iron-loaded transferrin (Fe-Tf) accelerated recovery from acute anemia. TfR1 engagement by either pIgA1 or Fe-Tf increased cell sensitivity to Epo by inducing activation of mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling pathways. These cellular responses were mediated through the TfR1-internalization motif, YXX Phi. Our results show that pIgA1 and TfR1 are positive regulators of erythropoiesis in both physiological and pathological situations. Targeting this pathway may provide alternate approaches to the treatment of ineffective erythropoiesis and anemia.	[Coulon, Severine; Dussiot, Michael; Grapton, Damien; Callens, Celine; Fricot, Aurelie; Vandekerckhove, Julie; Zermati, Yael; Ribeil, Jean-Antoine; Courtois, Genevieve; Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, CNRS,UMR 8147, Paris, France; [Arnulf, Bertrand] Univ Paris 07, Hop St Louis, Assistance Publ Hop Paris, Paris, France; [Djedaini, Kamel] Clin Geoffroy St Hilaire, Paris, France; [Oruc, Zeliha; Pascal, Virginie; Cogne, Michel] Univ Limoges, CNRS, UMR 6101, Limoges, France; [Arnulf, Bertrand] Fac Med, Serv Immunohematol, Paris, France; [Alyanakian, Marie-Alexandra] Univ Paris 05, Fac Med, Hop Necker Enfants Malad, INSERM,U1013, Paris, France; [Arnulf, Bertrand] Fac Med, Lab EA3963, Paris, France; [Alyanakian, Marie-Alexandra] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Lab Immunol Biol, Paris, France; [Mayeux, Patrick] Inst Cochin, Dept Hematol, Paris, France; [Mayeux, Patrick] INSERM, U567, Paris, France; [Mayeux, Patrick] Univ Paris 05, Fac Med, CNRS, UMR 8104, Paris, France; [Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Hermine, Olivier] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Hematol Clin, Paris, France; [Dussiot, Michael; Grapton, Damien; Maciel, Thiago Trovati; Wang, Pamella Huey Mei; Tiwari, Meetu Kaushik; Agarwal, Saurabh; Tamouza, Houda; Benhamou, Marc; Monteiro, Renato C.; Moura, Ivan C.] INSERM, U699, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Lund University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Moura, IC (corresponding author), INSERM, U699, Paris, France.	renato.monteiro@inserm.fr; olivier.hermine@nck.aphp.fr; ivan.moura@inserm.fr	Hermine, Olivier/Q-7072-2018; cogné, michel/D-7370-2015; Moura, Ivan C/A-9510-2013; Maciel, Thiago/A-4475-2013; Maciel, Thiago Trovati/AAF-5462-2021; Ribeil, Jean-Antoine/F-7896-2017; Monteiro, Renato C/U-8633-2017; Ribeil, Jean-Antoine/AAK-7979-2020; agarwal, saurabh/G-2410-2015; Cruz Moura, Ivan/A-9510-2013	cogné, michel/0000-0002-8519-4427; Moura, Ivan C/0000-0002-2977-0354; Maciel, Thiago/0000-0002-9347-981X; Maciel, Thiago Trovati/0000-0002-9347-981X; Ribeil, Jean-Antoine/0000-0002-5733-9123; Monteiro, Renato C/0000-0001-5202-5646; Ribeil, Jean-Antoine/0000-0002-4549-4783; agarwal, saurabh/0000-0001-9758-6746; Hermine, Olivier/0000-0003-2574-3874; Benhamou, Marc/0000-0001-7763-3795; Cruz Moura, Ivan/0000-0002-8418-2803; courtois, genevieve/0000-0001-6370-5575	Agence Nationale pour la Recherche; Institut National contre le Cancer; canceropole d'Ile de France; Fondation pour la Recherche Medicale; Fondation de France; Association Laurette Fugain; Association pour la Recherche contre le Cancer; Societe Francaise d'Hematologie; cent pour sang la vie; la Ligue contre le Cancer; CNRS [UMR-S 8147];  [INSERM/PNRNU]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National contre le Cancer; canceropole d'Ile de France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Association Laurette Fugain; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Societe Francaise d'Hematologie; cent pour sang la vie; la Ligue contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); 	This work was supported by Agence Nationale pour la Recherche, Institut National contre le Cancer, canceropole d'Ile de France, Fondation pour la Recherche Medicale, Fondation de France, Association Laurette Fugain, Association pour la Recherche contre le Cancer, Societe Francaise d'Hematologie, cent pour sang la vie, la Ligue contre le Cancer and INSERM/PNRNU2007 grants. S. C. is a recipient of Fondation pour la Recherche Medicale grant and a Societe Francaise d'Hematologie grant. We would like to thank J. Kersual and S. Dauzet (CNRS UMR-S 8147) for experimental help and the Departments of Hematology, Obstetrics and Otorhinolaryngology at the Necker Hospital (Paris, France) for providing blood samples, cord blood samples and tonsil samples, respectively. We would like to thank J. L. Danan (CNRS FRE 3210), M. Heinis (INSERM U845), B. Ruiz (INSERM U780) (located at Paris Descartes University, Paris, France) and C. Clerici (INSERM U773, Bichat Hospital, Paris, France) for providing the hypoxia chambers and L.-J. Couderc at the Foch Hospital (Suresnes, France) for providing blood samples. We are especially thankful to S. Izui (Department of Pathology and Immunology, University Medical Center, Geneva, Switzerland) for providing the 34-3C IgG2a monoclonal antibody and for fruitful discussions.	Arcasoy MO, 2005, BRIT J HAEMATOL, V130, P121, DOI 10.1111/j.1365-2141.2005.05580.x; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Besarab A, 2010, NAT REV NEPHROL, V6, P699, DOI 10.1038/nrneph.2010.139; BOZZINI CE, 1994, ANN NY ACAD SCI, V718, P83; Broudy VC, 1996, BLOOD, V88, P75; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; CHAN RYY, 1992, EXP CELL RES, V202, P326, DOI 10.1016/0014-4827(92)90082-J; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; COOK JD, 1976, BLOOD, V48, P449; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Erlandsson L, 2001, J EXP MED, V194, P557, DOI 10.1084/jem.194.5.557; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Fossati-Jimack L, 1999, J EXP MED, V190, P1689, DOI 10.1084/jem.190.11.1689; GOLDWASSER E, 1984, BLOOD CELLS, V10, P147; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hirschler-Laszkiewicz I, 2009, J BIOL CHEM, V284, P4567, DOI 10.1074/jbc.M804734200; HUEBERS HA, 1984, P NATL ACAD SCI-BIOL, V81, P4326, DOI 10.1073/pnas.81.14.4326; Jacob CMA, 2008, J CLIN IMMUNOL, V28, pS56, DOI 10.1007/s10875-007-9163-2; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Keel SB, 2009, NEW ENGL J MED, V361, P1904, DOI 10.1056/NEJMcibr0906391; KELLEY LL, 1993, BLOOD, V82, P2340; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Koury MJ, 2005, EXP HEMATOL, V33, P1263, DOI 10.1016/j.exphem.2005.06.031; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; LEV S, 1992, J BIOL CHEM, V267, P15970; LEV S, 1992, J BIOL CHEM, V267, P10866; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Li K, 2003, BLOOD, V102, P3147, DOI 10.1182/blood-2003-01-0078; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; MEANS RT, 1992, BLOOD, V80, P1639; MEEHAN R, 1988, J CLIN IMMUNOL, V8, P397, DOI 10.1007/BF00917156; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MESTECKY J, 1991, GASTROENTEROL CLIN N, V20, P441; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Moura IC, 2005, J AM SOC NEPHROL, V16, P2667, DOI 10.1681/ASN.2004111006; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; Moura IC, 2004, J AM SOC NEPHROL, V15, P622, DOI 10.1097/01.ASN.0000115401.07980.0C; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Suzuki M, 2006, BLOOD, V108, P726, DOI 10.1182/blood-2005-10-4064; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	60	51	52	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1456	U163		10.1038/nm.2462	http://dx.doi.org/10.1038/nm.2462			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019886				2022-12-27	WOS:000296779300037
J	Croce, CM				Croce, Carlo M.			miRNAs in the spotlight: Understanding cancer gene dependency	NATURE MEDICINE			English	Editorial Material							MICRORNA; LEUKEMIA; LYMPHOMA		Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Croce, CM (corresponding author), Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NCI NIH HHS [U01 CA152758] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA152758] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CIALFRE SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103	11	28	30	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					935	936		10.1038/nm0811-935	http://dx.doi.org/10.1038/nm0811-935			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21818092				2022-12-27	WOS:000293507400025
J	Paragas, N; Qiu, AD; Zhang, QY; Samstein, B; Deng, SX; Schmidt-Ott, KM; Viltard, M; Yu, WQ; Forster, CS; Gong, GL; Liu, YD; Kulkarni, R; Mori, K; Kalandadze, A; Ratner, AJ; Devarajan, P; Landry, DW; D'Agati, V; Lin, CS; Barasch, J				Paragas, Neal; Qiu, Andong; Zhang, Qingyin; Samstein, Benjamin; Deng, Shi-Xian; Schmidt-Ott, Kai M.; Viltard, Melanie; Yu, Wenqiang; Forster, Catherine S.; Gong, Gangli; Liu, Yidong; Kulkarni, Ritwij; Mori, Kiyoshi; Kalandadze, Avtandil; Ratner, Adam J.; Devarajan, Prasad; Landry, Donald W.; D'Agati, Vivette; Lin, Chyuan-Sheng; Barasch, Jonathan			The Ngal reporter mouse detects the response of the kidney to injury in real time	NATURE MEDICINE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; EARLY URINARY BIOMARKER; INNATE IMMUNE-RESPONSE; CARDIAC-SURGERY; ESCHERICHIA-COLI; EPITHELIAL-CELLS; SERUM CREATININE; RENAL INJURY; RAT-KIDNEY	Many proteins have been proposed to act as surrogate markers of organ damage, yet for many candidates the essential biomarker characteristics that link the protein to the injured organ have not yet been described. We generated an Ngal reporter mouse by inserting a double-fusion reporter gene encoding luciferase-2 and mCherry (Luc2-mC) into the Ngal (Lcn2) locus. The Ngal-Luc2-mC reporter accurately recapitulated the endogenous message and illuminated injuries in vivo in real time. In the kidney, Ngal-Luc2-mC imaging showed a sensitive, rapid, dose-dependent, reversible, and organ-and cell-specific relationship with tubular stress, which correlated with the level of urinary Ngal (uNgal). Unexpectedly, specific cells of the distal nephron were the source of uNgal. Cells isolated from Ngal-Luc2-mC mice also revealed both the onset and the resolution of the injury, and the actions of NF-kappa B inhibitors and antibiotics during infection. Thus, imaging of Ngal-Luc2-mC mice and cells identified injurious and reparative agents that affect kidney damage.	[Paragas, Neal; Qiu, Andong; Zhang, Qingyin; Samstein, Benjamin; Deng, Shi-Xian; Viltard, Melanie; Yu, Wenqiang; Forster, Catherine S.; Gong, Gangli; Liu, Yidong; Kulkarni, Ritwij; Kalandadze, Avtandil; Ratner, Adam J.; Landry, Donald W.; D'Agati, Vivette; Lin, Chyuan-Sheng; Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Schmidt-Ott, Kai M.] Max Delbruck Ctr Mol Med Berlin Buch, Berlin, Germany; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Devarajan, Prasad] Cincinnati Childrens Hosp, Cincinnati, OH USA	Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Kyoto University; Cincinnati Children's Hospital Medical Center	Barasch, J (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.	jmb4@columbia.edu	Schmidt-Ott, Kai/F-4588-2011; Qiu, Andong/AAY-1179-2021; Samstein, Benjamin/AAJ-5846-2020; Mori, Kiyoshi/N-1267-2014	Schmidt-Ott, Kai/0000-0002-7700-7142; Samstein, Benjamin/0000-0002-3934-2564; Mori, Kiyoshi/0000-0002-7285-8351; Devarajan, Prasad/0000-0002-7847-8552; Forster, Catherine/0000-0002-6233-1070; Ratner, Adam/0000-0003-1761-794X; Paragas, Neal/0000-0001-6084-8220	Office of Columbia University Technology Ventures; US National Institute of Diabetes and Digestive and Kidney Diseases [DK-55388, DK-58872]; March of Dimes for Birth Defects; Glomerular Center of Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055388, R01DK058872, R01DK073462] Funding Source: NIH RePORTER	Office of Columbia University Technology Ventures; US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); March of Dimes for Birth Defects(March of Dimes); Glomerular Center of Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the advice of Q. Al-Awqati and J.A. Oliver. This work was supported by a grant from the Office of Columbia University Technology Ventures. J.B., N.P. and A. Q. are supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (DK-55388 and DK-58872) and the March of Dimes for Birth Defects. Additional funding to J.B. was provided by the Glomerular Center of Columbia University.	Barasch J, 2004, NATURE, V432, P811, DOI 10.1038/432811a; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bolignano D, 2007, AM J NEPHROL, V27, P373, DOI 10.1159/000103912; BOSCH JP, 1983, AM J MED, V75, P943, DOI 10.1016/0002-9343(83)90873-2; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Christensen EI, 2008, KIDNEY INT, V74, P1233, DOI 10.1038/ki.2008.421; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Damman K, 2009, EUR J HEART FAIL, V11, P847, DOI 10.1093/eurjhf/hfp108; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gong GL, 2009, BIOORG MED CHEM LETT, V19, P1191, DOI 10.1016/j.bmcl.2008.12.086; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Haase M, 2009, CRIT CARE MED, V37, P39, DOI 10.1097/CCM.0b013e318193216f; Haase-Fielitz A, 2009, NEPHROL DIAL TRANSPL, V24, P3349, DOI 10.1093/ndt/gfp234; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; HAN KH, 2008, J AM SOC NEPHROL, V19, P1538; Heyman SN, 2010, KIDNEY INT, V77, P9, DOI 10.1038/ki.2009.347; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Newby LK, 1998, CIRCULATION, V98, P1853, DOI 10.1161/01.CIR.98.18.1853; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Steen H, 2006, J AM COLL CARDIOL, V48, P2192, DOI 10.1016/j.jacc.2006.06.002; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Xie YL, 2008, BIOORG MED CHEM LETT, V18, P329, DOI 10.1016/j.bmcl.2007.10.100; ZHANG Z, 1995, MICROSURG, V16, P103, DOI 10.1002/micr.1920160212	42	300	325	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					216	U113		10.1038/nm.2290	http://dx.doi.org/10.1038/nm.2290			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21240264	Green Accepted			2022-12-27	WOS:000286969900031
J	Haass, C				Haass, Christian			Initiation and propagation of neurodegeneration	NATURE MEDICINE			English	Article							AMYLOID-BETA-PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; CELLULAR PRION PROTEIN; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SYNAPTIC PLASTICITY; MOUSE MODEL; IN-VIVO; MUTATIONS	Although substantial progress has been made in understanding the molecular and pathological bases of neurodegeneration, there have been few successes in the clinic and a number of fundamental questions remain unanswered. Is this skepticism misplaced, or do the words of Sir Isaac Newton hold true, that "what we know is a drop, what we don't know is an ocean"?	[Haass, Christian] DZNE German Ctr Neurodegenerat Dis, Munich, Germany; [Haass, Christian] Univ Munich, Adolf Butenandt Inst, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Haass, C (corresponding author), DZNE German Ctr Neurodegenerat Dis, Munich, Germany.	chaass@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This article reports on some of the main points raised at the Herrenhausen Symposium on Neurodegeneration in Seeon, Germany (May 2010) during the session on the initiation and propagation of neurodegeneration. I thank A. Aguzzi, D. Rubinsztein, S. Sisodia, D. Edbauer and M. Meyer-Luhmann for reading this manuscript. This work was supported by the Deutsche Forschungsgemeinschaft.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cataldo AM, 1996, J NEUROSCI, V16, P186; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROHRER JD, 2010, NEUROIMAGE      0104, DOI DOI 10.1016/J.NEUROIMAGE.2009.12.088; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; THAL DR, 2006, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2006.6.RE1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	52	36	39	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1201	1204		10.1038/nm.2223	http://dx.doi.org/10.1038/nm.2223			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052073				2022-12-27	WOS:000283860100025
J	[Anonymous]				[Anonymous]			Pain, from bench to bedside	NATURE MEDICINE			English	Editorial Material								There has been substantial progress in understanding the neurobiological basis of pain, but these advances have yet to translate into new and improved analgesics.											0	0	0	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1236	1236		10.1038/nm1110-1236	http://dx.doi.org/10.1038/nm1110-1236			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052080	Bronze			2022-12-27	WOS:000283860100032
J	Ng, CT; Jaworski, JP; Jayaraman, P; Sutton, WF; Delio, P; Kuller, L; Anderson, D; Landucci, G; Richardson, BA; Burton, DR; Forthal, DN; Haigwood, NL				Ng, Cherie T.; Jaworski, J. Pablo; Jayaraman, Pushpa; Sutton, William F.; Delio, Patrick; Kuller, LaRene; Anderson, David; Landucci, Gary; Richardson, Barbra A.; Burton, Dennis R.; Forthal, Donald N.; Haigwood, Nancy L.			Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-1/SIV CHIMERIC VIRUS; MONOCLONAL-ANTIBODIES; PROTECTION; TRANSMISSION; TYPE-1; BROAD	Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.	[Ng, Cherie T.; Jayaraman, Pushpa; Haigwood, Nancy L.] Univ Washington, Dept Global Hlth, Pathobiol Program, Seattle, WA 98195 USA; [Ng, Cherie T.; Jayaraman, Pushpa] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Jaworski, J. Pablo; Sutton, William F.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Jaworski, J. Pablo; Sutton, William F.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Delio, Patrick; Kuller, LaRene; Anderson, David] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Center for Infectious Disease Research; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Haigwood, NL (corresponding author), Univ Washington, Dept Global Hlth, Pathobiol Program, Seattle, WA 98195 USA.	haigwoon@ohsu.edu	Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020	Jaworski, Juan/0000-0002-1311-060X; Haigwood, Nancy/0000-0002-1477-9575	US National Institutes of Health [R01HD038653, R01AI33292, R01AI052039]; Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R01AI052039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Z. Brower for technical support, D. Morris and K. Filer for manuscript preparation, M. L. Marthas and K. K. A. Van Rompay for advice on subcutaneous dosing of IgG and oral inoculation of infants, J. Overbaugh (Fred Hutchinson Cancer Research Center) for the Env-deleted viral backbone plasmid Q23 Delta Env, S. Barnett and I. Srinivasan (Novartis) for recombinant gp120-SF162 and V. Planelles (University of Utah) for the plasmid pEMC*. M. Piatak and J. D. Lifson (Science Applications International Corporation) kindly provided RNA standards and advice on real-time PCR. SHIV<INF>SF162P3</INF> was supplied by N. Miller (US National Institutes of Health Division of AIDS) and R. Pal (Advanced Bioscience Labs). TZM-bl were supplied by the US National Institutes of Health AIDS Research Reference Reagent Program. This study was supported by grants from the US National Institutes of Health R01HD038653 (N. L. H.), R01AI33292 (D. R. B.) and R01AI052039 (D. N. F.) and from the Elizabeth Glaser Pediatric AIDS Foundation (N. L. H.).	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Forthal DN, 2005, J VIROL, V79, P2042, DOI 10.1128/JVI.79.4.2042-2049.2005; Forthal DN, 2006, J VIROL, V80, P9217, DOI 10.1128/JVI.02746-05; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Jayaraman P, 2007, J VIROL, V81, P822, DOI 10.1128/JVI.01759-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; STEIMER KS, 1991, SCIENCE, V254, P105, DOI 10.1126/science.1718036; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540	19	115	119	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1117	1119		10.1038/nm.2233	http://dx.doi.org/10.1038/nm.2233			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20890292	Green Accepted, Green Submitted			2022-12-27	WOS:000282644800041
J	Gliklich, R				Gliklich, Richard			Prepare for the long haul of drug monitoring	NATURE MEDICINE			English	Editorial Material								As concerns have emerged in recent years over medications such as Vioxx and now Avandia, the need to improve the surveillance of approved drugs has become increasingly apparent. To ensure the success of the drugs they develop, biomedical researchers should track a wider set of clinical endpoints in drug trials and prepare to distinguish between real and false risks suggested by long-term safety monitoring.	[Gliklich, Richard] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gliklich, Richard] Outcome Sci, Cambridge, MA USA	Harvard University; Harvard Medical School	Gliklich, R (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					848	848		10.1038/nm0810-848	http://dx.doi.org/10.1038/nm0810-848			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20689542				2022-12-27	WOS:000280649200016
J	Herber, DL; Cao, W; Nefedova, Y; Novitskiy, SV; Nagaraj, S; Tyurin, VA; Corzo, A; Cho, HI; Celis, E; Lennox, B; Knight, SC; Padhya, T; McCaffrey, TV; McCaffrey, JC; Antonia, S; Fishman, M; Ferris, RL; Kagan, VE; Gabrilovich, DI				Herber, Donna L.; Cao, Wei; Nefedova, Yulia; Novitskiy, Sergey V.; Nagaraj, Srinivas; Tyurin, Vladimir A.; Corzo, Alex; Cho, Hyun-Il; Celis, Esteban; Lennox, Brianna; Knight, Stella C.; Padhya, Tapan; McCaffrey, Thomas V.; McCaffrey, Judith C.; Antonia, Scott; Fishman, Mayer; Ferris, Robert L.; Kagan, Valerian E.; Gabrilovich, Dmitry I.			Lipid accumulation and dendritic cell dysfunction in cancer	NATURE MEDICINE			English	Article							POLYUNSATURATED FATTY-ACIDS; MACROPHAGE SCAVENGER RECEPTOR; CLASS-A; INHIBITION; ACTIVATION; EXPRESSION; MATURATION	Dendritic cells (DCs), a type of professional antigen-presenting cells, are responsible for initiation and maintenance of immune responses. Here we report that a substantial proportion of DCs in tumor-bearing mice and people with cancer have high amounts of triglycerides as compared with DCs from tumor-free mice and healthy individuals. In our studies, lipid accumulation in DCs was caused by increased uptake of extracellular lipids due to upregulation of scavenger receptor A. DCs with high lipid content were not able to effectively stimulate allogeneic T cells or present tumor-associated antigens. DCs with high and normal lipid levels did not differ in expression of major histocompatibility complex and co-stimulatory molecules. However, lipid-laden DCs had a reduced capacity to process antigens. Pharmacological normalization of lipid abundance in DCs with an inhibitor of acetyl-CoA carboxylase restored the functional activity of DCs and substantially enhanced the effects of cancer vaccines. These findings suggest that immune responses in cancer can be improved by manipulating the lipid levels in DCs.	[Herber, Donna L.; Cao, Wei; Nefedova, Yulia; Novitskiy, Sergey V.; Nagaraj, Srinivas; Corzo, Alex; Cho, Hyun-Il; Celis, Esteban; Lennox, Brianna; Gabrilovich, Dmitry I.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm Hlth, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA; [Celis, Esteban; Gabrilovich, Dmitry I.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Knight, Stella C.] Univ London Imperial Coll Sci Technol & Med, Dept Immunopathol, London, England; [Padhya, Tapan; McCaffrey, Thomas V.; McCaffrey, Judith C.] Univ S Florida, Dept Otolaryngol, Tampa, FL USA; [Antonia, Scott] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Fishman, Mayer] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA; [Ferris, Robert L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of South Florida; Imperial College London; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gabrilovich, DI (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA.	dmitry.gabrilovich@moffitt.org	Gabrilovich, Dmitry/ABE-7122-2020; Fishman, Mayer/AAG-6640-2021; Bharadwaj, Srinivas Nagaraj/I-4947-2012	Kagan, Valerian E./0000-0002-7245-1885; Nefedova, Yulia/0000-0002-5121-9294; Ferris, Robert/0000-0001-6605-2071; Tyurin, Vladimir/0000-0002-3474-1697	US National Institutes of Health [1R21AI070598]; National Institutes of Health [HL70755, HL094488, OH008282]; MRC [G0500677] Funding Source: UKRI; Medical Research Council [G0500677] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K24CA128953] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094488, R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070598] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant 1R21AI070598 to D.I.G., National Institutes of Health grants HL70755, HL094488 and OH008282 to V.E.K. and, in part, by the flow cytometry core of H. Lee Moffitt Cancer Center. Poly-IC was provided by A. Salazar (Oncovir).	Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660; Calder P. C., 2004, BIOACTIVE LIPIDS, V17, P1; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Delimaris L, 2007, CLIN BIOCHEM, V40, P1129, DOI 10.1016/j.clinbiochem.2007.06.007; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; HALVORSON DL, 1984, LIPIDS, V19, P851, DOI 10.1007/BF02534514; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Knight SC, 2008, IMMUNITY, V28, P135, DOI 10.1016/j.immuni.2008.01.003; Motta M, 2003, PANMINERVA MED, V45, P69; Nagaraj S, 2007, J IMMUNOTHER, V30, P169, DOI 10.1097/01.cji.0000211329.83890.ba; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Packard RRS, 2008, CIRC RES, V103, P965, DOI 10.1161/CIRCRESAHA.108.185793; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Saemann MD, 2002, J LEUKOCYTE BIOL, V71, P238; Sanderson P, 1997, J LEUKOCYTE BIOL, V62, P771, DOI 10.1002/jlb.62.6.771; Shaikh SR, 2006, AM J CLIN NUTR, V84, P1277, DOI 10.1093/ajcn/84.6.1277; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Shurin Michael R., 2008, P101, DOI 10.1007/978-0-387-69118-3_6; Touitou E, 2002, J CONTROL RELEASE, V80, P1, DOI 10.1016/S0168-3659(02)00004-4; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200	30	399	415	5	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					880	U57		10.1038/nm.2172	http://dx.doi.org/10.1038/nm.2172			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20622859	Green Accepted, Green Submitted			2022-12-27	WOS:000280649200027
J	Kim, H; Toyofuku, Y; Lynn, FC; Chak, E; Uchida, T; Mizukami, H; Fujitani, Y; Kawamori, R; Miyatsuka, T; Kosaka, Y; Yang, K; Honig, G; van der Hart, M; Kishimoto, N; Wang, JH; Yagihashi, S; Tecott, LH; Watada, H; German, MS				Kim, Hail; Toyofuku, Yukiko; Lynn, Francis C.; Chak, Eric; Uchida, Toyoyoshi; Mizukami, Hiroki; Fujitani, Yoshio; Kawamori, Ryuzo; Miyatsuka, Takeshi; Kosaka, Yasuhiro; Yang, Katherine; Honig, Gerard; van der Hart, Marieke; Kishimoto, Nina; Wang, Juehu; Yagihashi, Soroku; Tecott, Laurence H.; Watada, Hirotaka; German, Michael S.			Serotonin regulates pancreatic beta cell mass during pregnancy	NATURE MEDICINE			English	Article							GESTATIONAL DIABETES-MELLITUS; INSULIN-SECRETION; PLACENTAL-LACTOGEN; 5-HT2B RECEPTORS; PROLACTIN RECEPTOR; TRANSGENIC MICE; PROLIFERATION; GROWTH; HORMONES; ISLETS	During pregnancy, the energy requirements of the fetus impose changes in maternal metabolism. Increasing insulin resistance in the mother maintains nutrient flow to the growing fetus, whereas prolactin and placental lactogen counterbalance this resistance and prevent maternal hyperglycemia by driving expansion of the maternal population of insulin-producing beta cells(1-3). However, the exact mechanisms by which the lactogenic hormones drive beta cell expansion remain uncertain. Here we show that serotonin acts downstream of lactogen signaling to stimulate beta cell proliferation. Expression of serotonin synthetic enzyme tryptophan hydroxylase-1 (Tph1) and serotonin production rose sharply in beta cells during pregnancy or after treatment with lactogens in vitro. Inhibition of serotonin synthesis by dietary tryptophan restriction or Tph inhibition blocked beta cell expansion and induced glucose intolerance in pregnant mice without affecting insulin sensitivity. Expression of the G alpha(q)-linked serotonin receptor 5-hydroxytryptamine receptor-2b (Htr2b) in maternal islets increased during pregnancy and normalized just before parturition, whereas expression of the G alpha(i)-linked receptor Htr1d increased at the end of pregnancy and postpartum. Blocking Htr2b signaling in pregnant mice also blocked beta cell expansion and caused glucose intolerance. These studies reveal an integrated signaling pathway linking beta cell mass to anticipated insulin need during pregnancy. Modulators of this pathway, including medications and diet, may affect the risk of gestational diabetes(4).	[Kim, Hail; Lynn, Francis C.; Chak, Eric; Miyatsuka, Takeshi; Kosaka, Yasuhiro; Yang, Katherine; Kishimoto, Nina; Wang, Juehu; German, Michael S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Toyofuku, Yukiko; Uchida, Toyoyoshi; Fujitani, Yoshio; Kawamori, Ryuzo; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Med Metab & Endocrinol, Tokyo, Japan; [Mizukami, Hiroki] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori, Japan; [Fujitani, Yoshio; Kawamori, Ryuzo; Yagihashi, Soroku] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Ctr Beta Cell Biol & Regenerat, Tokyo, Japan; [Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan; [Honig, Gerard; van der Hart, Marieke; Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [German, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Juntendo University; Hirosaki University; Juntendo University; Juntendo University; Juntendo University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	German, MS (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	mgerman@diabetes.ucsf.edu	Mizukami, Hiroki/ABE-7877-2021; Kim, Hail/C-1849-2011; Kim, Hail/C-5608-2018; Honig, Gerard/ABB-5333-2020	Mizukami, Hiroki/0000-0003-2920-582X; Kim, Hail/0000-0002-6652-1349; Watada, Hirotaka/0000-0001-5961-1816; Lynn, Francis/0000-0001-9318-1063; Honig, Gerard/0000-0001-9147-7450	Larry L. Hillblom Foundation; Juvenile Diabetes Research Foundation; American Diabetes Association; US National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases; Ministry of Education, Sports and Culture of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061245, P30DK063720, R01DK021344] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); US National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Education, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Grodsky, W. Rutter and members of the German laboratory for helpful discussions; F. Schaufle and the UCSF Diabetes and Endocrinology Research Center Microscopy Core Laboratory; G. Szot and the UCSF Diabetes and Endocrinology Research Center Islet Core; Y. Zhang, Z. Li and S. Zhao for technical assistance with mouse husbandry and genotyping; N. Daimaru, E. Magoshi and K. Nakamura for technical assistance; K. Takahashi, W. Inaba, M. Tsujii and S. Nakayama for immunohistochemical studies; Y. Katayama (Hirosaki University) and P. Ursell (UCSF) for providing human pancreatic samples; and D. Kuhn (Wayne State University), L. Maroteaux (Institut National de la Sante et de la Recherche Medicale) and M. Hara (University of Chicago) for generously providing the Tph1-specific antisera, Htr2b-targeted mice and MIP-GFP mice, respectively. This work was supported by grants from the Larry L. Hillblom Foundation, the Juvenile Diabetes Research Foundation, the American Diabetes Association, the US National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases and the Ministry of Education, Sports and Culture of Japan.	Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; De Lucchini S, 2005, MOL CELL NEUROSCI, V29, P299, DOI 10.1016/j.mcn.2005.03.008; Fadda F, 2000, NEWS PHYSIOL SCI, V15, P260; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gianfrancesco FD, 2002, J CLIN PSYCHIAT, V63, P920, DOI 10.4088/JCP.v63n1010; GOODNER CJ, 1989, DIABETES, V38, P925, DOI 10.2337/diabetes.38.7.925; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HOYER D, 1994, PHARMACOL REV, V46, P157; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kozhimannil KB, 2009, JAMA-J AM MED ASSOC, V301, P842, DOI 10.1001/jama.2009.201; LEAHY JL, 1984, DIABETES, V33, P667, DOI 10.2337/diabetes.33.7.667; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; MOLDRUP A, 1993, ENDOCRINOLOGY, V133, P1165, DOI 10.1210/en.133.3.1165; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Rothman RB, 2000, CIRCULATION, V102, P2836; Sakowski SA, 2006, BRAIN RES, V1085, P11, DOI 10.1016/j.brainres.2006.02.047; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Wouters MM, 2007, GASTROENTEROLOGY, V133, P897, DOI 10.1053/j.gastro.2007.06.017	30	390	399	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					804	U106		10.1038/nm.2173	http://dx.doi.org/10.1038/nm.2173			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20581837	Green Submitted, Green Accepted			2022-12-27	WOS:000279631900031
J	Uygun, BE; Soto-Gutierrez, A; Yagi, H; Izamis, ML; Guzzardi, MA; Shulman, C; Milwid, J; Kobayashi, N; Tilles, A; Berthiaume, F; Hertl, M; Nahmias, Y; Yarmush, ML; Uygun, K				Uygun, Basak E.; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Izamis, Maria-Louisa; Guzzardi, Maria A.; Shulman, Carley; Milwid, Jack; Kobayashi, Naoya; Tilles, Arno; Berthiaume, Francois; Hertl, Martin; Nahmias, Yaakov; Yarmush, Martin L.; Uygun, Korkut			Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix	NATURE MEDICINE			English	Article							HEPATOCYTE TRANSPLANTATION; EXTRACELLULAR-MATRIX; STEM-CELLS; IN-VITRO; FAILURE; OXYGEN; DIFFERENTIATION; ATTACHMENT; PERFUSION; SURVIVAL	Orthotopic liver transplantation is the only available treatment for severe liver failure, but it is currently limited by organ shortage. One technical challenge that has thus far limited the development of a tissue-engineered liver graft is oxygen and nutrient transport. Here we demonstrate a novel approach to generate transplantable liver grafts using decellularized liver matrix. The decellularization process preserves the structural and functional characteristics of the native microvascular network, allowing efficient recellularization of the liver matrix with adult hepatocytes and subsequent perfusion for in vitro culture. The recellularized graft supports liver-specific function including albumin secretion, urea synthesis and cytochrome P450 expression at comparable levels to normal liver in vitro. The recellularized liver grafts can be transplanted into rats, supporting hepatocyte survival and function with minimal ischemic damage. These results provide a proof of principle for the generation of a transplantable liver graft as a potential treatment for liver disease.	[Uygun, Basak E.; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Izamis, Maria-Louisa; Guzzardi, Maria A.; Shulman, Carley; Milwid, Jack; Tilles, Arno; Berthiaume, Francois; Nahmias, Yaakov; Yarmush, Martin L.; Uygun, Korkut] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Hosp Children, Boston, MA 02129 USA; [Guzzardi, Maria A.] Scuola Super Sant Anna, Sector Med, Pisa, Italy; [Kobayashi, Naoya] Okayama Univ, Grad Sch Med & Dent, Dept Surg, Shikata, Okayama, Japan; [Berthiaume, Francois; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Hertl, Martin] Massachusetts Gen Hosp, Transplantat Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Scuola Superiore Sant'Anna; Okayama University; Rutgers State University New Brunswick; Harvard University; Massachusetts General Hospital	Uygun, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Hosp Children, Boston, MA 02129 USA.	kuygun@partners.org	Sano, Michael/E-1715-2011; aksel, hacer/H-1572-2015; Guzzardi, Maria-Angela/K-1389-2016; Berthiaume, Francois/ABD-2139-2020; Uygun, Korkut/AAH-3950-2020; Uygun, Basak/I-1792-2012; Nahmias, Yaakov/H-4725-2013; Nahmias, Yaakov/AAM-3872-2020	Guzzardi, Maria-Angela/0000-0001-9574-5088; Uygun, Korkut/0000-0003-2088-7860; Uygun, Basak/0000-0002-2600-7900; Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	US National Institutes of Health [R01DK59766, R01DK084053, K99/R00 DK080942, K99DK083556]; US National Science Foundation [CBET-0853569]; Shriners Hospitals for Children [8503]; American Liver Foundation; Massachusetts General Hospital; Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK088962, K99DK088962, K99DK080942, K99DK083556, R00DK080942, R01DK059766, R00DK083556, R01DK084053] Funding Source: NIH RePORTER; Directorate For Engineering [0853569] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Shriners Hospitals for Children; American Liver Foundation; Massachusetts General Hospital(General Electric); Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the US National Institutes of Health, R01DK59766 and R01DK084053 to M.L.Y., K99/R00 DK080942 to K. U. and K99DK083556 to A. S.-G., and US National Science Foundation CBET-0853569 to K. U. We thank the support of the Shriners Hospitals for Children to B. E. U. (grant no. 8503), the American Liver Foundation to A. S.-G. and Massachusetts General Hospital Junior Faculty Grant to K. U. and the Shriners Hospitals for Children. We would like to thank A. Vitalo, C. Calhoun and B. Crowther for technical support.	Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Balis UJ, 1999, METAB ENG, V1, P49, DOI 10.1006/mben.1998.0105; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cho CH, 2008, FASEB J, V22, P898, DOI 10.1096/fj.06-7764com; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; FOY BD, 1993, BIOTECHNOL BIOENG, V42, P579, DOI 10.1002/bit.260420505; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; HOFFENBERG R, 1972, BIOCHEM J, V129, pP9; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005; LANGER R, 1993, SCIENCE, V920, P260, DOI DOI 10.1126/SCIENCE.8493529; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Melonie Heron Ph.D, 2009, NATL VITAL STAT REPO, V57; Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Nahmias Y, 2006, TISSUE ENG, V12, P1627, DOI 10.1089/ten.2006.12.1627; Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Punch JD, 2007, AM J TRANSPLANT, V7, P1327, DOI 10.1111/j.1600-6143.2007.01779.x; ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715; SAFAR P, 1988, CRIT CARE MED, V16, P919; Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com; Schleimer K, 2006, LANGENBECK ARCH SURG, V391, P102, DOI 10.1007/s00423-006-0032-x; Shafritz DA, 2006, HEPATOLOGY, V43, pS89, DOI 10.1002/hep.21047; Smets F, 2008, PEDIATR TRANSPLANT, V12, P6, DOI 10.1111/j.1399-3046.2007.00788.x; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Tolboom H, 2009, TRANSPLANTATION, V87, P170, DOI 10.1097/TP.0b013e318192df6b; Totsugawa T, 2007, J HEPATOL, V47, P74, DOI 10.1016/j.jhep.2007.02.019; UYGUN K, TRANSPLANT IN PRESS; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4	38	950	1014	11	352	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					814	U120		10.1038/nm.2170	http://dx.doi.org/10.1038/nm.2170			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20543851	Green Accepted			2022-12-27	WOS:000279631900033
J	Guo, W; Schafer, S; Greaser, ML; Radke, MH; Liss, M; Govindarajan, T; Maatz, H; Schulz, H; Li, SJ; Parrish, AM; Dauksaite, V; Vakeel, P; Klaassen, S; Gerull, B; Thierfelder, L; Regitz-Zagrosek, V; Hacker, TA; Saupe, KW; Dec, GW; Ellinor, PT; MacRae, CA; Spallek, B; Fischer, R; Perrot, A; Ozcelik, C; Saar, K; Hubner, N; Gotthardt, M				Guo, Wei; Schafer, Sebastian; Greaser, Marion L.; Radke, Michael H.; Liss, Martin; Govindarajan, Thirupugal; Maatz, Henrike; Schulz, Herbert; Li, Shijun; Parrish, Amanda M.; Dauksaite, Vita; Vakeel, Padmanabhan; Klaassen, Sabine; Gerull, Brenda; Thierfelder, Ludwig; Regitz-Zagrosek, Vera; Hacker, Timothy A.; Saupe, Kurt W.; Dec, G. William; Ellinor, Patrick T.; MacRae, Calum A.; Spallek, Bastian; Fischer, Robert; Perrot, Andreas; Oezcelik, Cemil; Saar, Kathrin; Hubner, Norbert; Gotthardt, Michael			RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing	NATURE MEDICINE			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; RNA-BINDING PROTEINS; ISOFORM EXPRESSION; PASSIVE STIFFNESS; HEART-FAILURE; SR PROTEINS; DISEASE; MUTATIONS; RAT; MYOCARDIUM	Alternative splicing has a major role in cardiac adaptive responses, as exemplified by the isoform switch of the sarcomeric protein titin, which adjusts ventricular filling. By positional cloning using a previously characterized rat strain with altered titin mRNA splicing, we identified a loss-of-function mutation in the gene encoding RNA binding motif protein 20 (Rbm20) as the underlying cause of pathological titin isoform expression. The phenotype of Rbm20-deficient rats resembled the pathology seen in individuals with dilated cardiomyopathy caused by RBM20 mutations. Deep sequencing of the human and rat cardiac transcriptome revealed an RBM20-dependent regulation of alternative splicing. In addition to titin (TTN), we identified a set of 30 genes with conserved splicing regulation between humans and rats. This network is enriched for genes that have previously been linked to cardiomyopathy, ion homeostasis and sarcomere biology. Our studies emphasize the key role of post-transcriptional regulation in cardiac function and provide mechanistic insights into the pathogenesis of human heart failure.	[Schafer, Sebastian; Radke, Michael H.; Liss, Martin; Govindarajan, Thirupugal; Maatz, Henrike; Schulz, Herbert; Dauksaite, Vita; Vakeel, Padmanabhan; Klaassen, Sabine; Gerull, Brenda; Thierfelder, Ludwig; Saar, Kathrin; Hubner, Norbert; Gotthardt, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Guo, Wei; Greaser, Marion L.; Li, Shijun; Parrish, Amanda M.] Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA; [Regitz-Zagrosek, Vera] Univ Med Berlin, Charite, Cardiovasc Res Ctr, Berlin, Germany; [Regitz-Zagrosek, Vera] Univ Med Berlin, Charite, Inst Gender Med, Berlin, Germany; [Hacker, Timothy A.; Saupe, Kurt W.] Univ Wisconsin, Dept Med, Madison, WI USA; [Dec, G. William; Ellinor, Patrick T.; MacRae, Calum A.] Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA USA; [Spallek, Bastian; Fischer, Robert] Univ Med Berlin, Charite, Univ Kilikum Benjamin Franklin, Berlin, Germany; [Perrot, Andreas; Oezcelik, Cemil] Charite, Campus Virchow Klinikum, Dept Cardiol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wisconsin System; University of Wisconsin Madison; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gotthardt, M (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	gotthardt@mdc-berlin.de	Gotthardt, Michael/ABE-8274-2021; Govindarajan, Thirupugal/A-8758-2015; Govindarajan, Thirupugal/ABF-9464-2020; Greaser, Marion L/C-6147-2012	Gotthardt, Michael/0000-0003-1788-3172; Govindarajan, Thirupugal/0000-0003-2660-9730; Govindarajan, Thirupugal/0000-0003-2660-9730; Greaser, Marion L/0000-0002-6583-9566; Govindarajan, Thirupugal/0000-0003-1714-1267; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Radke, Michael/0000-0003-0112-9917; Liss, Martin/0000-0002-0585-7850; Perrot, Andreas/0000-0002-8800-342X; Saar, Kathrin/0000-0002-4483-1557; Klaassen, Sabine/0000-0001-5925-9912; Ellinor, Patrick/0000-0002-2067-0533; Schafer, Sebastian/0000-0002-6909-8275	US National Institutes of Health [HL77196, HL075431]; Deutsche Forschungsgemeinschaft, Bonn, Germany; European Research Council [StG282078]; German Ministry of Science and Education (Nationales Genomforschungsnetz, NGFN-Plus Heart Failure Network) and EURATRANS [HEALTH-F4-2010-241504]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431, R01HL077196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Ministry of Science and Education (Nationales Genomforschungsnetz, NGFN-Plus Heart Failure Network) and EURATRANS; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to B. Goldbrich, O. Hummel, S. Lubitz, S. Makino, G. Patone, S. Blachut, R. Plehm, S. Probst, S. Schmidt and M. Wehle for expert technical assistance. R. Hetzer (Deutsches Herzzentrum Berlin) generously provided human cardiac tissue. Mammalian expression vectors for PTBP1 and HuD were gifts from R. Darnell, The Rockefeller University. This work was supported by the US National Institutes of Health grants HL77196 (M.L.G.) and HL075431 (C.A.M.), the Deutsche Forschungsgemeinschaft, Bonn, Germany and the European Research Council grant StG282078 (M.G.), the German Ministry of Science and Education (Nationales Genomforschungsnetz, NGFN-Plus Heart Failure Network) and EURATRANS (HEALTH-F4-2010-241504) (N.H.) and the American Heart Association (P.T.E.).	Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chaturvedi RR, 2010, CIRCULATION, V121, P979, DOI 10.1161/CIRCULATIONAHA.109.850677; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Feng Y, 2009, DEV CELL, V16, P528, DOI 10.1016/j.devcel.2009.02.009; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Greaser ML, 2005, J MUSCLE RES CELL M, V26, P325, DOI 10.1007/s10974-005-9039-0; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kruger M, 2008, CIRC RES, V102, P439, DOI 10.1161/CIRCRESAHA.107.162719; Kruger M, 2010, J MOL CELL CARDIOL, V48, P910, DOI 10.1016/j.yjmcc.2010.02.012; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Okano HJ, 1997, J NEUROSCI, V17, P3024; Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Tang ZZ, 2011, J BIOL CHEM, V286, P10007, DOI 10.1074/jbc.M110.208116; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang D, 2006, PHARMACOGENET GENOM, V16, P735, DOI 10.1097/01.fpc.0000230119.34205.8a; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; Williams L, 2009, CLIN SCI, V117, P237, DOI 10.1042/CS20080248; Wu YM, 2007, J MOL CELL CARDIOL, V42, P186, DOI 10.1016/j.yjmcc.2006.09.017; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	51	326	339	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					766	U162		10.1038/nm.2693	http://dx.doi.org/10.1038/nm.2693			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22466703	Green Accepted			2022-12-27	WOS:000303763500044
J	Gulbransen, BD; Bashashati, M; Hirota, SA; Gui, XY; Roberts, JA; MacDonald, JA; Muruve, DA; Mckay, DM; Beck, PL; Mawe, GM; Thompson, RJ; Sharkey, KA				Gulbransen, Brian D.; Bashashati, Mohammad; Hirota, Simon A.; Gui, Xianyong; Roberts, Jane A.; MacDonald, Justin A.; Muruve, Daniel A.; Mckay, Derek M.; Beck, Paul L.; Mawe, Gary M.; Thompson, Roger J.; Sharkey, Keith A.			Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis	NATURE MEDICINE			English	Article							MYENTERIC NEURONS; P2X(7) RECEPTORS; ATP; RELEASE; GLIA; INNERVATION; STIMULATION; INHIBITION; RECOVERY; MOTILITY	Inflammatory bowel diseases (IBDs) are chronic relapsing and remitting conditions associated with long-term gut dysfunction resulting from alterations to the enteric nervous system and a loss of enteric neurons(1,2). The mechanisms underlying inflammation-induced enteric neuron death are unknown. Here using in vivo models of experimental colitis we report that inflammation causes enteric neuron death by activating a neuronal signaling complex composed of P2X7 receptors (P2X7Rs), pannexin-1 (Panx1) channels, the Asc adaptor protein and caspases. Inhibition of P2X7R, Panx1, Asc or caspase activity prevented inflammation-induced neuron cell death. Preservation of enteric neurons by inhibiting Panx1 in vivo prevented the onset of inflammation-induced colonic motor dysfunction. Panx1 expression was reduced in Crohn's disease but not ulcerative colitis. We conclude that activation of neuronal Panx1 underlies neuron death and the subsequent development of abnormal gut motility in IBD. Targeting Panx1 represents a new neuroprotective strategy to ameliorate the progression of IBD-associated dysmotility.	[Gulbransen, Brian D.; Bashashati, Mohammad; Thompson, Roger J.; Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Gulbransen, Brian D.; Bashashati, Mohammad; Mckay, Derek M.; Sharkey, Keith A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Gulbransen, Brian D.; Bashashati, Mohammad; Hirota, Simon A.; MacDonald, Justin A.; Muruve, Daniel A.; Mckay, Derek M.; Beck, Paul L.; Sharkey, Keith A.] Univ Calgary, Snyder Inst Infect Immun & Inflammat, Calgary, AB, Canada; [Hirota, Simon A.; Muruve, Daniel A.; Beck, Paul L.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hirota, Simon A.; MacDonald, Justin A.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Hirota, Simon A.; MacDonald, Justin A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Gui, Xianyong] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Roberts, Jane A.; Mawe, Gary M.] Univ Vermont Coll Med, Dept Anat & Neurobiol, Burlington, VT USA; [Thompson, Roger J.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary; University of Vermont; University of Calgary	Gulbransen, BD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	bgulbran@ucalgary.ca; ksharkey@ucalgary.ca	McKay, Derek/HCH-3240-2022; Thompson, Roger/L-3930-2016	Thompson, Roger/0000-0002-7019-7246; Sharkey, Keith/0000-0001-9560-1711; MacDonald, Justin/0000-0002-9238-8473; Gulbransen, Brian/0000-0003-1145-3227	Canadian Institutes of Health Research (CIHR); Crohn's & Colitis Foundation of Canada (CCFC); US National Institutes of Health [DK62267]; Canadian Foundation for Innovation; Alberta Science and Research Authority; Canadian Association of Gastroenterology/CIHR; Alberta Innovates-Health Solutions (AI-HS)/CCFC; AI-HS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062267] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Crohn's & Colitis Foundation of Canada (CCFC); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Science and Research Authority; Canadian Association of Gastroenterology/CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS)/CCFC; AI-HS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR, to K.A.S., R.J.T. and D.M.M.), the Crohn's & Colitis Foundation of Canada (CCFC to D.M.M.) and US National Institutes of Health grant DK62267 (to G.M.M.). Some of the equipment used in the study was provided by funds from the Canadian Foundation for Innovation and the Alberta Science and Research Authority. B.D.G. holds fellowships from the Canadian Association of Gastroenterology/CIHR and Alberta Innovates-Health Solutions (AI-HS)/CCFC. K.A.S. is an AI-HS Medical Scientist and holds the CCFC Chair in IBD Research at the University of Calgary. R.J.T. is an AI-HS Scholar. P.L.B. is supported by AI-HS, CIHR and CCFC. J.A.M. is an AI-HS Senior Scholar and Canada Research Chair. D.M.M. is an AI-HS Scientist and holds a Canada Research Chair (Tier 1). S.A.H. holds fellowships from CIHR and AI-HS. We thank C. MacNaughton, W. Ho and A. Wang for technical support, D.M. McCafferty (University of Calgary) for providing Il10<SUP>-/-</SUP> mice, V. Dixit (Genentech) and J. Tschopp (University of Lausanne) for providing male Pycard<SUP>-/-</SUP> and Nlrp3<SUP>-/-</SUP> mice, respectively, N. Hyman (University of Vermont), O. Bathe (University of Calgary) and the IBD Tissue Bank for providing human tissue samples and J. Bains for reviewing and commenting on the manuscript.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bossone C, 2001, AM J PHYSIOL-GASTR L, V280, pG949, DOI 10.1152/ajpgi.2001.280.5.G949; Cavaliere F, 2004, J CEREBR BLOOD F MET, V24, P392, DOI 10.1097/00004647-200404000-00004; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; De Giorgio R, 2004, GASTROENTEROLOGY, V126, P1872, DOI 10.1053/j.gastro.2004.02.024; Depoortere I, 2002, BRIT J PHARMACOL, V135, P2011, DOI 10.1038/sj.bjp.0704648; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gomes P, 2009, NEUROGASTROENT MOTIL, V21, P870, DOI 10.1111/j.1365-2982.2009.01302.x; Gulbransen BD, 2010, J NEUROSCI, V30, P6801, DOI 10.1523/JNEUROSCI.0603-10.2010; Gulbransen BD, 2009, GASTROENTEROLOGY, V136, P1349, DOI 10.1053/j.gastro.2008.12.058; Guzman J, 2006, INFLAMM BOWEL DIS, V12, P766, DOI 10.1097/00054725-200608000-00014; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Krauter EM, 2007, NEUROGASTROENT MOTIL, V19, P990, DOI 10.1111/j.1365-2982.2007.00986.x; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Lomax AE, 2005, J PHYSIOL-LONDON, V564, P863, DOI 10.1113/jphysiol.2005.084285; Mawe GM, 2009, NEUROGASTROENT MOTIL, V21, P481, DOI 10.1111/j.1365-2982.2009.01291.x; McCafferty DM, 2000, AM J PHYSIOL-GASTR L, V279, pG90, DOI 10.1152/ajpgi.2000.279.1.G90; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; Rybaczyk L, 2009, INFLAMM BOWEL DIS, V15, P971, DOI 10.1002/ibd.20893; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; Strong DS, 2010, J PHYSIOL-LONDON, V588, P847, DOI 10.1113/jphysiol.2009.185082; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wynn G, 2004, AM J PHYSIOL-GASTR L, V287, pG647, DOI 10.1152/ajpgi.00020.2004; Yiangou Y, 2001, NEUROGASTROENT MOTIL, V13, P365, DOI 10.1046/j.1365-2982.2001.00276.x; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052	38	288	298	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					600	604		10.1038/nm.2679	http://dx.doi.org/10.1038/nm.2679			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426419	Green Accepted			2022-12-27	WOS:000302617800038
J	Yui, SR; Nakamura, T; Sato, T; Nemoto, Y; Mizutani, T; Zheng, X; Ichinose, S; Nagaishi, T; Okamoto, R; Tsuchiya, K; Clevers, H; Watanabe, M				Yui, Shiro; Nakamura, Tetsuya; Sato, Toshiro; Nemoto, Yasuhiro; Mizutani, Tomohiro; Zheng, Xiu; Ichinose, Shizuko; Nagaishi, Takashi; Okamoto, Ryuichi; Tsuchiya, Kiichiro; Clevers, Hans; Watanabe, Mamoru			Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell	NATURE MEDICINE			English	Article							INTESTINAL EPITHELIUM; SELF-RENEWAL; R-SPONDIN1; GROWTH; REGENERATION; INHIBITION; RECEPTORS; SIGNALS; LRP6; MICE	Adult stem-cell therapy holds promise for the treatment of gastrointestinal diseases. Here we describe methods for long-term expansion of colonic stem cells positive for leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5(+) cells) in culture. To test the transplantability of these cells, we reintroduced cultured GFP(+) colon organoids into superficially damaged mouse colon. The transplanted donor cells readily integrated into the mouse colon, covering the area that lacked epithelium as a result of the introduced damage in recipient mice. At 4 weeks after transplantation, the donor-derived cells constituted a single-layered epithelium, which formed self-renewing crypts that were functionally and histologically normal. Moreover, we observed long-term (>6 months) engraftment with transplantation of organoids derived from a single Lgr5(+) colon stem cell after extensive in vitro expansion. These data show the feasibility of colon stem-cell therapy based on the in vitro expansion of a single adult colonic stem cell.	[Sato, Toshiro; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Sato, Toshiro; Clevers, Hans] Univ Med Ctr, Utrecht, Netherlands; [Yui, Shiro; Nemoto, Yasuhiro; Mizutani, Tomohiro; Zheng, Xiu; Nagaishi, Takashi; Tsuchiya, Kiichiro; Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Grad Sch, Bunkyo Ku, Tokyo, Japan; [Nakamura, Tetsuya; Okamoto, Ryuichi] Tokyo Med & Dent Univ, Dept Adv Therapeut Gastrointestinal Dis, Bunkyo Ku, Tokyo, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.	h.clevers@hubrecht.eu; mamoru.gast@tmd.ac.jp	Watanabe, Mamoru/AHE-0489-2022; Mizutani, Tomohiro/AAX-5650-2021; Sato, Toshiro/J-3522-2014; Tsuchiya, Kiichiro/AAB-1769-2020; Okamoto, Ryuichi/I-1130-2019	Mizutani, Tomohiro/0000-0002-8373-7969; Sato, Toshiro/0000-0001-8353-8137; Tsuchiya, Kiichiro/0000-0002-1977-8707; Okamoto, Ryuichi/0000-0002-7047-571X; Yui, Shiro/0000-0003-4268-647X	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan; European Research Council; Dutch Cancer Foundation; Grants-in-Aid for Scientific Research [21590803, 24112508, 24390186, 22590696, 21590806] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Foundation(KWF Kankerbestrijding); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okabe (Osaka University) for EGFP transgenic mice and Y. Kato, J. Inazawa, I. Sekiya (TMDU), H. Snippert and R. Vries (Hubrecht Institute) for technical assistance. This study was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, by the Health and Labour Sciences Research Grants for Research on Intractable Diseases from Ministry of Health, Labour and Welfare of Japan, and by a grant from the European Research Council and from the Dutch Cancer Foundation.	Avansino JR, 2006, J SURG RES, V132, P74, DOI 10.1016/j.jss.2005.09.009; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Booth C, 1995, EPITHELIAL CELL BIOL, V4, P76; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kanayama M, 2007, AM J PHYSIOL-GASTR L, V293, pG230, DOI 10.1152/ajpgi.00068.2007; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tahara Y, 2003, J PHARMACOL EXP THER, V307, P146, DOI 10.1124/jpet.103.054106; TAIT IS, 1994, AM J SURG, V167, P67, DOI 10.1016/0002-9610(94)90055-8; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	34	495	532	3	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					618	623		10.1038/nm.2695	http://dx.doi.org/10.1038/nm.2695			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22406745				2022-12-27	WOS:000302617800041
J	Xia, DR; Wang, DZ; Kim, SH; Katoh, H; DuBois, RN				Xia, Dianren; Wang, Dingzhi; Kim, Sun-Hee; Katoh, Hiroshi; DuBois, Raymond N.			Prostaglandin E-2 promotes intestinal tumor growth via DNA methylation	NATURE MEDICINE			English	Article							METHYLTRANSFERASE EXPRESSION; CPG; HYPOMETHYLATION; PHENOTYPE; CANCER	Although aberrant DNA methylation is considered to be one of the key ways by which tumor-suppressor and DNA-repair genes are silenced during tumor initiation and progression, the mechanisms underlying DNA methylation alterations in cancer remain unclear. Here we show that prostaglandin E-2 (PGE(2)) silences certain tumor-suppressor and DNA-repair genes through DNA methylation to promote tumor growth. These findings uncover a previously unrecognized role for PGE(2) in the promotion of tumor progression.	[Xia, Dianren; Wang, Dingzhi; Kim, Sun-Hee; Katoh, Hiroshi; DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	DuBois, RN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	rdubois@mdanderson.org	DuBois, Raymond N./AAX-8869-2020; Kim, Sun/GSN-4867-2022		US National Institutes of Health MERIT [R37 DK47297, RO1 DK62112, NCI P01 CA77839, CPRIT RP100960]; National Colorectal Cancer Research Alliance (NCCRA); National Cancer Institute [R25T CA57730]; NATIONAL CANCER INSTITUTE [P01CA077839, R25CA057730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047297, R01DK062112] Funding Source: NIH RePORTER	US National Institutes of Health MERIT; National Colorectal Cancer Research Alliance (NCCRA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Menter and P. Yang for their suggestions and help in the measurement of PGE<INF>2</INF>. This work is supported, in part, by the US National Institutes of Health MERIT award grants R37 DK47297, RO1 DK62112, NCI P01 CA77839 and CPRIT RP100960. We also thank the National Colorectal Cancer Research Alliance (NCCRA) for its generous support (R.N.D.) and a cancer prevention fellowship (D.X.) supported by the National Cancer Institute grant R25T CA57730 (principal investigator, S. Chang).	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Baba Y, 2010, CANCER EPIDEM BIOMAR, V19, P822, DOI 10.1158/1055-9965.EPI-09-1154; De Marzo AM, 1999, CANCER RES, V59, P3855; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Lin HJ, 2006, MOL CELL BIOL, V26, P2976, DOI 10.1128/MCB.26.8.2976-2983.2006; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Schmidt WM, 2007, MOL CARCINOGEN, V46, P766, DOI 10.1002/mc.20307; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809	20	128	129	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					224	226		10.1038/nm.2608	http://dx.doi.org/10.1038/nm.2608			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270723	Green Accepted			2022-12-27	WOS:000300140300035
J	Avci, FY; Li, XM; Tsuji, M; Kasper, DL				Avci, Fikri Y.; Li, Xiangming; Tsuji, Moriya; Kasper, Dennis L.			A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design	NATURE MEDICINE			English	Article							INFLUENZAE TYPE-B; T-CELL RECOGNITION; CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CARRIER PROTEIN; MHCII PATHWAY; POLYSACCHARIDE; ANTIGEN; IMMUNOGENICITY; GLYCOPEPTIDE	Glycoconjugate vaccines have provided enormous health benefits globally, but they have been less successful in some populations at high risk for developing disease. To identify new approaches to enhancing glycoconjugate effectiveness, we investigated molecular and cellular mechanisms governing the immune response to a prototypical glycoconjugate vaccine. We found that in antigen-presenting cells a carbohydrate epitope is generated upon endolysosomal processing of group B streptococcal type III polysaccharide coupled to a carrier protein. In conjunction with a carrier protein-derived peptide, this carbohydrate epitope binds major histocompatibility class II (MHCII) and stimulates carbohydrate-specific CD4(+) T cell clones to produce interleukins 2 and 4-cytokines essential for providing T cell help to antibody-producing B cells. An archetypical glycoconjugate vaccine that we constructed to maximize the presentation of carbohydrate-specific T cell epitopes is 50-100 times more potent and substantially more protective in a neonatal mouse model of group B Streptococcus infection than a vaccine constructed by methods currently used by the vaccine industry. Our discovery of how glycoconjugates are processed resulting in presentation of carbohydrate epitopes that stimulate CD4(+) T cells has key implications for glycoconjugate vaccine design that could result in greatly enhanced vaccine efficacy.	[Avci, Fikri Y.; Kasper, Dennis L.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; [Avci, Fikri Y.; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Li, Xiangming; Tsuji, Moriya] Rockefeller Univ, HIV & Malaria Vaccine Program, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University	Kasper, DL (corresponding author), Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu		Avci, Fikri/0000-0002-1902-7532; Tsuji, Moriya/0000-0001-8587-277X	US National Institutes of Health [AI-089915, AI-070258, AI-081510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089915, R56AI070258, R01AI070258, R01AI081510] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Reinap and S. Mascuch for their valuable technical assistance and L. Paoletti for his advice. We also thank J. McCoy for her outstanding editorial assistance and T. DiCesare for his excellent artwork. This work was supported by funding from the following grants: US National Institutes of Health AI-089915, AI-070258 and AI-081510.	AbdelMotal UM, 1996, EUR J IMMUNOL, V26, P544, DOI 10.1002/eji.1830260307; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Barrett D J, 1985, Adv Pediatr, V32, P139; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; BEUVERY EC, 1982, INFECT IMMUN, V37, P15, DOI 10.1128/IAI.37.1.15-22.1982; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Colino J, 2009, J IMMUNOL, V183, P1551, DOI 10.4049/jimmunol.0900238; COUTINHO A, 1973, NATURE-NEW BIOL, V245, P12, DOI 10.1038/newbio245012a0; DECK B, 1995, J IMMUNOL, V155, P1074; DeNardo GL, 2008, CANCER BIOTHER RADIO, V23, P783, DOI 10.1089/cbr.2008.0589; Duan JY, 2008, P NATL ACAD SCI USA, V105, P5183, DOI 10.1073/pnas.0800974105; Dzhambazov B, 2005, EUR J IMMUNOL, V35, P357, DOI 10.1002/eji.200425637; Gad M, 2002, GLYCOCONJUGATE J, V19, P59, DOI 10.1023/A:1022537031617; GalliStampino L, 1997, CANCER RES, V57, P3214; GREENBERG DP, 1995, J PEDIATR-US, V126, P206, DOI 10.1016/S0022-3476(95)70546-5; Guttormsen HK, 1998, INFECT IMMUN, V66, P2026, DOI 10.1128/IAI.66.5.2026-2032.1998; Guttormsen HK, 1999, INFECT IMMUN, V67, P6375; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Haurum JS, 1995, EUR J IMMUNOL, V25, P3270, DOI 10.1002/eji.1830251211; Hitzel C, 1999, J IMMUNOL, V162, P4671; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; JANEWAY CA, 2005, IMMUNOBIOLOGY, pCH9; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; Kamboj KK, 2003, J INFECT DIS, V187, P1629, DOI 10.1086/374785; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Lai ZZ, 2009, VACCINE, V27, P3137, DOI 10.1016/j.vaccine.2009.03.064; Leonard EG, 2003, INFECT IMMUN, V71, P4186, DOI 10.1128/IAI.71.7.4186-4189.2003; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MOURITSEN S, 1994, EUR J IMMUNOL, V24, P1066, DOI 10.1002/eji.1830240509; Paoletti LC, 1999, J INFECT DIS, V180, P892, DOI 10.1086/314955; PAOLETTI LC, 1994, INFECT IMMUN, V62, P3236, DOI 10.1128/IAI.62.8.3236-3243.1994; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361; SHIMOJO N, 1994, INT ARCH ALLERGY IMM, V105, P155, DOI 10.1159/000236818; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; TSUJI M, 1990, J EXP MED, V172, P1353, DOI 10.1084/jem.172.5.1353; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Tsuji Moriya, 2002, Methods Mol Med, V72, P361, DOI 10.1385/1-59259-271-6:361; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; WESSELS MR, 1993, INFECT IMMUN, V61, P4760, DOI 10.1128/IAI.61.11.4760-4766.1993; WESSELS MR, 1990, J CLIN INVEST, V86, P1428, DOI 10.1172/JCI114858	46	231	247	1	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1602	U115		10.1038/nm.2535	http://dx.doi.org/10.1038/nm.2535			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101769	Green Accepted, Bronze			2022-12-27	WOS:000297978000031
J	Coffman, TM				Coffman, Thomas M.			Under pressure: the search for the essential mechanisms of hypertension	NATURE MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; II-INDUCED HYPERTENSION; BLOOD-PRESSURE; ANGIOTENSIN-II; COMMON VARIANTS; T-CELL; DISEASE; MUTATIONS; RECEPTORS; SODIUM	High blood pressure, or hypertension, is a very common disorder with a substantial impact on public health because of its associated complications. Despite the high prevalence of essential hypertension and years of research, the basic causes remain obscure. Here I review recent advances in understanding the pathophysiology of hypertension. I present a general overview of the field and, by necessity, use broad strokes to portray recent progress and place it in context. For this purpose, I use illustrative examples from the large number of important developments in hypertension research over the last five years. The intent of this review is to provide a sense of where the field is progressing, with an emphasis on work that sheds light on pathogenic mechanisms and that is therefore likely to inform new translational advances.	[Coffman, Thomas M.] Duke Univ, Dept Med, Div Nephrol, Cardiovasc Res Ctr, Durham, NC 27708 USA; [Coffman, Thomas M.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Coffman, Thomas M.] Duke Natl Univ Singapore Grad Med Sch, Cardiovasc & Metab Disorders Res Program, Singapore, Singapore	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Coffman, TM (corresponding author), Duke Univ, Dept Med, Div Nephrol, Cardiovasc Res Ctr, Durham, NC 27708 USA.	tcoffman@duke.edu			US National Institutes of Health [HL056122]; Veteran's Affairs Research Administration; Edna and Fred L. Mandel Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056122] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Research Administration; Edna and Fred L. Mandel Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The author's work in this area has been supported by the US National Institutes of Health (HL056122), the Veteran's Affairs Research Administration and the Edna and Fred L. Mandel Jr. Foundation.	[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Auchus RJ, 2001, ENDOCRIN METAB CLIN, V30, P101, DOI 10.1016/S0889-8529(08)70021-5; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Crowley S., 2009, AM J PHYSIOL-REG I, V298, pR1089; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Ge YQ, 2006, AM J PHYSIOL-RENAL, V291, pF1274, DOI 10.1152/ajprenal.00190.2006; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li H., 2011, AM J PHYSIOL-REG I, V298, pR1209; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Rettig R, 2005, HYPERTENSION, V46, P463, DOI 10.1161/01.HYP.0000178189.68229.8a; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666	44	200	207	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1402	1409		10.1038/nm.2541	http://dx.doi.org/10.1038/nm.2541			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064430				2022-12-27	WOS:000296779300031
J	Chang, SH; Wang, RH; Akagi, K; Kim, KA; Martin, BK; Cavallone, L; Haines, DC; Basik, M; Mai, P; Poggi, E; Isaacs, C; Looi, LM; Mun, KS; Greene, MH; Byers, SW; Teo, SH; Deng, CX; Sharan, SK				Chang, Suhwan; Wang, Rui-Hong; Akagi, Keiko; Kim, Kyung-Ae; Martin, Betty K.; Cavallone, Luca; Haines, Diana C.; Basik, Mark; Mai, Phuong; Poggi, Elizabeth; Isaacs, Claudine; Looi, Lai M.; Mun, Kein S.; Greene, Mark H.; Byers, Stephen W.; Teo, Soo H.; Deng, Chu-Xia; Sharan, Shyam K.		Kathleen Cuningham Fdn Consortium	Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155	NATURE MEDICINE			English	Article							CELL-CYCLE CHECKPOINT; DNA-DAMAGE RESPONSE; BREAST-CANCER; LIGASE ACTIVITY; HIGH EXPRESSION; STEM-CELLS; IN-VIVO; C-MYC; PROTEIN; GENE	BRCA1, a well-known tumor suppressor with multiple interacting partners, is predicted to have diverse biological functions. However, so far its only well-established role is in the repair of damaged DNA and cell cycle regulation. In this regard, the etiopathological study of low-penetrant variants of BRCA1 provides an opportunity to uncover its other physiologically important functions. Using this rationale, we studied the R1699Q variant of BRCA1, a potentially moderate-risk variant, and found that it does not impair DNA damage repair but abrogates the repression of microRNA-155 (miR-155), a bona fide oncomir. Mechanistically, we found that BRCA1 epigenetically represses miR-155 expression via its association with HDAC2, which deacetylates histones H2A and H3 on the miR-155 promoter. We show that overexpression of miR-155 accelerates but the knockdown of miR-155 attenuates the growth of tumor cell lines in vivo. Our findings demonstrate a new mode of tumor suppression by BRCA1 and suggest that miR-155 is a potential therapeutic target for BRCA1-deficient tumors.	[Sharan, Shyam K.; Kathleen Cuningham Fdn Consortium] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Chang, Suhwan; Kim, Kyung-Ae] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Wang, Rui-Hong; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, Bethesda, MD USA; [Akagi, Keiko] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol, Columbus, OH 43210 USA; [Akagi, Keiko] Ohio State Univ, Human Canc Genet Program, Dept Immunol, Columbus, OH 43210 USA; [Akagi, Keiko] Ohio State Univ, Human Canc Genet Program, Dept Med Genet, Columbus, OH 43210 USA; [Martin, Betty K.] NCI, Sci Applicat Int Corp SAIC Frederick, Frederick, MD 21701 USA; [Cavallone, Luca; Basik, Mark] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Cavallone, Luca] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Cavallone, Luca] McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Haines, Diana C.] NCI, Pathol Histotechnol Lab, SAIC Frederick, Frederick, MD 21701 USA; [Mai, Phuong; Greene, Mark H.] NCI, Clin Genet Branch, Rockville, MD USA; [Poggi, Elizabeth; Isaacs, Claudine; Byers, Stephen W.] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA; [Looi, Lai M.; Mun, Kein S.] Univ Malaya, Dept Pathol, Med Ctr, Kuala Lumpur, Malaysia; [Teo, Soo H.] Univ Malaya, Med Ctr, Dept Surg, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia; [Teo, Soo H.] Sime Darby Med Ctr, Canc Res Initiat Fdn, Kuala Lumpur, Malaysia	Peter Maccallum Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Lady Davis Institute; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; Universiti Malaya; Universiti Malaya	Sharan, SK (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	sharans@mail.nih.gov	Looi, Lai Meng/A-3382-2009; Teo, Soo-hwang/H-2353-2014; deng, chuxia/N-6713-2016; Looi, Lai Meng/AAB-9403-2019; Mun, Kein Seong/E-4155-2010	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Chang, Suhwan/0000-0002-0282-0120; Thorne, Heather/0000-0003-3610-2511	Center for Cancer Research, US National Cancer Institute; US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010144, ZIABC011181, ZIABC010387] Funding Source: NIH RePORTER	Center for Cancer Research, US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Acharya, K. Biswas, R. Chittela, I. Daar, K. Reilly and A. Spurdle for helpful discussions and critical review of the manuscript. We also thank D. M. Livingston (Dana-Farber Cancer Institute) and D. L. Turner (University of Michigan) for providing DNA constructs; D. Swing for help with BAC transgenic mice and allograft experiment; W. D. Foulkes, A. Spurdle, H. Thorne, Y.C. Har, P.S. Yee, A. Saleh, the Georgetown-Lombardi Comprehensive Cancer Center, Familial Cancer and Histopathology and Tissue Share Resources, who helped with the human tumor samples; S. Burkett for cytogenetic analysis; C. H. Kim for microarray analysis, and A. Kane and R. Frederickson for illustrations. The research was sponsored by the Center for Cancer Research, US National Cancer Institute and US National Institutes of Health.	Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Cable PL, 2003, MOL CARCINOGEN, V38, P85, DOI 10.1002/mc.10148; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chen JJ, 2000, CANCER RES, V60, P5037; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Garcia EBG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2223; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lovelock PK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1826; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016841; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	46	169	178	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1275	U308		10.1038/nm.2459	http://dx.doi.org/10.1038/nm.2459			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946536	Green Accepted			2022-12-27	WOS:000296022100046
J	Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; Paliege, A; Howie, AJ; Conley, J; Bachmann, S; Unwin, RJ; Ellison, DH				Hoorn, Ewout J.; Walsh, Stephen B.; McCormick, James A.; Fuerstenberg, Antje; Yang, Chao-Ling; Roeschel, Tom; Paliege, Alexander; Howie, Alexander J.; Conley, James; Bachmann, Sebastian; Unwin, Robert J.; Ellison, David H.			The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension	NATURE MEDICINE			English	Article							KIDNEY-TRANSPLANTATION; ALTERED EXPRESSION; CL-COTRANSPORTER; DOWN-REGULATION; FOLLOW-UP; CYCLOSPORINE; IMMUNOSUPPRESSION; NEPHROPATHY; MECHANISMS; RECIPIENTS	Calcineurin inhibitors (CNIs) are immunosuppressive drugs that are used widely to prevent rejection of transplanted organs and to treat autoimmune disease. Hypertension and renal tubule dysfunction, including hyperkalemia, hypercalciuria and acidosis, often complicate their use(1,2). These side effects resemble familial hyperkalemic hypertension, a genetic disease characterized by overactivity of the renal sodium chloride cotransporter (NCC) and caused by mutations in genes encoding WNK kinases. We hypothesized that CNIs induce hypertension by stimulating NCC. In wild-type mice, the CNI tacrolimus caused salt-sensitive hypertension and increased the abundance of phosphorylated NCC and the NCC-regulatory kinases WNK3, WNK4 and SPAK. We demonstrated the functional importance of NCC in this response by showing that tacrolimus did not affect blood pressure in NCC-knockout mice, whereas the hypertensive response to tacrolimus was exaggerated in mice overexpressing NCC. Moreover, hydrochlorothiazide, an NCC-blocking drug, reversed tacrolimus-induced hypertension. These observations were extended to humans by showing that kidney transplant recipients treated with tacrolimus had a greater fractional chloride excretion in response to bendroflumethiazide, another NCC-blocking drug, than individuals not treated with tacrolimus; renal NCC abundance was also greater. Together, these findings indicate that tacrolimus-induced chronic hypertension is mediated largely by NCC activation, and suggest that inexpensive and well-tolerated thiazide diuretics may be especially effective in preventing the complications of CNI treatment.	[Hoorn, Ewout J.; McCormick, James A.; Yang, Chao-Ling; Conley, James; Ellison, David H.] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA; [Walsh, Stephen B.; Fuerstenberg, Antje; Unwin, Robert J.] UCL, UCL Ctr Nephrol, London, England; [Roeschel, Tom; Paliege, Alexander; Bachmann, Sebastian] Charite, Dept Anat, Berlin, Germany; [Howie, Alexander J.] UCL, Dept Pathol, London, England; [Ellison, David H.] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA	Oregon Health & Science University; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; University College London; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ellison, DH (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA.	ellisond@ohsu.edu	McCormick, James A/A-9121-2010; , David/X-5730-2019; Walsh, Stephen Benedict/AAB-9930-2020; Hoorn, Ewout/S-4135-2019	Hoorn, Ewout/0000-0002-8738-3571; Paliege, Alexander/0000-0001-5092-5472; Ellison, David/0000-0003-2915-265X; McCormick, James/0000-0003-4000-6653; Walsh, Stephen/0000-0002-8693-1353	Erasmus Medical Center; Dutch Kidney Foundation [KJPB 08.004]; US National Institutes of Health (NIH) [K01 DK076617]; NIH [RO1 DK51496]; Department of Veterans Affairs; American Heart Association [10 GRNT 2630199]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051496, T32DK067864, K01DK076617] Funding Source: NIH RePORTER	Erasmus Medical Center; Dutch Kidney Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	For technical assistance, we thank N. Desmerais (animal studies), S. Rogers, K. Risowsky (immunohistochemistry), D. Gannon and A. Bakke (tacrolimus measurements in mice). We thank G. Jones and M. Harber for help in identifying human subjects. We also thank G. Shull (University of Cincinnati) for the NCC-knockout mice, and E. Delpire (Vanderbilt Kennedy Center) for SPAK antibodies. E.J.H. is supported by an Erasmus Medical Center Fellowship and Kolff Junior Postdoc Grant (Dutch Kidney Foundation, KJPB 08.004); J.A.M. is supported by the US National Institutes of Health (NIH) (K01 DK076617); D. H. E. is supported by the NIH (RO1 DK51496), the Department of Veterans Affairs (Merit Review) and the American Heart Association (10 GRNT 2630199). Portions of this work were presented at the High Blood Pressure Research Council Meeting of the American Heart Association, 13-16 October 2010, and the American Society of Nephrology, 15-18 November 2010.	ADU D, 1983, LANCET, V2, P370; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Arthur JM, 2000, KIDNEY INT, V58, P325, DOI 10.1046/j.1523-1755.2000.00169.x; Calo L, 2002, KIDNEY INT, V61, P353, DOI 10.1046/j.1523-1755.2002.00128.x; Calo L, 2000, CRIT REV CL LAB SCI, V37, P503, DOI 10.1080/10408360091174295; Colussi G, 2007, CLIN J AM SOC NEPHRO, V2, P454, DOI 10.2215/CJN.02950906; CURTIS JJ, 1988, AM J MED, V85, P134; Curtis JJ, 2002, CURR HYPERTENS REP, V4, P377, DOI 10.1007/s11906-002-0067-5; Esteva-Font C, 2007, NEPHROL DIAL TRANSPL, V22, P2810, DOI 10.1093/ndt/gfm390; Feng MJ, 2009, HYPERTENSION, V54, P802, DOI 10.1161/HYPERTENSIONAHA.109.134569; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Heering PJ, 2004, CLIN TRANSPLANT, V18, P186, DOI 10.1046/j.1399-0012.2003.00154.x; Higgins R, 2004, NEPHROL DIAL TRANSPL, V19, P444, DOI 10.1093/ndt/gfg515; Hu DC, 2006, AM J MED SCI, V331, P105, DOI 10.1097/00000441-200602000-00021; Jain A, 1999, ANN SURG, V230, P441, DOI 10.1097/00000658-199909000-00016; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kim HC, 2004, TRANSPL P, V36, P2082, DOI 10.1016/j.transproceed.2004.08.006; Koomans HA, 2001, TRANSPLANTATION, V72, pS9; Madala VK, 2008, AM J PHYSIOL-RENAL, V294, pF1222, DOI 10.1152/ajprenal.00604.2007; McCormick JA, 2011, HYPERTENSION, V58, P888, DOI 10.1161/HYPERTENSIONAHA.110.167809; Melnikov S, 2011, EUR J CLIN INVEST, V41, P1113, DOI 10.1111/j.1365-2362.2011.02517.x; Mohebbi N, 2009, AM J PHYSIOL-RENAL, V297, pF499, DOI 10.1152/ajprenal.90489.2008; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; PAVER W K, 1964, Med J Aust, V2, P305; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Schindler R, 2000, NEPHROL DIAL TRANSPL, V15, P8, DOI 10.1093/ndt/15.1.8; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Segal AS, 2002, AM J PHYSIOL-RENAL, V283, pF765, DOI 10.1152/ajprenal.00253.2001; Smith KD, 2003, J AM SOC NEPHROL, V14, P1037, DOI 10.1097/01.ASN.0000057542.86377.5A; Takeda Y, 1999, HYPERTENSION, V33, P130, DOI 10.1161/01.HYP.33.1.130; Van Laecke S, 2009, AM J TRANSPLANT, V9, P2140, DOI 10.1111/j.1600-6143.2009.02752.x; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	33	227	235	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1304	U339		10.1038/nm.2497	http://dx.doi.org/10.1038/nm.2497			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21963515	Green Accepted			2022-12-27	WOS:000296022100050
J	Balachandran, VP; Cavnar, MJ; Zeng, S; Bamboat, ZM; Ocuin, LM; Obaid, H; Sorenson, EC; Popow, R; Ariyan, C; Rossi, F; Besmer, P; Guo, TH; Antonescu, CR; Taguchi, T; Yuan, JD; Wolchok, JD; Allison, JP; DeMatteo, RP				Balachandran, Vinod P.; Cavnar, Michael J.; Zeng, Shan; Bamboat, Zubin M.; Ocuin, Lee M.; Obaid, Hebroon; Sorenson, Eric C.; Popow, Rachel; Ariyan, Charlotte; Rossi, Ferdinand; Besmer, Peter; Guo, Tianhua; Antonescu, Cristina R.; Taguchi, Takahiro; Yuan, Jianda; Wolchok, Jedd D.; Allison, James P.; DeMatteo, Ronald P.			Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido	NATURE MEDICINE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; RECEPTOR TYROSINE KINASE; DENDRITIC CELLS; MOUSE MODEL; COMBINATION IMMUNOTHERAPY; TRYPTOPHAN CATABOLISM; CTLA-4 BLOCKADE; OVARIAN-CANCER; REGULATORY CELLS; C-KIT	Imatinib mesylate targets mutated KIT oncoproteins in gastrointestinal stromal tumor (GIST) and produces a clinical response in 80% of patients. The mechanism is believed to depend predominantly on the inhibition of KIT-driven signals for tumor-cell survival and proliferation. Using a mouse model of spontaneous GIST, we found that the immune system contributes substantially to the antitumor effects of imatinib. Imatinib therapy activated CD8(+) T cells and induced regulatory T cell (T-reg cell) apoptosis within the tumor by reducing tumor-cell expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (Ido). Concurrent immunotherapy augmented the efficacy of imatinib in mouse GIST. In freshly obtained human GIST specimens, the T cell profile correlated with imatinib sensitivity and IDO expression. Thus, T cells are crucial to the antitumor effects of imatinib in GIST, and concomitant immunotherapy may further improve outcomes in human cancers treated with targeted agents.	[Balachandran, Vinod P.; Cavnar, Michael J.; Zeng, Shan; Bamboat, Zubin M.; Ocuin, Lee M.; Obaid, Hebroon; Sorenson, Eric C.; Popow, Rachel; Ariyan, Charlotte; DeMatteo, Ronald P.] Mem Hosp, Dept Surg, New York, NY USA; [Rossi, Ferdinand; Besmer, Peter] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Guo, Tianhua; Antonescu, Cristina R.] Mem Hosp, Dept Pathol, New York, NY USA; [Taguchi, Takahiro] Kochi Univ, Div Human Hlth & Med Sci, Grad Sch Kuroshio Sci, Kochi 780, Japan; [Yuan, Jianda; Wolchok, Jedd D.; Allison, James P.] Ludwig Ctr Canc Immunotherapy, New York, NY USA; [Wolchok, Jedd D.] Mem Hosp, Dept Med, New York, NY USA; [Allison, James P.] Sloan Kettering Inst, Program Immunol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Kochi University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	DeMatteo, RP (corresponding author), Mem Hosp, Dept Surg, New York, NY USA.	dematter@mskcc.org		Ariyan, Charlotte/0000-0003-0818-3895; Guo, Tianhua/0000-0003-0876-9837; Allison, James/0000-0001-8980-5697	US National Institutes of Health (NIH) [R01 CA102613]; Geoffrey Beene Cancer Research Center; Dutch GIST Foundation; GIST; Society for University; NIH [R01 CA102774, R01 HL55748, P50 CA140146, R24 CA83084, P30 CA08748]; LifeRaft Group and Starr Cancer Consortium; Cancer Center [NCI P30-CA008748]; NATIONAL CANCER INSTITUTE [R01CA102774, P30CA008748, R01CA102613, T32CA009501, P50CA140146, R24CA083084] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055748] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research Center; Dutch GIST Foundation; GIST; Society for University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LifeRaft Group and Starr Cancer Consortium; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Genomics, Tissue Procurement, Monoclonal Antibody, Molecular Cytology and Animal Imaging core facilities and the Laboratory of Comparative Pathology of Sloan-Kettering Institute. We acknowledge H.F. Gallardo, Y. Li, B. Zaidi, T. Rasalan, R. Chua, the Research Animal Resource Center, members of the laboratories of B. Singh and M. Weiser, and R. Holmes for technical assistance and logistical support, G. Rizzuto, D. Hirschhorn-Cymerman, D. Schaer, F. Avogadri and T. Merghoub for helpful discussions, and M. Gonen for statistical assistance. This work was supported by US National Institutes of Health (NIH) grant R01 CA102613, the Geoffrey Beene Cancer Research Center, Mr. J.H.L. Pit and Mrs. Pit-van Karnebeek and the Dutch GIST Foundation, GIST Cancer Research Fund and Swim Across America (R.P.D.); the Society for University Surgeons Ethicon Research Fellowship Award (V.P.B.); and NIH grants R01 CA102774, R01 HL55748 and P50 CA140146, LifeRaft Group and Starr Cancer Consortium (P.B.). Technical services provided by the Animal Imaging Core Facility were supported by the Small-Animal Imaging Research Program (SAIRP) NIH grants R24 CA83084 and P30 CA08748; the Molecular Cytology Core Facility was supported by Cancer Center Support grant NCI P30-CA008748.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Cameron S, 2008, EUR J GASTROEN HEPAT, V20, P327, DOI 10.1097/MEG.0b013e3282f3a403; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Cho HJ, 2009, NEOPLASIA, V11, P247, DOI 10.1593/neo.81360; Cohen AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010436; Curti A, 2007, BLOOD, V109, P2871, DOI 10.1182/blood-2006-07-036863; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hirschhorn-Cymerman D, 2009, J EXP MED, V206, P1103, DOI 10.1084/jem.20082205; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hurwitz AA, 2000, CANCER RES, V60, P2444; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Klein S, 2005, NAT REV CANCER, V5, P573, DOI 10.1038/nrc1651; Koch LK, 2009, BLOOD, V114, P5062, DOI 10.1182/blood-2009-06-227587; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Larmonier N, 2008, J IMMUNOL, V181, P6955, DOI 10.4049/jimmunol.181.10.6955; Lee HJ, 2007, BIOCHEM PHARMACOL, V73, P1412, DOI 10.1016/j.bcp.2006.12.018; Lee KC, 2010, LEUKEMIA, V24, P896, DOI 10.1038/leu.2010.11; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menard C, 2009, CANCER RES, V69, P3563, DOI 10.1158/0008-5472.CAN-08-3807; Mokyr MB, 1998, CANCER RES, V58, P5301; Muller AJ, 2010, CANCER RES, V70, P1845, DOI 10.1158/0008-5472.CAN-09-3613; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Pedicord VA, 2011, P NATL ACAD SCI USA, V108, P266, DOI 10.1073/pnas.1016791108; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Perez D, 2008, INT J CANCER, V123, P1551, DOI 10.1002/ijc.23698; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Rossi F, 2006, P NATL ACAD SCI USA, V103, P12843, DOI 10.1073/pnas.0511076103; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Seggewiss R, 2005, BLOOD, V105, P2473, DOI 10.1182/blood-2004-07-2527; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Takao M, 2007, ONCOL REP, V17, P1333; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; van Dongen M, 2010, INT J CANCER, V127, P899, DOI 10.1002/ijc.25113; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	58	388	423	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1094	U99		10.1038/nm.2438	http://dx.doi.org/10.1038/nm.2438			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21873989	Green Accepted			2022-12-27	WOS:000294605100029
J	Kottke, T; Errington, F; Pulido, J; Galivo, F; Thompson, J; Wongthida, P; Diaz, RM; Chong, H; Ilett, E; Chester, J; Pandha, H; Harrington, K; Selby, P; Melcher, A; Vile, R				Kottke, Timothy; Errington, Fiona; Pulido, Jose; Galivo, Feorillo; Thompson, Jill; Wongthida, Phonphimon; Diaz, Rosa Maria; Chong, Heung; Ilett, Elizabeth; Chester, John; Pandha, Hardev; Harrington, Kevin; Selby, Peter; Melcher, Alan; Vile, Richard			Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors	NATURE MEDICINE			English	Article							VESICULAR STOMATITIS-VIRUS; STEM-CELL ANTIGEN; PROSTATE-CANCER; ONCOLYTIC VIRUSES; MESENCHYMAL TRANSITION; GENE-THERAPY; T-CELLS; IN-VIVO; IMMUNITY; IMMUNOTHERAPY	Effective cancer immunotherapy requires the release of a broad spectrum of tumor antigens in the context of potent immune activation. We show here that a cDNA library of normal tissue, expressed from a highly immunogenic viral platform, cures established tumors of the same histological type from which the cDNA library was derived. Immune escape occurred with suboptimal vaccination, but tumor cells that escaped the immune pressure were readily treated by second-line virus-based immunotherapy. This approach has several major advantages. Use of the cDNA library leads to presentation of a broad repertoire of (undefined) tumor-associated antigens, which reduces emergence of treatment-resistant variants and also permits rational, combined-modality approaches in the clinic. Finally, the viral vectors can be delivered systemically, without the need for tumor targeting, and are amenable to clinical-grade production. Therefore, virus-expressed cDNA libraries represent a novel paradigm for cancer treatment addressing many of the key issues that have undermined the efficacy of immuno-and virotherapy to date.	[Kottke, Timothy; Pulido, Jose; Galivo, Feorillo; Thompson, Jill; Wongthida, Phonphimon; Diaz, Rosa Maria; Vile, Richard] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Errington, Fiona; Ilett, Elizabeth; Chester, John; Selby, Peter; Melcher, Alan; Vile, Richard] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Errington, Fiona; Ilett, Elizabeth; Chester, John; Selby, Peter; Melcher, Alan; Vile, Richard] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Pulido, Jose] Mayo Clin, Dept Ophthalmol & Ocular Oncol, Rochester, MN USA; [Chong, Heung] St George Hosp, Sch Med, London, England; [Pandha, Hardev] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England; [Vile, Richard] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Saint James's University Hospital; University of Leeds; Cancer Research UK; Saint James's University Hospital; University of Leeds; Mayo Clinic; St Georges University London; University of Surrey; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Mayo Clinic	Vile, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	vile.richard@mayo.edu	Errington-Mais, Fiona/AAK-7245-2020	Harrington, Kevin/0000-0002-6014-348X; Melcher, Alan/0000-0002-2042-3380; Errington-Mais, Fiona/0000-0003-2155-534X; Galivo, Feorillo/0000-0002-0553-922X; Ilett, Elizabeth/0000-0002-9875-0322	Richard M. Schulze Family Foundation; Mayo Foundation, Cancer Research UK; US National Institutes of Health [R01 CA107082, R01 CA130878, R01 CA132734]; Terry and Judith Paul; NATIONAL CANCER INSTITUTE [R01CA107082, R01CA132734, R01CA130878] Funding Source: NIH RePORTER	Richard M. Schulze Family Foundation; Mayo Foundation, Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry and Judith Paul; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Higgins for secretarial assistance. This work was supported by The Richard M. Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, the US National Institutes of Health grants R01 CA107082, R01 CA130878 and R01 CA132734, and a grant from Terry and Judith Paul.	Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Braxton CL, 2010, J VIROL, V84, P3552, DOI 10.1128/JVI.01572-09; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Bridle BW, 2009, MOL THER, V17, P1814, DOI 10.1038/mt.2009.154; Cobleigh MA, 2010, J VIROL, V84, P7513, DOI 10.1128/JVI.00200-10; Daniels GA, 2004, NAT BIOTECHNOL, V22, P1125, DOI 10.1038/nbt1007; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Dumas F, 1999, INT J CANCER, V80, P799, DOI 10.1002/(SICI)1097-0215(19990315)80:6<799::AID-IJC1>3.3.CO;2-L; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Ferrone S, 2004, NAT BIOTECHNOL, V22, P1096, DOI 10.1038/nbt0904-1096; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Guevara-Patino JA, 2003, ADV CANCER RES, V90, P157, DOI 10.1016/S0065-230X(03)90005-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ilett EJ, 2009, GENE THER, V16, P689, DOI 10.1038/gt.2009.29; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Koos D, 2010, CELL IMMUNOL, V263, P138, DOI 10.1016/j.cellimm.2010.03.019; Kottke T, 2007, CANCER RES, V67, P11970, DOI 10.1158/0008-5472.CAN-07-2259; Kottke T, 2009, CANCER RES, V69, P7767, DOI 10.1158/0008-5472.CAN-09-1597; Le DT, 2010, CANCER J, V16, P304, DOI 10.1097/PPO.0b013e3181eb33d7; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Motrich RD, 2007, SCAND J IMMUNOL, V66, P217, DOI 10.1111/j.1365-3083.2007.01971.x; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Parato KA, 2009, CURR OPIN MOL THER, V11, P13; Prestwich RJ, 2008, EXPERT REV ANTICANC, V8, P1581, DOI 10.1586/14737140.8.10.1581; Prestwich RJ, 2009, CLIN CANCER RES, V15, P4374, DOI 10.1158/1078-0432.CCR-09-0334; Qiao J, 2008, NAT MED, V14, P37, DOI 10.1038/nm1681; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Sanchez-Perez L, 2007, GENE THER, V14, P998, DOI 10.1038/sj.gt.3302935; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; Sanchez-Perez L, 2006, J IMMUNOL, V177, P4168, DOI 10.4049/jimmunol.177.6.4168; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schwartz JA, 2010, J VIROL, V84, P4611, DOI 10.1128/JVI.02637-09; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Tanaka S, 2000, CANCER GENE THER, V7, P1241, DOI 10.1038/sj.cgt.7700219; Thorne SH, 2008, GENE THER, V15, P753, DOI 10.1038/gt.2008.42; Tsavaler L, 2001, CANCER RES, V61, P3760; Turk MJ, 2002, IMMUNOL REV, V188, P122, DOI 10.1034/j.1600-065X.2002.18811.x; Willmon C, 2009, MOL THER, V17, P1667, DOI 10.1038/mt.2009.194; Yang DM, 2001, CANCER RES, V61, P5857	43	79	84	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					854	U223		10.1038/nm.2390	http://dx.doi.org/10.1038/nm.2390			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21685898	Green Accepted			2022-12-27	WOS:000292500800040
J	Bochkov, YA; Palmenberg, AC; Lee, WM; Rathe, JA; Amineva, SP; Sun, X; Pasic, TR; Jarjour, NN; Liggett, SB; Gern, JE				Bochkov, Yury A.; Palmenberg, Ann C.; Lee, Wai-Ming; Rathe, Jennifer A.; Amineva, Svetlana P.; Sun, Xin; Pasic, Thomas R.; Jarjour, Nizar N.; Liggett, Stephen B.; Gern, James E.			Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C	NATURE MEDICINE			English	Article							RECEPTOR; SEQUENCE; EXACERBATIONS; SEROTYPES; ILLNESSES; FEATURES; GENOME	A recently recognized human rhinovirus species C (HRV-C) is associated with up to half of HRV infections in young children. Here we propagated two HRV-C isolates ex vivo in organ culture of nasal epithelial cells, sequenced a new C15 isolate and developed the first, to our knowledge, reverse genetics system for HRV-C. Using contact points for the known HRV receptors, intercellular adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptor (LDLR), inter-and intraspecies footprint analyses predicted a unique cell attachment site for HRV-Cs. Antibodies directed to binding sites for HRV-A and -B failed to inhibit HRV-C attachment, consistent with the alternative receptor footprint. HRV-A and HRV-B infected HeLa and WisL cells but HRV-C did not. However, HRV-C RNA synthesized in vitro and transfected into both cell types resulted in cytopathic effect and recovery of functional virus, indicating that the viral attachment mechanism is a primary distinguishing feature of HRV-C.	[Bochkov, Yury A.; Lee, Wai-Ming; Amineva, Svetlana P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Rathe, Jennifer A.; Liggett, Stephen B.] Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Pasic, Thomas R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI USA; [Jarjour, Nizar N.; Gern, James E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland Baltimore; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bochkov, YA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA.	yabochkov@wisc.edu	liggett, stephen b/E-7453-2012	Bochkov, Yury/0000-0003-2618-4496; Liggett, Stephen B./0000-0002-0128-3669	US National Institutes of Health [U19 AI070503, U19 AI070503-04S1, R01 HL080412, R01 HL091490]; University of Maryland School of Medicine Genome Sequencing Center for Infectious Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080412, R01HL091490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland School of Medicine Genome Sequencing Center for Infectious Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Heatley, G. Hartig and J.S. McMurray (University of Wisconsin-Madison) for providing surgical samples and R. Brockman-Schneider, R. Vrtis, T. Pappas, G. Crisafi, M. Hill, J. Bork, R. Massey, A. Lashua and E. Domyan for technical assistance. This work was supported by US National Institutes of Health grants U19 AI070503, U19 AI070503-04S1, R01 HL080412 and R01 HL091490 and the National Institute of Allergy and Infectious Diseases-funded University of Maryland School of Medicine Genome Sequencing Center for Infectious Disease.	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Arden KE, 2010, J CLIN VIROL, V47, P219, DOI 10.1016/j.jcv.2010.01.001; Arden KE, 2010, REV MED VIROL, V20, P156, DOI 10.1002/rmv.644; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Briese T, 2008, EMERG INFECT DIS, V14, P944, DOI 10.3201/eid1406.080271; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Gern JE, 1999, CLIN MICROBIOL REV, V12, P9, DOI 10.1128/CMR.12.1.9; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Laine P, 2006, J GEN VIROL, V87, P129, DOI 10.1099/vir.0.81137-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; LEE WM, 1995, VIRUS GENES, V9, P177, DOI 10.1007/BF01702661; Lee WM, 2003, J VIROL, V77, P6235, DOI 10.1128/JVI.77.11.6235-6244.2003; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Mackay IM, 2008, EMERG INFECT DIS, V14, P1823, DOI 10.3201/eid1411.080725; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; McManus TE, 2008, RESP MED, V102, P1575, DOI 10.1016/j.rmed.2008.06.006; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Reischl A, 2001, J VIROL, V75, P9312, DOI 10.1128/JVI.75.19.9312-9319.2001; ROSSMANN MG, 1988, VIROLOGY, V164, P373, DOI 10.1016/0042-6822(88)90550-8; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Weber C, 2009, FEBS LETT, V583, P2547, DOI 10.1016/j.febslet.2009.07.015; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004; Zhao R, 1996, STRUCTURE, V4, P1205, DOI 10.1016/S0969-2126(96)00128-1	40	139	144	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					627	U152		10.1038/nm.2358	http://dx.doi.org/10.1038/nm.2358			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21483405	Green Accepted, Green Published			2022-12-27	WOS:000290250400041
J	Monsalvo, AC; Batalle, JP; Lopez, MF; Krause, JC; Klemenc, J; Hernandez, JZ; Maskin, B; Bugna, J; Rubinstein, C; Aguilar, L; Dalurzo, L; Libster, R; Savy, V; Baumeister, E; Aguilar, L; Cabral, G; Font, J; Solari, L; Weller, KP; Johnson, J; Echavarria, M; Edwards, KM; Chappell, JD; Crowe, JE; Williams, JV; Melendi, GA; Polack, FP				Clara Monsalvo, Ana; Batalle, Juan P.; Florencia Lopez, M.; Krause, Jens C.; Klemenc, Jennifer; Zea Hernandez, Johanna; Maskin, Bernardo; Bugna, Jimena; Rubinstein, Carlos; Aguilar, Leandro; Dalurzo, Liliana; Libster, Romina; Savy, Vilma; Baumeister, Elsa; Aguilar, Liliana; Cabral, Graciela; Font, Julia; Solari, Liliana; Weller, Kevin P.; Johnson, Joyce; Echavarria, Marcela; Edwards, Kathryn M.; Chappell, James D.; Crowe, James E., Jr.; Williams, John V.; Melendi, Guillermina A.; Polack, Fernando P.			Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes	NATURE MEDICINE			English	Article							PNEUMONIA; INFECTION; RESPONSES; CHILDREN; VIRUSES; DEATH	Pandemic influenza viruses often cause severe disease in middle-aged adults without preexisting comorbidities. The mechanism of illness associated with severe disease in this age group is not well understood(1-10). Here we find preexisting serum antibodies that cross-react with, but do not protect against, 2009 H1N1 influenza virus in middle-aged adults. Nonprotective antibody is associated with immune complex-mediated disease after infection. We detected high titers of serum antibody of low avidity for H1-2009 antigen, and low-avidity pulmonary immune complexes against the same protein, in severely ill individuals. Moreover, C4d deposition-a marker of complement activation mediated by immune complexes-was present in lung sections of fatal cases. Archived lung sections from middle-aged adults with confirmed fatal influenza 1957 H2N2 infection revealed a similar mechanism of illness. These observations provide a previously unknown biological mechanism for the unusual age distribution of severe cases during influenza pandemics.	[Clara Monsalvo, Ana; Batalle, Juan P.; Florencia Lopez, M.; Zea Hernandez, Johanna; Bugna, Jimena; Libster, Romina; Melendi, Guillermina A.; Polack, Fernando P.] Fdn INFANT, Buenos Aires, DF, Argentina; [Krause, Jens C.; Klemenc, Jennifer; Zea Hernandez, Johanna; Weller, Kevin P.; Edwards, Kathryn M.; Crowe, James E., Jr.; Williams, John V.; Melendi, Guillermina A.; Polack, Fernando P.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Maskin, Bernardo; Aguilar, Liliana; Cabral, Graciela; Font, Julia; Solari, Liliana] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Rubinstein, Carlos; Aguilar, Leandro] Hosp Dr Federico Abete, Buenos Aires, DF, Argentina; [Dalurzo, Liliana] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Savy, Vilma; Baumeister, Elsa] Adm Nacl Labs, Buenos Aires, DF, Argentina; [Savy, Vilma; Baumeister, Elsa] Inst Salud Dr Carlos G Malbran, Buenos Aires, DF, Argentina; [Johnson, Joyce; Chappell, James D.] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Echavarria, Marcela] Ctr Educ Med & Invest Clin, Dept Microbiol, Buenos Aires, DF, Argentina	Vanderbilt University; Hospital Italiano de Buenos Aires; University of Buenos Aires; Vanderbilt University; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC)	Polack, FP (corresponding author), Fdn INFANT, Buenos Aires, DF, Argentina.	gmelendi@infant.org.ar; fernando.p.polack@vanderbilt.edu	Williams, John/ABE-3227-2020; Echavarria, Marcela/AAQ-2897-2021; Crowe, James/B-5549-2009; Williams, John/F-6962-2010	Williams, John/0000-0001-8377-5175; Echavarria, Marcela/0000-0001-6987-8397; Crowe, James/0000-0002-0049-1079; Williams, John/0000-0001-8377-5175	Fundacion INFANT 2008 Fundraising Campaign [AI-054952]; Thrasher Research Fund Early Career Award and Fogarty International Center International Clinical Research Fellows Program at Vanderbilt [R24 TW007988]; US Department of Defense [HDTRA1-08-10-BRCWMD-BAA]; US National Institutes of Health [P01 AI058113]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054952, P01AI058113] Funding Source: NIH RePORTER	Fundacion INFANT 2008 Fundraising Campaign; Thrasher Research Fund Early Career Award and Fogarty International Center International Clinical Research Fellows Program at Vanderbilt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Fundacion INFANT 2008 Fundraising Campaign and AI-054952 (F. P. P.), the Thrasher Research Fund Early Career Award and Fogarty International Center International Clinical Research Fellows Program at Vanderbilt (R24 TW007988) (G. A. M. and J.P.B.), US Department of Defense grant HDTRA1-08-10-BRCWMD-BAA and US National Institutes of Health grant P01 AI058113 (J.E.C. Jr.). Doctoral awards from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (A. C. M. and J.P.B.).	Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; HALL CB, 1978, J PEDIATR-US, V93, P28, DOI 10.1016/S0022-3476(78)80594-0; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; LEWIS DE, 1986, J IMMUNOL, V137, P3777; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Regele H, 2001, NEPHROL DIAL TRANSPL, V16, P2058, DOI 10.1093/ndt/16.10.2058; REICHERT T, 2010, AM J RESP CRIT CARE, V181, P72; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	29	188	193	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					195	U225		10.1038/nm.2262	http://dx.doi.org/10.1038/nm.2262			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21131958	Green Accepted, Bronze, Green Published			2022-12-27	WOS:000286969900027
J	Jagani, Z; Mora-Blanco, EL; Sansam, CG; McKenna, ES; Wilson, B; Chen, DS; Klekota, J; Tamayo, P; Nguyen, PTL; Tolstorukov, M; Park, PJ; Cho, YJ; Hsiao, K; Buonamici, S; Pomeroy, SL; Mesirov, JP; Ruffner, H; Bouwmeester, T; Luchansky, SJ; Murtie, J; Kelleher, JF; Warmuth, M; Sellers, WR; Roberts, CWM; Dorsch, M				Jagani, Zainab; Mora-Blanco, E. Lorena; Sansam, Courtney G.; McKenna, Elizabeth S.; Wilson, Boris; Chen, Dongshu; Klekota, Justin; Tamayo, Pablo; Nguyen, Phuong T. L.; Tolstorukov, Michael; Park, Peter J.; Cho, Yoon-Jae; Hsiao, Kathy; Buonamici, Silvia; Pomeroy, Scott L.; Mesirov, Jill P.; Ruffner, Heinz; Bouwmeester, Tewis; Luchansky, Sarah J.; Murtie, Joshua; Kelleher, Joseph F.; Warmuth, Markus; Sellers, William R.; Roberts, Charles W. M.; Dorsch, Marion			Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway	NATURE MEDICINE			English	Article							SWI/SNF COMPLEX; SONIC-HEDGEHOG; GENE; MUTATIONS; CHROMATIN; IDENTIFICATION; EXPRESSION; HSNF5/INI1; INHIBITORS; TARGET	Aberrant activation of the Hedgehog (Hh) pathway can drive tumorigenesis(1). To investigate the mechanism by which glioma-associated oncogene family zinc finger-1 (GLI1), a crucial effector of Hh signaling(2), regulates Hh pathway activation, we searched for GLI1-interacting proteins. We report that the chromatin remodeling protein SNF5 (encoded by SMARCB1, hereafter called SNF5), which is inactivated in human malignant rhabdoid tumors (MRTs), interacts with GLI1. We show that Snf5 localizes to Gli1-regulated promoters and that loss of Snf5 leads to activation of the Hh-Gli pathway. Conversely, re-expression of SNF5 in MRT cells represses GLI1. Consistent with this, we show the presence of a Hh-Gli-activated gene expression profile in primary MRTs and show that GLI1 drives the growth of SNF5-deficient MRT cells in vitro and in vivo. Therefore, our studies reveal that SNF5 is a key mediator of Hh signaling and that aberrant activation of GLI1 is a previously undescribed targetable mechanism contributing to the growth of MRT cells.	[Mora-Blanco, E. Lorena; Sansam, Courtney G.; McKenna, Elizabeth S.; Wilson, Boris; Nguyen, Phuong T. L.; Roberts, Charles W. M.] Childrens Hosp Boston, Dept Pediat Oncol, Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA USA; [Tamayo, Pablo; Cho, Yoon-Jae; Mesirov, Jill P.] Broad Inst Harvard, Cambridge, MA USA; [Tamayo, Pablo; Cho, Yoon-Jae; Mesirov, Jill P.] MIT, Cambridge, MA 02139 USA; [Tolstorukov, Michael; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Cho, Yoon-Jae; Pomeroy, Scott L.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA; [Ruffner, Heinz; Bouwmeester, Tewis] Novartis Inst BioMed Res, Basel, Switzerland; [Jagani, Zainab; Chen, Dongshu; Klekota, Justin; Hsiao, Kathy; Buonamici, Silvia; Luchansky, Sarah J.; Murtie, Joshua; Kelleher, Joseph F.; Warmuth, Markus; Sellers, William R.; Dorsch, Marion] Novartis Inst BioMed Res, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Novartis; Novartis	Dorsch, M (corresponding author), Sanofi Aventis, Cambridge, MA USA.	charles_roberts@dfci.harvard.edu; marion.dorsch@sanofi-aventis.com	Mesirov, Jill/AGF-7626-2022; Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896; Sansam, Courtney/0000-0002-0253-8643; Park, Peter/0000-0001-9378-960X	NATIONAL CANCER INSTITUTE [R01CA109467, R01CA121941, R01CA113794] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA121941, R01 CA113794, R01 CA109467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Biegel JA, 1999, CANCER RES, V59, P74; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lee J, 1997, DEVELOPMENT, V124, P2537; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raffel C, 1997, CANCER RES, V57, P842; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Theil T, 1999, CELL TISSUE RES, V296, P75, DOI 10.1007/s004410051268; Tsikitis M, 2005, P NATL ACAD SCI USA, V102, P12129, DOI 10.1073/pnas.0505300102; Turner FB, 2006, METH MOL B, V325, P261; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wisniewski D, 2002, CANCER RES, V62, P4244; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009	39	170	178	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1429	U112		10.1038/nm.2251	http://dx.doi.org/10.1038/nm.2251			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21076395	Green Accepted			2022-12-27	WOS:000285048900037
J	Blennow, K				Blennow, Kaj			Biomarkers in Alzheimer's disease drug development	NATURE MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; BETA IMMUNIZATION AN1792; PLACEBO-CONTROLLED TRIAL; A-BETA; CEREBROSPINAL-FLUID; CSF BIOMARKERS; GAMMA-SECRETASE; DOUBLE-BLIND; FOLLOW-UP; IN-VIVO	Biomarkers may be of great value in Alzheimer's disease drug development to select the most optimal drug candidates for large and expensive phase 3 clinical trials. Biomarkers will also be important to provide evidence that a drug affects the underlying pathophysiology of the disease, which, together with a beneficial effect on the clinical course, will be essential for labeling the drug as having a disease-modifying effect.	Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Molndal, Sweden	University of Gothenburg	Blennow, K (corresponding author), Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Molndal, Sweden.	kaj.blennow@neuro.gu.se						Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Blennow K, 2007, NEUROSCI LETT, V419, P18, DOI 10.1016/j.neulet.2007.03.064; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Chen XY, 2006, J NEUROPSYCH CLIN N, V18, P178, DOI 10.1176/appi.neuropsych.18.2.178; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; Davidsson P, 1999, ELECTROPHORESIS, V20, P431; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Galasko DR, 2007, ALZ DIS ASSOC DIS, V21, P292, DOI 10.1097/WAD.0b013e31815d1048; Garcia-Alloza M, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-19; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Gunnarsson MD, 2010, DEMENT GERIATR COGN, V29, P204, DOI 10.1159/000281832; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto M, 2005, AM J PSYCHIAT, V162, P676, DOI 10.1176/appi.ajp.162.4.676; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Nelson PT, 2010, J NEUROPATH EXP NEUR, V69, P449, DOI 10.1097/NEN.0b013e3181d8db07; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; PORTELIUS E, 2010, J ALZHEIMERS DI 0715, DOI DOI 10.3233/JALZHEIMER'SDISEASE-2010-100573; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Tune L, 2003, AM J GERIAT PSYCHIAT, V11, P169, DOI 10.1176/appi.ajgp.11.2.169; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wilcock GK, 2008, LANCET NEUROL, V7, P483, DOI 10.1016/S1474-4422(08)70090-5; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307	45	103	104	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1218	1222		10.1038/nm.2221	http://dx.doi.org/10.1038/nm.2221			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052077				2022-12-27	WOS:000283860100029
J	Duric, V; Banasr, M; Licznerski, P; Schmidt, HD; Stockmeier, CA; Simen, AA; Newton, SS; Duman, RS				Duric, Vanja; Banasr, Mounira; Licznerski, Pawel; Schmidt, Heath D.; Stockmeier, Craig A.; Simen, Arthur A.; Newton, Samuel S.; Duman, Ronald S.			A negative regulator of MAP kinase causes depressive behavior	NATURE MEDICINE			English	Article							POSTMORTEM BRAIN; PATHWAY CONTRIBUTES; HIPPOCAMPAL ATROPHY; SUICIDE VICTIMS; ECONOMIC BURDEN; STRESS SYSTEM; EXPRESSION; PHOSPHATASE-1; GENE; MODELS	The lifetime prevalence (similar to 16%)(1) and the economic burden ($100 billion annually)(2,3) associated with major depressive disorder (MDD) make it one of the most common and debilitating neurobiological illnesses. To date, the exact cellular and molecular mechanisms underlying the pathophysiology of MDD have not been identified. Here we use whole-genome expression profiling of postmortem tissue and show significantly increased expression of mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1, encoded by DUSP1, but hereafter called MKP-1) in the hippocampal subfields of subjects with MDD compared to matched controls. MKP-1, also known as dual-specificity phosphatase-1 (DUSP1), is a member of a family of proteins that dephosphorylate both threonine and tyrosine residues and thereby serves as a key negative regulator of the MAPK cascade(4), a major signaling pathway involved in neuronal plasticity, function and survival(5,6). We tested the role of altered MKP-1 expression in rat and mouse models of depression and found that increased hippocampal MKP-1 expression, as a result of stress or viral-mediated gene transfer, causes depressive behaviors. Conversely, chronic antidepressant treatment normalizes stress-induced MKP-1 expression and behavior, and mice lacking MKP-1 are resilient to stress. These postmortem and preclinical studies identify MKP-1 as a key factor in MDD pathophysiology and as a new target for therapeutic interventions.	[Duric, Vanja; Banasr, Mounira; Licznerski, Pawel; Schmidt, Heath D.; Simen, Arthur A.; Newton, Samuel S.; Duman, Ronald S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Stockmeier, Craig A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA	Yale University; University of Mississippi; University of Mississippi Medical Center; Case Western Reserve University	Duman, RS (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.	ronald.duman@yale.edu	Yan, Shuo/B-8381-2009	Licznerski, Pawel/0000-0003-2761-8428	US Public Health Service [MH45481, 2 P01 MH25642, MH67996, P20 RR17701]; Connecticut Mental Health Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642, R29MH045481, R01MH045481, R37MH045481, R01MH067996] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Mental Health Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by US Public Health Service grants MH45481 (R.S.D.), 2 P01 MH25642 (R.S.D.), MH67996 (C.A.S.) and P20 RR17701 (C.A.S.) and the Connecticut Mental Health Center (R.S.D.). We acknowledge the invaluable contributions made by the families consenting to donate brain tissue and be interviewed. We also thank the Cuyahoga County Coroner and staff for their willing assistance. We are grateful for the contributions of J. Overholser, G. Jurjus, H. Meltzer, L. Konick, L. Dieter, N. Herbst, G. Mahajan, H. Kooiman and J. Cobb in the psychiatric assessment and human tissue dissection and preparation. We also thank R. Terwilliger and H.J. Kang for technical assistance with gene expression analysis, A. Bennett (Yale University School of Medicine) for Mkp-1<SUP>-/-</SUP> mice, X.Y. Li for assistance in breeding and genotyping Mkp-1<SUP>-/-</SUP> mice and R. DiLeone (Yale University School of Medicine) for generously donating AAV-CMV-GFP plasmid used to generate recombinant AAVs.	Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Creson TK, 2009, BIPOLAR DISORD, V11, P339, DOI 10.1111/j.1399-5618.2009.00697.x; Dorfman K, 1996, ONCOGENE, V13, P925; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Dwivedi Y, 2006, MOL PSYCHIATR, V11, P86, DOI 10.1038/sj.mp.4001744; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Einat H, 2003, J NEUROSCI, V23, P7311; Engel SR, 2009, MOL PSYCHIATR, V14, P448, DOI 10.1038/sj.mp.4002135; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Magarinos AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Seta KA, 2001, J BIOL CHEM, V276, P44405, DOI 10.1074/jbc.M103346200; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simon GE, 2003, BIOL PSYCHIAT, V54, P208, DOI 10.1016/S0006-3223(03)00420-7; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; VERKHRATSKY NS, 1995, EXP GERONTOL, V30, P415, DOI 10.1016/0531-5565(94)00056-9; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010	40	299	312	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1328	U36		10.1038/nm.2219	http://dx.doi.org/10.1038/nm.2219			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20953200	Green Accepted			2022-12-27	WOS:000283860100046
J	Heineke, J; Auger-Messier, M; Correll, RN; Xu, JA; Benard, MJ; Yuan, WP; Drexler, H; Parise, LV; Molkentin, JD				Heineke, Joerg; Auger-Messier, Mannix; Correll, Robert N.; Xu, Jian; Benard, Matthew J.; Yuan, Weiping; Drexler, Helmut; Parise, Leslie V.; Molkentin, Jeffery D.			CIB1 is a regulator of pathological cardiac hypertrophy	NATURE MEDICINE			English	Article							CALCIUM-BINDING PROTEIN; MUSCLE LIM PROTEIN; CALCINEURIN B; HEART; IDENTIFICATION; ACTIVATION; EXPRESSION; INTERACTS; DISEASE; ADHESION	Hypertrophic heart disease is a leading health problem in Western countries. Here we identified the small EF hand domain-containing protein Ca2+ and integrin-binding protein-1 (CIB1) in a screen for previously unknown regulators of cardiomyocyte hypertrophy. Yeast two-hybrid screening for CIB1-interacting partners identified a related EF hand domain-containing protein, calcineurin B, the regulatory subunit of the prohypertrophic protein phosphatase calcineurin. CIB1 localizes primarily to the sarcolemma in mouse and human myocardium, where it anchors calcineurin to control its activation in coordination with the L-type Ca2+ channel. CIB1 protein amounts and membrane association were enhanced in cardiac pathological hypertrophy, but not in physiological hypertrophy. Consistent with these observations, Cib1-deleted mice showed a marked reduction in myocardial hypertrophy, fibrosis, cardiac dysfunction and calcineurin-nuclear factor of activated T cells (NFAT) activity after pressure overload, whereas the degree of physiologic hypertrophy after swimming exercise was not altered. Transgenic mice with inducible and cardiac-specific overexpression of CIB1 showed enhanced cardiac hypertrophy in response to pressure overload or calcineurin signaling. Moreover, mice lacking Ppp3cb (encoding calcineurin A, beta isozyme) showed no enhancement in cardiac hypertrophy associated with CIB1 overexpression. Thus, CIB1 functions as a previously undescribed regulator of cardiac hypertrophy through its ability to regulate the association of calcineurin with the sarcolemma and its activation.	[Heineke, Joerg; Auger-Messier, Mannix; Correll, Robert N.; Xu, Jian; Benard, Matthew J.; Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Heineke, Joerg; Drexler, Helmut] Hannover Med Sch, Klin Kardiol & Angiol, D-30623 Hannover, Germany; [Yuan, Weiping; Parise, Leslie V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; Hannover Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	Heineke.Joerg@mh-hannover.de; jeff.molkentin@cchmc.org	Xu, Jian/AAE-1415-2019	Molkentin, Jeffery/0000-0002-3558-6529	US National Institutes of Health; Howard Hughes Medical Institute; Fondation Leducq; Deutsche Forschungsgemeinschaft, Bonn, Germany [HE 3658/1-1]; Cluster of Excellence Rebirth (also Deutsche Forschungsgemeinschaft); National Institutes of Health [5 T32 HL07382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL062927] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fondation Leducq(Leducq Foundation); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Cluster of Excellence Rebirth (also Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the US National Institutes of Health (J.D.M. and L.V.P.) and the Howard Hughes Medical Institute (J.D.M.) and by the Fondation Leducq (J.D.M. and H.D.). J.H. was supported in part by a grant from the Deutsche Forschungsgemeinschaft, Bonn, Germany (HE 3658/1-1) and the Cluster of Excellence Rebirth (also Deutsche Forschungsgemeinschaft). M.J.B. was supported by National Institutes of Health training grant 5 T32 HL07382 (principal investigator A. Schwartz).	Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; Hager M, 2008, J BIOL CHEM, V283, P24760, DOI 10.1074/jbc.M801166200; Haq S, 2001, CIRCULATION, V103, P670; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Heineke J, 2003, CIRCULATION, V107, P1424, DOI 10.1161/01.CIR.0000055319.94801.FC; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Iida T, 2008, BIOCHEM BIOPH RES CO, V375, P655, DOI 10.1016/j.bbrc.2008.08.090; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Jernigan NL, 2008, AM J PHYSIOL-HEART C, V294, pH409, DOI 10.1152/ajpheart.00571.2007; Kabaeva Z, 2008, AM J PHYSIOL-HEART C, V294, pH1667, DOI 10.1152/ajpheart.01144.2007; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li W, 2002, BBA-PROTEINS PROTEOM, V1599, P72, DOI 10.1016/S1570-9639(02)00402-8; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; POLITINO M, 1990, J BIOL CHEM, V265, P7619; POLITINO M, 1987, J BIOL CHEM, V262, P10109; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saito T, 1999, MAMM GENOME, V10, P315, DOI 10.1007/s003359900994; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Vila-Carriles WH, 2007, J BIOL CHEM, V282, P34381, DOI 10.1074/jbc.M705354200; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zhu JS, 2004, EXP CELL RES, V300, P440, DOI 10.1016/j.yexcr.2004.07.020	48	75	85	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					872	U68		10.1038/nm.2181	http://dx.doi.org/10.1038/nm.2181			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20639889	Green Accepted, Green Submitted			2022-12-27	WOS:000280649200026
J	Dilts, D				Dilts, David			US cancer trials may go the way of the Oldsmobile	NATURE MEDICINE			English	Editorial Material								Cancer clinical trials in the US are at a major crossroads. Current government-sponsored research is some of the best in the world, but the field shares a worrying number of similarities with the American auto industry in its heyday. For clinical research to survive, the field must transform itself now to prevent a similar decline.	Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Management Res Healthcare, Portland, OR 97201 USA	Oregon Health & Science University	Dilts, D (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Management Res Healthcare, Portland, OR 97201 USA.							ADAMS W, 2004, BIGNESS COMPLEX, V52; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; DILTS DM, 2010, J CLIN CANC RES, DOI DOI 10.1158/1078-0432.CCR-10-1273; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; *I MED, 2010, NAT CANC CLIN TRIAL; *OP EFF WORK GROUP, 2010, COMPR TIM CANC CLIN	7	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					632	632		10.1038/nm0610-632	http://dx.doi.org/10.1038/nm0610-632			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526311	Bronze			2022-12-27	WOS:000278394200022
J	Murphy, BD				Murphy, Bruce D.			What a difference a gene makes	NATURE MEDICINE			English	Editorial Material							TRANSCRIPTION FACTOR FOXL2; POLYCYSTIC-OVARY-SYNDROME; MUTATIONS; BPES		Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada	Universite de Montreal	Murphy, BD (corresponding author), Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada.	bruce.d.murphy@umontreal.ca		Murphy, Bruce/0000-0001-7158-3360				Benayoun BA, 2008, PROTEOMICS, V8, P3118, DOI 10.1002/pmic.200800084; Bentsi-Barnes IK, 2010, FERTIL STERIL, V94, P353, DOI 10.1016/j.fertnstert.2009.09.050; Beysen D, 2009, HUM MUTAT, V30, P158, DOI 10.1002/humu.20807; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Kobel M, 2009, CANCER RES, V69, P9160, DOI 10.1158/0008-5472.CAN-09-2669; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Magoffin DA, 2006, FERTIL STERIL, V86, pS9, DOI 10.1016/j.fertnstert.2006.03.015; Meduri G, 2010, HUM REPROD, V25, P235, DOI 10.1093/humrep/dep355; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021	14	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					527	529		10.1038/nm0510-527	http://dx.doi.org/10.1038/nm0510-527			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20448577				2022-12-27	WOS:000277394700029
J	Strutt, TM; McKinstry, KK; Dibble, JP; Winchell, C; Kuang, Y; Curtis, JD; Huston, G; Dutton, RW; Swain, SL				Strutt, Tara M.; McKinstry, K. Kai; Dibble, John P.; Winchell, Caylin; Kuang, Yi; Curtis, Jonathan D.; Huston, Gail; Dutton, Richard W.; Swain, Susan L.			Memory CD4(+) T cells induce innate responses independently of pathogen	NATURE MEDICINE			English	Article							INFLUENZA-A; ANTIVIRAL RESPONSES; PROTECTIVE IMMUNITY; VIRAL-INFECTIONS; IFN-GAMMA; ACTIVATION; CD8(+); INTERLEUKIN-12; GENERATION; CHEMOKINES	Inflammation induced by recognition of pathogen-associated molecular patterns markedly affects subsequent adaptive responses. We asked whether the adaptive immune system can also affect the character and magnitude of innate inflammatory responses. We found that the response of memory, but not naive, CD4(+) T cells enhances production of multiple innate inflammatory cytokines and chemokines (IICs) in the lung and that, during influenza infection, this leads to early control of virus. Memory CD4(+) T cell-induced IICs and viral control require cognate antigen recognition and are optimal when memory cells are either T helper type 1 (T(H)1) or T(H)17 polarized but are independent of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) production and do not require activation of conserved pathogen recognition pathways. This represents a previously undescribed mechanism by which memory CD4(+) T cells induce an early innate response that enhances immune protection against pathogens.	[Strutt, Tara M.; McKinstry, K. Kai; Dibble, John P.; Winchell, Caylin; Kuang, Yi; Curtis, Jonathan D.; Huston, Gail; Dutton, Richard W.; Swain, Susan L.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Strutt, TM (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	tms139@mail.usask.ca			US National Institutes of Health [P01AI04630, P01AI04566]; US Department of Defense [3222]; Trudeau Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076534, P01AI046530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG025805] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Trudeau Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (P01AI04630 to and P01AI04566 to S. L. S.), the US Department of Defense (HR#3222) and the Trudeau Institute. We thank J. Kohlmeier and D. Woodland (Trudeau Institute) for Ccr5<SUP>-/-</SUP> and Ifnar2<SUP>-/-</SUP> mice and M. Mohrs (Trudeau Institute) for C57BL/6-Tg (IFN-gamma-EYFP) mice. Influenza A/Philippines was obtained from S. Epstein (CBER FDA), and engineered virus A/PR8-OVA<INF>II</INF> was obtained from P. Doherty (University of Melbourne). LPS-free whole OVA protein was a generous gift from T. Moran (Mount Sinai School of Medicine).	Amichay D, 1996, J IMMUNOL, V157, P4511; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRADLEY LM, 1993, J IMMUNOL, V150, P3119; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; CHACE JH, 1994, J IMMUNOL, V152, P405; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; DE TP, 1994, SCIENCE, V264, P703; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Elyaman W, 2008, AM J PATHOL, V173, P411, DOI 10.2353/ajpath.2008.080142; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hama Y, 2009, ACTA VIROL, V53, P233, DOI 10.4149/av_2009_04_233; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kalinski P, 2005, NAT REV IMMUNOL, V5, P251, DOI 10.1038/nri1569; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Latham KA, 2005, J IMMUNOL, V174, P3978, DOI 10.4049/jimmunol.174.7.3978; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; Lee SW, 1999, VACCINE, V17, P490, DOI 10.1016/S0264-410X(98)00223-0; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Mayer KD, 2005, J IMMUNOL, V174, P7732, DOI 10.4049/jimmunol.174.12.7732; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Monteiro JM, 1998, J VIROL, V72, P4825, DOI 10.1128/JVI.72.6.4825-4831.1998; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Strutt TM, 2006, INT IMMUNOL, V18, P719, DOI 10.1093/intimm/dxl009; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Zhao MQ, 2000, J CLIN INVEST, V106, pR49, DOI 10.1172/JCI9786	50	132	137	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					558	U91		10.1038/nm.2142	http://dx.doi.org/10.1038/nm.2142			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20436484	Green Accepted			2022-12-27	WOS:000277394700034
J	Ayres, JS; Trinidad, NJ; Vance, RE				Ayres, Janelle S.; Trinidad, Norver J.; Vance, Russell E.			Lethal inflammasome activation by a multidrug- resistant pathobiont upon antibiotic disruption of the microbiota	NATURE MEDICINE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; III SECRETION SYSTEM; ESCHERICHIA-COLI; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; CECAL LIGATION; GUT MICROBIOTA; SEPSIS; MICE; SUSCEPTIBILITY	The mammalian intestine harbors a complex microbial community that provides numerous benefits to its host. However, the microbiota can also include potentially virulent species, termed pathobiont, which can cause disease when intestinal homeostasis is disrupted. The molecular mechanisms by which pathobionts cause disease remain poorly understood. Here we describe a sepsis-like disease that occurs upon gut injury in antibiotic-treated mice. Sepsis was associated with the systemic spread of a specific multidrug-resistant Escherichia coli pathobiont that expanded markedly in the microbiota of antibiotic-treated mice. Rapid sepsis-like death required a component of the innate immune system, the Naip5-Nlrc4 inflammasome. In accordance with Koch's postulates, we found the E. coli pathobiont was sufficient to activate Naip5-Nlrc4 and cause disease when injected intravenously into unmanipulated mice. These findings reveal how sepsis-like disease can result from recognition of pathobionts by the innate immune system.	[Ayres, Janelle S.; Trinidad, Norver J.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ayres, JS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	jayres@berkeley.edu; rvance@berkeley.edu			US National Institutes of Health [AI063302, AI075039, AI080749]; National Institutes of Health Ruth L. Kirschstein National Research Service [AI091068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080749, R01AI075039, F32AI091068, P01AI063302] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Schapiro and J. LaPan for biochemical characterization of E. coli O21:H+ and S. Brandt for helpful discussions about the isolate; K. Bodi for helpful advice about whole-genome sequencing analysis; G. Barton, D. Portnoy and K. Barry for helpful discussions and critical reading of the manuscript; E. Kofoed (University of California-Berkeley) for the flaA-IRES-GFP construct; K. Sotelo-Troha for technical help and L. Lopez for support in our mouse facility (University of California-Berkeley). Nlrc4<SUP>-/-</SUP>mice were from S. Mariathasan and V. Dixit (Genentech). Casp1<SUP>-/-</SUP> mice and S. Typhimurium LT2 Delta fliC Delta fljB were a gift from A. Van der Velden and M. Starnbach (Harvard Medical School). Il1b<SUP>-/-</SUP> mice were from the Zychlinsky lab at Max Planck Institute. This work was supported in part by US National Institutes of Health grants AI063302, AI075039 and AI080749 awarded to R.E.V. and National Institutes of Health Ruth L. Kirschstein National Research Service Award fellowship AI091068 awarded to J.S.A. R.E.V. is an Investigator of the Cancer Research Institute and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Boots M, 2008, TRENDS ECOL EVOL, V23, P248, DOI 10.1016/j.tree.2008.01.006; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; EVANS DJ, 1981, J CLIN MICROBIOL, V13, P171, DOI 10.1128/JCM.13.1.171-178.1981; EVANS DJ, 1980, J CLIN MICROBIOL, V12, P235, DOI 10.1128/JCM.12.2.235-242.1980; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Ideses D, 2005, J BACTERIOL, V187, P8164, DOI 10.1128/JB.187.23.8164-8171.2005; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Korczak B, 2005, J CLIN MICROBIOL, V43, P1024, DOI 10.1128/JCM.43.3.1024-1031.2005; Lakhan SE, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-79; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Mapes S, 2007, VET REC, V161, P716, DOI 10.1136/vr.161.21.716; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; OREILLY M, 1992, J SURG RES, V52, P518; ORSKOV I, 1985, J HYG-CAMBRIDGE, V95, P551, DOI 10.1017/S0022172400060678; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramos NL, 2010, EUR J CLIN MICROBIOL, V29, P15, DOI 10.1007/s10096-009-0809-2; Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004; Ren Y, 2008, J MICROBIOL METH, V75, P329, DOI 10.1016/j.mimet.2008.07.010; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Russell Deborah A., 1993, Current Opinion in Biotechnology, V4, P714, DOI 10.1016/0958-1669(93)90055-2; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sannes MR, 2004, J INFECT DIS, V190, P2121, DOI 10.1086/425984; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sherwood ER, 2004, LAB INVEST, V84, P1655, DOI 10.1038/labinvest.3700184; STEVENS P, 1983, IMMUNOLOGY, V50, P497; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WONG WT, 1982, J HYG-CAMBRIDGE, V88, P513, DOI 10.1017/S0022172400070364; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	63	143	148	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					799	U201		10.1038/nm.2729	http://dx.doi.org/10.1038/nm.2729			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22522562	Green Submitted, Green Accepted			2022-12-27	WOS:000303763500048
J	Chandarana, K; Batterham, RL				Chandarana, Keval; Batterham, Rachel L.			Metabolic insights from cutting the gut	NATURE MEDICINE			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; SLEEVE-GASTRECTOMY; BARIATRIC SURGERY; WEIGHT-LOSS		[Chandarana, Keval; Batterham, Rachel L.] UCL, Rayne Inst, Dept Med, Obes Res Ctr, London, England	University of London; King's College London; University College London	Chandarana, K (corresponding author), UCL, Rayne Inst, Dept Med, Obes Res Ctr, London, England.	r.batterham@ucl.ac.uk		Batterham, Rachel/0000-0002-5477-8585				Asmar M, 2010, CURR OPIN ENDOCRINOL, V17, P57, DOI 10.1097/MED.0b013e3283339051; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Chandarana K, 2008, CURR OPIN ENDOCRINOL, V15, P65, DOI 10.1097/MED.0b013e3282f3f4b1; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Gill RS, 2011, OBESITY, V19, P701, DOI 10.1038/oby.2010.261; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Melissas J, 2008, OBES SURG, V18, P1251, DOI 10.1007/s11695-008-9634-4; Olivan B, 2009, ANN SURG, V249, P948, DOI 10.1097/SLA.0b013e3181a6cdb0; Peterli R, 2009, ANN SURG, V250, P234, DOI 10.1097/SLA.0b013e3181ae32e3; Rogers GJ, 2011, J PHYSIOL-LONDON, V589, P1081, DOI 10.1113/jphysiol.2010.198069; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Scott WR, 2011, AM J PHYSIOL-REG I, V301, pR15, DOI 10.1152/ajpregu.00038.2011; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tymitz K, 2011, OBES SURG, V21, P125, DOI 10.1007/s11695-010-0311-z	16	30	31	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					668	669		10.1038/nm.2748	http://dx.doi.org/10.1038/nm.2748			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561824				2022-12-27	WOS:000303763500034
J	Liu, PT; Wheelwright, M; Teles, R; Komisopoulou, E; Edfeldt, K; Ferguson, B; Mehta, MD; Vazirnia, A; Rea, TH; Sarno, EN; Graeber, TG; Modlin, RL				Liu, Philip T.; Wheelwright, Matthew; Teles, Rosane; Komisopoulou, Evangelia; Edfeldt, Kristina; Ferguson, Benjamin; Mehta, Manali D.; Vazirnia, Aria; Rea, Thomas H.; Sarno, Euzenir N.; Graeber, Thomas G.; Modlin, Robert L.			MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy	NATURE MEDICINE			English	Article							MYCOBACTERIUM-LEPRAE; HUMAN MACROPHAGES; CANCER-RISK; ACTIVATION; EXPRESSION; RESPONSES; PROFILES; GAMMA	Leprosy provides a model to investigate mechanisms of immune regulation in humans, given that the disease forms a spectrum of clinical presentations that correlate with host immune responses. Here we identified 13 miRNAs that were differentially expressed in the lesions of subjects with progressive lepromatous (L-lep) versus the self-limited tuberculoid (T-lep) disease, Bioinformatic analysis revealed a significant enrichment of L-lep-specific miRNAs that preferentially target key immune genes downregulated in L-lep versus T-lep lesions. The most differentially expressed miRNA in L-lep lesions, hsa-mir-21, was upregulated in Mycobacterium leprae-infected monocytes. By directly downregulating Toll-like receptor 2/1 heterodimer (TLR2/1)-induced CYP2781 and IL1B expression as well as indirectly upregulating interleukin-10 (IL-10), hsa-mir-21 inhibited expression of the genes encoding two vitamin D-dependent antimicrobial peptides, CAMP and DEFB4A. Conversely, knockdown of hsa-mir-21 in M. leprae-infected monocytes enhanced expression of CAMP and DEFB4A and restored TLR2/1-mediated antimicrobial activity against M. leprae. Therefore, the ability of M. leprae to upregulate hsa-mir-21 targets multiple genes associated with the immunologically localized disease form, providing an effective mechanism to escape from the vitamin D-dependent antimicrobial pathway.	[Liu, Philip T.] Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Los Angeles, CA 90024 USA; [Liu, Philip T.; Wheelwright, Matthew; Teles, Rosane; Edfeldt, Kristina; Ferguson, Benjamin; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Mehta, Manali D.; Vazirnia, Aria; Modlin, Robert L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Rea, Thomas H.] Univ So Calif, Sch Med, Dept Dermatol, Los Angeles, CA USA; [Sarno, Euzenir N.] Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, Brazil; [Graeber, Thomas G.] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA USA; [Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Graeber, Thomas G.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, PT (corresponding author), Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Los Angeles, CA 90024 USA.	ptliu@mednet.ucla.edu	Teles, Rosane/AAQ-3436-2020; Teles, Rosane/E-9607-2017; Liu, Philip/C-9638-2011; Modlin, Robert L/M-7941-2014	Teles, Rosane/0000-0003-2908-3244; Teles, Rosane/0000-0003-2908-3244; Modlin, Robert L/0000-0003-4720-031X; Liu, Philip/0000-0002-6144-0304; Wheelwright, Matthew/0000-0001-8883-4453; Graeber, Thomas/0000-0001-8574-9181; Nunes Sarno, Euzenir/0000-0003-0129-2159	US National Institutes of Health [AI 022553, AI 047868, AR 040312, AI 073539, AI 85025]; Wenner-Gren Foundations (Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047868, K22AI085025, R22AI022553, R01AI022553, R01AI082575, R01AI047868, R01AI073539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations (Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank G. Cheng, R. O'Connell, J. Krahenbuhl, R. Lahiri and B. Bloom for their helpful discussions. The live M. leprae was provided by the US National Hansen's Disease Programs through the generous support of the American Leprosy Missions and Society of St. Lazarus of Jerusalem. This work was supported by US National Institutes of Health grants AI 022553, AI 047868, AR 040312 and AI 073539. P.T.L. is supported by US National Institutes of Health K22 Career Development Award AI 85025. K.E. is supported by a postdoctoral grant from the Wenner-Gren Foundations (Sweden). We would like to thank M. Schibler and the University of California-Los Angeles, California NanoSystems Institute, Advanced Light Microscopy Core Facility for their assistance with the confocal studies.	Adams LB, 2002, J INFECT DIS, V185, pS1, DOI 10.1086/338002; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; CLARKCURTISS JE, 1989, J BACTERIOL, V171, P4844, DOI 10.1128/jb.171.9.4844-4851.1989; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; CROWLE AJ, 1987, INFECT IMMUN, V55, P2945, DOI 10.1128/IAI.55.12.2945-2950.1987; Hansen GHA., 1874, NORSK MAG LAEGEVIDEN, V4, P1; HERRERA G, 1949, Int J Lepr, V17, P35; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; NEILL MA, 1988, J EXP MED, V167, P30, DOI 10.1084/jem.167.1.30; Pena MT, 2008, CYTOKINE, V43, P124, DOI 10.1016/j.cyto.2008.04.014; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; ROOK GAW, 1988, AM REV RESPIR DIS, V138, P768, DOI 10.1164/ajrccm/138.4.768; Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; VACHULA M, 1989, J IMMUNOL, V142, P1696; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	27	147	153	1	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					267	273		10.1038/nm.2584	http://dx.doi.org/10.1038/nm.2584			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286305	Green Accepted, Green Submitted			2022-12-27	WOS:000300140300041
J	Mateescu, B; Batista, L; Cardon, M; Gruosso, T; de Feraudy, Y; Mariani, O; Nicolas, A; Meyniel, JP; Cottu, P; Sastre-Garau, X; Mechta-Grigoriou, F				Mateescu, Bogdan; Batista, Luciana; Cardon, Melissa; Gruosso, Tina; de Feraudy, Yvan; Mariani, Odette; Nicolas, Andre; Meyniel, Jean-Philippe; Cottu, Paul; Sastre-Garau, Xavier; Mechta-Grigoriou, Fatima			miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION PROFILES; CANCER-CELLS; E-CADHERIN; P38 MAPK; GENE-EXPRESSION; REPRESSORS ZEB1; TARGETING ZEB1; MESSENGER-RNA; FAMILY	Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38 alpha and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38 alpha deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38 alpha and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.	[Mateescu, Bogdan; Batista, Luciana; Cardon, Melissa; Gruosso, Tina; de Feraudy, Yvan; Mechta-Grigoriou, Fatima] Inst Curie, Stress & Canc Lab, Paris, France; [Mateescu, Bogdan; Batista, Luciana; Cardon, Melissa; Gruosso, Tina; de Feraudy, Yvan; Mechta-Grigoriou, Fatima] INSERM, U830, Paris, France; [Mariani, Odette; Nicolas, Andre; Sastre-Garau, Xavier] Inst Curie, Dept Pathol, Paris, France; [Cottu, Paul] Inst Curie, Dept Med Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Mechta-Grigoriou, F (corresponding author), Inst Curie, Stress & Canc Lab, Paris, France.	fatima.mechta-grigoriou@curie.fr	Mateescu, bogdan/A-3101-2014; Cottu, Paul/ABC-8595-2020; MECHTA-GRIGORIOU, Fatima/C-5253-2017; mateescu, bogdan/C-5194-2012	Mateescu, bogdan/0000-0002-0937-352X; MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; mateescu, bogdan/0000-0002-0937-352X; MEYNIEL, Jean-Philippe/0000-0003-0222-3198; Sastre-Garau, Xavier/0000-0001-5992-2083; Cardon, Melissa/0000-0001-9906-3236	Institut National de la Sante et de la Recherche Medicale; Institut Curie; Ligue Nationale Contre le Cancer; Institut National du Cancer; Association pour la Recherche Contre le Cancer; INSERM	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank O. Delattre and S. Chanock for fruitful discussions and comments on the manuscript. We acknowledge S. Alran and B. Baranger (Surgery Department of Institut Curie) and the Biological Resource Center of Institut Curie for providing human ovarian tumors and B. Hasselain and D. Hajage for advice regarding our statistical analyses. We thank the members of the animal facility and the flow-cytometry platform of Institut Curie for their expertise. The experimental work was supported by grants from Institut National de la Sante et de la Recherche Medicale, the Institut Curie, the Ligue Nationale Contre le Cancer, the Institut National du Cancer and the Association pour la Recherche Contre le Cancer. B.M. was supported by a post-doctoral fellowship from the INSERM Avenir program and the Association pour la Recherche Contre le Cancer.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Konstantinopoulos PA, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-59; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Meyniel Jean-Philippe, 2010, BMC Cancer, V10, P222, DOI 10.1186/1471-2407-10-222; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Z, 2010, BRAIN RES, V1346, P14, DOI 10.1016/j.brainres.2010.05.059; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	60	368	383	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1627	U144		10.1038/nm.2512	http://dx.doi.org/10.1038/nm.2512			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101765				2022-12-27	WOS:000297978000034
J	Nakashima, T; Hayashi, M; Fukunaga, T; Kurata, K; Oh-Hora, M; Feng, JQ; Bonewald, LF; Kodama, T; Wutz, A; Wagner, EF; Penninger, JM; Takayanagi, H				Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Kurata, Kosaku; Oh-hora, Masatsugu; Feng, Jian Q.; Bonewald, Lynda F.; Kodama, Tatsuhiko; Wutz, Anton; Wagner, Erwin F.; Penninger, Josef M.; Takayanagi, Hiroshi			Evidence for osteocyte regulation of bone homeostasis through RANKL expression	NATURE MEDICINE			English	Article							OSTEOBLASTS; MECHANISMS; RECEPTOR; MOUSE	Osteocytes embedded in bone have been postulated to orchestrate bone homeostasis by regulating both bone-forming osteoblasts and bone-resorbing osteoclasts. We find here that purified osteocytes express a much higher amount of receptor activator of nuclear factor-kappa B ligand (RANKL) and have a greater capacity to support osteoclastogenesis in vitro than osteoblasts and bone marrow stromal cells. Furthermore, the severe osteopetrotic phenotype that we observe in mice lacking RANKL specifically in osteocytes indicates that osteocytes are the major source of RANKL in bone remodeling in vivo.	[Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Hayashi, Mikihito; Fukunaga, Takanobu; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Bunkyo Ku, Tokyo, Japan; [Kurata, Kosaku] Kyushu Univ, Fac Engn, Dept Mech Engn, Nishi Ku, Fukuoka 812, Japan; [Feng, Jian Q.] Baylor Coll Dent, Dept Biomed Sci, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA; [Bonewald, Lynda F.] Univ Missouri, Dept Oral Biol, Kansas City, MO 64110 USA; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Tokyo, Japan; [Wutz, Anton] Univ Cambridge, Dept Biochem, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QW, England; [Wagner, Erwin F.] Spanish Natl Canc Ctr, Genes Dev & Dis Grp, Banco Bilbao Vizcaya Argentaria Fdn, Canc Cell Biol Program, Madrid, Spain; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Takayanagi, Hiroshi] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Perth, WA 6009, Australia	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Kyushu University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Missouri System; University of Missouri Kansas City; University of Tokyo; University of Cambridge; Centro Nacional de Investigaciones Oncologicas (CNIO); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Western Australia	Nakashima, T (corresponding author), Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	taka.csi@tmd.ac.jp	Penninger, Josef M/I-6860-2013; Bonewald, Lynda/Q-3638-2019	Penninger, Josef M/0000-0002-8194-3777; Wagner, Erwin F/0000-0001-7872-0196	Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo Biochemical Research Foundation; Life Science Foundation of Japan; Takeda Science Foundation; Uehara Memorial Foundation; Nakatomi Foundation; Nagao Memorial Foundation; Kowa Life Science Foundation; Naito Foundation; Ichiro Kanehara Foundation; Senri Life Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [22021014] Funding Source: KAKEN; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Nagao Memorial Foundation; Kowa Life Science Foundation; Naito Foundation(Naito Memorial Foundation); Ichiro Kanehara Foundation; Senri Life Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to J. Miyazaki for providing CAG-CAT-EGFP transgenic mice and U. Mohle-Steinlein for assisting the generation of A9 embryonic stem cells. We thank S. Fukuse, T. Suda-Kayamori, T. Nishioka-Honda, T. Ando, Y. Kunisawa, E. Idrus, K. Nishikawa, H. Inoue, K. Okamoto, T. Negishi-Koga, M. Shinohara, L. Bakiri,. Uluckan, N. Amizuka, K. Kayamori, A. Yamaguchi and S. Iseki for discussion and assistance. We also thank T. Wada, H. Hara, Y. Nakashima, R. Hanada, T. Hanada, A. Leibbrant, S. J. Cronin, G. G. Neely, N. Joza, J. A. Pospisilik and A. Meixner for technical assistance. This work was supported in part by a grant for the Exploratory Research for Advanced Technology Program, the Takayanagi Osteonetwork Project from the Japan Science and Technology Agency; Grant-in-Aids for Young Scientist A from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Challenging Exploratory Research from the JSPS; grants for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Tokyo Biochemical Research Foundation, the Life Science Foundation of Japan, Takeda Science Foundation, Uehara Memorial Foundation, Nakatomi Foundation, Nagao Memorial Foundation, Kowa Life Science Foundation, Naito Foundation, Ichiro Kanehara Foundation, Senri Life Science Foundation and Astellas Foundation for Research on Metabolic Disorders.	Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hanada R, 2011, J MOL MED, V89, P647, DOI 10.1007/s00109-011-0749-z; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Martin T. J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P243; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062	20	1104	1153	11	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1231	1234		10.1038/nm.2452	http://dx.doi.org/10.1038/nm.2452			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21909105				2022-12-27	WOS:000296022100040
J	Lancaster, MA; Gopal, DJ; Kim, J; Saleem, SN; Silhavy, JL; Louie, CM; Thacker, BE; Williams, Y; Zaki, MS; Gleeson, JG				Lancaster, Madeline A.; Gopal, Dipika J.; Kim, Joon; Saleem, Sahar N.; Silhavy, Jennifer L.; Louie, Carrie M.; Thacker, Bryan E.; Williams, Yuko; Zaki, Maha S.; Gleeson, Joseph G.			Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome	NATURE MEDICINE			English	Article							RETINAL DEGENERATION; CENTROSOMAL PROTEIN; PROGENITOR POOL; MUTATIONS CAUSE; PRIMARY CILIUM; AHI1 GENE; DISORDERS; MORPHOGENESIS; CEP290; MEDULLOBLASTOMA	The ciliopathy Joubert syndrome is marked by cerebellar vermis hypoplasia, a phenotype for which the pathogenic mechanism is unclear(1-3). To investigate Joubert syndrome pathogenesis, we have examined mice with mutated Ahi1, the first identified Joubert syndrome-associated gene(4,5). These mice show cerebellar hypoplasia with a vermis-midline fusion defect early in development. This defect is concomitant with expansion of the roof plate and is also evident in a mouse mutant for another Joubert syndrome-associated gene, Cep290(6,7). Furthermore, fetal magnetic resonance imaging (MRI) of human subjects with Joubert syndrome reveals a similar midline cleft, suggesting parallel pathogenic mechanisms. Previous evidence has suggested a role for Jouberin (Jbn), the protein encoded by Ahi1, in canonical Wnt signaling(8). Consistent with this, we found decreased Wnt reporter activity at the site of hemisphere fusion in the developing cerebellum of Ahi1-mutant mice. This decrease was accompanied by reduced proliferation at the site of fusion. Finally, treatment with lithium, a Wnt pathway agonist(9), partially rescued this phenotype. Our findings implicate a defect in Wnt signaling in the cerebellar midline phenotype seen in Joubert syndrome that can be overcome with Wnt stimulation.	[Lancaster, Madeline A.; Gopal, Dipika J.; Kim, Joon; Silhavy, Jennifer L.; Louie, Carrie M.; Thacker, Bryan E.; Williams, Yuko; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat & Neurosci,Inst Genom Med, San Diego, CA 92103 USA; [Saleem, Sahar N.] Cairo Univ, Kasr Al Ainy Hosp, Dept Radiol, Cairo, Egypt; [Zaki, Maha S.] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo, Egypt	Howard Hughes Medical Institute; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat & Neurosci,Inst Genom Med, San Diego, CA 92103 USA.	jogleeson@ucsd.edu	Zaki, Maha S/B-9361-2013; Kim, Joon/C-1833-2011; Saleem, Sahar N/A-3651-2008	Saleem, Sahar N/0000-0001-6713-9099; Lancaster, Madeline/0000-0003-2324-8853; Zaki, Maha/0000-0001-7840-0002; Thacker, Bryan/0000-0003-0517-0810	Bear Necessities Pediatric Cancer Foundation; US National Institutes of Health-National Institute of General Medical Sciences [T32 GM08666]; US National Institutes of Health [P30NS047101, R01NS052455, R01NS048453]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, R01NS052455] Funding Source: NIH RePORTER	Bear Necessities Pediatric Cancer Foundation; US National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to members of the Gleeson lab for technical expertise and feedback and B. Hamilton, M. Hatten and A. Joyner for helpful discussions on cerebellar development. We also thank the study subjects and the UCSD Neuroscience Microscopy Core. We thank J.K. Lee and B. Zheng for help with the biotinylated dextran amine tracing assay. We are grateful to S. Piccolo (University of Padua) for the BATgal mice. We thank R.T. Moon (University of Washington) for the Super Topflash construct and P. Mellon (UCSD) for the beta-galactosidase expression construct, as well as K. Willert (UCSD) for stably transfected L cells and the beta-catenin expression plasmid. M.A.L. received support from the Bear Necessities Pediatric Cancer Foundation and US National Institutes of Health-National Institute of General Medical Sciences-funded UCSD Genetics Training Program (T32 GM08666). This work was supported by the US National Institutes of Health (grants P30NS047101, R01NS052455 and R01NS048453) and the Burroughs Wellcome Fund in Translational Research (J.G.G.). J.G.G. is an investigator with Howard Hughes Medical Institute.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; COOPER PA, 1991, BEHAV GENET, V21, P405, DOI 10.1007/BF01065976; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; FRIEDE RL, 1978, DEV MED CHILD NEUROL, V20, P758; Grimmer MR, 2008, GENE DEV, V22, P693, DOI 10.1101/gad.1657808; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Saleem SN, 2010, AM J NEURORADIOL, V31, P424, DOI 10.3174/ajnr.A1867; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013	40	104	112	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					726	U119		10.1038/nm.2380	http://dx.doi.org/10.1038/nm.2380			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21623382	Green Accepted			2022-12-27	WOS:000291308800034
J	Flach, TL; Ng, G; Hari, A; Desrosiers, MD; Zhang, P; Ward, SM; Seamone, ME; Vilaysane, A; Mucsi, AD; Fong, Y; Prenner, E; Ling, CC; Tschopp, J; Muruve, DA; Amrein, MW; Shi, Y				Flach, Tracy L.; Ng, Gilbert; Hari, Aswin; Desrosiers, Melanie D.; Zhang, Ping; Ward, Sandra M.; Seamone, Mark E.; Vilaysane, Akosua; Mucsi, Ashley D.; Fong, Yin; Prenner, Elmar; Ling, Chang Chun; Tschopp, Jurg; Muruve, Daniel A.; Amrein, Matthias W.; Shi, Yan			Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity	NATURE MEDICINE			English	Article							MONOSODIUM URATE CRYSTALS; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; CROSS-PRESENTATION; VACCINE ADJUVANTS; IMMUNE-RESPONSES; SOLID-SURFACES; URIC-ACID; ACTIVATION; PHAGOCYTOSIS	As an approved vaccine adjuvant for use in humans, alum has vast health implications, but, as it is a crystal, questions remain regarding its mechanism. Furthermore, little is known about the target cells, receptors, and signaling pathways engaged by alum. Here we report that, independent of inflammasome and membrane proteins, alum binds dendritic cell (DC) plasma membrane lipids with substantial force. Subsequent lipid sorting activates an abortive phagocytic response that leads to antigen uptake. Such activated DCs, without further association with alum, show high affinity and stable binding with CD4(+) T cells via the adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1). We propose that alum triggers DC responses by altering membrane lipid structures. This study therefore suggests an unexpected mechanism for how this crystalline structure interacts with the immune system and how the DC plasma membrane may behave as a general sensor for solid structures.	[Flach, Tracy L.; Ng, Gilbert; Hari, Aswin; Desrosiers, Melanie D.; Mucsi, Ashley D.; Fong, Yin; Shi, Yan] Univ Calgary, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB, Canada; [Flach, Tracy L.; Ng, Gilbert; Hari, Aswin; Desrosiers, Melanie D.; Mucsi, Ashley D.; Fong, Yin; Shi, Yan] Univ Calgary, Snyder Inst, Calgary, AB, Canada; [Zhang, Ping; Ward, Sandra M.; Ling, Chang Chun] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; [Zhang, Ping; Ward, Sandra M.; Ling, Chang Chun] Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB, Canada; [Seamone, Mark E.; Vilaysane, Akosua; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Prenner, Elmar] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Amrein, Matthias W.] Univ Calgary, Dept Biol & Anat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Lausanne; University of Calgary	Shi, Y (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB, Canada.	yshi@ucalgary.ca	Shi, Yan/Y-6642-2019; Prenner, Elmar J/E-5549-2011		US National Institutes of Health; JPK instruments; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089963] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPK instruments; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Lanier and C. Lowell (University of California-San Francisco) for providing mouse bone marrows; P. Kubes (University of Calgary) for ICAM-1-, LFA-1- and TLR4-knockout mice; K. Rock (University of Massachusetts Medical School), P. Cresswell (Yale University), G. Dranoff (Harvard Medical School) and R. Yates and J. Deans (University of Calgary) for cell lines, L. J. Shen, M. Ho, Y. Yang and P. Santamaria for manuscript review; C. Olson and T. Fung for statistical software and advice; E. Chau for manuscript editing; F. Oskouie for cell culture assistance; and M. Schoel and W.-D. Xiang for SEM and transmission electron microscopy technical assistance. This work was supported by grants from the US National Institutes of Health to Y. S. and equipment donation from JPK instruments to M. W. A.	Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; COLIGAN JE, 2005, SHORT PROTOCOLS IMMU, pCH1; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; GARRY VF, 1993, J LAB CLIN MED, V122, P739; Glenny AT, 1931, J PATHOL BACTERIOL, V34, P267, DOI 10.1002/path.1700340214; GOLDSTEIN J, 2003, SCANNING ELECT MICRO, pCH7; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Harlow E., 1988, ANTIBODIES; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kanevets U, 2009, J IMMUNOL, V182, P1912, DOI 10.4049/jimmunol.0803777; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kovjazin R, 2003, FASEB J, V17, P467, DOI 10.1096/fj.02-0558fje; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Leonenko Z, 2007, ULTRAMICROSCOPY, V107, P948, DOI 10.1016/j.ultramic.2007.02.036; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; NOLLERT P, 1995, BIOPHYS J, V69, P1447, DOI 10.1016/S0006-3495(95)80014-7; PARHAM P, 2004, IMMUNE SYSTEM, pCH12; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; Rimaniol AC, 2004, VACCINE, V22, P3127, DOI 10.1016/j.vaccine.2004.01.061; Rock KL, 2006, IMMUNITY, V25, P523, DOI 10.1016/j.immuni.2006.09.003; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003; Sun HF, 2003, VACCINE, V21, P849, DOI 10.1016/S0264-410X(02)00531-5; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	50	273	279	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					479	U121		10.1038/nm.2306	http://dx.doi.org/10.1038/nm.2306			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21399646				2022-12-27	WOS:000289245100039
J	Bassat, Q; Alonso, PL				Bassat, Quique; Alonso, Pedro L.			Defying malaria Fathoming severe Plasmodium vivax disease	NATURE MEDICINE			English	Editorial Material							CLINICAL-FEATURES; CHILDREN; BIKANER; PAPUA; INDIA		[Bassat, Quique; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain; [Bassat, Quique; Alonso, Pedro L.] Ctr Invest Saude Manhica, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Bassat, Q (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain.	quique.bassat@cresib.cat	Alonso, Pedro L/AAZ-3645-2020; Bassat, Quique/P-2341-2016	Alonso, Pedro L/0000-0003-3292-3443; Bassat, Quique/0000-0003-0875-7596				Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Clark IA, 1999, PARASITOL TODAY, V15, P458, DOI 10.1016/S0169-4758(99)01535-5; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128	16	50	50	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2011	17	1					48	49		10.1038/nm0111-48	http://dx.doi.org/10.1038/nm0111-48			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21217683				2022-12-27	WOS:000285994000034
J	Ridky, TW; Chow, JM; Wong, DJ; Khavari, PA				Ridky, Todd W.; Chow, Jennifer M.; Wong, David J.; Khavari, Paul A.			Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia	NATURE MEDICINE			English	Article							EXTRACELLULAR-MATRIX; CANCER PROGRESSION; BASEMENT-MEMBRANE; CELLS; RAS; TRANSFORMATION; GENOME; TISSUE; REQUIREMENTS; ASSOCIATION	Refined cancer models are required if researchers are to assess the burgeoning number of potential targets for cancer therapeutics in a clinically relevant context that allows a fast turnaround. Here we use tumor-associated genetic pathways to transform primary human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-dimensional (3D) tissue environment that incorporates cell-populated stroma and intact basement membrane. These engineered organotypic tissues recapitulated natural features of tumor progression, including epithelial invasion through basement membrane, a complex process that is necessary for biological malignancy in 90% of human cancers. Invasion was rapid and was potentiated by stromal cells. Oncogenic signals in 3D tissue, but not 2D culture, resembled gene expression profiles from spontaneous human cancers. We screened 3D organotypic neoplasia with well-characterized signaling pathway inhibitors to distill a clinically faithful cancer gene signature. Multitissue 3D human tissue cancer models may provide an efficient and relevant complement to current approaches to characterizing cancer progression.	[Ridky, Todd W.; Chow, Jennifer M.; Wong, David J.; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Ridky, Todd W.; Chow, Jennifer M.; Wong, David J.; Khavari, Paul A.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Ridky, Todd/0000-0001-8482-1284	National Institutes of Health [AR43799, K08AR053195]; NATIONAL CANCER INSTITUTE [R01CA163566, F32CA099473, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR053195, R01AR043799, R29AR043799, R01AR049737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant AR43799 to P. A. K. We thank A. Oro, P. Marinkovich, H. Chang, D. Felsher, S. Artandi, A. Sweet-Cordero, M. Scott, G. Sen, Z. Siprashvili, M. Kretz and J. Reuter for presubmission review of the manuscript. T. W. R. is the recipient of career development award National Institutes of Health K08AR053195.	Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Cox AD, 2010, CANCER CELL, V17, P221, DOI 10.1016/j.ccr.2010.02.029; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Forbes SA, 2008, CURR PROTOC HUM GENE, V57, DOI DOI 10.11.1-10.11.26; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Horner MJ, 2010, SEER CANC STAT REV 1; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Kao WT, 2008, ANTICANCER RES, V28, P2109; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee TL, 2007, CLIN CANCER RES, V13, P5680, DOI 10.1158/1078-0432.CCR-07-0670; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MARINKOVICH MP, 1993, DEV DYNAM, V197, P255, DOI 10.1002/aja.1001970404; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tarutani M, 2003, CANCER RES, V63, P319; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026	28	157	165	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1450	U137		10.1038/nm.2265	http://dx.doi.org/10.1038/nm.2265			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102459	Green Accepted			2022-12-27	WOS:000285048900041
J	Barry-Hamilton, V; Spangler, R; Marshall, D; McCauley, S; Rodriguez, HM; Oyasu, M; Mikels, A; Vaysberg, M; Ghermazien, H; Wai, C; Garcia, CA; Velayo, AC; Jorgensen, B; Biermann, D; Tsai, D; Green, J; Zaffryar-Eilot, S; Holzer, A; Ogg, S; Thai, D; Neufeld, G; Van Vlasselaer, P; Smith, V				Barry-Hamilton, Vivian; Spangler, Rhyannon; Marshall, Derek; McCauley, Scott; Rodriguez, Hector M.; Oyasu, Miho; Mikels, Amanda; Vaysberg, Maria; Ghermazien, Haben; Wai, Carol; Garcia, Carlos A.; Velayo, Arleene C.; Jorgensen, Brett; Biermann, Donna; Tsai, Daniel; Green, Jennifer; Zaffryar-Eilot, Shelly; Holzer, Alison; Ogg, Scott; Thai, Dung; Neufeld, Gera; Van Vlasselaer, Peter; Smith, Victoria			Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment	NATURE MEDICINE			English	Article							TUMOR-GROWTH; PULMONARY-FIBROSIS; HUMAN BREAST; IN-VIVO; DESMOPLASTIC REACTION; STROMAL FIBROBLASTS; MOLECULAR ROLE; CELL-LINES; CANCER; PROMOTES	We have identified a new role for the matrix enzyme lysyl oxidase-like-2 (LOXL2) in the creation and maintenance of the pathologic microenvironment of cancer and fibrotic disease. Our analysis of biopsies from human tumors and fibrotic lung and liver tissues revealed an increase in LOXL2 in disease-associated stroma and limited expression in healthy tissues. Targeting LOXL2 with an inhibitory monoclonal antibody (AB0023) was efficacious in both primary and metastatic xenograft models of cancer, as well as in liver and lung fibrosis models. Inhibition of LOXL2 resulted in a marked reduction in activated fibroblasts, desmoplasia and endothelial cells, decreased production of growth factors and cytokines and decreased transforming growth factor-beta (TGF-beta) pathway signaling. AB0023 outperformed the small-molecule lysyl oxidase inhibitor beta-aminoproprionitrile. The efficacy and safety of LOXL2-specific AB0023 represents a new therapeutic approach with broad applicability in oncologic and fibrotic diseases.	[Barry-Hamilton, Vivian; Spangler, Rhyannon; Marshall, Derek; McCauley, Scott; Rodriguez, Hector M.; Oyasu, Miho; Mikels, Amanda; Vaysberg, Maria; Ghermazien, Haben; Wai, Carol; Garcia, Carlos A.; Velayo, Arleene C.; Jorgensen, Brett; Biermann, Donna; Tsai, Daniel; Green, Jennifer; Holzer, Alison; Ogg, Scott; Thai, Dung; Van Vlasselaer, Peter; Smith, Victoria] Arresto BioSci, Palo Alto, CA USA; [Zaffryar-Eilot, Shelly; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Smith, V (corresponding author), Arresto BioSci, Palo Alto, CA USA.	vsmith@arresto.com	Neufeld, Gera/F-1524-2019	McCauley, Scott/0000-0003-4549-5599				Akiri G, 2003, CANCER RES, V63, P1657; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cardone A, 1997, PANMINERVA MED, V39, P174; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Constandinou C, 2005, METH MOLEC MED, V117, P237; Conti JA, 2008, CLIN CANCER RES, V14, P6405, DOI 10.1158/1078-0432.CCR-08-0816; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; HLATKY L, 1994, CANCER RES, V54, P6083; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Inagaki Y, 2001, J CELL PHYSIOL, V187, P117, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Park SH, 1997, AM J RESP CRIT CARE, V156, P600, DOI 10.1164/ajrccm.156.2.9607123; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Pulichino AM, 2008, AM J RESP CELL MOL, V39, P324, DOI 10.1165/rcmb.2007-0186OC; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Tahashi Y, 2002, HEPATOLOGY, V35, P49, DOI 10.1053/jhep.2002.30083; TANG SS, 1983, J BIOL CHEM, V258, P4331; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702	58	609	643	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1009	U107		10.1038/nm.2208	http://dx.doi.org/10.1038/nm.2208			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20818376				2022-12-27	WOS:000281622900030
J	Ellisen, LW				Ellisen, Leif W.			Smoking and emphysema: the stress connection	NATURE MEDICINE			English	Editorial Material							HYPOXIA; DISEASE; REDD1	The stress response protein Rtp801 mediates damage to the lung in response to smoke. This finding might lead to new ways to treat chronic obstructive pulmonary disease and emphysema ( pages 767-773).	[Ellisen, Leif W.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ellisen, Leif W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ellisen, LW (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	ellisen@helix.mgh.harvard.edu	Ellisen, Leif W/AAA-6572-2022	Ellisen, Leif W/0000-0003-0444-7910	NCI NIH HHS [R01 CA122589] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA122589] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157	11	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					754	755		10.1038/nm0710-754	http://dx.doi.org/10.1038/nm0710-754			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613751				2022-12-27	WOS:000279631900021
J	Loser, K; Vogl, T; Voskort, M; Lueken, A; Kupas, V; Nacken, W; Klenner, L; Kuhn, A; Foell, D; Sorokin, L; Luger, TA; Roth, J; Beissert, S				Loser, Karin; Vogl, Thomas; Voskort, Maik; Lueken, Aloys; Kupas, Verena; Nacken, Wolfgang; Klenner, Lars; Kuhn, Annegret; Foell, Dirk; Sorokin, Lydia; Luger, Thomas A.; Roth, Johannes; Beissert, Stefan			The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8(+) T cells	NATURE MEDICINE			English	Article							CUTANEOUS LUPUS-ERYTHEMATOSUS; CD40 LIGAND; S100 PROTEINS; SYSTEMIC AUTOIMMUNITY; DENDRITIC CELLS; IN-VITRO; ARTHRITIS; DISEASE; SKIN; EXPRESSION	Mechanisms linking innate immunity and autoimmune responses are poorly understood(1). Myeloid-related protein-8 (Mrp8) and Mrp14 are damage-associated molecular pattern molecules (DAMPs) highly upregulated in various autoimmune disorders. We show in a mouse autoimmune model that local Mrp8 and Mrp14 production is essential for the induction of autoreactive CD8(+) T cells and the development of systemic autoimmunity. This effect is mediated via Toll-like receptor 4 (TLR4) signaling leading to increased interleukin-17 (IL-17) expression. Notably, expression of Mrp8 and Mrp14 was upregulated in cutaneous lupus erythematosus, and stimulation of CD8(+) T cells from individuals with lupus erythematosus with MRP proteins resulted in an upregulation of IL-17, suggesting a key role for MRP8 and MRP14 for the development of autoreactive lymphocytes during human autoimmunity as well. These results demonstrate a link between local expression of DAMP molecules and the development of systemic autoimmunity.	[Loser, Karin; Voskort, Maik; Kupas, Verena; Klenner, Lars; Kuhn, Annegret; Luger, Thomas A.; Beissert, Stefan] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Loser, Karin; Vogl, Thomas; Luger, Thomas A.; Roth, Johannes; Beissert, Stefan] Univ Munster, Interdisciplinary Ctr Clin Res, D-4400 Munster, Germany; [Vogl, Thomas; Lueken, Aloys; Foell, Dirk; Roth, Johannes] Univ Munster, Inst Immunol, D-4400 Munster, Germany; [Nacken, Wolfgang] Univ Munster, Inst Mol Virol, D-4400 Munster, Germany; [Sorokin, Lydia] Univ Munster, Inst Pathobiochem, D-4400 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster	Loser, K (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-4400 Munster, Germany.	loserk@uni-muenster.de		Sorokin, Lydia/0000-0001-7704-7921	Interdisciplinary Center of Clinical Research [Lo2/017/07, Vo2/014/09]; German Cancer Society [107891]; Federal Ministry of Education and Research [AID-Net]; German Research Association [Lo817/21]	Interdisciplinary Center of Clinical Research; German Cancer Society; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Association(German Research Foundation (DFG))	We would like to thank H. Hinte and C. Sole for excellent technical assistance. This work was supported by the Interdisciplinary Center of Clinical Research grant Lo2/017/07 to K.L. and S.B. as well as grant Vo2/014/09 to T.V., by the German Cancer Society grant 107891 to K.L. and S.B., by the Federal Ministry of Education and Research, project AID-Net to J.R. and by the German Research Association grant Lo817/21 to K.L. and S.B.	Bogumil T, 1998, NEUROSCI LETT, V247, P195, DOI 10.1016/S0304-3940(98)00263-8; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Caproni M, 2007, J RHEUMATOL, V34, P2412; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Lee HJ, 2006, AUTOIMMUNITY, V39, P433, DOI 10.1080/08916930600886851; Loser K, 2005, GENE THER, V12, P1294, DOI 10.1038/sj.gt.3302567; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stutte S, 2008, J INVEST DERMATOL, V128, P1470, DOI 10.1038/sj.jid.5701228; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	29	212	222	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					713	U119		10.1038/nm.2150	http://dx.doi.org/10.1038/nm.2150			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473308				2022-12-27	WOS:000278394200039
J	Sun, Z; Miller, RA; Patel, RT; Chen, J; Dhir, R; Wang, H; Zhang, DY; Graham, MJ; Unterman, TG; Shulman, GI; Sztalryd, C; Bennett, MJ; Ahima, RS; Birnbaum, MJ; Lazar, MA				Sun, Zheng; Miller, Russell A.; Patel, Rajesh T.; Chen, Jie; Dhir, Ravindra; Wang, Hong; Zhang, Dongyan; Graham, Mark J.; Unterman, Terry G.; Shulman, Gerald I.; Sztalryd, Carole; Bennett, Michael J.; Ahima, Rexford S.; Birnbaum, Morris J.; Lazar, Mitchell A.			Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration	NATURE MEDICINE			English	Article							DIFFERENTIATION-RELATED PROTEIN; FATTY LIVER-DISEASE; INDUCED INSULIN-RESISTANCE; HISTONE DEACETYLASES; METABOLIC-DISORDERS; VLDL SECRETION; MICE; GLUCOSE; STEATOSIS; FOXO1	Fatty liver disease is associated with obesity and type 2 diabetes, and hepatic lipid accumulation may contribute to insulin resistance. Histone deacetylase 3 (Hdac3) controls the circadian rhythm of hepatic lipogenesis. Here we show that, despite severe hepatosteatosis, mice with liver-specific depletion of Hdac3 have higher insulin sensitivity without any changes in insulin signaling or body weight compared to wild-type mice. Hdac3 depletion reroutes metabolic precursors towards lipid synthesis and storage within lipid droplets and away from hepatic glucose production. Perilipin 2, which coats lipid droplets, is markedly induced upon Hdac3 depletion and contributes to the development of both steatosis and improved tolerance to glucose. These findings suggest that the sequestration of hepatic lipids in perilipin 2-coated droplets ameliorates insulin resistance and establish Hdac3 as a pivotal epigenomic modifier that integrates signals from the circadian clock in the regulation of hepatic intermediary metabolism.	[Sun, Zheng; Miller, Russell A.; Patel, Rajesh T.; Dhir, Ravindra; Ahima, Rexford S.; Birnbaum, Morris J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng; Miller, Russell A.; Patel, Rajesh T.; Dhir, Ravindra; Ahima, Rexford S.; Birnbaum, Morris J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Chen, Jie; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Hong; Sztalryd, Carole] Univ Maryland, Baltimore Vet Affairs Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, Dept Med,Div Endocrinol,Sch Med, Baltimore, MD 21201 USA; [Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Graham, Mark J.] Isis Pharmaceut Inc, Carlsbad, CA USA; [Unterman, Terry G.] Univ Illinois, Sect Endocrinol Diabet & Metab, Chicago, IL USA; [Unterman, Terry G.] Jesse Brown Virginia Med Ctr, Chicago, IL USA; [Bennett, Michael J.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; Yale University; Isis Pharmaceuticals Inc; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Sun, Zheng/C-1146-2012; Lazar, Mitchell A/AAF-3738-2019; Shulman, Gerald I./P-7176-2019; Ahima, Rexford/W-1394-2019	Sun, Zheng/0000-0002-6858-0633; Shulman, Gerald I./0000-0003-1529-5668; Chen, Jie/0000-0002-7887-3747; Birnbaum, Morris/0000-0001-9972-8680	US National Institutes of Health [R37 DK43806, P01 DK49210, R01 DK40936, R01 DK075017]; Department of Veteran Affairs [F32 DK079572]; JPB Foundation; Cox Institute for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075017, P01DK049210, P01DK049814, U24DK059635, R01DK056886, F32DK079572, P30DK072488, R01DK040936, P30DK019525, R37DK043806] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); JPB Foundation; Cox Institute for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Millar and the Metabolic Tracer Resource at the Penn Institute for Diabetes, Obesity and Metabolism for the lipogenesis flux assay. We thank the Mouse Metabolic Phenotyping Core and the Viral Vector Core at Penn Diabetes Research Center (P30 DK19525) and the Penn Digestives Disease Center Morphology Core (P30 DK050306) at the University of Pennsylvania. We thank the Vanderbilt (DK59637) and Yale (U24 DK059635) Mouse Metabolic Phenotyping Centers and the Children's Hospital of Philadelphia Pathology Core. We thank B. Agarwal and S. Mullican for helpful discussion. This work was supported by US National Institutes of Health grants R37 DK43806 (M. A. L.), P01 DK49210 (M. A. L., M. J. Birnbaum and R. S. A.) and R01 DK40936 (G. I. S.), R01 DK075017 (C. S.), the Department of Veteran Affairs Merit Review Program (T. G. U.), grant F32 DK079572 (R. A. M.), the JPB Foundation and the Cox Institute for Medical Research.	Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lonardo A, 2011, EXPERT REV GASTROENT, V5, P279, DOI [10.1586/EGH.11.19, 10.1586/egh.11.19]; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Mutel E, 2011, DIABETES, V60, P3121, DOI 10.2337/db11-0571; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; NILSSON A, 1984, LIPIDS, V19, P187, DOI 10.1007/BF02534796; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schonfeld G., 2008, T AM CLIN CLIMAT ASS, V119, P223; Schonfeld Gustav, 2008, Trans Am Clin Climatol Assoc, V119, P217; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sun Z, 2011, COLD SH Q B, V76, P49, DOI 10.1101/sqb.2011.76.011494; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	61	231	234	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					934	+		10.1038/nm.2744	http://dx.doi.org/10.1038/nm.2744			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561686	Green Accepted			2022-12-27	WOS:000305116600031
J	Cummings, DE				Cummings, David E.			Metabolic surgery for type 2 diabetes	NATURE MEDICINE			English	Editorial Material							BARIATRIC SURGERY; LIFE-STYLE; MECHANISMS; MORTALITY; RISK	Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.	[Cummings, David E.] Univ Washington, Seattle, WA 98195 USA; [Cummings, David E.] VA Puget Sound Hlth Care Syst, Diabet & Obes Ctr Excellence, Seattle, WA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Cummings, DE (corresponding author), Univ Washington, Seattle, WA 98195 USA.	davidec@u.washington.edu						Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GRUNDY SM, 1991, ANN INTERN MED, V115, P956; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mingrone G, 2012, NEW ENGL J MED, DOI [10.1056/NEJMoa1200111, DOI 10.1056/NEJMOA1200111]; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Schauer PR, 2012, NEW ENGL J MED, DOI [10.1056/NEJMoa1200225, DOI 10.1056/NEJMOA1200225]; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Zimmet P, 2011, LANCET, V378, P108, DOI 10.1016/S0140-6736(11)61027-1	16	24	26	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					656	658		10.1038/nm.2773	http://dx.doi.org/10.1038/nm.2773			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561818				2022-12-27	WOS:000303763500026
J	Little, TJ; Allen, JE; Babayan, SA; Matthews, KR; Colegrave, N				Little, Tom J.; Allen, Judith E.; Babayan, Simon A.; Matthews, Keith R.; Colegrave, Nick			Harnessing evolutionary biology to combat infectious disease	NATURE MEDICINE			English	Article							RESISTANCE; DYNAMICS; INFLAMMATION	Pathogens have remarkable abilities to flout therapeutic intervention. This characteristic is driven by evolution, either as a direct response to intervention (for example, the evolution of antibiotic resistance) or through long-term co-evolution that generates host or parasite traits that interact with therapy in undesirable or unpredicted ways. To make progress towards successful control of infectious diseases, the concepts and techniques of evolutionary biology must be deeply integrated with traditional approaches to immunology and pathogen biology. An interdisciplinary approach can inform our strategies to control pathogens or even the treatment of infected patients, positioning us to meet the current and future challenges of controlling infectious diseases.	[Little, Tom J.; Allen, Judith E.; Babayan, Simon A.; Matthews, Keith R.; Colegrave, Nick] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Little, TJ (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	tom.little@ed.ac.uk	Little, Tom J/B-7890-2009; Allen, Judith E/C-9198-2011; Babayan, Simon/E-1807-2011	Little, Tom J/0000-0002-8945-0416; Allen, Judith E/0000-0002-3829-066X; Babayan, Simon/0000-0002-4949-1117; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184	Wellcome Trust [079235] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Babayan SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000525; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; CONRADT U, 1992, PARASITOL RES, V78, P123, DOI 10.1007/BF00931653; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gandon S, 2008, VACCINE, V26, pC4, DOI 10.1016/j.vaccine.2008.02.007; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Harnett W, 2006, PARASITE IMMUNOL, V28, P535, DOI 10.1111/j.1365-3024.2006.00893.x; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Kafatos FC, 2004, SCIENCE, V303, P1257, DOI 10.1126/science.303.5662.1257; Koella JC, 2009, ADV PARASIT, V68, P315, DOI 10.1016/S0065-308X(08)00612-X; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Leslie M, 2010, SCIENCE, V327, P1573, DOI 10.1126/science.327.5973.1573; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; McGeer A, 2003, NAT MED, V9, P390, DOI 10.1038/nm0403-390; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pedersen A., 2010, MOL ECOL, V20, P643; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Schneider P., 2010, MALARIA J, V9, pP45; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; SCOTT ME, 1991, PARASITOLOGY, V103, P429, DOI 10.1017/S0031182000059953; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	46	23	23	0	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					217	220		10.1038/nm.2572	http://dx.doi.org/10.1038/nm.2572			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310693	Green Accepted			2022-12-27	WOS:000300140300033
J	Sullivan, PF				Sullivan, Patrick F.			Schizophrenia as a pathway disease	NATURE MEDICINE			English	Editorial Material							MICRORNA	Effective treatment for schizophrenia is still an unmet clinical need. Alleviating problems associated with cognitive impairment and finding the root of the disease remain priorities for clinicians and scientists. The incomplete understanding of the basis of this pathology has urged for research that will unravel the genetic origin of schizophrenia. But studies involving environmental exposure and social impact have also hinted at extrinsic factors as players in the pathogenesis of schizophrenia, which may be exploited to prevent the development of the disease. In 'Bench to Bedside', Patrick Sullivan proposes a model putting forward how genetic variants may confer risk by functioning together within the same pathway. This disease pathway hypothesis would imply a polygenetic variation affecting the same pathway and the alteration of a transcriptional network as a root for increasing schizophrenia risk. In 'Bedside to Bench', Andreas Meyer-Linderberg and Heike Tost discuss human-based population studies that suggest that environmental factors linked to development of schizophrenia can affect brain regions involved in the human social-emotional processing network. Genetic risk variants for schizophrenia can also influence similar regions in the brain, suggesting that environmental and intrinsic factors may converge in the same neural circuit.	[Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	Sullivan, PF (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	pfsulliv@med.unc.edu			NIMH NIH HHS [R01 MH077139, U01 MH085520] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, U01MH085520] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; FRIEDHOFF AJ, 1962, NATURE, V194, P897, DOI 10.1038/194897b0; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lee S., NAT GENET IN PRESS; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456	20	58	58	0	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					210	211		10.1038/nm.2670	http://dx.doi.org/10.1038/nm.2670			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310687	Green Accepted			2022-12-27	WOS:000300140300031
J	Koyama, M; Kuns, RD; Olver, SD; Raffelt, NC; Wilson, YA; Don, ALJ; Lineburg, KE; Cheong, M; Robb, RJ; Markey, KA; Varelias, A; Malissen, B; Hammerling, GJ; Clouston, AD; Engwerda, CR; Bhat, P; MacDonald, KPA; Hill, GR				Koyama, Motoko; Kuns, Rachel D.; Olver, Stuart D.; Raffelt, Neil C.; Wilson, Yana A.; Don, Alistair L. J.; Lineburg, Katie E.; Cheong, Melody; Robb, Renee J.; Markey, Kate A.; Varelias, Antiopi; Malissen, Bernard; Haemmerling, Guenter J.; Clouston, Andrew D.; Engwerda, Christian R.; Bhat, Purnima; MacDonald, Kelli P. A.; Hill, Geoffrey R.			Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease	NATURE MEDICINE			English	Article							PLASMACYTOID DENDRITIC CELLS; MEMORY T-CELLS; ALLOANTIGEN; EXPRESSION; PREVENTION; TOLERANCE; DEPLETION; GVHD; APCS	The presentation pathways by which allogeneic peptides induce graft-versus-host disease (GVHD) are unclear. We developed a bone marrow transplant (BMT) system in mice whereby presentation of a processed recipient peptide within major histocompatibility complex (MHC) class II molecules could be spatially and temporally quantified. Whereas donor antigen presenting cells (APCs) could induce lethal acute GVHD via MHC class II, recipient APCs were 100-1,000 times more potent in this regard. After myeloablative irradiation, T cell activation and memory differentiation occurred in lymphoid organs independently of alloantigen. Unexpectedly, professional hematopoietic-derived recipient APCs within lymphoid organs had only a limited capacity to induce GVHD, and dendritic cells were not required. In contrast, nonhematopoietic recipient APCs within target organs induced universal GVHD mortality and promoted marked alloreactive donor T cell expansion within the gastrointestinal tract and inflammatory cytokine generation. These data challenge current paradigms, suggesting that experimental lethal acute GVHD can be induced by nonhematopoietic recipient APCs.	[Koyama, Motoko; Kuns, Rachel D.; Olver, Stuart D.; Raffelt, Neil C.; Wilson, Yana A.; Don, Alistair L. J.; Lineburg, Katie E.; Cheong, Melody; Robb, Renee J.; Markey, Kate A.; Varelias, Antiopi; Engwerda, Christian R.; MacDonald, Kelli P. A.; Hill, Geoffrey R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Malissen, Bernard] Ctr Immunol Marseille Luminy, Marseille, France; [Haemmerling, Guenter J.] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Clouston, Andrew D.] Envoi Pathol, Brisbane, Qld, Australia; [Bhat, Purnima] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Hill, Geoffrey R.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; German Cancer Research Center (DKFZ); University of Queensland; Royal Brisbane & Women's Hospital	Hill, GR (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	geoff.hill@qimr.edu.au	MacDonald, Kelli/AAV-5365-2020; Bhat, Purnima/D-9071-2012; Engwerda, Christian/I-3072-2015; Bhat, Purnima/I-5368-2016; MacDonald, Kelli PA/O-2722-2016; Wilson, Yana/AAM-9544-2021; Clouston, Andrew D/E-7199-2011; Hill, Geoffrey/O-2630-2016; Lineburg, Katie E/L-3268-2018; Robb, Renee/I-6853-2012; Varelias, Antiopi/A-6516-2015; Markey, Kate/A-5385-2016; Malissen, Bernard/AAK-4659-2020	Bhat, Purnima/0000-0002-2980-0584; MacDonald, Kelli PA/0000-0003-3451-4221; Clouston, Andrew D/0000-0002-9601-7952; Hill, Geoffrey/0000-0003-2994-0429; Lineburg, Katie E/0000-0002-5712-2610; Varelias, Antiopi/0000-0002-3437-9659; Engwerda, Christian/0000-0003-2813-4804; Markey, Kate/0000-0002-7064-2362; Wilson, Yana/0000-0002-6878-1806; Malissen, Bernard/0000-0003-1340-9342	Australian National Health and Medical Research Council (NHMRC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Supported by research grants from the Australian National Health and Medical Research Council (NHMRC). G.R.H. is an NHMRC Australia Fellow. C.R.E. is an NHMRC Research Fellow. K.P.A.M. is a Cancer Council of Queensland Fellow K.A.M. is an NHMRC Clinical Training Fellow. We thank C. Winterford for expert preparation of histology samples and P. Hall and G. Chojnowski for expert cell sorting. We obtained transgenic and knockout mice as follows: OT-II R. Steptoe, Diamantina Institute; H2<SUP>dlAb1-Ea</SUP>, Australian National University; beta-actin-luciferase<SUP>25</SUP>, R. Negrin, Stanford University; TEa<SUP>14</SUP>, J. Bromberg, Albert Einstein College; cfms.EGFP<SUP>12</SUP>, D. Hume, Institute of Molecular Biology; MHC class II.EGFP, B. Fazekas de St Groth, Garvan Institute.	Anderson BE, 2005, BLOOD, V105, P2227, DOI 10.1182/blood-2004-08-3032; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; Anderson BE, 2008, BLOOD, V111, P5242, DOI 10.1182/blood-2007-09-107953; Beers C, 2005, J IMMUNOL, V174, P1205, DOI 10.4049/jimmunol.174.3.1205; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Chen BJ, 2004, BLOOD, V103, P1534, DOI 10.1182/blood-2003-08-2987; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Jones SC, 2003, J CLIN INVEST, V112, P1880, DOI 10.1172/JCI200319427; Juchem KW, 2011, BLOOD, V118, P6209, DOI 10.1182/blood-2011-01-330035; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Koyama M, 2009, BLOOD, V113, P2088, DOI 10.1182/blood-2008-07-168609; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Li HM, 2011, BLOOD, V117, P697, DOI 10.1182/blood-2010-07-299073; MacDonald KPA, 2007, BLOOD, V109, P5049, DOI 10.1182/blood-2007-01-067249; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Markey KA, 2009, BLOOD, V113, P5644, DOI 10.1182/blood-2008-12-191833; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; Matte-Martone C, 2010, BIOL BLOOD MARROW TR, V16, P1222, DOI 10.1016/j.bbmt.2010.03.015; Morris ES, 2009, NAT MED, V15, P436, DOI 10.1038/nm.1948; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Pinchuk IV, 2008, GASTROENTEROLOGY, V135, P1228, DOI 10.1053/j.gastro.2008.07.016; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Sandner SE, 2005, AM J TRANSPLANT, V5, P31, DOI 10.1111/j.1600-6143.2004.00640.x; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Wang H, 2010, J IMMUNOL, V184, P3401, DOI 10.4049/jimmunol.0901550; Zhang Y, 2002, J CLIN INVEST, V109, P1335, DOI 10.1172/JCI200214989	35	155	156	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					135	142		10.1038/nm.2597	http://dx.doi.org/10.1038/nm.2597			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22127134				2022-12-27	WOS:000299018600039
J	Ortiz-Zapater, E; Pineda, D; Martinez-Bosch, N; Fernandez-Miranda, G; Iglesias, M; Alameda, F; Moreno, M; Eliscovich, C; Eyras, E; Real, FX; Mendez, R; Navarro, P				Ortiz-Zapater, Elena; Pineda, David; Martinez-Bosch, Neus; Fernandez-Miranda, Gonzalo; Iglesias, Mar; Alameda, Francesc; Moreno, Mireia; Eliscovich, Carolina; Eyras, Eduardo; Real, Francisco X.; Mendez, Raul; Navarro, Pilar			Key contribution of CPEB4-mediated translational control to cancer progression	NATURE MEDICINE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GENE-EXPRESSION; PANCREAS CANCER; CELLULAR SENESCENCE; UROKINASE RECEPTOR; CELLS; MOUSE; CPEB; POLYADENYLATION; GROWTH	Malignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.	[Ortiz-Zapater, Elena; Pineda, David; Martinez-Bosch, Neus; Iglesias, Mar; Moreno, Mireia; Real, Francisco X.; Navarro, Pilar] Hosp Mar Res Inst IMIM, Canc Res Programme, Barcelona, Spain; [Ortiz-Zapater, Elena; Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain; [Ortiz-Zapater, Elena; Real, Francisco X.] UPF, Dept Expt & Hlth Sci, Barcelona, Spain; [Fernandez-Miranda, Gonzalo; Mendez, Raul] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Iglesias, Mar; Alameda, Francesc] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08193 Barcelona, Spain; [Eyras, Eduardo] UPF, Computat Genom Grp, Barcelona, Spain; [Pineda, David; Eliscovich, Carolina; Mendez, Raul] CRG, Barcelona, Spain; [Eyras, Eduardo; Mendez, Raul] ICREA, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Centro Nacional de Investigaciones Oncologicas (CNIO); Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Mendez, R (corresponding author), CRG, Barcelona, Spain.	raul.mendez@irbbarcelona.es; pnavarro@imim.es	Navarro, Pilar/A-2122-2010; Eyras, Eduardo/ABG-7144-2020; Navarro, Pilar/ABF-2728-2020; Martínez-Bosch, Neus/HHN-5405-2022; Eduardo, Eyras/L-1053-2014; Ortiz-Zapater, Elena/HCI-3340-2022; Gasull, Martina/J-4076-2019; Arribas, Francisco X Real/H-5275-2015	Navarro, Pilar/0000-0003-4314-4584; Eyras, Eduardo/0000-0003-0793-6218; Navarro, Pilar/0000-0003-4314-4584; Eduardo, Eyras/0000-0003-0793-6218; Arribas, Francisco X Real/0000-0001-9501-498X; Mendez, Raul/0000-0002-1952-6905; Ortiz Zapater, Elena/0000-0002-7437-4772; Martinez Bosch, Neus/0000-0003-3596-0039	Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER) [PI080421]; Ministerio de Ciencia e Innovacion (MICINN); Fundacio La MaratoTV3 [051110]; American Institute for Cancer Research (AICR) [11-0086]; Generalitat de Catalunya [2009SGR1409, 2009SGR1436]; Consolider RNAREG from MICINN [CSD2009-00080]; AICR [11-0086]; Xarxa de Bancs de; Pla Director d'Oncologia de Catalunya; Instituto de Salud Carlos III; Departament de Sanitat de la Generalitat de Catalunya; MICINN; Fundacion Ramon Areces; DURSI (Generalitat de Catalunya); Eons Social Europeu (ESF);  [BFU2008-02373]; ICREA Funding Source: Custom; Worldwide Cancer Research [11-0086] Funding Source: researchfish	Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La MaratoTV3; American Institute for Cancer Research (AICR); Generalitat de Catalunya(Generalitat de Catalunya); Consolider RNAREG from MICINN; AICR; Xarxa de Bancs de; Pla Director d'Oncologia de Catalunya; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Departament de Sanitat de la Generalitat de Catalunya(Generalitat de Catalunya); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Ramon Areces; DURSI (Generalitat de Catalunya)(Generalitat de Catalunya); Eons Social Europeu (ESF); ; ICREA(ICREA); Worldwide Cancer Research	The authors acknowledge F. Gebauer, S. Aznar-Benitah, A. Garcia de Herreros and J. Valcarcel for critical comments on the manuscript and for other valuable contributions. We also thank S. Hahn (Department of Molecular GI-Oncology, University of Bochum, Germany) and M. Buchholz (Department of Gastroenterology, Endocrinology and Metabolism, Philipps-University of Marburg, Marburg, Germany) for providing normal pancreas RNA, O. Casanovas (Translational Research Laboratory, Catalan Institute of Oncology (ICO-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain) for his help with the T98G nude mice injections, J. R. Gonzalez-Vallinas (Computational Genomics Group, Universitat Pompeu Fabra, Parc de Recerca Biomedica de Barcelona (PRBB)) for assistance with Gene Ontology tools and E. Castillo from the Ultrasequencing Unit (Centre for Gcnomic Regulation, PRBB), S. Mojal from the Statistics Unit (IMIM, PRBB) and T. Lobato from the Histopathological Unit (IMIM, PRBB) for technical assistance. This work was funded by the research grants Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER) (PI080421) from the Ministerio de Ciencia e Innovacion (MICINN) and grants from Fundacio La MaratoTV3 (051110), the American Institute for Cancer Research (AICR) (11-0086) and Generalitat de Catalunya (2009SGR1409) to P.N.; grants BFU2008-02373 and Consolider RNAREG CSD2009-00080 from the MICINN and grants from Fundacio La MaratoTV3 (051110), AICR (11-0086) and Generalitat de Catalunya (2009SGR1436) to R.M.; grant SAF2007-60860 and Consolider ONCOBIO from the MICINN and a grant from the VI EU Framework Programme MolDiag-PaCa project to F.X.R.; grants Consolider RNAREG CSD2009-00080 and BIO2008-01091 from the MICINN to E.E.; and grants from the Instituto de Salud Carlos III FEDER (RD09/0076/00036) and the Xarxa de Bancs de tumors sponsored by the Pla Director d'Oncologia de Catalunya to the MARBiobanc. P.N. is supported by the Instituto de Salud Carlos III and the Departament de Sanitat de la Generalitat de Catalunya. D.P. holds a Juan de Is Cierva grant from the MICINN. N.M.-B. holds a grant from the Fundacion Ramon Areces. C.E. was supported by a fellowship from the DURSI (Generalitat de Catalunya) and Eons Social Europeu (ESF).	Aguilar S, 2004, AM J PATHOL, V165, P1129, DOI 10.1016/S0002-9440(10)63374-3; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441; Diaz VM, 2002, GASTROENTEROLOGY, V122, P806, DOI 10.1053/gast.2002.31885; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Groppo R, 2009, CURR OPIN CELL BIOL, V21, P444, DOI 10.1016/j.ceb.2009.01.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; HUARTE J, 1985, CELL, V43, P551, DOI 10.1016/0092-8674(85)90184-9; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Israel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006045; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; Paciucci R, 1996, FEBS LETT, V385, P72, DOI 10.1016/0014-5793(96)00352-3; Paciucci R, 1998, ONCOGENE, V16, P625, DOI 10.1038/sj.onc.1201564; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ryu B, 2002, CANCER RES, V62, P819; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819	55	111	120	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					83	90		10.1038/nm.2540	http://dx.doi.org/10.1038/nm.2540			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138752				2022-12-27	WOS:000299018600033
J	Nieman, KM; Kenny, HA; Penicka, CV; Ladanyi, A; Buell-Gutbrod, R; Zillhardt, MR; Romero, IL; Carey, MS; Mills, GB; Hotamisligil, GS; Yamada, SD; Peter, ME; Gwin, K; Lengyel, E				Nieman, Kristin M.; Kenny, Hilary A.; Penicka, Carla V.; Ladanyi, Andras; Buell-Gutbrod, Rebecca; Zillhardt, Marion R.; Romero, Iris L.; Carey, Mark S.; Mills, Gordon B.; Hotamisligil, Goekhan S.; Yamada, S. Diane; Peter, Marcus E.; Gwin, Katja; Lengyel, Ernst			Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth	NATURE MEDICINE			English	Article							ACID-BINDING PROTEIN; CELL-GROWTH; CARCINOMA CELLS; PROSTATE-CANCER; METABOLISM; PATHWAY; AP2; PHOSPHORYLATION; OXIDATION; GLUCOSE	Intra-abdominal tumors, such as ovarian cancer(1,2), have a clear predilection for metastasis to the omentum, an organ primarily composed of adipocytes. Currently, it is unclear why tumor cells preferentially home to and proliferate in the omentum, yet omental metastases typically represent the largest tumor in the abdominal cavities of women with ovarian cancer. We show here that primary human omental adipocytes promote homing, migration and invasion of ovarian cancer cells, and that adipokines including interleukin-8 (IL-8) mediate these activities. Adipocyte-ovarian cancer cell coculture led to the direct transfer of lipids from adipocytes to ovarian cancer cells and promoted in vitro and in vivo tumor growth. Furthermore, coculture induced lipolysis in adipocytes and beta-oxidation in cancer cells, suggesting adipocytes act as an energy source for the cancer cells. A protein array identified upregulation of fatty acid-binding protein 4 (FABP4, also known as aP2) in omental metastases as compared to primary ovarian tumors, and FABP4 expression was detected in ovarian cancer cells at the adipocyte-tumor cell interface. FABP4 deficiency substantially impaired metastatic tumor growth in mice, indicating that FABP4 has a key role in ovarian cancer metastasis. These data indicate adipocytes provide fatty acids for rapid tumor growth, identifying lipid metabolism and transport as new targets for the treatment of cancers where adipocytes are a major component of the microenvironment.	[Nieman, Kristin M.; Kenny, Hilary A.; Penicka, Carla V.; Ladanyi, Andras; Zillhardt, Marion R.; Romero, Iris L.; Yamada, S. Diane; Lengyel, Ernst] Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA; [Buell-Gutbrod, Rebecca; Gwin, Katja] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Carey, Mark S.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Broad Inst, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, MIT, Boston, MA 02115 USA; [Peter, Marcus E.] Northwestern Univ, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA	University of Chicago; University of Chicago; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Northwestern University; Feinberg School of Medicine	Lengyel, E (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA.	elengyel@uchicago.edu	Lengyel, Ernst/D-9220-2014; Romero, Iris/N-8451-2018	Lengyel, Ernst/0000-0001-8624-1507; Romero, Iris/0000-0001-5849-5024; Nieman, Kristin/0000-0001-7529-0872; Peter, Marcus Ernst/0000-0003-3216-036X; Curtis, Marion/0000-0002-7152-6929	Burroughs Wellcome Fund; Ovarian Cancer Research Fund; US National Cancer Institute [R01 CA111882]; Bears Care; Committee on Cancer Biology at the University of Chicago; National Cancer Institute [T32 CA959421, K99 CA134750]; US National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK064360]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA169604, K99CA134750, P50CA098258, R01CA111882, P30CA016672, U01CA151461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064360] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ovarian Cancer Research Fund; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bears Care; Committee on Cancer Biology at the University of Chicago; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. F. Haney (University of Chicago) for collecting omental biopsies and D. Bernlohr (University of Minnesota) for helpful discussions and kindly providing the FABP4 inhibitor. We thank S. Dogan for her contribution to the initiation of this project, G. Isenberg (University of Chicago) for editing the manuscript and A. Mitra (University of Chicago) for helpful discussions regarding the in vitro homing assay. We also thank K. Roby (University of Kansas Medical Center), N. Auersperg (University of British Columbia) and C. Clevenger (Northwestern University) for providing the ID8, IOSE and T47D cell lines, respectively. Finally, we thank all the patients, resident physicians and attending physicians in the Department of Obstetrics and Gynecology at the University of Chicago; without their commitment to tissue donation, this project would not have been possible. E. L. holds a Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund. He is also supported by grants from the Ovarian Cancer Research Fund (Liz Tilberis Scholars Program), the US National Cancer Institute (R01 CA111882) and Bears Care, the charitable beneficiary of the Chicago Bears Football Club. K. M. N. is funded by a Cancer Biology Training Grant from the Committee on Cancer Biology at the University of Chicago and the National Cancer Institute (T32 CA959421). H. A. K. is supported by an award from the National Cancer Institute K99 CA134750). G. S. H. is supported by a grant from the US National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK064360).	Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; ELLIOTT BE, 1992, INT J CANCER, V51, P416, DOI 10.1002/ijc.2910510314; Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gagnon A, 2010, METABOLISM, V59, P547, DOI 10.1016/j.metabol.2009.08.018; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; RODBELL M, 1964, J BIOL CHEM, V239, P375; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	36	1328	1379	10	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1498	U207		10.1038/nm.2492	http://dx.doi.org/10.1038/nm.2492			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22037646	Green Accepted			2022-12-27	WOS:000296779300042
J	Haemmerle, G; Moustafa, T; Woelkart, G; Buttner, S; Schmidt, A; van de Weijer, T; Hesselink, M; Jaeger, D; Kienesberger, PC; Zierler, K; Schreiber, R; Eichmann, T; Kolb, D; Kotzbeck, P; Schweiger, M; Kumari, M; Eder, S; Schoiswohl, G; Wongsiriroj, N; Pollak, NM; Radner, FPW; Preiss-Landl, K; Kolbe, T; Rulicke, T; Pieske, B; Trauner, M; Lass, A; Zimmermann, R; Hoefler, G; Cinti, S; Kershaw, EE; Schrauwen, P; Madeo, F; Mayer, B; Zechner, R				Haemmerle, Guenter; Moustafa, Tarek; Woelkart, Gerald; Buettner, Sabrina; Schmidt, Albrecht; van de Weijer, Tineke; Hesselink, Matthijs; Jaeger, Doris; Kienesberger, Petra C.; Zierler, Kathrin; Schreiber, Renate; Eichmann, Thomas; Kolb, Dagmar; Kotzbeck, Petra; Schweiger, Martina; Kumari, Manju; Eder, Sandra; Schoiswohl, Gabriele; Wongsiriroj, Nuttaporn; Pollak, Nina M.; Radner, Franz P. W.; Preiss-Landl, Karina; Kolbe, Thomas; Ruelicke, Thomas; Pieske, Burkert; Trauner, Michael; Lass, Achim; Zimmermann, Robert; Hoefler, Gerald; Cinti, Saverio; Kershaw, Erin E.; Schrauwen, Patrick; Madeo, Frank; Mayer, Bernd; Zechner, Rudolf			ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1	NATURE MEDICINE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; HORMONE-SENSITIVE LIPASE; LIPID STORAGE DISEASE; ACID-METABOLIZING ENZYMES; TRIGLYCERIDE LIPASE; ENERGY-METABOLISM; HYPOLIPIDEMIC DRUGS; INSULIN SENSITIVITY; GENE-EXPRESSION; TRANSGENIC MICE	Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate genes involved in energy metabolism and inflammation. For biological activity, PPARs require cognate lipid ligands, heterodimerization with retinoic X receptors, and coactivation by PPAR-gamma coactivator-1 alpha or PPAR-gamma coactivator-1 beta (PGC-1 alpha or PGC-1 beta, encoded by Ppargc1a and Ppargc1b, respectively). Here we show that lipolysis of cellular triglycerides by adipose triglyceride lipase (patatin-like phospholipase domain containing protein 2, encoded by Pnpla2; hereafter referred to as Atgl) generates essential mediator(s) involved in the generation of lipid ligands for PPAR activation. Atgl deficiency in mice decreases mRNA levels of PPAR-alpha and PPAR-delta target genes. In the heart, this leads to decreased PGC-1 alpha and PGC-1 beta expression and severely disrupted mitochondrial substrate oxidation and respiration; this is followed by excessive lipid accumulation, cardiac insufficiency and lethal cardiomyopathy. Reconstituting normal PPAR target gene expression by pharmacological treatment of Atgl-deficient mice with PPAR-alpha agonists completely reverses the mitochondrial defects, restores normal heart function and prevents premature death. These findings reveal a potential treatment for the excessive cardiac lipid accumulation and often-lethal cardiomyopathy in people with neutral lipid storage disease, a disease marked by reduced or absent ATGL activity.	[Haemmerle, Guenter; Buettner, Sabrina; Jaeger, Doris; Kienesberger, Petra C.; Zierler, Kathrin; Schreiber, Renate; Eichmann, Thomas; Kolb, Dagmar; Kotzbeck, Petra; Schweiger, Martina; Kumari, Manju; Eder, Sandra; Schoiswohl, Gabriele; Wongsiriroj, Nuttaporn; Pollak, Nina M.; Radner, Franz P. W.; Preiss-Landl, Karina; Lass, Achim; Zimmermann, Robert; Madeo, Frank; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, Graz, Austria; [Moustafa, Tarek; Trauner, Michael] Med Univ Graz, Lab Expt & Mol Hepatol, Dept Internal Med, Graz, Austria; [Woelkart, Gerald; Mayer, Bernd] Graz Univ, Dept Pharmacol & Toxicol, Graz, Austria; [Schmidt, Albrecht; Pieske, Burkert] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria; [van de Weijer, Tineke; Schrauwen, Patrick] Maastricht Univ Med Ctr, Dept Human Biol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Hesselink, Matthijs; Kolbe, Thomas] Maastricht Univ Med Ctr, Dept Human Movement Sci, NUTRIM, Maastricht, Netherlands; [Ruelicke, Thomas] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Cinti, Saverio] Univ Ancona, Dept Mol Pathol & Innovat Therapies, Fac Med, Politecn Marche, Ancona, Italy; [Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA USA	University of Graz; Medical University of Graz; University of Graz; Medical University of Graz; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Veterinary Medicine Vienna; Medical University of Graz; Marche Polytechnic University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	rudolf.zechner@uni-graz.at	Hoefler, Gerald/B-7006-2008; Moustafa, Tarek/P-9509-2016; Lass, Achim/C-3332-2008; Kershaw, Erin E/G-9587-2013; Pollak, Nina M./L-3308-2018; Hoefler, Gerald/H-1796-2016	Moustafa, Tarek/0000-0002-6755-4687; Lass, Achim/0000-0002-8190-7151; Kershaw, Erin E/0000-0002-3887-4868; Pollak, Nina M./0000-0001-8437-3303; Madeo, Frank/0000-0002-5070-1329; Schmidt, Albrecht/0000-0003-4783-4603; Zimmermann, Robert/0000-0002-7354-870X; Schweiger, Martina/0000-0002-3419-1007; Schoiswohl, Gabriele/0000-0002-7346-2834; Kienesberger, Petra/0000-0001-9643-8338; schrauwen, patrick/0000-0002-0973-847X; Eichmann, Thomas O./0000-0002-8521-2795; Schreiber, Renate/0000-0002-3475-157X; Buttner, Sabrina/0000-0002-2786-8542; Trauner, Michael/0000-0002-1275-6425; Radner, Franz/0000-0003-3466-0181; Kotzbeck, Petra/0000-0003-4039-3745; Hoefler, Gerald/0000-0002-9056-3063; Mayer, Bernd/0000-0002-2921-3494; Haemmerle, Guenter/0000-0001-9900-5896; Zechner, Rudolf/0000-0001-5483-1182; Woelkart, Gerald/0000-0003-2552-1999; CINTI, Saverio/0000-0003-0362-5017	GOLD - Genomics of Lipid-Associated Disorders; Forschungsforderungsgesellschaft (FFG); Bundesministerium fur Wissenschaft und Forschung (BMWF); Spezialforschungsbereich (SFB [LIPOTOX F30]; Doktoratskolleg: Molecular Enzymology [W901]; Austrian Science Fund (FWF) [2007 Z136, P20602]; Targeting Obesity-driven Inflammation (TOBI) [201608]; LipidomicNet [202272]; European Commission; County of Styria; City of Graz; Netherlands Organization for Scientific Research [918.96.618]; Center for Translational Molecular Medicine (CTMM) [01C-104]; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Austrian Science Fund (FWF) [F 3008, F 3002, W 901, Z 136, F 3003] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090166] Funding Source: NIH RePORTER	GOLD - Genomics of Lipid-Associated Disorders; Forschungsforderungsgesellschaft (FFG); Bundesministerium fur Wissenschaft und Forschung (BMWF); Spezialforschungsbereich (SFB; Doktoratskolleg: Molecular Enzymology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Targeting Obesity-driven Inflammation (TOBI); LipidomicNet; European Commission(European CommissionEuropean Commission Joint Research Centre); County of Styria; City of Graz; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Translational Molecular Medicine (CTMM); Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the following grants: GOLD - Genomics of Lipid-Associated Disorders as part of the Austrian Genome Project (GEN-AU) funded by the Forschungsforderungsgesellschaft (FFG) and the Bundesministerium fur Wissenschaft und Forschung (BMWF); Spezialforschungsbereich (SFB) LIPOTOX F30, Doktoratskolleg: Molecular Enzymology W901, the Wittgenstein Award 2007 Z136 and research grant P20602 funded by the Austrian Science Fund (FWF); Targeting Obesity-driven Inflammation (TOBI) contract no. 201608 and LipidomicNet contract no. 202272 funded by the European Commission. Additional funding for the SFB LIPOTOX was granted by the County of Styria and the City of Graz. P.S. is supported by the Research Grant for Innovative Research from the Netherlands Organization for Scientific Research (Grant 918.96.618). T.v.d.W. was supported by the Center for Translational Molecular Medicine (CTMM) project PREDICCt (Grant 01C-104) and the Netherlands Heart Foundation, the Dutch Diabetes Research Foundation and the Dutch Kidney Foundation. We thank E. Zechner and C. Schober-Trummler for proofreading the manuscript and S. Lang for the preparation of the cartoon. The pBS II SK+ vector containing the alpha-MHC promoter region (Genbank: U71441) was provided by J. Robbins (University of Cincinnati). The expression plasmids for (PPRE)<INF>6</INF>-tk-luciferase and human PPAR-alpha were provided by B. Staels (University of Lille).	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Blattner JR, 2001, ANAL BIOCHEM, V295, P220, DOI 10.1006/abio.2001.5219; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cheng LH, 2004, BIOCHEM BIOPH RES CO, V313, P277, DOI 10.1016/j.bbrc.2003.11.127; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GULICK J, 1991, J BIOL CHEM, V266, P9180; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Nemoto Y, 2000, J CLIN INVEST, V105, P1819, DOI 10.1172/JCI9575; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rosenson Robert S, 2008, Expert Rev Cardiovasc Ther, V6, P1319, DOI 10.1586/14779072.6.10.1319; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Song QJ, 2003, J CLIN INVEST, V111, P859, DOI 10.1172/JCI200316738; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vikramadithyan RK, 2005, J PHARMACOL EXP THER, V313, P586, DOI 10.1124/jpet.104.080259; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhao G, 2000, AM J PHYSIOL-HEART C, V279, pH520, DOI 10.1152/ajpheart.2000.279.2.H520; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	60	483	492	5	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1076	U82		10.1038/nm.2439	http://dx.doi.org/10.1038/nm.2439			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21857651	Green Accepted			2022-12-27	WOS:000294605100027
J	Ma, C; Fan, R; Ahmad, H; Shi, QH; Comin-Anduix, B; Chodon, T; Koya, RC; Liu, CC; Kwong, GA; Radu, CG; Ribas, A; Heath, JR				Ma, Chao; Fan, Rong; Ahmad, Habib; Shi, Qihui; Comin-Anduix, Begonya; Chodon, Thinle; Koya, Richard C.; Liu, Chao-Chao; Kwong, Gabriel A.; Radu, Caius G.; Ribas, Antoni; Heath, James R.			A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells	NATURE MEDICINE			English	Article							CANCER; INFLAMMATION; RESPONSES; DIFFERENTIATION; EXPRESSION; PROTECTION; INFECTION; PROTEINS; MELANOMA; SUBSETS	Cellular immunity has an inherent high level of functional heterogeneity. Capturing the full spectrum of these functions requires analysis of large numbers of effector molecules from single cells. We report a microfluidic platform designed for highly multiplexed (more than ten proteins), reliable, sample-efficient (similar to 1 x 10(4) cells) and quantitative measurements of secreted proteins from single cells. We validated the platform by assessment of multiple inflammatory cytokines from lipopolysaccharide (LPS)-stimulated human macrophages and comparison to standard immunotechnologies. We applied the platform toward the ex vivo quantification of T cell polyfunctional diversity via the simultaneous measurement of a dozen effector molecules secreted from tumor antigen-specific cytotoxic T lymphocytes (CTLs) that were actively responding to tumor and compared against a cohort of healthy donor controls. We observed profound, yet focused, functional heterogeneity in active tumor antigen-specific CTLs, with the major functional phenotypes quantitatively identified. The platform represents a new and informative tool for immune monitoring and clinical assessment.	[Ma, Chao; Fan, Rong; Ahmad, Habib; Shi, Qihui; Kwong, Gabriel A.; Radu, Caius G.; Ribas, Antoni; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Ma, Chao; Fan, Rong; Ahmad, Habib; Shi, Qihui; Liu, Chao-Chao; Kwong, Gabriel A.; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Comin-Anduix, Begonya; Chodon, Thinle; Koya, Richard C.; Radu, Caius G.; Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Heath, JR (corresponding author), CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA.	heath@caltech.edu	Fan, Rong/B-1613-2014; Kwong, Gabriel A/M-5376-2013; Radu, Caius/D-3936-2013; Kwong, Gabriel/AAO-8266-2021	Kwong, Gabriel A/0000-0002-6255-6755; Radu, Caius/0000-0002-9338-5397; Kwong, Gabriel/0000-0002-6255-6755; Liu, Chao/0000-0003-0057-3397	Benjamin M. Rosen Fellowship; US National Institutes of Health [1 K99 CA136759-01, CA-16042, AI-28697]; US National Cancer Institute [5U54 CA119347]; Ivy Foundation; Jean Perkins Foundation; California Institute for Regenerative Medicine New Faculty [RN2-00902-1]; Caltech/UCLA Joint Center for Translational Medicine; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [P30CA016042, K99CA136759, U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Benjamin M. Rosen Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ivy Foundation; Jean Perkins Foundation; California Institute for Regenerative Medicine New Faculty; Caltech/UCLA Joint Center for Translational Medicine; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Marzolf at the Institute for Systems Biology for printing DNA-spotted arrays and the UCLA nanolab for photomask fabrication. We thank L. Yang, S. Wang, R. Diamond and H. Wu for valuable discussion. C. M. acknowledges the support of the Benjamin M. Rosen Fellowship. R.F. is supported by the US National Institutes of Health K99 Pathway to Independence Award (No. 1 K99 CA136759-01). This work was funded by the US National Cancer Institute Grant No. 5U54 CA119347 (J.R.H.), by the Ivy Foundation and the Jean Perkins Foundation (J.R.H.), by the California Institute for Regenerative Medicine New Faculty Award RN2-00902-1 (A.R.), by the Caltech/UCLA Joint Center for Translational Medicine (A.R. and J.R.H.) and the Melanoma Research Alliance (A.R. and J.R.H.). The UCLA Flow Cytometry Core Facility is supported by the US National Institutes of Health awards CA-16042 and AI-28697.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bailey RC, 2007, J AM CHEM SOC, V129, P1959, DOI 10.1021/ja065930i; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Comin-Anduix B, 2006, CLIN CANCER RES, V12, P107, DOI 10.1158/1078-0432.CCR-05-0136; Comin-Anduix B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-22; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hagemann T, 2007, CANCER CELL, V12, P300, DOI 10.1016/j.ccr.2007.10.005; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kwong GA, 2009, J AM CHEM SOC, V131, P9695, DOI 10.1021/ja9006707; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Re F, 2004, IMMUNOBIOLOGY, V209, P191, DOI 10.1016/j.imbio.2004.03.005; Ribas A, 2009, CLIN CANCER RES, V15, P6267, DOI 10.1158/1078-0432.CCR-09-1254; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shin YS, 2010, CHEMPHYSCHEM, V11, P3063, DOI 10.1002/cphc.201000528; SHIN YS, BIOPHYS J IN PRESS; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; Wang J, 2010, LAB CHIP, V10, P3157, DOI [10.1039/c0lc00132e, 10.1039/c01c00132e]; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	37	326	345	6	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					738	U133		10.1038/nm.2375	http://dx.doi.org/10.1038/nm.2375			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602800	Green Accepted			2022-12-27	WOS:000291308800036
J	Nikic, I; Merkler, D; Sorbara, C; Brinkoetter, M; Kreutzfeldt, M; Bareyre, FM; Bruck, W; Bishop, D; Misgeld, T; Kerschensteiner, M				Nikic, Ivana; Merkler, Doron; Sorbara, Catherine; Brinkoetter, Mary; Kreutzfeldt, Mario; Bareyre, Florence M.; Brueck, Wolfgang; Bishop, Derron; Misgeld, Thomas; Kerschensteiner, Martin			A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VIVO; NITRIC-OXIDE; MITOCHONDRIAL DYSFUNCTION; SPINAL-CORD; DEGENERATION; MODEL; INFLAMMATION; LESIONS; MECHANISMS	In multiple sclerosis, a common inflammatory disease of the central nervous system, immune-mediated axon damage is responsible for permanent neurological deficits(1,2). How axon damage is initiated is not known. Here we use in vivo imaging to identify a previously undescribed variant of axon damage in a mouse model of multiple sclerosis. This process, termed 'focal axonal degeneration' (FAD), is characterized by sequential stages, beginning with focal swellings and progressing to axon fragmentation. Notably, most swollen axons persist unchanged for several days, and some recover spontaneously. Early stages of FAD can be observed in axons with intact myelin sheaths. Thus, contrary to the classical view(2-6), demyelination-a hallmark of multiple sclerosis-is not a prerequisite for axon damage. Instead, focal intra-axonal mitochondrial pathology is the earliest ultrastructural sign of damage, and it precedes changes in axon morphology. Molecular imaging and pharmacological experiments show that macrophage-derived reactive oxygen and nitrogen species (ROS and RNS) can trigger mitochondrial pathology and initiate FAD. Indeed, neutralization of ROS and RNS rescues axons that have already entered the degenerative process. Finally, axonal changes consistent with FAD can be detected in acute human multiple sclerosis lesions. In summary, our data suggest that inflammatory axon damage might be spontaneously reversible and thus a potential target for therapy.	[Nikic, Ivana; Sorbara, Catherine; Bareyre, Florence M.; Kerschensteiner, Martin] Univ Munich, Inst Clin Neuroimmunol, Res Unit Therapy Dev, Munich, Germany; [Merkler, Doron; Kreutzfeldt, Mario; Brueck, Wolfgang] Univ Gottingen, Inst Neuropathol, Gottingen, Germany; [Merkler, Doron; Kreutzfeldt, Mario] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Merkler, Doron; Kreutzfeldt, Mario] Univ Geneva, Univ Hosp Geneva, Div Clin Pathol, CH-1211 Geneva 4, Switzerland; [Brinkoetter, Mary; Bishop, Derron] Indiana Univ Sch Med, Dept Physiol, Muncie, IN USA; [Misgeld, Thomas] Tech Univ Munich, Inst Neurosci, Ctr Integrated Prot Sci Munich, Chair Biomol Sensors, Munich, Germany; [Misgeld, Thomas] Tech Univ Munich, Inst Adv Study, Munich, Germany	University of Munich; University of Gottingen; University of Geneva; University of Geneva; Indiana University System; Technical University of Munich; University of Munich; Technical University of Munich	Kerschensteiner, M (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Res Unit Therapy Dev, Munich, Germany.	thomas.misgeld@lrz.tu-muenchen.de; martin.kerschensteiner@med.uni-muenchen.de	Merkler, Doron/N-9157-2016	Merkler, Doron/0000-0002-0247-2007; Nikic, Ivana/0000-0002-6666-3486; Kreutzfeldt, Mario/0000-0003-0335-2733	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 571, Sonderforschungsbereich Transregio 43]; 'Verein Therapieforschung fur MS-Kranke e.V'. M. Kerschensteiner; German Federal Ministry of Education and Research; Institute for Advanced Study, Technische Universitat Munchen; Alexander von Humboldt Foundation; Center for Integrated Protein Science (Munich); Swiss National Science Foundation [PP00P3 128372]; US National Institutes of Health; Dana Foundation; Hertie Foundation; Christopher and Dana Reeve Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 'Verein Therapieforschung fur MS-Kranke e.V'. M. Kerschensteiner; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute for Advanced Study, Technische Universitat Munchen; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Center for Integrated Protein Science (Munich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Hertie Foundation; Christopher and Dana Reeve Foundation	We would like to thank B. Fiedler, G. Heitmann, M. Schedensack, A. Schmalz and S. Knecht for excellent technical assistance; D. Matzek for animal husbandry; A. Dagkalis for help with immunizations; M. Krumbholz for advice on statistical analysis; and R. Hohlfeld, H. Wekerle, J. Sanes, J. Lichtman, L. Godinho, D. Kerschensteiner, P. Williams, T. Dick, E. Meinl and K. Dornmair for discussions or critical reading of the manuscript. Work in M. Kerschensteiner's laboratory is financed through grants from the Deutsche Forschungsgemeinschaft (DFG; Emmy Noether Program and Sonderforschungsbereich 571) and the 'Verein Therapieforschung fur MS-Kranke e.V'. M. Kerschensteiner and W. B. are supported by a grant from the German Federal Ministry of Education and Research (Competence Network Multiple Sclerosis). T. M. is supported by the Institute for Advanced Study, Technische Universitat Munchen, by the Alexander von Humboldt Foundation and by the Center for Integrated Protein Science (Munich). D. M. and W. B. are supported by grants from the DFG (Sonderforschungsbereich Transregio 43). D. M. is supported by the Swiss National Science Foundation (PP00P3 128372). D. B. is supported by the US National Institutes of Health. This project was further financed by grants to M. Kerschensteiner and T. M. from the Dana Foundation and the Hertie Foundation, and by a grant from the Christopher and Dana Reeve Foundation to T. M. and D. B.	Abdul-Majid KB, 2000, J NEUROIMMUNOL, V111, P23, DOI 10.1016/S0165-5728(00)00360-X; Aboul-Enein F, 2006, ACTA NEUROPATHOL, V111, P539, DOI 10.1007/s00401-006-0047-y; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kizelsztein P, 2009, J NEUROIMMUNOL, V213, P20, DOI 10.1016/j.jneuroim.2009.05.019; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Medana I, 2001, AM J PATHOL, V159, P809, DOI 10.1016/S0002-9440(10)61755-5; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Singbartl K, 2001, J IMMUNOL, V166, P7520, DOI 10.4049/jimmunol.166.12.7520; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Smith KJ, 2001, ANN NEUROL, V49, P470; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023	40	483	486	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					495	U135		10.1038/nm.2324	http://dx.doi.org/10.1038/nm.2324			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21441916				2022-12-27	WOS:000289245100041
J	[Anonymous]				[Anonymous]			Highly cited cancer papers, 2008-2010	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					280	282		10.1038/nm0311-280	http://dx.doi.org/10.1038/nm0311-280			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383735				2022-12-27	WOS:000288070000032
J	Deshpande, DA; Wang, WCH; McIlmoyle, EL; Robinett, KS; Schillinger, RM; An, SS; Sham, JSK; Liggett, SB				Deshpande, Deepak A.; Wang, Wayne C. H.; McIlmoyle, Elizabeth L.; Robinett, Kathryn S.; Schillinger, Rachel M.; An, Steven S.; Sham, James S. K.; Liggett, Stephen B.			Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction	NATURE MEDICINE			English	Article							CELLS; CONTRACTILITY; HETEROGENEITY; RELAXATION; EXPRESSION; LACTONES; CHANNELS; SPARKS; ASTHMA	Bitter taste receptors (TAS2Rs) on the tongue probably evolved to evoke signals for avoiding ingestion of plant toxins. We found expression of TAS2Rs on human airway smooth muscle (ASM) and considered these to be avoidance receptors for inhalants that, when activated, lead to ASM contraction and bronchospasm. TAS2R agonists such as saccharin, chloroquine and denatonium evoked increased intracellular calcium ([Ca2+](i)) in ASM in a G beta gamma-, phospholipase C beta (PLC beta)-and inositol trisphosphate (IP3) receptor-dependent manner, which would be expected to evoke contraction. Paradoxically, bitter tastants caused relaxation of isolated ASM and dilation of airways that was threefold greater than that elicited by beta-adrenergic receptor agonists. The relaxation induced by TAS2Rs is associated with a localized [Ca2+](i) response at the cell membrane, which opens large-conductance Ca2+-activated K+ (BKCa) channels, leading to ASM membrane hyperpolarization. Inhaled bitter tastants decreased airway obstruction in a mouse model of asthma. Given the need for efficacious bronchodilators for treating obstructive lung diseases, this pathway can be exploited for therapy with the thousands of known synthetic and naturally occurring bitter tastants.	[Deshpande, Deepak A.; Wang, Wayne C. H.; McIlmoyle, Elizabeth L.; Robinett, Kathryn S.; Schillinger, Rachel M.; Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [An, Steven S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Sham, James S. K.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Liggett, SB (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012; An, Steven/AAM-3848-2020	An, Steven/0000-0003-4723-1888; Liggett, Stephen B./0000-0002-0128-3669; Sham, James/0000-0002-3571-8712	US National Heart, Lung, and Blood Institute [HL104119, HL045967, HL071609, HL071835, HL075134, HL087560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071835, R01HL045967, R01HL075134, R56HL071835, R37HL045967, R01HL104119, K99HL087560, R01HL071609, R00HL087560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Heart, Lung, and Blood Institute grants HL104119 (to W.C.H.W.), HL045967 and HL071609 (to S.B.L.), HL071835 and HL075134 (to J.S.K.S.) and HL087560 (to D.A.D.).	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Billington CK, 2003, RESP RES, V4; Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; GREEN SA, 1996, GENETICS ASTHMA, P67; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardo LJ, 2000, ENVIRON HEALTH PERSP, V108, P697, DOI 10.2307/3454406; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Martin G, 2008, EXP PHYSIOL, V93, P908, DOI 10.1113/expphysiol.2008.042432; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Morin C, 2007, AM J PHYSIOL-LUNG C, V293, pL1037, DOI 10.1152/ajplung.00145.2007; Panebra A, 2007, AM J PHYSIOL-LUNG C, V293, pL453, DOI 10.1152/ajplung.00084.2007; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Small KM, 2004, P NATL ACAD SCI USA, V101, P13020, DOI 10.1073/pnas.0405074101; Vignola AM, 1998, LUNG BIOL HEALTH DIS, V115, P139; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	33	436	469	6	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1299	U8		10.1038/nm.2237	http://dx.doi.org/10.1038/nm.2237			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20972434	Green Accepted			2022-12-27	WOS:000283860100042
J	Coleman, DL				Coleman, Douglas L.			A historical perspective on leptin	NATURE MEDICINE			English	Article							GENETICALLY DIABETIC MICE; MOUSE; OBESE; PARABIOSIS; EXPRESSION; LESIONS; GENE		Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Coleman, DL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	doug.coleman@jax.org		Coleman, David/0000-0003-4803-5387				COLEMAN DL, 1969, AM J PHYSIOL, V217, P1298; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; COLEMAN DL, 1970, DIABETOLOGIA, V6, P263, DOI 10.1007/BF01212236; HERVEY GR, 1959, J PHYSIOL-LONDON, V145, P336, DOI 10.1113/jphysiol.1959.sp006145; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	10	70	74	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1097	1099		10.1038/nm1010-1097	http://dx.doi.org/10.1038/nm1010-1097			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930752				2022-12-27	WOS:000282644800037
J	Zhou, YF; Kawasaki, H; Hsu, SC; Lee, RT; Yao, X; Plunkett, B; Fu, JR; Yang, K; Lee, YC; Huang, SK				Zhou, Yufeng; Kawasaki, Hirokazu; Hsu, Shih-Chang; Lee, Reiko T.; Yao, Xu; Plunkett, Beverly; Fu, Jinrong; Yang, Kuender; Lee, Yuan C.; Huang, Shau-Ku			Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1	NATURE MEDICINE			English	Article							INTESTINAL LAMINA PROPRIA; MESENTERIC LYMPH-NODES; REGULATORY T-CELLS; DENDRITIC CELLS; DC-SIGN; PATHOGEN RECOGNITION; IMMUNE REGULATION; RETINOIC-ACID; ANTIGEN; INTERLEUKIN-10	We propose that a C-type lectin receptor, SIGNR-1 (also called Cd209b), helps to condition dendritic cells (DCs) in the gastrointestinal lamina propria (LPDCs) for the induction of oral tolerance in a model of food-induced anaphylaxis. Oral delivery of BSA bearing 51 molecules of mannoside (Man(51)-BSA) substantially reduced the BSA-induced anaphylactic response. Man(51)-BSA selectively targeted LPDCs that expressed SIGNR1 and induced the expression of interleukin-10 (IL-10), but not IL-6 or IL-12 p70. We found the same effects in IL-10-GFP knock-in (tiger) mice treated with Man(51)-BSA. The Man(51)-BSA-SIGNR1 axis in LPDCs, both in vitro and in vivo, promoted the generation of CD4(+) type 1 regulatory T (Tr1)-like cells that expressed IL-10 and interferon-gamma (IFN-gamma), in a SIGNR-1-and IL-10-dependent manner, but not of CD4(+)CD25(+)Foxp3(+) regulatory T cells. The Tr1-like cells could transfer tolerance. These results suggest that sugar-modified antigens might be used to induce oral tolerance by targeting SIGNR1 and LPDCs.	[Zhou, Yufeng; Kawasaki, Hirokazu; Hsu, Shih-Chang; Yao, Xu; Plunkett, Beverly; Fu, Jinrong; Huang, Shau-Ku] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Lee, Reiko T.; Lee, Yuan C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Yao, Xu] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China; [Yang, Kuender] Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Huang, Shau-Ku] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Huang, Shau-Ku] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Huang, SK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA.	skhuang@jhmi.edu	zhou, yufeng/G-6429-2010; Huang, Shau-Ku/F-5509-2010; Hsu, Shih-Chang/I-4277-2012	Hsu, Shih-Chang/0000-0003-1010-1182; zhou, Yufeng/0000-0002-6050-4951	US National Institutes of Health [AI052468, AI073610]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052468, R21AI073610] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Myers and H. Rohde for technical assistance; K. Takahara (Kyoto University) for SIGNR1-transfectant cells; and the Consortium for Functional Glycomics for SIGNR1-deficient mice. This work was supported, in part, by US National Institutes of Health grants (AI052468 and AI073610).	Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bashir MEH, 2002, J IMMUNOL, V169, P3284, DOI 10.4049/jimmunol.169.6.3284; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Hsu SC, 2010, J BIOL CHEM, V285, P7903, DOI 10.1074/jbc.M109.058370; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; LEE RT, 1997, GLYCOPROTEINS, V2, P601; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Numazaki M, 2009, BIOCHEM BIOPH RES CO, V386, P202, DOI 10.1016/j.bbrc.2009.06.011; Poulsen LK, 2005, ALLERGY, V60, P549, DOI 10.1111/j.1398-9995.2005.00821.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Stowell C P, 1980, Adv Carbohydr Chem Biochem, V37, P225; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	39	101	102	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1128	U105		10.1038/nm.2201	http://dx.doi.org/10.1038/nm.2201			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20835248	Green Accepted			2022-12-27	WOS:000282644800043
J	Ellis, LM; Fidler, IJ				Ellis, Lee M.; Fidler, Isaiah J.			Therapy fails, patients don't	NATURE MEDICINE			English	Editorial Material							METASTATIC COLORECTAL-CANCER; LUNG-CANCER; BEVACIZUMAB; TRIAL; CHEMOTHERAPY; MUTATIONS; GEFITINIB; CETUXIMAB; KINASE; TUMOR		[Ellis, Lee M.; Fidler, Isaiah J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ellis, LM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	lellis@mdanderson.org; ifidler@mdanderson.org						Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; Shaheen RM, 2001, BRIT J CANCER, V85, P584, DOI 10.1054/bjoc.2001.1936; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; TALMADGE JE, 2010, J CANC RES, V70, P5649; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268	12	81	82	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					974	975		10.1038/nm0910-974	http://dx.doi.org/10.1038/nm0910-974			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823880				2022-12-27	WOS:000281622900023
J	Viscomi, C; Burlina, AB; Dweikat, I; Savoiardo, M; Lamperti, C; Hildebrandt, T; Tiranti, V; Zeviani, M				Viscomi, Carlo; Burlina, Alberto B.; Dweikat, Imad; Savoiardo, Mario; Lamperti, Costanza; Hildebrandt, Tatjana; Tiranti, Valeria; Zeviani, Massimo			Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy	NATURE MEDICINE			English	Article							HYDROGEN-SULFIDE; MICE; ETHE1; MUTATIONS; GENE	Ethylmalonic encephalopathy is caused by mutations in ETHE1, a mitochondrial matrix sulfur dioxygenase, leading to failure to detoxify sulfide, a product of intestinal anaerobes and, in trace amounts, tissues. Metronidazole, a bactericide, or N-acetylcysteine, a precursor of sulfide-buffering glutathione, substantially prolonged the lifespan of Ethe1-deficient mice, with the combined treatment being additive. The same dual treatment caused marked clinical improvement in five affected children, with hardly any adverse or side effects.	[Viscomi, Carlo; Lamperti, Costanza; Tiranti, Valeria; Zeviani, Massimo] Fdn Carlo Besta Inst Neurol, Unit Mol Neurogenet, Milan, Italy; [Burlina, Alberto B.] Univ Padua, Sch Med, Clin Paediat, Padua, Italy; [Dweikat, Imad] Makassed Hosp, Metab Dis Unit, Jerusalem, Israel; [Savoiardo, Mario] Fdn Carlo Besta Inst Neurol, Unit Neuroradiol, Milan, Italy; [Hildebrandt, Tatjana] Leibnitz Univ, Inst Plant Genet, Hannover, Germany	IRCCS Istituto Neurologico Besta; University of Padua; IRCCS Istituto Neurologico Besta	Zeviani, M (corresponding author), Fdn Carlo Besta Inst Neurol, Unit Mol Neurogenet, Milan, Italy.	tiranti@istituto-besta.it; zeviani@istituto-besta.it	burlina, alberto/AHE-6095-2022; Tiranti, Valeria/J-8233-2016; Zeviani, Massimo/K-2891-2014; lamperti, costanza/J-8801-2016; Tiranti, Valeria/AFN-5783-2022; Zeviani, Massimo/AAU-2632-2021; viscomi, Carlo/R-1940-2016	Tiranti, Valeria/0000-0002-3584-7338; lamperti, costanza/0000-0002-2280-2253; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Hildebrandt, Tatjana/0000-0002-3562-5241; Viscomi, Carlo/0000-0001-6050-0566	Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy [GGP07019]; Italian Ministry of Health [RF-INN-2007-634163]	Pierfranco and Luisa Mariani Foundation Italy; Fondazione Telethon-Italy(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Pierfranco and Luisa Mariani Foundation Italy, Fondazione Telethon-Italy grant number GGP07019 and grant RF-INN-2007-634163 of the Italian Ministry of Health. We thank E. Lamantea for assistance in the preparation of figures and S. Ravaglia for help in statistical analyses.	Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mancardi D, 2009, BBA-BIOENERGETICS, V1787, P864, DOI 10.1016/j.bbabio.2009.03.005; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499	14	97	102	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					869	871		10.1038/nm.2188	http://dx.doi.org/10.1038/nm.2188			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20657580	Green Published			2022-12-27	WOS:000280649200025
J	Weller, ML; Amornphimoltham, P; Schmidt, M; Wilson, PA; Gutkind, JS; Chiorini, JA				Weller, Melodie L.; Amornphimoltham, Panomwat; Schmidt, Michael; Wilson, Paul A.; Gutkind, J. Silvio; Chiorini, John A.			Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6	NATURE MEDICINE			English	Article							PROTEIN-TYROSINE KINASE; GENE-EXPRESSION; VECTORS; TRANSDUCTION; EGFR; LUNG	A key step in gene therapy is the efficient transfer of genes in a cell type- and tissue-specific manner. To better understand the mechanism of adeno-associated virus serotype 6 (AAV6) transduction, we used comparative gene analysis (CGA) combined with pathway visualization software to identify a positive correlation between AAV6 transduction and epidermal growth factor receptor (EGFR) expression. Subsequent experiments suggested that EGFR is necessary for vector internalization and probably functions as a co-receptor for AAV6.	[Weller, Melodie L.; Schmidt, Michael; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, US Natl Inst Hlth NIH, Bethesda, MD USA; [Amornphimoltham, Panomwat; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Wilson, Paul A.] NIH, Custom Applicat Branch, Div Enterprise & Custom Applicat, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chiorini, JA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, US Natl Inst Hlth NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov	Amornphimoltham, Walt/AAP-9654-2020; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009	Gutkind, J. Silvio/0000-0002-5150-4482; 	Intramural NIH HHS [Z01 DE000695-09] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558, ZIADE000695, ZIADE000551] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Gilbert JL, 2008, ANTI-CANCER DRUG, V19, P783, DOI 10.1097/CAD.0b013e32830c432d; Halbert CL, 2007, HUM GENE THER, V18, P344, DOI 10.1089/hum.2006.182; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Lebherz C, 2005, HUM GENE THER, V16, P178, DOI 10.1089/hum.2005.16.178; Magne N, 2002, BRIT J CANCER, V86, P1518, DOI 10.1038/sj/bjc/6600299; Mah C, 1998, J VIROL, V72, P9835, DOI 10.1128/JVI.72.12.9835-9843.1998; Schmidt M, 2006, J VIROL, V80, P5082, DOI 10.1128/JVI.80.10.5082-5085.2006; Thariat J, 2007, INT J CLIN ONCOL, V12, P99, DOI 10.1007/s10147-006-0663-5; Zhong L, 2007, MOL THER, V15, P1323, DOI 10.1038/sj.mt.6300170; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	15	84	90	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					662	664		10.1038/nm.2145	http://dx.doi.org/10.1038/nm.2145			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473307	Green Accepted			2022-12-27	WOS:000278394200031
J	Luker, KE; Mihalko, LA; Schmidt, BT; Lewin, SA; Ray, P; Shcherbo, D; Chudakov, DM; Luker, GD				Luker, Kathryn E.; Mihalko, Laura Anne; Schmidt, Bradley T.; Lewin, Sarah A.; Ray, Paramita; Shcherbo, Dmitry; Chudakov, Dmitriy M.; Luker, Gary D.			In vivo imaging of ligand receptor binding with Gaussia luciferase cornplementation	NATURE MEDICINE			English	Article							BREAST-CANCER CELLS; CHEMOKINE RECEPTOR; ANTIBODY; OVARIAN; CXCL12; CXCR7; ASSAY; RDC1	Studies of ligand-receptor binding and the development of receptor antagonists would benefit greatly from imaging techniques that translate directly from cell-based assays to living animals. We used Gaussia luciferase protein fragment complementation to quantify the binding of chemokine (C-X-C motif) ligand 12 (CXCL12) to chemokine (C-X-C motif) receptor 4 (CXCR4) and CXCR7. Studies established that smallmolecule inhibitors of CXCR4 or CXCR7 specifically blocked CXCL12 binding in cell-based assays and revealed differences in kinetics of inhibiting chemokine binding to each receptor. Bioluminescence imaging showed CXCL12-CXCR7 binding in primary and metastatic tumors in a mouse model of breast cancer. We used this imaging technique to quantify drugmediated inhibition of CXCL12-CXCR4 binding in living mice. We expect this imaging technology to advance research in areas such as ligand-receptor interactions and the development of new therapeutic agents in cell-based assays and small animals.	[Luker, Kathryn E.; Mihalko, Laura Anne; Schmidt, Bradley T.; Lewin, Sarah A.; Ray, Paramita; Luker, Gary D.] Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Shcherbo, Dmitry; Chudakov, Dmitriy M.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Shcherbo, Dmitry; Chudakov, Dmitriy M.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Privolzhsky Research Medical University; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA.	gluker@umich.edu	Shcherbo, Dmitry S/B-3549-2019; Chudakov, Dmitriy M/G-7741-2014	Chudakov, Dmitriy M/0000-0003-0430-790X; luker, gary/0000-0001-6832-2581; Schmidt, Bradley/0000-0002-4011-4630	US National Institutes of Health [R01 CA 136553, R01 CA 136829, R01 CA142750, P50 CA93990, U24 CA083099]; Russian Educational Institutions [11.G34.31.0017]; Russian Ministry of Education and Science [16.740.11.0367, 16.512.11.2139]; NATIONAL CANCER INSTITUTE [R01CA136829, R01CA136553, P50CA093990, U24CA083099, R01CA142750] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028819] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Educational Institutions; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the US National Institutes of Health grants R01 CA 136553, R01 CA 136829, R01 CA142750 and P50 CA93990 (G.D.L.) and Measures to Attract Leading Scientists to Russian Educational Institutions grant 11.G34.31.0017 and Russian Ministry of Education and Science grants 16.740.11.0367 and 16.512.11.2139 (D.M.C.). We thank ChemoCentryx for the monoclonal antibody 11G8 and the small-molecule inhibitors of CXCR7. We acknowledge support from the US National Institutes of Health grant U24 CA083099 to B.D. Ross for the Michigan Small Animal Imaging Resource. We thank). Jaen, M. Penfold and D. Dairaghi for helpful discussions.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Datema R, 1996, ANTIMICROB AGENTS CH, V40, P750, DOI 10.1128/AAC.40.3.750; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Lin LS, 2009, J MED CHEM, V52, P3449, DOI 10.1021/jm900257b; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Patel KG, 2009, BIOCHEM BIOPH RES CO, V390, P971, DOI 10.1016/j.bbrc.2009.10.087; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shin SY, 2010, J BIOL CHEM, V285, P30731, DOI 10.1074/jbc.M110.128124; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Woska JR, 2003, J IMMUNOL METHODS, V277, P101, DOI 10.1016/S0022-1759(03)00176-5	21	56	62	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					172	177		10.1038/nm.2590	http://dx.doi.org/10.1038/nm.2590			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138753	Green Accepted			2022-12-27	WOS:000299018600045
J	Ohh, M				Ohh, Michael			Cancer SUMmOns Otto's metabolism	NATURE MEDICINE			English	Editorial Material							NEDD8-ACTIVATING ENZYME; PARAGANGLIOMA; MUTATIONS; MELANOMA; OXYGEN; MITF; GENE		[Ohh, Michael] Univ Toronto, Toronto, ON, Canada	University of Toronto	Ohh, M (corresponding author), Univ Toronto, Toronto, ON, Canada.	michael.ohh@utoronto.ca						Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Okura T, 1996, J IMMUNOL, V157, P4277; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	13	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					30	+		10.1038/nm.2631	http://dx.doi.org/10.1038/nm.2631			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227664				2022-12-27	WOS:000299018600023
J	Fafalios, A; Ma, JH; Tan, XP; Stoops, J; Luo, JH; DeFrances, MC; Zarnegar, R				Fafalios, Arlee; Ma, Jihong; Tan, Xinping; Stoops, John; Luo, Jianhua; DeFrances, Marie C.; Zarnegar, Reza			A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism	NATURE MEDICINE			English	Article							INDUCED FATTY LIVER; UP-REGULATION; C-MET; MICE; REGENERATION; PATHWAY; IRS-2; RATS; FAS	Met is the transmembrane tyrosine kinase cell surface receptor for hepatocyte growth factor (HGF) and is structurally related to the insulin receptor (INSR) tyrosine kinase. Here we report that the HGF-Met axis regulates metabolism by stimulating hepatic glucose uptake and suppressing hepatic glucose output. We show that Met is essential for an optimal hepatic insulin response by directly engaging INSR to form a Met-INSR hybrid complex, which culminates in a robust signal output. We also found that the HGF-Met system restores insulin responsiveness in a mouse model of insulin refractoriness. These results provide new insights into the molecular basis of hepatic insulin resistance and suggest that HGF may have therapeutic potential for type 2 diabetes in the clinical setting.	[Fafalios, Arlee; Ma, Jihong; Tan, Xinping; Stoops, John; Luo, Jianhua; DeFrances, Marie C.; Zarnegar, Reza] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [DeFrances, Marie C.; Zarnegar, Reza] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [DeFrances, Marie C.; Zarnegar, Reza] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zarnegar, R (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	rezazar@pitt.edu	Luo, jian/HGE-7331-2022		US National Institutes of Health [R01NIAA001871301]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018713] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank G. K. Michalopoulos and S. Strom (University of Pittsburgh) for providing primary rodent and human hepatocyte cultures. We also thank A. Eaker and C. Johnson for their technical assistance. This study was supported by an R01 grant (R01NIAA001871301) awarded to R.Z. by the US National Institutes of Health.	APPASAMY R, 1993, LAB INVEST, V68, P270; Bertola A, 2007, J BIOL CHEM, V282, P10325, DOI 10.1074/jbc.M611770200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; Deangelis T, 2010, J CELL PHYSIOL, V224, P658, DOI 10.1002/jcp.22164; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jiang JG, 2001, J BIOL CHEM, V276, P25049, DOI 10.1074/jbc.M101611200; Johnston AM, 2003, FEBS LETT, V546, P32, DOI 10.1016/S0014-5793(03)00438-1; Kosone T, 2007, AM J PHYSIOL-GASTR L, V293, pG204, DOI 10.1152/ajpgi.00021.2007; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LIU ML, 1994, AM J PATHOL, V144, P129; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; Perdomo G, 2008, J BIOL CHEM, V283, P13700, DOI 10.1074/jbc.M707551200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; SURWIT RS, 1986, PSYCHOSOM MED, V48, P278, DOI 10.1097/00006842-198603000-00013; Taniguchi CM, 2005, J CLIN INVEST, V115, P1388, DOI 10.1172/JCI200523187C1; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tomita K, 2004, GASTROENTEROLOGY, V126, P873, DOI 10.1053/j.gastro.2003.12.008; Turner SM, 2005, ACTA DIABETOL, V42, P187, DOI 10.1007/s00592-005-0201-3; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	28	72	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1577	U87		10.1038/nm.2531	http://dx.doi.org/10.1038/nm.2531			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081023	Green Accepted			2022-12-27	WOS:000297978000028
J	Mielgo, A; Seguin, L; Huang, M; Camargo, MF; Anand, S; Franovic, A; Weis, SM; Advani, SJ; Murphy, EA; Cheresh, DA				Mielgo, Ainhoa; Seguin, Laetitia; Huang, Miller; Camargo, Maria Fernanda; Anand, Sudarshan; Franovic, Aleksandra; Weis, Sara M.; Advani, Sunil J.; Murphy, Eric A.; Cheresh, David A.			A MEK-independent role for CRAF in mitosis and tumor progression	NATURE MEDICINE			English	Article							B-RAF; SELECTIVE INHIBITOR; MITOTIC ENTRY; KINASE; BRAF; CELLS; POLO; GROWTH; CANCER; CHECKPOINT	RAF kinases regulate cell proliferation and survival and can be dysregulated in tumors(1,2). The role of RAF in cell proliferation has been linked to its ability to activate mitogen-activated protein kinase kinase 1 (MEK) and mitogen-activated protein kinase 1 (ERK). Here we identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tumors with allosteric inhibitors, but not ATP-competitive RAF inhibitors, prevents CRAF phosphorylation on Ser338 and localization to the mitotic spindle and causes cell-cycle arrest at prometaphase. Furthermore, we identify phospho-Ser338 CRAF as a potential biomarker for tumor progression and a surrogate marker for allosteric RAF blockade. Mechanistically, CRAF, but not BRAF, associates with Aurora kinase A (Aurora-A) and Polo-like kinase 1 (Plk1) at the centrosomes and spindle poles during G2/M. Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice. These findings show a previously undefined role for RAF in tumor progression beyond the RAF-MEK-ERK paradigm, opening new avenues for targeting RAF in cancer.	[Mielgo, Ainhoa; Seguin, Laetitia; Huang, Miller; Camargo, Maria Fernanda; Anand, Sudarshan; Franovic, Aleksandra; Weis, Sara M.; Murphy, Eric A.; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Advani, Sunil J.] Univ Calif San Diego, Dept Radiat Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	ANAND, SUDARSHAN/I-5316-2019	ANAND, SUDARSHAN/0000-0002-4969-6884; SEGUIN, Laetitia/0000-0003-2950-4766; Huang, Miller/0000-0002-3371-0100; Mielgo, Ainhoa/0000-0002-4159-5931; Seguin, Laetitia/0000-0002-9610-7093	US National Institutes of Health [CA78045, CA119335, CA95262, CA104898]; NATIONAL CANCER INSTITUTE [U54CA119335, P01CA104898, P01CA078045, R01CA095262, R37CA050286, R01CA045726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Elliott and J. Lesperance for their assistance with the mouse experiments and immunohistochemistry, and M. Schmid, M. Kaulich and J. Desgrosellier for discussions. We thank K. Lee (US National Institutes of Health National Cancer Institute) and R. Erikson (Harvard University) for providing Plk1 constructs. D.A.C. was supported by grants CA78045, CA119335, CA95262 and CA104898 from the US National Institutes of Health.	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Alavi AS, 2007, CANCER RES, V67, P2766, DOI 10.1158/0008-5472.CAN-06-3648; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Borysov SI, 2008, MOL BIOL CELL, V19, P2907, DOI 10.1091/mbc.E07-07-0679; Borysov SI, 2006, J BIOL CHEM, V281, P22586, DOI 10.1074/jbc.M601432200; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hindley A, 2002, J CELL SCI, V115, P1575; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kamata T, 2010, CANCER RES, V70, P8475, DOI 10.1158/0008-5472.CAN-10-0603; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McGlynn LM, 2009, CLIN CANCER RES, V15, P1487, DOI 10.1158/1078-0432.CCR-07-4967; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Murphy EA, 2010, P NATL ACAD SCI USA, V107, P4299, DOI 10.1073/pnas.0909299107; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	37	43	51	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1641	U156		10.1038/nm.2464	http://dx.doi.org/10.1038/nm.2464			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22081024	Green Accepted			2022-12-27	WOS:000297978000036
J	DeRose, YS; Wang, GY; Lin, YC; Bernard, PS; Buys, SS; Ebbert, MTW; Factor, R; Matsen, C; Milash, BA; Nelson, E; Neumayer, L; Randall, RL; Stijleman, IJ; Welm, BE; Welm, AL				DeRose, Yoko S.; Wang, Guoying; Lin, Yi-Chun; Bernard, Philip S.; Buys, Saundra S.; Ebbert, Mark T. W.; Factor, Rachel; Matsen, Cindy; Milash, Brett A.; Nelson, Edward; Neumayer, Leigh; Randall, R. Lor; Stijleman, Inge J.; Welm, Bryan E.; Welm, Alana L.			Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; MOUSE MODELS; IN-VITRO; MICE; XENOGRAFTS; SUBTYPES; PREDICTOR; LINES	Development and preclinical testing of new cancer therapies is limited by the scarcity of in vivo models that authentically reproduce tumor growth and metastatic progression. We report new models for breast tumor growth and metastasis in the form of transplantable tumors derived directly from individuals undergoing treatment for breast cancer. These tumor grafts illustrate the diversity of human breast cancer and maintain essential features of the original tumors, including metastasis to specific sites. Co-engraftment of primary human mesenchymal stem cells maintains phenotypic stability of the grafts and increases tumor growth by promoting angiogenesis. We also report that tumor engraftment is a prognostic indicator of disease outcome for women with newly diagnosed breast cancer; orthotopic breast tumor grafting is a step toward individualized models for tumor growth, metastasis and prognosis. This bank of tumor grafts also serves as a publicly available resource for new models in which to study the biology of breast cancer.	[DeRose, Yoko S.; Wang, Guoying; Lin, Yi-Chun; Welm, Bryan E.; Welm, Alana L.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Bernard, Philip S.; Factor, Rachel; Stijleman, Inge J.] Univ Utah, Dept Pathol, Huntsman Canc Inst, Salt Lake City, UT USA; [Bernard, Philip S.; Ebbert, Mark T. W.] Associated Reg & Univ Pathologists Inst Clin & Ex, Salt Lake City, UT USA; [Buys, Saundra S.] Univ Utah, Dept Internal Med, Div Med Oncol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Matsen, Cindy; Nelson, Edward; Neumayer, Leigh; Welm, Bryan E.] Univ Utah, Dept Surg, Huntsman Canc Inst, Salt Lake City, UT USA; [Milash, Brett A.] Univ Utah, Hlth Sci Ctr, Bioinformat Core Facil, Huntsman Canc Inst, Salt Lake City, UT USA; [Randall, R. Lor] Univ Utah, Dept Orthopaed Surg, Huntsman Canc Inst, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Welm, AL (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	alana.welm@hci.utah.edu		Nelson, Edward/0000-0002-1170-0032; Ebbert, Mark/0000-0001-9158-4440; Matsen, Cindy/0000-0003-0179-5311	Department of Defense [BC075015]; American Association for Cancer Research and Breast Cancer Research Foundation [07-60-26-WELM]; Huntsman Cancer Foundation; Huntsman Cancer Institute [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA143815, R01CA140296] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); American Association for Cancer Research and Breast Cancer Research Foundation; Huntsman Cancer Foundation; Huntsman Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the individuals who donated tissue toward this endeavor and the Associated Regional and University Pathologists Research Institute staff for performing the clinical stains. This work was supported by funding from the Department of Defense Breast Cancer Research Program (to A. L. W.; BC075015), the American Association for Cancer Research and Breast Cancer Research Foundation (to A. L. W.; 07-60-26-WELM) and the Huntsman Cancer Foundation. We also used the Huntsman Cancer Institute Tissue Resource and Application Core and Comparative Oncology Core facilities, which is supported in part by P30 CA042014 (to the Huntsman Cancer Institute).	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Clarke MF, 2005, CANCER CHEMOTH PHARM, V56, pS64, DOI 10.1007/s00280-005-0097-1; Clarke Robert, 2009, Breast Cancer Res, V11 Suppl 3, pS22, DOI 10.1186/bcr2441; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; El-Haibi CP, 2010, J MAMMARY GLAND BIOL, V15, P399, DOI 10.1007/s10911-010-9196-7; Ethier SP, 1996, J MAMMARY GLAND BIOL, V1, P111, DOI 10.1007/BF02096306; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Hoffman RM, 1999, METHOD ENZYMOL, V302, P20, DOI 10.1016/S0076-6879(99)02005-4; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wagner KU, 2004, BREAST CANCER RES, V6, P31, DOI 10.1186/bcr723; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002	34	661	678	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1514	U227		10.1038/nm.2454	http://dx.doi.org/10.1038/nm.2454			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22019887	Green Accepted			2022-12-27	WOS:000296779300045
J	Diouf, B; Cheng, Q; Krynetskaia, NF; Yang, WJ; Cheok, M; Pei, DQ; Fan, YP; Cheng, C; Krynetskiy, EY; Geng, H; Chen, SY; Thierfelder, WE; Mullighan, CG; Downing, JR; Hsieh, P; Pui, CH; Relling, MV; Evans, WE				Diouf, Barthelemy; Cheng, Qing; Krynetskaia, Natalia F.; Yang, Wenjian; Cheok, Meyling; Pei, Deqing; Fan, Yiping; Cheng, Cheng; Krynetskiy, Evgeny Y.; Geng, Hui; Chen, Siying; Thierfelder, William E.; Mullighan, Charles G.; Downing, James R.; Hsieh, Peggy; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.			Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HMUTS-ALPHA; EXPRESSION; MECHANISMS; BINDING; ADULT; TSC1	DNA mismatch repair enzymes (for example, MSH2) maintain genomic integrity, and their deficiency predisposes to several human cancers and to drug resistance. We found that leukemia cells from a substantial proportion of children (similar to 11%) with newly diagnosed acute lymphoblastic leukemia have low or undetectable MSH2 protein levels, despite abundant wild-type MSH2 mRNA. Leukemia cells with low levels of MSH2 contained partial or complete somatic deletions of one to four genes that regulate MSH2 degradation (FRAP1 (also known as MTOR), HERC1, PRKCZ and PIK3C2B); we also found these deletions in individuals with adult acute lymphoblastic leukemia (16%) and sporadic colorectal cancer (13.5%). Knockdown of these genes in human leukemia cells recapitulated the MSH2 protein deficiency by enhancing MSH2 degradation, leading to substantial reduction in DNA mismatch repair and increased resistance to thiopurines. These findings reveal a previously unrecognized mechanism whereby somatic deletions of genes regulating MSH2 degradation result in undetectable levels of MSH2 protein in leukemia cells, DNA mismatch repair deficiency and drug resistance.	[Diouf, Barthelemy; Cheng, Qing; Krynetskaia, Natalia F.; Yang, Wenjian; Cheok, Meyling; Pei, Deqing; Cheng, Cheng; Krynetskiy, Evgeny Y.; Thierfelder, William E.; Mullighan, Charles G.; Downing, James R.; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 USA; [Diouf, Barthelemy; Cheng, Qing; Krynetskaia, Natalia F.; Yang, Wenjian; Cheok, Meyling; Krynetskiy, Evgeny Y.; Thierfelder, William E.; Relling, Mary V.; Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Geng, Hui; Chen, Siying; Hsieh, Peggy] NIDDK, Genet & Biochem Branch, US Natl Inst Hlth NIH, Bethesda, MD USA; [Mullighan, Charles G.; Downing, James R.; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); St Jude Children's Research Hospital; St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Hematol Malignancies Program, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Cheng, Cheng/N-8075-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018; CHEN, SI/GZL-4800-2022; Cheok, Meyling h/C-3822-2014; Cheok, Meyling/AFS-4025-2022; Mullighan, Charles/H-3253-2011	Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Cheok, Meyling h/0000-0002-7820-8026; Cheok, Meyling/0000-0002-7820-8026; Mullighan, Charles/0000-0002-1871-1850	NIH National Institute of General Medical Sciences [U01 GM92666]; National Cancer Institute [CA 21765]; American Lebanese Syrian Associated Charities (ALSAC); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH;  [R37 CA36401]; NATIONAL CANCER INSTITUTE [R37CA036401, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the subjects and parents who participated in this study and the outstanding technical support of the Hartwell Center for Bioinformatics and Biotechnology at St. Jude Children's Research Hospital. We also thank Y. Wang, T. Brooks, J. Smith, W. Du, S. Mukatira, Y. Chu, M. Needham, P. Hargrove, G. Stocco and S. Paugh for their advice and technical support; J. Groff for preparation of the figures; K. Crews, N. Kornegay and M. Wilkinson for their research database expertise; J. C. Panetta for his modeling expertise; J. Jenkins for his immunohistochemistry expertise; T. Kunkel and A. B. Clark (National Institute of Environmental Health Sciences) for providing the E. coli strains, the wild-type and mutant M13mp2 phage and for their contributions to our MMR experiments; and J. Luis Rosa (Universitat de Barcelona) for providing us with antibodies to HERC1. We thank M. Kastan and D. Green for their critical review and advice. This work was supported in part by grant R37 CA36401 (W. E. E. and M. V. R.), NIH National Institute of General Medical Sciences Pharmacogenomics Research Network grant U01 GM92666 (M. V. R. and W. E. E.), CGM is a Pew Scholar and a St. Baldrick's scholar, and St. Jude is supported by a Cancer Center Support Grant CA 21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC). H. G., S. C. and P. H. were funded by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH.	Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Belloni M, 1999, J NEUROCHEM, V72, P974, DOI 10.1046/j.1471-4159.1999.0720974.x; Bouffler SD, 2000, BRIT J CANCER, V83, P1291, DOI 10.1054/bjoc.2000.1422; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; de Wind N, 1998, CANCER RES, V58, P248; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Dosch J, 1998, CARCINOGENESIS, V19, P567, DOI 10.1093/carcin/19.4.567; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Felton KEA, 2007, CLIN GENET, V71, P483, DOI 10.1111/j.1399-0004.2007.00803.x; Fink D, 1996, CANCER RES, V56, P4881; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hernandez-Pigeon H, 2005, J MOL BIOL, V348, P63, DOI 10.1016/j.jmb.2005.02.001; Hernandez-Pigeon H, 2004, FEBS LETT, V562, P40, DOI 10.1016/S0014-5793(04)00181-4; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Krynetskaia NF, 2003, MOL PHARMACOL, V64, P456, DOI 10.1124/mol.64.2.456; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Matheson EC, 1999, ADV EXP MED BIOL, V457, P579; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Papaefthymiou MA, 2008, MED SCI MONITOR, V14, pRA8; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Rowley PT, 2005, ANNU REV MED, V56, P539, DOI 10.1146/annurev.med.56.061704.135235; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968; Zhu YM, 1999, BLOOD, V94, P733, DOI 10.1182/blood.V94.2.733.414k03_733_740	36	95	95	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1298	U332		10.1038/nm.2430	http://dx.doi.org/10.1038/nm.2430			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946537	Green Accepted			2022-12-27	WOS:000296022100049
J	Gallin, JI				Gallin, John I.			The NIH Clinical Center and the future of clinical research	NATURE MEDICINE			English	Article							COMBINATION CHEMOTHERAPY; DISEASE		NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Gallin, JI (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.	jig@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000155] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FLAMENT MF, 1985, ARCH GEN PSYCHIAT, V42, P977; FREDRICKSON D, 1961, ANN INTERN MED, V55, P1016, DOI 10.7326/0003-4819-55-6-1016; FREDRICKSON DONALD S., 1967, N ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107; FREI E, 1958, BLOOD, V13, P1126, DOI 10.1182/blood.V13.12.1126.1126; Gallin JI, 2006, CLIN CANCER RES, V12, P4131, DOI 10.1158/1078-0432.CCR-06-1095; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; GOODWIN FK, 1969, ARCH GEN PSYCHIAT, V21, P486; LI MC, 1956, P SOC EXP BIOL MED, V93, P361; Linehan WM, 2004, CANCER CELL, V6, P223, DOI 10.1016/j.ccr.2004.09.006; MCCARTHY C, 2008, OXFORD U TXB CLIN RE, P543; MCNEES P, 2003, BUILDING 10 50 50 YE, V26, P78; *NAT I HLTH SCI MA, 2010, REP NIH CLIN CTR; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; RUSK HA, 1953, NY TIMES        0628; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TRAUTMAN JA, 1952, MIN MED BOARD CLIN C; Turkbey B, 2011, BJU INT, V107, P53, DOI 10.1111/j.1464-410X.2010.09483.x; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEISS SH, 1985, JAMA-J AM MED ASSOC, V253, P221, DOI 10.1001/jama.253.2.221; YARCHOAN R, 1986, LANCET, V1, P575	24	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1221	1223		10.1038/nm.2466	http://dx.doi.org/10.1038/nm.2466			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989014	Bronze			2022-12-27	WOS:000296022100037
J	Gattinoni, L; Lugli, E; Ji, Y; Pos, Z; Paulos, CM; Quigley, MF; Almeida, JR; Gostick, E; Yu, ZY; Carpenito, C; Wang, E; Douek, DC; Price, DA; June, CH; Marincola, FM; Roederer, M; Restifo, NP				Gattinoni, Luca; Lugli, Enrico; Ji, Yun; Pos, Zoltan; Paulos, Chrystal M.; Quigley, Maire F.; Almeida, Jorge R.; Gostick, Emma; Yu, Zhiya; Carpenito, Carmine; Wang, Ena; Douek, Daniel C.; Price, David A.; June, Carl H.; Marincola, Francesco M.; Roederer, Mario; Restifo, Nicholas P.			A human memory T cell subset with stem cell-like properties	NATURE MEDICINE			English	Article							BETA-CATENIN; NAIVE RATHER; CANCER; DIFFERENTIATION; LYMPHOCYTE; EXPRESSION; PHENOTYPE; PRECURSOR; IMMUNITY; HOMEOSTASIS	Immunological memory is thought to depend on a stem cell-like, self-renewing population of lymphocytes capable of differentiating into effector cells in response to antigen re-exposure. Here we describe a long-lived human memory T cell population that has an enhanced capacity for self-renewal and a multipotent ability to derive central memory, effector memory and effector T cells. These cells, specific to multiple viral and self-tumor antigens, were found within a CD45RO(-), CCR7(+), CD45RA(+), CD62L(+), CD27(+), CD28(+) and IL-7R alpha(+) T cell compartment characteristic of naive T cells. However, they expressed large amounts of CD95, IL-2R beta, CXCR3, and LFA-1, and showed numerous functional attributes distinctive of memory cells. Compared with known memory populations, these lymphocytes had increased proliferative capacity and more efficiently reconstituted immunodeficient hosts, and they mediated superior antitumor responses in a humanized mouse model. The identification of a human stem cell-like memory T cell population is of direct relevance to the design of vaccines and T cell therapies.	[Gattinoni, Luca; Ji, Yun; Yu, Zhiya; Restifo, Nicholas P.] NCI, Ctr Canc Res, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Lugli, Enrico; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Pos, Zoltan; Wang, Ena; Marincola, Francesco M.] US Natl Inst Hlth, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD USA; [Pos, Zoltan; Wang, Ena; Marincola, Francesco M.] US Natl Inst Hlth, Ctr Human Immunol, Bethesda, MD USA; [Paulos, Chrystal M.; Carpenito, Carmine; June, Carl H.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Paulos, Chrystal M.; Carpenito, Carmine; June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Quigley, Maire F.; Gostick, Emma; Price, David A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales; [Quigley, Maire F.; Almeida, Jorge R.; Douek, Daniel C.; Price, David A.] NIAID, Human Immunol Sect, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gattinoni, L (corresponding author), NCI, Ctr Canc Res, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA.	gattinol@mail.nih.gov; restifo@nih.gov	Waldmann, Thomas/AAT-5972-2021; Pós, Zoltán/C-3623-2014; Restifo, Nicholas P/A-5713-2008; Price, David A/C-7876-2013; Restifo, Nicholas Phillip/Z-1614-2019; Lugli, Enrico/AAB-7933-2019; Gattinoni, Luca/A-2281-2008; Ji, Yun/B-7245-2009; Roederer, Mario/G-1887-2011; Restifo, Nicholas Phillip/M-6549-2019	Waldmann, Thomas/0000-0003-4500-6660; Pós, Zoltán/0000-0002-2574-7616; Price, David A/0000-0001-9416-2737; Lugli, Enrico/0000-0002-1964-7678; Gattinoni, Luca/0000-0003-2239-3282; Ji, Yun/0000-0001-6340-7009; Restifo, Nicholas P./0000-0003-4229-4580; Ramos de Almeida, Jorge/0000-0002-5009-8478; June, Carl/0000-0003-0241-3557	US National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Institute of Allergy and Infectious Diseases; MRC [G0501963] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIABC011037, ZIABC010763] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER; Medical Research Council [G0501963] Funding Source: researchfish	US National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Programs of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research and National Institute of Allergy and Infectious Diseases. We thank S.A. Rosenberg and J.R. Wunderlich for providing samples from HLA-A*0201 patients with melanoma; P. Scheinberg for providing HLA-A*0201 samples; M. Sabatino for coordinating phereses; B.J. Hill for assistance with the TREC assay; S. P. Perfetto, R. Nguyen, D. A. Ambrozak, A. Mixon and S. Farid for help with cell sorting; P. K. Chattopadhyay and J. Yu for antibody conjugation; and R. A. Seder and C. A. Klebanoff for critical review of the manuscript.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Beier CP, 2009, CELL STEM CELL, V5, P128, DOI 10.1016/j.stem.2009.07.008; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gattinoni L, 2010, NAT MED, V16, P514, DOI 10.1038/nm0510-514; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Khan J, 1998, CANCER RES, V58, P5009; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lugli E, 2007, CYTOM PART A, V71A, P334, DOI 10.1002/cyto.a.20387; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Neuenhahn M, 2009, IMMUNITY, V31, P702, DOI 10.1016/j.immuni.2009.10.002; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schenkel JM, 2010, J IMMUNOL, V185, P2013, DOI 10.4049/jimmunol.0902572; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhao CF, 2010, J EXP MED, V207, P2883, DOI 10.1084/jem.20100598; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	56	1163	1253	5	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1290	U325		10.1038/nm.2446	http://dx.doi.org/10.1038/nm.2446			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21926977	Green Accepted			2022-12-27	WOS:000296022100048
J	Horwich, AL				Horwich, Arthur L.			Protein folding in the cell: an inside story	NATURE MEDICINE			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; BACTERIAL CHAPERONIN GROEL; T-COMPLEX POLYPEPTIDE-1; CRYSTAL-STRUCTURE; MOLECULAR CHAPERONE; YEAST MITOCHONDRIA; CENTRAL CAVITY; HEAT-SHOCK; ATP; BINDING		Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	arthur.horwich@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG MY, 1987, P NATL ACAD SCI USA, V84, P4063, DOI 10.1073/pnas.84.12.4063; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GEORGOPOULOS CP, 1972, NATURE-NEW BIOL, V239, P38, DOI 10.1038/newbio239038a0; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; HORWICH AL, MOL MACHINE IN PRESS; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SAIBIL H, 1991, NATURE, V353, P25, DOI 10.1038/353025b0; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; TAKANO T, 1972, NATURE-NEW BIOL, V239, P34, DOI 10.1038/newbio239034a0; TRENT JD, 1991, NATURE, V354, P490, DOI 10.1038/354490a0; URSIC D, 1991, MOL CELL BIOL, V11, P2629, DOI 10.1128/MCB.11.5.2629; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	41	28	29	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1211	1216		10.1038/nm.2468	http://dx.doi.org/10.1038/nm.2468			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989012				2022-12-27	WOS:000296022100035
J	Lee, J; Sun, C; Zhou, YJ; Lee, J; Gokalp, D; Herrema, H; Park, SW; Davis, RJ; Ozcan, U				Lee, Jaemin; Sun, Cheng; Zhou, Yingjiang; Lee, Justin; Gokalp, Deniz; Herrema, Hilde; Park, Sang Won; Davis, Roger J.; Ozcan, Umut			p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SIGNAL-TRANSDUCTION; TRANSMEMBRANE PROTEIN; INSULIN-RESISTANCE; ER STRESS; PHOSPHOLIPID BIOSYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; INFLAMMATION	Here we show that p38 mitogen-activated protein kinase (p38 MAPK) phosphorylates the spliced form of X-box binding protein 1 (Xbp1s) on its Thr48 and Ser61 residues and greatly enhances its nuclear migration in mice, whereas mutation of either residue to alanine substantially reduces its nuclear translocation and activity. We also show that p38 MAPK activity is markedly reduced in the livers of obese mice compared with lean mice. Further, we show that activation of p38 MAPK by expression of constitutively active MAP kinase kinase 6 (MKK6Glu) greatly enhances nuclear translocation of Xbp1s, reduces endoplasmic reticulum stress and establishes euglycemia in severely obese and diabetic mice. Hence, our results define a crucial role for phosphorylation on Thr48 and Ser61 of Xbp1s in the maintenance of glucose homeostasis in obesity, and they suggest that p38 MAPK activation in the livers of obese mice could lead to a new therapeutic approach to the treatment of type 2 diabetes.	[Lee, Jaemin; Sun, Cheng; Zhou, Yingjiang; Lee, Justin; Gokalp, Deniz; Herrema, Hilde; Park, Sang Won; Ozcan, Umut] Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02114 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02114 USA.	umut.ozcan@childrens.harvard.edu	Lee, Jaemin/AAP-4875-2021	Davis, Roger/0000-0002-0130-1652; Herrema, Hilde/0000-0002-0112-6348; Lee, Jaemin/0000-0002-0224-7141	Children's Hospital Boston [R01DK081009]; US National Institutes of Health [R56DK089111]; Timothy Murphy funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009, R56DK089111] Funding Source: NIH RePORTER	Children's Hospital Boston; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Timothy Murphy funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Ozcan laboratory for their help during the execution of the experiments. We thank L. Glimcher (Harvard School of Public Health) for providing us with the Xbp1<SUP>flox/flox</SUP> mouse strain. We thank P. Blackshear (National Institute of Environment Health Sciences) for kindly providing us with Zfp<SUP>36-/-</SUP> cells and M. Gaestel (Hannover Medical School, Germany) for generously providing Mapkapk<SUP>2-/-</SUP> cells. We thank R. Davis (University of Massachusetts Medical School) for providing Mapk8<SUP>-/-</SUP>; Mapk9<SUP>-/-</SUP>, Map2k3<SUP>-/-</SUP>; Map2k6<SUP>-/-</SUP>, Map2k4<SUP>-/-</SUP>; Map2k7<SUP>-/-</SUP> and Mapk14<SUP>-/-</SUP> MEFs as well as their wild-type control MEFs. We are grateful to H. Feldman (Harvard Medical School) for helping us with the statistical analysis. This study was supported by the junior faculty start-up funds provided to U.O. by Children's Hospital Boston, an RO1 grant (R01DK081009) and R56 grant (R56DK089111) provided to U.O. by the US National Institutes of Health and the Timothy Murphy funds provided to the Division of Endocrinology, Children's Hospital Boston.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; MORI K, 1993, CELL, V74, P743; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Park SK, 2010, BREAST CANCER RES TR, V124, P361, DOI 10.1007/s10549-010-0786-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	50	142	149	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1251	U283		10.1038/nm.2449	http://dx.doi.org/10.1038/nm.2449			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21892182	Green Accepted			2022-12-27	WOS:000296022100043
J	van Dam, GM; Themelis, G; Crane, LMA; Harlaar, NJ; Pleijhuis, RG; Kelder, W; Sarantopoulos, A; de Jong, JS; Arts, HJG; van der Zee, AGJ; Bart, J; Low, PS; Ntziachristos, V				van Dam, Gooitzen M.; Themelis, George; Crane, Lucia M. A.; Harlaar, Niels J.; Pleijhuis, Rick G.; Kelder, Wendy; Sarantopoulos, Athanasios; de Jong, Johannes S.; Arts, Henriette J. G.; van der Zee, Ate G. J.; Bart, Joost; Low, Philip S.; Ntziachristos, Vasilis			Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results	NATURE MEDICINE			English	Article							SURGERY; EXPRESSION; MANAGEMENT; SURVIVAL; FUTURE; MODEL	The prognosis in advanced-stage ovarian cancer remains poor. Tumor-specific intraoperative fluorescence imaging may improve staging and debulking efforts in cytoreductive surgery and thereby improve prognosis. The overexpression of folate receptor-alpha (FR-alpha) in 90-95% of epithelial ovarian cancers prompted the investigation of intraoperative tumor-specific fluorescence imaging in ovarian cancer surgery using an FR-alpha-targeted fluorescent agent. In patients with ovarian cancer, intraoperative tumor-specific fluorescence imaging with an FR-alpha-targeted fluorescent agent showcased the potential applications in patients with ovarian cancer for improved intraoperative staging and more radical cytoreductive surgery.	[van Dam, Gooitzen M.; Crane, Lucia M. A.; Harlaar, Niels J.; Pleijhuis, Rick G.; Kelder, Wendy; de Jong, Johannes S.] Univ Groningen, BioOpt Imaging Ctr, Div Surg Oncol, Dept Surg, Groningen, Netherlands; [Themelis, George; Harlaar, Niels J.; Sarantopoulos, Athanasios; Ntziachristos, Vasilis] Tech Univ Munich, Munich, Germany; [Themelis, George; Harlaar, Niels J.; Sarantopoulos, Athanasios; Ntziachristos, Vasilis] Helmholtz Zentrum, Munich, Germany; [Arts, Henriette J. G.; van der Zee, Ate G. J.] Univ Groningen, Div Gynaecol Oncol, Dept Gynaecol, Groningen, Netherlands; [Bart, Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Mol Biol, Groningen, Netherlands; [Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	University of Groningen; Technical University of Munich; Helmholtz Association; University of Groningen; University of Groningen; Purdue University System; Purdue University; Purdue University West Lafayette Campus	van Dam, GM (corresponding author), Univ Groningen, BioOpt Imaging Ctr, Div Surg Oncol, Dept Surg, Groningen, Netherlands.	g.m.van.dam@umcg.nl	de Jong, J.S./AAC-9908-2019; Bart, Joost/A-5642-2013	Bart, Joost/0000-0002-0985-071X; Low, Philip/0000-0001-9042-5528				Aletti GD, 2006, OBSTET GYNECOL, V107, P77, DOI 10.1097/01.AOG.0000192407.04428.bb; Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Armstrong DK, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5500; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Crane LMA, 2012, CELL ONCOL, V35, P9, DOI 10.1007/s13402-011-0052-6; Gondos A, 2009, ANN ONCOL, V20, P564, DOI 10.1093/annonc/mdn639; Ibeanu OA, 2010, INT J GYNECOL CANCER, V20, pS1, DOI 10.1111/IGC.0b013e3181cff38b; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalli KR, 2008, GYNECOL ONCOL, V108, P619, DOI 10.1016/j.ygyno.2007.11.020; Kennedy MD, 2003, J BIOMED OPT, V8, P636, DOI 10.1117/1.1609453; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koppe MJ, 2006, ANN SURG, V243, P212, DOI 10.1097/01.sla.0000197702.46394.16; Leamon CP, 2002, BIOCONJUGATE CHEM, V13, P1200, DOI 10.1021/bc0200430; Low PS, 2004, ADV DRUG DELIVER REV, V56, P1055, DOI 10.1016/j.addr.2004.02.003; Lu YJ, 2009, AAPS J, V11, P628, DOI 10.1208/s12248-009-9139-7; Lu YJ, 2002, CANCER IMMUNOL IMMUN, V51, P153, DOI 10.1007/s00262-002-0266-6; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Markert S, 2008, ANTICANCER RES, V28, P3567; Mathias CJ, 1998, J NUCL MED, V39, P1579; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Sega EI, 2008, CANCER METAST REV, V27, P655, DOI 10.1007/s10555-008-9155-6; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Themelis G, 2008, OPT LETT, V33, P1023, DOI 10.1364/OL.33.001023; Themelis G, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259362; Tromberg BJ, 2008, MED PHYS, V35, P2443, DOI 10.1118/1.2919078; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Vergote I, 2008, INT J GYNECOL CANCER, V18, P11, DOI 10.1111/j.1525-1438.2007.01098.x; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Winter WE, 2008, J CLIN ONCOL, V26, P83, DOI 10.1200/JCO.2007.13.1953	32	1160	1193	11	391	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1315	U202		10.1038/nm.2472	http://dx.doi.org/10.1038/nm.2472			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21926976				2022-12-27	WOS:000296022100052
J	Lamb, D				Lamb, Dolores			Getting to the bare bones of fertility	NATURE MEDICINE			English	Editorial Material							ENERGY-METABOLISM; GENDER		Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA	Baylor College of Medicine	Lamb, D (corresponding author), Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA.			Khosla, Sundeep/0000-0002-2936-4372				Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1995, DOI 10.1210/jc.2007-0634; Bouxsein ML, 2004, J BONE MINER RES, V19, P587, DOI 10.1359/JBMR.0301255; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Gundberg CM, 2002, BONE, V31, P703, DOI 10.1016/S8756-3282(02)00902-X; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Wilson JD, 2001, HORM BEHAV, V40, P358, DOI 10.1006/hbeh.2001.1684	7	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					550	551						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21546972				2022-12-27	WOS:000290250400027
J	Ryan, KK; Li, B; Grayson, BE; Matter, EK; Woods, SC; Seeley, RJ				Ryan, Karen K.; Li, Bailing; Grayson, Bernadette E.; Matter, Emily K.; Woods, Stephen C.; Seeley, Randy J.			A role for central nervous system PPAR-gamma in the regulation of energy balance	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NEUROTROPHIC FACTOR; IN-VIVO; LEPTIN; ROSIGLITAZONE; BRAIN; GENE; RATS; HOMEOSTASIS; WEIGHT	The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a nuclear receptor that is activated by lipids to induce the expression of genes involved in lipid and glucose metabolism, thereby converting nutritional signals into metabolic consequences(1). PPAR-gamma is the target of the thiazolidinedione (TZD) class of insulin-sensitizing drugs, which have been widely prescribed to treat type 2 diabetes mellitus. A common side effect of treatment with TZDs is weight gain(2). Here we report a previously unknown role for central nervous system (CNS) PPAR-gamma in the regulation of energy balance. We found that both acute and chronic activation of CNS PPAR-gamma, by either TZDs or hypothalamic overexpression of a fusion protein consisting of PPAR-gamma and the viral transcriptional activator VP16 (VP16-PPAR-gamma), led to positive energy balance in rats. Blocking the endogenous activation of CNS PPAR-gamma with pharmacological antagonists or reducing its expression with shRNA led to negative energy balance, restored leptin sensitivity in high-fat-diet (HFD)-fed rats and blocked the hyperphagic response to oral TZD treatment. These findings have implications for the widespread clinical use of TZD drugs and for understanding the etiology of diet-induced obesity.	[Ryan, Karen K.; Li, Bailing; Grayson, Bernadette E.; Matter, Emily K.; Seeley, Randy J.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Endocrinol, Cincinnati, OH 45221 USA; [Woods, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Seeley, RJ (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Endocrinol, Cincinnati, OH 45221 USA.	randy.seeley@uc.edu	Ryan, Karen/A-4626-2014	Ryan, Karen/0000-0003-4563-3744; Seeley, Randy/0000-0002-3721-5625	US National Institute of Diabetes and Digestive and Kidney Diseases [DK082173, DK17844, DK056863, DK073505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073505, P01DK056863, F32DK082173, R01DK054890, R01DK017844, R37DK017844] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the US National Institute of Diabetes and Digestive and Kidney Diseases (DK082173 to K. K. R., DK17844 to S. C. W. and DK056863 and DK073505 to R.J.S.). The VP16-PPAR-gamma construct was generously provided by M. Lazar (University of Pennsylvania).	CHAVEZ M, 1995, BEHAV NEUROSCI, V109, P528, DOI 10.1037/0735-7044.109.3.528; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Joosen AMCP, 2006, DIABETES-METAB RES, V22, P204, DOI 10.1002/dmrr.592; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kelly JF, 2004, DIABETES, V53, P911, DOI 10.2337/diabetes.53.4.911; Kouidhi S, 2010, MOL CELL ENDOCRINOL, V317, P44, DOI 10.1016/j.mce.2009.11.001; Larsen PJ, 2003, DIABETES, V52, P2249, DOI 10.2337/diabetes.52.9.2249; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Mouihate A, 2004, J NEUROSCI, V24, P1312, DOI 10.1523/JNEUROSCI.3145-03.2004; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; Patel NG, 2003, DIABETES, V52, P43, DOI 10.2337/diabetes.52.1.43; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Scarpace PJ, 2001, NEUROSCIENCE, V104, P1111, DOI 10.1016/S0306-4522(01)00142-7; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wetzler S, 2004, PHYSIOL BEHAV, V83, P65, DOI [10.1016/j.physbeh.2004.06.024, 10.1016/S0031-9384(04)00311-7]; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	30	161	167	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					623	U145		10.1038/nm.2349	http://dx.doi.org/10.1038/nm.2349			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21532595	Green Accepted			2022-12-27	WOS:000290250400040
J	Aagaard, C; Hoang, T; Dietrich, J; Cardona, PJ; Izzo, A; Dolganov, G; Schoolnik, GK; Cassidy, JP; Billeskov, R; Andersen, P				Aagaard, Claus; Hoang, Truc; Dietrich, Jes; Cardona, Pere-Joan; Izzo, Angelo; Dolganov, Gregory; Schoolnik, Gary K.; Cassidy, Joseph P.; Billeskov, Rolf; Andersen, Peter			A multistage tuberculosis vaccine that confers efficient protection before and after exposure	NATURE MEDICINE			English	Article							GUINEA-PIG MODEL; CD4 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; SUBUNIT VACCINE; GENE-EXPRESSION; ANTIGEN 85B; IMMUNE-RESPONSES; FUSION PROTEIN; HIV EPIDEMIC; BCG	All tuberculosis vaccines currently in clinical trials are designed as prophylactic vaccines based on early expressed antigens. We have developed a multistage vaccination strategy in which the early antigens Ag85B and 6-kDa early secretory antigenic target (ESAT-6) are combined with the latency-associated protein Rv2660c (H56 vaccine). In CB6F1 mice we show that Rv2660c is stably expressed in late stages of infection despite an overall reduced transcription. The H56 vaccine promotes a T cell response against all protein components that is characterized by a high proportion of polyfunctional CD4(+) T cells. In three different pre-exposure mouse models, H56 confers protective immunity characterized by a more efficient containment of late-stage infection than the Ag85B-ESAT6 vaccine (H1) and BCG. In two mouse models of latent tuberculosis, we show that H56 vaccination after exposure is able to control reactivation and significantly lower the bacterial load compared to adjuvant control mice.	[Aagaard, Claus; Hoang, Truc; Dietrich, Jes; Billeskov, Rolf; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Cardona, Pere-Joan] Univ Autonoma Barcelona, Inst Invest Ciencies Salut Germans Trias & Pujol, Unitat TB Expt, Badalona, Catalonia, Spain; [Izzo, Angelo] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Dolganov, Gregory; Schoolnik, Gary K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Cassidy, Joseph P.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Vet Sci Ctr, Dublin 2, Ireland	Statens Serum Institut; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Colorado State University; Stanford University; University College Dublin	Aagaard, C (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	caa@ssi.dk; pa@ssi.dk	Izzo, Angelo A/F-1229-2017; Cardona, Pere-Joan/A-5258-2011; Rivet, Catherine A/M-7978-2014	Izzo, Angelo A/0000-0003-3208-2330; Cardona, Pere-Joan/0000-0001-5623-7873; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304; Cassidy, Joseph/0000-0002-9229-1831	Bill and Melinda Gates Foundation [37885]; EC [LSHP-CT-2003-503367]; US National Institutes of Health and National Institute of Allergy and Infectious Diseases [HHSN266200400091c]; TB Vaccine Testing and Research [NOI-AI-40091]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EC(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health and National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); TB Vaccine Testing and Research	We thank the Bill and Melinda Gates Foundation (GC12 # 37885), EC-FP6: TB-VAC (LSHP-CT-2003-503367), the US National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHSN266200400091c) and the TB Vaccine Testing and Research Materials Contract (NOI-AI-40091). Thanks to N. Caceres for her contribution on the model of latent tuberculosis, to L. Rasmussen, M. Henriksen, J. Brady and V. Andersen for excellent technical help and to E. M. Agger for critical reading of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Butcher PD, 1998, METH MOL B, V101, P285, DOI 10.1385/0-89603-471-2:285; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022; Heeney Jonathan L, 2006, Nat Immunol, V7, P1281, DOI 10.1038/ni1206-1281; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Palendira U, 2005, VACCINE, V23, P1680, DOI 10.1016/j.vaccine.2004.10.007; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wilkinson D, 1997, S AFR MED J, V87, P447; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	39	401	430	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					189	U224		10.1038/nm.2285	http://dx.doi.org/10.1038/nm.2285			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21258338				2022-12-27	WOS:000286969900026
J	Kobayashi, SD; Deleo, FR				Kobayashi, Scott D.; Deleo, Frank R.			A MRSA-terious enemy among us	NATURE MEDICINE			English	Editorial Material							STAPHYLOCOCCUS-AUREUS INFECTIONS; VACCINE; MICE; INSIGHTS	Infection with methicillin-resistant Staphylococcus aureus (MRSA) can cause symptoms ranging from mild skin infections to more severe disease in various organs, even among healthy individuals. The ability of this pathogen to escape our immune arsenal and overcome antibiotic therapy poses a challenge to preventing their spread and treating the related symptoms. In 'Bench to Bedside', Scott Kobayashi and Frank DeLeo explore new approaches for vaccine development that focus on antigens required for establishment of disease. Studies with infected mice immunized against S. aureus coagulases-important for abscess formation and bloodstream infection-suggest such an approach may be used to reduce bacterial load and protect against severe disease in humans. In 'Bedside to Bench', Michael Otto examines a large human study where the presence of genes encoding Panton-Valentine leukocidin toxin (PVL) in community-associated MRSA did not correlate with complicated skin structure infections-a result opposing the widespread notion that PVL is the primary CA-MRSA virulence factor.	[Kobayashi, Scott D.; Deleo, Frank R.] US Natl Inst Allergy & Infect Dis, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kobayashi, SD (corresponding author), US Natl Inst Allergy & Infect Dis, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	fdeleo@niaid.nih.gov		Kobayashi, Scott/0000-0002-5705-1381; DeLeo, Frank/0000-0003-3150-2516	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001079] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Harro C, 2010, CLIN VACCINE IMMUNOL, V17, P1868, DOI 10.1128/CVI.00356-10; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Projan SJ, 2008, DRUG DISCOV TODAY, V13, P279, DOI 10.1016/j.drudis.2008.03.010; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; SMITH W, 1947, BRIT J EXP PATHOL, V28, P57; Spellberg B, 2010, HUM VACCINES, V6, P857, DOI 10.4161/hv.6.10.12469; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208	16	12	12	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					168	169		10.1038/nm0211-168	http://dx.doi.org/10.1038/nm0211-168			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297611	Bronze			2022-12-27	WOS:000286969900022
J	Otto, M				Otto, Michael			End of the PVL controversy?	NATURE MEDICINE			English	Editorial Material							PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; VIRULENCE DETERMINANT; SKIN; INFECTIONS; RESISTANCE		US Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), US Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA.	motto@niaid.nih.gov		Otto, Michael/0000-0002-2222-4115	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Hermos CR, 2010, CLIN INFECT DIS, V51, P1138, DOI 10.1086/656742; Jones RN, 2007, ANTIMICROB AGENTS CH, V51, P3381, DOI 10.1128/AAC.01588-06; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053	15	37	39	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					169	170		10.1038/nm0211-169	http://dx.doi.org/10.1038/nm0211-169			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297612				2022-12-27	WOS:000286969900023
J	Goldstein, JL				Goldstein, Joseph L.			How to win a Lasker? Take a close look at Bathers and Bulls	NATURE MEDICINE			English	Article												joe.goldstein@utsouthwestern.edu						DAllessandro S, 2010, MATISSE RADICAL INVE; Kan YW, 2004, AM J HUM GENET, V74, P382, DOI 10.1086/381938; LAVIN I, 1993, ART AM, V81, P76; LAVIN I, 1993, ART AM, V81, P121; LAVIN I, 1993, ART AM, V81, P123	5	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1091	1096		10.1038/nm1010-1091	http://dx.doi.org/10.1038/nm1010-1091			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930751				2022-12-27	WOS:000282644800036
J	Kerbel, RS; Ebos, JML				Kerbel, Robert S.; Ebos, John M. L.			Peering into the aftermath	NATURE MEDICINE			English	Editorial Material							ANTIANGIOGENIC THERAPY; CELL MOBILIZATION; SUNITINIB; VEGF; ANGIOGENESIS; METASTASIS; INHIBITION; BIOMARKERS; RESISTANCE; TUMORS		[Kerbel, Robert S.; Ebos, John M. L.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Mol & Cellular Biol, Toronto, ON M4N 3M5, Canada; [Kerbel, Robert S.; Ebos, John M. L.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Kerbel, RS (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Mol & Cellular Biol, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca; jebos@sri.utoronto.ca						Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; DePrimo SE, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-32; Desar IME, 2009, ACTA ONCOL, V48, P927, DOI 10.1080/02841860902974167; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Lindauer A, 2010, CLIN PHARMACOL THER, V87, P601, DOI 10.1038/clpt.2010.20; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Murukesh N, 2010, BRIT J CANCER, V102, P8, DOI 10.1038/sj.bjc.6605483; Nikolinakos PG, 2010, CANCER RES, V70, P2171, DOI 10.1158/0008-5472.CAN-09-2533; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106	14	21	21	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1084	1085		10.1038/nm1010-1084	http://dx.doi.org/10.1038/nm1010-1084			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930748				2022-12-27	WOS:000282644800034
J	Ruhrberg, C; De Palma, M				Ruhrberg, Christiana; De Palma, Michele			A double agent in cancer: Deciphering macrophage roles in human tumors	NATURE MEDICINE			English	Editorial Material							TIE2-EXPRESSING MONOCYTES; HODGKINS LYMPHOMA; ANGIOGENESIS; INFLAMMATION; PROGRESSION; POPULATION; EXPRESSION; SURVIVAL; BLOOD	Macrophages engulf microbes and cellular debris to protect us from disease and help repair wounded tissues. In cancer, they also infiltrate the tumor, but studies in humans and mice now uncover more sinister roles for these immune cells in cancer. In 'Bedside to Bench', Christiana Ruhrberg and Michele De Palma scrutinize a clinical study where the presence of macrophages correlates with a high risk of disease progression in people with Hodgkin's lymphoma, indicating a clinical value of macrophages as biomarkers of survival. The authors also emphasize how characterizing of the mechanisms by which subpopulations of macrophages promote tumor cell motility and angiogenesis might help in the development of antiangiogenic therapies to stop tumor progression. In 'Bench to Bedside', Joseph Qualls and Peter Murray examine a study that shows how stopping migration of macrophages into the tumor can impair tumor regrowth after radiation treatment.	[Ruhrberg, Christiana] UCL, UCL Inst Ophthalmol, London, England; [De Palma, Michele] Ist Sci San Raffaele, Div Regenerat Med, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy	University of London; University College London; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ruhrberg, C (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	c.ruhrberg@ucl.ac.uk; depalma.michele@hsr.it	Ruhrberg, Christiana/C-6404-2009; De Palma, Michele/L-5350-2016	Ruhrberg, Christiana/0000-0002-3212-9381; De Palma, Michele/0000-0001-9128-5459				Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Birgersdotter A, 2009, BRIT J CANCER, V101, P1393, DOI 10.1038/sj.bjc.6605238; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; FANTIN A, 2010, BLOOD           0419, DOI DOI 10.1182/BLOOD-2009-12-257832; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Nakayama Y, 2002, ANTICANCER RES, V22, P4291; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Vacca A, 1999, BRIT J CANCER, V79, P965, DOI 10.1038/sj.bjc.6690154; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504	16	25	25	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					861	862		10.1038/nm0810-861	http://dx.doi.org/10.1038/nm0810-861			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20689550				2022-12-27	WOS:000280649200023
J	Sullivan, SP; Koutsonanos, DG; Martin, MD; Lee, JW; Zarnitsyn, V; Choi, SO; Murthy, N; Compans, RW; Skountzou, I; Prausnitz, MR				Sullivan, Sean P.; Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Lee, Jeong Woo; Zarnitsyn, Vladimir; Choi, Seong-O; Murthy, Niren; Compans, Richard W.; Skountzou, Ioanna; Prausnitz, Mark R.			Dissolving polymer microneedle patches for influenza vaccination	NATURE MEDICINE			English	Article							PERCUTANEOUS-ABSORPTION; IMMUNIZATION; DELIVERY; IL-21; SKIN; DESIGN	Influenza prophylaxis would benefit from a vaccination method enabling simplified logistics and improved immunogenicity without the dangers posed by hypodermic needles. Here we introduce dissolving microneedle patches for influenza vaccination using a simple patch-based system that targets delivery to skin's antigen-presenting cells. Microneedles were fabricated using a biocompatible polymer encapsulating inactivated influenza virus vaccine for insertion and dissolution in the skin within minutes. Microneedle vaccination generated robust antibody and cellular immune responses in mice that provided complete protection against lethal challenge. Compared to conventional intramuscular injection, microneedle vaccination resulted in more efficient lung virus clearance and enhanced cellular recall responses after challenge. These results suggest that dissolving microneedle patches can provide a new technology for simpler and safer vaccination with improved immunogenicity that could facilitate increased vaccination coverage.	[Sullivan, Sean P.; Murthy, Niren; Prausnitz, Mark R.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Lee, Jeong Woo; Zarnitsyn, Vladimir; Choi, Seong-O; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Prausnitz, MR (corresponding author), Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.	iskount@emory.edu; prausnitz@gatech.edu	Compans, Richard W/I-4087-2013; Skountzou, Ioanna/A-4454-2010	Compans, Richard W/0000-0003-2360-335X; Skountzou, Ioanna/0000-0002-6429-244X; Prausnitz, Mark/0000-0002-9076-8448	US National Institutes of Health [R01-EB006369, U01-AI084579, HHSN266200700006C]; US Department of Education; US National Institutes of Health-National Institute of Allergy and Infectious Diseases [HHSN266200700006C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579, K23AI084579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Education(US Department of Education); US National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was carried out at the Emory Vaccine Center and the Georgia Tech Center for Drug Design, Development and Delivery and Institute for Bioengineering and Biosciences. The work was supported in part by US National Institutes of Health grants R01-EB006369 and U01-AI084579 and contract HHSN266200700006C. S.P.S. was a trainee supported by a fellowship from the US Department of Education Graduate Assistance in Areas of National Need program. M.d.P.M. was a trainee supported by contract HHSN266200700006C from the US National Institutes of Health-National Institute of Allergy and Infectious Diseases.	Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; BRONAUGH RL, 1982, TOXICOL APPL PHARM, V62, P481, DOI 10.1016/0041-008X(82)90149-1; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; FLYNN PM, 1994, CHEST, V106, P1463, DOI 10.1378/chest.106.5.1463; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Glenn GM, 2006, CURR TOP MICROBIOL, V304, P247; Hickling Julian, 2009, INTRADERMAL DELIVERY; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Ito Y, 2006, J DRUG TARGET, V14, P255, DOI 10.1080/10611860600785080; Katsikis Peter D, 2007, Nat Immunol, V8, P899, DOI 10.1038/ni0907-899; Kim YC, 2010, J INFECT DIS, V201, P190, DOI 10.1086/649228; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; Mikszta JA, 2002, NAT MED, V8, P415, DOI 10.1038/nm0402-415; Miller LS, 2007, SEMIN IMMUNOPATHOL, V29, P15, DOI 10.1007/s00281-007-0061-8; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Miyano T, 2005, BIOMED MICRODEVICES, V7, P185, DOI 10.1007/s10544-005-3024-7; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; RAVIN HA, 1952, NEW ENGL J MED, V247, P921, DOI 10.1056/NEJM195212112472403; REED LJ, 1938, AM J HYG, V27; Robinson B. V., 1990, PVP CRITICAL REV KIN, DOI [10.1201/9780203741672, DOI 10.1201/9780203741672]; Skountzou I, 2006, VACCINE, V24, P6110, DOI 10.1016/j.vaccine.2006.05.014; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Sullivan SP, 2008, ADV MATER, V20, P933, DOI 10.1002/adma.200701205; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	37	596	633	26	433	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					915	U116		10.1038/nm.2182	http://dx.doi.org/10.1038/nm.2182			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20639891	Green Published, Green Accepted			2022-12-27	WOS:000280649200032
J	Saito, T; Fukai, A; Mabuchi, A; Ikeda, T; Yano, F; Ohba, S; Nishida, N; Akune, T; Yoshimura, N; Nakagawa, T; Nakamura, K; Tokunaga, K; Chung, U; Kawaguchi, H				Saito, Taku; Fukai, Atsushi; Mabuchi, Akihiko; Ikeda, Toshiyuki; Yano, Fumiko; Ohba, Shinsuke; Nishida, Nao; Akune, Toru; Yoshimura, Noriko; Nakagawa, Takumi; Nakamura, Kozo; Tokunaga, Katsushi; Chung, Ung-il; Kawaguchi, Hiroshi			Transcriptional regulation of endochondral ossification by HIF-2 alpha during skeletal growth and osteoarthritis development	NATURE MEDICINE			English	Article							METALLOPROTEINASE 13-DEFICIENT MICE; EXPERIMENTAL MOUSE MODELS; KNEE-JOINT INSTABILITY; BONE-DEVELOPMENT; CHONDROCYTE HYPERTROPHY; METABOLIC ABNORMALITIES; TRANSACTIVATION DOMAIN; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; COLLAGEN-X	Chondrocyte hypertrophy followed by cartilage matrix degradation and vascular invasion, characterized by expression of type X collagen (COL10A1), matrix metalloproteinase-13 (MMP-13) and vascular endothelial growth factor (VEGF), respectively, are central steps of endochondral ossification during normal skeletal growth and osteoarthritis development. A COL10A1 promoter assay identified hypoxia-inducible factor-2 alpha (HIF-2 alpha, encoded by EPAS1) as the most potent transactivator of COL10A1. HIF-2 alpha enhanced promoter activities of COL10A1, MMP13 and VEGFA through specific binding to the respective hypoxia-responsive elements. HIF-2 alpha, independently of oxygen-dependent hydroxylation, was essential for endochondral ossification of cultured chondrocytes and embryonic skeletal growth in mice. HIF-2 alpha expression was higher in osteoarthritic cartilages versus nondiseased cartilages of mice and humans. Epas1-heterozygous deficient mice showed resistance to osteoarthritis development, and a functional single nucleotide polymorphism (SNP) in the human EPAS1 gene was associated with knee osteoarthritis in a Japanese population. The EPAS1 promoter assay identified RELA, a nuclear factor-kappa B (NF-kappa B) family member, as a potent inducer of HIF-2 alpha expression. Hence, HIF-2 alpha is a central transactivator that targets several crucial genes for endochondral ossification and may represent a therapeutic target for osteoarthritis.	[Saito, Taku; Fukai, Atsushi; Mabuchi, Akihiko; Ikeda, Toshiyuki; Nishida, Nao; Nakagawa, Takumi; Nakamura, Kozo; Tokunaga, Katsushi; Kawaguchi, Hiroshi] Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan; [Yano, Fumiko; Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Akune, Toru; Yoshimura, Noriko] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022	Ohba, Shinsuke/0000-0002-6874-8539	Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 20689028]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Yamaguchi and H. Kawahara for technical assistance. This study was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (19109007 and 20689028). The sponsor had no role in study design, data collection, data analysis, data interpretation or writing of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kawaguchi H, 2008, MOL CELLS, V25, P1; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kitamura T, 1998, INT J HEMATOL, V67, P351; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Miyagishi Makoto, 2004, Methods Mol Biol, V252, P483; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Ostergaard K, 1999, ANN RHEUM DIS, V58, P208, DOI 10.1136/ard.58.4.208; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2000, GENE DEV, V14, P1983; Srinivas V, 2009, CELL CYCLE, V8, P391, DOI 10.4161/cc.8.3.7545; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	53	377	397	6	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					678	U83		10.1038/nm.2146	http://dx.doi.org/10.1038/nm.2146			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495570				2022-12-27	WOS:000278394200034
J	Hoshi, N; Medzhitov, R				Hoshi, Namiko; Medzhitov, Ruslan			Germs gone wild	NATURE MEDICINE			English	Editorial Material							IMMUNE-SYSTEM; INFLAMMASOME; RECOGNITION; HOMEOSTASIS; FLAGELLIN; INTESTINE	The normally harmless behavior of bacteria in the intestinal tract is maintained by community structure and the integrity of host defenses. When either or both of these are compromised, a few disgruntled outcasts can cause a riot, taking down the whole neighborhood (pages 799-806).	[Hoshi, Namiko; Medzhitov, Ruslan] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Hoshi, Namiko; Medzhitov, Ruslan] Yale Univ, Sch Med, New Haven, CT USA	Howard Hughes Medical Institute; Yale University	Hoshi, N (corresponding author), Howard Hughes Med Inst, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu	Hoshi, Namiko/V-8370-2019		NIDDK NIH HHS [R01 DK071754] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beaugerie L, 2004, BEST PRACT RES CL GA, V18, P337, DOI 10.1016/j.bpg.2003.10.002; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	15	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					654	656		10.1038/nm.2767	http://dx.doi.org/10.1038/nm.2767			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561817	Green Accepted			2022-12-27	WOS:000303763500025
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			The airway epithelium in asthma	NATURE MEDICINE			English	Review							HOUSE-DUST MITE; RESPIRATORY SYNCYTIAL VIRUS; EPIDERMAL-GROWTH-FACTOR; THYMIC STROMAL LYMPHOPOIETIN; INFLAMMATORY DENDRITIC CELLS; INNATE IMMUNE-RESPONSES; FACTOR-KAPPA-B; BARRIER FUNCTION; FACTOR RECEPTOR; E-CADHERIN	Asthma is a T lymphocyte-controlled disease of the airway wall caused by inflammation, overproduction of mucus and airway wall remodeling leading to bronchial hyperreactivity and airway obstruction. The airway epithelium is considered an essential controller of inflammatory, immune and regenerative responses to allergens, viruses and environmental pollutants that contribute to asthma pathogenesis. Epithelial cells express pattern recognition receptors that detect environmental stimuli and secrete endogenous danger signals, thereby activating dendritic cells and bridging innate and adaptive immunity. Improved understanding of the epithelium's function in maintaining the integrity of the airways and its dysfunction in asthma has provided important mechanistic insight into how asthma is initiated and perpetuated and could provide a framework by which to select new therapeutic strategies that prevent exacerbations and alter the natural course of the disease.	[Lambrecht, Bart N.; Hammad, Hamida] VIB, Dept Mol Biomed Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Lambrecht, Bart N.] Univ Hosp, Dept Resp Med, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), VIB, Dept Mol Biomed Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium.	bart.lambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603	Flemish Organization for Scientific Research (FWO); ERC; UGent; National Institutes of Health [5R21AI083690-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083690] Funding Source: NIH RePORTER	Flemish Organization for Scientific Research (FWO)(FWO); ERC(European Research Council (ERC)European Commission); UGent; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.N.L. is a recipient of an Odysseus Grant of the Flemish Organization for Scientific Research (FWO) and recipient of an ERC Consolidator grant and a UGent Multidisciplinary Research Partnership grant (Group-ID). H.H. and B.N.L. are supported by National Institutes of Health grant 5R21AI083690-02. H.H. is a recipient of an FWO program grant.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Ahdieh M, 2001, AM J PHYSIOL-CELL PH, V281, pC2029, DOI 10.1152/ajpcell.2001.281.6.C2029; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Antony AB, 2002, J ALLERGY CLIN IMMUN, V110, P589, DOI 10.1067/mai.2002.127798; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Ather JL, 2011, AM J RESP CELL MOL, V44, P631, DOI 10.1165/rcmb.2010-0106OC; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bleck B, 2010, J IMMUNOL, V185, P6636, DOI 10.4049/jimmunol.1000719; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen G, 2010, J IMMUNOL, V184, P6133, DOI 10.4049/jimmunol.1000223; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Cho JY, 2011, INT IMMUNOPHARMACOL, V11, P1038, DOI 10.1016/j.intimp.2011.02.024; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Ckless K, 2011, BBA-GEN SUBJECTS, V1810, P1025, DOI 10.1016/j.bbagen.2011.03.005; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dabbagh K, 1999, J IMMUNOL, V162, P6233; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; El Bakkouri K, 2005, J BIOL CHEM, V280, P17938, DOI 10.1074/jbc.M413588200; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Finkelman MA, 2006, J ENDOTOXIN RES, V12, P241, DOI 10.1179/096805106X102237; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Hasnain SZ, 2011, PARASITE IMMUNOL, V33, P45, DOI 10.1111/j.1365-3024.2010.01258.x; Heijink IH, 2010, EUR RESPIR J, V36, P1016, DOI 10.1183/09031936.00125809; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hirota N, 2012, FASEB J, V26, P1704, DOI 10.1096/fj.11-197061; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kaiko GE, 2010, J IMMUNOL, V185, P4681, DOI 10.4049/jimmunol.1001758; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kelly C, 2011, AM J RESP CELL MOL, V44, P743, DOI 10.1165/rcmb.2010-0339TR; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lackie PM, 1997, AM J RESP CELL MOL, V16, P14, DOI 10.1165/ajrcmb.16.1.8998074; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee S.H., 2012, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2011-0369O, DOI 10.1165/RCMB.2011-03690]; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Maeda Y, 2011, AM J RESP CRIT CARE, V184, P421, DOI 10.1164/rccm.201101-0106OC; Malmstrom K, 2011, THORAX, V66, P157, DOI 10.1136/thx.2010.139246; Marino R, 2011, J IMMUNOL, V186, P4433, DOI 10.4049/jimmunol.1001539; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Mitchell C, 2011, J IMMUNOL, V187, P3815, DOI 10.4049/jimmunol.1100436; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moriwaki A, 2011, BIOCHEM BIOPH RES CO, V404, P922, DOI 10.1016/j.bbrc.2010.12.082; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Ohta K, 1999, J ALLERGY CLIN IMMUN, V104, P1024, DOI 10.1016/S0091-6749(99)70084-9; Olivera DS, 2007, INHAL TOXICOL, V19, P13, DOI 10.1080/08958370600985768; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; Reardon C, 2011, IMMUNITY, V35, P223, DOI 10.1016/j.immuni.2011.05.015; Rezaee F, 2011, J ALLERGY CLIN IMMUN, V128, P1216, DOI 10.1016/j.jaci.2011.08.035; Ritz SA, 2002, TRENDS IMMUNOL, V23, P396, DOI 10.1016/S1471-4906(02)02278-0; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Royce SG, 2011, J ASTHMA, V48, P653, DOI 10.3109/02770903.2011.599906; Runswick S, 2007, RESPIROLOGY, V12, P834, DOI 10.1111/j.1440-1843.2007.01175.x; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Saito T, 2005, CELL TISSUE RES, V321, P75, DOI 10.1007/s00441-005-1113-9; Schmidt LM, 2011, J IMMUNOL, V186, P2095, DOI 10.4049/jimmunol.1002414; Schneider E, 2009, J IMMUNOL, V183, P3591, DOI 10.4049/jimmunol.0900328; Semlali A, 2010, J ALLERGY CLIN IMMUN, V125, P844, DOI 10.1016/j.jaci.2010.01.044; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sidhaye VK, 2011, AM J RESP CELL MOL, V45, P120, DOI 10.1165/rcmb.2010-0235OC; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sivaprasad U, 2011, J ALLERGY CLIN IMMUN, V127, P254, DOI 10.1016/j.jaci.2010.10.009; Song DJ, 2010, INT ARCH ALLERGY IMM, V151, P285, DOI 10.1159/000250437; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Tomee JFC, 1998, J ALLERGY CLIN IMMUN, V102, P75, DOI 10.1016/S0091-6749(98)70057-0; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Tourdot S, 2008, CLIN EXP ALLERGY, V38, P1016, DOI 10.1111/j.1365-2222.2008.02974.x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; van Rijt LS, 2011, AM J RESP CRIT CARE, V184, P303, DOI 10.1164/rccm.201101-0019OC; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Whitsett JA, 2011, AM J RESP CRIT CARE, V184, P401, DOI 10.1164/rccm.201103-0495PP; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	156	607	627	5	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					684	692		10.1038/nm.2737	http://dx.doi.org/10.1038/nm.2737			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561832				2022-12-27	WOS:000303763500036
J	Sakai, M; Matsumoto, M; Tujimura, T; Cao, Y; Noguchi, T; Inagaki, K; Inoue, H; Hosooka, T; Takazawa, K; Kido, Y; Yasuda, K; Hiramatsu, R; Matsuki, Y; Kasuga, M				Sakai, Mashito; Matsumoto, Michihiro; Tujimura, Tomoko; Cao Yongheng; Noguchi, Tetsuya; Inagaki, Kenjiro; Inoue, Hiroshi; Hosooka, Tetsuya; Takazawa, Kazuo; Kido, Yoshiaki; Yasuda, Kazuki; Hiramatsu, Ryuji; Matsuki, Yasushi; Kasuga, Masato			CITED2 links hormonal signaling to PGC-1 alpha acetylation in the regulation of gluconeogenesis	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCONEOGENESIS; BINDING-PROTEIN; MICE LACKING; COACTIVATOR; METABOLISM; PGC-1; ACTIVATION; COMPLEX; KINASE	During fasting, induction of hepatic gluconeogenesis is crucial to ensure proper energy homeostasis(1). Such induction is dysregulated in type 2 diabetes, resulting in the development of fasting hyperglycemia(2). Hormonal and nutrient regulation of metabolic adaptation during fasting is mediated predominantly by the transcriptional coactivator peroxisome proliferative activated receptor gamma coactivator 1 alpha (PGC-1 alpha) in concert with various other transcriptional regulators(3-8). Although CITED2 (CBP- and p300-interacting transactivator with glutamic acid-and aspartic acid-rich COOH-terminal domain 2) interacts with many of these molecules(9-11), the role of this protein in the regulation of hepatic gluconeogenesis was previously unknown. Here we show that CITED2 is required for the regulation of hepatic gluconeogenesis through PGC-1 alpha. The abundance of CITED2 was increased in the livers of mice by fasting and in cultured hepatocytes by glucagon-cAMP-protein kinase A (PKA) signaling, and the amount of CITED2 in liver was higher in mice with type 2 diabetes than in non-diabetic mice. CITED2 inhibited the acetylation of PGC-1 alpha by blocking its interaction with the acetyltransferase general control of amino acid synthesis 5-like 2 (GCN5). The consequent downregulation of PGC-1 alpha acetylation resulted in an increase in its transcriptional coactivation activity and an increased expression of gluconeogenic genes. The interaction of CITED2 with GCN5 was disrupted by insulin in a manner that was dependent on phosphoinositide 3-kinase (PI3K)-thymoma viral proto-oncogene (Akt) signaling. Our results show that CITED2 functions as a transducer of glucagon and insulin signaling in the regulation of PGC-1 alpha activity that is associated with the transcriptional control of gluconeogenesis and that this function is mediated through the modulation of GCN5-dependent PGC-1 alpha acetylation. We also found that loss of hepatic CITED2 function suppresses gluconeogenesis in diabetic mice, suggesting it as a therapeutic target for hyperglycemia.	[Sakai, Mashito; Matsumoto, Michihiro; Tujimura, Tomoko; Cao Yongheng; Inagaki, Kenjiro] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Mol Metab Regulat, Tokyo, Japan; [Sakai, Mashito; Noguchi, Tetsuya; Hosooka, Tetsuya; Takazawa, Kazuo; Kido, Yoshiaki] Kobe Univ Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo, Japan; [Inoue, Hiroshi] Kanazawa Univ, Frontier Sci Org, Kanazawa, Ishikawa, Japan; [Kido, Yoshiaki] Kobe Univ Grad Sch Hlth Sci, Div Med Chem, Dept Biophys, Kobe, Hyogo, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan; [Hiramatsu, Ryuji; Matsuki, Yasushi] Dainippon Sumitomo Pharmaceut, Pharmacol Res Labs, Suita, Osaka, Japan; [Kasuga, Masato] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kobe University; Kanazawa University; Kobe University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Matsumoto, M (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Mol Metab Regulat, Tokyo, Japan.	mmatsumoto@ri.ncgm.go.jp; kasuga@ri.ncgm.go.jp		Sakai, Mashito/0000-0002-4908-2727; Inoue, Hiroshi/0000-0002-7724-6637	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591155]; National Center for Global Health and Medicine [21S116]; Takeda Science Foundation; Novo Nordisk	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novo Nordisk(Novo Nordisk)	We thank D. Schmoll (Sanofi-Aventis Deutschland GmbH) for the G6PC-promoter reporter plasmid, H. Shimano (University of Tsukuba) for the pcDNA3.1-3 x Flag-HNF-4 alpha plasmid and H. Takamoto for technical assistance. This work was supported by a Grant-in-Aid for Creative Scientific Research (to M.K.) and a Grant-in-Aid for Scientific Research (C) (21591155 to M.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the National Center for Global Health and Medicine (21S116 to M.M.), a grant from Takeda Science Foundation (to M.M.) and a Novo Nordisk Pharma Insulin Award (to M.M.).	Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Matsumoto M, 2006, NAT MED, V12, P33, DOI 10.1038/nm0106-33; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schmoll D, 2001, BIOCHEM J, V357, P867, DOI 10.1042/0264-6021:3570867; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	31	54	56	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					612	617		10.1038/nm.2691	http://dx.doi.org/10.1038/nm.2691			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426420				2022-12-27	WOS:000302617800040
J	Murphy, WJ; Ferrara, JLM; Malek, T				Murphy, William J.; Ferrara, James L. M.; Malek, Thomas			A delicate balance: tweaking IL-2 immunotherapy	NATURE MEDICINE			English	Editorial Material							VERSUS-HOST-DISEASE; REGULATORY T-CELLS; INTERLEUKIN-2; EXPANSION	The cytokine interleukin-2 (IL-2) is important for the activation of several types of immune cells, including T cells, and its clinical potential has been previously explored in the context of boosting immune responses to cancer and infectious diseases. However, two recent studies provide evidence that low-dose IL-2 therapy can suppress adverse immune reactions. Koreth et al.(1) showed that IL-2 therapy reversed graft-versus-host disease (GVHD) in patients who had undergone allogeneic hematopoietic stem cell transplantation (HSCT) to treat lymphoma or leukemia. Similarly, Saadoun et al.(2) found that IL-2 treatment had clinical benefit in hepatitis C virus (HCV)-related vasculitis with IL-2. Both studies suggested that IL-2's therapeutic effects might be mediated through suppressive regulatory T cells (T-reg cells), as T-reg cell counts were higher in treated individuals. We asked three experts to comment on the implications of these studies for IL-2 immunotherapy.										Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; ROSENBERG SA, 1986, ANNU REV IMMUNOL, V4, P681, DOI 10.1146/annurev.immunol.4.1.681; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Willenbacher W, 2001, BRIT J HAEMATOL, V112, P820, DOI 10.1046/j.1365-2141.2001.02582.x; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	11	8	8	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					208	209		10.1038/nm0212-208	http://dx.doi.org/10.1038/nm0212-208			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310686				2022-12-27	WOS:000300140300030
J	Maxwell, PH				Maxwell, Patrick H.			Aspiring to prevent colon cancer	NATURE MEDICINE			English	Editorial Material							METAANALYSIS; RISK		UCL, Fac Med Sci, London, England	University of London; University College London	Maxwell, PH (corresponding author), UCL, Fac Med Sci, London, England.	p.maxwell@ucl.ac.uk	Maxwell, Patrick H/C-5557-2008	Maxwell, Patrick H/0000-0002-0338-2679	National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Burn J, 2008, NEW ENGL J MED, V359, P2567, DOI 10.1056/NEJMoa0801297; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Duthie GG, 2011, FOOD FUNCT, V2, P515, DOI 10.1039/c1fo10128e; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Yeomans ND, 2011, J GASTROEN HEPATOL, V26, P426, DOI 10.1111/j.1440-1746.2010.06569.x	12	7	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					32	33		10.1038/nm.2637	http://dx.doi.org/10.1038/nm.2637			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227665				2022-12-27	WOS:000299018600024
J	Sakaguchi, S; Powrie, F; Ransohoff, RM				Sakaguchi, Shimon; Powrie, Fiona; Ransohoff, Richard M.			Re-establishing immunological self-tolerance in autoimmune disease	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; INTESTINAL INFLAMMATION; IMMUNE-SYSTEM; TGF-BETA; IN-VIVO; NEGATIVE SELECTION; THYMIC SELECTION; INDUCTION; GENERATION	Recent progress has revealed the molecular basis of how self-reactive T cells are normally generated in the immune system and differentiate into autoimmune effector T cells and how they are controlled by central and peripheral mechanisms of self-tolerance. There is also evidence that target tissues and cells in autoimmune disease have different sensitivities to immune mediators. Here we describe how these basic findings can be clinically translated to re-establish self-tolerance in individuals with autoimmune disease.	[Sakaguchi, Shimon] Osaka Univ, World Premier Initiat Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto, Japan; [Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit,Expt Med Div, Oxford OX3 9DU, England; [Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Mississippi Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA	Osaka University; Kyoto University; University of Oxford; University of Oxford; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sakaguchi, S (corresponding author), Osaka Univ, World Premier Initiat Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009		Wellcome Trust [095688] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Laakso SM, 2010, J AUTOIMMUN, V35, P351, DOI 10.1016/j.jaut.2010.07.008; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2005, CURR OPIN IMMUNOL, V17, P589, DOI 10.1016/j.coi.2005.09.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	72	58	62	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					54	58		10.1038/nm.2622	http://dx.doi.org/10.1038/nm.2622			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227673				2022-12-27	WOS:000299018600028
J	Shulzhenko, N; Morgun, A; Hsiao, W; Battle, M; Yao, M; Gavrilova, O; Orandle, M; Mayer, L; Macpherson, AJ; McCoy, KD; Fraser-Liggett, C; Matzinger, P				Shulzhenko, Natalia; Morgun, Andrey; Hsiao, William; Battle, Michele; Yao, Michael; Gavrilova, Oksana; Orandle, Marlene; Mayer, Lloyd; Macpherson, Andrew J.; McCoy, Kathy D.; Fraser-Liggett, Claire; Matzinger, Polly			Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut	NATURE MEDICINE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; COMMON VARIABLE IMMUNODEFICIENCY; IGA RESPONSE; SYSTEM; MICE; HOMEOSTASIS; NETWORKS; CELLS; DIFFERENTIATION; MALABSORPTION	Using a systems biology approach, we discovered and dissected a three-way interaction between the immune system, the intestinal epithelium and the microbiota. We found that, in the absence of B cells, or of IgA, and in the presence of the microbiota, the intestinal epithelium launches its own protective mechanisms, upregulating interferon-inducible immune response pathways and simultaneously repressing Gata4-related metabolic functions. This shift in intestinal function leads to lipid malabsorption and decreased deposition of body fat. Network analysis revealed the presence of two interconnected epithelial-cell gene networks, one governing lipid metabolism and another regulating immunity, that were inversely expressed. Gene expression patterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection and intestinal malabsorption were very similar to those of the B cell-deficient mice, providing a possible explanation for a longstanding enigmatic association between immunodeficiency and defective lipid absorption in humans.	[Shulzhenko, Natalia; Morgun, Andrey; Matzinger, Polly] NIAID, Ghost Lab, T Cell Tolerance & Memory Sect, Lab Cellular & Mol Immunol,US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Hsiao, William; Fraser-Liggett, Claire] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Battle, Michele] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Yao, Michael] NIAID, Mucosal Immunol Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD USA; [Orandle, Marlene] NIAID, Comparat Med Branch, NIH, Bethesda, MD 20892 USA; [Mayer, Lloyd] Mt Sinai Med Ctr, Inst Immunol, New York, NY 10029 USA; [Macpherson, Andrew J.; McCoy, Kathy D.] Univ Bern, Bern, Switzerland; [McCoy, Kathy D.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Icahn School of Medicine at Mount Sinai; University of Bern; McMaster University	Morgun, A (corresponding author), Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA.	natalia.shulzhenko@oregonstate.edu; anemorgun@hotmail.com; pcm@helix.nih.gov	McCoy, Kathy/ABD-5814-2021	Fraser, Claire/0000-0003-1462-2428	NIAID, NIH; NIH [U24 DK059630];  [P40RR018603]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000868, ZIAAI000903, ZIAAI000581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, R01DK087873, ZICDK070002] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Intramural Research Program of the NIAID, NIH. We thank T. Myers, Q. Su and A. Godinez of the NIAID microarray facility for excellent technical support; R. Schwartz for providing funding for germ-free re-derivation; W. Strober for help with human subjects; C. Jones for technical support of bacterial pyrosequencing; T. D. Randall (Trudeau Institute) for AID/mu S mice; S. Epstein (US Food and Drug Administration), J. Misplon (US Food and Drug Administration) and D. P. Huston (Texas A&M Health Science Center) for IgAKO mice; D. Kaiserlian (Institut National de la Sante et de la Recherche Medicale) and R. Blumberg (Harvard University) for providing the MODE-K cell line; R. Varma for help in experiments; Laboratory of Cellular and Molecular Immunology members and M. Sterman Dolnikoff, I. Shmulevich and A. Dzutsev for discussions and suggestions; Y. Kotliarov for help with graphics; S. Varma for help finding human gene homologues; J. Coursen for excellent technical support; B. Epstein for assistance with software programming; and the personnel of NIH mouse facilities in buildings 4 and 6B. The Cincinnati Mouse Metabolic Phenotyping Center is supported by NIH grant U24 DK059630 and National Gnotobiotic Rodent Resource Center at the University of North Carolina is supported by grant P40RR018603.	Agarwal S, 2009, J ALLERGY CLIN IMMUN, V124, P658, DOI 10.1016/j.jaci.2009.06.018; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; Berger K, 2004, PHYSIOL BEHAV, V83, P623, DOI 10.1016/j.physbeh.2004.08.040; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gordon JI, 1997, AM J PHYSIOL-GASTR L, V273, pG565, DOI 10.1152/ajpgi.1997.273.3.G565; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; HUGHES WS, 1971, ANN INTERN MED, V74, P903, DOI 10.7326/0003-4819-74-6-903; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Koch J, 1996, NUTRITION, V12, P507, DOI 10.1016/S0899-9007(96)91728-1; KOTLER DP, 1987, DIGEST DIS SCI, V32, P129, DOI 10.1007/BF01297100; Lehto M, 2001, J LIPID RES, V42, P1203; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Malamut G, 2010, AM J GASTROENTEROL, V105, P2262, DOI 10.1038/ajg.2010.214; Mannon PJ, 2006, GASTROENTEROLOGY, V131, P748, DOI 10.1053/j.gastro.2006.06.022; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Nishiyama Y, 2002, J IMMUNOL, V168, P2626, DOI 10.4049/jimmunol.168.6.2626; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Owens SR, 2007, HISTOPATHOLOGY, V50, P64, DOI 10.1111/j.1365-2559.2006.02547.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SANFORD JP, 1954, NEW ENGL J MED, V250, P1027, DOI 10.1056/NEJM195406172502403; Scamurra RW, 2002, J IMMUNOL, V169, P4008, DOI 10.4049/jimmunol.169.7.4008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shulzhenko N, 2009, GENES IMMUN, V10, P722, DOI 10.1038/gene.2009.70; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Skinner J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-286; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; ULLRICH R, 1991, IMMUNOL RES, V10, P456, DOI 10.1007/BF02919742; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; WATSCHINGER K, 2010, GUT, V107, P13672; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005	58	252	265	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1585	U97		10.1038/nm.2505	http://dx.doi.org/10.1038/nm.2505			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101768	Green Accepted			2022-12-27	WOS:000297978000029
J	Jackson, SP				Jackson, Shaun P.			Arterial thrombosis-insidious, unpredictable and deadly	NATURE MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; HUMAN ATHEROSCLEROTIC PLAQUES; VON-WILLEBRAND-FACTOR; GLYCOPROTEIN-VI; PLATELET-ADHESION; TISSUE FACTOR; MICE LACKING; FACTOR-XI; IN-VIVO	The formation of blood clots-thrombosis-at sites of atherosclerotic plaque rupture is a major clinical problem despite ongoing improvements in antithrombotic therapy. Progress in identifying the pathogenic mechanisms regulating arterial thrombosis has led to the development of newer therapeutics, and there is general anticipation that these treatments will have greater efficacy and improved safety. However, major advances in this field require the identification of specific risk factors for arterial thrombosis in affected individuals and a rethink of the 'one size fits all' approach to antithrombotic therapy.	[Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Jackson, Shaun P.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Monash University; Scripps Research Institute	Jackson, SP (corresponding author), Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	shaun.jackson@monash.edu		Jackson, Shaun/0000-0002-4750-1991	National Health and Medical Research Council of Australia (NHMRC)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	I would like to thank S. Schoenwaelder for preparation of the figures, constructive advice and for assistance with the manuscript. I also acknowledge H. Salem, M. Cooper and Z. Kaplan for their constructive advice and assistance with the manuscript. This work was supported by the National Health and Medical Research Council of Australia (NHMRC). I am an NHMRC Australia Fellow.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; ARAI M, 1995, BRIT J HAEMATOL, V89, P124, DOI 10.1111/j.1365-2141.1995.tb08900.x; ARBUSTINI E, 1993, CORONARY ARTERY DIS, V4, P751, DOI 10.1097/00019501-199309000-00001; Badimon JJ, 1999, CIRCULATION, V99, P1780, DOI 10.1161/01.CIR.99.14.1780; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barg A, 2007, THROMB HAEMOSTASIS, V97, P514, DOI 10.1160/TH06-05-0274; Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1060, DOI 10.1016/j.jacc.2008.06.027; Bizzozero G, 1881, LOSSERVATORE GAZZ CL, V17, P785; Bizzozero G., 1882, VIRCHOWS ARCH PATH A, V90, P261; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Boylan B, 2004, BLOOD, V104, P1350, DOI 10.1182/blood-2004-03-0896; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; BROWN BG, 1986, CIRCULATION, V73, P653, DOI 10.1161/01.CIR.73.4.653; BRUSCHKE AVG, 1989, AM HEART J, V117, P296, DOI 10.1016/0002-8703(89)90772-2; Burke AP, 2001, CIRCULATION, V103, P934; Caen J, 2010, J THROMB HAEMOST, V8, P1670, DOI 10.1111/j.1538-7836.2010.03893.x; CHAZOV EI, 1976, TERAPEVT ARKH, V48, P8; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; DAVIES MJ, 1990, CIRCULATION, V82, P38; DAVIES MJ, 1979, J PATHOL, V127, P99, DOI 10.1002/path.1711270208; de Boer OJ, 1999, CARDIOVASC RES, V41, P443, DOI 10.1016/S0008-6363(98)00255-7; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Deplano V, 1999, J BIOMECH, V32, P1081, DOI 10.1016/S0021-9290(99)00098-6; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; EHRLICH JC, 1964, ARCH PATHOL, V78, P432; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; FALK E, 1989, AM J CARDIOL, V63, pE114, DOI 10.1016/0002-9149(89)90242-7; FALK E, 1983, BRIT HEART J, V50, P127; FALK E, 1985, CIRCULATION, V71, P699, DOI 10.1161/01.CIR.71.4.699; Fisher M, 2011, CIRCULATION, V123, P232, DOI 10.1161/CIR.0b013e31820841ce; Friedberg CK, 1939, J AMER MED ASSOC, V112, P1675, DOI 10.1001/jama.1939.02800170021007; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Gkaliagkousi E, 2011, FRONT BIOSCI-LANDMRK, V16, P1873, DOI 10.2741/3828; Goto S, 2010, EUR HEART J, V31, P2601, DOI 10.1093/eurheartj/ehq320; Gross PL, 2005, J LEUKOCYTE BIOL, V78, P1318, DOI 10.1189/jlb.0405193; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; HACKETT D, 1988, EUR HEART J, V9, P1317, DOI 10.1093/oxfordjournals.eurheartj.a062449; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; HAMET P, 1985, HYPERTENSION, V7, P135; Hammer A, 1878, WIEN MED WSCHR, V28, P97; HANTGAN RR, 1988, BIOCHIM BIOPHYS ACTA, V968, P24, DOI 10.1016/0167-4889(88)90040-7; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Herrick JB, 1912, J AMER MED ASSOC, V59, P2015; HIRSH J, 1987, NEW ENGL J MED, V316, P1543, DOI 10.1056/NEJM198706113162410; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2010, BLOOD, V116, P2011, DOI 10.1182/blood-2010-01-261669; Jandrot-Perrus M., 2008, BLOOD AM SOC HEMATOL, V112; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Kato K, 2004, BLOOD, V104, P2339, DOI 10.1182/blood-2004-03-1127; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; KJELDSEN SE, 1991, AM HEART J, V122, P330, DOI 10.1016/0002-8703(91)90843-7; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Konstantinides S, 2006, J THROMB HAEMOST, V4, P2014, DOI 10.1111/j.1538-7836.2006.02086.x; Kuijpers MJE, 2009, J THROMB HAEMOST, V7, P152, DOI 10.1111/j.1538-7836.2008.03186.x; Kulkarni S, 2000, J CLIN INVEST, V105, P783, DOI 10.1172/JCI7569; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lesault PF, 2011, BRIT J CLIN PHARMACO, V71, P844, DOI 10.1111/j.1365-2125.2010.03858.x; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lincoff AM, 2003, CIRCULATION, V107, P1556, DOI 10.1161/01.CIR.0000055653.52489.E9; Long Q, 2001, J BIOMECH, V34, P1229, DOI 10.1016/S0021-9290(01)00100-2; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; LOWE GDO, 1986, CLIN SCI, V71, P137, DOI 10.1042/cs0710137; Ma Y, 2010, BLOOD, V116, P1932, DOI 10.1182/blood-2010-02-268508; MAILHAC A, 1994, CIRCULATION, V90, P988, DOI 10.1161/01.CIR.90.2.988; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Matuskova J, 2006, ARTERIOSCL THROM VAS, V26, P1391, DOI 10.1161/01.ATV.0000216282.58291.c6; Michelson AD, 2010, NAT REV DRUG DISCOV, V9, P154, DOI 10.1038/nrd2957; MILLER RD, 1951, ARCH INTERN MED, V88, P597, DOI 10.1001/archinte.1951.03810110049005; Miszti-Blasius K, 2011, THROMB RES, V127, P228, DOI 10.1016/j.thromres.2010.11.022; MIZUNO K, 1992, NEW ENGL J MED, V326, P287, DOI 10.1056/NEJM199201303260502; MIZUNO K, 1991, LANCET, V337, P809, DOI 10.1016/0140-6736(91)92514-3; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; MULLER JE, 1983, J AM COLL CARDIOL, V1, P893, DOI 10.1016/S0735-1097(83)80205-8; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nanda N, 2005, BLOOD, V106, P3028, DOI 10.1182/blood-2005-01-0333; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M; OPPER C, 1995, ATHEROSCLEROSIS, V113, P211, DOI 10.1016/0021-9150(94)05448-R; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Payne J. F., 1870, BMJ-BRIT MED J, V1, P130; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; RATHBONE RL, 1970, PATHOLOGY, V2, P307, DOI 10.3109/00313027009077146; Reed GL, 2004, SEMIN THROMB HEMOST, V30, P441, DOI 10.1055/s-2004-833479; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; RENTROP K P, 1979, Clinical Cardiology, V2, P354; Roffi M, 2001, CIRCULATION, V104, P2767, DOI 10.1161/hc4801.100029; Rosen ED, 2002, THROMB HAEMOSTASIS, V87, P774; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roux DTL, 2000, BLOOD, V96, P1399, DOI 10.1182/blood.V96.4.1399.h8001399_1399_1408; Ruggeri ZM, 2009, MICROCIRCULATION, V16, P58, DOI 10.1080/10739680802651477; Ruggeri ZM, 1999, THROMB HAEMOSTASIS, V82, P576; RUGGERI ZM, 1982, P NATL ACAD SCI-BIOL, V79, P6038, DOI 10.1073/pnas.79.19.6038; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RYO R, 1992, AM J HEMATOL, V39, P25, DOI 10.1002/ajh.2830390107; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Siess W, 2002, BBA-MOL CELL BIOL L, V1582, P204, DOI 10.1016/S1388-1981(02)00173-7; Smyth SS, 2001, BLOOD, V98, P1055, DOI 10.1182/blood.V98.4.1055; Sobieraj-Teague M, 2008, CURR OPIN CARDIOL, V23, P327, DOI 10.1097/HCO.0b013e3283021c5b; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Sugidachi A, 2007, J THROMB HAEMOST, V5, P1545, DOI 10.1111/j.1538-7836.2007.02598.x; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TERRES W, 1994, AM J MED, V97, P242, DOI 10.1016/0002-9343(94)90007-8; TERRES W, 1991, THROMB RES, V62, P649, DOI 10.1016/0049-3848(91)90369-8; Toschi V, 1997, CIRCULATION, V95, P594, DOI 10.1161/01.CIR.95.3.594; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; van Giezen JJJ, 2005, SEMIN THROMB HEMOST, V31, P195, DOI 10.1055/s-2005-869525; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Vulpian E. F. A., 1866, CASE REPORT SALPETRI, V29, P417; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Wei AH, 2009, BRIT J HAEMATOL, V147, P415, DOI 10.1111/j.1365-2141.2009.07819.x; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; Weisse AB, 2006, J HIST MED ALL SCI, V61, P66, DOI 10.1093/jhmas/jrj003; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Yokoya K, 1999, CIRCULATION, V100, P903, DOI 10.1161/01.CIR.100.9.903; Yousuf O, 2011, NAT REV CARDIOL, V8, P547, DOI 10.1038/nrcardio.2011.96; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104	173	413	431	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1423	1436		10.1038/nm.2515	http://dx.doi.org/10.1038/nm.2515			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064432				2022-12-27	WOS:000296779300033
J	[Anonymous]				[Anonymous]			An unSIRTain role in longevity	NATURE MEDICINE			English	Editorial Material							ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; C. ELEGANS; SIR2						de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; Sinclair, David/0000-0002-9936-436X; de Cabo, Rafael/0000-0002-3354-2442	NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG019719, R01AG028730] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG028730, R01 AG019719, R01 AG028730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2011, NATURE, V477, P411; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440	11	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1350	1350		10.1038/nm1111-1350	http://dx.doi.org/10.1038/nm1111-1350			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064411				2022-12-27	WOS:000296779300021
J	Cua, DJ; Sherlock, JP				Cua, Daniel J.; Sherlock, Jonathan P.			Gut microbiota strikes 'back'	NATURE MEDICINE			English	Editorial Material							HOST IMMUNE-SYSTEM; CELLS		[Cua, Daniel J.; Sherlock, Jonathan P.] Merck Res Labs, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Merck Res Labs, Palo Alto, CA 94304 USA.	daniel.cua@merck.com; jonathan.sherlock@merck.com						Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGonagle D, 1998, ARTHRITIS RHEUM, V41, P694, DOI 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#; MIELANTS H, 1995, J RHEUMATOL, V22, P2273; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	16	27	29	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1055	1056		10.1038/nm0911-1055	http://dx.doi.org/10.1038/nm0911-1055			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900923				2022-12-27	WOS:000294605100024
J	Tabas, I				Tabas, Ira			Finding the culprit in your heart	NATURE MEDICINE			English	Editorial Material							APOPTOTIC CELL ACCUMULATION; ATHEROSCLEROSIS; MACROPHAGES		[Tabas, Ira] Columbia Univ, Dept Med, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Columbia University; Columbia University	Tabas, I (corresponding author), Columbia Univ, Dept Med, Dept Pathol & Cell Biol, New York, NY 10027 USA.	iat1@columbia.edu			NHLBI NIH HHS [R01 HL107497, P01 HL087123-05, R01 HL075662, R01 HL106019, R01 HL107497-02, P01 HL087123, R01 HL106019-03, R01 HL075662-09] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106019, P01HL087123, R01HL107497, R01HL075662] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Libby P, 2008, J INTERN MED, V263, P517, DOI 10.1111/j.1365-2796.2008.01965.x; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Martinet W, 2006, J PHARMACOL EXP THER, V317, P1356, DOI 10.1124/jpet.106.102970; Martinet W, 2011, BRIT J PHARMACOL, V164, P1, DOI 10.1111/j.1476-5381.2011.01342.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Rosenfeld Michael E, 2002, Curr Atheroscler Rep, V4, P238, DOI 10.1007/s11883-002-0025-3; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x	16	23	25	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					791	793		10.1038/nm0711-791	http://dx.doi.org/10.1038/nm0711-791			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738159	Green Accepted			2022-12-27	WOS:000292500800031
J	Mu, S; Shimosawa, T; Ogura, S; Wang, H; Uetake, Y; Kawakami-Mori, F; Marumo, T; Yatomi, Y; Geller, DS; Tanaka, H; Fujita, T				Mu, ShengYu; Shimosawa, Tatsuo; Ogura, Sayoko; Wang, Hong; Uetake, Yuzaburo; Kawakami-Mori, Fumiko; Marumo, Takeshi; Yatomi, Yutaka; Geller, David S.; Tanaka, Hirotoshi; Fujita, Toshiro			Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension	NATURE MEDICINE			English	Article							NA-CL COTRANSPORTER; PROTEIN-KINASE-A; MINERALOCORTICOID RECEPTOR FUNCTION; SYMPATHETIC NERVOUS-SYSTEM; GLUCOCORTICOID-RECEPTOR; BLOOD-PRESSURE; HISTONE ACETYLATION; MMTV PROMOTER; WNK KINASES; IN-VIVO	How high salt intake increases blood pressure is a key question in the study of hypertension. Salt intake induces increased renal sympathetic activity resulting in sodium retention. However, the mechanisms underlying the sympathetic control of renal sodium excretion remain unclear. In this study, we found that beta(2)-adrenergic receptor (beta(2)AR) stimulation led to decreased transcription of the gene encoding WNK4, a regulator of sodium reabsorption. beta(2)AR stimulation resulted in cyclic AMP-dependent inhibition of histone deacetylase-8 (HDAC8) activity and increased histone acetylation, leading to binding of the glucocorticoid receptor to a negative glucocorticoid-responsive element in the promoter region. In rat models of salt-sensitive hypertension and sympathetic overactivity, salt loading suppressed renal WNK4 expression, activated the Na(+)-Cl(-) cotransporter and induced salt-dependent hypertension. These findings implicate the epigenetic modulation of WNK4 transcription in the development of salt-sensitive hypertension. The renal beta(2)AR-WNK4 pathway may be a therapeutic target for salt-sensitive hypertension.	[Mu, ShengYu; Shimosawa, Tatsuo; Ogura, Sayoko; Wang, Hong; Uetake, Yuzaburo; Kawakami-Mori, Fumiko; Marumo, Takeshi; Fujita, Toshiro] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan; [Shimosawa, Tatsuo; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab, Tokyo, Japan; [Geller, David S.] Yale Univ, Sch Med, W Haven Vet Affairs Med Ctr, New Haven, CT USA; [Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol, Tokyo, Japan	University of Tokyo; University of Tokyo; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; University of Tokyo	Fujita, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan.	fujita-dis@h.u-tokyo.ac.jp	Shimosawa, Tatsuo/A-2920-2015	Shimosawa, Tatsuo/0000-0002-8742-5129; Fujita, Toshiro/0000-0001-9141-7060; Yatomi, Yutaka/0000-0003-1719-4297	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Tamura (Yokohama City Medical University) for providing mDCT cells. Antibodies targeting NCC and p-NCC were provided by D. H. Ellison (Oregon Health and Science University) and S. Uchida (Tokyo Dental and Medical University), respectively. We also thank G. McMahon for his contribution to data discussion. Eplerenone and olmesartan were provided by Pfizer and Daiichi-Sankyo, respectively. This work was supported by research grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (T.F.).	Adams JM, 2007, HYPERTENSION, V50, P354, DOI 10.1161/HYPERTENSIONAHA.107.091843; Astrand C, 2009, EXP CELL RES, V315, P2604, DOI 10.1016/j.yexcr.2009.05.012; BARAJAS L, 1984, AM J PHYSIOL, V247, pF50, DOI 10.1152/ajprenal.1984.247.1.F50; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; CAMPESE VM, 1982, KIDNEY INT, V21, P371, DOI 10.1038/ki.1982.32; Cat AND, 2009, ENDOCRINOLOGY, V150, P2202, DOI 10.1210/en.2008-1531; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; DiBona GF, 2005, AM J PHYSIOL-REG I, V289, pR633, DOI 10.1152/ajpregu.00258.2005; FUJITA T, 1992, HYPERTENSION, V20, P466, DOI 10.1161/01.HYP.20.4.466; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; FUJITA T, 1988, J CLIN INVEST, V82, P993, DOI 10.1172/JCI113709; GILL JR, 1988, HYPERTENSION, V11, P312, DOI 10.1161/01.HYP.11.4.312; Goodwin JE, 2010, BIOCHEM BIOPH RES CO, V394, P266, DOI 10.1016/j.bbrc.2010.02.123; GREVEN J, 1975, N-S ARCH PHARMACOL, V287, P117, DOI 10.1007/BF00510444; Guild SJ, 2002, AM J PHYSIOL-REG I, V283, pR1177, DOI 10.1152/ajpregu.00151.2002; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huang BS, 2001, AM J PHYSIOL-HEART C, V281, pH1881, DOI 10.1152/ajpheart.2001.281.5.H1881; ISOHASHI F, 1989, CANCER RES, V49, pS2235; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; KATHOLI RE, 1980, HYPERTENSION, V2, P266, DOI 10.1161/01.HYP.2.3.266; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; KOEPKE JP, 1986, CIRC RES, V58, P241, DOI 10.1161/01.RES.58.2.241; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li CY, 2008, J MOL ENDOCRINOL, V40, P3, DOI 10.1677/JME-07-0049; Li JP, 2007, J HYPERTENS, V25, P1065, DOI 10.1097/HJH.0b013e3280a8b87d; LOHMEIER TE, 1984, HYPERTENSION, V6, pI177, DOI 10.1161/01.HYP.6.2_Pt_2.I177; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Massaad C, 1999, MOL ENDOCRINOL, V13, P57, DOI 10.1210/me.13.1.57; MEIER KE, 1983, J CELL BIOL, V97, P405, DOI 10.1083/jcb.97.2.405; Mulholland NM, 2003, EXP CELL RES, V287, P361, DOI 10.1016/S0014-4827(03)00153-8; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Ono A, 1997, HYPERTENSION, V29, P808, DOI 10.1161/01.HYP.29.3.808; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pojoga L, 2006, HYPERTENSION, V48, P892, DOI 10.1161/01.HYP.0000244688.45472.95; RANGARAJAN PN, 1992, MOL ENDOCRINOL, V6, P1451, DOI 10.1210/me.6.9.1451; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4020, DOI 10.1073/pnas.0611727104; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Snyder EM, 2006, J PHYSIOL-LONDON, V574, P947, DOI 10.1113/jphysiol.2006.107672; Vasquez MM, 2008, J CELL PHYSIOL, V217, P632, DOI 10.1002/jcp.21534; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Willyard C, 2010, NAT MED, V16, P18, DOI 10.1038/nm0110-18; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wurtele H, 2010, NAT MED, V16, P774, DOI 10.1038/nm.2175; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033	53	164	166	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					573	U92		10.1038/nm.2337	http://dx.doi.org/10.1038/nm.2337			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499270				2022-12-27	WOS:000290250400033
J	Bartelt, A; Bruns, OT; Reimer, R; Hohenberg, H; Ittrich, H; Peldschus, K; Kaul, MG; Tromsdorf, UI; Weller, H; Waurisch, C; Eychmuller, A; Gordts, PLSM; Rinninger, F; Bruegelmann, K; Freund, B; Nielsen, P; Merkel, M; Heeren, J				Bartelt, Alexander; Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinz; Ittrich, Harald; Peldschus, Kersten; Kaul, Michael G.; Tromsdorf, Ulrich I.; Weller, Horst; Waurisch, Christian; Eychmueller, Alexander; Gordts, Philip L. S. M.; Rinninger, Franz; Bruegelmann, Karoline; Freund, Barbara; Nielsen, Peter; Merkel, Martin; Heeren, Joerg			Brown adipose tissue activity controls triglyceride clearance	NATURE MEDICINE			English	Article							LIPOPROTEIN-LIPASE; RICH LIPOPROTEINS; COLD-EXPOSURE; FATTY-ACID; METABOLISM; INSULIN; DYSLIPIDEMIA; INACTIVATION; HUMANS; PLASMA	Brown adipose tissue (BAT) burns fatty acids for heat production to defend the body against cold(1,2) and has recently been shown to be present in humans(3-5). Triglyceride-rich lipoproteins (TRLs) transport lipids in the bloodstream, where the fatty acid moieties are liberated by the action of lipoprotein lipase (LPL)(6). Peripheral organs such as muscle and adipose tissue take up the fatty acids, whereas the remaining cholesterol-rich remnant particles are cleared by the liver(6). Elevated plasma triglyceride concentrations and prolonged circulation of cholesterol-rich remnants, especially in diabetic dyslipidemia, are risk factors for cardiovascular disease(7-11). However, the precise biological role of BAT for TRL clearance remains unclear. Here we show that increased BAT activity induced by short-term cold exposure controls TRL metabolism in mice. Cold exposure drastically accelerated plasma clearance of triglycerides as a result of increased uptake into BAT, a process crucially dependent on local LPL activity and transmembrane receptor CD36. In pathophysiological settings, cold exposure corrected hyperlipidemia and improved deleterious effects of insulin resistance. In conclusion, BAT activity controls vascular lipoprotein homeostasis by inducing a metabolic program that boosts TRL turnover and channels lipids into BAT. Activation of BAT might be a therapeutic approach to reduce elevated triglyceride concentrations and combat obesity in humans.	[Bartelt, Alexander; Bruegelmann, Karoline; Freund, Barbara; Nielsen, Peter; Merkel, Martin; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany; [Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinz] Heinrich Pette Inst, Dept Electron Microscopy & Micro Technol, Hamburg, Germany; [Ittrich, Harald; Peldschus, Kersten; Kaul, Michael G.] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Tromsdorf, Ulrich I.; Weller, Horst] Univ Hamburg, Inst Phys Chem, D-2000 Hamburg, Germany; [Waurisch, Christian; Eychmueller, Alexander] Tech Univ Dresden, Dresden, Germany; [Gordts, Philip L. S. M.] Univ Louvain, Dept Human Genet, Leuven, Belgium; [Rinninger, Franz] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 3, Hamburg, Germany; [Merkel, Martin] Asklepios Clin St Georg, Dept Internal Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Asklepios Klinik St. Georg	Bartelt, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany.	abartelt@uke.uni-hamburg.de; heeren@uke.uni-hamburg.de	Weller, Horst/B-5715-2014; Bruns, Oliver T/D-6735-2015; Bartelt, Alexander/ABC-2525-2020; Waurisch, Christian/A-4686-2012	Bruns, Oliver T/0000-0002-5738-0126; Merkel, Martin/0000-0002-2850-5110; Eychmuller, Alexander/0000-0001-9926-6279; Gordts, Philip/0000-0001-7224-4328; Waurisch, Christian/0000-0002-9058-3996	Graduiertenkolleg der Deutschen Forschungsgemeinschaft [1459]; Landesexzellenzinitiative Hamburg; Norgenta; Deutsche Forschungsgemeinschaft [ME1507]; Institute for the Promotion of Innovation through Science and Technology in Flanders; Bundesministerium fur Bildung und Forschung for the Tailored Magnetic Nanoparticles for Cancer Targeting (TOMCAT) [01 EZ 0824]	Graduiertenkolleg der Deutschen Forschungsgemeinschaft(German Research Foundation (DFG)); Landesexzellenzinitiative Hamburg; Norgenta; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Bundesministerium fur Bildung und Forschung for the Tailored Magnetic Nanoparticles for Cancer Targeting (TOMCAT)(Federal Ministry of Education & Research (BMBF))	We thank S. Ehret, B. Henkel, E.-M. Azizi, W. Tauscher, C. Edeling, M. Warmer and M. Holthaus for excellent technical assistance. We thank U. Beisiegel for support and critical reading of the manuscript. We thank G. Adam for helpful discussions and support. We thank L. Scheja for helpful discussions and expert technical advice. We are grateful to K.J. Moore (New York University), A. Roebroeck (Katholieke Universiteit Leuven), E. M. Rubin (University of California Berkeley) and L. A. Pennacchio (University of California-Berkeley) for providing transgenic mouse models. A. B. is a fellow of the Ernst Schering Foundation and is supported by the Graduiertenkolleg der Deutschen Forschungsgemeinschaft 1459. This work was supported by the Landesexzellenzinitiative Hamburg, by Norgenta and by grants from the Deutsche Forschungsgemeinschaft to J.H. and M. M. (ME1507) and A. E. (Schwerpunktprogramm 1313), from the Institute for the Promotion of Innovation through Science and Technology in Flanders to P. L. S. M. G. and from the Bundesministerium fur Bildung und Forschung for the Tailored Magnetic Nanoparticles for Cancer Targeting project (TOMCAT, 01 EZ 0824) to H. H., H. I. and P.N. Intravital imaging was performed in collaboration with the Nikon-Applikationszentrum Norddeutschland (Nikon GmbH) at the Heinrich-Pette-Institute.	Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Bruns OT, 2009, NAT NANOTECHNOL, V4, P193, DOI [10.1038/nnano.2008.405, 10.1038/NNANO.2008.405]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CARNEHEIM C, 1984, AM J PHYSIOL, V246, pE327, DOI 10.1152/ajpendo.1984.246.4.E327; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hohenberg H, 1996, J MICROSC-OXFORD, V183, P133, DOI 10.1046/j.1365-2818.1996.820642.x; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Neuger Lucyna, 2004, BMC Physiol, V4, P13, DOI 10.1186/1472-6793-4-13; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; VALLERAND AL, 1987, AM J PHYSIOL, V253, pE179, DOI 10.1152/ajpendo.1987.253.2.E179; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	36	1105	1160	11	218	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					200	U93		10.1038/nm.2297	http://dx.doi.org/10.1038/nm.2297			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21258337				2022-12-27	WOS:000286969900028
J	[Anonymous]				[Anonymous]			The ART of preventing HIV	NATURE MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY; TRANSMISSION											Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Mellors J.W., 1996, NAT MED, V2, P1	9	0	0	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					46	47		10.1038/nm0111-46	http://dx.doi.org/10.1038/nm0111-46			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21217682				2022-12-27	WOS:000285994000033
J	Bunnik, EM; Euler, Z; Welkers, MRA; Boeser-Nunnink, BDM; Grijsen, ML; Prins, JM; Schuitemaker, H				Bunnik, Evelien M.; Euler, Zelda; Welkers, Matthijs R. A.; Boeser-Nunnink, Brigitte D. M.; Grijsen, Marlous L.; Prins, Jan M.; Schuitemaker, Hanneke			Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level	NATURE MEDICINE			English	Article							NEUTRALIZING ANTIBODY-RESPONSE; TYPE-1 INFECTION; C INFECTION; VIRUS; SENSITIVITY; EVOLUTION; DOMAIN	By comparing HIV-1 variants from people who became infected at the beginning of the epidemic and from people who have recently contracted the virus, we observed an enhanced resistance of the virus to antibody neutralization over time, accompanied by an increase in the length of the variable loops and in the number of potential N-linked glycosylation sites on the HIV-1 envelope gp120 subunit. The enhanced neutralization resistance of HIV-1 in contemporary seroconverters coincided with the poorer elicitation of neutralizing antibody responses, which may have implications for vaccine design.	[Bunnik, Evelien M.; Euler, Zelda; Welkers, Matthijs R. A.; Boeser-Nunnink, Brigitte D. M.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect & Immun Amsterdam,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Grijsen, Marlous L.; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Schuitemaker, H (corresponding author), Crucell Holland BV, Leiden, Netherlands.	h.schuitemaker@amc.uva.nl	Prins, Jan M./AAF-4945-2020	Bunnik, Evelien/0000-0003-4003-3053; Welkers, Matthijs/0000-0002-2982-0278	Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment; Dutch AIDS fund [2004064]; Netherlands Organization for Scientific research [918.66.628]	Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment; Dutch AIDS fund; Netherlands Organization for Scientific research(Netherlands Organization for Scientific Research (NWO))	The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Amsterdam Health Service, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, the University Medical Center Utrecht and the Jan van Goyen Clinic are part of The Netherlands HIV Monitoring Foundation and are financially supported by the Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment. This study was financially supported by the Dutch AIDS fund (grant 2004064), The Netherlands Organization for Scientific research (grant 918.66.628), an Academic Medical Center graduate school PhD scholarship (M. R. A. W.), the European Community's Six Framework Programme European HIV Enterprise (EUROPRISE; FP6/2007-2012) under grant agreement 037611 and the European Community's Seventh Framework Programme Next Generation HIV-1 Immunogens inducing broadly reactive Neutralizing antibodies (NGIN) (FP7/2007-2013) under grant agreement 201433. We thank the International Antiviral Therapy Evaluation Center for providing financial support for the follow-up of contemporary seroconverters, D. Burton and A. Hessell (The Scripps Research Institute) for their generous supply of IgG1b12, D. Katinger (Polymun, as a partner in EUROPRISE) for his supply of mAbs 2G12, 2F5 and 4E10, and D. Montefiori (Duke University Medical Center) for his supply of HIVIg. The following reagents were obtained through the US National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases: HIV-IG from North American Biologicals and the National Heart, Lung, and Blood Institute.	Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Laird ME, 2008, J VIROL, V82, P11054, DOI 10.1128/JVI.01341-08; Lambert JS, 1997, J INFECT DIS, V175, P283, DOI 10.1093/infdis/175.2.283; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	14	87	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					995	997		10.1038/nm.2203	http://dx.doi.org/10.1038/nm.2203			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20802498				2022-12-27	WOS:000281622900027
J	Esmon, CT				Esmon, Charles T.			BENCH TO BEDSIDE Counteracting coagulation	NATURE MEDICINE			English	Editorial Material							MEDIATORS		[Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Howard Hughes Med Inst, Cardiovasc Biol Res Program,Oklahoma Med Res Fdn, Oklahoma City, OK 73190 USA; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA	Howard Hughes Medical Institute; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Esmon, CT (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Howard Hughes Med Inst, Cardiovasc Biol Res Program,Oklahoma Med Res Fdn, Oklahoma City, OK 73190 USA.	Chuck-Esmon@omrf.ouhsc.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Holdenrieder S, 2009, CRIT REV CL LAB SCI, V46, P1, DOI [10.1080/10408360802485875 , 10.1080/10408360802485875]; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; RATNOFF OD, 1968, NEW ENGL J MED, V279, P760, DOI 10.1056/NEJM196810032791407; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	10	8	9	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					759	760		10.1038/nm0710-759	http://dx.doi.org/10.1038/nm0710-759			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613754				2022-12-27	WOS:000279631900023
J	Pang, TK; Garrett, L				Pang, Tikki; Garrett, Laurie			The WHO must reform for its own health	NATURE MEDICINE			English	Editorial Material									[Pang, Tikki] WHO, CH-1211 Geneva, Switzerland; [Garrett, Laurie] Council Foreign Relat, New York, NY USA	World Health Organization	Pang, TK (corresponding author), Natl Univ Singapore, Singapore, Singapore.							Chow JC., 2010, FOREIGN POLICY  1208; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9	2	6	6	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					646	646		10.1038/nm0512-646	http://dx.doi.org/10.1038/nm0512-646			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561812	Bronze			2022-12-27	WOS:000303763500021
J	Schenk, M; Krutzik, SR; Sieling, PA; Lee, DJ; Teles, RMB; Ochoa, MT; Komisopoulou, E; Sarno, EN; Rea, TH; Graeber, TG; Kim, S; Cheng, GH; Modlin, RL				Schenk, Mirjam; Krutzik, Stephan R.; Sieling, Peter A.; Lee, Delphine J.; Teles, Rosane M. B.; Ochoa, Maria Teresa; Komisopoulou, Evangelia; Sarno, Euzenir N.; Rea, Thomas H.; Graeber, Thomas G.; Kim, Soohyun; Cheng, Genhong; Modlin, Robert L.			NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTOR-2; MHC CLASS-II; CUTTING EDGE; LEPROMATOUS LEPROSY; ADJUVANT ACTIVITY; T-CELLS; ACTIVATION; POLYMORPHISM; DIFFERENTIATION; RESPONSES	It is unclear whether the ability of the innate immune system to recognize distinct ligands from a single microbial pathogen via multiple pattern recognition receptors (PRRs) triggers common pathways or differentially triggers specific host responses. In the human mycobacterial infection leprosy, we found that activation of monocytes via nucleotide-binding oligomerization domain-containing protein 2 (NOD2) by its ligand muramyl dipeptide, as compared to activation via heterodimeric Toll-like receptor 2 and Toll-like receptor 1 (TLR2/1) by triacylated lipopeptide, preferentially induced differentiation into dendritic cells (DCs), which was dependent on a previously unknown interleukin-32 (IL-32)-dependent mechanism. Notably, IL-32 was sufficient to induce monocytes to rapidly differentiate into DCs, which were more efficient than granulocyte-macrophage colony-stimulating factor (GM-CSF)-derived DCs in presenting antigen to major histocompatibility complex (MHC) class I-restricted CD8(+) T cells. Expression of NOD2 and IL-32 and the frequency of CD1b(+) DCs at the site of leprosy infection correlated with the clinical presentation; they were greater in patients with limited as compared to progressive disease. The addition of recombinant IL-32 restored NOD2-induced DC differentiation in patients with the progressive form of leprosy. In conclusion, the NOD2 ligand-induced, IL-32-dependent DC differentiation pathway contributes a key and specific mechanism for host defense against microbial infection in humans.	[Schenk, Mirjam; Krutzik, Stephan R.; Sieling, Peter A.; Lee, Delphine J.; Teles, Rosane M. B.; Ochoa, Maria Teresa; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr,Inst Mol Med, Crump Inst Mol Imaging,Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Sarno, Euzenir N.] Fundacao Oswaldo Cruz, Dept Mycobacteriosis, Rio De Janeiro, Brazil; [Rea, Thomas H.] Univ So Calif, Sch Med, Dept Dermatol, Los Angeles, CA USA; [Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Seoul, South Korea; [Cheng, Genhong; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fundacao Oswaldo Cruz; University of Southern California; Konkuk University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Modlin, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Teles, Rosane/E-9607-2017; Modlin, Robert L/M-7941-2014; Teles, Rosane/AAQ-3436-2020	Teles, Rosane/0000-0003-2908-3244; Modlin, Robert L/0000-0003-4720-031X; Teles, Rosane/0000-0003-2908-3244; Ochoa, Maria T/0000-0001-6550-5008; Nunes Sarno, Euzenir/0000-0003-0129-2159; Schenk, Mirjam/0000-0002-1637-0730; Graeber, Thomas/0000-0001-8574-9181	US National Institutes of Health [R01s AI022553, AR040312, AI047868]; Swiss National Science Foundation (SSMBS) [PASMP3-123256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022553, R37AI047868, R01AI082575, R22AI022553, R01AI056154, R01AI047868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059126, R01AR040312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SSMBS)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Liu, B. Bloom and F. Martinon for helpful scientific discussions, D. Vu for technical assistance and A. De Leon for help with the immunolabeling. This work was supported in parts by grants from the US National Institutes of Health (R01s AI022553, AR040312 and AI047868) and the Swiss National Science Foundation (SSMBS, PASMP3-123256).	ADAM A, 1974, BIOCHEM BIOPH RES CO, V56, P561, DOI 10.1016/0006-291X(74)90640-8; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; BLOOM BR, 1986, J IMMUNOL, V137, pR1; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Kang TJ, 2004, IMMUNOLOGY, V112, P674, DOI 10.1111/j.1365-2567.2004.01926.x; Kang TJ, 2002, CYTOKINE, V20, P56, DOI 10.1006/cyto.2002.1982; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; KLEINERMAN ES, 1992, CANCER IMMUNOL IMMUN, V34, P211, DOI 10.1007/BF01741788; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Lee DJ, 2007, J IMMUNOL, V179, P8128, DOI 10.4049/jimmunol.179.12.8128; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Malhotra D, 2005, HUM GENET, V116, P413, DOI 10.1007/s00439-004-1249-9; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; MODLIN RL, 1983, J AM ACAD DERMATOL, V8, P182, DOI 10.1016/S0190-9622(83)70021-6; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; MORTON DL, 1970, SURGERY, V68, P158; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Niazi KR, 2007, IMMUNOLOGY, V122, P522, DOI 10.1111/j.1365-2567.2007.02666.x; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; RIDLEY DS, 1974, B WORLD HEALTH ORGAN, V51, P451; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Sieling PA, 1999, J IMMUNOL, V162, P1851; SIELING PA, 1993, J IMMUNOL, V150, P5501; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; SILVA CL, 1992, MICROB PATHOGENESIS, V12, P27, DOI 10.1016/0882-4010(92)90063-T; SPECTER S, 1978, Journal of Immunology, V120, P487; SUGIMOTO M, 1978, J IMMUNOL, V120, P980; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	55	86	89	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					555	563		10.1038/nm.2650	http://dx.doi.org/10.1038/nm.2650			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22447076	Green Accepted			2022-12-27	WOS:000302617800032
J	Kohno, T; Ichikawa, H; Totoki, Y; Yasuda, K; Hiramoto, M; Nammo, T; Sakamoto, H; Tsuta, K; Furuta, K; Shimada, Y; Iwakawa, R; Ogiwara, H; Oike, T; Enari, M; Schetter, AJ; Okayama, H; Haugen, A; Skaug, V; Chiku, S; Yamanaka, I; Arai, Y; Watanabe, SI; Sekine, I; Ogawa, S; Harris, CC; Tsuda, H; Yoshida, T; Yokota, J; Shibata, T				Kohno, Takashi; Ichikawa, Hitoshi; Totoki, Yasushi; Yasuda, Kazuki; Hiramoto, Masaki; Nammo, Takao; Sakamoto, Hiromi; Tsuta, Koji; Furuta, Koh; Shimada, Yoko; Iwakawa, Reika; Ogiwara, Hideaki; Oike, Takahiro; Enari, Masato; Schetter, Aaron J.; Okayama, Hirokazu; Haugen, Aage; Skaug, Vidar; Chiku, Suenori; Yamanaka, Itaru; Arai, Yasuhito; Watanabe, Shun-ichi; Sekine, Ikuo; Ogawa, Seishi; Harris, Curtis C.; Tsuda, Hitoshi; Yoshida, Teruhiko; Yokota, Jun; Shibata, Tatsuhiro			KIF5B-RET fusions in lung adenocarcinoma	NATURE MEDICINE			English	Article							CANCER; RET; IDENTIFICATION; THERAPY	We identified in-frame fusion transcripts of KIF5B (the kinesin family 5B gene) and the RET oncogene, which are present in 1-2% of lung adenocarcinomas (LADCs) from people from Japan and the United States, using whole-transcriptome sequencing. The KIF5B-RET fusion leads to aberrant activation of RET kinase and is considered to be a new driver mutation of LADC because it segregates from mutations or fusions in EGFR, KRAS, HER2 and ALK, and a RET tyrosine kinase inhibitor, vandetanib, suppresses the fusion-induced anchorage-independent growth activity of NIH3T3 cells.	[Kohno, Takashi; Shimada, Yoko; Ogiwara, Hideaki] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Ichikawa, Hitoshi; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan; [Totoki, Yasushi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Yasuda, Kazuki; Hiramoto, Masaki; Nammo, Takao] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst,Shinjuku Ku, Tokyo, Japan; [Tsuta, Koji; Furuta, Koh; Tsuda, Hitoshi] Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Iwakawa, Reika; Oike, Takahiro; Okayama, Hirokazu; Yokota, Jun] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Chuo Ku, Tokyo 104, Japan; [Enari, Masato] Natl Canc Ctr, Res Inst, Div Refractory Canc Res, Tokyo 104, Japan; [Schetter, Aaron J.; Okayama, Hirokazu; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Haugen, Aage; Skaug, Vidar] Natl Inst Occupat Hlth, Sect Toxicol, Dept Chem & Biol Working Environm, Oslo, Norway; [Chiku, Suenori] Mizuho Informat & Res Inst, Sci Solut Div, Chiyoda Ku, Tokyo, Japan; [Yamanaka, Itaru] StaGen, Stat Genet Anal Div, Taito Ku, Tokyo, Japan; [Watanabe, Shun-ichi] Natl Canc Ctr, Div Thorac Surg, Chuo Ku, Tokyo, Japan; [Sekine, Ikuo] Natl Canc Ctr, Div Thorac Oncol, Chuo Ku, Tokyo, Japan; [Ogawa, Seishi] Univ Tokyo, Bunkyo Ku, Canc Genom Project, Tokyo 113, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Center for Global Health & Medicine - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mizuho Research & Technologies, Ltd.; National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo	Kohno, T (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan.	tkkohno@ncc.go.jp	Enari, Masato/E-5507-2014; Shibata, Tatsuhiro/ABA-8234-2020; Ogawa, Seishi/AAE-7088-2019; Shibata, Tatsuhiro/AAO-1278-2021; yamanaka, itaru/AAA-6290-2022	Enari, Masato/0000-0003-4293-3848; Arai, Yasuhito/0000-0001-6306-9409; Ogiwara, Hideaki/0000-0003-0860-1807; Okayama, Hirokazu/0000-0003-0966-4746	National Institute of Biomedical Innovation (NiBio); Ministry of Health, Labour and Welfare; National Cancer Center; Norwegian Cancer Society; National Cancer Center, Japan; NATIONAL CANCER INSTITUTE [ZIABC010874, ZIABC005480] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24390288] Funding Source: KAKEN	National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Cancer Center; Norwegian Cancer Society(Norwegian Cancer Society); National Cancer Center, Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), Grants-in-Aid from the Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control, the National Cancer Center Research and Development Fund and the Norwegian Cancer Society. National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. We thank T. Urushidate, S. Ohashi, S. Mitani, K. Yokozawa, S. Wakai, C. Otsubo and H. Isomura of the National Cancer Center and D. Suzuki and K. Nagase of the National Center for Global Health and Medicine for technical assistance. We also thank J.D. Minna and L. Girard of the University of Texas Southwestern Medical Center, K. Kumamoto of Saitama Medical University and A. Okamoto of Jikei University for RET fusion screening, N. Morii of the National Institute of Advanced Industrial Science and Technology (AIST) for thermodynamic characterization of the KIF5B protein and M. Maekawa of the GSP laboratory for rapid preparation of the FISH probes.	Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Carlomagno F, 2002, CANCER RES, V62, P7284; Commander H, 2011, DRUGS, V71, P1355, DOI 10.2165/11595310-000000000-00000; Croyle M, 2008, CANCER RES, V68, P4183, DOI 10.1158/0008-5472.CAN-08-0413; DeLellis R.A., 2010, IMMUNOHISTOLOGY ENDO; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Morii H, 1997, BIOCHEMISTRY-US, V36, P1933, DOI 10.1021/bi962392l; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742	19	579	642	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					375	377		10.1038/nm.2644	http://dx.doi.org/10.1038/nm.2644			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22327624	Green Accepted			2022-12-27	WOS:000301264800036
J	Lanner, JT; Georgiou, DK; Dagnino-Acosta, A; Ainbinder, A; Cheng, Q; Joshi, AD; Chen, ZW; Yarotskyy, V; Oakes, JM; Lee, CS; Monroe, TO; Santillan, A; Dong, KK; Goodyear, L; Ismailov, II; Rodney, GG; Dirksen, RT; Hamilton, SL				Lanner, Johanna T.; Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Ainbinder, Alina; Cheng, Qing; Joshi, Aditya D.; Chen, Zanwen; Yarotskyy, Viktor; Oakes, Joshua M.; Lee, Chang Seok; Monroe, Tanner O.; Santillan, Arturo; Dong, Keke; Goodyear, Laurie; Ismailov, Iskander I.; Rodney, George G.; Dirksen, Robert T.; Hamilton, Susan L.			AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation	NATURE MEDICINE			English	Article							MALIGNANT HYPERTHERMIA; PROTEIN-KINASE; RYANODINE RECEPTOR; S-NITROSYLATION; CA2+ RELEASE; IDENTIFICATION; MUTATION; GLYCOGEN; RHABDOMYOLYSIS; FLUORESCENCE	Mice with a knock-in mutation (Y524S) in the type I ryanodine receptor (Ryr1), a mutation analogous to the Y522S mutation that is associated with malignant hyperthermia in humans, die when exposed to short periods of temperature elevation (>= 37 degrees C). We show here that treatment with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) prevents this heat-induced sudden death in this mouse model. The protection by AICAR is independent of AMP-activated protein kinase (AMPK) activation and results from a newly identified action of the compound on mutant Ryr1 to reduce Ca2+ leak from the sarcoplasmic reticulum to the sarcoplasm. AICAR thus prevents Ca2+-dependent increases in the amount of both reactive oxygen species (ROS) and reactive nitrogen species (RNS) that act to further increase resting Ca2+ concentrations. If unchecked, the temperature-driven increases in resting Ca2+ concentrations and the amounts of ROS and RNS create an amplifying cycle that ultimately triggers sustained muscle contractions, rhabdomyolysis and death. Although antioxidants are effective in reducing this cycle in vitro, only AICAR prevents heat-induced death in vivo. Our findings suggest that AICAR is probably effective in prophylactic treatment of humans with enhanced susceptibility to exercise- and/or heat-induced sudden death associated with RYR1 mutations.	[Lanner, Johanna T.; Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Cheng, Qing; Joshi, Aditya D.; Chen, Zanwen; Oakes, Joshua M.; Lee, Chang Seok; Monroe, Tanner O.; Santillan, Arturo; Dong, Keke; Ismailov, Iskander I.; Rodney, George G.; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Ainbinder, Alina; Yarotskyy, Viktor; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Goodyear, Laurie] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA	Baylor College of Medicine; University of Rochester; Harvard University; Joslin Diabetes Center, Inc.	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	susanh@bcm.edu	Monroe, Tanner O./AAQ-5901-2021; Dagnino-Acosta, Adan/K-6786-2012	Monroe, Tanner/0000-0001-9117-2227; Lanner, Johanna/0000-0002-1222-9473; Rodney, George G/0000-0002-6968-1516; Hamilton, Susan/0000-0003-0241-9369; Dagnino-Acosta, Adan/0000-0001-8903-807X	US National Institutes of Health [AR053349]; Department of Defense [DAMD W81XWH-10-2-0117]; Muscular Dystrophy Association of America; The Swedish Research Council; The Mexican National Council of Science and Technology [150489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R01AR053349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Muscular Dystrophy Association of America(Muscular Dystrophy Association); The Swedish Research Council(Swedish Research Council); The Mexican National Council of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from US National Institutes of Health (AR053349), the Department of Defense (DAMD W81XWH-10-2-0117) and the Muscular Dystrophy Association of America. J.T.L. was supported by a postdoc fellowship from The Swedish Research Council. A.D.-A. was supported by a postdoctoral fellowship from The Mexican National Council of Science and Technology (150489). The model shown in Figure 6 was created by S.A. Weldon.	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Capacchione JF, 2009, ANESTH ANALG, V109, P1065, DOI 10.1213/ane.0b013e3181a9d8d9; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; KONISHI M, 1988, BIOPHYS J, V54, P1089, DOI 10.1016/S0006-3495(88)83045-5; Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Larach MG, 2010, ANESTH ANALG, V110, P498, DOI 10.1213/ANE.0b013e3181c6b9b2; Mackrill JJ, 2010, BIOCHEM PHARMACOL, V79, P1535, DOI 10.1016/j.bcp.2010.01.014; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Meissner G, 1997, J BIOL CHEM, V272, P1628, DOI 10.1074/jbc.272.3.1628; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nishio Hajime, 2009, Legal Medicine, V11, P142, DOI 10.1016/j.legalmed.2008.12.004; Pirone A, 2010, AM J PHYSIOL-CELL PH, V299, pC1345, DOI 10.1152/ajpcell.00008.2010; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; QUANE KA, 1994, GENOMICS, V23, P236, DOI 10.1006/geno.1994.1483; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; ROCK E, 1987, ARCH BIOCHEM BIOPHYS, V256, P703, DOI 10.1016/0003-9861(87)90628-X; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Solberg G, 2005, J SPORT SCI MED, V4, P29; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Vladutiu GD, 2011, MOL GENET METAB, V104, P167, DOI 10.1016/j.ymgme.2011.07.001; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Wasserman K, 1990, CIRCULATION S2, V81, P1114; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; WILLIAMS JH, 1991, AM J PHYSIOL, V261, pR782, DOI 10.1152/ajpregu.1991.261.4.R782; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219	48	81	81	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					244	251		10.1038/nm.2598	http://dx.doi.org/10.1038/nm.2598			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22231556	Green Accepted			2022-12-27	WOS:000300140300038
J	Wilkinson, TM; Li, CKF; Chui, CSC; Huang, AKY; Perkins, M; Liebner, JC; Lambkin-Williams, R; Gilbert, A; Oxford, J; Nicholas, B; Staples, KJ; Dong, T; Douek, DC; McMichael, AJ; Xu, XN				Wilkinson, Tom M.; Li, Chris K. F.; Chui, Cecilia S. C.; Huang, Arthur K. Y.; Perkins, Molly; Liebner, Julia C.; Lambkin-Williams, Rob; Gilbert, Anthony; Oxford, John; Nicholas, Ben; Staples, Karl J.; Dong, Tao; Douek, Daniel C.; McMichael, Andrew J.; Xu, Xiao-Ning			Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans	NATURE MEDICINE			English	Article							VIRUS-INFECTION; IMMUNITY; RESPONSES; VACCINE; H5N1	Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but the precise role of T cells in human influenza immunity is uncertain. We conducted influenza infection studies in healthy volunteers with no detectable antibodies to the challenge viruses H3N2 or H1N1. We mapped T cell responses to influenza before and during infection. We found a large increase in influenza-specific T cell responses by day 7, when virus was completely cleared from nasal samples and serum antibodies were still undetectable. Preexisting CD4(+), but not CD8(+), T cells responding to influenza internal proteins were associated with lower virus shedding and less severe illness. These CD4(+) cells also responded to pandemic H1N1 (A/CA/07/2009) peptides and showed evidence of cytotoxic activity. These cells are an important statistical correlate of homotypic and heterotypic response and may limit severity of influenza infection by new strains in the absence of specific antibody responses. Our results provide information that may aid the design of future vaccines against emerging influenza strains.	[Wilkinson, Tom M.; Nicholas, Ben; Staples, Karl J.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Li, Chris K. F.; Chui, Cecilia S. C.; Huang, Arthur K. Y.; Dong, Tao; McMichael, Andrew J.; Xu, Xiao-Ning] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Huang, Arthur K. Y.] Chang Gung Childrens Hosp, Dept Paediat, Tao Yuan, Taiwan; [Perkins, Molly; Liebner, Julia C.; Douek, Daniel C.] US Natl Inst Hlth, Vaccine Res Ctr, Bethesda, MD USA; [Lambkin-Williams, Rob; Gilbert, Anthony; Oxford, John] Retroscreen Virol, London, England	University of Southampton; University of Oxford; Chang Gung Memorial Hospital; National Institutes of Health (NIH) - USA	Wilkinson, TM (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	t.wilkinson@soton.ac.uk; xiaoning.xu@imm.ox.ac.uk	Lambkin-Williams, Robert/P-5963-2016; LI, chris/HDO-6232-2022; Lambkin-Williams, Rob/L-2397-2019	Lambkin-Williams, Robert/0000-0003-2107-0174; Lambkin-Williams, Rob/0000-0003-2107-0174; Dong, Tao/0000-0003-3545-3758; Wilkinson, Tom/0000-0003-1771-3851; Nicholas, Benjamin/0000-0003-1467-9643; Gilbert, Anthony Saul/0000-0002-6582-3820; Staples, Karl/0000-0003-3844-6457	UK Medical Research Council; Medical Research Council [G1001046, G1001047, MC_U137881015, G0600520, MC_U137884177] Funding Source: researchfish; Asthma UK [08/026] Funding Source: researchfish; MRC [G1001047, MC_U137881015, G0600520, G1001046, MC_U137884177] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Roederer, P. Chattopadhyay and J. Yu (US National Institutes of Health) for providing the antibody conjugates used for flow cytometry.. We also thank G. Balaratnam and the Retroscreen Clinical team for their expert conduct of the clinical study. In addition, we thank N. Goonetilleke for discussion of the statistics, H. Hong and L. Wang for assistance in blood separation and ELISPOT assay, and J. Ward of the Southampton Histochemistry Research Unit for assistance with immunohistochemistry. This study was partially funded by the UK Medical Research Council.	Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Aymard M, 1999, VACCINE, V17, pS30, DOI 10.1016/S0264-410X(99)00103-6; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Belshe RB, 2003, IMMUNOL ALLERGY CLIN, V23, P745, DOI 10.1016/S0889-8561(03)00098-5; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Couch R B, 2003, Dev Biol (Basel), V115, P25; Creanza N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008544; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; HO PPK, 1976, J GEN VIROL, V33, P143, DOI 10.1099/0022-1317-33-1-143; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; McKinstry KK, 2011, J INTERN MED, V269, P507, DOI 10.1111/j.1365-2796.2011.02367.x; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Monto AS, 2000, AM J MANAG CARE, V6, pS255; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Newton DW, 2000, AM J MANAG CARE, V6, pS265; Oxford John S, 2005, Expert Rev Anti Infect Ther, V3, P1, DOI 10.1586/14787210.3.1.1; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Stambas J, 2008, PHARMACOL THERAPEUT, V120, P186, DOI 10.1016/j.pharmthera.2008.08.007; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Topham DJ, 1997, J IMMUNOL, V159, P5197; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; WHO, 2009, INFL SEAS; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996	39	682	698	0	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					274	280		10.1038/nm.2612	http://dx.doi.org/10.1038/nm.2612			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286307	Bronze			2022-12-27	WOS:000300140300042
J	Sela-Passwell, NA; Kikkeri, R; Dym, O; Rozenberg, H; Margalit, R; Arad-Yellin, R; Eisenstein, M; Brenner, O; Shoham, T; Danon, T; Shanzer, A; Sagi, I				Sela-Passwell, Nett A.; Kikkeri, Raghavendra; Dym, Orly; Rozenberg, Haim; Margalit, Raanan; Arad-Yellin, Rina; Eisenstein, Miriam; Brenner, Ori; Shoham, Tsipi; Danon, Tamar; Shanzer, Abraham; Sagi, Irit			Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; CRYSTAL-STRUCTURE; CANCER-THERAPY; INHIBITORS; TISSUE; MECHANISM; EXPRESSION; TIMP-1; MICE	Endogenous tissue inhibitors of metalloproteinases (TIMPs) have key roles in regulating physiological and pathological cellular processes(1-3). Imitating the inhibitory molecular mechanisms of TIMPs while increasing selectivity has been a challenging but desired approach for antibody-based therapy(4). TIMPs use hybrid protein-protein interactions to form an energetic bond with the catalytic metal ion, as well as with enzyme surface residues(5-7). We used an innovative immunization strategy that exploits aspects of molecular mimicry to produce inhibitory antibodies that show TIMP-like binding mechanisms toward the activated forms of gelatinases (matrix metalloproteinases 2 and 9). Specifically, we immunized mice with a synthetic molecule that mimics the conserved structure of the metalloenzyme catalytic zinc-histidine complex residing within the enzyme active site. This immunization procedure yielded selective function-blocking monoclonal antibodies directed against the catalytic zinc-protein complex and enzyme surface conformational epitopes of endogenous gelatinases. The therapeutic potential of these antibodies has been demonstrated with relevant mouse models of inflammatory bowel disease(8). Here we propose a general experimental strategy for generating inhibitory antibodies that effectively target the in vivo activity of dysregulated metalloproteinases by mimicking the mechanism employed by TIMPs.	[Sela-Passwell, Nett A.; Dym, Orly; Rozenberg, Haim; Margalit, Raanan; Arad-Yellin, Rina; Shoham, Tsipi; Sagi, Irit] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Sela-Passwell, Nett A.; Dym, Orly; Rozenberg, Haim; Margalit, Raanan; Arad-Yellin, Rina; Shoham, Tsipi; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Kikkeri, Raghavendra; Shanzer, Abraham] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Danon, Tamar] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	irit.sagi@weizmann.ac.il			Israel Science Foundation; Minerva Foundation; Helmsley Foundation; Kimmelman Center at the Weizmann Institute	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Helmsley Foundation; Kimmelman Center at the Weizmann Institute	We would like to thank D. Tawfik and I. Shachar for critical reading of the manuscript, K. Vyacheslav for assistance in optical imaging data collection and analysis, and C. Power, O. Leger and O. Lightner for technical support in antibody production. This work was supported by the Israel Science Foundation, the Minerva Foundation, the Helmsley Foundation, the Kimmelman Center at the Weizmann Institute and funds from C. Berall and L. Berall, M. Steinberg and C. Adelson. I.S. is the Incumbent of the Maurizio Pontecorvo Professorial Chair.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Aychek T, 2011, MAGN RESON MED, V66, P235, DOI 10.1002/mrm.22798; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kirkegaard T, 2004, GUT, V53, P701, DOI 10.1136/gut.2003.017442; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Monteleone G, 2006, CURR OPIN GASTROEN, V22, P361, DOI 10.1097/01.mog.0000231808.10773.8e; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; Santana A, 2006, WORLD J GASTROENTERO, V12, P6464, DOI 10.3748/wjg.v12.i40.6464; Sela-Passwell N, 2011, EXPERT OPIN DRUG DIS, V6, P527, DOI 10.1517/17460441.2011.560936; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200	33	102	104	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					143	147		10.1038/nm.2582	http://dx.doi.org/10.1038/nm.2582			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22198278				2022-12-27	WOS:000299018600040
J	Cvetanovic, M; Patel, JM; Marti, HH; Kini, AR; Opal, P				Cvetanovic, Marija; Patel, Jay M.; Marti, Hugo H.; Kini, Ameet R.; Opal, Puneet			Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1	NATURE MEDICINE			English	Article							MOTOR-NEURON DEGENERATION; HYPOXIA-RESPONSE ELEMENT; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; SCA1; NEURODEGENERATION; VEGF; PROTEIN; EXPRESSION; DISORDERS	Spinocerebellar ataxia type 1 (SCA1) is an adult-onset, dominantly inherited neurodegenerative disease caused by expansion of a glutamine repeat tract in ataxin-1 (ATXN1). Although the precise function of ATXN1 remains elusive, it seems to be involved in transcriptional repression. We find that mutant ATXN1 represses transcription of the neurotrophic and angiogenic factor vascular endothelial growth factor (VEGF). Genetic overexpression or pharmacologic infusion of recombinant VEGF mitigates SCA1 pathogenesis, suggesting a new therapeutic strategy for this disease.	[Cvetanovic, Marija; Patel, Jay M.; Opal, Puneet] Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Marti, Hugo H.] Univ Heidelberg, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Kini, Ameet R.] Loyola Univ Chicago, Stritch Sch Med, Dept Pathol, Maywood, IL USA; [Kini, Ameet R.] Loyola Univ Chicago, Stritch Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL USA; [Opal, Puneet] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ruprecht Karls University Heidelberg; Loyola University Chicago; Loyola University Chicago; Northwestern University; Feinberg School of Medicine	Opal, P (corresponding author), Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-opal@northwestern.edu	Cvetanovic, Marija/B-8907-2016	Patel, Jay/0000-0003-2746-5716; Marti, Hugo/0000-0002-8456-334X	US National Institutes of Health [K02 NS051340, R21 NS060080, R01 NS062051, T32]; US National Organization for Rare Disorders; US Brain Research Foundation; US National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082351, R01NS062051, R21NS060080, K02NS051340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Organization for Rare Disorders; US Brain Research Foundation; US National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Zoghbi (Baylor College of Medicine) and H. Orr (University of Minnesota) for generously providing ATXN1 constructs and the SCA1 mouse models, and S. Leibovich (University of Medicine and Dentistry of New Jersey) and P. D'Amore (Harvard Medical School) for VEGF luciferase reporter constructs. We also thank K. Gobeske for assistance with the intracerebroventricular delivery methods, A. Ma for help with pathological analyses and V. Brandt for editorial assistance. This work was funded by US National Institutes of Health grants K02 NS051340, R21 NS060080 and R01 NS062051 (P.O.); a US National Organization for Rare Disorders grant (P.O.), a US Brain Research Foundation Grant (P.O.) and a US National Ataxia Foundation grant (P.O.). M. C. received funding from the US National Institutes of Health training grant T32. The authors wish to dedicate this manuscript to fellow scientist T. Spann, who is currently fighting amyotrophic lateral sclerosis.	Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; de Almodovar CR, 2010, J NEUROSCI, V30, P15052, DOI 10.1523/JNEUROSCI.0477-10.2010; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2008, P NATL ACAD SCI USA, V105, P1291, DOI 10.1073/pnas.0711257105; Lambrechts D, 2006, BBA-MOL BASIS DIS, V1762, P1109, DOI 10.1016/j.bbadis.2006.04.005; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X	18	72	73	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1445	1447		10.1038/nm.2494	http://dx.doi.org/10.1038/nm.2494			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22001907	Green Accepted			2022-12-27	WOS:000296779300035
J	Pei, LM; Leblanc, M; Barish, G; Atkins, A; Nofsinger, R; Whyte, J; Gold, D; He, MX; Kawamura, K; Li, HR; Downes, M; Yu, RT; Powell, HC; Lingrel, JB; Evans, RM				Pei, Liming; Leblanc, Mathias; Barish, Grant; Atkins, Annette; Nofsinger, Russell; Whyte, Jamie; Gold, David; He, Mingxiao; Kawamura, Kazuko; Li, Hai-Ri; Downes, Michael; Yu, Ruth T.; Powell, Henry C.; Lingrel, Jerry B.; Evans, Ronald M.			Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome	NATURE MEDICINE			English	Article							FETAL LUNG DEVELOPMENT; GENE-EXPRESSION; CO-REPRESSOR; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; NUCLEAR RECEPTORS; CELL; MATURATION; MICE; MORPHOGENESIS	Although the lung is a defining feature of air-breathing animals, the pathway controlling the formation of type I pneumocytes, the cells that mediate gas exchange, is poorly understood. In contrast, the glucocorticoid receptor and its cognate ligand have long been known to promote type II pneumocyte maturation; prenatal administration of glucocorticoids is commonly used to attenuate the severity of infant respiratory distress syndrome (RDS). Here we show that knock-in mutations of the nuclear co-repressor SMRT (silencing mediator of retinoid and thyroid hormone receptors) in C57BL/6 mice (SMRT(mRID)) produces a previously unidentified respiratory distress syndrome caused by prematurity of the type I pneumocyte. Though unresponsive to glucocorticoids, treatment with anti-thyroid hormone drugs (propylthiouracil or methimazole) completely rescues SMRT-induced RDS, suggesting an unrecognized and essential role for the thyroid hormone receptor (TR) in lung development. We show that TR and SMRT control type I pneumocyte differentiation through Klf2, which, in turn, seems to directly activate the type I pneumocyte gene program. Conversely, mice without lung Klf2 lack mature type I pneumocytes and die shortly after birth, closely recapitulating the SMRTmRID phenotype. These results identify TR as a second nuclear receptor involved in lung development, specifically type I pneumocyte differentiation, and suggest a possible new type of therapeutic option in the treatment of RDS that is unresponsive to glucocorticoids.	[Pei, Liming; Atkins, Annette; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Pei, Liming; Leblanc, Mathias; Barish, Grant; Atkins, Annette; Nofsinger, Russell; Whyte, Jamie; Gold, David; He, Mingxiao; Kawamura, Kazuko; Downes, Michael; Yu, Ruth T.; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Li, Hai-Ri; Powell, Henry C.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Atkins, Annette/0000-0003-2558-7058; Yu, Ruth/0000-0002-9527-9627; Pei, Liming/0000-0002-1924-0333	Francis Family Foundation; Howard Hughes Medical Institute; US National Institutes of Health [2RO1DK057978, 2RO1HL105278, 5U19DK062434, RO1HL57281]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057281, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R37DK057978] Funding Source: NIH RePORTER	Francis Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Juguilon, M. Karunasiri, S. Kaufman and Y. Dayn for technical support, J. Stubbs, C. Kintner, L. Nagy, S.-H. Hong, J. Jonker and J. Fitzpatrick for helpful discussions, M. Montminy of Salk Institute for GFP adenovirus, J. Simon, L. Grabowski and J. Belcovson for artistic work, and E. Ong and S. Ganley for administrative assistance. We appreciate the help and expertise from M. Wood for the electron microscopy study. We thank J. Codey and the Leona M. and Harry B. Helmsley Charitable Trust for their generous support. L. P. is a Parker B. Francis Fellow supported by the Francis Family Foundation. R. M. E. is an investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. This work was supported by the Howard Hughes Medical Institute and US National Institutes of Health grants 2RO1DK057978, 2RO1HL105278, 5U19DK062434 (R. M. E.) and RO1HL57281 (J.B.L.).	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bizzarro MJ, 2004, OBSTET GYN CLIN N AM, V31, P949, DOI 10.1016/j.ogc.2004.08.001; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Dobbs LG, 2010, CELL PHYSIOL BIOCHEM, V25, P55, DOI 10.1159/000272063; Domyan ET, 2011, DEV DYNAM, V240, P477, DOI 10.1002/dvdy.22504; Evans R, 2004, NAT MED, V10, P1022, DOI 10.1038/nm1004-1022; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Fraichard A, 1997, EMBO J, V16, P4412, DOI 10.1093/emboj/16.14.4412; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; GROSS I, 1990, AM J PHYSIOL, V259, pL337, DOI 10.1152/ajplung.1990.259.6.L337; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; HETZEL BS, 1989, J NUTR, V119, P145, DOI 10.1093/jn/119.2.145; Ho N. K., 1993, Singapore Medical Journal, V34, P74; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jepsen K, 2002, J CELL SCI, V115, P689; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Merrill JD, 1998, CLIN PERINATOL, V25, P983, DOI 10.1016/S0095-5108(18)30093-9; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Purdy Isabell B, 2004, Neonatal Netw, V23, P15; Salto C, 2001, MOL ENDOCRINOL, V15, P2115, DOI 10.1210/me.15.12.2115; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P695, DOI 10.1513/pats.200801-011AW; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Yue BF, 2008, CLIN CHEM, V54, P642, DOI 10.1373/clinchem.2007.098293; Zhang YT, 2005, J AM SOC MASS SPECTR, V16, P1781, DOI 10.1016/j.jasms.2005.06.017; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	50	51	51	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2011	17	11					1466	U172		10.1038/nm.2450	http://dx.doi.org/10.1038/nm.2450			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22001906	Green Accepted			2022-12-27	WOS:000296779300038
J	Weis, SM; Cheresh, DA				Weis, Sara M.; Cheresh, David A.			Tumor angiogenesis: molecular pathways and therapeutic targets	NATURE MEDICINE			English	Review							ENDOTHELIAL GROWTH-FACTOR; VASCULOGENIC MIMICRY; IN-VIVO; INTEGRIN ALPHA(V)BETA(3); ENDOGENOUS INHIBITORS; CELL-ADHESION; STEM-CELLS; MICRORNA DELIVERY; PROGENITOR CELLS; BLOOD-VESSELS	As angiogenesis is essential for tumor growth and metastasis, controlling tumor-associated angiogenesis is a promising tactic in limiting cancer progression. The tumor microenvironment comprises numerous signaling molecules and pathways that influence the angiogenic response. Understanding how these components functionally interact as angiogenic stimuli or as repressors and how mechanisms of resistance arise is required for the identification of new therapeutic strategies. Achieving a durable and efficient antiangiogenic response will require approaches to simultaneously or sequentially target multiple aspects of the tumor microenvironment.	[Cheresh, David A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu			US National Institutes of Health [R37 CA50286, R01 CA95262, R01 CA45726, P01 HL57900, R01 HL103956]; NATIONAL CANCER INSTITUTE [R01CA045726, R01CA095262, R37CA050286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, R01HL103956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	D.A.C. is supported by grants from the US National Institutes of Health (grants R37 CA50286, R01 CA95262, R01 CA45726, P01 HL57900 and R01 HL103956).	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Alvero AB, 2009, STEM CELLS, V27, P2405, DOI 10.1002/stem.191; Anand S, 2011, CURR OPIN HEMATOL, V18, P171, DOI 10.1097/MOH.0b013e328345a180; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Battle MR, 2011, J NUCL MED, V52, P424, DOI 10.2967/jnumed.110.077479; Beer AJ, 2006, CLIN CANCER RES, V12, P3942, DOI 10.1158/1078-0432.CCR-06-0266; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bissell MJ, 1999, AM J PATHOL, V155, P675, DOI 10.1016/S0002-9440(10)65164-4; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Bussolati B, 2006, EXP CELL RES, V312, P913, DOI 10.1016/j.yexcr.2005.12.004; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Bussolati B, 2007, J MOL MED, V85, P897, DOI 10.1007/s00109-007-0184-3; Bussolati B, 2011, FASEB J, V25, P2874, DOI 10.1096/fj.10-180323; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Cao QZ, 2011, AMINO ACIDS, V41, P1103, DOI 10.1007/s00726-010-0548-9; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Christensen M, 2010, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.016.2009; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Daenen LG, 2009, MOL CANCER THER, V8, P2872, DOI 10.1158/1535-7163.MCT-09-0583; Dahlberg SE, 2010, J CLIN ONCOL, V28, P949, DOI 10.1200/JCO.2009.25.4482; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; De Palma M, 2008, CANCER CELL, V14, P299, DOI 10.1016/j.ccr.2008.09.004; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dumont RA, 2009, CANCER RES, V69, P3173, DOI 10.1158/0008-5472.CAN-08-3390; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fausto N, 2000, AM J PATHOL, V156, P359, DOI 10.1016/S0002-9440(10)64738-4; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 1991, Princess Takamatsu Symp, V22, P339; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Frenkel S, 2008, EYE, V22, P948, DOI 10.1038/sj.eye.6702783; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gladson CL, 1996, J NEUROPATH EXP NEUR, V55, P1143, DOI 10.1097/00005072-199611000-00005; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Hu H, 2009, MOL CELL PROTEOMICS, V8, P816, DOI 10.1074/mcp.M800331-MCP200; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kerbel Robert S, 2007, Cancer Res Treat, V39, P150, DOI 10.4143/crt.2007.39.4.150; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Lassoued W, 2010, CANCER BIOL THER, V10, P1326, DOI 10.4161/cbt.10.12.14009; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Loges S, 2009, CLIN CANCER RES, V15, P3648, DOI 10.1158/1078-0432.CCR-08-2276; Loi M, 2010, J CONTROL RELEASE, V145, P66, DOI 10.1016/j.jconrel.2010.03.015; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Maitland ML, 2009, CLIN CANCER RES, V15, P6250, DOI 10.1158/1078-0432.CCR-09-0058; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McCarty MF, 2007, J CLIN INVEST, V117, P2114, DOI 10.1172/JCI31334; McDonald DM, 2000, AM J PATHOL, V156, P383, DOI 10.1016/S0002-9440(10)64740-2; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Mueller J, 2009, MOL CANCER RES, V7, P1078, DOI 10.1158/1541-7786.MCR-08-0538; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Nagengast WB, 2011, EUR J CANCER, V47, P1595, DOI 10.1016/j.ejca.2011.02.009; Nagengast WB, 2011, CANCER RES, V71, P143, DOI 10.1158/0008-5472.CAN-10-1088; Nayak TK, 2011, INT J CANCER, V128, P920, DOI 10.1002/ijc.25409; Niu G, 2009, PET CLIN, V4, P17, DOI 10.1016/j.cpet.2009.04.011; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Osterlund P, 2011, BRIT J CANCER, V104, P599, DOI 10.1038/bjc.2011.2; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Park YH, 2009, BRIT J CANCER, V100, P894, DOI 10.1038/sj.bjc.6604941; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Reardon DA, 2011, FUTURE ONCOL, V7, P339, DOI [10.2217/fon.11.8, 10.2217/FON.11.8]; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rizzolio S, 2011, CURR MED CHEM, V18, P3563, DOI 10.2174/092986711796642544; Ruhrberg C, 2010, NAT MED, V16, P861, DOI 10.1038/nm0810-861; Ruoslahti E, 2004, BIOCHEM SOC T, V32, P397, DOI 10.1042/BST0320397; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Samanta S, 2010, BIOMATERIALS, V31, P1787, DOI 10.1016/j.biomaterials.2009.10.027; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Serini G, 2008, CARDIOVASC RES, V78, P213, DOI 10.1093/cvr/cvn045; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2007, CANCER RES, V67, P7055, DOI 10.1158/0008-5472.CAN-07-0905; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shen RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001652; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shubik P, 2000, AM J PATHOL, V156, P736, DOI 10.1016/S0002-9440(10)64778-5; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Somanath PR, 2009, CELL BIOCHEM BIOPHYS, V53, P53, DOI 10.1007/s12013-008-9040-5; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Xiong YQ, 2009, CLIN CANCER RES, V15, P4838, DOI 10.1158/1078-0432.CCR-08-2780; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yao XH, 2011, PROTEIN CELL, V2, P266, DOI 10.1007/s13238-011-1041-2; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	155	1230	1280	9	390	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2011	17	11					1359	1370		10.1038/nm.2537	http://dx.doi.org/10.1038/nm.2537			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	844VV	22064426				2022-12-27	WOS:000296779300027
J	Dorard, C; de Thonel, A; Collura, A; Marisa, L; Svrcek, M; Lagrange, A; Jego, G; Wanherdrick, K; Joly, AL; Buhard, O; Gobbo, J; Penard-Lacronique, V; Zouali, H; Tubacher, E; Kirzin, S; Selves, J; Milano, G; Etienne-Grimaldi, MC; Bengrine-Lefevre, L; Louvet, C; Tournigand, C; Lefevre, JH; Parc, Y; Tiret, E; Flejou, JF; Gaub, MP; Garrido, C; Duval, A				Dorard, Coralie; de Thonel, Aurelie; Collura, Ada; Marisa, Laetitia; Svrcek, Magali; Lagrange, Anais; Jego, Gaetan; Wanherdrick, Kristell; Joly, Anne Laure; Buhard, Olivier; Gobbo, Jessica; Penard-Lacronique, Virginie; Zouali, Habib; Tubacher, Emmanuel; Kirzin, Sylvain; Selves, Janick; Milano, Gerard; Etienne-Grimaldi, Marie-Christine; Bengrine-Lefevre, Leila; Louvet, Christophe; Tournigand, Christophe; Lefevre, Jeremie H.; Parc, Yann; Tiret, Emmanuel; Flejou, Jean-Francois; Gaub, Marie-Pierre; Garrido, Carmen; Duval, Alex			Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis	NATURE MEDICINE			English	Article							MICROSATELLITE INSTABILITY; MONONUCLEOTIDE REPEATS; INDUCED APOPTOSIS; MISMATCH REPAIR; TARGET GENES; MUTATIONS; HEAT-SHOCK-PROTEIN-105; MECHANISM; SEQUENCES; PATHWAY	Heat shock proteins (HSPs) are necessary for cancer cell survival. We identified a mutant of HSP110 (HSP110 Delta E9) in colorectal cancer showing microsatellite instability (MSI CRC), generated from an aberrantly spliced mRNA and lacking the HSP110 substrate-binding domain. This mutant was expressed at variable levels in almost all MSI CRC cell lines and primary tumors tested. HSP11 Delta DE9 impaired both the normal cellular localization of HSP110 and its interaction with other HSPs, thus abrogating the chaperone activity and antiapoptotic function of HSP110 in a dominant-negative manner. HSP110 Delta E9 overexpression caused the sensitization of cells to anticancer agents such as oxaliplatin and 5-fluorouracil, which are routinely prescribed in the adjuvant treatment of people with CRC. The survival and response to chemotherapy of subjects with MSI CRCs was associated with the tumor expression level of HSP110 Delta E9. HSP110 may thus constitute a major determinant for both prognosis and treatment response in CRC.	[Dorard, Coralie; Collura, Ada; Svrcek, Magali; Lagrange, Anais; Wanherdrick, Kristell; Buhard, Olivier; Flejou, Jean-Francois; Duval, Alex] INSERM, Ctr Rech St Antoine, Equipe Instabilite Microsatellites & Canc, Paris, France; [Dorard, Coralie; Collura, Ada; Svrcek, Magali; Lagrange, Anais; Wanherdrick, Kristell; Buhard, Olivier; Lefevre, Jeremie H.; Parc, Yann; Tiret, Emmanuel; Flejou, Jean-Francois; Duval, Alex] Univ Paris 06, Paris, France; [de Thonel, Aurelie; Jego, Gaetan; Joly, Anne Laure; Gobbo, Jessica; Garrido, Carmen] INSERM, Dijon, France; [de Thonel, Aurelie; Jego, Gaetan; Joly, Anne Laure; Gobbo, Jessica; Garrido, Carmen] Univ Burgundy, Dijon, France; [Marisa, Laetitia] Programme Cartes Identite Tumeurs, Paris, France; [Svrcek, Magali] Hop St Antoine, AP HP, Serv Anat & Cytol Pathol, F-75571 Paris, France; [Penard-Lacronique, Virginie] Inst Gustave Roussy, INSERM, F-94805 Villejuif, France; [Zouali, Habib; Tubacher, Emmanuel] Inst Genet Mol, Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, Paris, France; [Kirzin, Sylvain; Selves, Janick] Ctr Physiopathol Toulouse Purpan, INSERM, Toulouse, France; [Milano, Gerard; Etienne-Grimaldi, Marie-Christine] Ctr Antoine Lacassagne, Lab Oncopharmacol, F-06054 Nice, France; [Bengrine-Lefevre, Leila; Louvet, Christophe; Tournigand, Christophe] Hop St Antoine, AP HP, Med Oncol Serv, F-75571 Paris, France; [Lefevre, Jeremie H.; Parc, Yann; Tiret, Emmanuel] Hop St Antoine, AP HP, Serv Chirurg Gen & Digest, F-75571 Paris, France; [Flejou, Jean-Francois] Hop St Antoine, AP HP, Tumorotheque Canc Est, F-75571 Paris, France; [Gaub, Marie-Pierre] INSERM, Strasbourg, France; [Garrido, Carmen] Ctr Hosp Univ Dijon, Dijon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Foundation Jean Dausset-CEPH; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Antoine Lacassagne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Dijon Bourgogne	Duval, A (corresponding author), INSERM, Ctr Rech St Antoine, Equipe Instabilite Microsatellites & Canc, Paris, France.	cgarrido@u-bourgogne.fr; alex.duval@inserm.fr	Garrido, carmen/G-1633-2018; Coralie, Dorard/A-8325-2012; Selves, Janick/M-7719-2014; Tournigand, Christophe/Q-2831-2018; Penard-Lacronique, Virginie/R-1938-2019; Penard-Lacronique, Virginie/E-5729-2016; jego, gaetan/N-7226-2018; Lefevre, Jeremie/I-6952-2019; Garrido, Carolina/GWM-5557-2022	Garrido, carmen/0000-0003-1368-1493; Penard-Lacronique, Virginie/0000-0001-9435-7331; Penard-Lacronique, Virginie/0000-0001-9435-7331; jego, gaetan/0000-0003-0376-9299; Lefevre, Jeremie/0000-0001-7601-7464; Collura, Ada/0000-0003-0496-1768; Milano, Gerard/0000-0003-2478-0040; de Thonel, Aurelie/0000-0003-0405-0745	Ligue Nationale Contre le Cancer; Fondation de France [RAF08005DDA]; Institut National du Cancer (INCa); Conseil Regional de Bourgogne; European Commission [SPEDOC 248835]	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Carte d'Identite des Tumeurs (CIT) program (http://cit.ligue-cancer.net/) from the Ligue Nationale Contre le Cancer and by grants from the Fondation de France (Ref. RAF08005DDA to A. D.), the Institut National du Cancer (INCa) (to A.D. and C.G.), the Conseil Regional de Bourgogne (to C.G.) and the European Commission Seventh Framework Programme (SPEDOC 248835 to C.G.). C.G.'s group is known as 'La Ligue Contre le Cancer'. A.C. is a recipient of an INCa fellowship. We thank B. Iacopetta for critical reading of the manuscript. We thank E. Roux, A. Hamman, E. Fourmaux and E. Bergman for their technical assistance.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Ceballos E, 2005, ONCOGENE, V24, P4559, DOI 10.1038/sj.onc.1208652; Duval A, 2004, P NATL ACAD SCI USA, V101, P5002, DOI 10.1073/pnas.0400945101; Duval A, 2002, CANCER RES, V62, P2447; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Gotoh K, 2004, FEBS LETT, V560, P19, DOI 10.1016/S0014-5793(04)00034-1; Grady WM, 1998, CANCER RES, V58, P3101; Hosaka S, 2006, CANCER SCI, V97, P623, DOI 10.1111/j.1349-7006.2006.00217.x; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kai M, 2003, ONCOL REP, V10, P1777; Manjili MH, 2003, J IMMUNOL, V171, P4054, DOI 10.4049/jimmunol.171.8.4054; Manjili MH, 2002, CANCER RES, V62, P1737; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siatskas C, 2005, FASEB J, V19, P1752, DOI 10.1096/fj.05-4006fje; Slaby O, 2009, ONCOL REP, V21, P1235, DOI 10.3892/or_00000346; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Wang XY, 2003, CANCER RES, V63, P2553; Yamagishi N, 2008, FEBS J, V275, P4558, DOI 10.1111/j.1742-4658.2008.06598.x; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Zaanan A, 2010, ANN ONCOL, V21, P772, DOI 10.1093/annonc/mdp383	27	110	113	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1283	U316		10.1038/nm.2457	http://dx.doi.org/10.1038/nm.2457			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21946539				2022-12-27	WOS:000296022100047
J	Chang, EI; Galvez, MG; Glotzbach, JP; Hamou, CD; El-ftesi, S; Rappleye, CT; Sommer, KM; Rajadas, J; Abilez, OJ; Fuller, GG; Longaker, MT; Gurtner, GC				Chang, Edward I.; Galvez, Michael G.; Glotzbach, Jason P.; Hamou, Cynthia D.; El-ftesi, Samyra; Rappleye, C. Travis; Sommer, Kristin-Maria; Rajadas, Jayakumar; Abilez, Oscar J.; Fuller, Gerald G.; Longaker, Michael T.; Gurtner, Geoffrey C.			Vascular anastomosis using controlled phase transitions in poloxamer gels	NATURE MEDICINE			English	Article							MICROVASCULAR ANASTOMOSIS; PURIFIED POLOXAMER-188; DISEASE CONFERENCE; WRITING GROUP; FORMULATIONS; LIDOCAINE; SURGERY; DEVICE; MODEL; CARE	Vascular anastomosis is the cornerstone of vascular, cardiovascular and transplant surgery. Most anastomoses are performed with sutures, which are technically challenging and can lead to failure from intimal hyperplasia and foreign body reaction. Numerous alternatives to sutures have been proposed, but none has proven superior, particularly in small or atherosclerotic vessels. We have developed a new method of sutureless and atraumatic vascular anastomosis that uses US Food and Drug Administration (FDA)-approved thermoreversible tri-block polymers to temporarily maintain an open lumen for precise approximation with commercially available glues. We performed end-to-end anastomoses five times more rapidly than we performed hand-sewn controls, and vessels that were too small (<1.0 mm) to sew were successfully reconstructed with this sutureless approach. Imaging of reconstructed rat aorta confirmed equivalent patency, flow and burst strength, and histological analysis demonstrated decreased inflammation and fibrosis at up to 2 years after the procedure. This new technology has potential for improving efficiency and outcomes in the surgical treatment of cardiovascular disease.	[Chang, Edward I.; Galvez, Michael G.; Glotzbach, Jason P.; Hamou, Cynthia D.; El-ftesi, Samyra; Rappleye, C. Travis; Abilez, Oscar J.; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Sommer, Kristin-Maria; Rajadas, Jayakumar; Fuller, Gerald G.] Stanford Univ, Sch Engn, Dept Chem Engn, Stanford, CA 94305 USA; [Abilez, Oscar J.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Gurtner, GC (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.	ggurtner@stanford.edu	Glotzbach, Jason P./O-4394-2019; Abilez, Oscar J./B-5014-2012; Rajadas, Jayakumar/AHC-0630-2022	Glotzbach, Jason P./0000-0002-8002-9422; Abilez, Oscar J./0000-0002-9991-400X; Rajadas, Jayakumar/0000-0001-6520-3923; Fuller, Gerald/0000-0002-2924-053X	Stanford Bio-X Interdisciplinary Initiatives	Stanford Bio-X Interdisciplinary Initiatives	We thank C. Zarins for providing use of his laboratory burst strength apparatus. We also thank T. Doyle for assistance in small-animal imaging (Stanford Center for Innovation in In-Vivo Imaging) and Y. Park for expert technical assistance. This work was supported by a Stanford Bio-X Interdisciplinary Initiatives Research Award (to G.G.F. and G.C.G.).	AMELI FM, 1987, J CARDIOVASC SURG, V28, P695; Apostolakis EE, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-66; Beris AE, 2010, ARCH ORTHOP TRAUM SU, V130, P1141, DOI 10.1007/s00402-009-1021-7; Bettmann MA, 2004, CIRCULATION, V109, P2643, DOI 10.1161/01.CIR.0000128526.35982.9A; Buijsrogge MP, 2002, ANN THORAC SURG, V73, P1451, DOI 10.1016/S0003-4975(02)03423-9; Carnero-Alcazar Manuel, 2009, Interact Cardiovasc Thorac Surg, V8, P619, DOI 10.1510/icvts.2008.200535; Charlson ME, 2003, NEW ENGL J MED, V348, P1456, DOI 10.1056/NEJMcp010691; Cho AB, 2009, MICROSURG, V29, P24, DOI 10.1002/micr.20554; Claude O, 2007, J RECONSTR MICROSURG, V23, P87, DOI 10.1055/s-2007-970188; Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Erdmann D, 2004, J VASC SURG, V40, P505, DOI 10.1016/j.jvs.2004.05.026; Escobar-Chavez JJ, 2006, J PHARM PHARM SCI, V9, P339; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; FRENCH BN, 1977, STROKE, V8, P597, DOI 10.1161/01.STR.8.5.597; Grassi G, 2006, J CONTROL RELEASE, V116, pE85, DOI 10.1016/j.jconrel.2006.09.063; Grindel JM, 2002, J PHARM SCI-US, V91, P1936, DOI 10.1002/jps.10190; HABAL SM, 1977, SURGERY, V81, P596; HUME SP, 1983, RADIAT RES, V94, P252, DOI 10.2307/3575961; Johnston TP, 1999, J CARDIOVASC PHARM, V34, P831, DOI 10.1097/00005344-199912000-00010; Kachhy RG, 2006, CIRCULATION, V114, pI425, DOI 10.1161/CIRCULATIONAHA.105.000695; Kohli E, 2007, J CONTROL RELEASE, V121, P19, DOI 10.1016/j.jconrel.2007.04.007; Liu LQ, 2006, ANN THORAC SURG, V82, P303, DOI 10.1016/j.athoracsur.2006.01.099; MOSELEY J, 1980, JAMA-J AM MED ASSOC, V244, P1119, DOI 10.1001/jama.244.10.1119; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Murray JE, 2005, J AM COLL SURGEONS, V200, P5, DOI 10.1016/j.jamcollsurg.2004.09.033; Nabeyama A, 2010, P NATL ACAD SCI USA, V107, P6436, DOI 10.1073/pnas.0912827107; Ojha M, 2000, ANN THORAC SURG, V70, P1338, DOI 10.1016/S0003-4975(00)01975-5; Ong YS, 2004, MICROSURG, V24, P304, DOI 10.1002/micr.20027; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; Ricci EJ, 2005, INT J PHARMACEUT, V288, P235, DOI 10.1016/j.ijpharm.2004.09.028; Ricci EJ, 2002, EUR J PHARM SCI, V17, P161, DOI 10.1016/S0928-0987(02)00166-5; Roques C, 2007, INT J PHARMACEUT, V331, P220, DOI 10.1016/j.ijpharm.2006.11.056; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023; Wiklund L, 2005, J THORAC CARDIOV SUR, V129, P146, DOI 10.1016/j.jtcvs.2004.02.027; Xiong XY, 2006, J NANOSCI NANOTECHNO, V6, P2638, DOI 10.1166/jnn.2006.449; Zubilewicz T, 2001, MED SCI MONITOR, V7, P316	39	71	79	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1147	U160		10.1038/nm.2424	http://dx.doi.org/10.1038/nm.2424			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21873986				2022-12-27	WOS:000294605100038
J	Geller, GB				Geller, George Barth			Lung stem cells: looking beyond the hype	NATURE MEDICINE			English	Editorial Material							OCT4 EXPRESSION	The human lung is known to contain regional pools of progenitor cells that can give rise to specific lung structures, but a multipotent stem cell that can give rise to both endodermal and mesodermal lineages has not been described before and was thought to not exist. Jan Kajstura et al.(1) now provide evidence that might overturn this long-held belief. The investigators identified a set of potential stem cells in human lungs that were self renewing, clonogenic and multipotent in vitro and that could regenerate many different lung components-including bronchioles, alveoli, smooth muscle and pulmonary vessels-when injected into a mouse model of lung injury. We asked three experts to discuss the relevance of these findings to understanding of lung development and the implications for regenerative medicine to treat lung disease.	[Geller, George Barth] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Geller, George Barth] Duke Univ, Med Ctr, Dept Pediat, Durham, NC USA; [Geller, George Barth] Duke Univ, Med Ctr, Dept Stem Cell, Durham, NC USA; [Geller, George Barth] Duke Univ, Med Ctr, Regenerat Med Program, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Geller, GB (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.							Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Krause Diane S, 2008, Proc Am Thorac Soc, V5, P323, DOI 10.1513/pats.200712-169DR; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sueblinvong V, 2009, CURR OPIN PHARMACOL, V9, P268, DOI 10.1016/j.coph.2009.03.002	8	24	24	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					788	+						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738157				2022-12-27	WOS:000292500800027
J	Clevers, H				Clevers, Hans			The cancer stem cell: premises, promises and challenges	NATURE MEDICINE			English	Review							ACUTE MYELOID-LEUKEMIA; TUMOR-INITIATING CELLS; BREAST-CANCER; LYMPHOBLASTIC-LEUKEMIA; PANCREATIC-CANCER; MELANOMA-CELLS; MOUSE MODEL; GENOMIC INSTABILITY; CLONAL EVOLUTION; SCID MICE	Over the last decade, the notion that tumors are maintained by their own stem cells, the so-called cancer stem cells, has created great excitement in the research community. This review attempts to summarize the underlying concepts of this notion, to distinguish hard facts from beliefs and to define the future challenges of the field.	[Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	h.clevers@hubrecht.eu						Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BELANGER LF, 1946, ENDOCRINOLOGY, V39, P8, DOI 10.1210/endo-39-1-8; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Charames GS, 2003, CURR MOL MED, V3, P589, DOI 10.2174/1566524033479456; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; CLARKSON B, 1970, CANCER, V25, P1237, DOI 10.1002/1097-0142(197006)25:6<1237::AID-CNCR2820250602>3.0.CO;2-7; CLARKSON B D, 1974, P945; CLARKSON BD, 1971, MED CLIN N AM, V55, P561, DOI 10.1016/S0025-7125(16)32504-4; CLARKSON BD, 1975, CANCER, V36, P775, DOI 10.1002/1097-0142(197508)36:2+<775::AID-CNCR2820360824>3.0.CO;2-V; CLARKSON BD, 1969, NATL CANCER I MONOGR, P81; CLERMONT Y, 1953, AM J ANAT, V93, P475, DOI 10.1002/aja.1000930308; Cronkite E P, 1970, Proc Natl Cancer Conf, V6, P113; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ebben JD, 2010, EXPERT OPIN THER TAR, V14, P621, DOI 10.1517/14712598.2010.485186; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Furth J., 1937, AM J CANCER, V31, P276, DOI DOI 10.1158/AJC.1937.276; Goldman JM, 2009, LEUKEMIA, V23, P1708, DOI 10.1038/leu.2009.142; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HEWITT HB, 1958, BRIT J CANCER, V12, P378, DOI 10.1038/bjc.1958.47; ILL CR, 1988, IN VITRO CELL DEV B, V24, P413, DOI 10.1007/BF02628492; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy JA, 2007, SCIENCE, V318, DOI 10.1126/science.1149590; KILLMANN SA, 1963, LAB INVEST, V12, P671; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Kristensen V, 2010, EMBO MOL MED, V2, P143, DOI 10.1002/emmm.201000071; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; MAKINO S, 1956, ANN NY ACAD SCI, V63, P818, DOI 10.1111/j.1749-6632.1956.tb50894.x; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; PIERCE GB, 1988, CANCER RES, V48, P1996; PIERCE GB, 1971, CANCER RES, V31, P127; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; SIKIC BI, 2008, MOL BASIS CANC, P583; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; UCKUN FM, 1995, BLOOD, V85, P873, DOI 10.1182/blood.V85.4.873.bloodjournal854873; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	82	1356	1434	2	368	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					313	319		10.1038/nm.2304	http://dx.doi.org/10.1038/nm.2304			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21386835				2022-12-27	WOS:000288070000042
J	Liu, J; Gao, BB; Clermont, AC; Blair, P; Chilcote, TJ; Sinha, S; Flaumenhaft, R; Feener, EP				Liu, Jia; Gao, Ben-Bo; Clermont, Allen C.; Blair, Price; Chilcote, Tamie J.; Sinha, Sukanto; Flaumenhaft, Robert; Feener, Edward P.			Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein	NATURE MEDICINE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; RECEPTOR GLYCOPROTEIN-VI; ACUTE STROKE; ADMISSION HYPERGLYCEMIA; VASCULAR-PERMEABILITY; PLATELET-COLLAGEN; ISCHEMIC-STROKE; MANAGEMENT; MORTALITY; GLUCOSE	Hyperglycemia is associated with greater hematoma expansion and poor clinical outcomes after intracerebral hemorrhage. We show that cerebral hematoma expansion triggered by intracerebral infusion of autologous blood is greater in diabetic rats and mice compared to nondiabetic controls and that this augmented expansion is ameliorated by plasma kallikrein (PK) inhibition or deficiency. Intracerebral injection of purified PK augmented hematoma expansion in both diabetic and acutely hyperglycemic rats, whereas injection of bradykinin, plasmin or tissue plasminogen activator did not elicit such a response. This response, which occurs rapidly, was prevented by co-injection of the glycoprotein VI agonist convulxin and was mimicked by glycoprotein VI inhibition or deficiency, implicating an effect of PK on inhibiting platelet aggregation. We show that PK inhibits collagen-induced platelet aggregation by binding collagen, a response enhanced by elevated glucose concentrations. The effect of hyperglycemia on hematoma expansion and PK-mediated inhibition of platelet aggregation could be mimicked by infusing mannitol. These findings suggest that hyperglycemia auguments cerebral hematoma expansion by PK-mediated osmotic-sensitive inhibition of hemostasis.	[Liu, Jia; Gao, Ben-Bo; Clermont, Allen C.; Feener, Edward P.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Liu, Jia; Gao, Ben-Bo; Clermont, Allen C.; Feener, Edward P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Blair, Price; Flaumenhaft, Robert] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Chilcote, Tamie J.; Sinha, Sukanto] ActiveSite Pharmaceut Inc, Berkeley, CA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Feener, EP (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	edward.feener@joslin.harvard.edu			US National Institutes of Health [EY19029, DK36836, HL090132, HL87203, HL07917]; American Heart Association [0855905D, 0840043N]; NATIONAL EYE INSTITUTE [R01EY019029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL090132, T32HL007917, P01HL087203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the US National Institutes of Health (grants EY19029, DK36836, HL090132, HL87203 and HL07917) and the American Heart Association (0855905D and 0840043N).	Acar K, 2006, THROMB RES, V118, P765, DOI 10.1016/j.thromres.2005.12.003; Arboix A, 2000, DIABETES CARE, V23, P1527, DOI 10.2337/diacare.23.10.1527; Arthur JF, 2007, BRIT J HAEMATOL, V139, P363, DOI 10.1111/j.1365-2141.2007.06799.x; Asmis LM, 2002, THROMB RES, V105, P463, DOI 10.1016/S0049-3848(02)00045-2; Bhalla A, 2000, STROKE, V31, P2043, DOI 10.1161/01.STR.31.9.2043; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; GALLIMORE MJ, 1978, THROMB RES, V12, P409, DOI 10.1016/0049-3848(78)90312-2; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; Godoy DA, 2009, NEUROCRIT CARE, V10, P150, DOI 10.1007/s12028-008-9098-3; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Kazui S, 1997, STROKE, V28, P2370, DOI 10.1161/01.STR.28.12.2370; Kehrel B, 1998, BLOOD, V91, P491; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Lee SH, 2010, DIABETOLOGIA, V53, P429, DOI 10.1007/s00125-009-1617-z; Lippi G, 2009, CLIN BIOCHEM, V42, P118, DOI 10.1016/j.clinbiochem.2008.10.012; McCormick MT, 2008, STROKE, V39, P2177, DOI 10.1161/STROKEAHA.107.496646; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Passero S, 2003, NEUROLOGY, V61, P1351, DOI 10.1212/01.WNL.0000094326.30791.2D; Phipps JA, 2009, HYPERTENSION, V53, P175, DOI 10.1161/HYPERTENSIONAHA.108.117663; Poppe AY, 2009, DIABETES CARE, V32, P617, DOI 10.2337/dc08-1754; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Stead LG, 2010, NEUROCRIT CARE, V13, P67, DOI 10.1007/s12028-010-9355-0; Stultz CM, 2003, BIOPHYS J, V85, P2198, DOI 10.1016/S0006-3495(03)74645-1; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Walkowiak B, 1997, THROMB RES, V87, P95, DOI 10.1016/S0049-3848(97)00108-4	40	83	93	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					206	U99		10.1038/nm.2295	http://dx.doi.org/10.1038/nm.2295			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21258336	Green Accepted			2022-12-27	WOS:000286969900029
J	Lee, H; Deng, JH; Kujawski, M; Yang, CM; Liu, Y; Herrmann, A; Kortylewski, M; Horne, D; Somlo, G; Forman, S; Jove, R; Yu, H				Lee, Heehyoung; Deng, Jiehui; Kujawski, Maciej; Yang, Chunmei; Liu, Yong; Herrmann, Andreas; Kortylewski, Marcin; Horne, David; Somlo, George; Forman, Stephen; Jove, Richard; Yu, Hua			STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors	NATURE MEDICINE			English	Article							LYMPHOCYTE EGRESS; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTOR; IMMUNE CELLS; CANCER; ANGIOGENESIS; RECEPTORS; SURVIVAL; SPHINGOSINE-1-PHOSPHATE; PHOSPHATE	Interleukin-6 (IL-6)-Janus kinase (JAK) signaling is viewed as crucial for persistent signal transducer and activator of transcription-3 (STAT3) activation in cancer. However, IL-6-induced STAT3 activation is normally transient. Here we identify a key mechanism for persistent STAT3 activation in tumor cells and the tumor microenvironment. We show that expression of sphingosine-1-phosphate receptor-1 (S1PR1), a G protein-coupled receptor for the lysophospholipid sphingosine-1-phosphate (S1P), is elevated in STAT3-positive tumors. STAT3 is a transcription factor for the S1pr1 gene. Reciprocally, enhanced S1pr1 expression activates STAT3 and upregulates II6 gene expression, thereby accelerating tumor growth and metastasis in a STAT3-dependent manner. Silencing S1pr1 in tumor cells or immune cells inhibits tumor STAT3 activity, tumor growth and metastasis. S1P-S1PR1-induced STAT3 activation is persistent, in contrast to transient STAT3 activation by IL-6. S1PR1 activates STAT3 in part by upregulating JAK2 tyrosine kinase activity. We show that STAT3-induced S1PR1 expression, as well as the S1P-S1PR1 pathway reciprocal regulation of STAT3 activity, is a major positive feedback loop for persistent STAT3 activation in cancer cells and the tumor microenvironment and for malignant progression. (C) 2010 Nature America, Inc. All rights reserved.	[Lee, Heehyoung; Deng, Jiehui; Kujawski, Maciej; Yang, Chunmei; Liu, Yong; Herrmann, Andreas; Kortylewski, Marcin; Yu, Hua] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; [Lee, Heehyoung; Deng, Jiehui; Kujawski, Maciej; Yang, Chunmei; Liu, Yong; Herrmann, Andreas; Kortylewski, Marcin; Horne, David; Somlo, George; Forman, Stephen; Jove, Richard; Yu, Hua] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Horne, David; Jove, Richard] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Somlo, George] City Hope Natl Med Ctr, Beckman Res Inst, Dept Med Oncol, Duarte, CA 91010 USA; [Forman, Stephen] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematopoiet Cell Transplantat, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Yu, H (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA.	Hyu@coh.org	Kortylewski, Marcin/H-8052-2019; Liu, Yong/A-2031-2013	Kortylewski, Marcin/0000-0002-6003-1816; Deng, Jiehui/0000-0001-7986-8643; YU, Hua/0000-0003-0931-1000	US National Institutes of Health [R01CA115815, R01CA115674, R01CA122976, P50CA107399]; National Cancer Institute [CA 33572]; American Bioscience; NATIONAL CANCER INSTITUTE [R01CA115674, P50CA107399, R01CA140692, R01CA115815, R01CA122976, P30CA033572] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Bioscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the flow cytometry core, light microscopy core, pathology core and translational research core, as well as the animal facility, of the Beckman Research Institute at City of Hope for their superb technical assistance. We would also like to thank P. Chu for evaluating histology of breast cancer tissue sections, R. L. Proia at US National Institutes of Health for generously providing the S1pr1<SUP>flox/flox</SUP> mice, V. Poli (University of Turin) for Stat3<SUP>-/-</SUP> MEF cells, T. Ratliff (University of Iowa) for MB49 mouse bladder transitional cell carcinoma cell line, A. Raubitschek (City of Hope Medical Center) for Jurkat human T cell leukemia and Karpas 299 human T cell lymphoma cell lines and S. Priceman for critical reading of this manuscript. This work is funded by US National Institutes of Health grants R01CA115815, R01CA115674, R01CA122976 and P50CA107399. Procurement of clinical specimens used in the study was supported by grants from the National Cancer Institute CA 33572 and American Bioscience.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Halak BK, 1999, CANCER RES, V59, P911; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sabbadini RA, 2006, BRIT J CANCER, V95, P1131, DOI 10.1038/sj.bjc.6603400; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	41	295	310	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1421	U105		10.1038/nm.2250	http://dx.doi.org/10.1038/nm.2250			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102457	Green Accepted			2022-12-27	WOS:000285048900036
J	Nabel, GJ; Fauci, AS				Nabel, Gary J.; Fauci, Anthony S.			Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine	NATURE MEDICINE			English	Article							A VIRUS; MICE; NEUTRALIZATION; HEMAGGLUTININ; ANTIBODIES; INFECTION	The immune system normally responds to influenza virus by making neutralizing antibodies to regions of the viral spike, the hemagglutinin, that vary year to year. This natural response protects against circulating subtypes but necessitates production of new vaccines annually. Newer vaccine approaches have succeeded in eliciting broadly neutralizing antibodies to highly conserved yet vulnerable regions of the hemagglutinin and suggest potential pathways for the development of universal influenza vaccines. (C) 2010 Nature America, Inc. All rights reserved.	[Nabel, Gary J.; Fauci, Anthony S.] NIAID, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Nabel, Gary J.] US Natl Inst Hlth, Vaccine Res Ctr, Inst Allergy & Infect Dis, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 1997, J IMMUNOL, V158, P1222; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; MBAWUIKE IN, 1990, J VIROL, V64, P1370, DOI 10.1128/JVI.64.3.1370-1374.1990; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517	19	125	145	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1389	1391		10.1038/nm1210-1389	http://dx.doi.org/10.1038/nm1210-1389			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135852				2022-12-27	WOS:000285048900030
J	Finkbeiner, S				Finkbeiner, Steven			Bridging the Valley of Death of therapeutics for neurodegeneration	NATURE MEDICINE			English	Article							NEUROIMAGING INITIATIVE PROGRESS; DRUG DEVELOPMENT	Neurodegenerative diseases are the sixth leading cause of death in the US. The market for disease-modifying drugs is enormous, but no drug exists. Academic scientists are increasingly pursuing the discovery and development of therapeutics. Their progress could potentially reduce the risk of failure sufficiently to warrant greater industry investment and movement of leads into clinical trials. Here we consider the many obstacles to the development of therapeutics for neurodegenerative disease within academia, with a special focus on organizational issues.	[Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, Consortium Fronto Temporal Dementia Res, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, Consortium Fronto Temporal Dementia Res, San Francisco, CA 94143 USA.	sfinkbeiner@gladstone.ucsf.edu			Taube-Koret Center for Huntington's Disease Research; NIH - National Institute of Neurological Disorders and Stroke [2R01 NS039074, 2R01 NS045091]; NIH - National Institute on Aging [2P01 AG022074]; J. David Gladstone Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045091, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Taube-Koret Center for Huntington's Disease Research; NIH - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH - National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); J. David Gladstone Institute(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Taube-Koret Center for Huntington's Disease Research, by NIH - National Institute of Neurological Disorders and Stroke grants 2R01 NS039074 and 2R01 NS045091 and NIH - National Institute on Aging grant 2P01 AG022074, and by The J. David Gladstone Institutes. I thank S. Williams, S. Freedman, M. Sutherland, F. Dorey, M. Lopez, L. Bruijn, R. Blumenstein, R. Pacifici, N. Wexler, C. Johnson, C. Austin, L. Vetter, A. Grove, P. Lansbury, T. Reisine, G. Naeve and members of the Finkbeiner laboratory for helpful discussions and/or comments on an early version of this manuscript. I thank G. Howard and S. Ordway for editorial assistance, and K. Nelson for administrative assistance.	Acemoglu D, 2004, Q J ECON, V119, P1049, DOI 10.1162/0033553041502144; Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; BENEDETTI F, 2010, NEUROPSYCHOPHAR 0630, DOI DOI 10.1038/NPP.2010.81; Boettiger S, 2006, NAT BIOTECHNOL, V24, P320, DOI 10.1038/nbt0306-320; BYNUM J, 2009, 1 ALZH ASS; *CDCP, 2007, STAT HLTH AG AM; COCKBURN IM, 2000, NBER INNOVATION POLI, V1, P20; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duggan M, 2005, J HEALTH ECON, V24, P1, DOI 10.1016/j.jhealeco.2004.08.001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fraser J., 2009, TOMORROWS TECHNOLOGY, V1, P9; Friedman J, 2003, J TECHNOL TRANSFER, V28, P17, DOI [DOI 10.1023/A:1021674618658, 10.1023/A:1021674618658]; HANSON S, 2009, VENT PHIL STRAT SUPP; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Lach S, 2004, J EUR ECON ASSOC, V2, P252, DOI 10.1162/154247604323067961; Lanjouw JO, 2001, WORLD DEV, V29, P265, DOI 10.1016/S0305-750X(00)00099-1; Link A. N., 2005, EUR J FINANC, V11, P169, DOI [10.1080/1351847042000254211, DOI 10.1080/1351847042000254211]; Lockett A, 2005, RES POLICY, V34, P1043, DOI 10.1016/j.respol.2005.05.006; Markman G., 2004, J TECHNOLOGY TRANSFE, V29, P353, DOI DOI 10.1023/B:JOTT.0000034127.01889.86; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; National Institutes of Health, NIH BLUEPR NEUR RES; Reinhardt UE, 2001, HEALTH AFFAIR, V20, P136, DOI 10.1377/hlthaff.20.5.136; SPIEGEL A, 2010, NATL PUBLIC RADIO; THURSBY J, 2000, AUTM J, V12, P9; THURSBY JG, 2001, J TECHNOLOGY TRANSFE, V26, P59, DOI DOI 10.1023/A:1007884111883; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Young T. A., 2005, INT J INTELLECT PROP, V1, P13; 2010, ECONOMIST       0617, V395, P81	31	35	35	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1227	1232		10.1038/nm.2222	http://dx.doi.org/10.1038/nm.2222			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052079				2022-12-27	WOS:000283860100031
J	Ray, NB; Durairaj, L; Chen, BB; McVerry, BJ; Ryan, AJ; Donahoe, M; Waltenbaugh, AK; O'Donnell, CP; Henderson, FC; Etscheidt, CA; Mccoy, DM; Agassandian, M; Hayes-Rowan, EC; Coon, TA; Butler, PL; Gakhar, L; Mathur, SN; Sieren, JC; Tyurina, YY; Kagan, VE; McLennan, G; Mallampalli, RK				Ray, Nancy B.; Durairaj, Lakshmi; Chen, Bill B.; McVerry, Bryan J.; Ryan, Alan J.; Donahoe, Michael; Waltenbaugh, Alisa K.; O'Donnell, Christopher P.; Henderson, Florita C.; Etscheidt, Christopher A.; Mccoy, Diann M.; Agassandian, Marianna; Hayes-Rowan, Emily C.; Coon, Tiffany A.; Butler, Phillip L.; Gakhar, Lokesh; Mathur, Satya N.; Sieren, Jessica C.; Tyurina, Yulia Y.; Kagan, Valerian E.; McLennan, Geoffrey; Mallampalli, Rama K.			Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia	NATURE MEDICINE			English	Article							PULMONARY-EDEMA; PROTEIN; SURFACE; GENE; PHOSPHOLIPIDS; EXPRESSION; RESPONSES; MEMBRANE; DISEASE; ENZYME	Pneumonia remains the leading cause of death from infection in the US, yet fundamentally new conceptual models underlying its pathogenesis have not emerged. We show that humans and mice with bacterial pneumonia have markedly elevated amounts of cardiolipin, a rare, mitochondrial-specific phospholipid, in lung fluid and find that it potently disrupts surfactant function. Intratracheal cardiolipin administration in mice recapitulates the clinical phenotype of pneumonia, including impaired lung mechanics, modulation of cell survival and cytokine networks and lung consolidation. We have identified and characterized the activity of a unique cardiolipin transporter, the P-type ATPase transmembrane lipid pump Atp8b1, a mutant version of which is associated with severe pneumonia in humans and mice. Atp8b1 bound and internalized cardiolipin from extracellular fluid via a basic residue-enriched motif. Administration of a peptide encompassing the cardiolipin binding motif or Atp8b1 gene transfer in mice lessened bacteria-induced lung injury and improved survival. The results unveil a new paradigm whereby Atp8b1 is a cardiolipin importer whose capacity to remove cardiolipin from lung fluid is exceeded during inflammation or when Atp8b1 is defective. This discovery opens the door for new therapeutic strategies directed at modulating the abundance or molecular interactions of cardiolipin in pneumonia.	[Chen, Bill B.; McVerry, Bryan J.; Donahoe, Michael; Waltenbaugh, Alisa K.; O'Donnell, Christopher P.; Hayes-Rowan, Emily C.; Coon, Tiffany A.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Internal Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15260 USA; [Ray, Nancy B.; Durairaj, Lakshmi; Ryan, Alan J.; Henderson, Florita C.; Etscheidt, Christopher A.; Mccoy, Diann M.; Agassandian, Marianna; Mathur, Satya N.; Sieren, Jessica C.; McLennan, Geoffrey] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Butler, Phillip L.; Gakhar, Lokesh] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Tyurina, Yulia Y.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Radl & Antioxidant Hlth, Pittsburgh, PA USA; [McLennan, Geoffrey] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [McLennan, Geoffrey] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Dept Internal Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15260 USA.	mallampallirk@upmc.edu	McVerry, Bryan/AAS-7790-2021; Gakhar, Lokesh/P-8356-2019; Gakhar, Lokesh/F-2113-2010	McVerry, Bryan/0000-0002-1175-4874; Gakhar, Lokesh/0000-0002-3319-1902; Gakhar, Lokesh/0000-0002-3319-1902; O'Donnell, Christopher/0000-0002-9120-6850; Tyurina, Yulia/0000-0003-0287-2091; Durairaj, Lakshmi/0000-0002-8072-3430; Sieren, Jessica/0000-0002-1109-7886; Kagan, Valerian E./0000-0002-7245-1885	US Department of Veterans Affairs; US National Institutes of Health [R01 HL068135, HL080229, HL081784, HL096376, HL097376, HL098174, HL70755, HL094488, NIOSH OH008282, K23 HL075402, U01 HL102288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344, R01HL094488, U01HL102288, R01HL080229, K08HL083101, R01HL081784, R01HL098174, R01HL070755, R01HL097376, R01HL068135, R01HL096376, K23HL075402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	We thank M. E. Anderson, M.J. Welsh, J. Zabner and M. Gladwin for critical review of the manuscript and helpful suggestions. The Atp8b1<SUP>G308V/G308V</SUP> 129S1/SvlmJ mutant mice14 were a generous gift from L. Bull (University of California-San Francisco). Nontypable H. influenza strain 12 bacteria were kindly provided by D. Look (University of Iowa) 29. Antibodies to ATP8b1 were generous gifts from D. Ortiz (Tufts University) 30 and M. Ananthanarayanan (Mount Sinai School of Medicine) 31. This material is based upon work supported, in part, by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was supported by a Merit Review Award from the US Department of Veterans Affairs and US National Institutes of Health R01 grants HL068135, HL080229, HL081784, HL096376, HL097376 and HL098174 (to R. K. M.), HL70755, HL094488 and NIOSH OH008282 (to V. E. K.) and K23 HL075402 and U01 HL102288 (to L. D.). The contents do not represent the views of the Department of Veterans Affairs or the US government.	ALBERT RK, 1979, J CLIN INVEST, V63, P1015, DOI 10.1172/JCI109369; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frankenberg T, 2008, HEPATOLOGY, V48, P1896, DOI 10.1002/hep.22431; Frick AG, 2000, J IMMUNOL, V164, P4185, DOI 10.4049/jimmunol.164.8.4185; Grossmann G, 1999, J APPL PHYSIOL, V86, P633, DOI 10.1152/jappl.1999.86.2.633; HUGHES DA, 1989, CHEST, V95, P82, DOI 10.1378/chest.95.1.82; Jirsa M, 2004, HEPATOL RES, V30, P1, DOI 10.1016/j.hepres.2004.05.001; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaewsuya P, 2007, ANAL BIOANAL CHEM, V387, P2775, DOI 10.1007/s00216-007-1135-0; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KENNEDY JI, 1990, J THORAC CARDIOV SUR, V100, P145; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Ksenzenko SM, 1997, J APPL PHYSIOL, V82, P2020, DOI 10.1152/jappl.1997.82.6.2020; LIAU DF, 1984, J LIPID RES, V25, P678; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MCCORMACK FX, 1991, AM REV RESPIR DIS, V144, P160, DOI 10.1164/ajrccm/144.1.160; McCoy DM, 2006, AM J RESP CELL MOL, V35, P394, DOI 10.1165/rcmb.2005-0401OC; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; Pawlikowska L, 2010, J HEPATOL, V53, P170, DOI 10.1016/j.jhep.2010.01.034; Ritov VB, 2006, J CHROMATOGR B, V831, P63, DOI 10.1016/j.jchromb.2005.11.031; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; SUTRINA SL, 1976, J GEN MICROBIOL, V92, P410, DOI 10.1099/00221287-92-2-410; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; Wang ZD, 1998, AM J RESP CRIT CARE, V158, P28, DOI 10.1164/ajrccm.158.1.9709041; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746; 2008, AHRQ NEWS NUMBE 0702	38	106	110	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1120	U1		10.1038/nm.2213	http://dx.doi.org/10.1038/nm.2213			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20852622	Green Accepted			2022-12-27	WOS:000282644800042
J	Chen, J; Smith, LEH				Chen, Jing; Smith, Lois E. H.			Protective inflammasome activation in AMD	NATURE MEDICINE			English	Editorial Material							MACULAR DEGENERATION	Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly. AMD progression is associated with alterations in inflammatory pathways and the immune system. A new study identifies a protective role for inflammasomes in AMD, suggesting that inflammasome activation might be manipulated as a potential therapeutic strategy for this condition (pages 791-798).	[Chen, Jing; Smith, Lois E. H.] Harvard Univ, Sch Med, Dept Ophthalmol, Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Childrens Hosp Boston, Boston, MA 02115 USA.	lois.smith@childrens.harvard.edu			NATIONAL EYE INSTITUTE [R01EY017017, R01EY022275] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 EY999999] Funding Source: Medline; NEI NIH HHS [R01 EY017017, R01 EY022275] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje	12	7	9	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					658	660		10.1038/nm.2761	http://dx.doi.org/10.1038/nm.2761			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561819	Green Published, Green Accepted			2022-12-27	WOS:000303763500027
J	Fujita, K; Iwasaki, M; Ochi, H; Fukuda, T; Ma, CS; Miyamoto, T; Takitani, K; Negishi-Koga, T; Sunamura, S; Kodama, T; Takayanagi, H; Tamai, H; Kato, S; Arai, H; Shinomiya, K; Itoh, H; Okawa, A; Takeda, S				Fujita, Koji; Iwasaki, Makiko; Ochi, Hiroki; Fukuda, Toru; Ma, Chengshan; Miyamoto, Takeshi; Takitani, Kimitaka; Negishi-Koga, Takako; Sunamura, Satoko; Kodama, Tatsuhiko; Takayanagi, Hiroshi; Tamai, Hiroshi; Kato, Shigeaki; Arai, Hiroyuki; Shinomiya, Kenichi; Itoh, Hiroshi; Okawa, Atsushi; Takeda, Shu			Vitamin E decreases bone mass by stimulating osteoclast fusion	NATURE MEDICINE			English	Article							TOCOPHEROL TRANSFER PROTEIN; NORMAL-MALE RATS; ALPHA-TOCOPHEROL; ASCORBIC-ACID; OXIDATIVE STRESS; IMMUNE-SYSTEM; GIANT-CELLS; OC-STAMP; DIFFERENTIATION; SUPPLEMENTATION	Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption(1-3). Osteoclasts are multinucleated cells that are formed by mononuclear preosteoclast fusion(1,2,4,5). Fat-soluble vitamins such as vitamin D are pivotal in maintaining skeletal integrity. However, the role of vitamin E in bone remodeling is unknown. Here, we show that mice deficient in alpha-tocopherol transfer protein (Ttpa(-/-) mice), a mouse model of genetic vitamin E deficiency(6), have high bone mass as a result of a decrease in bone resorption. Cell-based assays indicated that alpha-tocopherol stimulated osteoclast fusion, independent of its antioxidant capacity, by inducing the expression of dendritic-cell-specific transmembrane protein, an essential molecule for osteoclast fusion, through activation of mitogen-activated protein kinase 14 (p38) and microphthalmia-associated transcription factor, as well as its direct recruitment to the Tm7sf4 (a gene encoding DC-STAMP) promoter(7-9). Indeed, the bone abnormality seen in Ttpa(-/-) mice was rescued by a Tm7sf4 transgene. Moreover, wild-type mice or rats fed an alpha-tocopherol-supplemented diet, which contains a comparable amount of alpha-tocopherol to supplements consumed by many people, lost bone mass. These results show that serum vitamin E is a determinant of bone mass through its regulation of osteoclast fusion.	[Ochi, Hiroki; Fukuda, Toru; Sunamura, Satoko; Itoh, Hiroshi; Takeda, Shu] Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab, Tokyo, Japan; [Fujita, Koji; Iwasaki, Makiko; Ma, Chengshan; Shinomiya, Kenichi; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan; [Fujita, Koji; Ma, Chengshan] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Takitani, Kimitaka; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Osaka, Japan; [Negishi-Koga, Takako; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Lab Syst Biol & Med, Tokyo, Japan; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan	Keio University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Keio University; Osaka Medical College; Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Takeda, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab, Tokyo, Japan.	shu-tky@umin.ac.jp	TAKITANI, Kimitaka/AAP-1250-2021; Fujita, Koji/K-3905-2019	Fujita, Koji/0000-0003-3733-0188	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science; Takeda Scientific Foundation; Funding Program for Next Generation World-Leading Researchers (NEXT Program); Grants-in-Aid for Scientific Research [22890178] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank G. Karsenty, R. Baron and S. Tanaka for discussions; Y. Hotta, K. Miyamoto, H. Inose, S. Sato, A. Kimura, R. Xu and C. Xu for technical assistance; and T. Kitamura (Divisions of Cellular Therapy and Hematopoietic Factors, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan) and I. Takada (Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan) for plasmids. This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program), grant-in-aid for scientific research from the Japan Society for the Promotion of Science, a grant for Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and a Takeda Scientific Foundation grant.	Arjmandi BH, 2002, J NUTR BIOCHEM, V13, P543, DOI 10.1016/S0955-2863(02)00199-7; Azzi A, 2000, J NUTR, V130, P1649, DOI 10.1093/jn/130.7.1649; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chuin A, 2009, OSTEOPOROSIS INT, V20, P1253, DOI 10.1007/s00198-008-0798-5; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Iwasaki R, 2008, BIOCHEM BIOPH RES CO, V377, P899, DOI 10.1016/j.bbrc.2008.10.076; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kato S, 2003, J BONE MINER METAB, V21, P323, DOI 10.1007/s00774-003-0453-3; Kim MH, 2011, AMINO ACIDS, V40, P1447, DOI 10.1007/s00726-010-0755-4; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Le Nihouannen D, 2010, BONE, V46, P1336, DOI 10.1016/j.bone.2009.11.021; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005; Mehat MZ, 2010, J BONE MINER METAB, V28, P503, DOI 10.1007/s00774-010-0159-2; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Ragab AA, 1998, J BONE MINER RES, V13, P970, DOI 10.1359/jbmr.1998.13.6.970; Ruiz-Ramos M, 2010, J NUTR HEALTH AGING, V14, P467, DOI 10.1007/s12603-010-0099-5; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Shuid AN, 2010, J BONE MINER METAB, V28, P149, DOI 10.1007/s00774-009-0122-2; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tsuneto M, 2005, BIOCHEM BIOPH RES CO, V335, P1239, DOI 10.1016/j.bbrc.2005.08.016; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x; Zu K, 2005, MOL CANCER THER, V4, P43	40	127	136	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					589	594		10.1038/nm.2659	http://dx.doi.org/10.1038/nm.2659			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388090				2022-12-27	WOS:000302617800036
J	Sweeney, KA; Dao, DN; Goldberg, MF; Hsu, T; Venkataswamy, MM; Henao-Tamayo, M; Ordway, D; Sellers, RS; Jain, P; Chen, B; Chen, M; Kim, J; Lukose, R; Chan, J; Orme, IM; Porcelli, SA; Jacobs, WR				Sweeney, Kari A.; Dao, Dee N.; Goldberg, Michael F.; Hsu, Tsungda; Venkataswamy, Manjunatha M.; Henao-Tamayo, Marcela; Ordway, Diane; Sellers, Rani S.; Jain, Paras; Chen, Bing; Chen, Mei; Kim, John; Lukose, Regy; Chan, John; Orme, Ian M.; Porcelli, Steven A.; Jacobs, William R., Jr.			A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis	NATURE MEDICINE			English	Article							BOVIS BCG; SECRETION SYSTEM; CALMETTE-GUERIN; PHAGOSOME MATURATION; VACCINE; INFECTION; MACROPHAGES; EXPRESSION; PROTECTION; ANTIGEN	We report the involvement of an evolutionarily conserved set of mycobacterial genes, the esx-3 region, in evasion of bacterial killing by innate immunity. Whereas high-dose intravenous infections of mice with the rapidly growing mycobacterial species Mycobacterium smegmatis bearing an intact esx-3 locus were rapidly lethal, infection with an M. smegmatis Delta esx-3 mutant (here designated as the IKE strain) was controlled and cleared by a MyD88-dependent bactericidal immune response. Introduction of the orthologous Mycobacterium tuberculosis esx-3 genes into the IKE strain resulted in a strain, designated IKEPLUS, that remained susceptible to innate immune killing and was highly attenuated in mice but had a marked ability to stimulate bactericidal immunity against challenge with virulent M. tuberculosis. Analysis of these adaptive immune responses indicated that the highly protective bactericidal immunity elicited by IKEPLUS was dependent on CD4(+) memory T cells and involved a distinct shift in the pattern of cytokine responses by CD4(+) cells. Our results establish a role for the esx-3 locus in promoting mycobacterial virulence and also identify the IKE strain as a potentially powerful candidate vaccine vector for eliciting protective immunity to M. tuberculosis.	[Sweeney, Kari A.; Dao, Dee N.; Hsu, Tsungda; Jain, Paras; Chen, Bing; Chen, Mei; Kim, John; Lukose, Regy; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA; [Sweeney, Kari A.; Dao, Dee N.; Goldberg, Michael F.; Hsu, Tsungda; Venkataswamy, Manjunatha M.; Jain, Paras; Chen, Bing; Chen, Mei; Kim, John; Lukose, Regy; Chan, John; Porcelli, Steven A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Henao-Tamayo, Marcela; Ordway, Diane; Orme, Ian M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Sellers, Rani S.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Kim, John; Porcelli, Steven A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Colorado State University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Jacobs, WR (corresponding author), Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA.	jacobsw@hhmi.org	Ordway, Diane/H-9732-2017; Rivet, Catherine A/M-7978-2014; Henao-Tamayo, Marcela/D-8189-2017	Ordway, Diane/0000-0003-0003-326X; Henao-Tamayo, Marcela/0000-0002-4249-9650; Jain, Paras/0000-0002-2288-6776; Jacobs, William/0000-0003-3321-3080	US National Institutes of Health (NIH) (Einstein Center for AIDS Research) [AI063537, AI093649, AI092448, AI26170, AI051519]; Bill and Melinda Gates Foundation; Albert Einstein College of Medicine [T32-AI007501]; Einstein Cancer Center (NIH/National Cancer Institute [CA013330]; Einstein Center for AIDS Research [NIH AI051519]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501, R01AI093649, R01AI026170, P01AI063537, R37AI026170, P30AI051519, R22AI026170, R21AI092448] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (Einstein Center for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Albert Einstein College of Medicine; Einstein Cancer Center (NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge the support of US National Institutes of Health (NIH) grants AI063537, AI093649, AI092448, AI26170 and AI051519 (Einstein Center for AIDS Research), and the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery. K.A.S. acknowledges support from the Albert Einstein College of Medicine's Institutional AIDS Training Grant T32-AI007501. We thank C. Harding, L. Ramachandra, G. Lauvau and S. Morris for advice and suggestions, as well as C. Colon-Berezin and S. Tiwari for helpful editing of the manuscript. Flow cytometry studies were carried out using core facilities supported by the Einstein Cancer Center (NIH/National Cancer Institute CA013330) and the Einstein Center for AIDS Research (NIH AI051519).	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Dubnau E, 2005, INFECT IMMUN, V73, P3754, DOI 10.1128/IAI.73.6.3754-3757.2005; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kita Y, 2005, VACCINE, V23, P2132, DOI 10.1016/j.vaccine.2005.01.057; Kumar K. Jagadish, 1995, Indian Journal of Pediatrics, V62, P619; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; ORME IM, 1983, J EXP MED, V158, P74, DOI 10.1084/jem.158.1.74; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yeremeev VV, 2000, CLIN EXP IMMUNOL, V120, P274, DOI 10.1046/j.1365-2249.2000.01212.x; Yi ZJ, 2007, VACCINE, V25, P638, DOI 10.1016/j.vaccine.2006.08.037	50	151	161	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1261	U292		10.1038/nm.2420	http://dx.doi.org/10.1038/nm.2420			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21892180	Green Accepted, Bronze			2022-12-27	WOS:000296022100044
J	Xiong, JH; Onal, M; Jilka, RL; Weinstein, RS; Manolagas, SC; O'Brien, CA				Xiong, Jinhu; Onal, Melda; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; O'Brien, Charles A.			Matrix-embedded cells control osteoclast formation	NATURE MEDICINE			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; OSTEOBLASTIC CELLS; CRE RECOMBINASE; DIFFERENTIATION; EXPRESSION; RANKL; OSTEOCYTES	Osteoclasts resorb the mineralized matrices formed by chondrocytes or osteoblasts. The cytokine receptor activator of nuclear factor-kappa B ligand (RANKL) is essential for osteoclast formation and thought to be supplied by osteoblasts or their precursors, thereby linking bone formation to resorption. However, RANKL is expressed by a variety of cell types, and it is unclear which of them are essential sources for osteoclast formation. Here we have used a mouse strain in which RANKL can be conditionally deleted and a series of Cre-deleter strains to demonstrate that hypertrophic chondrocytes and osteocytes, both of which are embedded in matrix, are essential sources of the RANKL that controls mineralized cartilage resorption and bone remodeling, respectively. Moreover, osteocyte RANKL is responsible for the bone loss associated with unloading. Contrary to the current paradigm, RANKL produced by osteoblasts or their progenitors does not contribute to adult bone remodeling. These results suggest that the rate-limiting step of matrix resorption is controlled by cells embedded within the matrix itself.	[Xiong, Jinhu; Onal, Melda; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Xiong, Jinhu; Onal, Melda; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; xiong, jinhu/E-1849-2011; Liu, Juan/J-5155-2015	Warren, Aaron D./0000-0002-0042-9021	US National Institutes of Health [AR049794, AG13918]; Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute [1UL1RR029884]; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank P. E. Cazer, S. B. Berryhill, W. Webb, R. Shelton, A. Deloose, L. K. Climer, K. Vyas, L. Han, A. D. Warren, E. A. Hogan and J.J. Goellner for technical support and advice; and M. Almeida and H. Zhao for helpful discussions. We thank the following individuals for providing Cre-deleter strains: C.J. Tabin (Harvard Medical School), Prx1-Cre; H. M. Kronenberg (Harvard Medical School), Osx1-Cre; K. von der Mark (University of Erlangen-Nuremberg) and B. de Crombrugghe (M. D. Anderson Cancer Center), ColX-Cre; T. L. Clemens (Johns Hopkins University School of Medicine), Ocn-Cre; and J.Q. Feng (Baylor College of Dentistry) Dmp1-Cre. We thank P. D. Pajevic (Harvard Medical School) for the collagenase digestion protocol; D. Chen (University of Rochester School of Medicine) for the X-gal staining protocol; T. Bellido (Indiana University School of Medicine) and I. Aguirre (University of Florida) for advice on tail suspension; the staff of the UAMS Department of Laboratory Animal Medicine; and L. Suva and R. Skinner of the UAMS Skeletal Imaging Core. This work was supported by the following grants from the US National Institutes of Health: AR049794 (to C.A.O.) and AG13918 (to S.C.M.). Support was also provided by the Central Arkansas Veteran's Healthcare System (Merit Reviews to C.A.O., S.C.M., R.L.J. and R.S.W.), by the UAMS Translational Research Institute (1UL1RR029884) and by UAMS tobacco settlement funds.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gebhard S, 2008, MATRIX BIOL, V27, P693, DOI 10.1016/j.matbio.2008.07.001; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kobayashi Y, 2009, CRIT REV EUKAR GENE, V19, P61, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.30; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Ogata N, 2007, J BIOL CHEM, V282, P35757, DOI 10.1074/jbc.M611902200; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	43	853	896	5	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1235	U262		10.1038/nm.2448	http://dx.doi.org/10.1038/nm.2448			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21909103	Green Accepted			2022-12-27	WOS:000296022100041
J	Diano, S; Liu, ZW; Jeong, JK; Dietrich, MO; Ruan, HB; Kim, E; Suyama, S; Kelly, K; Gyengesi, E; Arbiser, JL; Belsham, DD; Sarruf, DA; Schwartz, MW; Bennett, AM; Shanabrough, M; Mobbs, CV; Yang, XY; Gao, XB; Horvath, TL				Diano, Sabrina; Liu, Zhong-Wu; Jeong, Jin Kwon; Dietrich, Marcelo O.; Ruan, Hai-Bin; Kim, Esther; Suyama, Shigetomo; Kelly, Kaitlin; Gyengesi, Erika; Arbiser, Jack L.; Belsham, Denise D.; Sarruf, David A.; Schwartz, Michael W.; Bennett, Anton M.; Shanabrough, Marya; Mobbs, Charles V.; Yang, Xiaoyong; Gao, Xiao-Bing; Horvath, Tamas L.			Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CENTRAL LEPTIN INFUSION; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; PPAR-GAMMA; ENDOPLASMIC-RETICULUM; NPY/AGRP NEURONS; ENERGY-BALANCE; HYPOTHALAMUS; INFLAMMATION	Previous studies have proposed roles for hypothalamic reactive oxygen species (ROS) in the modulation of circuit activity of the melanocortin system(1,2). Here we show that suppression of ROS diminishes pro-opiomelanocortin (POMC) cell activation and promotes the activity of neuropeptide Y (NPY)- and agouti-related peptide (AgRP)-co-producing (NPY/AgRP) neurons and feeding, whereas ROS-activates POMC neurons and reduces feeding. The levels of ROS in POMC neurons were positively correlated with those of leptin in lean and ob/ob mice, a relationship that was diminished in diet-induced obese (DIO) mice. High-fat feeding resulted in proliferation of peroxisomes and elevated peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels within the hypothalamus. The proliferation of peroxisomes in POMC neurons induced by the PPAR-gamma agonist rosiglitazone decreased ROS levels and increased food intake in lean mice on high-fat diet. Conversely, the suppression of peroxisome proliferation by the PPAR antagonist GW9662 increased ROS concentrations and c-fos expression in POMC neurons. Also, it reversed high-fat feeding-triggered elevated NPY/AgRP and low POMC neuronal firing, and resulted in decreased feeding of DIO mice. Finally, central administration of ROS alone increased c-fos and phosphorylated signal transducer and activator of transcription 3 (pStat3) expression in POMC neurons and reduced feeding of DIO mice. These observations unmask a previously unknown hypothalamic cellular process associated with peroxisomes and ROS in the central regulation of energy metabolism in states of leptin resistance.	[Diano, Sabrina; Liu, Zhong-Wu; Jeong, Jin Kwon; Dietrich, Marcelo O.; Ruan, Hai-Bin; Suyama, Shigetomo; Kelly, Kaitlin; Gyengesi, Erika; Bennett, Anton M.; Shanabrough, Marya; Yang, Xiaoyong; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Diano, Sabrina; Jeong, Jin Kwon; Kelly, Kaitlin; Gyengesi, Erika; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; [Diano, Sabrina; Liu, Zhong-Wu; Dietrich, Marcelo O.; Ruan, Hai-Bin; Suyama, Shigetomo; Bennett, Anton M.; Shanabrough, Marya; Yang, Xiaoyong; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Diano, Sabrina; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Dietrich, Marcelo O.; Mobbs, Charles V.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Kim, Esther] Mt Sinai Sch Med, Dept Neurosci, Friedman Brain Inst, New York, NY USA; [Kim, Esther] Mt Sinai Sch Med, Dept Geriatr, Friedman Brain Inst, New York, NY USA; [Arbiser, Jack L.] Emory Univ, Sch Med, Dept Dermatol, Winship Canc Inst,Atlanta VA Med Ctr, Atlanta, GA 30322 USA; [Belsham, Denise D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Belsham, Denise D.] Toronto Gen Hosp, Div Cellular & Mol Biol, Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Sarruf, David A.; Schwartz, Michael W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Sarruf, David A.; Schwartz, Michael W.] Univ Washington, Dept Med, Seattle, WA USA; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Universidade Federal do Rio Grande do Sul; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yale University	Diano, S (corresponding author), Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.	sabrina.diano@yale.edu; tamas.horvath@yale.edu	Schwartz, Michael W/H-9950-2012; Gyengesi, Erika/S-1251-2019; Liu, Zhong-Wu/C-2794-2011; Dietrich, Marcelo/A-9928-2009; Gao, Xiao-Bing/C-3121-2011; Ruan, Hai-Bin/AAN-7777-2021; Ruan, Hai-Bin/G-9907-2012; Jeong, Jin Kwon/AAU-2951-2020	Gyengesi, Erika/0000-0001-7371-7385; Dietrich, Marcelo/0000-0001-9781-2221; Gao, Xiao-Bing/0000-0002-2035-4936; Ruan, Hai-Bin/0000-0002-3858-1272; Ruan, Hai-Bin/0000-0002-3858-1272; Mobbs, Charles/0000-0002-5815-8711; Bennett, Anton/0000-0001-5187-7599; Jeong, Jin Kwon/0000-0002-5261-4915	US National Institutes of Health (NIH) [DK084065, DK080000, OD006850]; American Diabetes Association [7-08-MN-25]; NIH [DK089098, DK072033, DK090320, DK052989, AR47901, P30 AR42687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901, P30AR042687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK072033, R01DK052989, R01DK080000, R01DK083042, R01DK084065, R01DK097566, R01DK090320, R01DK089098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087004] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J.M. Olefsky, Department of Medicine, University of California-San Diego, for generating and providing brain-specific PPAR-gamma-knockout mice and B.B. Lowell, Beth Israel Deaconess Medical Center, for providing breeding pairs of UCP2-knockout mice. This work was supported by US National Institutes of Health (NIH) grants DK084065 (S.D.) and DK080000 and OD006850 (T.L.H.) and by American Diabetes Association grant 7-08-MN-25 (T.L.H.). This work was also supported by NIH grants DK089098 (X.Y.), DK072033 (C.V.M.) DK090320 and DK052989 (M.W.S.) and AR47901 and P30 AR42687 (J.L.A.).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Green S, 1995, MUTAT RES-FUND MOL M, V333, P101, DOI 10.1016/0027-5107(95)00136-0; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Horvath TL, 2009, TRENDS ENDOCRIN MET, V20, P78, DOI 10.1016/j.tem.2008.10.003; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Kouidhi S, 2010, MOL CELL ENDOCRINOL, V317, P44, DOI 10.1016/j.mce.2009.11.001; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Pal R, 2003, ENDOCRINOLOGY, V144, P3789, DOI 10.1210/en.2002-0148; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Poplawski MM, 2010, ENDOCRINOLOGY, V151, P5206, DOI 10.1210/en.2010-0702; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047	37	199	201	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2011	17	9					1121	U130		10.1038/nm.2421	http://dx.doi.org/10.1038/nm.2421			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21873987	Green Accepted			2022-12-27	WOS:000294605100033
J	Fawcett, JW; Kalluri, R; Duffield, JS; Silver, J				Fawcett, James W.; Kalluri, Raghu; Duffield, Jeremy S.; Silver, Jerry			Starting the scar: a primary role for pericytes?	NATURE MEDICINE			English	Editorial Material							REACTIVE ASTROCYTES; CELLS		[Fawcett, James W.] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA USA; [Duffield, Jeremy S.] Univ Washington, Div Renal, Seattle, WA USA; [Duffield, Jeremy S.] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA USA; [Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA USA; [Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	University of Cambridge; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Case Western Reserve University	Fawcett, JW (corresponding author), Univ Cambridge, Ctr Brain Repair, Robinson Way, Cambridge, England.		Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; Fawcett, James/0000-0002-7990-4568				Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Shibata T, 1997, J NEUROSCI, V17, P9212; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wirz W, 2008, DIFFERENTIATION, V76, P784, DOI 10.1111/j.1432-0436.2007.00260.x; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	14	3	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1052	1053		10.1038/nm0911-1052	http://dx.doi.org/10.1038/nm0911-1052			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900921				2022-12-27	WOS:000294605100022
J	Chin, CD; Laksanasopin, T; Cheung, YK; Steinmiller, D; Linder, V; Parsa, H; Wang, J; Moore, H; Rouse, R; Umviligihozo, G; Karita, E; Mwambarangwe, L; Braunstein, SL; van de Wijgert, J; Sahabo, R; Justman, JE; El-Sadr, W; Sia, SK				Chin, Curtis D.; Laksanasopin, Tassaneewan; Cheung, Yuk Kee; Steinmiller, David; Linder, Vincent; Parsa, Hesam; Wang, Jennifer; Moore, Hannah; Rouse, Robert; Umviligihozo, Gisele; Karita, Etienne; Mwambarangwe, Lambert; Braunstein, Sarah L.; van de Wijgert, Janneke; Sahabo, Ruben; Justman, Jessica E.; El-Sadr, Wafaa; Sia, Samuel K.			Microfluidics-based diagnostics of infectious diseases in the developing world	NATURE MEDICINE			English	Article							RESOURCE-POOR SETTINGS; GLOBAL HEALTH; DEVICES; HIV; OPPORTUNITIES; IMMUNOASSAYS; COUNTRIES; FUTURE; VIRUS; TIME	One of the great challenges in science and engineering today is to develop technologies to improve the health of people in the poorest regions of the world. Here we integrated new procedures for manufacturing, fluid handling and signal detection in microfluidics into a single, easy-to-use point-of-care (POC) assay that faithfully replicates all steps of ELISA, at a lower total material cost. We performed this 'mChip' assay in Rwanda on hundreds of locally collected human samples. The chip had excellent performance in the diagnosis of HIV using only 1 mu l of unprocessed whole blood and an ability to simultaneously diagnose HIV and syphilis with sensitivities and specificities that rival those of reference benchtop assays. Unlike most current rapid tests, the mChip test does not require user interpretation of the signal. Overall, we demonstrate an integrated strategy for miniaturizing complex laboratory assays using microfluidics and nanoparticles to enable POC diagnostics and early detection of infectious diseases in remote settings.	[Chin, Curtis D.; Laksanasopin, Tassaneewan; Cheung, Yuk Kee; Parsa, Hesam; Wang, Jennifer; Moore, Hannah; Rouse, Robert; Sia, Samuel K.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Steinmiller, David; Linder, Vincent] Claros Diagnost, Woburn, MA USA; [Umviligihozo, Gisele; Karita, Etienne] Projet San Francisco, Rwanda Zambia HIV Res Grp, Kigali, Rwanda; [Mwambarangwe, Lambert; van de Wijgert, Janneke] Projet Ubuzima, Kigali, Rwanda; [Braunstein, Sarah L.; Sahabo, Ruben; Justman, Jessica E.; El-Sadr, Wafaa] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Ctr Infect & Immun, Amsterdam, Netherlands	Columbia University; Columbia University; University of Amsterdam; Academic Medical Center Amsterdam	Sia, SK (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	ss2735@columbia.edu	Justman, Jessica/AAA-3572-2020	Poh, Yukkee/0000-0001-6925-8614; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Parsa, Hesam/0000-0003-1266-2135	Wallace H. Coulter Foundation; US National Institutes of Health [1R41AI076187]; Royal Thai Government; Croucher Foundation Scholarship; Frank H. Buck Scholarship	Wallace H. Coulter Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government; Croucher Foundation Scholarship; Frank H. Buck Scholarship	We thank the Wallace H. Coulter Foundation, the US National Institutes of Health (1R41AI076187), a Royal Thai Government Scholarship (to T. L.), a Croucher Foundation Scholarship (to Y.K.C.) and a Frank H. Buck Scholarship (to C. D. C.) for financial support. We thank A. Leek, J. Taylor, N. Karaseva and E. Tan for helping in assay development and data on reagent stability and for assisting in design of the reader. We thank J. Kymissis, M. Steele, R. Peck, G. Whitesides and R. Peeling for helpful discussions. We thank S. Koblavi-Deme, A. Nyaruhirira, J. Kamwesiga, V. Mugisha, N. Micheu, M. Munyangabo, D. Nash, J. Mushingantahe, C. Mutezemariya, A. Binagwaho and N. Veldhuijzen for assistance with the procurement of laboratory supplies and approval of study protocols in Rwanda and for facilitating access to clinical specimens. We thank D. Rouse, R. Satcher, E. Bailey and M. Wirth for assessments of clinical need and social impact.	Aledort Julia E, 2006, Nature, V444 Suppl 1, P59, DOI 10.1038/nature05447; Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X; Beelaert G, 2002, J VIROL METHODS, V105, P197, DOI 10.1016/S0166-0934(02)00102-7; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; GATARAYIHA JP, 2006, RWANDA DEMOGRAPHIC H; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Hay Burgess Deborah C, 2006, Nature, V444 Suppl 1, P1; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; LAKSANASOPIN T, 2009, P SOC PHOTO-OPT INS, V7318, P1057; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Linder V, 2005, ANAL CHEM, V77, P64, DOI 10.1021/ac049071x; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Miranda AE, 2001, SEX TRANSM DIS, V28, P710, DOI 10.1097/00007435-200112000-00008; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; Parsa H, 2008, LAB CHIP, V8, P2062, DOI 10.1039/b813350f; Patakfalvi R, 2007, J NANOPART RES, V9, P353, DOI 10.1007/s11051-006-9139-9; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Sia SK, 2004, ANGEW CHEM INT EDIT, V43, P498, DOI 10.1002/anie.200353016; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; West J, 2008, ANAL CHEM, V80, P4403, DOI 10.1021/ac800680j; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wootton RCR, 2010, NATURE, V464, P839, DOI 10.1038/464839a; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	34	532	559	7	425	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					1015	U138		10.1038/nm.2408	http://dx.doi.org/10.1038/nm.2408			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804541				2022-12-27	WOS:000293507400037
J	Salzman, DW; Weidhaas, JB				Salzman, David W.; Weidhaas, Joanne B.			miRNAs in the spotlight Making 'silent' mutations speak up	NATURE MEDICINE			English	Editorial Material							SEQUENCE VARIANTS; GENE-EXPRESSION; CROHNS-DISEASE; HUMAN GENOME; MICRORNAS; CANCER; POLYMORPHISM; SITE	Genetic mutations can cause numerous diseases. These alterations affect not only protein-coding genes but also regions that were until recently thought to be trivial in disease. In 'Bedside to Bench', David Salzman and Joanne Weidhaas examine a human study showing how a silent mutation impairs the binding of miR-196, increasing the risk for Crohn's disease. Therefore, alterations of miRNA target sites as pathogenic mechanism begs further investigation. miRNAs themselves can also be the root of disease. In 'Bench to Bedside', Carlo Croce peruses a study in vivo showing evidence of tumor addiction to miR-21 in a mouse model of cancer, which highlights the role of miRNAs as initiators of disease. Targeting these drivers will help to develop effective drugs.	[Salzman, David W.; Weidhaas, Joanne B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA	Yale University	Salzman, DW (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	joanne.weidhaas@yale.edu		Weidhaas, Joanne/0000-0002-5096-3281	NATIONAL CANCER INSTITUTE [R01CA131301] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089	13	7	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					934	935		10.1038/nm0811-934	http://dx.doi.org/10.1038/nm0811-934			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21818091				2022-12-27	WOS:000293507400024
J	Doherty, TA; Soroosh, P; Khorram, N; Fukuyama, S; Rosenthal, P; Cho, JY; Norris, PS; Choi, H; Scheu, S; Pfeffer, K; Zuraw, BL; Ware, CF; Broide, DH; Croft, M				Doherty, Taylor A.; Soroosh, Pejman; Khorram, Naseem; Fukuyama, Satoshi; Rosenthal, Peter; Cho, Jae Youn; Norris, Paula S.; Choi, Heonsik; Scheu, Stefanie; Pfeffer, Klaus; Zuraw, Bruce L.; Ware, Carl F.; Broide, David H.; Croft, Michael			The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; T-CELL-ACTIVATION; TGF-BETA; LYMPHOTOXIN-BETA; BASEMENT-MEMBRANE; EPITHELIAL-CELLS; TNF SUPERFAMILY; INFLAMMATION; EXPRESSION; RECEPTOR	Individuals with chronic asthma show a progressive decline in lung function that is thought to be due to structural remodeling of the airways characterized by subepithelial fibrosis and smooth muscle hyperplasia. Here we show that the tumor necrosis factor (TNF) family member LIGHT is expressed on lung inflammatory cells after allergen exposure. Pharmacological inhibition of LIGHT using a fusion protein between the IgG Fc domain and lymphotoxin beta receptor (LT beta R) reduces lung fibrosis, smooth muscle hyperplasia and airway hyperresponsiveness in mouse models of chronic asthma, despite having little effect on airway eosinophilia. LIGHT-deficient mice also show a similar impairment in fibrosis and smooth muscle accumulation. Blockade of LIGHT suppresses expression of lung transforming growth factor-beta (TGF-beta) and interleukin-13 (IL-13), cytokines implicated in remodeling in humans, whereas exogenous administration of LIGHT to the airways induces fibrosis and smooth muscle hyperplasia, Thus, LIGHT may be targeted to prevent asthma-related airway remodeling.	[Doherty, Taylor A.; Soroosh, Pejman; Fukuyama, Satoshi; Choi, Heonsik; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA; [Doherty, Taylor A.; Khorram, Naseem; Rosenthal, Peter; Cho, Jae Youn; Zuraw, Bruce L.; Broide, David H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Norris, Paula S.; Ware, Carl F.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Scheu, Stefanie; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany	La Jolla Institute for Immunology; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Heinrich Heine University Dusseldorf	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA.	mick@liai.org	Soroosh, Pejman/AAD-8386-2021; Scheu, Stefanie/H-3670-2019	Scheu, Stefanie/0000-0002-9707-8191; Doherty, Taylor/0000-0003-3256-0398; Pfeffer, Klaus/0000-0002-5652-6330; Broide, David/0000-0001-8405-9090	US National Institutes of Health (NIH) [AI070535]; American Academy of Asthma, Allergy and Immunology, UCSD Clinical and Translational Research Institute; NIH [1K08AI080938-01A1, R37AI068033, AI067890]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, U19AI070535, K08AI080938, R01AI067890, R01AI068033, R01AI048073, R37AI038425] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Asthma, Allergy and Immunology, UCSD Clinical and Translational Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Meilan, Y. Adams, X. Tang and M. Macauley for technical assistance and the UCSD histology core for lung section processing and staining. Antibody to LT beta BBF6 was kindly provided by J. Browning, Biogen Idec. This work was supported by US National Institutes of Health (NIH) grant AI070535 to M. C., a fellowship from the American Academy of Asthma, Allergy and Immunology, UCSD Clinical and Translational Research Institute and NIH grant 1K08AI080938-01A1 award to T. A. D. and NIH grants R37AI068033 and AI067890 to C. F. W. This is manuscript number 1285 of the La Jolla Institute for Allergy and Immunology.	Berger P, 2003, FASEB J, V17, P2139, DOI 10.1096/fj.03-0041fje; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bogaert P, 2009, AM J PATHOL, V174, P3, DOI 10.2353/ajpath.2009.071151; Booth BW, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-51; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; Boussaud V, 1998, EUR RESPIR J, V12, P926, DOI 10.1183/09031936.98.12040926; Burton OT, 2010, J IMMUNOL, V185, P2754, DOI 10.4049/jimmunol.1001365; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Cho JY, 2004, AM J RESP CELL MOL, V30, P651, DOI 10.1165/rcmb.2003-0066OC; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; DiGiovanni FA, 2009, DIS MODEL MECH, V2, P275, DOI 10.1242/dmm.001859; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; HASTIE AT, 2010, J ALLERGY CLIN IMMUN, V125; Heo SK, 2006, J LEUKOCYTE BIOL, V79, P330, DOI 10.1189/jlb.1104694; Hikichi Y, 2001, BIOCHEM BIOPH RES CO, V289, P670, DOI 10.1006/bbrc.2001.6039; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kelly EA, 2003, CURR OPIN PULM MED, V9, P28, DOI 10.1097/00063198-200301000-00005; KHALIL N, 1993, J CLIN INVEST, V92, P1812, DOI 10.1172/JCI116771; Kitani A, 2000, J EXP MED, V192, P41, DOI 10.1084/jem.192.1.41; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945; Lim DH, 2006, AM J PHYSIOL-LUNG C, V291, pL265, DOI 10.1152/ajplung.00305.2005; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Luzina IG, 2003, ARTHRITIS RHEUM-US, V48, P2262, DOI 10.1002/art.11080; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wei CY, 2006, J CELL PHYSIOL, V209, P735, DOI 10.1002/jcp.20742; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595; Zaslona Z, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-2; Zhou XX, 2005, AM J PHYSIOL-CELL PH, V288, pC435, DOI 10.1152/ajpcell.00035.2004	60	123	132	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					596	U118		10.1038/nm.2356	http://dx.doi.org/10.1038/nm.2356			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499267	Green Accepted			2022-12-27	WOS:000290250400036
J	Chin, L; Andersen, JN; Futreal, PA				Chin, Lynda; Andersen, Jannik N.; Futreal, P. Andrew			Cancer genomics: from discovery science to personalized medicine	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ANAPLASTIC LYMPHOMA KINASE; EML4-ALK FUSION GENE; SOMATIC MUTATIONS; ALK KINASE; ACTIVATING MUTATIONS; MONOCLONAL-ANTIBODY; FGFR2 MUTATIONS; PIK3CA GENE	Recent advances in genome technologies and the ensuing outpouring of genomic information related to cancer have accelerated the convergence of discovery science and clinical medicine. Successful examples of translating cancer genomics into therapeutics and diagnostics reinforce its potential to make possible personalized cancer medicine. However, the bottlenecks along the path of converting a genome discovery into a tangible clinical endpoint are numerous and formidable. In this Perspective, we emphasize the importance of establishing the biological relevance of a cancer genomic discovery in realizing its clinical potential and discuss some of the major obstacles to moving from the bench to the bedside.	[Chin, Lynda; Andersen, Jannik N.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Chin, Lynda] Broad Inst MIT & Harvard, Cambridge, MA USA; [Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Chin, L (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu		Andersen, Jannik/0000-0003-4528-2120				Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Kwong LN, 2010, CELL, V140, P180, DOI 10.1016/j.cell.2010.01.013; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; SHIMIZU K, 1983, NATURE, V304, P497, DOI 10.1038/304497a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Sousa SF, 2008, CURR MED CHEM, V15, P1478, DOI 10.2174/092986708784638825; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Turke AB, 2010, CLIN CANCER RES, V16, P3523, DOI 10.1158/1078-0432.CCR-10-1201; Uckun FM, 2010, BRIT J HAEMATOL, V149, P508, DOI 10.1111/j.1365-2141.2010.08106.x; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	67	410	421	1	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					297	303		10.1038/nm.2323	http://dx.doi.org/10.1038/nm.2323			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383744				2022-12-27	WOS:000288070000040
J	Atarashi, R; Satoh, K; Sano, K; Fuse, T; Yamaguchi, N; Ishibashi, D; Matsubara, T; Nakagaki, T; Yamanaka, H; Shirabe, S; Yamada, M; Mizusawa, H; Kitamoto, T; Klug, G; McGlade, A; Collins, SJ; Nishida, N				Atarashi, Ryuichiro; Satoh, Katsuya; Sano, Kazunori; Fuse, Takayuki; Yamaguchi, Naohiro; Ishibashi, Daisuke; Matsubara, Takehiro; Nakagaki, Takehiro; Yamanaka, Hitoki; Shirabe, Susumu; Yamada, Masahito; Mizusawa, Hidehiro; Kitamoto, Tetsuyuki; Klug, Genevieve; McGlade, Amelia; Collins, Steven J.; Nishida, Noriyuki			Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion	NATURE MEDICINE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; SEEDED CONVERSION; 14-3-3 PROTEIN; DIAGNOSIS	The development of technologies for the in vitro amplification of abnormal conformations of prion protein (PrPSc) has generated the potential for sensitive detection of prions. Here we developed a new PrPSc amplification assay, called real-time quaking-induced conversion (RT-QUIC), which allows the detection of >= 1 fg of PrPSc in diluted Creutzfeldt-Jakob disease (CJD) brain homogenate. Moreover, we assessed the technique first in a series of Japanese subjects and then in a blind study of 30 cerebrospinal fluid specimens from Australia, which achieved greater than 80% sensitivity and 100% specificity. These findings indicate the promising enhanced diagnostic capacity of RT-QUIC in the antemortem evaluation of suspected CJD.	[Atarashi, Ryuichiro; Satoh, Katsuya; Sano, Kazunori; Fuse, Takayuki; Yamaguchi, Naohiro; Ishibashi, Daisuke; Matsubara, Takehiro; Nakagaki, Takehiro; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Atarashi, Ryuichiro] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 852, Japan; [Sano, Kazunori; Nishida, Noriyuki] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Yamanaka, Hitoki] Nagasaki Univ, Ctr Frontier Life Sci, Div Comparat Med, Nagasaki 852, Japan; [Shirabe, Susumu] Nagasaki Univ Hosp, Org Rural Med & Residency Educ, Nagasaki, Japan; [Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Prion Res, Div Creutzfeldt Jakob Dis Sci & Technol, Sendai, Miyagi 980, Japan; [Klug, Genevieve; McGlade, Amelia; Collins, Steven J.] Univ Melbourne, Australian Natl Creutzfeldt Jakob Dis Registry, Dept Pathol, Melbourne, Vic, Australia	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Kanazawa University; Tokyo Medical & Dental University (TMDU); Tohoku University; University of Melbourne	Atarashi, R (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan.	atarashi@nagasaki-u.ac.jp		Nakagaki, Takehiro/0000-0003-1960-8326	Global Centers of Excellence Program [F12]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20390287]; Ministry of Health, Labor and Welfare of Japan	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank the members of the CJD Surveillance Committee in Japan for their support of this work, K. Yamaguchi and K. Kuwata for helping with the circular dichroism analysis of rPrP-sen, M. Tsujihata (Nagasaki Kita Hospital) for providing CSF samples and information about subjects and A. Yamakawa and A. Matsuo for technical assistance. The work was supported by the Global Centers of Excellence Program (F12); a grant-in-aid for science research (B; grant no. 20390287) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant for bovine spongiform encephalopathy research and a grant-in-aid of the Research Committee of Prion disease and Slow Virus Infection, from the Ministry of Health, Labor and Welfare of Japan.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Satoh K, 2010, LAB INVEST, V90, P1637, DOI 10.1038/labinvest.2009.68; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	18	374	385	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					175	178		10.1038/nm.2294	http://dx.doi.org/10.1038/nm.2294			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21278748	Green Submitted			2022-12-27	WOS:000286969900024
J	Lopez, M; Varela, L; Vazquez, MJ; Rodriguez-Cuenca, S; Gonzalez, CR; Velagapudi, VR; Morgan, DA; Schoenmakers, E; Agassandian, K; Lage, R; de Morentin, PBM; Tovar, S; Nogueiras, R; Carling, D; Lelliott, C; Gallego, R; Oresic, M; Chatterjee, K; Saha, AK; Rahmouni, K; Dieguez, C; Vidal-Puig, A				Lopez, Miguel; Varela, Luis; Vazquez, Maria J.; Rodriguez-Cuenca, Sergio; Gonzalez, Carmen R.; Velagapudi, Vidya R.; Morgan, Donald A.; Schoenmakers, Erik; Agassandian, Khristofor; Lage, Ricardo; Martinez de Morentin, Pablo Blanco; Tovar, Sulay; Nogueiras, Ruben; Carling, David; Lelliott, Christopher; Gallego, Rosalia; Oresic, Matej; Chatterjee, Krishna; Saha, Asish K.; Rahmouni, Kamal; Dieguez, Carlos; Vidal-Puig, Antonio			Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; FOOD-INTAKE; VENTROMEDIAL HYPOTHALAMUS; INSULIN SENSITIVITY; SKELETAL-MUSCLE; NERVOUS-SYSTEM; ADULT HUMANS; MALONYL-COA	Thyroid hormones have widespread cellular effects; however it is unclear whether their effects on the central nervous system (CNS) contribute to global energy balance. Here we demonstrate that either whole-body hyperthyroidism or central administration of triiodothyronine (T3) decreases the activity of hypothalamic AMP-activated protein kinase (AMPK), increases sympathetic nervous system (SNS) activity and upregulates thermogenic markers in brown adipose tissue (BAT). Inhibition of the lipogenic pathway in the ventromedial nucleus of the hypothalamus (VMH) prevents CNS-mediated activation of BAT by thyroid hormone and reverses the weight loss associated with hyperthyroidism. Similarly, inhibition of thyroid hormone receptors in the VMH reverses the weight loss associated with hyperthyroidism. This regulatory mechanism depends on AMPK inactivation, as genetic inhibition of this enzyme in the VMH of euthyroid rats induces feeding-independent weight loss and increases expression of thermogenic markers in BAT. These effects are reversed by pharmacological blockade of the SNS. Thus, thyroid hormone-induced modulation of AMPK activity and lipid metabolism in the hypothalamus is a major regulator of whole-body energy homeostasis.	[Lopez, Miguel; Varela, Luis; Vazquez, Maria J.; Gonzalez, Carmen R.; Lage, Ricardo; Martinez de Morentin, Pablo Blanco; Tovar, Sulay; Nogueiras, Ruben; Dieguez, Carlos] Univ Santiago de Compostela, Inst Invest Sanitaria, Sch Med, Dept Physiol, Santiago De Compostela, A Coruna, Spain; [Lopez, Miguel; Varela, Luis; Vazquez, Maria J.; Gonzalez, Carmen R.; Lage, Ricardo; Martinez de Morentin, Pablo Blanco; Tovar, Sulay; Nogueiras, Ruben; Dieguez, Carlos] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, La Coruna, Spain; [Lopez, Miguel; Rodriguez-Cuenca, Sergio; Schoenmakers, Erik; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Velagapudi, Vidya R.; Oresic, Matej] Tech Res Ctr Finland VTT, Espoo, Finland; [Morgan, Donald A.; Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Agassandian, Khristofor] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC,Cellular Stress Grp, London, England; [Lelliott, Christopher] AstraZeneca, Res & Dev, Dept Biosci, Molndal, Sweden; [Gallego, Rosalia] Univ Santiago de Compostela, Sch Med, Dept Morphol Sci, Santiago De Compostela, A Coruna, Spain; [Saha, Asish K.] Boston Med Ctr, Diabet Res Unit, Boston, MA USA	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; VTT Technical Research Center Finland; University of Iowa; University of Iowa; Imperial College London; AstraZeneca; Universidade de Santiago de Compostela; Boston Medical Center	Lopez, M (corresponding author), Univ Santiago de Compostela, Inst Invest Sanitaria, Sch Med, Dept Physiol, Santiago De Compostela, A Coruna, Spain.	m.lopez@usc.es; ajv22@cam.ac.uk	Oresic, Matej/K-7673-2016; Morgan, Donald A/L-6907-2013; Carling, David/F-1943-2014; Oresic, Matej/AAV-3978-2020; López, Miguel/ABF-4844-2021; Rahmouni, Kamal/Y-1788-2019; Dieguez, Carmen Ruth Gonzalez/AAC-1339-2020; Velagapudi, Vidya/L-7278-2015; Tovar, Sulay/ABF-4037-2021; Nogueiras, Ruben/AAS-9427-2021; Lelliott, Christopher J/G-4620-2011; Varela, Luis/ABG-7581-2020; de Morentin, Pablo B Martinez/K-5403-2014; Rodriguez-Cuenca, Sergio/C-5901-2011	Oresic, Matej/0000-0002-2856-9165; Morgan, Donald A/0000-0003-3167-1643; Carling, David/0000-0002-2316-1830; López, Miguel/0000-0002-7823-1648; Dieguez, Carmen Ruth Gonzalez/0000-0001-9311-1866; Velagapudi, Vidya/0000-0002-8261-7164; Nogueiras, Ruben/0000-0002-9976-9930; Lelliott, Christopher J/0000-0001-8087-4530; Varela, Luis/0000-0001-7794-7241; de Morentin, Pablo B Martinez/0000-0002-0684-3215; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Lage Fernandez, Ricardo/0000-0002-8779-7723; Saha, Asish/0000-0003-1001-5110; Vidal-Puig, Antonio/0000-0003-4220-9577; Rosalia, Gallego/0000-0002-6015-4680; Tovar, Sulay/0000-0001-7813-6520; Rahmouni, Kamal/0000-0001-5136-6748	UK Medical Research Council [G0802051]; Wellcome Trust [080237, 065326/Z/01/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067509, R01DK019514] Funding Source: NIH RePORTER; Medical Research Council [G0802051, MC_U120027537] Funding Source: researchfish; MRC [G0802051] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Adams and A. Whittle for discussion and editing and L. Casas, M. Portas and K. Burling for excellent technical assistance. This work has been supported by grants from the UK Medical Research Council (A. V.-P.: G0802051), the Wellcome Trust (K. C.: 080237; A. V.-P.: 065326/Z/01/Z), Xunta de Galicia (R. G.: PGIDITPXIB20811PR), Fondo Investigaciones Sanitarias (M. L.: PS09/01880), Ministerio de Ciencia e Innovacion (C. D.: BFU2008; M. L.: RyC-2007-00211; R.N.: RyC-2008-02219 and SAF2009-07049), the EU (A. V.-P. and M.O.: FP7MITIN; A. V.-P. and M. O.: LSHM-CT-2005-018734; C. D., M. L. and R. N.: Health-F2-2008223713; M. L.: Marie Curie Program QLK6-CT-2002-51671) and the US National Institutes of Health (A. K. S.: DK-19514 and DK-67509; K. R.: HL-084207). CIBER de Fisiopatolog a de la Obesidad y Nutricion is an initiative of Instituto de Salud Carlos III (ISCIII).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; BEYLOT M, 1991, J CLIN ENDOCR METAB, V73, P42, DOI 10.1210/jcem-73-1-42; BLENNEMANN B, 1992, ENDOCRINOLOGY, V130, P637, DOI 10.1210/en.130.2.637; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Branvold DJ, 2008, J APPL PHYSIOL, V105, P1218, DOI 10.1152/japplphysiol.00997.2007; Cachefo A, 2001, J CLIN ENDOCR METAB, V86, P5353, DOI 10.1210/jc.86.11.5353; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; GNONI GV, 1983, BIOCHIM BIOPHYS ACTA, V751, P271, DOI 10.1016/0005-2760(83)90284-9; HAGENFELDT L, 1981, J CLIN INVEST, V67, P1672, DOI 10.1172/JCI110204; HALVORSON I, 1990, BRAIN RES, V522, P76, DOI 10.1016/0006-8993(90)91579-6; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; HOLT SJ, 1987, BRAIN RES, V405, P227, DOI 10.1016/0006-8993(87)90292-7; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Irrcher I, 2008, J APPL PHYSIOL, V104, P178, DOI 10.1152/japplphysiol.00643.2007; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; KRISHNA V, 1991, J CLIN INVEST, V87, P1977, DOI 10.1172/JCI115225; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MORINI P, 1991, BIOCHEM MED METAB B, V46, P169, DOI 10.1016/0885-4505(91)90064-R; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; NIIJIMA A, 1984, AM J PHYSIOL, V247, pR650, DOI 10.1152/ajpregu.1984.247.4.R650; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Park SH, 2002, J APPL PHYSIOL, V93, P2081, DOI 10.1152/japplphysiol.00504.2002; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5848, DOI 10.1210/jc.86.12.5848; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Rahmouni K, 2004, J CLIN INVEST, V114, P652, DOI 10.1172/JCI200421737; Riis ALD, 2002, J CLIN ENDOCR METAB, V87, P4747, DOI 10.1210/jc.2002-020174; Sangiao-Alvarellos S, 2010, J NEUROENDOCRINOL, V22, P543, DOI 10.1111/j.1365-2826.2010.01994.x; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; VOLPE JJ, 1972, J NEUROCHEM, V19, P737, DOI 10.1111/j.1471-4159.1972.tb01389.x; Winder WW, 2003, BIOCHEM SOC T, V31, P182, DOI 10.1042/bst0310182; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103	58	490	505	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					1001	U97		10.1038/nm.2207	http://dx.doi.org/10.1038/nm.2207			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20802499	Green Accepted			2022-12-27	WOS:000281622900029
J	Nattel, S				Nattel, Stanley			When normal ECG variants turn lethal	NATURE MEDICINE			English	Editorial Material							EARLY REPOLARIZATION; BRUGADA-SYNDROME; LONG	Numerous factors can contribute to sudden cardiac death, from underlying disease after myocardial infarction to genetic variants that can claim young lives. In 'Bedside to Bench', Stanley Nattel examines recent clinical studies suggesting that a particular type of readout on an electrocardiogram (ECG) may increase the risk of the condition. This ECG 'variant' is relatively common and was previously thought to be benign. In 'Bench to Bedside', Gordon Tomaselli and Andreas Barth take a look at studies at the bench examining how oxidative stress may promote sudden cardiac death.	[Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada; [Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Nattel, S (corresponding author), Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada.	Stanley.nattel@icm-mhi.org		Nattel, Stanley/0000-0002-5565-3311				Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Haissaguerre M, 2009, J CARDIOVASC ELECTR, V20, P93, DOI 10.1111/j.1540-8167.2008.01326.x; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Krahn AD, 2009, CIRCULATION, V120, P278, DOI 10.1161/CIRCULATIONAHA.109.853143; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; MYERS GB, 1947, AM HEART J, V34, P785, DOI 10.1016/0002-8703(47)90144-0; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A	13	7	8	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					646	647		10.1038/nm0610-646	http://dx.doi.org/10.1038/nm0610-646			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526318				2022-12-27	WOS:000278394200028
J	Doyle, SL; Campbell, M; Ozaki, E; Salomon, RG; Mori, A; Kenna, PF; Farrar, GJ; Kiang, AS; Humphries, MM; Lavelle, EC; O'Neill, LAJ; Hollyfield, JG; Humphries, P				Doyle, Sarah L.; Campbell, Matthew; Ozaki, Ema; Salomon, Robert G.; Mori, Andres; Kenna, Paul F.; Farrar, Gwyneth Jane; Kiang, Anna-Sophia; Humphries, Marian M.; Lavelle, Ed C.; O'Neill, Luke A. J.; Hollyfield, Joe G.; Humphries, Peter			NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components	NATURE MEDICINE			English	Article							OXIDATIVE STRESS; INTRAVITREAL INFLIXIMAB; NALP3 INFLAMMASOME; PROTEIN; CELLS; C1Q; ACTIVATION; CRYSTALS; BINDING; RETINA	Age-related macular degeneration (AMD) is the leading cause of central vision loss worldwide. Drusen accumulation is the major pathological hallmark common to both dry and wet AMD. Although activation of the immune system has been implicated in disease progression, the pathways involved are unclear. Here we show that drusen isolated from donor AMD eyes activates the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome, causing secretion of interleukin-1 beta (IL-1 beta) and IL-18. Drusen component C1Q also activates the NLRP3 inflammasome. Moreover, the oxidative-stress-related protein-modification carboxyethylpyrrole (CEP), a biomarker of AMD, primes the inflammasome. We found cleaved caspase-1 and NLRP3 in activated macrophages in the retinas of mice immunized with CEP-adducted mouse serum albumin, modeling a dry-AMD-like pathology. We show that laser-induced choroidal neovascularization (CNV), a mouse model of wet AMD, is exacerbated in Nlrp3(-/-) but not Il1r1(-/-) mice, directly implicating IL-18 in the regulation of CNV development. These findings indicate a protective role for NLRP3 and IL-18 in the progression of AMD.	[Campbell, Matthew; Ozaki, Ema; Kenna, Paul F.; Farrar, Gwyneth Jane; Kiang, Anna-Sophia; Humphries, Marian M.; Humphries, Peter] Trinity Coll Dublin, Smurfit Inst Genet, Ocular Genet Unit, Dublin 2, Ireland; [Doyle, Sarah L.; Mori, Andres; Lavelle, Ed C.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Kenna, Paul F.] Royal Victoria Eye & Ear Hosp, Res Fdn, Dublin 2, Ireland; [Hollyfield, Joe G.] Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalmol, Cleveland, OH 44106 USA	Trinity College Dublin; Trinity College Dublin; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Campbell, M (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Ocular Genet Unit, Lincoln Pl Gate, Dublin 2, Ireland.	matthew.campbell@tcd.ie	Lavelle, Ed/A-1716-2008; Doyle, Sarah/C-1453-2014; Salomon, Robert G/C-3463-2008; Bateson, Jane Farrar/AAO-6147-2020	Lavelle, Ed/0000-0002-3167-1080; Doyle, Sarah/0000-0002-6294-9380; Salomon, Robert/0000-0001-9456-3557; O'Neill, Luke/0000-0002-4333-2748	American Health Assistance Foundation (AHAF); Science Foundation Ireland (SFI) [07/SRC/B1144, 08/RFP/MBT1363]; Health Research Board of Ireland (HRB); Irish Research Council for Science Engineering and Technology (IRCSET); Enterprise Ireland (EI); Telemedicine and Advanced Technology Research Center (TATRC); Fighting Blindness Ireland (FB-Ireland); SFI Immunology Research Centre (IRC); US National Institutes of Health [EY014240, GM021249, EY016813]; Macular Vision Research Foundation; Research to Prevent Blindness; Llura and Gordon Gund Foundation; NATIONAL EYE INSTITUTE [R56EY014240, R01EY014240, R01EY016813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	American Health Assistance Foundation (AHAF); Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board of Ireland (HRB); Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland (EI); Telemedicine and Advanced Technology Research Center (TATRC); Fighting Blindness Ireland (FB-Ireland); SFI Immunology Research Centre (IRC)(Science Foundation Ireland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Llura and Gordon Gund Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Ocular Genetics Unit at Trinity College Dublin is supported by the American Health Assistance Foundation (AHAF), Science Foundation Ireland (SFI), The Health Research Board of Ireland (HRB), Irish Research Council for Science Engineering and Technology (IRCSET), Enterprise Ireland (EI), Telemedicine and Advanced Technology Research Center (TATRC) and Fighting Blindness Ireland (FB-Ireland). S.L.D. and L.A.J.O. are supported by the SFI Immunology Research Centre (IRC) and the SFI Strategic Research Cluster (07/SRC/B1144). Support for the laboratory of J.G.H. was provided by the US National Institutes of Health through grant EY014240, the Macular Vision Research Foundation, Research to Prevent Blindness and the Llura and Gordon Gund Foundation. Support for the laboratory of R.G.S. was provided by the US National Institutes of Health through grants GM021249 and EY016813. Support for the laboratory of E.C.L. was from SFI grant number 08/RFP/MBT1363 and SFI Strategic Research Cluster 07/SRC/B1144. We would like to thank C. Woods, C. Murray, D. Flynn and R. Robertson for animal husbandry. The authors would also like to thank the Research Foundation at the Royal Victoria Eye and Ear Hospital for assistance in the acquisition of the Iridex laser system. We thank E. Latz (University of Bonn) for the provision of BMDMs expressing YFP-labeled ASC. We would like to acknowledge the expertise of K. Shadrach in isolating drusen from AMD donor eyes.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Arias L, 2010, RETINA-J RET VIT DIS, V30, P1601, DOI 10.1097/IAE.0b013e3181e9f942; Blanquet-Grossard F, 2005, BIOCHEMISTRY-US, V44, P4349, DOI 10.1021/bi047370a; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Campbell M, 2011, EMBO MOL MED, V3, P235, DOI 10.1002/emmm.201100126; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Edwards Albert O., 2007, Angiogenesis, V10, P119, DOI 10.1007/s10456-007-9064-2; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Giganti M, 2010, RETINA-J RET VIT DIS, V30, P71, DOI 10.1097/IAE.0b013e3181bcef3b; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Hageman GS, 1999, MOL VIS, V5; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ishii T, 1984, Appl Pathol, V2, P370; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jiang HR, 2001, INVEST OPHTH VIS SCI, V42, P177; Leveziel N, 2011, OPHTHALMOLOGICA, V226, DOI 10.1159/000328981; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Luo XG, 2003, J NEUROIMMUNOL, V135, P62, DOI 10.1016/S0165-5728(02)00444-7; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mallat Z, 2002, CIRC RES, V91, P441, DOI 10.1161/01.RES.0000033592.11674.D8; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; PERCOPO CM, 1990, J IMMUNOL, V145, P4101; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiao H, 2004, LAB INVEST, V84, P973, DOI 10.1038/labinvest.3700115; Qiao H, 2007, J LEUKOCYTE BIOL, V81, P1012, DOI 10.1189/jlb.0506342; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; SARKS SH, 1980, T OPHTHAL SOC UK, V100, P414; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; VINDING T, 1990, ACTA OPHTHALMOL, V68, P410; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	56	290	327	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					791	U191		10.1038/nm.2717	http://dx.doi.org/10.1038/nm.2717			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22484808	Green Accepted			2022-12-27	WOS:000303763500047
J	Wagner, J				Wagner, Jennifer			Cockamamie state laws threaten genetic rights	NATURE MEDICINE			English	Editorial Material								In the US, states anxious to establish genetic rights are acting in the absence of clear, informed leadership. The result is specious legislative language and conflicting proposals that create confusion and disrupt genetic research and healthcare activities. It's time to look beyond our state and national borders for guidance.	Univ Penn, Ctr Integrat Genet Healthcare Technol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wagner, J (corresponding author), Univ Penn, Ctr Integrat Genet Healthcare Technol, Philadelphia, PA 19104 USA.							[Anonymous], 2010, PRIVACY CONTEXT TECH, V148; Mitchell R, 2011, SCIENCE, V332, P309, DOI 10.1126/science.1199554; Vorhaus D., 2011, GENOMICS LAW REPORT	3	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					485	485		10.1038/nm0412-485	http://dx.doi.org/10.1038/nm0412-485			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22481400	Bronze			2022-12-27	WOS:000302617800016
J	Eichhorn, PJA; Rodon, L; Gonzalez-Junca, A; Dirac, A; Gili, M; Martinez-Saez, E; Aura, C; Barba, I; Peg, V; Prat, A; Cuartas, I; Jimenez, J; Garcia-Dorado, D; Sahuquillo, J; Bernards, R; Baselga, J; Seoane, J				Eichhorn, Pieter J. A.; Rodon, Laura; Gonzalez-Junca, Alba; Dirac, Annette; Gili, Maguei; Martinez-Saez, Elena; Aura, Claudia; Barba, Ignasi; Peg, Vicente; Prat, Aleix; Cuartas, Isabel; Jimenez, Jose; Garcia-Dorado, David; Sahuquillo, Juan; Bernards, Rene; Baselga, Jose; Seoane, Joan			USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma	NATURE MEDICINE			English	Article							E3 UBIQUITIN LIGASE; GROWTH-FACTOR-BETA; GLIOMA; SMURF2; DEGRADATION; PATHWAY; SMAD7; GENETICS; TARGETS; BIOLOGY	In advanced cancer, including glioblastoma, the transforming growth factor beta (TGF-beta) pathway acts as an oncogenic factor and is considered to be a therapeutic target. Using a functional RNAi screen, we identified the deubiquitinating enzyme ubiquitin-specific peptidase 15 (USP15) as a key component of the TGF-beta signaling pathway. USP15 binds to the SMAD7-SMAD specific E3 ubiquitin protein ligase 2 (SMURF2) complex and deubiquitinates and stabilizes type I TGF-beta receptor (T beta R-I), leading to an enhanced TGF-beta signal. High expression of USP15 correlates with high TGF-beta activity, and the USP15 gene is found amplified in glioblastoma, breast and ovarian cancer. USP15 amplification confers poor prognosis in individuals with glioblastoma. Downregulation or inhibition of USP15 in a patient-derived orthotopic mouse model of glioblastoma decreases TGF-beta activity. Moreover, depletion of USP15 decreases the oncogenic capacity of patient-derived glioma-initiating cells due to the repression of TGF-beta signaling. Our results show that USP15 regulates the TGF-beta pathway and is a key factor in glioblastoma pathogenesis.	[Seoane, Joan] Vall dHebron Univ Hosp, VHIO, Barcelona, Spain; [Dirac, Annette; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Dirac, Annette; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; [Martinez-Saez, Elena; Barba, Ignasi; Peg, Vicente; Garcia-Dorado, David; Sahuquillo, Juan] Vall dHebron Univ Hosp, VHIR, Barcelona, Spain; [Prat, Aleix] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Baselga, Jose; Seoane, Joan] Univ Autonoma Barcelona, Cerdanyola Del Valless, Spain; [Baselga, Jose] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA USA; [Seoane, Joan] ICREA, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Netherlands Cancer Institute; Netherlands Cancer Institute; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of North Carolina; University of North Carolina Chapel Hill; Autonomous University of Barcelona; Harvard University; Harvard Medical School; Massachusetts General Hospital; ICREA	Seoane, J (corresponding author), Vall dHebron Univ Hosp, VHIO, Barcelona, Spain.	jseoane@vhio.net	Martinez-Saez, Elena/E-9097-2018; Peg, Vicente/E-9160-2018; Sahuquillo, Juan/B-3577-2008; Prat, Aleix/P-8561-2014; Barba, Ignasi/A-5221-2011; Peg., Vicente/AAC-9447-2020; Barba, Ignasi/H-5104-2013; Seoane, Joan/AAG-9173-2019	Martinez-Saez, Elena/0000-0001-6004-5364; Peg, Vicente/0000-0002-5203-6166; Sahuquillo, Juan/0000-0003-0713-5875; Prat, Aleix/0000-0003-2377-540X; Barba, Ignasi/0000-0001-9886-3776; Peg., Vicente/0000-0002-5203-6166; Seoane, Joan/0000-0002-6541-5974; Eichhorn, Pieter/0000-0001-5840-943X; Bernards, Rene/0000-0001-8677-3423; Jimenez, Jose/0000-0002-2576-1776	Medical Oncology department; Neurosurgery department; Pathology department of the Vall d'Hebron Hospital; Instituto Carlos III [CM09/143, FIS (PI070648)]; Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA, ISCIII); European Research Council [ERC 205819]; Ministry of Science and Innovation [CSD2009-00080]; Asociacion Espanola Contra el Cancer (AECC); ICREA Funding Source: Custom	Medical Oncology department; Neurosurgery department; Pathology department of the Vall d'Hebron Hospital; Instituto Carlos III(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA, ISCIII); European Research Council(European Research Council (ERC)European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Asociacion Espanola Contra el Cancer (AECC); ICREA(ICREA)	We thank A. Saez-Border as and A. Arias for technical support. We also thank the Medical Oncology department, the Neurosurgery department and the Pathology department of the Vall d'Hebron Hospital for support. E. M. S. is supported by the Instituto Carlos III (CM09/143). I. B. and D.G.-D. were supported by the Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA, ISCIII). This work was supported by the European Research Council grant (ERC 205819), Instituto Carlos III grant FIS (PI070648), Ministry of Science and Innovation grant Consolider Ingenio 2010 program (CSD2009-00080) and the Asociacion Espanola Contra el Cancer (AECC) grant.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Huang XH, 2009, J MOL BIOL, V391, P691, DOI 10.1016/j.jmb.2009.06.066; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oettle, 2011, AM SOC CLIN ONCOLOGY; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rodon, 2011, J CLIN ONCOL S, V29; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; van der Eb A J, 1980, Methods Enzymol, V65, P826; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Xu ML, 2009, BIOCHEM BIOPH RES CO, V388, P366, DOI 10.1016/j.bbrc.2009.08.015; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	37	278	291	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					429	U192		10.1038/nm.2619	http://dx.doi.org/10.1038/nm.2619			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344298				2022-12-27	WOS:000301264800045
J	Goldman, M				Goldman, Michel			Public-private partnerships need honest brokering	NATURE MEDICINE			English	Editorial Material								Given the current challenges in research and development, it's increasingly apparent that collaboration between large pharmaceutical companies, academic teams and biotechnology enterprises is essential for converting basic biomedical discoveries into lifesaving medicines. But these partnerships work best when a neutral third party helps foster them.	Innovat Med Initiat, Brussels, Belgium		Goldman, M (corresponding author), Innovat Med Initiat, Brussels, Belgium.							Melese T, 2009, NAT MED, V15, P502, DOI 10.1038/nm0509-502; Pardoe D.A., 2011, DRUG DISCOV WORLD, V12, P9; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Strauss S, 2010, NAT BIOTECHNOL, V28, P631, DOI 10.1038/nbt0710-631; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819	5	13	13	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					342	342		10.1038/nm0312-341	http://dx.doi.org/10.1038/nm0312-341			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22395691	Bronze			2022-12-27	WOS:000301264800025
J	Guan, M; Yao, W; Liu, RW; Lam, KS; Nolta, J; Jia, JJ; Panganiban, B; Meng, LP; Zhou, P; Shahnazari, M; Ritchie, RO; Lane, NE				Guan, Min; Yao, Wei; Liu, Ruiwu; Lam, Kit S.; Nolta, Jan; Jia, Junjing; Panganiban, Brian; Meng, Liping; Zhou, Ping; Shahnazari, Mohammad; Ritchie, Robert O.; Lane, Nancy E.			Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass	NATURE MEDICINE			English	Article							IN-VIVO DISTRIBUTION; PARATHYROID-HORMONE; MARROW; INTEGRIN; DIFFERENTIATION; MATRIX; TRANSPLANTATION; REGENERATION; EXPRESSION; PREVENTS	Aging reduces the number of mesenchymal stem cells (MSCs) that can differentiate into osteoblasts in the bone marrow, which leads to impairment of osteogenesis. However, if MSCs could be directed toward osteogenic differentiation, they could be a viable therapeutic option for bone regeneration. We have developed a method to direct MSCs to the bone surface by attaching a synthetic high-affinity and specific peptidomimetic ligand (LLP2A) against integrin alpha 4 beta 1 on the MSC surface to a bisphosphonate (alendronate, Ale) that has a high affinity for bone. LLP2A-Ale induced MSC migration and osteogenic differentiation in vitro. A single intravenous injection of LLP2A-Ale increased trabecular bone formation and bone mass in both xenotransplantation studies and in immunocompetent mice. Additionally, LLP2A-Ale prevented trabecular bone loss after peak bone acquisition was achieved or as a result of estrogen deficiency. These results provide proof of principle that LLP2A-Ale can direct MSCs to the bone to form new bone and increase bone strength.	[Guan, Min; Yao, Wei; Lam, Kit S.; Jia, Junjing; Shahnazari, Mohammad; Lane, Nancy E.] Univ Calif, Davis Med Ctr, Dept Internal Med, Musculoskeletal Res Grp, Sacramento, CA USA; [Lam, Kit S.; Meng, Liping] Univ Calif, Davis Med Ctr, Dept Biochem & Mol Med, Sacramento, CA USA; [Nolta, Jan; Zhou, Ping] Univ Calif, Davis Med Ctr, Dept Internal Med, Stem Cell Program, Sacramento, CA USA; [Nolta, Jan; Zhou, Ping] Univ Calif, Davis Med Ctr, Inst Regenerat Cures, Sacramento, CA USA; [Panganiban, Brian; Ritchie, Robert O.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Yao, W (corresponding author), Univ Calif, Davis Med Ctr, Dept Internal Med, Musculoskeletal Res Grp, Sacramento, CA USA.	wei.yao@ucdmc.ucdavis.edu	Shahnazari, Mohammad Reza/AAU-8573-2020; Yao, Wei/O-8187-2019; yao, wei/GVS-3913-2022; meng, li/GVT-2063-2022; Ritchie, Robert O/A-8066-2008	Shahnazari, Mohammad Reza/0000-0001-8647-5426; Yao, Wei/0000-0002-1198-1161; yao, wei/0000-0002-1198-1161; Ritchie, Robert O/0000-0002-0501-6998; Nolta, Jan/0000-0003-4576-8542; Guan, Min/0000-0003-3851-8553	National Center for Research Resources of the US National Institutes of Health [P40RR017447]; US National Institutes of Health [NIAMS-5R21AR057515, NIAM-R01AR043052, 1K12HD05195801]; US National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (ORWH); Office of Dietary Supplements (ODS); US National Institute of Aging (NIA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063043, R01AR043052, R21AR057515, R01AR061366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099688] Funding Source: NIH RePORTER	National Center for Research Resources of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Aging (NIA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The mouse MSCs used in this work were provided by the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White through a grant from National Center for Research Resources of the US National Institutes of Health grant P40RR017447. This work was funded by the US National Institutes of Health grants NIAMS-5R21AR057515 (to W.Y.), NIAM-R01AR043052 (to N.E.L.) and 1K12HD05195801 and was co-funded by the US National Institute of Child Health and Human Development (NICHD), the Office of Research on Women's Health (ORWH), the Office of Dietary Supplements (ODS) and the US National Institute of Aging (NIA).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Dao MA, 1998, P NATL ACAD SCI USA, V95, P13006, DOI 10.1073/pnas.95.22.13006; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Gutwald R, 2010, BRIT J ORAL MAX SURG, V48, P285, DOI 10.1016/j.bjoms.2009.06.226; Halleux C., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P71; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Kamibayashi L.K., 1999, J BONE MINER RES, V14, P1; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Li HX, 2009, CELLS TISSUES ORGANS, V190, P94, DOI 10.1159/000166547; Longobardi L, 2009, GROWTH FACTORS, V27, P309, DOI 10.1080/08977190903138874; Luo JT, 2008, J COMB CHEM, V10, P599, DOI 10.1021/cc8000663; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Muraglia A, 2000, J CELL SCI, V113, P1161; OWEN M, 1988, CIBA F SYMP, V136, P42; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pedram MS, 2010, SPINAL CORD, V48, P457, DOI 10.1038/sc.2009.153; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Sato M, 2002, ENDOCRINOLOGY, V143, P3230, DOI 10.1210/en.2002-220149; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Vertenten G, 2009, TISSUE ENG PT A, V15, P1501, DOI 10.1089/ten.tea.2008.0367; VUKICEVIC S, 1990, CELL, V63, P437, DOI 10.1016/0092-8674(90)90176-F; Yao W, 2008, ARTHRITIS RHEUM, V58, P3485, DOI 10.1002/art.23954; Yao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011410; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029	39	197	211	2	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					456	U159		10.1038/nm.2665	http://dx.doi.org/10.1038/nm.2665			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22306732	Green Accepted, Green Submitted			2022-12-27	WOS:000301264800050
J	Wang, Y; Barker, K; Shi, SP; Diaz, M; Mo, B; Gutstein, HB				Wang, Yan; Barker, Katherine; Shi, Shanping; Diaz, Miguel; Mo, Bing; Gutstein, Howard B.			Blockade of PDGFR-beta activation eliminates morphine analgesic tolerance	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; INHIBITION; DEPENDENCE; CHANNEL; BRAIN; CELLS	For centuries, opioid drugs have been the mainstay of chronic pain treatment. However, over time analgesic tolerance develops, leaving few treatment options. Here we show that platelet-derived growth factor receptor-beta (PDGFR-beta)-mediated signaling plays a key role in morphine tolerance. PDGFR-beta inhibition selectively eliminates morphine tolerance in rats. PDGFR-beta inhibitors are widely used and well tolerated, suggesting that clinical translation of our findings could reduce the suffering endured by individuals with intractable pain.	[Wang, Yan; Barker, Katherine; Shi, Shanping; Diaz, Miguel; Mo, Bing; Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA; [Wang, Yan; Barker, Katherine; Shi, Shanping; Diaz, Miguel; Mo, Bing; Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Genes & Dev Grad Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gutstein, HB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA.	hgutstein@mdanderson.org			US National Institute on Drug Abuse [R01DA15146]; US National Institute on Alcohol Abuse and Alcoholism [R01AA16157]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015146] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Dulin, T. Sylvester and C. Schultz for technical support. This work was funded by grants from the US National Institute on Drug Abuse R01DA15146 and the US National Institute on Alcohol Abuse and Alcoholism R01AA16157 to H. B. G. We dedicate this work to the memory of our colleague and dear friend Bing Mo, who tragically passed away before these studies were completed.	AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Black MJ, 2003, J NEUROSCI RES, V74, P23, DOI 10.1002/jnr.10748; Chen C, 2006, CURR NEUROVASC RES, V3, P171, DOI 10.2174/156720206778018767; CODERRE TJ, 1994, PAIN, V59, P345, DOI 10.1016/0304-3959(94)90020-5; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; FRACE AM, 1989, P NATL ACAD SCI USA, V86, P2511, DOI 10.1073/pnas.86.7.2511; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOLD LH, 1994, EUR J PHARMACOL, V253, P45, DOI 10.1016/0014-2999(94)90755-2; Gutstein HB, 2006, GOODMAN GILMANS PHAR, P547; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kolesnikov Y, 1998, J PHARMACOL EXP THER, V284, P455; MALMBERG AB, 1993, PAIN, V54, P291, DOI 10.1016/0304-3959(93)90028-N; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; TIMPE LC, 1994, J NEUROSCI, V14, P1195, DOI 10.1523/JNEUROSCI.14-03-01195.1994; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299	20	42	44	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					385	387		10.1038/nm.2633	http://dx.doi.org/10.1038/nm.2633			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344297	Green Accepted			2022-12-27	WOS:000301264800039
J	Lei, P; Ayton, S; Finkelstein, DI; Spoerri, L; Ciccotosto, GD; Wright, DK; Wong, BXW; Adlard, PA; Cherny, RA; Lam, LQ; Roberts, BR; Volitakis, I; Egan, GF; McLean, CA; Cappai, R; Duce, JA; Bush, AI				Lei, Peng; Ayton, Scott; Finkelstein, David I.; Spoerri, Loredana; Ciccotosto, Giuseppe D.; Wright, David K.; Wong, Bruce X. W.; Adlard, Paul A.; Cherny, Robert A.; Lam, Linh Q.; Roberts, Blaine R.; Volitakis, Irene; Egan, Gary F.; McLean, Catriona A.; Cappai, Roberto; Duce, James A.; Bush, Ashley I.			Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export	NATURE MEDICINE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMER-DISEASE; MOUSE MODEL; NEURONS; IMPAIRMENT; VARIANTS; MRI	The microtubule-associated protein tau has risk alleles for both Alzheimer's disease and Parkinson's disease and mutations that cause brain degenerative diseases termed tauopathies(1-4). Aggregated tau forms neurofibrillary tangles in these pathologies(3,5), but little is certain about the function of tau or its mode of involvement in pathogenesis. Neuronal iron accumulation has been observed pathologically in the cortex in Alzheimer's disease(6,7), the substantia nigra (SN) in Parkinson's disease(8-11) and various brain regions in the tauopathies(11,12). Here we report that tau-knockout mice develop age-dependent brain atrophy, iron accumulation and SN neuronal loss, with concomitant cognitive deficits and parkinsonism. These changes are prevented by oral treatment with a moderate iron chelator, clioquinol. Amyloid precursor protein (APP) ferroxidase activity couples with surface ferroportin to export iron, but its activity is inhibited in Alzheimer's disease, thereby causing neuronal iron accumulation(7). In primary neuronal culture, we found loss of tau also causes iron retention, by decreasing surface trafficking of APP. Soluble tau levels fall in affected brain regions in Alzheimer's disease and tauopathies(13-15), and we found a similar decrease of soluble tau in the SN in both Parkinson's disease and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model. These data suggest that the loss of soluble tau could contribute to toxic neuronal iron accumulation in Alzheimer's disease, Parkinson's disease and tauopathies, and that it can be rescued pharmacologically.	[Lei, Peng; Ayton, Scott; Finkelstein, David I.; Ciccotosto, Giuseppe D.; Wong, Bruce X. W.; Adlard, Paul A.; Cherny, Robert A.; Lam, Linh Q.; Roberts, Blaine R.; Volitakis, Irene; Duce, James A.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia; [Lei, Peng; Spoerri, Loredana; Ciccotosto, Giuseppe D.; Adlard, Paul A.; McLean, Catriona A.; Cappai, Roberto; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Ayton, Scott; Finkelstein, David I.; Duce, James A.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Spoerri, Loredana; Ciccotosto, Giuseppe D.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Wright, David K.; Egan, Gary F.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia.	ashleyib@unimelb.edu.au	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Wong, Bruce/AAY-5884-2020; Spoerri, Loredana/G-4862-2014; Egan, Gary F./A-1381-2013; Ayton, Scott/J-8000-2015; Lei, Peng/F-6326-2010; Finkelstein, David/B-9617-2009; Ayton, Scott/AAJ-3414-2021; Cappai, Roberto/B-3347-2010	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Wong, Bruce/0000-0002-1687-4138; Spoerri, Loredana/0000-0003-0756-9390; Ayton, Scott/0000-0002-3479-2427; Lei, Peng/0000-0001-5652-1962; Finkelstein, David/0000-0002-8167-4917; Egan, Gary/0000-0002-3186-4026; Volitakis, Irene/0000-0003-0766-817X; Cappai, Roberto/0000-0002-9505-8496; Duce, James/0000-0002-8762-2245; Wright, David/0000-0002-7535-8651; Roberts, Blaine/0000-0001-5466-0053; McLean, Catriona/0000-0002-0302-5727	Australian Research Council; National Health & Medical Research Council of Australia (NHMRC); Alzheimer's Association; The University of Melbourne; The Mental Health Research Institute; The Alfred Hospital; Victorian Forensic Institute of Medicine; Neurosciences Australia; NHMRC; Alzheimers Research UK [ART-SRF2011-1] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Association(Alzheimer's Association); The University of Melbourne(University of Melbourne); The Mental Health Research Institute; The Alfred Hospital; Victorian Forensic Institute of Medicine; Neurosciences Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by funds from the Australian Research Council, the National Health & Medical Research Council of Australia (NHMRC) and the Alzheimer's Association. The Victorian Brain Bank Network is supported by The University of Melbourne, The Mental Health Research Institute, The Alfred Hospital and the Victorian Forensic Institute of Medicine, and funded by Neurosciences Australia and the NHMRC. The authors thank Y-H. Hung, H. Kim, S.H. Bush and A. Sedjahtera for helpful discussion and technical assistance, H.N. Dawson (Duke University) for providing the tau-knockout mice, and TA. Rouault and D.L. Zhang (US National Institutes of Health) for MAP23 antibody.	Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson HN, 2001, J CELL SCI, V114, P1179; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7948; Laws SM, 2008, NEUROBIOL AGING, V29, P1276, DOI 10.1016/j.neurobiolaging.2007.02.019; Laws SM, 2007, MOL PSYCHIATR, V12, P510, DOI 10.1038/sj.mp.4001935; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; O'Neill J, 2002, MOVEMENT DISORD, V17, P917, DOI 10.1002/mds.10214; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; Paisan-Ruiz C., NEUROBIOL A IN PRESS; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; SMITH MA, 1995, NAT MED, V1, P365, DOI 10.1038/nm0495-365; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhukareva V, 2003, ACTA NEUROPATHOL, V105, P469, DOI 10.1007/s00401-002-0668-8	32	391	405	2	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					291	295		10.1038/nm.2613	http://dx.doi.org/10.1038/nm.2613			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286308				2022-12-27	WOS:000300140300045
J	Marichal, T; Ohata, K; Bedoret, D; Mesnil, C; Sabatel, C; Kobiyama, K; Lekeux, P; Coban, C; Akira, S; Ishii, KJ; Bureau, F; Desmet, CJ				Marichal, Thomas; Ohata, Keiichi; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Kobiyama, Kouji; Lekeux, Pierre; Coban, Cevayir; Akira, Shizuo; Ishii, Ken J.; Bureau, Fabrice; Desmet, Christophe J.			DNA released from dying host cells mediates aluminum adjuvant activity	NATURE MEDICINE			English	Article							INFLAMMATORY DENDRITIC CELLS; INNATE IMMUNE-RESPONSE; HELPER T-CELLS; NALP3 INFLAMMASOME; CYTOSOLIC DNA; STEADY-STATE; I INTERFERON; HYDROXIDE; ACTIVATION; NLRP3	Aluminum-based adjuvants (aluminum salts or alum) are widely used in human vaccination, although their mechanisms of action are poorly understood. Here we report that, in mice, alum causes cell death and the subsequent release of host cell DNA, which acts as a potent endogenous immunostimulatory signal mediating alum adjuvant activity. Furthermore, we propose that host DNA signaling differentially regulates IgE and IgG1 production after alum-adjuvanted immunization. We suggest that, on the one hand, host DNA induces primary B cell responses, including IgG1 production, through interferon response factor 3 (Irf3)-independent mechanisms. On the other hand, we suggest that host DNA also stimulates 'canonical' T helper type 2 (T(H)2) responses, associated with IgE isotype switching and peripheral effector responses, through Irf3-dependent mechanisms. The finding that host DNA released from dying cells acts as a damage-associated molecular pattern that mediates alum adjuvant activity may increase our understanding of the mechanisms of action of current vaccines and help in the design of new adjuvants.	[Marichal, Thomas; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Grp Interdisciplinaire Genoprote Appl, Lab Cellular & Mol Physiol, Liege, Belgium; [Marichal, Thomas; Bedoret, Denis; Mesnil, Claire; Sabatel, Catherine; Lekeux, Pierre; Bureau, Fabrice; Desmet, Christophe J.] Univ Liege, Fac Vet Med, Biochem Lab, Liege, Belgium; [Ohata, Keiichi; Kobiyama, Kouji; Coban, Cevayir; Akira, Shizuo; Ishii, Ken J.] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Kobiyama, Kouji; Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Osaka, Japan	University of Liege; University of Liege; Osaka University; National Institute of Health Sciences - Japan	Desmet, CJ (corresponding author), Univ Liege, Grp Interdisciplinaire Genoprote Appl, Lab Cellular & Mol Physiol, Liege, Belgium.	kenishii@biken.osaka-u.ac.jp; christophe.desmet@ulg.ac.be	Akira, Shizuo/C-3134-2009; Coban, Cevayir/B-2129-2012; COBAN, Cevayir/P-1928-2019; Ishii, Ken J/B-1685-2012	COBAN, Cevayir/0000-0002-4467-7799; Ishii, Ken J/0000-0002-6728-3872; Ohata, Keiichi/0000-0002-5635-4292	FRS-FNRS; Belgian Fonds de la Recherche Scientifique Medicale; Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE, Belgian Science Policy); Knowledge Cluster Initiative; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE, Belgian Science Policy)(Belgian Federal Science Policy Office); Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	T. M., D. B., C. M. and C. S. are research fellows, and C. J. D. is a postdoctoral fellow of the Fonds National de la Recherche Scientifique (FRS-FNRS; Belgium). This work was supported by grants of the FRS-FNRS, the Belgian Fonds de la Recherche Scientifique Medicale and the Belgian Programme on Interuniversity Attraction Poles (IUAP; FEDIMMUNE, Belgian Science Policy). This work was also partly supported by the Knowledge Cluster Initiative (K. J. I.); a Grant-in-Aid for Scientific Research (K. J. I. and C. C.) of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); and by the Core Research Evolutionary Science and Technology (CREST) program at the Japan Science and Technology Agency (K.J.I.).	Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Goto N, 1997, VACCINE, V15, P1364, DOI 10.1016/S0264-410X(97)00054-6; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; MANNHALTER JW, 1985, CLIN EXP IMMUNOL, V61, P143; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nigg AP, 2007, J IMMUNOL, V178, P7251, DOI 10.4049/jimmunol.178.11.7251; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Robinson RT, 2008, J IMMUNOL, V181, P5560, DOI 10.4049/jimmunol.181.8.5560; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	53	371	380	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					996	U118		10.1038/nm.2403	http://dx.doi.org/10.1038/nm.2403			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21765404				2022-12-27	WOS:000293507400034
J	Iadecola, C; Anrather, J				Iadecola, Costantino; Anrather, Josef			The immunology of stroke: from mechanisms to translation	NATURE MEDICINE			English	Review							FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; TOLL-LIKE RECEPTOR; FACTOR-KAPPA-B; DELTA-T-CELLS; MAST-CELLS; ARTERY OCCLUSION; GROWTH-FACTOR; NEUTROPHIL RECRUITMENT; INFLAMMATORY RESPONSE	Immunity and inflammation are key elements of the pathobiology of stroke, a devastating illness second only to cardiac ischemia as a cause of death worldwide. The immune system participates in the brain damage produced by ischemia, and the damaged brain, in turn, exerts an immunosuppressive effect that promotes fatal infections that threaten the survival of people after stroke. Inflammatory signaling is involved in all stages of the ischemic cascade, from the early damaging events triggered by arterial occlusion to the late regenerative processes underlying post-ischemic tissue repair. Recent developments have revealed that stroke engages both innate and adaptive immunity. But adaptive immunity triggered by newly exposed brain antigens does not have an impact on the acute phase of the damage. Nevertheless, modulation of adaptive immunity exerts a remarkable protective effect on the ischemic brain and offers the prospect of new stroke therapies. As immunomodulation is not devoid of deleterious side effects, a better understanding of the reciprocal interaction between the immune system and the ischemic brain is essential to harness the full therapeutic potential of the immunology of stroke.	[Iadecola, Costantino; Anrather, Josef] Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA	Cornell University	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA.	coi2001@med.cornell.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	US National Institutes of Health [R37-NS34179, NS35806]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035806, R37NS034179, R01NS056456] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the US National Institutes of Health grants R37-NS34179 and NS35806. We apologize that the scope of the topic prevented citation of many important studies.	Abbas A.K., 2010, BASIC IMMUNOLOGY UPD; Andrews DM, 2010, IMMUNOL CELL BIOL, V88, P107, DOI 10.1038/icb.2009.94; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Bacigaluppi Marco, 2010, Open Neurol J, V4, P26, DOI 10.2174/1874205X01004020026; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Becker K, 2003, STROKE, V34, P1809, DOI 10.1161/01.STR.0000078308.77727.EA; Becker KJ, 2009, NEUROSCIENCE, V158, P1090, DOI 10.1016/j.neuroscience.2008.07.027; Becker KJ, 2005, J CEREBR BLOOD F MET, V25, P1634, DOI 10.1038/sj.jcbfm.9600160; Becker KJ, 1997, P NATL ACAD SCI USA, V94, P10873, DOI 10.1073/pnas.94.20.10873; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bornstein NM, 2001, NEUROLOGY, V56, P529, DOI 10.1212/WNL.56.4.529; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Bune LT, 2010, BLOOD COAGUL FIBRIN, V21, P436, DOI 10.1097/MBC.0b013e328338db27; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carmichael ST, 2010, NEUROBIOL DIS, V37, P237, DOI 10.1016/j.nbd.2009.09.005; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Cui M, 2010, NEUROBIOL DIS, V39, P138, DOI 10.1016/j.nbd.2010.03.018; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Zoppo GJ, 2004, E SCHERING RES FDN W, V47, P155; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Denes A, 2011, J CEREBR BLOOD F MET, V31, P1036, DOI 10.1038/jcbfm.2010.198; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Frenkel D, 2003, J IMMUNOL, V171, P6549, DOI 10.4049/jimmunol.171.12.6549; Furuya K, 2001, STROKE, V32, P2665, DOI 10.1161/hs3211.098535; Gee J Michael, 2009, Exp Transl Stroke Med, V1, P3, DOI 10.1186/2040-7378-1-3; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Genain CP, 1996, SCIENCE, V274, P2054, DOI 10.1126/science.274.5295.2054; Gendron A, 2002, BRAIN RES, V955, P85, DOI 10.1016/S0006-8993(02)03368-1; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Greenberg David A, 2006, NeuroRx, V3, P458, DOI 10.1016/j.nurx.2006.08.003; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Haeusler KG, 2012, INT J CARDIOL, V155, P372, DOI 10.1016/j.ijcard.2010.10.053; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hao Q, 2007, J CEREBR BLOOD F MET, V27, P1853, DOI 10.1038/sj.jcbfm.9600485; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Ishikawa M, 2004, FRONT BIOSCI-LANDMRK, V9, P1339, DOI 10.2741/1330; Itakura A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-75; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Kostulas N, 2002, STROKE, V33, P1129, DOI 10.1161/hs0402.105379; Kreisel D, 2002, J IMMUNOL, V169, P6154, DOI 10.4049/jimmunol.169.11.6154; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Matsumoto H, 2007, NEUROSCI LETT, V418, P44, DOI 10.1016/j.neulet.2007.03.027; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Mena H, 2004, ACTA NEUROPATHOL, V108, P524, DOI 10.1007/s00401-004-0918-z; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; Peachell P, 2006, CLIN REV ALLERG IMMU, V31, P131, DOI 10.1385/CRIAI:31:2:131; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.009; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Pradillo JM, 2005, J CEREBR BLOOD F MET, V25, P193, DOI 10.1038/sj.jcbfm.9600019; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prestigiacomo CJ, 1999, STROKE, V30, P1110, DOI 10.1161/01.STR.30.5.1110; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Ren XF, 2011, METAB BRAIN DIS, V26, P87, DOI 10.1007/s11011-010-9226-6; ROCKLIN RE, 1971, NEW ENGL J MED, V284, P803, DOI 10.1056/NEJM197104152841501; Sairanen TR, 1997, J CEREBR BLOOD F MET, V17, P1107, DOI 10.1097/00004647-199710000-00013; Samson MT, 2003, J IMMUNOL, V170, P4953, DOI 10.4049/jimmunol.170.10.4953; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schock SC, 2007, BRAIN RES, V1168, P129, DOI 10.1016/j.brainres.2007.06.070; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwartz M, 2009, NEUROSCIENCE, V158, P1133, DOI 10.1016/j.neuroscience.2008.12.013; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stowe AM, 2009, NEUROBIOL DIS, V35, P82, DOI 10.1016/j.nbd.2009.04.006; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Subramanian S, 2009, STROKE, V40, P2539, DOI 10.1161/STROKEAHA.108.543991; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Yanamadala V, 2010, TRENDS MOL MED, V16, P69, DOI 10.1016/j.molmed.2009.12.001; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yilmaz A, 2010, CLIN SCI, V118, P147, DOI 10.1042/CS20090154; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Yilmaz G, 2010, NEUROMOL MED, V12, P193, DOI 10.1007/s12017-009-8074-1; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zierath D, 2010, NEUROCRIT CARE, V12, P274, DOI 10.1007/s12028-009-9270-4; Ziv Y, 2007, STROKE, V38, P774, DOI 10.1161/01.STR.0000255784.27298.23	140	1561	1645	14	349	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					796	808		10.1038/nm.2399	http://dx.doi.org/10.1038/nm.2399			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21738161	Green Accepted			2022-12-27	WOS:000292500800032
J	Cui, YJ; Niziolek, PJ; MacDonald, BT; Zylstra, CR; Alenina, N; Robinson, DR; Zhong, ZD; Matthes, S; Jacobsen, CM; Conlon, RA; Brommage, R; Liu, QY; Mseeh, F; Powell, DR; Yang, QM; Zambrowicz, B; Gerrits, H; Gossen, JA; He, X; Bader, M; Williams, BO; Warman, ML; Robling, AG				Cui, Yajun; Niziolek, Paul J.; MacDonald, Bryan T.; Zylstra, Cassandra R.; Alenina, Natalia; Robinson, Daniel R.; Zhong, Zhendong; Matthes, Susann; Jacobsen, Christina M.; Conlon, Ronald A.; Brommage, Robert; Liu, Qingyun; Mseeh, Faika; Powell, David R.; Yang, Qi M.; Zambrowicz, Brian; Gerrits, Han; Gossen, Jan A.; He, Xi; Bader, Michael; Williams, Bart O.; Warman, Matthew L.; Robling, Alexander G.			Lrp5 functions in bone to regulate bone mass	NATURE MEDICINE			English	Article							RECEPTOR-RELATED PROTEIN-5; RECOMBINASE EXPRESSION; SEROTONIN SYNTHESIS; NEGATIVE REGULATOR; MISSENSE MUTATIONS; CRE RECOMBINASE; MICE DEFICIENT; WNT CORECEPTOR; GENE; MOUSE	The human skeleton is affected by mutations in low-density lipoprotein receptor-related protein 5 (LRP5). To understand how LRP5 influences bone properties, we generated mice with osteocyte-specific expression of inducible Lrp5 mutations that cause high and low bone mass phenotypes in humans. We found that bone properties in these mice were comparable to bone properties in mice with inherited mutations. We also induced an Lrp5 mutation in cells that form the appendicular skeleton but not in cells that form the axial skeleton; we observed that bone properties were altered in the limb but not in the spine. These data indicate that Lrp5 signaling functions locally, and they suggest that increasing LRP5 signaling in mature bone cells may be a strategy for treating human disorders associated with low bone mass, such as osteoporosis.	[Cui, Yajun; Jacobsen, Christina M.; Warman, Matthew L.] Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Boston, MA 02115 USA; [Cui, Yajun; Conlon, Ronald A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Niziolek, Paul J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Niziolek, Paul J.; Robling, Alexander G.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Niziolek, Paul J.; Robling, Alexander G.] Indiana Univ Sch Med, Dept Biomed Engn, Indianapolis, IN USA; [MacDonald, Bryan T.; He, Xi] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [MacDonald, Bryan T.; He, Xi] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Zylstra, Cassandra R.; Robinson, Daniel R.; Zhong, Zhendong; Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI USA; [Alenina, Natalia; Matthes, Susann; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Brommage, Robert; Liu, Qingyun; Mseeh, Faika; Powell, David R.; Yang, Qi M.; Zambrowicz, Brian] Lexicon Pharmaceut, The Woodlands, TX USA; [Gerrits, Han; Gossen, Jan A.] Merck Sharp & Dohme Res Labs, Oss, Netherlands; [Warman, Matthew L.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Boston Children's Hospital; Case Western Reserve University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Van Andel Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Lexicon Pharmaceuticals; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Warman, ML (corresponding author), Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu	Zhong, Zhendong/K-5223-2013; Williams, Bart/A-3539-2013; Brommage, Robert/J-5670-2019; Bader, Michael/K-2124-2013	Williams, Bart/0000-0002-5261-5301; Brommage, Robert/0000-0002-9947-3822; Bader, Michael/0000-0003-4780-4164; Diegel, Cassandra/0000-0002-6526-9372	US National Institutes of Health (NIH) [AR53237]; Public Health Service [UL 1RR025761-02]; NIH [GM74241, AR053293]; Leukemia and Lymphoma Society; Van Andel Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237, R01AR053293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Van Andel Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratories for technical support: B. Newby, K. Kurek and E. Boyden for assistance with the HBM mouse studies; G. Zhou for assistance with histomorphometry; M. Niedecker and E. Kleinschmidt for assistance with radiography; the Case Transgenic and Targeting Facility; K. Sisson and P. Swiatek of the Van Andel Research Institute Mouse Germline Modification Core; B. Eagleson and the staff of the Van Andel Research Institute Vivarium; J. Bardenhagen, J. Greer, S. Jeter-Jones, J. Liu, M.K. Shadoan, D.D. Smith, W. Xiong and A. Yu of Lexicon Pharmaceuticals; and F. Bourgondien, R. Zhang and S. Yeh of Merck Sharp & Dohme Research Laboratories. This work was supported by the following grants: US National Institutes of Health (NIH) grant AR53237 (to A.G.R.); Public Health Service Career Development Award (UL 1RR025761-02) (to P.J.N.); NIH grant (GM74241) and a Leukemia and Lymphoma Society Scholarship (both to X.H.); NIH grant AR053293 and Van Andel Research Institute funds (to B.O.W.). M.L.W. is an investigator with the Howard Hughes Medical Institute.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; ANDERSON GM, 1987, LIFE SCI, V41, P1777, DOI 10.1016/0024-3205(87)90696-5; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; INGEBRETSEN OC, 1985, CLIN CHEM, V31, P695; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2008, CELL, V135, P795, DOI 10.1016/j.cell.2008.11.007; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rosen CJ, 2009, NEW ENGL J MED, V360, P957, DOI 10.1056/NEJMp0810058; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Tenner K, 2008, NEUROSCI LETT, V431, P21, DOI 10.1016/j.neulet.2007.11.012; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wolff J., 1892, LAW BONE REMODELING; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	57	330	346	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					684	U73		10.1038/nm.2388	http://dx.doi.org/10.1038/nm.2388			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602802	Green Accepted			2022-12-27	WOS:000291308800028
J	Pitcher, GM; Kalia, LV; Ng, D; Goodfellow, NM; Yee, KT; Lambe, EK; Salter, MW				Pitcher, Graham M.; Kalia, Lorraine V.; Ng, David; Goodfellow, Nathalie M.; Yee, Kathleen T.; Lambe, Evelyn K.; Salter, Michael W.			Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors	NATURE MEDICINE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; TYROSINE KINASE SRC; PREFRONTAL CORTEX; IN-VIVO; ERBB4; EXPRESSION; HIPPOCAMPUS; PROTEIN; MICE	Hypofunction of the N-methyl D-aspartate subtype of glutamate receptor (NMDAR) is hypothesized to be a mechanism underlying cognitive dysfunction in individuals with schizophrenia. For the schizophrenia-linked genes NRG1 and ERBB4, NMDAR hypofunction is thus considered a key detrimental consequence of the excessive NRG1-ErbB4 signaling found in people with schizophrenia. However, we show here that neuregulin 1 beta-ErbB4 (NRG1 beta-ErbB4) signaling does not cause general hypofunction of NMDARs. Rather, we find that, in the hippocampus and prefrontal cortex, NRG1 beta-ErbB4 signaling suppresses the enhancement of synaptic NMDAR currents by the nonreceptor tyrosine kinase Src. NRG1 beta-ErbB4 signaling prevented induction of long-term potentiation at hippocampal Schaffer collateral-CA1 synapses and suppressed Src-dependent enhancement of NMDAR responses during theta-burst stimulation. Moreover, NRG1 beta-ErbB4 signaling prevented theta burst-induced phosphorylation of GluN2B by inhibiting Src kinase activity. We propose that NRG1-ErbB4 signaling participates in cognitive dysfunction in schizophrenia by aberrantly suppressing Src-mediated enhancement of synaptic NMDAR function.	[Pitcher, Graham M.; Kalia, Lorraine V.; Ng, David; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Pitcher, Graham M.; Goodfellow, Nathalie M.; Lambe, Evelyn K.; Salter, Michael W.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A1, Canada; [Kalia, Lorraine V.; Salter, Michael W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Yee, Kathleen T.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Tufts University	Salter, MW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca	Lambe, Evelyn K/K-3699-2015	Lambe, Evelyn K/0000-0002-5994-6090; Kalia, Lorraine/0000-0002-9384-1305	Canadian Institutes of Health Research (CIHR) [MT-12682, MOP-89825]; Deafness Research Foundation; Merck Frosst Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Deafness Research Foundation; Merck Frosst Fellowship	We thank J. F. MacDonald, P. A. Frankland, L. Y. Wang, M. F. Jackson and M. H. Pitcher for critical reading of the manuscript, and Genentech and L. Mei for providing NRG1 beta. Src knockout mice were obtained as a gift from B. F. Boyce, University of Rochester Medical Center. This study was supported by grants from the Canadian Institutes of Health Research (CIHR) to M. W. S. (MT-12682) and to E. K. L. (MOP-89825), and from the Deafness Research Foundation to K. T. Y. M. W. S. holds a Canada research chair (tier I) in neuroplasticity and pain, and is an International Research Scholar of the Howard Hughes Medical Institute. E. K. L. holds a Canada research chair (tier II) in developmental cortical physiology. G. M. P. was a CIHR postdoctoral fellow and was supported by a Merck Frosst Fellowship award. D. N. held a CIHR doctoral research award, L. V. K. was a CIHR MD-PhD student, and N. M. G. holds a CIHR Canada Graduate Scholarship doctoral award. We thank D. Wong, J. Hicks and S. Singhroy for technical support.	Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Benetti S, 2009, BRAIN, V132, P2426, DOI 10.1093/brain/awp098; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Colantuoni C, 2008, BRAIN STRUCT FUNCT, V213, P255, DOI 10.1007/s00429-008-0181-5; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Grant SGN, 2001, J NEUROSCI, V21, P8315, DOI 10.1523/JNEUROSCI.21-21-08315.2001; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Iyengar SS, 2008, BRAIN RES, V1208, P67, DOI 10.1016/j.brainres.2008.02.045; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014185; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lindsley CW, 2006, CURR TOP MED CHEM, V6, P771, DOI 10.2174/156802606777057599; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Ma L, 2003, J NEUROSCI, V23, P3164; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; MacDonald JF, 2001, CURR DRUG TARGETS, V2, P299, DOI 10.2174/1389450013348452; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Nicodemus KK, 2009, MOL PSYCHIATR, V14, P741, DOI 10.1038/mp.2008.150; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tan W, 2007, J BIOL CHEM, V282, P24343, DOI 10.1074/jbc.M702953200; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xu JD, 2008, J BIOL CHEM, V283, P17503, DOI 10.1074/jbc.M800917200; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zierhut K, 2010, PSYCHIAT RES-NEUROIM, V183, P187, DOI 10.1016/j.pscychresns.2010.03.007	60	123	127	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					470	U111		10.1038/nm.2315	http://dx.doi.org/10.1038/nm.2315			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21441918	Green Accepted			2022-12-27	WOS:000289245100038
J	Wang, TJ; Larson, MG; Vasan, RS; Cheng, S; Rhee, EP; McCabe, E; Lewis, GD; Fox, CS; Jacques, PF; Fernandez, C; O'Donnell, CJ; Carr, SA; Mootha, VK; Florez, JC; Souza, A; Melander, O; Clish, CB; Gerszten, RE				Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan; Rhee, Eugene P.; McCabe, Elizabeth; Lewis, Gregory D.; Fox, Caroline S.; Jacques, Paul F.; Fernandez, Celine; O'Donnell, Christopher J.; Carr, Stephen A.; Mootha, Vamsi K.; Florez, Jose C.; Souza, Amanda; Melander, Olle; Clish, Clary B.; Gerszten, Robert E.			Metabolite profiles and the risk of developing diabetes	NATURE MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; AMINO-ACID; INSULIN-SECRETION; PROTEIN; PREDICTION; RESISTANCE; MIXTURES; MELLITUS; MUSCLE; OBESE	Emerging technologies allow the high-throughput profiling of metabolic status from a blood specimen (metabolomics). We investigated whether metabolite profiles could predict the development of diabetes. Among 2,422 normoglycemic individuals followed for 12 years, 201 developed diabetes. Amino acids, amines and other polar metabolites were profiled in baseline specimens by liquid chromatography-tandem mass spectrometry (LC-MS). Cases and controls were matched for age, body mass index and fasting glucose. Five branched-chain and aromatic amino acids had highly significant associations with future diabetes: isoleucine, leucine, valine, tyrosine and phenylalanine. A combination of three amino acids predicted future diabetes (with a more than fivefold higher risk for individuals in top quartile). The results were replicated in an independent, prospective cohort. These findings underscore the potential key role of amino acid metabolism early in the pathogenesis of diabetes and suggest that amino acid profiles could aid in diabetes risk assessment.	[Wang, Thomas J.; Rhee, Eugene P.; Lewis, Gregory D.; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Wang, Thomas J.; Cheng, Susan; McCabe, Elizabeth; Lewis, Gregory D.; O'Donnell, Christopher J.; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan; McCabe, Elizabeth; Fox, Caroline S.; O'Donnell, Christopher J.] Boston Univ, Sch Med, Framingham, MA USA; [Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan; McCabe, Elizabeth; Fox, Caroline S.; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Boston Med Ctr, Cardiol Sect, Boston, MA 02118 USA; [Cheng, Susan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiol, Boston, MA USA; [Rhee, Eugene P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Renal, Boston, MA USA; [Rhee, Eugene P.; Lewis, Gregory D.; O'Donnell, Christopher J.; Carr, Stephen A.; Mootha, Vamsi K.; Florez, Jose C.; Souza, Amanda; Clish, Clary B.; Gerszten, Robert E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol, Boston, MA USA; [Fox, Caroline S.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Jacques, Paul F.] Tufts Univ, Jean Mayer US Dept, Agr Human Nutr Res Ctr, Boston, MA 02111 USA; [Fernandez, Celine] Lund Univ, Dept Expt Med Sci, Malmo, Sweden; [Mootha, Vamsi K.; Florez, Jose C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Diabet Unit, Boston, MA USA; [Mootha, Vamsi K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston Medical Center; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; Lund University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Lund University	Wang, TJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA.	tjwang@partners.org; rgerszten@partners.org	Carr, Steven A./AAH-8366-2019; Fernandez, Celine/ABH-9332-2020; Lorkiewicz, Pawel/A-2126-2011; Clish, Clary B/ABB-9374-2021; Ramachandran, Vasan/Y-2527-2019; Clish, Clary/AAB-7124-2019	Fernandez, Celine/0000-0003-1290-4982; Lorkiewicz, Pawel/0000-0002-1755-9826; Clish, Clary B/0000-0001-8259-9245; Ramachandran, Vasan/0000-0001-7357-5970; Cheng, Susan/0000-0002-4977-036X; Larson, Martin/0000-0002-9631-1254; Melander, Olle/0000-0002-2581-484X; Wang, Thomas/0000-0003-4063-6508	US National Institutes of Health [NO1-HC-25195, R01-DK-HL081572]; Donald W. Reynolds Foundation; Leducq Foundation; American Heart Association; Ellison Foundation; Massachusetts General Hospital; Doris Duke Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002, ZIAHL006094] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); Ellison Foundation(Lawrence Ellison Foundation); Massachusetts General Hospital(General Electric); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by US National Institutes of Health contract NO1-HC-25195, R01-DK-HL081572, the Donald W. Reynolds Foundation, the Leducq Foundation and the American Heart Association. S. C. is also supported by an award from the Ellison Foundation. J.C.F. is also supported by the Massachusetts General Hospital and a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	31	2037	2109	20	644	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					448	U83		10.1038/nm.2307	http://dx.doi.org/10.1038/nm.2307			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21423183	Green Accepted			2022-12-27	WOS:000289245100035
J	Schiffer, JT; Scott, J; Corey, L				Schiffer, Joshua T.; Scott, John; Corey, Lawrence			Fighting a defiant virus	NATURE MEDICINE			English	Editorial Material							HEPATITIS-C VIRUS; GENOTYPE 1 INFECTION; RIBAVIRIN; TELAPREVIR; PLACEBO; INTERFERON-ALPHA-2B; PEGINTERFERON; COMBINATION; TRIAL		[Schiffer, Joshua T.; Scott, John; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Schiffer, Joshua T.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Schiffer, JT (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jschiffe@fhcrc.org; lcorey@u.washington.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436				Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; DAVIS GL, 2009, GASTROENTEROLOGY, V138; Fletcher NF, 2010, GASTROENTEROLOGY, V139, P1365, DOI 10.1053/j.gastro.2010.06.008; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Roberts SK, 2008, HEPATOLOGY, V48, P398, DOI 10.1002/hep.22321; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411	15	4	4	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					253	254		10.1038/nm0311-253	http://dx.doi.org/10.1038/nm0311-253			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383719				2022-12-27	WOS:000288070000019
J	Pang, T; Daulaire, N; Keusch, G; Leke, R; Piot, P; Reddy, S; Rys, A; Szlezak, N				Pang, Tikki; Daulaire, Nils; Keusch, Gerald; Leke, Rose; Piot, Peter; Reddy, Srinath; Rys, Andrzej; Szlezak, Nicole			The new age of global health governance holds promise	NATURE MEDICINE			English	Editorial Material								The recognition that many diseases present worldwide challenges has spurred nations and institutions to participate in the development of what is known as 'global health governance'. But this new form of governance will only succeed with strengthened country commitment, collaborations across disparate sectors and improved accountability.	[Pang, Tikki] WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland; [Daulaire, Nils] US Dept HHS, Off Global Hlth Affairs, Washington, DC 20201 USA; [Keusch, Gerald] Boston Univ, Boston, MA 02215 USA; [Leke, Rose] Univ Yaounde 1, Yaounde, Cameroon; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India; [Rys, Andrzej] Commiss European Communities, L-2920 Luxembourg, Luxembourg; [Szlezak, Nicole] McKinsey & Co Inc, Berlin, Germany; [Szlezak, Nicole] Harvard Univ, John F Kennedy Sch Govt, Sustainabil Sci Program, Cambridge, MA 02138 USA	World Health Organization; Boston University; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; Harvard University	Pang, T (corresponding author), WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland.			Reddy, K Srinath/0000-0003-3416-3548; /0000-0001-5724-2965					0	9	13	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1181	1181		10.1038/nm1110-1181	http://dx.doi.org/10.1038/nm1110-1181			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052062	Bronze			2022-12-27	WOS:000283860100013
J	Kudo, M; Melton, AC; Chen, C; Engler, MB; Huang, KE; Ren, X; Wang, YL; Bernstein, X; Li, JT; Atabai, K; Huang, XZ; Sheppard, D				Kudo, Makoto; Melton, Andrew C.; Chen, Chun; Engler, Mary B.; Huang, Katherine E.; Ren, Xin; Wang, Yanli; Bernstein, Xin; Li, John T.; Atabai, Kamran; Huang, Xiaozhu; Sheppard, Dean			IL-17A produced by alpha beta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; ROR-GAMMA-T; ALLERGIC-ASTHMA; GENE POLYMORPHISMS; T(H)17 CELLS; RHO-KINASE; RECEPTOR; INFLAMMATION; INTERLEUKIN-17; ASSOCIATION	Emerging evidence suggests that the T helper 17 (T(H)17) subset of alpha beta T cells contributes to the development of allergic asthma. In this study, we found that mice lacking the alpha v beta 8 integrin on dendritic cells did not generate T(H)17 cells in the lung and were protected from airway hyper-responsiveness in response to house dust mite and ovalbumin sensitization and challenge. Because loss of T(H)17 cells inhibited airway narrowing without any obvious effects on airway inflammation or epithelial morphology, we examined the direct effects of T(H)17 cytokines on mouse and human airway smooth muscle function. Interleukin-17A (IL-17A), but not IL-17F or IL-22, enhanced contractile force generation of airway smooth muscle through an IL-17 receptor A (IL-17RA)-IL-17RC, nuclear factor kappa light-chain enhancer of activated B cells (NF-kappa B)-ras homolog gene family, member A (RhoA)-Rho-associated coiled-coil containing protein kinase 2 (ROCK2) signaling cascade. Mice lacking integrin alpha v beta 8 on dendritic cells showed impaired activation of this pathway after ovalbumin sensitization and challenge, and the diminished contraction of the tracheal rings in these mice was reversed by IL-17A. These data indicate that the IL-17A produced by T(H)17 cells contributes to allergen-induced airway hyper-responsiveness through direct effects on airway smooth muscle.	[Kudo, Makoto; Melton, Andrew C.; Chen, Chun; Huang, Katherine E.; Ren, Xin; Wang, Yanli; Bernstein, Xin; Li, John T.; Atabai, Kamran; Huang, Xiaozhu; Sheppard, Dean] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Kudo, Makoto] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Engler, Mary B.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA; [Li, John T.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Yokohama City University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sheppard, D (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA.	dean.sheppard@ucsf.edu			US National Institutes of Health (NIH) [HL64353, HL53949, HL083950, AI024674, U19 AI077439]; NIH Ruth L. Kirschstein National Research Service [HL095314]; American Lung Association of California; University of California, San Francisco (UCSF) Strategic Asthma Basic Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053949, R01HL064353, R01HL102292, R01HL053949, F32HL095314, R01HL083950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R01AI024674, R37AI024674] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association of California; University of California, San Francisco (UCSF) Strategic Asthma Basic Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health (NIH) grants HL64353, HL53949, HL083950, AI024674 and U19 AI077439 (to D.S.), a NIH Ruth L. Kirschstein National Research Service Award HL095314 (to A.C.M.), an American Lung Association of California Research Training Fellowship Award (to A.C.M.) and funds from the University of California, San Francisco (UCSF) Strategic Asthma Basic Research Center. Deidentified human lung was kindly provided by M. Matthay (UCSF) and P. Wolters (UCSF). IL-17RC knockout mice were kindly provided by W. Ouyang (Genentech).	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; BARNES PJ, 1985, BRIT J PHARMACOL, V86, P685, DOI 10.1111/j.1476-5381.1985.tb08946.x; BARNETT K, 1988, AM REV RESPIR DIS, V138, P780, DOI 10.1164/ajrccm/138.4.780; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; de Faria ICJ, 2008, J PEDIAT-BRAZIL, V84, P203, DOI [10.2223/JPED.1783, 10.1590/S0021-75572008000300004]; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oda N, 2005, AM J RESP CRIT CARE, V171, P12, DOI 10.1164/rccm.200406-778OC; Ohama T, 2003, J BIOL CHEM, V278, P48794, DOI 10.1074/jbc.M310166200; Parris JRM, 1999, J PHYSIOL-LONDON, V518, P561, DOI 10.1111/j.1469-7793.1999.0561p.x; Patil SB, 2006, AM J PHYSIOL-GASTR L, V290, pG83, DOI 10.1152/ajpgi.00178.2005; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Settin A, 2008, INDIAN J PEDIATR, V75, P1019, DOI 10.1007/s12098-008-0161-z; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Souwer Y, 2010, CURR OPIN IMMUNOL, V22, P821, DOI 10.1016/j.coi.2010.10.013; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zeyrek D, 2008, ALLERGY ASTHMA PROC, V29, P468, DOI 10.2500/aap.2008.29.3154; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	55	325	345	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					547	554		10.1038/nm.2684	http://dx.doi.org/10.1038/nm.2684			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388091	Green Accepted, Green Submitted			2022-12-27	WOS:000302617800031
J	Ng, KP; Hillmer, AM; Chuah, CTH; Juan, WC; Ko, TK; Teo, ASM; Ariyaratne, PN; Takahashi, N; Sawada, K; Fei, Y; Soh, S; Lee, WH; Huang, JWJ; Allen, JC; Woo, XY; Nagarajan, N; Kumar, V; Thalamuthu, A; Poh, WT; Ang, AL; Mya, HT; How, GF; Yang, LY; Koh, LP; Chowbay, B; Chang, CT; Nadarajan, VS; Chng, WJ; Than, H; Lim, LC; Goh, YT; Zhang, SL; Poh, D; Tan, P; Seet, JE; Ang, MK; Chau, NM; Ng, QS; Tan, DSW; Soda, M; Isobe, K; Nothen, MM; Wong, TY; Shahab, A; Ruan, XA; Cacheux-Rataboul, V; Sung, WK; Tan, EH; Yatabe, Y; Mano, H; Soo, RA; Chin, TM; Lim, WT; Ruan, YJ; Ong, ST				Ng, King Pan; Hillmer, Axel M.; Chuah, Charles T. H.; Juan, Wen Chun; Ko, Tun Kiat; Teo, Audrey S. M.; Ariyaratne, Pramila N.; Takahashi, Naoto; Sawada, Kenichi; Fei, Yao; Soh, Sheila; Lee, Wah Heng; Huang, John W. J.; Allen, John C., Jr.; Woo, Xing Yi; Nagarajan, Niranjan; Kumar, Vikrant; Thalamuthu, Anbupalam; Poh, Wan Ting; Ang, Ai Leen; Mya, Hae Tha; How, Gee Fung; Yang, Li Yi; Koh, Liang Piu; Chowbay, Balram; Chang, Chia-Tien; Nadarajan, Veera S.; Chng, Wee Joo; Than, Hein; Lim, Lay Cheng; Goh, Yeow Tee; Zhang, Shenli; Poh, Dianne; Tan, Patrick; Seet, Ju-Ee; Ang, Mei-Kim; Chau, Noan-Minh; Ng, Quan-Sing; Tan, Daniel S. W.; Soda, Manabu; Isobe, Kazutoshi; Noethen, Markus M.; Wong, Tien Y.; Shahab, Atif; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Tan, Eng Huat; Yatabe, Yasushi; Mano, Hiroyuki; Soo, Ross A.; Chin, Tan Min; Lim, Wan-Teck; Ruan, Yijun; Ong, S. Tiong			A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer	NATURE MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; FACTOR RECEPTOR EGFR; EYE DISEASES; GROWTH; MUTATIONS; GEFITINIB; APOPTOSIS; RESPONSIVENESS; IDENTIFICATION	Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and epidermal growth factor receptor-mutated non-small-cell lung cancer (EGFR NSCLC). However, the extent and duration of these responses are heterogeneous, suggesting the existence of genetic modifiers affecting an individual's response to TKIs. Using paired-end DNA sequencing, we discovered a common intronic deletion polymorphism in the gene encoding BCL2-like 11 (BIM). BIM is a pro-apoptotic member of the B-cell CLL/lymphoma 2 (BCL2) family of proteins, and its upregulation is required for TKIs to induce apoptosis in kinase-driven cancers. The polymorphism switched BIM splicing from exon 4 to exon 3, which resulted in expression of BIM isoforms lacking the pro-apoptotic BCL2-homology domain 3 (BH3). The polymorphism was sufficient to confer intrinsic TKI resistance in CML and EGFR NSCLC cell lines, but this resistance could be overcome with BH3-mimetic drugs. Notably, individuals with CML and EGFR NSCLC harboring the polymorphism experienced significantly inferior responses to TKIs than did individuals without the polymorphism (P = 0.02 for CML and P = 0.027 for EGFR NSCLC). Our results offer an explanation for the heterogeneity of TKI responses across individuals and suggest the possibility of personalizing therapy with BH3 mimetics to overcome BIM-polymorphism-associated TKI resistance.	[Hillmer, Axel M.; Teo, Audrey S. M.; Ariyaratne, Pramila N.; Fei, Yao; Lee, Wah Heng; Woo, Xing Yi; Nagarajan, Niranjan; Kumar, Vikrant; Thalamuthu, Anbupalam; Poh, Wan Ting; Tan, Patrick; Shahab, Atif; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Sung, Wing-Kin; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Ng, King Pan; Chuah, Charles T. H.; Juan, Wen Chun; Ko, Tun Kiat; Soh, Sheila; Huang, John W. J.; Chang, Chia-Tien; Zhang, Shenli; Poh, Dianne; Tan, Patrick; Ong, S. Tiong] Duke Natl Univ Singapore NUS Grad Med Sch, Canc & Stem Cell Biol Signature Res Programme, Singapore, Singapore; [Chuah, Charles T. H.; Ang, Ai Leen; Mya, Hae Tha; How, Gee Fung; Yang, Li Yi; Than, Hein; Lim, Lay Cheng; Goh, Yeow Tee; Ong, S. Tiong] Singapore Gen Hosp, Dept Haematol, Singapore 0316, Singapore; [Takahashi, Naoto; Sawada, Kenichi] Akita Univ Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita, Japan; [Fei, Yao] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Allen, John C., Jr.] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Koh, Liang Piu; Chng, Wee Joo; Soo, Ross A.; Chin, Tan Min] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Hematol Oncol, Singapore, Singapore; [Chowbay, Balram] Natl Canc Ctr, Clin Pharmacol Lab, Singapore, Singapore; [Nadarajan, Veera S.] Univ Malaya, Kuala Lumpur, Malaysia; [Chng, Wee Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chng, Wee Joo; Tan, Patrick; Soo, Ross A.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Seet, Ju-Ee] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Ang, Mei-Kim; Chau, Noan-Minh; Ng, Quan-Sing; Tan, Daniel S. W.; Tan, Eng Huat; Lim, Wan-Teck; Ong, S. Tiong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Isobe, Kazutoshi] Toho Univ Omori Med Ctr, Dept Resp Med, Tokyo, Japan; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Mano, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan; [Lim, Wan-Teck] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Ruan, Yijun] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Ong, S. Tiong] Duke Univ Med Ctr, Div Med Oncol, Dept Med, Durham, NC USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Singapore General Hospital; Akita University; National University of Singapore; National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Universiti Malaya; National University of Singapore; National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Toho University; University of Bonn; National University of Singapore; Singapore National Eye Center; University of Tokyo; National University of Singapore; National University of Singapore; Duke University	Ruan, YJ (corresponding author), Genome Inst Singapore, Singapore, Singapore.	dmolwt@nccs.com.sg; ruanyj@gis.a-star.edu.sg; sintiong.ong@duke-nus.edu.sg	Lim, Darren Wan-Teck/V-8435-2019; Hillmer, Axel M/N-2927-2014; Thalamuthu, Anbupalam/Z-5545-2019; Wong, Tien Yin/AAC-9724-2020; Lim, Darren Wan Teck/L-2007-2016; YATABE, Yasushi/J-6461-2014; NADARAJAN, VEERA SEKARAN/B-9190-2010; Hillmer, Axel M/B-7485-2015	Lim, Darren Wan-Teck/0000-0002-4655-0206; Hillmer, Axel M/0000-0002-3381-7266; Thalamuthu, Anbupalam/0000-0002-7114-1260; Wong, Tien Yin/0000-0002-8448-1264; Lim, Darren Wan Teck/0000-0002-4655-0206; YATABE, Yasushi/0000-0003-1788-559X; Hillmer, Axel M/0000-0002-3381-7266; Ong, S. Tiong/0000-0001-9460-3483; Nothen, Markus/0000-0002-8770-2464; Sung, Wing-Kin/0000-0001-7806-7086; Nagarajan, Niranjan/0000-0003-0850-5604	National Medical Research Council of Singapore; Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore; Genome Institute of Singapore from the BMRC; Department of Clinical Research, Singapore General Hospital	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore from the BMRC; Department of Clinical Research, Singapore General Hospital	This study was supported by grants from the National Medical Research Council of Singapore and the Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore. Additional support was also provided by the Genome Institute of Singapore internal research funds from the BMRC and the Department of Clinical Research, Singapore General Hospital. We are grateful for insightful conversations regarding this study with G. Bourque, M. Garcia-Blanco, E. Liu, X. Roca, S. Rosen, S. Shenolikar, D. Virshup and M. Voorhoeve. We thank C.-L. Wei and H. Thoreau for management of the sequencing platform, S.T. Leong, S.C. Neo and P.S. Choi for sequencing, J. Chen and C.S. Chan for help in data processing, H.P. Lim, Y.Y. Sia and Y.H. Choy for PCR validation and A. Lim and T.H. Lim for assistance in the fluorescence in situ hybridization (FISH) analysis. We also thank M. Garcia-Blanco (Duke University), K. Itahana (Duke-NUS), A. Vazquez (Institut National de la Sante et de la Recherche Medicale U. 1014, Villejuif, France and Universite Paris-Sud, Paris, France) and P. Koeffler (Cedars-Sinai Medical Center, Los Angeles, California, USA and Cancer Science Institute of Singapore, Singapore) for the kind gifts of the pl-12 vector, pcDNA3-FLAG3 plasmid, BIM expression vectors and NSCLC cell lines, respectively. Finally, we are grateful to the patients and physicians at the Department of Haematology, Singapore General Hospital, the Department of Hematology-Oncology, Akita University Hospital, Japan, the Toho University Omori Medical Center, Japan, the Aichi Cancer Center, Japan, the National University Cancer Institute, National University Health System, Singapore, National Cancer Centre, Singapore and the University of Malaya Medical Centre, Kuala Lumpur, Malaysia who contributed patient material.	Adachi M, 2005, CELL DEATH DIFFER, V12, P192, DOI 10.1038/sj.cdd.4401529; Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Au WY, 2009, INT J HEMATOL, V89, P14, DOI 10.1007/s12185-008-0230-0; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Carella AM, 1997, HAEMATOLOGICA, V82, P478; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; La Rosee Paul, 2008, Curr Hematol Malig Rep, V3, P72, DOI 10.1007/s11899-008-0012-z; Ladd AN, 2002, GENOME BIOL, V3; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Liu JW, 2002, CANCER RES, V62, P2976; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Ly C, 2003, CANCER RES, V63, P5716; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machida K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013470; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park K, 2006, CURR MED RES OPIN, V22, P561, DOI 10.1185/030079906X89847; Sasaki H, 2007, LUNG CANCER, V58, P324, DOI 10.1016/j.lungcan.2007.06.024; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeda M, 2010, J THORAC ONCOL, V5, P399, DOI 10.1097/JTO.0b013e3181cee47e; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Wu JY, 2008, CLIN CANCER RES, V14, P4877, DOI 10.1158/1078-0432.CCR-07-5123; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	53	429	458	0	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					521	528		10.1038/nm.2713	http://dx.doi.org/10.1038/nm.2713			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426421				2022-12-27	WOS:000302617800028
J	Cai, KJ; Haris, M; Singh, A; Kogan, F; Greenberg, JH; Hariharan, H; Detre, JA; Reddy, R				Cai, Kejia; Haris, Mohammad; Singh, Anup; Kogan, Feliks; Greenberg, Joel H.; Hariharan, Hari; Detre, John A.; Reddy, Ravinder			Magnetic resonance imaging of glutamate	NATURE MEDICINE			English	Article							CEREBRAL-ARTERY OCCLUSION; GAMMA-AMINOBUTYRIC-ACID; IN-VIVO; HUMAN BRAIN; CONTRAST AGENTS; MRI; PH; QUANTIFICATION; SPECTROSCOPY; PENUMBRA	Glutamate, a major neurotransmitter in the brain, shows a pH- and concentration-dependent chemical exchange saturation transfer effect (GluCEST) between its amine group and bulk water, with potential for in vivo imaging by nuclear magnetic resonance. GluCEST asymmetry is observed similar to 3 p.p.m. downfield from bulk water. Middle cerebral artery occlusion in the rat brain resulted in an similar to 100% elevation of GluCEST in the ipsilateral side compared with the contralateral side, predominantly owing to pH changes. In a rat brain tumor model with blood-brain barrier disruption, intravenous glutamate injection resulted in a clear elevation of GluCEST and a similar increase in the proton magnetic resonance spectroscopy signal of glutamate. GluCEST maps from healthy human brain were also obtained. These results demonstrate the feasibility of using GluCEST for mapping relative changes in glutamate concentration, as well as pH, in vivo. Contributions from other brain metabolites to the GluCEST effect are also discussed.	[Cai, Kejia; Haris, Mohammad; Singh, Anup; Kogan, Feliks; Hariharan, Hari; Detre, John A.; Reddy, Ravinder] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA; [Greenberg, Joel H.; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Dept Radiol, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Reddy, R (corresponding author), Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA.	ravi@mail.mmrrcc.upenn.edu	Kogan, Feliks/AAH-5814-2019	Hariharan, Hari/0000-0002-7032-6968; Kogan, Feliks/0000-0003-0580-7308; Singh, Anup/0000-0001-6744-8326; Reddy, Ravinder/0000-0003-4580-2392; Haris, Mohammad/0000-0002-4945-2935	US National Institutes of Health;  [P41RR002305]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We gratefully acknowledge stimulating discussions with R.N. Bryan, M.D. Schnall, J.D. Glickson and WS. Englander. We thank W. Liu and S. Pickup for their technical assistance in using the 9.4 T research scanners, W.R.T. Witschey for technical support, P. Waghray for experimental help and D. Reddy, K. Nath and T. Hiraki for help with animal models. This work was carried out at a US National Institutes of Health-supported resource, with funding from P41RR002305.	Ametamey SM, 2007, J NUCL MED, V48, P247; Choi IY, 2006, NEUROIMAGE, V33, P85, DOI 10.1016/j.neuroimage.2006.06.016; Chojnacka-Wojcik E, 2001, Curr Opin Investig Drugs, V2, P1112; Chu WJ, 1996, NEUROLOGY, V47, P756, DOI 10.1212/WNL.47.3.756; Davalos A, 2000, J Stroke Cerebrovasc Dis, V9, P2, DOI 10.1053/jscd.2000.18908; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Gottschalk M, 2008, NMR BIOMED, V21, P507, DOI 10.1002/nbm.1219; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Harrison PJ, 2008, BRIT J PSYCHIAT, V192, P86, DOI 10.1192/bjp.bp.107.045088; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; McMahon MT, 2008, MAGN RESON MED, V60, P803, DOI 10.1002/mrm.21683; Melani A, 1999, STROKE, V30, P2448, DOI 10.1161/01.STR.30.11.2448; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Petroff O A, 2000, Adv Neurol, V83, P261; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; RYNER LN, 1995, J MAGN RESON SER B, V107, P126, DOI 10.1006/jmrb.1995.1068; RYNER LN, 1995, MAGN RESON IMAGING, V13, P853, DOI 10.1016/0730-725X(95)00031-B; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Sun PZ, 2008, MAGN RESON MED, V60, P390, DOI 10.1002/mrm.21653; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Tuor UI, 2008, J CEREBR BLOOD F MET, V28, P1613, DOI 10.1038/jcbfm.2008.49; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Woessner DE, 2005, MAGN RESON MED, V53, P790, DOI 10.1002/mrm.20408; Zhou JY, 2006, PROG NUCL MAG RES SP, V48, P109, DOI 10.1016/j.pnmrs.2006.01.001; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	35	426	438	4	100	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					302	306		10.1038/nm.2615	http://dx.doi.org/10.1038/nm.2615			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270722	Green Accepted			2022-12-27	WOS:000300140300047
J	Cunnington, AJ; de Souza, JB; Walther, M; Riley, EM				Cunnington, Aubrey J.; de Souza, J. Brian; Walther, Michael; Riley, Eleanor M.			Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization	NATURE MEDICINE			English	Article							CARBON-MONOXIDE; TYPHIMURIUM INFECTION; OXIDATIVE STRESS; CEREBRAL MALARIA; NADPH OXIDASE; IN-VIVO; SUSCEPTIBILITY; MICE; PROTOPORPHYRIN; INDUCTION	In sub-Saharan Africa, invasive nontyphoid Salmonella (NTS) infection is a common and often fatal complication of Plasmodium falciparum infection. Induction of heme oxygenase-1 (HO-1) mediates tolerance to the cytotoxic effects of heme during malarial hemolysis but might impair resistance to NTS by limiting production of bactericidal reactive oxygen species. We show that co-infection of mice with Plasmodium yoelii 17XNL (Py17XNL) and Salmonella enterica serovar Typhimurium 12023 (Salmonella typhimurium) causes acute, fatal bacteremia with high bacterial load, features reproduced by phenylhydrazine-induced hemolysis or hemin administration. S. typhimurium localized predominantly in granulocytes. Py17XNL, phenylhydrazine and hemin caused premature mobilization of granulocytes from bone marrow with a quantitative defect in the oxidative burst. Inhibition of HO by tin protoporphyrin abrogated the impairment of resistance to S. typhimurium by hemolysis. Thus, a mechanism of tolerance to one infection, malaria, impairs resistance to another, NTS. Furthermore, HO inhibitors may be useful adjunctive therapy for NTS infection in the context of hemolysis.	[Cunnington, Aubrey J.; de Souza, J. Brian; Riley, Eleanor M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England; [de Souza, J. Brian] UCL, Sch Med, Div Infect & Immun, London W1N 8AA, England; [Walther, Michael] MRC Labs, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School; MRC Laboratory Molecular Biology	Riley, EM (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.	eleanor.riley@Ishtm.ac.uk	Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Cunnington, Aubrey/0000-0002-1305-3529	UK Medical Research Council [G0701427]; European Society for Pediatric Infectious Diseases; Medical Research Council [G0701427] Funding Source: researchfish; MRC [G0701427] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Society for Pediatric Infectious Diseases; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a UK Medical Research Council Clinical Research Training Fellowship (G0701427) and a small grant award from the European Society for Pediatric Infectious Diseases awarded to A.J.C. We wish to thank D. Holden (Imperial College, London) for providing GFP-expressing S. typhimurium and R. Motterlini, S. Baines, H. Kaur, L. King, C. Stanley, R. Gregory, L. McCarthy, K. Couper, J. Hafalla, E. Findlay and D. Blount for technical advice and assistance.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; DEHAAS M, 1994, BLOOD, V84, P3885, DOI 10.1182/blood.V84.11.3885.bloodjournal84113885; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; GLASSER L, 1987, BLOOD, V69, P937; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; HESTDAL K, 1991, J IMMUNOL, V147, P22; KAPPAS A, 1988, PEDIATRICS, V81, P485; KAYE D, 1963, J IMMUNOL, V91, P65; KAYE D, 1965, P SOC EXP BIOL MED, V120, P810, DOI 10.3181/00379727-120-30661; KAYE D, 1963, J IMMUNOL, V91, P518; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Li XL, 2008, J IMMUNOL, V180, P6933, DOI 10.4049/jimmunol.180.10.6933; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; MAINES MD, 1984, BIOCHEM J, V217, P409, DOI 10.1042/bj2170409; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; MURPHY JR, 1981, INFECT IMMUN, V31, P396, DOI 10.1128/IAI.31.1.396-407.1981; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Otterbein LE, 2009, RESP CARE, V54, P925, DOI 10.4187/002013209793800394; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pham NK, 2005, INFECT IMMUN, V73, P8322, DOI 10.1128/IAI.73.12.8322-8333.2005; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wright J, 1997, J PEDIATR-US, V130, P394, DOI 10.1016/S0022-3476(97)70201-4; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zaki MH, 2009, J IMMUNOL, V182, P3746, DOI 10.4049/jimmunol.0803363	55	173	174	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					120	127		10.1038/nm.2601	http://dx.doi.org/10.1038/nm.2601			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179318	Green Accepted			2022-12-27	WOS:000299018600037
J	Clark, AT; Phillips, BT; Orwig, KE				Clark, Amander T.; Phillips, Bart T.; Orwig, Kyle E.			Fruitful progress to fertility Male fertility in the test tube	NATURE MEDICINE			English	Editorial Material							PLURIPOTENT STEM-CELLS; GERMLINE TRANSMISSION; CULTURE; FETAL		[Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA USA; [Phillips, Bart T.; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Clark, AT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	orwigke@upmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD055475] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARDEKANI HS, 2011, JAMA-J AM MED ASSOC, V305, P2416; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hermann BP, 2011, HUM REPROD, V26, P3222, DOI 10.1093/humrep/der343; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Moragianni VA, 2010, CURR OPIN OBSTET GYN, V22, P189, DOI 10.1097/GCO.0b013e328338493f; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Richardson TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006308; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Wyns C, 2011, HUM REPROD, V26, P737, DOI 10.1093/humrep/deq387	16	20	20	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1564	1565		10.1038/nm.2594	http://dx.doi.org/10.1038/nm.2594			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146462				2022-12-27	WOS:000297978000025
J	Pajvani, UB; Shawber, CJ; Samuel, VT; Birkenfeld, AL; Shulman, GI; Kitajewski, J; Accili, D				Pajvani, Utpal B.; Shawber, Carrie J.; Samuel, Varman T.; Birkenfeld, Andreas L.; Shulman, Gerald I.; Kitajewski, Jan; Accili, Domenico			Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; GLUCOSE-6-PHOSPHATASE GENE-EXPRESSION; GLUCOSE-PRODUCTION; ADIPOSE-TISSUE; PROTEIN-KINASE; MICE LACKING; FACTOR FKHR; IN-VIVO; DIFFERENTIATION; LIVER	Transcription factor FoxO1 promotes hepatic glucose production. Genetic inhibition of FoxO1 function prevents diabetes in experimental animal models, providing impetus to identify pharmacological approaches to modulate this function. Altered Notch signaling is evident in tumorigenesis, and Notch antagonists are in clinical testing for application in cancer. Here we report that FoxO1 and Notch coordinately regulate hepatic glucose metabolism. Combined haploinsufficiency of FoxO1 and Notch1 markedly raises insulin sensitivity in diet-induced insulin resistance, as does liver-specific knockout of the Notch transcriptional effector Rbp-J kappa. Conversely, Notch1 gain-of-function promotes insulin resistance in a FoxO1-dependent manner and induces glucose-6-phosphatase expression. Pharmacological blockade of Notch signaling with gamma-secretase inhibitors raises insulin sensitivity after in vivo administration in lean mice and in obese, insulin-resistant mice. The data identify a heretofore unknown metabolic function of Notch and suggest that Notch inhibition is beneficial in diabetes treatment, in part by helping to offset excessive FoxO1-driven hepatic glucose production.	[Pajvani, Utpal B.; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10027 USA; [Shawber, Carrie J.; Kitajewski, Jan] Columbia Univ, Dept Pathol, New York, NY USA; [Shawber, Carrie J.; Kitajewski, Jan] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Samuel, Varman T.; Birkenfeld, Andreas L.; Shulman, Gerald I.] Yale Univ, Dept Internal Med, New Haven, CT USA	Columbia University; Columbia University; Columbia University; Yale University	Accili, D (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	da230@columbia.edu	Birkenfeld, Andreas L./U-3954-2019; Shulman, Gerald I./P-7176-2019	Birkenfeld, Andreas L./0000-0003-1407-9023; Shulman, Gerald I./0000-0003-1529-5668	US National Institutes of Health [DK57539, DK084583, HL062454]; US National Institutes of Health (Columbia Diabetes and Endocrinology Research Center) [DK63608]; US National Institutes of Health (Yale Mouse Metabolic Phenotyping Center) [DK76169]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085638, U24DK059635, R37DK058282, P30DK063608, R01DK057539, R01DK040936, P30DK045735, U24DK076169, F32DK084583] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Columbia Diabetes and Endocrinology Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Yale Mouse Metabolic Phenotyping Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants DK57539 (D. A.), DK084583 (U. B. P.), DK63608 (Columbia Diabetes and Endocrinology Research Center), HL062454 (J.K.) and DK76169 (Yale Mouse Metabolic Phenotyping Center). We thank D. Schmoll (Sanofi-Aventis) for the G6pc-luciferase constructs, members of the Accili, Kitajewski and Shulman laboratories for insightful discussion of the data, and A. Flete, T. Kolar and T. Lu for technical support.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fujikura J, 2006, CELL METAB, V3, P59, DOI 10.1016/j.cmet.2005.12.005; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang A, 2004, FEBS LETT, V558, P69, DOI 10.1016/S0014-5793(03)01499-6; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kim-Muller JY, 2011, SCIENCE, V331, P1529, DOI 10.1126/science.1204504; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Krebs LT, 2000, GENE DEV, V14, P1343; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; OKA C, 1995, DEVELOPMENT, V121, P3291; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Purow B, 2009, CURR PHARM BIOTECHNO, V10, P154, DOI 10.2174/138920109787315060; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang J, 2001, DIABETES OBES METAB, V3, P367, DOI 10.1046/j.1463-1326.2001.00173.x; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	46	135	144	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					961	U78		10.1038/nm.2378	http://dx.doi.org/10.1038/nm.2378			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21804540	Green Accepted			2022-12-27	WOS:000293507400029
J	Mi, S; Lee, XH; Hu, YH; Ji, BX; Shao, ZH; Yang, WX; Huang, GR; Walus, L; Rhodes, K; Gong, BJ; Miller, RH; Pepinsky, RB				Mi, Sha; Lee, Xinhua; Hu, Yinghui; Ji, Benxiu; Shao, Zhaohui; Yang, Weixing; Huang, Guanrong; Walus, Lee; Rhodes, Kenneth; Gong, Bang Jian; Miller, Robert H.; Pepinsky, R. Blake			Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; TNF RECEPTOR; AXON REGENERATION; NOGO RECEPTOR; FAMILY-MEMBER; REMYELINATION; CNS; DIFFERENTIATION; LINGO-1; MOUSE	Survival and differentiation of oligodendrocytes are important for the myelination of central nervous system (CNS) axons during development and crucial for myelin repair in CNS demyelinating diseases such as multiple sclerosis. Here we show that death receptor 6 (DR6) is a negative regulator of oligodendrocyte maturation. DR6 is expressed strongly in immature oligodendrocytes and weakly in mature myelin basic protein (MBP)-positive oligodendrocytes. Overexpression of DR6 in oligodendrocytes leads to caspase 3 (casp3) activation and cell death. Attenuation of DR6 function leads to enhanced oligodendrocyte maturation, myelination and downregulation of casp3. Treatment with a DR6 antagonist antibody promotes remyelination in both lysolecithin-induced demyelination and experimental autoimmune encephalomyelitis (EAE) models. Consistent with the DR6 antagoinst antibody studies, DR6-null mice show enhanced remyelination in both demyelination models. These studies reveal a pivotal role for DR6 signaling in immature oligodendrocyte maturation and myelination that may provide new therapeutic avenues for the treatment of demyelination disorders such as multiple sclerosis.	[Mi, Sha; Lee, Xinhua; Hu, Yinghui; Ji, Benxiu; Shao, Zhaohui; Yang, Weixing; Huang, Guanrong; Walus, Lee; Rhodes, Kenneth; Gong, Bang Jian; Pepinsky, R. Blake] Biogen Idec Inc, Cambridge, MA USA; [Miller, Robert H.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Ctr Translat Neurosci, Cleveland, OH 44106 USA	Biogen; Case Western Reserve University	Mi, S (corresponding author), Biogen Idec Inc, Cambridge, MA USA.	sha.mi@biogenidec.com						Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Clarke P, 2009, J VIROL, V83, P6161, DOI 10.1128/JVI.02488-08; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Franklin RJM, 2002, BRAIN RES BULL, V57, P827, DOI 10.1016/S0361-9230(01)00765-1; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Guan J, 2001, J CEREBR BLOOD F MET, V21, P493, DOI 10.1097/00004647-200105000-00003; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2003, J NEUROSCI, V23, P7710; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; MI S, 2007, NAT PROTOC, DOI DOI 10.1038/NPROT.2007.389; Mi S, 2008, INT J BIOCHEM CELL B, V40, P1971, DOI 10.1016/j.biocel.2008.03.018; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pang Y, 2005, J NEUROSCI RES, V80, P226, DOI 10.1002/jnr.20450; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	40	62	70	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					816	U180		10.1038/nm.2373	http://dx.doi.org/10.1038/nm.2373			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21725297				2022-12-27	WOS:000292500800035
J	Stossel, TP; Stell, LK				Stossel, Thomas P.; Stell, Lance K.			Time to 'walk the walk' about industry ties to enhance health	NATURE MEDICINE			English	Article							OF-INTEREST; SCIENCE	Overwhelming evidence that relationships between universities, physicians and the medical products industry benefit patients explains the ubiquitous calls to encourage such relationships. Yet accumulating 'conflict of interest' regulations in academic health centers, government and industry have had the opposite effect. Justifications underlying the regulations lack quantitative rigor, and the rules they enforce impose costly bureaucratic requirements of dubious benefit. Evidence shows that they have diminished the collaborations deemed beneficial to health enhancement.	[Stossel, Thomas P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Stell, Lance K.] Davidson Coll, Dept Philosophy, Davidson, NC 28036 USA	Harvard University; Harvard Medical School; Davidson College	Stossel, TP (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	tstossel@partners.org						*ACCR COUNC CONT M, 2009, ANN REP ACCR COUNC C; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Healy WL, 2009, J BONE JOINT SURG AM, V91A, P1791, DOI 10.2106/JBJS.I.00096; Kawczak S, 2010, ACAD MED, V85, P80, DOI 10.1097/ACM.0b013e3181c42f80; Osborn John E, 2010, Yale J Health Policy Law Ethics, V10, P299; ROTHMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P2782, DOI 10.1001/jama.269.21.2782; SILVERGLATE H, 2009, 3 FELONIES DAY FEDS, pCH3; Stell LK, 2009, J LAW MED ETHICS, V37, P431, DOI 10.1111/j.1748-720X.2009.00404.x; Stossel TP, 2007, PERSPECT BIOL MED, V50, P54, DOI 10.1353/pbm.2007.0011; Stossel TP, 2005, NEW ENGL J MED, V353, P1060, DOI 10.1056/NEJMsb051758; Zycher B, 2010, AM J THER, V17, P101, DOI 10.1097/MJT.0b013e3181ca7f10	11	17	17	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					437	438		10.1038/nm0411-437	http://dx.doi.org/10.1038/nm0411-437			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475240				2022-12-27	WOS:000289245100033
J	Liu, C; Kelnar, K; Liu, BG; Chen, X; Calhoun-Davis, T; Li, HW; Patrawala, L; Yan, H; Jeter, C; Honorio, S; Wiggins, JF; Bader, AG; Fagin, R; Brown, D; Tang, DAG				Liu, Can; Kelnar, Kevin; Liu, Bigang; Chen, Xin; Calhoun-Davis, Tammy; Li, Hangwen; Patrawala, Lubna; Yan, Hong; Jeter, Collene; Honorio, Sofia; Wiggins, Jason F.; Bader, Andreas G.; Fagin, Randy; Brown, David; Tang, Dean G.			The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44	NATURE MEDICINE			English	Article							TUMOR-INITIATING CELLS; SELF-RENEWAL; PROSPECTIVE IDENTIFICATION; PROGENITOR CELLS; MARKER CD44; APOPTOSIS; POPULATION; ACTIVATION; EXPRESSION; CARCINOMA	Cancer stem cells (CSCs), or tumor-initiating cells, are involved in tumor progression and metastasis(1). MicroRNAs (miRNAs) regulate both normal stem cells and CSCs2-5, and dysregulation of miRNAs has been implicated in tumorigenesis(6). CSCs in many tumors-including cancers of the breast(7), pancreas(8), head and neck(9), colon(10,11), small intestine(12), liver(13), stomach(14), bladder(15) and ovary(16)-have been identified using the adhesion molecule CD44, either individually or in combination with other marker(s). Prostate CSCs with enhanced clonogenic(17) and tumor-initiating and metastatic(18,19) capacities are enriched in the CD44(+) cell population, but whether miRNAs regulate CD44(+) prostate cancer cells and prostate cancer metastasis remains unclear. Here we show, through expression analysis, that miR-34a, a p53 target(20-24), was underexpressed in CD44(+) prostate cancer cells purified from xenograft and primary tumors. Enforced expression of miR-34a in bulk or purified CD44(+) prostate cancer cells inhibited clonogenic expansion, tumor regeneration, and metastasis. In contrast, expression of miR-34a antagomirs in CD44(-) prostate cancer cells promoted tumor development and metastasis. Systemically delivered miR-34a inhibited prostate cancer metastasis and extended survival of tumor-bearing mice. We identified and validated CD44 as a direct and functional target of miR-34a and found that CD44 knockdown phenocopied miR-34a overexpression in inhibiting prostate cancer regeneration and metastasis. Our study shows that miR-34a is a key negative regulator of CD44(+) prostate cancer cells and establishes a strong rationale for developing miR-34a as a novel therapeutic agent against prostate CSCs.	[Liu, Can; Liu, Bigang; Chen, Xin; Calhoun-Davis, Tammy; Li, Hangwen; Yan, Hong; Jeter, Collene; Honorio, Sofia; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Liu, Can; Chen, Xin; Patrawala, Lubna; Tang, Dean G.] Univ Texas Grad Sch Biomed Sci GSBS, Program Mol Carcinogenesis, Houston, TX USA; [Kelnar, Kevin; Wiggins, Jason F.; Bader, Andreas G.; Brown, David] Mirna Therapeut Inc, Austin, TX USA; [Fagin, Randy] Hosp Westlake, Austin, TX USA	University of Texas System; UTMD Anderson Cancer Center	Tang, DAG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020; Jackson, Benjamin L/C-4297-2012	Tang, Dean/0000-0001-5029-1174; Jeter, Collene/0000-0002-9627-4529; Chen, Xin/0000-0002-0566-7678	US National Institutes of Health [R01-AG023374, R01-ES015888, R21-ES015893, R21-CA150009]; US Department of Defense [W81XWH-07-1-0616, W81XWH-08-1-0472]; Elsa Pardee Foundation; M. D. Anderson Cancer Center [CCSG-5 P30 CA016672-34, ES007784]; NATIONAL CANCER INSTITUTE [P30CA016672, R21CA150009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, R01ES015888, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Elsa Pardee Foundation; M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Claypool and P. Whitney for FACS, the Histology Core for help with immunohistochemistry, K. Lin for statistical analysis, G. Calin for critically reading the manuscript and other members of the Tang lab for support and discussions. We also thank G. Hannon (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA) for the MSCV-PIG vector. This work was supported in part by grants from the US National Institutes of Health (R01-AG023374, R01-ES015888, R21-ES015893, R21-CA150009), the US Department of Defense (W81XWH-07-1-0616, W81XWH-08-1-0472) and Elsa Pardee Foundation (D. G. T.) and by two M. D. Anderson Cancer Center grants (CCSG-5 P30 CA016672-34 and ES007784). C. Liu and H. Li were supported in part by predoctoral fellowships from the US Department of Defense.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li H, 2009, METHODS MOL BIOL, V568, P85, DOI 10.1007/978-1-59745-280-9_7; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	39	1108	1176	1	260	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					211	U105		10.1038/nm.2284	http://dx.doi.org/10.1038/nm.2284			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21240262	Green Accepted			2022-12-27	WOS:000286969900030
J	Zhang, YJ; Dai, YB; Wen, JM; Zhang, WR; Grenz, A; Sun, H; Tao, LJ; Lu, GX; Alexander, DC; Milburn, MV; Carter-Dawson, L; Lewis, DE; Zhang, WZ; Eltzschig, HK; Kellems, RE; Blackburn, MR; Juneja, HS; Xia, Y				Zhang, Yujin; Dai, Yingbo; Wen, Jiaming; Zhang, Weiru; Grenz, Almut; Sun, Hong; Tao, Lijian; Lu, Guangxiu; Alexander, Danny C.; Milburn, Michael V.; Carter-Dawson, Louvenia; Lewis, Dorothy E.; Zhang, Wenzheng; Eltzschig, Holger K.; Kellems, Rodney E.; Blackburn, Michael R.; Juneja, Harinder S.; Xia, Yang			Detrimental effects of adenosine signaling in sickle cell disease	NATURE MEDICINE			English	Article							ENZYME REPLACEMENT THERAPY; PULMONARY INFLAMMATION; DEAMINASE DEFICIENCY; KNOCKOUT MICE; 2,3-BISPHOSPHOGLYCERATE; 2,3-DIPHOSPHOGLYCERATE; HEMOGLOBIN; ADA; PATHOPHYSIOLOGY; POLYMERIZATION	Hypoxia can act as an initial trigger to induce erythrocyte sickling and eventual end organ damage in sickle cell disease (SCD). Many factors and metabolites are altered in response to hypoxia and may contribute to the pathogenesis of the disease. Using metabolomic profiling, we found that the steady-state concentration of adenosine in the blood was elevated in a transgenic mouse model of SCD. Adenosine concentrations were similarly elevated in the blood of humans with SCD. Increased adenosine levels promoted sickling, hemolysis and damage to multiple tissues in SCD transgenic mice and promoted sickling of human erythrocytes. Using biochemical, genetic and pharmacological approaches, we showed that adenosine A(2B) receptor (A(2B)R)-mediated induction of 2,3-diphosphoglycerate, an erythrocyte-specific metabolite that decreases the oxygen binding affinity of hemoglobin, underlies the induction of erythrocyte sickling by excess adenosine both in cultured human red blood cells and in SCD transgenic mice. Thus, excessive adenosine signaling through the A(2B)R has a pathological role in SCD. These findings may provide new therapeutic possibilities for this disease.	[Zhang, Yujin; Dai, Yingbo; Wen, Jiaming; Zhang, Weiru; Kellems, Rodney E.; Blackburn, Michael R.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77225 USA; [Dai, Yingbo; Wen, Jiaming] Third Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Zhang, Weiru; Tao, Lijian] First Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Grenz, Almut; Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA; [Sun, Hong] Third Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China; [Lu, Guangxiu; Xia, Yang] Cent S Univ, Inst Reprod & Genet Med, Changsha, Hunan, Peoples R China; [Alexander, Danny C.; Milburn, Michael V.] Metabolon Inc, Durham, NC USA; [Carter-Dawson, Louvenia] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Houston, TX USA; [Lewis, Dorothy E.; Zhang, Wenzheng; Juneja, Harinder S.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Central South University; Central South University; University of Colorado System; University of Colorado Denver; Central South University; Central South University; Metabolon; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	yang.xia@uth.tmc.edu	TAO, Li/HIR-4254-2022	Blackburn, Michael/0000-0002-1394-9966	US National Institute of Health [DK077748, DK083559, HL070952, HL092188]; China National Science Foundation Scholarship Council [2008637068]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL070952, R01HL113574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083559, R21DK077748] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China National Science Foundation Scholarship Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by US National Institute of Health grants DK077748 (to Y.X.), DK083559 (to Y.X.), HL070952 (to M.R.B.) and HL092188 (to H.K.E.) and by China National Science Foundation Scholarship Council 2008637068 (to J.W.). We thank T. Krahn (Bayer HealthCare AG) for the adenosine receptor A<INF>2B</INF>R agonist BAY 60-6583. Adenosine receptor-deficient mice were obtained from the following sources: A<INF>1</INF>R-deficient mice (J. Schnermann, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health); A<INF>2A</INF>R-deficient mice (J.-F. Chen, Boston University School of Medicine); A<INF>2B</INF>R-deficient mice (M.R. Blackburn, University of Texas-Houston Medical School); and A<INF>3</INF>R-deficient mice (M. Jacobson, Merck Research Laboratories).	Ballas Samir K, 2007, Hematology Am Soc Hematol Educ Program, P97; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; Carbonaro DA, 2008, BLOOD, V111, P5745, DOI 10.1182/blood-2007-08-103663; Carbonaro DA, 2006, MOL THER, V13, P1110, DOI 10.1016/j.ymthe.2006.02.013; Chan B, 2005, CLIN IMMUNOL, V117, P133, DOI 10.1016/j.clim.2005.07.006; Chiba H, 1978, Curr Top Cell Regul, V14, P75; Christoph GW, 2005, BIOPHYS J, V88, P1371, DOI 10.1529/biophysj.104.051250; Chui DHK, 2001, CURR OPIN PEDIATR, V13, P22, DOI 10.1097/00008480-200102000-00004; de Montalembert M., 2008, B ACAD NATL MED, V192; de Montalembert M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1397; de Montalembert M, 2008, B ACAD NAT MED PARIS, V192, P1375, DOI 10.1016/S0001-4079(19)32687-1; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; ERICSON A, 1972, SCAND J CLIN LAB INV, V29, P85, DOI 10.3109/00365517209081059; Ferrone FA, 2004, MICROCIRCULATION, V11, P115, DOI 10.1080/10739680490278312; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fung EB, 2007, AM J HEMATOL, V82, P255, DOI 10.1002/ajh.20809; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; HEBBEL RP, 1991, BLOOD, V77, P214; HERSHFIELD MS, 1995, CLIN IMMUNOL IMMUNOP, V76, pS228, DOI 10.1016/S0090-1229(95)90306-2; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Lanzkron S, 2006, AM J HEMATOL, V81, P927, DOI 10.1002/ajh.20703; Madigan Catherine, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010659; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; NARITA H, 1981, J BIOL CHEM, V256, P7059; Palmer TM, 1997, BIOCHEMISTRY-US, V36, P832, DOI 10.1021/bi962290v; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Paszty C, 1997, Curr Opin Hematol, V4, P88; Perumbeti A, 2009, BLOOD, V114, P1174, DOI 10.1182/blood-2009-01-201863; POILLON WN, 1986, ARCH BIOCHEM BIOPHYS, V249, P301, DOI 10.1016/0003-9861(86)90006-8; POILLON WN, 1995, BLOOD, V85, P3289, DOI 10.1182/blood.V85.11.3289.bloodjournal85113289; POILLON WN, 1990, BLOOD, V76, P1028; Sasaki R, 1983, Tanpakushitsu Kakusan Koso, V28, P957; SASAKI R, 1983, MOL CELL BIOCHEM, V53-4, P247; Scheinman JI, 2009, NAT CLIN PRACT NEPHR, V5, P78, DOI 10.1038/ncpneph1008; Sebastiani P, 2007, BLOOD, V110, P2727, DOI 10.1182/blood-2007-04-084921; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stiles Gary L., 1997, P29; Urbinati Fabrizia, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010805; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	45	139	139	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					79	U252		10.1038/nm.2280	http://dx.doi.org/10.1038/nm.2280			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21170046	Green Accepted			2022-12-27	WOS:000285994000039
J	Hartman, IZ; Kim, A; Cotter, RJ; Walter, K; Dalai, SK; Boronina, T; Griffith, W; Lanar, DE; Schwenk, R; Krzych, U; Cole, RN; Sadegh-Nasseri, S				Hartman, Isamu Z.; Kim, AeRyon; Cotter, Robert J.; Walter, Kimberly; Dalai, Sarat K.; Boronina, Tatiana; Griffith, Wendell; Lanar, David E.; Schwenk, Robert; Krzych, Urszula; Cole, Robert N.; Sadegh-Nasseri, Scheherazade			A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes	NATURE MEDICINE			English	Article							LIVER-STAGE ANTIGEN-1; COLLAGEN TYPE-II; HLA-DM; PLASMODIUM-FALCIPARUM; MASS-SPECTROMETRY; T-CELLS; REMNANT EPITOPES; MHC MOLECULES; GELATINASE-B; CATHEPSIN-S	Immunodominance is defined as restricted responsiveness of T cells to a few selected epitopes from complex antigens. Strategies currently used for elucidating CD4(+) T cell epitopes are inadequate. To understand the mechanism of epitope selection for helper T cells, we established a cell-free antigen processing system composed of defined proteins: human leukocyte antigen-DR1 (HLA-DR1), HLA-DM and cathepsins. Our reductionist system successfully identified the physiologically selected immunodominant epitopes of two model antigens: hemagglutinin-1 (HA1) from influenza virus (A/Texas/1/77) and type II collagen (CII). When applied for identification of new epitopes from a recombinant liver-stage antigen of malaria falciparum (LSA-NRC) or HA1 from H5N1 influenza virus ('avian flu'), the system selected single epitopes from each protein that were confirmed to be immunodominant by their capacity to activate CD4(+) T cells from H5N1-immunized HLA-DR1-transgenic mice and LSA-NRC-vaccinated HLA-DR1-positive human volunteers. Thus, we provide a new tool for the identification of physiologically relevant helper T cell epitopes from antigens.	[Hartman, Isamu Z.; Kim, AeRyon; Sadegh-Nasseri, Scheherazade] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21218 USA; [Cotter, Robert J.; Griffith, Wendell] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Walter, Kimberly; Dalai, Sarat K.; Sadegh-Nasseri, Scheherazade] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Boronina, Tatiana; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Lanar, David E.; Schwenk, Robert; Krzych, Urszula] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Inst Basic Biomed Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johns Hopkins University	Sadegh-Nasseri, S (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21218 USA.	ssadegh@jhmi.edu	Lanar, David E/B-3560-2011; Boronina, Tatiana/AAN-6332-2021; Griffith, Wendell/AAG-6193-2020	Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720	Johns Hopkins Malaria Research Institute [AI063764, GM053549]; US National Science Foundation; Johns Hopkins University Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063764, R01AI063764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053549] Funding Source: NIH RePORTER	Johns Hopkins Malaria Research Institute; US National Science Foundation(National Science Foundation (NSF)); Johns Hopkins University Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank S. Landry, A. Hamad, J. Pomerantz and K. Narayan for reading the manuscript and insightful discussions, S. Khoruzhenko for protein production, S. Kalb-Ramirez and D. Wang for the initial mass spectrometry, F. Korangy and D. Pardoll (Johns Hopkins University) for Escherichia coli transformed with an expression vector encoding influenza HA, D. Zaller (Merck) for the original DR1-transgenic mice, L. Rein for testing the human samples and the US National Institutes of Health Tetramer Facility for providing DR1 and CLIP monomers. This work was supported by R01 grants AI063764 and GM053549, a grant from Johns Hopkins Malaria Research Institute to S.S.-N., a US National Science Foundation predoctoral award to I.Z.H. and a Johns Hopkins University Rheumatology T32 Fellowship to A.K.	AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Beltrami A, 2008, J BIOL CHEM, V283, P27189, DOI 10.1074/jbc.M802818200; Boja ES, 2001, ANAL CHEM, V73, P3576, DOI 10.1021/ac0103423; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Gebe John A., 2007, V136, P39; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ireland J, 2006, J IMMUNOL, V177, P1421, DOI 10.4049/jimmunol.177.3.1421; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; KRZYCH U, 1995, J IMMUNOL, V155, P4072; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Narayan K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006188; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Parker CE, 1996, J IMMUNOL, V157, P198; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Sadegh-Nasseri S, 2008, TRENDS IMMUNOL, V29, P141, DOI 10.1016/j.it.2008.01.001; Schey KL, 2000, ACCOUNTS CHEM RES, V33, P299, DOI 10.1021/ar9800744; Sercarz EE, 1998, IMMUNOL REV, V164, P5, DOI 10.1111/j.1600-065X.1998.tb01202.x; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Strug I, 2008, J PROTEOME RES, V7, P2703, DOI 10.1021/pr700780x; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; Van den Steen PE, 2004, BIOCHEMISTRY-US, V43, P10809, DOI 10.1021/bi0493665; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com	37	41	44	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1333	U192		10.1038/nm.2248	http://dx.doi.org/10.1038/nm.2248			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21037588	Bronze, Green Accepted			2022-12-27	WOS:000283860100047
J	Kuner, R				Kuner, Rohini			Central mechanisms of pathological pain	NATURE MEDICINE			English	Review							PERIPHERAL-NERVE INJURY; DORSAL-HORN NEURONS; CENTRAL SEROTONERGIC NEURONS; MICROGLIAL CATHEPSIN-S; AMPA RECEPTOR SUBUNITS; SPINAL-CORD NEURONS; NEUROPATHIC PAIN; INFLAMMATORY PAIN; GABAERGIC INHIBITION; SYNAPTIC PLASTICITY	Chronic pain is a major challenge to clinical practice and basic science. The peripheral and central neural networks that mediate nociception show extensive plasticity in pathological disease states. Disease- induced plasticity can occur at both structural and functional levels and is manifest as changes in individual molecules, synapses, cellular function and network activity. Recent work has yielded a better understanding of communication within the neural matrix of physiological pain and has also brought important advances in concepts of injury- induced hyperalgesia and tactile allodynia and how these might contribute to the complex, multidimensional state of chronic pain. This review focuses on the molecular determinants of network plasticity in the central nervous system (CNS) and discusses their relevance to the development of new therapeutic approaches.	Univ Heidelberg, Inst Pharmacol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kuner, R (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-6900 Heidelberg, Germany.	rohini.kuner@pharma.uni-heidelberg.de	Kuner, Rohini/AGU-0204-2022					Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Baba H, 2003, MOL CELL NEUROSCI, V24, P818, DOI 10.1016/S1044-7431(03)00236-7; Bajwa ZH, 2004, PRINCIPLES PRACTICE, P1; Bao L, 2002, EUR J NEUROSCI, V16, P175, DOI 10.1046/j.1460-9568.2002.02080.x; Baron Ralf, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79090-7_1; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cain DM, 2001, J NEUROSCI, V21, P9367, DOI 10.1523/JNEUROSCI.21-23-09367.2001; Cao H, 2009, J NEUROSCI, V29, P3307, DOI 10.1523/JNEUROSCI.4300-08.2009; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Cheong EJ, 2008, J NEUROSCI, V28, P13331, DOI 10.1523/JNEUROSCI.3013-08.2008; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; Derjean D, 2003, NAT NEUROSCI, V6, P274, DOI 10.1038/nn1016; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Fang M, 2003, J PHYSIOL-LONDON, V549, P903, DOI 10.1113/jphysiol.2002.036384; Fields HL, 2000, PROG BRAIN RES, V122, P245; Fu Y, 2008, J NEUROSCI, V28, P3861, DOI 10.1523/JNEUROSCI.0227-08.2008; Galan A, 2004, PAIN, V112, P315, DOI 10.1016/j.pain.2004.09.011; Garry EM, 2003, MOL CELL NEUROSCI, V24, P10, DOI 10.1016/S1044-7431(03)00134-9; Garry EM, 2003, CURR BIOL, V13, P321, DOI 10.1016/S0960-9822(03)00084-8; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hofer SB, 2010, CURR BIOL, V20, pR157, DOI 10.1016/j.cub.2009.12.040; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jolivalt CG, 2008, PAIN, V140, P48, DOI 10.1016/j.pain.2008.07.005; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; Kurejova M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-18; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lu Y, 2008, J PHYSIOL-LONDON, V586, P5701, DOI 10.1113/jphysiol.2008.152348; Luo C, 2008, PAIN, V140, P358, DOI 10.1016/j.pain.2008.09.008; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; May A, 2009, BRAIN, V132, P1419, DOI 10.1093/brain/awp116; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Milenkovic N, 2007, NEURON, V56, P893, DOI 10.1016/j.neuron.2007.10.040; Miletic G, 2010, PAIN, V149, P152, DOI 10.1016/j.pain.2010.02.001; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Neugebauer V, 2003, J NEUROSCI, V23, P52; Neumann S, 1996, NATURE, V384, P360, DOI 10.1038/384360a0; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; Schoffnegger D, 2008, PAIN, V135, P300, DOI 10.1016/j.pain.2007.12.016; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; SHIR Y, 1990, NEUROSCI LETT, V115, P62, DOI 10.1016/0304-3940(90)90518-E; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Tan AM, 2008, J NEUROSCI, V28, P13173, DOI 10.1523/JNEUROSCI.3142-08.2008; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tong CK, 2006, J PHYSIOL-LONDON, V575, P133, DOI 10.1113/jphysiol.2006.110072; Torsney C, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-17; TOYODA H, 2009, MOL PAIN, V5; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yamanaka H, 2004, EUR J NEUROSCI, V19, P93, DOI 10.1046/j.1460-9568.2003.03080.x; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhang WJ, 2009, BRAIN, V132, P778, DOI 10.1093/brain/awn330; Zhang ZZ, 2001, PAIN, V92, P351, DOI 10.1016/S0304-3959(01)00276-7; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104; Zhao ZQ, 2007, J NEUROSCI, V27, P6045, DOI 10.1523/JNEUROSCI.1623-07.2007; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	100	478	514	0	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1258	1266		10.1038/nm.2231	http://dx.doi.org/10.1038/nm.2231			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948531				2022-12-27	WOS:000283860100037
J	Fallarino, F; Volpi, C; Fazio, F; Notartomaso, S; Vacca, C; Busceti, C; Bicciato, S; Battaglia, G; Bruno, V; Puccetti, P; Fioretti, MC; Nicoletti, F; Grohmann, U; Di Marco, R				Fallarino, Francesca; Volpi, Claudia; Fazio, Francesco; Notartomaso, Serena; Vacca, Carmine; Busceti, Carla; Bicciato, Silvio; Battaglia, Giuseppe; Bruno, Valeria; Puccetti, Paolo; Fioretti, Maria C.; Nicoletti, Ferdinando; Grohmann, Ursula; Di Marco, Roberto			Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; T-CELL; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; TH17 CELLS; EXPRESSION; INFLAMMATION; ACTIVATION; DIFFERENTIATION	High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory disease marked by progressive demyelination. Glutamate might affect neuroinflammation via effects on immune cells. Knockout mice lacking metabotropic glutamate receptor-4 (mGluR4) were markedly vulnerable to experimental autoimmune encephalomyelitis (EAE, a mouse model of multiple sclerosis) and developed responses dominated by interleukin-17-producing T helper (T(H)17) cells. In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular cAMP formation-biased T(H) cell commitment to the T(H)17 phenotype. In wild-type mice, mGluR4 was constitutively expressed in all peripheral DCs, and this expression increased after cell activation. Treatment of wild-type mice with a selective mGluR4 enhancer increased EAE resistance via regulatory T (T(reg)) cells. The high amounts of glutamate in neuroinflammation might reflect a counterregulatory mechanism that is protective in nature and might be harnessed therapeutically for restricting immunopathology in multiple sclerosis.	[Fallarino, Francesca; Volpi, Claudia; Vacca, Carmine; Puccetti, Paolo; Fioretti, Maria C.; Grohmann, Ursula] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Fazio, Francesco; Notartomaso, Serena; Busceti, Carla; Battaglia, Giuseppe; Bruno, Valeria; Nicoletti, Ferdinando; Di Marco, Roberto] Ist Neurol Mediterraneo, Pozzilli, Italy; [Notartomaso, Serena; Di Marco, Roberto] Univ Molise, Dept Hlth Sci, Campobasso, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Bruno, Valeria; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy	University of Perugia; IRCCS Neuromed; University of Molise; Universita di Modena e Reggio Emilia; Sapienza University Rome	Grohmann, U (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	ugrohmann@tin.it	Notartomaso, Serena/A-9118-2013; bruno, Valeria/F-3146-2012; Nicoletti, Ferdinando/K-4410-2016; Bicciato, Silvio/C-9825-2009; Fallarino, Francesca/O-3358-2013; Battaglia, Giuseppe/A-7709-2010; Di Marco, Roberto/G-7765-2012; BICCIATO, Silvio/J-4466-2019; Vacca, Carmine/AAE-7046-2019; notartomaso, serena/S-1810-2019; Grohmann, Ursula/T-6545-2019; Busceti, Carla Letizia/K-6485-2016; Notartomaso, Serena/K-1642-2016; Busceti, Carla Letizia/F-9941-2011; Nicoletti, Ferdinando/T-4898-2019; Fazio, Francesco/B-5662-2013; Nicoletti, Ferdinando/A-2446-2010	bruno, Valeria/0000-0003-4231-0739; Bicciato, Silvio/0000-0002-1944-7078; Fallarino, Francesca/0000-0002-8501-2136; Battaglia, Giuseppe/0000-0001-7571-3417; Di Marco, Roberto/0000-0001-5075-4597; BICCIATO, Silvio/0000-0002-1944-7078; Vacca, Carmine/0000-0002-3799-8164; notartomaso, serena/0000-0003-4374-9233; Busceti, Carla Letizia/0000-0002-1417-1893; Notartomaso, Serena/0000-0003-4374-9233; Fazio, Francesco/0000-0003-2662-1588; VOLPI, CLAUDIA/0000-0002-3967-7954; Nicoletti, Ferdinando/0000-0003-0917-443X; Grohmann, Ursula/0000-0001-7952-1850; NICOLETTI, Ferdinando/0000-0003-3366-7269; Puccetti, Paolo/0000-0001-6674-2128	Fondazione Italiana Sclerosi Multipla [2008/R/2]	Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by Fondazione Italiana Sclerosi Multipla Project No. 2008/R/2 (to G.B., U.G. and R.D.M.). We thank G. Andrielli for digital art and image editing, P. Scarselli for technical support and S. Iacobelli for statistical advice.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Besong G, 2002, J NEUROSCI, V22, P5403; Betti M, 2006, ANN ONCOL, V17, P235; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Centonze D, 2010, CELL DEATH DIFFER, V17, P1083, DOI 10.1038/cdd.2009.179; Chen TC, 1998, LAB INVEST, V78, P165; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2009, J EXP MED, V206, P2511, DOI 10.1084/jem.20090134; Fazio F, 2008, NEUROPHARMACOLOGY, V55, P491, DOI 10.1016/j.neuropharm.2008.06.066; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li K, 2008, BLOOD, V112, P5084, DOI 10.1182/blood-2008-05-156646; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Matrisciano F, 2008, NEUROPHARMACOLOGY, V55, P525, DOI 10.1016/j.neuropharm.2008.05.014; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Ngomba RT, 2008, NEUROPHARMACOLOGY, V54, P344, DOI 10.1016/j.neuropharm.2007.10.004; Orabona C, 2005, EUR J IMMUNOL, V35, P3111, DOI 10.1002/eji.200535289; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Pampliega O, 2008, J NEUROIMMUNOL, V195, P194, DOI 10.1016/j.jneuroim.2008.01.011; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Segal B, 2010, SEMIN IMMUNOPATHOL, V32, P71, DOI 10.1007/s00281-009-0186-z; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Storto M, 2000, J NEUROIMMUNOL, V109, P112, DOI 10.1016/S0165-5728(00)00269-1; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zozulya AL, 2010, J MOL MED, V88, P535, DOI 10.1007/s00109-010-0607-4	51	112	116	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					897	U94		10.1038/nm.2183	http://dx.doi.org/10.1038/nm.2183			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20657581				2022-12-27	WOS:000280649200029
J	Jaini, R; Kesaraju, P; Johnson, JM; Altuntas, CZ; Jane-Wit, D; Tuohy, VK				Jaini, Ritika; Kesaraju, Pavani; Johnson, Justin M.; Altuntas, Cengiz Z.; Jane-Wit, Daniel; Tuohy, Vincent K.			An autoimmune-mediated strategy for prophylactic breast cancer vaccination	NATURE MEDICINE			English	Article							MOUSE ALPHA-LACTALBUMIN; PROGNOSTIC-SIGNIFICANCE; METASTATIC-DISEASE; EXPRESSION; GENE; IMMUNOTHERAPY; CARCINOMAS; CELLS; ANTIGENS; VACCINES	Although vaccination is most effective when used to prevent disease, cancer vaccine development has focused predominantly on providing therapy against established growing tumors(1). The difficulty in developing prophylactic cancer vaccines is primarily due to the fact that tumor antigens are variations of self proteins and would probably mediate profound autoimmune complications if used in a preventive vaccine setting(2). Here we use several mouse breast cancer models to define a prototypic strategy for prophylactic cancer vaccination. We selected a-lactalbumin as our target vaccine autoantigen because it is a breast-specific differentiation protein expressed in high amounts in the majority of human breast carcinomas(3-5) and in mammary epithelial cells only during lactation(6-9). We found that immunoreactivity against a-lactalbumin provides substantial protection and therapy against growth of autochthonous tumors in transgenic mouse models of breast cancer and against 4T1 transplantable breast tumors in BALB/c mice. Because alpha-lactalbumin is conditionally expressed only during lactation, vaccination-induced prophylaxis occurs without any detectable inflammation in normal nonlactating breast tissue. Thus, alpha-lactalbumin vaccination may provide safe and effective protection against the development of breast cancer for women in their post-child-bearing, premenopausal years, when lactation is readily avoidable and risk for developing breast cancer is high(10).	[Jaini, Ritika; Kesaraju, Pavani; Johnson, Justin M.; Altuntas, Cengiz Z.; Jane-Wit, Daniel; Tuohy, Vincent K.] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Kesaraju, Pavani; Tuohy, Vincent K.] Cleveland State Univ, Dept Biol, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Tuohy, VK (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA.	tuohyv@ccf.org		Jaini, Ritika/0000-0002-4580-8789	US National Institutes of Health [R01CA-14035]; NATIONAL CANCER INSTITUTE [R01CA140350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grant R01CA-14035 (V.K.T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altuntas CZ, 2006, J IMMUNOL, V177, P1988, DOI 10.4049/jimmunol.177.3.1988; Anderson LM, 2000, CANCER GENE THER, V7, P845, DOI 10.1038/sj.cgt.7700191; Anderson LM, 1999, GENE THER, V6, P854, DOI 10.1038/sj.gt.3300909; Baek MJ, 2006, J IMMUNOL, V177, P4203, DOI 10.4049/jimmunol.177.6.4203; COHEN C, 1987, CANCER, V60, P1294, DOI 10.1002/1097-0142(19870915)60:6<1294::AID-CNCR2820600622>3.0.CO;2-2; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dudley A, 2003, BIOTECHNIQUES, V35, P724, DOI 10.2144/03354st02; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HALL L, 1981, NATURE, V290, P602, DOI 10.1038/290602a0; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE AK, 1985, AM J CLIN PATHOL, V84, P687, DOI 10.1093/ajcp/84.6.687; Li X, 2005, MOL CANCER THER, V4, P1850, DOI 10.1158/1535-7163.MCT-05-0167; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Ludewig B, 2000, J EXP MED, V191, P795, DOI 10.1084/jem.191.5.795; Marzo AL, 1999, CANCER RES, V59, P1071; NAGAMATSU Y, 1980, BIOCHEM J, V185, P227, DOI 10.1042/bj1850227; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; REN JS, 1993, J BIOL CHEM, V268, P19292; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Setiawan VW, 2006, TXB BREAST CANC CLIN, P1; STINNAKRE MG, 1994, P NATL ACAD SCI USA, V91, P6544, DOI 10.1073/pnas.91.14.6544; VILOTTE JL, 1992, GENE, V112, P251, DOI 10.1016/0378-1119(92)90385-3; VILOTTE JL, 1992, GENE, V119, P287, DOI 10.1016/0378-1119(92)90285-W; WRBA F, 1988, PATHOL RES PRACT, V183, P277, DOI 10.1016/S0344-0338(88)80122-5; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030	26	74	79	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					799	U100		10.1038/nm.2161	http://dx.doi.org/10.1038/nm.2161			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20512124	Green Accepted, Bronze			2022-12-27	WOS:000279631900030
J	Obeso, JA; Rodriguez-Oroz, MC; Goetz, CG; Marin, C; Kordower, JH; Rodriguez, M; Hirsch, EC; Farrer, M; Schapira, AHV; Halliday, G				Obeso, Jose A.; Rodriguez-Oroz, Maria C.; Goetz, Christopher G.; Marin, Concepcion; Kordower, Jeffrey H.; Rodriguez, Manuel; Hirsch, Etienne C.; Farrer, Matthew; Schapira, Anthony H. V.; Halliday, Glenda			Missing pieces in the Parkinson's disease puzzle	NATURE MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; GENE-THERAPY; DOUBLE-BLIND; GLUCOCEREBROSIDASE MUTATIONS; CONTROLLED-TRIAL; FUTURE-RESEARCH; RISK-FACTORS	Parkinson's disease is a neurodegenerative process characterized by numerous motor and nonmotor clinical manifestations for which effective, mechanism-based treatments remain elusive. Here we discuss a series of critical issues that we think researchers need to address to stand a better chance of solving the different challenges posed by this pathology.	[Obeso, Jose A.; Rodriguez-Oroz, Maria C.] Clin Univ, Dept Neurol, Pamplona, Spain; [Obeso, Jose A.; Rodriguez-Oroz, Maria C.] Ctr Appl Med Res, Med Sch Navarra, Ctr Neurosci, Pamplona, Spain; [Obeso, Jose A.; Rodriguez-Oroz, Maria C.; Marin, Concepcion; Rodriguez, Manuel] Inst Salud Carlos III, Minist Invest & Ciencias, Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Madrid, Spain; [Goetz, Christopher G.; Kordower, Jeffrey H.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Marin, Concepcion] Univ Barcelona, Lab Neurol Expt, Area Neurociencies, Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain; [Marin, Concepcion] CIBERNED, Barcelona, Spain; [Rodriguez, Manuel] Univ La Laguna, Dept Fisiol, Fac Med, Tenerife, Spain; [Rodriguez, Manuel] CIBERNED, Tenerife, Spain; [Hirsch, Etienne C.] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, Paris, France; [Farrer, Matthew] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Schapira, Anthony H. V.] Univ Dept Clin Neurosci, Inst Neurol, London, England; [Halliday, Glenda] Prince Wales Med Res Inst, Sydney, NSW, Australia; [Halliday, Glenda] Univ New S Wales, Sydney, NSW, Australia	University of Navarra; University of Navarra; CIBERNED; Instituto de Salud Carlos III; Rush University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; Universidad de la Laguna; CIBERNED; UDICE-French Research Universities; Sorbonne Universite; Mayo Clinic; University of London; University College London; Prince Wales Medical Research Institute; University of New South Wales Sydney	Obeso, JA (corresponding author), Clin Univ, Dept Neurol, Pamplona, Spain.	jobeso@unav.es	Rodriguez, Manuel/L-1024-2014; Rodriguez-Oroz, Maria Cruz/D-1490-2018; Halliday, Glenda M/E-8555-2011; Hirsch, Etienne/AAC-7655-2019; Schapira, Anthony H V/A-1245-2010	Rodriguez, Manuel/0000-0001-7569-2898; Rodriguez-Oroz, Maria Cruz/0000-0001-5962-772X; Halliday, Glenda M/0000-0003-0422-8398; Hirsch, Etienne/0000-0003-4823-276X; Schapira, Anthony H V/0000-0002-3018-3966; Farrer, Matthew/0000-0003-1159-5321	Lundbeck Spain	Lundbeck Spain(Lundbeck Corporation)	This article is the result of a meeting held by the authors in the village of Marcalain (Navarra, Spain) with the support of an unrestricted educational grant from Lundbeck Spain. R. Coll, J. Brenninkmeijer and M. Hickery (Lundbeck) assisted on logistical aspects of the meeting, but the company had no role whatsoever in the content of the meeting and the scope of this article. We are particularly thankful to the Idoate family for their hospitality.	Aarsland D, 2005, ANN NEUROL, V58, P773, DOI 10.1002/ana.20635; Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2008, CURR OPIN NEUROL, V21, P676, DOI 10.1097/WCO.0b013e3283168df0; Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Beauchamp MH, 2008, BRAIN COGNITION, V68, P134, DOI 10.1016/j.bandc.2008.03.008; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Brar S, 2009, ARCH NEUROL-CHICAGO, V66, P371, DOI 10.1001/archneurol.2008.586; Brooks J, 2009, J MED GENET, V46, P375, DOI 10.1136/jmg.2008.063917; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Burke RE, 2008, ANN NEUROL, V64, P485, DOI 10.1002/ana.21541; CAI J, 2009, STEM CELLS DEV  1013, DOI DOI 10.1089/SCD.2009-0319; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; DePaolo J, 2009, MOVEMENT DISORD, V24, P1571, DOI 10.1002/mds.22538; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Esteves AR, 2010, NEUROBIOL DIS, V37, P723, DOI 10.1016/j.nbd.2009.12.011; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FROST B, 2010, NAT REV NEUROSCI; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Gao X, 2009, ANN NEUROL, V65, P76, DOI 10.1002/ana.21535; Gasmi M, 2007, NEUROBIOL DIS, V27, P67, DOI 10.1016/j.nbd.2007.04.003; GIBB WRG, 1990, ADV NEUROL, V53, P31; GIBB WRG, 1988, NEUROLOGY, V38, P1402, DOI 10.1212/WNL.38.9.1402; Gluck M, 2002, J NEUROCHEM, V82, P66, DOI 10.1046/j.1471-4159.2002.00938.x; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Gomez-Tortosa E, 1999, NEUROLOGY, V53, P1284, DOI 10.1212/WNL.53.6.1284; Gonzalez-Hernandez T, 2004, J COMP NEUROL, V479, P198, DOI 10.1002/cne.20323; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; Harding AJ, 2002, BRAIN, V125, P391, DOI 10.1093/brain/awf033; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Hart RG, 2009, MOVEMENT DISORD, V24, P647, DOI 10.1002/mds.22432; Hawkes CH, 2008, MOVEMENT DISORD, V23, P1799, DOI 10.1002/mds.22242; Hawkes CH, 2008, MOVEMENT DISORD, V23, P47, DOI 10.1002/mds.21766; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hilker R, 2005, NEUROLOGY, V65, P1716, DOI 10.1212/01.wnl.0000191154.78131.f6; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; Hung AY, 2007, CURR OPIN NEUROL, V20, P477, DOI 10.1097/WCO.0b013e32826388d6; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kempster PA, 2007, BRAIN, V130, P2123, DOI 10.1093/brain/awm142; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2006, ANN NEUROL, V60, P706, DOI 10.1002/ana.21032; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; Lang AE, 2004, LANCET NEUROL, V3, P309, DOI 10.1016/S1474-4422(04)00740-9; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis J, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-19; LeWittt PA, 2008, NEUROTHERAPEUTICS, V5, P210, DOI 10.1016/j.nurt.2008.01.007; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Litvan I, 2007, J NEUROPATH EXP NEUR, V66, P329, DOI 10.1097/nen.0b013e318053716a; Litvan I, 2007, J NEUROPATH EXP NEUR, V66, P251, DOI 10.1097/nen.0b013e3180415e42; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; MacDonald V, 2002, MOVEMENT DISORD, V17, P1166, DOI 10.1002/mds.10258; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; MARRAS C, 2010, MOVEMENT DISORDERS N, P102; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Moss J, 2010, DOPAMINE HDB, P49; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Naoi M, 2009, NEUROSCI LETT, V465, P118, DOI 10.1016/j.neulet.2009.08.082; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; O'Sullivan SS, 2008, MOVEMENT DISORD, V23, P101, DOI 10.1002/mds.21813; Olanow CW, 2009, ANN NEUROL, V66, P591, DOI 10.1002/ana.21778; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palfi S, 2008, LANCET NEUROL, V7, P375, DOI 10.1016/S1474-4422(08)70066-8; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; RIGHTS P, 2007, P NATL ACAD SCI USA, V104, P8161; Rinne JO, 2008, PARKINSONISM RELAT D, V14, P553, DOI 10.1016/j.parkreldis.2008.01.006; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sato K, 2006, MOVEMENT DISORD, V21, P1384, DOI 10.1002/mds.20993; Schapira AHV, 2009, TRENDS PHARMACOL SCI, V30, P41, DOI 10.1016/j.tips.2008.10.005; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schrag A, 2007, MOVEMENT DISORD, V22, P938, DOI 10.1002/mds.21429; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Shepherd CE, 2002, NEUROBIOL DIS, V9, P249, DOI 10.1006/nbdi.2001.0469; Shoulson I, 2002, ANN NEUROL, V51, P604, DOI 10.1002/ana.10191; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Thacker EL, 2008, MOVEMENT DISORD, V23, P69, DOI 10.1002/mds.21772; Thannickal TC, 2007, BRAIN, V130, P1586, DOI 10.1093/brain/awm097; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Yamamoto R, 2007, NEUROSCI LETT, V415, P219, DOI 10.1016/j.neulet.2007.01.029; Yang YX, 2009, NEUROREPORT, V20, P150, DOI 10.1097/WNR.0b013e32831c50df; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; 2009, NAT MED, V15, P1250	126	508	524	0	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					653	661		10.1038/nm.2165	http://dx.doi.org/10.1038/nm.2165			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495568				2022-12-27	WOS:000278394200030
J	Tomaselli, GF; Barth, AS				Tomaselli, Gordon F.; Barth, Andreas S.			Oxidative stress irritates the heart	NATURE MEDICINE			English	Editorial Material							II INHIBITION PROTECTS; RECEPTOR; MODULATION; COMPLEX		[Tomaselli, Gordon F.; Barth, Andreas S.] Johns Hopkins Univ, Div Cardiol, Baltimore, MD 21218 USA	Johns Hopkins University	Tomaselli, GF (corresponding author), Johns Hopkins Univ, Div Cardiol, Baltimore, MD 21218 USA.	gtomase1@jhmi.edu						[Anonymous], 1989, NEW ENGL J MED, V321, P406; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Munzel T, 2009, J AM COLL CARDIOL, V54, P1491, DOI 10.1016/j.jacc.2009.05.066; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	12	29	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					648	649		10.1038/nm0610-648	http://dx.doi.org/10.1038/nm0610-648			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526319				2022-12-27	WOS:000278394200029
J	Hirota, Y; Cha, J; Dey, SK				Hirota, Yasushi; Cha, Jeeyeon; Dey, Sudhansu K.			Prematurity and the puzzle of progesterone resistance	NATURE MEDICINE			English	Editorial Material							PRETERM BIRTH; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; HUMAN PARTURITION; DOUBLE-BLIND; RECEPTOR; MYOMETRIUM; PREVENTION; WITHDRAWAL; MODELS; WOMEN		[Hirota, Yasushi; Cha, Jeeyeon; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center	Hirota, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH USA.	sk.dey@cchmc.org	Hirota, Yasushi/AAD-8713-2020	Hirota, Yasushi/0000-0003-0241-9780	NATIONAL INSTITUTE ON AGING [F30AG040858] Funding Source: NIH RePORTER; NIA NIH HHS [F30 AG040858] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; FAIMAN C, 1981, REPROD BIOL GREAT AP, P45; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; FRYDMAN R, 1992, OBSTET GYNECOL, V80, P972; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; MAZOR M, 1994, AM J OBSTET GYNECOL, V171, P231, DOI 10.1016/0002-9378(94)90474-X; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; PINTO RM, 1967, AM J OBSTET GYNECOL, V98, P547, DOI 10.1016/0002-9378(67)90109-3; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Tranguch S, 2007, J CLIN INVEST, V117, P1824, DOI 10.1172/JCI31622; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808	19	17	17	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					529	531		10.1038/nm0510-529	http://dx.doi.org/10.1038/nm0510-529			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20448578	Green Accepted			2022-12-27	WOS:000277394700030
J	Della Gatta, G; Palomero, T; Perez-Garcia, A; Ambesi-Impiombato, A; Bansal, M; Carpenter, ZW; De Keersmaecker, K; Sole, X; Xu, LY; Paietta, E; Racevskis, J; Wiernik, PH; Rowe, JM; Meijerink, JP; Califano, A; Ferrando, AA				Della Gatta, Giusy; Palomero, Teresa; Perez-Garcia, Arianne; Ambesi-Impiombato, Alberto; Bansal, Mukesh; Carpenter, Zachary W.; De Keersmaecker, Kim; Sole, Xavier; Xu, Luyao; Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.; Rowe, Jacob M.; Meijerink, Jules P.; Califano, Andrea; Ferrando, Adolfo A.			Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; FAMILIAL PLATELET DISORDER; POINT MUTATIONS; REGULATORY NETWORKS; CELL LEUKEMIA; GENE; TRANSFORMATION; EXPRESSION; HOX11	The TLX1 and TLX3 transcription factor oncogenes have a key role in the pathogenesis of T cell acute lymphoblastic leukemia (T-ALL)(1,2). Here we used reverse engineering of global transcriptional networks to decipher the oncogenic regulatory circuit controlled by TLX1 and TLX3. This systems biology analysis defined T cell leukemia homeobox 1 (TLX1) and TLX3 as master regulators of an oncogenic transcriptional circuit governing T-ALL. Notably, a network structure analysis of this hierarchical network identified RUNX1 as a key mediator of the T-ALL induced by TLX1 and TLX3 and predicted a tumor-suppressor role for RUNX1 in T cell transformation. Consistent with these results, we identified recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL. Overall, these results place TLX1 and TLX3 at the top of an oncogenic transcriptional network controlling leukemia development, show the power of network analyses to identify key elements in the regulatory circuits governing human cancer and identify RUNX1 as a tumor-suppressor gene in T-ALL.	[Della Gatta, Giusy; Palomero, Teresa; Perez-Garcia, Arianne; Ambesi-Impiombato, Alberto; Carpenter, Zachary W.; Xu, Luyao; Califano, Andrea; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Palomero, Teresa; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Bansal, Mukesh; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [De Keersmaecker, Kim] Vlaams Inst Biotechnol VIB, Dept Mol & Dev Genet, Louvain, Belgium; [De Keersmaecker, Kim] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Sole, Xavier] Inst Invest Biomed Bellvitge IDIBELL, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Barcelona, Spain; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] Montefiore Med Ctr N, New York, NY USA; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] New York Med Coll, New York, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel; [Rowe, Jacob M.] Technion Israel Inst Technol, Israel Inst Technol, Haifa, Israel; [Meijerink, Jules P.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Oncol & Hematol, Rotterdam, Netherlands; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Flanders Institute for Biotechnology (VIB); KU Leuven; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Montefiore Medical Center; New York Medical College; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Columbia University	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	af2196@columbia.edu	xu, Luyao/F-2381-2015; Meijerink, Jules P/D-4393-2017; Solé, Xavier/AAF-3015-2019; De Keersmaecker, Kim/W-9702-2018	Meijerink, Jules P/0000-0002-6860-798X; Solé, Xavier/0000-0002-2197-3325; De Keersmaecker, Kim/0000-0002-7420-9531; Califano, Andrea/0000-0003-4742-3679	US National Institutes of Health [R01CA120196, R01CA129382, U24 CA114737]; New York Community Trust; Stand Up to Cancer Foundation; Eastern Cooperative Oncology Group tumor bank; Leukemia and Lymphoma Society; Stichting Kinderen Kankervrij (KiKa) [2007-012]; Dutch Cancer Society [KWF-EMCR 2006-3500]; Rally Foundation; Marie Curie International Outgoing fellowship; NATIONAL CANCER INSTITUTE [R01CA120196, R01CA129382, U24CA114737] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Community Trust; Stand Up to Cancer Foundation; Eastern Cooperative Oncology Group tumor bank; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Stichting Kinderen Kankervrij (KiKa); Dutch Cancer Society(KWF Kankerbestrijding); Rally Foundation; Marie Curie International Outgoing fellowship(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health (grants R01CA120196 and R01CA129382 to A. A. F.; and U24 CA114737 to E. P.), the New York Community Trust (A. A. F.), the Innovative Research Award by the Stand Up to Cancer Foundation (A. A. F.), the Eastern Cooperative Oncology Group tumor bank, the Leukemia and Lymphoma Society Scholar Award (A. A. F.), the Stichting Kinderen Kankervrij (KiKa; grant 2007-012) (J.P.M.) and the Dutch Cancer Society (KWF-EMCR 2006-3500) (J.P.M.). A. P.-G. is a postdoctoral researcher funded by the Rally Foundation. G. D. G. was supported by a Marie Curie International Outgoing fellowship. We thank S. Nimer (Memorial Sloan Kettering Cancer Center) for the pCDNA3 RUNX1 expression vector, D. Zhang (University of California, San Diego) for the pM-CSF-R-luc promoter reporter and the pCMV CBFB plasmids and J. Downing (St. Jude Children's Research Hospital) for the Runx1 knockout mice.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Auewarakul CU, 2007, HAEMATOLOGICA, V92, P861, DOI 10.3324/haematol.10914; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Christiansen DH, 2004, BLOOD, V104, P1474, DOI 10.1182/blood-2004-02-0754; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fischer M, 2011, NUCLEIC ACIDS RES, V39, pW357, DOI 10.1093/nar/gkr468; Grossmann V, 2011, HAEMATOL-HEMATOL J, V96, P1874, DOI 10.3324/haematol.2011.043919; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; Langabeer SE, 2002, GENE CHROMOSOME CANC, V34, P24, DOI 10.1002/gcc.10031; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Nishimoto N, 2010, INT J HEMATOL, V92, P194, DOI 10.1007/s12185-010-0612-y; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Osato M, 2001, INT J HEMATOL, V74, P245, DOI 10.1007/BF02982056; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preudhomme C, 2009, BLOOD, V113, P5583, DOI 10.1182/blood-2008-07-168260; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Su XY, 2004, GENE CHROMOSOME CANC, V41, P243, DOI 10.1002/gcc.20088; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	31	103	108	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					436	U198		10.1038/nm.2610	http://dx.doi.org/10.1038/nm.2610			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366949	Green Accepted			2022-12-27	WOS:000301264800046
J	Garofalo, M; Romano, G; Di Leva, G; Nuovo, G; Jeon, YJ; Ngankeu, A; Sun, J; Lovat, F; Alder, H; Condorelli, G; Engelman, JA; Ono, M; Rho, JK; Cascione, L; Volinia, S; Nephew, KP; Croce, CM				Garofalo, Michela; Romano, Giulia; Di Leva, Gianpiero; Nuovo, Gerard; Jeon, Young-Jun; Ngankeu, Apollinaire; Sun, Jin; Lovat, Francesca; Alder, Hansjuerg; Condorelli, Gerolama; Engelman, Jeffrey A.; Ono, Mayumi; Rho, Jin Kyung; Cascione, Luciano; Volinia, Stefano; Nephew, Kenneth P.; Croce, Carlo M.			EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; MESENCHYMAL TRANSITION; CELLS; AMPLIFICATION; INHIBITORS; ADENOCARCINOMA; SENSITIVITY; METASTASIS; ACTIVATION; PTEN	The involvement of the MET oncogene in de novo and acquired resistance of non-small cell lung cancers (NSCLCs) to tyrosine kinase inhibitors (TKIs) has previously been reported, but the precise mechanism by which MET overexpression contributes to TKI-resistant NSCLC remains unclear. MicroRNAs (miRNAs) negatively regulate gene expression, and their dysregulation has been implicated in tumorigenesis. To understand their role in TKI-resistant NSCLCs, we examined changes in miRNA that are mediated by tyrosine kinase receptors. Here we report that miR-30b, miR-30c, miR-221 and miR-222 are modulated by both epidermal growth factor (EGF) and MET receptors, whereas miR-103 and miR-203 are controlled only by MET. We showed that these miRNAs have important roles in gefitinib-induced apoptosis and epithelial-mesenchymal transition of NSCLC cells in vitro and in vivo by inhibiting the expression of the genes encoding BCL2-like 11 (BIM), apoptotic peptidase activating factor 1 (APAF-1), protein kinase C epsilon (PKC-epsilon) and sarcoma viral oncogene homolog (SRC). These findings suggest that modulation of specific miRNAs may provide a therapeutic approach for the treatment of NSCLCs.	[Garofalo, Michela; Di Leva, Gianpiero; Nuovo, Gerard; Jeon, Young-Jun; Ngankeu, Apollinaire; Sun, Jin; Lovat, Francesca; Alder, Hansjuerg; Cascione, Luciano; Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Romano, Giulia] Ist Ricovero & Cura Carattere Sci, Studio Diagnost Nucl SDN, Naples, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Fac Biotechnol Sci, Inst Expt Endocrinol & Oncol, Dept Cellular & Mol Biol & Pathol,Consiglio Nazl, Naples, Italy; [Engelman, Jeffrey A.] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Engelman, Jeffrey A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Sci, Fukuoka 812, Japan; [Rho, Jin Kyung] Univ Ulsan, Dept Pulm & Crit Care Med, Seoul, South Korea; [Cascione, Luciano] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Nephew, Kenneth P.] Indiana Univ, Simon Canc Ctr, Bloomington, IN USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Med Sci Program, Dept Cellular & Integrated Physiol, Bloomington, IN USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kyushu University; University of Ulsan; University of Catania; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Croce, CM (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Cascione, Luciano/X-3115-2019; Volinia, Stefano/A-3029-2010; Volinia, Stefano/AAA-9264-2019; Young, Richard A/F-6495-2012; Condorelli, Gerolama/AAC-3472-2022; Ngankeu, Apollinaire/J-8188-2012	Cascione, Luciano/0000-0002-4606-0637; Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Condorelli, Gerolama/0000-0003-0177-8829; Jeon, Young-Jun/0000-0002-5998-9605	Ohio State University; US National Institutes of Health [CA113001]; Kimmel Scholar Award; NATIONAL CANCER INSTITUTE [R01CA085289, U54CA113001, P01CA129242] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23300350] Funding Source: KAKEN	Ohio State University(Ohio State University); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Huebner and S. Lutz for revisions to the paper and P. Fadda and S. Miller for qRT-PCR assistance. We also thank K. Sergott and Ventana Medical Systems for supplying the immunohistochemistry reagents used in this study. M. Nuovo (The Ohio State University Medical Center) kindly provided the photomicroscopy work. We are grateful for research support from The Ohio State University Targeted Investment in Excellence Award, the US National Institutes of Health grant CA113001 and the Kimmel Scholar Award (M.G.).	Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Deng WG, 2011, MELANOMA RES, V21, P44, DOI 10.1097/CMR.0b013e3283382155; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Politi K, 2010, DIS MODEL MECH, V3, P111, DOI 10.1242/dmm.003681; Qin BL, 2006, CANCER CHEMOTH PHARM, V58, P577, DOI 10.1007/s00280-006-0219-4; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sekido Y, 2010, CANCER SCI, V101, P1, DOI 10.1111/j.1349-7006.2009.01336.x; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Stabile Laura P, 2010, Cancers (Basel), V2, P2153, DOI 10.3390/cancers2042153; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Weisheit S, 2011, CELL SIGNAL, V23, P436, DOI 10.1016/j.cellsig.2010.10.018; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu NN, 2011, FEBS J, V278, P2044, DOI 10.1111/j.1742-4658.2011.08120.x; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Yuan Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-57; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074	31	320	338	0	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					74	82		10.1038/nm.2577	http://dx.doi.org/10.1038/nm.2577			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157681	Green Accepted, Green Submitted			2022-12-27	WOS:000299018600032
J	Steinman, L; Merrill, JT; McInnes, IB; Peakman, M				Steinman, Lawrence; Merrill, Joan T.; McInnes, Iain B.; Peakman, Mark			Optimization of current and future therapy for autoimmune diseases	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIGEN-SPECIFIC IMMUNOTHERAPY; RELAPSING MULTIPLE-SCLEROSIS; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; MYELIN BASIC-PROTEIN; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; NEUROMYELITIS-OPTICA; INTERFERON-BETA	There are multiple immune-based therapeutics available for some of the most prevalent autoimmune diseases, but for others, there are few or no approved immune therapies. This dichotomy poses discrete challenges. First, for diseases in which multiple therapy choices exist, a rational decision tree is required to select the best therapy. Second, we must devise new strategies for the autoimmune diseases that have the highest unmet clinical need. This commentary outlines new strategies for designing more efficient and selective approaches for immune therapy of autoimmune diseases.	[Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Merrill, Joan T.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Clin Pharmacol Res Program, Oklahoma City, OK USA; [McInnes, Iain B.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Peakman, Mark] Kings Coll London, Dept Immunobiol, London WC2R 2LS, England; [Peakman, Mark] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England	Stanford University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Glasgow; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu	Merrill, Joan/HDL-9141-2022	McInnes, Iain/0000-0002-6462-4280; Steinman, Lawrence/0000-0002-2437-2250; Peakman, Mark/0000-0003-3328-3513	Medical Research Council [MR/J006742/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arnon R, 2003, J MOL RECOGNIT, V16, P412, DOI 10.1002/jmr.628; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comi G, 2010, MULT SCLER, V16, P1360, DOI 10.1177/1352458510378127; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; Dolgin E, 2010, NAT MED, V16, P740, DOI 10.1038/nm0710-740; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Dunoyer M, 2011, NAT REV DRUG DISCOV, V10, P475, DOI 10.1038/nrd3493; Eisenbarth George S., 2002, Autoimmunity Reviews, V1, P139, DOI 10.1016/S1568-9972(02)00035-6; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Feldmann M, 2009, ANNU REV IMMUNOL, V27, P1, DOI 10.1146/annurev-immunol-082708-100732; Fourlanos S, 2011, DIABETES, V60, P1237, DOI 10.2337/db10-1360; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Graham KL, 2008, ARTHRITIS RHEUM, V58, P2098, DOI 10.1002/art.23605; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; Hueber W, 2002, ARTHRITIS RES, V4, P290, DOI 10.1186/ar426; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Illa I, 2008, J NEUROIMMUNOL, V201, P90, DOI 10.1016/j.jneuroim.2008.04.039; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Kagan JM, 2011, J AM MED INFORM ASSN, V18, pI161, DOI 10.1136/amiajnl-2011-000114; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Laurberg P, 2008, EUR J ENDOCRINOL, V158, P69, DOI 10.1530/EJE-07-0450; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lozanoska-Ochser B, 2006, DIABETES, V55, P1004, DOI 10.2337/diabetes.55.04.06.db05-1261; Lutterotti A, 2008, J NEUROL SCI, V274, P18, DOI 10.1016/j.jns.2008.05.021; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Mantegazza R, 2011, NEUROPSYCH DIS TREAT, V7, P151, DOI 10.2147/NDT.S8915; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Merrill JT, 2011, LUPUS, V20, P709, DOI 10.1177/0961203310395802; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Michels AW, 2011, SEMIN IMMUNOL, V23, P214, DOI 10.1016/j.smim.2011.07.003; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; OSSERMAN K E, 1956, J Mt Sinai Hosp N Y, V23, P711; Owczarczyk K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002432; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Sattar N, 2005, CURR OPIN RHEUMATOL, V17, P286, DOI 10.1097/01.bor.0000158150.57154.f9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shimizu Y, 2008, J NEUROL, V255, P305, DOI 10.1007/s00415-007-0730-5; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; STEINMAN L, 1993, SCI AM, V269, P106, DOI 10.1038/scientificamerican0993-106; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2010, J INTERN MED, V267, P441, DOI 10.1111/j.1365-2796.2010.02224.x; Steinman L., ANN NEUROL IN PRESS; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Sthoeger ZM, 2009, J AUTOIMMUN, V33, P77, DOI 10.1016/j.jaut.2009.03.009; Strober BE, 2011, BRIT J DERMATOL, V165, P661, DOI 10.1111/j.1365-2133.2011.10419.x; Thrower SL, 2009, CLIN EXP IMMUNOL, V155, P156, DOI 10.1111/j.1365-2249.2008.03814.x; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; Tradtrantip L., ANN NEUROL IN PRESS; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; Vehik K, 2011, DIABETES CARE, V34, P1585, DOI 10.2337/dc11-0523; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Wagner JA, 2010, CLIN PHARMACOL THER, V87, P539, DOI 10.1038/clpt.2009.227; Wallace DJ, 2004, LUPUS, V13, P323, DOI 10.1191/0961203304lu1020oa; Warabi Y, 2007, J NEUROL SCI, V252, P57, DOI 10.1016/j.jns.2006.10.008; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7	89	62	66	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					59	65		10.1038/nm.2625	http://dx.doi.org/10.1038/nm.2625			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227674				2022-12-27	WOS:000299018600029
J	Cheng, LZ				Cheng, Linzhao			Zinc fingers hit off target	NATURE MEDICINE			English	Editorial Material							NUCLEASES; GENOME; CELLS		Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Cheng, LZ (corresponding author), Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21218 USA.				NCI NIH HHS [P01 CA065493] Funding Source: Medline; NHLBI NIH HHS [R01 HL073781] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073781] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	8	6	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2011	17	10					1192	1193		10.1038/nm1011-1192	http://dx.doi.org/10.1038/nm1011-1192			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21988995				2022-12-27	WOS:000296022100030
J	Liu, LB; Gardecki, JA; Nadkarni, SK; Toussaint, JD; Yagi, Y; Bouma, BE; Tearney, GJ				Liu, Linbo; Gardecki, Joseph A.; Nadkarni, Seemantini K.; Toussaint, Jimmy D.; Yagi, Yukako; Bouma, Brett E.; Tearney, Guillermo J.			Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography	NATURE MEDICINE			English	Article							SCANNING ELECTRON-MICROSCOPY; PLAQUE RUPTURE; CLASSIFICATION; THROMBOSIS; DEPTH	Progress in understanding, diagnosis, and treatment of coronary artery disease (CAD) has been hindered by our inability to observe cells and extracellular components associated with human coronary atherosclerosis in situ. The current standards for microstructural investigation, histology and electron microscopy are destructive and prone to artifacts. The highest-resolution intracoronary imaging modality, optical coherence tomography (OCT), has a resolution of similar to 10 mu m, which is too coarse for visualizing most cells. Here we report a new form of OCT, termed micro-optical coherence tomography (mu OCT), whose resolution is improved by an order of magnitude. We show that mu OCT images of cadaver coronary arteries provide clear pictures of cellular and subcellular features associated with atherogenesis, thrombosis and responses to interventional therapy. These results suggest that mu OCT can complement existing diagnostic techniques for investigating atherosclerotic specimens, and that mu OCT may eventually become a useful tool for cellular and subcellular characterization of the human coronary wall in vivo.	[Liu, Linbo; Gardecki, Joseph A.; Nadkarni, Seemantini K.; Toussaint, Jimmy D.; Yagi, Yukako; Bouma, Brett E.; Tearney, Guillermo J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA; [Liu, Linbo; Gardecki, Joseph A.; Nadkarni, Seemantini K.; Toussaint, Jimmy D.; Bouma, Brett E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Nadkarni, Seemantini K.; Bouma, Brett E.; Tearney, Guillermo J.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA; [Yagi, Yukako; Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital	Tearney, GJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	gtearney@partners.org	Liu, Linbo/O-2572-2018	Liu, Linbo/0000-0001-6691-9253	US National Institutes of Health [R01HL076398, R01HL093717]; Cystic Fibrosis Foundation [TEARNE07XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093717, R01HL076398] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to acknowledge contributions from D. Winsor-Hines of Boston Scientific for providing the stents that were used to create Supplementary Figure 4, G. Veytsman of Capital Biosciences for providing explanted human hearts, and J. Zhao and the Wellman Center Photopathology Laboratory staff for expert histology processing. Swine arterial tissue was obtained from the Massachusetts General Hospital Knight Surgical Laboratory. Human tissue was provided by the National Disease Research Interchange and Capital Biosciences. Endothelial cells were supplied by the Schepens Eye Research Institute. This research was supported in part by the US National Institutes of Health (contracts R01HL076398 and R01HL093717) and the Cystic Fibrosis Foundation (contract TEARNE07XX0).	Abela GS, 2006, SCANNING, V28, P1, DOI 10.1002/sca.4950280101; Boppart SA, 1998, NAT MED, V4, P861, DOI 10.1038/nm0798-861; BOURASSA MG, 1976, CIRCULATION, V53, P992, DOI 10.1161/01.CIR.53.6.992; Davies MJ, 1995, EUR HEART J, V16, P3, DOI 10.1093/eurheartj/16.suppl_L.3; Ding ZH, 2002, OPT LETT, V27, P243, DOI 10.1364/OL.27.000243; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gronholdt MLM, 1998, EUR HEART J, V19, pC24; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Lee KS, 2008, OPT LETT, V33, P1696, DOI 10.1364/OL.33.001696; Leitgeb RA, 2006, OPT LETT, V31, P2450, DOI 10.1364/OL.31.002450; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Liu LB, 2007, OPT LETT, V32, P2375, DOI 10.1364/OL.32.002375; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; PASTERNAK RC, 1980, AM J CARDIOL, V45, P591, DOI 10.1016/S0002-9149(80)80009-9; Povazay B, 2002, OPT LETT, V27, P1800, DOI 10.1364/OL.27.001800; Ralston TS, 2007, NAT PHYS, V3, P129, DOI 10.1038/nphys514; Rasband W., 2006, IMAGEJ; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Vakhtin AB, 2003, APPL OPTICS, V42, P6953, DOI 10.1364/AO.42.006953; Vengrenyuk Yuliya, 2008, Molecular & Cellular Biomechanics, V5, P37; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	27	332	342	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2011	17	8					1010	U132		10.1038/nm.2409	http://dx.doi.org/10.1038/nm.2409			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21743452	Green Accepted			2022-12-27	WOS:000293507400036
J	Dreier, JP				Dreier, Jens P.			The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease	NATURE MEDICINE			English	Review							FOCAL CEREBRAL-ISCHEMIA; CA1 PYRAMIDAL CELLS; PERIINFARCT DEPOLARIZATIONS; SUBARACHNOID HEMORRHAGE; NITRIC-OXIDE; DYNAMIC CHANGES; MIGRAINE AURA; BLOOD-FLOW; DC SHIFTS; IN-SITU	The term spreading depolarization describes a wave in the gray matter of the central nervous system characterized by swelling of neurons, distortion of dendritic spines, a large change of the slow electrical potential and silencing of brain electrical activity (spreading depression). In the clinic, unequivocal electrophysiological evidence now exists that spreading depolarizations occur abundantly in individuals with aneurismal subarachnoid hemorrhage, delayed ischemic stroke after subarachnoid hemorrhage, malignant hemispheric stroke, spontaneous intracerebral hemorrhage or traumatic brain injury. Spreading depolarization is induced experimentally by various noxious conditions including chemicals such as potassium, glutamate, inhibitors of the sodium pump, status epilepticus, hypoxia, hypoglycemia and ischemia, but it can can also invade healthy, naive tissue. Resistance vessels respond to it with tone alterations, causing either transient hyperperfusion (physiological hemodynamic response) in healthy tissue or severe hypoperfusion (inverse hemodynamic response, or spreading ischemia) in tissue at risk for progressive damage, which contributes to lesion progression. Therapies that target spreading depolarization or the inverse hemodynamic response may potentially treat these neurological conditions.	[Dreier, Jens P.] Charite, Dept Expt Neurol, Ctr Stroke Res, D-13353 Berlin, Germany; [Dreier, Jens P.] Charite, Dept Neurol, Ctr Stroke Res, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dreier, JP (corresponding author), Charite, Dept Expt Neurol, Ctr Stroke Res, D-13353 Berlin, Germany.	jens.dreier@charite.de		Dreier, Jens/0000-0001-7459-2828	Deutsche Forschungsgemeinschaft [DFG DR 323/2-2, 323/3-1, 323/5-1, SFB Tr3 D10]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin) [01 EO 0801]; Bernstein Center for Computational Neuroscience Berlin [01GQ1001C B2]; Kompetenznetz Schlaganfall	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)(Federal Ministry of Education & Research (BMBF)); Bernstein Center for Computational Neuroscience Berlin; Kompetenznetz Schlaganfall	Supported by grants of the Deutsche Forschungsgemeinschaft (DFG DR 323/2-2, 323/3-1, 323/5-1, SFB Tr3 D10), the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801), Bernstein Center for Computational Neuroscience Berlin 01GQ1001C B2 and the Kompetenznetz Schlaganfall. I would like to thank C. Reiffurth and S. Major for help with the figures.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; AITKEN PG, 1988, NEUROSCI LETT, V89, P187, DOI 10.1016/0304-3940(88)90379-5; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; Canals S, 2005, J NEUROPHYSIOL, V94, P943, DOI 10.1152/jn.01145.2004; CharriautMarlangue C, 1996, J CEREBR BLOOD F MET, V16, P186, DOI 10.1097/00004647-199603000-00002; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2002, NEUROSURGERY, V51, P1457, DOI 10.1097/00006123-200212000-00017; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Erdemli G, 1998, J NEUROPHYSIOL, V80, P2378, DOI 10.1152/jn.1998.80.5.2378; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fleidervish IA, 2001, J NEUROSCI, V21, P4600, DOI 10.1523/JNEUROSCI.21-13-04600.2001; Golding EM, 2001, BRAIN RES, V889, P98, DOI 10.1016/S0006-8993(00)03121-8; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; HENRICH JB, 1986, J NEUROL, V233, P257, DOI 10.1007/BF00314155; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; IADECOLA C, 1994, AM J PHYSIOL, V267, pR228, DOI 10.1152/ajpregu.1994.267.1.R228; JING J, 1994, J NEUROPHYSIOL, V71, P2548, DOI 10.1152/jn.1994.71.6.2548; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Knierim E, 2011, STROKE, V42, pE14, DOI 10.1161/STROKEAHA.110.600023; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; LAMANNA JC, 1975, BRAIN RES, V88, P145, DOI 10.1016/0006-8993(75)90963-4; Largo C, 1996, J NEUROSCI, V16, P1219; LAURITZEN M, 1990, J CEREBR BLOOD F MET, V10, P115, DOI 10.1038/jcbfm.1990.14; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; LEAO AAP, 1945, J NEUROPHYSIOL, V8, P33; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Matsushima K, 1996, J CEREBR BLOOD F MET, V16, P221, DOI 10.1097/00004647-199603000-00006; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Richter F, 2008, J CEREBR BLOOD F MET, V28, P984, DOI 10.1038/sj.jcbfm.9600594; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Saito R, 1997, J CEREBR BLOOD F MET, V17, P857, DOI 10.1097/00004647-199708000-00004; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Sasaki T, 2009, NEUROSCI LETT, V449, P61, DOI 10.1016/j.neulet.2008.10.054; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Somjen GG, 2004, IONS BRAIN; SRAMKA M, 1978, APPL NEUROPHYSIOL, V40, P48; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yanamoto H, 2005, STROKE, V36, P1544, DOI 10.1161/01.STR.0000169903.09253.c7; YOUNG JN, 1991, BRAIN RES, V548, P343, DOI 10.1016/0006-8993(91)91146-R	81	711	734	3	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					439	447		10.1038/nm.2333	http://dx.doi.org/10.1038/nm.2333			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475241				2022-12-27	WOS:000289245100034
J	Zhang, Y; Li, XA; Carpinteiro, A; Goettel, JA; Soddemann, M; Gulbins, E				Zhang, Yang; Li, Xiang; Carpinteiro, Alexander; Goettel, Jeremy A.; Soddemann, Matthias; Gulbins, Erich			Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; CYSTIC-FIBROSIS; MAPK SCAFFOLD; UP-REGULATION; IN-VIVO; ACTIVATION; MACROPHAGES; EXPRESSION; KSR	Pseudomonas aeruginosa is a Gram-negative pathogen that causes severe infections in immunocompromised individuals and individuals with cystic fibrosis or chronic obstructive pulmonary disease (COPD). Here we show that kinase suppressor of Ras-1 (Ksr1)-deficient mice are highly susceptible to pulmonary P. aeruginosa infection accompanied by uncontrolled pulmonary cytokine release, sepsis and death, whereas wild-type mice clear the infection. Ksr1 recruits and assembles inducible nitric oxide (NO) synthase (iNOS) and heat shock protein-90 (Hsp90) to enhance iNOS activity and to release NO upon infection. Ksr1 deficiency prevents lung alveolar macrophages and neutrophils from activating iNOS, producing NO and killing bacteria. Restoring NO production restores the bactericidal capability of Ksr1-deficient lung alveolar macrophages and neutrophils and rescues Ksr1-deficient mice from P. aeruginosa infection. Our findings suggest that Ksr1 functions as a previously unknown scaffold that enhances iNOS activity and is therefore crucial for the pulmonary response to P. aeruginosa infections.	[Zhang, Yang; Li, Xiang; Carpinteiro, Alexander; Soddemann, Matthias; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Goettel, Jeremy A.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Goettel, Jeremy A.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA	University of Duisburg Essen; Vanderbilt University; Vanderbilt University	Gulbins, E (corresponding author), Univ Duisburg Essen, Dept Mol Biol, Essen, Germany.	erich.gulbins@uni-due.de	Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342	Deutsche Forschungsgemeinschaft [Gu 335/13-3, Gu 335/16-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank R. Kolesnick (Memorial Sloan-Kettering Cancer Center) for providing us with Ksr1-deficient mice. This study was supported by Deutsche Forschungsgemeinschaft grants Gu 335/13-3 and Gu 335/16-2 to E.G.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Assis MC, 2006, INT J MOL MED, V18, P355; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Currie AJ, 2003, SEM RESP CRIT CARE M, V24, P671, DOI 10.1055/s-2004-815663; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Fusello AM, 2006, J IMMUNOL, V177, P6152, DOI 10.4049/jimmunol.177.9.6152; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kolesnick R, 2004, J CLIN INVEST, V114, P1233, DOI 10.1172/JCI200423441; Kuncewicz T, 2001, AM J PHYSIOL-RENAL, V281, pF326, DOI 10.1152/ajprenal.2001.281.2.F326; Lozano J, 2003, CANCER RES, V63, P4232; Martin TR, 2000, AM J RESP CELL MOL, V23, P128, DOI 10.1165/ajrcmb.23.2.f189; Morrison DK, 2001, J CELL SCI, V114, P1609; Murphy TF, 2009, CURR OPIN PULM MED, V15, P138, DOI 10.1097/MCP.0b013e328321861a; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Peshes-Yaloz N, 2007, IMMUNOLOGY, V120, P502, DOI 10.1111/j.1365-2567.2006.02521.x; Poch DS, 2009, SEMIN RESP CRIT CARE, V30, P26, DOI 10.1055/s-0028-1119806; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Satoh S, 2001, CLIN EXP IMMUNOL, V126, P266, DOI 10.1046/j.1365-2249.2001.01656.x; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Xing HR, 2003, NAT MED, V9, P1266, DOI 10.1038/nm927; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P963; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000; Zhang Y, 2008, J IMMUNOL, V181, P4247, DOI 10.4049/jimmunol.181.6.4247; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	31	46	47	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					341	U140		10.1038/nm.2296	http://dx.doi.org/10.1038/nm.2296			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21297617				2022-12-27	WOS:000288070000045
J	Holland, WL; Miller, RA; Wang, ZV; Sun, K; Barth, BM; Bui, HH; Davis, KE; Bikman, BT; Halberg, N; Rutkowski, JM; Wade, MR; Tenorio, VM; Kuo, MS; Brozinick, JT; Zhang, BB; Birnbaum, MJ; Summers, SA; Scherer, PE				Holland, William L.; Miller, Russell A.; Wang, Zhao V.; Sun, Kai; Barth, Brian M.; Bui, Hai H.; Davis, Kathryn E.; Bikman, Benjamin T.; Halberg, Nils; Rutkowski, Joseph M.; Wade, Mark R.; Tenorio, Vincent M.; Kuo, Ming-Shang; Brozinick, Joseph T.; Zhang, Bei B.; Birnbaum, Morris J.; Summers, Scott A.; Scherer, Philipp E.			Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin	NATURE MEDICINE			English	Article							PROTEIN-KINASE; INSULIN SENSITIVITY; FATTY-ACIDS; MOUSE MODEL; PKC-ZETA; CELL; SPHINGOSINE; RESISTANCE; INHIBITION; APOPTOSIS	The adipocyte-derived secretory factor adiponectin promotes insulin sensitivity, decreases inflammation and promotes cell survival. No unifying mechanism has yet explained how adiponectin can exert such a variety of beneficial systemic effects. Here, we show that adiponectin potently stimulates a ceramidase activity associated with its two receptors, AdipoR1 and AdipoR2, and enhances ceramide catabolism and formation of its antiapoptotic metabolite-sphingosine-1-phosphate (S1P)-independently of AMP-dependent kinase (AMPK). Using models of inducible apoptosis in pancreatic beta cells and cardiomyocytes, we show that transgenic overproduction of adiponectin decreases caspase-8-mediated death, whereas genetic ablation of adiponectin enhances apoptosis in vivo through a sphingolipid-mediated pathway. Ceramidase activity is impaired in cells lacking both adiponectin receptor isoforms, leading to elevated ceramide levels and enhanced susceptibility to palmitate-induced cell death. Combined, our observations suggest a unifying mechanism of action for the beneficial systemic effects exerted by adiponectin, with sphingolipid metabolism as its core upstream signaling component.	[Holland, William L.; Wang, Zhao V.; Sun, Kai; Davis, Kathryn E.; Halberg, Nils; Rutkowski, Joseph M.; Tenorio, Vincent M.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Miller, Russell A.; Birnbaum, Morris J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Barth, Brian M.; Summers, Scott A.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Bui, Hai H.; Wade, Mark R.; Kuo, Ming-Shang; Brozinick, Joseph T.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Bikman, Benjamin T.; Summers, Scott A.] Duke Natl Univ Singapore, Grad Sch Med, Program Cardiovasc & Metab Dis, Singapore, Singapore; [Halberg, Nils] Univ Copenhagen, Dept Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Zhang, Bei B.] Merck Res Labs, Dept Metab Disorders, Rahway, NJ USA; [Summers, Scott A.] Duke Univ, Med Ctr, Stedman Ctr Nutr & Metab Res, Durham, NC USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Colorado State University; Eli Lilly; National University of Singapore; University of Copenhagen; Merck & Company; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; /AAE-5384-2020; Bikman, Benjamin/AAT-9606-2021; Halberg, Nils/AAF-8153-2019	Scherer, Philipp E/0000-0003-0680-3392; Halberg, Nils/0000-0002-2943-3147; Rutkowski, Joseph/0000-0002-4197-0236; Sun, Kai/0000-0002-4778-4549; Birnbaum, Morris/0000-0001-9972-8680; Barth, Brian/0000-0002-3542-1804; Wang, Zhao/0000-0002-9904-9538	US National Institutes of Health [R01-DK55758, R01-CA112023, RC1-DK086629, P01-DK088761, R01-DK56886, P01-DK49210, R21-DK073181]; National Research Service Award [F32-DK083866, TL1-DK081181]; University of Copenhagen;  [F32-DK085935];  [T32-HL007360];  [F32-DK081279]; NATIONAL CANCER INSTITUTE [R01CA112023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073181, R01DK056886, R01DK055758, F32DK085935, R01DK081456, F32DK083866, P01DK049210, F32DK081279, TL1DK081181, P01DK088761, RC1DK086629] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Scherer and Summers laboratories for comments. We would like to thank R. Kitsis for discussions regarding the generation of HEART-ATTAC mice. We thank B. Hammer and the Transgenic Core Facility at UT Southwestern for the generation of the mouse models used in this study and the Metabolic Core Facility at UT Southwestern for help with phenotyping of the mice. Lkb1<SUP>-/-</SUP> mice and cells were a kind gift from R. DePinho, Massachusetts General Hospital. INS-1 832/13 cells were generously provided by C. Newgard, Duke University Medical Center. We thank Ariad Pharmaceuticals for providing the dimerization kit and compound AP20187. This work was supported by US National Institutes of Health grants R01-DK55758, R01-CA112023, RC1-DK086629 and P01-DK088761 (P.E.S.); R01-DK56886 and P01-DK49210 (M.J.B.); as well as R21-DK073181 (S.A.S.). W.L.H. was supported by National Research Service Award F32-DK083866 and TL1-DK081181. J.M.R. was supported by F32-DK085935 and T32-HL007360 and K.E.D. was supported by F32-DK081279. N.H. was funded by a grant from University of Copenhagen.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Brakch N, 2010, EUR HEART J, V31, P67, DOI 10.1093/eurheartj/ehp387; Burger D, 2006, CARDIOVASC RES, V72, P51, DOI 10.1016/j.cardiores.2006.06.026; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; El Bawab S, 2002, J LIPID RES, V43, P141; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; He LS, 1997, EXP CELL RES, V232, P64, DOI 10.1006/excr.1997.3494; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hohmeier HE, 2003, INT J OBESITY, V27, pS12, DOI 10.1038/sj.ijo.0802493; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Karliner JS, 2009, J CARDIOVASC PHARM, V53, P189, DOI 10.1097/FJC.0b013e3181926706; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; King CC, 2000, J BIOL CHEM, V275, P18108, DOI 10.1074/jbc.M909663199; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kupchak BR, 2007, BBA-MOL CELL RES, V1773, P1124, DOI 10.1016/j.bbamcr.2007.04.003; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	60	631	664	1	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					55	U226		10.1038/nm.2277	http://dx.doi.org/10.1038/nm.2277			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21186369	Green Accepted			2022-12-27	WOS:000285994000036
J	Zhou, L; Li, F; Xu, HB; Luo, CX; Wu, HY; Zhu, MM; Lu, W; Ji, X; Zhou, QG; Zhu, DY				Zhou, Li; Li, Fei; Xu, Hai-Bing; Luo, Chun-Xia; Wu, Hai-Yin; Zhu, Ming-Mei; Lu, Wei; Ji, Xing; Zhou, Qi-Gang; Zhu, Dong-Ya			Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; MICE LACKING; SUBCELLULAR-LOCALIZATION; PROTEIN INTERACTIONS; BRAIN-INJURY; PDZ DOMAIN; NEUROPROTECTION; EXCITOTOXICITY; NEUROTOXICITY; ANTAGONISTS	Stroke is a major public health problem leading to high rates of death and disability in adults(1,2). Excessive stimulation of N-methyl-D-aspartate receptors (NMDARs) and the resulting neuronal nitric oxide synthase (nNOS) activation are crucial for neuronal injury after stroke insult(3-7). However, directly inhibiting NMDARs or nNOS can cause severe side effects because they have key physiological functions in the CNS5,8-12. Here we show that cerebral ischemia induces the interaction of nNOS with postsynaptic density protein-95 (PSD-95). Disrupting nNOS-PSD-95 interaction via overexpressing the N-terminal amino acid residues 1-133 of nNOS (nNOS-N1-133) prevented glutamate-induced excitotoxicity and cerebral ischemic damage. Given the mechanism of nNOS-PSD-95 interaction, we developed a series of compounds and discovered a small-molecular inhibitor of the nNOS-PSD-95 interaction, ZL006. This drug blocked the ischemia-induced nNOS-PSD-95 association selectively, had potent neuroprotective activity in vitro and ameliorated focal cerebral ischemic damage in mice and rats subjected to middle cerebral artery occlusion (MCAO) and reperfusion. Moreover, it readily crossed the blood-brain barrier, did not inhibit NMDAR function, catalytic activity of nNOS or spatial memory, and had no effect on aggressive behaviors. Thus, this new drug may serve as a treatment for stroke, perhaps without major side effects.	[Zhou, Li; Xu, Hai-Bing; Luo, Chun-Xia; Wu, Hai-Yin; Zhu, Ming-Mei; Zhou, Qi-Gang; Zhu, Dong-Ya] Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Peoples R China; [Li, Fei; Ji, Xing] Nanjing Med Univ, Sch Pharm, Dept Med Chem, Nanjing, Peoples R China; [Luo, Chun-Xia; Wu, Hai-Yin; Zhou, Qi-Gang; Zhu, Dong-Ya] Nanjing Med Univ, Lab Cerebrovasc Dis, Nanjing, Peoples R China; [Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, DY (corresponding author), Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Peoples R China.	chunxialuo@njmu.edu.cn; dyzhu@njmu.edu.cn			National Natural Science Foundation of China [30971021, 81030023, 30901550]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China ((30971021, 81030023) (D.-Y.Z.) and (30901550) (C.-X. L.)). We thank X. Jin, Q.-P. Li, C.-C. Cao, H.-H. Zhou, W.-X. Sun, D.-L. Wu, Y. Hu and J. Zhang for technical assistance.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Dawson VL, 1996, J NEUROSCI, V16, P2479; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; Gallego J, 2009, CEREBROVASC DIS, V27, P88, DOI 10.1159/000200445; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; HECKER M, 1994, J NEUROCHEM, V62, P1524; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Kelley JB, 2009, LEARN MEMORY, V16, P371, DOI 10.1101/lm.1329209; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Qoronfleh MW, 2003, J BIOMED BIOTECHNOL, P249; Quintana E, 2004, FASEB J, V18, P531, DOI 10.1096/fj.03-0596fje; Rothe F, 1998, NEUROSCIENCE, V83, P259, DOI 10.1016/S0306-4522(97)00373-4; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Smith Paul F, 2003, Curr Opin Investig Drugs, V4, P826; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	34	276	306	2	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1439	U123		10.1038/nm.2245	http://dx.doi.org/10.1038/nm.2245			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102461				2022-12-27	WOS:000285048900039
J	Wurtele, H; Tsao, S; Lepine, G; Mullick, A; Tremblay, J; Drogaris, P; Lee, EH; Thibault, P; Verreault, A; Raymond, M				Wurtele, Hugo; Tsao, Sarah; Lepine, Guylaine; Mullick, Alaka; Tremblay, Jessy; Drogaris, Paul; Lee, Eun-Hye; Thibault, Pierre; Verreault, Alain; Raymond, Martine			Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy	NATURE MEDICINE			English	Article							DNA-DAMAGE RESPONSE; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; INVASIVE CANDIDIASIS; H3-K56 ACETYLATION; H3K56 ACETYLATION; CELL-CYCLE; YEAST; RESISTANCE	Candida albicans is a major fungal pathogen that causes serious systemic and mucosal infections in immunocompromised individuals. In yeast, histone H3 Lys56 acetylation (H3K56ac) is an abundant modification regulated by enzymes that have fungal-specific properties, making them appealing targets for antifungal therapy. Here we demonstrate that H3K56ac in C. albicans is regulated by the RTT109 and HST3 genes, which respectively encode the H3K56 acetyltransferase (Rtt109p) and deacetylase (Hst3p). We show that reduced levels of H3K56ac sensitize C. albicans to genotoxic and antifungal agents. Inhibition of Hst3p activity by conditional gene repression or nicotinamide treatment results in a loss of cell viability associated with abnormal filamentous growth, histone degradation and gross aberrations in DNA staining. We show that genetic or pharmacological alterations in H3K56ac levels reduce virulence in a mouse model of C. albicans infection. Our results demonstrate that modulation of H3K56ac is a unique strategy for treatment of C. albicans and, possibly, other fungal infections.	[Wurtele, Hugo; Tsao, Sarah; Lepine, Guylaine; Drogaris, Paul; Lee, Eun-Hye; Thibault, Pierre; Verreault, Alain; Raymond, Martine] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Mullick, Alaka; Tremblay, Jessy] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Mullick, Alaka; Tremblay, Jessy] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Verreault, Alain] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Raymond, Martine] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; National Research Council Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Verreault, A (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	alain.verreault@umontreal.ca; martine.raymond@umontreal.ca		Tsao, Sarah/0000-0002-9645-4490; Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes of Health Research [CTP-79843, III-94587, CTP-79392]; National Science and Engineering Research Council of Canada [STGP-322143-05]; Canadian Center of Excellence in Commercialization and Research; Canadian Foundation for Innovation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Center of Excellence in Commercialization and Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	We are grateful to T. Roemer (Merck Research Laboratory) for providing strain CaSS1 and plasmids pHIS3 and pSAT-Tet, G. St-Germain (Laboratoire de sante publique du Quebec) for strains MY067497, MY067743, MY070362, MY070589, MY069520, MY070954, MY070968 and MY070627, C. Restieri and M. Laverdiere (Hospital Maisonneuve-Rosemont) for strain 372.73374.1, C. Bachewich (Concordia University) for strain R153 and T. Edlind (Drexel University College of Medicine) for strain 20464. We are indebted to T. Roemer and M. Whiteway for critical reading of the manuscript. We thank F. Malenfant, J. Leroy, M. Mercier and P. Liscourt for excellent assistance in mouse handling. We are also grateful for the availability of the Candida Genome Database. This work was supported by research grants from the Canadian Institutes of Health Research to M. R. (CTP-79843, III-94587), A. M. (CTP-79843) and A. V. (CTP-79392) and from the National Science and Engineering Research Council of Canada to P. T. (STGP-322143-05). This is National Research Council of Canada publication number 52756. The Institute for Research in Immunology and Cancer is supported by funds from the Canadian Center of Excellence in Commercialization and Research, the Canadian Foundation for Innovation, and the Fonds de la Recherche en Sante du Quebec.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Deere D, 1998, YEAST, V14, P147, DOI 10.1002/(SICI)1097-0061(19980130)14:2<147::AID-YEA207>3.3.CO;2-C; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Drogaris P, 2008, ANAL CHEM, V80, P6698, DOI 10.1021/ac800739d; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Garske AL, 2006, BIOCHEMISTRY-US, V45, P94, DOI 10.1021/bi052015l; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Horsman MR, 1997, RADIOTHER ONCOL, V45, P167, DOI 10.1016/S0167-8140(97)00127-8; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Kelly J, 2009, MED MYCOL, V47, P697, DOI 10.3109/13693780802552606; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06; Niren Neil M, 2006, Cutis, V77, P11; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sims CR, 2005, ARCH MED RES, V36, P660, DOI 10.1016/j.arcmed.2005.05.015; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Trunk K, 2009, EUKARYOT CELL, V8, P756, DOI 10.1128/EC.00332-08; Tsao S, 2009, ANTIMICROB AGENTS CH, V53, P1344, DOI 10.1128/AAC.00926-08; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	53	107	113	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					774	U73		10.1038/nm.2175	http://dx.doi.org/10.1038/nm.2175			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20601951	Green Accepted			2022-12-27	WOS:000279631900026
J	Lee, SH; Hu, LL; Gonzalez-Navajas, J; Seo, GS; Shen, C; Brick, J; Herdman, S; Varki, N; Corr, M; Lee, J; Raz, E				Lee, Sung Hee; Hu, Li-Li; Gonzalez-Navajas, Jose; Seo, Geom Seog; Shen, Carol; Brick, Jonathan; Herdman, Scott; Varki, Nissi; Corr, Maripat; Lee, Jongdae; Raz, Eyal			ERK activation drives intestinal tumorigenesis in Apc(min/+) mice	NATURE MEDICINE			English	Article							C-MYC PROTEOLYSIS; INNATE IMMUNITY; KAPPA-B; INFLAMMATION; CANCER; TRANSCRIPTION; NEOPLASIA; MUTATION; PATHWAY; TARGET	Toll-like receptor (TLR) signaling is essential for intestinal tumorigenesis in Apc(min/+) mice, but the mechanisms by which Apc enhances tumor growth are unknown. Here we show that microflora-MyD88-ERK signaling in intestinal epithelial cells (IECs) promotes tumorigenesis by increasing the stability of the c-Myc oncoprotein. Activation of ERK (extracellular signal-related kinase) phosphorylates c-Myc, preventing its ubiquitination and subsequent proteasomal degradation. Accordingly, Apc(min/+)/Myd88(-/-) mice have lower phospho-ERK (p-ERK) levels and fewer and smaller IEC tumors than Apc(min/+) mice. MyD88 (myeloid differentiation primary response gene 88)-independent activation of ERK by epidermal growth factor (EGF) increased p-ERK and c-Myc and restored the multiple intestinal neoplasia (Min) phenotype in Apc(min)/(+)/Myd88(-/-) mice. Administration of an ERK inhibitor suppressed intestinal tumorigenesis in EGF-treated Apc(min/+)/Myd88(-/-) and Apcmin/+ mice and increased their survival. Our data reveal a new facet of oncogene-environment interaction, in which microflora-induced TLR activation regulates oncogene expression and related IEC tumor growth in a susceptible host.	[Lee, Sung Hee; Hu, Li-Li; Gonzalez-Navajas, Jose; Seo, Geom Seog; Shen, Carol; Brick, Jonathan; Herdman, Scott; Corr, Maripat; Lee, Jongdae; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Nissi] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Raz, E (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	eraz@ucsd.edu	González-Navajas, Jose Manuel/AAB-1575-2019; 高, 雨莉/HGU-8187-2022; LEE, Sunghee/HCH-4510-2022	González-Navajas, Jose Manuel/0000-0002-1591-939X; Lee, Jongdae/0000-0002-6270-4658	US National Institutes of Health [AI068685, CA133702, DK35108, DK080506]; NATIONAL CANCER INSTITUTE [R21CA133702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, P01DK035108] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank P. Charos for animal breeding and S. Shenouda for tissue processing. This work was supported by US National Institutes of Health grants AI068685, CA133702, DK35108 and DK080506.	Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Chang WCL, 2005, ANN NY ACAD SCI, V1059, P41, DOI 10.1196/annals.1339.020; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dakour J, 1999, PLACENTA, V20, P119, DOI 10.1053/plac.1998.0336; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dove WF, 1997, CANCER RES, V57, P812; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Lee YR, 2006, DERMATOL SURG, V32, P1327, DOI 10.1111/j.1524-4725.2006.32302.x; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Michelsen KS, 2007, CURR OPIN HEMATOL, V14, P48, DOI 10.1097/00062752-200701000-00010; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Sanderson IR, 2007, AM J PHYSIOL-GASTR L, V292, pG6, DOI 10.1152/ajpgi.00275.2006; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seo TC, 2008, J MED FOOD, V11, P687, DOI 10.1089/jmf.2007.0053; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wickenden JA, 2008, ONCOGENE, V27, P7150, DOI 10.1038/onc.2008.335; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232	40	159	164	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					665	U65		10.1038/nm.2143	http://dx.doi.org/10.1038/nm.2143			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473309	Green Accepted			2022-12-27	WOS:000278394200032
J	Boulter, L; Govaere, O; Bird, TG; Radulescu, S; Ramachandran, P; Pellicoro, A; Ridgway, RA; Seo, SS; Spee, B; Van Rooijen, N; Sansom, OJ; Iredale, JP; Lowell, S; Roskams, T; Forbes, SJ				Boulter, Luke; Govaere, Olivier; Bird, Tom G.; Radulescu, Sorina; Ramachandran, Prakash; Pellicoro, Antonella; Ridgway, Rachel A.; Seo, Sang Soo; Spee, Bart; Van Rooijen, Nico; Sansom, Owen J.; Iredale, John P.; Lowell, Sally; Roskams, Tania; Forbes, Stuart J.			Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease	NATURE MEDICINE			English	Article							BILE-DUCT DEVELOPMENT; ALAGILLE-SYNDROME; REGULATES FORMATION; CHOLINE-DEFICIENT; GENE-EXPRESSION; HUMAN JAGGED1; MOUSE MODEL; OVAL CELLS; DIFFERENTIATION; NUMB	During chronic injury a population of bipotent hepatic progenitor cells (HPCs) become activated to regenerate both cholangiocytes and hepatocytes. Here we show in human diseased liver and mouse models of the ductular reaction that Notch and Wnt signaling direct specification of HPCs via their interactions with activated myofibroblasts or macrophages. In particular, we found that during biliary regeneration, expression of Jagged 1 (a Notch ligand) by myofibroblasts promoted Notch signaling in HPCs and thus their biliary specification to cholangiocytes. Alternatively, during hepatocyte regeneration, macrophage engulfment of hepatocyte debris induced Wnt3a expression. This resulted in canonical Wnt signaling in nearby HPCs, thus maintaining expression of Numb (a cell fate determinant) within these cells and the promotion of their specification to hepatocytes. By these two pathways adult parenchymal regeneration during chronic liver injury is promoted.	[Boulter, Luke; Bird, Tom G.; Seo, Sang Soo; Lowell, Sally; Forbes, Stuart J.] Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Boulter, Luke; Bird, Tom G.; Ramachandran, Prakash; Pellicoro, Antonella; Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Govaere, Olivier; Van Rooijen, Nico; Roskams, Tania] Katholieke Univ Leuven, Dept Morphol & Mol Pathol, Louvain, Belgium; [Radulescu, Sorina; Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Animals, Utrecht, Netherlands; [Van Rooijen, Nico] Vrije Univ Med Ctr, Dept Mol Cell Biol, Fac Med, Amsterdam, Netherlands	University of Edinburgh; University of Edinburgh; KU Leuven; Beatson Institute; Utrecht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Forbes, SJ (corresponding author), Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Ramachandran, Prakash/AAR-9600-2021; Lowell, Sally/AAW-2992-2020; Govaere, Olivier/R-9372-2019; Van Rooijen, Nico/Z-1578-2019; Bird, Tom/H-3840-2019	Lowell, Sally/0000-0002-4018-9480; Govaere, Olivier/0000-0002-4426-6930; Bird, Tom/0000-0002-6120-1581; Iredale, John/0000-0003-2174-5127; Roskams, Tania/0000-0002-2816-1530; Forbes, Stuart/0000-0003-3715-2561; Sansom, Owen J./0000-0001-9540-3010; Ramachandran, Prakash/0000-0001-5996-2413	MRC; Sir Jules Thorn Trust; Wellcome Trust; MRC [G1000868, G0901697, G0600033, MR/J010766/1] Funding Source: UKRI; Cancer Research UK [12481] Funding Source: researchfish; Medical Research Council [G1000868, G0901697, G0600033, G0700711B, MR/J010766/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [07JTA] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Trust; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	Clodronate (Cl<INF>2</INF>MDP) was a gift of Roche Diagnostics (Mannheim, Germany). Thanks to R. Aucott (UK Medical Research Council (MRC)/University of Edinburgh Centre for Inflammation Research) for the donation of mouse hepatic fibroblasts. Krt19CreER<SUP>T</SUP> mice were a kind gift from G. Gu (Vanderbilt University), and the Ctnnb1<SUP>Delta Ex3</SUP> strain was provided by O. Sansom (The Beatson Institute for Cancer Research, Glasgow). S.J.F. is supported by the MRC, Sir Jules Thorn Trust and Wellcome Trust; L.G.B. is funded through an MRC project grant and was supported through an MRC studentship.	Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Clotman F, 2002, DEVELOPMENT, V129, P1819; Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fletcher J, 2008, CLONING STEM CELLS, V10, P331, DOI 10.1089/clo.2007.0094; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Glise B, 2002, DEV BIOL, V248, P93, DOI 10.1006/dbio.2002.0720; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Hay DC, 2010, GASTROENTEROLOGY, V139, P729, DOI 10.1053/j.gastro.2010.07.013; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Katoh M, 2006, INT J MOL MED, V18, P517; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lee YJ, 1999, J BIOL CHEM, V274, P1566, DOI 10.1074/jbc.274.3.1566; Lemaigre FP, 2008, HEPATOLOGY, V48, P358, DOI 10.1002/hep.22480; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McCright B, 2002, DEVELOPMENT, V129, P1075; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619; Omenetti A, 2011, CURR OPIN GASTROEN, V27, P268, DOI 10.1097/MOG.0b013e32834550b4; Park J, 2010, DEV DYNAM, V239, P514, DOI 10.1002/dvdy.22192; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; VANHOUTE L, 1993, J BIOL CHEM, V268, P18083; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; *WHO, 2009, DIS INJ COUNTR EST B; Yamasaki H, 2006, DEVELOPMENT, V133, P4233, DOI 10.1242/dev.02591	59	524	546	3	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					572	579		10.1038/nm.2667	http://dx.doi.org/10.1038/nm.2667			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388089	Green Accepted			2022-12-27	WOS:000302617800034
J	Kalivas, PW; Brady, K				Kalivas, Peter W.; Brady, Kathleen			Hatching the addiction egg	NATURE MEDICINE			English	Editorial Material							NUCLEUS-ACCUMBENS; COCAINE; IMPULSIVITY; PLASTICITY		[Kalivas, Peter W.; Brady, Kathleen] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kalivas, Peter W.; Brady, Kathleen] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu		Brady, Kathleen/0000-0002-3944-8051	NIDA NIH HHS [R01 DA003906, R01 DA012513] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003906, R01DA012513] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Knackstedt LA, 2010, J NEUROSCI, V30, P7984, DOI 10.1523/JNEUROSCI.1244-10.2010; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003	14	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					502	503		10.1038/nm.2726	http://dx.doi.org/10.1038/nm.2726			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22481410				2022-12-27	WOS:000302617800025
J	Blank, M; Tang, Y; Yamashita, M; Burkett, SS; Cheng, SY; Zhang, YE				Blank, Michael; Tang, Yi; Yamashita, Motozo; Burkett, Sandra S.; Cheng, Steven Y.; Zhang, Ying E.			A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20	NATURE MEDICINE			English	Article							UBIQUITIN LIGASE SMURF2; BREAST-CANCER CELLS; HISTONE H2B; DEPENDENT DEGRADATION; H3 METHYLATION; UBIQUITYLATION; DNA; MONOUBIQUITINATION; ELONGATION; EXPRESSION	In addition to allelic mutations, cancers are known to harbor alterations in their chromatin landscape. Here we show that genomic ablation of Smad ubiquitin regulatory factor 2 (Smurf2), a HECT-domain E3 ubiquitin ligase, results in dysregulation of both the DNA damage response and genomic stability, culminating in increased susceptibility to various types of cancers in aged mice. We show that Smurf2 regulates the monoubiquitination of histone H2B as well as the trimethylation of histone H3 at Lys4 and Lys79 by targeting ring finger protein 20 (RNF20) for proteasomal degradation in both mouse and human cells. We also show that Smurf2 and RNF20 are colocalized at the gamma-H2AX foci of double-stranded DNA breaks in the nucleus. Thus, Smurf2 has a tumor suppression function that normally maintains genomic stability by controlling the epigenetic landscape of histone modifications through RNF20.	[Blank, Michael; Tang, Yi; Yamashita, Motozo; Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Burkett, Sandra S.] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Cheng, Steven Y.] Nanjing Med Univ, Dept Dev Genet, Sch Basic Med Sci, Nanjing, Jiangsu, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nanjing Medical University	Zhang, YE (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Burkett, Sandra/0000-0002-5476-4028	US National Cancer Institute, US National Institutes of Health, Center for Cancer Research; Japan Society for the Promotion of Science [21689053]; NATIONAL CANCER INSTITUTE [ZIABC011168] Funding Source: NIH RePORTER	US National Cancer Institute, US National Institutes of Health, Center for Cancer Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Anver for pathology services, V. Barr for assistance with microscope, X. Wu for assistance with the microarray experiments, N. Morris for the animal husbandry and N. Teja for assistance with cell culture. We also thank K. Sixt for comments on the manuscript. This research is supported by the Intramural Research Program of the US National Cancer Institute, US National Institutes of Health, Center for Cancer Research. M.Y. was partially supported by the Japan Society for the Promotion of Science grant 21689053.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fukuchi M, 2002, CANCER RES, V62, P7162; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	38	114	122	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					227	234		10.1038/nm.2596	http://dx.doi.org/10.1038/nm.2596			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22231558	Green Accepted			2022-12-27	WOS:000300140300036
J	Amson, R; Pece, S; Lespagnol, A; Vyas, R; Mazzarol, G; Tosoni, D; Colaluca, I; Viale, G; Rodrigues-Ferreira, S; Wynendaele, J; Chaloin, O; Hoebeke, J; Marine, JC; Di Fiore, PP; Telerman, A				Amson, Robert; Pece, Salvatore; Lespagnol, Alexandra; Vyas, Rajesh; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Rodrigues-Ferreira, Sylvie; Wynendaele, Jessika; Chaloin, Olivier; Hoebeke, Johan; Marine, Jean-Christophe; Di Fiore, Pier Paolo; Telerman, Adam			Reciprocal repression between P53 and TCTP	NATURE MEDICINE			English	Article							CONTROLLED TUMOR PROTEIN; TRANSCRIPTIONAL REPRESSION; EXOSOME SECRETION; CELL-CYCLE; IN-VIVO; APOPTOSIS; GENE; REVERSION; CANCER; ACTIVATION	Screening for genes that reprogram cancer cells for the tumor reversion switch identified TCTP (encoding translationally controlled tumor protein) as a crucial regulator of apoptosis. Here we report a negative feedback loop between P53 and TCTP. TCTP promotes P53 degradation by competing with NUMB for binding to P53-MDM2-containing complexes. TCTP inhibits MDM2 auto-ubiquitination and promotes MDM2-mediated ubiquitination and degradation of P53. Notably, Tctp haploinsufficient mice are sensitized to P53-dependent apoptosis. In addition, P53 directly represses TCTPtranscription. In 508 breast cancers, high-TCTP status associates with poorly differentiated, aggressive G3-grade tumors, predicting poor prognosis (P < 0.0005). Tctp knockdown in primary mammary tumor cells from ErbB2 transgenic mice results in increased P53 expression and a decreased number of stem-like cancer cells. The pharmacological compounds sertraline and thioridazine increase the amount of P53 by neutralizing TCTP's action on the MDM2-P53 axis. This study links TCTP and P53 in a previously unidentified regulatory circuitry that may underlie the relevance of TCTP in cancer.	[Amson, Robert; Lespagnol, Alexandra; Rodrigues-Ferreira, Sylvie; Telerman, Adam] Ecole Normale Super, Lab Biotechnol & Pharmacol Genet Appl LBPA, CNRS, UMR 8113, Cachan, France; [Pece, Salvatore; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Di Fiore, Pier Paolo] Ist Fdn Italiana Ric Canc FIRC Oncol Mol, Milan, Italy; [Pece, Salvatore; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy; [Pece, Salvatore; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy; [Vyas, Rajesh; Wynendaele, Jessika; Marine, Jean-Christophe] VIB Katholieke Univ Leuven KULeuven, Ctr Biol Dis, Lab Mol Canc Biol, Louvain, Belgium; [Chaloin, Olivier; Hoebeke, Johan] Unite Propre UPR CNRS 9021, Inst Biol Mol & Cellulaire, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; Flanders Institute for Biotechnology (VIB)	Telerman, A (corresponding author), Ecole Normale Super, Lab Biotechnol & Pharmacol Genet Appl LBPA, CNRS, UMR 8113, Cachan, France.	telerman@noos.fr	Marine, Jean Christophe/J-2237-2015; Viale, Giuseppe/AAE-8921-2019; Pece, Salvatore/B-9609-2013; Marine, Jean-Christophe/K-3292-2016; Di Fiore, Pier Paolo/K-2130-2012; Tosoni, Daniela/K-4524-2014; 高, 雨莉/HGU-8187-2022; colaluca, ivan nicola/AAB-2571-2019; Colaluca, Ivan Nicola/K-9776-2016	Pece, Salvatore/0000-0003-1764-3929; Marine, Jean-Christophe/0000-0003-2433-9837; Di Fiore, Pier Paolo/0000-0002-2252-0950; Vyas, Rajesh/0000-0001-9427-5942; Colaluca, Ivan Nicola/0000-0002-3371-112X	Agence Nationale de la Recherche Programme Blanc [ANR-09-BLAN-0292-01]; European Union; Association Sclerose Tubereuse de Bourneville; Associazione Italiana per la Ricerca sul Cancro; Italian Ministries of Education University Research (MIUR); Italian Ministry of Health; European Community; European Research Council; Ferrari Foundation; Monzino Foundation and the Cassa Risparmio Provincie Lombarde (CARIPLO) Foundation; Vollaro Foundation; Agency for Innovation by Science and Technology (IWT)	Agence Nationale de la Recherche Programme Blanc(French National Research Agency (ANR)); European Union(European Commission); Association Sclerose Tubereuse de Bourneville; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministries of Education University Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Ferrari Foundation; Monzino Foundation and the Cassa Risparmio Provincie Lombarde (CARIPLO) Foundation; Vollaro Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	A.T. and R.A. dedicate this work to G. Schnek for his sustained care. We thank C. Auclair for constant support; D. Galvagno for technical assistance; G. D'Ario and S. Confalonieri for statistical analyses; and B. Vogelstein (Johns Hopkins University), M. Oren (Weizmann Institute of Science) and B. Wasilyk and C. lArasilyk (IGBMC Illkirch) for HCT116, H1299 Trp53-null, temperature-sensitive P53 Val138 mutant cells, and P53 protein and plasmids, respectively. This work was supported by grants from the Agence Nationale de la Recherche Programme Blanc (ANR-09-BLAN-0292-01), the European Union Network of Excellence CONTICANET and the Association Sclerose Tubereuse de Bourneville to A.T. and R.A., the Associazione Italiana per la Ricerca sul Cancro and the Italian Ministries of Education University Research (MIUR) and the Italian Ministry of Health to S.P. and P.P.D.F., the European Community (FP6 and FP7), the European Research Council, the Ferrari Foundation, the Monzino Foundation and the Cassa Risparmio Provincie Lombarde (CARIPLO) Foundation to P.P.D.F. and the G. Vollaro Foundation to S.P. J.W. received support from Agency for Innovation by Science and Technology (IWT).	Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Amson R, 2011, CELL CYCLE, V10, P1, DOI 10.4161/cc.10.1.14288; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bazile F, 2009, CARCINOGENESIS, V30, P555, DOI 10.1093/carcin/bgp022; Bommer UA, 2010, ONCOGENE, V29, P763, DOI 10.1038/onc.2009.380; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Deng Shi-Shan, 2006, Genomics Proteomics & Bioinformatics, V4, P165, DOI 10.1016/S1672-0229(06)60029-6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCELLA M, 1993, ONCOGENE, V8, P1519; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Koziol MJ, 2007, CURR BIOL, V17, P801, DOI 10.1016/j.cub.2007.03.062; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Linares-Cruz G, 1998, P NATL ACAD SCI USA, V95, P1131, DOI 10.1073/pnas.95.3.1131; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; TELERMAN A, 1993, P NATL ACAD SCI USA, V90, P8702, DOI 10.1073/pnas.90.18.8702; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	60	143	149	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					91	99		10.1038/nm.2546	http://dx.doi.org/10.1038/nm.2546			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157679				2022-12-27	WOS:000299018600034
J	Jiang, ML; Wang, JW; Fu, JR; Du, L; Jeong, H; West, T; Xiang, L; Peng, Q; Hou, ZP; Cai, H; Seredenina, T; Arbez, N; Zhu, SS; Sommers, K; Qian, J; Zhang, JY; Mori, S; Yang, XW; Tamashiro, KLK; Aja, S; Moran, TH; Luthi-Carter, R; Martin, B; Maudsley, S; Mattson, MP; Cichewicz, RH; Ross, CA; Holtzman, DM; Krainc, D; Duan, WZ				Jiang, Mali; Wang, Jiawei; Fu, Jinrong; Du, Lin; Jeong, Hyunkyung; West, Tim; Xiang, Lan; Peng, Qi; Hou, Zhipeng; Cai, Huan; Seredenina, Tamara; Arbez, Nicolas; Zhu, Shanshan; Sommers, Katherine; Qian, Jennifer; Zhang, Jiangyang; Mori, Susumu; Yang, X. William; Tamashiro, Kellie L. K.; Aja, Susan; Moran, Timothy H.; Luthi-Carter, Ruth; Martin, Bronwen; Maudsley, Stuart; Mattson, Mark P.; Cichewicz, Robert H.; Ross, Christopher A.; Holtzman, David M.; Krainc, Dimitri; Duan, Wenzhen			Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO3A; NEUROTROPHIC FACTOR; MUTANT HUNTINGTIN; IN-VIVO; PGC-1-ALPHA; METABOLISM; FORKHEAD; GLUCOSE; RESTRICTION; PROTECTS	Huntington's disease is a fatal neurodegenerative disorder caused by an expanded polyglutamine repeat in huntingtin (HIT) protein. We previously showed that calorie restriction ameliorated Huntington's disease pathogenesis and slowed disease progression in mice that model Huntington's disease (Huntington's disease mice)'. We now report that overexpression of sirtuin 1 (Sirt1), a mediator of the beneficial metabolic effects of calorie restriction, protects neurons against mutant HIT toxicity, whereas reduction of Sirt1 exacerbates mutant HIT toxicity. Overexpression of Sirt1 improves motor function, reduces brain atrophy and attenuates mutant-HTT-mediated metabolic abnormalities in Huntington's disease mice. Further mechanistic studies suggested that Sirt1 prevents the mutantHIT-induced decline in brain-derived neurotrophic factor (BDNF) concentrations and the signaling of its receptor, TrkB, and restores dopamine- and cAMP-regulated phosphoprotein, 32 kDa (DARPP32) concentrations in the striatum. Sirt1 deacetylase activity is required for Sirt1-mediated neuroprotection in Huntington's disease cell models. Notably, we show that mutant HIT interacts with Sirt1 and inhibits Sirti deacetylase activity, which results in hyperacetylation of Sirt1 substrates such as forkhead box O3A (Foxo3a), thereby inhibiting its pro-survival function. Overexpression of Sirt1 counteracts the mutant-HIT-induced deacetylase deficit, enhances the deacetylation of Foxo3a and facilitates cell survival. These findings show a neuroprotective role for Sirt1 in mammalian Huntington's disease models and open new avenues for the development of neuroprotective strategies in Huntington's disease.	[Jiang, Mali; Wang, Jiawei; Fu, Jinrong; Xiang, Lan; Peng, Qi; Arbez, Nicolas; Zhu, Shanshan; Sommers, Katherine; Qian, Jennifer; Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA; [Wang, Jiawei] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Du, Lin; Cichewicz, Robert H.] Univ Oklahoma, Dept Chem & Biochem, Nat Prod Discovery Grp, Norman, OK 73019 USA; [Jeong, Hyunkyung; Krainc, Dimitri] Harvard Univ, Sch Med, Dept Neurol, MassGen Inst Neurodegenerat Dis,Massachusetts Gen, Boston, MA 02115 USA; [West, Tim; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [West, Tim; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Hou, Zhipeng; Zhang, Jiangyang; Mori, Susumu] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Cai, Huan; Martin, Bronwen] NIA, Metab Unit, Lab Clin Invest, US Natl Inst Hlth NIH, Baltimore, MD 21224 USA; [Seredenina, Tamara; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Yang, X. William] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA; [Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD USA	Johns Hopkins University; Capital Medical University; University of Oklahoma System; University of Oklahoma - Norman; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California Los Angeles; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA.	wduan2@jhmi.edu	Du, Lin/G-7889-2011; Jiang, Mali/B-2631-2012; Ross, Christopher A/H-8395-2013; Cichewicz, Robert H/H-5233-2012; Maudsley, Stuart/Q-4782-2019; Mattson, Mark P/F-6038-2012; Maudsley, Stuart/AAV-9929-2021; Cai, Huan/B-6578-2016	Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Zhang, Jiangyang/0000-0003-4146-8163; Cichewicz, Robert/0000-0003-0744-4117; Zhang, Jiangyang/0000-0003-0740-2662; Martin, Bronwen/0000-0002-9185-6925; Tamashiro, Kellie/0000-0002-9398-8796	Hereditary Disease Foundation; CHDI Foundation [A-2120]; NIH [NS 16375, NS35902, ROINS051303, EB003543, ES012665, NS065306]; NIA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051303, P50NS016375, R21NS065306, P01NS016375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000319, ZIAAG000916, ZIAAG000915, ZIAAG000314, ZIAAG000318, ZIAAG000313, ZIAAG000325, ZIAAG000917, ZIAAG000331, ZIAAG000315] Funding Source: NIH RePORTER	Hereditary Disease Foundation; CHDI Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Tsai at Massachusetts Institute of Technology for providing Sirt1 and H363Y retrovirus constructs, S. Imai at Washington University for providing Sir2 complementary DNAs (cDNAs), M. Macdonald at Harvard Medical School for providing STHdh<SUP>Q7/Q7</SUP> and STHdh<SUP>Q111/Q111</SUP> cells, S. Li and X. Li at Emory University for providing antibodies to EM48 and E. Waldron, C. Berlinicke, Y. Chen and J. Jin at Johns Hopkins University School of Medicine for their technical assistance. This work was supported by the Hereditary Disease Foundation (W.D.), CHDI Foundation grant A-2120 (W.D.), NIH grant NS 16375 (C.A.R.), NIH grant NS35902 (D.M.H.), the NIA Intramural Research Program (B.M., H.C., S. Maudesley and M.P.M.), NIH grant ROINS051303 (D.K.), NIH grant EB003543 and ES012665 (S. Mori) and NIH grant NS065306 (J.Z.).	Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Oliveira RM, 2010, CURR DRUG TARGETS, V11, P1270; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Ivkovic S, 1997, NEUROSCIENCE, V79, P509, DOI 10.1016/S0306-4522(96)00684-7; JEONG H, 2011, NAT MED         1218, DOI DOI 10.1038/NM.2558; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Nakagawa T, 2002, DIABETES-METAB RES, V18, P185, DOI 10.1002/dmrr.290; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Peng K, 2010, NEUROSCI LETT, V484, P98, DOI 10.1016/j.neulet.2010.07.068; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang WF, 2005, NEUROBIOL DIS, V20, P500, DOI 10.1016/j.nbd.2005.03.026; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	41	254	261	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					153	158		10.1038/nm.2558	http://dx.doi.org/10.1038/nm.2558			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179319	Green Accepted			2022-12-27	WOS:000299018600042
J	Waterfield, M; Anderson, MS				Waterfield, Michael; Anderson, Mark S.			Immunodeficiency hints at autoreactivity to cytokines	NATURE MEDICINE			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS; OMENN-SYNDROME; CELLS; AIRE; AUTOANTIBODIES; TOLERANCE; GENE		[Waterfield, Michael] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94122 USA; [Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Waterfield, M (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94122 USA.	manderson@diabetes.ucsf.edu						Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goyal R, 2009, CURR OPIN RHEUMATOL, V21, P78, DOI 10.1097/BOR.0b013e32831cb939; Honig M, 2006, CURR OPIN RHEUMATOL, V18, P383; Khiong K, 2007, J CLIN INVEST, V117, P1270, DOI 10.1172/JCI30513; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Matsumoto M, 2011, EUR J IMMUNOL, V41, P12, DOI 10.1002/eji.201041024; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983	14	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2011	17	9					1054	1055		10.1038/nm0911-1054	http://dx.doi.org/10.1038/nm0911-1054			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	816MM	21900922				2022-12-27	WOS:000294605100023
J	Rodriguez-Diaz, R; Dando, R; Jacques-Silva, MC; Fachado, A; Molina, J; Abdulreda, MH; Ricordi, C; Roper, SD; Berggren, PO; Caicedo, A				Rodriguez-Diaz, Rayner; Dando, Robin; Jacques-Silva, M. Caroline; Fachado, Alberto; Molina, Judith; Abdulreda, Midhat H.; Ricordi, Camillo; Roper, Stephen D.; Berggren, Per-Olof; Caicedo, Alejandro			Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans	NATURE MEDICINE			English	Article							POSITIVE AUTOCRINE SIGNAL; INSULIN-RELEASE; VESICULAR ACETYLCHOLINE; GLUCOSE; PANCREAS; GLUCAGON; RECEPTOR; ISLETS; OSCILLATIONS; POLYPEPTIDE	Acetylcholine is a neurotransmitter that has a major role in the function of the insulin-secreting pancreatic beta cell(1,2). Parasympathetic innervation of the endocrine pancreas, the islets of Langerhans, has been shown to provide cholinergic input to the beta cell in several species(1,3,4), but the role of autonomic innervation in human beta cell function is at present unclear. Here we show that, in contrast to the case in mouse islets, cholinergic innervation of human islets is sparse. Instead, we find that the alpha cells of human islets provide paracrine cholinergic input to surrounding endocrine cells. Human alpha cells express the vesicular acetylcholine transporter and release acetylcholine when stimulated with kainate or a lowering in glucose concentration. Acetylcholine secretion by alpha cells in turn sensitizes the beta cell response to increases in glucose concentration. Our results demonstrate that in human islets acetylcholine is a paracrine signal that primes the beta cell to respond optimally to subsequent increases in glucose concentration. Cholinergic signaling within islets represents a potential therapeutic target in diabetes(5), highlighting the relevance of this advance to future drug development.	[Rodriguez-Diaz, Rayner; Jacques-Silva, M. Caroline; Fachado, Alberto; Abdulreda, Midhat H.; Ricordi, Camillo; Berggren, Per-Olof; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Rodriguez-Diaz, Rayner; Ricordi, Camillo; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Dando, Robin; Roper, Stephen D.; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Molina, Judith; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Roper, Stephen D.; Caicedo, Alejandro] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA; [Berggren, Per-Olof] Univ Sci & Technol, World Class Univ Program, Div Integrat Biosci & Biotechnol, Pohang, South Korea	University of Miami; Karolinska Institutet; University of Miami; University of Miami; University of Miami; Pohang University of Science & Technology (POSTECH)	Berggren, PO (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.	per-olof.berggren@ki.se; acaicedo@med.miami.edu	RICORDI, CAMILLO/AAA-4740-2019; Tuluc, Petronel/C-2527-2011; Caicedo, Alejandro/AAC-8544-2020	Tilahin, Shimelis/0000-0001-8975-8026; Berggren, Per-Olof/0000-0001-8991-413X; Ricordi, Camillo/0000-0001-8092-7153; Roper, Stephen/0000-0001-6049-8320	Diabetes Research Institute Foundation; US National Institutes of Health [R56DK084321, R01DK084321, R01DC000374, R01DC007630, F32DK083226, 5U01DK070460-07]; Juvenile Diabetes Research Foundation; Swedish Research Council; Novo Nordisk Foundation; Swedish Diabetes Association; Family Erling-Persson Foundation; Ministry of Education, Science and Technology [R31-2008-000-10105-0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084321, F32DK083226, U01DK070460, R01DK084321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007630, R01DC000374] Funding Source: NIH RePORTER	Diabetes Research Institute Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Family Erling-Persson Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Formoso for help with data analyses, K. Johnson for histological work and M. Correa-Medina for assistance with RT-PCR. This work was funded by the Diabetes Research Institute Foundation, US National Institutes of Health grants R56DK084321 (A.C.), R01DK084321 (A.C.), R01DC000374 (S.D.R.), R01DC007630 (S.D.R.), F32DK083226 (M.H.A.) and 5U01DK070460-07 (C.R.), the Juvenile Diabetes Research Foundation, the Swedish Research Council, the Novo Nordisk Foundation, the Swedish Diabetes Association, the Family Erling-Persson Foundation and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10105-0). Human islets were made available through the Islet Cell Resource basic science islet distribution program, Islet Cell Resource Centers Consortium, Division of Clinical Research, National Center for Research Resources, US National Institutes of Health.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; AHREN B, 1986, DIABETOLOGIA, V29, P827, DOI 10.1007/BF00870137; AMENTA F, 1983, ACTA HISTOCHEM, V73, P273, DOI 10.1016/S0065-1281(83)80038-5; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Becker H D, 1979, World J Surg, V3, P615; BLACKMAN JD, 1992, DIABETES, V41, P1346, DOI 10.2337/diabetes.41.10.1346; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brunicardi FC, 1995, INT J PANCREATOL, V18, P177; BUCK MA, 1990, BIOCHEM BIOPH RES CO, V173, P666, DOI 10.1016/S0006-291X(05)80087-7; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cabrera O, 2007, CELL TRANSPLANT, V16, P1039, DOI 10.3727/000000007783472408; Conn P.M., 1998, ENDOCRINE SYSTEM END, P153; COUPLAND RE, 1958, J ANAT, V92, P143; DIEM P, 1990, J CLIN INVEST, V86, P2008, DOI 10.1172/JCI114936; Doliba NM, 2004, AM J PHYSIOL-ENDOC M, V286, pE834, DOI 10.1152/ajpendo.00292.2003; Eiden LE, 1998, J NEUROCHEM, V70, P2227; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GREIDER MH, 1970, LAB INVEST, V22, P344; Guenifi A, 2001, PANCREAS, V22, P164, DOI 10.1097/00006676-200103000-00009; Guo Y, 2006, DIABETES, V55, P3625, DOI 10.2337/db06-0379; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Karlsson S, 1997, AM J PHYSIOL-REG I, V272, pR1371, DOI 10.1152/ajpregu.1997.272.5.R1371; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; POZZA G, 1985, BMJ-BRIT MED J, V291, P510, DOI 10.1136/bmj.291.6494.510; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; TAYLOR IL, 1982, J CLIN ENDOCR METAB, V55, P1114, DOI 10.1210/jcem-55-6-1114; TEFF KL, 1993, METABOLISM, V42, P1600, DOI 10.1016/0026-0495(93)90157-J; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; WOODS SC, 1974, PHYSIOL REV, V54, P596, DOI 10.1152/physrev.1974.54.3.596; ZAWALICH WS, 1989, ENDOCRINOLOGY, V125, P2400, DOI 10.1210/endo-125-5-2400	40	204	211	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					888	U258		10.1038/nm.2371	http://dx.doi.org/10.1038/nm.2371			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21685896	Green Accepted			2022-12-27	WOS:000292500800045
J	Mehal, WZ; Iredale, J; Friedman, SL				Mehal, Wajahat Z.; Iredale, John; Friedman, Scott L.			Scraping fibrosis	NATURE MEDICINE			English	Editorial Material							CHRONIC HEPATITIS-C; LIVER FIBROSIS; MOLECULAR-MECHANISMS; THERAPY; CELLS		[Mehal, Wajahat Z.] Yale Univ, Sect Digest Dis, New Haven, CT 06520 USA; [Iredale, John] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA	Yale University; University of Edinburgh; Icahn School of Medicine at Mount Sinai	Mehal, WZ (corresponding author), Yale Univ, Sect Digest Dis, New Haven, CT 06520 USA.	wajahat.mehal@yale.edu		Iredale, John/0000-0003-2174-5127	Medical Research Council [G0600033] Funding Source: Medline; NIDDK NIH HHS [R01 DK076674, R01 DK076674-05] Funding Source: Medline; MRC [G0600033] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076674] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; McHutchison J, 2010, GASTROENTEROLOGY, V138, P1365, DOI 10.1053/j.gastro.2009.12.003; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Pockros PJ, 2007, HEPATOLOGY, V45, P569, DOI 10.1002/hep.21561; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	12	134	144	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					552	553		10.1038/nm0511-552	http://dx.doi.org/10.1038/nm0511-552			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21546973	Green Accepted			2022-12-27	WOS:000290250400029
J	Wuest, SC; Edwan, JH; Martin, JF; Han, S; Perry, JSA; Cartagena, CM; Matsuura, E; Maric, D; Waldmann, TA; Bielekova, B				Wuest, Simone C.; Edwan, Jehad H.; Martin, Jayne F.; Han, Sungpil; Perry, Justin S. A.; Cartagena, Casandra M.; Matsuura, Eiji; Maric, Dragan; Waldmann, Thomas A.; Bielekova, Bibiana			A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy	NATURE MEDICINE			English	Article							IL-2 RECEPTOR; ALPHA-CHAIN; MULTIPLE-SCLEROSIS; ANTIBODIES; DISEASE; CD25; LYMPHOCYTES; DEFICIENCY; EXPRESSION; DECREASE	Although previous studies have described CD25 expression and production of interleukin-2 (IL-2) by mature dendritic cells (mDCs), it remains unclear how these molecules participate in the activation of T cells. In search of the mechanisms by which daclizumab, a humanized monoclonal antibody against CD25, inhibits brain inflammation in multiple sclerosis, we observed that although the drug has limited effects on polyclonal T cell activation, it potently inhibits activation of antigen-specific T cells by mDCs. We show that mDCs (and antigen-experienced T cells) secrete IL-2 toward the mDC-T cell interface in an antigen-specific manner, and mDCs 'lend' their CD25 to primed T cells in trans to facilitate early high-affinity IL-2 signaling, which is crucial for subsequent T cell expansion and development of antigen-specific effectors. Our data reveal a previously unknown mechanism for the IL-2 receptor system in DC-mediated activation of T cells.	[Wuest, Simone C.; Edwan, Jehad H.; Martin, Jayne F.; Han, Sungpil; Perry, Justin S. A.; Cartagena, Casandra M.; Matsuura, Eiji; Bielekova, Bibiana] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Han, Sungpil] Pusan Natl Univ, Sch Med, Yangsan, South Korea; [Maric, Dragan] NINDS, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA; [Waldmann, Thomas A.] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Pusan National University; Pusan National University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bielekova, B (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	bibi.bielekova@nih.gov	Han, Sungpil/AAL-3279-2021; Bielekova, Bibiana/AAA-8115-2020; MATSUURA, EIJI/E-1231-2013; Waldmann, Thomas/AAT-5972-2021; Bielekova, Bibiana/V-1452-2017	Han, Sungpil/0000-0002-4674-7682; Bielekova, Bibiana/0000-0002-0959-9430; MATSUURA, EIJI/0000-0001-8215-8853; Waldmann, Thomas/0000-0003-4500-6660; Bielekova, Bibiana/0000-0002-0959-9430	NINDS/NIH; NATIONAL CANCER INSTITUTE [ZIASC004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003056] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the intramural research program of the NINDS/NIH. We thank A. Kashani for expert technical assistance in processing apheresis samples and M. Lenardo, W. Leonard and H. McFarland for their critical review of the manuscript and helpful comments. Additionally, we are thankful to M. Lenardo and H. Su (NIH) for providing cryopreserved peripheral blood mononuclear cells (PBMCs) from the CD25<SUP>-</SUP> individual. Daclizumab F<INF>ab</INF> was provided by Abbott Biotherapeutics, under Material Transfer Agreement.	Aoki CA, 2006, J AUTOIMMUN, V27, P50, DOI 10.1016/j.jaut.2006.04.005; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Cartagena CM, 2010, BRAIN RES, V1319, P1, DOI 10.1016/j.brainres.2009.12.080; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Martin JF, 2010, J IMMUNOL, V185, P1311, DOI 10.4049/jimmunol.0902238; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mnasria K, 2008, J LEUKOCYTE BIOL, V84, P460, DOI 10.1189/jlb.1007712; Mnasria K, 2009, TRANSPL P, V41, P695, DOI 10.1016/j.transproceed.2009.01.028; Mnasria K, 2008, INT IMMUNOPHARMACOL, V8, P414, DOI 10.1016/j.intimp.2007.11.004; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; Oh U, 2009, ARCH NEUROL-CHICAGO, V66, P471, DOI 10.1001/archneurol.2009.16; Roifman CM, 2000, PEDIATR RES, V48, P6, DOI 10.1203/00006450-200007000-00004; Rose JW, 2007, NEUROLOGY, V69, P785, DOI 10.1212/01.wnl.0000267662.41734.1f; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Velten FW, 2007, MOL IMMUNOL, V44, P1544, DOI 10.1016/j.molimm.2006.08.020; Waldmann TA, 1998, CURR OPIN IMMUNOL, V10, P507, DOI 10.1016/S0952-7915(98)80215-X; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8	34	196	199	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2011	17	5					604	U125		10.1038/nm.2365	http://dx.doi.org/10.1038/nm.2365			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21532597	Green Accepted			2022-12-27	WOS:000290250400037
J	Wu, H; Pomeroy, SL; Ferreira, M; Teider, N; Mariani, J; Nakayama, KI; Hatakeyama, S; Tron, VA; Saltibus, LF; Spyracopoulos, L; Leng, RP				Wu, Hong; Pomeroy, Scott L.; Ferreira, Manuel; Teider, Natalia; Mariani, Juliana; Nakayama, Keiichi I.; Hatakeyama, Shigetsugu; Tron, Victor A.; Saltibus, Linda F.; Spyracopoulos, Leo; Leng, Roger P.			UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53	NATURE MEDICINE			English	Article							EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NEGATIVE REGULATOR; UBIQUITIN; LIGASE; MDM2; MUTATIONS; GENE; POLYUBIQUITINATION; MEDULLOBLASTOMA	The TP53 gene (encoding the p53 tumor suppressor) is rarely mutated, although frequently inactivated, in medulloblastoma and ependymoma. Recent work in mouse models showed that the loss of p53 accelerated the development of medulloblastoma. The mechanism underlying p53 inactivation in human brain tumors is not completely understood. We show that ubiquitination factor E4B (UBE4B), an E3 and E4 ubiquitin ligase, physically interacts with p53 and Hdm2 (also known as Mdm2 in mice). UBE4B promotes p53 polyubiquitination and degradation and inhibits p53-dependent transactivation and apoptosis. Notably, silencing UBE4B expression impairs xenotransplanted tumor growth in a p53-dependent manner and overexpression of UBE4B correlates with decreased expression of p53 in these tumors. We also show that UBE4B overexpression is often associated with amplification of its gene in human brain tumors. Our data indicate that amplification and overexpression of UBE4B represent previously undescribed molecular mechanisms of inactivation of p53 in brain tumors.	[Wu, Hong; Leng, Roger P.] Univ Alberta, Heritage Med Res Ctr, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Pomeroy, Scott L.; Teider, Natalia; Mariani, Juliana] Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp Boston, Boston, MA 02115 USA; [Ferreira, Manuel] Harvard Univ, Dept Neurosurg, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 812, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Dept Mol Biochem, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Tron, Victor A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Saltibus, Linda F.; Spyracopoulos, Leo] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Kyushu University; Hokkaido University; McMaster University; Queens University - Canada; University of Alberta	Leng, RP (corresponding author), Univ Alberta, Heritage Med Res Ctr, Dept Lab Med & Pathol, Edmonton, AB, Canada.	rleng@ualberta.ca	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; Leng, Roger/0000-0001-9652-4703	Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA109467] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge W. Gu (Columbia University) for the His-ubiquitin (wild-type) and His-Ub-ko plasmids, A.G. Jochemsen (Erasmus University Medical Center) for the Myc-Mdm2 plasmid, C. Blattner (Universitat Heidelberg) for pSuper.neo.gpf-Mdm2 siRNA plasmid, J.A. Mahoney (Johns Hopkins University) for pEF-DEST51-Flag-UBE4B plasmid, B. Vogelstein (Johns Hopkins University) for HCT116 TP53<SUP>-/-</SUP> cells, S. Benchimol (York University) for BJT and BJT/DD cell lines and G. Lozano (University of Texas, M. D. Anderson Cancer Center) for Mdm2<SUP>-/-</SUP> Trp53<SUP>-/-</SUP> MEFs as described in the text. We thank T. Turner for technical help in making the figures. This work was supported by grants from the Alberta Heritage Foundation for Medical Research and Canadian Institutes of Health Research (to R.P.L.) and from the US National Institutes of Health (to S.L.P.). R.P.L. is an Alberta Heritage Foundation for Medical Research scholar.	ADESINA AM, 1994, CANCER RES, V54, P5649; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; CROOK T, 1992, EMBO J, V11, P3935, DOI 10.1002/j.1460-2075.1992.tb05487.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Gaspar N, 2006, PEDIATR BLOOD CANCER, V46, P604, DOI 10.1002/pbc.20532; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LUNA RMD, 1995, NATURE, V378, P203; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; SAYLORS RL, 1991, CANCER RES, V51, P4721; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034	42	78	86	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					347	U150		10.1038/nm.2283	http://dx.doi.org/10.1038/nm.2283			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21317885				2022-12-27	WOS:000288070000046
J	Farrar, JT				Farrar, John T.			Advances in clinical research methodology for pain clinical trials	NATURE MEDICINE			English	Review							NEUROPATHIC PAIN; OUTCOME MEASURES; PLACEBO-RESPONSE; RATING-SCALES; RELIEF SCALE; INTENSITY; VALIDATION; MECHANISMS; NUMBER; PREVALENCE	Pain is a ubiquitous phenomenon, but the experience of pain varies considerably from person to person. Advances in understanding of the growing number of pathophysiologic mechanisms that underlie the generation of pain and the influence of the brain on the experience of pain led to the investigation of numerous compounds for treating pain. Improved knowledge of the subjective nature of pain, the variations in the measurement of pain, the mind-body placebo effect and the impact of differences in the conduct of a clinical trial on the outcome have changed approaches to design and implement studies. Careful consideration of how these concepts affect the choice of study population, the randomization and blinding process, the measurement and collection of data, and the analysis and interpretation of results should improve the quality of clinical trials for potential pain therapies.	Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Farrar, JT (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	jfarrar@upenn.edu	Farrar, John T/AAP-4788-2021; Farrar, John/A-1037-2007	Farrar, John T/0000-0001-8656-5157; Farrar, John/0000-0001-8656-5157				Angst MS, 1999, ANESTHESIOLOGY, V91, P34, DOI 10.1097/00000542-199907000-00009; Baker R, 1998, INT J QUAL HEALTH C, V10, P207, DOI 10.1093/intqhc/10.3.207; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beecher H. K., 1959, MEASUREMENT SUBJECTI; Bellamy N, 1997, J RHEUMATOL, V24, P799; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bergh I, 2000, AGING CLIN EXP RES, V12, P380, DOI 10.1007/BF03339864; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Breivik EK, 2000, CLIN J PAIN, V16, P22, DOI 10.1097/00002508-200003000-00005; Cepeda MS, 2003, PAIN, V106, P439, DOI 10.1016/j.pain.2003.09.006; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; *COMM NAT STAT, 2010, CLIN TRIALS PANEL HA, pCH2; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; de Tovar C, 2010, PAIN RES MANAG, V15, P163, DOI 10.1155/2010/475907; Decruynaere C, 2009, EUR J PAIN, V13, P641, DOI 10.1016/j.ejpain.2008.07.004; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dworkin RH, 2005, NEUROLOGY, V65, pS7, DOI 10.1212/WNL.65.12_suppl_4.S7; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2010, PAIN, V150, P12, DOI 10.1016/j.pain.2010.02.002; Edelsberg J, 2009, EUR J PAIN, V13, P11, DOI 10.1016/j.ejpain.2008.03.012; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Farrar JT, 2010, J PAIN, V11, P109, DOI 10.1016/j.jpain.2009.06.007; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; FISHMAN B, 1987, PAIN, V30, pS415; FITZPATRICK R, 1993, BRIT J RHEUMATOL, V32, P807; Flaherty S A, 1996, AANA J, V64, P133; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; GRACELY RH, 1978, INT DENT J, V28, P52; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; HEFT MW, 1980, PAIN, V9, P363, DOI 10.1016/0304-3959(80)90050-0; HILL AB, 1952, NEW ENGL J MED, V247, P113, DOI 10.1056/NEJM195207242470401; Horny C, 1996, MED CARE, V34, P234; Houde R.W., 1956, FED PROC, V15, P440; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Irizarry MC, 2009, CLIN J PAIN, V25, P469, DOI 10.1097/AJP.0b013e31819ddded; Jamison RN, 2002, PAIN, V99, P341, DOI 10.1016/S0304-3959(02)00178-1; Jenkinson C, 1999, INDIVIDUAL QUALITY L, P75; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Katz N, 2005, NEUROLOGY, V65, pS32, DOI 10.1212/WNL.65.12_suppl_4.S32; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; Kundt G, 2009, METHOD INFORM MED, V48, P129, DOI 10.3414/ME0538; LASAGNA L, 1954, J PHARMACOL EXP THER, V112, P356; Lee S, 2004, DEPRESS ANXIETY, V19, P10, DOI 10.1002/da.10134; Marceau LD, 2007, PAIN MED, V8, pS101, DOI 10.1111/j.1526-4637.2007.00374.x; MCDOWELL I, 1996, MEASURING HLTH GUIDE, pCH8; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Moiniche S, 2002, ANESTHESIOLOGY, V96, P725, DOI 10.1097/00000542-200203000-00032; Moore A, 1996, PAIN, V66, P229, DOI 10.1016/0304-3959(96)03032-1; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Shavit Y, 2006, J NEUROIMMUNE PHARM, V1, P443, DOI 10.1007/s11481-006-9043-1; Sloan JA, 2002, MAYO CLIN PROC, V77, P479, DOI 10.4065/77.5.479; Temple RJ, 2003, ARCH INTERN MED, V163, P371, DOI 10.1001/archinte.163.3.371-b; TESLER MD, 1991, RES NURS HEALTH, V14, P361, DOI 10.1002/nur.4770140507; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turner JA, 2002, PAIN, V99, P91, DOI 10.1016/S0304-3959(02)00060-X; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	73	52	56	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1284	1293		10.1038/nm.2249	http://dx.doi.org/10.1038/nm.2249			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948532				2022-12-27	WOS:000283860100040
J	Jucker, M				Jucker, Mathias			The benefits and limitations of animal models for translational research in neurodegenerative diseases	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA-PEPTIDE; FRONTOTEMPORAL LOBAR DEGENERATION; POSITRON-EMISSION-TOMOGRAPHY; MULTIPLE SYSTEM ATROPHY; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; TAU-PATHOLOGY	Age-related neurodegenerative diseases are largely limited to humans and rarely occur spontaneously in animals. Genetically engineered mouse models recapitulate aspects of the corresponding human diseases and are instrumental in studying disease mechanisms and testing therapeutic strategies. If considered within the range of their validity, mouse models have been predictive of clinical outcome. Translational failure is less the result of the incomplete nature of the models than of inadequate preclinical studies and misinterpretation of the models. This commentary summarizes current models and highlights key questions we should be asking about animal models, as well as questions that cannot be answered with the current models.	[Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Jucker, Mathias] DZNE German Ctr Neurodegenerat Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jucker, M (corresponding author), Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	mathias.jucker@uni-tuebingen.de			German National Genome Network (NGFNPlus)	German National Genome Network (NGFNPlus)	I would like to thank L. Walker and M. Staufenbiel for various discussions and help with this manuscript. The systematic review of the literature by R. Radde is greatly acknowledged. I also thank M. Neumann, V. Lee, J. McLaurin, D. Schenk, D. Thal, J. Gotz, D. DiMonte, M. Goedert, T. Gasser and P. Kahle for comments on various parts of this commentary and the attendees of the Herrenhausen Symposium on Neurodegeneration for the inspiring discussions from which this commentary has emerged. The work was supported by the German National Genome Network (NGFNPlus).	Abbott A, 2010, NATURE, V465, P410, DOI 10.1038/465410a; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blennow K, 2010, NAT MED, V16, P1218, DOI 10.1038/nm.2221; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P629, DOI 10.1097/00005072-198811000-00006; CUMMINGS BJ, 1993, NEUROBIOL AGING, V14, P547, DOI 10.1016/0197-4580(93)90038-D; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fukuhara R, 2002, GENE, V296, P99, DOI 10.1016/S0378-1119(02)00837-5; Furlan R, 2003, BRAIN, V126, P285, DOI 10.1093/brain/awg031; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hamilton BA, 2004, GENOMICS, V83, P739, DOI 10.1016/j.ygeno.2003.09.016; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herzig MC, 2006, BRAIN PATHOL, V16, P40, DOI 10.1111/j.1750-3639.2006.tb00560.x; Heutink P, 2000, HUM MOL GENET, V9, P979, DOI 10.1093/hmg/9.6.979; Higuchi M, 2005, J NEUROSCI, V25, P9434, DOI 10.1523/JNEUROSCI.2691-05.2005; Hock BJ, 2001, TRENDS GENET, V17, P7, DOI DOI 10.1016/S0168-9525(01)02449-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holzer M, 2004, GENE, V341, P313, DOI 10.1016/j.gene.2004.07.013; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; Kahle PJ, 2008, ACTA NEUROPATHOL, V115, P87, DOI 10.1007/s00401-007-0302-x; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lee EB, 2005, FEBS LETT, V579, P2564, DOI 10.1016/j.febslet.2005.03.070; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2010, NEUROBIOL AGING, V31, P542, DOI 10.1016/j.neurobiolaging.2008.05.026; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; MACKENZIE IRA, LANCET NEUR IN PRESS; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; NELSON PT, 1994, NEUROSCI LETT, V170, P187, DOI 10.1016/0304-3940(94)90270-4; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Price DL, 1991, BRAIN PATHOL, V1, P287, DOI 10.1111/j.1750-3639.1991.tb00672.x; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744; Rosen RF, 2010, ACTA NEUROPATHOL, V119, P221, DOI 10.1007/s00401-009-0583-3; Rosen RF, 2011, NEUROBIOL AGING, V32, P223, DOI 10.1016/j.neurobiolaging.2009.02.011; RUPP NJ, NEUROBIOL A IN PRESS; Ryan NS, 2010, BIOMARK MED, V4, P99, DOI 10.2217/BMM.09.92; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schultz C, 2001, ADV EXP MED BIOL, V487, P59; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Teschendorf D, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-38; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Walker LC, 1997, BRAIN RES REV, V25, P70, DOI 10.1016/S0165-0173(97)00017-9; Walker LC, 1999, ALZHEIMER DIS, P233; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zilka N, 2009, ACTA NEUROPATHOL, V118, P71, DOI 10.1007/s00401-009-0499-y	106	225	227	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1210	1214		10.1038/nm.2224	http://dx.doi.org/10.1038/nm.2224			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052075				2022-12-27	WOS:000283860100027
J	Woolf, CJ				Woolf, Clifford J.			Overcoming obstacles to developing new analgesics	NATURE MEDICINE			English	Review							TRIALS IMMPACT RECOMMENDATIONS; OF-FUNCTION MUTATIONS; CHRONIC PAIN; NEUROPATHIC PAIN; CENTRAL SENSITIZATION; GTP CYCLOHYDROLASE; PLACEBO ANALGESIA; SODIUM-CHANNEL; IN-VIVO; PREGABALIN	Despite substantial investment by the pharmaceutical industry over several decades, there has been little progress in developing new, efficacious and safe analgesics. As a result, many large pharmaceutical companies are leaving the area of pain medication. Nevertheless, the chances of success could increase if analgesic drug development strategy changed. To achieve such a paradigm shift we must understand why development of drugs for pain relief is so challenging.	[Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Dept Neurol, Boston, MA 02115 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010		US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank E. Forster, P. Vallance, S. Tate, R. Mannion, B. Wainger and J. Sprague for useful and constructive criticism and comments. This work was supported by the US National Institutes of Health.	Aquina CT, 2009, POSTGRAD MED, V121, P163, DOI 10.3810/pgm.2009.03.1988; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bauer CS, 2010, BIOCHEM SOC T, V38, P525, DOI 10.1042/BST0380525; Becerra L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008016; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bradley Laurence A, 2009, Am J Med, V122, pS22, DOI 10.1016/j.amjmed.2009.09.008; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Chen Y, 2009, CURR PAIN HEADACHE R, V13, P484, DOI 10.1007/s11916-009-0078-x; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; DIDHAJJ SD, 2010, ANNU REV NEUROSCI, V33, P325; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Finnerup Nanna B, 2007, MedGenMed, V9, P36; Fischer TZ, 2010, ANN NY ACAD SCI, V1184, P196, DOI 10.1111/j.1749-6632.2009.05110.x; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Hauser W, 2010, J PAIN, V11, P505, DOI 10.1016/j.jpain.2010.01.002; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jensen TS, 2009, CURR OPIN NEUROL, V22, P467, DOI 10.1097/WCO.0b013e3283311e13; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kissin I, 2010, ANESTH ANALG, V110, P780, DOI 10.1213/ANE.0b013e3181cde882; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lotsch J, 2010, PAIN, V148, P103, DOI 10.1016/j.pain.2009.10.021; Marchand Fabien, 2009, Handb Exp Pharmacol, P589, DOI 10.1007/978-3-540-79090-7_17; McCormick CG, 2009, DRUG ALCOHOL DEPEN, V105, pS42, DOI 10.1016/j.drugalcdep.2009.08.003; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Moore RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007076.pub2; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Petrovic P, 2010, PAIN, V150, P59, DOI 10.1016/j.pain.2010.03.011; Pollo A, 2009, PROG BRAIN RES, V175, P283, DOI 10.1016/S0079-6123(09)17520-9; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Rappaport BA, 2010, ANESTHESIOLOGY, V112, P509, DOI 10.1097/ALN.0b013e3181cf4279; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Saito YA, 2010, GASTROENTEROLOGY, V138, P1276, DOI 10.1053/j.gastro.2010.02.037; Schneider MF, 2009, PHARMACOEPIDEM DR S, V18, P778, DOI 10.1002/pds.1780; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Sharma U, 2010, AM J THER, V17, P577, DOI 10.1097/MJT.0b013e3181d5e4f3; Straube S, 2010, RHEUMATOLOGY, V49, P706, DOI 10.1093/rheumatology/kep432; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Tegeder I, 2009, J CELL MOL MED, V13, P1605, DOI 10.1111/j.1582-4934.2009.00703.x; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Whiteside GT, 2008, NEUROPHARMACOLOGY, V54, P767, DOI 10.1016/j.neuropharm.2008.01.001; Williams DA, 2009, J PAIN, V10, P777, DOI 10.1016/j.jpain.2009.06.001; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	58	161	163	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1241	1247		10.1038/nm.2230	http://dx.doi.org/10.1038/nm.2230			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948534				2022-12-27	WOS:000283860100035
J	Ferrara, N				Ferrara, Napoleone			Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy	NATURE MEDICINE			English	Article							ANTI-VEGF ANTIBODY; PERMEABILITY FACTOR; TYROSINE KINASE; EXTRACELLULAR-MATRIX; NUCLEOTIDE-SEQUENCE; TUMOR ANGIOGENESIS; CELLS SECRETE; BLOOD-VESSELS; NEOVASCULARIZATION; RANIBIZUMAB		Genentech Inc, San Francisco, CA USA	Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, San Francisco, CA USA.	nf@gene.com						ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALGIRE GH, 1945, J NATL CANCER I, V6, P73, DOI 10.1093/jnci/6.1.73; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Bressler NM, 2006, RETINA, P1075; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Campochiaro PA, 2003, ONCOGENE, V22, P6537, DOI 10.1038/sj.onc.1206773; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; FERRARA N, 1987, AM J PHYSIOL, V252, pE304, DOI 10.1152/ajpendo.1987.252.3.E304; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; IDE A. GORDON, 1939, AMER JOUR ROENTGENOL AND RADIUM THERAP, V42, P891; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Presta LG, 1997, CANCER RES, V57, P4593; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHIBUYA M, 1990, ONCOGENE, V5, P519; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; STERNBERG P, 1991, ARCH OPHTHALMOL-CHIC, V109, P1242; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	56	130	147	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1107	1111		10.1038/nm1010-1107	http://dx.doi.org/10.1038/nm1010-1107			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930754				2022-12-27	WOS:000282644800039
J	Zhang, EE; Liu, Y; Dentin, R; Pongsawakul, PY; Liu, AC; Hirota, T; Nusinow, DA; Sun, XJ; Landais, S; Kodama, Y; Brenner, DA; Montminy, M; Kay, SA				Zhang, Eric E.; Liu, Yi; Dentin, Renaud; Pongsawakul, Pagkapol Y.; Liu, Andrew C.; Hirota, Tsuyoshi; Nusinow, Dmitri A.; Sun, Xiujie; Landais, Severine; Kodama, Yuzo; Brenner, David A.; Montminy, Marc; Kay, Steve A.			Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis	NATURE MEDICINE			English	Article							RESPONSE ELEMENT; GLUCOSE; PHOSPHORYLATION; TRANSCRIPTION	During fasting, mammals maintain normal glucose homeostasis by stimulating hepatic gluconeogenesis1. Elevations in circulating glucagon and epinephrine, two hormones that activate hepatic gluconeogenesis, trigger the cAMP-mediated phosphorylation of cAMP response element-binding protein (Creb) and dephosphorylation of the Creb-regulated transcription coactivator-2 (Crtc2)-two key transcriptional regulators of this process(2). Although the underlying mechanism is unclear, hepatic gluconeogenesis is also regulated by the circadian clock, which coordinates glucose metabolism with changes in the external environment(3-6). Circadian control of gene expression is achieved by two transcriptional activators, Clock and Bmal1, which stimulate cryptochrome (Cry1 and Cry2) and Period (Per1, Per2 and Per3) repressors that feed back on Clock-Bmal1 activity. Here we show that Creb activity during fasting is modulated by Cry1 and Cry2, which are rhythmically expressed in the liver. Cry1 expression was elevated during the night-day transition, when it reduced fasting gluconeogenic gene expression by blocking glucagon-mediated increases in intracellular cAMP concentrations and in the protein kinase A-mediated phosphorylation of Creb. In biochemical reconstitution studies, we found that Cry1 inhibited accumulation of cAMP in response to G protein-coupled receptor (GPCR) activation but not to forskolin, a direct activator of adenyl cyclase. Cry proteins seemed to modulate GPCR activity directly through interaction with G(s)alpha. As hepatic overexpression of Cry1 lowered blood glucose concentrations and improved insulin sensitivity in insulin-resistant db/db mice, our results suggest that compounds that enhance cryptochrome activity may provide therapeutic benefit to individuals with type 2 diabetes.	[Liu, Yi; Dentin, Renaud; Landais, Severine; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Zhang, Eric E.; Pongsawakul, Pagkapol Y.; Liu, Andrew C.; Hirota, Tsuyoshi; Nusinow, Dmitri A.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Zhang, Eric E.; Liu, Andrew C.; Hirota, Tsuyoshi] Novartis Res Fdn, Gen Inst, San Diego, CA USA; [Liu, Yi; Sun, Xiujie] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutrit & Metab, Shanghai, Peoples R China; [Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Kodama, Yuzo; Brenner, David A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Novartis; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Memphis; University of California System; University of California San Diego	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu; skay@ucsd.edu	Hirota, Tsuyoshi/D-8158-2015; dentin, Renaud/P-4939-2017; Liu, Andrew C/B-3548-2009; Kay, Steve A/F-6025-2011; Sun, Xiujie/L-1244-2017; Dentin, Renaud/AAV-5818-2020; Pongsawakul, Pagkapol Y./GSD-2959-2022; Nusinow, Dmitri A/K-9129-2013	Hirota, Tsuyoshi/0000-0003-4876-3608; dentin, Renaud/0000-0003-0988-4458; Liu, Andrew C/0000-0003-1927-0900; Kay, Steve A/0000-0002-0402-2878; Sun, Xiujie/0000-0003-3814-7406; Dentin, Renaud/0000-0003-0988-4458; Nusinow, Dmitri A/0000-0002-0497-1723; Brenner, David/0000-0003-2573-525X; Zhang, Eric/0000-0002-4472-7493	US National Institutes of Health [R01 GM074868, R01 MH051573, R01 DK083834, R01 DK049777, GM083585]; Chinese Academy of Sciences [2010OHTP08]; Shanghai Pujiang Program in China [10PJ1411200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK083834, R01DK049777, R01DK083834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868, R01GM041804, F32GM083585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program in China(Shanghai Pujiang Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Vera, A. Luzader, E. Rodrigo and X. Li for adenoviral injections, J. Altarejos and M. Lindstrom for mouse blood collection and glucose measurement and N. Goebel for preparing primary hepatocytes. We also thank M. Yamout and P. E. Wright for stimulating discussions and N. Gekakis, D. Welsh and S. Wang for reading the manuscript. This is manuscript 080809 of Genomics Institute of the Novartis Research Foundation, and the research was supported in part by grants from the US National Institutes of Health (R01 GM074868 and R01 MH051573 to S. A. K; R01 DK083834 and R01 DK049777 to M. M.). Y.L. is supported by the "One Hundred Talents" Program of the Chinese Academy of Sciences (No. 2010OHTP08) and Shanghai Pujiang Program (10PJ1411200) in China, and D.A.N. is supported by a fellowship (GM083585) from the US National Institutes of Health.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; KIDA K, 1980, J BIOCHEM-TOKYO, V88, P1009, DOI 10.1093/oxfordjournals.jbchem.a133051; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	19	352	383	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1152	U133		10.1038/nm.2214	http://dx.doi.org/10.1038/nm.2214			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20852621	Green Accepted			2022-12-27	WOS:000282644800047
J	Weinberg, R; Fisher, DE; Rich, J				Weinberg, Robert; Fisher, David E.; Rich, Jeremy			Dynamic and transient cancer stem cells nurture melanoma	NATURE MEDICINE			English	Editorial Material									[Weinberg, Robert] Whitehead Inst Biomed Res, Cambridge, MA USA; [Weinberg, Robert] Massachusetts Inst Tech, Cambridge, MA USA; [Fisher, David E.] Harvard Med Sch, Massachusetts Gen Hosp, Melanoma Program, Boston, MA USA; [Rich, Jeremy] Lerner Res Inst, Dept Stem Cell Biol & Regenerative Med, Cleveland, OH USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Cleveland Clinic Foundation	Weinberg, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA USA.		Rich, Jeremy/AAM-1445-2021; Fisher, David/AAH-2878-2019		Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NCI NIH HHS [R01 CA116659, R01 CA129958] Funding Source: Medline; NIAMS NIH HHS [R01 AR043369] Funding Source: Medline; NINDS NIH HHS [K02 NS047409] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	3	8	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					758	758		10.1038/nm0710-758	http://dx.doi.org/10.1038/nm0710-758			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613753	Green Accepted			2022-12-27	WOS:000279631900037
J	Kiefer, FW; Vernochet, C; O'Brien, P; Spoerl, S; Brown, JD; Nallamshetty, S; Zeyda, M; Stulnig, TM; Cohen, DE; Kahn, CR; Plutzky, J				Kiefer, Florian W.; Vernochet, Cecile; O'Brien, Patrick; Spoerl, Steffen; Brown, Jonathan D.; Nallamshetty, Shriram; Zeyda, Maximilian; Stulnig, Thomas M.; Cohen, David E.; Kahn, C. Ronald; Plutzky, Jorge			Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue	NATURE MEDICINE			English	Article							RETINOIC ACID; BROWN FAT; RECEPTOR ANTAGONISTS; OBESITY; MICE; ADIPOGENESIS; METABOLISM; RECRUITMENT; HOMEOSTASIS; ADIPOCYTES	Promoting brown adipose tissue (BAT) formation and function may reduce obesity. Recent data link retinoids to energy balance, but a specific role for retinoid metabolism in white versus brown fat is unknown. Retinaldehyde dehydrogenases (Aldhs), also known as aldehyde dehydrogenases, are rate-limiting enzymes that convert retinaldehyde (Rald) to retinoic acid. Here we show that Aldh1a1 is expressed predominately in white adipose tissue (WAT), including visceral depots in mice and humans. Deficiency of the Aldh1a1 gene induced a BAT-like transcriptional program in WAT that drove uncoupled respiration and adaptive thermogenesis. WAT-selective Aldh1a1 knockdown conferred this BAT program in obese mice, limiting weight gain and improving glucose homeostasis. Rald induced uncoupling protein-1 (Ucp1) mRNA and protein levels in white adipocytes by selectively activating the retinoic acid receptor (RAR), recruiting the coactivator PGC-1 alpha and inducing Ucp1 promoter activity. These data establish Aldh1a1 and its substrate Rald as previously unrecognized determinants of adipocyte plasticity and adaptive thermogenesis, which may have potential therapeutic implications.	[Kiefer, Florian W.; O'Brien, Patrick; Spoerl, Steffen; Brown, Jonathan D.; Nallamshetty, Shriram; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA; [Vernochet, Cecile; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Zeyda, Maximilian; Stulnig, Thomas M.] Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria; [Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Med, Clin Div Endocrinol & Metab, Vienna, Austria; [Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Medical University of Vienna; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Plutzky, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Plutzky, Jorge/V-3410-2019; Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Zeyda, Maximilian/0000-0001-5000-1974; O'Brien, Patrick/0000-0002-9692-8019; Stulnig, Thomas/0000-0003-3300-6161; Kiefer, Florian/0000-0003-2191-025X	US National Institutes of Health [HL048743, AR054604-03S1, 5P30DK057521-12]; Mary K. Iacocca Professorship [DK082659]; National Institute of Diabetes and Digestive and Kidney Diseases [DK056626, DK048873, DK048873-14S2]; Austrian Science Fund (FWF) [J3107-B19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK048873, R01DK056626, R01DK048873, R01DK082659, R37DK048873, P30DK057521] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary K. Iacocca Professorship; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Wang, G. Sukhova, E. Shvartz, T. A. Dang and V. Demchev for excellent technical support, R. Koza (Pennington Biomedical Research Center) for providing the Ucp1 promoter luciferase construct, H. Kagechika (University of Tokyo) for providing HX531 and G. Duester (Burnham Medical Research Institute) for the Aldh1a1<SUP>-/-</SUP> mice and helpful discussions. This work was supported by the US National Institutes of Health grants HL048743, AR054604-03S1, 5P30DK057521-12 (J.P.); Mary K. Iacocca Professorship DK082659 and the National Institute of Diabetes and Digestive and Kidney Diseases DK056626 (C. R. K.); DK048873 and DK048873-14S2 (D. E. C.); the Austrian Science Fund (FWF); J3107-B19 (F.W.K.).	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Johnson AT, 1999, BIOORG MED CHEM LETT, V9, P573, DOI 10.1016/S0960-894X(99)00047-5; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Molotkov A, 2003, J BIOL CHEM, V278, P36085, DOI 10.1074/jbc.M303709200; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; ROSS AC, 1993, J NUTR, V123, P346, DOI 10.1093/jn/123.suppl_2.346; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Silva JE, 1997, EUR J ENDOCRINOL, V136, P251, DOI 10.1530/eje.0.1360251; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	48	144	150	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					918	+		10.1038/nm.2757	http://dx.doi.org/10.1038/nm.2757			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561685	Green Accepted			2022-12-27	WOS:000305116600029
J	An, SS; Robinett, KS; Deshpande, DA; Wang, WCH; Liggett, SB				An, Steven S.; Robinett, Kathryn S.; Deshpande, Deepak A.; Wang, Wayne C. H.; Liggett, Stephen B.			Activation of BK channels may not be required for bitter tastant-induced bronchodilation Reply	NATURE MEDICINE			English	Letter							AIRWAY SMOOTH-MUSCLE; HYPERREACTIVITY; RECEPTORS; RESPONSES; MOUSE; CELLS		[Robinett, Kathryn S.; Deshpande, Deepak A.; Wang, Wayne C. H.; Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [An, Steven S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Liggett, SB (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012; An, Steven/AAM-3848-2020	An, Steven/0000-0003-4723-1888; Liggett, Stephen B./0000-0002-0128-3669	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071609, R01 HL107361] Funding Source: Medline; NIA NIH HHS [R01 AG041265] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Bai Y, 2007, AM J RESP CELL MOL, V36, P122, DOI 10.1165/rcmb.2006-0036OC; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Gallos G, 2012, AM J PHYSIOL-LUNG C, V302, pL248, DOI 10.1152/ajplung.00131.2011; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Tolic-Norrelykke IM, 2002, AM J PHYSIOL-CELL PH, V283, pC1254, DOI 10.1152/ajpcell.00169.2002; Zhang CH, 2012, NAT MED, V18, P648, DOI 10.1038/nm.2733	12	17	17	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					650	651		10.1038/nm.2734	http://dx.doi.org/10.1038/nm.2734			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561815	Green Accepted			2022-12-27	WOS:000303763500023
J	Cohen, TS; Prince, A				Cohen, Taylor Sitarik; Prince, Alice			Cystic fibrosis: a mucosal immunodeficiency syndrome	NATURE MEDICINE			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; AERUGINOSA LUNG INFECTION; FACTOR-KAPPA-B; RESPIRATORY VIRAL-INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; COLONY-STIMULATING FACTOR; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-4; CL-CHANNEL FUNCTION	Cystic fibrosis transmembrane conductance regulator (CFTR) functions as a channel that regulates the transport of ions and the movement of water across the epithelial barrier. Mutations in CFTR, which form the basis for the clinical manifestations of cystic fibrosis, affect the epithelial innate immune function in the lung, resulting in exaggerated and ineffective airway inflammation that fails to eradicate pulmonary pathogens. Compounding the effects of excessive neutrophil recruitment, the mutant CFTR channel does not transport antioxidants to counteract neutrophil-associated oxidative stress. Whereas mutant CFTR expression in leukocytes outside of the lung does not markedly impair their function, the expected regulation of inflammation in the airways is clearly deficient in cystic fibrosis. The resulting bacterial infections, which are caused by organisms that have substantial genetic and metabolic flexibility, can resist multiple classes of antibiotics and evade phagocytic clearance. The development of animal models that approximate the human pulmonary phenotypes-airway inflammation and spontaneous infection-may provide the much-needed tools to establish how CFTR regulates mucosal immunity and to test directly the effect of pharmacologic potentiation and correction of mutant CFTR function on bacterial clearance.	[Cohen, Taylor Sitarik; Prince, Alice] Columbia Univ, Dept Pediat, New York, NY 10027 USA	Columbia University	Prince, A (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	asp7@columbia.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	US National Institutes of Health [5R21AI083491, 2R01HL079395, 5R01HL073989]; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073989, R01HL079395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083491] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the laboratory is supported by US National Institutes of Health grants 5R21AI083491, 2R01HL079395 and 5R01HL073989 (A.P.) and a Parker B. Francis Fellowship (T.S.C.).	Accurso FJ, 2011, AM J RESP CRIT CARE, V183, P627, DOI 10.1164/rccm.201008-1267OC; Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Al Alam D, 2010, AM J RESP CELL MOL, V42, P644, DOI 10.1165/rcmb.2008-0021OC; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; AUERBACH HS, 1985, LANCET, V2, P686; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Bartling TR, 2009, AM J RESP CELL MOL, V40, P58, DOI 10.1165/rcmb.2007-0464OC; BERGER M, 1994, PEDIATR RES, V35, P68, DOI 10.1203/00006450-199401000-00015; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Besier S, 2007, J CLIN MICROBIOL, V45, P168, DOI 10.1128/JCM.01510-06; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Blackwell TS, 1996, J IMMUNOL, V157, P1630; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Boncoeur E, 2008, AM J PATHOL, V172, P1184, DOI 10.2353/ajpath.2008.070310; BONFIELD TL, 1995, AM J RESP CELL MOL, V13, P257, DOI 10.1165/ajrcmb.13.3.7544594; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Carrigan SO, 2010, J IMMUNOL, V185, P3602, DOI 10.4049/jimmunol.0903429; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Ciornei CD, 2010, INNATE IMMUN-LONDON, V16, P288, DOI 10.1177/1753425909341807; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Colucci-Guyon E, 2011, J CELL SCI, V124, P3053, DOI 10.1242/jcs.082792; Cosgrove S, 2011, J BIOL CHEM, V286, P7692, DOI 10.1074/jbc.M110.183863; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Davies JC, 1997, AM J RESP CELL MOL, V16, P657, DOI 10.1165/ajrcmb.16.6.9191467; de Gracia J, 2005, THORAX, V60, P558, DOI 10.1136/thx.2004.031153; de Vrankrijker AMM, 2009, J MED VIROL, V81, P2096, DOI 10.1002/jmv.21623; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; Dechecchi MC, 2008, J CYST FIBROS, V7, P555, DOI 10.1016/j.jcf.2008.06.002; Decraene A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-177; Deterding RR, 2007, AM J RESP CRIT CARE, V176, P362, DOI 10.1164/rccm.200608-1238OC; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Dubin PJ, 2011, AM J RESP CRIT CARE, V184, P155, DOI 10.1164/rccm.201104-0617ED; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Estell K, 2003, MOL CELL BIOL, V23, P594, DOI 10.1128/MCB.23.2.594-606.2003; Fulcher ML, 2009, AM J PHYSIOL-LUNG C, V296, pL82, DOI 10.1152/ajplung.90314.2008; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; GUGLER E, 1968, J PEDIATR-US, V73, P548, DOI 10.1016/S0022-3476(68)80270-7; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Huse HK, 2010, MBIO, V1, DOI 10.1128/mBio.00199-10; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; John G, 2010, AM J RESP CELL MOL, V42, P424, DOI 10.1165/rcmb.2008-0408OC; Johnson JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002053; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kahl BC, 2005, INFECT IMMUN, V73, P4119, DOI 10.1128/IAI.73.7.4119-4126.2005; Karp CL, 2005, PROSTAG LEUKOTR ESS, V73, P263, DOI 10.1016/j.plefa.2005.05.015; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; Kelley TJ, 2000, J CLIN INVEST, V106, P403, DOI 10.1172/JCI9560; Kelly FJ, 1999, FOOD CHEM TOXICOL, V37, P963, DOI 10.1016/S0278-6915(99)00087-3; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kieninger E, 2012, EUR RESPIR J, V39, P297, DOI 10.1183/09031936.00054511; Kingma P, 2010, PEDIAT PULMONOL S33, V45, P1; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Laan M, 1999, J IMMUNOL, V162, P2347; Laube BL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-45; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; LETHEM MI, 1990, AM REV RESPIR DIS, V142, P1053, DOI 10.1164/ajrccm/142.5.1053; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Liu JL, 2011, FEMS IMMUNOL MED MIC, V61, P179, DOI 10.1111/j.1574-695X.2010.00764.x; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Martens CJ, 2011, AM J PHYSIOL-LUNG C, V301, pL236, DOI 10.1152/ajplung.00388.2010; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; MCDONALD TV, 1992, J BIOL CHEM, V267, P3242; McKeon DJ, 2008, THORAX, V63, P660, DOI 10.1136/thx.2008.096834; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Minasian C, 2008, PEDIATR PULM, V43, P1078, DOI 10.1002/ppul.20903; Mitchell G, 2011, INFECT IMMUN, V79, P3541, DOI 10.1128/IAI.00078-11; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Mueller C, 2011, AM J RESP CELL MOL, V44, P922, DOI 10.1165/rcmb.2010-0224OC; Muhlebach MS, 2002, AM J RESP CRIT CARE, V165, P911, DOI 10.1164/ajrccm.165.7.2107114; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Parker D, 2012, AM J RESP CELL MOL, V46, P6, DOI 10.1165/rcmb.2011-0080OC; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pedersen S S, 1992, APMIS Suppl, V28, P1; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pezzulo AA, 2011, PEDIATR PULM, P269; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pilcer G, 2008, EUR J PHARM BIOPHARM, V68, P413, DOI 10.1016/j.ejpb.2007.05.005; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; PUCHELLE E, 1985, EUR J CLIN INVEST, V15, P389, DOI 10.1111/j.1365-2362.1985.tb00290.x; Quinn Derek J, 2010, Open Respir Med J, V4, P20, DOI 10.2174/1874306401004020020; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reeves EP, 2011, AM J RESP CRIT CARE, V183, P1517, DOI 10.1164/rccm.201101-0072OC; Ren CL, 2008, J PEDIATR, V153, P746, DOI 10.1016/j.jpeds.2008.07.010; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RINGE D, 1990, NATURE, V346, P312, DOI 10.1038/346312a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; SAIMAN L, 1993, J CLIN INVEST, V92, P1875, DOI 10.1172/JCI116779; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; SCHIOTZ PO, 1978, ACTA PATH MICRO IM C, V86, P37; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Schwiebert LM, 1999, AM J PHYSIOL-CELL PH, V276, pC700, DOI 10.1152/ajpcell.1999.276.3.C700; Secor PR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-143; Sedor J, 2007, PEDIATR RES, V61, P26, DOI 10.1203/01.pdr.0000250043.90468.c2; Sibley CD, 2010, J CLIN MICROBIOL, V48, P2592, DOI 10.1128/JCM.00414-10; Silo-Suh L, 2002, P NATL ACAD SCI USA, V99, P15699, DOI 10.1073/pnas.242343999; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Starosta V, 2006, EUR RESPIR J, V28, P581, DOI 10.1183/09031936.06.00071405; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Teper A, 2011, J CYST FIBROS, V10, P1, DOI 10.1016/j.jcf.2010.08.020; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; van Ewijk BE, 2008, PEDIATRICS, V122, P1171, DOI 10.1542/peds.2007-3139; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Velsor LW, 2001, AM J PHYSIOL-LUNG C, V281, pL31, DOI 10.1152/ajplung.2001.281.1.L31; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, J CYST FIBROS, V6, P304, DOI 10.1016/j.jcf.2006.12.001; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; WANG EEL, 1984, NEW ENGL J MED, V311, P1653, DOI 10.1056/NEJM198412273112602; Waters V, 2005, AM J RESP CELL MOL, V33, P138, DOI 10.1165/rcmb.2005-0005OC; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; WILMERS MJ, 1950, P ROY SOC MED, V43, P829; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Xu YP, 2009, P NATL ACAD SCI USA, V106, P20515, DOI 10.1073/pnas.0911412106; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; Zheng S, 2004, AM J PHYSIOL-LUNG C, V287, pL374, DOI 10.1152/ajplung.00039.2004; Zheng S, 2003, IMMUNITY, V18, P619, DOI 10.1016/S1074-7613(03)00114-6	191	343	348	3	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					509	519		10.1038/nm.2715	http://dx.doi.org/10.1038/nm.2715			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22481418	Green Accepted			2022-12-27	WOS:000302617800027
J	Jin, YM; Ratnam, K; Chuang, PY; Fan, Y; Zhong, YF; Dai, Y; Mazloom, AR; Chen, EY; D'Agati, V; Xiong, HB; Ross, MJ; Chen, N; Ma'ayan, A; He, JC				Jin, Yuanmeng; Ratnam, Krishna; Chuang, Peter Y.; Fan, Ying; Zhong, Yifei; Dai, Yan; Mazloom, Amin R.; Chen, Edward Y.; D'Agati, Vivette; Xiong, Huabao; Ross, Michael J.; Chen, Nan; Ma'ayan, Avi; He, John Cijiang			A systems approach identifies HIPK2 as a key regulator of kidney fibrosis	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HIV-ASSOCIATED NEPHROPATHY; DNA-DAMAGE RESPONSE; TGF-BETA; INTERSTITIAL FIBROSIS; N-ACETYLCYSTEINE; APOPTOSIS; TRANSCRIPTION; ACTIVATION; GROWTH	Kidney fibrosis is a common process that leads to the progression of various types of kidney disease. We used an integrated computational and experimental systems biology approach to identify protein kinases that regulate gene expression changes in the kidneys of human immunodeficiency virus (HIV) transgenic mice (Tg26 mice), which have both tubulointerstitial fibrosis and glomerulosclerosis. We identified homeo-domain interacting protein kinase 2 (HIPK2) as a key regulator of kidney fibrosis. HIPK2 was upregulated in the kidneys of Tg26 mice and in those of patients with various kidney diseases. HIV infection increased the protein concentrations of HIPK2 by promoting oxidative stress, which inhibited the seven in absentia homolog 1 (SIAH1)-mediated proteasomal degradation of HIPK2. HIPK2 induced apoptosis and the expression of epithelial-to-mesenchymal transition markers in kidney epithelial cells by activating the p53, transforming growth factor beta (TGF-beta)-SMAD family member 3 (Smad3) and Wnt-Notch pathways. Knockout of HIPK2 improved renal function and attenuated proteinuria and kidney fibrosis in Tg26 mice, as well as in other murine models of kidney fibrosis. We therefore conclude that HIPK2 is a potential target for anti-fibrosis therapy.	[Jin, Yuanmeng; Ratnam, Krishna; Chuang, Peter Y.; Fan, Ying; Zhong, Yifei; Dai, Yan; Ross, Michael J.; He, John Cijiang] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Jin, Yuanmeng; Chen, Nan] Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai, Peoples R China; [Mazloom, Amin R.; Chen, Edward Y.; Ma'ayan, Avi; He, John Cijiang] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Mazloom, Amin R.; Chen, Edward Y.; Ma'ayan, Avi] SBCNY, New York, NY USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, New York, NY USA; [Xiong, Huabao] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA; [He, John Cijiang] James J Peters Vet Adm Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; Columbia University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	He, JC (corresponding author), Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA.	avi.maayan@mssm.edu; cijiang.he@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	US National Institutes of Health (NIH) [1R01DK078897]; Veterans Affairs Merit Award; NIH [1R01DK088541, P01-DK-56492, 1RC4DK090860, RC2OD006536, 5P50GM071558, 5K08DK082760]; Chinese 973 fund [2012CB517601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541, P01DK056492, K08DK065495, K08DK082760, R01DK078897, RC4DK090860, R01DK078510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 fund(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge and thank G.L. Gusella (Mount Sinai School of Medicine, New York) for providing the lentiviral construct, E. Huang (University of California San Francisco) for providing the HIPK2 KO mice, P. Mundel (Massachusetts General Hospital, Boston) for synaptopodin antibody and conditionally immortalized murine podocyte cell line, L. Holzman (University of Pennsylvania, Philadelphia) for nephrin antibody and R.H. Goodman (Oregon Health and Science University, Portland) for WT-HIPK2 and KD-HIPK2 constructs. We also thank R. Iyengar and P. Klotman for critical suggestions on experimental design and for other valuable contributions. J.C.H. is supported by US National Institutes of Health (NIH) grant 1R01DK078897 and a Veterans Affairs Merit Award; J.C.H. and A.M. are supported by NIH 1R01DK088541, NIH P01-DK-56492 and NIH 1RC4DK090860; A.M. is supported by NIH RC2OD006536 and 5P50GM071558; P.Y.C. is supported by NIH 5K08DK082760. N.C. is supported by Chinese 973 fund 2012CB517601.	Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hertig A, 2008, NEPHROL THER, V4, pS25, DOI 10.1016/S1769-7255(08)73648-4; Hertig A, 2010, TRANSPL P, V42, pS7, DOI 10.1016/j.transproceed.2010.07.040; Hikasa H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185280; Hofmann TG, 2003, CANCER RES, V63, P8271; Husain M, 2009, J BIOL CHEM, V284, P16648, DOI 10.1074/jbc.M109.008482; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Ivanovski O, 2005, KIDNEY INT, V67, P2288, DOI 10.1111/j.1523-1755.2005.00332.x; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Leventhal JS, 2008, SEMIN NEPHROL, V28, P523, DOI 10.1016/j.semnephrol.2008.08.003; Long DA, 2008, KIDNEY INT, V74, P300, DOI 10.1038/ki.2008.179; Mainra R, 2007, NEPHROLOGY, V12, P510, DOI 10.1111/j.1440-1797.2007.00833.x; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mizui M, 2006, KIDNEY INT, V70, P298, DOI 10.1038/sj.ki.5001541; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rosenstiel PE, 2008, KIDNEY INT, V74, P1049, DOI 10.1038/ki.2008.303; Rosenstiel PE, 2009, AIDS, V23, P2054, DOI 10.1097/QAD.0b013e32833088a0; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wyatt CM, 2007, AM J MED, V120, P488, DOI 10.1016/j.amjmed.2007.01.025; Yadav A, 2010, AM J PHYSIOL-RENAL, V298, pF734, DOI 10.1152/ajprenal.00415.2009; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang JS, 2007, NAT NEUROSCI, V10, P77, DOI 10.1038/nn1816; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	56	111	116	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					580	588		10.1038/nm.2685	http://dx.doi.org/10.1038/nm.2685			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22406746	Green Accepted			2022-12-27	WOS:000302617800035
J	Cummings, DE; Bloom, SR; Rubino, F				Cummings, David E.; Bloom, Stephen R.; Rubino, Francesco			At the heart of the benefits of bariatric surgery	NATURE MEDICINE			English	Editorial Material							MORTALITY; WEIGHT; OBESE	Obesity is associated with an increased risk of cardiovascular events, thus weight loss would be expected to have a beneficial effect on cardiovascular disease. This view is supported by a recent paper that used participants from the ongoing Swedish Obese Subjects (SOS) study, a nonrandomized, prospective study to investigate the effects of bariatric surgery on cardiovascular disease(1). Individuals who underwent bariatric surgery had a significantly reduced number of total and fatal cardiovascular events compared with matched obese controls who did not undergo surgery. Surprisingly, the reduction in cardiovascular events was not related to the baseline body mass index (BMI) or the weight loss experienced by the treated patients. We asked three experts how this study affects understanding of the relationship between weight loss, metabolic and cardiovascular disease, as well as how bariatric surgery may mediate its effects on human health.	[Cummings, David E.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Cummings, David E.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Bloom, Stephen R.] Imperial Coll London Hammersmith, London, England; [Rubino, Francesco] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Imperial College London; Cornell University; NewYork-Presbyterian Hospital	Cummings, DE (corresponding author), Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA.							Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Pinkney JH, 2010, DIABETOLOGIA, V53, P1815, DOI 10.1007/s00125-010-1845-2; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zimmet P, 2011, LANCET, V378, P108, DOI 10.1016/S0140-6736(11)61027-1	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					358	359		10.1038/nm0312-358	http://dx.doi.org/10.1038/nm0312-358			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22395701				2022-12-27	WOS:000301264800034
J	Funston, GM; Young, AMH				Funston, Garth M.; Young, Adam M. H.			Action is required to safeguard the future of academic medicine in theUK	NATURE MEDICINE			English	Editorial Material								The long-term decline in the number of UK doctors who conduct research is well recognized. Although some signs of recovery have been noted in the last few years, government budget cuts and the imminent rise in the tuition fee cap may make a bad situation worse.	[Funston, Garth M.; Young, Adam M. H.] Univ Cambridge, Cambridge CB2 1TN, England; [Funston, Garth M.; Young, Adam M. H.] UK Natl Student Assoc Med Res, London, England	University of Cambridge	Funston, GM (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.			Funston, Garth/0000-0002-4156-6401				Fitzpatrick S., 2011, SURVEY STAFFING LEVE; McManus IC, 1999, BRIT MED J, V319, P542, DOI 10.1136/bmj.319.7209.542	2	8	8	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					194	194		10.1038/nm0212-194	http://dx.doi.org/10.1038/nm0212-194			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310678	Bronze			2022-12-27	WOS:000300140300023
J	Robinson, DR; Kalyana-Sundaram, S; Wu, YM; Shankar, S; Cao, XH; Ateeq, B; Asangani, IA; Iyer, M; Maher, CA; Grasso, CS; Lonigro, RJ; Quist, M; Siddiqui, J; Mehra, R; Jing, XJ; Giordano, TJ; Sabel, MS; Kleer, CG; Palanisamy, N; Natrajan, R; Lambros, MB; Reis-Filho, JS; Kumar-Sinha, C; Chinnaiyan, AM				Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi; Shankar, Sunita; Cao, Xuhong; Ateeq, Bushra; Asangani, Irfan A.; Iyer, Matthew; Maher, Christopher A.; Grasso, Catherine S.; Lonigro, Robert J.; Quist, Michael; Siddiqui, Javed; Mehra, Rohit; Jing, Xiaojun; Giordano, Thomas J.; Sabel, Michael S.; Kleer, Celina G.; Palanisamy, Nallasivam; Natrajan, Rachael; Lambros, Maryou B.; Reis-Filho, Jorge S.; Kumar-Sinha, Chandan; Chinnaiyan, Arul M.			Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer	NATURE MEDICINE			English	Article							FUSIONS; ACTIVATION; EXPRESSION	Breast cancer is a heterogeneous disease that has a wide range of molecular aberrations and clinical outcomes. Here we used paired-end transcriptome sequencing to explore the landscape of gene fusions in a panel of breast cancer cell lines and tissues. We observed that individual breast cancers have a variety of expressed gene fusions. We identified two classes of recurrent gene rearrangements involving genes encoding microtubule-associated serine-threonine kinase (MAST) and members of the Notch family. Both MAST and Notch-family gene fusions have substantial phenotypic effects in breast epithelial cells. Breast cancer cell lines harboring Notch gene rearrangements are uniquely sensitive to inhibition of Notch signaling, and overexpression of MAST1 or MAST2 gene fusions has a proliferative effect both in vitro and in vivo. These findings show that recurrent gene rearrangements have key roles in subsets of carcinomas and suggest that transcriptome sequencing could identify individuals with rare, targetable gene fusions.	[Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi; Shankar, Sunita; Cao, Xuhong; Ateeq, Bushra; Asangani, Irfan A.; Iyer, Matthew; Maher, Christopher A.; Grasso, Catherine S.; Lonigro, Robert J.; Quist, Michael; Siddiqui, Javed; Mehra, Rohit; Jing, Xiaojun; Palanisamy, Nallasivam; Kumar-Sinha, Chandan; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi; Shankar, Sunita; Cao, Xuhong; Ateeq, Bushra; Asangani, Irfan A.; Maher, Christopher A.; Grasso, Catherine S.; Lonigro, Robert J.; Quist, Michael; Siddiqui, Javed; Mehra, Rohit; Jing, Xiaojun; Giordano, Thomas J.; Kleer, Celina G.; Palanisamy, Nallasivam; Kumar-Sinha, Chandan; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, Shanker] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Iyer, Matthew; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Giordano, Thomas J.; Sabel, Michael S.; Kleer, Celina G.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Sabel, Michael S.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Natrajan, Rachael; Lambros, Maryou B.; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	chakumar@med.umich.edu; arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020	Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Kumar, Chandan/0000-0002-8696-3400; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Natrajan, Rachael/0000-0002-9987-2946; Giordano, Thomas/0000-0003-0641-8873; asangani, irfan/0000-0001-5381-1702	Department of Defense [W81XWH-08-0110]; American Association for Cancer Research [R01 CA125577]; National Functional Genomics Center [W81XWH-11-1-0520]; US National Institutes of Health through the University of Michigan's Cancer Center [5 P30 CA46592]; US National Cancer Institute's Early Detection Research Network [U01 CA111275]; Doris Duke Charitable Foundation; Burroughs Welcome Foundation; Breakthrough Breast Cancer; NATIONAL CANCER INSTITUTE [U01CA111275, R01CA125577, R00CA149182, P30CA046592] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); American Association for Cancer Research; National Functional Genomics Center; US National Institutes of Health through the University of Michigan's Cancer Center; US National Cancer Institute's Early Detection Research Network; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Welcome Foundation(Burroughs Wellcome Fund); Breakthrough Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Morey for high-throughput sequencing support; T. Barrette for hardware and database management; R. Wang, N. Consul, C. Malla, L. Ma, J. Milton, L. Cai and M. Mei for technical help; and K. Suleman and W. Yan for help with cytogenetic analysis. D. Appledorn from Essen Bioscience performed the IncuCyte analyses. The aims of this project were defined by the Department of Defense Breast Cancer Research Program (W81XWH-08-0110) to A.M.C. This project was supported in part by an American Association for Cancer Research Stand Up to Cancer (SU2C) award to A.M.C. and J.S.R.-F., grant R01 CA125577 to C.G.K. The National Functional Genomics Center (W81XWH-11-1-0520), which is supported by the Department of Defense (A.M.C.) and, in part, by the US National Institutes of Health through the University of Michigan's Cancer Center Support grant 5 P30 CA46592. A.M.C. is supported by the US National Cancer Institute's Early Detection Research Network (U01 CA111275), the Doris Duke Charitable Foundation Clinical Scientist Award and the Burroughs Welcome Foundation Award in Clinical Translational Research. R. N., M. B. L. and J.S.R.-F. are funded in part by Breakthrough Breast Cancer. A.M.C. is an American Cancer Society Research professor and Taubman Scholar. C.K.S. and A.M.C. share senior authorship.	DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Garland P, 2008, BRAIN RES, V1195, P12, DOI 10.1016/j.brainres.2007.12.027; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ling H, 2010, ONCOGENE, V29, P4543, DOI 10.1038/onc.2010.186; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Prensner JR, 2009, CURR OPIN GENET DEV, V19, P82, DOI 10.1016/j.gde.2008.11.008; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	18	247	251	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1646	U163		10.1038/nm.2580	http://dx.doi.org/10.1038/nm.2580			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22101766	Green Accepted			2022-12-27	WOS:000297978000037
J	Hope, TJ				Hope, Thomas J.			To neutralize or not, a key HIV vaccine question	NATURE MEDICINE			English	Editorial Material							BROAD; PROTECTION; ANTIBODIES; INFECTION		Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL USA	Northwestern University	Hope, TJ (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL USA.	thope@northwestern.edu						Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; WALKER LM, 2011, NATURE          0817, DOI DOI 10.1038/NATURE10373; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	14	28	28	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1195	1197		10.1038/nm.2528	http://dx.doi.org/10.1038/nm.2528			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21988997				2022-12-27	WOS:000296022100032
J	Tu, YY				Tu, Youyou			The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine	NATURE MEDICINE			English	Article							MICROCIRCULATORY DISTURBANCE; TNF-ALPHA; ISCHEMIA; EXTRACT; INJURY; ACID		China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Tu, YY (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	youyoutu1930cn@yahoo.com.cn						[Anonymous], 1979, CHINESE MED J-PEKING, V92, P811; Chen GQ, 1997, BLOOD, V89, P3345; Chen KJ, 2006, CHINESE MED J-PEKING, V119, P6, DOI 10.1097/00029330-200601010-00002; CHEN P, 1998, JI SHENG CHONG XUE Y, V16, P421; *COLL RES GROUP QI, 1982, J TRADIT CHIN MED, V2, P3; Collaboration Research Group for Qinghaosu, 1977, KEXUE TONGBAO, V22, P142; Collaboration research group for Qinghaosu, 1979, YAOXUE TONGBAO, V14, P49; Dong Yan-jun, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P676; [董妍君 Dong Yanjun], 2003, [中国药理学通报, Chinese Pharmacological Bulletin], V19, P1125; Gao D, 2010, CHIN J INTEGR MED, V16, P50, DOI 10.1007/s11655-010-0050-y; Goldstein JL, 2007, NAT MED, V13, P1151, DOI 10.1038/nm1642; Gu YC, 1993, CHIN HERBAL MED, V24, P122; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Huang L, 1993, Zhongguo Zhong Yao Za Zhi, V18, P44; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Li WD, 2006, INT IMMUNOPHARMACOL, V6, P1243, DOI 10.1016/j.intimp.2006.03.004; Liao FL, 2006, TRENDS PHARMACOL SCI, V27, P287, DOI 10.1016/j.tips.2006.04.001; Liu J., 1979, ACTA CHIM SINICA, V37, P129; Sun K, 2010, J ETHNOPHARMACOL, V130, P398, DOI 10.1016/j.jep.2010.05.030; SUN XZ, 1993, ZHONGGUO ZHONG XI YI, V11, P37; Tang Xi Can, 1999, CNS Drug Reviews, V5, P281; TU Y, 1987, B CHIN MAT MED, V12, P2; Tu Y Y, 1981, Yao Xue Xue Bao, V16, P366; Tu Y.Y, 2009, QINGHAO JI QINGHAOSU; Tu Youyou, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P250; Tu YY, 1999, CHINESE MED J-PEKING, V112, P976; TU YY, 1982, PLANTA MED, V44, P143, DOI 10.1055/s-2007-971424; TU YY, 1981, REV WORLD INVENT, V4, P26; Tu YY, 1985, CHIN HERBAL MED, V16, P200; TU YY, 1985, ZONGYAO TONGBAO, V10, P419; Tu YY, 1981, B CHIN MAT MED, V6, P31; WU C, 1985, CHIN TRADIT HERBAL D, V6, P2; Wu C M, 1985, Zhong Yao Tong Bao, V10, P31; Wu CM., 1985, CHIN B BOT, V3, P34; Xiao Y Q, 1984, Yao Xue Xue Bao, V19, P909; XIAO Y-Q, 1986, Acta Botanica Sinica, V28, P307; Xie LX, 2010, CLIN HEMORHEOL MICRO, V44, P245, DOI 10.3233/CH-2010-1269; Xu L, 2002, CHIN J DERMATOVENERO, V1, P19; Xu XS, 2009, SHOCK, V32, P201, DOI [10.1097/SHK.0b013e3181971f47, 10.1097/SHK.0b013e3181996d61]; YANG L, 2006, CHIN J EXP TRADIT ME, V12, P10; YANG SX, 1992, CHIN B PHARM, V9, P61; Yin JP, 1989, CHIN TRADIT HERBAL D, V20, P149; You Y, 2011, CLIN HEMORHEOL MICRO, V47, P187, DOI 10.3233/CH-2010-1380; Zhang Dong, 2007, Yaoxue Xuebao, V42, P978; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhao N, 2010, AM J PHYSIOL-HEART C, V298, pH1166, DOI 10.1152/ajpheart.01186.2009	46	740	789	208	1419	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2011	17	10					1217	1220		10.1038/nm.2471	http://dx.doi.org/10.1038/nm.2471			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	835FW	21989013				2022-12-27	WOS:000296022100036
J	Best, T; Li, DL; Skol, AD; Kirchhoff, T; Jackson, SA; Yasui, Y; Bhatia, S; Strong, LC; Domchek, SM; Nathanson, KL; Olopade, OI; Huang, RS; Mack, TM; Conti, DV; Offit, K; Cozen, W; Robison, LL; Onel, K				Best, Timothy; Li, Dalin; Skol, Andrew D.; Kirchhoff, Tomas; Jackson, Sarah A.; Yasui, Yutaka; Bhatia, Smita; Strong, Louise C.; Domchek, Susan M.; Nathanson, Katherine L.; Olopade, Olufunmilayo I.; Huang, R. Stephanie; Mack, Thomas M.; Conti, David V.; Offit, Kenneth; Cozen, Wendy; Robison, Leslie L.; Onel, Kenan			Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma	NATURE MEDICINE			English	Article							CHILDHOOD-CANCER SURVIVOR; WIDE ASSOCIATION; 5-YEAR SURVIVORS; CELL LYMPHOMA; NEOPLASMS; DISEASE; CHEMOTHERAPY; RADIATION; BLIMP1; RISK	Survivors of pediatric Hodgkin's lymphoma are at risk for radiation therapy-induced second malignant neoplasms (SMNs). We identified two variants at chromosome 6q21 associated with SMNs in survivors of Hodgkin's lymphoma treated with radiation therapy as children but not as adults. The variants comprise a risk locus associated with decreased basal expression of PRDM1 (encoding PR domain containing 1, with ZNF domain) and impaired induction of the PRDM1 protein after radiation exposure. These data suggest a new gene-exposure interaction that may implicate PRDM1 in the etiology of radiation therapy-induced SMNs.	[Best, Timothy; Onel, Kenan] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Li, Dalin; Mack, Thomas M.; Conti, David V.; Cozen, Wendy] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Li, Dalin; Mack, Thomas M.; Conti, David V.; Cozen, Wendy] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Skol, Andrew D.; Jackson, Sarah A.; Olopade, Olufunmilayo I.; Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kirchhoff, Tomas; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Yasui, Yutaka] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Bhatia, Smita] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Mack, Thomas M.; Cozen, Wendy] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Robison, Leslie L.] St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Onel, Kenan] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Southern California; University of Southern California; University of Chicago; Memorial Sloan Kettering Cancer Center; University of Alberta; City of Hope; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Southern California; St Jude Children's Research Hospital; University of Chicago	Onel, K (corresponding author), Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA.	konel@uchicago.edu	Li, Dalin/F-4266-2011; Robison, Leslie/N-8122-2018; Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638; Huang, R. Stephanie/0000-0002-9862-0368; Nathanson, Katherine/0000-0002-6740-0901; Kirchhoff, Tomas/0000-0002-9055-2364	US National Institutes of Health [HD0433871, CA129045, CA40046, CA55727, GM089941, CA139278, CA58839, CA110836]; US National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents [U01GM61393, N01-PC-35139]; US Army Medical Research and Materiel Command (Department of Defense) [PR054600]; Department of Defense DAMD [17-097-1-7147]; American Cancer Society-Illinois Division; American Lebanese Syrian Associated Charities; Leukemia Lymphoma Society [TR 6137-07, TR 6202-09]; Breast Cancer Research Foundation; Lymphoma Foundation; Robert and Kate Niehaus Research Fund; University of Chicago Cancer Center [P30 CA14599]; Breast Cancer Specialized Program; Cancer Research Foundation; California Department of Health Services; NATIONAL CANCER INSTITUTE [P01CA040046, U01CA055727, U24CA055727, R01CA058839, R21CA129045, R03CA110836, P30CA014599, R21CA139278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, K08GM089941] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Materiel Command (Department of Defense)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Department of Defense DAMD(United States Department of Defense); American Cancer Society-Illinois Division(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Breast Cancer Research Foundation; Lymphoma Foundation; Robert and Kate Niehaus Research Fund; University of Chicago Cancer Center(University of Chicago); Breast Cancer Specialized Program; Cancer Research Foundation; California Department of Health Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health (HD0433871, CA129045 and CA40046 to K. Onel, CA55727 to L. L. R., GM089941 and CA139278 to R. S. H., CA58839 to T. M. M. and CA110836 to W. C.); US National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents grant U01GM61393 (R. S. H.); contract number N01-PC-35139 (W. C.); the US Army Medical Research and Materiel Command (Department of Defense PR054600 to W. C. and Department of Defense DAMD 17-097-1-7147 to K. Offit); the American Cancer Society-Illinois Division (K. Onel); the American Lebanese Syrian Associated Charities (L. L. R.); the Leukemia Lymphoma Society (TR 6137-07 to W. C. and TR 6202-09 to T. K.); the Breast Cancer Research Foundation (S. M. D., K.L.N. and K. Offit); the Lymphoma Foundation (K. Offit); the Robert and Kate Niehaus Research Fund (K. Offit); the University of Chicago Cancer Center Support Grant (#P30 CA14599) (R. S. H.); the Breast Cancer Specialized Program of Research Excellence Career Development Award (R. S. H.); and the Cancer Research Foundation (K. Onel). We thank the University of Chicago Pharmacogenomics of Anticancer Agents Research Group cell core for providing lymphoblastoid cell lines. The collection of some samples from individuals with Hodgkin's lymphoma used in this publication was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. The ideas and opinions expressed herein are those of the authors, and no endorsement by the State of California Department of Health Services is intended or should be inferred. We thank N.A. Ellis for many productive discussions and thoughtful feedback. We are especially grateful for the contributions of the many participating subjects and their parents, without whom this work would not have been possible.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Behrens C, 2000, CANCER EPIDEM BIOMAR, V9, P1027; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Calame K, 2010, J IMMUNOL, V185, P3, DOI 10.4049/jimmunol.1090044; Constine LS, 2008, INT J RADIAT ONCOL, V72, P24, DOI 10.1016/j.ijrobp.2008.04.067; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Brien MM, 2010, J CLIN ONCOL, V28, P1232, DOI 10.1200/JCO.2009.24.8062; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Robison LL, 2005, CANCER-AM CANCER SOC, V104, P2557, DOI 10.1002/cncr.21249; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465	20	111	114	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2011	17	8					941	943		10.1038/nm.2407	http://dx.doi.org/10.1038/nm.2407			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	802JW	21785431	Green Accepted			2022-12-27	WOS:000293507400026
J	Geddes, K; Rubino, SJ; Magalhaes, JG; Streutker, C; Le Bourhis, L; Cho, JH; Robertson, SJ; Kim, CJ; Kaul, R; Philpott, DJ; Girardin, SE				Geddes, Kaoru; Rubino, Stephen J.; Magalhaes, Joao G.; Streutker, Catherine; Le Bourhis, Lionel; Cho, Joon Ho; Robertson, Susan J.; Kim, Connie J.; Kaul, Rupert; Philpott, Dana J.; Girardin, Stephen E.			Identification of an innate T helper type 17 response to intestinal bacterial pathogens	NATURE MEDICINE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; INDUCER-LIKE CELLS; HOST-DEFENSE; DENDRITIC CELLS; IL-17; DIFFERENTIATION; INTERLEUKIN-17; INFECTION; EXPRESSION; T(H)17	Interleukin 17 (IL-17) is a central cytokine implicated in inflammation and antimicrobial defense. After infection, both innate and adaptive IL-17 responses have been reported, but the type of cells involved in innate IL-17 induction, as well as their contribution to in vivo responses, are poorly understood. Here we found that Citrobacter and Salmonella infection triggered early IL-17 production, which was crucial for host defense and was mediated by CD4(+) T helper cells. Enteric innate T helper type 17 (iT(H)17) responses occurred principally in the cecum, were dependent on the Nod-like receptors Nod1 and Nod2, required IL-6 induction and were associated with a decrease in mucosal CD103(+) dendritic cells. Moreover, imprinting by the intestinal microbiota was fully required for the generation of iT(H)17 responses. Together, these results identify the Nod-iT(H)17 axis as a central element in controlling enteric pathogens, which may implicate Nod-driven iT(H)17 responses in the development of inflammatory bowel diseases.	[Geddes, Kaoru; Magalhaes, Joao G.; Le Bourhis, Lionel; Cho, Joon Ho; Robertson, Susan J.; Kaul, Rupert; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rubino, Stephen J.; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Streutker, Catherine] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Kim, Connie J.; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	dana.philpott@utoronto.ca; stephen.girardin@utoronto.ca	Magalhaes, Joao/AAK-2686-2020	Kaul, Rupert/0000-0002-1586-4093; Le Bourhis, Lionel/0000-0002-7524-3539	Crohn's and Colitis Foundation of Canada; Canadian Institute of Health Research [480142, HET-85518]; Ontario HIV Treatment Network [OGB-G123]; Canadian Association of Gastroenterology/Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec graduate scholarship	Crohn's and Colitis Foundation of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Canadian Association of Gastroenterology/Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec graduate scholarship	We thank L. Morikawa for help with preparing histological sections and K. Banks for help with animal experimentation. We also are very grateful to those individuals who volunteered for intestinal biopsies. Nod2<SUP>-/-</SUP> mice were provided by J.P. Hugot at Institut National de la Sante et de la Recherche Medicale U843. C. rodentium strain DBS100 was provided by B. Finlay at the University of British Columbia. This work was supported by a grant from the Crohn's and Colitis Foundation of Canada to S.E.G., a Crohn's and Colitis Foundation of Canada and a Canadian Institute of Health Research operating grant (480142) to D.J.P. and by a Canadian Institutes of Health Research grant (HET-85518) and an Ontario HIV Treatment Network grant (OGB-G123) to R.K. K.G. was supported by a Canadian Association of Gastroenterology/Canadian Institutes of Health Research postdoctoral research award, and S.J.R. was supported by a Fonds de la Recherche en Sante du Quebec graduate scholarship.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Symonds EL, 2009, CLIN EXP IMMUNOL, V157, P148, DOI 10.1111/j.1365-2249.2009.03934.x; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	42	193	196	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2011	17	7					837	U202		10.1038/nm.2391	http://dx.doi.org/10.1038/nm.2391			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21666695				2022-12-27	WOS:000292500800038
J	Oskarsson, T; Acharyya, S; Zhang, XHF; Vanharanta, S; Tavazoie, SF; Morris, PG; Downey, RJ; Manova-Todorova, K; Brogi, E; Massague, J				Oskarsson, Thordur; Acharyya, Swarnali; Zhang, Xiang H-F; Vanharanta, Sakari; Tavazoie, Sohail F.; Morris, Patrick G.; Downey, Robert J.; Manova-Todorova, Katia; Brogi, Edi; Massague, Joan			Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs	NATURE MEDICINE			English	Article							IN-VITRO PROPAGATION; STEM-CELLS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; SIGNALING PATHWAYS; PROGRESSION; SURVIVAL; GROWTH; NOTCH; FATE	We report that breast cancer cells that infiltrate the lungs support their own metastasis-initiating ability by expressing tenascin C (TNC). We find that the expression of TNC, an extracellular matrix protein of stem cell niches, is associated with the aggressiveness of pulmonary metastasis. Cancer cell-derived TNC promotes the survival and outgrowth of pulmonary micrometastases. TNC enhances the expression of stem cell signaling components, musashi homolog 1 (MSI1) and leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5). MSI1 is a positive regulator of NOTCH signaling, whereas LGR5 is a target gene of the WNT pathway. TNC modulation of stem cell signaling occurs without affecting the expression of transcriptional enforcers of the stem cell phenotype and pluripotency, namely nanog homeobox (NANOG), POU class 5 homeobox 1 (POU5F1), also known as OCT4, and SRY-box 2 (SOX2). TNC protects MSI1-dependent NOTCH signaling from inhibition by signal transducer and activator of transcription 5 (STAT5), and selectively enhances the expression of LGR5 as a WNT target gene. Cancer cell-derived TNC remains essential for metastasis outgrowth until the tumor stroma takes over as a source of TNC. These findings link TNC to pathways that support the fitness of metastasis-initiating breast cancer cells and highlight the relevance of TNC as an extracellular matrix component of the metastatic niche.	[Oskarsson, Thordur; Acharyya, Swarnali; Zhang, Xiang H-F; Vanharanta, Sakari; Tavazoie, Sohail F.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA; [Morris, Patrick G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Downey, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA.	massaguj@mskcc.org	Oskarsson, Thordur/HBP-9601-2022	Zhang, Xiang/0000-0002-5674-8670; Massague, Joan/0000-0001-9324-8408; Oskarsson, Thordur/0000-0002-0983-6969	US National Institutes of Health [CA94060]; Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA094060, P01CA129243] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense(United States Department of Defense); Breast Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Kim and E. Montalvo for technical support. This work was funded by grant CA94060 from the US National Institutes of Health (J.M.), the Hearst Foundation and the Alan and Sandra Gerry Metastasis Research Initiative. S.A. is supported by a Department of Defense Era of Hope postdoctoral fellowship. E.B. is a recipient of the Exceptional Project Award from the Breast Cancer Alliance. J.M. is an investigator of the Howard Hughes Medical Institute.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anan K, 2010, BREAST CANCER-TOKYO, V17, P48, DOI 10.1007/s12282-009-0103-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Cameron MD, 2000, CANCER RES, V60, P2541; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; CHAMMAS R, 1994, J CELL SCI, V107, P1031; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Deryugina EI, 1996, J CELL SCI, V109, P643; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eilon T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-231; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Ishihara A, 1995, CLIN CANCER RES, V1, P1035; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mackie EJ, 1999, J CELL SCI, V112, P3847; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Ruiz C, 2004, CANCER RES, V64, P7377, DOI 10.1158/0008-5472.CAN-04-1234; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sandberg EM, 2004, J BIOL CHEM, V279, P34547, DOI 10.1074/jbc.M405045200; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; von Holst A, 2008, CELLS TISSUES ORGANS, V188, P170, DOI 10.1159/000112848; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	59	607	624	0	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2011	17	7					867	U256		10.1038/nm.2379	http://dx.doi.org/10.1038/nm.2379			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	789FT	21706029	Green Accepted			2022-12-27	WOS:000292500800042
J	Giamas, G; Filipovic, A; Jacob, J; Messier, W; Zhang, H; Yang, DY; Zhang, W; Shifa, BA; Photiou, A; Tralau-Stewart, C; Castellano, L; Green, AR; Coombes, RC; Ellis, IO; Ali, S; Lenz, HJ; Stebbing, J				Giamas, Georgios; Filipovic, Aleksandra; Jacob, Jimmy; Messier, Walter; Zhang, Hua; Yang, Dongyun; Zhang, Wu; Shifa, Belul Assefa; Photiou, Andrew; Tralau-Stewart, Cathy; Castellano, Leandro; Green, Andrew R.; Coombes, R. Charles; Ellis, Ian O.; Ali, Simak; Lenz, Heinz-Josef; Stebbing, Justin			Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR; NONHUMAN-PRIMATES; PROTEIN-KINASE; ALPHA EXPRESSION; ER-ALPHA; PHOSPHORYLATION; ACTIVATION; RESISTANCE; PATHWAYS; TUMORS	Therapies targeting estrogen receptor. (ER alpha, encoded by ESR1) have transformed the treatment of breast cancer. However, large numbers of women relapse, highlighting the need for the discovery of new regulatory targets modulating ER alpha pathways(1-5). An siRNA screen identified kinases whose silencing alters the estrogen response including those previously implicated in regulating ER alpha activity (such as mitogen-activated protein kinase and AKT). Among the most potent regulators was lemur tyrosine kinase-3 (LMTK3), for which a role has not previously been assigned. In contrast to other modulators of ER alpha activity, LMTK3 seems to have been subject to Darwinian positive selection, a noteworthy result given the unique susceptibility of humans to ER alpha(+) breast cancer. LMTK3 acts by decreasing the activity of protein kinase C (PKC) and the phosphorylation of AKT (Ser473), thereby increasing binding of forkhead box O3 (FOXO3) to the ESR1 promoter. LMTK3 phosphorylated ER alpha, protecting it from proteasomal degradation in vitro. Silencing of LMTK3 reduced tumor volume in an orthotopic mouse model and abrogated proliferation of ER alpha(+) but not ER alpha(-) cells, indicative of its role in ER alpha activity. In human cancers, LMTK3 abundance and intronic polymorphisms were significantly associated with disease-free and overall survival and predicted response to endocrine therapies. These findings yield insights into the natural history of breast cancer in humans and reveal LMTK3 as a new therapeutic target.	[Giamas, Georgios; Filipovic, Aleksandra; Jacob, Jimmy; Zhang, Hua; Shifa, Belul Assefa; Photiou, Andrew; Castellano, Leandro; Coombes, R. Charles; Ali, Simak; Stebbing, Justin] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Messier, Walter] Evolutionary Genom Inc, Lafayette, CO USA; [Yang, Dongyun; Zhang, Wu; Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90033 USA; [Tralau-Stewart, Cathy] Univ London Imperial Coll Sci Technol & Med, Ctr Drug Discovery, London, England; [Green, Andrew R.; Ellis, Ian O.] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Green, Andrew R.; Ellis, Ian O.] Nottingham Univ NHS Hosp Trust, Nottingham, England	Imperial College London; University of Southern California; Imperial College London; University of Nottingham; Nottingham University Hospital NHS Trust	Giamas, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Hammersmith Hosp Campus, London, England.	g.giamas@imperial.ac.uk; j.stebbing@imperial.ac.uk	Zhang, Hua/AAV-2344-2020; Yang, Dongyun/M-2579-2019; Castellano, Leandro/AAE-1366-2021; Green, Andrew/AAF-1991-2020; Giamas, Georgios/AAP-3487-2021; Ali, Simak/N-4740-2019	Zhang, Hua/0000-0001-7704-4712; Yang, Dongyun/0000-0003-0736-4977; Ali, Simak/0000-0002-1320-0816; Ellis, Ian/0000-0001-5292-8474; Green, Andrew/0000-0002-0488-5913; Coombes, Raoul Charles/0000-0002-4811-1100; Giamas, Georgios/0000-0002-4417-2707; Castellano, Leandro/0000-0002-3059-4829; Stebbing, Justin/0000-0002-1117-6947	US National Institutes of Health [5 P30CA14089-27I]; Cancer Research UK; Department of Health; Cancer Research UK [12011] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10267] Funding Source: researchfish; Worldwide Cancer Research [10-0510] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Department of Health; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank P. Hexley and J. Elliott of the Flow Cytometry Core Facility (Imperial College London) for analyzing FACS data, J. Gronau for helping with confocal microscopy, P. Trivedi for performing the immunohistochemistry staining and T. Rapoz D'Silva for helping in the laboratory. We are grateful to G. Dranitsaris (Princess Margaret Hospital, Toronto) for statistical advice. Li93 software was a kind gift from W. Hsiung-Li (University of Chicago). The single-nucleotide polymorphism analyses were funded in part by US National Institutes of Health grant 5 P30CA14089-27I. S.A. and R.C.C. are supported by grants from Cancer Research UK and the Department of Health-funded Imperial College Cancer Medicine Centre (ECMC) grant. We thank R. and E. Girling and friends for their support.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; BENIASHVILI DS, 1989, J MED PRIMATOL, V18, P423; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunner N, 1997, CANCER RES, V57, P3486; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Cordera F, 2006, SEMIN ONCOL, V33, P631, DOI 10.1053/j.seminoncol.2006.08.020; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Ghosh MG, 2000, CANCER RES, V60, P6367; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; HAMMOND ME, J CLIN ONCOL, V28, P2784; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; MCCLURE HM, 1973, AM J PHYS ANTHROPOL, V38, P425, DOI 10.1002/ajpa.1330380243; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; MORELLI C, MOL CELL BIOL, V30, P857; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Powe DG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2461; Puente XS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-15; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; SEIBOLD HR, 1973, LAB ANIM SCI, V23, P533; Stack G, 1988, Cancer Treat Res, V40, P185; Tolhurst RS, 2011, BREAST CANCER RES TR, V128, P357, DOI 10.1007/s10549-010-1122-6; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Waters DJ, 1998, PROSTATE, V36, P64; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	40	104	110	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2011	17	6					715	U105		10.1038/nm.2351	http://dx.doi.org/10.1038/nm.2351			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	773LM	21602804				2022-12-27	WOS:000291308800032
J	Lu, M; Sarruf, DA; Talukdar, S; Sharma, S; Li, PP; Bandyopadhyay, G; Nalbandian, S; Fan, WQ; Gayen, JR; Mahata, SK; Webster, NJ; Schwartz, MW; Olefsky, JM				Lu, Min; Sarruf, David A.; Talukdar, Saswata; Sharma, Shweta; Li, Pingping; Bandyopadhyay, Gautam; Nalbandian, Sarah; Fan, WuQiang; Gayen, Jiaur R.; Mahata, Sushil K.; Webster, Nicholas J.; Schwartz, Michael W.; Olefsky, Jerrold M.			Brain PPAR-gamma promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones	NATURE MEDICINE			English	Article							RESISTANCE; EXPRESSION; MUSCLE; MICE	In adipose tissue, muscle, liver and macrophages, signaling by the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a determinant of insulin sensitivity and this receptor mediates the insulin-sensitizing effects of thiazolidinediones (TZDs)(1-4). As PPAR-gamma is also expressed in neurons(5), we generated mice with neuron-specific Pparg knockout (Pparg brain knockout (BKO)) to determine whether neuronal PPAR-gamma signaling contributes to either weight gain or insulin sensitivity. During high-fat diet (HFD) feeding, food intake was reduced and energy expenditure increased in Pparg-BKO mice compared to Pparg(f/f) mice, resulting in reduced weight gain. Pparg-BKO mice also responded better to leptin administration than Pparg(f/f) mice. When treated with the TZD rosiglitazone, Pparg-BKO mice were resistant to rosiglitazone-induced hyperphagia and weight gain and, relative to rosiglitazone-treated Pparg(f/f) mice, experienced only a marginal improvement in glucose metabolism. Hyperinsulinemic euglycemic clamp studies showed that the increase in hepatic insulin sensitivity induced by rosiglitazone treatment during HFD feeding was completely abolished in Pparg-BKO mice, an effect associated with the failure of rosiglitazone to improve liver insulin receptor signal transduction. We conclude that excess weight gain induced by HFD feeding depends in part on the effect of neuronal PPAR-g signaling to limit thermogenesis and increase food intake. Neuronal PPAR-gamma signaling is also required for the hepatic insulin sensitizing effects of TZDs.	[Lu, Min; Talukdar, Saswata; Sharma, Shweta; Li, Pingping; Bandyopadhyay, Gautam; Nalbandian, Sarah; Fan, WuQiang; Gayen, Jiaur R.; Mahata, Sushil K.; Webster, Nicholas J.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Sarruf, David A.; Schwartz, Michael W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Sharma, Shweta; Gayen, Jiaur R.; Mahata, Sushil K.; Webster, Nicholas J.] Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	mschwart@u.washington.edu; jolefsky@ucsd.edu	Webster, Nick/AAI-8410-2021; Mahata, Sushil/AAF-8781-2021; Li, Pingping/F-1109-2019; Schwartz, Michael W/H-9950-2012	Li, Pingping/0000-0003-0679-270X; 	US National Institutes of Health (NIH) [DK033651, DK063491, DK074868, DK09062]; Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH [U54 HD012303-25]; NIH [DK068384, DK083042, DK052989]; National Research Service [F32DK080604-01]; Nutrition Obesity Research Center [DK035816]; Mouse Metabolic Phenotyping Center at the University of Washington [U24 DK076126]; UCSD Cancer Center [P30 CA23100]; Mouse Metabolic Phenotyping Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, U24DK076126, R01DK083042, P01DK068384, R01DK033651, R01DK090320, P30DK063491, R01DK052989, P01DK074868, F32DK009062, F32DK080604, P30DK035816] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; Nutrition Obesity Research Center; Mouse Metabolic Phenotyping Center at the University of Washington; UCSD Cancer Center; Mouse Metabolic Phenotyping Center at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the P. Mellon lab at UCSD for providing Syn1-Cre mice. We thank J. Pimentel, A. Amidi, B. Scott, J. Meadows and J. Ficsher for technical support. We thank D. Oh, J. Xu, E. Bae, O. Osborne, A. Chen and D. Sears for helpful discussions. We thank the Histology and Immunohistochemistry Resource (L. Gapuz and N. Varki) at the Rebecca & John Moores UCSD Cancer Center. This work was supported by US National Institutes of Health (NIH) grants DK033651, DK063491, DK074868 and DK09062 (to J. M. O.) and by the Eunice Kennedy Shriver National Institutes of Child Health and Human Development/NIH through cooperative agreement of U54 HD012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by NIH grants DK068384, DK083042 and DK052989 (to M. W. S.), by Ruth L. Kirschstein National Research Service Award fellowship F32DK080604-01 (to D. A. S.), and by the Nutrition Obesity Research Center grant DK035816 and the Mouse Metabolic Phenotyping Center (U24 DK076126) at the University of Washington. UCSD Cancer Center microscopy core is supported by the UCSD Cancer Center Specialized Support Grant P30 CA23100. Body composition and energy expenditure analyses were performed with support from the NIH-funded Mouse Metabolic Phenotyping Center at the University of Washington. Calorimetry was performed by K. Ogimoto and expert assistance in analyses of these data was provided by K. Kaiyala.	Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Gayen JR, 2009, ENDOCRINOLOGY, V150, P5027, DOI 10.1210/en.2009-0429; HE W, 2003, P NATL ACAD SCI US, V100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lu M, 2010, MOL ENDOCRINOL, V24, P1413, DOI 10.1210/me.2009-0462; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shimizu H, 1998, DIABETES CARE, V21, P1470, DOI 10.2337/diacare.21.9.1470; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	19	170	178	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					618	U140		10.1038/nm.2332	http://dx.doi.org/10.1038/nm.2332			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21532596	Green Accepted			2022-12-27	WOS:000290250400039
J	Winer, DA; Winer, S; Shen, L; Wadia, PP; Yantha, J; Paltser, G; Tsui, H; Wu, P; Davidson, MG; Alonso, MN; Leong, HX; Glassford, A; Caimol, M; Kenkel, JA; Tedder, TF; McLaughlin, T; Miklos, DB; Dosch, HM; Engleman, EG				Winer, Daniel A.; Winer, Shawn; Shen, Lei; Wadia, Persis P.; Yantha, Jason; Paltser, Geoffrey; Tsui, Hubert; Wu, Ping; Davidson, Matthew G.; Alonso, Michael N.; Leong, Hwei X.; Glassford, Alec; Caimol, Maria; Kenkel, Justin A.; Tedder, Thomas F.; McLaughlin, Tracey; Miklos, David B.; Dosch, H-Michael; Engleman, Edgar G.			B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; ADIPOCYTE DEATH; OBESITY; MICE; INFLAMMATION; DEPLETION; DISEASE; FAT	Chronic inflammation characterized by T cell and macrophage infiltration of visceral adipose tissue (VAT) is a hallmark of obesity-associated insulin resistance and glucose intolerance. Here we show a fundamental pathogenic role for B cells in the development of these metabolic abnormalities. B cells accumulate in VAT in diet-induced obese (DIO) mice, and DIO mice lacking B cells are protected from disease despite weight gain. B cell effects on glucose metabolism are mechanistically linked to the activation of proinflammatory macrophages and T cells and to the production of pathogenic IgG antibodies. Treatment with a B cell-depleting CD20 antibody attenuates disease, whereas transfer of IgG from DIO mice rapidly induces insulin resistance and glucose intolerance. Moreover, insulin resistance in obese humans is associated with a unique profile of IgG autoantibodies. These results establish the importance of B cells and adaptive immunity in insulin resistance and suggest new diagnostic and therapeutic modalities for managing the disease.	[Winer, Daniel A.; Shen, Lei; Davidson, Matthew G.; Alonso, Michael N.; Leong, Hwei X.; Caimol, Maria; Kenkel, Justin A.; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Winer, Daniel A.; Winer, Shawn] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Winer, Shawn; Yantha, Jason; Paltser, Geoffrey; Tsui, Hubert; Wu, Ping; Dosch, H-Michael] Univ Toronto, Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Wadia, Persis P.; Miklos, David B.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Glassford, Alec; McLaughlin, Tracey] Stanford Univ, Sch Med, Div Endocrinol, Palo Alto, CA 94304 USA; [Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University; Stanford University; Duke University	Winer, DA (corresponding author), Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA.	dan.winer@uhn.on.ca; edengleman@stanford.edu			NIH [CA141468, DK082537]; NATIONAL CANCER INSTITUTE [U01CA141468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082537, R01DK080436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Jones for secretarial assistance; C. Benike for critical review of the manuscript; A. Chawla for critical review of the figures; C. Wang, L. Tolentino and K. Heydari for assistance with flow cytometry; and Y. Yang and L. Herzenberg for help in developing macrophage and B cell subset gates. These studies were supported by NIH grants CA141468 and DK082537 (E.G.E).	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Falorni A, 2000, J CLIN ENDOCR METAB, V85, P309, DOI 10.1210/jc.85.1.309; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hussain Badrudeen M, 2006, World J Surg Oncol, V4, P89, DOI 10.1186/1477-7819-4-89; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; TOURINO IG, 2010, DIABETIC MED, V27, P246; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zimering MB, 2009, J CLIN ENDOCR METAB, V94, P2171, DOI 10.1210/jc.2008-2354	42	678	701	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2011	17	5					610	U134		10.1038/nm.2353	http://dx.doi.org/10.1038/nm.2353			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	759MR	21499269	Green Accepted			2022-12-27	WOS:000290250400038
J	Shimono, K; Tung, WE; Macolino, C; Chi, AHT; Didizian, JH; Mundy, C; Chandraratna, RA; Mishina, Y; Enomoto-Iwamoto, M; Pacifici, M; Iwamoto, M				Shimono, Kengo; Tung, Wei-en; Macolino, Christine; Chi, Amber Hsu-Tsai; Didizian, Johanna H.; Mundy, Christina; Chandraratna, Roshantha A.; Mishina, Yuji; Enomoto-Iwamoto, Motomi; Pacifici, Maurizio; Iwamoto, Masahiro			Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists	NATURE MEDICINE			English	Article							ENDOCHONDRAL BONE-FORMATION; I RECEPTOR; MORPHOGENETIC PROTEIN; VITAMIN-A; SKELETOGENESIS; IDENTIFICATION; GROWTH; DIFFERENTIATION; PROGRESSIVA; ANTAGONISTS	Heterotopic ossification consists of ectopic bone formation within soft tissues after surgery or trauma. It can have debilitating consequences, but there is no definitive cure. Here we show that heterotopic ossification was essentially prevented in mice receiving a nuclear retinoic acid receptor-gamma (RAR-gamma) agonist. Side effects were minimal, and there was no significant rebound effect. To uncover the mechanisms of these responses, we treated mouse mesenchymal stem cells with an RAR-gamma agonist and transplanted them into nude mice. Whereas control cells formed ectopic bone masses, cells that had been pretreated with the RAR-gamma agonist did not, suggesting that they had lost their skeletogenic potential. The cells became unresponsive to rBMP-2 treatment in vitro and showed decreases in phosphorylation of Smad1, Smad5 and Smad8 and in overall levels of Smad proteins. In addition, an RAR-gamma agonist blocked heterotopic ossification in transgenic mice expressing activin receptor-like kinase-2 (ALK2) Q207D, a constitutively active form of the receptor that is related to ALK2 R206H found in individuals with fibrodysplasia ossificans progressiva. The data indicate that RAR-gamma agonists are potent inhibitors of heterotopic ossification in mouse models and, thus, may also be effective against injury-induced and congenital heterotopic ossification in humans.	[Chandraratna, Roshantha A.] Io Therapeut, Irvine, CA USA; [Mishina, Yuji] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Shimono, Kengo; Tung, Wei-en; Macolino, Christine; Chi, Amber Hsu-Tsai; Didizian, Johanna H.; Mundy, Christina; Enomoto-Iwamoto, Motomi; Pacifici, Maurizio; Iwamoto, Masahiro] Thomas Jefferson Univ, Coll Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA	University of Michigan System; University of Michigan; Jefferson University	Iwamoto, M (corresponding author), Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA.	pacificim@email.chop.edu; iwamotom@email.chop.edu			Department of the Army [W81XWH-07-1-0212]; United States Army Medical Research Acquisition Activity; US National Institutes of Health [AR056837]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056837] Funding Source: NIH RePORTER	Department of the Army; United States Army Medical Research Acquisition Activity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Katagiri (Saitama) for the Id1-luc reporter plasmid; S. Otsuru and E. Horwitz (Children's Hospital of Philadelphia) for the GFP-expressing MSCs and culture methods; and N. Ghyselinck and P. Chambon (Institut National de la Sante et de la Recherche Medicale, Illkirch Cedex) for the RAR floxed and null mouse lines. This work was supported by contract no. W81XWH-07-1-0212 from the Department of the Army, United States Army Medical Research Acquisition Activity (M. P.) and US National Institutes of Health RO1 grant AR056837 (M. I. and M. P.).	Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; Blaner William S., 1994, P229; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Chao ST, 2007, ORTHOPEDICS, V30, P457, DOI 10.3928/01477447-20070601-18; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DESIMONE DP, 1983, CALCIFIED TISSUE INT, V35, P732, DOI 10.1007/BF02405115; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gehin M, 1999, CHEM BIOL, V6, P519, DOI 10.1016/S1074-5521(99)80084-2; Hind M, 2009, CURR OPIN INVEST DR, V10, P1243; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033; KAPLAN FS, 2008, CLIN P INT CLIN CONS, V3, P1082; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Nilsson Olle S., 1999, Current Opinion in Rheumatology, V11, P127, DOI 10.1097/00002281-199903000-00008; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; Otsuru S, 2010, EXP HEMATOL, V38, P836, DOI 10.1016/j.exphem.2010.04.015; PACIFICI M, 1980, EXP CELL RES, V129, P469, DOI 10.1016/0014-4827(80)90517-0; Pendaries V, 2003, ONCOGENE, V22, P8212, DOI 10.1038/sj.onc.1206913; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P195, DOI 10.1385/BMM:3:3-4:195; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shimono K, 2010, J ORTHOP RES, V28, P271, DOI 10.1002/jor.20985; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Thacher SM, 2000, CURR PHARM DESIGN, V6, P25, DOI 10.2174/1381612003401415; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Yasuhara R, 2010, J BIOL CHEM, V285, P317, DOI 10.1074/jbc.M109.053926; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zasloff MA, 1998, CLIN ORTHOP RELAT R, P121; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593	45	234	253	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					454	U91		10.1038/nm.2334	http://dx.doi.org/10.1038/nm.2334			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21460849	Green Accepted, Green Submitted			2022-12-27	WOS:000289245100036
J	Ponomarev, ED; Veremeyko, T; Barteneva, N; Krichevsky, AM; Weiner, HL				Ponomarev, Eugene D.; Veremeyko, Tatyana; Barteneva, Natasha; Krichevsky, Anna M.; Weiner, Howard L.			MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE LINEAGE COMMITMENT; NECROSIS-FACTOR RECEPTOR; C/EBP-ALPHA; NEURONAL DIFFERENTIATION; CELLS; PU.1; CNS; PROLIFERATION; EXPRESSION	MicroRNAs are a family of regulatory molecules involved in many physiological processes, including differentiation and activation of cells of the immune system. We found that brain-specific miR-124 is expressed in microglia but not in peripheral monocytes or macrophages. When overexpressed in macrophages, miR-124 directly inhibited the transcription factor CCAAT/enhancer-binding protein-alpha (C/EBP-alpha) and its downstream target PU.1, resulting in transformation of these cells from an activated phenotype into a quiescent CD45(low), major histocompatibility complex (MHC) class IIlow phenotype resembling resting microglia. During experimental autoimmune encephalomyelitis (EAE), miR-124 was downregulated in activated microglia. Peripheral administration of miR-124 in EAE caused systemic deactivation of macrophages, reduced activation of myelin-specific T cells and marked suppression of disease. Conversely, knockdown of miR-124 in microglia and macrophages resulted in activation of these cells in vitro and in vivo. These findings identify miR-124 both as a key regulator of microglia quiescence in the central nervous system and as a previously unknown modulator of monocyte and macrophage activation.	[Ponomarev, Eugene D.; Veremeyko, Tatyana; Krichevsky, Anna M.; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Immune Dis Inst, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Krichevsky, AM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	akrichevsky@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Barteneva, Natalie/V-3826-2019; Barteneva, Natasha/B-9094-2017; Ponomarev, Eugene D./K-1546-2013	Barteneva, Natalie/0000-0002-8109-1754; Ponomarev, Eugene D./0000-0002-0871-8522; Krichevsky, Anna/0000-0002-5080-5507	US National Institutes of Health [R01 NS071039-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Kuchroo and F.J. Quintana for critical discussion of the results and I. Sotnikov for technical assistance with immunohistochemistry. 2D2 mice were kindly provided by V. Kuchroo (Brigham and Women's Hospital, Harvard Medical School). This work was supported in part by US National Institutes of Health grant R01 NS071039-01A1.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson KL, 2001, J BIOL CHEM, V276, P7637, DOI 10.1074/jbc.M009133200; Basson M, 2007, NAT MED, V13, P541, DOI 10.1038/nm0507-541; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bristol JA, 2009, MOL IMMUNOL, V46, P2706, DOI 10.1016/j.molimm.2009.05.024; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; GORDON EJ, 1995, J NEUROIMMUNOL, V62, P153, DOI 10.1016/0165-5728(95)00120-2; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nishiyama C, 2004, FEBS LETT, V561, P63, DOI 10.1016/S0014-5793(04)00116-4; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tran EH, 1998, J IMMUNOL, V161, P3767; TREFZER U, 1993, J CLIN INVEST, V92, P462, DOI 10.1172/JCI116589; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Walton M, 1998, MOL BRAIN RES, V61, P11, DOI 10.1016/S0169-328X(98)00169-7; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	45	588	616	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					64	U234		10.1038/nm.2266	http://dx.doi.org/10.1038/nm.2266			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21131957	Green Accepted			2022-12-27	WOS:000285994000037
J	Beronja, S; Livshits, G; Williams, S; Fuchs, E				Beronja, Slobodan; Livshits, Geulah; Williams, Scott; Fuchs, Elaine			Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos	NATURE MEDICINE			English	Article							ALPHA-CATENIN; IN-VIVO; SKIN CARCINOGENESIS; STEM-CELLS; E-CADHERIN; MICE; RESPONSES; RAS; HOMEOSTASIS; EXPRESSION	Using ultrasound-guided in utero infections of fluorescently traceable lentiviruses carrying RNAi or Cre recombinase into mouse embryos, we have demonstrated noninvasive, highly efficient selective transduction of surface epithelium, in which progenitors stably incorporate and propagate the desired genetic alterations. We achieved epidermal-specific infection using small generic promoters of existing lentiviral short hairpin RNA libraries, thus enabling rapid assessment of gene function as well as complex genetic interactions in skin morphogenesis and disease in vivo. We adapted this technology to devise a new quantitative method for ascertaining whether a gene confers a growth advantage or disadvantage in skin tumorigenesis. Using alpha 1-catenin as a model, we uncover new insights into its role as a widely expressed tumor suppressor and reveal physiological interactions between Ctnna1 and the Hras1-Mapk3 and Trp53 gene pathways in regulating skin cell proliferation and apoptosis. Our study illustrates the strategy and its broad applicability for investigations of tissue morphogenesis, lineage specification and cancers.	[Beronja, Slobodan; Livshits, Geulah; Williams, Scott; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334; Beronja, Slobodan/0000-0002-6769-9261	International Human Frontier Science Program Organization; US National Institutes of Health [R01-AR27883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Takeichi (RIKEN CDB) for antibodies and reagents; N. Stokes and Rockefeller Comparative Bioscience Center staff for expert care of mice; M. Schober and M. Perez-Moreno for helpful discussions; A. North and Rockefeller Bioimaging Resource Center staff for assistance with image acquisition and analysis; and S. Mazel and Rockefeller Flow Cytometry Resource Center staff for assistance with FACS. S. B. is supported by the International Human Frontier Science Program Organization. S. W. is an American Cancer Society Postdoctoral Fellow. This work was supported by a grant from the US National Institutes of Health (R01-AR27883). E. F. is an investigator with the Howard Hughes Medical Institute.	Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Che XM, 1999, ONCOLOGY-BASEL, V57, P131, DOI 10.1159/000012020; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Follenzi A, 2007, CURR GENE THER, V7, P306, DOI 10.2174/156652307782151515; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; HOLZINGER A, 1995, PEDIATR RES, V38, P844, DOI 10.1203/00006450-199512000-00004; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lu B, 1997, J INVEST DERMATOL, V108, P803, DOI 10.1111/1523-1747.ep12292254; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Nozawa N, 2006, PATHOL RES PRACT, V202, P639, DOI 10.1016/j.prp.2006.03.007; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Slevin JC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-10; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072	33	135	139	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					821	U128		10.1038/nm.2167	http://dx.doi.org/10.1038/nm.2167			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20526348	Green Accepted			2022-12-27	WOS:000279631900034
J	Lowy, DR; Kim, J; Smith-McCune, KK; Melief, CJM				Lowy, Douglas R.; Kim, Jane; Smith-McCune, Karen K.; Melief, Cornelis J. M.			The value of HPV vaccination	NATURE MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS INFECTION; IMMUNOGENICITY; IMPACT		[Lowy, Douglas R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Lowy, Douglas R.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lowy, DR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.			Chun, Hyung/0000-0003-3508-2678	Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NHLBI NIH HHS [R37 HL060917, P30 HL101284, HL101284, HL093362, R01 HL113005, R01 HL069170, HL113005, K08 HL095654, K08 HL093362, HL069170, HL095654, U10 HL109250] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Hoy T, 2009, CURR MED RES OPIN, V25, P2343, DOI 10.1185/03007990903136378; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	14	35	39	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					28	29						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227663				2022-12-27	WOS:000299018600021
